0001564590-22-005428.txt : 20220217 0001564590-22-005428.hdr.sgml : 20220217 20220216183937 ACCESSION NUMBER: 0001564590-22-005428 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 138 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220217 DATE AS OF CHANGE: 20220216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Syneos Health, Inc. CENTRAL INDEX KEY: 0001610950 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 273403111 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 22645093 BUSINESS ADDRESS: STREET 1: 1030 SYNC STREET CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-876-9300 MAIL ADDRESS: STREET 1: 1030 SYNC STREET CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: INC Research Holdings, Inc. DATE OF NAME CHANGE: 20140616 10-K 1 synh-10k_20211231.htm 10-K synh-10k_20211231.htm
false FY --12-31 0001610950 P30D P90D http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member true P1Y P3Y P5Y P2Y P10Y P3Y P4Y P8Y 0.0025 0.0125 0.0075 0.0175 0.0025 0.0125 0.0050 0.0150 0.0100 0.0200 0.0050 0.0150 0.253 0.277 0.391 0.0006 0.0013 0.0188 P6M P6M P6M 0.383 0.551 0.519 0.0007 0.0095 0.0252 P3Y3M3D P3Y3M3D P3Y3M3D 0001610950 2021-01-01 2021-12-31 iso4217:USD 0001610950 2021-06-30 xbrli:shares 0001610950 2022-02-10 0001610950 2020-01-01 2020-12-31 0001610950 2019-01-01 2019-12-31 iso4217:USD xbrli:shares 0001610950 2021-12-31 0001610950 2020-12-31 0001610950 2019-12-31 0001610950 2018-12-31 0001610950 us-gaap:AccountingStandardsUpdate201613Member srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0001610950 us-gaap:CommonStockMember 2020-12-31 0001610950 us-gaap:CommonStockMember 2019-12-31 0001610950 us-gaap:CommonStockMember 2018-12-31 0001610950 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001610950 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001610950 us-gaap:CommonStockMember 2019-01-01 2019-12-31 0001610950 us-gaap:CommonStockMember 2021-12-31 0001610950 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001610950 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001610950 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001610950 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001610950 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001610950 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0001610950 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001610950 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001610950 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001610950 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001610950 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001610950 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001610950 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0001610950 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001610950 us-gaap:RetainedEarningsMember 2020-12-31 0001610950 us-gaap:RetainedEarningsMember 2019-12-31 0001610950 us-gaap:RetainedEarningsMember 2018-12-31 0001610950 us-gaap:AccountingStandardsUpdate201613Member us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0001610950 us-gaap:RetainedEarningsMember 2021-12-31 0001610950 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001610950 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001610950 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0001610950 synh:StudyKikAcquisitionMember 2021-01-01 2021-12-31 0001610950 synh:SynteractAcquisitionMember 2021-01-01 2021-12-31 synh:Segment 0001610950 us-gaap:BuildingMember 2021-01-01 2021-12-31 0001610950 us-gaap:FurnitureAndFixturesMember 2021-01-01 2021-12-31 0001610950 us-gaap:EquipmentMember srt:MinimumMember 2021-01-01 2021-12-31 0001610950 us-gaap:EquipmentMember srt:MaximumMember 2021-01-01 2021-12-31 0001610950 synh:ComputerEquipmentandSoftwareMember srt:MinimumMember 2021-01-01 2021-12-31 0001610950 synh:ComputerEquipmentandSoftwareMember srt:MaximumMember 2021-01-01 2021-12-31 0001610950 synh:ComputerEquipmentandSoftwareMember 2021-01-01 2021-12-31 synh:reportingunit 0001610950 2018-10-01 2021-12-31 0001610950 us-gaap:CustomerRelationshipsMember srt:WeightedAverageMember 2021-01-01 2021-12-31 0001610950 us-gaap:CustomerRelationshipsMember srt:WeightedAverageMember 2020-01-01 2020-12-31 0001610950 us-gaap:OrderOrProductionBacklogMember srt:WeightedAverageMember 2021-01-01 2021-12-31 0001610950 us-gaap:OrderOrProductionBacklogMember srt:WeightedAverageMember 2020-01-01 2020-12-31 0001610950 us-gaap:TrademarksAndTradeNamesMember srt:WeightedAverageMember 2021-01-01 2021-12-31 0001610950 us-gaap:TrademarksAndTradeNamesMember srt:WeightedAverageMember 2020-01-01 2020-12-31 0001610950 us-gaap:IntellectualPropertyMember srt:WeightedAverageMember 2020-01-01 2020-12-31 0001610950 synh:PatientCommunitiesMember srt:WeightedAverageMember 2021-01-01 2021-12-31 0001610950 synh:AcquiredTechnologyMember srt:WeightedAverageMember 2021-01-01 2021-12-31 0001610950 synh:InventivMember 2021-01-01 2021-12-31 0001610950 synh:InventivMember 2020-01-01 2020-12-31 0001610950 srt:MinimumMember 2021-01-01 2021-12-31 0001610950 srt:MaximumMember 2021-01-01 2021-12-31 0001610950 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-01-01 2020-01-01 0001610950 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2021-12-31 0001610950 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2021-12-31 0001610950 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2020-12-31 0001610950 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001610950 us-gaap:LeaseholdImprovementsMember 2020-12-31 0001610950 us-gaap:ComputerEquipmentMember 2021-12-31 0001610950 us-gaap:ComputerEquipmentMember 2020-12-31 0001610950 us-gaap:VehiclesMember 2021-12-31 0001610950 us-gaap:VehiclesMember 2020-12-31 0001610950 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001610950 us-gaap:FurnitureAndFixturesMember 2020-12-31 0001610950 us-gaap:BuildingAndBuildingImprovementsMember 2021-12-31 0001610950 us-gaap:BuildingAndBuildingImprovementsMember 2020-12-31 0001610950 synh:AssetsNotYetPlacedInServiceMember 2021-12-31 0001610950 synh:AssetsNotYetPlacedInServiceMember 2020-12-31 0001610950 synh:ClinicalSolutionsSegmentMember 2019-12-31 0001610950 synh:CommercialSolutionsSegmentMember 2019-12-31 0001610950 synh:ClinicalSolutionsSegmentMember 2020-01-01 2020-12-31 0001610950 synh:CommercialSolutionsSegmentMember 2020-01-01 2020-12-31 0001610950 synh:ClinicalSolutionsSegmentMember 2020-12-31 0001610950 synh:CommercialSolutionsSegmentMember 2020-12-31 0001610950 synh:ClinicalSolutionsSegmentMember 2021-01-01 2021-12-31 0001610950 synh:CommercialSolutionsSegmentMember 2021-01-01 2021-12-31 0001610950 synh:ClinicalSolutionsSegmentMember 2021-12-31 0001610950 synh:CommercialSolutionsSegmentMember 2021-12-31 0001610950 synh:ClinicalSolutionsSegmentMember 2019-01-01 2019-12-31 0001610950 synh:CommercialSolutionsSegmentMember 2019-01-01 2019-12-31 0001610950 us-gaap:CustomerRelationshipsMember 2021-12-31 0001610950 us-gaap:OrderOrProductionBacklogMember 2021-12-31 0001610950 us-gaap:TrademarksAndTradeNamesMember 2021-12-31 0001610950 us-gaap:PatentsMember 2021-12-31 0001610950 synh:AcquiredTechnologyMember 2021-12-31 0001610950 us-gaap:CustomerRelationshipsMember 2020-12-31 0001610950 us-gaap:OrderOrProductionBacklogMember 2020-12-31 0001610950 us-gaap:TrademarksAndTradeNamesMember 2020-12-31 0001610950 us-gaap:IntellectualPropertyMember 2020-12-31 0001610950 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-12-31 0001610950 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-31 0001610950 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-01 2021-12-31 0001610950 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-12-31 0001610950 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-12-31 0001610950 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0001610950 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0001610950 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-12-31 0001610950 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-12-31 0001610950 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0001610950 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-01-01 2019-12-31 0001610950 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-12-31 0001610950 synh:StudyKikAcquisitionMember 2021-09-12 2021-09-13 0001610950 synh:StudyKikAcquisitionMember 2021-09-13 0001610950 us-gaap:CustomerRelationshipsMember synh:StudyKikAcquisitionMember 2021-09-12 2021-09-13 0001610950 synh:AcquiredBacklogMember synh:StudyKikAcquisitionMember 2021-09-12 2021-09-13 0001610950 us-gaap:TradeNamesMember synh:StudyKikAcquisitionMember 2021-09-12 2021-09-13 0001610950 synh:PatientCommunitiesMember synh:StudyKikAcquisitionMember 2021-09-12 2021-09-13 0001610950 synh:AcquiredTechnologyMember synh:StudyKikAcquisitionMember 2021-09-12 2021-09-13 0001610950 synh:RxDataScienceAcquisitionsMember 2021-10-05 2021-10-06 0001610950 synh:RxDataScienceAcquisitionsMember 2021-10-06 0001610950 synh:SynteractAcquisitionMember 2020-12-08 2020-12-09 xbrli:pure 0001610950 synh:SynteractAcquisitionMember 2020-12-09 0001610950 synh:SynteractAcquisitionMember 2021-01-01 2021-03-31 0001610950 synh:SynteractAcquisitionMember us-gaap:OrderOrProductionBacklogMember 2020-12-08 2020-12-09 0001610950 synh:SynteractAcquisitionMember us-gaap:TradeNamesMember 2020-12-08 2020-12-09 0001610950 synh:SynteractAcquisitionMember srt:MaximumMember us-gaap:OrderOrProductionBacklogMember 2020-12-08 2020-12-09 0001610950 synh:SynteractAcquisitionMember srt:MaximumMember us-gaap:TradeNamesMember 2020-12-08 2020-12-09 0001610950 synh:IllingworthResearchMember 2020-12-17 2020-12-17 0001610950 synh:IllingworthResearchMember 2021-01-01 2021-03-31 0001610950 synh:IllingworthResearchMember 2020-12-17 0001610950 srt:MaximumMember synh:RelatedPartyMember 2020-04-01 2020-06-30 0001610950 synh:RelatedPartyMember 2020-06-30 0001610950 synh:ClinicalSolutionsSegmentMember 2020-10-01 2020-12-31 0001610950 2020-04-01 2020-06-30 0001610950 2021-07-01 2021-09-30 0001610950 us-gaap:SecuredDebtMember synh:TermLoanATrancheOneDueMarch2024Member 2021-12-31 0001610950 us-gaap:SecuredDebtMember synh:TermLoanATrancheOneDueMarch2024Member 2020-12-31 0001610950 us-gaap:SecuredDebtMember synh:TermLoanATrancheTwoDueAugust2024Member 2021-12-31 0001610950 us-gaap:SecuredDebtMember synh:TermLoanATrancheTwoDueAugust2024Member 2020-12-31 0001610950 us-gaap:SecuredDebtMember synh:A2017CreditAgreementTermLoanBDueAugust2024Member 2020-12-31 0001610950 us-gaap:SecuredDebtMember synh:AccountsReceivableFinancingAgreementDueOctober2022Member synh:AccountsReceivableSecuritizationMember 2021-12-31 0001610950 us-gaap:SecuredDebtMember synh:AccountsReceivableFinancingAgreementDueOctober2022Member synh:AccountsReceivableSecuritizationMember 2020-12-31 0001610950 us-gaap:SecuredDebtMember 2021-12-31 0001610950 us-gaap:SecuredDebtMember 2020-12-31 0001610950 us-gaap:UnsecuredDebtMember synh:SeniorUnsecuredNotesDueJanuary2029Member 2021-12-31 0001610950 us-gaap:UnsecuredDebtMember synh:SeniorUnsecuredNotesDueJanuary2029Member 2020-12-31 0001610950 us-gaap:UnsecuredDebtMember 2021-12-31 0001610950 us-gaap:UnsecuredDebtMember 2020-12-31 0001610950 synh:A2017CreditAgreementAmendmentNo2TermLoanADueMarch2024Member synh:TermLoanMember us-gaap:SecuredDebtMember 2021-12-31 0001610950 synh:A2017CreditAgreementTermLoanBDueAugust2024Member synh:TermLoanMember us-gaap:SecuredDebtMember 2021-12-31 0001610950 synh:A2017CreditAgreementAmendmentNo2RevolvingCreditFacilityDueAugust2024Member us-gaap:RevolvingCreditFacilityMember us-gaap:SecuredDebtMember 2021-12-31 0001610950 synh:CreditAgreementAmendmentNo5TermLoanAMember synh:IncrementalTermLoanMember us-gaap:SecuredDebtMember 2021-12-31 0001610950 synh:CreditAgreementAmendmentNo5TermLoanAMember synh:TermLoanMember us-gaap:SecuredDebtMember 2021-12-31 0001610950 us-gaap:SecuredDebtMember synh:A2017CreditAgreementAmendmentNo2TermLoanADueMarch2024Member 2021-01-01 2021-12-31 0001610950 us-gaap:SecuredDebtMember synh:A2017CreditAgreementTermLoanBDueAugust2024Member 2021-01-01 2021-12-31 0001610950 us-gaap:SecuredDebtMember 2021-01-01 2021-12-31 0001610950 us-gaap:SecuredDebtMember synh:A2017CreditAgreementAmendmentNo2TermLoanADueMarch2024FundedAmountMember 2021-01-01 2021-12-31 0001610950 us-gaap:FederalFundsEffectiveSwapRateMember us-gaap:SecuredDebtMember synh:A2017CreditAgreementTermBLoanMember 2017-08-01 2017-08-01 0001610950 us-gaap:EurodollarMember us-gaap:SecuredDebtMember synh:A2017CreditAgreementTermBLoanMember 2017-08-01 2017-08-01 0001610950 us-gaap:BaseRateMember us-gaap:SecuredDebtMember synh:A2017CreditAgreementTermBLoanMember 2017-08-01 2017-08-01 0001610950 srt:MinimumMember us-gaap:BaseRateMember synh:A2017CreditAgreementAmendmentNo1TermLoanADueAugust2022Member synh:TermLoanMember us-gaap:SecuredDebtMember 2021-01-01 2021-12-31 0001610950 srt:MaximumMember us-gaap:BaseRateMember synh:A2017CreditAgreementAmendmentNo1TermLoanADueAugust2022Member synh:TermLoanMember us-gaap:SecuredDebtMember 2021-01-01 2021-12-31 0001610950 srt:MinimumMember synh:EurocurrencyRateMember synh:A2017CreditAgreementAmendmentNo1TermLoanADueAugust2022Member synh:TermLoanMember us-gaap:SecuredDebtMember 2021-01-01 2021-12-31 0001610950 srt:MaximumMember synh:EurocurrencyRateMember synh:A2017CreditAgreementAmendmentNo1TermLoanADueAugust2022Member synh:TermLoanMember us-gaap:SecuredDebtMember 2021-01-01 2021-12-31 0001610950 srt:MinimumMember us-gaap:BaseRateMember synh:AmendmentNo1TermBLoanMember synh:TermLoanMember us-gaap:SecuredDebtMember 2021-01-01 2021-12-31 0001610950 srt:MaximumMember us-gaap:BaseRateMember synh:AmendmentNo1TermBLoanMember synh:TermLoanMember us-gaap:SecuredDebtMember 2021-01-01 2021-12-31 0001610950 srt:MinimumMember synh:EurocurrencyRateMember synh:AmendmentNo1TermBLoanMember synh:TermLoanMember us-gaap:SecuredDebtMember 2021-01-01 2021-12-31 0001610950 srt:MaximumMember synh:EurocurrencyRateMember synh:AmendmentNo1TermBLoanMember synh:TermLoanMember us-gaap:SecuredDebtMember 2021-01-01 2021-12-31 0001610950 srt:MinimumMember us-gaap:BaseRateMember synh:A2017CreditAgreementRevolvingCreditFacilityDueAugust2022Member us-gaap:RevolvingCreditFacilityMember us-gaap:SecuredDebtMember 2021-01-01 2021-12-31 0001610950 srt:MaximumMember us-gaap:BaseRateMember synh:A2017CreditAgreementRevolvingCreditFacilityDueAugust2022Member us-gaap:RevolvingCreditFacilityMember us-gaap:SecuredDebtMember 2021-01-01 2021-12-31 0001610950 srt:MinimumMember synh:EurocurrencyRateMember synh:A2017CreditAgreementRevolvingCreditFacilityDueAugust2022Member us-gaap:RevolvingCreditFacilityMember us-gaap:SecuredDebtMember 2021-01-01 2021-12-31 0001610950 srt:MaximumMember synh:EurocurrencyRateMember synh:A2017CreditAgreementRevolvingCreditFacilityDueAugust2022Member us-gaap:RevolvingCreditFacilityMember us-gaap:SecuredDebtMember 2021-01-01 2021-12-31 0001610950 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember us-gaap:SecuredDebtMember synh:A2017CreditAgreementRevolvingCreditFacilityDueAugust2022Member 2017-08-01 2017-08-01 0001610950 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:SecuredDebtMember synh:A2017CreditAgreementRevolvingCreditFacilityDueAugust2022Member 2017-08-01 2017-08-01 0001610950 us-gaap:RevolvingCreditFacilityMember us-gaap:SecuredDebtMember synh:A2017CreditAgreementRevolvingCreditFacilityDueAugust2022Member 2021-12-31 0001610950 synh:TermLoanMember us-gaap:SecuredDebtMember synh:A2017CreditAgreementAmendmentNo2TermLoanBDueAugust2024Member 2021-02-26 2021-02-28 0001610950 srt:MaximumMember synh:TermLoanMember us-gaap:SecuredDebtMember synh:A2017CreditAgreementAmendmentNo2TermLoanBDueAugust2024Member 2021-02-28 0001610950 srt:MinimumMember synh:TermLoanMember us-gaap:SecuredDebtMember synh:A2017CreditAgreementAmendmentNo2TermLoanBDueAugust2024Member 2021-02-28 0001610950 us-gaap:SecuredDebtMember us-gaap:LetterOfCreditMember synh:A2017CreditAgreementRevolvingCreditFacilityDueAugust2022Member 2020-12-31 0001610950 us-gaap:SecuredDebtMember us-gaap:LetterOfCreditMember 2021-12-31 0001610950 srt:SubsidiariesMember synh:AccountsReceivableSecuritizationMember us-gaap:SecuredDebtMember synh:AccountsReceivableFinancingAgreementDueOctober2022Member 2020-09-24 0001610950 srt:SubsidiariesMember synh:AccountsReceivableSecuritizationMember us-gaap:SecuredDebtMember synh:AccountsReceivableFinancingAgreementDueOctober2022Member 2021-01-27 0001610950 srt:SubsidiariesMember synh:AccountsReceivableSecuritizationMember us-gaap:SecuredDebtMember synh:AccountsReceivableFinancingAgreementDueOctober2022Member 2021-12-31 0001610950 srt:SubsidiariesMember synh:AccountsReceivableSecuritizationMember us-gaap:SecuredDebtMember synh:AccountsReceivableFinancingAgreementDueOctober2022Member 2020-09-25 0001610950 srt:SubsidiariesMember synh:AccountsReceivableSecuritizationMember us-gaap:SecuredDebtMember synh:AccountsReceivableFinancingAgreementDueOctober2022Member 2021-01-28 0001610950 2021-10-11 2021-10-13 0001610950 2021-01-27 2021-01-28 0001610950 srt:SubsidiariesMember synh:AccountsReceivableSecuritizationMember us-gaap:SecuredDebtMember synh:AccountsReceivableFinancingAgreementDueOctober2022Member synh:FederalFundsRateMember 2021-01-01 2021-12-31 0001610950 synh:AccountsReceivableSecuritizationMember us-gaap:SecuredDebtMember synh:AccountsReceivableFinancingAgreementDueSeptember2021Member 2021-12-31 0001610950 synh:SeniorUnsecuredNotesDue2029Member synh:ThreePointSixHundredTwentyFivePercentageSeniorNotesMember 2020-11-24 0001610950 synh:SeniorUnsecuredNotesDue2029Member synh:ThreePointSixHundredTwentyFivePercentageSeniorNotesMember 2021-01-01 2021-12-31 0001610950 synh:SeniorUnsecuredNotesDue2029Member 2021-01-01 2021-12-31 0001610950 synh:SeniorUnsecuredNotesDue2029Member 2021-12-31 0001610950 synh:InterestRateSwapExpiringJune302021Member 2018-12-31 0001610950 synh:InterestRateSwapExpiringMarch312023Member 2020-03-31 0001610950 synh:InterestRateSwapExpiringMarch312023Member 2021-06-30 0001610950 synh:InterestRateSwapExpiringMarch312023Member 2021-12-31 0001610950 us-gaap:ForeignExchangeForwardMember 2021-12-31 0001610950 us-gaap:ForeignExchangeForwardMember 2021-01-01 2021-12-31 0001610950 us-gaap:ForeignExchangeForwardMember 2020-01-01 2020-12-31 0001610950 us-gaap:InterestRateSwapMember us-gaap:OtherNoncurrentAssetsMember us-gaap:CashFlowHedgingMember 2021-12-31 0001610950 us-gaap:CashFlowHedgingMember 2021-12-31 0001610950 us-gaap:InterestRateSwapMember us-gaap:AccruedLiabilitiesMember us-gaap:CashFlowHedgingMember 2021-12-31 0001610950 us-gaap:InterestRateSwapMember us-gaap:AccruedLiabilitiesMember us-gaap:CashFlowHedgingMember 2020-12-31 0001610950 us-gaap:InterestRateSwapMember us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CashFlowHedgingMember 2020-12-31 0001610950 us-gaap:CashFlowHedgingMember 2020-12-31 0001610950 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001610950 us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001610950 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:FairValueMeasurementsRecurringMember srt:PartnershipInterestMember 2021-12-31 0001610950 us-gaap:FairValueMeasurementsRecurringMember srt:PartnershipInterestMember 2021-12-31 0001610950 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001610950 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001610950 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001610950 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001610950 us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001610950 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:FairValueMeasurementsRecurringMember srt:PartnershipInterestMember 2020-12-31 0001610950 us-gaap:FairValueMeasurementsRecurringMember srt:PartnershipInterestMember 2020-12-31 0001610950 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001610950 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001610950 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001610950 synh:HealthcareAndLifeSciencesIndustryMember 2021-12-31 synh:EquityFund 0001610950 us-gaap:FairValueMeasurementsNonrecurringMember 2021-12-31 0001610950 us-gaap:FairValueMeasurementsNonrecurringMember 2020-12-31 0001610950 us-gaap:CarryingReportedAmountFairValueDisclosureMember synh:A2017CreditAgreementAmendmentNo2TermLoanATrancheOneDueMarch2024Member us-gaap:FairValueInputsLevel2Member us-gaap:SecuredDebtMember 2021-12-31 0001610950 us-gaap:CarryingReportedAmountFairValueDisclosureMember synh:A2017CreditAgreementAmendmentNo2TermLoanATrancheTwoDueAugust2024Member us-gaap:FairValueInputsLevel2Member us-gaap:SecuredDebtMember 2021-12-31 0001610950 us-gaap:EstimateOfFairValueFairValueDisclosureMember synh:A2017CreditAgreementAmendmentNo2TermLoanATrancheOneDueMarch2024Member us-gaap:FairValueInputsLevel2Member us-gaap:SecuredDebtMember 2021-12-31 0001610950 us-gaap:EstimateOfFairValueFairValueDisclosureMember synh:A2017CreditAgreementAmendmentNo2TermLoanATrancheTwoDueAugust2024Member us-gaap:FairValueInputsLevel2Member us-gaap:SecuredDebtMember 2021-12-31 0001610950 us-gaap:CarryingReportedAmountFairValueDisclosureMember synh:A2017CreditAgreementAmendmentNo2TermLoanATrancheOneDueMarch2024Member us-gaap:FairValueInputsLevel2Member us-gaap:SecuredDebtMember 2020-12-31 0001610950 us-gaap:CarryingReportedAmountFairValueDisclosureMember synh:A2017CreditAgreementAmendmentNo2TermLoanATrancheTwoDueAugust2024Member us-gaap:FairValueInputsLevel2Member us-gaap:SecuredDebtMember 2020-12-31 0001610950 us-gaap:CarryingReportedAmountFairValueDisclosureMember synh:A2017CreditAgreementAmendmentNo2TermLoanBDueAugust2024Member us-gaap:FairValueInputsLevel2Member us-gaap:SecuredDebtMember 2020-12-31 0001610950 us-gaap:EstimateOfFairValueFairValueDisclosureMember synh:A2017CreditAgreementAmendmentNo2TermLoanATrancheOneDueMarch2024Member us-gaap:FairValueInputsLevel2Member us-gaap:SecuredDebtMember 2020-12-31 0001610950 us-gaap:EstimateOfFairValueFairValueDisclosureMember synh:A2017CreditAgreementAmendmentNo2TermLoanATrancheTwoDueAugust2024Member us-gaap:FairValueInputsLevel2Member us-gaap:SecuredDebtMember 2020-12-31 0001610950 us-gaap:EstimateOfFairValueFairValueDisclosureMember synh:A2017CreditAgreementAmendmentNo2TermLoanBDueAugust2024Member us-gaap:FairValueInputsLevel2Member us-gaap:SecuredDebtMember 2020-12-31 0001610950 synh:SeniorNoteDue2029Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:UnsecuredDebtMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001610950 synh:SeniorNoteDue2029Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:UnsecuredDebtMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001610950 synh:SeniorNoteDue2029Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:UnsecuredDebtMember us-gaap:FairValueInputsLevel2Member 2020-12-31 0001610950 synh:SeniorNoteDue2029Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:UnsecuredDebtMember us-gaap:FairValueInputsLevel2Member 2020-12-31 0001610950 us-gaap:EmployeeSeveranceMember 2021-01-01 2021-12-31 0001610950 us-gaap:EmployeeSeveranceMember 2020-01-01 2020-12-31 0001610950 us-gaap:EmployeeSeveranceMember 2019-01-01 2019-12-31 0001610950 us-gaap:FacilityClosingMember 2021-01-01 2021-12-31 0001610950 us-gaap:FacilityClosingMember 2020-01-01 2020-12-31 0001610950 us-gaap:FacilityClosingMember 2019-01-01 2019-12-31 0001610950 us-gaap:OtherRestructuringMember 2021-01-01 2021-12-31 0001610950 us-gaap:OtherRestructuringMember 2020-01-01 2020-12-31 0001610950 us-gaap:OtherRestructuringMember 2019-01-01 2019-12-31 0001610950 us-gaap:BusinessRestructuringReservesMember synh:EmployeeSeveranceCostsIncludingExecutiveTransitionCostsMember 2019-12-31 0001610950 us-gaap:BusinessRestructuringReservesMember us-gaap:OtherRestructuringMember 2019-12-31 0001610950 us-gaap:BusinessRestructuringReservesMember 2019-12-31 0001610950 us-gaap:BusinessRestructuringReservesMember synh:EmployeeSeveranceCostsIncludingExecutiveTransitionCostsMember 2020-01-01 2020-12-31 0001610950 us-gaap:BusinessRestructuringReservesMember us-gaap:OtherRestructuringMember 2020-01-01 2020-12-31 0001610950 us-gaap:BusinessRestructuringReservesMember 2020-01-01 2020-12-31 0001610950 us-gaap:BusinessRestructuringReservesMember synh:EmployeeSeveranceCostsIncludingExecutiveTransitionCostsMember 2020-12-31 0001610950 us-gaap:BusinessRestructuringReservesMember 2020-12-31 0001610950 us-gaap:BusinessRestructuringReservesMember synh:EmployeeSeveranceCostsIncludingExecutiveTransitionCostsMember 2021-01-01 2021-12-31 0001610950 us-gaap:BusinessRestructuringReservesMember us-gaap:OtherRestructuringMember 2021-01-01 2021-12-31 0001610950 us-gaap:BusinessRestructuringReservesMember 2021-01-01 2021-12-31 0001610950 us-gaap:BusinessRestructuringReservesMember synh:EmployeeSeveranceCostsIncludingExecutiveTransitionCostsMember 2021-12-31 0001610950 us-gaap:BusinessRestructuringReservesMember 2021-12-31 0001610950 2018-02-26 0001610950 2019-12-05 0001610950 us-gaap:CommonClassAMember 2021-12-31 0001610950 us-gaap:CommonClassAMember 2021-01-01 2021-12-31 0001610950 us-gaap:CommonStockMember 2018-03-01 2018-03-31 0001610950 us-gaap:CommonStockMember 2018-04-01 2018-04-30 0001610950 us-gaap:CommonStockMember 2019-01-01 2019-01-31 0001610950 us-gaap:CommonStockMember 2019-02-01 2019-02-28 0001610950 us-gaap:CommonStockMember 2019-06-01 2019-06-30 0001610950 us-gaap:CommonStockMember 2019-08-01 2019-08-31 0001610950 us-gaap:CommonStockMember 2020-03-01 2020-03-31 0001610950 us-gaap:CommonStockMember 2020-09-01 2020-09-30 0001610950 us-gaap:CommonStockMember 2020-10-01 2020-10-31 0001610950 us-gaap:CommonStockMember 2021-03-01 2021-03-31 0001610950 us-gaap:CommonStockMember 2021-05-01 2021-05-31 0001610950 us-gaap:CommonStockMember 2021-06-01 2021-06-30 0001610950 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001610950 us-gaap:CommonStockMember 2021-12-31 0001610950 us-gaap:CommonClassAMember 2020-12-31 0001610950 us-gaap:CommonClassBMember 2021-12-31 0001610950 us-gaap:CommonClassBMember 2020-12-31 synh:NumberOfVote 0001610950 us-gaap:CommonClassBMember 2021-01-01 2021-12-31 0001610950 synh:ResearchAndGeneralBusinessTaxCreditsMember 2021-01-01 2021-12-31 0001610950 synh:ResearchAndGeneralBusinessTaxCreditsMember 2020-01-01 2020-12-31 0001610950 us-gaap:CapitalLossCarryforwardMember 2021-01-01 2021-12-31 0001610950 us-gaap:CapitalLossCarryforwardMember 2020-01-01 2020-12-31 0001610950 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2020-12-31 0001610950 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-12-31 0001610950 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-12-31 0001610950 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2020-01-01 2020-12-31 0001610950 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2021-01-01 2021-12-31 0001610950 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-01-01 2019-12-31 0001610950 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2021-12-31 0001610950 us-gaap:DomesticCountryMember 2021-12-31 0001610950 us-gaap:DomesticCountryMember 2020-12-31 0001610950 us-gaap:StateAndLocalJurisdictionMember 2021-12-31 0001610950 us-gaap:StateAndLocalJurisdictionMember 2020-12-31 0001610950 us-gaap:ForeignCountryMember 2021-12-31 0001610950 us-gaap:ForeignCountryMember 2020-12-31 0001610950 us-gaap:DomesticCountryMember 2021-01-01 2021-12-31 0001610950 us-gaap:DomesticCountryMember 2020-01-01 2020-12-31 0001610950 us-gaap:ResearchMember us-gaap:CanadaRevenueAgencyMember 2021-12-31 0001610950 us-gaap:ResearchMember us-gaap:CanadaRevenueAgencyMember 2020-12-31 0001610950 us-gaap:ForeignCountryMember 2021-01-01 2021-12-31 0001610950 2021-10-01 2021-12-31 0001610950 synh:ClinicalSolutionsSegmentMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-12-31 0001610950 synh:ClinicalSolutionsSegmentMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0001610950 synh:ClinicalSolutionsSegmentMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0001610950 synh:CommercialSolutionsSegmentMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-12-31 0001610950 synh:CommercialSolutionsSegmentMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0001610950 synh:CommercialSolutionsSegmentMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0001610950 us-gaap:OperatingSegmentsMember 2021-01-01 2021-12-31 0001610950 us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0001610950 us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0001610950 us-gaap:CorporateNonSegmentMember synh:CostofServicesMember 2021-01-01 2021-12-31 0001610950 us-gaap:CorporateNonSegmentMember synh:CostofServicesMember 2020-01-01 2020-12-31 0001610950 us-gaap:CorporateNonSegmentMember synh:CostofServicesMember 2019-01-01 2019-12-31 0001610950 us-gaap:CorporateNonSegmentMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0001610950 us-gaap:CorporateNonSegmentMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0001610950 us-gaap:CorporateNonSegmentMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-12-31 0001610950 us-gaap:CorporateNonSegmentMember 2021-01-01 2021-12-31 0001610950 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-12-31 0001610950 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-12-31 0001610950 srt:NorthAmericaMember 2021-01-01 2021-12-31 0001610950 srt:NorthAmericaMember 2020-01-01 2020-12-31 0001610950 srt:NorthAmericaMember 2019-01-01 2019-12-31 0001610950 us-gaap:EMEAMember 2021-01-01 2021-12-31 0001610950 us-gaap:EMEAMember 2020-01-01 2020-12-31 0001610950 us-gaap:EMEAMember 2019-01-01 2019-12-31 0001610950 srt:AsiaPacificMember 2021-01-01 2021-12-31 0001610950 srt:AsiaPacificMember 2020-01-01 2020-12-31 0001610950 srt:AsiaPacificMember 2019-01-01 2019-12-31 0001610950 srt:LatinAmericaMember 2021-01-01 2021-12-31 0001610950 srt:LatinAmericaMember 2020-01-01 2020-12-31 0001610950 srt:LatinAmericaMember 2019-01-01 2019-12-31 0001610950 country:US 2021-01-01 2021-12-31 0001610950 country:US 2020-01-01 2020-12-31 0001610950 country:US 2019-01-01 2019-12-31 0001610950 country:US us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember 2021-01-01 2021-12-31 0001610950 country:US us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember 2020-01-01 2020-12-31 0001610950 country:US us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember 2019-01-01 2019-12-31 0001610950 srt:NorthAmericaMember 2021-12-31 0001610950 srt:NorthAmericaMember 2020-12-31 0001610950 us-gaap:EMEAMember 2021-12-31 0001610950 us-gaap:EMEAMember 2020-12-31 0001610950 srt:AsiaPacificMember 2021-12-31 0001610950 srt:AsiaPacificMember 2020-12-31 0001610950 srt:LatinAmericaMember 2021-12-31 0001610950 srt:LatinAmericaMember 2020-12-31 0001610950 country:US 2021-12-31 0001610950 country:US 2020-12-31 0001610950 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember us-gaap:OtherCustomerMember 2021-01-01 2021-12-31 0001610950 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember us-gaap:OtherCustomerMember 2020-01-01 2020-12-31 0001610950 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember us-gaap:OtherCustomerMember 2019-01-01 2019-12-31 0001610950 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember us-gaap:OtherCustomerMember 2021-01-01 2021-12-31 0001610950 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember us-gaap:OtherCustomerMember 2020-01-01 2020-12-31 0001610950 srt:DirectorMember 2021-01-01 2021-12-31 synh:Customer 0001610950 srt:DirectorMember 2020-01-01 2020-12-31 0001610950 srt:MaximumMember 2020-01-01 2020-12-31 0001610950 2018-01-01 2018-12-31 0001610950 srt:AffiliatedEntityMember 2019-01-01 2019-12-31 synh:numberOfAction 0001610950 us-gaap:PendingLitigationMember synh:BermudezAndVaitkuvieneActionMember 2017-12-01 2017-12-01 0001610950 synh:InVentivMergerMember us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001610950 synh:InVentivMergerMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001610950 synh:RxDataScienceMember 2021-12-31 synh:Plan 0001610950 synh:TwoThousandFourteenEquityIncentivePlanMember 2021-01-01 2021-12-31 0001610950 srt:MaximumMember synh:TwoThousandFourteenEquityIncentivePlanMember us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001610950 synh:EmployeeStockPurchasePlanMember 2021-01-01 2021-12-31 0001610950 synh:EmployeeStockPurchasePlanMember 2016-03-31 0001610950 synh:EmployeeStockPurchasePlanMember 2016-03-01 2016-03-31 0001610950 synh:EmployeeStockPurchasePlanMember 2020-01-01 2020-12-31 0001610950 synh:EmployeeStockPurchasePlanMember 2019-01-01 2019-12-31 0001610950 synh:EmployeeStockPurchasePlanMember 2021-12-31 0001610950 us-gaap:EmployeeStockMember 2021-01-01 2021-12-31 0001610950 us-gaap:EmployeeStockMember 2020-01-01 2020-12-31 0001610950 us-gaap:EmployeeStockMember 2019-01-01 2019-12-31 0001610950 us-gaap:EmployeeStockOptionMember 2020-12-31 0001610950 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001610950 us-gaap:EmployeeStockOptionMember 2021-12-31 0001610950 synh:TimeBasedRestrictedStockUnitsAwardsMember 2020-12-31 0001610950 synh:TimeBasedRestrictedStockUnitsAwardsMember 2021-01-01 2021-12-31 0001610950 synh:TimeBasedRestrictedStockUnitsAwardsMember 2021-12-31 0001610950 synh:PerformanceBasedRestrictedStockUnitsMember 2020-12-31 0001610950 synh:PerformanceBasedRestrictedStockUnitsMember 2021-01-01 2021-12-31 0001610950 synh:PerformanceBasedRestrictedStockUnitsMember 2021-12-31 0001610950 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001610950 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001610950 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001610950 synh:TimeBasedRestrictedStockUnitsAwardsMember 2020-01-01 2020-12-31 0001610950 synh:TimeBasedRestrictedStockUnitsAwardsMember 2019-01-01 2019-12-31 0001610950 synh:PerformanceBasedRestrictedStockUnitsMember 2020-01-01 2020-12-31 0001610950 synh:PerformanceBasedRestrictedStockUnitsMember 2019-01-01 2019-12-31 0001610950 synh:CostofServicesMember 2021-01-01 2021-12-31 0001610950 synh:CostofServicesMember 2020-01-01 2020-12-31 0001610950 synh:CostofServicesMember 2019-01-01 2019-12-31 0001610950 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0001610950 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0001610950 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-12-31 0001610950 us-gaap:ForeignPlanMember 2021-01-01 2021-12-31 0001610950 us-gaap:ForeignPlanMember 2020-01-01 2020-12-31 0001610950 us-gaap:ForeignPlanMember 2019-01-01 2019-12-31

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549 

FORM 10-K 

(Mark One)

☒

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2021

or

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______ to ______

Commission File Number: 001-36730

SYNEOS HEALTH, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

27-3403111

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

 

 

1030 Sync Street

Morrisville, North Carolina

 

27560-5468

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (919) 876-9300

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Class A Common Stock, par value $0.01 per share

 

SYNH

 

The Nasdaq Stock Market LLC

 

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  ☒   No  ☐

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act.  Yes  ☐   No  ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒   No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).     Yes  ☒   No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

☒

 

Accelerated filer

 

☐

Non-accelerated filer

 

☐

 

Smaller reporting company

 

☐

 

 

 

 

Emerging growth company

 

☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☒

The aggregate market value of the registrant’s common stock held by non-affiliates of the registrant, based on the closing sale price of $89.49 on June 30, 2021, was approximately $9,235,907,535.

As of February 10, 2022, there were approximately 104,221,138 shares of the registrant’s Class A common stock outstanding. 

Portions of the registrant’s Proxy Statement for its 2022 Annual Meeting of Stockholders are incorporated by reference into Part III hereof.

Table of Contents

 

SYNEOS HEALTH, INC.

FORM 10-K

For the Fiscal Year Ended December 31, 2021

 

TABLE OF CONTENTS

 

Page

 

Summary of Principal Risk Factors

4

 

 

 

 

PART I

 

 

 

 

Item 1.

Business

6

 

 

 

Item 1A.

Risk Factors

34

 

 

 

Item 1B.

Unresolved Staff Comments

66

 

 

 

Item 2.

Properties

66

 

 

 

Item 3.

Legal Proceedings

67

 

 

 

Item 4.

Mine Safety Disclosures

67

 

 

 

 

PART II

 

 

 

 

Item 5.

Market for Registrants’ Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities

67

 

 

 

Item 6.

[Reserved]

69

 

 

 

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

70

 

 

 

Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

87

 

 

 

Item 8.

Financial Statements and Supplementary Data

89

 

 

 

Item 9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

141

 

 

 

Item 9A.

Controls and Procedures

141

 

 

 

Item 9B.

Other Information

142

 

 

 

Item 9C.

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

142

 

 

 

 

PART III

 

 

 

 

Item 10.

Directors, Executive Officers and Corporate Governance

142

 

 

 

Item 11.

Executive Compensation

143

 

 

 

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

143

 

 

 

Item 13.

Certain Relationships and Related Transactions and Director Independence

144

 

 

 

Item 14.

Principal Accountant Fees and Services

144

 

 

 

 

Part IV

 

 

 

 

Item 15.

Exhibits and Financial Statement Schedules

144

 

 

 

Item 16.

Form 10-K Summary

150

 

 

 

 

Signatures

151

2

 

Table of Contents

 

 

FORWARD-LOOKING STATEMENTS

This Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. Such forward-looking statements reflect, among other things, our business plans and strategy, market trends, beliefs regarding our competitive strengths, current expectations, future capital expenditures, and anticipated results of operations, all of which are subject to known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements, market trends, or industry results to differ materially from those expressed or implied by such forward-looking statements. Therefore, any statements contained herein that are not statements of historical fact may be forward-looking statements and should be evaluated as such, including our business strategy, the future impact of the COVID-19 pandemic on our business, financial results, and financial condition, and planned capital expenditures. Without limiting the foregoing, the words “anticipates,” “believes,” “can,” “continue,” “could,” “estimates,” “expects,” “intends,” “may,” “might,” “plans,” “projects,” “should,” “would,” “targets,” “will” and the negative thereof and similar words and expressions are intended to identify forward-looking statements. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in Part I, Item 1A, “Risk Factors” in this Annual Report on Form 10-K. Unless legally required, we assume no obligation to update any such forward-looking information to reflect actual results or changes in the factors affecting such forward-looking information.

As used in this report, the terms “Syneos Health, Inc.,” “Company,” “we,” “us,” and “our” mean Syneos Health, Inc. and its subsidiaries unless the context indicates otherwise.

3

 

Table of Contents

 

Summary of Principal Risk Factors

We operate in a rapidly changing environment that involves a number of risks, some of which are beyond our control. In evaluating our company, you should consider carefully the summary risks and uncertainties described below together with the other information included in this Annual Report on Form 10-K, including our consolidated financial statements and related notes included in Part II, Item 8, “Financial Statements and Supplementary Data” in this Annual Report on Form 10-K. The occurrence of any of the following risks may materially and adversely affect our business, financial condition, results of operations and future prospects.

 

•

The COVID-19 pandemic and associated economic repercussions have adversely impacted our business and results of operations, and are expected to continue to do so.

 

•

If we do not generate a large number of new business awards, or if new business awards are delayed, terminated, reduced in scope, or fail to go to contract, our business, financial condition, results of operations, or cash flows may be materially adversely affected.

 

•

Our backlog might not be indicative of our future revenues, and we might not realize all of the anticipated future revenue reflected in our backlog.

 

•

If we underprice our contracts, overrun our cost estimates, or fail to receive approval for or experience delays in documentation of change orders, our business, financial condition, results of operations, or cash flows may be materially adversely affected.

 

•

Our business depends on the continued effectiveness and availability of our information systems, including the information systems we use to provide services to our customers and to store employee data, and failures of these systems, including cyber-attacks, may materially limit our operations or have an adverse effect on our reputation.

 

•

Our customer or therapeutic area concentration may have a material adverse effect on our business, financial condition, results of operations or cash flows.

 

•

Our business is subject to international economic, political and other risks that could have a material adverse effect on our business, financial condition, results of operations, cash flows or reputation.

 

•

Governmental authorities may question our intercompany transfer pricing policies or change their laws in a manner that could increase our effective tax rate or otherwise harm our business.

 

•

If we are unable to successfully increase our market share, our ability to grow our business and execute our growth strategies could be materially adversely affected.

 

•

Upgrading the information systems that support our operating processes and evolving the technology platform for our services pose risks to our business.

 

•

The operation of our early phase (Phase I and IIA) clinical facilities and the services we provide there as well as our clinical trial management, including direct interaction with clinical trial patients or volunteers, and our mobile research nursing clinical trial services, could create potential liability that may adversely affect our business, financial condition, results of operations, cash flows, and reputation.

 

•

If we are unable to attract suitable principal investigators and recruit and enroll patients for clinical trials, our clinical development business might suffer.

 

•

Our business could result in liability to us if a drug causes harm to a patient. While we are generally indemnified and insured against such risks, we may still suffer financial losses.

4

 

Table of Contents

 

 

•

If we lose the services of key personnel or are unable to recruit experienced personnel, our business, financial condition, results of operations, cash flows, or reputation could be materially adversely affected.

 

•

Our acquisition strategy may present additional risks, including the risk that we may be unable to fully realize the competitive and operating synergies projected to be achieved through any specific acquisition.

 

•

Our relationships with existing or potential customers who are in competition with each other may adversely impact the degree to which other customers or potential customers use our services, which may adversely affect our business, financial condition, results of operations, or cash flows.

 

•

We face risks arising from the restructuring of our operations, which could adversely affect our financial condition, results of operations, cash flows, or business reputation.

 

•

We operate in many different jurisdictions and we could be adversely affected by violations of the Foreign Corrupt Practices Act, U.K. Bribery Act of 2010, and/or similar worldwide anti-corruption and anti-bribery laws.

 

•

The failure of third parties to provide us critical support services could adversely affect our business, financial condition, results of operations, cash flows, or reputation.

 

•

The biopharmaceutical services industry is highly competitive and our business could be materially impacted if we do not compete effectively. Outsourcing trends in the biopharmaceutical industry and changes in aggregate spending and research and development budgets could adversely affect our operating results and growth rate.

 

•

Actions by government regulators or customers to limit a prescription’s scope or withdraw an approved product from the market could adversely affect our business, results of operations, and financial condition.

 

•

If we fail to comply with federal, state, and foreign healthcare laws, including fraud and abuse laws, we could face substantial penalties and our business, financial condition, results of operations, cash flows, and prospects could be adversely affected.

 

•

We may be affected by healthcare reform and potential additional reforms which may adversely impact the biopharmaceutical industry and reduce the need for our services or negatively impact our profitability.

 

•

Current and proposed laws and regulations regarding the protection of personal data could result in increased risks of liability or increased cost to us or could limit our service offerings.

 

•

Our customers face intense competition from lower cost generic products and other competing products, which may lower the amount that they spend on our services and could have a material adverse effect on our business, results of operations, cash flows, and financial condition.

 

•

Our substantial debt could adversely affect our financial condition and cash flows from operations. Despite our level of indebtedness, we are able to incur more debt and undertake additional obligations. Incurring such debt or undertaking such additional obligations could further exacerbate the risks to our financial condition.

 

•

Interest rate fluctuations or foreign currency exchange rate fluctuations may have a material adverse effect on our business, financial condition, results of operations, or cash flows.

 

•

Our internal control over financial reporting is required to meet all the standards of Section 404 of Sarbanes-Oxley, and failure to achieve and maintain effective internal controls over financial reporting could have a material adverse effect on our stock price, reputation, business, financial condition, results of operations and cash flows.

5

 

Table of Contents

 

PART I

Item 1. Business.

Overview

We are the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. We lead with a product development mindset, strategically blending clinical development, medical affairs and commercial capabilities to address modern market realities for customers in the pharmaceutical, biotechnology, and healthcare industries. We offer both stand-alone and integrated biopharmaceutical product development solutions ranging from early phase (Phase I) clinical trials to the full commercialization of biopharmaceutical products, with the goal of increasing the likelihood of regulatory approval and commercial success while accelerating our customers’ delivery to patients in need worldwide.

We bring a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies, and apply advanced business practices to speed our customers’ delivery of important therapies to patients.

Our operations are divided into two reportable segments, Clinical Solutions and Commercial Solutions. Our Clinical Solutions segment offers comprehensive global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. The segment is organized around clinical pharmacology and bioanalytical services, workforce deployment, full-service clinical studies, real world evidence, and consulting. This segment offers individual services including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs; all across a comprehensive range of therapeutic areas. Our Commercial Solutions segment provides commercialization services, including deployment solutions, communication solutions (public relations, advertising, and medical communications), and consulting services. We integrate our clinical and commercial capabilities into customized solutions by sharing knowledge, data, and insights. This collaboration across the development and commercialization continuum facilitates unique insights into patient populations, therapeutic environments, product timelines, and the competitive landscape.

Founded more than three decades ago as an academic organization dedicated to central nervous system (“CNS”) research, we have translated that knowledge into a global organization with deep expertise across a wide range of therapeutic specialties, as well as full data services and regulatory advisory and implementation support capabilities. Over the past decade, we have built our scale and capabilities to become a leading global provider of Phase I to Phase IV clinical development services, as well as a full range of commercialization and other complementary services. We were established as INC Research in 1998, and our corporate headquarters are located in Morrisville, North Carolina. INC Research Holdings, Inc. was incorporated in Delaware in August 2010. We changed our name to Syneos Health, Inc. after our 2017 merger (the “Merger”) with Double Eagle Parent, Inc. (“inVentiv”), the parent company of inVentiv Health, Inc.

COVID-19 Pandemic

The ongoing COVID-19 pandemic and associated economic repercussions have significantly impacted, and are expected to continue to impact, our business and our operations. With the spread of COVID-19 variants, the ongoing impacts of the COVID-19 pandemic could adversely impact our business and results of operations. See Part I, Item 1A, “Risk Factors” in this Annual Report on Form 10-K for further discussion of the potential continued impact of the pandemic on our business.

6

 

Table of Contents

 

Our Market

The market for our solutions is primarily the biopharmaceutical industry that utilizes outsourced clinical drug and medical device development and commercialization services. We believe we are well-positioned to benefit from the following market trends:

Trends in clinical drug and medical device development. Biopharmaceutical companies continue to prioritize the outsourcing of Phase I to Phase IV clinical trials to contract research organizations (“CROs”). Several biopharmaceutical industry trends are increasing demand for outsourced research and development services from CROs:

 

•

Large biopharmaceutical companies (top 50 by prior year research and development (“R&D”) expenditure) rely on CRO relationships in order to remain flexible and efficient as they seek to reduce costs and accelerate development timelines, particularly in complex therapeutic areas such as oncology.

 

•

Small and mid-sized biopharmaceutical companies typically have limited infrastructure and resources, making them more likely to outsource their clinical development. While biotechnology funding in 2021 was lighter than the peak experienced in 2020, the funding environment remains robust relative to historical levels. As a result of this increased funding, emerging biotechnology companies represent a high growth customer segment opportunity within the market.

 

•

Phase IV/post-approval/real world evidence represents an increasing area of spending across all customer segments.

We believe that, based on industry sources and management estimates, the Phase I – IV clinical development market for CRO services will grow at a compound average annual rate of 6% to 8% through 2023, driven by a combination of research and development budget increases and further outsourcing spend. We estimate the total addressable clinical development market to be approximately $105 billion, of which $50 billion was outsourced to CROs in 2021.

Trends in commercialization outsourcing. We believe that, based on industry sources and management estimates, the market for biopharmaceutical commercial outsourcing will grow at a compound average growth rate of approximately 3% to 5% through 2023. We believe this potential growth is supported by: (i) significant biopharmaceutical sales and marketing budgets; (ii) a continuing shift toward specialty and more complex therapies requiring more complex and integrated sales and marketing execution; (iii) a robust funding environment, which provides capital to fuel development and commercialization spending, particularly for small to mid-sized companies; (iv) the strength of new drug approvals by the U.S. Food and Drug Administration (“FDA”) in recent years; (v) continued political scrutiny of pharmaceutical pricing, which is intensifying pressure for our customers to further reduce fixed costs by outsourcing; and (vi) an evolving industry landscape illustrated by a shift to more strategic relationships, particularly where economies of scale can reduce costs.

Increasingly challenging clinical development and commercialization environment. The biopharmaceutical industry is currently facing a number of challenges, including: (i) margin deterioration; (ii) reimbursement and provider access hurdles; (iii) fewer blockbuster and high profitability drugs; (iv) continued pressure from generic brand exposure; and (v) the consolidation of payers, healthcare systems, providers, and pharmacies. These challenges also make it more complicated to engage physicians and patients, making new product launches more difficult. At the same time, the industry is experiencing growing demand for specialty drugs, pressure to improve R&D productivity, the transition of the healthcare industry worldwide from a volume-based to a value-based reimbursement structure, and growing political and pricing pressures. Existing approaches to address these challenges include reducing overhead costs,

7

 

Table of Contents

 

optimizing the deployment of marketing and field assets, and refocusing product portfolios around therapeutic areas with depth of presence and expanded market access capabilities.

Optimization of biopharmaceutical R&D efficiency. Market forces and healthcare reform, including the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, the 21st Century Cures Act, and other governmental initiatives, place significant pressure on biopharmaceutical companies to improve cost efficiencies. At the same time, the complexity, size, duration, and globalization of clinical trials has increased drug development costs. In an effort to reduce these rising costs, biopharmaceutical companies need to demonstrate a new therapy’s relative improvement in quality, safety, and effectiveness compared to the current standard of care as early as possible in the development process. Outsourcing to CROs allows biopharmaceutical companies to deploy capital more efficiently, quickly benefiting from the CROs’ existing infrastructure and therapeutic expertise without having to continuously scale in-house development resources.

Globalization of clinical trials. Clinical trials have become increasingly global as biopharmaceutical companies seek to accelerate patient recruitment, particularly within protocol-eligible, treatment-naïve patient populations without co-morbidities that could skew clinical outcomes. Biopharmaceutical companies are also increasingly seeking to expand the commercial potential of their products by applying for regulatory approvals in multiple countries, including fast-growing economies that are spending more on healthcare. As part of the biopharmaceutical approval process in newer markets, especially in certain Asian and emerging markets, regulators now often require clinical trials to include specific percentages or numbers of people from local populations, resulting in a combination of multinational and domestic clinical trials.

Management of increasingly complex clinical trials. The biopharmaceutical industry operates in an increasingly sophisticated and highly regulated environment and has responded to the demands of novel therapeutics by adapting efficient drug development processes. Complex clinical trial design expertise has emerged as a significant competitive advantage for select CROs that have a track record of successfully navigating country-specific regulatory, clinical trial protocol, and patient enrollment barriers, including sometimes subjective, evolving clinical endpoints. In addition, the therapeutic areas where we have significant experience and expertise, including neuroscience, hematology/oncology, and other complex disease areas, often require more complicated protocols than other disease indications. Many of these studies have longer durations due to these factors, resulting in demand for greater clinical trial proficiency and expertise in these therapeutic areas, particularly in light of new methods such as the use of biomarkers, gene therapy, and digital therapeutics.

Evolving commercialization outsourcing needs for large versus small to mid-sized biopharmaceutical companies. The needs of large versus small to mid-sized customers are evolving differently based upon their distinct infrastructure and corporate commercialization goals. Large biopharmaceutical companies tend to have robust internal resources and generally are seeking to augment these resources with individual outsourced services on a brand-by-brand basis. Frequently, they are also looking to establish enterprise vendor relationships with volume considerations to support broader cost savings initiatives. Conversely, small to mid-sized biopharmaceutical companies typically have limited product portfolios with fewer internal resources and less commercialization experience. As a result, these companies generally require the full spectrum of commercialization capabilities, what we call full-service commercial solutions. Historically, their only viable commercialization option was to enter into licensing agreements or a divestiture, which often meant surrendering a significant portion of an asset’s long-term economic value. However, with today’s funding environment driving sufficient capital for product launch, we believe these companies are becoming more receptive to commercialization alternatives that allow them to maintain their independence.

8

 

Table of Contents

 

Rapid adoption of remote technology-enabled platforms. Accelerated by the COVID-19 pandemic, we have observed a significant increase in the adoption of remote and digital solutions to facilitate continued healthcare delivery to patients and support to healthcare providers (“HCPs”) for our customers’ products. Technology-enabled, insights-powered site- and patient-centric solutions that have been on the rise include risk-based and remote monitoring, home health, and virtual personal and non-personal outreach to medical facilities and clinics. In light of these trends, we have continued to invest in our Decentralized Solutions and Kinetic capabilities. Decentralized Solutions are designed to speed clinical trial data collection, ease site and patient burden, expand available patient populations, and improve patient diversity. Kinetic is designed to digitally enhance our Commercial Solutions by synchronizing customer engagement across multiple personal and digital channels to provide real-time performance data and intelligence. In addition to investing in our current technologies, we invested in new technology and data capabilities in 2021 through our acquisitions of StudyKIK Corporation (“StudyKIK”) and RxDataScience, Inc. (“RxDataScience”). StudyKIK expands our portfolio of patient-direct, technology-enabled solutions while RxDataScience helps biopharmaceutical customers solve challenging problems through advanced analytics, data management, and artificial intelligence. As adoption of remote technology-enabled platforms increases over the longer term, we believe these capabilities provide an opportunity for improved efficiencies that could help to offset the potential revenue impact from reduced travel and other reimbursable expenses, while improving access to clinical trials and the health of patients worldwide.

Our Competitive Strengths

Our key competitive strengths are:

Differentiated positioning through our full suite of clinical and commercial services. We believe our customers are facing an increasingly complex and evolving market where regulatory approval no longer guarantees a successful product launch. To address this modern market reality, we believe that clinical development and commercial disciplines must work together to accelerate the delivery of differentiated therapies to the market that meet the needs of patients, healthcare professionals, and payers. As the only company with in-house capabilities to provide a full suite of integrated clinical development and commercial solutions, we believe we are well-positioned to successfully navigate this increasingly complex and evolving market for our customers.

Global leadership and experience in biopharmaceutical outsourcing. We believe our scale, global reach, and breadth of services, coupled with our deep industry expertise and experience, are critical to our customers who are seeking to consolidate their outsourcing to a smaller set of large global providers. We offer our services through a highly skilled staff of more than 28,000 employees and contingent workers located in more than 60 countries as of December 31, 2021, and have conducted work in more than 110 countries. In addition, over the last five years, more than 94% of all new molecular entities approved by the U.S. Food and Drug Administration (“FDA”) and 95% of the products granted marketing authorization by the European Medicines Agency (“EMA”) have been developed or commercialized with our support.

Syneos One® represents a unique offering in the market. Our Syneos One® offering coordinates integrated solutions across the full clinical development and commercialization continuum. This offering provides our small to mid-sized customers with an economic alternative to divesting, out-licensing, or co-promoting assets, and provides our large biopharmaceutical customers with further opportunity to reduce their fixed-cost infrastructure, and an alternative approach to developing and promoting their non-core assets. We believe this offering represents a unique capability in the market that can reduce program risk and optimize clinical development timelines, while maximizing return on investment.

9

 

Table of Contents

 

Proprietary Methodology – the Trusted Process®. Since 2006, we have used the Trusted Process® to standardize our delivery methodology in the conduct of clinical trials, which increases our service delivery predictability, accelerates median clinical study start-up time on new projects, and reduces operational risk. We have recently evolved the Trusted Process to reflect the “product development mindset” that biopharmaceutical customers are increasingly expecting from a service provider and to provide our customers an operational strategy best designed to maximize their research and development investments.  

Our dedicated Operations Management function defines, maintains, improves, and ensures consistent application of the Trusted Process® across our global footprint. In addition, it contributes to the absolute reduction of cycle times in critical path milestones, providing greater operating efficiency, more predictable project schedules, and a reduction in overall delivery timelines. Our metrics-driven Trusted Process® methodology is divided into four phases:

 

•

PlanActivation® – the design phase, where the objectives are analyzed utilizing our therapeutic and technical subject matter experience to develop a quality-driven strategy for success;

 

•

QuickStart® – the engineering phase, which serves to align the team to the strategy, create shared expectations, and develop a joint execution plan;

 

•

ProgramAccelerate® – the execution and control phase, where we proactively manage conduct. Data is used to ensure timelines, risks, issues, and quality are actively managed while maintaining positive relationships with all stakeholders; and

 

•

QualityFinish® – the closing phase, where we develop a closeout plan that accounts for the remaining deliverables and provision of actionable data and/or the final product.

While initially developed to better manage clinical trial complexity, the Trusted Process® is also actively deployed in our early phase, real world and late phase (“RWLP”), functional service provider (“FSP” or “FSP360”), Global Client Solutions, and Syneos One® offerings. Additionally, it is being adapted and deployed as warranted within our commercial service portfolio to further drive efficiency, consistency, and quality in our integrated operations.

Functional Service Provider Model. Our FSP360 model provides flexible resourcing solutions in the areas of biostatistics and programming, data management, drug safety and pharmacovigilance, study start-up, medical writing, clinical monitoring, trial master file support, and site and investigator payments. Our model includes a comprehensive plan designed to ensure both speed and quality for operations, relationship management, communication, quality and risk mitigation, and internal processes and tools. We collaborate extensively across functional teams to ensure customer needs are appropriately identified and supported.

Adding value across the biopharmaceutical product life cycle. We believe our ability to utilize our broad experience, data assets, and information technology assets across our full suite of services uniquely positions us to provide solutions that help biopharmaceutical customers optimize execution and reduce costs throughout the product development life cycle using the following capabilities:

 

•

Superior clinical trial design: We believe our expanding clinical and commercial knowledge and our access to electronic medical records and claims data allows us to expedite the completion of clinical trials without sacrificing quality, improving the probability of regulatory approval, and subsequent commercial success.

10

 

Table of Contents

 

 

•

Enhanced site selection and patient recruitment: We utilize our data assets, behavioral insights, social media, communications capabilities, and our expanded portfolio of patient-direct, technology-enabled solutions to enhance the speed and success of site selection and patient recruitment. These capabilities provide additional value with effective patient engagement, particularly for compliance with protocol requirements, and long-term patient retention.

 

•

Proactive pre-launch reimbursement and formulary management: We bridge the gap between clinical development and commercialization by using insights derived from our diverse capabilities and ability to communicate clinical benefits to payers and Pharmacy Benefit Managers (“PBMs”) to help optimize reimbursement and patient access.

 

•

Effective commercial product launch capabilities: We help our customers navigate the global complexities of launching a product by orchestrating interconnected work streams to develop and execute an effective product launch strategy that incorporates current therapeutic insights and market realities.

 

•

Full-service commercial: We enable companies to develop, launch, and commercially support their brands by accessing our comprehensive solutions, and acting as their virtual commercialization infrastructure. In 2021, approximately 33% of our commercialization customers purchased services from more than one of our commercialization services offerings. These customers represented approximately 88% of our Commercial Solutions revenue in 2021.

 

•

Efficient project ramp-up: We scale clinical or commercial projects rapidly and effectively through our recruiting, training, and deployment capabilities, leveraging our dedicated recruiting personnel and our proprietary database of approximately 1.1 million industry professionals.

Harmonizing diverse data via Dynamic Assembly® to create “asset customized” insights. Our strategic, capital-efficient approach to data and technology, Dynamic Assembly®, allows us to quickly address the nuances of each customer challenge from their clinical trial protocol through to their commercial product launch. Our open, source-agnostic and flexible architecture focuses on integrating quality data with the insights and best practices we have established during our decades of developing and commercializing biopharmaceutical products. We have access to significant data assets from a diverse number of sources including a variety of third-party data and technology providers, as well as our clinical and commercial operations. Our recent acquisitions of StudyKIK and RxDataScience are intended to deliver new technology-enabled, data-driven insights to customers, helping to improve access to and diversity in clinical trials. Together, our acquisitions and partnerships with best-of-breed providers for Dynamic Assembly are helping customers harmonize multiple data types and sources, both structured and unstructured, creating new “asset-customized” data aimed at achieving deeper patient behavioral learnings and insights.

Agile, insights-driven virtual/digital solutions. We believe our innovative digital solutions, underpinned by our unique combination of therapeutic and behavioral insights, position us to address the evolving market dynamics in which our customers operate. These solutions include:

 

•

Decentralized Solutions is our clinical model that allows for configurable, decentralized trials using a patient-centric approach supported by Dynamic Assembly to move beyond traditional trial design. We partner with best of breed technology and data providers, including some of our own – and leverage our clinical and commercial insights, therapeutic expertise, and knowledge of the site and patient communities – to design solutions that best fit the needs of a particular customer and protocol.

11

 

Table of Contents

 

 

•

Technology-enabled solutions. These solutions help to drive increased performance in areas like clinical trial diversity, clinical trial protocol insights, decentralized clinical trials, real world evidence generation, and omnichannel analytics. For example, Kinetic is designed to optimize HCP engagement and accelerate patient referrals into clinical trials through advanced targeting and digital capabilities. Kinetic is our modern customer engagement capability that integrates intelligence to accelerate impact and optimize commercial performance of customer brands. This omnichannel capability enables our field teams to transition to virtual and hybrid teams, while overlaying new digital capabilities. As adoption of telehealth and digital channels increases, a greater number of siloed and uncoordinated channels are touching HCPs. This leads to reduced effectiveness of commercial programs. Kinetic addresses this challenge by deploying advanced targeting, analytics, and the latest technologies – powered by a team of data scientists and behavioral experts – to create connected intelligence across channels, platforms, and content. The net result of Kinetic is optimized outcomes for our customers, leveraging the appropriate combination and timing of communications to drive improved brand performance.

 

•

Therapeutic expertise and organizational alignment. We believe our approach for aligning Clinical Solutions business units therapeutically, particularly local country team alignment of clinical research associates (“CRAs”) by therapeutic area, differentiates us from our competitors and has played a key role in our growth, ability to win new clinical trials, and the successful relationships we have developed with clinical research sites. Our therapeutic expertise is managed by our senior leadership and delivered by our senior scientific and medical staff. Looking ahead, we are strengthening our local country teams for effective employee engagement while maintaining our advantage of therapeutically aligning CRAs. We believe this “global to local” therapeutic approach improves the effectiveness and efficiency of our customers’ clinical trials by ensuring that our clinical staff working at our investigative sites have the therapeutic expertise and experience required to manage clinical trials. We also believe our specialized therapeutic expertise within our Commercial Solutions segment is unique in our industry and is becoming increasingly important to our customers as therapies become more complex and targeted. Our experienced medical and scientific professionals include more than 1,700 employees with M.D.s, Ph.D.s, or Pharm D.s. These employees apply innovative insights and science to clinical trials as well as to the commercialization of products and support customers across both our Clinical Solutions and Commercial Solutions segments.

Industry-leading principal investigator and clinical research site relationships. We have extensive, often longstanding relationships with principal investigators and clinical research sites. We believe quality site relationships are critical for delivering clinical trial results on time and on budget for our customers. Motivated and engaged investigator sites can facilitate faster patient recruitment, increase retention, maintain safety, ensure compliance with protocols as well as with local and international regulations, and streamline reporting. We have dedicated personnel focused on enhancing clinical research site relationships. We work with these sites in collaborative partnerships to improve cycle times and standardize start-up activities to drive efficiency.

12

 

Table of Contents

 

Diversified customer base with a growing number of preferred provider relationships. We have a customer base of over 800 customers that includes nearly all of the 50 largest global biopharmaceutical companies (based on annual investment in research and development). Additionally, our customer base is geographically diverse with well-established relationships in the United States (“U.S.”), Europe, and Asia. We have several customers with whom we have achieved “preferred provider” or strategic alliance relationships. We define these customers as relationships from which we generate significant revenue and where we have executed master service agreements in addition to regularly scheduled strategy meetings to discuss the status of our relationship, and for which we serve as a preferred supplier of services. We have also entered into strategic agreements with small to mid-sized (“SMID”) biopharmaceutical companies to develop their full portfolio of products from early clinical development through commercialization. We believe these relationships provide us enhanced opportunities for more business, although they are not a guarantee of future business. Our 2020 acquisition of Synteract further enhanced our leading position for serving customers across the SMID category, diversifying our customer base and expanding support to the high-growth emerging biopharmaceutical segment. We continue to experience strong SMID demand, as evidenced by double-digit growth in our request-for-proposal volumes in 2021 as compared to 2020.

Highly experienced management team with a successful track record of delivering growth. We have a dedicated executive management team with significant experience and knowledge focused on the biopharmaceutical industry. Each member of our leadership team has 15 years or more of experience, including experience with biopharmaceutical companies, payers, healthcare systems, and outsourced services providers. This team has successfully grown our company into a leading biopharmaceutical solutions organization through a combination of organic growth and strategic acquisitions.

Our Business Strategy

Our goal is to increase our market share and improve our market position. We believe our end-to-end product development model, where clinical insights inform commercialization and commercial insights improve clinical trial design and execution, is unique to the industry. The key elements of our business strategy include:

Further penetrate the large pharmaceutical market. We believe one of the largest opportunities to increase our market share and improve our market position is to further penetrate large pharmaceutical companies. Large pharmaceutical companies have increasingly focused on partnering with larger outsourcing vendors that offer a full suite of service capabilities. We have invested in expanding our global scale, breadth of services, and infrastructure to build up our service capabilities for this customer sector.

Continued penetration of the small and mid-sized biopharmaceutical market. We are a leader in the small and mid-sized biopharmaceutical market, which is the fastest growing segment of the market, and we believe there is further opportunity to grow this segment. Our 2020 acquisition of Synteract further enhanced our leading position for serving SMID customers, diversifying our customer base and expanding support to high-growth emerging biopharmaceutical companies. Small and mid-sized biopharmaceutical companies typically have fewer internal resources, less existing infrastructure, and less clinical development and commercialization experience. This customer segment is attracted to our full suite of clinical and commercialization services, our Syneos One® offering, our therapeutic expertise and organizational alignment down to the CRA level, and our Trusted Process® operating model.

13

 

Table of Contents

 

Bring differentiated solutions to the market and increase cross-selling opportunities. We believe we are uniquely positioned to address our customers’ evolving needs as the only fully integrated provider of a full suite of services across the product development continuum. Our breadth of services enables us to provide customized solutions designed to successfully accelerate the time to market for our customers’ clinical or commercial projects. We believe sharing commercial insights during the early phases of clinical trials can lead to better informed decisions around clinical trial design and strategies. Similarly, we believe our therapeutic and clinical trial expertise can lead to improved decisions about regulatory and payer approvals, market access, reimbursement and formulary inclusion, field team development, and other steps that are critical to the commercial success of our customers.

We believe that we have substantial opportunities to expand the reach of services that we provide to our existing customers. Given our past success in expanding the scope of services provided to current customers, we intend to further expand our business with our existing customers by cross-selling additional clinical and commercial services.

Strengthen our geographic footprint. We have developed a global platform with a presence in all of the major biopharmaceutical markets and intend to further expand our business outside of the U.S., targeting regions where we are underpenetrated and that offer significant growth opportunities. We have expanded our capabilities, existing relationships, and local regulatory knowledge, which we believe will continue to position us well for new customer wins in a wide array of markets. We have added geographic reach through both acquisitions and organic growth in areas such as Asia-Pacific, Latin America, the Middle East and Africa, and Europe, which we believe is critical to obtaining business awards from large and mid-sized biopharmaceutical companies. We may also selectively identify and acquire complementary businesses to enhance our services, capabilities, and geographic presence.

Capitalize on industry trends favoring outsourcing. Our Clinical Solutions and Commercial Solutions segments are benefiting from specific industry trends that are expected to drive attractive growth rates. Global demand for biopharmaceutical products continues to increase, driven by expanding access to healthcare, increasing life expectancy, and the growing prevalence of chronic conditions in both developed and emerging markets. However, higher costs and increased complexity are driving our customers to seek efficiency and expertise through outsourcing services. We believe outsourcing both clinical development and commercialization services optimizes returns on invested R&D for biopharmaceutical companies. Further, as business models continue to evolve in the healthcare sector, we believe that the rate of commercial outsourcing may follow a similar long-term path as that of the clinical development market.

Drive acceleration of commercial outsourcing with our Syneos One® offering. We believe regulatory approval is only the first step towards a successful outcome, as our customers cannot earn a positive economic return for their asset until they achieve significant adoption in the commercial marketplace. We believe our Syneos One® offering is uniquely positioned to determine the appropriate mix of clinical and commercial solutions to help customers optimize the development process of their products and maximize the return on their investment. In addition, Syneos One® enables multiple selling points along the operational timeline of product development. The need for a full suite of product development services is particularly strong with our small to mid-sized customers in the near-term, given their increased access to funding to bring a product to the market coupled with their limited internal resources. Large biopharmaceutical companies may represent a long-term opportunity if market pressures to reduce fixed-cost infrastructures further intensify. Given our strong relationships in both customer segments and our breadth of services, including our focus on Medical Affairs, we believe we are well positioned to capitalize on the needs of both customer types.

14

 

Table of Contents

 

Meet demand for comprehensive commercialization solutions. Customer preference and the complexity of product development in the modern market is creating increasing demand for a full-service experience for commercial customers. We believe a move to more integrated outsourcing will drive future growth and further diversify our revenue and backlog. This full-service model creates a collaborative relationship, allowing for solutions that incorporate data and insights to drive patient-centric approaches. This combination helps achieve the customer’s goal of maximizing product performance while diversifying our Commercial portfolio, which we believe can drive more predictable revenue.

Successfully acquire and integrate companies and evaluate and pursue other strategic initiatives to augment our organic growth. As part of our ongoing business strategy, we regularly evaluate new opportunities for growth through strategic initiatives, including potential acquisitions, investments, dispositions, or other transformative transactions.

We closed the following strategic acquisitions during 2021:

 

•

StudyKIK, a leading clinical trial recruitment and retention company, expanding our portfolio of patient-direct, technology-enabled solutions. StudyKIK supports patient recruitment, patient retention, eConsent Solutions, Telemedicine Video Calling, and study companion mobile applications to expedite clinical trials, which we believe will result in benefits to customers including accelerated patient enrollment and retention, extensive patient population-based insights, improved site, sponsor, and physician experiences, and reduced patient burden.

 

•

RxDataScience, a specialist organization that helps biopharmaceutical customers solve challenging problems through advanced analytics, data management, and artificial intelligence. RxDataScience is well aligned to our lab to life model offering advanced analytic solutions across the entire product development spectrum from clinical through commercial.

Over the past decade, we have developed a systematic approach for integrating strategic and tuck-in acquisitions. These acquisitions have enabled us to provide fully integrated clinical and commercial solutions and expand our global service offerings while also allowing us to achieve significant synergies and cost reductions. We intend to continue evaluating selective strategic growth opportunities that we believe will enhance our services offerings and geographic presence and thereby create value for our shareholders.

Continue to enhance our Trusted Process® methodology to deliver superior outcomes. We intend to continue the development and enhancement of our Trusted Process® methodology, which has delivered measurable, beneficial results for our customers and provides actionable data that can expedite drug development decisions. While originally developed through years of experience and refinement in our Clinical Solutions segment, we are proactively evaluating opportunities to also deploy the Trusted Process® within our RWLP, FSP360 and Syneos One® offerings and is being adapted and deployed as warranted across our commercial service portfolio to further drive efficiency, consistency, and quality in our integrated operations. We believe our Trusted Process® will continue to lead to high levels of customer satisfaction, particularly as we evolve to a product life cycle operating model.

15

 

Table of Contents

 

Our Services

We provide services through two reportable segments: Clinical Solutions and Commercial Solutions. Each reportable segment provides multiple service offerings that – when combined through the sharing of critical insights and data – creates a fully-integrated biopharmaceutical outsourced services provider. Our Clinical Solutions segment offers a variety of clinical development services spanning Phase I to Phase IV, including full-service global studies, unbundled service offerings, and real world evidence studies. Our Commercial Solutions segment provides customers with the full range of commercialization solutions, which include specialized field teams, communications solutions (advertising, public relations, and medical communications), and consulting services.

Clinical Solutions

Our extensive range of clinical solutions supports the entire clinical development process from Phase I to Phase IV and allows us to offer our customers an integrated suite of investigative site support and clinical development services. We offer these services across a wide variety of therapeutic areas with deep clinical expertise for Phase I to Phase IV clinical trials. We have particular strengths in the complex therapeutic areas such as neuroscience and hematology/oncology with the latter representing the largest and fastest growing therapeutic area. We provide total biopharmaceutical program development through our full-service platform, while also providing discrete services for any part of a trial, primarily through our FSP360 group. The combination of service area experts and the depth of clinical capability allows for enhanced protocol design and actionable clinical trial data. Importantly, all of our services in Clinical Solutions operate with the discipline of the Trusted Process®. Our comprehensive suite of clinical development services and delivery platforms includes:

16

 

Table of Contents

 

Full-service Clinical Development

Our full-service clinical development offering provides comprehensive solutions to address the clinical development needs of our customers for Phase I to Phase IV clinical trials. Our solutions can be delivered on a full-service project basis, on a functional or resource basis (see FSP360 below), or through a hybrid approach depending on the needs of our customers. We are able to customize our services to provide customers support within an individual clinical study, a single function, multiple functions within a single therapeutic area, or across a customer’s entire product portfolio. Our comprehensive suite of clinical development services includes the following, among others:

 

•

Patient Recruitment and Retention. Our patient recruitment services group helps identify and manage appropriate vendors, focuses on patient recruitment and retention strategies by utilizing our patient-direct, technology-enabled solutions, and acts as a liaison to media outlets and other vendors. These services also provide significant value for patient engagement and long-term retention throughout the conduct of a trial.

 

•

Site Start-Up. Our site start-up team helps maximize the enrollment period of the study by arranging applicable regulatory authority and ethics committee approvals, site contract negotiations, regulatory authority submissions, and the corresponding oversight of those activities.

 

•

Project Management. Our project managers and directors provide customer-focused leadership in managing clinical trials and are accountable for the successful execution of all assigned projects, where success includes on-time, on-budget, and high quality results that lead to satisfied customers. Project managers and directors have the skills, education, experience, and training to support the successful conduct of clinical trials.

 

•

Clinical Monitoring. Our CRAs oversee the conduct of a clinical trial by working with and monitoring clinical research sites to ensure the quality of the clinical data being gathered by the sites. The clinical monitor ensures the clinical trial is conducted according to Good Clinical Practice (“GCP”), International Conference on Harmonisation (“ICH”) guidelines, and local regulations, to meet the customers’ and regulatory authorities’ requirements according to the study protocol. CRAs engage with clinical research sites in site initiation, training, and patient recruitment. We deploy and manage CRAs in all regions of the globe.

 

•

Decentralized Solutions. The COVID-19 pandemic has accelerated the adoption of remote engagement with sites and patients, creating increased demand for decentralized solutions capabilities, including the provision of mobile research nursing clinical trial services. This is an area we invested in both before and during the pandemic, allowing us to quickly respond to demand. Our approach brings together our experts, data, process, and technology to create fit-for-purpose solutions to address the nuances of each study. This approach delivers on our goal of achieving decentralized clinical trial operations supporting sites and patients, focused on patient recruitment and retention, engagement, improved access, and patient diversity.

 

•

Drug Safety/Pharmacovigilance. Our drug safety teams are strategically located across the U.S., Europe, Latin America, and Asia-Pacific. We provide global drug safety expertise in all phases of clinical research for serious adverse event/adverse event collection, evaluation, classification, reporting, reconciliation, post-marketing safety, and pharmacovigilance.

17

 

Table of Contents

 

 

•

Quality Assurance. Quality control steps are built into all of our processes. We have an independent quality assurance department that, in addition to conducting independent audits of all ongoing projects and processes as part of our internal quality assurance program, offers quality assurance services to customers, including audits of clinical research sites and of various vendors to the clinical research industry, mock regulatory inspections and clinical research site inspection-readiness training, standard operating procedure development, and quality assurance program development/consultation.

 

•

Regulatory and Medical Writing. We offer regulatory and medical writing expertise across the entire biopharmaceutical product life cycle. Our team has hands-on regulatory and medical writing knowledge gained through experience from working in large biopharmaceutical companies, as well as high-growth, small and mid-sized biopharmaceutical companies, CROs, and the FDA. Additionally, each member is trained in FDA regulations, including GCP/standard operating practice compliance guidelines and guidelines established by the ICH.

 

•

Clinical Data Management. Our clinical data management services allow us to confirm that the clinical trial database is ready, accurately populated, and locked in an expeditious manner, with verification and validation procedures throughout every phase of a clinical trial. This processing is done in synchronization with the clinical team, utilizing the information provided from the clinical trial to help ensure efficient processes are employed, regardless of the data collection method used.

 

•

Electronic Data Capture. To compete in today’s changing global drug and device development environment, companies must collect and distribute data faster than ever. We have the ability to manage electronic data capture (“EDC”) systems and processes to help our customers take advantage of the efficiencies available through EDC, which include improved access to data, reduced cycle time, increased productivity, and improved relationships with customers, vendors, and other parties.

 

•

Biostatistics. Our biostatistics team has a depth of experience with the FDA and EMA that allows our teams to provide customers with guidance on building a statistical plan to meet regulatory and safety requirements as well as a careful analysis of the resulting study data. In addition, we provide support for independent drug safety monitoring boards and a full range of related services. Our biostatisticians are also heavily involved in our Trusted Process® methodology, so that protocol and project development can be grounded in advanced statistical methodology. As part of a project team, our biostatisticians can provide data oversight throughout a clinical trial and address any data or data handling issues that may arise.

FSP360

Our FSP360 offering helps sponsors review their approach to key functional areas of clinical research, specifically those areas not core to their clinical development business or in areas where they need to augment internal resources. We are able to customize our full-service offering to provide customers support within an individual clinical study, a single function, multiple functions within a single therapeutic area, or across a customer’s entire product portfolio. Any of our full-service clinical solutions outlined above can be delivered on an unbundled or functional basis or on a hybrid approach, based on our customers’ specific needs. We currently operate FSP360 hubs in North America, South America, Europe, and Asia.

18

 

Table of Contents

 

Early Phase

Our early phase offering provides a full range of services for Phase I to Phase IIA clinical trial conduct, bioanalytical assay development and analysis, targeted translational science offerings, and clinical pharmacology services, including modeling and simulation. We also provide validation and sample analysis services from pre-clinical development through post-marketing support and purpose-built early phase biometrics support from North America and India. We conduct clinical trial studies at our facilities located in Quebec City, Canada, and Miami, Florida. We have extensive experience in first-in-human, proof-of concept, bioequivalence and bioavailability, biosimilars, and clinical pharmacology study conduct. We collaborate with leading hospitals for the conduct of early development and clinical pharmacology studies that require access to patients. We have a large base of available subjects, including patient populations with specific medical conditions, and healthy volunteers, which provide efficient and rapid patient recruitment. Furthermore, we can also provide early stage and clinical pharmacology studies through our Asia-Pacific Catalyst Model with Phase I to Phase IIA conduct capabilities in Australia, New Zealand, South Korea, and Japan.

Our two bioanalytical laboratories located in Quebec City, Canada and Princeton, New Jersey have extensive experience in method development, validation, and bioanalytical analysis support for both small molecule therapeutics and biologics using a variety of analytical techniques and instrumentation platforms, as well as the provision of critical reagents handling services for biologics.

Real World Evidence and Late Phase Services

Our RWLP group conducts studies to understand how a treatment, service, or method of delivering care works when applied in real world, clinical practice environments. Because real world evidence (“RWE”) provides both clinical and commercial benefits, adding value for customers across the product life cycle, our end-to-end model position allows us to uniquely provide value to our customers in this space.

The market for these services is increasing as regulatory changes are encouraging the use of RWE and payers are demanding these outcomes. Customers are using RWE to supplement clinical efficacy and safety data, to build a value story and in designing and implementing a successful commercialization strategy. RWE shows relatively low levels of outsourcing penetration, offering a growth opportunity for us.

We provide both consultative and operational expertise to our customers in real world data generation, from concept through core development, launch, and commercialization. This is informed by our Dynamic Assembly platform, which allows us to expand our data access and analytic capabilities, enhancing our ability to help customers demonstrate product value. By utilizing our successful drug life cycle management, we ensure we partner with our customers to gain better outcomes for patients, physicians, payers, and regulators. These services allow our customers to make timely and cost-effective advances in clinical treatment by providing data about actual experience of doctors and patients outside of the regulated environment of clinical development. The data and insights from our experience across the commercialization spectrum inform the design and conduct of these studies. Our services include patient registries, surveillance and observational studies, patient/health outcomes research, and economic studies.

Commercial Solutions

Our Commercial Solutions segment provides a broad suite of complementary commercialization services including specialized field teams, communications solutions (advertising, public relations, and medical communications), and consulting services. Additionally, these capabilities provide behavioral and patient insights used by our Clinical Solutions segment to design smarter clinical trials and to accelerate patient recruitment. Our comprehensive capabilities portfolio also allows us to provide full-service commercialization. This integrated approach allows us to maximize product or portfolio performance for customers, by sharing insights and expertise across the integrated commercial outsourcing team.

19

 

Table of Contents

 

These services are enhanced by our Kinetic offering, our modern customer engagement capability. We use an intelligent and data-enabled approach to digitally enhance our Commercial Solutions by understanding the audiences for our customers’ products, synchronizing their experiences across multiple personal and digital channels and decoding the performance of these interactions to adapt in real-time.

Deployment Solutions

Deployment Solutions include field-based promotional and market access solutions, field-based clinical solutions, inside sales and contact center, insight and strategy design, patient support services, training, talent sourcing, and end-to-end sales operations. We provide contract field promotion teams with a broad array of capabilities, support services, and non-personal engagement solutions including tele-detailing and electronic detailing (“e-detailing”). Our field-based promotional teams are supported by recruiting and training capabilities, clinical and scientific professionals who advocate for and inform markets of novel therapies, and our customized patient behavioral models built on our proprietary insights and data-driven analytics. Services offered include market research, commercial analytics, managed markets access, biotechnology and specialty managed markets, and full-service commercialization. Our field promotion teams can be supported by our communications and consulting services.

 

•

Value Access and Medical Teams. We are a leading provider of outsourced Value Access and Medical Team solutions to the biopharmaceutical industry. Our Teams – consisting of Field Reimbursement and Market Access Specialists, Medical Science Liaisons (“MSLs”), Contract US Medical Directors, and/or Nurse Educators – educate healthcare professionals, patients, advocacy organizations, and others with evidence-based scientific and practical information about disease states, current treatments, reimbursement, access, and the use of customers’ products.

 

•

Promotional Field Teams and Support. We are an industry leader in providing scalable capabilities to recruit, train, target, deploy, and support successful biopharmaceutical sales teams. As one of the largest providers of outsourced sales teams and sales solutions to the healthcare industry, we have well-established flexible processes and infrastructure to efficiently build, scale, deploy, execute, and retain high-performing field sales teams.

 

•

Commercial Recruiting Solutions. We are a market leading recruiting partner to the commercial life science industry based on our experience, branding capabilities, talent assessment process, and our proprietary talent database of the top MSL, Nurse Educator, Sales, Sales Management, and Market Access performers.

 

•

Training and Learning Solutions. We are a full-service provider of practical, high-impact training solutions that combine assessment, instructional design expertise, delivery services, interactive technologies, and deep subject matter expertise to assist customers globally in achieving business results.

 

•

Operations Support Services. We offer comprehensive, best-in-class operations support services that include field automation hardware/software, data management, targeting and alignment, analytics and reporting, incentive plan design and implementation, quality management, and help desk. These capabilities are used both individually and collectively to ensure that our deployed field teams perform optimally, respond rapidly to changing marketplace dynamics, and continuously improve. 

 

•

Digital Enhancement. Our Deployment Solutions offerings leverage Kinetic to enhance established relationships. The relationships between HCPs and our field representatives remain central to the customer experience. However, Kinetic allows us to create virtually-enabled representatives, especially important for continuity during the pandemic, while overlaying new digital capabilities to optimize brand performance.

20

 

Table of Contents

 

Communications Services

Our healthcare focused communications services offering provides advertising, public relations, interactive digital strategies, branding and identity consulting services, and medical communications and education services. These services are scalable, as we can support product commercialization both domestically and internationally. Communications services are deployed throughout a product’s existence, beginning well before commercial launch, encompassing regulatory approval and market introduction, and continuing throughout the life of a product.

 

•

Healthcare Advertising. We are one of the largest independent global communications groups in the world. Our advertising teams are immersed in healthcare data and connected to frontline experts who help them delve deeply into the real-life experience of healthcare, harvesting insights to create optimal communications strategies. We help our customers navigate the most critical challenges in healthcare, including, but not limited to, brand launch, utilization of mass and personalized media, advertising content creation and campaigns, patient analysis, disease state campaigns, and market perception analysis. Our advertising teams have deep therapeutic expertise, with agencies solely dedicated to oncology, chronic disease care and activation, biologics, and industry innovation.

 

•

Public Relations. Our Public Relations teams develop creative campaigns grounded in deep customer insight and integrated under a multi-channel strategy. These programs raise awareness and produce meaningful, measurable behavior change among audiences. With a diverse set of healthcare communications specialties under one umbrella, we deliver integrated advice and expert insight from a variety of strategic perspectives. We offer best-in-class capabilities spanning public relations, digital and social media, medical and scientific education, and research and analytics. Our teams create communications that enhance brand perception, drive engagement, and activate behavior shifts.

 

•

Medical Communications. Medical Communications helps our customers to frame their product position in a way that clinicians will find relevant, and creates strategies, campaigns, and tactics to help these stakeholders at the right time, with the right content. Our Medical Communications team provides support through strategic planning, publication planning, content development, and peer-to-peer education.

Consulting Services

Our consulting services support critical decision points during a biopharmaceutical product’s life cycle, from licensing, to product and portfolio strategy development, to drug commercialization. Consulting services include commercial strategy development and planning, pricing and market access, medical affairs advisory, quality management and regulatory advisory, and risk and program management. We offer specialized practices in business development, managed markets, and brand management, including strategic product launch planning. Consulting services teams generate insights and solutions developed from their deep, functional knowledge of our customers’ core business. These services are centered on maximizing the commercial value of a client’s product pipeline, helping clinical leaders better deploy strategic resources, improve efficiency, and enhance the effectiveness of marketing and sales activities. Our overall consulting services capabilities include the following:

 

•

Commercial Strategy Development and Planning. Our strategic consulting group offers advisory services that include strategic drug development, clinical development plans, registration strategies, exit strategies, transitional clarity, good clinical practice compliance strategies, clinical operations optimization, pricing and reimbursement, and due diligence.

21

 

Table of Contents

 

 

•

Pricing and Market Access. Our team offers a full spectrum of market access solutions and services, including market assessment and analysis, comparative effectiveness research, pricing reimbursement, patient assistance services, and legislative and regulatory analysis.

 

•

Medical Affairs Advisory. Our Medical Affairs Advisory team assesses where customers are in their medical transformation by helping them identify their competitive position, prioritize their needs, understand their brand perception, and inform their market engagement strategy.

 

•

Quality Management and Regulatory Compliance Advisory. Our quality and compliance team delivers independent quality management services through audit, inspection, and implementation services, and assists our customers with developing and executing a clinical regulatory strategy through our Regulatory Content and Submission Management Services.

 

•

Risk and Program Management. Our communications consultants provide advice and subject matter expertise for risk evaluation on medicine affordability, compassionate use, and litigation and access barriers. We provide an evidence-based approach to ensure policy, patient, and provider acceptance on price, use best practices for how life sciences companies can deploy effective preventative strategies, implement compliance strategies to prepare for expanded access and compassionate use inquiries, and execute an Institute for Clinical and Economic Review strategy to demonstrate product value.

Customers

We have a well-diversified customer base of over 800 customers that includes nearly all of the world’s largest biopharmaceutical companies, which we define as the top 50 biopharmaceutical companies measured by annual R&D spend, as well as numerous emerging and specialty biotechnology companies, medical device and diagnostics companies. We are diversified across our segments, deriving 77% and 23% of our revenue during 2021 from our Clinical Solutions and Commercial Solutions segments, respectively.

For the year ended December 31, 2021, our revenue attributable to large biopharmaceutical companies represented approximately 49% of our total revenue and revenue attributable to small and mid-sized biopharmaceutical companies represented approximately 51%. Additionally, we serve customers in a variety of locations throughout the world, with approximately 60% of our 2021 revenue generated from work performed in the U.S. and Canada; 26% from Europe, the Middle East, and Africa; 11% from Asia-Pacific; and 3% from Latin America. This diversification allows us to grow our business in multiple customer segments and geographies.

Our top five customers accounted for approximately 22% of our revenue in 2021. Among the majority of our customers, revenue is diversified by multiple projects and services. We believe that the tenure of our customer relationships as well as the depth of penetration of our services reflects our strong reputation and track record. We believe we are uniquely positioned to further penetrate our existing customer base and expand our services across the biopharmaceutical industry, as a significant number of the top 50 biopharmaceutical companies utilize both our clinical and commercial services.

Sales and Marketing

Our global team of business development professionals and support staff identifies needs, designs solutions, and promotes our services to the biopharmaceutical, biotechnology, and medical device industries. In addition to significant customer engagement and development experience, many of these individuals have technical and scientific backgrounds.

22

 

Table of Contents

 

Our business development organization works with our leadership team to identify, develop, and maintain key customer relationships in addition to new business development activities. Teams use an integrated, customer-focused approach to develop joint engagement plans for key accounts. For many of our largest customer relationships, dedicated strategic account management teams under our Global Client Solutions and Syneos One® groups provide account leadership to meet financial goals, align delivery with strategic goals, and promote innovation. These teams are directly accountable for gross business award growth in our largest accounts by creating a differentiated customer experience, which is a key aspect of our growth strategy to improve patient access to new medicines by unleashing the power of our product development mindset and approach that drives value for patients and our customers.

The global reach and strong operational experience of our business development personnel ensure project demands are fulfilled. In general, each business development employee is responsible for a specific customer segment and for strengthening and expanding customer relationships. Each individual is responsible for developing a customer base, responding to customer requests for information, developing and defending proposals, and presenting to customers.

Competition

We operate in a number of highly competitive markets. Our competitors include a variety of companies providing services to the biopharmaceutical industry, including large CROs and smaller specialty CROs, large global communications holding companies, smaller specialized communications agencies, contract sales organizations, and a wide range of consulting companies. Both of our reportable segments face distinct competitors within the markets they serve. Notwithstanding competitive factors, we believe that our deep therapeutic expertise, global reach, integrated model, and operational strengths differentiate us from our competitors across both of our segments.

Clinical Solutions

Our Clinical Solutions segment competes primarily against other full-service CROs and services provided by in-house R&D departments of biopharmaceutical companies, universities, and teaching hospitals. Although the CRO industry has experienced increased consolidation in the past several years, the landscape remains fragmented. We generally compete on the basis of the following factors:

 

•

experience within specific therapeutic areas;

 

•

the quality and availability of staff and services;

 

•

the range of services provided;

 

•

the ability to recruit principal investigators and patients into studies expeditiously;

 

•

the ability to organize and manage large-scale, global clinical trials;

 

•

an international presence with strategically located facilities;

 

•

medical database management capabilities;

 

•

the ability to deploy and integrate IT systems to improve the efficiency of contract research;

 

•

experience with a particular customer;

 

•

the ability to form strategic partnerships;

23

 

Table of Contents

 

 

 

•

speed to completion;

 

•

financial strength and stability;

 

•

price; and

 

•

overall value.

Commercial Solutions

Our Commercial Solutions segment competes primarily against the in-house sales and marketing departments of biopharmaceutical companies, other contract pharmaceutical sales and service organizations, communications holding companies and specialized agencies, and consulting firms. We generally compete on the basis of the following factors:

 

•

experience within the specific therapeutic area;

 

•

quality of the staff and services;

 

•

creativity of the proposed solution;

 

•

perceived “chemistry” with the staff to be deployed;

 

•

previous experience with a particular customer;

 

•

price; and

 

•

overall value.

Government Regulation

The biopharmaceutical industry is subject to a high degree of governmental regulation in both domestic and international markets. Regardless of the country or region in which approval is being sought, before a marketing application for a drug is ready for submission to regulatory authorities, the candidate drug must undergo rigorous testing in pre-clinical studies and clinical trials. The clinical trial process must be conducted in accordance with the Federal Food, Drug and Cosmetic Act in the U.S. and similar laws and regulations in the relevant foreign jurisdictions (e.g., the European Union Clinical Trial Regulation). These laws and regulations require the candidate drug to be tested and studied in certain ways prior to submission for approval.

24

 

Table of Contents

 

Regulation of Our Clinical Solutions Segment

In the U.S., the FDA regulates the conduct of clinical trials of drug products in human subjects, and the form and content of regulatory applications. The FDA also regulates the development, approval, manufacture, safety, labeling, storage, record keeping, import, export, distribution, advertising, sale, and marketing of drug products. The FDA has similar authority and similar requirements with respect to the clinical testing of biological products and medical devices. In the EU and other jurisdictions where our customers intend to apply for marketing authorization (of drug products) or seek certification (of medical devices), similar laws and regulations apply. Within the EU, these requirements are enforced by the EMA and competent authorities of the EU member states. Additional national requirements vary slightly from one member state to another. In Canada, clinical trials are regulated by the Health Products Food Branch of Health Canada as well as provincial regulations. Similar requirements also apply in other jurisdictions, including Australia, Japan, and other Asian countries, where we operate or where our customers intend to apply for marketing authorization. Sponsors of clinical trials also follow the International Council for Harmonisation (“ICH”) Good Clinical Practice (“GCP”) guidelines, which are enforced by the FDA and other comparable regulatory authorities, and may be amended from time to time.

Our services are subject to various regulatory requirements designed to ensure the quality and integrity of the clinical trial process. In the U.S., we must perform our clinical development services in compliance with applicable laws, rules and regulations, including GCP and Good Pharmacovigilance Practice, which govern, among other things, the design, conduct, performance, monitoring, auditing, recording, analysis, and reporting of clinical trials. Before a human clinical trial may begin, the manufacturer or sponsor of the investigational drug or biologic must file an investigational new drug application (“IND”) with the FDA, which contains, among other things, the results of pre-clinical tests, manufacturing information, and other analytical data. A separate submission to an existing IND must also be made for each successive clinical trial conducted during product development. Each clinical trial conducted in the U.S. must be conducted pursuant to, and in accordance with, an effective IND. In addition, under GCP regulations, each human clinical trial we conduct is subject to the oversight of an independent institutional review board (“IRB”) which is an independent committee that has the regulatory authority to review, approve and monitor a clinical trial. The FDA, the IRB, or the sponsor may suspend or terminate a clinical trial at any time on various grounds, including a finding that the study subjects are being exposed to an unacceptable health risk.

Clinical trials conducted outside the U.S. are subject to the laws and regulations of the country where the trials are conducted. These laws and regulations might not be similar to the laws and regulations administered by the FDA and other laws and regulations regarding the protection of patient safety and privacy and the control of study pharmaceuticals, medical devices or other study materials. Studies conducted outside the U.S. can also be subject to regulation by the FDA if the studies are conducted pursuant to an IND, or in the case of a medical device, an investigational device exemption. It is the responsibility of the study sponsor or the parties conducting the studies to ensure that all applicable legal and regulatory requirements are fulfilled.

In order to comply with GCP and other regulations, we must, among other things:

 

•

comply with specific requirements governing the selection of qualified principal investigators and clinical research sites;

 

•

obtain specific written commitments from principal investigators;

 

•

obtain review, approval, and supervision of the clinical trials by an IRB or ethics committee;

 

•

obtain favorable opinion from regulatory agencies to commence a clinical trial;

 

•

verify that appropriate patient informed consents are obtained before the patient participates in a clinical trial;

25

 

Table of Contents

 

 

•

ensure that adverse drug reactions resulting from the administration of a drug or biologic during a clinical trial are medically evaluated and reported in a timely manner;

 

•

monitor the validity and accuracy of data;

 

•

monitor drug, biologic or device accountability at clinical research sites; and

 

•

verify that principal investigators and study staff maintain records and reports and permit appropriate governmental authorities access to data for review.

Similar regulations and guidelines exist in various states and in other countries. In the EU, similarly to the U.S., the various phases of non-clinical and clinical research are subject to significant regulatory controls. Clinical trials of medicinal products must be conducted in accordance with EU and national regulations and the ICH guidelines on GCP, as well as the applicable regulatory requirements and the ethical principles that have their origin in the Declaration of Helsinki. If the sponsor of a clinical trial is not established within the EU, it must appoint an EU entity to act as its legal representative.

 

The regulatory landscape related to clinical trials in the EU has been subject to recent changes. The EU Clinical Trials Regulation (“CTR”), which was adopted in April 2014 and repeals the EU Clinical Trials Directive, became applicable on January 31, 2022. Unlike directives, the CTR is directly applicable in all EU member states, as well as Norway, Liechtenstein and Iceland, without the need for member states to further implement it into national law. The CTR notably harmonizes the assessment and supervision processes for clinical trials throughout the EU via a Clinical Trials Information System, which contains a centralized EU portal and database.

The United Kingdom (“UK”) left the EU on January 31, 2020, following which existing EU medicinal product legislation continued to apply in the UK during the transition period under the terms of the EU-UK Withdrawal Agreement. As of January 1, 2021, the Medicines and Healthcare products Regulatory Agency (“MHRA”) is the UK’s standalone medicines and medical devices regulator. MHRA seeks to amend the UK Medical Devices Regulations 2002 (which are based on EU legislation), in particular to create new access pathways to support innovation, create an innovative framework for regulating software and artificial intelligence as medical devices, reform in vitro diagnostics regulation, and foster sustainability through the reuse and remanufacture of medical devices. The new regime is expected to come into force in July 2023, coinciding with the end of the acceptance period for EU CE marks in Great Britain, subject to appropriate transitional arrangements.

We may be subject to regulatory action if we fail to comply with applicable rules and regulations. Failure to comply with certain regulations can also result in the termination of ongoing research and disqualification of data collected during the clinical trials. For example, violations of GCP could result, depending on the nature of the violation and the type of product involved, in the issuance of a warning letter, suspension or termination of a clinical study, refusal of the FDA or other comparable regulatory authorities to approve clinical trial or marketing applications or withdrawal of such applications, injunction, seizure of investigational products, civil penalties, criminal prosecutions, or debarment from assisting in the submission of new drug applications. See Part I, Item 1A, “Risk Factors – Risks Related to Our Business – If we fail to perform our services in accordance with contractual requirements, regulatory requirements, and ethical considerations, we could be subject to significant costs or liability and our reputation could be harmed.”

We monitor our clinical trials to test for compliance with applicable laws and regulations in the U.S and the foreign jurisdictions in which we operate. We have adopted standard operating procedures that are designed to satisfy regulatory requirements and serve as a mechanism for controlling and enhancing the quality of our clinical trials. In the U.S. and in foreign jurisdictions where we operate, our procedures were developed to ensure compliance with GCP and associated guidelines.

26

 

Table of Contents

 

In addition to its comprehensive regulation of safety in the workplace, the U.S. Occupational Safety and Health Administration has established extensive requirements relating to workplace safety for healthcare employers whose workers might be exposed to blood-borne pathogens such as HIV and the hepatitis virus. Furthermore, certain employees might have to receive initial and periodic training to ensure compliance with applicable hazardous materials regulations and health and safety guidelines. We are subject to similar regulations in Canada and Spain.

Regulation of Our Commercial Solutions Segment

The safety of medicines continues to be monitored after drug product approvals and throughout their use in healthcare practice. Post-marketing safety surveillance is therefore also subject to FDA regulations as well as the EU Pharmacovigilance Legislation and other countries’ regulations.

In addition, our field personnel are subject to all laws, rules and regulations governing the promotion of pharmaceutical products in the U.S. and in every other country where such personnel perform work. In particular, these rules and regulations include limitations on the indications for which a product may be promoted and on promotional spending. Additionally, these laws, rules and regulations govern the manner in which the product may be promoted, and the scientific exchange of information related to the product. Violations of these rules may leave us at risk of direct regulatory enforcement action and/or cause us to be in breach of contract with our customers.

Some of our field personnel handle and distribute samples of pharmaceutical products. In the U.S., the handling and distribution of prescription drug product samples are subject to regulation under the Prescription Drug Marketing Act and other applicable federal, state and local laws and regulations and other countries may have similar laws or regulations. These laws and regulations regulate the distribution of drug samples by mandating procedures for storage and record-keeping requirements for drug samples and ban the purchase or sale of drug samples. Further, we must comply with the requirements of the U.S. Drug Enforcement Administration, which regulates the distribution, record-keeping, handling, security, and disposal of controlled substances.

Our communications solutions offerings are subject to all regulatory risks applicable to similar communications businesses as well as risks that relate specifically to the provision of these services to the biopharmaceutical industry. Such regulatory risks include enforcement by the FDA and the Federal Trade Commission in the U.S., Health Canada, the Department of Health in the UK, competent authorities of the EU member states, as well as state agencies and other foreign regulators enforcing laws relating to product advertising, false advertising, and unfair and deceptive trade practices. In addition to enforcement actions initiated by government agencies, there has been an increasing tendency in the U.S. and in foreign jurisdictions among biopharmaceutical companies to resort to the courts and industry and self-regulatory bodies to challenge comparative prescription drug advertising on the grounds that the advertising is false and deceptive. There continues to be an expansion of specific rules, prohibitions, media restrictions, labeling disclosures, and warning requirements with respect to the advertising for certain products.

27

 

Table of Contents

 

Data Protection Regulation

We are subject to data protection laws and regulations in the countries in which we operate that address the privacy, security and other processing of personal information. These laws and regulations govern the collection, use, handling and disclosure of health-related and other personal information and require that we adopt and maintain reasonable and appropriate security measures that are designed to protect the confidentiality, integrity and availability of the information. These laws and regulations also typically require the adoption and maintenance of procedures that facilitate the exercise of an individual’s rights with respect to the information about them. Certain of these laws may also contain requirements relating to the location of the personal information, or the transfer of personal information from one country or region to other countries. Examples of data protection laws and regulations to which we may be subject include Canada’s Personal Information Protection and Electronic Documents Act, the EU’s General Data Protection Regulation (“GDPR”), and the California Consumer Privacy Act (“CCPA”). For additional information regarding these laws and regulations and their potential impacts on our business, see Part I, Item 1A, “Risk Factors – Risks Related to Our Business – Current and proposed laws and regulations regarding the protection of personal data could result in increased risks of liability or increased cost to us or could limit our service offerings.”

Intellectual Property

We develop and use a number of proprietary methodologies, analytics, systems, technologies, and other intellectual property in the conduct of our business. We rely upon a combination of confidentiality policies, nondisclosure agreements, and other contractual arrangements to protect our trade secrets, and patent, copyright and trademark laws to protect other intellectual property rights. We have obtained or applied for patents, trademarks and copyright protection in the U.S. and in a number of foreign countries. Our material trademarks include Trusted Process®, PlanActivation®, QuickStart®, ProgramAccelerate®, QualityFinish®, Shortening the distance from lab to life®, Syneos One®, Biopharmaceutical Acceleration Model®, Dynamic Assembly®, KineticTM, Syneos Health, and other corporate emblems. Although the duration of our intellectual property rights varies from country to country, trademarks generally may be renewed indefinitely so long as they are in use and/or their registrations are properly maintained, and so long as they have not been found to have become generic. Although we believe that the ownership of trademarks is an important factor in our business and that our success does depend in part on the ownership thereof, we rely primarily on the innovative skills, technical competence, and marketing abilities of our employees. We do not have any material patents, licenses, franchises, or concessions.

Human Capital Resources

As of December 31, 2021, we had 27,525 employees. Of these, 26,751 employees were regular and 774 were temporary. An additional 610 contingent workers provided services for us.

Our Culture and Values. Our culture is the cornerstone of all our human capital programs. Our shared purpose, Shortening the Distance from Lab to Life®, aligns our employees and the customers we serve. This purpose is surrounded by three agile-oriented values, designed to foster innovation, including Challenge the Status Quo, Collaborate to Deliver Solutions, and Passionate to Change Lives. We work hard and smart to speed much-needed therapies to those who need them most. This environment is fueled by a belief in caring for our collective well-being, which we refer to as Total Self. This belief enables employees to be their authentic selves at work, fostering a diverse, equitable, and inclusive culture where employees are empowered.

28

 

Table of Contents

 

Safety and Health. The safety, health, and welfare of our employees are paramount to us. We work closely with our customers and regulatory agencies to continuously monitor our employees’ working conditions and implement measures to ensure their wellness. During 2021, in response to the ongoing COVID‑19 pandemic, we continued extensive safety measures to protect our employees, enabling the organization to continue to work with customers pursuing innovative ways to get effective therapies to patients as quickly as possible. These efforts included a U.S. employee vaccination mandate, adherence to stringent safety protocols for employees working at clinical study sites, and compliance with local government regulations. These efforts were further supported by extensive internal and external CEO-led communications supported by our medical community, making all stakeholders aware of the precautions taken to protect the health and safety of our employees and their families, our customers, patients, and communities.

Diversity, Equity, and Inclusion (“DE&I”). We strive to lead our industry in our DE&I efforts both internally and externally. We believe that addressing complex healthcare challenges requires contributions from diverse viewpoints and an inclusive, equitable space where our employees are able to succeed to their highest potential. We strive to foster a work environment that includes and embraces racial, ethnic, and gender diversity and other individual differences. Our policies prohibit unlawful discrimination based on race, color, creed, gender, religion, marital status, age, national origin or ancestry, genetic information, physical or mental disability, medical condition, sexual orientation, gender expression or identity, or any other characteristic protected by applicable law. The emphasis placed on DE&I by the Company and by our Board of Directors (the “Board”) is demonstrated by the inclusion of DE&I updates and metrics in the materials for each meeting of the Compensation and Management Development Committee of the Board. In addition, we have also created an external DE&I Advisory Council where we provide our clients with top-tier expertise to navigate corporate and healthcare initiatives.

As of December 31, 2021, 68% of our total workforce were women. Additionally, 56% of our management roles at Director level and above and 69% of our new hires in 2021 were women. Throughout 2021, 33% of our new hires in the U.S. were minorities. Our DE&I strategy is enabled by our DE&I Council, which was established in 2020, led by an executive leadership team member and comprised of leadership who represent and/or have oversight of our global, regionally diverse workforce. The Council oversees and strategically plans for diversity and inclusion within our Company under three pillars of focus: People, Customer, and Community.

Throughout 2021, we grew our existing Employee Resource Groups (“ERGs”) across the globe: Women, Veterans, LGBTQIA+ and Black. We also formed three new ERGs: Asian, People with Disabilities, and Developing Professionals. These ERGs further honor and support our inclusive environment of Total Self through building and supporting internal communities. We also have several development programs dedicated to women and minority representation in leadership, including actively partnering with the Healthcare Businesswomen’s Association, partnering with McKinsey Leadership programs targeting our underrepresented leadership populations, and establishing mentoring programs within our ERGs. We have a zero-tolerance policy on discrimination and harassment and have several programs under which employees can report incidents confidentially or anonymously and without fear of reprisal.

Recruitment, Retention and Development. The primary ways we recruit and retain employees are by (1) ensuring that our compensation and benefits are competitive in our industry and in local labor markets, (2) ensuring our leadership and development programs support our culture and values while preparing people for the future, and (3) maintaining an effective service delivery model conducive to work-life balance and employee needs.

Our Global Talent Acquisition Team leverages numerous resources including industry networks, online and social media platforms, university relations, and industry-focused career events to source talent for open positions. Candidates are thoroughly screened and evaluated against job-specific skills, experience, and education criteria. We continuously work at improving our candidate experience, which has been recognized seven years in a row with a North American Candidate Experience (“CandE”) Award, awarded by the Talent Board for excellence in Talent Acquisition.

29

 

Table of Contents

 

In early 2021 we dedicated a small group of professionals, reporting to the Chief Human Resources Officer and the Chief Development Officer & Global Head Clinical Development Solutions, to focus on increased demand for clinical resources with an ultimate focus on our talent acquisition and retention strategies. This small and impactful team, called Enabling our Talent Advantage, or “ETA” is imbedded in the business and Human Resources (“HR”) organizations and focuses on talent optimization. Going beyond simply hiring replacements and additions, this team works with business leaders and our HR Centers of Excellence to refine policies, practices, and procedures to make it easier to join, work, and stay at Syneos Health. Examples of ETA initiatives include improving our internal mobility policy, developing feeder pools for key roles in support of our early talent strategy, and developing a line manager curriculum to better and more simply equip managers to support our workforce. 

We regularly evaluate our compensation and benefit programs using external market data and feedback from our Global Talent Acquisition Team and have established processes to make necessary revisions. Our Total Rewards Team introduced a new global salary structure to drive consistent enterprise-wide compensation and job level practices, ensuring our compensation remains competitive in the many countries in which our employees reside.

Developing Our People for Current and Future Success. We are a continuous learning organization, listening to employees at all levels – particularly at key moments that matter – and harvesting actionable insights to shape the employee experience. Key elements of our listening strategy include purposeful pulse surveys designed to check on key audiences at key moments. Overall, our listening includes our employee engagement survey and regular employee life cycle surveys, including onboarding (following the first week and at 90 days of employment) and exit surveys. Ultimately, we leverage these insights to better enable our employee programs and services.

We offer extensive, award-winning training programs that provide regulatory, business, foreign language, and management training and other opportunities for professional and personal development. As part of our empowered employee experience, we offer a suite of tools to assist employees to proactively own their careers and aim to reach their highest professional potential. These opportunities include a mix of company-wide, role-based or business-specific individualized courses and programs to drive career development. As an organization with solutions spanning Clinical and Commercial as well as numerous corporate functions, we encourage internal mobility to support retention.

Ensuring Competence and Qualification. Syneos Health is the only organization to have achieved the prestigious and internationally recognized Silver Workforce Accreditation from the International Accrediting Organization for Clinical Research in 2020. We offer credentialed, competency-based training programs for clinical monitoring employees to provide customers and investors with confidence that our CRAs are trained to a high standard. Credentials are available at all levels, including entry level (CRA I), intermediate (CRA II), and advanced (Senior CRAs).

Specific training highlights for 2021 include the design of our Business Leader Program, built by some of our leaders for fellow senior leaders across the Company. The program lasts six months and features executive coaching, customized simulation trainings, cohort leader labs, and assessments against a newly developed Syneos Health Great Leader profile. Our Great Leader profile attracts, retains, and develops diverse talent, creates and maintains strong customer relationships, instills a sense of ownership and accountability, leads using a growth and enterprise mindset, and balances strategic thinking with execution.

30

 

Table of Contents

 

Our pipeline leadership programs for aspiring, first-line, experienced, and senior managers now center around our Great Leader profile and these programs cover every step in a manager’s journey. These programs are accessible to all employees to develop and enhance their leadership skills and are purposely designed to support each person to meet their unique development and career needs. One of our values is “Collaborate to Deliver Solutions,” which encourages employees to learn from the expertise of their peers and to share knowledge and experience with colleagues using self-service coaching and mentoring, utilizing software to support mentoring and innovative reverse mentoring programs.

Indemnification and Insurance

In conjunction with our Clinical Solutions services, we employ or contract with research institutions and, in some jurisdictions, principal investigators and pharmacies on behalf of biopharmaceutical companies to serve as research centers and principal investigators in conducting clinical trials to test new candidate drugs on human volunteers. Such testing creates the risk of liability for personal injury or death of volunteers, particularly to volunteers with life-threatening illnesses, resulting from adverse reactions to the candidate drugs administered. It is possible that we could be held liable for claims and expenses arising from any professional malpractice of the principal investigators with whom we contract or engage, or in the event of personal injury to or death of persons participating in clinical trials. In addition, as a result of our operation of Phase I clinical trial facilities, we could be liable for the general risks associated with clinical trials including, but not limited to, adverse events resulting from the administration of candidate drugs to clinical trial participants or the professional malpractice of medical care providers. We also could be held liable for errors or omissions in connection with the services we perform through each of our service groups. For example, we could be held liable for errors, omissions, or breach of contract, if monitoring obligations have been transferred to us and one of our CRA’s inaccurately reports from source documents or fails to adequately monitor a human clinical trial resulting in inaccurately recorded results.

We have sought to reduce our risks by implementing the following where practicable:

 

•

securing contractual assurances such as indemnification provisions and provisions seeking to limit or exclude liability contained in our contracts with customers, institutions, pharmacies, vendors and principal investigators;

 

•

securing contractual and other assurances that adequate insurance will be maintained to the extent applicable by customers, institutions, pharmacies, vendors, principal investigators and us; and

 

•

complying with various regulatory requirements, including monitoring that the oversight of independent review boards and ethics committees are intact where obligations are transferred to us and monitoring the oversight of the procurement by the principal investigator of each participant’s informed consent to participate in the study.

Our contractual indemnifications generally do not fully protect us against certain of our own actions, such as negligence. Contractual arrangements are subject to negotiation with customers, and the terms and scope of any indemnification, limitation of liability or exclusion of liability varies from customer to customer and from clinical trial to clinical trial. Additionally, financial performance of these indemnities is not secured. Therefore, we bear the risk that any indemnifying party against which we have claims may not have the financial ability to fulfill its indemnification obligations to us.

31

 

Table of Contents

 

While we maintain a global insurance program including professional liability and other types of insurance standard to our industry to cover our liability while conducting our business activities and contracted services, including drug safety issues as well as data processing and other errors and omissions, it is possible that we could become subject to claims not covered by insurance or that exceed our coverage limits. We could be materially and adversely affected if we were required to pay damages or bear the costs of defending any claim that is outside the scope of, or in excess of, a contractual indemnification provision, beyond the level of insurance coverage or not covered by insurance, or in the event that an indemnifying party does not fulfill its indemnification obligations.

Information about our Executive Officers

The following table sets forth information concerning our executive officers:

 

Name

 

Age

 

 

Position

Alistair Macdonald

 

 

52

 

 

Chief Executive Officer and Director

Jason Meggs

 

 

46

 

 

Chief Financial Officer

Michael Brooks

 

 

48

 

 

Chief Development Officer & Global Head Clinical Development Solutions

Michelle Keefe

 

 

55

 

 

President, Medical Affairs & Commercial Solutions

Jonathan Olefson

 

 

46

 

 

General Counsel and Corporate Secretary

The following is a biographical summary of the experience of our executive officers:

Alistair Macdonald – Chief Executive Officer and Director

Alistair Macdonald has been our Chief Executive Officer (“CEO”) and a member of the Board since October 2016. He joined our Company in May 2002 and has served in various senior leadership roles during that time. Prior to his current role, Mr. Macdonald most recently served as President and Chief Operating Officer from January 2015 to September 2016 and Chief Operating Officer from January 2013 to January 2015. He also served as our President, Clinical Development Services from March 2012 to January 2013, Executive Vice President of our Global Oncology Unit from February 2011 to March 2012, Executive Vice President, Strategic Development from October 2009 to February 2011, and Senior Vice President, Biometrics from May 2002 to September 2009. He also previously served as the Chairman of the Board for the Association of Clinical Research Organizations (ACRO). He received his Master of Science in Environmental Diagnostics from Cranfield University. We believe Mr. Macdonald brings to our Board valuable perspective and experience as our Chief Executive Officer, and as a former Chief Operating Officer of our Company, as well as extensive knowledge of the CRO and biopharmaceutical industries, all of which qualify him to serve as one of our directors.

Jason Meggs – Chief Financial Officer

Jason Meggs was appointed our Chief Financial Officer (“CFO”) in May 2018 after serving as Executive Vice President and Interim CFO beginning in February 2018. Prior to his appointment to this role, he served as our Executive Vice President and CFO of the Commercial Solutions segment from August 2017 to February 2018. He also previously served as our Executive Vice President, Oncology Operations from January 2017 to August 2017 and our Senior Vice President, Business Finance from 2014 to 2016. Prior to joining Syneos Health, Mr. Meggs was Global Vice President, Internal Audit, at Quintiles Transnational Corporation, a leading global CRO, from 2013 to 2014 and held a number of finance roles at Quintiles from 2005 to 2013. He began his career as an auditor with Deloitte & Touche LLP and Arthur Anderson LLP, and is a certified public accountant. He also previously served as the Treasurer for the ACRO. He received his Bachelor of Science in Business Administration with a Major in Accounting from Western Carolina University.

32

 

Table of Contents

 

Michael Brooks – Chief Development Officer & Global Head Clinical Development Solutions

Michael Brooks was appointed our Chief Development Officer & Global Head Clinical Development Solutions in November 2021 after serving as Chief Development Officer beginning in July 2021. Prior to joining Syneos Health, Mr. Brooks held multiple leadership roles at LabCorp (Covance), a leading global CRO. From November 2019 to November 2020, Mr. Brooks served as President & Global Head, Clinical Development & Commercialization Services and from December 2018 to November 2019 as Chief Diagnostics Operations Excellence Officer. Prior to joining LabCorp, Mr. Brooks held various leadership positions at PRA Health Sciences from February 2015 to November 2018. He received his Bachelor of Science in Biological Sciences from North Carolina State University (“NCSU”) and is currently a member of the NCSU College of Sciences Foundation Board of Directors.

Michelle Keefe – President, Medical Affairs & Commercial Solutions

Michelle Keefe has been our President, Medical Affairs & Commercial Solutions since November 2021, and previously served as our President, Commercial Solutions since December 2017. Prior to joining Syneos Health, Ms. Keefe spent six years at the Publicis Groupe, a communications holding company, taking on roles of increasing responsibility culminating as a group president in the Publicis Health Division from February 2012 to December 2017. From January 2015 to April 2016, Ms. Keefe was President and CEO of Publicis Touchpoint Solutions. From May 2016 to November 2017, Ms. Keefe was Group President at Publicis Health. Ms. Keefe broadened her healthcare experience by joining the Visiting Nurse Service of New York (“VNSNY”), the largest not for profit homecare business in the U.S., from 2010 to 2012 where she was the VP of market development. Prior to joining the VNSNY, Ms. Keefe spent 22 years rising through the ranks at Pfizer, a global pharmaceutical corporation, in a variety of sales, marketing and general management roles, culminating as a Regional President. Ms. Keefe received her Bachelor of Science in Marketing from Seton Hall University.

Jonathan Olefson – General Counsel and Corporate Secretary

Jonathan Olefson has been our General Counsel and Corporate Secretary since November 2018. Prior to joining Syneos Health, Mr. Olefson was Senior Vice President, General Counsel and Secretary at Cotiviti Holdings, Inc., a healthcare analytics firm, from October 2013 to October 2018. Prior to that, Mr. Olefson spent nine years in senior legal and compliance roles at Cognizant Technology Solutions, a multinational information technology and consulting services firm, most recently as Vice President and General Counsel (Corporate, M&A and Intellectual Property). Mr. Olefson received his Bachelor of Arts degree from Emory University and his J.D. from The George Washington University Law School, graduating with honors.

Available Information

Our website address is syneoshealth.com. Information on our website is not incorporated by reference herein. Copies of our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and our proxy statements for our annual stockholders meetings, and any amendments to those reports, as well as Section 16 reports filed by our insiders, are available free of charge on our website as soon as reasonably practicable after we file the reports with, or furnish the reports to, the Securities and Exchange Commission (the “SEC”).

33

 

Table of Contents

 

Item 1A. Risk Factors.

We operate in a rapidly changing environment that involves a number of risks, some of which are beyond our control. In evaluating our company, you should consider carefully the risks and uncertainties described below together with the other information included in this Annual Report on Form 10-K, including our consolidated financial statements and related notes included in Part II, Item 8, “Financial Statements and Supplementary Data” in this Annual Report on Form 10-K. The occurrence of any of the following risks may materially and adversely affect our business, financial condition, results of operations and future prospects.

Risks Related to Our Business

The COVID-19 pandemic and associated economic repercussions have adversely impacted our business and results of operations, and are expected to continue to do so.

The ongoing COVID-19 pandemic and associated economic repercussions have significantly impacted, and are expected to continue to impact, our business and our operations. With the spread of COVID-19 variants, the ongoing impacts of the COVID-19 pandemic could continue to adversely impact our business and results of operations in a number of ways, including but not limited to:

 

•

delays or difficulties in commencing new and operating ongoing clinical trials, including intermittent challenges accessing investigative sites, delays in enrolling patients, delays in obtaining approvals from regulatory authorities, and difficulty obtaining necessary pharmaceutical products and supplies;

 

•

restrictions on the ability of our field teams to visit HCPs and difficulty securing appropriate PPE and COVID-19 testing and other tools required for client-facing engagements and visits to sites/HCPs;

 

•

diversion of healthcare resources away from the conduct of clinical trials, including the diversion of hospitals serving as our clinical trial sites and hospital staff supporting the conduct of our clinical trials, as well as the reduction of our customers’ operating budgets;

 

•

interruption of key clinical trial activities, such as clinical trial site data monitoring, due to social distancing requirements, COVID-19 quarantine and isolation protocols or interruption of clinical trial subject visits and study procedures, which may impact the collection and integrity of study data and ability to measure clinical trial endpoints;

 

•

business disruptions at our customers;

 

•

limitations on our employee resources, including because of COVID-19 quarantine and isolation protocols, sickness of employees or their families or the desire of employees to avoid contact with large groups of people;

 

•

diversion of management resources to focus on mitigating the impacts of the COVID-19 pandemic; and

 

•

impacts from prolonged remote work arrangements, such as strains on our business continuity plans, cybersecurity risks, and inability of certain employees to perform their work remotely.

34

 

Table of Contents

 

These and other impacts of the COVID-19 pandemic could also have the effect of heightening many of the other risk factors included below in this Item 1A. The ultimate impact depends on the severity and duration of the COVID-19 pandemic, including the emergence and spread of COVID-19 variants, the continued availability and effectiveness of vaccines and treatments, and actions taken by governmental authorities and other third parties in response to the pandemic, each of which is uncertain, rapidly changing and difficult to predict. Any of these disruptions could adversely impact our business and results of operations. In addition, the continued prevalence of COVID-19 has led to disruption and volatility in the global capital markets, which increases the cost of, and adversely impacts access to, capital and increases economic uncertainty. This volatility and uncertainty has adversely affected our stock price, and may again adversely affect our stock price in the future.

If we do not generate a large number of new business awards, or if new business awards are delayed, terminated, reduced in scope, or fail to go to contract, our business, financial condition, results of operations, or cash flows may be materially adversely affected.

Our business is dependent on our ability to generate new business awards from new and existing customers and maintain existing customer contracts. Our inability to generate new business awards on a timely basis and subsequently enter into contracts for such awards could have a material adverse effect on our business, financial condition, results of operations or cash flows.

There is risk of cancelability in both the clinical and commercial businesses. The time between when a clinical study is awarded and when it goes to contract is typically several months, and prior to a new business award going to contract, our customer can cancel the award without notice. Once an award goes to contract, the majority of our customers can terminate the contract without cause with a notice period that generally ranges from 30 to 90 days. Our contracts may be delayed or terminated by our customers or reduced in scope for a variety of reasons beyond our control, including but not limited to:

 

•

decisions to forego or terminate a particular trial;

 

•

budgetary limits or changing priorities;

 

•

actions by regulatory authorities;

 

•

production problems resulting in shortages of the candidate drug being tested;

 

•

failure of products being tested to satisfy safety requirements or efficacy criteria;

 

•

unexpected or undesired clinical results for products;

 

•

insufficient patient enrollment in a trial;

 

•

insufficient principal investigator recruitment;

 

•

production problems resulting in shortages of the product being tested;

 

•

the customers’ decision to terminate or scale back the development or commercialization of a product or to end a particular project;

 

•

shift of business to a competitor or internal resources; or

 

•

product withdrawal following market launch.

35

 

Table of Contents

 

 

Our commercial services contracts typically have a significantly shorter wind down period than clinical contracts, particularly within our Deployment Solutions offerings. Furthermore, many of our communications services and consulting services projects are tied to a customer’s annual marketing budget or ad hoc service requests, which can lead to seasonal variability in revenue and less predictability in future revenues. In addition, many of our biopharmaceutical Deployment Solutions service contracts provide our customers with the opportunity to internalize the resources provided under the contract and terminate all or a portion of the services we provide under the contract. Our customers may also decide to shift their business to a competitor. Each of these factors results in less visibility to future revenues and may result in high volatility in future revenues.

Contract terminations, delays and modifications are a regular part of our business across each of our segments. For example, our full-service offering within our Clinical Solutions business has been, and may continue to be, negatively impacted by project delays, which impact near term revenue disproportionately. In addition, project delays, downsizings and cancellations, particularly within our Deployment Solutions and communications offerings, which are part of our Commercial Solutions business, have impacted our results in the past and might impact them in the future. The loss, reduction in scope or delay of a large project or of multiple projects could have a material adverse effect on our business, results of operations, and financial condition. In addition, we might not realize the full benefits of our backlog if our customers cancel, delay, or reduce their commitments to us.

In the event of termination, our contracts often provide for fees for winding down the project, which include both fees incurred and actual and non-cancellable expenditures and may include a fee to cover a percentage of the remaining professional fees on the project. These fees might not be sufficient for us to maintain our margins, and termination may result in lower resource utilization rates and therefore lower operating margins. In addition, cancellation of a contract or project for the reasons noted above may result in the unwillingness or inability of our customer to satisfy its existing obligations to us such as payments of accounts receivable, which may in turn result in a material impact to our results of operations and cash flow. Historically, cancellations and delays have negatively impacted our operating results, and they might again. In addition, we might not realize the full benefits of our backlog if our customers cancel, delay, or reduce their commitments to us, which may occur if, among other things, a customer decides to shift its business to a competitor or revoke our status as a preferred provider. Thus, the loss or delay of a large business award or the loss or delay of multiple awards could adversely affect our revenues and profitability. Additionally, a change in the timing of a new business award could affect the period over which we recognize revenue and reduce our revenue in any one quarter.

Our backlog might not be indicative of our future revenues, and we might not realize all of the anticipated future revenue reflected in our backlog.

Our backlog consists of anticipated revenue awarded from contract and pre-contract commitments that are supported by written communications. Once work begins on a project, revenue is recognized over the duration of the project, provided the award has gone to contract. Projects may be canceled or delayed by the customer or delayed by regulatory authorities for reasons beyond our control. To the extent projects are delayed, the timing of our revenue could be adversely affected. In addition, if a customer terminates a contract, we typically would be entitled to receive payment for all services performed up to the termination date and subsequent customer-authorized services related to terminating the canceled project. Typically, however, we have no contractual right to the full amount of the future revenue reflected in our backlog in the event of a contract termination or subsequent changes in scope that reduce the value of the contract. The duration of the projects included in our backlog, and the related revenue recognition, typically range from a few months to several years. Our backlog might not be indicative of our future revenues, and we might not realize all the anticipated future revenue reflected in that backlog. A number of factors may affect backlog, including:

 

•

the size, complexity, and duration of projects or strategic relationships;

36

 

Table of Contents

 

 

 

•

the cancellation or delay of projects;

 

•

the failure of one or more business awards to go to contract; and

 

•

changes in the scope of work during the course of projects.

The rate at which our backlog converts to revenue may vary over time. The revenue recognition on larger, more global projects could be slower than on smaller, more regional projects for a variety of reasons, including, but not limited to, an extended period of negotiation between the time the project is awarded to us and the actual execution of the contract, as well as an increased time frame for obtaining the necessary regulatory approvals.

Our backlog as of December 31, 2021 was $11.43 billion. Although an increase in backlog will generally result in an increase in revenues over time, an increase in backlog at a particular point in time does not necessarily correspond directly to an increase in revenues during any particular period, or at all. The extent to which contracts in backlog will result in revenue depends on many factors, including, but not limited to, delivery against project schedules, scope changes, contract terminations and the nature, duration, and complexity of the contracts, and can vary significantly over time.

Our operating results have historically fluctuated between fiscal quarters and may continue to fluctuate in the future, which may adversely affect the market price of our stock.

Our operating results have fluctuated in previous quarters and years and may continue to vary significantly from quarter to quarter and are influenced by a variety of factors, such as:

 

•

timing of contract amendments for changes in scope that could affect the value of a contract and potentially impact the amount of net new business awards and revenue from quarter to quarter;

 

•

commencement, completion, execution, postponement, or termination of large contracts;

 

•

contract terms for the recognition of revenue milestones;

 

•

progress of ongoing contracts and retention of customers;

 

•

timing of and charges associated with completion of acquisitions, integration of acquired businesses, and other events;

 

•

changes in the mix of services delivered, both in terms of geography and type of services;

 

•

potential customer disputes, penalties or other issues that may impact the revenue we are able to recognize, or the collectability of our related accounts receivable; and

 

•

exchange rate fluctuations.

Our operating results for any particular quarter are not necessarily a meaningful indicator of future results and fluctuations in our quarterly operating results could negatively affect the market price and liquidity of our stock.

37

 

Table of Contents

 

If we underprice our contracts, overrun our cost estimates, or fail to receive approval for or experience delays in documentation of change orders, our business, financial condition, results of operations, or cash flows may be materially adversely affected.

We price our contracts based on assumptions regarding the scope of work required and cost to complete the work. We bear the financial risk if we initially underprice our contracts or otherwise overrun our cost estimates, which could adversely affect our cash flows and financial performance. In addition, contracts with our customers are subject to change orders, which occur when the scope of work we perform needs to be modified from that originally contemplated in our contract with the customers. This can occur, for example, when there is a change in a key study assumption or parameter or a significant change in timing. We may be unable to successfully negotiate changes in scope or change orders on a timely basis or at all, which could require us to incur cost outlays ahead of the receipt of any additional revenue. In addition, under generally accepted accounting principles in the United States of America (“GAAP”) we cannot recognize additional revenue anticipated from change orders until appropriate documentation is received by us from the customer authorizing the change. However, if we incur additional expense in anticipation of receipt of that documentation, we must recognize the expense as incurred. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations or cash flows.

Our business depends on the continued effectiveness and availability of our information systems, including the information systems we use to provide services to our customers and to store employee data, and failures of these systems may materially limit our operations or have an adverse effect on our reputation.

Our information systems consist of systems we have purchased or developed, legacy information systems from organizations we have acquired and, increasingly, web-enabled and other integrated information systems. In using these information systems, we frequently rely on third-party vendors to provide hosting and system management services, where our infrastructure is dependent upon the reliability of their underlying platforms, facilities, and communications systems. We also utilize integrated information systems that we provide customers access to or install for our customers in conjunction with our delivery of services.

As the breadth and complexity of our information systems continue to grow, we will increasingly be exposed to the risks inherent in maintaining the stability of our legacy systems due to prior customization, attrition of employees or vendors involved in their development, and obsolescence of the underlying technology, as well as risks from the increasing number and scope of external data breaches on multi-national companies. Because certain customers, clinical trials, and other long-term projects depend upon these legacy systems, we also face an increased level of embedded risk in maintaining the legacy systems and limited options to mitigate such risk. We are also exposed to risks associated with the availability of all our information systems, including:

 

•

disruption, impairment or failure of data centers, telecommunications facilities or other key infrastructure platforms, including those maintained by our third-party vendors;

 

•

security breaches of, cyber-attacks on, and other failures or malfunctions in our internal systems, including our employee data and communications, critical application systems or their associated hardware, software, and databases;

 

•

excessive costs, excessive delays, or other deficiencies in systems development and deployment; and

 

•

potential for encryption based “Ransomware” attacks that could hinder our ability to access our systems and data until we are able to recover from backups.

38

 

Table of Contents

 

In addition to these availability risks, due to the interconnectedness of IT systems across platforms and hosts, we could see disruptions to our systems as “collateral damage” from attacks targeting our connected partners.

The materialization of any of these risks may impede the processing of data, the delivery of databases and services, and the day-to-day management of our business and could result in the corruption, loss or unauthorized disclosure of proprietary, confidential, or other data. In addition, a security breach could require that we expend substantial additional resources related to the security of our technical infrastructure, databases and services, diverting resources from other projects and disrupting our business. Despite any precautions we take, damage from fire, floods, hurricanes, power loss, telecommunications failures, computer viruses, break-ins, and similar events at our various computer facilities or those of our third-party vendors could result in interruptions in the flow of data to us and from us to our customers.

Corruption or loss of data may result in the need to repeat a project at no cost to the customer, but at significant cost to us, the termination of a contract, civil or criminal enforcement actions and penalties, or damage to our reputation. Additionally, significant delays in system enhancements or inadequate performance of new or upgraded systems once completed could damage our reputation and harm our business. Finally, long-term disruptions in the infrastructure caused by events such as natural disasters, the outbreak of war, the escalation of hostilities and acts of terrorism, particularly involving cities in which we have offices, and cyber-attacks such as those recently faced by other multi-national companies could adversely affect our businesses. As our business continues to expand globally, these types of risks may be further increased by instability in the geopolitical climate of certain regions, underdeveloped and less stable utilities and communications infrastructure, and other local and regional factors. Although we carry property, cyber incident, and business interruption insurance that we believe is customary for our industry, our coverage might not be adequate to compensate us for all losses that may occur.

We have been and expect that we will continue to be subject to attempts to gain unauthorized access to or through our information systems or those we internally or externally develop for our customers. In addition, we may be susceptible to physical or computer-based attacks by terrorists, nation states, or hackers due to our role in the biopharmaceutical service industry. Bad actors may be motivated by a desire to access or steal our or our clients’ intellectual property. These concerns about security are increased when information is transmitted over the Internet. In response to the COVID-19 pandemic, more of our employees are working remotely, which may increase the risk of such attacks. If such attacks are not detected immediately, their effect could be compounded. To date these attacks have not had a material impact on our operations or financial results. However, successful attacks in the future could result in negative publicity, significant remediation and recovery costs, legal liability and damage to our reputation and could have a material adverse effect on our financial condition, results of operations, and cash flows. In addition, our liability insurance might not be sufficient in type or amount to cover us against claims related to security breaches, cyber-attacks and other related breaches.

Additionally, we rely on service providers for the timely transmission of information across our global data network. If a service provider fails to provide the communications capacity or services we require for similar reasons, the failure could interrupt our services. Because of the centrality of our processing systems to our business, any interruption or degradation could adversely affect the perception of our brands’ reliability and harm our business. If a service provider experiences the unauthorized disclosure of sensitive or confidential data they are processing on our behalf, whether through systems failure or employee actions, cyber-attacks, fraud, or misappropriation, it could damage our reputation and cause us to lose customers. Similarly, such disclosure could result in negative publicity, significant remediation and recovery costs, legal liability and damage to our reputation, and could have a material adverse effect on our financial condition, results of operations, and cash flows. In addition, contractual indemnity, the service provider’s liability insurance and our liability insurance might not be sufficient in type or amount to cover us against claims related to security breaches, cyber-attacks, and other related breaches.

39

 

Table of Contents

 

Our customer or therapeutic area concentration may have a material adverse effect on our business, financial condition, results of operations or cash flows.

If any large customer decreases or terminates its relationship with us, our business, financial condition, results of operations or cash flows could be materially adversely affected. For the year ended December 31, 2021, our top ten customers based on revenue accounted for approximately 36% of our consolidated revenue and our top ten Clinical Solutions customers based on backlog accounted for approximately 45% of our total backlog. No single customer accounted for greater than 10% of our total consolidated revenue for the years ended December 31, 2021, 2020, and 2019. It is possible that an even greater portion of our revenues will be attributable to a smaller number of customers in the future, including as a result of our entering into strategic provider relationships with customers. Also, consolidation in our potential customer base results in increased competition for important market segments and fewer available customer accounts.

Additionally, conducting multiple clinical trials for different sponsors in a single therapeutic class involving drugs with the same or similar chemical action may adversely affect our business if some or all of the trials are canceled because of new scientific information or regulatory judgments that affect the drugs as a class.

Similarly, marketing and selling products for different sponsors with similar drug action subjects us to risk if new scientific information or regulatory judgment prejudices the products as a class, leading to compelled or voluntary prescription limitations or withdrawal of some or all of the products from the market.

Our business is subject to international economic, political and other risks that could have a material adverse effect on our business, financial condition, results of operations, cash flows or reputation.

We have operations in many foreign countries, including, but not limited to, countries in the Asia-Pacific region, Europe, Latin America and the Middle East and Africa. As of December 31, 2021, approximately 58% of our workforce was located outside of the U.S., and for the fiscal year ended December 31, 2021, approximately 43% of our revenue was earned from work performed outside of the U.S. Our international operations are subject to risks and uncertainties inherent in operating in these regions, including:

 

•

conducting a single project across multiple countries is complex, and issues in one country, such as a failure to comply with or unanticipated changes to local regulations, or restrictions such as restrictions on import or export of clinical trial material or availability of clinical trial data may affect the progress of the clinical trial in the other countries, resulting in delays or potential termination of contracts, which in turn may result in loss of revenue;

 

•

the U.S. or other countries could enact legislation or impose regulations or other restrictions, including unfavorable labor regulations, tax policies, data protection regulations or economic sanctions, which could have an adverse effect on our ability to conduct business in or expatriate profits from the countries in which we operate;

 

•

the U.S. has previously enacted and it or other countries may in the future enact legislation that limits or prohibits the use of foreign manufactured equipment or supplies, such as the Uyghur Forced Labor Prevention Act, which imposes a ban on virtually all imports from the Xinjiang region of China unless companies are able to prove that the products were not made with forced labor, which could have an adverse effect on our ability to conduct business;

40

 

Table of Contents

 

 

•

foreign countries are expanding or may expand their banking regulations that govern international currency transactions, particularly cross-border transfers, which may inhibit our ability to transfer funds into or within a jurisdiction, impeding our ability to pay our principal investigators, vendors and employees, thereby impacting our ability to conduct trials in such jurisdictions;

 

•

foreign countries are expanding or may expand their regulatory framework with respect to patient informed consent, protection and compensation in clinical trials, or transparency reporting requirements (similar to the Physician Payments Sunshine Act in the U.S.), which could delay, inhibit or prohibit our ability to conduct projects in such jurisdictions;

 

•

the regulatory or judicial authorities of foreign countries might not enforce legal rights and recognize business procedures in a manner in which we are accustomed or would reasonably expect;

 

•

changes in political and economic conditions, including the UK’s withdrawal from the European Union and the policies of the current U.S. presidential administration, may lead to changes in the business environment in which we operate, as well as changes in inflation and foreign currency exchange rates;

 

•

potential violations of applicable anti-bribery/anti-corruption laws, including the U.S. Foreign Corrupt Practices Act (“FCPA”) and the UK Bribery Act of 2010, may cause a material adverse effect on our business, financial condition, results of operations, cash flows, or reputation;

 

•

customers in foreign jurisdictions may have longer payment cycles, and it may be more difficult to collect receivables in those jurisdictions;

 

•

natural disasters, pandemics, or international conflict, including terrorist acts, could interrupt our services, endanger our personnel, or cause project delays or loss of clinical trial materials or results;

 

•

political unrest, such as the current situation with Ukraine and Russia, could delay or disrupt the ability to conduct clinical trials or other business, and if such political unrest escalates or spills over to or otherwise impacts additional regions it could heighten many of the other risk factors included in this Item 1A; and

 

•

foreign governments may enact currency exchange controls that may limit the ability to fund our operations or significantly increase the cost of maintaining operations.

These risks and uncertainties could negatively impact our ability to, among other things, perform large, global projects for our customers. Furthermore, our ability to deal with these issues could be affected by applicable U.S. laws. Any such risks could have an adverse impact on our business, financial condition, results of operations, cash flows, or reputation.

41

 

Table of Contents

 

Governmental authorities may question our intercompany transfer pricing policies or change their laws in a manner that could increase our effective tax rate or otherwise harm our business.

As a U.S. company doing business in international markets through subsidiaries, we are subject to foreign tax and intercompany pricing laws, including those relating to the flow of funds between legal entities in various international jurisdictions. Tax authorities in the U.S. and in international markets have the right to examine our corporate structure and how we account for intercompany fund transfers. If such authorities challenge our corporate structure, transfer pricing mechanisms or intercompany transfers and the resulting assessments are upheld, our operations may be negatively impacted, and our effective tax rate may increase. Tax rates vary from country to country and if a tax authority determines that our profits in one jurisdiction should be increased, we might not be able to realize the full tax benefits in the event we cannot utilize all foreign tax credits that are generated, or we do not realize a compensating offsetting adjustment in another taxing jurisdiction. The effects of either would increase our effective tax rate. Additionally, the Organization for Economic Cooperation and Development has issued certain guidelines regarding base erosion and profit shifting. As these guidelines continue to be formally adopted by separate taxing jurisdictions, we may need to change our approach to intercompany transfer pricing in order to maintain compliance under the new guidelines. Our effective tax rate may increase or decrease depending on the current location of global operations at the time of the change. Finally, we might not always be in compliance with all applicable customs, exchange control, Value Added Tax, and transfer pricing laws despite our efforts to be aware of and to comply with such laws. If these laws change we may need to adjust our operating procedures and our business could be adversely affected.

If we are unable to successfully increase our market share, our ability to grow our business and execute our growth strategies could be materially adversely affected.

A key element of our growth strategy is increasing our market share within the biopharmaceutical services market, the clinical development market and in the geographic markets in which we operate. In addition, we continue to invest in expanding new services such as our medical affairs offerings and technology-enabled solutions. As we grow our market share within the biopharmaceutical services and clinical development markets and make investments in growing our newer service offerings, we might not have or adequately build the competencies necessary to perform our services satisfactorily or may face increased competition. If we are unable to succeed in increasing our market share or realize the benefits of our investments in our new service offerings, we may be unable to implement this element of our growth strategy, and our ability to grow our business or maintain our operating margins could be adversely affected.

Upgrading the information systems that support our operating processes and evolving the technology platform for our services pose risks to our business.

Continued efficient operation of our business requires that we implement standardized global business processes and evolve our information systems to enable this implementation, especially in the course of integrating acquired businesses into our company. We have continued to undertake significant programs to optimize business processes with respect to our services. Our inability to effectively manage the implementation of new information systems or upgrades and adapt to new processes designed into these new or upgraded systems in a timely and cost-effective manner may result in disruption to our business and negatively affect our operations.

42

 

Table of Contents

 

We have entered into agreements with certain vendors to provide systems development, integration, and hosting services that develop or license to us the information technology (“IT”) platforms and capacity for programs to optimize our business processes. If such vendors or their products fail to perform as required or if there are substantial delays in developing, implementing, securing, and updating our IT platforms, our customer delivery may be impaired, and we may have to make substantial further investments, internally or with third parties, to achieve our objectives. For example, we rely on an external vendor to provide the clinical trial management software used in managing the completion of our customer clinical trials. If that externally provided system is not properly maintained we might not be able to meet the obligations of our contracts or may need to incur significant costs to replace the system or capability. Additionally, our progress may be limited by parties with existing or claimed patents who seek to enjoin us from using preferred technology or seek license payments from us.

Meeting our objectives is dependent on a number of factors which might not take place as we anticipate, including obtaining adequate technology-enabled services, depending upon our third-party vendors to develop and enhance existing applications to adequately support our business, creating IT-enabled services that our customers will find desirable, and implementing our business model with respect to these services. Also, increased IT-related expenditures and our potential inability to anticipate increases in service costs may negatively impact our business, financial condition, results of operations, or cash flows.

If we fail to perform our services in accordance with contractual requirements, regulatory requirements, and ethical considerations, we could be subject to significant costs or liability and our reputation could be harmed.

We contract with biopharmaceutical companies to perform a wide range of services to assist them in bringing new drugs to market and to support the commercial activity of products already in the marketplace. Our services include monitoring clinical trials, data and laboratory analysis, electronic data capture, patient recruitment, product launch consulting, Deployment Solutions, advertising, publications, and medical communications, and other related services. Such services are complex and subject to contractual requirements, regulatory standards, and ethical considerations. For example, we must adhere to applicable regulatory requirements such as those required by the FDA, the European Medicines Agency and the competent authorities of the member states of the European Union (“EU”), and the Medicines and Healthcare Products Regulatory Agency (“MHRA”) in the UK, including those laws and regulations governing the promotion, sales, and marketing of biopharmaceutical products, and Good Clinical Practice (“GCP”) requirements, which govern, among other things, the design, conduct, performance, monitoring, auditing, recording, analysis, and reporting of clinical trials. Once initiated, clinical trials must be conducted pursuant to and in accordance with the applicable investigational new drug application or clinical trial application, the requirements of the relevant institutional review boards or ethics committees, and GCP regulations. We are also subject to regulation by the Drug Enforcement Administration (“DEA”) which regulates the distribution, recordkeeping, handling, security, and disposal of controlled substances. If we fail to perform our services in accordance with these requirements, regulatory agencies may take action against us or our customers. Such actions may include sanctions such as injunctions or failure of such regulatory authorities to grant marketing approval of products, imposition of clinical holds or delays, suspension or withdrawal of approvals, rejection of data collected in our studies, license revocation, product seizures or recalls, operational restrictions, civil or criminal penalties or prosecutions, damages, or fines. Additionally, there is a risk that actions by regulatory authorities, if they result in significant inspectional observations or other measures, could harm our reputation and cause customers not to award us future contracts or to cancel existing contracts. Customers may also bring claims against us for breach of our contractual obligations, and patients in the clinical trials and patients taking drugs approved on the basis of those trials may bring personal injury claims against us. Any such action could have a material adverse effect on our business, financial condition, results of operations, cash flows, or reputation.

43

 

Table of Contents

 

Such consequences could arise if, among other things, the following occur:

Improper performance of our services. The performance of our clinical development and other biopharmaceutical services is complex and time-consuming. For example, we may make mistakes in conducting a clinical trial that could negatively impact or obviate the usefulness of the clinical trial or cause the results of the clinical trial to be reported improperly. If the clinical trial results are compromised, we could be subject to significant costs or liability, which could have an adverse impact on our ability to perform our services and our reputation could be harmed. For example:

 

•

non-compliance generally could result in the termination of ongoing clinical trials or the disqualification of data for submission to regulatory authorities;

 

•

compromise of data from a particular trial, such as failure to verify that adequate informed consent was obtained from subjects or improper monitoring of data, could require us to repeat the clinical trial under the terms of our contract at no further cost to our customer, but at a substantial cost to us; and

 

•

breach of a contractual term could result in liability for damages or termination of the contract.

Large clinical trials can cost hundreds of millions of dollars and improper performance of our services could have a material adverse effect on our financial condition, damage our reputation, and result in the termination of current contracts or failure to obtain future contracts from the affected customer or other customers.

Interactive Voice/Web Response Technology malfunction. We develop, maintain, and use third-party computer-based interactive voice/web response systems to automatically manage the randomization of patients in a given clinical trial to different treatment arms and regulate the supply of investigational drugs, all by means of interactive voice/web response systems. An error in the design, programming, or validation of these systems could lead to inappropriate assignment or dosing of patients which could give rise to patient safety issues, invalidation of the trial, or liability claims against us. Furthermore, negative publicity associated with such a malfunction could have an adverse effect on our business and reputation. Additionally, errors in randomization may require us to repeat the clinical trial at no further cost to our customer, but at a substantial cost to us.

Investigation of customers. From time to time, one or more of our customers are audited or investigated by regulatory authorities or enforcement agencies with respect to regulatory compliance of their clinical trials, programs, or the marketing and sale of their drugs. In these situations, we have often provided services to our customers with respect to the clinical trials, programs, or activities being audited or investigated, and we are called upon to respond to requests for information by the authorities and agencies. There is a risk that either our customers or regulatory authorities could claim that we performed our services improperly or that we are responsible for clinical trial or program compliance. If our customers or regulatory authorities make such claims against us and prove them, we could be subject to damages, fines, or penalties. In addition, negative publicity regarding regulatory compliance of our customers’ clinical trials, programs, or drugs could have an adverse effect on our business and reputation.

Insufficient customer funding to complete a clinical trial. As noted above, clinical trials can cost hundreds of millions of dollars. There is a risk that we may initiate a clinical trial for a customer, and then the customer becomes unwilling or unable to fund the completion of the trial. In such a situation, notwithstanding the customer’s ability or willingness to pay for or otherwise facilitate the completion of the trial, we may be ethically bound to complete or wind down the clinical trial at our own expense.

44

 

Table of Contents

 

In addition to the above U.S. laws and regulations, we must comply with the laws of all countries where we do business, including laws governing clinical trials in the jurisdiction where the trials are performed. Failure to comply with applicable requirements could subject us to regulatory risk, liability, and potential costs associated with redoing the trials, which could damage our reputation and adversely affect our operating results.

The operation of our early phase (Phase I and IIA) clinical facilities and the services we provide there as well as our clinical trial management, including direct interaction with clinical trial patients or volunteers, and our mobile research nursing clinical trial services, could create potential liability that may adversely affect our business, financial condition, results of operations, cash flows, and reputation.

We operate facilities where early phase clinical trials are conducted, which ordinarily involve testing an investigational drug on a limited number of individuals to evaluate a product’s safety, determine a safe dosage range and identify side effects. Additionally, our business involves clinical trial management, which is one of our clinical development service offerings, and includes the testing of investigational drugs on human volunteers. Some of these trials involve the administration of investigational drugs to known substance abusers or volunteers and patients that are already seriously ill and are at risk for further illness or death. Failure to operate any of our early phase facilities in accordance with applicable regulations could result in that facility being shut down, which could disrupt our operations and adversely affect our business, financial condition, results of operations, cash flows, and reputation.

Additionally, we face risks resulting from the administration of drugs to volunteers, including adverse events, and the professional malpractice of medical care providers, including improper administration of a drug or device. We also directly employ doctors, nurses, and other trained employees who assist in implementing the testing involved in our clinical trials, such as drawing blood from healthy volunteers. Our mobile research nurses engage in a wide range of services, from observing clinical trial participants ingesting drugs, to administering an infusion of oncology medicine to a pediatric study participant. Our exposure with respect to these activities could exceed any contractual limits on indemnification in our contracts with customers and vendors. Any professional malpractice or negligence by such doctors, nurses, principal investigators, or other employees could potentially result in liability to us in the event of personal injury to or death of a volunteer in clinical trials. This liability, particularly if it were to exceed the limits of any indemnification agreements and insurance coverage we may have, may adversely affect our business and financial condition, results of operations, cash flows, and reputation.

If we are unable to attract suitable principal investigators and recruit and enroll patients for clinical trials, our clinical development business might suffer.

The recruitment of principal investigators and patients for clinical trials is essential to our business. Principal investigators are typically located at hospitals, clinics, or other sites and supervise the administration of the investigational drug to patients during the course of a clinical trial. Patients generally include people from the communities in which the clinical trials are conducted. Several of our competitors have purchased site networks or site management organizations as a strategy for priority access to a specific site, which could put us at a competitive disadvantage. Our clinical development business could be adversely affected if we are unable to attract suitable and willing principal investigators or recruit and enroll patients for clinical trials on a consistent basis. The expanding global nature of clinical trials increases the risk associated with attracting suitable principal investigators and patients, especially if these trials are conducted in regions where our resources or experience may be more limited. For example, if we are unable to engage principal investigators to conduct clinical trials as planned or enroll sufficient patients in clinical trials, we might need to expend additional funds to obtain access to more principal investigators and patients than planned or else be compelled to delay or modify the clinical trial plans, which may result in additional costs to us or cancellation of the clinical trial by our customer. If realized, these risks may also inhibit our ability to attract new business, particularly in certain regions.

45

 

Table of Contents

 

Our business could result in liability to us if a drug causes harm to a patient. While we are generally indemnified and insured against such risks, we may still suffer financial losses.

When we market drugs under contract for a biopharmaceutical company, we could suffer liability for harm allegedly caused by those drugs, either as a result of a lawsuit against the biopharmaceutical company to which we are joined, a lawsuit naming us or any of our subsidiaries, or an action launched by a regulatory body. Any claim could result in potential liability for us if the claim is outside the scope of the indemnification agreement we have with the biopharmaceutical company, the biopharmaceutical company does not abide by the indemnification agreement as required, or the liability exceeds the amount of any applicable indemnification limits or available insurance coverage. Such a result could have an adverse impact on our financial condition, results of operations, cash flows, and reputation. Furthermore, negative publicity associated with harm caused by drugs we helped to market could have an adverse effect on our business and reputation.

If we lose the services of key personnel or are unable to recruit experienced personnel, our business, financial condition, results of operations, cash flows, or reputation could be materially adversely affected.

Our success substantially depends on the collective performance, contributions, and expertise of our senior management team and other key personnel including qualified management, professional, scientific, and technical operating staff, and business development personnel, particularly as we integrate acquired businesses into our company. There is significant competition for qualified personnel, particularly those with higher educational degrees, in the biopharmaceutical and related services industries. For the year ended December 31, 2021, we experienced increased employee turnover and challenges due to the current industry-wide labor shortage and resulting competition to retain and attract qualified personnel. In addition, the close proximity of some of our facilities to offices of our major competitors could adversely impact our ability to successfully recruit and retain key personnel. The departure of any key executive, or our inability to continue to identify, attract and retain qualified personnel or replace any departed personnel in a timely fashion, might impact our ability to grow our business and compete effectively in our industry and might negatively affect our business, financial condition, results of operations, cash flows, or reputation.

Foreign currency exchange rate fluctuations may have a material adverse effect on our financial condition, results of operations, and cash flows.

Approximately 19% of our revenue for the year ended December 31, 2021 was denominated in currencies other than the U.S. dollar and 35% of our direct and operating costs are incurred in countries with functional currencies other than the U.S. dollar. Our financial statements are reported in U.S. dollars and changes in foreign currency exchange rates could significantly affect our financial condition, results of operations, or cash flows. Our primary exposure to fluctuations in foreign currency exchange rates is related to the following risks:

Foreign Currency Risk from Differences in Customer Contract Currency and Operating Costs Currency. The majority of our global contracts are denominated in U.S. dollars or Euros while our operating costs in foreign countries are denominated in various local currencies. Fluctuations in the exchange rates of the currencies we use to contract with our customers and the currencies in which we incur cost to fulfill those contracts can have a significant impact on our results of operations.

Foreign Currency Translation Risk. The revenue and expenses of our international operations are generally denominated in local currencies and translated into U.S. dollars for financial reporting purposes. Accordingly, exchange rate fluctuations between the value of the U.S. dollar versus local currencies will affect the U.S. dollar value of our foreign currency denominated revenue, costs, and results of operations.

46

 

Table of Contents

 

Foreign Currency Transaction Risk. We earn revenue from our service contracts over a period of several months and, in many cases, over several years, resulting in timing differences between the consummation and cash settlement of a transaction. Accordingly, profitability of the transactions denominated in foreign currencies is subject to effects of fluctuations in foreign currency exchange rates during the period of time between the consummation and cash settlement of a transaction.

We may seek to limit our exposure to these risks through inclusion of foreign currency exchange rate provisions in our service contracts, and/or by hedging certain exposures with foreign exchange derivative instruments. These measures, however, might not offset or mitigate any, or all, of the adverse financial effects of unfavorable movements in foreign currency exchange rates.

Unfavorable economic conditions have previously and could in the future have a material adverse effect on our business, financial condition, results of operations, or cash flows.

Unfavorable economic conditions and other adverse macroeconomic factors on global and domestic markets have previously and may in the future result, among other matters, in tightening in the credit and capital markets, high levels of inflation, low liquidity, and volatility in fixed income, credit, currency, and equity markets. Such conditions have and could in the future have a negative effect on our business, financial condition, results of operations, or cash flows. For example, our customers might not be able to raise money to conduct existing clinical trials, or to fund new drug development and related future clinical trials. Resource-sharing customers may also scale back commercial support for their products. In addition, economic or market disruptions could negatively impact our vendors, contractors, or principal investigators which might have a negative effect on our business.

Our effective income tax rate may fluctuate, which may adversely affect our results of operations.

Our effective income tax rate is influenced by our profitability in the various taxing jurisdictions in which we operate. Changes in the distribution of profits and losses among taxing jurisdictions may have a significant impact on our effective income tax rate, which in turn could have an adverse effect on our results of operations. Factors that may affect our effective income tax rate include, but are not limited to:

 

•

jurisdictional earnings;

 

•

the repatriation of foreign earnings to the U.S.;

 

•

uncertain tax positions;

 

•

changes in tax laws in various taxing jurisdictions, including interpretations of regulations related to the Tax Cuts and Jobs Act;

 

•

audits by taxing authorities;

 

•

the establishment of valuation allowances against deferred income tax assets if we determine that it is more likely than not that future income tax benefits will not be realized;

 

•

the release of a previously established valuation allowances against deferred income tax assets if we determine that it is more likely than not that future income tax benefits will be realized;

 

•

changes in the relative mix and size of clinical studies in various tax jurisdictions; and

 

•

the timing and amount of the vesting and exercising of share-based compensation.

47

 

Table of Contents

 

 

These changes may cause fluctuations in our effective income tax rate that could adversely affect our results of operations and cause fluctuations in our earnings and earnings per share.

We have only a limited ability to protect our intellectual property rights, and these rights are important to our success.

We develop, use, and protect our proprietary methodologies, analytics, systems, technologies, and other intellectual property. Existing laws of the various countries in which we provide services or solutions offer only limited protection of our intellectual property rights, and the protection in some countries may be very limited. We rely upon a combination of trade secrets, confidentiality policies, nondisclosure agreements, and other contractual arrangements, as well as patent, copyright and trademark laws, to protect our intellectual property rights. These laws are subject to change at any time and certain agreements might not be fully enforceable, which could further restrict our ability to protect our innovations. Our intellectual property rights might not prevent competitors from independently developing services similar to or duplicative of ours or alleging infringement of their intellectual property rights in certain jurisdictions. The steps we take in this regard might not be adequate to prevent or deter infringement or misappropriation of our intellectual property or claims against us for alleged infringement or misappropriation by competitors, former employees, or other third parties. Furthermore, we might not be able to detect unauthorized use of, or take appropriate and timely steps to enforce, our intellectual property rights. Enforcing our rights might also require considerable time, money, and oversight, and we might not be successful in enforcing our rights.

Our acquisition strategy may present additional risks, including the risk that we may be unable to fully realize the competitive and operating synergies projected to be achieved through any specific acquisition.

We have historically grown our business both organically and through acquisitions. We have and will continue to assess the need and opportunity to offer additional services through acquisitions of other companies. Acquisitions involve numerous risks, including the following:

 

•

ability to identify suitable acquisition opportunities or obtain any necessary financing on commercially acceptable terms;

 

•

increased risk to our financial position and liquidity through changes to our capital structure and assumption of acquired liabilities, including any indebtedness incurred to finance the acquisitions and related interest expense;

 

•

diversion of management’s attention from normal daily operations of the business;

 

•

insufficient revenues to offset increased expenses associated with acquisitions;

 

•

assumption of liabilities and exposure to unforeseen liabilities of acquired companies, including liabilities for their failure to comply with healthcare, tax, and other regulations;

 

•

inability to achieve identified operating and financial synergies and other benefits anticipated to result from an acquisition;

 

•

difficulties integrating and documenting processes and controls in conformance with the requirements of Section 404 of the Sarbanes-Oxley Act of 2002;

 

•

ability to integrate acquired operations, products, and technologies into our business;

 

•

difficulties retaining and integrating acquired personnel and distinct cultures into our business; and

48

 

Table of Contents

 

 

•

the potential loss of key employees, customers, or projects.

We may also spend time and money investigating and negotiating with potential acquisition targets but not complete the transaction. Any acquisition could involve other risks, including, among others, the assumption of additional liabilities and expenses, difficulties and expenses in connection with integrating the acquired companies and achieving the expected benefits, issuances of potentially dilutive securities or interest-bearing debt, loss of key employees of the acquired companies, transaction expenses, diversion of management's attention from other business concerns, and, with respect to the acquisition of international companies, the inability to overcome differences in international business practices, language and customs. Our failure to successfully integrate potential future acquisitions could have a material adverse effect on our business, financial condition, results of operations, and cash flows.

Our relationships with existing or potential customers who are in competition with each other may adversely impact the degree to which other customers or potential customers use our services, which may adversely affect our business, financial condition, results of operations, or cash flows.

The biopharmaceutical industry is highly competitive, with biopharmaceutical companies each seeking to persuade payers, providers, and patients that their drug therapies are better and more cost-effective than competing therapies marketed or being developed by competing firms. In addition to the adverse competitive interests that biopharmaceutical companies have with each other, biopharmaceutical companies also have adverse interests with respect to drug selection and reimbursement with other participants in the healthcare industry, including payers and providers. Biopharmaceutical companies also compete to be first to market with new drug therapies. We regularly provide services to biopharmaceutical companies that compete with each other, and we sometimes provide services to such customers regarding competing drugs in the market and in development. Our existing or future relationships, particularly broader strategic provider and commercial relationships, with our biopharmaceutical customers may therefore deter other biopharmaceutical customers from using our services or may result in our customers seeking to place limits on our ability to serve other biopharmaceutical industry participants. In addition, our further expansion into the broader healthcare market may adversely impact our relationships with biopharmaceutical customers, and such customers may elect not to use our services, reduce the scope of services that we provide to them or seek to place restrictions on our ability to serve customers in the broader healthcare market with interests that are adverse to theirs. Any loss of customers or reductions in the level of revenues from a customer could have a material adverse effect on our business, financial condition, results of operations, or cash flows.

Our results of operations may be adversely affected if we fail to realize the full value of our goodwill and intangible assets.

As of December 31, 2021, our goodwill and net intangible assets were valued at $5.81 billion, which constituted approximately 71% of our total assets.

Our goodwill is principally related to the acquisition of inVentiv completed in August 2017. Goodwill is tested for impairment at the reporting unit level, which is one level below the operating segment level. This test requires us to determine if the implied fair value of the reporting unit’s goodwill is less than its carrying amount. The impairment analysis requires significant judgments, estimates and assumptions. There is no assurance that the actual future earnings or cash flows of the reporting units will not decline significantly from the projections used in the impairment analysis. Goodwill impairment charges may be recognized in future periods in one or more of the reporting units to the extent changes in factors or circumstances occur, including deterioration in the macroeconomic environment or industry, deterioration in our performance or our future projections, or changes in plans for one or more of our reporting units. As of December 31, 2021, our goodwill is assigned to four reporting units. We completed our annual impairment test as of October 1, 2021 for all of our reporting units and concluded that there were no impairments.

49

 

Table of Contents

 

Intangible assets consist of customer relationships, acquired backlog, trade names, trademarks, patient communities, and acquired technologies. We review intangible assets at the end of each reporting period to determine if facts and circumstances indicate that the useful life is shorter than originally estimated or that the carrying amount of the assets might not be recoverable. If such facts and circumstances exist, we assess the recoverability of identified assets by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining lives to their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amount over the fair value of those assets and occur in the period in which the impairment determination was made. We have experienced material impairment losses in the past, and could experience additional material impairment losses in the future. The process of testing intangible assets for impairment involves numerous judgments, assumptions, and estimates made by management including expected future profitability, cash flows, and the fair values of assets and liabilities, which inherently reflect a high degree of uncertainty and may be affected by significant variability. If the business climate deteriorates, then actual results may not be consistent with these judgments, assumptions, and estimates, and our intangible assets may become impaired in future periods. Both the deterioration of the business climate and any potential impairment losses caused as a result of such deterioration could in turn have an adverse impact on our business, financial condition, and results of operations.

We face risks arising from the restructuring of our operations, which could adversely affect our financial condition, results of operations, cash flows, or business reputation.

From time to time, we have adopted cost savings initiatives to improve our operating efficiency through various means such as: (i) the reduction of overcapacity, primarily in our costs of services (billable) function; (ii) elimination of non-billable support roles; and (iii) the consolidation or other realignment of our resources. During the year ended December 31, 2021, we recognized approximately $14.5 million of employee severance costs, facility closure and lease termination costs of $8.2 million, and other costs of $0.1 million related to our focus on optimizing our resources worldwide.

Restructuring actions present significant risks that could have a material adverse effect on our operations, financial condition, results of operations, cash flows, or business reputation. Such risks include:

 

•

a decrease in employee morale and retention of key employees;

 

•

a greater number of employment claims;

 

•

actual or perceived disruption of service or reduction in service standards to customers;

 

•

the failure to preserve supplier relationships and distribution, sales and other important relationships, and to resolve conflicts that may arise;

 

•

the failure to achieve targeted cost savings; and

 

•

the failure to meet operational targets and customer requirements due to the loss of employees and any work stoppages that might occur.

50

 

Table of Contents

 

We operate in many different jurisdictions and we could be adversely affected by violations of the FCPA, U.K. Bribery Act of 2010, and/or similar worldwide anti-corruption and anti-bribery laws.

The FCPA, U.K. Bribery Act of 2010, and similar worldwide anti-corruption laws prohibit companies and their intermediaries from making improper payments for the purpose of obtaining or retaining business. Our internal policies mandate compliance with these anti-corruption laws. We operate in many parts of the world that have experienced corruption to some degree and, in certain circumstances, anti-corruption laws have appeared to conflict with local customs and practices. Despite our training and compliance programs, we cannot assure that our internal control policies and procedures will protect us from acts in violation of anti-corruption laws committed by persons associated with us, and our continued expansion outside the U.S., including in developing countries, could increase such risk in the future. Violations of the FCPA or other ex-U.S. anti-corruption laws, or even allegations of such violations, could disrupt our business and result in a material adverse effect on our financial condition, results of operations, cash flows, and reputation. For example, violations of anti-corruption laws can result in restatements of, or irregularities in, our financial statements as well as severe criminal or civil sanctions. In some cases, companies that violate the FCPA (or similar laws in other jurisdictions outside the U.S.) might be debarred by the U.S. government and/or lose their U.S. export privileges. In addition, U.S. or other governments might seek to hold us liable for successor liability for FCPA violations or violations of other anti-corruption laws committed by companies that we acquire or in which we invest, or by or on behalf of persons working for or representing our Company. Changes in anti-corruption laws or enforcement priorities could also result in increased compliance requirements and related costs which could adversely affect our business, financial condition, results of operations, and cash flows.

The failure of third parties to provide us critical support services could adversely affect our business, financial condition, results of operations, cash flows, or reputation.

We depend on third parties for support services vital to our business. Such support services include, but are not limited to, IT services, laboratory services, third-party transportation and travel providers, freight forwarders and customs brokers, drug depots and distribution centers, suppliers or contract manufacturers of drugs for patients participating in clinical trials, and providers of licensing agreements, maintenance contracts, or other services. In addition, we also rely on third-party CROs and other contract clinical personnel for clinical services either in regions where we have limited resources, or in cases where demand cannot be met by our internal staff. The failure of any of these third parties to adequately provide us critical support services could have a material adverse effect on our business, financial condition, results of operations, cash flows, or reputation.

Our embedded and functional outsourcing services could subject us to employment liability, which may cause adverse effects on our business.

With our embedded and functional outsourcing services, we place employees at the physical workplaces of our customers. The risks of this activity include claims of errors and omissions, misuse or misappropriation of client proprietary information, theft of client property, and torts or other claims under employment liability, co-employment liability, or joint employment liability. We have policies and guidelines in place to reduce our exposure to such risks, but if we fail to follow these policies and guidelines we may suffer reputational damage, loss of customer relationships and business, and monetary damages.

51

 

Table of Contents

 

Our increasing focus on environmental sustainability and social initiatives could increase our costs, and inaction could harm our reputation and adversely impact our financial results.

There has been increasing public focus by investors, customers, environmental activists, the media and governmental and nongovernmental organizations on a variety of environmental, social and other sustainability matters. As an organization, we understand the importance of our role in lessening our environmental footprint and supporting positive social impact. We established a cross-functional team to make commitments relating to sustainability matters that affect us, including the design and implementation of specific risk mitigation strategic initiatives relating to sustainability. In light of the importance of this to our culture, as well as internal and external stakeholders, if we are not effective in addressing environmental, social and other sustainability matters affecting our business, or setting and meeting relevant sustainability goals, our reputation and financial results may suffer. We may experience increased costs in order to execute upon our sustainability goals and measure achievement of those goals, which could have an adverse impact on our business and financial condition.

In addition, this emphasis on environmental, social, and other sustainability matters has resulted and may result in the adoption of new laws and regulations, including new reporting requirements. If we fail to comply with new laws, regulations, or reporting requirements, our reputation and business could be adversely impacted.

We might not be able to utilize certain of our net operating loss carryforwards and certain other tax attributes, which could harm our profitability.

As of December 31, 2021, we had approximately $317.4 million of net operating loss (“NOL”) carryforwards available to reduce U.S. federal taxable income in future years. Under Section 382 and similar provisions of the Internal Revenue Code (the “Code”), if a corporation undergoes an “ownership change,” that corporation’s ability to use its pre-change NOL carryforwards and other pre-change tax attributes, such as research tax credits, to offset its post-change income and taxes may be limited for U.S. federal income tax purposes (or similar provisions of other jurisdictions). These limitations may be subject to certain exceptions, including if there is “net unrealized built-in gain” in the assets of the corporation undergoing the ownership change.

Downgrades of our credit ratings could adversely affect us.

We can be adversely affected by downgrades of our credit ratings because ratings are a factor influencing our ability to access capital and the terms of any new indebtedness, including covenants and interest rates. Our customers and vendors may also consider our credit profile when negotiating contract terms, and if they were to change the terms on which they deal with us, it could have a material adverse effect on our business, results of operations, cash flows, and financial condition.

Many of our vendors have the right to declare us in default of our agreements if any such vendor, including the lessors under our vehicle fleet leases, determines that a change in our financial condition poses a substantially increased credit risk. Upon default, the lessors can repossess the vehicles and require us to compensate them for any remaining lease payments in excess of the value of the repossessed vehicles. As of December 31, 2021, we had $54.8 million in finance lease obligations, primarily related to vehicles used in Deployment Solutions in the U.S. Deployment Solutions may be negatively impacted if we lose the use of vehicles for any period of time.

Our credit agreement (as amended, the “Credit Agreement”) contains covenants that may restrict our ability to, among other things, borrow money, pay dividends, make capital expenditures, make strategic acquisitions and effect a consolidation, merger, or disposal of all or substantially all of our assets. Refer to “Risks Related to Our Indebtedness – Covenant restrictions under the Credit Agreement may limit our ability to operate our business” for further details on our covenant restrictions.

52

 

Table of Contents

 

Risks Related to Our Industry

The biopharmaceutical services industry is highly competitive and our business could be materially impacted if we do not compete effectively.

The biopharmaceutical services industry is highly competitive. Our business often competes with other biopharmaceutical services companies, internal discovery departments, development departments, sales and marketing departments, information technology departments, and other departments within our customers, some of which could be considered large biopharmaceutical services companies in their own right with greater resources than ours. To the extent that our clients choose to internally perform the clinical development and commercialization tasks that we provide, our business will suffer. We also compete with universities, teaching hospitals, governmental agencies, and others. If we do not compete successfully, our business will suffer. The industry is highly fragmented, with numerous smaller specialized companies and a handful of companies with global capabilities similar to certain of our own capabilities. Increased competition has led to price and other forms of competition (such as acceptance of less favorable contract terms) that could adversely affect our operating results. There are few barriers to entry for companies considering offering any one or more of the services we offer. Because of their size and focus, these companies might compete effectively against us, which could have a material adverse impact on our business.

In recent years, our industry has experienced increased consolidation which may continue and might put us at risk of growing more slowly than our competitors that make acquisitions. This trend is likely to produce more competition from the resulting larger companies, and ones without the cost pressures of being public, for both customers and acquisition candidates. One specific aspect of this consolidation competition involves CROs entering into transactions to attempt to control more access to clinical trial participants, like acquisition of site networks and data. These trends could make it harder for us to compete successfully.

In addition, the emergence of the use of real world evidence and new tools such as machine learning and artificial intelligence that capitalize on the availability of large data sets may reduce the time and costs of the discovery and development process, may allow our clients to more readily perform clinical development tasks and services that we provide themselves or may cause price competition. More broadly, our current competitors or other businesses might develop technologies or services that are more effective or commercially attractive than, or render obsolete, our current or future technologies and services. Our failure to develop and offer competitive solutions that address these and other technological advances in a timely, cost-effective manner or to keep pace with rapid technological change could adversely affect our competitive position and our results of operations.

53

 

Table of Contents

 

Our future growth and success will depend on our ability to successfully compete with other companies that provide similar services in the same markets, some of which may have financial, marketing, technical, and other advantages. We also expect that competition will continue to increase as a result of consolidation among these various companies. Large technology companies with substantial resources, technical expertise, and greater brand power could also decide to enter or further expand in the markets where our business operates and compete with us. If one or more of our competitors or potential competitors were to merge or partner with another of our competitors, or if a new entrant emerged with substantial resources, the change in the competitive landscape could adversely affect our ability to compete effectively. We compete on the basis of various factors, including breadth and depth of services, reputation, reliability, quality, innovation, security, price, and industry expertise and experience. In addition, our ability to compete successfully may be impacted by the growing availability of health information from social media, government health information systems, and other free or low-cost sources. In addition, consolidation or integration of wholesalers, retail pharmacies, health networks, payers, or other healthcare stakeholders may lead any of them to provide information services directly to customers or indirectly through a designated service provider, resulting in increased competition from firms that may have lower costs to market (e.g., no data supply costs). Any of the above may result in lower demand for our services, which could result in a material adverse impact on our operating results and financial condition.

Outsourcing trends in the biopharmaceutical industry and changes in aggregate spending and research and development budgets could adversely affect our operating results and growth rate.

Our revenues depend on the level of R&D and commercialization expenditures, size of the drug-development pipelines, and outsourcing trends of the biopharmaceutical industry, including the amount of such R&D and commercialization spend that is outsourced and subject to competitive bidding amongst us and our competitors. Accordingly, economic factors and industry trends that affect biopharmaceutical companies affect our business.

Biopharmaceutical companies continue to seek long-term strategic collaborations with global CROs with favorable pricing terms. Competition for these collaborations is intense and we might not be selected, in which case a competitor may enter into the collaboration and our business with the customer, if any, may be limited. Our success depends in part on our ability to establish and maintain preferred provider relationships with large biopharmaceutical companies. Our failure to develop or maintain these preferred provider relationships could have a material adverse effect on our business and results of operations. Furthermore, in order to obtain preferred provider relationships or other large contracts for commercialization services, we may have to reduce the prices for our services, which could negatively impact our gross margin for these services.

Our small and mid-sized biopharmaceutical company clients may rely on funding from venture capital and other sources to drive their business. To the extent that this funding is reduced, our small and mid-sized biopharmaceutical company clients may be forced to reduce their outsourced R&D and commercialization expenditures, which could have a material adverse effect on our business and results of operations.

In addition, if the biopharmaceutical industry reduces its outsourcing of clinical trials or commercialization services or such outsourcing fails to grow at projected rates, our business, financial condition, results of operations, and cash flows could be materially and adversely affected. We may also be negatively impacted by consolidation and other factors in the biopharmaceutical industry, which may slow decision making by our customers, result in the delay or cancellation of existing projects, cause reductions in overall R&D expenditures, or lead to increased pricing pressures. Further, in the event that one of our customers combines with a company that is using the services of one of our competitors, the combined company could decide to use the services of that competitor or another provider. All of these events could adversely affect our business, financial condition, cash flows, or results of operations.

54

 

Table of Contents

 

Actions by government regulators or customers to limit a prescription’s scope or withdraw an approved product from the market could adversely affect our business, results of operations, and financial condition.

Government regulators have the authority, after approving a biopharmaceutical product, to limit its indicated use, impose restrictions on its marketing, or withdraw it from the market completely based on safety or other concerns. Similarly, customers may act to voluntarily limit the sales of biopharmaceutical products or withdraw them from the market. Actions by payers to limit a product on a formulary list or restrict coverage or reimbursement for a product can influence customer decisions to withdraw or limit market support for a product. In the past, we have provided services with respect to products that have been limited or withdrawn. If we are providing services to customers for products that are limited or withdrawn, we may be required to narrow the scope of or terminate our services with respect to such products, which would prevent us from earning the full amount of revenues anticipated under the related contracts with negative impacts to our business, results of operations, cash flows, and financial condition.

If we fail to comply with federal, state, and foreign healthcare laws, including fraud and abuse laws, we could face substantial penalties and our business, financial condition, results of operations, cash flows, and prospects could be adversely affected.

Even though we do not and will not order healthcare services or bill directly to Medicare, Medicaid, or other third-party payers, certain federal and state healthcare laws and regulations pertaining to fraud and abuse are and will be applicable to our business. We could be subject to healthcare fraud and abuse laws of both the federal government and the states in which we conduct our business. Because of the breadth of these laws and the narrowness of available statutory and regulatory exceptions, it is possible that some of our business activities could be subject to challenge under one or more of such laws. If we or our operations are found to be in violation of any of the laws described above or any other governmental regulations that apply to us, we may be subject to penalties, including civil and criminal penalties, damages, fines, imprisonment, and the curtailment or restructuring of our operations, any of which could materially adversely affect our ability to operate our business, our financial results, and our reputation.

We may be affected by healthcare reform and potential additional reforms which may adversely impact the biopharmaceutical industry and reduce the need for our services or negatively impact our profitability.

Numerous government bodies are considering or have adopted healthcare reforms and may undertake, or are in the process of undertaking, efforts to control healthcare costs through legislation, regulation, and agreements with HCPs and biopharmaceutical companies, including many of our customers. As governmental administrations change and reforms take place, we are unable to predict what legislative proposals, if any, will be adopted in the future. If regulatory cost-containment efforts limit the profitability of new drugs by, for example, continuing to place downward pressure on pharmaceutical pricing and/or increasing regulatory burdens and operating costs of the biopharmaceutical industry, our customers may reduce their commercialization and R&D spending, which could reduce the business they outsource to us. In addition, if regulatory requirements are relaxed or simplified drug approval procedures are adopted, the demand for our services could decrease.

55

 

Table of Contents

 

Government bodies have adopted and may continue to adopt new healthcare legislation or regulations that are more burdensome than existing regulations. For example, product safety concerns and recommendations by the Drug Safety Oversight Board could change the regulatory environment for drug products, and new or heightened regulatory requirements may increase our expenses or limit our ability to offer some of our services. We might have to incur additional costs to comply with these or other new regulations, and failure to comply could harm our financial condition, results of operations, cash flows, and reputation, and result in adverse legal action(s). Additionally, new or heightened regulatory requirements may have a negative impact on the ability of our customers to conduct industry-sponsored clinical trials, which could reduce the need for our post-approval development services. For instance, in the EU, the Clinical Trials Regulation (“CTR”), which was adopted in April 2014, will become applicable on January 31, 2022. The CTR will be directly applicable in all EU member states, repealing the current Clinical Trials Directive. The CTR harmonizes the assessment and supervision processes for clinical trials throughout the EU via a Clinical Trials Information System, which will notably contain a centralized EU portal and database.

It is currently unclear to what extent the UK will seek to align its regulations with the EU Clinical Trials Regulation (EU) No 536/2014, which was enacted in 2014 and became effective on January 31, 2022. The UK regulatory framework in relation to clinical trials is derived from existing EU legislation (as implemented into UK law, through secondary legislation). If the decision by the UK is not to closely align its regulations with the new approach that will be adopted in the EU, it could have an effect on the cost of conducting clinical trials in the UK as opposed to other countries and/or make it harder to seek a marketing authorization in the EU for product candidates on the basis of clinical trials conducted in the UK.

Current and proposed laws and regulations regarding the protection of personal data could result in increased risks of liability or increased cost to us or could limit our service offerings.

The global data protection landscape is rapidly evolving, and we are or may become subject to numerous state, federal and foreign laws, requirements, and regulations governing the collection, use, disclosure, retention, and security of personal information, such as information we may collect about individuals in the U.S., the EEA, the UK, and other countries where we have operations, including but not limited to Japan, China, South Korea, Brazil, and Singapore. Federal, state, and foreign governments may propose or have adopted additional legislation governing the collection, possession, use, storage, or disclosure of personal data, including but not limited to health and financial data, as well as security breach notification rules for loss or theft of such data. Additional legislation or regulation of this type might, among other things, require us to implement additional security measures and processes or to anonymize or de-identify health or other personal data in excess of what we are already obliged to do, each of which may require substantial expenditures or limit our ability to offer some of our services. Failure to comply with these data protection and privacy laws, rules, and regulations, or to resolve any privacy or security complaints, could subject us to regulatory sanctions, fines, delays in clinical trials, criminal prosecution, or civil liability, as well as reputational damage.

56

 

Table of Contents

 

In the U.S., we are subject to certain state privacy and data security laws and regulations in the states in which we operate, such as the CCPA, which became effective as of January 2020, and creates individual privacy rights for California consumers and increases the privacy and security obligations of entities handling certain personal information. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches that is expected to increase data breach litigation. Further, the California Privacy Rights Act (the “CPRA”) recently passed in California. The CPRA will impose additional data protection obligations on covered businesses, including additional consumer rights processes, limitations on data uses, new audit requirements for higher risk data, and opt outs for certain uses of sensitive data. It will also create a new California data protection agency authorized to issue substantive regulations and could result in increased privacy and information security enforcement. The majority of the provisions will go into effect on January 1, 2023, and additional compliance investment and potential business process changes may be required. Similar laws have passed in Virginia and Colorado, and have been proposed in other states and at the federal level, reflecting a trend toward more stringent privacy legislation in the U.S. The enactment of such laws could have potentially conflicting requirements that would make compliance challenging. In the event that we are subject to or affected by the CCPA, the CPRA, or other domestic privacy and data protection laws, any liability from failure to comply with the requirements of these laws could adversely affect our financial condition.  

In the EEA, we are subject to the EU GDPR, and in the UK, we are subject to the UK data protection regime consisting primarily of the UK General Data Protection Regulation, or UK GDPR, and the UK Data Protection Act 2018, (collectively, the GDPR), in each case in relation to our collection, control, processing, sharing, disclosure, and other use of data relating to an identifiable living individual (personal data). The GDPR contains provisions specifically directed at the processing of health data, rights of data subjects, data breach notification, and extra-territoriality measures intended to extend the applicability of the law to certain activities performed by non-EEA/UK organizations (such as the targeting or monitoring of individuals located in the EEA/UK by organizations located in other locations). Failure by us, or by our partners, our service providers, or our employees or contractors, to comply with the GDPR could result in regulatory investigations, reputational damage, orders to cease/ change our use of data, enforcement notices and/ or fines of the greater of €20 million/£17.5 million or 4% of total global annual revenue, as well as potential civil claims including class actions where individuals suffer harm. These changes may lead to additional compliance costs and could increase our overall risk. As we expand into other foreign countries and jurisdictions, we may be subject to additional laws and regulations that may affect how we conduct business.

In addition to data protection laws and regulations, regulators are considering (or are adopting) other laws, regulations and guidelines that impact the processing of personal information. For example, the evolving landscape surrounding the use of artificial intelligence and online advertising may lead to additional compliance costs and could increase our overall risk.

In addition, we operate on a global basis and may transfer personal data to our affiliates and service providers in the course of administering our business and performing our services. As a result, we are subject to legal requirements that govern the cross-border transfer of personal data. For example, the GDPR prohibits the transfer of personal data outside the EEA and the UK to third countries that have not been found to provide adequate protection to such personal data, including the U.S., in the absence of certain safeguards. We rely upon Standard Contractual Clauses (“SCCs”) and other appropriate safeguards or derogations for such transfers of personal data.

57

 

Table of Contents

 

The European Commission issued revised SCCs on June 4, 2021 to account for the decision of the CJEU and recommendations made by the European Data Protection Board. The revised SCCs must be used for relevant new data transfers from September 27, 2021; existing standard contractual clauses arrangements must be migrated to the revised clauses by December 27, 2022. The new SCCs apply only to the transfer of personal data outside of the EEA and not the UK; the UK’s Information Commissioner’s Office launched a public consultation on its draft revised data transfers mechanisms in August 2021. There is some uncertainty around whether the revised clauses can be used for all types of data transfers, particularly whether they can be relied on for data transfers to non-EEA entities subject to the GDPR.

As noted in prior disclosures, certain of our clinical entities relied in part on the EU-U.S. and Swiss-U.S. Privacy Shield frameworks to transfer certain personal data from the EU and Switzerland, respectively, to the U.S. On July 16, 2020, the Court of Justice of the European Union (“CJEU”) invalidated the EU-US Privacy Shield. Similarly, on September 8, 2020, Switzerland’s Federal Data Protection and Information Commissioner (“FDPIC”) issued an opinion concluding that the Swiss-US Privacy Shield Framework does not provide an adequate level of protection to transfer Personal Data from Switzerland to the U.S. Because of these developments, we no longer leverage these frameworks to support the transfer of personal data from the EU and Switzerland to the U.S., although we continue participation in them, in an effort to demonstrate our commitment to the protection of personal data.

We are accountable for the acts and omissions of our third-party service providers we engage to process personal data on our behalf, subject to limitations and exclusions provided by law. There is no assurance that contractual measures and our own privacy and security-related safeguards will protect us from the risks associated with the third-party processing, storage and transmission of such information. Any violation of data protection laws by our third-party processors could have a material adverse effect on our business and result in the fines and penalties outlined above.

Although we work to comply with applicable laws, regulations and standards, our contractual obligations, and other legal obligations, these requirements are evolving and may be modified, interpreted and applied in an inconsistent manner from one jurisdiction to another, and may conflict with one another or other legal obligations with which we must comply. Any failure or perceived failure by us or our employees, representatives, contractors, consultants, collaborators, or other third parties to comply with such requirements or adequately address privacy and security concerns, even if unfounded, could result in additional cost and liability to us, damage our reputation, and adversely affect our business and results of operations.

Our customers face intense competition from lower cost generic products and other competing products, which may lower the amount that they spend on our services and could have a material adverse effect on our business, results of operations, cash flows, and financial condition.

Our customers face increasing competition from competing products and, in particular, from lower cost generic products, which in turn may affect their ability to pursue clinical development and commercialization activities. In the U.S., the EU and Japan, political pressure to reduce spending on prescription products has led to legislation and other measures which encourage the use of generic products. In addition, proposals emerge from time to time in the U.S. and other countries for legislation to further encourage the early and rapid approval of generic products. Loss of patent protection for a product typically is followed promptly by generic substitutes, reducing our customers’ sales of that product and their overall profitability. Availability of generic substitutes for our customers’ products or other competing products may cause them to lose market share and, as a result, may adversely affect their results of operations and cash flow, which in turn may mean that they would not have adequate capital to purchase our services. If competition from generic or other products impacts our customers’ finances such that they decide to curtail our services, our net revenues may decline and this could have a material adverse effect on our business, results of operations, and financial condition.

58

 

Table of Contents

 

The biopharmaceutical industry has a history of patent and other intellectual property litigation and we might be involved in costly intellectual property lawsuits.

The biopharmaceutical industry has a history of intellectual property litigation and these lawsuits will likely continue in the future. Accordingly, we may face patent infringement suits or be called upon to provide documentation by companies that have patents for similar business processes or other suits alleging infringement of their intellectual property rights. Legal proceedings relating to intellectual property could be expensive, take significant time, and divert management’s attention from other business concerns, regardless of the outcome of the litigation. In the event an infringement lawsuit were brought against us and we did not prevail, we might have to pay substantial damages and we could be required to stop infringing activity or obtain a license to use technology on unfavorable terms.

Risks Related to Our Indebtedness

Our substantial debt could adversely affect our financial condition and cash flows from operations.

As of December 31, 2021, our total principal amount of indebtedness was $2.84 billion, which consisted of: (i) $1.79 billion in term loan debt; (ii) $600.0 million of 3.625% senior notes (the “Notes”); (iii) borrowings of $400.0 million under our accounts receivable financing agreement; and (iv) $54.8 million in current and non-current finance lease obligations. Our substantial indebtedness could adversely affect our financial condition and cash flows from operations and thus make it more difficult for us to satisfy our obligations with respect to our senior secured facilities. If our cash flow is not sufficient to service our debt and adequately fund our business, we may be required to seek further additional financing or refinancing or dispose of assets. We might not be able to influence any of these alternatives on satisfactory terms or at all. Our substantial indebtedness could also:

 

•

increase our vulnerability to adverse general economic, industry, or competitive developments;

 

•

require us to dedicate a more substantial portion of our cash flows from operations to payments on our indebtedness, thereby reducing the availability of our cash flows to fund working capital, investments, acquisitions, capital expenditures, and other general corporate purposes;

 

•

limit our ability to make required payments under our existing contractual commitments, including our existing long-term indebtedness;

 

•

limit our ability to fund a change of control offer;

 

•

require us to sell certain assets;

 

•

restrict us from making strategic investments, including acquisitions, or causing us to make non-strategic divestitures;

 

•

limit our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate;

 

•

place us at a competitive disadvantage compared to our competitors that have less debt;

 

•

cause us to incur substantial fees from time to time in connection with debt amendments or refinancings;

 

•

increase our exposure to rising interest rates because a substantial portion of our borrowings is at variable interest rates; and

59

 

Table of Contents

 

 

•

limit our ability to borrow additional funds or to borrow on terms that are satisfactory to us.

Despite our level of indebtedness, we are able to incur more debt and undertake additional obligations. Incurring such debt or undertaking such additional obligations could further exacerbate the risks to our financial condition.

We also may be able to incur additional indebtedness in the future. Although covenants under the Credit Agreement limit our ability to incur certain additional indebtedness, these restrictions are subject to a number of qualifications and exceptions, and the indebtedness incurred in compliance with these restrictions could be substantial. To the extent we incur additional indebtedness, the risks associated with our leverage, including our possible inability to service our debt obligations, would increase.

Servicing our debt will require a significant amount of cash, and our ability to generate sufficient cash depends on many factors, some of which are beyond our control.

Our ability to make payments on and refinance our debt, make strategic acquisitions, and fund capital expenditures depends on our ability to generate cash flow in the future. To some extent, our ability to generate future cash flow is subject to general economic, financial, competitive, and other factors that are beyond our control. We cannot assure you that:

 

•

our business will generate sufficient cash flow from operations;

 

•

we will continue to realize the cost savings, revenue growth, and operating improvements that resulted from the execution of our long-term strategic plan; or

 

•

future sources of funding will be available to us in amounts sufficient to enable us to fund our liquidity needs.

We also may experience difficulties repatriating cash from foreign subsidiaries and accounts due to law, regulation, or contracts which could further constrain our liquidity. If we cannot fund our liquidity needs, we will have to take actions such as reducing or delaying capital expenditures, marketing efforts, strategic acquisitions, investments and alliances, selling assets, restructuring or refinancing our debt, or seeking additional equity capital. We cannot assure you that any of these remedies could, if necessary, be effected on commercially reasonable or favorable terms, or at all, or that they would permit us to meet our scheduled debt service obligations. Any inability to generate sufficient cash flow or refinance our debt on favorable terms could have a material adverse effect on our financial condition.

60

 

Table of Contents

 

Covenant restrictions under the Credit Agreement, our other financing arrangements, and lease agreement may limit our ability to operate our business.

The Credit Agreement and our indentures governing our Notes contain covenants that may restrict our ability to, among other things, borrow money, pay dividends, make capital expenditures, make strategic acquisitions and effect a consolidation, merger or disposal of all or substantially all of our assets. Although the covenants in the Credit Agreement and our other debt instruments are subject to various exceptions, we cannot assure you that these covenants will not adversely affect our ability to finance future operations, capital needs, or to engage in other activities that may be in our best interest. In addition, in certain circumstances, our long-term debt requires us to maintain a specified financial ratio and satisfy certain financial condition tests, which may require that we take action to reduce our debt or to act in a manner contrary to our business objectives. A breach of any of these covenants could result in a default under our senior secured facilities or our indentures governing our senior unsecured notes. If an event of default under the Credit Agreement or our other debt instruments occurs, the lenders thereunder or holders of the defaulted debt could elect to declare all amounts outstanding, together with accrued interest, to be immediately due and payable. In such case, we might not have sufficient funds to repay all the outstanding amounts. In addition, the Credit Agreement is secured by first priority security interests on substantially all of our real and personal property, including the capital stock of certain of our subsidiaries. If an event of default under the Credit Agreement occurs, the lenders thereunder could exercise their rights under the related security documents. Any acceleration of amounts due under the Credit Agreement or the substantial exercise by the lenders of their rights under the security documents would likely have a material adverse effect on us. Our receivables facility also contains covenants customary in such facilities that may restrict our ability to operate our business.

Under the terms of the lease agreement for our corporate headquarters in Morrisville, North Carolina we may be required to issue a letter of credit (“LOCs”) to the landlord based on our debt rating issued by Moody’s Investors Service (or other nationally-recognized debt rating agency, such as S&P Global Ratings). 

As of December 31, 2021, our debt rating was such that no LOC is currently required. Any LOCs issued in accordance with the aforementioned requirements could be issued under our revolving credit facility (the “Revolver”) under the Credit Agreement, and, if issued under our Revolver, would reduce our available borrowing capacity by the same amount accordingly.

Interest rate fluctuations may have a material adverse effect on our business, financial condition, results of operations, or cash flows.

Because we have substantial variable rate debt, fluctuations in interest rates may affect our business, financial condition, results of operations, or cash flows. We currently utilize interest rate swaps to limit our exposure to interest rate fluctuations; however, such instruments may not be effective. As of December 31, 2021, we had approximately $2.84 billion of total principal indebtedness consisting of $1.79 billion in term loan debt, $600.0 million under the Notes, borrowings of $400.0 million under our accounts receivable financing agreement, and $54.8 million in current and non-current of finance lease obligations, of which $1.03 billion (excluding finance leases) was subject to variable interest rates.

61

 

Table of Contents

 

A portion of our indebtedness bears interest at variable interest rates, primarily based on the London Inter-bank Offered Rate (“LIBOR”), which may be subject to regulatory guidance and/or reform that could cause interest rates under our current or future debt agreements to perform differently than in the past or cause other unanticipated consequences. Some tenors of LIBOR were discontinued on December 31, 2021. Although we expect that the capital and debt markets will cease to use LIBOR as a benchmark in the near future and the administrator of LIBOR has announced its intention to extend the publication of most tenors of LIBOR for U.S. dollars through June 30, 2023, we cannot predict whether or when LIBOR will actually cease to be available, whether the Secured Overnight Funding Rate, or SOFR, will become the market benchmark in its place or what impact such a transition may have on our business, financial condition, and results of operations.

A lowering or withdrawal of the ratings assigned to our debt securities by rating agencies may increase our future borrowing costs and reduce our access to capital.

Our debt currently has a non-investment grade rating, and any rating assigned could be lowered or withdrawn entirely by a rating agency if, in that rating agency’s judgment, future circumstances relating to the basis of the rating, such as adverse changes, so warrant. Consequently, real or anticipated changes in our credit ratings will generally affect the market value of our debt. Credit ratings are not recommendations to purchase, hold, or sell the Notes. Any future lowering of our ratings likely would make it more difficult or more expensive for us to obtain additional debt financing.

Risks Related to Ownership of Our Common Stock

We do not expect to pay any cash dividends for the foreseeable future.

We do not anticipate that we will pay any dividends to holders of our stock for the foreseeable future. Any payment of cash dividends will be at the discretion of our Board and will depend on our financial condition, capital requirements, legal requirements, earnings, and other factors. Our ability to pay dividends is restricted by the terms of the Credit Agreement and might be restricted by the terms of any indebtedness that we incur in the future. Consequently, you should not rely on dividends in order to receive a return on your investment.

Provisions of our corporate governance documents and Delaware law could make an acquisition of our company more difficult and may prevent attempts by our shareholders to replace or remove our current management, even if beneficial to our shareholders.

Provisions of our certificate of incorporation and our amended and restated bylaws contain provisions that delay, defer or discourage transactions involving an actual or potential change in control of us or change in our management that shareholders may consider favorable, including transactions in which you might otherwise receive a premium for your shares. These provisions could also limit the price that investors might be willing to pay in the future for shares of our stock, thereby depressing the market price of our stock. In addition, these provisions may frustrate or prevent any attempts by our shareholders to replace or remove our current management by making it more difficult for shareholders to replace members of the Board. Because the Board is responsible for appointing the members of our management team, these provisions could in turn affect any attempt to replace current members of our management team. Among others, these provisions include: (i) our ability to issue preferred stock without shareholder approval; (ii) the requirement that our shareholders may not act without a meeting; (iii) requirements for advance notification of shareholder nominations and proposals contained in our bylaws; (iv) the absence of cumulative voting for our directors; and (v) requirements for shareholder approval of certain business combinations.

62

 

Table of Contents

 

Additionally, Section 203 of the Delaware General Corporation Law prohibits a publicly held Delaware corporation from engaging in a business combination with an interested shareholder, generally a person which together with its affiliates owns, or within the last three years has owned, 15% of our voting stock, for a period of three years after the date of the merger in which the person became an interested shareholder, unless the business combination is approved in a prescribed manner. The existence of the foregoing provision could also limit the price that investors might be willing to pay in the future for shares of our stock, thereby depressing the market price of our stock.

Our certificate of incorporation, as amended, provides, subject to certain exceptions, that the Court of Chancery of the State of Delaware will be the sole and exclusive forum for certain stockholder litigation matters, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or stockholders.

Our certificate of incorporation, as amended, provides, subject to limited exceptions, that the Court of Chancery of the State of Delaware will, to the fullest extent permitted by law, be the sole and exclusive forum for (1) any derivative action or proceeding brought on our behalf; (2) any action asserting a claim of breach of a fiduciary duty owed by, or any wrongdoing by, any of our directors, officers or stockholders to us or our stockholders; (3) any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law, our certificate of incorporation, as amended, or our amended and restated bylaws; (4) any action to interpret, apply, enforce or determine the validity of our certificate of incorporation, as amended, or our amended and restated bylaws or (5) any action asserting a claim governed by the internal affairs doctrine. This provision would not apply to suits brought to enforce a duty or liability created by the Exchange Act, Securities Act, or, in each case, the rules and regulations thereunder, or any other claim for which the U.S. federal courts have exclusive jurisdiction. Any person or entity purchasing or otherwise acquiring or holding any interest in shares of our capital stock shall be deemed to have notice of and to have consented to the provisions of our certificate of incorporation, as amended, described above. This exclusive forum provision may increase the costs associated with bringing a claim, discourage claims or limit a stockholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or any of our directors, officers or stockholders, any of which may discourage lawsuits with respect to such claims. Alternatively, if a court were to find the exclusive forum provision in our certificate of incorporation, as amended, to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could materially adversely affect our business, financial condition and results of operations.

The outcome of the putative class action lawsuit filed against us could have a material adverse effect on our business, financial condition, results of operation, and cash flows.

On January 25, 2018, a complaint was filed in the Eastern District of North Carolina on behalf of a putative class of shareholders who purchased our common stock during the period between May 10, 2017 and November 8, 2017. The complaint names us and certain of our executive officers as defendants and alleges violations of the Securities Exchange Act of 1934, as amended, based upon allegedly inaccurate or incomplete information regarding, among other things, the financial performance and business outlook for inVentiv’s business prior to the Merger and with respect to the combined company following the Merger. The plaintiffs seek awards of compensatory damages, among other relief, and their costs and attorneys’ and experts’ fees. We are presently unable to predict the duration, scope or result of this putative class action, or any other related lawsuit or investigation.

63

 

Table of Contents

 

Our internal control over financial reporting is required to meet all the standards of Section 404 of Sarbanes-Oxley, and failure to achieve and maintain effective internal controls over financial reporting could have a material adverse effect on our stock price, reputation, business, financial condition, results of operations and cash flows.

Section 404 of Sarbanes-Oxley requires management and our independent registered public accounting firm to assess and attest to the effectiveness of internal control over financial reporting on an annual basis. The rules governing the standards that must be met to assess our internal control over financial reporting are complex and require significant documentation, testing, and possible remediation of our existing controls and could result in incurring significant additional expenditures. We are required to design, implement, and test our internal control over financial reporting in order to comply with this obligation. The effort necessary to meet these requirements is time consuming, costly, and complicated, and we must continually evaluate and refine these processes on an ongoing basis. We might encounter problems or delays in completing the implementation of any required improvements and therefore fail to receive a favorable attestation provided by our independent registered public accounting firm.

Further, we have previously had material weaknesses or significant deficiencies in our internal control over financial reporting and new material weaknesses or significant deficiencies may exist or otherwise be discovered in the future. If we fail to maintain an effective internal control environment, such failure could limit our ability to report our financial results accurately and timely, resulting in misstatements and/or restatements of our consolidated financial statements, which may cause investors to lose confidence and have a material adverse effect on our stock price, reputation, business, financial condition, results of operations, and cash flows.

We are a holding company and rely on dividends and other payments, advances, and transfers of funds from our subsidiaries to meet our obligations and pay any dividends.

We have no direct operations and no significant assets other than ownership of 100% of the capital stock of our subsidiaries. Because we conduct our operations through our subsidiaries, we depend on those entities for dividends and other payments to generate the funds necessary to meet our financial obligations, and to pay any dividends with respect to our stock. Legal and contractual restrictions in the Credit Agreement and other agreements, which may govern future indebtedness of our subsidiaries, as well as the financial condition and operating requirements of our subsidiaries, may limit our ability to obtain cash from our subsidiaries. The earnings from, or other available assets of, our subsidiaries might not be sufficient to pay dividends, make distributions, or loans to enable us to pay any dividends on our stock or other obligations. Any of the foregoing could materially and adversely affect our business, financial condition, results of operations, and cash flows.

General Risk Factors

Our stock price is subject to volatility, which could have a material adverse impact on investors and employee retention.

Since our initial public offering in November 2014 (the “IPO”), the price of our stock, as reported by Nasdaq, has ranged from a low of $19.61 on November 7, 2014 to a high of $104.18 on November 12, 2021. In addition, securities markets worldwide have experienced, and are likely to continue to experience, significant price and volume fluctuations. This market volatility, as well as general economic, market or political conditions, could affect stock price in ways that may be unrelated to our operating performance. The trading price of our stock is subject to significant price fluctuations in response to many factors, including:

 

•

market conditions or trends in our industry, including with respect to the regulatory environment, or the economy as a whole;

64

 

Table of Contents

 

 

•

fluctuations in quarterly operating results, as well as differences between our actual financial and operating results and those expected by investors;

 

•

future performance guidance, if any, that we provide to the public, any changes in this guidance or our failure to meet this guidance;

 

•

changes in financial estimates or ratings by any securities analysts who follow our stock, our failure to meet those estimates or the failure of those analysts to initiate or maintain coverage of our stock;

 

•

changes in key personnel;

 

•

entry into new markets;

 

•

announcements by us or our competitors of new service offerings or significant acquisitions, divestitures, strategic partnerships, joint ventures or capital commitments;

 

•

actions by competitors;

 

•

changes in operating performance and market valuations of other companies in the industry;

 

•

investors’ perceptions of our prospects and the prospects of the industry;

 

•

investors’ perceptions of the investment opportunity associated with our stock relative to other investment alternatives;

 

•

the public’s reaction to press releases or other public announcements by us or third parties, including our filings with the SEC;

 

•

announcements related to litigation;

 

•

changes in the credit ratings of our debt;

 

•

the sustainability of an active trading market for our stock;

 

•

future sales of our stock by our significant shareholders, officers, and directors; and

 

•

other events or factors, including those resulting from system failures and disruptions, cyber-attacks, earthquakes, hurricanes, war, acts of terrorism, pandemics, other natural disasters, or responses to these events.

These and other factors may cause the market price and demand for shares of our stock to fluctuate substantially, which could result in reduced liquidity and a decline in the price of our stock. When the market price of a stock is volatile, security holders often institute class action litigation against the company that issued the stock. If we become involved in this type of litigation, regardless of the outcome, we could incur substantial legal costs and our management’s attention could be diverted from the operation of our business, which could have a material adverse effect on our business, financial condition, results of operations, and cash flows.

 

 

65

 

Table of Contents

 

 

Any litigation against us could be costly and time-consuming to defend.

We are subject to and may become subject, from time to time, to additional legal proceedings and claims that arise in the ordinary course of business or pursuant to governmental or regulatory enforcement activity. While we do not believe that the resolution of any currently pending lawsuits against us will, individually or in the aggregate, have a material adverse effect on our business, financial condition, results of operations, or cash flows, we might be wrong, and future litigation might result in substantial costs and divert management’s attention and resources, which might seriously harm our business, financial condition, results of operations, and cash flows. Insurance might not cover such claims, provide sufficient payments to cover all of the costs to resolve one or more such claims, or continue to be available on terms acceptable to us. In particular, any claim could result in potential liability for us if the claim is outside the scope of the indemnification agreement we have with our customers, our customers do not abide by the indemnification agreement as required or the liability exceeds the amount of any applicable indemnification limits or available insurance coverage. A claim brought against us that is uninsured or underinsured could result in unanticipated costs and could have a material adverse effect on our financial condition, results of operations, cash flows, or reputation.

If our insurance does not cover all of our indemnification obligations and other liabilities associated with our operations, our business, financial condition, results of operations, or cash flows may be materially adversely affected.

We maintain insurance designed to provide coverage for ordinary risks associated with our operations and our ordinary indemnification obligations that we believe to be customary for our industry. The coverage provided by such insurance might not be adequate for all claims we make or may be contested by our insurance carriers. If our insurance is not adequate or available to pay all claims or exposures associated with our operations, or if we are unable to purchase adequate insurance at reasonable rates in the future, our business, financial condition, results of operations, or cash flows may be materially adversely affected.

Item 1B. Unresolved Staff Comments.

None.

Item 2. Properties.

As of December 31, 2021, we had 113 operating facilities located in 50 countries. Most of our facilities consist solely of office space. We lease all of our facilities, except for non-material office space owned in Madrid, Spain; Tiraine, Latvia; and Macclesfield, United Kingdom. Our corporate headquarters and principal executive offices are in Morrisville, North Carolina, where we lease space totaling approximately 258,250 square feet. The lease will expire in January 2032. We also lease space totaling approximately 62,000 square feet in Farnborough, United Kingdom, which will expire in January 2028.

In addition, we lease substantial facilities in Columbus, Ohio; Gurgaon, India; Hyderabad, India; Mexico City, Mexico; Munich, Germany; New York, New York; Newtown, Pennsylvania; Princeton, New Jersey; Pune, India; Quebec City, Canada; Somerset, New Jersey; and Tokyo, Japan. We also maintain offices in various other Asian-Pacific, European, Latin American and North American locations, as well as Australia, the Middle East and Africa. Our leases are not individually material to our business model and all either have options to renew or are in major markets where we believe there are adequate opportunities to continue business operations at terms satisfactory to us.

66

 

Table of Contents

 

We are party to legal proceedings incidental to our business. While our management currently believes the ultimate outcome of these proceedings, individually and in the aggregate, will not have a material adverse effect on our consolidated financial statements, litigation is subject to inherent uncertainties. Were an unfavorable ruling to occur, there exists the possibility of a material adverse impact on our financial condition and results of operations.

Please refer to “Note 17 – Commitments and Contingencies” to our consolidated financial statements included in Part II, Item 8, “Financial Statements and Supplementary Data” in this Annual Report on Form 10-K for information pertaining to legal proceedings.

Item 4. Mine Safety Disclosures.

Not applicable.

PART II

Item 5. Market for Registrants’ Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities.

Holders of Record

On February 10, 2022, there were approximately 20 shareholders of record of our common stock as reported by our transfer agent. Shareholders of record are those who have the rights, benefits, and responsibilities of ownership of shares registered in their own names. This number does not include shareholders for whom shares are held in “nominee” or “street” name or beneficial owners of common stock whose shares are held in the names of brokers, dealers, or clearing agencies outside of our transfer agent.

Dividend Policy

Since becoming a public company, we have not declared or paid cash dividends on our common stock, nor do we intend to pay cash dividends on our common stock in the foreseeable future. However, in the future, subject to the factors described below and our future liquidity and capitalization, we may change this policy and choose to pay dividends.

We are a holding company that does not conduct any business operations of our own. As a result, our ability to pay cash dividends on our common stock is dependent upon cash dividends, distributions, and other transfers from our subsidiaries. Our ability to pay dividends is currently restricted by the terms of our credit agreement, dated August 1, 2017, as amended (the “Credit Agreement”), and other financing agreements, and may be further restricted by any future indebtedness we or our subsidiaries incur. In addition, under Delaware law, the Board of Directors (the “Board”) may declare dividends only to the extent of our surplus (which is defined as total assets at fair market value minus total liabilities, minus statutory capital) or, if there is no surplus, out of our net profits for the then current and/or immediately preceding fiscal year.

67

 

Table of Contents

 

Any future determination to pay dividends will be at the discretion of the Board and will take into account restrictions in our debt instruments, including the Credit Agreement, general economic business conditions, our financial condition, results of operations and cash flows, our capital requirements, our business prospects, the ability of our operating subsidiaries to pay dividends and make distributions to us, legal restrictions, and such other factors as the Board may deem relevant. For additional information on these restrictive covenants, see Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources” and “Note 4 – Long-Term Debt Obligations” to our consolidated financial statements included in Part II, Item 8, “Financial Statements and Supplementary Data” in this Annual Report on Form 10-K.

Recent Sales of Unregistered Equity Securities

We did not have any sales of unregistered equity securities during 2021.

Purchases of Equity Securities by the Issuer

On November 17, 2020, the Board authorized the repurchase of up to an aggregate of $300.0 million of our Class A common stock, par value $0.01 per share, to be executed from time to time in open market transactions effected through a broker at prevailing market prices, in block trades, or privately negotiated transactions through December 31, 2022 (the “2021 Stock Repurchase Program”). The 2021 Stock Repurchase Program took effect on January 1, 2021. Share repurchases are funded primarily with our working capital, cash flow from operations, and funds available through various borrowing arrangements.

The 2021 Stock Repurchase Program does not obligate us to repurchase any particular amount of our Class A common stock, and may be modified, extended, suspended, or discontinued at any time. The timing and amount of repurchases are determined by our management based on a variety of factors such as the market price of our Class A common stock, our corporate cash requirements, and overall market conditions. The 2021 Stock Repurchase Program is subject to applicable legal requirements, including federal and state securities laws and applicable Nasdaq rules. We may also repurchase shares of our Class A common stock pursuant to a trading plan meeting the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, which would permit shares of our Class A common stock to be repurchased when we might otherwise be precluded from doing so by law.

For the year ended December 31, 2021, we repurchased 1,500,000 shares of our Class A common stock in private transactions, for a total purchase price of approximately $117.5 million, representing the entirety of our share repurchases for the year. All such shares were purchased under our 2021 Stock Repurchase Program. We immediately retired all of the repurchased common stock and charged the par value of the shares to common stock. The excess of the repurchase price over the par value was applied on a pro rata basis against additional paid-in capital, with the remainder applied to accumulated deficit.

There were no share repurchases during the three months ended December 31, 2021. As of December 31, 2021, we have remaining authorization to repurchase up to approximately $182.5 million of shares of our Class A Common Stock under the 2021 Stock Repurchase Program.

68

 

Table of Contents

 

Stock Performance Graph

The information included under the heading “Stock Performance Graph” is “furnished” and not “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed to be “soliciting material” subject to Regulation 14A or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act of 1934, as amended.

Our common stock is traded on the Nasdaq under the symbol “SYNH.” From November 7, 2014 through January 7, 2018, our common stock was listed on the Nasdaq under the trading symbol “INCR.” The Stock Price Performance Graph set forth below compares the cumulative total shareholder return on our common stock for the period from December 31, 2016 through December 31, 2021, with the cumulative total return of the Nasdaq Composite Index and the Nasdaq Health Care Index over the same period. The comparison assumes $100 was invested on December 31, 2016 in our common stock, in the Nasdaq Composite Index, and in the Nasdaq Health Care Index and assumes reinvestment of dividends, if any.

 

 

The stock price performance shown on the graph above is not necessarily indicative of future price performance. Information used in the graph was obtained from the Nasdaq Stock Market, a source believed to be reliable, but we are not responsible for any errors or omissions in such information.

Item 6. [Reserved]

69

 

Table of Contents

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis of our financial condition and results of operations should be read together with the consolidated financial statements and the related notes included in Part II, Item 8, “Financial Statements and Supplementary Data” in this Annual Report on Form 10-K. This discussion contains forward-looking statements related to future events and our future financial performance that are based on current expectations and subject to risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many important factors, including those described in Part I, Item 1A, “Risk Factors” and elsewhere in this Annual Report on Form 10-K.

This section of the Form 10-K generally discusses our results of operations for the years ended December 31, 2021 and 2020, including a year-to-year comparison between 2021 and 2020. For a full discussion related to the results of operations for the year ended December 31, 2019, including a year-to-year comparison between 2020 and 2019, refer to Part II, Item 7, “Management's Discussion and Analysis of Financial Condition and Results of Operations” in our Form 10-K for the year ended December 31, 2020.

Overview of Our Business and Services

We are the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. We lead with a product development mindset, strategically blending clinical development, medical affairs, and commercial capabilities to address modern market realities for customers in the biopharmaceutical, biotechnology, and healthcare industries. We offer both stand-alone and integrated biopharmaceutical product development solutions ranging from early phase (Phase I) clinical trials to the full commercialization of biopharmaceutical products, with the goal of increasing the likelihood of regulatory approval and commercial success.

Our operations are divided into two reportable segments, Clinical Solutions and Commercial Solutions. Our Clinical Solutions segment offers comprehensive global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phases I to IV of clinical development. The segment is organized around clinical pharmacology and bioanalytical services, workforce deployment, full-service clinical studies, real world evidence, and consulting. Our Commercial Solutions segment provides commercialization services, including deployment solutions, communication solutions (public relations, advertising, and medical communications), and consulting services. We integrate our clinical and commercial capabilities into customized solutions by sharing knowledge, data, and insights. This collaboration across the development and commercialization continuum facilitates unique insights into patient populations, therapeutic environments, product timelines, and the competitive landscape. For further discussion, refer to Part I, Item 1, “Business” in this Annual Report on Form 10-K.

We acquired the following companies during 2021:

 

•

StudyKIK, a leading clinical trial recruitment and retention company, expanding our portfolio of patient-direct, technology-enabled solutions. StudyKIK supports patient recruitment, patient retention, eConsent Solutions, Telemedicine Video Calling, and study companion mobile applications to expedite clinical trials, which we believe will result in benefits to customers including accelerated patient enrollment and retention, extensive patient population-based insights, improved site, sponsor, and physician experiences, and reduced patient burden.

 

•

RxDataScience, a specialist organization that helps biopharmaceutical customers solve challenging problems through advanced analytics, data management, and artificial intelligence. RxDataScience is well aligned to our lab to life model offering advanced analytic solutions across the entire product development spectrum from clinical through commercial.

70

 

Table of Contents

 

Prior period segment results have been recast to reflect the transfer of the Kinapse Regulatory and Operations Consulting service lines from Commercial Solutions to Clinical Solutions to align with management reporting in 2021.

COVID-19 Pandemic

The ongoing COVID-19 pandemic and associated economic repercussions have significantly impacted, and are expected to continue to impact, our business and our operations. Within Clinical Solutions, the pandemic has accelerated the adoption of virtual engagement with sites and patients, creating increased demand for decentralized solutions capabilities. As a result, we have continued to experience reduced travel and other reimbursable out-of-pocket expenses related to lower physical monitoring visits for Clinical Solutions relative to pre-pandemic levels. We have also experienced a reduction in the costs associated with investigational medicinal products, which has also resulted in lower reimbursable out-of-pocket expenses. Within Commercial Solutions, we have continued to experience fewer field team visits to healthcare providers and increased virtual investigator meetings. Therefore, we expect reimbursable out-of-pocket expenses as a percentage of revenue to remain lower relative to pre-pandemic levels. With the spread of COVID-19 variants, the ongoing impacts of the COVID-19 pandemic could adversely impact our business and results of operations. See Part I, Item 1A “Risk Factors” in this Annual Report on Form 10-K for further discussion of the potential impact of the pandemic on our business.

New Business Awards and Backlog

We add new business awards to backlog when we enter into a contract or when we receive a written commitment from the customer selecting us as a service provider, provided that:

 

•

collection of the award value is probable;

 

•

the project or projects are expected to commence within a certain period of time from the end of the quarter in which the award was granted;

 

•

project contingencies such as the outcome of other clinical trials, funding approvals, or other events, are not anticipated to prevent the project or projects from commencing in accordance with the expected timeline;

 

•

the customer has entered or intends to enter into a comprehensive contract as soon as practicable; and

 

•

for awards related to deployment solutions and functional service provider offerings, a maximum of twelve months of services are included in the award value.

In addition, we continually evaluate our backlog to determine if any of the previously awarded work is no longer expected to be performed, regardless of whether we have received formal cancellation notice from the customer. If we determine that any previously awarded work is no longer probable of being performed, we remove the value from our backlog based on the risk of cancellation. We recognize revenue from these awards as services are performed, provided we have received proper authorization from the customer.

We report new business awards for our Clinical Solutions and Commercial Solutions segments as well as backlog for our Clinical Solutions segment and the deployment solutions offering within our Commercial Solutions segment. We do not report backlog for the remaining service offerings in the Commercial Solutions segment.

71

 

Table of Contents

 

Backlog

Our backlog consists of anticipated future revenue from business awards that either have not started, or that are in process and have not been completed. Our backlog also reflects any cancellation or adjustment activity related to these awards. The average duration of our contracts will fluctuate from period to period based on the contracts comprising our backlog at any given time. The majority of our contracts contain early termination provisions that typically require notice periods ranging from 30 to 90 days.

Our backlog as of December 31 was as follows (in millions):

 

 

2021

 

 

2020

 

 

Change

 

Clinical Solutions

 

$

10,567.3

 

 

$

10,270.5

 

 

$

296.8

 

 

 

2.9

%

Commercial Solutions - Deployment Solutions

 

 

860.3

 

 

 

711.6

 

 

 

148.7

 

 

 

20.9

%

Total backlog

 

$

11,427.6

 

 

$

10,982.1

 

 

$

445.5

 

 

 

4.1

%

We expect approximately $4.68 billion of our backlog as of December 31, 2021 will be recognized as revenue during 2022. We adjust the amount of our backlog each quarter for the effects of fluctuations in foreign currency exchange rates.

Net New Business Awards

New business awards, net of cancellations, were as follows (in millions):

 

 

 

Year Ended December 31,

 

 

Change

 

 

 

2021

 

 

2020

 

 

2019

 

 

2021 to 2020

 

 

2020 to 2019

 

Clinical Solutions

 

$

4,362.6

 

 

$

4,735.1

 

 

$

4,183.0

 

 

$

(372.5

)

 

 

(7.9

)%

 

$

552.1

 

 

 

13.2

%

Commercial Solutions

 

 

1,370.1

 

 

 

1,128.0

 

 

 

1,270.6

 

 

 

242.1

 

 

 

21.5

%

 

 

(142.6

)

 

 

(11.2

)%

Total net new business awards

 

$

5,732.7

 

 

$

5,863.1

 

 

$

5,453.6

 

 

$

(130.4

)

 

 

(2.2

)%

 

$

409.5

 

 

 

7.5

%

 

New business awards have varied and may continue to vary significantly from year to year. Fluctuations in our net new business award levels often result from the fact that we may receive a small number of relatively large orders in any given reporting period. Because of these large orders, our backlog and net new business awards in a reporting period may reach levels that are not sustainable in subsequent reporting periods.

We believe that our backlog and net new business awards might not be consistent indicators of future revenue because they have been, and likely will continue to be, affected by a number of factors, including the variable size and duration of projects, many of which are performed over several years, and changes to the scope of work during the course of projects. Additionally, projects may be canceled or delayed by the customer or regulatory authorities. Net new business awards and backlog have been and we expect will continue to be affected by the broad effects of the COVID-19 pandemic on the global economy and major financial markets, as well as various other risks and uncertainties detailed in Part I, Item 1A, “Risk Factors – Risks Related to Our Business – The COVID-19 pandemic has adversely impacted our business and results of operations, and is expected to continue to do so” of this Annual Report on Form 10-K. We generally do not have a contractual right to the full amount of the awards reflected in our backlog. If a customer cancels an award, we might be reimbursed for the costs we have incurred. As we increasingly compete for and enter into large contracts that are more global in nature, we expect that the rate at which our backlog and net new business awards convert into revenue is likely to decrease, and the duration of projects and the period over which related revenue is recognized to lengthen. For more information about risks related to our backlog see Part I, Item 1A, “Risk Factors – Risks Related to Our Business – Our backlog might not be indicative of our future revenues, and we might not realize all of the anticipated future revenue reflected in our backlog” of this Annual Report on Form 10-K.

72

 

Table of Contents

 

Results of Operations

The following table sets forth amounts from our consolidated financial statements along with dollar and percentage changes (in thousands, except percentages):

 

 

 

Year Ended December 31,

 

 

Change

 

 

 

2021

 

 

2020

 

 

2019

 

 

2021 to 2020

 

 

2020 to 2019

 

Revenue

 

$

5,212,970

 

 

$

4,415,777

 

 

$

4,675,815

 

 

$

797,193

 

 

 

18.1

%

 

$

(260,038

)

 

 

(5.6

)%

Costs and operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Direct costs (exclusive of

depreciation and amortization)

 

 

3,994,484

 

 

 

3,398,142

 

 

 

3,645,905

 

 

 

596,342

 

 

 

17.5

%

 

 

(247,763

)

 

 

(6.8

)%

Selling, general, and

administrative expenses

 

 

570,765

 

 

 

472,726

 

 

 

507,556

 

 

 

98,039

 

 

 

20.7

%

 

 

(34,830

)

 

 

(6.9

)%

Restructuring and other costs

 

 

22,816

 

 

 

29,414

 

 

 

42,135

 

 

 

(6,598

)

 

 

(22.4

)%

 

 

(12,721

)

 

 

(30.2

)%

Depreciation and amortization

 

 

235,625

 

 

 

222,352

 

 

 

242,465

 

 

 

13,273

 

 

 

6.0

%

 

 

(20,113

)

 

 

(8.3

)%

Total operating expenses

 

 

4,823,690

 

 

 

4,122,634

 

 

 

4,438,061

 

 

 

701,056

 

 

 

17.0

%

 

 

(315,427

)

 

 

(7.1

)%

Income from operations

 

 

389,280

 

 

 

293,143

 

 

 

237,754

 

 

 

96,137

 

 

 

32.8

%

 

 

55,389

 

 

 

23.3

%

Total other expense, net

 

 

74,120

 

 

 

89,485

 

 

 

136,045

 

 

 

(15,365

)

 

 

(17.2

)%

 

 

(46,560

)

 

 

(34.2

)%

Income before provision for income taxes

 

 

315,160

 

 

 

203,658

 

 

 

101,709

 

 

 

111,502

 

 

 

54.7

%

 

 

101,949

 

 

 

100.2

%

Income tax expense (benefit)

 

 

80,329

 

 

 

10,871

 

 

 

(29,549

)

 

 

69,458

 

 

 

638.9

%

 

 

40,420

 

 

n/m

 

Net income

 

$

234,831

 

 

$

192,787

 

 

$

131,258

 

 

$

42,044

 

 

 

21.8

%

 

$

61,529

 

 

 

46.9

%

Revenue

For the year ended December 31, 2021, our revenue increased by $797.2 million, or 18.1%, to $5.21 billion from $4.42 billion for the year ended December 31, 2020. This increase was primarily driven by growth in both our Clinical Solutions and Commercial Solutions segments as discussed below.

No single customer accounted for greater than 10% of our total consolidated revenue for the year ended December 31, 2021 or 2020. Revenue from our top five customers accounted for approximately 22% of revenue for both of the years ended December 31, 2021 and 2020.

Revenue for each of our segments was as follows (dollars in thousands):

 

 

 

Year Ended December 31,

 

 

Change

 

 

 

2021

 

 

2020

 

 

2019

 

 

2021 to 2020

 

 

2020 to 2019

 

Clinical Solutions

 

$

4,009,057

 

 

$

3,339,451

 

 

$

3,450,223

 

 

$

669,606

 

 

 

20.1

%

 

$

(110,772

)

 

 

(3.2

)%

% of total

 

 

76.9

%

 

 

75.6

%

 

 

73.8

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial Solutions

 

 

1,203,913

 

 

 

1,076,326

 

 

 

1,225,592

 

 

 

127,587

 

 

 

11.9

%

 

 

(149,266

)

 

 

(12.2

)%

% of total

 

 

23.1

%

 

 

24.4

%

 

 

26.2

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total revenue

 

$

5,212,970

 

 

$

4,415,777

 

 

$

4,675,815

 

 

$

797,193

 

 

 

18.1

%

 

$

(260,038

)

 

 

(5.6

)%

Clinical Solutions

For the year ended December 31, 2021, revenue attributable to our Clinical Solutions segment increased compared to the prior year, primarily driven by recovery from the COVID-19 pandemic and the acquisitions of Synteract and Illingworth Research that were completed in the fourth quarter of 2020. The recovery from the COVID-19 pandemic includes increased project start-ups, including larger pharmaceutical customer relationships and COVID-19 projects that generally have higher reimbursable out-of-pocket expenses. For the year ended December 31, 2021, revenue was positively impacted by $40.9 million from foreign currency exchange rates fluctuations compared to the prior year.

73

 

Table of Contents

 

We experienced reduced impacts from the COVID-19 pandemic to our Clinical Solutions revenue during 2021 as compared to 2020 as governments eased restrictions. Future impacts are dependent on the continuation of the pandemic including the potential spread of COVID-19 variants. We believe the primary ongoing impact to revenue relates to increased demand for decentralized solutions capabilities including remote monitoring, which results in lower reimbursable out-of-pocket expenses. Therefore, we expect reimbursable out-of-pocket expenses as a percentage of revenue to remain lower relative to pre-pandemic levels.

Commercial Solutions

For the year ended December 31, 2021, revenue attributable to our Commercial Solutions segment increased compared to the prior year, primarily driven by recovery from the COVID-19 pandemic and strength in new project start-ups. The revenue increases were partially offset by decreases related to the divestiture of our medication adherence business in the fourth quarter of 2020.

We experienced reduced impacts from the COVID-19 pandemic to our Commercial Solutions revenue during 2021 as compared to 2020 as governments eased restrictions. Future impacts are dependent on the continuation of the pandemic including the potential spread of COVID-19 variants. We believe the primary ongoing impacts to revenue relate to declines in field team visits to healthcare providers and increased virtual investigator meetings, which result in lower reimbursable out-of-pocket expenses. Therefore, we expect reimbursable out-of-pocket expenses as a percentage of revenue to remain lower relative to pre-pandemic levels.

Direct Costs

Direct costs consist principally of compensation expense and benefits associated with our employees and other employee-related costs, and reimbursable out-of-pocket expenses directly related to delivering on our projects. While we have some ability to manage the majority of these costs relative to the amount of contracted services we have during any given period, direct costs as a percentage of revenue can vary from period to period. Such fluctuations are due to a variety of factors, including, among others: (i) the level of staff utilization on our projects; (ii) adjustments to the timing of work on specific customer contracts; (iii) the experience mix of personnel assigned to projects; (iv) the service mix and pricing of our contracts; and (v) the timing of the incurrence of reimbursable out-of-pocket expenses. Relative to pre-pandemic levels, we continue to experience reduced travel and other reimbursable out-of-pocket expenses related to lower physical monitoring visits for Clinical Solutions, as well as fewer field team visits to healthcare providers and investigator meetings for Commercial Solutions.

Direct costs were as follows (dollars in thousands):

 

 

 

Year Ended December 31,

 

 

Change

 

 

 

2021

 

 

2020

 

 

2019

 

 

2021 to 2020

 

 

2020 to 2019

 

Direct costs (exclusive of depreciation and amortization)

 

$

3,994,484

 

 

$

3,398,142

 

 

$

3,645,905

 

 

$

596,342

 

 

 

17.5

%

 

$

(247,763

)

 

 

(6.8

)%

% of revenue

 

 

76.6

%

 

 

77.0

%

 

 

78.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin %

 

 

23.4

%

 

 

23.0

%

 

 

22.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the year ended December 31, 2021, our direct costs increased by $596.3 million, or 17.5%, compared to the year ended December 31, 2020, primarily driven by higher reimbursable out-of-pocket expenses, impacts from acquisitions, and the end of temporary cost management strategies in response to the COVID-19 pandemic implemented in the prior year. These increases were partially offset by decreases from business divestitures in 2020.

74

 

Table of Contents

 

Clinical Solutions

Direct costs for our Clinical Solutions segment, excluding share-based compensation expense, were as follows (dollars in thousands):

 

 

 

Year Ended December 31,

 

 

Change

 

 

 

2021

 

 

2020

 

 

2019

 

 

2021 to 2020

 

 

2020 to 2019

 

Direct costs

 

$

3,005,938

 

 

$

2,513,240

 

 

$

2,637,016

 

 

$

492,698

 

 

 

19.6

%

 

$

(123,776

)

 

 

(4.7

)%

% of segment revenue

 

 

75.0

%

 

 

75.3

%

 

 

76.4

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Segment gross margin %

 

 

25.0

%

 

 

24.7

%

 

 

23.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the year ended December 31, 2021, our Clinical Solutions segment direct costs increased by $492.7 million, or 19.6%, compared to the year ended December 31, 2020, primarily driven by impacts from acquisitions, higher reimbursable out-of-pocket expenses, the end of temporary cost management strategies in response to the COVID-19 pandemic implemented in the prior year, and negative impacts of foreign exchange rate fluctuations. These increases were partially offset by positive impacts from our ForwardBound margin enhancement initiative.

Gross margins for our Clinical Solutions segment were 25.0% and 24.7% for the years ended December 31, 2021 and 2020, respectively. Gross margin was higher during 2021 as compared to the prior year primarily due to revenue growth and positive impacts from our ForwardBound margin enhancement initiative, partially offset by higher reimbursable out-of-pocket expenses, the end of temporary cost management strategies in response to the COVID-19 pandemic implemented in the prior year, and negative impacts of foreign exchange rate fluctuations.

Commercial Solutions

Direct costs for our Commercial Solutions segment, excluding share-based compensation expense, were as follows (dollars in thousands):

 

 

 

Year Ended December 31,

 

 

Change

 

 

 

2021

 

 

2020

 

 

2019

 

 

2021 to 2020

 

 

2020 to 2019

 

Direct costs

 

$

955,326

 

 

$

853,555

 

 

$

979,878

 

 

$

101,771

 

 

 

11.9

%

 

$

(126,323

)

 

 

(12.9

)%

% of segment revenue

 

 

79.4

%

 

 

79.3

%

 

 

80.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Segment gross margin %

 

 

20.6

%

 

 

20.7

%

 

 

20.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the year ended December 31, 2021, our Commercial Solutions segment direct costs increased by $101.8 million, or 11.9%, compared to the year ended December 31, 2020, primarily related to recovery from the COVID-19 pandemic and the end of temporary cost management strategies implemented in the prior year, partially offset by the divestiture of our medication adherence business in the fourth quarter of 2020.

Gross margins for our Commercial Solutions segment were 20.6% and 20.7% for the years ended December 31, 2021 and 2020, respectively. Gross margin was lower during 2021 as compared to the prior year primarily due to higher costs in the current year primarily driven by recovery from the COVID-19 pandemic, including higher reimbursable out-of-pocket expenses and the end of temporary cost management strategies in response to the COVID-19 pandemic implemented in the prior year, partially offset by revenue growth.

75

 

Table of Contents

 

Selling, General and Administrative Expenses

Selling, general and administrative expenses were as follows (dollars in thousands):

 

 

 

Year Ended December 31,

 

 

Change

 

 

 

2021

 

 

2020

 

 

2019

 

 

2021 to 2020

 

 

2020 to 2019

 

Selling, general and administrative expenses

 

$

570,765

 

 

$

472,726

 

 

$

507,556

 

 

$

98,039

 

 

 

20.7

%

 

$

(34,830

)

 

 

(6.9

)%

% of total revenue

 

 

10.9

%

 

 

10.7

%

 

 

10.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general, and administrative expenses for the year ended December 31, 2021 increased compared to the prior year primarily due to acquisitions, including higher transaction and integration-related expenses, and the end of temporary cost management strategies in response to the COVID-19 pandemic implemented in the prior year. Transaction and integration-related expenses are no longer reported separately and are included in selling, general, and administrative expenses. These increases were partially offset by positive impacts from our ForwardBound margin enhancement initiative.

Restructuring and Other Costs

Restructuring and other costs were $22.8 million and $29.4 million for the years ended December 31, 2021 and 2020, respectively. The costs incurred during 2021 were primarily related to our ForwardBound margin enhancement initiative as we continue the ongoing evaluations of our workforce and facilities infrastructure needs in an effort to optimize our resources. The costs incurred during 2020 were primarily related to our cost management strategies in response to the COVID-19 pandemic, as well as our ForwardBound initiative.

Restructuring and other costs consisted of the following (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Employee severance and benefit costs

 

$

14,526

 

 

$

26,321

 

 

$

25,243

 

Facility and lease termination costs

 

 

8,226

 

 

 

2,313

 

 

 

16,202

 

Other costs

 

 

64

 

 

 

780

 

 

 

690

 

Total restructuring and other costs

 

$

22,816

 

 

$

29,414

 

 

$

42,135

 

We expect to continue to incur costs related to the restructuring of our operations in order to achieve cost savings and targeted synergies related to our acquisitions. However, the timing and the amount of these costs depends on various factors, including, but not limited to, identifying and realizing synergy opportunities and executing the integration of our combined operations. We may also continue to incur additional restructuring and other costs during and beyond 2022 related to our ForwardBound margin enhancement initiative.

Depreciation and Amortization Expense

Total depreciation and amortization expense was $235.6 million and $222.4 million for the years ended December 31, 2021 and 2020, respectively. The increase in total depreciation and amortization expense in 2021 compared to 2020 was primarily due to the acquisitions that were completed in the fourth quarter of 2020, partially offset by decreases due to fully amortized intangible assets from prior acquisitions.

76

 

Table of Contents

 

Total Other Expense, Net

Total other expense, net consisted of the following (dollars in thousands):

 

 

Year Ended December 31,

 

 

Change

 

 

 

2021

 

 

2020

 

 

2019

 

 

2021 to 2020

 

 

2020 to 2019

 

Interest income

 

$

(111

)

 

$

(265

)

 

$

(7,542

)

 

$

154

 

 

 

58.1

%

 

$

7,277

 

 

 

96.5

%

Interest expense

 

 

79,252

 

 

 

91,145

 

 

 

129,820

 

 

 

(11,893

)

 

 

(13.0

)%

 

 

(38,675

)

 

 

(29.8

)%

Loss (gain) on extinguishment of debt

 

 

3,612

 

 

 

1,581

 

 

 

(10,395

)

 

 

2,031

 

 

 

128.5

%

 

 

11,976

 

 

n/m

 

Other (income) expense, net

 

 

(8,633

)

 

 

(2,976

)

 

 

24,162

 

 

 

(5,657

)

 

 

(190.1

)%

 

 

(27,138

)

 

n/m

 

Total other expense, net

 

$

74,120

 

 

$

89,485

 

 

$

136,045

 

 

$

(15,365

)

 

 

(17.2

)%

 

$

(46,560

)

 

 

(34.2

)%

Total other expense, net was $74.1 million and $89.5 million for the years ended December 31, 2021 and 2020, respectively. The decrease in total other expense, net in 2021 compared to 2020 was primarily due to a decrease in interest expense, primarily related to reductions in our higher interest rate debt as a result of debt prepayments and refinancing transactions and lower interest rates on our variable interest rate debt. Other (income) expense, net primarily consists of foreign currency gains and losses that result from exchange rate fluctuations on our monetary asset balances denominated in currencies other than our functional currency, other gains and losses related to investments, and contingent consideration related to divested businesses.

The loss on extinguishment of debt was $3.6 million for the year ended December 31, 2021 compared to $1.6 million for the year ended December 31, 2020. These losses were incurred primarily as a result of our debt prepayments and refinancing transactions.

Income Tax Expense

For the year ended December 31, 2021, we recorded income tax expense of $80.3 million, on pre-tax income of $315.2 million. The effective income tax rate for the year ended December 31, 2021 varied from the U.S. federal statutory income tax rate of 21.0% primarily due to foreign income inclusions such as the Global Intangible Low-Taxed Income (“GILTI”) provisions, state and local taxes on U.S. income, and research and general business credits.

For the year ended December 31, 2020, we recorded income tax expense of $10.9 million, on pre-tax income of $203.7 million. The effective income tax rate for the year ended December 31, 2020 varied from the U.S. federal statutory income tax rate of 21.0% primarily due to the recognition of U.S. federal and foreign unrecognized tax benefits, changes to income tax valuation allowances on deferred tax assets, and tax benefits recognized related to the elections to retroactively apply regulations relative to the GILTI high-tax exclusion and Section 163(j) CFC group election for interest deductibility.

We currently maintain valuation allowances against a portion of our state deferred tax assets and a portion of our foreign deferred tax assets as of December 31, 2021. We intend to continue to maintain valuation allowances on these deferred tax assets until there is sufficient evidence to support the reversal of all or some portion of these allowances.

Liquidity and Capital Resources

Key measures of our liquidity were as follows as of December 31 (in thousands):

 

 

 

2021

 

 

2020

 

Balance sheet statistics:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

106,363

 

 

$

271,901

 

Restricted cash

 

 

112

 

 

 

272

 

Working capital (excluding restricted cash)

 

 

112,228

 

 

 

160,409

 

77

 

Table of Contents

 

 

As of December 31, 2021, we had $106.5 million of cash, cash equivalents, and restricted cash. As of December 31, 2021, substantially all of our cash, cash equivalents, and restricted cash was held within the U.S. In addition, we had $585.8 million (net of $14.2 million in outstanding letters of credit (“LOCs”)) available for borrowing under our $600.0 million Revolver, of which $135.8 million was available for LOCs.

We have historically funded our operations and growth, including acquisitions, primarily with our working capital, cash flow from operations and funds available through various borrowing arrangements. Our principal liquidity requirements are to fund our debt service obligations, capital expenditures, expansion of service offerings, possible acquisitions, integration and restructuring costs, geographic expansion, stock repurchases, working capital, and other general corporate expenses. Cash from operations also could be affected by various risks and uncertainties, including, but not limited to, the effects of the COVID-19 pandemic on the global economy and major financial markets, as well as other risks detailed in Part I, Item 1A, “Risk Factors” in this Annual Report on Form 10-K. Based on past performance and current expectations, we believe our cash and cash equivalents, cash generated from operations, and funds available under the Revolver will be sufficient to meet our working capital needs, capital expenditures, scheduled debt and interest payments, income tax obligations, and other currently anticipated liquidity requirements for at least the next 12 months.

We may seek to raise additional capital, particularly in the event of a sustained market deterioration, which could be in the form of bonds, convertible debt, or equity. If we obtain additional capital by issuing equity, the interests of our existing stockholders will be diluted. If we incur additional indebtedness, that indebtedness may contain significant financial and other covenants that may significantly restrict our operations. We cannot assure you that we could obtain any refinancing or additional financing we may seek on favorable terms or at all.

Contractual Obligations

In addition to the indebtedness and related interest payments, operating leases, deferred compensation, commitments to unconsolidated affiliates, contingent obligations assumed in business combinations, and uncertain tax positions discussed elsewhere, we signed a non-cancellable purchase obligation of $22.1 million during the fourth quarter of 2021, with equal quarterly payments due over the next four years, beginning in the third quarter of 2022.

Indebtedness

As of December 31, 2021, we had approximately $2.84 billion of total principal indebtedness (including $54.8 million in finance lease obligations), consisting of $1.79 billion in term loan debt, $600.0 million under the Notes, and $400.0 million in borrowings against our accounts receivable financing agreement. Approximately $1.03 billion of our indebtedness (excluding finance leases) was subject to variable interest rates.

Credit Agreement

We are party to a credit agreement (as amended, the “Credit Agreement”) that included a $1.55 billion Term Loan A facility (“Term Loan A”) that has two tranches, tranche one that matures on March 26, 2024 and tranche two that matures on August 1, 2024, a $1.60 billion Term Loan B facility (“Term Loan B”) that was paid in full during the second quarter of 2021, and a $600.0 million Revolver that matures on August 1, 2024. The Revolver includes LOCs with a sublimit of $150.0 million.

78

 

Table of Contents

 

On June 30, 2021 (the “Closing Date”), we entered into Amendment No. 5 (the “Fifth Amendment”) to the Credit Agreement. The Fifth Amendment modified the Credit Agreement to increase Term Loan A in an aggregate principal amount of $495.0 million (“Incremental Term Loan A”). Incremental Term Loan A was funded on the Closing Date, and the proceeds were used, along with cash on hand, to repay the outstanding Term Loan B in full under the Credit Agreement and to pay fees and expenses in connection with the Fifth Amendment and the incurrence of Incremental Term Loan A. Incremental Term Loan A has the same terms as Term Loan A under the Credit Agreement, and is subject to the same covenants. We recorded an additional discount of $0.5 million against the Term Loan A borrowings in connection with the Fifth Amendment, which is being amortized as a component of interest expense using the effective interest method over the term of Term Loan A.

During the year ended December 31, 2021, we made $166.8 million and $560.5 million of voluntary prepayments against Term Loan A and Term Loan B, respectively, that were applied to future mandatory principal payments due. As a result of these and previous voluntary prepayments, we are not required to make a mandatory payment against the principal balance of Term Loan A until October 2023 and Term Loan B has been paid in full. In connection with these prepayments, we recorded a $3.6 million loss on extinguishment of debt during the year ended December 31, 2021.

In February 2021, as a result of our First Lien Leverage Ratio (as defined in the Credit Agreement) being less than or equal to 2.5x, the Adjusted Eurocurrency Rate Spread (as defined in the Credit Agreement) on Term Loan A and the Revolver decreased from 1.50% to 1.25%. As of December 31, 2021, the interest rate on the Term Loan A and the Revolver was 1.35%.

Our ability to make payments on our indebtedness and to fund planned capital expenditures and necessary working capital will depend on our ability to generate cash in the future. Our ability to meet our cash needs through cash flows from operations will depend on the demand for our services, as well as general economic, financial, competitive, and other factors, many of which are beyond our control, including the broad effects of the COVID-19 pandemic on the global economy and major financial markets. Our business may not generate cash flow in an amount sufficient to enable us to pay the principal of, or interest on, our indebtedness, or to fund our other liquidity needs, including working capital, capital expenditures, acquisitions, investments, and other general corporate requirements. If we cannot fund our liquidity needs, we will have to take actions such as reducing or delaying capital expenditures, acquisitions or investments, selling assets, restructuring or refinancing our debt, reducing the scope of our operations and growth plans, or seeking additional capital. We cannot assure you that any of these remedies could, if necessary, be affected on commercially reasonable terms, or at all, or that they would permit us to meet our scheduled debt service obligations. The Credit Agreement contains covenant restrictions that limit our ability to direct the use of proceeds from any disposition of assets and, as a result, we may not be allowed to use the proceeds from any such dispositions to satisfy all current debt service obligations.

Revolver and Letters of Credit

The Revolver includes LOCs with a sublimit of $150.0 million. As of December 31, 2021, we had no outstanding Revolver borrowings and $14.2 million of LOCs outstanding, leaving $585.8 million of available borrowings under the Revolver, including $135.8 million available for LOCs.

The lease agreement for our corporate headquarters in Morrisville, North Carolina includes a provision that may require us to issue a LOC to the landlord based on our debt rating issued by Moody’s Investors Service (or other nationally-recognized debt rating agency, such as S&P Global Ratings). As of December 31, 2021, our debt rating was such that no LOC is currently required. Any LOCs issued in accordance with the aforementioned requirements could be issued under our Revolver, and if issued under our Revolver, would reduce our available borrowing capacity by the same amount.

79

 

Table of Contents

 

We pay a quarterly commitment fee between 0.25% and 0.375% on the average daily unused balance of the Revolver based on the “First Lien Leverage Ratio” at the adjustment date. Fees are charged on all outstanding LOCs at an annual rate equal to the margin in effect on Eurocurrency Rate revolving loans plus participation and fronting fees.

The Notes

On November 24, 2020, we completed the issuance and sale of the Notes, with an aggregate principal amount of $600.0 million, which bears interest at a rate of 3.625% per annum, payable semi-annually in arrears beginning on July 15, 2021, and matures on January 15, 2029. The Notes were issued pursuant to an indenture (the “Indenture”), which provides, among other things, that the Notes are senior unsecured obligations of us and are guaranteed, jointly and severally, on a senior unsecured basis, by certain of our subsidiaries.

We may redeem some or all of the Notes at any time prior to January 15, 2024 at a redemption price equal to 100% of the aggregate principal amount of the Notes to be redeemed plus a “make-whole” premium and accrued and unpaid interest. In addition, prior to July 15, 2023, we may redeem up to 40% of the original principal amount of the Notes with proceeds of certain equity offerings at a redemption price equal to 103.625% of the aggregate principal amount of such Notes plus accrued and unpaid interest. On or after January 15, 2024, we may redeem some or all of the Notes at the redemption prices set forth in the Indenture plus accrued and unpaid interest.

The Indenture contains covenants that limit the ability of us and our restricted subsidiaries to, among other things, (1) incur additional liens, (2) engage in certain sale and leaseback transactions, and (3) conduct mergers, consolidations, or asset sales. These covenants are subject to exceptions and qualifications set forth in the Indenture.

If we sell certain of our assets or experience specific kinds of changes of control, we are required to offer to repurchase the Notes at a repurchase price equal to (1) par plus any accrued and unpaid interest in the case of an asset sale or (2) 101% of the aggregate principal amount thereof plus any accrued and unpaid interest in the case of a change of control.

Debt Covenants

The Credit Agreement contains usual and customary restrictive covenants that among other things, place limitations on our ability to pay dividends or make other restricted payments; prepay, redeem or purchase debt; incur liens; make loans and investments; incur additional indebtedness; amend or otherwise alter debt and other material arrangements; make acquisitions and dispose of assets; transact with affiliates; and engage in transactions that are not related to our existing business. Each of the restrictive covenants is subject to important exceptions and qualifications that would allow us to engage in these activities under certain conditions, including our ability to: (i) pay dividends each year in an amount up to the greater of (a) 6% of the net cash proceeds received by us from any public offering and (b) 5% of our market capitalization; and (ii) pay unlimited dividends if our Secured Leverage Ratio (as defined in the Credit Agreement) is no greater than 3.0 to 1.0. In addition, the Credit Agreement requires us to maintain a maximum First Lien Leverage Ratio (as defined in the Credit Agreement) of no more than 4.5 to 1.0 as of the last day of each fiscal quarter from and after March 31, 2020.

The Indenture also contains customary events of default, including (1) failure to make required payments, (2) failure to comply with certain covenants, (3) failure to pay certain other indebtedness, (4) certain events of bankruptcy and insolvency, and (5) failure to pay certain judgments. An event of default under the Indenture allows either the Trustee or the holders of at least 25% in aggregate principal amount of the Notes, as applicable, issued under such Indenture, to accelerate the amounts due under the Notes, or in the case of a bankruptcy or insolvency, will automatically cause the acceleration of the amounts due under the Notes.

80

 

Table of Contents

 

As of December 31, 2021, we were in compliance with all applicable debt covenants.

Accounts Receivable Financing Agreement

Under our accounts receivable financing agreement, certain of our consolidated subsidiaries sell accounts receivable and unbilled services (including contract assets) balances to a wholly-owned, bankruptcy-remote special purpose entity (“SPE”), which is the borrower under the facility. The facility is without recourse to us or any subsidiaries of ours other than the SPE, other than with respect to limited indemnity obligations of the selling entities and the servicer of the receivables in respect of the character of the receivables sold by them and the performance of the servicing duties.

On January 28, 2021, we amended our accounts receivable financing agreement to increase the amount we can borrow from $300.0 million to $365.0 million and drew down the additional $65.0 million to partially fund the Term Loan A and Term Loan B voluntary prepayments. Accordingly, there was no incremental impact on our total debt.

On October 13, 2021, we further amended our accounts receivable financing agreement to increase the amount we can borrow from $365.0 million to $400.0 million, extended the maturity to October 2024, and drew down the additional $35.0 million. At the same time, we paid down $35.0 million on facilities under our Credit Agreement, resulting in no net impact on leverage.

As of December 31, 2021, we had $400.0 million of outstanding borrowings under this agreement with no remaining borrowing capacity available.

This agreement is secured by a lien on certain receivables and other assets, and we have guaranteed the performance of the obligations of existing and future subsidiaries that sell and service the accounts receivable under this agreement. The available borrowing capacity varies monthly according to the levels of our eligible accounts receivable and unbilled receivables. Loans under this agreement will accrue interest at a reserve-adjusted LIBOR rate or a base rate equal to the higher of (i) the applicable lender’s prime rate and (ii) the federal funds rate plus 0.50%. As of December 31, 2021, the interest rate on the accounts receivable financing agreement was 1.05%. 

Interest Rates

We have entered into various interest rate swaps to mitigate our exposure to changes in interest rates on our term loans. As of December 31, 2021, the percentage of our total principal debt (excluding finance leases) that is subject to fixed interest rates was approximately 63%. Each quarter-point increase or decrease in the applicable floating interest rate as of December 31, 2021 would change our annual interest expense by approximately $2.6 million.

We do not expect the transition from LIBOR to impact our debt agreements during 2022 and therefore we are under no obligation to amend these agreements in 2022.

2021 Stock Repurchase Program

On November 17, 2020, our Board authorized the repurchase of up to an aggregate of $300.0 million of our Class A common stock, par value $0.01 per share, to be executed from time to time in open market transactions effected through a broker at prevailing market prices, in block trades, or through privately negotiated transactions through December 31, 2022. The 2021 Stock Repurchase Program took effect on January 1, 2021. Share repurchases are funded primarily with our working capital, cash flow from operations, and funds available through various borrowing arrangements.

81

 

Table of Contents

 

The 2021 Stock Repurchase Program does not obligate us to repurchase any particular amount of our Class A common stock, and may be modified, extended, suspended, or discontinued at any time. The timing and amount of repurchases are determined by our management based on a variety of factors such as the market price of our Class A common stock, our corporate cash requirements, and overall market conditions. The 2021 Stock Repurchase Program is subject to applicable legal requirements, including federal and state securities laws and applicable Nasdaq rules. We may also repurchase shares of our Class A common stock pursuant to a trading plan meeting the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, which would permit shares of our Class A common stock to be repurchased when we might otherwise be precluded from doing so by law.

The following table sets forth repurchase activity under the 2021 Stock Repurchase Program from inception through December 31, 2021:

 

Period

 

Total number of

shares purchased

 

 

Average price

paid per share

 

 

Approximate dollar

value of shares

purchased

(in thousands)

 

March 2021

 

 

600,000

 

 

$

74.18

 

 

$

44,505

 

May 2021

 

 

400,000

 

 

 

81.04

 

 

 

32,416

 

June 2021

 

 

500,000

 

 

 

81.20

 

 

 

40,600

 

Total

 

 

1,500,000

 

 

 

 

 

 

$

117,521

 

As of December 31, 2021, we had remaining authorization to repurchase up to approximately $182.5 million of shares of our common stock under the 2021 Stock Repurchase Program.

Cash, Cash Equivalents and Restricted Cash

Our cash flows from operating, investing, and financing activities were as follows (in thousands):

 

 

Year Ended December 31,

 

 

Change

 

 

 

2021

 

 

2020

 

 

2019

 

 

2021 to 2020

 

 

2020 to 2019

 

Net cash provided by operating activities

 

$

450,278

 

 

$

425,493

 

 

$

318,481

 

 

$

24,785

 

 

 

5.8

%

 

$

107,012

 

 

 

33.6

%

Net cash used in investing activities

 

 

(340,346

)

 

 

(504,084

)

 

 

(81,661

)

 

 

163,738

 

 

 

32.5

%

 

 

(422,423

)

 

 

(517.3

)%

Net cash (used in) provided by financing activities

 

 

(277,577

)

 

 

178,265

 

 

 

(215,469

)

 

 

(455,842

)

 

n/m

 

 

 

393,734

 

 

n/m

 

Cash Flows from Operating Activities

Cash flows provided by operating activities increased by $24.8 million during the year ended December 31, 2021 as compared to the prior year. The increase was primarily due to higher cash-related net income, partially offset by negative changes in operating assets and liabilities relative to the prior year including payment of certain taxes deferred in 2020 as permitted by the Coronavirus Aid, Relief, and Economic Security Act. Fluctuations in accounts receivable, unbilled services (including contract assets), and deferred revenue occur on a regular basis as we perform services, achieve milestones or other billing criteria, send invoices to customers, and collect outstanding accounts receivable. This activity varies by individual customer and contract. We attempt to negotiate payment terms that provide for payment of services prior to or soon after the provision of services, but the levels of accounts receivable, unbilled services (including contract assets), and deferred revenue can vary significantly from period to period.

82

 

Table of Contents

 

Cash Flows from Investing Activities

For the year ended December 31, 2021, we used $340.3 million in cash for investing activities, which consisted of $278.9 million of payments related to acquisitions, including StudyKIK and RxDataScience, and $56.8 million for purchases of property and equipment. We continue to closely monitor our capital expenditures, especially in light of the COVID-19 pandemic, while making strategic investments in the development of our information technology infrastructure to meet the needs of our workforce, enable efficiencies, reduce business continuity risks, and conform to changes in governing rules and regulations.

For the year ended December 31, 2020, we used $504.1 million in cash for investing activities, which primarily consisted of $456.5 million of cash paid for the acquisitions of Synteract and Illingworth Research. Additionally, we used $50.0 million in cash for purchases of property and equipment and $15.6 million in cash for investments in unconsolidated affiliates, partially offset by cash received of $18.0 million for the sale of our medication adherence business.

Cash Flows from Financing Activities

For the year ended December 31, 2021, we used $277.6 million in cash for financing activities, which consisted primarily of net repayments of long-term debt and repurchases of our common stock. These payments were partially offset by proceeds from our accounts receivable financing arrangement.

For the year ended December 31, 2020, financing activities provided $178.3 million in cash, primarily resulting from a net increase in long-term debt from the issuance of the Notes, partially offset by repayments of other long-term debt, repurchases of our common stock, and contingent consideration payments.

Inflation

The majority of our long-term contracts include inflation or cost of living adjustments for the portion of the services to be performed beyond the year in which services begin. In the event actual inflation rates are greater than our contractual inflation rates or cost of living adjustments, generally our contracts allow for increases to our inflationary assumptions to offset.

Critical Accounting Policies and Estimates

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses during the period, as well as disclosures of contingent assets and liabilities at the date of the financial statements. We evaluate our estimates on an ongoing basis, including those related to revenue recognition, valuation of goodwill and identifiable intangibles, and tax-related contingencies and valuation allowances. These estimates are based on the information available to management at the time these estimates, judgments, and assumptions are made. Actual results may differ materially from these estimates.

Acquisitions

We account for acquisitions in accordance with ASC Topic 805, Business Combinations, using the acquisition method of accounting. The purchase price, or total consideration transferred, is determined as the fair value of assets exchanged, equity instruments issued, and liabilities assumed at the acquisition date. The acquisition method of accounting requires that the identifiable assets acquired, the liabilities assumed, and any non-controlling interest in the acquiree are measured and recorded at their fair values on the date of an acquisition. Goodwill represents the excess of the purchase price over the estimated fair value of the net assets acquired, including the amount assigned to identifiable intangible assets.

83

 

Table of Contents

 

Acquisition-related costs are expensed as incurred. The consolidated financial statements reflect the results of operations of the acquiree from the date of the acquisition. For additional information, see Part II, Item 8, “Financial Statements and Supplemental Data – Note 3 – Acquisitions, Divestitures, and Investments.”

Revenue Recognition

We adopted ASC Topic 606, Revenue from Contracts with Customers and all the related amendments (“new revenue standard” or “ASC 606”) on January 1, 2018 using the modified retrospective method for all contracts not completed as of the date of adoption. In accordance with ASC 606, revenue is recognized when, or as, a customer obtains control of promised services. The amount of revenue recognized reflects the consideration to which we expect to be entitled to receive in exchange for these services.

The majority of our Clinical Solutions segment revenue is for service offerings that range in duration from a few months to several years and typically represent a single performance obligation. Revenue for these service contracts is recognized over time using an input measure of progress. The input measure reflects costs (including investigator payments and pass-through costs) incurred to date relative to total estimated costs to complete the contract (“cost-to-cost measure of progress”). Under the cost-to-cost measure of progress methodology, revenue is recorded proportionally to costs incurred. Contract costs principally include direct labor, investigator payments, and pass-through costs. The estimate of total revenue and costs to completion requires significant judgment. Contract estimates are based on various assumptions to project future outcomes of events that often span several years, as well as on evaluations and updates made on an ongoing basis. These estimates are reviewed periodically and any adjustments are recognized on a cumulative catch-up basis in the period they become known. Updates and adjustments to estimates are likely to result in variability in revenue recognized from period to period and may cause unexpected variability in our operating results. In addition, in certain instances a customer contract may include forms of variable consideration such as incentive fees, volume rebates or other provisions that can increase or decrease the transaction price. This variable consideration is generally awarded upon achievement of certain performance metrics, program milestones or cost targets. For the purposes of revenue recognition, variable consideration is assessed on a contract-by-contract basis and the amount to be recorded is estimated based on the assessment of our anticipated performance and consideration of all information that is reasonably available. Variable consideration is recognized as revenue if and when it is deemed probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved in the future.

The largest of the service offerings within the Commercial Solutions segment relates to Deployment Solutions. Deployment Solutions contracts consist of services to promote and sell commercial products on behalf of a customer. The remaining Commercial Solutions contracts are generally short-term, month-to-month contracts or time and materials contracts. As such, Commercial Solutions revenue is generally recognized as services are performed for the amount we estimate we are entitled to for the period. For contracts billed on a fixed price basis, revenue is recognized over time based on the proportion of labor costs expended to total labor costs expected to complete the contract.

Most of our contracts can be terminated by the customer without cause with a notice period that generally ranges from 30 to 90 days. In the event of termination, our contracts generally provide that the customer pay us for: (i) fees earned through the termination date; (ii) fees and expenses for winding down the project, which include both fees incurred and actual expenses; (iii) non-cancellable expenditures; and (iv) in some cases, a fee to cover a portion of the remaining professional fees on the project. Our long-term clinical trial contracts contain implied substantive termination penalties because of the significant wind-down cost of terminating a clinical trial. These provisions for termination penalties result in these types of contracts being treated as long-term for revenue recognition purposes.

84

 

Table of Contents

 

Changes in the scope of work are common, especially under long-term contracts, and generally result in a renegotiation of future contract pricing terms and change in contract transaction price. If the customer does not agree to a contract modification, we could bear the risk of cost overruns. Most of our contract modifications are for services that are not distinct from the services under the existing contract due to the significant integration service provided in the context of the contract and therefore result in a cumulative catch-up adjustment to revenue at the date of contract modification.

Timing of Billing and Performance

Differences in the timing of revenue recognition and associated billings and cash collections result in recording of billed accounts receivable, unbilled accounts receivable, contract assets, and deferred revenue on the consolidated balance sheet. Amounts are billed as work progresses in accordance with agreed-upon contractual terms either at periodic intervals or upon achievement of contractual milestones. Billings generally occur subsequent to revenue recognition, resulting in recording of unbilled accounts receivable in instances where the right to bill is contingent solely on the passage of time (e.g., in the following month) and contract assets in instances where the right to bill is associated with a contingency (e.g., achievement of a milestone).

Accounts receivable are recorded at net realizable value. Unbilled accounts receivable (including contract assets) arise when services have been rendered for which revenue has been recognized but the customers have not been billed. In general, prerequisites for billings and payments are established by contractual provisions, including predetermined payment schedules, which may or may not correspond to the timing of the performance of services under the contract. Contract assets include unbilled amounts typically resulting from revenue recognized in excess of the amounts billed to the customer for which the right to payment is subject to factors other than the passage of time. These amounts may not exceed their net realizable value. Contract assets are generally classified as current. Deferred revenue represents contract liabilities and consists of customer payments received in advance of performance and billings in excess of revenue recognized, net of revenue recognized from the balance at the beginning of the period. Contract assets and deferred revenue are presented on the balance sheet on a net contract-by-contract basis at the end of each reporting period.

Goodwill and Intangible Assets

Goodwill represents the excess of purchase price over the estimated fair value of net assets acquired, including the amount assigned to identifiable intangible assets, in acquisitions. In accordance with ASC Topic 350, Intangibles – Goodwill and Other, goodwill is not subject to amortization but must be tested for impairment annually or more frequently if events or changes in circumstances indicate that goodwill might be impaired. Goodwill is tested for impairment at the reporting unit level, which is one level below the operating segment level. This test requires us to determine if the implied fair value of the reporting unit’s goodwill is less than its carrying amount.

The impairment analysis requires significant judgments, estimates and assumptions. There is no assurance that the actual future earnings or cash flows of the reporting units will not decline significantly from the projections used in the impairment analysis. Goodwill impairment charges may be recognized in future periods in one or more of the reporting units to the extent changes in factors or circumstances occur, including deterioration in the macroeconomic environment, industry, deterioration in our performance or our future projections, or changes in plans for one or more of our reporting units.

We completed our annual impairment test for potential impairment as of October 1, 2021 for all four of our reporting units, determining that there were no impairments. Our goodwill is principally related to the Merger completed on August 1, 2017. Depending on the extent to which future developments negatively impact our results of operations and financial outlook, an interim impairment test may be required in the future.

85

 

Table of Contents

 

Intangible assets consist of customer relationships, acquired backlog, trade names, trademarks, patient communities, and acquired technologies. We amortize intangible assets related to customer relationships, trade names, trademarks, patient communities, and acquired technologies on a straight-line basis over the estimated useful life of the asset. Intangible assets related to acquired backlog are amortized based on our expectations of the timing of when revenue associated with the backlog is expected to be recognized.

We review intangible assets at the end of each reporting period to determine if facts and circumstances indicate that the useful life is shorter than originally estimated or that the carrying amount of the assets might not be recoverable. If such facts and circumstances exist, we assess the recoverability of identified assets by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining lives to their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amount over the fair value of those assets and occur in the period in which the impairment determination is made.

Income Taxes

The majority of our U.S. subsidiaries file a consolidated U.S. federal income tax return, while certain U.S. subsidiaries, including recently acquired entities, may file separate U.S. federal tax returns. Our subsidiaries in international jurisdictions file tax returns in their respective jurisdictions.

We provide for income taxes on all transactions that have been recognized in the consolidated financial statements. Specifically, we estimate our tax liability based on current tax laws in the statutory jurisdictions in which we operate. Accordingly, the impact of changes in income tax laws on deferred tax assets and deferred tax liabilities are recognized in net earnings in the period during which such changes are enacted. We record deferred tax assets and liabilities based on temporary differences between the financial statement and tax bases of assets and liabilities and for tax benefit carryforwards using enacted tax rates in effect in the year in which the differences are expected to reverse.

We provide valuation allowances against deferred tax assets for amounts that are not considered more likely than not to be realized. The valuation of the deferred tax asset is dependent on, among other things, our ability to generate a sufficient level of future taxable income. In estimating future taxable income, we have considered both positive and negative evidence, such as historical and forecasted results of operations, and have considered the implementation of prudent and feasible tax planning strategies. If the objectively verifiable negative evidence outweighs any available positive evidence (or the only available positive is subjective and cannot be verified), then a valuation allowance will likely be deemed necessary. If a valuation allowance is deemed to be unnecessary, such allowance is released and any related benefit is recognized in the period of the change.

We recognize a tax benefit from an uncertain tax position only if we believe it is more likely than not to be sustained upon examination based on the technical merits of the position. Judgment is required in determining what constitutes an individual tax position, as well as the assessment of the outcome of each tax position. We consider many factors when evaluating and estimating tax positions and tax benefits. In addition, the calculation of tax liabilities involves dealing with uncertainties in the application of complex tax regulations in domestic and foreign jurisdictions. We evaluate uncertain tax positions pursuant to the more likely than not standard, and benefits related to such uncertain tax positions are recognized as the largest amount of benefit, determined on a cumulative probability basis, to be realized upon ultimate settlement of the position. If the calculation of the liability related to uncertain tax positions proves to be more or less than the ultimate settlement, a tax expense or benefit, respectively, would result. Unrecognized tax benefits are presented as either a reduction to a deferred tax asset or as a separate liability.

86

 

Table of Contents

 

Recently Issued Accounting Standards

For a description of recently issued accounting pronouncements, including the expected dates of adoption and the estimated effects, if any, on our consolidated financial statements, see “Note 1 - Basis of Presentation and Summary of Significant Accounting Policies” to our consolidated financial statements in Part II, Item 8, “Financial Statements and Supplementary Data” in this Annual Report on Form 10-K.

Item 7A. Quantitative and Qualitative Disclosures About Market Risk.

Market risk is the potential loss arising from adverse changes in market rates and prices, such as foreign currency exchange rates, interest rates, and other relevant market rate or price changes. In the ordinary course of business, we are exposed to various market risks, including changes in foreign currency exchange rates and interest rates, and we regularly evaluate our exposure to such changes. Our overall risk management strategy seeks to balance the magnitude of the exposure and the cost and availability of appropriate financial instruments. From time to time, we have utilized forward exchange contracts to manage our foreign currency exchange rate and interest rate risk.

Foreign Currency Exchange Rates

Approximately 19% of our revenues for the year ended December 31, 2021 were denominated in currencies other than the U.S. dollar. Our financial statements are reported in U.S. dollars and, accordingly, fluctuations in exchange rates will affect the translation of our revenues and expenses denominated in foreign currencies into U.S. dollars for purposes of reporting our consolidated financial results. During 2021 and 2020, the most significant currency exchange rate exposures were the British Pound, Euro, Canadian Dollar, and Japanese Yen. A hypothetical change of 10% in average exchange rates used to translate all foreign currencies to U.S. dollars would have impacted income before income taxes for 2021 by approximately $54.4 million. The impact of this could be partially offset by exchange rate fluctuation provisions stated in some of our contracts with customers designed to mitigate our exposure to fluctuations in currency exchange rates over the life of the contract. For example, during the year ended December 31, 2021, our revenue was reduced by $2.1 million to reflect the reduced operating costs required to fulfill the contracts as a result of the fluctuations in foreign currency exchange rates. We do not have significant operations in countries in which the economy is considered to be highly inflationary.

We are subject to foreign currency transaction risk for fluctuations in exchange rates during the period of time between the consummation and cash settlement of a transaction. Accordingly, exchange rate fluctuations during this period may affect our profitability with respect to such contracts. We are able to partially offset our foreign currency transaction risk through exchange rate fluctuation adjustment provisions stated in our contracts with customers, or we may hedge our transaction risk with foreign currency exchange contracts.

Foreign Exchange Forward

On October 30, 2020, we entered into a foreign exchange forward in order to minimize monthly foreign currency remeasurement gains or losses on non-functional currency monetary balances. The foreign exchange forward notional value may be adjusted each month as the exposure balance changes. We elected not to designate the derivative as a hedge. All changes in the mark-to-market of the foreign exchange forward are recorded in earnings every month to other (income) expense, net in the accompanying consolidated statements of income. We recognized $0.7 million of realized losses and $1.5 million of realized gains during the year ended December 31, 2021 and 2020, respectively, related to this foreign exchange forward. As of December 31, 2021, the notional value of this foreign exchange forward was $70.0 million.

87

 

Table of Contents

 

Interest Rates

We are subject to market risk associated with changes in interest rates. In June 2018, we entered into an interest rate swap with multiple counterparties that had an initial aggregate notional value of $1.01 billion, an effective date of December 31, 2018, and expired on June 30, 2021.

In March 2020, we entered into an interest rate swap with an initial aggregate notional value of $549.2 million, that increased to $1.42 billion on June 30, 2021, an effective date of March 31, 2020, and will expire on March 31, 2023. As of December 31, 2021, the notional value of this interest rate swap was $1.16 billion.

As of December 31, 2021 and 2020, we had $2.84 billion and $2.97 billion, respectively, of total principal indebtedness (including finance leases of $54.8 million and $49.0 million, respectively), of which $1.03 billion and $809.5 million, respectively, was subject to variable interest rates (excluding finance leases). Each quarter-point increase or decrease in the applicable interest rate as of December 31, 2021 and 2020 would change our annual interest expense by approximately $2.6 million and $2.0 million, respectively.

88

 

Table of Contents

 

Item 8. Financial Statements and Supplementary Data.

Index to Consolidated Financial Statements

 

 

89

 

Table of Contents

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the shareholders and the Board of Directors of Syneos Health, Inc.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Syneos Health, Inc. and subsidiaries (the “Company”) as of December 31, 2021 and 2020, the related consolidated statements of income, comprehensive income, cash flows, and shareholders’ equity, for each of the three years in the period ended December 31, 2021, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 16, 2022, expressed an unqualified opinion on the Company’s internal control over financial reporting.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

90

 

Table of Contents

 

Revenue – Full-service Clinical Contracts – Refer to Notes 1 and 12 to the consolidated financial statements

Critical Audit Matter Description

The majority of the Company’s Clinical Solutions segment contracts have a single performance obligation because the promise to transfer individual services is not separately identifiable from other promises in the contracts, and therefore, is not distinct. Revenue is recognized over time using an input measure of progress. The input measure reflects costs (including investigator payments and pass-through costs) incurred to date relative to total estimated costs to complete (“cost-to-cost measure of progress”). Under the cost-to-cost measure of progress methodology, revenue is recorded proportionally to costs incurred. Contract costs principally include direct labor, investigator payments, and pass-through costs. The accounting for these contracts involves judgment, particularly as it relates to estimating total contract costs based on the scope of work, the complexity of the clinical trial services, the geographical locations involved, industry information, and historical experience, among other factors.

Given the judgments necessary to estimate total contract costs in order to estimate the amount of revenue to recognize for certain long-term clinical research contracts which use the cost-to-cost method, auditing such estimates required extensive audit effort due to the complexity of these contracts and a high degree of auditor judgment when performing audit procedures and evaluating the results of those procedures.

How the Critical Audit Matter Was Addressed in the Audit

Our audit procedures related to management’s estimates of total contract costs to estimate the amount of revenue to recognize for full-service clinical research contracts included the following, among others:

 

•

We tested the effectiveness of controls over long-term contract revenue, including those over the estimates of total contract costs related to the performance obligation.

 

•

We selected a sample of long-term contracts and performed the following:

 

-

Evaluated whether the contracts were properly included in management’s calculation of long-term contract revenue based on the terms and conditions of each contract, including whether continuous transfer of control to the customer occurred as progress was made toward fulfilling the performance obligation.

 

-

Compared the transaction prices to the consideration expected to be received based on current rights and obligations under the contracts and any contract modifications that were agreed upon with the customers.

 

-

Evaluated management’s identification of distinct performance obligations by assessing whether the underlying services were highly interdependent and interrelated.

 

-

Tested the accuracy and completeness of the total contract costs incurred to date for the performance obligation.

 

-

Evaluated the estimates of total contract cost for the performance obligation by:

 

•

Evaluating management’s ability to achieve the estimates of total contract cost by performing corroborating inquiries with the Company’s project managers and project financial analysts and comparing the estimates to management’s work plans and cost estimates.

91

 

Table of Contents

 

 

•

Comparing management’s estimates of cost and revenue for the selected contracts to historical experience, and evaluating the reasonableness of management’s forecast of remaining costs to be incurred for each contract based on progress to date.

 

-

Tested the mathematical accuracy of management’s calculation of revenue for the performance obligation.

 

•

We evaluated management’s ability to accurately estimate total contract costs and revenue by comparing actual costs to management’s historical estimates for performance obligations that have been fulfilled.

/s/ Deloitte & Touche LLP

Raleigh, North Carolina

February 16, 2022

We have served as the Company’s auditor since 2016.

92

 

Table of Contents

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the shareholders and the Board of Directors of Syneos Health, Inc.

Opinion on Internal Control over Financial Reporting

We have audited the internal control over financial reporting of Syneos Health, Inc. and subsidiaries (the “Company”) as of December 31, 2021, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control – Integrated Framework (2013) issued by COSO.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2021, of the Company and our report dated February 16, 2022 expressed an unqualified opinion on those financial statements.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ Deloitte & Touche LLP

Raleigh, North Carolina

February 16, 2022

93

 

Table of Contents

 

SYNEOS HEALTH, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

 

 

(in thousands, except per share data)

 

Revenue

 

$

5,212,970

 

 

$

4,415,777

 

 

$

4,675,815

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs and operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Direct costs (exclusive of depreciation and amortization)

 

 

3,994,484

 

 

 

3,398,142

 

 

 

3,645,905

 

Selling, general, and administrative expenses

 

 

570,765

 

 

 

472,726

 

 

 

507,556

 

Restructuring and other costs

 

 

22,816

 

 

 

29,414

 

 

 

42,135

 

Depreciation

 

 

73,832

 

 

 

70,185

 

 

 

76,532

 

Amortization

 

 

161,793

 

 

 

152,167

 

 

 

165,933

 

Total operating expenses

 

 

4,823,690

 

 

 

4,122,634

 

 

 

4,438,061

 

Income from operations

 

 

389,280

 

 

 

293,143

 

 

 

237,754

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total other expense, net:

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

(111

)

 

 

(265

)

 

 

(7,542

)

Interest expense

 

 

79,252

 

 

 

91,145

 

 

 

129,820

 

Loss (gain) on extinguishment of debt

 

 

3,612

 

 

 

1,581

 

 

 

(10,395

)

Other (income) expense, net

 

 

(8,633

)

 

 

(2,976

)

 

 

24,162

 

Total other expense, net

 

 

74,120

 

 

 

89,485

 

 

 

136,045

 

Income before provision for income taxes

 

 

315,160

 

 

 

203,658

 

 

 

101,709

 

Income tax expense (benefit)

 

 

80,329

 

 

 

10,871

 

 

 

(29,549

)

Net income

 

$

234,831

 

 

$

192,787

 

 

$

131,258

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

2.26

 

 

$

1.85

 

 

$

1.27

 

Diluted

 

$

2.24

 

 

$

1.83

 

 

$

1.25

 

Weighted average common shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

103,872

 

 

 

104,168

 

 

 

103,618

 

Diluted

 

 

105,065

 

 

 

105,465

 

 

 

105,005

 

 

The accompanying notes are an integral part of these consolidated financial statements.

94

 

Table of Contents

 

SYNEOS HEALTH, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

 

 

(in thousands)

 

Net income

 

$

234,831

 

 

$

192,787

 

 

$

131,258

 

Unrealized gain (loss) on derivative instruments, net of income tax expense (benefit) of $5,599, $(1,394), and $(2,122), respectively

 

 

16,140

 

 

 

(3,925

)

 

 

(7,596

)

Foreign currency translation adjustments, net of income tax (benefit) expense of $(1,472), $1,354, and $0, respectively

 

 

(24,957

)

 

 

34,717

 

 

 

24,198

 

Comprehensive income

$

226,014

 

 

$

223,579

 

 

$

147,860

 

 

The accompanying notes are an integral part of these consolidated financial statements.

95

 

Table of Contents

 

SYNEOS HEALTH, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

 

 

 

December 31,

 

 

 

2021

 

 

2020

 

 

 

(in thousands, except par value)

 

ASSETS

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash, cash equivalents, and restricted cash

 

$

106,475

 

 

$

272,173

 

Accounts receivable and unbilled services, net

 

 

1,524,890

 

 

 

1,344,781

 

Prepaid expenses and other current assets

 

 

135,091

 

 

 

121,058

 

Total current assets

 

 

1,766,456

 

 

 

1,738,012

 

Property and equipment, net

 

 

222,657

 

 

 

216,200

 

Operating lease right-of-use assets

 

 

209,408

 

 

 

223,285

 

Goodwill

 

 

4,956,015

 

 

 

4,776,178

 

Intangible assets, net

 

 

854,067

 

 

 

933,525

 

Deferred income tax assets

 

 

35,387

 

 

 

35,059

 

Other long-term assets

 

 

193,103

 

 

 

141,047

 

Total assets

 

$

8,237,093

 

 

$

8,063,306

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

107,535

 

 

$

113,684

 

Accrued expenses

 

 

614,441

 

 

 

611,042

 

Deferred revenue

 

 

868,455

 

 

 

793,068

 

Current portion of operating lease obligations

 

 

43,058

 

 

 

42,082

 

Current portion of finance lease obligations

 

 

20,627

 

 

 

17,455

 

Total current liabilities

 

 

1,654,116

 

 

 

1,577,331

 

Long-term debt

 

 

2,775,721

 

 

 

2,902,054

 

Operating lease long-term obligations

 

 

205,798

 

 

 

221,760

 

Finance lease long-term obligations

 

 

34,181

 

 

 

31,522

 

Deferred income tax liabilities

 

 

78,062

 

 

 

20,216

 

Other long-term liabilities

 

 

76,660

 

 

 

68,311

 

Total liabilities

 

 

4,824,538

 

 

 

4,821,194

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies (Note 17)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

Preferred stock, $0.01 par value; 30,000 shares authorized, 0 shares issued and outstanding as of December 31, 2021 and 2020

 

 

—

 

 

 

—

 

Common stock, $0.01 par value; 600,000 shares authorized, 103,764 and 103,935 shares issued and outstanding as of December 31, 2021 and 2020, respectively

 

 

1,038

 

 

 

1,039

 

Additional paid-in capital

 

 

3,474,088

 

 

 

3,461,747

 

Accumulated other comprehensive loss, net of taxes

 

 

(49,618

)

 

 

(40,801

)

Accumulated deficit

 

 

(12,953

)

 

 

(179,873

)

Total shareholders’ equity

 

 

3,412,555

 

 

 

3,242,112

 

Total liabilities and shareholders’ equity

 

$

8,237,093

 

 

$

8,063,306

 

 

The accompanying notes are an integral part of these consolidated financial statements.

96

 

Table of Contents

 

SYNEOS HEALTH, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

 

 

(in thousands)

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

234,831

 

 

$

192,787

 

 

$

131,258

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

235,625

 

 

 

222,352

 

 

 

242,465

 

Share-based compensation

 

 

65,204

 

 

 

58,491

 

 

 

55,193

 

Provision for doubtful accounts

 

 

367

 

 

 

695

 

 

 

1,897

 

Provision for (benefit from) deferred income taxes

 

 

46,522

 

 

 

(3,839

)

 

 

(40,069

)

Foreign currency transaction adjustments

 

 

(5,928

)

 

 

4,148

 

 

 

11,166

 

Fair value adjustment of contingent obligations

 

 

(597

)

 

 

(3,664

)

 

 

17,260

 

Gain on sale of business

 

 

—

 

 

 

(7,133

)

 

 

—

 

Loss (gain) on extinguishment of debt

 

 

3,612

 

 

 

1,581

 

 

 

(10,395

)

Other non-cash items

 

 

7,789

 

 

 

1,765

 

 

 

2,766

 

Changes in operating assets and liabilities, net of effect of acquisitions:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable, unbilled services, and deferred revenue

 

 

(109,364

)

 

 

16,316

 

 

 

(120,389

)

Accounts payable and accrued expenses

 

 

24,620

 

 

 

(2,561

)

 

 

28,316

 

Other assets and liabilities

 

 

(52,403

)

 

 

(55,445

)

 

 

(987

)

Net cash provided by operating activities

 

 

450,278

 

 

 

425,493

 

 

 

318,481

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Payments related to acquisitions of businesses, net of cash acquired

 

 

(278,920

)

 

 

(456,455

)

 

 

(712

)

Proceeds from notes receivable from divestiture

 

 

5,000

 

 

 

—

 

 

 

—

 

Proceeds from sale of business

 

 

—

 

 

 

17,970

 

 

 

—

 

Purchases of property and equipment

 

 

(56,841

)

 

 

(50,010

)

 

 

(63,973

)

Investments in unconsolidated affiliates

 

 

(5,741

)

 

 

(15,589

)

 

 

(16,976

)

Loan to unconsolidated affiliate

 

 

(3,844

)

 

 

—

 

 

 

—

 

Net cash used in investing activities

 

 

(340,346

)

 

 

(504,084

)

 

 

(81,661

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from issuance of long-term debt, net of discount

 

 

494,505

 

 

 

600,000

 

 

 

582,000

 

Payments of debt financing costs

 

 

(1,008

)

 

 

(9,570

)

 

 

(2,636

)

Repayments of long-term debt

 

 

(727,277

)

 

 

(327,294

)

 

 

(437,936

)

Proceeds from accounts receivable financing agreement

 

 

100,000

 

 

 

31,600

 

 

 

127,815

 

Repayments of accounts receivable financing agreement

 

 

—

 

 

 

(6,600

)

 

 

(22,400

)

Proceeds from revolving line of credit

 

 

80,000

 

 

 

300,000

 

 

 

—

 

Repayments of revolving line of credit

 

 

(80,000

)

 

 

(300,000

)

 

 

—

 

Redemption of Senior Notes and associated breakage fees

 

 

—

 

 

 

—

 

 

 

(418,112

)

Payments of contingent consideration related to acquisitions

 

 

(7,197

)

 

 

(26,634

)

 

 

(178

)

Payments of finance leases

 

 

(15,774

)

 

 

(16,434

)

 

 

(14,493

)

Payments for repurchases of common stock

 

 

(117,521

)

 

 

(70,151

)

 

 

(56,716

)

Proceeds from exercises of stock options

 

 

28,148

 

 

 

24,568

 

 

 

40,322

 

Payments related to tax withholdings for share-based compensation

 

 

(31,453

)

 

 

(21,220

)

 

 

(13,135

)

Net cash (used in) provided by financing activities

 

 

(277,577

)

 

 

178,265

 

 

 

(215,469

)

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

 

 

1,947

 

 

 

8,810

 

 

 

(13,594

)

Net change in cash, cash equivalents, and restricted cash

 

 

(165,698

)

 

 

108,484

 

 

 

7,757

 

Cash, cash equivalents, and restricted cash - beginning of period

 

 

272,173

 

 

 

163,689

 

 

 

155,932

 

Cash, cash equivalents, and restricted cash - end of period

 

$

106,475

 

 

$

272,173

 

 

$

163,689

 

The accompanying notes are an integral part of these consolidated financial statements.

 

97

 

Table of Contents

 

 

SYNEOS HEALTH, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

 

 

(in thousands)

 

Shareholders’ equity, beginning balance

 

$

3,242,112

 

 

$

3,029,654

 

 

$

2,856,144

 

Impact from adoption of ASU 2016-13

 

 

—

 

 

 

(2,771

)

 

 

—

 

Shareholders’ equity, adjusted beginning balance

 

 

3,242,112

 

 

 

3,026,883

 

 

 

2,856,144

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock:

 

 

 

 

 

 

 

 

 

 

 

 

Beginning balance

 

 

1,039

 

 

 

1,039

 

 

 

1,034

 

Repurchases of common stock

 

 

(15

)

 

 

(13

)

 

 

(13

)

Issuances of common stock

 

 

14

 

 

 

13

 

 

 

18

 

Ending balance

 

 

1,038

 

 

 

1,039

 

 

 

1,039

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional paid-in capital:

 

 

 

 

 

 

 

 

 

 

 

 

Beginning balance

 

 

3,461,747

 

 

 

3,441,471

 

 

 

3,402,638

 

Repurchases of common stock

 

 

(49,595

)

 

 

(41,512

)

 

 

(43,515

)

Issuances of common stock

 

 

(3,268

)

 

 

3,297

 

 

 

27,155

 

Share-based compensation

 

 

65,204

 

 

 

58,491

 

 

 

55,193

 

Ending balance

 

 

3,474,088

 

 

 

3,461,747

 

 

 

3,441,471

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated other comprehensive loss:

 

 

 

 

 

 

 

 

 

 

 

 

Beginning balance

 

 

(40,801

)

 

 

(71,593

)

 

 

(88,195

)

Unrealized gain (loss) on derivative instruments, net of taxes

 

 

16,140

 

 

 

(3,925

)

 

 

(7,596

)

Foreign currency translation adjustment, net of taxes

 

 

(24,957

)

 

 

34,717

 

 

 

24,198

 

Ending balance

 

 

(49,618

)

 

 

(40,801

)

 

 

(71,593

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated deficit:

 

 

 

 

 

 

 

 

 

 

 

 

Beginning balance

 

 

(179,873

)

 

 

(341,263

)

 

 

(459,333

)

Impact from adoption of ASU 2016-13

 

 

—

 

 

 

(2,771

)

 

 

—

 

Adjusted beginning balance

 

 

(179,873

)

 

 

(344,034

)

 

 

(459,333

)

Repurchases of common stock

 

 

(67,911

)

 

 

(28,626

)

 

 

(13,188

)

Net income

 

 

234,831

 

 

 

192,787

 

 

 

131,258

 

Ending balance

 

 

(12,953

)

 

 

(179,873

)

 

 

(341,263

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders’ equity, ending balance

 

$

3,412,555

 

 

$

3,242,112

 

 

$

3,029,654

 

 

The accompanying notes are an integral part of these consolidated financial statements.

98

 

Table of Contents

 

Syneos Health, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

1. Basis of Presentation and Summary of Significant Accounting Policies

Principal Business

Syneos Health, Inc. (the “Company”) is a global provider of end-to-end biopharmaceutical outsourcing solutions. The Company operates under two reportable segments, Clinical Solutions and Commercial Solutions, and derives its revenue through a suite of services designed to enhance its customers’ ability to successfully develop, launch, and market their products. The Company offers its solutions on both a standalone and integrated basis with biopharmaceutical development and commercialization services ranging from Phase I to IV clinical trial services to services associated with the commercialization of biopharmaceutical products. The Company’s customers include small, mid-sized, and large companies in the pharmaceutical, biotechnology, and medical device industries.

Principles of Consolidation

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), and include the accounts and results of operations of the Company and its controlled subsidiaries. All intercompany balances and transactions have been eliminated.

Reclassification

Certain previously reported amounts have been reclassified to conform to the current year presentation.

COVID-19 Pandemic

The ongoing COVID-19 pandemic and associated economic repercussions have significantly impacted, and are expected to continue to impact, the Company’s business and operations. The continued availability and effectiveness of vaccines may partially mitigate the risks around the continued spread of COVID-19, however, with the spread of COVID-19 variants, the ongoing impacts of the COVID-19 pandemic could adversely impact its business and results of operations. See Part I, Item 1A “Risk Factors” in this Annual Report on Form 10-K for further discussion of the potential impact of the pandemic on its business.

Use of Estimates

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of revenue and expenses for the periods presented in the financial statements. Examples of estimates and assumptions include, but are not limited to, determining the fair value of goodwill and intangible assets and their potential impairment, useful lives of tangible and intangible assets, useful lives of assets subject to leases, valuation of the Company’s right of use assets, allowances for doubtful accounts, potential future outcomes of events for which income tax consequences have been recognized in the Company’s consolidated financial statements or tax returns, valuation allowances for deferred tax assets, fair value of share-based compensation and its recognition period, loss contingencies, fair value of derivative instruments and related hedge effectiveness, fair value of contingent tax sharing obligations, and judgments related to revenue recognition, among others. In addition, estimates and assumptions are used in the accounting for acquisitions, including the fair value and useful lives of acquired tangible and intangible assets and the fair value of assumed liabilities.

99

 

Table of Contents

 

The Company evaluates its estimates and assumptions on an ongoing basis and bases its estimates on historical experience, current and expected future conditions, third-party evaluations, and various other assumptions that management believes are reasonable under the circumstances based on the information available to management at the time these estimates and assumptions are made. Actual results and outcomes may differ significantly from these estimates and assumptions.

Acquisitions

The Company accounts for acquisitions in accordance with ASC Topic 805, Business Combinations, using the acquisition method of accounting. The purchase price, or total consideration transferred, is determined as the fair value of assets exchanged, equity instruments issued, and liabilities assumed at the acquisition date. The acquisition method of accounting requires that the identifiable assets acquired, the liabilities assumed, and any non-controlling interest in the acquiree are measured and recorded at their fair values on the date of an acquisition. Goodwill represents the excess of the purchase price over the estimated fair value of the net assets acquired, including the amount assigned to identifiable intangible assets. Acquisition-related costs are expensed as incurred. The consolidated financial statements reflect the results of operations of the acquiree from the date of the acquisition. For additional information, see “Note 3 – Acquisitions, Divestitures, and Investments.”

Foreign Currency Translation and Transactions

For subsidiaries outside of the U.S. that operate in a local currency environment, revenue and expenses are translated to U.S. dollars at the monthly average rates of exchange prevailing during the period, assets and liabilities are translated at period-end exchange rates, and equity accounts are translated at historical exchange rates. The net effect of foreign currency translation adjustments is included in shareholders’ equity as a component of accumulated other comprehensive loss in the accompanying consolidated balance sheets.

Foreign currency transaction gains and losses are the result of exchange rate changes during the period of time between the consummation and cash settlement of transactions denominated in currencies other than the functional currency. Foreign currency transaction gains and losses are recognized in earnings as incurred and are included in other (income) expense, net in the accompanying consolidated statements of income.

Comprehensive Income

Comprehensive income refers to revenue, expenses, gains, and losses that, under U.S. GAAP, are recorded as an element of shareholders’ equity but are excluded from net income. The Company’s comprehensive income consists of foreign currency translation adjustments, net of applicable taxes, resulting from the translation of foreign subsidiaries with functional currencies other than the U.S. dollar and the effective portions of the unrealized gains or losses associated with derivative instruments designated and accounted for as hedging instruments.

100

 

Table of Contents

 

Cash and Cash Equivalents

Cash and cash equivalents consist of demand deposits with banks and other financial institutions and highly liquid investments with an original maturity of three months or less at the date of purchase. Cash and cash equivalents are carried at cost, which approximates their fair value.

Certain of the Company’s subsidiaries participate in a notional cash pooling arrangement to manage global liquidity requirements. As part of a master netting arrangement, the participants combine their cash balances in pooling accounts at the same financial institution with the ability to offset bank overdrafts of one participant against positive cash account balances held by another participant. Under the terms of the master netting arrangement, the financial institution has the right, ability, and intent to offset a positive balance in one account against an overdrawn amount in another account. Amounts in each of the accounts are unencumbered and unrestricted with respect to use. As such, the net cash balance related to this pooling arrangement is included in cash, cash equivalents, and restricted cash in the accompanying consolidated balance sheets.

The Company’s net cash pool position consisted of the following as of December 31 (in thousands):

 

 

 

2021

 

 

2020

 

Gross cash position

 

$

179,160

 

 

$

220,261

 

Less: cash borrowings

 

 

(167,507

)

 

 

(204,647

)

Net cash position

 

$

11,653

 

 

$

15,614

 

 

Restricted Cash

Restricted cash represents cash and deposits held as security over bank deposits, lease guarantees, and insurance obligations that are restricted as to withdrawal or use. Restricted cash is classified as a current or long-term asset based on the timing and nature of when and how the cash is expected to be used or when the restrictions are expected to lapse. As of December 31, 2021 and 2020, restricted cash balances were $0.1 million and $0.3 million, respectively.

Fair Value

The Company records certain assets and liabilities at fair value in accordance with ASC Topic 820, Fair Value Measurement (see “Note 7 - Fair Value Measurements”). Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. This guidance also specifies a fair value hierarchy that distinguishes between valuation assumptions developed based on market data obtained from independent external sources and the reporting entity’s own assumptions. Fair value measurements are classified according to the lowest level input or value-driver that is significant to the valuation. In accordance with this guidance, fair value measurements are classified under the following hierarchy:

Level 1 – Unadjusted quoted prices in active markets for identical instruments;

Level 2 – Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs or significant value-drivers are observable in active markets; and

Level 3 – Model-derived valuations in which one or more significant inputs or significant value-drivers are unobservable, including internally developed models.

101

 

Table of Contents

 

Derivative Financial Instruments

Interest Rate Swaps

The Company uses interest rate swaps to manage exposure to variable interest rates on its debt obligations. The Company designates its interest rate swaps as cash flow hedges because they are executed to hedge the Company’s exposure to the variability in expected future cash flows that are attributable to changes in interest rates.

Derivative financial instruments are measured at fair value and recognized in the accompanying consolidated balance sheets in prepaid expenses and other current assets, other long-term assets, accrued expenses, and other long-term liabilities, as disclosed in “Note 6 – Derivatives.” The fair value of interest rate swaps is determined using the market standard methodology of discounted future variable cash receipts. The variable cash receipts are determined by discounting the future expected cash receipts that would occur if variable interest rates rise above the fixed rate of the swaps. The variable interest rates used in the calculation of projected receipts on the swap are based on an expectation of future interest rates derived from observable market interest rate curves and volatilities. Changes in the fair value of derivative instruments designated as hedging instruments are recorded each period according to the determination of the derivative’s effectiveness. The effective portion of changes in the fair value of derivatives designated as cash flow hedges is recorded in accumulated other comprehensive loss and subsequently reclassified into earnings in the period during which the hedged transaction is recognized in earnings. The ineffective portion of the change in fair value of the derivatives is recognized as non-operating income or expense immediately when incurred and included in interest expense in the accompanying consolidated statements of income.

Foreign Exchange Forward

The Company utilizes a foreign exchange forward in order to minimize monthly foreign currency remeasurement gains or losses on non-functional currency monetary balances. The Company did not designate the derivative as a hedge. All changes in the fair value of the foreign exchange forward are recorded in earnings every month to other (income) expense, net in the accompanying consolidated statements of income, as disclosed in “Note 6 – Derivatives.”

Allowance for Doubtful Accounts

The Company maintains a credit approval process and makes judgments in connection with assessing its customers’ ability to pay for contracted services. Generally, the Company has the ability to limit credit exposure by discontinuing services in the event of non-payment. The Company monitors its customers’ credit worthiness and applies judgment in establishing a provision for estimated credit losses based on historical experience, the aging of receivables, and customer-specific circumstances that would affect the customers’ ability to pay for services rendered.

Property and Equipment

Property and equipment primarily consists of furniture, vehicles, software, office equipment, computer equipment, and lab equipment. Purchased and constructed property and equipment is initially recorded at historical cost plus the estimated value of any associated legally or contractually required retirement obligations. Property and equipment acquired in an acquisition are recorded based on the estimated fair value as of the acquisition date. The Company leases vehicles for certain sales representatives in the Commercial Solutions segment. These leases are classified and accounted for as leases in accordance with ASC Topic 842, Leases (“ASC 842”). For further information about lease arrangements, see “Note 5 - Leases.”

102

 

Table of Contents

 

Property and equipment assets are depreciated using the straight-line method over the respective estimated useful lives as follows:

 

 

 

Useful Life

Buildings

 

39 years

Furniture and fixtures

 

7 years

Equipment

 

5 to 10 years

Computer equipment and software

 

2 to 3 years

Vehicles

 

Lesser of lease term or the estimated economic life of the leased asset

Leasehold improvements

 

Lesser of remaining life of lease or the useful life of the asset

 

Expenditures for repairs and maintenance are expensed as incurred and expenditures for major improvements that increase the functionality or extend the useful life of the asset are capitalized and depreciated over the estimated useful life of the asset.

The Company capitalizes costs of computer software obtained for internal use and amortizes these costs on a straight-line basis over the estimated useful life of the product, not to exceed five years. Software cloud computing arrangements containing a software license are accounted for consistently with the acquisition of other software licenses. In the event such an arrangement does not contain a software license, the Company accounts for the arrangement as a service contract.

The Company reviews property and equipment for impairment whenever facts and circumstances indicate that the carrying amounts of these assets might not be recoverable. For assessment purposes, property and equipment are grouped with other assets and liabilities at the lowest level that identifiable cash flows are largely independent of the cash flows of other assets and liabilities. Recoverability of the carrying amount of an asset group is assessed by comparing its carrying amount to the estimated undiscounted future cash flows expected to be generated by the asset group. If the carrying value of the asset group exceeds its fair value, an impairment charge is recognized for the excess.

Leases

At inception, a contract contains a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. In evaluating whether it has the right to control the use of an identified asset, the Company assesses whether they have the right to direct the use of the identified asset and to obtain substantially all of the economic benefit from the use of the identified asset.

Right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset during the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Assets and liabilities are recognized based on the present value of lease payments over the lease term. Most leases include one or more options to renew. The exercise of the renewal option is at the Company’s sole discretion and the Company includes these options in determining the lease term used to establish its right-of-use assets and lease liabilities when it is reasonably certain the Company will exercise its option.

Because most of the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The Company uses the implicit rate when readily determinable. Operating lease expense is generally recognized on a straight-line basis over the lease term.

103

 

Table of Contents

 

The Company has agreements with lease and non-lease components, which are accounted for as a single lease component. Leases with a lease term of 12 months or less are not recorded on the balance sheet. The Company recognizes lease expense for these leases on a straight-line basis over the lease term. Variable lease payment amounts that cannot be determined at the commencement of the lease, such as increases in lease payments based on changes in index rates, are not included in the right-of-use assets or liabilities. These variable lease payments are expensed as incurred.

Goodwill and Intangible Assets

Goodwill represents the excess of the purchase price over the estimated fair value of net assets acquired, including the amount assigned to identifiable intangible assets, in acquisitions. In accordance with ASC Topic 350, Intangibles – Goodwill and Other, goodwill is not subject to amortization but must be tested for impairment annually or more frequently if events or changes in circumstances indicate that goodwill might be impaired. Goodwill is tested for impairment at the reporting unit level, which is one level below the operating segment level. This test requires the Company to determine if the implied fair value of the reporting unit’s goodwill is less than its carrying amount.

The Company has assigned goodwill to four reporting units. The Company completed an annual impairment test as of October 1, 2021 for all of its reporting units, and concluded that there were no impairments.

Intangible assets consist of customer relationships, acquired backlog, trade names, trademarks, patient communities, and acquired technologies. The Company amortizes intangible assets related to customer relationships, trade names, trademarks, patient communities, and acquired technologies on a straight-line basis over the estimated useful life of the asset. Intangible assets related to acquired backlog are amortized based on the Company’s expectations of the timing of when revenue associated with the backlog is expected to be recognized.

The Company reviews intangible assets at the end of each reporting period to determine if facts and circumstances indicate that the useful life is shorter than originally estimated or that the carrying amount of the assets might not be recoverable. If such facts and circumstances exist, the Company assesses the recoverability of identified assets by comparing the projected undiscounted cash flows associated with the related asset or group of assets to their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amount over the fair value of those assets and occur in the period in which the impairment determination is made.

The weighted average estimated useful lives of the Company’s intangible assets were as follows as of December 31:

 

 

 

2021

 

2020

Customer relationships

 

9.8 years

 

9.9 years

Acquired backlog

 

2.6 years

 

2.6 years

Trade names and trademarks

 

5.5 years

 

5.5 years

Intellectual property (medical patent)

 

n/a

 

9.0 years

Patient communities

 

6.0 years

 

n/a

Acquired technologies

 

6.0 years

 

n/a

No intangible asset impairment charges were recorded for the years ended December 31, 2021 or 2020. For additional information regarding the carrying values of intangible assets, see “Note 2 – Financial Statement Details.”

104

 

Table of Contents

 

Contingencies

In the normal course of business, the Company periodically becomes involved in various proceedings and claims, including investigations, disputes, litigations, and regulatory matters that are incidental to its business. The Company evaluates the likelihood of an unfavorable outcome of all legal and regulatory matters and records accruals for probable loss contingencies for which the amount of the loss can be reasonably estimated. Gain contingencies are not recognized until realized. Legal fees are expensed as incurred.

Because these matters are inherently unpredictable, and unfavorable developments or resolutions can occur, assessing contingencies is highly subjective and requires judgments about future events. These judgments and estimates are based, among other factors, on the status of the proceedings, the merits of the Company’s defenses, and the consultation with in-house and external counsel. The Company regularly reviews contingencies to determine whether its accruals and related disclosures are adequate. Although the Company believes that it has substantial defenses in these matters, the amount of losses incurred as a result of actual outcomes may differ significantly from the Company’s estimates.

Revenue Recognition

In accordance with ASC Topic 606, Revenue from Contracts with Customers and all related amendments (“ASC 606”), revenue is recognized when, or as, a customer obtains control of promised services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these services.

A performance obligation is a promise (or a combination of promises) in a contract to transfer distinct goods or services to a customer and is the unit of accounting under ASC 606 for the purposes of revenue recognition. A contract’s transaction price is allocated to each performance obligation and is recognized as revenue, when, or as, each performance obligation is satisfied. The majority of the Company’s Clinical Solutions segment contracts have a single performance obligation because the promise to transfer individual services is not separately identifiable from other promises in the contracts, and therefore, is not distinct. For contracts with multiple performance obligations, the contract’s transaction price is allocated to each performance obligation using the best estimate of the standalone selling price of each distinct good or service in the contract.

The majority of the Company’s revenue arrangements are service contracts that range in duration from a few months to several years. Substantially all of the Company’s performance obligations, and associated revenue, are transferred to the customer over time. The Company generally receives compensation based on measuring progress toward completion using anticipated project budgets for direct labor and prices for each service offering. The Company is also reimbursed for certain third-party pass-through and out-of-pocket costs. In addition, in certain instances a customer contract may include forms of variable consideration such as incentive fees, volume rebates or other provisions that can increase or decrease the transaction price. This variable consideration is generally awarded upon achievement of certain performance metrics, program milestones or cost targets. For the purposes of revenue recognition, variable consideration is assessed on a contract-by-contract basis and the amount included in the transaction price is estimated based on the Company’s anticipated performance and consideration of all information that is reasonably available. Variable consideration is recognized as revenue if and when it is deemed probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved in the future.

105

 

Table of Contents

 

Most of the Company’s contracts can be terminated by the customer without cause with a notice period that generally ranges from 30 to 90 days. In the event of termination, the Company’s contracts generally provide that the customer pay the Company for: (i) fees earned through the termination date; (ii) fees and expenses for winding down the project, which include both fees incurred and actual expenses; (iii) non-cancellable expenditures; and (iv) in some cases, a fee to cover a portion of the remaining professional fees on the project. The Company’s long-term clinical trial contracts contain implied substantive termination penalties because of the significant wind-down cost of terminating a clinical trial. These provisions for termination penalties result in these types of contracts being treated as long-term for revenue recognition purposes.

Changes in the scope of work are common, especially under long-term contracts, and generally result in a change in the total contract transaction price. If the customer does not agree to a contract modification, the Company could bear the risk of cost overruns. Most of the Company’s contract modifications are for services that are not distinct from the services under the existing contract due to the significant integration service provided in the context of the contract and therefore result in a cumulative catch-up adjustment to revenue at the date of contract modification.

Capitalized Costs

The Company capitalizes certain costs associated with commissions and bonuses paid to its employees in the Clinical Solutions segment because these costs are incurred in obtaining contracts that have a term greater than one year. Capitalized costs are included in prepaid expenses and other current assets and other long-term assets in the accompanying consolidated balance sheets. The Company amortizes these costs in a manner that is consistent with the pattern of revenue recognition described below. The Company expenses costs to obtain contracts that have a term of one year or less.

Clinical Solutions

The Company’s Clinical Solutions segment provides solutions to address the clinical development needs of customers. The Company provides total biopharmaceutical program development through its full-service platform, while also providing discrete services for any part of a clinical trial, primarily through functional service provider, Early Stage, and Real World and Late Phase (“RWLP”) services. The services provided via the full-service platform and RWLP platforms generally span several years and a significant benefit to the customer is provided by integrating the services provided by the Company’s employees as well as those performed by third parties. Because the Company’s full-service platform provides a significant integration service to the customer, these contracts contain a single performance obligation. Revenue is recognized over time using an input measure of progress. The input measure reflects costs (including investigator payments and pass-through costs) incurred to date relative to total estimated costs to complete (“cost-to-cost measure of progress”). Under the cost-to-cost measure of progress methodology, revenue is recorded proportionally to costs incurred. Contract costs principally include direct labor, investigator payments, and pass-through costs. The estimate of total estimated costs at completion requires significant judgment. Contract estimates are based on various assumptions to project future outcomes of events that often span several years. These estimates are reviewed periodically and any adjustments are recognized on a cumulative catch-up basis in the period they become known.

The remaining service offerings within the Clinical Solutions segment are generally short-term, month-to-month contracts, time and materials basis contracts, or provide a series of distinct services that are substantially the same and have the same pattern of transfer to the customer (“series”). As such, revenue for these service offerings is generally recognized as services are performed for the amount the Company estimates it is entitled to for the period.

106

 

Table of Contents

 

Commercial Solutions

The Company’s Commercial Solutions segment provides a broad suite of complementary commercialization services including Deployment Solutions, communications (advertising and public relations), and consulting services. Deployment Solutions contracts offer outsourced services to promote commercial products on behalf of a customer.

The remaining Commercial Solutions contracts are generally short-term, month-to-month contracts or time and materials contracts. As such, Commercial Solutions revenue is generally recognized as services are performed for the amount of consideration the Company estimates it is entitled to for the period. For contracts billed on a fixed price basis, revenue is recognized over time based on the proportion of labor costs expended to total labor costs expected to complete the contract.

Accounts Receivable, Unbilled Services, and Deferred Revenue

Accounts receivable are recorded at net realizable value. Unbilled accounts receivable arise when services have been rendered for which revenue has been recognized but the customers have not been billed. Contractual provisions and payment schedules may or may not correspond to the timing of the performance of services under the contract.

Unbilled services include contract assets, under which the right to bill the customer is subject to factors other than the passage of time. These amounts may not exceed their net realizable value. Contract assets are generally classified as current.

Deferred revenue is a contract liability that consists of customer payments received in advance of performance and billings in excess of revenue recognized, net of revenue recognized from the balance at the beginning of the period.

Timing of Billing and Performance

Differences in the timing of revenue recognition and associated billings and cash collections result in recording of billed accounts receivable, unbilled accounts receivable (including contract assets), and deferred revenue on the consolidated balance sheet. Amounts are billed as work progresses in accordance with agreed-upon contractual terms either at periodic intervals or upon achievement of contractual milestones. Billings generally occur subsequent to revenue recognition, resulting in recording unbilled accounts receivable in instances where the right to bill is contingent solely on the passage of time (e.g., in the following month), and contract assets in instances where the right to bill is associated with achievement of a milestone.

Reimbursable Out-of-Pocket Expenses

The Company incurs and is reimbursed by its customers for certain costs, including fees paid to principal investigators and for other out-of-pocket costs (such as travel expenses for the Company’s clinical monitors and sales representatives). The Company includes these costs in total operating expenses, and the related reimbursements in revenue, as the Company is the principal in the applicable arrangements and is responsible for fulfilling the promise to provide the specified services.

Share-Based Compensation

The Company measures and recognizes compensation expense related to all share-based awards based on the estimated fair value of the awards. The fair value of restricted stock and stock unit awards is measured on the grant date based on the fair market value of the Company’s common stock.

107

 

Table of Contents

 

Share-based compensation expense is recognized on a straight-line basis over the shorter of the requisite service period or the vesting term. For awards with performance conditions, stock-based compensation expense is recognized when the achievement of each individual performance target becomes probable, and the number of shares expected to vest is adjusted for the weighted probability of attainment of the relevant performance targets. Forfeitures are accounted for as they occur.

All excess tax benefits and tax deficiencies (including tax benefits of dividends on share-based payment awards, if applicable) are recognized as income tax expense or benefit in the consolidated statements of income. The tax effects of exercised or vested awards are treated as discrete items in the reporting period in which they occur. The Company also recognizes excess tax benefits regardless of whether the benefit reduces taxes payable in the current period.

Income Taxes

The majority of the Company’s U.S. subsidiaries file a consolidated U.S. federal income tax return, while certain U.S. subsidiaries, including recently acquired entities, may file separate U.S. federal tax returns. The Company’s subsidiaries in international jurisdictions file tax returns in their respective jurisdictions.

The Company estimates its tax liability based on current tax laws in the statutory jurisdictions in which it operates. Accordingly, the impact of changes in income tax laws on deferred tax assets and deferred tax liabilities is recognized in earnings in the period during which such changes are enacted. The Company records deferred tax assets and liabilities based on temporary differences between the financial reporting basis and tax basis of the Company’s assets and liabilities at enacted tax rates expected to be in effect when the differences are realized or settled.

Deferred income tax assets represent amounts available to reduce income taxes payable on taxable income in future years. Such assets arise because of temporary differences between the financial reporting and tax bases of assets and liabilities, as well as from net operating loss and tax credit carryforwards. The Company evaluates recoverability of these future tax deductions. The Company establishes a valuation allowance for deferred income tax assets when the Company believes it is more likely than not the assets will not be realized. The Company evaluates the recoverability of these future tax deductions by assessing future expected taxable income. In estimating future taxable income, the Company considers both positive and negative evidence, such as historical and forecasted results of operations, and implementation of prudent and feasible tax planning strategies. If the objectively verifiable negative evidence outweighs any available positive evidence (or the only available positive is subjective and cannot be verified), then a valuation allowance will likely be deemed necessary. If a valuation allowance is deemed to be unnecessary, such allowance is released and any related benefit is recognized in the period of the change.

The Company recognizes a tax benefit from any uncertain tax positions only if they are more likely than not to be sustained upon examination based on the technical merits of the position. The Company evaluates uncertain tax positions pursuant to the more likely than not standard, and benefits related to such uncertain tax positions are recognized as the largest amount of benefit, determined on a cumulative probability basis, to be realized upon ultimate settlement of the position. Components of the reserve for uncertain tax positions are classified as either a current or a long-term liability in the accompanying consolidated balance sheets based on management’s expectation of future cash settlements.

Judgment is required in determining what constitutes an uncertain tax position, as well as assessing the outcome of each tax position. The Company considers many factors when evaluating and estimating tax positions and tax benefits. In addition, the calculation of tax liabilities involves dealing with uncertainties in the application of complex tax regulations in domestic and foreign jurisdictions. If the calculation of the liability related to uncertain tax positions proves to be more or less than the ultimate settlement, a tax expense or tax benefit, respectively, would result. Unrecognized tax benefits are presented as either a reduction to a deferred tax asset or as a separate liability.

108

 

Table of Contents

 

Restructuring and Other Costs

Restructuring and other costs primarily consist of one-time employee termination benefits, contract termination costs, and other costs associated with an exit or disposal activity. The Company accounts for restructuring costs in accordance with ASC Topic 420, Exit or Disposal Cost Obligations. This guidance requires that a liability for a cost associated with an exit or disposal activity be recognized in the period in which the liability is incurred, as opposed to the period in which management commits to a plan of action for termination. The guidance also requires that the liabilities associated with an exit or disposal activity be measured at the fair value in the period in which the liability is incurred, except for: (i) liabilities related to one-time employee termination benefits, which shall be measured and recognized at the date the entity notifies employees of termination, unless employees are required to render services beyond a minimum retention period, in which case the liability is recognized ratably over the future service period; and (ii) liabilities related to an operating lease, which shall be measured and recognized when the contract does not have any future economic benefit to the entity (i.e., the entity ceases to utilize the rights conveyed by the contract). Restructuring liabilities are included in accrued expenses and other long-term liabilities in the accompanying consolidated balance sheets.

Earnings Per Share

The Company determines earnings per share in accordance with ASC Topic 260, Earnings Per Share. The Company has one class of common stock for purposes of the earnings per share calculation and therefore computes basic earnings per share by dividing net income (loss) by the weighted average number of common shares outstanding for the applicable period. Diluted earnings per share are computed in the same manner as basic earnings per share, except that the number of shares is increased to assume exercise of potentially dilutive equity awards using the treasury stock method, unless the effect of such increase would be anti-dilutive. Under the treasury stock method, the amount the employee must pay for exercising equity awards and the amount of compensation cost for future service that the Company has not yet recognized are assumed to be used to repurchase shares.

Subsequent Events

The Company considers events or transactions that occur after the balance sheet date but before the financial statements are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. The Company evaluated all events and transactions through the date that these financial statements were issued.

Recently Adopted Accounting Standards

In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13 (“ASU 2016-13”), Financial Instruments - Credit Losses (Topic 326) to modify the impairment model to utilize an expected loss methodology in place of the previous incurred loss methodology and require consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The Company adopted ASU 2016-13 on January 1, 2020, and recorded the impact of the adoption through a cumulative-effect adjustment to accumulated deficit. Results for reporting periods beginning on January 1, 2020 are presented under ASU No. 2016-13, while prior period amounts continue to be reported and disclosed in accordance with the Company’s historical accounting treatment. Adoption of the new standard resulted in the recording of additional allowance for doubtful accounts of approximately $2.8 million as of January 1, 2020.

109

 

Table of Contents

 

2. Financial Statement Details

Accounts Receivable and Unbilled Services, net

Accounts receivable and unbilled services (including contract assets), net of allowance for doubtful accounts, consisted of the following as of December 31 (in thousands):

 

 

 

2021

 

 

2020

 

Accounts receivable billed

 

$

873,265

 

 

$

774,605

 

Accounts receivable unbilled

 

 

241,799

 

 

 

211,285

 

Contract assets

 

 

417,411

 

 

 

366,506

 

Less: Allowance for doubtful accounts

 

 

(7,585

)

 

 

(7,615

)

Accounts receivable and unbilled services, net

 

$

1,524,890

 

 

$

1,344,781

 

The following table summarizes the changes in the allowance for doubtful accounts (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Balance at the beginning of the period

 

$

(7,615

)

 

$

(5,381

)

 

$

(4,587

)

Impact from adoption of ASU 2016-13

 

 

—

 

 

 

(2,771

)

 

 

—

 

Current year provision

 

 

(367

)

 

 

(695

)

 

 

(1,897

)

Write-offs, net of recoveries and the effects of foreign currency exchange

 

 

397

 

 

 

1,232

 

 

 

1,103

 

Balance at the end of the period

 

$

(7,585

)

 

$

(7,615

)

 

$

(5,381

)

 

Accounts Receivable Factoring Arrangement

The Company has an accounts receivable factoring agreement to sell certain eligible unsecured trade accounts receivable, at its option, without recourse, to an unrelated third-party financial institution for cash. For the years ended December 31, 2021 and 2020, the Company factored $129.1 million and $152.4 million, respectively, of trade accounts receivable on a non-recourse basis and received $128.9 million and $151.9 million, respectively, in cash proceeds from the sale. The fees associated with these transactions were insignificant.

Property and Equipment, net

Property and equipment, net of accumulated depreciation, consisted of the following as of December 31 (in thousands):

 

 

 

2021

 

 

2020

 

Software

 

$

159,736

 

 

$

129,731

 

Leasehold improvements

 

 

96,188

 

 

 

94,596

 

Computer equipment

 

 

91,937

 

 

 

108,230

 

Vehicles

 

 

77,674

 

 

 

63,985

 

Office furniture, fixtures, and equipment

 

 

65,018

 

 

 

37,287

 

Buildings and land

 

 

5,692

 

 

 

5,211

 

Assets not yet placed in service

 

 

28,706

 

 

 

28,129

 

Property and equipment, gross

 

 

524,951

 

 

 

467,169

 

Less: Accumulated depreciation

 

 

(302,294

)

 

 

(250,969

)

Property and equipment, net

 

$

222,657

 

 

$

216,200

 

110

 

Table of Contents

 

 

As of December 31, 2021 and 2020, the gross book value of vehicles under finance leases was $77.7 million and $64.0 million, respectively, and accumulated depreciation was $30.0 million and $20.5 million, respectively. For the years ended December 31, 2021 and 2020, amortization charges related to these assets, net of rebates, were $17.5 million and $15.8 million, respectively, and were included in depreciation on the accompanying consolidated statements of income.

Goodwill and Intangible Assets

The changes in carrying amount of goodwill by segment were as follows (in thousands):

 

 

 

Clinical

Solutions (a)

 

 

Commercial

Solutions (b)

 

 

Total

 

Balance as of December 31, 2019

 

$

2,784,952

 

 

$

1,565,428

 

 

$

4,350,380

 

Acquisitions and divestitures (c)

 

 

418,619

 

 

 

(14,453

)

 

 

404,166

 

Impact of foreign currency translation

 

 

12,764

 

 

 

8,868

 

 

 

21,632

 

Balance as of December 31, 2020

 

 

3,216,335

 

 

 

1,559,843

 

 

 

4,776,178

 

Acquisitions (d)

 

 

192,286

 

 

 

—

 

 

 

192,286

 

Impact of foreign currency translation and other (e)

 

 

40,078

 

 

 

(52,527

)

 

 

(12,449

)

Balance as of December 31, 2021

 

$

3,448,699

 

 

$

1,507,316

 

 

$

4,956,015

 

 

(a) Accumulated impairment losses of $8.1 million associated with the Clinical Solutions segment were recorded prior to 2016 and related to the former Phase I Services segment, now a component of the Clinical Solutions segment. No impairment of goodwill was recorded for the years ended December 31, 2021, 2020, or 2019.

(b) Accumulated impairment losses of $8.0 million associated with the Commercial Solutions segment were recorded prior to 2015 and related to the former Global Consulting segment, now a component of the Commercial Solutions segment. No impairment of goodwill was recorded for the years ended December 31, 2021, 2020, or 2019.

(c) Amounts represent goodwill recognized in connection with the 2020 acquisitions of SHCR Holdings Corporation (“Synteract”) and Illingworth Research Group™ (“Illingworth Research”) within the Clinical Solutions segment and goodwill disposed upon the sale of the medication adherence business within the Commercial Solutions segment.

(d) Amount represents goodwill recognized in connection with the acquisitions of StudyKIK Corporation (“StudyKIK”) and RxDataScience, Inc. (“RxDataScience”), other insignificant acquisitions in 2021, and insignificant measurement period adjustments recognized in connection with the 2020 acquisitions of Synteract and Illingworth Research within the Clinical Solutions segment.

(e) Includes $44.2 million reallocation of goodwill from the Commercial Solutions segment to the Clinical Solutions segment to reflect the transfer of the Kinapse Regulatory and Operations Consulting service lines to align with management reporting in 2021.

Intangible assets, net consisted of the following (in thousands):

 

 

 

December 31, 2021

 

 

December 31, 2020

 

 

 

Gross

 

 

Accumulated

Amortization

 

 

Net

 

 

Gross

 

 

Accumulated

Amortization

 

 

Net

 

Customer relationships

 

$

1,547,925

 

 

$

(811,542

)

 

$

736,383

 

 

$

1,518,081

 

 

$

(685,021

)

 

$

833,060

 

Acquired backlog

 

 

175,826

 

 

 

(154,475

)

 

 

21,351

 

 

 

174,180

 

 

 

(132,733

)

 

 

41,447

 

Trade names and trademarks

 

 

55,728

 

 

 

(28,806

)

 

 

26,922

 

 

 

52,475

 

 

 

(21,817

)

 

 

30,658

 

Intellectual property (medical patent)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

30,028

 

 

 

(1,668

)

 

 

28,360

 

Patient communities

 

 

45,100

 

 

 

(2,192

)

 

 

42,908

 

 

 

—

 

 

 

—

 

 

 

—

 

Acquired technologies

 

 

27,800

 

 

 

(1,297

)

 

 

26,503

 

 

 

—

 

 

 

—

 

 

 

—

 

Intangible assets, net

 

$

1,852,379

 

 

$

(998,312

)

 

$

854,067

 

 

$

1,774,764

 

 

$

(841,239

)

 

$

933,525

 

 

111

 

Table of Contents

 

 

The future estimated amortization expense for intangible assets as of December 31, 2021 is expected to be as follows (in thousands):

 

Year Ended December 31,

 

 

 

 

2022

 

$

162,193

 

2023

 

 

153,334

 

2024

 

 

146,487

 

2025

 

 

132,512

 

2026

 

 

110,597

 

2027 and thereafter

 

 

148,944

 

Total

 

$

854,067

 

 

Accrued Expenses

Accrued expenses consisted of the following as of December 31 (in thousands):

 

 

 

2021

 

 

2020

 

Professional fees, investigator fees, and pass-through costs

 

$

283,432

 

 

$

231,638

 

Compensation, including bonuses, fringe benefits, and payroll taxes

 

 

215,386

 

 

 

255,042

 

Income and other taxes

 

 

25,723

 

 

 

28,890

 

Rebates to customers

 

 

22,367

 

 

 

22,528

 

Restructuring and other costs, current portion

 

 

6,657

 

 

 

5,830

 

Contingent obligations, current

 

 

3,397

 

 

 

4,327

 

Interest rate swaps - current

 

 

1,827

 

 

 

17,045

 

Other liabilities

 

 

55,652

 

 

 

45,742

 

Total accrued expenses

 

$

614,441

 

 

$

611,042

 

Accumulated Other Comprehensive Loss, Net of Taxes

Accumulated other comprehensive loss, net of taxes, consisted of the following (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Beginning balance

 

$

(40,801

)

 

$

(71,593

)

 

 

 

 

 

 

 

 

 

Derivative Instruments:

 

 

 

 

 

 

 

 

Beginning balance

 

 

(18,761

)

 

 

(14,836

)

Other comprehensive gain (loss) before reclassifications

 

 

2,963

 

 

 

(20,446

)

Reclassification adjustments

 

 

13,177

 

 

 

16,521

 

Ending balance

 

 

(2,621

)

 

 

(18,761

)

 

 

 

 

 

 

 

 

 

Foreign Currency Translation:

 

 

 

 

 

 

 

 

Beginning balance

 

 

(22,040

)

 

 

(56,757

)

Other comprehensive (loss) income before reclassifications

 

 

(24,957

)

 

 

34,717

 

Ending balance

 

 

(46,997

)

 

 

(22,040

)

 

 

 

 

 

 

 

 

 

Accumulated other comprehensive loss, net of taxes

 

$

(49,618

)

 

$

(40,801

)

112

 

Table of Contents

 

 

Changes in accumulated other comprehensive loss consisted of the following (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Unrealized loss on derivative instruments:

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized gain (loss) during period, before taxes

 

$

4,084

 

 

$

(27,647

)

 

$

(14,306

)

Income tax expense (benefit)

 

 

1,121

 

 

 

(7,201

)

 

 

(2,777

)

Unrealized gain (loss) during period, net of taxes

 

 

2,963

 

 

 

(20,446

)

 

 

(11,529

)

Reclassification adjustment, before taxes

 

 

17,655

 

 

 

22,328

 

 

 

4,588

 

Income tax expense

 

 

4,478

 

 

 

5,807

 

 

 

655

 

Reclassification adjustment, net of taxes

 

 

13,177

 

 

 

16,521

 

 

 

3,933

 

Total unrealized gain (loss) on derivative instruments, net of taxes

 

 

16,140

 

 

 

(3,925

)

 

 

(7,596

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments, before taxes

 

 

(26,429

)

 

 

36,071

 

 

 

24,198

 

Income tax (benefit) expense

 

 

(1,472

)

 

 

1,354

 

 

 

—

 

Foreign currency translation adjustments, net of taxes

 

 

(24,957

)

 

 

34,717

 

 

 

24,198

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total other comprehensive (loss) income, net of taxes

 

$

(8,817

)

 

$

30,792

 

 

$

16,602

 

Other (Income) Expense, Net

Other (income) expense, net consisted of the following (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Net realized foreign currency loss

 

$

2,190

 

 

$

3,175

 

 

$

11,853

 

Net unrealized foreign currency (gain) loss

 

 

(5,928

)

 

 

4,147

 

 

 

11,166

 

Gain on sale of business

 

 

—

 

 

 

(7,133

)

 

 

—

 

Equity investment (income) expense

 

 

(1,950

)

 

 

(3,745

)

 

 

261

 

Other, net

 

 

(2,945

)

 

 

580

 

 

 

882

 

Total other (income) expense, net

 

$

(8,633

)

 

$

(2,976

)

 

$

24,162

 

 

Supplemental disclosure of cash flow information

The following table provides details of supplemental cash flow information (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Cash paid for income taxes, net of refunds

 

$

35,100

 

 

$

23,400

 

 

$

12,200

 

Cash paid for interest (excluding finance leases)

 

 

63,952

 

 

 

83,690

 

 

 

129,756

 

Supplemental disclosure of noncash investing and financing activities

 

 

 

 

 

 

 

 

 

 

 

 

Non-cash investment to acquire certain intellectual property rights from a customer in lieu of cash payment for services rendered

 

 

—

 

 

 

27,300

 

 

 

—

 

Fair value of contingent consideration related to acquisitions

 

 

19,158

 

 

 

—

 

 

 

—

 

Change in property and equipment included in liabilities

 

 

1,753

 

 

 

11,684

 

 

 

5,977

 

Vehicles acquired through finance lease agreements

 

 

28,994

 

 

 

20,203

 

 

 

37,701

 

 

113

 

Table of Contents

 

 

3. Acquisitions, Divestitures, and Investments

StudyKIK Acquisition

On September 13, 2021, the Company completed the acquisition of StudyKIK, a leading clinical trial recruitment and retention company, expanding the Company’s portfolio of patient-direct, technology-enabled solutions. The total purchase consideration was $203.6 million (net of cash acquired of $1.0 million). The Company recognized $115.3 million of goodwill and $91.8 million of intangible assets. The remainder of consideration was attributed to other net assets, primarily related to net working capital.

The purchase price has been allocated to the tangible assets and identifiable intangible assets acquired and liabilities assumed based upon their fair values. The excess of the purchase price over the tangible and intangible assets acquired and liabilities assumed has been recorded as goodwill. Goodwill is attributable to the acquired workforce as well as future synergies and is not deductible for income tax purposes. The operating results from the acquisition have been included in the Company’s Clinical Solutions segment from the date of acquisition.

The following table summarizes the fair values of identified intangible assets and their respective useful lives (dollars in thousands):

 

 

 

Estimated Fair Value

 

 

Estimated Useful Life

Customer relationships

 

$

22,300

 

 

6 years

Acquired backlog

 

 

1,800

 

 

1.25 years

Trade name

 

 

2,700

 

 

6 years

Patient communities

 

 

45,100

 

 

6 years

Acquired technologies

 

 

19,900

 

 

6 years

Total intangible assets

 

$

91,800

 

 

 

 

RxDataScience Acquisition

On October 6, 2021, the Company completed the acquisition of RxDataScience, a specialist organization that helps biopharmaceutical customers solve challenging problems through advanced analytics, data management, and artificial intelligence. The total purchase consideration was $67.5 million (net of cash acquired of $2.4 million). The Company recognized $52.9 million of goodwill and $18.0 million of intangible assets. The remainder of consideration was attributed to other net assets, primarily related to net working capital. Refer to “Note 16 – Related-Party Transactions” for further information.

The purchase price has been allocated to the tangible assets and identifiable intangible assets acquired and liabilities assumed based upon their fair values. The excess of the purchase price over the tangible and intangible assets acquired and liabilities assumed has been recorded as goodwill. Goodwill is attributable to the acquired workforce as well as future synergies and is not deductible for income tax purposes. The operating results from the acquisition have been included in the Company’s Clinical Solutions segment from the date of acquisition.

The Company’s assessments of fair value and the purchase price allocations related to these 2021 acquisitions are preliminary and further adjustments may be necessary as additional information related to the fair values of assets acquired and liabilities assumed is assessed during the measurement period (up to one year from the respective acquisition dates).

114

 

Table of Contents

 

Synteract Acquisition

On December 9, 2020, the Company completed the acquisition of Synteract, effected through the purchase of 100% of the outstanding shares of Synteract for approximately $385.5 million in cash (net of approximately $28.0 million of cash acquired), which included payment of $1.0 million during the first quarter of 2021. Synteract is a contract research organization focused on the emerging biopharmaceutical industry, strengthening the Company’s position in the small to mid-sized (“SMID”) category. The Company recognized $363.7 million of goodwill and $56.4 million of intangible assets, including acquired backlog and trade name, as a result of the acquisition.

Allocation of Consideration Transferred

The following table summarizes the estimated fair value of the net assets acquired at the date of the acquisition:

 

Assets acquired:

 

 

 

 

Cash and cash equivalents

 

$

28,028

 

Accounts receivable and unbilled services

 

 

39,723

 

Prepaid expenses and other current assets

 

 

2,160

 

Property and equipment

 

 

3,978

 

Operating lease right-of-use assets

 

 

10,839

 

Other identifiable intangible assets

 

 

56,400

 

Goodwill

 

 

363,733

 

Other assets

 

 

4,121

 

Total assets acquired

 

 

508,982

 

Liabilities assumed:

 

 

 

 

Accounts payable and accrued expenses

 

 

25,623

 

Deferred revenue

 

 

45,272

 

Operating lease obligations

 

 

15,693

 

Deferred income taxes, net

 

 

7,754

 

Other liabilities

 

 

1,126

 

Total liabilities assumed

 

 

95,468

 

Net assets acquired

 

$

413,514

 

 

The purchase price has been allocated to the tangible assets and identifiable intangible assets acquired and liabilities assumed based upon their fair values. The excess of the purchase price over the tangible and intangible assets acquired and liabilities assumed has been recorded as goodwill. Goodwill is attributable to the acquired workforce as well as future synergies and is not deductible for income tax purposes. The operating results from the acquisition of Synteract have been included in the Company’s Clinical Solutions segment from the date of acquisition.

The following table summarizes the fair value of identified intangible assets and their respective useful lives at the date of the acquisition (dollars in thousands):

 

 

 

Estimated Fair Value

 

 

Estimated Useful Life

Acquired backlog

 

$

37,200

 

 

4 years

Trade name

 

 

19,200

 

 

8 years

Total intangible assets

 

$

56,400

 

 

 

115

 

Table of Contents

 

 

Illingworth Research Group Acquisition

On December 17, 2020, the Company completed the acquisition of Illingworth Research, a leading provider of clinical research home health services, adding new scale and capabilities to the Company’s clinical trial solutions. The total purchase consideration was $80.9 million (net of cash acquired of $1.1 million), which included payments of $9.0 million during the first quarter of 2021. The Company recognized $64.6 million of goodwill and $21.5 million of intangible assets, principally customer relationships, as a result of the acquisition.

The purchase price has been allocated to the tangible assets and identifiable intangible assets acquired and liabilities assumed based upon their fair values. The excess of the purchase price over the tangible and intangible assets acquired and liabilities assumed has been recorded as goodwill. Goodwill is attributable to the acquired workforce as well as future synergies and is not deductible for income tax purposes. The operating results from the acquisition of Illingworth Research have been included in the Company’s Clinical Solutions segment from the date of acquisition.

Pro forma information for these acquisitions is not presented as the operations of the acquired businesses, individually and in the aggregate, are not significant to the overall operations of the Company.

Divestitures

During the second quarter of 2020, the Company sold its contingent staffing business to a related party in exchange for potential future cash consideration not to exceed $4.0 million. Based on the financial results of the business one year after the divestiture date, the Company recognized $1.8 million of contingent consideration in other (income) expense, net in the accompanying statement of income during the second quarter of 2021. Refer to “Note 16 – Related-Party Transactions” for further information.

During the fourth quarter of 2020, the Company sold its medication adherence business for consideration of $23.0 million, including cash consideration of $18.0 million, net of cash transferred, and convertible notes of $5.0 million, resulting in a gain on sale of $7.1 million. The Company received $5.0 million of cash proceeds from the notes receivable during the second quarter of 2021. Based on the performance of the business through 2021, the Company recognized $3.0 million and $3.6 million of contingent consideration for the years ended December 31, 2021 and 2020, respectively. The gain on sale and contingent consideration were recognized in other (income) expense, net in the accompanying consolidated statements of income.

Investments

During the second quarter of 2020, the Company made a non-cash investment of $27.3 million to acquire certain intellectual property rights from a customer in lieu of cash payment for services rendered. The Company subsequently exchanged the intellectual property for an equity method investment in an unconsolidated variable interest entity. The Company provided the entity $3.8 million in cash, in the form of a loan, during the third quarter of 2021. Based on the hypothetical liquidation book value of its investment as of December 31, 2021, the Company recorded a $5.3 million loss to other (income) expense, net in the accompanying statement of income for the year ended December 31, 2021. As of December 31, 2021, the book value of the Company’s investment was $16.2 million and was included in other long-term assets in the accompanying consolidated balance sheet, with a maximum exposure to loss of approximately $20.3 million, which includes the outstanding loan balance and accrued interest.

116

 

Table of Contents

 

4. Long-Term Debt Obligations

The Company’s debt obligations consisted of the following as of December 31 (in thousands):

 

 

 

2021

 

 

2020

 

Secured Debt

 

 

 

 

 

 

 

 

Term Loan A - tranche one due March 2024

 

$

149,195

 

 

$

183,715

 

Term Loan A - tranche two due August 2024

 

 

1,636,797

 

 

 

1,273,991

 

Term Loan B due August 2024

 

 

—

 

 

 

560,564

 

Accounts receivable financing agreement due October 2024

 

 

400,000

 

 

 

300,000

 

Total secured debt

 

 

2,185,992

 

 

 

2,318,270

 

Unsecured Debt

 

 

 

 

 

 

 

 

Senior notes due January 2029 (the “Notes”)

 

 

600,000

 

 

 

600,000

 

Total debt obligations

 

 

2,785,992

 

 

 

2,918,270

 

Less: Term loans original issuance discount

 

 

(2,228

)

 

 

(3,500

)

Less: Unamortized deferred issuance costs

 

 

(8,043

)

 

 

(12,716

)

Total long-term debt

 

$

2,775,721

 

 

$

2,902,054

 

 

Credit Agreement

 

The Company is party to a credit agreement (as amended, the “Credit Agreement”) that included a $1.55 billion Term Loan A facility (“Term Loan A”) that has two tranches, tranche one that matures on March 26, 2024 and tranche two that matures on August 1, 2024, a $1.60 billion Term Loan B facility (“Term Loan B”) that was paid in full during the second quarter of 2021, and a $600.0 million revolving credit facility (the “Revolver”) that matures on August 1, 2024.

On June 30, 2021 (the “Closing Date”), the Company entered into Amendment No. 5 (the “Fifth Amendment”) to the Credit Agreement. The Fifth Amendment modified the Credit Agreement to increase Term Loan A in an aggregate principal amount of $495.0 million (“Incremental Term Loan A”). Incremental Term Loan A was funded on the Closing Date, and the proceeds were used, along with cash on hand, to repay the outstanding Term Loan B in full under the Credit Agreement and to pay fees and expenses in connection with the Fifth Amendment and the incurrence of Incremental Term Loan A. Incremental Term Loan A has the same terms as Term Loan A under the Credit Agreement, and is subject to the same covenants. The Company recorded an additional discount of $0.5 million against the Term Loan A borrowings in connection with the Fifth Amendment, which is being amortized as a component of interest expense using the effective interest method over the term of Term Loan A.

During the year ended December 31, 2021, the Company made $166.8 million and $560.5 million of voluntary prepayments against Term Loan A and Term Loan B, respectively, that were applied to future mandatory principal payments due. As a result of these and previous voluntary prepayments, the Company is not required to make a mandatory payment against the principal balance of Term Loan A until October 2023 and Term Loan B has been paid in full. In connection with these prepayments, the Company recorded a $3.6 million loss on extinguishment of debt during the year ended December 31, 2021.

All obligations under the Credit Agreement are guaranteed by the Company and certain of the Company’s direct and indirect wholly-owned domestic subsidiaries. The obligations under the Credit Agreement are secured by substantially all of the assets of the Company and the guarantors, including 65% of the capital stock of certain controlled foreign subsidiaries.

117

 

Table of Contents

 

The term loans and the Revolver bear interest at a rate per annum equal to the Adjusted Eurocurrency Rate (“Eurocurrency Rate”) plus an applicable margin or an Alternate Base Rate plus an applicable margin. The Company may select among the Adjusted Eurocurrency Rate or the Alternate Base Rate, whichever is lower, except in circumstances where the Company requests a loan with less than a three-day notice. In such cases, the Company must use the Alternate Base Rate. The Adjusted Eurocurrency Rate is equal to the London Inter-bank Offered Rate (“LIBOR”), subject to adjustment for reserve requirements. The Alternate Base Rate is equal to the highest of: (i) the federal funds rate plus 0.50%; (ii) the Adjusted Eurocurrency Rate for an interest period of one month plus 1.00%; (iii) the rate of interest per annum quoted by The Wall Street Journal as the prime rate; and (iv) 0.00%. 

The applicable margins with respect to Alternate Base Rate and Adjusted Eurocurrency Rate borrowings are determined depending on the “First Lien Leverage Ratio” or the “Secured Net Leverage Ratio” (as defined in the Credit Agreement) and range as follows:

 

 

 

Alternate Base Rate

 

Adjusted

Eurocurrency Rate

Term Loan A

 

0.25% - 0.50%

 

1.25% - 1.50%

Term Loan B

 

0.75% - 1.00%

 

1.75% - 2.00%

Revolver

 

0.25% - 0.50%

 

1.25% - 1.50%

In February 2021, as a result of the Company’s First Lien Leverage Ratio (as defined in the Credit Agreement) being less than or equal to 2.5x, the Adjusted Eurocurrency Rate Spread (as defined in the Credit Agreement) on Term Loan A and the Revolver decreased from 1.50% to 1.25%. As of December 31, 2021, the interest rate on the Term Loan A and the Revolver was 1.35%. 

The Company also pays a quarterly commitment fee between 0.25% and 0.375% on the average daily unused balance of the Revolver depending on the “First Lien Leverage Ratio” at the adjustment date.

Revolver and Letters of Credit

The Revolver includes letters of credit (“LOCs”) with a sublimit of $150.0 million. Fees are charged on all outstanding LOCs at an annual rate equal to the margin in effect on Eurocurrency Rate revolving loans plus participation and fronting fees. The fee is payable quarterly in arrears on the last day of each quarter ending April, July, October and January until the underlying LOC expires. As of December 31, 2021, there were no outstanding Revolver borrowings and $14.2 million of LOCs outstanding, leaving $585.8 million of available borrowings under the Revolver, including $135.8 million available for LOCs.

Accounts Receivable Financing Agreement

Under the Company’s accounts receivable financing agreement, certain of the Company’s consolidated subsidiaries sell accounts receivable and unbilled services (including contract assets) balances to a wholly-owned, bankruptcy-remote special purpose entity (“SPE”), which is the borrower under the facility. The facility is without recourse to the Company or any subsidiaries of the Company other than the SPE, other than with respect to limited indemnity obligations of the selling entities and the servicer of the receivables in respect of the character of the receivables sold by them and the performance of the servicing duties.

On January 28, 2021, the Company amended its accounts receivable financing agreement to increase the amount it can borrow from $300.0 million to $365.0 million and drew down the additional $65.0 million to partially fund the Term Loan A and Term Loan B voluntary prepayments. Accordingly, there was no incremental impact on the Company’s total debt.

118

 

Table of Contents

 

On October 13, 2021, the Company further amended its accounts receivable financing agreement to increase the amount it can borrow from $365.0 million to $400.0 million, extended the maturity to October 2024, and drew down the additional $35.0 million. At the same time, the Company paid down $35.0 million on facilities under its Credit Agreement, resulting in no net impact on leverage.

As of December 31, 2021, the Company had $400.0 million of outstanding borrowings under this agreement, which are recorded in long-term debt on the accompanying consolidated balance sheet. There was no remaining borrowing capacity available under this agreement as of December 31, 2021.

This agreement is secured by a lien on certain receivables and other assets, and the Company has guaranteed the performance of the obligations of existing and future subsidiaries that sell and service the accounts receivable under this agreement. The available borrowing capacity varies monthly according to the levels of its eligible accounts receivable and unbilled receivables. Loans under this agreement will accrue interest at a reserve-adjusted LIBOR rate or a base rate equal to the higher of (i) the applicable lender’s prime rate and (ii) the federal funds rate plus 0.50%. As of December 31, 2021, the interest rate on the accounts receivable financing agreement was 1.05%.

The Notes

On November 24, 2020, the Company completed the issuance and sale of the Notes, with an aggregate principal amount of $600.0 million, which bears interest at a rate of 3.625% per annum, payable semi-annually in arrears beginning on July 15, 2021, and matures on January 15, 2029. The Notes were issued pursuant to an indenture (the “Indenture”), which provides, among other things, that the Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, on a senior unsecured basis, by certain of the Company’s subsidiaries.

The Company may redeem some or all of the Notes at any time prior to January 15, 2024 at a redemption price equal to 100% of the aggregate principal amount of the Notes to be redeemed plus a “make-whole” premium and accrued and unpaid interest. In addition, prior to July 15, 2023, the Company may redeem up to 40% of the original principal amount of the Notes with proceeds of certain equity offerings at a redemption price equal to 103.625% of the aggregate principal amount of such Notes plus accrued and unpaid interest. On or after January 15, 2024, the Company may redeem some or all of the Notes at the redemption prices set forth in the Indenture plus accrued and unpaid interest.

The Indenture contains covenants that limit the ability of the Company and its restricted subsidiaries to, among other things, (1) incur additional liens, (2) engage in certain sale and leaseback transactions, and (3) conduct mergers, consolidations, or asset sales. These covenants are subject to exceptions and qualifications set forth in the Indenture.

If the Company sells certain of its assets or experience specific kinds of changes of control, the Company is required to offer to repurchase the Notes at a repurchase price equal to (1) par plus any accrued and unpaid interest in the case of an asset sale or (2) 101% of the aggregate principal amount thereof plus any accrued and unpaid interest in the case of a change of control.

119

 

Table of Contents

 

Maturities of Debt Obligations

As of December 31, 2021, the contractual maturities of the Company’s debt obligations (excluding finance leases that are presented in “Note 5 – Leases”) were as follows (in thousands):

 

2022

 

$

—

 

2023

 

 

21,732

 

2024

 

 

2,164,260

 

2025

 

 

—

 

2026

 

 

—

 

2027 and thereafter

 

 

600,000

 

Less: Term loan original issuance discount

 

 

(2,228

)

Less: Unamortized deferred issuance costs

 

 

(8,043

)

Total

 

$

2,775,721

 

 

5. Leases

The Company’s operating leases are primarily related to its office facilities. The Company’s finance leases are related to vehicles that the Company leases for certain sales representatives in its Commercial Solutions segment. The Company’s leases have remaining lease terms of less than one year to 11 years, some of which include options to extend the term or terminate the lease.

ROU assets and lease liabilities are recognized based on the present value of the fixed lease payments over the lease term at the commencement date. The ROU assets also include any initial direct costs incurred and lease payments made at or before the commencement date, and are reduced by lease incentives. The Company uses its incremental borrowing rate as the discount rate to determine the present value of the lease payments for leases that do not have a readily determinable implicit discount rate. The Company’s incremental borrowing rate is the rate of interest that it would have to borrow on a collateralized basis over a similar term and amount in a similar economic environment. The Company determines the incremental borrowing rates for its leases by adjusting the local risk free interest rate with a credit risk premium corresponding to the Company’s credit rating.

The Company records rent expense for its operating leases on a straight-line basis from the lease commencement date until the end of the lease term. The Company records finance lease cost as a combination of the amortization expense for the ROU assets and interest expense for the outstanding lease liabilities using the discount rate discussed above. Variable lease payments for operating leases are related to office facilities and include but are not limited to common area maintenance, parking, electricity, and management fees. The variable lease payments for finance leases are related to maintenance programs for leased vehicles. Variable lease payments are based on occurrence or based on usage; therefore, they are not included as part of the initial calculations of the ROU assets and liabilities.

120

 

Table of Contents

 

The components of lease cost were as follows for the year ended December 31 and the line items on the accompanying consolidated statements of income to which they were recorded were as follows (in thousands):

 

 

 

Statement of Income Classification

 

2021

 

 

2020

 

Operating leases:

 

 

 

 

 

 

 

 

 

 

Fixed lease costs

 

Direct costs, selling, general, and administrative expenses and restructuring and other costs

 

$

55,168

 

 

$

53,531

 

Short-term lease costs

 

Direct costs and selling, general, and administrative expenses

 

 

1,994

 

 

 

2,930

 

Variable lease costs

 

Direct costs, selling, general, and administrative expenses and restructuring and other costs

 

 

36,760

 

 

 

29,572

 

Total operating lease costs

 

 

 

$

93,922

 

 

$

86,033

 

Finance leases:

 

 

 

 

 

 

 

 

 

 

Amortization of right-of-use assets

 

Depreciation

 

$

17,453

 

 

$

15,843

 

Interest on lease liabilities

 

Interest expense

 

 

605

 

 

 

944

 

Variable lease costs

 

Direct costs

 

 

6,231

 

 

 

6,321

 

Total finance lease costs

 

 

 

$

24,289

 

 

$

23,108

 

 

Supplemental balance sheet information related to finance leases was as follows as of December 31 (in thousands):

 

 

2021

 

 

2020

 

Property and equipment, gross

 

$

77,674

 

 

$

63,985

 

Accumulated depreciation

 

 

(30,021

)

 

 

(20,479

)

Property and equipment, net

 

$

47,653

 

 

$

43,506

 

 

 

 

 

 

 

 

 

 

Current portion of finance lease obligations

 

$

20,627

 

 

$

17,455

 

Finance lease long-term obligations

 

 

34,181

 

 

 

31,522

 

Total finance lease liabilities

 

$

54,808

 

 

$

48,977

 

Supplemental cash flow information related to leases was as follows for the year ended December 31 (in thousands):

 

 

2021

 

 

2020

 

Cash paid for amounts included in the measurement of lease liabilities:

 

 

 

 

 

 

 

 

Operating cash flows for operating leases

 

$

(59,863

)

 

$

(60,361

)

Operating cash flows for finance leases

 

 

(605

)

 

 

(944

)

Financing cash flows for finance leases

 

 

(15,774

)

 

 

(16,434

)

 

 

 

 

 

 

 

 

 

Right-of-use assets obtained in exchange for lease obligations:

 

 

 

 

 

 

 

 

Operating leases

 

$

43,385

 

 

$

47,415

 

Finance leases

 

 

28,994

 

 

 

20,203

 

 

 

 

 

 

 

 

 

 

Lease obligations closed out in exchange for right-of-use assets:

 

 

 

 

 

 

 

 

Operating leases

 

$

(10,122

)

 

$

(2,834

)

 

Weighted average remaining lease term as of December 31:

 

2021

 

2020

Operating leases

 

6 years

 

7 years

Finance leases

 

3 years

 

3 years

121

 

Table of Contents

 

 

 

Weighted average discount rate as of December 31:

 

2021

 

 

2020

 

Operating leases

 

 

4.7

%

 

 

4.8

%

Finance leases

 

 

1.1

%

 

 

1.3

%

As of December 31, 2021, maturities of lease liabilities were as follows (in thousands):

 

 

 

Operating Leases

 

 

Finance Leases

 

 

Total

 

2022

 

$

53,612

 

 

$

21,443

 

 

$

75,055

 

2023

 

 

53,033

 

 

 

17,768

 

 

 

70,801

 

2024

 

 

44,428

 

 

 

11,624

 

 

 

56,052

 

2025

 

 

38,036

 

 

 

5,688

 

 

 

43,724

 

2026

 

 

29,128

 

 

 

130

 

 

 

29,258

 

2027 and thereafter

 

 

73,262

 

 

 

—

 

 

 

73,262

 

Total lease payments

 

 

291,499

 

 

 

56,653

 

 

$

348,152

 

Less: Management fee

 

 

—

 

 

 

(762

)

 

 

 

 

Less: Imputed interest

 

 

(42,643

)

 

 

(1,083

)

 

 

 

 

Total lease liabilities

 

$

248,856

 

 

$

54,808

 

 

 

 

 

 

6. Derivatives

Interest Rate Swaps

The Company has entered into various interest rate swaps to mitigate its exposure to changes in interest rates on its term loan. In June 2018, the Company entered into an interest rate swap with multiple counterparties that had an initial aggregate notional value of $1.01 billion, an effective date of December 31, 2018, and expired on June 30, 2021.

In March 2020, the Company entered into interest rate swaps with multiple counterparties. The interest rate swaps had an initial aggregate notional value of $549.2 million that increased to $1.42 billion on June 30, 2021, an effective date of March 31, 2020, and will expire on March 31, 2023. As of December 31, 2021, the notional value of this interest rate swap was $1.16 billion.

The significant terms of these derivatives are substantially the same as those contained within the Credit Agreement, including monthly settlements with the swap counterparties. Interest rate swaps are designated as hedging instruments. The amounts of hedge ineffectiveness recorded in net income during the years ended December 31, 2021, 2020, and 2019 were insignificant.

Foreign Exchange Forward

On October 30, 2020, the Company entered into a foreign exchange forward in order to minimize monthly foreign currency remeasurement gains or losses on non-functional currency monetary balances. The foreign exchange forward notional value may be adjusted each month as the exposure balance changes. The Company did not designate the derivative as a hedge. All changes in the fair value of the foreign exchange forward are recorded in earnings every month to other (income) expense, net in the accompanying consolidated statements of income. The Company recognized $0.7 million of realized losses and $1.5 million of realized gains during the years ended December 31, 2021 and 2020, respectively, related to this foreign exchange forward. As of December 31, 2021, the notional value of this foreign exchange forward was $70.0 million.

122

 

Table of Contents

 

Fair Values

The fair values of the Company’s derivative financial instruments as of December 31 and the line items on the accompanying consolidated balance sheets to which they were recorded were as follows (in thousands):

 

 

Balance Sheet Classification

 

2021

 

 

2020

 

Interest rate swaps - non-current

 

Other long-term assets

 

$

948

 

 

$

—

 

Fair value of derivative assets

 

 

 

$

948

 

 

$

—

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps - current

 

Accrued expenses

 

$

1,827

 

 

$

17,045

 

Interest rate swaps - non-current

 

Other long-term liabilities

 

 

—

 

 

 

5,572

 

Fair value of derivative liabilities

 

 

 

$

1,827

 

 

$

22,617

 

 

7. Fair Value Measurements

Assets and Liabilities Carried at Fair Value

As of December 31, 2021 and 2020, the Company’s financial assets and liabilities carried at fair value included cash and cash equivalents, restricted cash, trading securities, accounts receivable, unbilled services (including contract assets), accounts payable, accrued expenses, deferred revenue, contingent obligations, liabilities under the accounts receivable financing agreement, and derivative instruments.

The fair values of cash and cash equivalents, restricted cash, accounts receivable, unbilled services (including contract assets), accounts payable, accrued expenses, deferred revenue, and the liabilities under the accounts receivable financing agreement approximate their respective carrying amounts because of the liquidity and short-term nature of these financial instruments.

Financial Instruments Subject to Recurring Fair Value Measurements

As of December 31, 2021, the fair values of the major classes of the Company’s assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Investments

Measured

at Net Asset

Value

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trading securities (a)

 

$

24,775

 

 

$

—

 

 

$

—

 

 

$

—

 

 

$

24,775

 

Partnership interest (b)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

11,176

 

 

 

11,176

 

Derivative instruments (c)

 

 

—

 

 

 

948

 

 

 

—

 

 

 

—

 

 

 

948

 

Total assets

 

$

24,775

 

 

$

948

 

 

$

—

 

 

$

11,176

 

 

$

36,899

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative instruments (c)

 

$

—

 

 

$

1,827

 

 

$

—

 

 

$

—

 

 

$

1,827

 

Contingent obligations related to acquisitions (d)

 

 

—

 

 

 

—

 

 

 

17,997

 

 

 

—

 

 

 

17,997

 

Total liabilities

 

$

—

 

 

$

1,827

 

 

$

17,997

 

 

$

—

 

 

$

19,824

 

 

123

 

Table of Contents

 

 

As of December 31, 2020, the fair value of the major classes of the Company’s assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Investments

Measured

at Net Asset

Value

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trading securities (a)

 

$

22,950

 

 

$

—

 

 

$

—

 

 

$

—

 

 

$

22,950

 

Partnership interest (b)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

8,665

 

 

 

8,665

 

Total assets

 

$

22,950

 

 

$

—

 

 

$

—

 

 

$

8,665

 

 

$

31,615

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative instruments (c)

 

$

—

 

 

$

22,617

 

 

$

—

 

 

$

—

 

 

$

22,617

 

Contingent obligations related to acquisitions (d)

 

 

—

 

 

 

—

 

 

 

6,793

 

 

 

—

 

 

 

6,793

 

Total liabilities

 

$

—

 

 

$

22,617

 

 

$

6,793

 

 

$

—

 

 

$

29,410

 

 

(a) Represents the fair value of investments in mutual funds based on quoted market prices that are used to fund the liability associated with the Company’s deferred compensation plan.

(b) The Company has committed to invest $21.5 million as a limited partner in two private equity funds. The private equity funds invest in opportunities in the healthcare and life sciences industry. As of December 31, 2021, the Company’s remaining unfunded commitment in the private equity funds was $12.8 million. The Company holds minor ownership interests (less than 3%) in each of the private equity funds and has determined that it does not exercise significant influence over the private equity funds’ operating or finance activities. As the private equity funds do not have readily determinable fair values, the Company has estimated the fair values using each fund’s Net Asset Value, the amount by which the value of all assets exceeds all debt and liabilities, in accordance with ASC Topic 946, Financial Services – Investment Companies.

(c) Represents the fair value of interest rate swap arrangements (see “Note 6 – Derivatives” for further information).

(d) Represents the fair value of contingent consideration obligations related to acquisitions. The fair values of these liabilities are determined based on the Company’s best estimate of the probable timing and amount of settlement.

The following table presents a reconciliation of changes in the carrying amount of contingent obligations classified as Level 3 for the years ended December 31, 2021 and 2020 (in thousands):

 

Balance as of December 31, 2019

 

$

37,324

 

Additions

 

 

—

 

Changes in fair value recognized in earnings (a)

 

 

(3,897

)

Payments

 

 

(26,634

)

Balance as of December 31, 2020

 

 

6,793

 

Additions (b)

 

 

19,158

 

Changes in fair value recognized in earnings

 

 

(757

)

Payments (c)

 

 

(7,197

)

Balance as of December 31, 2021

 

$

17,997

 

 

(a) The change in fair value recognized in earnings for the year ended December 31, 2020 is primarily due to a decrease in the estimate of the contingent consideration associated with the acquisition of Kinapse (see “Note 17 – Commitments and Contingencies” for further information).

(b) Represents obligations in connection with the acquisition of RxDataScience and insignificant acquisitions completed during 2021.

124

 

Table of Contents

 

(c) The Company made payments to fully settle the contingent tax-sharing obligation arising from inVentiv Health, Inc.’s 2016 merger with Double Eagle Parent, Inc. (see “Note 17 – Commitments and Contingencies” for further information) during the first quarter of 2021 and obligations in connection with the insignificant acquisition completed during the second quarter of 2021.

During the years ended December 31, 2021 and 2020, there were no transfers of assets or liabilities between Level 1, Level 2, or Level 3 fair value measurements.

Financial Instruments Subject to Non-Recurring Fair Value Measurements

Certain assets, including goodwill and identifiable intangible assets, are carried on the accompanying consolidated balance sheets at cost and, subsequent to initial recognition, are measured at fair value on a non-recurring basis when certain identified events or changes in circumstances that may have a significant adverse effect on the carrying values of these assets occur. These assets are classified as Level 3 fair value measurements within the fair value hierarchy. Goodwill is tested for impairment annually or more frequently if events or changes in circumstances indicate a triggering event has occurred. Intangible assets are tested for impairment upon the occurrence of certain triggering events. As of December 31, 2021 and 2020, assets carried on the consolidated balance sheets and not remeasured to fair value on a recurring basis totaled $5.83 billion and $5.71 billion, respectively.

Fair Value Disclosures for Financial Instruments Not Carried at Fair Value

The estimated fair values of the term loans and the Notes are determined based on the price that the Company would have had to pay to settle the liabilities. As these liabilities are not actively traded, they are classified as Level 2 fair value measurements. The estimated fair values of the Company’s term loans and the Notes were as follows (in thousands):

 

 

 

December 31, 2021

 

 

December 31, 2020

 

 

 

Carrying

Value (a)

 

 

Estimated

Fair Value

 

 

Carrying

Value (a)

 

 

Estimated

Fair Value

 

Term Loan A - tranche one due March 2024

 

$

149,008

 

 

$

148,945

 

 

$

183,320

 

 

$

183,026

 

Term Loan A - tranche two due August 2024

 

 

1,634,756

 

 

 

1,635,138

 

 

 

1,271,255

 

 

 

1,269,213

 

Term Loan B due August 2024

 

 

—

 

 

 

—

 

 

 

560,194

 

 

 

560,144

 

Senior notes due January 2029

 

 

600,000

 

 

 

595,500

 

 

 

600,000

 

 

 

602,412

 

 

(a) The carrying value of the term loan debt is shown net of original issue discounts.

8. Restructuring and Other Costs

During the year ended December 31, 2021, the Company incurred employee severance and benefit costs, facility and lease termination costs, and other costs related to its restructuring activities. These costs were primarily related to the Company’s ForwardBound margin enhancement initiative. The costs incurred during the year ended December 31, 2020 were primarily related to the Company’s cost management strategies in response to the COVID-19 pandemic as well as the Company’s ForwardBound initiative.

Restructuring and other costs consisted of the following (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Employee severance and benefit costs

 

$

14,526

 

 

$

26,321

 

 

$

25,243

 

Facility and lease termination costs

 

 

8,226

 

 

 

2,313

 

 

 

16,202

 

Other costs

 

 

64

 

 

 

780

 

 

 

690

 

Total restructuring and other costs

 

$

22,816

 

 

$

29,414

 

 

$

42,135

 

125

 

Table of Contents

 

 

The Company expects to continue to incur costs related to restructuring of its operations in order to achieve cost savings and the targeted synergies related to its acquisitions. However, the timing and the amount of these costs depends on various factors, including, but not limited to, identifying and realizing synergy opportunities and executing the integration of its combined operations. The Company may also continue to incur additional restructuring and other costs during and beyond 2022 related to its ForwardBound margin enhancement initiative.

Accrued Restructuring Liabilities

The following table summarizes activity related to the liabilities associated with restructuring and other costs (in thousands):

 

 

 

Employee

Severance Costs

 

 

Other Costs

 

 

Total

 

Balance as of December 31, 2019

 

$

5,728

 

 

$

22

 

 

$

5,750

 

Expenses incurred (a)

 

 

26,321

 

 

 

791

 

 

 

27,112

 

Payments

 

 

(26,219

)

 

 

(813

)

 

 

(27,032

)

Balance as of December 31, 2020

 

 

5,830

 

 

 

—

 

 

 

5,830

 

Expenses incurred (a)

 

 

14,574

 

 

 

17

 

 

 

14,591

 

Payments

 

 

(13,747

)

 

 

(17

)

 

 

(13,764

)

Balance as of December 31, 2021

 

$

6,657

 

 

$

—

 

 

$

6,657

 

 

(a) There were no non-cash restructuring and other expenses incurred for the years ended December 31, 2021 and 2020. The amount of expenses incurred for the years ended December 31, 2021 and 2020 excludes $8.2 million and $2.3 million, respectively, of facility lease closure and lease termination costs that are reflected as a reduction of operating lease right-of-use assets on the accompanying consolidated balance sheets under ASC 842.

The Company expects the employee severance costs accrued as of December 31, 2021 will be paid within the next twelve months. Liabilities associated with restructuring and other costs are included in accrued expenses and other long-term liabilities on the accompanying consolidated balance sheets.

9. Shareholders’ Equity

Shares Outstanding

Shares of common stock outstanding were as follows (in thousands):

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Common stock shares, beginning balance

 

 

103,935

 

 

 

103,866

 

 

 

103,372

 

Repurchases of common stock

 

 

(1,500

)

 

 

(1,256

)

 

 

(1,323

)

Issuances of common stock

 

 

1,329

 

 

 

1,325

 

 

 

1,817

 

Common stock shares, ending balance

 

 

103,764

 

 

 

103,935

 

 

 

103,866

 

Stock Repurchase Programs

On February 26, 2018, the Company’s Board of Directors (the “Board”) authorized the repurchase of up to an aggregate of $250.0 million of the Company’s common stock to be executed from time to time in open market transactions effected through a broker at prevailing market prices, in block trades or through privately negotiated transactions through December 31, 2019 (the “2018 Stock Repurchase Program”). On December 5, 2019, the Board increased the dollar amount authorized under the 2018 Stock Repurchase Program to up to an aggregate of $300.0 million and extended the term of the 2018 Stock Repurchase Program to December 31, 2020. The 2018 Stock Repurchase Program expired on December 31, 2020.

126

 

Table of Contents

 

On November 17, 2020, the Company’s Board authorized the repurchase of up to an aggregate of $300.0 million of the Company’s Class A common stock, par value $0.01 per share, to be executed from time to time in open market transactions effected through a broker at prevailing market prices, in block trades, or through privately negotiated transactions through December 31, 2022 (the “2021 Stock Repurchase Program”). The 2021 Stock Repurchase Program took effect on January 1, 2021.

The 2021 Stock Repurchase Program does not obligate the Company to repurchase any particular amount of the Company’s common stock, and may be modified, extended, suspended, or discontinued at any time. The timing and amount of repurchases are determined by the Company’s management based on a variety of factors such as the market price of the Company’s common stock, the Company’s corporate cash requirements, and overall market conditions. The 2021 Stock Repurchase Program is subject to applicable legal requirements, including federal and state securities laws and applicable Nasdaq rules. The Company may also repurchase shares of its common stock pursuant to a trading plan meeting the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, which would permit shares of the Company’s common stock to be repurchased when the Company might otherwise be precluded from doing so by law.

During the year ended December 31, 2021, the Company repurchased 1,500,000 shares of its common stock in private transactions under the 2021 Stock Repurchase Program, for a total purchase price of approximately $117.5 million.

The following table sets forth repurchase activity under the Company’s stock repurchase programs from inception through December 31, 2021:

 

 

Total number of

shares purchased

 

 

Average price

paid per share

 

 

Approximate dollar

value of shares

purchased

(in thousands)

 

March 2018

 

 

948,100

 

 

$

39.55

 

 

$

37,493

 

April 2018

 

 

1,024,400

 

 

 

36.60

 

 

 

37,492

 

January 2019

 

 

552,100

 

 

 

39.16

 

 

 

21,623

 

February 2019

 

 

120,600

 

 

 

41.40

 

 

 

4,993

 

June 2019

 

 

509,100

 

 

 

45.29

 

 

 

23,055

 

August 2019

 

 

141,100

 

 

 

49.93

 

 

 

7,045

 

March 2020

 

 

600,000

 

 

 

53.38

 

 

 

32,029

 

September 2020

 

 

506,244

 

 

 

59.26

 

 

 

30,000

 

October 2020

 

 

150,000

 

 

 

54.14

 

 

 

8,122

 

March 2021

 

 

600,000

 

 

 

74.18

 

 

 

44,505

 

May 2021

 

 

400,000

 

 

 

81.04

 

 

 

32,416

 

June 2021

 

 

500,000

 

 

 

81.20

 

 

 

40,600

 

Total

 

 

6,051,644

 

 

 

 

 

 

$

319,373

 

 

The Company immediately retired all of the repurchased common stock and charged the par value of the shares to common stock. The excess of the repurchase price over the par value was applied on a pro rata basis against additional paid-in capital, with the remainder applied to accumulated deficit.

 

As of December 31, 2021, the Company had remaining authorization to repurchase up to approximately $182.5 million of shares of its common stock under the 2021 Stock Repurchase Program.

127

 

Table of Contents

 

The following is a summary of the Company’s authorized, issued, and outstanding shares as of December 31:

 

 

2021

 

 

2020

 

Shares Authorized:

 

 

 

 

 

 

 

 

Class A common stock

 

 

300,000,000

 

 

 

300,000,000

 

Class B common stock

 

 

300,000,000

 

 

 

300,000,000

 

Preferred stock

 

 

30,000,000

 

 

 

30,000,000

 

Total shares authorized

 

 

630,000,000

 

 

 

630,000,000

 

Shares Issued and Outstanding:

 

 

 

 

 

 

 

 

Class A common stock

 

 

103,763,635

 

 

 

103,934,738

 

Class B common stock

 

 

—

 

 

 

—

 

Preferred stock

 

 

—

 

 

 

—

 

Total shares issued and outstanding

 

 

103,763,635

 

 

 

103,934,738

 

Voting Rights and Conversion Rights of Common Stock

Each share of Class A common stock is entitled to one vote on all matters to be voted on by the shareholders of the Company, including the election of directors. Each share of Class B common stock is entitled to one vote on all matters to be voted on by the shareholders of the Company, except for the right to vote in the election of directors. Additionally, each share of Class B common stock is convertible (on a one-for-one basis) into Class A common stock at any time at the election of the holder.

Dividend Rights and Preferences of Common Stock

The holders of Class A and Class B common stock are entitled to dividends on a pro rata basis at such time and in such amounts as declared by the Board. There were no dividends paid during the years ended December 31, 2021, 2020, or 2019.

Liquidation Rights and Preferences of Common Stock

The holders of Class A and Class B common stock are entitled to participate on a pro rata basis in all distributions made in connection with a voluntary or involuntary liquidation, dissolution, or winding up of the affairs of the Company.

10. Earnings Per Share

The following table provides a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations (in thousands, except per share data):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

234,831

 

 

$

192,787

 

 

$

131,258

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Basic weighted average common shares outstanding

 

 

103,872

 

 

 

104,168

 

 

 

103,618

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

Stock options and other awards under deferred share-based compensation programs

 

 

1,193

 

 

 

1,297

 

 

 

1,387

 

Diluted weighted average common shares outstanding

 

 

105,065

 

 

 

105,465

 

 

 

105,005

 

Earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

2.26

 

 

$

1.85

 

 

$

1.27

 

Diluted

 

$

2.24

 

 

$

1.83

 

 

$

1.25

 

 

128

 

Table of Contents

 

 

Potential common shares outstanding that are considered anti-dilutive are excluded from the computation of diluted earnings per share. Potential common shares related to stock options and other awards under share-based compensation programs may be determined to be anti-dilutive based on the application of the treasury stock method. Potential common shares are also anti-dilutive in periods when the Company incurs a net loss.

The number of potential shares outstanding that were anti-dilutive and therefore excluded from the computation of diluted earnings per share, weighted for the portion of the period they were outstanding, were 145,342, 582,760, and 277,128 for the years ended December 31, 2021, 2020, and 2019, respectively.

11. Income Taxes

The components of income before provision for income taxes were as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Domestic

 

$

186,445

 

 

$

122,659

 

 

$

(17,066

)

Foreign

 

 

128,715

 

 

 

80,999

 

 

 

118,775

 

Income before provision for income taxes

 

$

315,160

 

 

$

203,658

 

 

$

101,709

 

The components of income tax expense (benefit) were as follows (in thousands):

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Federal income taxes:

 

 

 

 

 

 

 

 

 

 

 

 

Current

 

$

926

 

 

$

(15,537

)

 

$

(13,952

)

Deferred

 

 

45,819

 

 

 

10,188

 

 

 

(11,693

)

Foreign income taxes:

 

 

 

 

 

 

 

 

 

 

 

 

Current

 

 

27,718

 

 

 

16,019

 

 

 

21,452

 

Deferred

 

 

(4,309

)

 

 

(3,106

)

 

 

(2,206

)

State income taxes:

 

 

 

 

 

 

 

 

 

 

 

 

Current

 

 

5,163

 

 

 

14,229

 

 

 

2,850

 

Deferred

 

 

5,012

 

 

 

(10,922

)

 

 

(26,000

)

Income tax expense (benefit)

 

$

80,329

 

 

$

10,871

 

 

$

(29,549

)

 

Foreign Earnings

The Company has approximately $689.7 million of undistributed foreign earnings, of which approximately $278.4 million will remain indefinitely reinvested in the foreign jurisdictions. These earnings are expected to be used to support the growth and working capital needs of the Company’s foreign subsidiaries. It is impracticable to determine the total amount of unrecognized deferred taxes with respect to these indefinitely reinvested earnings. The remaining $411.3 million of undistributed foreign earnings are not considered indefinitely reinvested, and the Company has provided a $7.8 million deferred tax liability, primarily related to the estimated withholding tax and state taxes that would be due upon repatriation.

BEAT

The Company’s base eroding payments do not exceed the three percent threshold of its deductible payments in 2021; therefore, the Company has not recorded any base erosion and anti-abuse minimum tax (“BEAT”) liability for the years ended December 31, 2021 and December 31, 2020.

129

 

Table of Contents

 

Actual income tax expense differed from the amount computed by applying the U.S. federal tax rate of 21% to pre-tax income as a result of the following (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Expected income tax expense at statutory rate

 

$

66,184

 

 

$

42,768

 

 

$

21,359

 

Change in income tax expense resulting from:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign income inclusion

 

 

11,019

 

 

 

6,013

 

 

 

39,557

 

Foreign earnings not indefinitely reinvested

 

 

278

 

 

 

5,071

 

 

 

—

 

Foreign tax credits

 

 

(4,390

)

 

 

—

 

 

 

—

 

Changes in income tax valuation allowance (all jurisdictions)

 

 

(1,462

)

 

 

14,503

 

 

 

(68,537

)

Change in fair value of contingent obligations

 

 

(122

)

 

 

(769

)

 

 

3,625

 

Share-based compensation

 

 

(5,662

)

 

 

(2,800

)

 

 

1,094

 

Research and general business tax credits (a)

 

 

(8,902

)

 

 

(12,872

)

 

 

(1,871

)

State and local taxes, net of federal benefit

 

 

11,978

 

 

 

6,924

 

 

 

(9,085

)

Capital loss carryforward (b)

 

 

(214

)

 

 

(16,506

)

 

 

—

 

Foreign rate differential

 

 

2,865

 

 

 

(1,777

)

 

 

(3,595

)

Changes in reserve for uncertain tax positions including interest

 

 

4,721

 

 

 

(18,839

)

 

 

5,393

 

Provision to tax return and other deferred tax adjustments

 

 

(771

)

 

 

(12,325

)

 

 

(6,950

)

Gain on sale of business

 

 

—

 

 

 

(2,350

)

 

 

—

 

Base erosion and anti-abuse tax

 

 

—

 

 

 

—

 

 

 

(15,054

)

Nondeductible executive compensation

 

 

1,649

 

 

 

367

 

 

 

1,802

 

Other, net

 

 

3,158

 

 

 

3,463

 

 

 

2,713

 

Income tax expense (benefit)

 

$

80,329

 

 

$

10,871

 

 

$

(29,549

)

 

(a) Year ended December 31, 2021 included a $0.8 million valuation allowance release and year ended December 31, 2020 was offset by a $9.4 million valuation allowance.

(b) Years ended December 31, 2021 and 2020 are offset by $0.2 million and $16.5 million, respectively, in valuation allowances.

The changes in the valuation allowance for deferred tax assets were as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Balance at the beginning of the period

 

$

100,310

 

 

$

84,159

 

 

$

150,316

 

Deferred tax assets assumed through acquisitions

 

 

—

 

 

 

479

 

 

 

—

 

Deferred tax assets released through divestitures

 

 

—

 

 

 

(271

)

 

 

—

 

(Credited) charged to income tax expense

 

 

(1,462

)

 

 

14,503

 

 

 

(68,537

)

Charged to equity

 

 

—

 

 

 

—

 

 

 

42

 

Foreign currency exchange

 

 

(407

)

 

 

1,440

 

 

 

2,338

 

Other adjustments

 

 

(479

)

 

 

—

 

 

 

—

 

Balance at the end of the period

 

$

97,962

 

 

$

100,310

 

 

$

84,159

 

 

As of December 31, 2021, the valuation allowance decreased by $2.3 million, resulting primarily from a net decrease of $1.5 million primarily due to releasing a domestic valuation allowance related to state deferred tax assets.

 

As of December 31, 2020, the valuation allowance increased by $16.2 million, resulting from a net increase of $14.5 million primarily due to recording a federal U.S. valuation allowance related to capital loss carryforwards as well as recording a valuation allowance related to foreign research and development credits, partially offset by the release of a valuation allowance on U.S. state deferred tax assets and an increase of $1.4 million for changes related to foreign currency exchange.

130

 

Table of Contents

 

The income tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities are as follows as of December 31 (in thousands):

 

 

 

2021

 

 

2020

 

Deferred tax assets:

 

 

 

 

 

 

 

 

Net operating losses

 

$

134,143

 

 

$

122,018

 

Tax credits

 

 

58,901

 

 

 

58,603

 

Deferred revenue

 

 

—

 

 

 

77,138

 

Employee compensation and other benefits

 

 

28,538

 

 

 

29,048

 

Allowance for doubtful accounts

 

 

1,787

 

 

 

1,739

 

Lease obligations

 

 

57,749

 

 

 

57,142

 

Accrued expenses

 

 

13,158

 

 

 

6,526

 

Prepaid royalty

 

 

—

 

 

 

3,451

 

Capital loss carryforward

 

 

20,021

 

 

 

20,157

 

Interest limitation carryforwards

 

 

30,847

 

 

 

20,219

 

Other

 

 

1,151

 

 

 

7,913

 

Total deferred tax assets

 

 

346,295

 

 

 

403,954

 

Less: valuation allowance

 

 

(97,962

)

 

 

(100,310

)

Net deferred tax assets

 

 

248,333

 

 

 

303,644

 

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Undistributed foreign earnings

 

 

(7,778

)

 

 

(10,912

)

Right of use asset

 

 

(47,532

)

 

 

(49,316

)

Depreciation and amortization

 

 

(214,636

)

 

 

(226,170

)

Deferred revenue

 

 

(17,247

)

 

 

—

 

Other

 

 

(3,814

)

 

 

(2,404

)

Total deferred tax liabilities

 

 

(291,007

)

 

 

(288,802

)

Net deferred tax assets

 

$

(42,674

)

 

$

14,842

 

 

As of December 31, 2021 and 2020, the Company had U.S. federal net operating loss (“NOL”) carryforwards of approximately $317.4 million and $260.6 million, respectively. These carryforwards begin to expire in 2029, but the Company anticipates utilizing such carryforwards prior to their expirations.

As of December 31, 2021 and 2020, the Company had state NOL carryforwards of approximately $840.4 million and $821.0 million, respectively, a portion of which expire annually. The Company also had foreign NOL carryforwards of $98.9 million and $80.1 million as of December 31, 2021 and 2020, respectively. The majority of these carryforwards have indefinite carryforward periods, but valuation allowances have been established for jurisdictions where the future benefits of the NOL carryforwards are not more likely than not to be realized.

As of December 31, 2021 and 2020, the Company had Canadian research and development credit carryforwards of $56.1 million and $56.7 million, respectively. These credit carryforwards have an indefinite life, but for the years ended December 31, 2021 and 2020, valuation allowances of $56.1 million and $56.7 million, respectively, have been established against these tax credits where the future benefits of the credits are not more likely than not to be realized.

The Company’s gross unrecognized tax benefits, exclusive of associated interest and penalties, were $12.1 million and $9.0 million as of December 31, 2021 and 2020, respectively. The increase of $3.1 million was primarily due to increase in positions relating to prior years in foreign jurisdictions partially offset with the settlement of unrecognized tax benefits in the U.S. The Company recognizes accrued interest and penalties related to uncertain tax positions in income tax expense in the accompanying consolidated statements of income. As of December 31, 2021 and 2020, the Company had accrued interest and penalties related to uncertain tax positions of $2.4 million and $2.8 million, respectively.

131

 

Table of Contents

 

The Company believes it is reasonably possible that its unrecognized tax benefits may decrease by approximately $1.6 million within the next 12 months as a result of lapses in statutes of limitations. A reconciliation of the beginning and ending balances of unrecognized tax benefits, excluding accrued interest and penalties, is as follows (in thousands):

 

Unrecognized tax benefits balance as of December 31, 2018

 

$

19,245

 

Increases for tax positions in the current year

 

 

2,222

 

Increases for tax positions of prior years

 

 

2,255

 

Decreases for tax positions in prior year

 

 

(440

)

Impact of foreign currency translation

 

 

(44

)

Unrecognized tax benefits balance as of December 31, 2019

 

 

23,238

 

Increases for tax positions in the current year

 

 

254

 

Increases for tax positions of prior years

 

 

3,237

 

Decreases for tax positions in prior year

 

 

(2,540

)

Impact of foreign currency translation

 

 

132

 

Lapse of statute limitations

 

 

(15,288

)

Unrecognized tax benefits balance as of December 31, 2020

 

 

9,033

 

Increases for tax positions in the current year

 

 

386

 

Increases for tax positions of prior years

 

 

4,233

 

Settlements with tax authorities

 

 

(1,131

)

Impact of foreign currency translation

 

 

(169

)

Lapse of statute limitations

 

 

(234

)

Unrecognized tax benefits balance as of December 31, 2021

 

$

12,118

 

 

Due to the geographic breadth of the Company’s operations, numerous tax audits may be ongoing throughout the world at any point in time. Income tax liabilities are recorded based on estimates of additional income taxes which will be due upon the conclusion of these audits. Estimates of these income tax liabilities are made based upon prior experience and are updated in light of changes in facts and circumstances. However, due to the uncertain and complex application of tax regulations, it is possible that the ultimate resolution of audits may result in liabilities which could be materially different from these estimates. In such an event, the Company will record additional income tax expense or benefit in the period in which such resolution occurs.

The Company is not currently under any U.S. federal income tax audits, however, income tax returns are under examination by tax authorities in several state and foreign jurisdictions. The Company’s federal and state tax filings are open to investigations in numerous years due to NOL carryforwards. Additionally, the Company currently has an ongoing examination for tax years 2017 to 2019 in the United Kingdom. The United Kingdom is the jurisdiction with the Company’s largest foreign operations. The Company believes that its reserve for uncertain tax positions is adequate to cover existing risks or exposures related to all open tax years and jurisdictions.

12. Revenue from Contracts with Customers

Unsatisfied Performance Obligations

As of December 31, 2021, the total aggregate transaction price allocated to the unsatisfied performance obligations under contracts with contract terms greater than one year and that are not accounted for as a series pursuant to ASC 606 was $6.70 billion. This amount includes revenue associated with reimbursable out-of-pocket expenses. The Company expects to recognize revenue over the remaining contract term of the individual projects, with contract terms generally ranging from one to five years. The amount of unsatisfied performance obligations is presented net of any constraints and, as a result, is lower than the potential contractual revenue. The contracts excluded due to constraints include contracts that do not commence within a certain period of time or that require the Company to undertake numerous activities to fulfill these performance obligations, including various activities that are outside of the Company’s control.

132

 

Table of Contents

 

Timing of Billing and Performance

During the year ended December 31, 2021, the Company recognized approximately $611.9 million of revenue that was included in the deferred revenue balance at the beginning of the year. During the year ended December 31, 2021, approximately $120.9 million of the Company’s revenue recognized was allocated to performance obligations partially satisfied in previous periods, substantially all of which was associated with changes in scope or price for full-service clinical studies. The Company reviews its portfolio level risk and inflation factors during the third quarter of each year. Based on this review, the Company modified the application of its portfolio level inflation factor, which was considered a change in estimate, and recognized additional revenue of $23.5 million related to this change during the third quarter of 2021. As a result of changing service delivery trends in connection with the COVID-19 pandemic and adoption of decentralized trial methodologies, the Company implemented a comprehensive approach during the fourth quarter of 2021 related to anticipated reductions in reimbursable out-of-pocket expenses, which was considered a change in estimate, and recognized additional net revenue of $44.0 million during the period. This amount related to anticipated changes in reimbursable out-of-pocket expenses, inclusive of both the revised approach as well as updates to project estimates made in the normal course of business. The additional revenue related to these changes in estimates was partially offset by insignificant changes in estimates related to projects recognized in the normal course of the Company’s revenue recognition processes.

13. Segment Information

The Company is managed through two reportable segments: Clinical Solutions and Commercial Solutions. Each reportable segment consists of multiple service offerings that, when combined, create a fully integrated biopharmaceutical services organization. Clinical Solutions offers comprehensive global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. The segment is organized around clinical pharmacology and bioanalytical services, workforce deployment, full-service clinical studies, real world evidence, and consulting. This segment offers individual services including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs; all across a comprehensive range of therapeutic areas. Commercial Solutions provides the pharmaceutical, biotechnology, and healthcare industries with commercialization services, including deployment solutions, communications solutions (public relations, advertising, and medical communications), and consulting services.

The Company’s Chief Operating Decision Maker (the “CODM”) reviews segment performance and allocates resources based upon segment revenue and income from operations. Inter-segment revenue is eliminated from the segment reporting provided to the CODM and is not included in the segment revenue presented in the table below. Certain costs are not allocated to the Company’s reportable segments and are reported as general corporate expenses. These costs primarily consist of share-based compensation, general operating expenses associated with the Board and the Company’s senior leadership, finance, investor relations, and internal audit functions, and transaction and integration-related expenses. The Company does not allocate depreciation, amortization, asset impairment charges, or restructuring and other costs to its segments. Prior period segment results have been recast to reflect the transfer of the Kinapse Regulatory and Operations Consulting service lines from Commercial Solutions to Clinical Solutions to align with management reporting in 2021. Additionally, the CODM reviews the Company’s assets on a consolidated basis and does not allocate assets to its reportable segments for purposes of assessing segment performance or allocating resources.

133

 

Table of Contents

 

Information about reportable segment operating results was as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Revenue:

 

 

 

 

 

 

 

 

 

 

 

 

Clinical Solutions

 

$

4,009,057

 

 

$

3,339,451

 

 

$

3,450,223

 

Commercial Solutions

 

 

1,203,913

 

 

 

1,076,326

 

 

 

1,225,592

 

Total revenue

 

 

5,212,970

 

 

 

4,415,777

 

 

 

4,675,815

 

Segment direct costs:

 

 

 

 

 

 

 

 

 

 

 

 

Clinical Solutions

 

 

3,005,938

 

 

 

2,513,240

 

 

 

2,637,016

 

Commercial Solutions

 

 

955,326

 

 

 

853,555

 

 

 

979,878

 

Total segment direct costs

 

 

3,961,264

 

 

 

3,366,795

 

 

 

3,616,894

 

Segment selling, general, and administrative expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Clinical Solutions

 

 

353,990

 

 

 

283,633

 

 

 

280,674

 

Commercial Solutions

 

 

82,516

 

 

 

82,709

 

 

 

87,258

 

Total segment selling, general, and administrative expenses

 

 

436,506

 

 

 

366,342

 

 

 

367,932

 

Segment operating income:

 

 

 

 

 

 

 

 

 

 

 

 

Clinical Solutions

 

 

649,129

 

 

 

542,578

 

 

 

532,533

 

Commercial Solutions

 

 

166,071

 

 

 

140,062

 

 

 

158,456

 

Total segment operating income

 

 

815,200

 

 

 

682,640

 

 

 

690,989

 

Direct costs and operating expenses not allocated to segments:

 

 

 

 

 

 

 

 

 

 

 

 

Share-based compensation included in direct costs

 

 

33,220

 

 

 

31,347

 

 

 

29,011

 

Share-based compensation included in selling, general, and administrative expenses

 

 

31,984

 

 

 

27,144

 

 

 

26,182

 

Corporate selling, general, and administrative expenses

 

 

102,275

 

 

 

79,240

 

 

 

113,442

 

Restructuring and other costs

 

 

22,816

 

 

 

29,414

 

 

 

42,135

 

Depreciation and amortization

 

 

235,625

 

 

 

222,352

 

 

 

242,465

 

Total income from operations

 

$

389,280

 

 

$

293,143

 

 

$

237,754

 

 

14. Operations by Geographic Location

The following table summarizes total revenue by geographic area (in thousands, all intercompany transactions have been eliminated):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Revenue:

 

 

 

 

 

 

 

 

 

 

 

 

North America (a)

 

$

3,144,475

 

 

$

2,791,590

 

 

$

3,079,608

 

Europe, Middle East and Africa

 

 

1,333,540

 

 

 

1,059,968

 

 

 

1,055,007

 

Asia-Pacific

 

 

594,163

 

 

 

465,116

 

 

 

444,819

 

Latin America

 

 

140,792

 

 

 

99,103

 

 

 

96,381

 

Total revenue

 

$

5,212,970

 

 

$

4,415,777

 

 

$

4,675,815

 

 

(a) Revenue for the North America region includes revenue attributable to the U.S. of $2.95 billion, $2.64 billion, and $2.93 billion, or 56.6%, 59.9%, and 62.7% of total revenue, for the years ended December 31, 2021, 2020 and 2019, respectively. No other country represented more than 10% of total revenue for any year.

134

 

Table of Contents

 

The following table summarizes long-lived assets by geographic area as of December 31 (in thousands, all intercompany transactions have been eliminated):

 

 

 

2021

 

 

2020

 

Property and equipment, net:

 

 

 

 

 

 

 

 

North America (a)

 

$

165,446

 

 

$

161,531

 

Europe, Middle East and Africa

 

 

37,004

 

 

 

38,745

 

Asia-Pacific

 

 

13,615

 

 

 

11,167

 

Latin America

 

 

6,592

 

 

 

4,757

 

Total property and equipment, net

 

$

222,657

 

 

$

216,200

 

 

(a) Long-lived assets for the North America region include property and equipment, net attributable to the U.S. of $160.0 million and $156.0 million as of December 31, 2021 and 2020, respectively.

15. Concentration of Credit Risk

Financial assets that subject the Company to credit risk primarily consist of cash and cash equivalents, accounts receivable and unbilled services (including contract assets). The Company’s cash and cash equivalents consist principally of cash and are maintained at several financial institutions with reputable credit ratings. The Company maintains cash depository accounts with several financial institutions worldwide and is exposed to credit risk related to the potential inability to access liquidity in financial institutions where its cash and cash equivalents are concentrated. The Company has not historically incurred any losses with respect to these balances and believes that they bear minimal credit risk.

As of December 31, 2021 and 2020, substantially all of the Company’s cash and cash equivalents were held within the U.S.

Substantially all of the Company’s revenue is earned by performing services under contracts with pharmaceutical and biotechnology companies. The concentration of credit risk is equal to the outstanding accounts receivable and unbilled services (including contract assets) balances less deferred revenue.

No single customer accounted for greater than 10% of the Company’s revenue for the years ended December 31, 2021, 2020 or 2019.

No single customer accounted for greater than 10% of the Company’s accounts receivable and unbilled services (including contract assets) balances for the year ended December 31, 2021 or 2020.

16. Related-Party Transactions

For the year ended December 31, 2021, the Company had combined revenue of $3.7 million from three customers whose board of directors each included a member who was also a member of the Company’s Board. The combined revenue reflects the periods in which the member served on both the customer’s board of directors and the Company’s Board. As of December 31, 2021, the Company had combined receivables of $0.6 million from two customers whose board of directors each included a member who was also a member of the Company’s Board. For the year ended December 31, 2021, the Company incurred expenses of $0.6 million for professional services obtained from the party noted below that purchased its contingent staffing business, for the period in which such party was a related party.

On October 6, 2021, the Company completed the acquisition of RxDataScience through an arm’s-length transaction. A member of the Company’s management was the co-founder and minority shareholder of RxDataScience and continued to be an executive advisor at RxDataScience up until the acquisition date. For additional information, refer to “Note 3 – Acquisitions, Divestitures, and Investments” and “Note 7 – Fair Value Measurements.”

135

 

Table of Contents

 

For the year ended December 31, 2020, the Company had revenue of $1.8 million and, as of December 31, 2020, receivables of $1.3 million from a customer whose board of directors included a member who was also a member of the Company’s Board. This customer became a related party during the third quarter of 2020. During the second quarter of 2020, the Company sold its contingent staffing business to a related party in exchange for potential future cash consideration not to exceed $4.0 million. The acquiring company had a significant shareholder who was also a significant shareholder of the Company. The significant shareholder sold their interest in the acquiring company during March 2021. Based on the financial results of the business one year after the divestiture date, the Company recognized $1.8 million of contingent consideration in other (income) expense, net in the second quarter of 2021. The future cash consideration is contingent on the financial performance of the sold business through May 31, 2023. The Company will recognize the contingent consideration in the consolidated statements of income in the period the contingency is resolved.

For the year ended December 31, 2019, the Company had revenue of $0.4 million from a customer whose board of directors included a member who was also a member of the Company’s Board. This customer became a related party of the Company during the fourth quarter of 2019. For the year ended December 31, 2018, the Company had revenue of $0.4 million from two customers each of whose respective boards of directors included a member who was also a member of the Company’s Board.

For the year ended December 31, 2019, the Company incurred reimbursable out-of-pocket expenses of $1.1 million for professional services obtained from a provider whose board of directors included a member who was also a member of the Company’s Board. These expenses are included within direct costs in the consolidated statements of income. This provider ceased to be a related party as of December 31, 2019.

17. Commitments and Contingencies

Legal Contingencies

The Company is involved in various claims and legal actions arising in the ordinary course of business. The Company accrues a liability when a loss is considered probable and the amount can be reasonably estimated. When a material loss contingency is reasonably possible but not probable, the Company does not record a liability, but instead discloses the nature and the amount of the claim, and an estimate of the loss or range of loss, if such an estimate can be made. Legal fees are expensed as incurred. In the opinion of management, the outcome of any existing claims and legal or regulatory proceedings, other than the specific matters described below, if decided adversely, is not expected to have a material adverse effect on the Company's business, financial condition, results of operations, or cash flows.

On December 1, 2017, the first of two virtually identical actions alleging federal securities law claims was filed against the Company and certain of its officers on behalf of a putative class of its shareholders. The first action, captioned Bermudez v. INC Research, Inc., et al, No. 17-09457 (S.D.N.Y.), was filed in the Southern District of New York (the “Bermudez action”), and the second action, Vaitkuvienë v. Syneos Health, Inc., et al, No. 18-0029 (E.D.N.C.), was filed on January 25, 2018 in the Eastern District of North Carolina (the “Vaitkuvienë action”). On March 30, 2018, the Bermudez action was dismissed voluntarily. After the San Antonio Fire & Police Pension Fund and El Paso Firemen & Policemen’s Pension Fund were appointed as Lead Plaintiffs in the Vaitkuvienë action, Lead Plaintiffs filed an amended complaint on July 30, 2018, which named as defendants the Company, Alistair Macdonald, Gregory S. Rush, Michael A. Bell, and each member of the Company’s Board at the time of the stockholder vote on the 2017 merger (the “Merger”) of INC Research with an affiliate of inVentiv Health, Inc. (“inVentiv”). The amended complaint alleged claims under Sections 10(b), 14(a) and 20(a) of the Securities Exchange Act of 1934 on behalf of a putative class of purchasers of the Company’s common stock between May 10, 2017 and November 8, 2017, contending that the Company published inaccurate or incomplete information regarding, among other things, the financial performance and business outlook for inVentiv’s business prior to and following the Merger. Lead Plaintiffs seek, among other things, orders (i) declaring that the lawsuit is a proper class

136

 

Table of Contents

 

action and (ii) awarding compensatory damages in an amount to be proven at trial, including interest thereon, and reasonable costs and expenses incurred in this action, including attorneys’ fees and expert fees, to Lead Plaintiffs and other class members. On September 20, 2018, Defendants moved to dismiss the action. On August 30, 2021, the District Court entered an order granting the motion to dismiss in its entirety, and on October 21, 2021, the Court entered judgment for Defendants. On November 19, 2021, Lead Plaintiffs appealed from this judgment to the U.S. Court of Appeals for the Fourth Circuit, which appeal remains pending.

The Company is presently unable to predict the duration, scope, or result of the foregoing putative class actions, or any other related lawsuit. As such, the Company is presently unable to develop a reasonable estimate of a possible loss or range of losses, if any, related to these matters. While the Company intends to defend any further proceedings in the putative class action litigation vigorously, the outcome of such litigation or any other litigation is necessarily uncertain. The Company could be forced to expend significant resources in the defense of these lawsuits or future ones, and it may not prevail. As such, these matters could have a material adverse effect on the Company's business, annual, or interim results of operations, cash flows, or its financial condition.

Assumed Contingent Tax-Sharing Obligation

As a result of the Merger, the Company assumed contingent tax-sharing obligations arising from inVentiv Health, Inc.’s 2016 merger with Double Eagle Parent, Inc. During the first quarter of 2021, the Company made payments of $6.2 million to fully settle this outstanding obligation. As of December 31, 2020, the estimated fair value of the assumed contingent tax-sharing obligations was $6.8 million.

Contingent Earn-out Liabilities

In connection with the RxDataScience acquisition, the Company recorded a contingent earn-out liability to be paid based on achievement of revenue targets in 2022 and the renewal of a specific customer contract. The estimated fair value of the contingent earn-out liability as of December 31, 2021 was $14.6 million and was included in other long-term liabilities in the accompanying consolidated balance sheet. For additional information, refer to “Note 3 - Acquisitions, Divestitures, and Investments.”

In connection with an insignificant acquisition in 2021, the Company recorded a contingent earn-out liability to be paid based on achievement of employee retention benchmarks. The estimated fair value of the contingent obligation was $3.4 million as of December 31, 2021 and was included in accrued expenses in the accompanying consolidated balance sheet.

137

 

Table of Contents

 

18. Share-Based Compensation

Overview of Employee Share-Based Compensation Plans

The Company has two share-based compensation plans, the Syneos Health, Inc. 2018 Equity Incentive Plan (“2018 Plan”) and the Syneos Health, Inc. 2016 Employee Stock Purchase Plan, as amended and restated (“ESPP”). In addition, the Company had the INC Research Holdings, Inc. 2014 Equity Incentive Plan (“2014 Plan”) and the INC Research Holdings, Inc. 2010 Equity Incentive Plan (“2010 Plan”) that were terminated effective May 24, 2018 and October 30, 2014, respectively, except as to outstanding awards. No further awards can be issued under the 2014 Plan or 2010 Plan. The 2018 Plan was effective on May 24, 2018, and permits granting of stock options, stock appreciation rights, restricted stock awards, restricted stock units (“RSUs”), or stock awards to employees, as well as non-employee directors, consultants, or other personal service providers. The terms of share-based instruments granted are determined at the time of grant and are typically subject to such conditions as continued employment, passage of time, and/or satisfaction of performance criteria. The Company has granted stock options and RSUs, which typically vest ratably over a three-year period from the grant date. In addition, the Company has granted performance-vesting RSUs. The Board and the Compensation and Management Development Committee have the discretion to determine different vesting schedules. Stock options have a maximum term of ten years. The exercise price per share of stock options may not be less than the fair market value of a share of the Company’s common stock on the date of grant.

As of December 31, 2021, the maximum number of shares reserved for issuance under the Company’s share-based compensation plans was 15,167,325, of which 3,446,778 shares were available for future grants as of December 31, 2021. In addition, under the 2018 Plan, any shares of the Company’s common stock that are retained by or returned to the Company under any outstanding awards that are canceled, expired, forfeited, surrendered, settled in cash, or otherwise terminated without delivery of the shares, in each case, will prior to vesting or exercise become available for future grants.

Employee Stock Purchase Plan

In March 2016, the Board approved the ESPP, which was also approved by the Company’s shareholders in May 2016. The ESPP was subsequently amended and restated and approved by the Board in March 2018, and also approved by the Company’s shareholders in May 2018. The ESPP allows eligible employees to authorize payroll deductions of up to 10% of their annual base salary or wages to be applied toward the purchase of full shares of the Company’s common stock on the last trading day of the offering period. Participating employees can purchase shares of the Company’s common stock at a 15% discount to the lesser of the closing price of the Company’s common stock as quoted on the Nasdaq Stock Exchange on (i) the first trading day of the offering period or (ii) the last trading day of the offering period. Offering periods under the ESPP are six months in duration, and the first offering period began on September 1, 2016. Under the ESPP, the Company recognized share-based compensation expense of $6.2 million, $5.8 million, and $6.5 million for the years ended December 31, 2021, 2020, and 2019, respectively. As of December 31, 2021, there were 1,594,312 shares issued and 1,905,688 shares reserved for future issuance under the ESPP.

The fair values of ESPP offerings were determined using the Black-Scholes valuation model and the following assumptions:

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Expected volatility

 

25.3% - 38.3%

 

 

27.7% - 55.1%

 

 

39.1% - 51.9%

 

Risk-free interest rate

 

0.06% - 0.07%

 

 

0.13% - 0.95%

 

 

1.88% - 2.52%

 

Expected term (in years)

 

 

0.5

 

 

 

0.5

 

 

 

0.5

 

 

138

 

Table of Contents

 

 

Stock Option Awards

The following table sets forth the summary of stock option activity for the year ended December 31, 2021:

 

 

 

Number

of

Options

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Contractual

Life (in years)

 

 

Aggregate

Intrinsic Value

(in thousands)(a)

 

Outstanding as of December 31, 2020

 

 

663,559

 

 

$

30.12

 

 

 

 

 

 

 

 

 

Exercised

 

 

(279,072

)

 

 

33.31

 

 

 

 

 

 

 

 

 

Forfeited

 

 

—

 

 

 

—

 

 

 

 

 

 

 

 

 

Outstanding as of December 31, 2021

 

 

384,487

 

 

 

27.81

 

 

 

3.26

 

 

$

28,787

 

Vested and expected to vest as of December 31, 2021

 

 

384,487

 

 

 

27.81

 

 

 

3.26

 

 

$

28,787

 

Exercisable as of December 31, 2021

 

 

384,487

 

 

 

27.81

 

 

 

3.26

 

 

$

28,787

 

 

(a) Represents the total pre-tax intrinsic value (i.e., the aggregate difference between the closing price of the Company’s common stock on December 31, 2021 of $102.68 and the exercise price for in-the-money options) that would have been received by the holders if all instruments had been exercised on December 31, 2021.

As of December 31, 2021, there was no unrecognized compensation expense related to non-vested stock options.

There have been no stock options granted since 2017. The total intrinsic value of options exercised was $14.7 million, $12.7 million, and $20.3 million for the years ended December 31, 2021, 2020, and 2019, respectively.

Restricted Stock Units Awards

The following table sets forth a summary of RSUs outstanding under the 2014 and 2018 Plans as of December 31, 2021 and changes during the year then ended:

 

 

 

Time-based

 

 

Performance-based

 

 

 

 

 

 

 

Number of Shares

 

 

Weighted Average

Grant Date Fair Value

 

 

Number of Shares

 

 

Weighted Average

Grant Date Fair Value

 

 

Total Number of Shares

 

Non-vested as of December 31, 2020

 

 

1,909,882

 

 

$

51.98

 

 

 

461,499

 

 

$

48.99

 

 

 

2,371,381

 

Granted

 

 

939,031

 

 

 

76.96

 

 

 

59,055

 

 

 

75.43

 

 

 

998,086

 

Vested

 

 

(997,632

)

 

 

48.45

 

 

 

(136,665

)

 

 

46.47

 

 

 

(1,134,297

)

Forfeited

 

 

(226,094

)

 

 

64.07

 

 

 

(27,890

)

 

 

58.71

 

 

 

(253,984

)

Non-vested as of December 31, 2021

 

 

1,625,187

 

 

$

66.90

 

 

 

355,999

 

 

$

60.75

 

 

 

1,981,186

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrecognized compensation expense (in millions)

 

$

62.6

 

 

 

 

 

 

$

10.7

 

 

 

 

 

 

 

 

 

Weighted average period unrecognized compensation is expected to be recognized

 

1.9 years

 

 

 

 

 

 

1.9 years

 

 

 

 

 

 

 

 

 

139

 

Table of Contents

 

 

Time-based Awards

The weighted-average grant-date fair value of the RSUs granted during the years ended December 31, 2020 and 2019 was $62.12 and $45.45, respectively. The total fair value of shares vested during the years ended December 31, 2021, 2020, and 2019, was $48.3 million, $43.0 million, and $30.3 million, respectively.

Performance-Based Awards

During the years ended December 31, 2021, 2020, and 2019, the Board and Compensation and Management Development Committee granted certain executive officers performance-based RSUs (“PRSUs”). The PRSUs are subject to the Company’s achieving certain performance targets including revenue growth, adjusted diluted EPS growth, and return on invested capital. Compensation expense related to PRSUs is recorded based on the estimated quantity of awards that are expected to vest. At each reporting period, management re-assesses the probability that the performance conditions will be achieved and adjusts compensation expense to reflect any changes in the estimated probability of vesting until the actual level of achievement of the performance targets is known.

The weighted-average grant-date fair value of the PRSUs granted during the years ended December 31, 2020 and 2019 was $62.50 and $45.00, respectively. The total fair value of shares vested during the year ended December 31, 2021, was $6.4 million. No PRSUs were vested or distributed in the years ended December 31, 2020 and 2019.

Share-Based Compensation Expense

Total share-based compensation expense recognized was as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Direct costs

 

$

33,220

 

 

$

31,347

 

 

$

29,011

 

Selling, general, and administrative expenses

 

 

31,984

 

 

 

27,144

 

 

 

26,182

 

Total share-based compensation expense

 

$

65,204

 

 

$

58,491

 

 

$

55,193

 

The total income tax benefit recognized in the consolidated statements of income for share-based compensation arrangements was approximately $13.8 million, $11.8 million, and $10.8 million for the years ended December 31, 2021, 2020, and 2019, respectively.

19. Employee Benefit Plans

Defined Contribution Retirement Plans

In the U.S., the Company offers defined contribution retirement benefit plans that comply with Section 401(a) of the Internal Revenue Code under which it matches employee deferrals at varying percentages and at specified limits of the employee’s salary. In 2020, the Company implemented cost management strategies, including suspending the Company match on U.S. employee 401(k) contributions for six months. The match was resumed in the fourth quarter of 2020.

The Company’s contributions related to these defined contribution retirement plans were as follows (in thousands):

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Defined contribution retirement plan contributions

 

$

30,932

 

 

$

15,049

 

 

$

29,834

 

140

 

Table of Contents

 

 

The Company also has defined contribution retirement plans outside of the U.S. The Company’s contributions related to these plans were approximately $23.2 million, $18.4 million, and $10.0 million for the years ended December 31, 2021, 2020, and 2019, respectively. The Company’s contributions associated with all of its defined contribution retirement plans are recorded in direct costs and selling, general, and administrative expenses on the accompanying consolidated statements of income.

Deferred Compensation Plan

The Company offers a Nonqualified Deferred Compensation Plan for certain employees pursuant to Section 409A of the Internal Revenue Code (“NQDC Plan”). Under this plan, participants can defer, on a pre-tax basis, from 1.0% up to a maximum of 80.0% of salary and from 1.0% up to a maximum of 100.0% of commissions and annual bonuses. The Company does not make matching contributions into the NQDC Plan. Distributions will be made to participants upon termination of employment or death in a lump sum, unless installments are selected.

As of December 31, 2021 and 2020, the NQDC Plan deferred compensation liabilities were $23.4 million and $22.3 million, respectively, and are included in other long-term liabilities on the accompanying consolidated balance sheets. The assets associated with the NQDC Plan are subject to the claims of the creditors and primarily consist of investments in mutual funds maintained in a “rabbi trust”. These investments are classified as trading securities and are included in other long-term assets on the accompanying consolidated balance sheets.

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

None.

Item 9A. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

As required by Rule 13a-15(b) under the Exchange Act, our management, with the participation of our CEO and CFO, carried out an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act). There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives.

Based upon their evaluation, our CEO and CFO concluded that, as of December 31, 2021, our disclosure controls and procedures were effective at the reasonable assurance level.

Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended December 31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

141

 

Table of Contents

 

Management’s Annual Report on Internal Control Over Financial Reporting

The management of Syneos Health, Inc. (the “Company”) is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles in the United States of America, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting might not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Management assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2021. In making this assessment, management used the framework established in the Internal Control-Integrated Framework issued in 2013 by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). As a result of this assessment and based on the criteria in the COSO framework, management has concluded that, as of December 31, 2021, the Company’s internal control over financial reporting was effective.

The effectiveness of the Company’s internal control over financial reporting as of December 31, 2021 has been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated in their attestation report which appears herein.

Item 9B. Other Information.

None.

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.

Not applicable.

PART III

Item 10. Directors, Executive Officers and Corporate Governance.

Pursuant to General Instruction G(3) on Form 10-K, information required by this Item concerning our directors and corporate governance is incorporated by reference from the sections captioned “Election of Directors” and “Corporate Governance Matters” contained in our 2022 Proxy Statement related to our Annual Meeting of Stockholders, which we intend to file with the SEC within 120 days of the end of our fiscal year.

142

 

Table of Contents

 

We have adopted a code of business conduct and ethics relating to the conduct of our business by all of our employees, officers, and directors, as well as a code of ethics specifically for our principal executive officer and senior financial officers. Each of these policies is posted on our website:  www.syneoshealth.com. We intend to post on our website all disclosures that are required by law or Nasdaq Stock Market listing standards concerning any amendments to, or waivers from, any provision of our code of business conduct and ethics and our code of ethics.

The information required by this Item concerning our executive officers is set forth at the end of Part I, Item 1, “Business” in this Annual Report on Form 10-K under the section captioned “Information About Executive Officers.”

The information required by this Item concerning compliance with Section 16(a) of the Securities Exchange Act of 1934, as amended, if applicable, is incorporated by reference from the section of the 2022 Proxy Statement captioned “Delinquent Section 16(a) Reports,” if any.

Item 11. Executive Compensation.

The information required by this Item is incorporated by reference to the information under the sections captioned “Executive Compensation and Other Matters,” “Director Compensation for Fiscal Year 2021” and “Corporate Governance Matters” in the 2022 Proxy Statement.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

Securities Authorized for Issuance Under Equity Compensation Plans

The following table sets forth the indicated information as of December 31, 2021 with respect to our equity compensation plans approved by security holders:

 

Plan Description

 

Number of

securities

to be issued

upon exercise

of outstanding

options,

warrants and

rights

 

 

Weighted-average

exercise price of

outstanding

options,

warrants and

rights

 

 

Number of

securities

remaining

available

for future

issuance

under equity

compensation

plans

 

2018 Equity Incentive Plan

 

 

—

 

 

$

—

 

 

 

3,446,778

 

2016 Employee Stock Purchase Plan

 

 

—

 

 

$

—

 

 

 

1,905,688

 

2014 Equity Incentive Plan

 

 

121,579

 

 

$

43.07

 

 

 

—

 

2010 Equity Incentive Plan

 

 

152,753

 

 

$

13.07

 

 

 

—

 

2016 Omnibus Equity Incentive Plan (a)

 

 

110,155

 

 

$

31.41

 

 

 

—

 

Total

 

 

384,487

 

 

 

 

 

 

 

5,352,466

 

(a) On August 1, 2017, in connection with the Merger, the Company filed a Form S-8 Registration Statement for the Double Eagle Parent, Inc. 2016 Omnibus Equity Incentive Plan. The number of shares registered in that filing was 1,500,000. Under this plan, the Company issued replacement awards consisting of stock options and RSUs. No further awards can be issued under the Double Eagle Plan.

143

 

Table of Contents

 

Our equity compensation plans consist of the 2018 Equity Incentive Plan, the 2016 Employee Stock Purchase Plan, the 2014 Equity Incentive Plan, the 2010 Equity Incentive Plan, and the 2016 Omnibus Equity Incentive Plan, which were approved by our shareholders. We do not have any equity compensation plans or arrangements that have not been approved by our shareholders.

The remaining information in response to this Item is incorporated by reference to the information under the section captioned “Security Ownership of Certain Beneficial Owners and Management” in the 2022 Proxy Statement.

The information required by this Item is incorporated by reference to the information under the section captioned “Certain Relationships and Related Person Transactions” and “Corporate Governance Matters” in the 2022 Proxy Statement.

Item 14. Principal Accounting Fees and Services.

The information required by this Item is incorporated by reference to the information under the section captioned “Audit Committee Report” in the 2022 Proxy Statement.

PART IV

Item 15. Exhibits and Financial Statement Schedules.

(a) The following documents are filed as part of this report:

(1) Financial Statements

The financial statements and report of the independent registered public accounting firm are filed as part of this Annual Report (see “Index to Consolidated Financial Statements” at Item 8).

(2) Financial Statement Schedules

The financial statements schedules are omitted because they are not applicable or the required information is shown in the consolidated financial statements or notes thereto.

(b) Exhibits

 

 

 

 

Incorporated by Reference (Unless Otherwise Indicated)

Exhibit   

Number   

 

Exhibit Description

Form    

File No.    

Exhibit    

Filing Date    

3.1

 

Certificate of Incorporation of INC Research Holdings, Inc.

8-K

001-36730 

 

3.1

August 1, 2017

3.2

 

Certificate of Amendment of Certificate of Incorporation of Syneos Health, Inc.

8-K

001-36730 

 

3.1

January 8, 2018

3.3

 

Amended and Restated Bylaws of Syneos Health, Inc.

8-K

001-36730 

 

3.2

January 8, 2018

4.1

 

Specimen Certificate for Class A Common Stock.

S-1/A

333-199178 

 

4.1

October 27, 2014

4.2

 

Indenture, dated as of November 24, 2020, between Syneos Health, Inc. and Wells Fargo Bank, National Association, as trustee.

8-K

001-36730 

 

4.1

November 25, 2020

4.3

 

Form of 3.625% senior note due 2029 (included in Exhibit 4.2).

8-K

001-36730 

 

4.2

November 25, 2020

4.4

 

First Supplemental Indenture, dated as of November 24, 2020, between the Company, the subsidiary guarantors named on the signature pages thereto and Wells Fargo Bank, National Association, as trustee.

8-K

001-36730 

 

4.3

November 25, 2020

144

 

Table of Contents

 

4.5

 

Second Supplemental Indenture, dated as of May 25, 2021, among the Company, the subsidiary guarantors named on the signature pages thereto, the other guarantors, and Wells Fargo Bank, National Association, as trustee.

10-Q

001-36730

 

4.1

August 6, 2021

4.6

 

Third Supplemental Indenture, dated as of November 19, 2021, among the Company, the subsidiary guarantors named on the signature pages thereto, the other guarantors, and Wells Fargo Bank, National Association, as trustee.

— 

— 

 

— 

Filed herewith

4.7

 

Description of Capital Stock.

10-K

001-36730

 

4.4

February 20, 2020

10.1#

 

Management Incentive Plan.

10-K

001-36730

 

10.3

February 20, 2020

10.2.1#

 

Executive Service Agreement, by and between INC Research Holding Limited and Alistair Macdonald, dated July 27, 2016.

8-K 

001-36730 

 

10.2

July 28, 2016

10.2.2#

 

Letter Agreement, by and between INC Research Holdings, Inc. and Alistair Macdonald, dated July 27, 2016.

8-K 

001-36730 

 

10.4

July 28, 2016

10.2.3#

 

Amendment One to the Executive Service Agreement, made as of April 1, 2017, between INC Research Holdings Limited and Alistair Macdonald.

8-K 

001-36730 

 

10.1

April 6, 2017

10.2.4#

 

Amendment Two to the Executive Service Agreement, made as of January 15, 2020, between INC Research Holding Limited and Alistair Macdonald.

10-K

001-36730

 

10.4.4

February 20, 2020

10.2.5#

 

Letter Agreement between Syneos Health UK Limited and Alistair Macdonald, dated May 3, 2019.

10-Q

001-36730 

 

10.8

April 30, 2020

10.3.1#

 

Executive Employment Agreement, effective April 8, 2014, by and between INC Research, LLC and Jason Meggs.

10-Q 

001-36730 

 

10.3

May 9, 2018

10.3.2#

 

Letter Agreement, dated March 20, 2018, by and among Syneos Health, Inc. and Jason Meggs.

10-Q 

001-36730 

 

10.4

May 9, 2018

10.3.3#

 

Letter Agreement, effective May 6, 2018, by and among Syneos Health, Inc. and Jason Meggs.

10-Q 

001-36730 

 

10.5

May 9, 2018

10.4.1#

 

Letter Agreement, dated November 13, 2018, by and among Syneos Health, Inc. and Jonathan Olefson.

10-K  

001-36730 

 

10.6 

March 18, 2019

10.5.1#

 

Letter Agreement, dated November 7, 2017, by and between INC Research/inVentiv Health and Michelle Keefe.

10-K

001-36730

 

10.7

February 20, 2020

10.6.1#

 

Letter Agreement, dated August 29, 2018, by and between Syneos Health, Inc. and Paul D. Colvin.

10-K

001-36730

 

10.8

February 20, 2020

10.7#

 

Letter Agreement, dated September 21, 2020, by and between Syneos Health, Inc. and Michael Brooks.

— 

— 

 

— 

Filed herewith

10.8#

 

Syneos Health, Inc. Executive Severance Plan, Adopted September 15, 2016, amended and restated August 20, 2018.

10-Q 

001-36730 

 

10.1

November 6, 2018

10.9#

 

Form of Director Indemnification Agreement

10-Q

001-36730 

 

10.1

August 6, 2020

145

 

Table of Contents

 

10.10#

 

Syneos Health, Inc. 2016 Employee Stock Purchase Plan (as Amended and Restated).

8-K 

001-36730 

 

10.2

May 25, 2018

10.11.1#

 

Syneos Health, Inc. 2018 Equity Incentive Plan.

8-K 

001-36730 

 

10.1

May 25, 2018

10.11.2#

 

Form of Global Restricted Stock Unit Award Agreement under Syneos Health, Inc. 2018 Equity Incentive Plan.

10-K 

001-36730 

 

10.17.2

March 18, 2019

10.11.3#

 

Form of Global Performance Restricted Stock Unit Award Agreement under Syneos Health, Inc. 2018 Equity Incentive Plan.

10-K 

001-36730 

 

10.17.3 

March 18, 2019

10.11.4#

 

Form of Global Performance Restricted Stock Unit Award Agreement under Syneos Health, Inc. 2018 Equity Incentive Plan (U.S. Participants).

8-K

001-36730 

 

10.1

January 21, 2021

10.11.5#

 

Form of Global Performance Restricted Stock Unit Award Agreement under Syneos Health, Inc. 2018 Equity Incentive Plan (Non-U.S. Participants).

8-K

001-36730 

 

10.2

January 21, 2021

10.11.6#

 

Form of Global Restricted Stock Unit Award Agreement for Directors under Syneos Health, Inc. 2018 Equity Incentive Plan.

10-Q

001-36730 

 

10.1

August 6, 2021

10.11.7#

 

Form of Global Performance Restricted Stock Unit Award Agreement under Syneos Health, Inc. 2018 Equity Incentive Plan (U.S. Participants) (2022).

— 

— 

 

— 

Filed herewith

10.11.8#

 

Form of Global Performance Restricted Stock Unit Award Agreement under Syneos Health, Inc. 2018 Equity Incentive Plan (Non-U.S. Participants) (2022).

— 

— 

 

— 

Filed herewith

10.11.9#

 

Form of Global Restricted Stock Unit Award Agreement under Syneos Health, Inc. 2018 Equity Incentive Plan (U.S. Participants) (2022).

— 

— 

 

— 

Filed herewith

10.11.10#

 

Form of Global Restricted Stock Unit Award Agreement under Syneos Health, Inc. 2018 Equity Incentive Plan (Non-U.S. Participants) (2022).

— 

— 

 

— 

Filed herewith

10.12.1

 

Credit Agreement, dated as of August 1, 2017, among INC Research Holdings, Inc., the Administrative Borrower, other Borrowers party thereto, the financial institution party thereto as lenders party thereto, Credit Suisse AG, as Administrative Agent, and each of the other parties as Joint Lead Arrangers and Joint Bookrunners party thereto.

8-K 

001-36730 

 

10.1

August 1, 2017

10.12.2

 

Amendment No. 1 to the Credit Agreement, dated as of May 4, 2018, among Syneos Health, Inc., the lenders party thereto, Credit Suisse AG, Cayman Islands Branch, as Administrative Agent, and each of the other parties thereto.

8-K 

001-36730 

 

10.1

May 7, 2018

10.12.3

 

Amendment No.2 to the Credit Agreement, dated as of March 26, 2019, among the Company, the lenders party thereto, JPMorgan Chase Bank N.A., as Administrative Agent, and each of the other parties thereto.

8-K 

001-36730 

 

10.1

March 28, 2019

146

 

Table of Contents

 

10.12.4

 

Amendment No. 3 to the Credit Agreement, dated as of April 7, 2020, by and between Syneos Health, Inc. as Administrative Borrower and JPMorgan Chase Bank, N.A., as Administrative Agent.

10-Q

001-36730 

 

10.2

April 30, 2020

10.12.5

 

Amendment No. 4 to the Credit Agreement dated as of November 24, 2020, by and among the Borrowers, the Lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent for the Lenders.

8-K

001-36730 

 

4.4

November 25, 2020

10.12.6

 

Amendment No. 5 to the Credit Agreement, dated as of June 30, 2021, among the Company, the other borrowers party thereto, the lenders party thereto, JPMorgan Chase Bank N.A., as Administrative Agent, and each of the other parties thereto.

8-K

001-36730 

 

10.1

July 1, 2021

10.12.7

 

Amendment No. 6 to the Credit Agreement, dated as of December 17, 2021, among the Company, JPMorgan Chase Bank N.A., as administrative agent and collateral agent for the Lenders, and the other parties thereto.

— 

— 

 

— 

Filed herewith

10.13.1

 

Purchase and Sale Agreement dated June 29, 2018 among various entities listed on Schedule I thereto, as originators, INC Research, LLC, as servicer, and Syneos Health Receivables LLC, as buyer.

8-K 

001-36730 

 

10.2

June 29, 2018

10.13.2†

 

First Amendment to the Purchase and Sale Agreement, dated as of January 2, 2019, among various entities listed on Schedule I thereto, as originators, and Syneos Health, LLC, as servicer, and Syneos Health Receivables LLC as buyer.

10-K

001-36730

 

10.16.2

February 18, 2021

10.13.3

 

Second Amendment to the Purchase and Sale Agreement, dated as of July 25, 2019, among inVentiv Commercial Services, LLC, each of the entities listed on the signature pages as an Existing Originator, and Syneos Health, LLC, as servicer, and Syneos Health Receivables LLC.

10-Q

001-36730 

 

10.3

October 29, 2020

10.13.4

 

Fourth Amendment to the Purchase and Sale Agreement, dated as of September 25, 2020, among each of the entities listed on the signature pages as a New Originator, each of the entities listed on the signature pages as an Existing Originator, and Syneos Health, LLC, as servicer, and Syneos Health Receivables LLC.

10-Q

001-36730 

 

10.1

October 29, 2020

10.13.5†

 

Fifth Amendment to the Purchase and Sale Agreement, dated as of January 22, 2021, among each of the entities listed on the signature pages hereto as an Originator, Syneos Health, LLC, as services, and Syneos Health Receivables LLC.

10-K

001-36730

 

10.16.5

February 18, 2021

10.13.6

 

Sixth Amendment to the Purchase and Sale Agreement, dated as of October 13, 2021, among each of the entities listed on the signature pages hereto as an Originator, Syneos Health, LLC, as servicer, and Syneos Health Receivables LLC.

10-Q

001-36730

 

10.2

November 3, 2021

147

 

Table of Contents

 

10.14.1

 

Receivables Financing Agreement, dated June 29, 2018 among Syneos Health Receivables, LLC, as borrower, PNC Bank, National Association, as administrative agent, INC Research, LLC, as initial servicer, PNC Capital Markets LLC, as structuring agent and the additional persons from time to time party thereto, as lenders.

8-K 

001-36730 

 

10.1

June 29, 2018

10.14.2

 

First Amendment to the Receivables Financing Agreement, dated August 1, 2018 among Syneos Health Receivables LLC, as borrower, PNC Bank, National Association, as administrative agent and as lender and INC Research, LLC, as initial servicer.

10-Q 

001-36730 

 

10.6

August 2, 2018

10.14.3

 

Second Amendment to the Receivables Financing Agreement, dated August 29, 2018 among Syneos Health Receivables LLC, as borrower, PNC Bank, National Association, as administrative agent and as lender and INC Research, LLC, as initial servicer.

10-Q 

001-36730 

 

10.2

November 6, 2018

10.14.4

 

Third Amendment to the Receivables Financing Agreement, dated October 25, 2018 among Syneos Health Receivables LLC, as borrower, PNC Bank, National Association, as administrative agent and as lender and INC Research, LLC, as initial servicer.

10-Q 

001-36730 

 

10.3

November 6, 2018

10.14.5

 

Fourth Amendment to the Receivables Financing Agreement, dated January 2, 2019, among Syneos Health Receivables LLC, as borrower, PNC Bank, National Association, as administrative agent and as lender and Syneos Health, LLC as initial servicer.

10-Q 

001-36730 

 

10.1

August 6, 2019

10.14.6

 

Fifth Amendment to the Receivables Financing Agreement, dated July 25, 2019, among Syneos Health Receivables LLC, as borrower, PNC Bank, National Association, as administrative agent and as lender and Syneos Health, LLC as initial servicer.

10-Q 

001-36730 

 

10.2

August 6, 2019

10.14.7

 

Sixth Amendment to the Receivables Financing Agreement, dated September 30, 2019, among Syneos Health Receivables LLC, as borrower, PNC Bank, National Association, as administrative agent and as lender and Syneos Health, LLC as initial servicer.

10-Q 

001-36730 

 

10.1

October 31, 2019

148

 

Table of Contents

 

10.14.8

 

Omnibus Amendment, dated January 31, 2020, that is the Third Amendment to the Purchase and Sale Agreement and the Seventh Amendment to the Receivables Financing Agreement, among Syneos Health Receivables LLC, as borrower, PNC Bank, National Association, as administrative agent and as lender, Syneos Health, LLC as the servicer and as a Remaining Originator, inVentiv Health Clinical, LLC as a released originator, and inVentiv Commercial Services, LLC as a remaining originator.

10-K

001-36730

 

10.19.8

February 20, 2020

10.14.9

 

Eighth Amendment to the Receivables Financing Agreement, dated March 18, 2020, among Syneos Health Receivables LLC, as borrower, Syneos Health, LLC as initial servicer, and PNC Bank, National Association, as administrative agent and as lender.

10-Q

001-36730

 

10.1

April 30, 2020

10.14.10

 

Ninth Amendment to the Receivables Financing Agreement, dated as of September 25, 2020, by and among Syneos Health Receivables LLC, as borrower, Syneos Health, LLC, as initial servicer, and PNC Bank, National Association, as administrative agent and as lender.

10-Q

001-36730

 

10.2

October 29, 2020

10.14.11

 

Tenth Amendment to the Receivables Financing Agreement, dated as of January 22, 2021, by and among Syneos Health Receivables LLC, as borrower, Syneos Health, LLC, as initial services, Regions Bank, as a lender, and PNC Bank, National Association, as administrative agent and as a lender.

10-K

001-36730

 

10.17.11

February 18, 2021

10.14.12

 

Eleventh Amendment to the Receivables Financing Agreement, dated as of October 13, 2021, by and among Syneos Health Receivables LLC, as borrower, Syneos Health, LLC, as initial servicer, Regions Bank, as lender, and PNC Bank, National Association, as administrative agent and as a lender.

10-Q

001-36730 

 

10.1

November 3, 2021

21.1

 

List of Subsidiaries of the Registrant.

— 

— 

 

— 

Filed herewith

23.1

 

Consent of Deloitte & Touche LLP.

— 

— 

 

— 

Filed herewith

31.1

 

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

— 

— 

 

— 

Filed herewith

31.2

 

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

— 

— 

 

— 

Filed herewith

32.1

 

Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

— 

— 

 

— 

Furnished herewith

32.2

 

Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

— 

— 

 

— 

Furnished herewith

101.INS

 

Inline XBRL Instance Document - the Instance Document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document.

— 

— 

 

— 

Filed herewith

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document.

— 

— 

 

— 

Filed herewith

149

 

Table of Contents

 

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

— 

— 

 

— 

Filed herewith

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document.

— 

— 

 

— 

Filed herewith

101.LAB

 

Inline XBRL Taxonomy Extension Label Linkbase Document.

— 

— 

 

— 

Filed herewith

101.PRE

 

Inline Taxonomy Extension Presentation Linkbase Document.

— 

— 

 

— 

Filed herewith

104

 

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

— 

— 

 

— 

Filed herewith

# Denotes management contract or compensatory plan.

† The annexes, schedules, and certain exhibits to this Exhibit have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Registrant hereby agrees to furnish supplementally a copy of any omitted annex, schedule or exhibit to the SEC upon request.

Item 16. Form 10-K Summary.

None.

150

 

Table of Contents

 

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Syneos Health, Inc.

 

By:

 

/s/ Alistair Macdonald

 

 

 

Name:

 

Alistair Macdonald

 

 

 

Title:

 

Chief Executive Officer (Principal
Executive Officer) and Director

 

 

 

Date:

 

February 16, 2022

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

 

 

 

 

 

/s/ Alistair Macdonald

 

Chief Executive Officer (Principal Executive Officer) and Director

 

February 16, 2022

Alistair Macdonald

 

 

 

 

 

 

 

 

 

/s/ Jason Meggs

 

Chief Financial Officer (Principal Financial Officer)

 

February 16, 2022

Jason Meggs

 

 

 

 

 

 

 

 

 

/s/ Donna Kralowetz

 

Senior Vice President, Chief Accounting Officer (Principal Accounting Officer)

 

February 16, 2022

Donna Kralowetz

 

 

 

 

 

 

 

 

 

/s/ John Dineen

 

Chair of the Board and Director

 

February 16, 2022

John Dineen

 

 

 

 

 

 

 

 

 

/s/ Todd Abbrecht

 

Director

 

February 16, 2022

Todd Abbrecht

 

 

 

 

 

 

 

 

 

/s/ Barbara Bodem

 

Director

 

February 16, 2022

Barbara Bodem

 

 

 

 

 

 

 

 

 

/s/ Bernadette Connaughton

 

Director

 

February 16, 2022

Bernadette Connaughton

 

 

 

 

 

 

 

 

 

/s/ Linda Harty

 

Director

 

February 16, 2022

Linda Harty

 

 

 

 

 

 

 

 

 

/s/ William Klitgaard

 

Director

 

February 16, 2022

William Klitgaard

 

 

 

 

 

 

 

 

 

/s/ Kenneth Meyers

 

Director

 

February 16, 2022

Kenneth Meyers

 

 

 

 

 

 

 

 

 

/s/ Matthew Monaghan

 

Director

 

February 16, 2022

Matthew Monaghan

 

 

 

 

 

 

 

 

 

/s/ David Wilkes

 

Director

 

February 16, 2022

David Wilkes, M.D.

 

 

 

 

 

 

 

 

 

/s/ Alfonso Zulueta

 

Director

 

February 16, 2022

Alfonso Zulueta

 

 

 

 

 

 

 

151

 

 EX-4.6 2 synh-ex46_433.htm EX-4.6 THIRD SUPPLEMENTAL INDENTURE synh-ex46_433.htm

Exhibit 4.6

THIRD SUPPLEMENTAL INDENTURE

Third Supplemental Indenture (this “Supplemental Indenture”), dated as of November 19, 2021, among each undersigned Subsidiary (the “Guaranteeing Subsidiaries”), each a subsidiary of Syneos Health, Inc. (or its permitted successor), a Delaware corporation (the “Company”), the Company, the other Guarantors (as defined in the Indenture referred to herein) and Wells Fargo Bank, National Association, as trustee under the Indenture referred to below (the “Trustee”).

W I T N E S S E T H

WHEREAS, the Company has heretofore executed and delivered to the Trustee an indenture (the “Original Indenture”), dated as of November 24, 2020, a First Supplemental Indenture, dated as of November 24, 2020 (the “First Supplemental Indenture”) and a Second Supplemental Indenture, dated as of May 25, 2021 (the “Second Supplemental Indenture” and, together with the Original Indenture, the First Supplemental Indenture and the Second Supplemental Indenture, the “Indenture”) providing for the issuance of 3.625% Senior Notes due 2029 (the “Notes”);

WHEREAS, the Indenture provides that under certain circumstances the Guaranteeing Subsidiaries shall execute and deliver to the Trustee a supplemental indenture pursuant to which the Guaranteeing Subsidiaries shall unconditionally guarantee all of the Company’s Obligations under the Notes and the Indenture on the terms and conditions set forth herein (the “Guarantee”); and

WHEREAS, pursuant to Section 10.01 of the First Supplemental Indenture, the Trustee is authorized to execute and deliver this Supplemental Indenture.

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Guaranteeing Subsidiaries and the Trustee mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes as follows:

1.Capitalized Terms.  Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

2.Agreement to Guarantee.  The Guaranteeing Subsidiaries hereby agree to provide an unconditional Guarantee on the terms and subject to the conditions set forth in the First Supplemental Indenture including but not limited to Article 9 thereof.

3.No Recourse Against Others.  No director, officer, employee, incorporator or stockholder of the Company or any Guarantor, as such, will have any liability for any obligations of the Company or the Guarantors under the Notes, the Indenture, the Guarantees or for any claim based on, in respect of, or by reason of, such obligations or their creation.  Each Holder of Notes by accepting a Note waives and releases all such liability.  The waiver and release are part of the consideration for issuance of the Notes.

 

 

4.NEW YORK LAW TO GOVERN.  THIS SUPPLEMENTAL INDENTURE AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS SUPPLEMENTAL INDENTURE SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.

5.Counterparts.  The parties may sign any number of copies of this Supplemental Indenture.  Each signed copy shall be an original, but all of them together represent the same agreement.

6.Effect of Headings.  The Section headings herein are for convenience only and shall not affect the construction hereof.

7.The Trustee.  The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Guaranteeing Subsidiaries and the Company.

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed, all as of the date first above written.

 

SYNEOS HEALTH, INC.

 

 

 

 

By:

/s/ Jason Meggs

 

Name: Jason Meggs

 

Title: Chief Financial Officer

 

STUDYKIK CORPORATION

 

 

 

 

By:

/s/ Sara Epstein

 

Name: Sara Epstein

 

Title: Director

 

CAERUS MARKETING GROUP, LLC

 

 

 

 

By:

/s/ Sara Epstein

 

Name: Sara Epstein

 

Title: Director

 

RXDATASCIENCE, INC.

 

 

 

 

By:

/s/ Sara Epstein

 

Name: Sara Epstein

 

Title: Director

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed, all as of the date first above written.

 

By:

 

 

Name: Jason Meggs

 

Title: Chief Financial Officer

 

STUDYKIK CORPORATION

 

 

 

 

By:

 

 

Name: Sara Epstein

 

Title: Director

 

CAERUS MARKETING GROUP, LLC

 

 

 

 

By:

 

 

Name: Sara Epstein

 

Title: Director

 

RXDATASCIENCE, INC.

 

 

 

 

By:

 

 

Name: Sara Epstein

 

Title: Director

 

COMPUTERSHARE TRUST COMPANY, N.A., as agent for Wells Fargo Bank, National Association, as Trustee

 

 

 

 

By:

/s/ Karla D. Sjostrom

 

Name: Karla D. Sjostrom

 

Title: Vice President

 

 

 EX-10.7 3 synh-ex107_432.htm EX-10.7 MICHAEL BROOKS EMPLOYMENT LETTER synh-ex107_432.htm

Exhibit 10.7

 

September 21, 2020

Michael Brooks

[redacted]

 

Dear Michael,

As you know, we’re on a journey to create the industry’s leading biopharmaceutical solutions organization. To that end, on behalf of the Board and all of us who’ve been engaged in the conversation, I’m delighted to offer you the position of Chief Development Officer reporting to Alistair Macdonald, CEO.

We’re confident that your contributions will shape the business, drive performance and actualize our vision of Shortening the Distance from Lab to Life. I know you’re going to find your Executive Team members a collaborative and committed set of peers.

We have discussed that you will be based out of our Morrisville, North Carolina location. This offer is contingent upon your execution of the Syneos Health Confidentiality Agreement and Non-Solicitation Agreement, successful completion of our background investigation that includes reference checking, drug screening, and check of educational and employment credentials, and confirmation that you do not have any post-employment obligations to any former employer(s) or third party that prohibits you from working for Syneos Health as Chief Development Officer after your employment start date.

Assuming favorable results from the above, and you accept our offer, your target start date will be agreed by you and Alistair Macdonald. The Company understands and agrees that your start date is dependent on discussions with your current employer. Your annual base salary will be $500,000.00 US Dollars (USD), less applicable taxes and withholding amounts. You will be eligible to participate in the Syneos Health Management Incentive Plan (MIP). The MIP provides eligible employees an annual cash incentive for achieving performance goals established annually, at the discretion of the Board of Directors. Your annual MIP target will be 70% of your annual base salary. MIP payouts can potentially range from zero to 200% of your target.

As an additional incentive to join Syneos Health, we are pleased to provide you with a Sign-on Payment of $250,000.00. Timing for the payment of this incentive will depend upon your start date, but it will not be paid earlier than the first pay period after April 1, 2021.

 

 

Summary of Employment Offer Key Terms

Compensation Element

Amount

Base Salary

$500,000

Management Incentive Plan

Target is 70% of Base Salary ($350,000)

Long Term Incentive Plan

Target is 200% of Base Salary ($1,000,000) *

Total

$1,850,000

 

 

Sign-On Equity Grant Value

$2,000,000**

Sign-On Cash Payment

$250,000***

 

*Long Term Incentive (LTI) awards are granted as part of the normal Syneos Health equity award cycle, which typically occurs in the first quarter of each year. LTI awards are subject to annual review and approval by the Syneos Health Board of Directors and consist of 50% Restricted Stock Units (RSUs) and 50% Performance Restricted Stock Units (PRSUs). RSUs vest equally over three years in accordance with the terms set forth in the grant. PRSUs vest after three years based on performance against EPS and ROIC targets established for the three-year performance period (vesting can range from 0% to 150% of PRSUs granted).

**Sign-On Equity Grant will be issued in the form of Restricted Stock Units (RSUs) and are typically awarded on the 15th day of the month following the date of hire.

***Sign-on Cash Payment. You are required to reimburse the Company an amount equal to the Sign-On Cash Payment that you receive (after applicable taxes and other withholdings) if you voluntarily leave the Company before the second anniversary of your hire date. If repayment of the Sign-On Cash Payment is triggered, then you shall repay this amount to the Company in full within thirty (30) days of your termination of employment.

Executive Severance Plan. You are eligible to participate in the Company’s Executive Severance Plan during your employment with the Company. This Plan provides severance benefits if your employment is terminated by the Company for any reason other than death, disability or Cause, or you resign for Good Reason (as those terms are defined by the Plan).If you are subject to a Qualifying Termination (as defined in the Plan) prior to the second anniversary of your hire date, (i) one-half of your Sign-On Equity Grant will become fully vested, and (ii) you will not be subject to any post-termination non-compete obligations. This paragraph supersedes the provisions contained in the agreement(s)evidencing the grant of the Sign-On Equity Grant, provided that the provisions of the equity award will control to the extent such provisions are more favorable to you.

Additional Sign-on Cash Payment. If you are unable to commence employment with Syneos Health due to continuing obligations to your current employer, the amount of the Sign-on Cash Payment will be increased to reflect the base salary that you otherwise would have received from the Company for a period of up to six month (less applicable

taxes and withholdings). This shall be calculated based on the time period between your separation from your current employer and your hire date with the Company, excluding any time (a) that you voluntarily choose to delay your commencement of employment with Syneos Health, or (b) that you receive continuation pay from your current employer. This additional payment will be made to you in a lump sum (less applicable taxes and withholdings) when the remainder of the Sign-on Cash Payment is made.

 

 

You are required to provide appropriate documentation for the completion of your new hire forms, including proof that you are eligible to work in the United States.

Please understand it is the policy of the Company not to solicit or accept proprietary information and/or trade secrets of other companies or third parties. If you have or have had access to trade secrets or other confidential, proprietary information from your former employer or another third party, the use of such information in performing your duties at the Company is prohibited. This may include, but is not limited to, confidential or proprietary information in the form of documents, magnetic media, software, customer lists, and business plans or strategies. By signing below, you represent that you have already advised the Company of any restrictions on your ability to work for the Company, such as any covenants not to compete or solicit with any former employers.

We greatly look forward to having you join our Company and becoming a member of our team. However, we recognize that you retain the option, as does the Company, of ending your employment with the Company at any time, with or without notice and with or without cause. As such, your employment with the Company is at-will and neither this letter nor any other oral or written representation may be considered a contract for any definite or specific period of time.

If you wish to accept this offer, please sign below and return the fully executed letter to us. You should keep one copy of this letter for your own records. Should you have any questions about starting with the Company, please do not hesitate to contact me or Catherine Baritell directly. We are happy to assist in making your employment transition as smooth as possible. Congratulations and welcome to Syneos Health.

Sincerely

/s/ Lisa van Capelle

Lisa van Capelle

Chief Human Resources Officer

 

 

 

By:

/s/ Michael Brooks

Date:

24 September 2020

Name:

Michael Brooks

 

 

 

 

 EX-10.11.7 4 synh-ex10117_431.htm EX-10.11.7 2022 FORM OF PRSU AWARD AGREEMENT US synh-ex10117_431.htm

Exhibit 10.11.7

 

SYNEOS HEALTH, INC.
2018 Equity Incentive Plan

Global Performance Restricted Stock Unit Award Agreement

This Global Performance Restricted Stock Unit Award Agreement including any special terms and conditions for the Participant’s country set forth in Appendix B, attached hereto (the Global Performance Restricted Stock Unit Agreement, the Appendix B and all other appendices attached hereto, collectively, the “Agreement”), is made by and between Syneos Health, Inc., a Delaware corporation (the “Company”), and [Participant Name] (the “Participant”), effective as of [Grant Date] (the “Date of Grant”).

Attention: Attached to this Agreement as Appendix D is a Restrictive Covenants Agreement, which imposes certain restrictions upon you both during and after your employment with the Company.  Attached to this Agreement as Appendix E is a Mutual Arbitration Agreement, which requires you and the Company to arbitrate on an individual basis most disputes arising from or relating to your employment with the Company, as set forth in more detail in the Mutual Arbitration Agreement.  Your acceptance of the Restricted Stock Unit Award requires that you agree to the terms and conditions of this Agreement, the Restrictive Covenants Agreement, and the Mutual Arbitration Agreement.  It is important that you review the terms of each of these Agreements

RECITALS

WHEREAS, the Company has adopted the Syneos Health, Inc. 2018 Equity Incentive Plan (as the same may be amended and/or amended and restated from time to time, the “Plan”), which Plan is incorporated herein by reference and made a part of this Agreement, and capitalized terms not otherwise defined in this Agreement will have the meanings ascribed to those terms in the Plan; and

WHEREAS, the Committee has authorized and approved the grant of an Award to the Participant of Performance Restricted Stock Units payable in shares of Common Stock (the “Shares”), subject to the terms and conditions set forth in the Plan and this Agreement.

NOW THEREFORE, in consideration of the premises and mutual covenants set forth in this Agreement, the parties agree as follows:

1.

Grant of Performance Restricted Stock Units. The Company has granted to the Participant, effective as of the Date of Grant, [Quantity Granted] (the “Target Award”) Performance Restricted Stock Units, on the terms and conditions set forth in the Plan and this Agreement, subject to adjustment as set forth in Section 4.5 of the Plan (the “PRSUs”).

2.

Vesting Eligibility of PRSUs. Subject to the terms and conditions set forth in the Plan and this Agreement, the PRSUs will be eligible for vesting as follows:

 

(a)

General. Except as otherwise provided in Sections 2(b) through 2(e), the PRSUs will vest (i) to the extent the Performance Goals are attained during the Performance Periods as set forth on Appendix A and (ii) as long as the Participant is in Service

1

US-DOCS\119733922.3

 

 

 

from the Date of Grant through the Service Vesting Date. The “Service Vesting Date” means (x) the date on which the Committee determines the attainment level of the Performance Goals for the final Performance Period, or (y) if a Qualifying Event occurs, January 1st of the year following the last Performance Period. The Committee will, promptly after the filing of the Company’s Form 10-K (or other report publicly furnished to the U.S. Securities and Exchange Commission (the “SEC”)) for each of the Performance Periods, review the applicable financial data as reported in the Form 10-K (or such other applicable report) and determine whether and to what extent the Performance Goals for each Performance Period set forth in Appendix A have been attained. On the basis of such determined level of attainment of the Performance Goals, the Committee shall determine the number of PRSUs that are eligible for vesting. Except as otherwise provided in Sections 2(b) through 2(e), PRSUs that do not become eligible for vesting based on the attainment of the Performance Goals become forfeited as of the determination date applicable to the corresponding Performance Period.

 

(b)

Effect of Death and Termination Due to Disability. Upon the Participant’s termination of Service due to Disability or death at any time on or prior to the last day of the last Performance Period, the Participant shall vest in the PRSUs as follows: (i) in the event the termination of Service occurs following a completed Performance Period, the Participant shall vest in the number of PRSUs subject to a Target Award Tranche (as defined in Appendix A) corresponding to such completed Performance Period based on the actual performance attainment level; (ii) in the event the termination of Service occurs during or prior to the commencement of a Performance Period, the Participant shall vest in the number of PRSUs subject to the Target Award Tranche corresponding to such Performance Periods. No fractional Shares shall be issued, and any fractional Shares that would have been deemed vested based on the foregoing calculation shall be rounded down to the next whole Share. In the event of the Participant’s death or termination of Service due to Disability after the last day of the last Performance Period, but prior to settlement of the PRSUs, the PRSUs shall continue to be eligible to vest in the number of PRSUs had the Participant continued in Service through the Service Vesting Date. Any PRSUs that are not eligible to vest upon the Participant’s termination of Service due to Disability or death in accordance with this Section 2(b) shall be forfeited as of such date.

 

(c)

Effect of Retirement. Upon the Participant’s Retirement after the first anniversary of the Date of Grant, but prior to the last day of the last Performance Period, the Participant shall vest in the PRSUs as follows: (i) in the event the Retirement occurs following a completed Performance Period, the Participant shall vest in the number of PRSUs subject to the Target Award Tranche corresponding to such completed Performance Period based on the actual performance attainment level; and (ii) in the event the Retirement occurs during a Performance Period, the Participant shall vest in a number of PRSUs subject to the Pro-Rated Target Award Tranche (defined below) corresponding to such Performance Period. The number of PRSUs that shall vest under the Pro-Rated Target Award Tranche shall be calculated by multiplying (i) the number of PRSUs subject to the Target Award Tranche for the applicable

2

US-DOCS\119733922.3

 

 

Performance Period by (ii) a fraction, the numerator of which shall be the number of days that have elapsed between the first day of such Performance Period and the date of the Participant’s Retirement, and the denominator of which shall be the number of calendar days in such Performance Period. No fractional Shares shall be issued, and any fractional Shares that would have been deemed vested based on the foregoing calculation shall be rounded down to the next whole Share. In the event of the Participant’s Retirement after the last day of the last Performance Period, but prior to settlement of the PRSUs, the PRSUs shall continue to be eligible to vest in the number of PRSUs had the Participant continued in Service through the Service Vesting Date. For the avoidance of any doubt, the remaining PRSUs subject to the Target Award Tranches corresponding to Performance Periods commencing following the date of the Participant’s Retirement shall be forfeited upon the Participant’s Retirement and all of the PRSUs shall be forfeited in the event of the Participant’s Retirement on or before the first anniversary of the Date of Grant. Any PRSUs that are not eligible to vest upon the Participant’s Retirement in accordance with this Section 2(c) shall be forfeited. For purposes of this Agreement, “Retirement” means a voluntary termination of Service on or after the Participant (i) has attained age 55; and (ii) completed 10 years of continuous Service. For purposes of this Section 2(c), a Participant’s Retirement shall not include: (i) a termination by the Company for Cause, as determined in the sole discretion of the Company, (ii) a resignation by the Participant after being notified that the Company has elected to terminate the Participant for Cause, (iii) a termination or resignation by the Participant during the pendency of an investigation with respect to the Participant or while the Participant is on a performance improvement plan, or (iv) any other circumstance upon which the Company determines in good faith the Participant is not in good standing at the time of such termination at the sole discretion of the Company.

Notwithstanding the foregoing, if the Company receives a legal opinion that there has been a legal judgment and/or legal development in the Participant’s jurisdiction that likely would result in the favorable treatment that applies to the PRSUs if the Participant attains the conditions set forth in this Section 2(c) being deemed unlawful and/or discriminatory, the provisions above regarding the treatment of the PRSUs shall not be applicable to the Participant.

 

(d)

Effect of a Qualifying Event. If a Qualifying Event occurs, a number of PRSUs equal to the following shall be converted into time-based RSUs that shall vest on the Service Vesting Date, subject to the Participant’s continued Service through such date: the sum of (i) the PRSUs subject to each completed Performance Period prior to the date of the Qualifying Event that became eligible to vest based on the attainment level of the applicable Performance Goals, plus (ii) the number of PRSUs subject to each Target Award Tranche for each Performance Period that have not yet been completed as of the date of the Qualifying Event (the “Converted Time-Based RSUs”).  

As used in this Agreement, “Qualifying Event” shall mean a Change in Control or a Significant Transaction.

3

US-DOCS\119733922.3

 

As used in this Agreement, a “Significant Transaction” shall mean any transaction, including without limitation a reorganization, merger or consolidation, to which the Company is a party that does not constitute a Change in Control but with respect to which any Persons become the Beneficial Owners, directly or indirectly, of more than forty percent (40%) of the combined voting power of the outstanding voting securities entitled to vote generally in the election of directors (or election of members of a comparable governing body) of the Successor Entity.

 

(e)

Effect of Involuntary Termination in Connection with Change in Control. The Converted Time-Based RSUs shall immediately vest in full in the event of (A) the Participant’s Service is terminated by the Company or a Subsidiary for any reason other than Cause, or (B) the Participant resigns for Good Reason, in each case, at the time of, or within 6 months following, the consummation of a Change in Control (either of such events of termination within such period, a “CIC Termination”).

As used in this Agreement, “Good Reason” shall mean the occurrence, without the Participant’s express written consent, of any of the following events: (i) a material reduction in the Participant’s annual base salary; (ii) a material adverse change to the Participant’s title compared to the Participant’s title immediately prior to the Change in Control; (iii) a requirement that the Participant relocate to a principal place of employment more than fifty (50) miles from the Participant’s assigned principle office location as of immediately prior to the occurrence of the Change in Control; or (iv) if the Participant has an effective employment agreement, service agreement, or other similar agreement with the Company or any Subsidiary, a material breach of such agreement, provided, that, any event described in clauses (i), (ii), (iii) and (iv) above shall constitute Good Reason only if the Participant provides the Company with written notice of the basis for the Participant’s Good Reason within forty-five (45) days of the initial actions or inactions of the Company or any Subsidiary giving rise to such Good Reason and the Company or applicable Subsidiary has not cured the identified actions or inactions within sixty (60) days of such notice, and provided further that the Participant terminates his or her Service within thirty (30) days following the Company’s or applicable Subsidiary’s failure to cure within the 60-day cure period.

Any vesting acceleration contemplated under this Section 2(e) shall be subject to the limitations provided in Section 5.5 of the Plan.

3.

Settlement of PRSUs.

 

(a)

Settlement in Stock. PRSUs that vest pursuant to Section 2 above will be settled by delivering to Participant a number of Shares equal to the number of PRSUs that vest in accordance with the following schedule: (i) within ninety (90) days following the last day of the last Performance Period in the event of a vesting event described in Section 2(a); (ii) within sixty (60) days following the Participant’s termination of Service in the event of a vesting event described in Section 2(b) or 2(c); (iii) in the case of a vesting event described in Section 2(d), within ninety (90) days following the last day of the last Performance Period; (iv) within sixty (60)

4

US-DOCS\119733922.3

 

 

days following the date of the Participant’s Termination of Service in the event of a vesting event described in Section 2(e), in each case, subject to the provisions of Section 15(l). In any case, the Company may provide a reasonable delay in the delivery of the Shares to address Tax-Related Items, withholding, and other administrative matters, provided that any such delay does not result in a violation of Section 409A of the Code. Neither the Company nor the Committee will be liable to the Participant or any other Person for damages relating to any delays in issuing the Shares or any mistakes or errors in the issuance of the Shares.

 

(b)

Book-Entry Registration of the Shares. The Company will deliver the Shares payable pursuant to this Agreement within the settlement period set forth in Section 3(a) by registering such Shares with the Company’s transfer agent (or another custodian selected by the Company) in book-entry form in the Participant’s name.

 

(c)

Shareholder Rights. The Participant will not have any rights of a stockholder with respect to the Shares subject to the PRSUs, including voting and dividend rights, unless and until the Shares are delivered as described in Section 3(b) above.

 

(d)

Responsibility for Taxes. The Participant acknowledges that, regardless of any action taken by the Company or, if different, the Subsidiary employing or retaining the Participant (the “Employer”), the ultimate liability for all Tax-Related Items is and remains the Participant’s responsibility and may exceed the amount actually withheld by the Company or the Employer. The Participant further acknowledges that the Company and/or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the PRSUs, including, but not limited to, the grant or vesting of the PRSUs, the delivery of Shares following the Vesting Date, the subsequent sale of Shares acquired pursuant to such vesting/delivery and the receipt of any dividends and/or dividend equivalents; and (2) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the PRSUs to reduce or eliminate the Participant’s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant is subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Company and/or the Employer (or former Employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

 

(e)

Withholding Requirements. Prior to any relevant taxable or tax withholding event, as applicable, the Participant agrees to make adequate arrangements satisfactory to the Company and/or the Employer to satisfy all Tax-Related Items. In this regard, the Participant authorizes the Company and/or the Employer, or their respective agents, at the Company’s and/or the Employer’s discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following: (1) cash payment by the Participant to the Company prior to the day of vesting of an amount that the Company will apply to the required withholding; (2) withholding from the Participant’s wages or other cash compensation paid to the Participant by the Company and/or the Employer; (3) withholding from

5

US-DOCS\119733922.3

 

 

proceeds of the sale of Shares acquired upon vesting/settlement of the PRSUs either through a voluntary sale or through a mandatory sale arranged by the Company (on the Participant’s behalf pursuant to this authorization); or (4) withholding in Shares to be issued upon settlement of the PRSUs, subject to approval by the Committee if the Participant is subject to the short-swing profit rules of Section 16(b) of the Exchange Act; or (5) any other method of withholding determined by the Company to be permitted under the Plan and, to the extent required by applicable law or under the Plan, approved by the Committee.  For the purposes of alternative (4) above, any Shares withheld shall be credited for purposes of the withholding requirements at the fair market value of the Shares on the date that the tax withholding is determined. Until such time as the Company provides notice to the contrary, it will satisfy any withholding requirements for Tax-Related Items pursuant to alternative (3) above; provided, however, that if such method (A) cannot be processed by the broker or (B) the Participant is subject to the Company’s Insider Trading Compliance Policy (the “Insider Trading Policy”), the sale of Shares pursuant to alternative (3) is prohibited under the Insider Trading Policy and the Participant has not entered into an arrangement that is intended to comply with the requirements of Rule 10b5-1(c)(1) of the Exchange Act and that provides for the sale of all of the Shares subject to this Agreement, the Company will instead collect withholding for Tax-Related Items pursuant to alternative (4).

The Company may withhold or account for Tax-Related Items by considering statutory withholding amounts or other applicable withholding rates, including the maximum applicable rates in the Participant’s jurisdiction(s). In the event of over-withholding, the Participant may receive a refund of any over-withheld amount in cash (with no entitlement to the equivalent amount in Common Stock) from the Company or the Employer.  In the event of under-withholding, the Participant may be required to pay any additional Tax-Related Items directly to the applicable tax authority or to the Company and/or the Employer.  If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant is deemed to have been issued the full number of Shares subject to the vested PRSUs, notwithstanding that a number of the Shares is held back solely for the purpose of paying the Tax-Related Items.

Finally, the Participant agrees to pay to the Company or the Employer, including through withholding from the Participant’s wages or other cash compensation payable to the Participant by the Company and/or the Employer, any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of the Participant’s participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse to issue or deliver the Shares or the proceeds of the sale of Shares, if the Participant fails to comply with the Participant’s obligations in connection with the Tax-Related Items.

In addition, to the extent that any U.S. Federal Insurance Contributions Act tax withholding obligations arise in connection with the PRSUs prior to the applicable vesting or settlement date, the Committee shall accelerate the payment of a portion of the award of PRSUs sufficient to satisfy (but not in excess of) such tax

6

US-DOCS\119733922.3

 

withholding obligations and any tax withholding obligations associated with any such accelerated payment, and the Committee shall withhold such amounts in satisfaction of such withholding obligations pursuant to the tax withholding method noted in alternative (4) above.

4.

Forfeiture. Except as provided in Sections 2(b) through 2(d), all PRSUs (whether eligible for vesting or not) will be forfeited immediately, automatically and without consideration upon a termination of the Participant’s Service for any reason (whether or not later to be found invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant’s employment agreement, if any). In addition, any PRSUs for a given Performance Period which are not eligible for vesting after determination of the attainment of the Performance Goals for such Performance Period will be forfeited as of the date of certification by the Committee and will not carry over to subsequent Performance Periods. Without limiting the generality of the foregoing, the PRSUs and the Shares (and any resulting proceeds) will continue to be subject to Section 13 of the Plan.

5.

Adjustment to PRSUs. In the event of any change with respect to the outstanding Shares contemplated by Section 4.5 of the Plan, the PRSUs may be adjusted in accordance with Section 4.5 of the Plan.

6.

Nature of Grant. In accepting the PRSUs, the Participant acknowledges, understands and agrees that:

 

(a)

the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan; provided, however, that the Mutual Arbitration Agreement set forth at Appendix E is a binding contract that may only be modified, amended, suspended or terminated by further agreement of the parties;

 

(b)

the grant of the PRSUs is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of PRSUs, or benefits in lieu of PRSUs, even if PRSUs have been granted in the past;

 

(c)

all decisions with respect to future PRSUs or other grants, if any, will be at the sole discretion of the Company;

 

(d)

the PRSUs and the Participant’s participation in the Plan shall not create a right to employment or be interpreted as forming an employment or services contract, nor be interpreted as amending the terms of an existing employment or services contract, with the Company or any Subsidiary, including the Employer, if applicable; provided, however, that the Mutual Arbitration Agreement set forth at Appendix E is a binding contract between the parties;

 

(e)

the Participant is voluntarily participating in the Plan;

 

(f)

the PRSUs and the Shares subject to the PRSUs, and the income from and value of same, are not intended to replace any pension rights or compensation;

7

US-DOCS\119733922.3

 

 

(g)

the PRSUs and the Shares subject to the PRSUs, and the income and value of same, are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, holiday pay, long-service awards, pension or retirement or welfare benefits or similar payments;

 

(h)

unless otherwise agreed with the Company, the PRSUs and the Shares subject to the PRSUs, and the income and value of same, are not granted as consideration for, or in connection with, the service that the Participant may provide as a director of a Subsidiary;

 

(i)

the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty;

 

(j)

no claim or entitlement to compensation or damages shall arise from forfeiture of the PRSUs resulting from the termination of the Participant’s Service (for any reason whatsoever whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant’s employment agreement, if any);

 

(k)

the following provision shall not apply to Participants in the state of California: In consideration of the grant of the PRSUs to which the Participant is otherwise not entitled, the Participant irrevocably agrees to release and never to institute any claims which have arisen, occurred or existed at any time prior to the date of this Agreement (“Claim”) against the Company or any of its Subsidiaries, and waives his or her ability, if any, to bring any such Claim; if, notwithstanding the foregoing, any such Claim is allowed by an arbitrator or other tribunal of competent jurisdiction, then, by participating in the Plan, the Participant shall be deemed irrevocably to have agreed not to pursue such Claim and agrees to execute any and all documents necessary to request dismissal or withdrawal of such Claim; and

 

(l)

The following provision applies if the Participant is providing services outside the United States: neither the Company nor any Subsidiary shall be liable for any foreign exchange rate fluctuation between the Participant’s local currency and the United States Dollar that may affect the value of the PRSUs or of any amounts due to the Participant pursuant to the settlement of the PRSUs or the subsequent sale of any Shares acquired upon settlement.

7.

No Advice Regarding Grant. The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Participant’s participation in the Plan, or the Participant’s acquisition or sale of the underlying Shares. The Participant should consult with the Participant’s own personal tax, legal and financial advisors regarding the Participant’s participation in the Plan before taking any action related to the Plan.

8.

Restrictive Covenants. The Participant acknowledges and recognizes that during the course of Participant’s employment with the Company or its Subsidiaries, the Participant will be

8

US-DOCS\119733922.3

 

given access to and become informed of Confidential Information and the Participant will be the beneficiary of the goodwill of the Company and its Subsidiaries, and, accordingly, agrees to the provisions of the Restrictive Covenants Agreement (“RCA”) annexed as Appendix D to this Agreement (the “Restrictive Covenants”). For the avoidance of doubt, the Restrictive Covenants contained in this Agreement are in addition to, and not in lieu of, any other restrictive covenants or similar covenants between the Participant and the Company or any of its Subsidiaries, including the Employer. If Participant breaches any non-competition, confidentiality or other restrictive covenant owed to the Company or any of its Subsidiaries pursuant to the RCA annexed hereto or any other agreement, as determined by the Committee in its sole discretion: (i) any unvested portion of the PRSUs held by the Participant shall be immediately rescinded; and (ii) the Participant shall automatically forfeit any rights that the Participant may have with respect to the PRSUs as of the date of such determination. The foregoing remedies set forth in this Section 8 shall not be the Company’s exclusive remedies. The Company reserves all other rights and remedies available to it at law or in equity.

9.

Data Privacy Provisions Applicable to Participants Outside the European Union/European Economic Area/United Kingdom (“EEA+”).

The Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant’s personal data as described in this Agreement and any other PRSU grant materials by and among, as applicable, the Employer, the Company and its Subsidiaries for the purpose of implementing, administering and managing the Participant’s participation in the Plan.

The Participant understands that the Company and the Employer may hold certain personal information about the Participant, including, but not limited to, the Participant’s name, home address, email address and telephone number, date of birth, passport, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all RSUs, Performance RSUs or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in the Participant’s favor (“Data”), for the exclusive purpose of implementing, administering and managing the Plan.

The Participant understands that Data will be transferred to Fidelity Stock Plan Services, LLC or any other broker selected by the Company, or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan. The Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipients’ country (e.g., the United States) may have different data privacy laws and protections than the Participant’s country. The Participant understands that the Participant may request a list with the names and addresses of any potential recipients of the Data by contacting the Syneos Health, Inc. Human Resources Department (HRSupportServicesAmerica@SyneosHealth.com). The Participant authorizes the Company, Fidelity Stock Plan Services, LLC or any other broker selected by the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing

9

US-DOCS\119733922.3

 

the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purpose of implementing, administering and managing the Participant’s participation in the Plan. The Participant understands that Data will be held only as long as is necessary to implement, administer and manage the Participant’s participation in the Plan. The Participant understands that the Participant may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Syneos Health, Inc. Human Resources Department (HRSupportServicesAmerica@SyneosHealth.com). Further, the Participant understands that the Participant is providing the consents herein on a purely voluntary basis. If the Participant does not consent, or if the Participant later seeks to revoke the Participant’s consent, the Participant’s Service with the Employer will not be affected; the only consequence of refusing or withdrawing the Participant’s consent is that the Company would not be able to grant PRSUs or other equity awards to the Participant or administer or maintain such awards. Therefore, the Participant understands that refusing or withdrawing the Participant’s consent may affect the Participant’s ability to participate in the Plan. For more information on the consequences of the Participant’s refusal to consent or withdrawal of consent, the Participant understands that the Participant may contact the Syneos Health, Inc. Privacy Office (data.privacy@syneoshealth.com).

Finally, upon request by the Company or the Employer, the Participant agrees to provide an executed data privacy consent form (or any other agreements or consents) that the Company and/or the Employer may deem necessary to obtain from the Participant for the purpose of administering the Participant’s participation in the Plan in compliance with the data privacy laws in the Participant’s country, either now or in the future. The Participant understands and agrees that the Participant will not be able to participate in the Plan if the Participant fails to provide any such consent or agreement requested by the Company and/or the Employer.

10.

Data Privacy Provisions Applicable to Participants in the EEA+.

The Company and the Employer hereby notify the Participant of the following in relation to the Participant’s Data (as defined below) and the collection, processing and transfer in electronic or other form of such Data in relation to the grant of PRSUs and the Participant’s participation in the Plan. The collection, processing and transfer of the Participant’s Data is necessary for the legitimate purpose of the Company’s administration of the Plan and the Participant’s participation in the Plan, and the Participant’s denial and/or objection to the collection, processing and transfer of Data may affect the Participant’s participation in the Plan. As such, by participating in the Plan, the Participant acknowledges the collection, use, processing and transfer of Data and with respect to the limited transfer to the third party administrator Fidelity Stock Plan Services, LLC, consents to the transfer of Data as described herein.

The Participant understands that the Company and the Employer will hold certain personal information about the Participant to administer the Plan. This personal information may include, the Participant’s name, home address, email address and

10

US-DOCS\119733922.3

 

telephone number, date of birth, passport, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all RSUs, Performance RSUs or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in the Participant’s favor (“Data”), for the exclusive purpose of implementing, administering and managing the Plan.

The Company and the Employer will transfer Data amongst themselves as necessary for the purpose of implementation, administration and management of the Plan, and the Company and the Employer may each further transfer Data to third parties assisting the Company or the Employer in the implementation, administration and management of the Plan. The Participant understands that Data will be transferred to Fidelity Stock Plan Services, LLC or any other broker selected by the Company, or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan. The Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipients’ country (e.g., the United States) may have different data privacy laws and protections than the Participant’s country. The Participant understands that the Participant may request a list with the names and addresses of any potential recipients of the Data by contacting the Syneos Health, Inc. Human Resources Department (HRSupportServicesAmerica@SyneosHealth.com). For any intragroup transfers of Data outside the EEA or the UK, the transfer will be under the European Commission’s model contracts for the transfer of personal data to third countries  (i.e., the standard contractual clauses) (the “Model Clauses”), or any equivalent contracts issued by the relevant competent authority of the UK (as applicable), unless the data transfer is to a country that has been determined by the European Commission or the relevant UK authorities (as applicable) to provide an adequate level of protection for individuals’ rights and freedoms for their personal data. Please contact the Syneos Health Privacy Office (data.privacy@syneoshealth.com) should you wish to receive a copy of the relevant Model Clauses.  

11.

Data Privacy Provisions Applicable to Participants in all Countries.

Where provided by applicable law, the Participant may have the right to exercise certain rights with respect to their Data, which may be subject to certain limitations and exclusions. For example, these rights may include the right to know what Data is processed, access to Data, rectification of Data, erasure of Data, restriction of processing of Data (including, where applicable, the restriction on the sale of Data), and portability of Data. The Participant may also have the right to object to the processing of Data, as well as to opt-out of the Plan, in any case without cost, by contacting in writing the Syneos Health, Inc. Human Resources Department. The Participant understands, however, that the Participant's participation in the Plan may be limited and the Company and the Employer may not be able to grant the Participant PRSUs or other equity awards or administer or maintain such awards if the Participant refuses to provide Data. The Participant agrees to provide full cooperation in executing data privacy consent forms, agreements or any related documentation that the Company and/or the Employer

11

US-DOCS\119733922.3

 

deem necessary for the purpose of administering the Plan in compliance with the data privacy laws in the Participant’s country, either now or in the future.

When the Company and the Employer no longer need to use Data for the purposes above or do not need to retain it for compliance with any legal or regulatory purpose, each will take reasonable steps to remove Data from their systems and/or records containing the Data and/or take steps to properly anonymize it so that the Participant can no longer be identified from it. Further information concerning the Company’s data retention practices can be found in the Company’s Records Management Policy.

12.

Language. The Participant acknowledges that he or she is sufficiently proficient in English, or has consulted with an advisor who is sufficiently proficient in English, so as to allow the Participant to understand the terms and conditions of this Agreement. Furthermore, if the Participant has received this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

13.

Electronic Delivery and Acceptance. The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.

14.

Imposition of Other Requirements. The Company reserves the right to impose any other requirements on the Participant’s participation in the Plan, on the PRSUs and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require the Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

15.

Appendix B. Notwithstanding any provisions in this Agreement, the PRSUs shall be subject to any additional terms and conditions set forth in Appendix B for the Participant’s country. Appendix B constitutes part of this Performance Restricted Stock Unit Agreement.

16.

Insider Trading Restrictions/Market Abuse Laws. The Participant acknowledges that, depending on the Participant’s or the Participant’s broker’s country of residence or where the Shares are listed, the Participant may be subject to insider trading restrictions and/or market abuse laws, which may affect the Participant’s ability to accept, acquire, sell or otherwise dispose of Shares or rights to Shares or rights linked to the value of Shares (e.g., phantom awards, futures) during such times as the Participant is considered to have “inside information” regarding the Company (as defined by the laws or regulations in the applicable jurisdiction). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders the Participant places before possessing inside information. Furthermore, the Participant could be prohibited from (i) disclosing the inside information to any third party (other than on a “need to know” basis) and (ii) “tipping” third parties or causing them otherwise to buy or sell securities. Keep in mind third parties include fellow employees.

12

US-DOCS\119733922.3

 

Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. The Participant is responsible for complying with any applicable restrictions and should speak with a personal legal advisor on this matter.

17.

Foreign Asset/Account Reporting; Exchange Controls. The Participant’s country may have certain foreign asset and/or account reporting requirements and/or exchange controls which may affect the Participant’s ability to acquire or hold Shares under the Plan or cash received from participating in the Plan (including from any dividends received or sale proceeds arising from the sale of Shares) in a brokerage or bank account outside the Participant’s country. The Participant may be required to report such accounts, assets or transactions to the tax or other authorities in his or her country. The Participant also may be required to repatriate sale proceeds or other funds received as a result of the Participant’s participation in the Plan to his or her country through a designated bank or broker and/or within a certain time after receipt. The Participant acknowledges that it is his or her responsibility to be compliant with such regulations, and the Participant should consult his or her personal legal advisor for any details.

18.

Miscellaneous Provisions

 

(a)

Securities or Exchange Control Laws Requirements. No Shares will be issued or transferred pursuant to this Agreement unless and until all then applicable requirements imposed by U.S. or non-U.S. federal and state securities or exchange control laws, rules and regulations and by any regulatory agencies having jurisdiction, and by any exchanges upon which the Shares may be listed, have been fully met. As a condition precedent to the issuance of Shares pursuant to this Agreement, the Company may require the Participant to take any reasonable action to meet those requirements. The Committee may impose such conditions on any Shares issuable pursuant to this Agreement as it may deem advisable, including, without limitation, restrictions under the U.S. Securities Act of 1933, as amended, under the requirements of any exchange upon which shares of the same class are then listed and under any blue sky or other securities laws applicable to those Shares.

 

(b)

Non-Transferability. The PRSUs and the rights and privileges conferred thereby shall be non-transferrable except as provided by Section 15.3 of the Plan. Any Shares delivered hereunder will be subject to such stop transfer orders and other restrictions as the Committee may deem advisable under the Plan or the rules, regulations and other requirements of the U.S. Securities and Exchange Commission, any stock exchange upon which such shares are listed, any applicable U.S. or non-U.S. federal, state or local laws and any agreement with, or policy of, the Company or the Committee to which the Participant is a party or subject, and the Committee may cause orders or designations to be placed upon any certificate(s) or other document(s) delivered to the Participant, or on the books and records of the Company’s transfer agent, to make appropriate reference to such restrictions.

13

US-DOCS\119733922.3

 

 

(c)

No Right to Continued Service. Nothing in this Agreement or the Plan confers any right or obligation upon the Participant or the Company, or any Subsidiary, including the Employer, to continue the Participant’s employment with the Employer.

 

(d)

Notification. Any notification required by the terms of this Agreement will be given by the Participant (i) in a writing addressed to the Company at its principal executive office and will be deemed effective upon actual receipt when delivered by personal delivery or by registered or certified mail, with postage and fees prepaid, or (ii) by electronic transmission to the Company’s e-mail address of the Company’s General Counsel and will be deemed effective upon actual receipt. Any notification required by the terms of this Agreement will be given by the Company (x) in a writing addressed to the address that the Participant most recently provided to the Company and will be deemed effective upon personal delivery or within three (3) days of deposit with the United States Postal Service or non-U.S. equivalent, by registered or certified mail, with postage and fees prepaid; or (y) by facsimile or electronic transmission to the Participant’s primary work fax number or e-mail address (as applicable) and will be deemed effective upon confirmation of receipt by the sender of such transmission.

 

(e)

Entire Agreement. This Agreement and the Plan constitute the entire agreement between the parties hereto with regard to the subject matter of this Agreement. This Agreement and the Plan supersede any other agreements, representations or understandings (whether oral or written and whether express or implied) that relate to the subject matter of this Agreement.

 

(f)

Waiver. No waiver by the Company of any breach or condition of this Agreement by the Participant or any other Participant will be deemed to be a waiver by the Company of any other or subsequent breach or condition whether of like or different nature.

 

(g)

Successors and Assigns. The provisions of this Agreement will inure to the benefit of, and be binding upon, the Company and its successors and assigns and upon the Participant, the Participant’s executor, personal representative(s), distributees, administrator, permitted transferees, permitted assignees, beneficiaries, and legatee(s), as applicable, whether or not any such person will have become a party to this Agreement and have agreed in writing to be joined herein and be bound by the terms hereof.

 

(h)

Severability. Except as provided in the Mutual Arbitration Agreement, the provisions of this Agreement are severable, and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, then the remaining provisions will nevertheless be binding and enforceable.

 

(i)

Amendment. Except as otherwise provided in the Plan or the Mutual Arbitration Agreement, this Agreement will not be amended unless the amendment is agreed to in writing by both the Participant and the Company.

14

US-DOCS\119733922.3

 

 

(j)

Choice of Law; Jurisdiction. Except as provided in the Mutual Arbitration Agreement, this Agreement and all claims, causes of action or proceedings (whether in contract, in tort, at law or otherwise) that may be based upon, arise out of or relate to this Agreement will be governed by the internal laws of the State of Delaware, excluding any conflicts or choice-of-law rule or principle that might otherwise refer construction or interpretation of this Agreement to the substantive law of another jurisdiction.

 

(k)

Signature in Counterparts. This Agreement may be signed in counterparts, manually or electronically, each of which will be an original, with the same effect as if the signatures to each were upon the same instrument.

 

(l)

IRC Section 409A. This Section 18(l) applies only to Participants who are U.S. taxpayers.

Anything in this Agreement to the contrary notwithstanding, PRSUs that are non-qualified deferred compensation subject to Section 409A of the Code and that vest as a result of the Participant’s termination of employment under Section 2(b), 2(c) or 2(e) hereof shall be settled within sixty (60) days following the Participant experiences a “separation from service,” within the meaning of Section 409A of the Code (“Separation from Service”). With respect to PRSUs that are settled as a result of the Participant’s termination of employment under Appendix C, any such PRSUs that are non-qualified deferred compensation subject to Section 409A, shall be settled within 60 days following the Separation from Service or Change in Control, provided that if the Change in Control is not a “change in control event” (within the meaning of the Treasury Regulations promulgated under Section 409A of the Code), the PRSUs shall be settled as described in Section 3(a)(i). If the Participant is a “specified employee” within the meaning of Section 409A of the Code as of the date of the Separation from Service (as determined in accordance with the methodology established by the Company as in effect on the Date of Termination), any PRSUs that are non-qualified deferred compensation that are payable upon a Separation from Service shall instead be settled on the first business day that is after the earlier of (i) the date that is six months following the date of the Participant’s Separation from Service or (ii) the date of the Participant’s death, to the extent such delayed payment is otherwise required in order to avoid a prohibited distribution under Section 409A(a)(2) of the Code, or any successor provision thereto.

 

(m)

Acceptance. The Participant hereby acknowledges receipt of a copy of the Plan and this Agreement, together with any appendices hereto. The Participant has read and understands the terms and provisions of the Plan and this Agreement, as well as the attached Restrictive Covenants Agreement and Mutual Arbitration Agreement and accepts the PRSUs subject to all of the terms and conditions of the Plan and these Agreements. In the event of a conflict between any term or provision contained in this Agreement and a term or provision of the Plan, the applicable term and provision of the Plan will govern and prevail. The Participant must accept this Agreement electronically pursuant to the online acceptance procedure established by the Company within 30 days after the Agreement is presented

15

US-DOCS\119733922.3

 

 

to the Participant for review. If the Participant fails to accept the Agreement within such 30-day period, the Company may, in its sole discretion, rescind the Award in its entirety. By electronically accepting the Agreement, the Participant is also accepting the Restrictive Covenants Agreement and Mutual Arbitration Agreement, and this Award is granted under and governed by the terms and conditions of the Plan and these Agreements.

[Signature page follows]

 

16

US-DOCS\119733922.3

 

 

IN WITNESS WHEREOF, the Company and the Participant have executed this Global Performance Restricted Stock Unit Award Agreement and any appendices thereto as of the date first written above.

 

 

 

SYNEOS HEALTH, INC.

 

By:

Name:

Title:

/s/ Alistair Macdonald

Alistair Macdonald

Chief Executive Officer

PARTICIPANT

[Electronic Signature]

________________________________
Participant Signature
Name: [Participant Name]
Acceptance Date: [Acceptance Date]

 

 

 

 

Signature Page to Performance Restricted Stock Unit Award Agreement

US-DOCS\119733922.3

 

 

APPENDIX A

PERFORMANCE GOALS FOR PRSU VESTING ELIGIBILITY

The vesting eligibility of the PRSUs granted pursuant to the attached Global Performance Restricted Stock Unit Award Agreement will be determined by the Committee in accordance with the Plan and this Appendix A.  The ROIC Performance Goal and each Adjusted EPS Performance Goal shall be referred to, collectively, as the “Performance Goals”.

ROIC Performance Goal

50% of the Target Award amount granted in Section 1 above (the “ROIC Target Award Tranche”) shall be eligible to vest based on the attainment of ROIC measured against the performance goals stated in the table below for the performance period beginning on (and including) [  ] and ending on (and including) [  ] (the “ROIC Performance Period”):

 

ROIC [  ]

Percentage of ROIC Target Award Tranche Eligible for Vesting

 

0% of ROIC Target Award

Tranche

 

50% of ROIC Target Award

Tranche

 

100% of ROIC Target Award

Tranche

 

150% of ROIC Target Award

Tranche

 

Adjusted EPS Performance Goals

50% of the Target Award amount granted in Section 1 above shall be eligible to vest based on the attainment of Adjusted EPS performance goals (the “Adjusted EPS PRSUs”), as set forth below.

The number of Adjusted EPS PRSUs that will be eligible for vesting in accordance with Section 2(a) of the Agreement shall be equal to the sum of A + B + C, where:

A =

number of Adjusted EPS PRSUs subject to an Adjusted EPS Target Award Tranche (as defined below) x the [  ] EPS Performance Attainment Factor (set forth below)

B =

number of Adjusted EPS PRSUs subject to an Adjusted EPS Target Award Tranche x the [  ] EPS Performance Attainment Factor (set forth below)

C =

number of Adjusted EPS PRSUs subject to an Adjusted EPS Target Award Tranche x the [  ] EPS Performance Attainment Factor (set forth below)

Performance Periods: With respect to the Adjusted EPS PRSUs, there will be three performance periods (each a “Adjusted EPS Performance Period”), as described in the below table, in which

Appendix A – Performance Restricted Stock Unit Award Agreement

US-DOCS\119733922.3

 

one-sixth (1/6) of the Target Award amount granted in Section 1 above (a “Adjusted EPS Target Award Tranche”) will be measured against the Performance Goals stated in the table below for such Adjusted EPS Performance Period.

 

Adjusted EPS Performance Period

 

Dates

 

 

Performance Goals

Units Subject to the Performance Goal

[  ] Performance Period

 

[  ]

 

[  ] Adjusted EPS

 

One Adjusted EPS Target Award Tranche

[  ] Performance Period

 

[  ]

 

[  ] Adjusted EPS

 

One Adjusted EPS Target Award Tranche

[  ] Performance Period

 

[  ]

 

[  ] Adjusted EPS

 

One Adjusted EPS Target Award Tranche

 

Company Adjusted EPS: One Adjusted EPS Target Award Tranche will be eligible for vesting based upon the Company’s Adjusted EPS for each Adjusted EPS Performance Period based on the following schedules:

[  ] Adjusted EPS

% of Adjusted EPS Target

[  ] EPS Performance Attainment Factor

[  ]

[  ]

0% of Adjusted EPS Target

Award Tranche

[  ]

[  ]

50% of Adjusted EPS Target

Award Tranche

[  ]

[  ]

100% of Adjusted EPS Target

Award Tranche

[  ]

[  ]

150% of Adjusted EPS Target Award Tranche

 

[  ] Adjusted EPS

% of Adjusted EPS Target

[  ] EPS Performance Attainment Factor

[  ]

[  ]

0% of Adjusted EPS Target

Award Tranche

[  ]

[  ]

50% of Adjusted EPS Target

Award Tranche

[  ]

[  ]

100% of Adjusted EPS Target

Award Tranche

[  ]

[  ]

150% of Adjusted EPS Target

Award Tranche

Appendix A – Performance Restricted Stock Unit Award Agreement

US-DOCS\119733922.3

 

 

 

 

[  ] Adjusted EPS

% of Adjusted EPS Target

[  ] EPS Performance Attainment Factor

[  ]

[  ]

0% of Adjusted EPS Target

Award Tranche

[  ]

[  ]

50% of Adjusted EPS Target

Award Tranche

[  ]

[  ]

100% of Adjusted EPS Target

Award Tranche

[  ]

[  ]

150% of Adjusted EPS Target

Award Tranche

 

General:

Subject to the minimum threshold requirements, linear interpolation will be used based on the level of attainment of the performance goal between vesting levels.

The Committee shall calculate and determine the level of achievement of the performance goals in its sole discretion, which shall be final and binding on all parties to the Agreement.

All amounts used to calculate and determine the level of achievement shall be in USD, with any currency conversions being determined by the Committee is its sole discretion.

Definitions:

“Adjusted EPS” means, for a given Adjusted EPS Performance Period, the Company’s Adjusted Diluted Earnings per share as reported in the applicable earnings release attached as an exhibit to the Company’s Report on Form 8-K for the applicable Adjusted EPS Performance Period.

“Performance Period” means an Adjusted EPS Performance Period or the ROIC Performance Period.

“ROIC” is defined as, with respect to the ROIC Performance Period, Non-GAAP Income from Operations calculated in a manner consistent with the calculation of Adjusted EBITDA as reported in the earnings release attached as an exhibit to the Company’s Report on Form 8-K with respect to the last fiscal year in the ROIC Performance Period, affected by the cash tax rate, divided by the end of period Invested Capital. For purposes of this paragraph, “Invested Capital” is defined as the sum of Total Debt (inclusive of finance lease obligations) as reported in the Company’s Annual Report on Form 10-K and Total Shareholders’ Equity (adjusted for cumulative Share-Based Compensation). The Committee may adjust the ROIC to account for the impact of all (i) mergers, divestitures, and/or acquisitions completed during the ROIC Performance Period, and (ii) changes in tax policy and/or legislation that occur during the ROIC Performance Period.

“Target Award Tranche” means any Adjusted EPS Target Award Tranche or the ROIC Target Award Tranche.

 

Appendix A – Performance Restricted Stock Unit Award Agreement

US-DOCS\119733922.3

 

 

APPENDIX B

SYNEOS HEALTH, INC.

2018 Equity Incentive Plan

Global Performance Restricted Stock Unit Award Agreement

Country-Specific Terms and Conditions

Capitalized terms used but not otherwise defined herein shall have the meaning given to such terms in the Syneos Health, Inc. 2018 Equity Incentive Plan (the “Plan”) and the Global Performance Restricted Stock Unit Award Agreement (the “Performance Restricted Stock Unit Agreement”). This Appendix constitutes part of the Performance Restricted Stock Unit Agreement.

Terms and Conditions

This Appendix B includes additional terms and conditions that govern the PRSUs granted to the Participant if the Participant resides and/or works in a country listed below. If the Participant moves to another country after receiving the grant of the PRSUs, the Company will, in its discretion, determine the extent to which the terms and conditions herein will be applicable to the Participant.

Notifications

This Appendix B also includes information regarding exchange controls and certain other issues of which the Participant should be aware with respect to the Participant’s participation in the Plan. The information is based on the securities, exchange control and other laws in effect in the respective countries as of June 2018. Such laws are often complex and change frequently. As a result, the Company strongly recommends that the Participant not rely on the information in this Appendix B as the only source of information relating to the consequences of the Participant’s participation in the Plan because the information may be out of date at the time that the PRSUs vest or the Participant sells Shares acquired under the Plan.

In addition, the information contained herein is general in nature and may not apply to the Participant’s particular situation and the Company is not in a position to assure the Participant of a particular result. Accordingly, the Participant should seek appropriate professional advice as to how the relevant laws in the Participant’s country may apply to the Participant’s situation.

Finally, if the Participant is a citizen or resident of a country other than the one in which he or she is currently residing and/or working (or if the Participant is considered as such for local law purposes), the information contained herein may not be applicable to the Participant in the same manner.

 

Appendix B – Performance Restricted Stock Unit Award

US-DOCS\119733922.3

 

 

UNITED KINGDOM

Terms and Conditions

Responsibility for Taxes. The following provisions supplement Section 3 of the Performance Restricted Stock Unit Agreement:

Without limitation to Section 3 of the Performance Restricted Stock Unit Award Agreement, the Participant agrees that the Participant is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items, as and when requested by the Company or the Employer or by Her Majesty’s Revenue and Customs (“HMRC”) (or any other tax authority or any other relevant authority). The Participant also agrees to indemnify and keep indemnified the Company and the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on the Participant’s behalf.

Notwithstanding the foregoing, if the Participant is a director or executive officer of the Company (within the meaning of Section 13(k) of the Exchange Act), the immediately foregoing provision will not apply; instead, the amount of any uncollected income tax may constitute a benefit to the Participant on which additional income tax and national insurance contributions may be payable. The Participant is responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for paying the Company or the Employer (as applicable) for the value of any employee national insurance contributions due on this additional benefit.

 

Appendix B – Performance Restricted Stock Unit Award

US-DOCS\119733922.3

 

 

APPENDIX C

SYNEOS HEALTH, INC.

2018 Equity Incentive Plan

Global Restricted Stock Unit Award Agreement

Special Provisions for Certain Executive Officers

The provisions in this Appendix C apply only to Participants in the Syneos Health, Inc.
Executive Severance Plan (as defined below).

1. Involuntary Termination in connection with Change in Control.

This provision replaces Section 2(e) of the Performance Restricted Stock Unit Agreement:

 

(e)

Effect of Involuntary Termination in connection with Change in Control.

The Converted Time-Based RSUs shall immediately vest in full in the event of (A) the Participant’s Service is terminated by the Company or a Subsidiary for any reason other than Cause, or (B) the Participant resigns for Good Reason, in each case, at the time of, or during the period commencing on the date three (3) months prior to a Change in Control and ending twenty-four (24) months following such Change in Control (either of such events of termination within such period, a “CIC Termination”).

 

(i)

For purposes of this Agreement (including Section 2(d)), “Cause,” “Change in Control,” and “Good Reason” shall have the meanings ascribed to such terms in the Syneos Health, Inc. Executive Severance Plan, adopted September 15, 2016, as amended and restated August 20, 2018 (the “Executive Severance Plan”).

 

(ii)

This Section 2(e) shall be interpreted consistently with the provisions of the Executive Severance Plan to give effect to the benefits intended to be provided under the Executive Severance Plan, to the extent the Executive Severance Plan is applicable to the Participant. Further, the vesting acceleration benefits provided under this Section 2(e) shall be subject to the conditions set forth in the Executive Severance Plan, to the extent the Executive Severance Plan is applicable to the Participant.

 

(iii)

Any vesting acceleration provisions contemplated under this Section 2(e) shall be subject to the limitations provided in Section 5.5 of the Plan.

 

(iv)

Any PRSUs that vest pursuant to this Section 2(e) shall also be subject to the additional settlement provisions and subject to the conditions set forth in the Executive Severance Plan, to the extent the Executive Severance Plan is applicable to the Participant.

 

Appendix C – Performance Restricted Stock Unit Award Agreement

US-DOCS\119733922.3

 

 

APPENDIX D

RESTRICTIVE COVENANTS AGREEMENT

The Participant acknowledges and agrees that in light of the Participant’s access to Confidential Information and Participant’s position of trust and confidence with the Company or its Subsidiaries, Participant shall be subject to the restrictive covenants set forth herein. The Participant knows that the promises in this Restrictive Covenants Agreement (“RCA”) are an important way for the Company and its Subsidiaries to protect their proprietary interests and understands that the terms of this RCA are affected by the location in which the Participant is employed, as stated in Attachment A and Attachment B to this RCA. As a condition of the grant of the PRSUs, the Participant agrees as follows:

1.Definitions. Capitalized terms not otherwise defined in this RCA shall have the same meanings as set forth in the Syneos Health, Inc. 2018 Equity Incentive Plan, and the Global Performance Restricted Stock Unit Award Agreement (including the Appendix B and any other appendix attached thereto). The following terms shall have the following meanings for the purposes of this RCA:

(a)“Termination Date” means the last day of the Participant’s employment by the Company or any of its Subsidiaries.

(b)“Non-Solicit Restricted Period” means the period commencing on the Termination Date and ending twelve (12) months after the Termination Date.

(c)“Non-Compete Restricted Period” means the period commencing on the Termination Date and ending twelve (12) months after the Termination Date.

(d)“Company Customer” means a person or entity for whom the Company or any of its Subsidiaries was providing services either at the time of, or at any time within the twelve (12) months preceding the Termination Date, and for whom the Participant had direct contact with and/or carried out or oversaw a material business responsibility during said twelve (12) month period or about whom the Participant had exposure to or received Confidential Information as a result of the Participant’s employment with the Company or any of its Subsidiaries.

(e)“Prospective Customer” means a person or entity (i) that the Participant contacted for the purpose of soliciting business on behalf of the Company or any of its Subsidiaries during the twelve (12) months preceding the Termination Date; or (ii) to which the Company or any of its Subsidiaries had submitted a bid or proposal for services during the twelve (12) months preceding the Termination Date, and in which bid or proposal the Participant was involved in any material respect.

(f)“Company Person” means any person who is an employee of or consultant to the Company or any of its Subsidiaries as of the Termination Date.

(g)“Company Business” means (i) developing, marketing, selling and/or providing services to pharmaceutical, biotechnology, life sciences, medical device and medical diagnostic companies regarding: (A) the commercialization of pharmaceuticals, biologics, medical devices

D-1

US-DOCS\119733922.3

 

or diagnostic products, including, but not limited to, outsourced sales and related operations, marketing, naming/branding, advertising, public relations, medical communications and medication adherence services for the Company’s clients, (B) the provision of clinical trials and related support services including, but not limited to, bioanalysis, biostatistics, data management, feasibility studies, global safety and pharmacovigilance, laboratory operations, medical writing, project management, protocol and case report form design, quality assurance, regulatory affairs and consulting, medical oversight, risk management, site and patient recruitment, site management, strategic planning, study monitoring and late stage services for the Company’s clients, (C) the staffing of clinical trial and/or clinical research and development personnel for the Company’s clients, and (D) the provision of consulting services including, but not limited to, brand management, business development, clinical development, commercial strategy and organizational design, product launch planning, medical affairs, pricing and market access and risk evaluation and mitigation strategy for the Company’s clients; and (ii) any other business that the Company and its Subsidiaries engage in, or that the Company and its Subsidiaries have developed definitive plans to engage in, as of the Termination Date.

(h)“Restricted Area” means the following geographical areas: (i) any city, metropolitan area, county (or similar political subdivision in foreign countries) in which the Participant personally provided material services on behalf of the Company during the twelve (12) months prior to the Termination Date; (ii) within a 60-mile radius of the location(s) where the Participant had an office during the twelve (12) months prior to the Termination Date; (iii) within a 60 mile radius of Raleigh, North Carolina; and (iv) any city, metropolitan area, county (or similar political subdivision in foreign countries) in which the Company or any of its Subsidiaries is located or does or did business, during the twelve (12) months prior to the Termination Date.

(i)“Confidential Information” means without limitation, any confidential or proprietary information or materials of the Company or its Subsidiaries, whether of a technical, business, or other nature, including information and materials which relate to operations, processes, products, promotional material, developments, patent applications, formulas, sponsor or client lists, manufacturing processes, trade secrets, basic scientific data, data systems, employment policies, formulation information, budgets, bids, proposals, study protocols, coding devices, and any other confidential data or proprietary information in connection with the Company, its Subsidiaries or their business affairs, including but not limited to any information relating to the operation of the Company’s and/or its Subsidiaries’ business which the Company or its Subsidiaries may from time to time designate as confidential or proprietary or that Participant reasonably knows should be, or has been, treated by the Company and/or its Subsidiaries as confidential or proprietary. Confidential Information encompasses all formats in which information is preserved, whether electronic, print or in any other form, including all originals, copies, notes or other reproductions or replicas thereof. Any trade secrets of the Company or its Subsidiaries will be entitled to all of the protections and benefits under any applicable trade secrets law, whether statutory or common law, including but not limited to the Delaware Uniform Trade Secrets Act, Del. Code Ann. tit. 6, §§ 2001–2009, the North Carolina Trade Secrets Protection Act, N.C. Gen. Stat. §§ 66-152 et seq., the Massachusetts Uniform Trade Secrets Act, M.G.L. ch. 93, §§ 42 to 42G, and the California Uniform Trade Secrets Act, Cal. Civ. Code §§ 3426 et seq. If any information that the Company deems to be a trade secret is found by a court of competent jurisdiction not to be a trade secret, such information will, nevertheless, be considered Confidential Information for purposes of this RCA.

D-2

US-DOCS\119733922.3

 

Notwithstanding the foregoing, the term “Confidential Information” shall not include information which (i) is already known to the Participant prior to its disclosure to the Participant by the Company; (ii) is or becomes generally available to the public through no wrongful act of any person; (iii) is at the time of disclosure part of the public knowledge or literature through no wrongful action by the Participant; or (iv) is received by the Participant from a third party without restriction and without any wrongful conduct on the part of such third party relating to such disclosure. The Participant acknowledges and agrees that the Confidential Information he/she obtains or becomes aware of as a result of his/her employment with the Company or any of its Subsidiaries is not generally known or available to the general public, but has been developed, compiled or acquired by the Company at its great effort and expense and that the Participant is required to protect and not disclose such information.

(j)“Subsidiary” or “Subsidiaries” means any corporation, partnership, limited liability company, joint venture, association, public or private limited company or other business entity at least 50% of the outstanding voting stock or voting interests of which is at the time owned or controlled, directly or indirectly, by the Company.

2.Non-Solicitation of Customers and Employees. The Participant agrees that during the Participant’s employment with the Company or any of its Subsidiaries and during the Non-Solicit Restricted Period, the Participant will not, on the Participant’s own behalf, nor as an officer, director, stockholder, partner, associate, employee, owner, executive, consultant or otherwise on behalf of any person, firm, partnership, corporation, or other entity:

(a)solicit, induce, influence or attempt to solicit, induce or influence any Company Customer to (i) cease doing business in whole or in part with the Company and/or its Subsidiaries, or to otherwise limit or reduce its business with the Company and/or its Subsidiaries, (ii) purchase or accept products or services competitive with those offered by the Company and/or its Subsidiaries from any person or entity (other than the Company and/or its Subsidiaries), or (iii) do business with any other person or business that is Competitive with the Company;

(b)solicit, induce, influence or attempt to solicit, induce or influence any Prospective Customer to (i) cease doing business in whole or in part with the Company and/or its Subsidiaries, or to otherwise limit or reduce its business with the Company and/or its Subsidiaries, (ii) purchase or accept products or services competitive with those offered by the Company and/or its Subsidiaries from any person or entity (other than the Company and/or its Subsidiaries), or (iii) do business with any other person or business that is Competitive with the Company;

(c)provide or sell any products or services competitive with those offered by the Company and/or its Subsidiaries to any Company Customer;

(d)provide or sell any products or services competitive with those offered by the Company and/or its Subsidiaries to any Prospective Customer;

(e)interfere with, disrupt or attempt to interfere with or disrupt the relationship, contractual or otherwise, that the Company and/or its Subsidiaries have with any sponsor, supplier, vendor, distributor, lessor, lessee, licensor or business partner that transacts business with the Company and/or its Subsidiaries;

D-3

US-DOCS\119733922.3

 

(f)solicit, induce, encourage, entice or attempt to solicit, induce, encourage or entice any Company Person to terminate or alter his or her employment or engagement with the Company or any of its Subsidiaries; or

(g)employ or hire as an officer, director, employee, agent, consultant or independent contractor any Company Person.

3.Non-Competition.

(a)The Participant agrees that, during the Participant’s employment with the Company or any of its Subsidiaries, and during the Non-Compete Restricted Period, the Participant will not, within the Restricted Area, for the Participant’s own behalf or for any other person or entity, own, manage, operate or participate in the ownership, management, operation or control of, or be employed by or provide services to, any person, business or entity which competes with the Company Business if Participant would:

(i)have responsibilities or perform services that are entirely or substantially similar to the responsibilities or services that the Participant had or provided at the time of, or at any time within the twelve (12) months preceding the Termination Date;

(ii)be involved in creating, developing, modifying, accessing, utilizing or relying upon confidential information that is similar or relevant to that Confidential Information to which Participant created, developed, modified, accessed, utilized or relied upon during the Participant’s employment with the Company or any of its Subsidiaries; or

(iii)use, disclose, or engage in activity in which the Participant would be reasonably expected to use or disclose any Confidential Information.

(b)Notwithstanding the foregoing, the Participant’s ownership, directly or indirectly, of not more than one percent (1%) of the issued and outstanding stock of a corporation the shares of which are regularly traded on a national securities exchange or in the over-the-counter market shall not violate this Section.

4.Business Opportunities. The Participant, while he or she is employed by the Company and its Subsidiaries, agrees to offer or otherwise make known or available to the Company or any Subsidiary, as directed by the Company and without additional compensation or consideration, any business prospects, contracts or other business opportunities that he or she may discover, find, develop or otherwise have available to him or her in any field in which the Company or any of its Subsidiaries is engaged, and further agrees that any such prospects, contracts or other business opportunities shall be the property of the Company.

5.Confidentiality.

(a)The Participant acknowledges that during his or her employment with the Company, he or she has and will necessarily become informed of, and have access to, the Confidential Information of the Company, and that the Confidential Information, even though it may be contributed, developed or acquired in whole or in part by the Participant is the Company’s exclusive property to be held by the Participant in trust and solely for the Company’s benefit.

D-4

US-DOCS\119733922.3

 

Accordingly, except as required by law, the Participant shall not, at any time, either during or subsequent to his or her employment, as applicable, use, reveal, report, publish, copy, transcribe, transfer or otherwise disclose to any person, corporation or other entity, any of the Confidential Information without the prior written consent of the Company, except to responsible officers and employees of the Company and its Subsidiaries and other responsible persons who are in a contractual or fiduciary relationship with the Company or one of its Subsidiaries and except for information that legally and legitimately is or becomes of general public knowledge from authorized sources other than the Participant.

(b)This RCA shall not prevent Participant from (i) reporting, without prior approval from the Company, possible violations of federal securities laws or regulations to any governmental agency or entity, including but not limited to, the Department of Justice, the Securities and Exchange Commission, the Congress, and any Inspector General, or making other disclosures that are protected under the whistleblower provisions of federal law or regulation; (ii) filing a charge of discrimination with the Equal Employment Opportunity Commission; (iii) cooperating with the Equal Employment Opportunity Commission in an investigation of alleged discrimination; (iv) revealing evidence of criminal wrongdoing to law enforcement; (v) testifying in any cause of action when required to do so by law, or (vi) divulging Confidential Information pursuant to an order of court or agency of competent jurisdiction. However, with respect to (v) and (vi) only, Participant must promptly inform the Company of any such situations and shall take such reasonable steps to prevent disclosure of the Company’s Confidential Information until the Company has been informed of such requested disclosure and the Company has had an opportunity to respond to the court or agency.

Further, 18 U.S.C. § 1833(b) states: “An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that—(A) is made—(i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.” Accordingly, the parties to this RCA have the right to disclose in confidence trade secrets to federal, state, and local government officials, or to an attorney, for the sole purpose of reporting or investigating a suspected violation of law. The parties also have the right to disclose trade secrets in a document filed in a lawsuit or other proceeding, but only if the filing is made under seal and protected from public disclosure. Nothing in this RCA is intended to conflict with 18 U.S.C. § 1833(b) or create liability for disclosures of trade secrets that are expressly allowed by 18 U.S.C.§ 1833(b).

6.Prior Restrictive Covenants. The restrictive covenants contained in this RCA are in addition to, and not in lieu of, any other restrictive covenants between the Participant and the Company or any of its Subsidiaries. For the avoidance of doubt, any and all of the Participant’s restrictive covenants agreed to prior to entering into this RCA (“Prior Restrictive Covenants”) will survive and supersede the restrictive covenants set forth in this RCA to the extent that any Prior Restrictive Covenant is for a longer period of time or is more restrictive in scope or location than the restrictive covenants set forth in this RCA. A breach of any such Prior Restrictive Covenant will also constitute a breach of this RCA.

D-5

US-DOCS\119733922.3

 

7.Injunctive Relief and Tolling. Participant acknowledges and agrees that if Participant breaches any of the provisions of Sections 2 through 6 hereof, it will cause irreparable damage to the Company and/or its Subsidiaries for which monetary damages alone will not constitute an adequate remedy. In the event of such breach or threatened breach, the Company shall be entitled as a matter of right (without being required to prove damages or furnish any bond or other security) to obtain a restraining order or an injunction to preserve or restore the status quo pending arbitration under the Mutual Arbitration Agreement, and will additionally be entitled to an award of attorneys’ fees incurred in connection with securing any relief hereunder. Such right to equitable or extraordinary relief shall not be exclusive but shall be in addition to all other rights and remedies to which the Company may be entitled at law or in equity, including, without limitation, the right to recover monetary damages for the breach by Participant of any of the provisions of this RCA. Further, Participant understands that if Participant breaches any of the provisions in Sections 2 through 6 of this RCA, the applicable restricted period will be extended for a period of time equal to the period of time Participant spent in breach of this RCA. If the Company is required to seek injunctive relief from such breach, then the applicable restricted period shall be extended for a period of time equal to the pendency of such proceedings, including all appeals.

8.Termination. Participant may terminate the employment relationship for any reason at any time upon giving the Company thirty (30) days prior written notice, as applicable law permits. In the case of a termination by the Company other than a termination for Cause (as defined in the Plan), the Company will provide thirty (30) days prior written notice of termination, as applicable law permits. In each case, the Company may, in its discretion, relieve the Participant of some or all of his/her duties during all or a part of such notice period. Subject to the forgoing notice obligation, the Participant’s employment with the Company shall remain at will, as applicable law permits.

9.Return of Company Property. By no later than the Termination Date, the Participant shall promptly deliver to the Company all property and possessions of the Company and its Subsidiaries, including all drawings, manuals, letters, notes, notebooks, reports, copies, deliverables containing Confidential Information and all other materials relating to the Company and any of its Subsidiaries’ business that are in the Participant’s possession or control.

10.Governing Law, Forum. Except as provided in any Mutual Arbitration Agreement, this RCA and all disputes, claims or controversies arising out of or related to this RCA, shall be governed (i) for U.S. Participants, by the laws of the State of Delaware without regard for reference to any choice or conflict of law principles of any jurisdiction. The parties agree that any proceeding seeking temporary or preliminary injunctive relief to preserve or restore the status quo pending arbitration of any disputes, claims or controversies arising out of or related to this RCA shall be brought exclusively in the state or federal courts in the State of Delaware, and the Participant voluntarily submits to the exclusive jurisdiction over the Participant’s person by a court of competent jurisdiction located within the State of Delaware. The parties hereby irrevocably waive any objection they may now or hereafter have to the laying of venue of any such proceeding in the State of Delaware, and further irrevocably waive any claim they may now or hereafter have that any such proceeding brought in said court(s) has been brought in an inconvenient forum. (ii) for Participants employed outside of the U.S, by the laws of the country in which Participant is employed without regard for reference to any choice or conflict of law principles of any

D-6

US-DOCS\119733922.3

 

jurisdiction, and the parties agree that any action or proceeding with respect to this RCA or the Participant’s employment with the Company shall be brought exclusively in the courts in the country in which the Participant is employed.

11.Amendment, Modification or Waiver. This RCA may not be changed orally, and no provision of this RCA may be amended or modified unless such amendment or modification is in writing, signed by the Participant and by a duly authorized officer of the Company. No act or failure to act by the Company will waive any right, condition or provision contained herein. Any waiver by the Company must be in writing and signed by a duly authorized officer of the Company to be effective.

12.Severability. In case any one or more of the provisions contained in this RCA shall, for any reason, be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provisions of this RCA, but this RCA shall be construed as if such invalid, illegal, or other unenforceable provision had never been contained herein. If, moreover, any one or more of the provisions contained in this RCA shall for any reason be held to be excessively broad as to duration, geographical scope or subject, it shall be construed by limiting it and reducing it so as to be enforceable to the extent compatible with applicable law as it shall then appear.

13.Miscellaneous.

(a)The Participant’s and the Company’s obligations hereunder shall continue in full force and effect in the event that the Participant’s job title, responsibilities, work location or other conditions of his/her employment with the Company change subsequent to the execution of the RCA, without the need to execute a new RCA.

(b)Participant agrees to provide a copy of Sections 1 through 6 of this RCA to any subsequent employers or prospective employers during the applicable period of restriction (including but not limited to the Non-Solicit Restricted Period and the Non-Compete Restricted Period). The Participant specifically authorizes the Company to notify any subsequent employers or prospective employers of the Participant of the restrictions on the Participant contained in this RCA and of any concerns the Company may have about actual or possible conduct by the Participant that may be in breach of this RCA. The Participant agrees to promptly notify the Company of any offers to perform services, any engagements to provide services, and/or actual work of any kind, whether as an individual, proprietor, partner, stockholder, officer, employee, director, consultant, joint venturer, investor, lender, or in any other capacity whatsoever during the period of his/her employment by the Company or any of its Subsidiaries and during the Non-Solicit Restricted Period and the Non-Compete Restricted Period. Such notice must be provided prior to the commencement of any such services or work.

(c)The rights and remedies of the parties under this RCA are cumulative (not alternative) and in addition to all other rights and remedies available to such parties at law, in equity, by contract or otherwise.

D-7

US-DOCS\119733922.3

 

(d)The obligations in this RCA shall survive Participant’s termination of employment with the Company or a Subsidiary and the assignment of this RCA by the Company to any successor in interest or other assignee.

[remainder of page intentionally blank]

 

D-8

US-DOCS\119733922.3

 

 

Attachment A to RCA

California Law Modifications

This Attachment A modifies certain terms of the RCA while Participant is providing services to the Company, if Participant is based in California. If, at any time, Participant is relocated by the Company, to another state outside of California, the unmodified terms of the RCA will apply and this Attachment A will no longer apply. Similarly if Participant is originally based in a state outside of California, but the Company relocates Participant to California, the modified terms of this Attachment A will apply, as set forth below. For purposes of this RCA, Participant may only be employed in one state at any given time and any travel required by Participant’s role will not affect the Company’s determination of where Participant is based.

Section 2 shall be deleted and replaced as follows:

2. Non-Solicitation of Employees.  The Participant agrees that during the Participant’s employment with the Company or any of its Subsidiaries and during the Non-Solicit Restricted Period, the Participant will not, on the Participant’s own behalf, nor as an officer, director, stockholder, partner, associate, employee, owner, executive, consultant or otherwise on behalf of any person, firm, partnership, corporation, or other entity, solicit, induce, encourage, entice or attempt to solicit, induce, encourage or entice any Company Person to terminate or alter his or her employment or engagement with the Company or any Subsidiaries or to accept employment or engagement with any other person or entity.

Section 3(a) shall be deleted and replaced as follows:

(a) During Participant’s employment with the Company or any of its Subsidiaries, Participant shall not, directly or indirectly, either alone or in conjunction with any person, firm, association, company, corporation or other entity own, manage, operate or participate in the ownership, management, operation or control of, or be employed by or provide services to, any person, business or entity which is competitive with the Company Business if Participant would: (i) have responsibilities that are entirely or substantially similar to the responsibilities Participant has, or had held, at any time during Participant’s employment with the Company or any of its Subsidiaries; or (ii) be involved in creating, developing, modifying, accessing, utilizing or relying upon confidential information that is similar or relevant to that Confidential Information to which Participant created, developed, modified, accessed, utilized or relied upon during Participant’s employment with the Company or any of its Subsidiaries.

Section 10 shall be deleted and replaced as follows:

10.Governing Law

This RCA and all disputes, claims or controversies arising out of or related to this RCA, shall be governed by and construed in accordance with the laws of the state of California, without giving effect to any choice of law or conflict of law provision or rule (whether of California or any other jurisdiction) that would cause the application of the law of any jurisdiction other than the State of California. Participant agrees that venue for any proceeding seeking temporary or preliminary injunctive relief to preserve or restore the status quo pending arbitration of any

D-9

US-DOCS\119733922.3

 

disputes, claims or controversies arising out of or related to this RCA is proper in the federal or state courts of Orange County, California and that these courts shall have exclusive jurisdiction over any such proceeding and Participant specifically consents to personal jurisdiction in such court(s), even if Participant does not reside in Orange County at the time of the dispute. Participant hereby irrevocably waives any objection Participant may now or hereafter have to the laying of venue of any such proceeding in the State of California, and further irrevocably waives any claim Participant may now or hereafter have that any such proceeding brought in said court(s) has been brought in an inconvenient forum.

 

D-10

US-DOCS\119733922.3

 

 

Attachment B to RCA

This Attachment B modifies certain terms of the RCA while Participant is providing services to the Company, if Participant is based in Massachusetts. If, at any time, Participant is relocated by the Company, to another state outside of Massachusetts, the unmodified terms of the RCA will apply and this Attachment B will no longer apply. Similarly if Participant is originally based in a state outside of Massachusetts, but the Company relocates Participant to Massachusetts, the modified terms of this Attachment B will apply, as set forth below. For purposes of this RCA, Participant may only be employed in one state at any given time and any travel required by Participant’s role will not affect the Company’s determination of where Participant is based.

Section 1(c) of the RCA shall be deleted and replaced as follows:

(c) “Non-Compete Restricted Period” means the period commencing on the Termination Date and ending twelve (12) months after the Termination Date, provided that the Participant’s employment with the Company was due to the Participant’s voluntary separation from employment with the Company or the involuntary termination of the Participant’s employment by the Company for cause; provided, however, that in the event that the Company files an action to enforce rights arising out of this RCA, the Non-Compete Restricted Period shall be extended for all periods in which the Participant is determined by the Court to have been in violation of the Participant’s obligations under this RCA or any other fiduciary obligation owed to the Company.

Section 3 of the RCA shall be amended to include the following:

(c) If, prior to October 1, 2018, the Participant entered into an agreement with the Company containing non-competition and/or non-solicitation covenants, the Participant hereby reaffirms that the Participant is subject to, and bound by, the pre- and post-termination non-competition and non-solicitation covenants set forth in those agreements.

Section 10 shall be deleted and replaced as follows:

10.Governing Law

This RCA and all disputes, claims or controversies arising out of or related to this RCA, shall be governed by and construed in accordance with the laws of the Commonwealth of Massachusetts, without giving effect to any choice of law or conflict of law provision or rule (whether of Massachusetts or any other jurisdiction) that would cause the application of the law of any jurisdiction other than the Commonwealth of Massachusetts. Participant agrees that venue for any proceeding seeking temporary or preliminary injunctive relief to preserve or restore the status quo pending arbitration of any disputes, claims or controversies arising out of or related to this RCA is proper in the federal or state courts in the county within Massachusetts where the Participant resides or the Suffolk County Business Litigation Session, and that these courts shall have exclusive jurisdiction over any such proceeding and Participant specifically consents to personal jurisdiction in such court(s), even if Participant does not reside in Suffolk County at the time of the dispute.  Participant hereby irrevocably waives any objection Participant may now or hereafter have to the laying of venue of any such proceeding in the Commonwealth of Massachusetts, and further irrevocably waives any claim Participant may now or hereafter have that any such proceeding brought in said court(s) has been brought in an inconvenient forum.

D-11

US-DOCS\119733922.3

 

Section 13 of the RCA shall be amended to include the following:

(e)Participant has the right to consult with legal counsel prior to entering into this RCA.


 

D-12

US-DOCS\119733922.3

 

 

APPENDIX E

 

MUTUAL ARBITRATION AGREEMENT

This Mutual Arbitration Agreement (“Agreement”) sets forth the terms of the agreement between Syneos Health, Inc. and the Participant (the “Parties”) regarding an alternative approach for resolving employment-related disputes.

1. Mutual Arbitration Agreement

 

a.

Except as described in Section 3, titled “Claims Not Covered by this Agreement,” all disputes, claims, complaints, or controversies (“Claims”) that Participant has now, or at any time in the future may have, against the Company and/or any of its parents, subsidiaries, affiliates, predecessors, successors, assigns, current, former, or future officers, directors, employees, and/or those acting as an agent of the Company (which make up the definition of the “Company” for purposes of this Agreement), or that the Company has now or at any time in the future may have against Participant (“Covered Claims”), arising out of and/or related to Participant’s application for employment with the Company, employment with the Company, and/or the termination of Participant’s employment with the Company will be resolved by arbitration and NOT by a court or jury.  

Claims that the Parties agree to arbitrate include, but are not limited to, the following:

 

•

claims for breach of contract, tort claims, and claims for wrongful discharge;

 

 

•

discrimination and/or harassment claims, retaliation claims, and claims for failure to accommodate;

 

 

•

claims for overtime, wages, leaves, paid time off, sick days, compensation, penalties or restitution, or any other form of remuneration or pay;

 

 

•

all claims for violation of a federal, state, or local statute or ordinance creating employment rights including but not limited to claims under the Fair Labor Standards Act (“FLSA”), Title VII of the Civil Rights Act of 1964 (“Title VII”), the Age Discrimination in Employment Act (“ADEA”), the Worker Adjustment and Retraining Notification Act (“WARN”), the Equal Pay Act (“EPA”), the Americans With Disabilities Act (“ADA”), and the Family and Medical Leave Act (“FMLA”); and

 

•

any other claim under any federal, state, or local statute, constitution, regulation, rule, ordinance, or common law, arising out of and/or related to your application for employment with the Company, your employment with the Company, and/or the termination of your employment with the Company.

E-1

US-DOCS\119733922.3

 

THE PARTIES HEREBY FOREVER WAIVE AND GIVE UP THE RIGHT TO HAVE A JUDGE OR A JURY DECIDE ANY COVERED CLAIMS.  Either party to this Agreement may make application to a court for temporary or preliminary injunctive relief in aid of arbitration or for the maintenance of the status quo pending arbitration.

2. Class, Collective, and Representative Action Waiver:

 

a.

Waiver of Class, Collective, and Representative Actions: To the maximum extent permitted by applicable law, the parties agree that no Covered Claims may be initiated or maintained on a class action, collective action, or representative action basis either in court or arbitration. In California, however, this waiver does not extend to representative claims brought pursuant to California’s Private Attorney General Act (“PAGA”). This means that neither party may serve or participate as a class, collective, or representative action member or representative, or receive any recovery from a class, collective, or representative action involving Covered Claims either in court or in arbitration. In addition, neither Participant nor the Company may participate as a plaintiff or claimant in a class, collective, or representative action to the extent that the action asserts Covered Claims against Participant or the Company. Nothing in this Agreement will preclude Participant or the Company from testifying or providing information in a class action, collective action or representative action.  Claims brought pursuant to the PAGA will be litigated in Court, not arbitration.

 

b.

Court to Decide Enforceability of the Waiver: A court of competent jurisdiction, not an arbitrator, must resolve issues concerning the enforceability or validity of the class action, collective action, or representative action waiver set forth above.

 

c.

No Prohibition On Filings Or Communications With Government Agencies: Nothing in this Agreement shall prohibit Participant from filing a charge, complaint or claim, or communicating or cooperating with, providing information to, or participating in an investigation by the U.S. Equal Employment Opportunity Commission, the National Labor Relations Board, the U.S. Department of Labor, the Occupational Safety and Health Administration, or any other federal, state or local administrative agency. To the extend a Covered Claim is not fully and finally resolved before the agency, it is subject to arbitration under this Agreement rather than any proceeding in court.

 

3.

Claims Not Covered by this Agreement. The following claims shall not be covered by this Agreement:

 

a.

Claims for workers’ compensation benefits (provided that claims for workers’ compensation retaliation remain Covered Claims);

b.Claims for unemployment compensation benefits;

 

c.

Claims for any relief asserted under or governed by the Employee Retirement Income Security Act of 1974 (“ERISA”); resolution of such claims will be governed by the terms of the applicable plan and applicable law;

E-2

US-DOCS\119733922.3

 

 

d.

Claims that are subject to the exclusive jurisdiction of the National Labor Relations Board;

 

e.

Claims brought with the California Division of Labor Standards Enforcement while pending with the agency;

 

f.

Claims brought pursuant to California’s Private Attorney General Act (“PAGA”); and

 

g.

Any claim that is expressly precluded from inclusion in this Arbitration Agreement by a governing federal statute.

4. Arbitration Procedures

 

a.

The parties will use the Judicial Arbitration and Mediation Services (“JAMS”), subject to the JAMS Employment Arbitration Rules and Procedures and the JAMS Policy on Employment Arbitration Minimum Standards of Procedural Fairness (“JAMS Arbitration Rules”), or any successor rules, available at www.jamsadr.com or a copy will be provided upon request from Human Resources, unless those rules and/or procedures conflict with any express term of this Agreement, in which case this Agreement is controlling.  To the extent JAMS is unavailable to process the arbitration, any successor arbitration forum will be used or, if there is no successor forum, the parties will select an alternative arbitrator or forum or one will be appointed by a court, and the arbitration will proceed under the rules most applicable to employment claims, except to the extent that such rules conflict with this Agreement, in which case this Agreement is controlling.

 

To initiate an arbitration with JAMS, complete a Demand for Arbitration Form, available at: www.jamsadr.com/files/Uploads/Documents/JAMS_Arbitration_Demand.pdf.  Please follow the instructions contained in the Demand for Arbitration Form and submit your completed Demand for Arbitration Form, along with a form showing that you served the Demand for Arbitration (“Proof of Service”), the entire contract containing the arbitration clause, and the requisite filing fee, to your local JAMS Resolution Center.  JAMS Resolution Centers can be found on the JAMS website at:  www.jamsadr.com/locations/

 

b.

No arbitration under this Agreement shall be subject to the JAMS Class Action Procedures.

 

c.

The arbitration will be heard by a single arbitrator at a location within 50 miles of where Participant worked for the Company in the U.S. at the time the claim arose, unless both parties agree otherwise.  In the event Participant is a field-based employee, or works primarily from their residence, the residence at the time the claim arose shall be considered the work location for purposes of determining the location of the arbitration.  In the event Participant is working for the Company

E-3

US-DOCS\119733922.3

 

 

outside of the U.S. on temporary assignment or is otherwise located outside the U.S. when the claim arises, Participant agrees that the arbitration will take place in North Carolina.

 

d.

Any Party shall have the right to file a motion to dismiss and/or a motion for summary judgment, which the arbitrator shall have the authority and obligation to decide by application of the Federal Rules of Civil Procedure governing such motions.

 

e.

The arbitrator is authorized to award any party the full remedies that would be available to such party if the Covered Claim had been filed in court, including attorneys’ fees and costs. Thus, for example, Participant shall be entitled to recover attorney’s fees and costs in any arbitration in which Participant asserts and prevails on any statutory claims to the same extent as Participant could in court.

 

f.

The arbitrator shall issue a final and binding written award, subject to review on the grounds set forth in the Federal Arbitration Act (“FAA”). No award or decision by the arbitrator shall have any preclusive effect on issues or claims in any other arbitration or court proceeding, unless all of the parties in the other proceeding were also named parties in the arbitration in which the award or decision was issued.

5. Arbitration Fees and Costs

 

a.

In the event Participant files a claim under this Agreement, Participant will pay the arbitration provider’s employee-designated filing fee, or the normal filing fee in the state or federal court in which the dispute arose, whichever is lowest, and the Company will pay any amount of the JAMS fee in excess of that amount.

 

b.

The Company will pay any other JAMS administrative fees, the arbitrator’s fees, and any additional fees charged by the arbitral forum.

6. Other Provisions:

 

a.

Time Limitation for Commencing Arbitration: The same statute of limitations (the maximum time that parties have to initiate legal proceedings from the date a claim arises) that would have applied if the Covered Claim was filed in court will apply to any Covered Claim. Arbitration is to be commenced consistent with the JAMS arbitration rules and procedures, as applicable.

 

b.

Agreement Survives Termination of Employment: This Agreement will survive the termination of Participant’s employment with the Company. This Agreement supersedes any prior agreement between the parties regarding the subject matter of dispute resolution of Covered Claims.

c.Construction and Severability:

E-4

US-DOCS\119733922.3

 

 

i.

Except as expressly provided elsewhere in this Agreement, any issue concerning the validity or enforceability of this Agreement, and any issue concerning the arbitrability of a particular issue or claim pursuant to this Agreement, must be resolved by the arbitrator, not the court.  A court, not an arbitrator, must resolve issues concerning the enforceability or validity of the class action, collective action, or representative action waivers set forth above.  

 

ii.

Except at stated below, if any part or provision of this Agreement is found to be void, voidable, or otherwise unenforceable, that part or provision shall be severed and such a finding will not affect the validity of the remainder of the Agreement, and all other parts and provisions remain in full force and effect.  To the extent any claims (or portions of claims) are found to be required to proceed in court, all other Covered Claims (or portions of such claims), shall still be required to be arbitrated.  

 

iii.

If any portion of the class action, collective action, or representative action waiver above is found to be void, voidable, or otherwise unenforceable, then the portion of the waiver found void or unenforceable shall be severed from this Agreement, and all other parts and provisions shall remain in full force and effect. In such a case, the claims (or portions of claims) found to be able to proceed on a class action, collective action, or representative action basis shall proceed in court and not in arbitration.

 

d.

Governing Law: This Agreement is governed by the FAA and, to the extent not inconsistent with or preempted by the FAA, by the laws of the state in which Participant last worked for the Company without regard to choice or conflicts of law rules.  The Company’s business, Participant’s employment with the Company, and this Agreement affect interstate commerce.  The arbitrator is obligated to follow and apply the law applicable to any Covered Claims, and does not have the authority to enlarge upon or add to, subtract from or disregard, or otherwise alter the Parties’ rights under such laws.

7. Acknowledgements: By accepting the terms of this Agreement, Participant acknowledges and represent that:

 

a.

Participant has carefully read this Agreement, understand the terms of this Agreement, and is entering into this Agreement voluntarily;

 

b.

Participant is not relying on any promises or representations by the Company except those contained in this Agreement;

 

c.

Participant is giving up the right to have Covered Claims decided by a court, judge or jury;

 

d.

Participant remains employed “at will,” and for no definite period of time;

E-5

US-DOCS\119733922.3

 

 

 

e.

These obligations are binding both upon Participant and Participant’s assigns, executors, administrators and legal representatives;

 

f.

Participant has been given a reasonable period of time in which to consider this Agreement; and

 

g.

Participant has been given the opportunity to discuss this Agreement with Participant’s own attorney or advisor if Participant wished to do so.

 

 

E-6

US-DOCS\119733922.3

 EX-10.11.8 5 synh-ex10118_430.htm EX-10.11.8 2022 FORM OF PRSU AWARD AGREEMENT NON-US synh-ex10118_430.htm

Exhibit 10.11.8

SYNEOS HEALTH, INC.
2018 Equity Incentive Plan

Global Performance Restricted Stock Unit Award Agreement

This Global Performance Restricted Stock Unit Award Agreement including any special terms and conditions for the Participant’s country set forth in Appendix B, attached hereto (the Global Performance Restricted Stock Unit Agreement, the Appendix B and all other appendices attached hereto, collectively, the “Agreement”), is made by and between Syneos Health, Inc., a Delaware corporation (the “Company”), and [Participant Name] (the “Participant”), effective as of [Grant Date] (the “Date of Grant”).

Attention: Attached to this Agreement as Appendix D is a Restrictive Covenants Agreement, which imposes certain restrictions upon you both during and after your employment with the Company.  Your acceptance of the Restricted Stock Unit Award requires that you agree to the terms and conditions of this Agreement and the Restrictive Covenants Agreement.  It is important that you review the terms of each of these Agreements

RECITALS

WHEREAS, the Company has adopted the Syneos Health, Inc. 2018 Equity Incentive Plan (as the same may be amended and/or amended and restated from time to time, the “Plan”), which Plan is incorporated herein by reference and made a part of this Agreement, and capitalized terms not otherwise defined in this Agreement will have the meanings ascribed to those terms in the Plan; and

WHEREAS, the Committee has authorized and approved the grant of an Award to the Participant of Performance Restricted Stock Units payable in shares of Common Stock (the “Shares”), subject to the terms and conditions set forth in the Plan and this Agreement.

NOW THEREFORE, in consideration of the premises and mutual covenants set forth in this Agreement, the parties agree as follows:

1.

Grant of Performance Restricted Stock Units. The Company has granted to the Participant, effective as of the Date of Grant, [Quantity Granted] (the “Target Award”) Performance Restricted Stock Units, on the terms and conditions set forth in the Plan and this Agreement, subject to adjustment as set forth in Section 4.5 of the Plan (the “PRSUs”).

2.

Vesting Eligibility of PRSUs. Subject to the terms and conditions set forth in the Plan and this Agreement, the PRSUs will be eligible for vesting as follows:

 

(a)

General. Except as otherwise provided in Sections 2(b) through 2(e), the PRSUs will vest (i) to the extent the Performance Goals are attained during the Performance Periods as set forth on Appendix A and (ii) as long as the Participant is in Service from the Date of Grant through the Service Vesting Date. The “Service Vesting Date” means (x) the date on which the Committee determines the attainment level of the Performance Goals for the final Performance Period, or (y) if a Qualifying

1

US-DOCS\119733922.3

 

 

 

Event occurs, January 1st of the year following the last Performance Period. The Committee will, promptly after the filing of the Company’s Form 10-K (or other report publicly furnished to the U.S. Securities and Exchange Commission (the “SEC”)) for each of the Performance Periods, review the applicable financial data as reported in the Form 10-K (or such other applicable report) and determine whether and to what extent the Performance Goals for each Performance Period set forth in Appendix A have been attained. On the basis of such determined level of attainment of the Performance Goals, the Committee shall determine the number of PRSUs that are eligible for vesting. Except as otherwise provided in Sections 2(b) through 2(e), PRSUs that do not become eligible for vesting based on the attainment of the Performance Goals become forfeited as of the determination date applicable to the corresponding Performance Period.

 

(b)

Effect of Death and Termination Due to Disability. Upon the Participant’s termination of Service due to Disability or death at any time on or prior to the last day of the last Performance Period, the Participant shall vest in the PRSUs as follows: (i) in the event the termination of Service occurs following a completed Performance Period, the Participant shall vest in the number of PRSUs subject to a Target Award Tranche (as defined in Appendix A) corresponding to such completed Performance Period based on the actual performance attainment level; (ii) in the event the termination of Service occurs during or prior to the commencement of a Performance Period, the Participant shall vest in the number of PRSUs subject to the Target Award Tranche corresponding to such Performance Periods. No fractional Shares shall be issued, and any fractional Shares that would have been deemed vested based on the foregoing calculation shall be rounded down to the next whole Share. In the event of the Participant’s death or termination of Service due to Disability after the last day of the last Performance Period, but prior to settlement of the PRSUs, the PRSUs shall continue to be eligible to vest in the number of PRSUs had the Participant continued in Service through the Service Vesting Date. Any PRSUs that are not eligible to vest upon the Participant’s termination of Service due to Disability or death in accordance with this Section 2(b) shall be forfeited as of such date.

 

(c)

Effect of Retirement. Upon the Participant’s Retirement after the first anniversary of the Date of Grant, but prior to the last day of the last Performance Period, the Participant shall vest in the PRSUs as follows: (i) in the event the Retirement occurs following a completed Performance Period, the Participant shall vest in the number of PRSUs subject to the Target Award Tranche corresponding to such completed Performance Period based on the actual performance attainment level; and (ii) in the event the Retirement occurs during a Performance Period, the Participant shall vest in a number of PRSUs subject to the Pro-Rated Target Award Tranche (defined below) corresponding to such Performance Period. The number of PRSUs that shall vest under the Pro-Rated Target Award Tranche shall be calculated by multiplying (i) the number of PRSUs subject to the Target Award Tranche for the applicable Performance Period by (ii) a fraction, the numerator of which shall be the number of days that have elapsed between the first day of such Performance Period and the date of the Participant’s Retirement, and the denominator of which shall be the

2

US-DOCS\119733922.3

 

 

number of calendar days in such Performance Period. No fractional Shares shall be issued, and any fractional Shares that would have been deemed vested based on the foregoing calculation shall be rounded down to the next whole Share. In the event of the Participant’s Retirement after the last day of the last Performance Period, but prior to settlement of the PRSUs, the PRSUs shall continue to be eligible to vest in the number of PRSUs had the Participant continued in Service through the Service Vesting Date. For the avoidance of any doubt, the remaining PRSUs subject to the Target Award Tranches corresponding to Performance Periods commencing following the date of the Participant’s Retirement shall be forfeited upon the Participant’s Retirement and all of the PRSUs shall be forfeited in the event of the Participant’s Retirement on or before the first anniversary of the Date of Grant. Any PRSUs that are not eligible to vest upon the Participant’s Retirement in accordance with this Section 2(c) shall be forfeited. For purposes of this Agreement, “Retirement” means a voluntary termination of Service on or after the Participant (i) has attained age 55; and (ii) completed 10 years of continuous Service. For purposes of this Section 2(c), a Participant’s Retirement shall not include: (i) a termination by the Company for Cause, as determined in the sole discretion of the Company, (ii) a resignation by the Participant after being notified that the Company has elected to terminate the Participant for Cause, (iii) a termination or resignation by the Participant during the pendency of an investigation with respect to the Participant or while the Participant is on a performance improvement plan, or (iv) any other circumstance upon which the Company determines in good faith the Participant is not in good standing at the time of such termination at the sole discretion of the Company.

Notwithstanding the foregoing, if the Company receives a legal opinion that there has been a legal judgment and/or legal development in the Participant’s jurisdiction that likely would result in the favorable treatment that applies to the PRSUs if the Participant attains the conditions set forth in this Section 2(c) being deemed unlawful and/or discriminatory, the provisions above regarding the treatment of the PRSUs shall not be applicable to the Participant.

 

(d)

Effect of a Qualifying Event. If a Qualifying Event occurs, a number of PRSUs equal to the following shall be converted into time-based RSUs that shall vest on the Service Vesting Date, subject to the Participant’s continued Service through such date: the sum of (i) the PRSUs subject to each completed Performance Period prior to the date of the Qualifying Event that became eligible to vest based on the attainment level of the applicable Performance Goals, plus (ii) the number of PRSUs subject to each Target Award Tranche for each Performance Period that have not yet been completed as of the date of the Qualifying Event (the “Converted Time-Based RSUs”).  

As used in this Agreement, “Qualifying Event” shall mean a Change in Control or a Significant Transaction.

As used in this Agreement, a “Significant Transaction” shall mean any transaction, including without limitation a reorganization, merger or consolidation, to which the

3

US-DOCS\119733922.3

 

Company is a party that does not constitute a Change in Control but with respect to which any Persons become the Beneficial Owners, directly or indirectly, of more than forty percent (40%) of the combined voting power of the outstanding voting securities entitled to vote generally in the election of directors (or election of members of a comparable governing body) of the Successor Entity.

 

(e)

Effect of Involuntary Termination in Connection with Change in Control. The Converted Time-Based RSUs shall immediately vest in full in the event of (A) the Participant’s Service is terminated by the Company or a Subsidiary for any reason other than Cause, or (B) the Participant resigns for Good Reason, in each case, at the time of, or within 6 months following, the consummation of a Change in Control (either of such events of termination within such period, a “CIC Termination”).

As used in this Agreement, “Good Reason” shall mean the occurrence, without the Participant’s express written consent, of any of the following events: (i) a material reduction in the Participant’s annual base salary; (ii) a material adverse change to the Participant’s title compared to the Participant’s title immediately prior to the Change in Control; (iii) a requirement that the Participant relocate to a principal place of employment more than fifty (50) miles from the Participant’s assigned principle office location as of immediately prior to the occurrence of the Change in Control; or (iv) if the Participant has an effective employment agreement, service agreement, or other similar agreement with the Company or any Subsidiary, a material breach of such agreement, provided, that, any event described in clauses (i), (ii), (iii) and (iv) above shall constitute Good Reason only if the Participant provides the Company with written notice of the basis for the Participant’s Good Reason within forty-five (45) days of the initial actions or inactions of the Company or any Subsidiary giving rise to such Good Reason and the Company or applicable Subsidiary has not cured the identified actions or inactions within sixty (60) days of such notice, and provided further that the Participant terminates his or her Service within thirty (30) days following the Company’s or applicable Subsidiary’s failure to cure within the 60-day cure period.

Any vesting acceleration contemplated under this Section 2(e) shall be subject to the limitations provided in Section 5.5 of the Plan.

3.

Settlement of PRSUs.

 

(a)

Settlement in Stock. PRSUs that vest pursuant to Section 2 above will be settled by delivering to Participant a number of Shares equal to the number of PRSUs that vest in accordance with the following schedule: (i) within ninety (90) days following the last day of the last Performance Period in the event of a vesting event described in Section 2(a); (ii) within sixty (60) days following the Participant’s termination of Service in the event of a vesting event described in Section 2(b) or 2(c); (iii) in the case of a vesting event described in Section 2(d), within ninety (90) days following the last day of the last Performance Period; (iv) within sixty (60) days following the date of the Participant’s Termination of Service in the event of a vesting event described in Section 2(e), in each case, subject to the provisions of

4

US-DOCS\119733922.3

 

 

Section 15(l). In any case, the Company may provide a reasonable delay in the delivery of the Shares to address Tax-Related Items, withholding, and other administrative matters, provided that any such delay does not result in a violation of Section 409A of the Code. Neither the Company nor the Committee will be liable to the Participant or any other Person for damages relating to any delays in issuing the Shares or any mistakes or errors in the issuance of the Shares.

 

(b)

Book-Entry Registration of the Shares. The Company will deliver the Shares payable pursuant to this Agreement within the settlement period set forth in Section 3(a) by registering such Shares with the Company’s transfer agent (or another custodian selected by the Company) in book-entry form in the Participant’s name.

 

(c)

Shareholder Rights. The Participant will not have any rights of a stockholder with respect to the Shares subject to the PRSUs, including voting and dividend rights, unless and until the Shares are delivered as described in Section 3(b) above.

 

(d)

Responsibility for Taxes. The Participant acknowledges that, regardless of any action taken by the Company or, if different, the Subsidiary employing or retaining the Participant (the “Employer”), the ultimate liability for all Tax-Related Items is and remains the Participant’s responsibility and may exceed the amount actually withheld by the Company or the Employer. The Participant further acknowledges that the Company and/or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the PRSUs, including, but not limited to, the grant or vesting of the PRSUs, the delivery of Shares following the Vesting Date, the subsequent sale of Shares acquired pursuant to such vesting/delivery and the receipt of any dividends and/or dividend equivalents; and (2) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the PRSUs to reduce or eliminate the Participant’s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant is subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Company and/or the Employer (or former Employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

 

(e)

Withholding Requirements. Prior to any relevant taxable or tax withholding event, as applicable, the Participant agrees to make adequate arrangements satisfactory to the Company and/or the Employer to satisfy all Tax-Related Items. In this regard, the Participant authorizes the Company and/or the Employer, or their respective agents, at the Company’s and/or the Employer’s discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following: (1) cash payment by the Participant to the Company prior to the day of vesting of an amount that the Company will apply to the required withholding; (2) withholding from the Participant’s wages or other cash compensation paid to the Participant by the Company and/or the Employer; (3) withholding from proceeds of the sale of Shares acquired upon vesting/settlement of the PRSUs either through a voluntary sale or through a mandatory sale arranged by the Company (on

5

US-DOCS\119733922.3

 

 

the Participant’s behalf pursuant to this authorization); or (4) withholding in Shares to be issued upon settlement of the PRSUs, subject to approval by the Committee if the Participant is subject to the short-swing profit rules of Section 16(b) of the Exchange Act; or (5) any other method of withholding determined by the Company to be permitted under the Plan and, to the extent required by applicable law or under the Plan, approved by the Committee.  For the purposes of alternative (4) above, any Shares withheld shall be credited for purposes of the withholding requirements at the fair market value of the Shares on the date that the tax withholding is determined. Until such time as the Company provides notice to the contrary, it will satisfy any withholding requirements for Tax-Related Items pursuant to alternative (3) above; provided, however, that if such method (A) cannot be processed by the broker or (B) the Participant is subject to the Company’s Insider Trading Compliance Policy (the “Insider Trading Policy”), the sale of Shares pursuant to alternative (3) is prohibited under the Insider Trading Policy and the Participant has not entered into an arrangement that is intended to comply with the requirements of Rule 10b5-1(c)(1) of the Exchange Act and that provides for the sale of all of the Shares subject to this Agreement, the Company will instead collect withholding for Tax-Related Items pursuant to alternative (4).

The Company may withhold or account for Tax-Related Items by considering statutory withholding amounts or other applicable withholding rates, including the maximum applicable rates in the Participant’s jurisdiction(s). In the event of over-withholding, the Participant may receive a refund of any over-withheld amount in cash (with no entitlement to the equivalent amount in Common Stock) from the Company or the Employer.  In the event of under-withholding, the Participant may be required to pay any additional Tax-Related Items directly to the applicable tax authority or to the Company and/or the Employer.  If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant is deemed to have been issued the full number of Shares subject to the vested PRSUs, notwithstanding that a number of the Shares is held back solely for the purpose of paying the Tax-Related Items.

Finally, the Participant agrees to pay to the Company or the Employer, including through withholding from the Participant’s wages or other cash compensation payable to the Participant by the Company and/or the Employer, any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of the Participant’s participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse to issue or deliver the Shares or the proceeds of the sale of Shares, if the Participant fails to comply with the Participant’s obligations in connection with the Tax-Related Items.

In addition, to the extent that any U.S. Federal Insurance Contributions Act tax withholding obligations arise in connection with the PRSUs prior to the applicable vesting or settlement date, the Committee shall accelerate the payment of a portion of the award of PRSUs sufficient to satisfy (but not in excess of) such tax withholding obligations and any tax withholding obligations associated with any such accelerated payment, and the Committee shall withhold such amounts in

6

US-DOCS\119733922.3

 

satisfaction of such withholding obligations pursuant to the tax withholding method noted in alternative (4) above.

4.

Forfeiture. Except as provided in Sections 2(b) through 2(d), all PRSUs (whether eligible for vesting or not) will be forfeited immediately, automatically and without consideration upon a termination of the Participant’s Service for any reason (whether or not later to be found invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant’s employment agreement, if any). In addition, any PRSUs for a given Performance Period which are not eligible for vesting after determination of the attainment of the Performance Goals for such Performance Period will be forfeited as of the date of certification by the Committee and will not carry over to subsequent Performance Periods. Without limiting the generality of the foregoing, the PRSUs and the Shares (and any resulting proceeds) will continue to be subject to Section 13 of the Plan.

5.

Adjustment to PRSUs. In the event of any change with respect to the outstanding Shares contemplated by Section 4.5 of the Plan, the PRSUs may be adjusted in accordance with Section 4.5 of the Plan.

6.

Nature of Grant. In accepting the PRSUs, the Participant acknowledges, understands and agrees that:

 

(a)

the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan;

 

(b)

the grant of the PRSUs is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of PRSUs, or benefits in lieu of PRSUs, even if PRSUs have been granted in the past;

 

(c)

all decisions with respect to future PRSUs or other grants, if any, will be at the sole discretion of the Company;

 

(d)

the PRSUs and the Participant’s participation in the Plan shall not create a right to employment or be interpreted as forming an employment or services contract, nor be interpreted as amending the terms of an existing employment or services contract, with the Company or any Subsidiary, including the Employer, if applicable;

 

(e)

the Participant is voluntarily participating in the Plan;

 

(f)

the PRSUs and the Shares subject to the PRSUs, and the income from and value of same, are not intended to replace any pension rights or compensation;

 

(g)

the PRSUs and the Shares subject to the PRSUs, and the income and value of same, are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end-of-service

7

US-DOCS\119733922.3

 

 

payments, bonuses, holiday pay, long-service awards, pension or retirement or welfare benefits or similar payments;

 

(h)

unless otherwise agreed with the Company, the PRSUs and the Shares subject to the PRSUs, and the income and value of same, are not granted as consideration for, or in connection with, the service that the Participant may provide as a director of a Subsidiary;

 

(i)

the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty;

 

(j)

no claim or entitlement to compensation or damages shall arise from forfeiture of the PRSUs resulting from the termination of the Participant’s Service (for any reason whatsoever whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant’s employment agreement, if any);

 

(k)

the following provision shall not apply to Participants in the state of California: In consideration of the grant of the PRSUs to which the Participant is otherwise not entitled, the Participant irrevocably agrees to release and never to institute any claims which have arisen, occurred or existed at any time prior to the date of this Agreement (“Claim”) against the Company or any of its Subsidiaries, and waives his or her ability, if any, to bring any such Claim; if, notwithstanding the foregoing, any such Claim is allowed by an arbitrator or other tribunal of competent jurisdiction, then, by participating in the Plan, the Participant shall be deemed irrevocably to have agreed not to pursue such Claim and agrees to execute any and all documents necessary to request dismissal or withdrawal of such Claim; and

 

(l)

The following provision applies if the Participant is providing services outside the United States: neither the Company nor any Subsidiary shall be liable for any foreign exchange rate fluctuation between the Participant’s local currency and the United States Dollar that may affect the value of the PRSUs or of any amounts due to the Participant pursuant to the settlement of the PRSUs or the subsequent sale of any Shares acquired upon settlement.

7.

No Advice Regarding Grant. The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Participant’s participation in the Plan, or the Participant’s acquisition or sale of the underlying Shares. The Participant should consult with the Participant’s own personal tax, legal and financial advisors regarding the Participant’s participation in the Plan before taking any action related to the Plan.

8.

Restrictive Covenants. The Participant acknowledges and recognizes that during the course of Participant’s employment with the Company or its Subsidiaries, the Participant will be given access to and become informed of Confidential Information and the Participant will be the beneficiary of the goodwill of the Company and its Subsidiaries, and, accordingly, agrees to the provisions of the Restrictive Covenants Agreement (“RCA”) annexed as

8

US-DOCS\119733922.3

 

Appendix D to this Agreement (the “Restrictive Covenants”). For the avoidance of doubt, the Restrictive Covenants contained in this Agreement are in addition to, and not in lieu of, any other restrictive covenants or similar covenants between the Participant and the Company or any of its Subsidiaries, including the Employer. If Participant breaches any non-competition, confidentiality or other restrictive covenant owed to the Company or any of its Subsidiaries pursuant to the RCA annexed hereto or any other agreement, as determined by the Committee in its sole discretion: (i) any unvested portion of the PRSUs held by the Participant shall be immediately rescinded; and (ii) the Participant shall automatically forfeit any rights that the Participant may have with respect to the PRSUs as of the date of such determination. The foregoing remedies set forth in this Section 8 shall not be the Company’s exclusive remedies. The Company reserves all other rights and remedies available to it at law or in equity.

9.

Data Privacy Provisions Applicable to Participants Outside the European Union/European Economic Area/United Kingdom (“EEA+”).

The Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant’s personal data as described in this Agreement and any other PRSU grant materials by and among, as applicable, the Employer, the Company and its Subsidiaries for the purpose of implementing, administering and managing the Participant’s participation in the Plan.

The Participant understands that the Company and the Employer may hold certain personal information about the Participant, including, but not limited to, the Participant’s name, home address, email address and telephone number, date of birth, passport, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all RSUs, Performance RSUs or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in the Participant’s favor (“Data”), for the exclusive purpose of implementing, administering and managing the Plan.

The Participant understands that Data will be transferred to Fidelity Stock Plan Services, LLC or any other broker selected by the Company, or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan. The Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipients’ country (e.g., the United States) may have different data privacy laws and protections than the Participant’s country. The Participant understands that the Participant may request a list with the names and addresses of any potential recipients of the Data by contacting the Syneos Health, Inc.Human Resources Department (HRSupportServicesAmerica@SyneosHealth.com). The Participant authorizes the Company, Fidelity Stock Plan Services, LLC or any other broker selected by the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purpose of implementing, administering and managing the Participant’s participation in the Plan. The Participant understands that Data will be held only as long

9

US-DOCS\119733922.3

 

as is necessary to implement, administer and manage the Participant’s participation in the Plan. The Participant understands that the Participant may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Syneos Health, Inc. Human Resources Department (HRSupportServicesAmerica@SyneosHealth.com). Further, the Participant understands that the Participant is providing the consents herein on a purely voluntary basis. If the Participant does not consent, or if the Participant later seeks to revoke the Participant’s consent, the Participant’s Service with the Employer will not be affected; the only consequence of refusing or withdrawing the Participant’s consent is that the Company would not be able to grant PRSUs or other equity awards to the Participant or administer or maintain such awards. Therefore, the Participant understands that refusing or withdrawing the Participant’s consent may affect the Participant’s ability to participate in the Plan. For more information on the consequences of the Participant’s refusal to consent or withdrawal of consent, the Participant understands that the Participant may contact the Syneos Health, Inc. Privacy Office (data.privacy@syneoshealth.com).

Finally, upon request by the Company or the Employer, the Participant agrees to provide an executed data privacy consent form (or any other agreements or consents) that the Company and/or the Employer may deem necessary to obtain from the Participant for the purpose of administering the Participant’s participation in the Plan in compliance with the data privacy laws in the Participant’s country, either now or in the future. The Participant understands and agrees that the Participant will not be able to participate in the Plan if the Participant fails to provide any such consent or agreement requested by the Company and/or the Employer.

10.

Data Privacy Provisions Applicable to Participants in the EEA+.

The Company and the Employer hereby notify the Participant of the following in relation to the Participant’s Data (as defined below) and the collection, processing and transfer in electronic or other form of such Data in relation to the grant of PRSUs and the Participant’s participation in the Plan. The collection, processing and transfer of the Participant’s Data is necessary for the legitimate purpose of the Company’s administration of the Plan and the Participant’s participation in the Plan, and the Participant’s denial and/or objection to the collection, processing and transfer of Data may affect the Participant’s participation in the Plan. As such, by participating in the Plan, the Participant acknowledges the collection, use, processing and transfer of Data and with respect to the limited transfer to the third party administrator Fidelity Stock Plan Services, LLC, consents to the transfer of Data as described herein.

The Participant understands that the Company and the Employer will hold certain personal information about the Participant to administer the Plan. This personal information may include, the Participant’s name, home address, email address and telephone number, date of birth, passport, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all RSUs, Performance RSUs or any other entitlement

10

US-DOCS\119733922.3

 

to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in the Participant’s favor (“Data”), for the exclusive purpose of implementing, administering and managing the Plan.

The Company and the Employer will transfer Data amongst themselves as necessary for the purpose of implementation, administration and management of the Plan, and the Company and the Employer may each further transfer Data to third parties assisting the Company or the Employer in the implementation, administration and management of the Plan. The Participant understands that Data will be transferred to Fidelity Stock Plan Services, LLC or any other broker selected by the Company, or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan. The Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipients’ country (e.g., the United States) may have different data privacy laws and protections than the Participant’s country. The Participant understands that the Participant may request a list with the names and addresses of any potential recipients of the Data by contacting the Syneos Health, Inc. Human Resources Department (HRSupportServicesAmerica@SyneosHealth.com). For any intragroup transfers of Data outside the EEA or the UK, the transfer will be under the European Commission’s model contracts for the transfer of personal data to third countries  (i.e., the standard contractual clauses) (the “Model Clauses”), or any equivalent contracts issued by the relevant competent authority of the UK (as applicable), unless the data transfer is to a country that has been determined by the European Commission or the relevant UK authorities (as applicable) to provide an adequate level of protection for individuals’ rights and freedoms for their personal data. Please contact the Syneos Health Privacy Office (data.privacy@syneoshealth.com) should you wish to receive a copy of the relevant Model Clauses.  

11.

Data Privacy Provisions Applicable to Participants in all Countries.

Where provided by applicable law, the Participant may have the right to exercise certain rights with respect to their Data, which may be subject to certain limitations and exclusions. For example, these rights may include the right to know what Data is processed, access to Data, rectification of Data, erasure of Data, restriction of processing of Data (including, where applicable, the restriction on the sale of Data), and portability of Data. The Participant may also have the right to object to the processing of Data, as well as to opt-out of the Plan, in any case without cost, by contacting in writing the Syneos Health, Inc. Human Resources Department. The Participant understands, however, that the Participant's participation in the Plan may be limited and the Company and the Employer may not be able to grant the Participant PRSUs or other equity awards or administer or maintain such awards if the Participant refuses to provide Data. The Participant agrees to provide full cooperation in executing data privacy consent forms, agreements or any related documentation that the Company and/or the Employer deem necessary for the purpose of administering the Plan in compliance with the data privacy laws in the Participant’s country, either now or in the future.

11

US-DOCS\119733922.3

 

When the Company and the Employer no longer need to use Data for the purposes above or do not need to retain it for compliance with any legal or regulatory purpose, each will take reasonable steps to remove Data from their systems and/or records containing the Data and/or take steps to properly anonymize it so that the Participant can no longer be identified from it. Further information concerning the Company’s data retention practices can be found in the Company’s Records Management Policy.

12.

Language. The Participant acknowledges that he or she is sufficiently proficient in English, or has consulted with an advisor who is sufficiently proficient in English, so as to allow the Participant to understand the terms and conditions of this Agreement. Furthermore, if the Participant has received this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

13.

Electronic Delivery and Acceptance. The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.

14.

Imposition of Other Requirements. The Company reserves the right to impose any other requirements on the Participant’s participation in the Plan, on the PRSUs and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require the Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

15.

Appendix B. Notwithstanding any provisions in this Agreement, the PRSUs shall be subject to any additional terms and conditions set forth in Appendix B for the Participant’s country. Appendix B constitutes part of this Performance Restricted Stock Unit Agreement.

16.

Insider Trading Restrictions/Market Abuse Laws. The Participant acknowledges that, depending on the Participant’s or the Participant’s broker’s country of residence or where the Shares are listed, the Participant may be subject to insider trading restrictions and/or market abuse laws, which may affect the Participant’s ability to accept, acquire, sell or otherwise dispose of Shares or rights to Shares or rights linked to the value of Shares (e.g., phantom awards, futures) during such times as the Participant is considered to have “inside information” regarding the Company (as defined by the laws or regulations in the applicable jurisdiction). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders the Participant places before possessing inside information. Furthermore, the Participant could be prohibited from (i) disclosing the inside information to any third party (other than on a “need to know” basis) and (ii) “tipping” third parties or causing them otherwise to buy or sell securities. Keep in mind third parties include fellow employees.

Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. The

12

US-DOCS\119733922.3

 

Participant is responsible for complying with any applicable restrictions and should speak with a personal legal advisor on this matter.

17.

Foreign Asset/Account Reporting; Exchange Controls. The Participant’s country may have certain foreign asset and/or account reporting requirements and/or exchange controls which may affect the Participant’s ability to acquire or hold Shares under the Plan or cash received from participating in the Plan (including from any dividends received or sale proceeds arising from the sale of Shares) in a brokerage or bank account outside the Participant’s country. The Participant may be required to report such accounts, assets or transactions to the tax or other authorities in his or her country. The Participant also may be required to repatriate sale proceeds or other funds received as a result of the Participant’s participation in the Plan to his or her country through a designated bank or broker and/or within a certain time after receipt. The Participant acknowledges that it is his or her responsibility to be compliant with such regulations, and the Participant should consult his or her personal legal advisor for any details.

18.

Miscellaneous Provisions

 

(a)

Securities or Exchange Control Laws Requirements. No Shares will be issued or transferred pursuant to this Agreement unless and until all then applicable requirements imposed by U.S. or non-U.S. federal and state securities or exchange control laws, rules and regulations and by any regulatory agencies having jurisdiction, and by any exchanges upon which the Shares may be listed, have been fully met. As a condition precedent to the issuance of Shares pursuant to this Agreement, the Company may require the Participant to take any reasonable action to meet those requirements. The Committee may impose such conditions on any Shares issuable pursuant to this Agreement as it may deem advisable, including, without limitation, restrictions under the U.S. Securities Act of 1933, as amended, under the requirements of any exchange upon which shares of the same class are then listed and under any blue sky or other securities laws applicable to those Shares.

 

(b)

Non-Transferability. The PRSUs and the rights and privileges conferred thereby shall be non-transferrable except as provided by Section 15.3 of the Plan. Any Shares delivered hereunder will be subject to such stop transfer orders and other restrictions as the Committee may deem advisable under the Plan or the rules, regulations and other requirements of the U.S. Securities and Exchange Commission, any stock exchange upon which such shares are listed, any applicable U.S. or non-U.S. federal, state or local laws and any agreement with, or policy of, the Company or the Committee to which the Participant is a party or subject, and the Committee may cause orders or designations to be placed upon any certificate(s) or other document(s) delivered to the Participant, or on the books and records of the Company’s transfer agent, to make appropriate reference to such restrictions.

 

(c)

No Right to Continued Service. Nothing in this Agreement or the Plan confers any right or obligation upon the Participant or the Company, or any Subsidiary,

13

US-DOCS\119733922.3

 

 

including the Employer, to continue the Participant’s employment with the Employer.

 

(d)

Notification. Any notification required by the terms of this Agreement will be given by the Participant (i) in a writing addressed to the Company at its principal executive office and will be deemed effective upon actual receipt when delivered by personal delivery or by registered or certified mail, with postage and fees prepaid, or (ii) by electronic transmission to the Company’s e-mail address of the Company’s General Counsel and will be deemed effective upon actual receipt. Any notification required by the terms of this Agreement will be given by the Company (x) in a writing addressed to the address that the Participant most recently provided to the Company and will be deemed effective upon personal delivery or within three (3) days of deposit with the United States Postal Service or non-U.S. equivalent, by registered or certified mail, with postage and fees prepaid; or (y) by facsimile or electronic transmission to the Participant’s primary work fax number or e-mail address (as applicable) and will be deemed effective upon confirmation of receipt by the sender of such transmission.

 

(e)

Entire Agreement. This Agreement and the Plan constitute the entire agreement between the parties hereto with regard to the subject matter of this Agreement. This Agreement and the Plan supersede any other agreements, representations or understandings (whether oral or written and whether express or implied) that relate to the subject matter of this Agreement.

 

(f)

Waiver. No waiver by the Company of any breach or condition of this Agreement by the Participant or any other Participant will be deemed to be a waiver by the Company of any other or subsequent breach or condition whether of like or different nature.

 

(g)

Successors and Assigns. The provisions of this Agreement will inure to the benefit of, and be binding upon, the Company and its successors and assigns and upon the Participant, the Participant’s executor, personal representative(s), distributees, administrator, permitted transferees, permitted assignees, beneficiaries, and legatee(s), as applicable, whether or not any such person will have become a party to this Agreement and have agreed in writing to be joined herein and be bound by the terms hereof.

 

(h)

Severability. The provisions of this Agreement are severable, and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, then the remaining provisions will nevertheless be binding and enforceable.

 

(i)

Amendment. This Agreement will not be amended unless the amendment is agreed to in writing by both the Participant and the Company.

 

(j)

Choice of Law; Jurisdiction. This Agreement and all claims, causes of action or proceedings (whether in contract, in tort, at law or otherwise) that may be based

14

US-DOCS\119733922.3

 

 

upon, arise out of or relate to this Agreement will be governed by the internal laws of the State of Delaware, excluding any conflicts or choice-of-law rule or principle that might otherwise refer construction or interpretation of this Agreement to the substantive law of another jurisdiction.

 

(k)

Signature in Counterparts. This Agreement may be signed in counterparts, manually or electronically, each of which will be an original, with the same effect as if the signatures to each were upon the same instrument.

 

(l)

IRC Section 409A. This Section 18(l) applies only to Participants who are U.S. taxpayers.

Anything in this Agreement to the contrary notwithstanding, PRSUs that are non-qualified deferred compensation subject to Section 409A of the Code and that vest as a result of the Participant’s termination of employment under Section 2(b), 2(c) or 2(e) hereof shall be settled within sixty (60) days following the Participant experiences a “separation from service,” within the meaning of Section 409A of the Code (“Separation from Service”). With respect to PRSUs that are settled as a result of the Participant’s termination of employment under Appendix C, any such PRSUs that are non-qualified deferred compensation subject to Section 409A, shall be settled within 60 days following the Separation from Service or Change in Control, provided that if the Change in Control is not a “change in control event” (within the meaning of the Treasury Regulations promulgated under Section 409A of the Code), the PRSUs shall be settled as described in Section 3(a)(i). If the Participant is a “specified employee” within the meaning of Section 409A of the Code as of the date of the Separation from Service (as determined in accordance with the methodology established by the Company as in effect on the Date of Termination), any PRSUs that are non-qualified deferred compensation that are payable upon a Separation from Service shall instead be settled on the first business day that is after the earlier of (i) the date that is six months following the date of the Participant’s Separation from Service or (ii) the date of the Participant’s death, to the extent such delayed payment is otherwise required in order to avoid a prohibited distribution under Section 409A(a)(2) of the Code, or any successor provision thereto.

 

(m)

Acceptance. The Participant hereby acknowledges receipt of a copy of the Plan and this Agreement, together with any appendices hereto. The Participant has read and understands the terms and provisions of the Plan and this Agreement, as well as the attached Restrictive Covenants Agreement and accepts the PRSUs subject to all of the terms and conditions of the Plan and these Agreements. In the event of a conflict between any term or provision contained in this Agreement and a term or provision of the Plan, the applicable term and provision of the Plan will govern and prevail. The Participant must accept this Agreement electronically pursuant to the online acceptance procedure established by the Company within 30 days after the Agreement is presented to the Participant for review. If the Participant fails to accept the Agreement within such 30-day period, the Company may, in its sole discretion, rescind the Award in its entirety. By electronically accepting the Agreement, the Participant is also accepting the Restrictive

15

US-DOCS\119733922.3

 

 

Covenants Agreement, and this Award is granted under and governed by the terms and conditions of the Plan and these Agreements.

 

[Signature page follows]

 

16

US-DOCS\119733922.3

 

 

IN WITNESS WHEREOF, the Company and the Participant have executed this Global Performance Restricted Stock Unit Award Agreement and any appendices thereto as of the date first written above.

 

 

 

SYNEOS HEALTH, INC.

 

By:

Name:

Title:

/s/ Alistair Macdonald

Alistair Macdonald

Chief Executive Officer

PARTICIPANT

[Electronic Signature]

________________________________
Participant Signature
Name: [Participant Name]
Acceptance Date: [Acceptance Date]

 

 

 

Signature Page to Performance Restricted Stock Unit Award Agreement

US-DOCS\119733922.3

 

 

APPENDIX A

PERFORMANCE GOALS FOR PRSU VESTING ELIGIBILITY

The vesting eligibility of the PRSUs granted pursuant to the attached Global Performance Restricted Stock Unit Award Agreement will be determined by the Committee in accordance with the Plan and this Appendix A.  The ROIC Performance Goal and each Adjusted EPS Performance Goal shall be referred to, collectively, as the “Performance Goals”.

ROIC Performance Goal

50% of the Target Award amount granted in Section 1 above (the “ROIC Target Award Tranche”) shall be eligible to vest based on the attainment of ROIC measured against the performance goals stated in the table below for the performance period beginning on (and including) [  ] and ending on (and including) [  ] (the “ROIC Performance Period”):

 

ROIC [  ]

Percentage of ROIC Target Award Tranche Eligible for Vesting

 

0% of ROIC Target Award

Tranche

 

50% of ROIC Target Award

Tranche

 

100% of ROIC Target Award

Tranche

 

150% of ROIC Target Award

Tranche

Adjusted EPS Performance Goals

50% of the Target Award amount granted in Section 1 above shall be eligible to vest based on the attainment of Adjusted EPS performance goals (the “Adjusted EPS PRSUs”), as set forth below.

The number of Adjusted EPS PRSUs that will be eligible for vesting in accordance with Section 2(a) of the Agreement shall be equal to the sum of A + B + C, where:

A =

number of Adjusted EPS PRSUs subject to an Adjusted EPS Target Award Tranche (as defined below) x the [  ] EPS Performance Attainment Factor (set forth below)

B =

number of Adjusted EPS PRSUs subject to an Adjusted EPS Target Award Tranche x the [  ] EPS Performance Attainment Factor (set forth below)

C =

number of Adjusted EPS PRSUs subject to an Adjusted EPS Target Award Tranche x the [  ] EPS Performance Attainment Factor (set forth below)

Performance Periods: With respect to the Adjusted EPS PRSUs, there will be three performance periods (each a “Adjusted EPS Performance Period”), as described in the below table, in which

Appendix A – Performance Restricted Stock Unit Award

US-DOCS\119733922.3

 

one-sixth (1/6) of the Target Award amount granted in Section 1 above (a “Adjusted EPS Target Award Tranche”) will be measured against the Performance Goals stated in the table below for such Adjusted EPS Performance Period.

 

Adjusted EPS Performance Period

 

Dates

 

Performance Goals

Units Subject to the Performance Goal

[  ]

Performance Period

 

[  ]

 

[  ] Adjusted EPS

 

One Adjusted EPS Target Award Tranche

[  ]

Performance Period

 

[  ]

 

[  ] Adjusted EPS

 

One Adjusted EPS Target Award Tranche

[  ]

Performance Period

 

[  ]

 

[  ] Adjusted EPS

 

One Adjusted EPS Target Award Tranche

Company Adjusted EPS: One Adjusted EPS Target Award Tranche will be eligible for vesting based upon the Company’s Adjusted EPS for each Adjusted EPS Performance Period based on the following schedules:

 

[  ] Adjusted EPS

% of Adjusted EPS Target

[  ] EPS Performance Attainment Factor

[  ]

[  ]

0% of Adjusted EPS Target

Award Tranche

[  ]

[  ]

50% of Adjusted EPS Target

Award Tranche

[  ]

[  ]

100% of Adjusted EPS Target

Award Tranche

[  ]

[  ]

150% of Adjusted EPS Target

Award Tranche

 

[  ] Adjusted EPS

% of Adjusted EPS Target

[  ] EPS Performance Attainment Factor

[  ]

[  ]

0% of Adjusted EPS Target

Award Tranche

[  ]

[  ]

50% of Adjusted EPS Target

Award Tranche

[  ]

[  ]

100% of Adjusted EPS Target

Award Tranche

[  ]

[  ]

150% of Adjusted EPS Target

Award Tranche

Appendix A – Performance Restricted Stock Unit Award

US-DOCS\119733922.3

 

[  ] Adjusted EPS

% of Adjusted EPS Target

[  ] EPS Performance Attainment Factor

[  ]

[  ]

0% of Adjusted EPS Target

Award Tranche

[  ]

[  ]

50% of Adjusted EPS Target

Award Tranche

[  ]

[  ]

100% of Adjusted EPS Target

Award Tranche

[  ]

[  ]

150% of Adjusted EPS Target

Award Tranche

 

General:

Subject to the minimum threshold requirements, linear interpolation will be used based on the level of attainment of the performance goal between vesting levels.

The Committee shall calculate and determine the level of achievement of the performance goals in its sole discretion, which shall be final and binding on all parties to the Agreement.

All amounts used to calculate and determine the level of achievement shall be in USD, with any currency conversions being determined by the Committee is its sole discretion.

Definitions:

“Adjusted EPS” means, for a given Adjusted EPS Performance Period, the Company’s Adjusted Diluted Earnings per share as reported in the applicable earnings release attached as an exhibit to the Company’s Report on Form 8-K for the applicable Adjusted EPS Performance Period.

“Performance Period” means an Adjusted EPS Performance Period or the ROIC Performance Period.

“ROIC” is defined as, with respect to the ROIC Performance Period, Non-GAAP Income from Operations calculated in a manner consistent with the calculation of Adjusted EBITDA as reported in the earnings release attached as an exhibit to the Company’s Report on Form 8-K with respect to the last fiscal year in the ROIC Performance Period, affected by the cash tax rate, divided by the end of period Invested Capital. For purposes of this paragraph, “Invested Capital” is defined as the sum of Total Debt (inclusive of finance lease obligations) as reported in the Company’s Annual Report on Form 10-K and Total Shareholders’ Equity (adjusted for cumulative Share-Based Compensation). The Committee may adjust the ROIC to account for the impact of all (i) mergers, divestitures, and/or acquisitions completed during the ROIC Performance Period, and (ii) changes in tax policy and/or legislation that occur during the ROIC Performance Period.

“Target Award Tranche” means any Adjusted EPS Target Award Tranche or the ROIC Target Award Tranche.


Appendix A – Performance Restricted Stock Unit Award

US-DOCS\119733922.3

 

 

APPENDIX B

SYNEOS HEALTH, INC.

2018 Equity Incentive Plan
Global Performance Restricted Stock Unit Award Agreement

Country-Specific Terms and Conditions

Capitalized terms used but not otherwise defined herein shall have the meaning given to such terms in the Syneos Health, Inc. 2018 Equity Incentive Plan (the “Plan”) and the Global Performance Restricted Stock Unit Award Agreement (the “Performance Restricted Stock Unit Agreement”). This Appendix constitutes part of the Performance Restricted Stock Unit Agreement.

Terms and Conditions

This Appendix B includes additional terms and conditions that govern the PRSUs granted to the Participant if the Participant resides and/or works in a country listed below. If the Participant moves to another country after receiving the grant of the PRSUs, the Company will, in its discretion, determine the extent to which the terms and conditions herein will be applicable to the Participant.

Notifications

This Appendix B also includes information regarding exchange controls and certain other issues of which the Participant should be aware with respect to the Participant’s participation in the Plan. The information is based on the securities, exchange control and other laws in effect in the respective countries as of June 2018. Such laws are often complex and change frequently. As a result, the Company strongly recommends that the Participant not rely on the information in this Appendix B as the only source of information relating to the consequences of the Participant’s participation in the Plan because the information may be out of date at the time that the PRSUs vest or the Participant sells Shares acquired under the Plan.

In addition, the information contained herein is general in nature and may not apply to the Participant’s particular situation and the Company is not in a position to assure the Participant of a particular result. Accordingly, the Participant should seek appropriate professional advice as to how the relevant laws in the Participant’s country may apply to the Participant’s situation.

Finally, if the Participant is a citizen or resident of a country other than the one in which he or she is currently residing and/or working (or if the Participant is considered as such for local law purposes), the information contained herein may not be applicable to the Participant in the same manner.

 

Appendix B – Performance Restricted Stock Unit Award

US-DOCS\119733922.3

 

 

UNITED KINGDOM

Terms and Conditions

Responsibility for Taxes. The following provisions supplement Section 3 of the Performance Restricted Stock Unit Agreement:

Without limitation to Section 3 of the Performance Restricted Stock Unit Award Agreement, the Participant agrees that the Participant is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items, as and when requested by the Company or the Employer or by Her Majesty’s Revenue and Customs (“HMRC”) (or any other tax authority or any other relevant authority). The Participant also agrees to indemnify and keep indemnified the Company and the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on the Participant’s behalf.

Notwithstanding the foregoing, if the Participant is a director or executive officer of the Company (within the meaning of Section 13(k) of the Exchange Act), the immediately foregoing provision will not apply; instead, the amount of any uncollected income tax may constitute a benefit to the Participant on which additional income tax and national insurance contributions may be payable. The Participant is responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for paying the Company or the Employer (as applicable) for the value of any employee national insurance contributions due on this additional benefit.

Appendix B – Performance Restricted Stock Unit Award Agreement

US-DOCS\119733922.3

 

 

APPENDIX C

SYNEOS HEALTH, INC.

2018 Equity Incentive Plan
Global Restricted Stock Unit Award Agreement

Special Provisions for Certain Executive Officers

The provisions in this Appendix C apply only to Participants in the Syneos Health, Inc.
Executive Severance Plan (as defined below).

1. Involuntary Termination in connection with Change in Control.

This provision replaces Section 2(e) of the Performance Restricted Stock Unit Agreement:

 

(e)

Effect of Involuntary Termination in connection with Change in Control.

The Converted Time-Based RSUs shall immediately vest in full in the event of (A) the Participant’s Service is terminated by the Company or a Subsidiary for any reason other than Cause, or (B) the Participant resigns for Good Reason, in each case, at the time of, or during the period commencing on the date three (3) months prior to a Change in Control and ending twenty-four (24) months following such Change in Control (either of such events of termination within such period, a “CIC Termination”).

 

(i)

For purposes of this Agreement (including Section 2(d)), “Cause,” “Change in Control,” and “Good Reason” shall have the meanings ascribed to such terms in the Syneos Health, Inc. Executive Severance Plan, adopted September 15, 2016, as amended and restated August 20, 2018 (the “Executive Severance Plan”).

 

(ii)

This Section 2(e) shall be interpreted consistently with the provisions of the Executive Severance Plan to give effect to the benefits intended to be provided under the Executive Severance Plan, to the extent the Executive Severance Plan is applicable to the Participant. Further, the vesting acceleration benefits provided under this Section 2(e) shall be subject to the conditions set forth in the Executive Severance Plan, to the extent the Executive Severance Plan is applicable to the Participant.

 

(iii)

Any vesting acceleration provisions contemplated under this Section 2(e) shall be subject to the limitations provided in Section 5.5 of the Plan.

 

(iv)

Any PRSUs that vest pursuant to this Section 2(e) shall also be subject to the additional settlement provisions and subject to the conditions set forth in the Executive Severance Plan, to the extent the Executive Severance Plan is applicable to the Participant.

 

Appendix C – Performance Restricted Stock Unit Award Agreement

US-DOCS\119733922.3

 

 

APPENDIX D

RESTRICTIVE COVENANTS AGREEMENT

The Participant acknowledges and agrees that in light of the Participant’s access to Confidential Information and Participant’s position of trust and confidence with the Company or its Subsidiaries, Participant shall be subject to the restrictive covenants set forth herein. The Participant knows that the promises in this Restrictive Covenants Agreement (“RCA”) are an important way for the Company and its Subsidiaries to protect their proprietary interests and understands that the terms of this RCA are affected by the location in which the Participant is employed, as stated in Attachment A and Attachment B to this RCA. As a condition of the grant of the PRSUs, the Participant agrees as follows:

1.Definitions. Capitalized terms not otherwise defined in this RCA shall have the same meanings as set forth in the Syneos Health, Inc. 2018 Equity Incentive Plan, and the Global Performance Restricted Stock Unit Award Agreement (including the Appendix B and any other appendix attached thereto). The following terms shall have the following meanings for the purposes of this RCA:

(a)“Termination Date” means the last day of the Participant’s employment by the Company or any of its Subsidiaries.

(b)“Non-Solicit Restricted Period” means the period commencing on the Termination Date and ending twelve (12) months after the Termination Date.

(c)“Non-Compete Restricted Period” means the period commencing on the Termination Date and ending twelve (12) months after the Termination Date.

(d)“Company Customer” means a person or entity for whom the Company or any of its Subsidiaries was providing services either at the time of, or at any time within the twelve (12) months preceding the Termination Date, and for whom the Participant had direct contact with and/or carried out or oversaw a material business responsibility during said twelve (12) month period or about whom the Participant had exposure to or received Confidential Information as a result of the Participant’s employment with the Company or any of its Subsidiaries.

(e)“Prospective Customer” means a person or entity (i) that the Participant contacted for the purpose of soliciting business on behalf of the Company or any of its Subsidiaries during the twelve (12) months preceding the Termination Date; or (ii) to which the Company or any of its Subsidiaries had submitted a bid or proposal for services during the twelve (12) months preceding the Termination Date, and in which bid or proposal the Participant was involved in any material respect.

(f)“Company Person” means any person who is an employee of or consultant to the Company or any of its Subsidiaries as of the Termination Date.

(g)“Company Business” means (i) developing, marketing, selling and/or providing services to pharmaceutical, biotechnology, life sciences, medical device and medical diagnostic

D-1

US-DOCS\119733922.3

 

companies regarding: (A) the commercialization of pharmaceuticals, biologics, medical devices or diagnostic products, including, but not limited to, outsourced sales and related operations, marketing, naming/branding, advertising, public relations, medical communications and medication adherence services for the Company’s clients, (B) the provision of clinical trials and related support services including, but not limited to, bioanalysis, biostatistics, data management, feasibility studies, global safety and pharmacovigilance, laboratory operations, medical writing, project management, protocol and case report form design, quality assurance, regulatory affairs and consulting, medical oversight, risk management, site and patient recruitment, site management, strategic planning, study monitoring and late stage services for the Company’s clients, (C) the staffing of clinical trial and/or clinical research and development personnel for the Company’s clients, and (D) the provision of consulting services including, but not limited to, brand management, business development, clinical development, commercial strategy and organizational design, product launch planning, medical affairs, pricing and market access and risk evaluation and mitigation strategy for the Company’s clients; and (ii) any other business that the Company and its Subsidiaries engage in, or that the Company and its Subsidiaries have developed definitive plans to engage in, as of the Termination Date.

(h)“Restricted Area” means the following geographical areas: (i) any city, metropolitan area, county (or similar political subdivision in foreign countries) in which the Participant personally provided material services on behalf of the Company during the twelve (12) months prior to the Termination Date; (ii) within a 60-mile radius of the location(s) where the Participant had an office during the twelve (12) months prior to the Termination Date; (iii) within a 60 mile radius of Raleigh, North Carolina; and (iv) any city, metropolitan area, county (or similar political subdivision in foreign countries) in which the Company or any of its Subsidiaries is located or does or did business, during the twelve (12) months prior to the Termination Date.

(i)“Confidential Information” means without limitation, any confidential or proprietary information or materials of the Company or its Subsidiaries, whether of a technical, business, or other nature, including information and materials which relate to operations, processes, products, promotional material, developments, patent applications, formulas, sponsor or client lists, manufacturing processes, trade secrets, basic scientific data, data systems, employment policies, formulation information, budgets, bids, proposals, study protocols, coding devices, and any other confidential data or proprietary information in connection with the Company, its Subsidiaries or their business affairs, including but not limited to any information relating to the operation of the Company’s and/or its Subsidiaries’ business which the Company or its Subsidiaries may from time to time designate as confidential or proprietary or that Participant reasonably knows should be, or has been, treated by the Company and/or its Subsidiaries as confidential or proprietary. Confidential Information encompasses all formats in which information is preserved, whether electronic, print or in any other form, including all originals, copies, notes or other reproductions or replicas thereof. Any trade secrets of the Company or its Subsidiaries will be entitled to all of the protections and benefits under any applicable trade secrets law, whether statutory or common law, including but not limited to the Delaware Uniform Trade Secrets Act, Del. Code Ann. tit. 6, §§ 2001–2009, the North Carolina Trade Secrets Protection Act, N.C. Gen. Stat. §§ 66-152 et seq., the Massachusetts Uniform Trade Secrets Act, M.G.L. ch. 93, §§ 42 to 42G, and the California Uniform Trade Secrets Act, Cal. Civ. Code §§ 3426 et seq. If any information that the Company deems to be a trade secret is found by a court of competent

D-2

US-DOCS\119733922.3

 

jurisdiction not to be a trade secret, such information will, nevertheless, be considered Confidential Information for purposes of this RCA.

Notwithstanding the foregoing, the term “Confidential Information” shall not include information which (i) is already known to the Participant prior to its disclosure to the Participant by the Company; (ii) is or becomes generally available to the public through no wrongful act of any person; (iii) is at the time of disclosure part of the public knowledge or literature through no wrongful action by the Participant; or (iv) is received by the Participant from a third party without restriction and without any wrongful conduct on the part of such third party relating to such disclosure. The Participant acknowledges and agrees that the Confidential Information he/she obtains or becomes aware of as a result of his/her employment with the Company or any of its Subsidiaries is not generally known or available to the general public, but has been developed, compiled or acquired by the Company at its great effort and expense and that the Participant is required to protect and not disclose such information.

(j)“Subsidiary” or “Subsidiaries” means any corporation, partnership, limited liability company, joint venture, association, public or private limited company or other business entity at least 50% of the outstanding voting stock or voting interests of which is at the time owned or controlled, directly or indirectly, by the Company.

2.Non-Solicitation of Customers and Employees. The Participant agrees that during the Participant’s employment with the Company or any of its Subsidiaries and during the Non-Solicit Restricted Period, the Participant will not, on the Participant’s own behalf, nor as an officer, director, stockholder, partner, associate, employee, owner, executive, consultant or otherwise on behalf of any person, firm, partnership, corporation, or other entity:

(a)solicit, induce, influence or attempt to solicit, induce or influence any Company Customer to (i) cease doing business in whole or in part with the Company and/or its Subsidiaries, or to otherwise limit or reduce its business with the Company and/or its Subsidiaries, (ii) purchase or accept products or services competitive with those offered by the Company and/or its Subsidiaries from any person or entity (other than the Company and/or its Subsidiaries), or (iii) do business with any other person or business that is Competitive with the Company;

(b)solicit, induce, influence or attempt to solicit, induce or influence any Prospective Customer to (i) cease doing business in whole or in part with the Company and/or its Subsidiaries, or to otherwise limit or reduce its business with the Company and/or its Subsidiaries, (ii) purchase or accept products or services competitive with those offered by the Company and/or its Subsidiaries from any person or entity (other than the Company and/or its Subsidiaries), or (iii) do business with any other person or business that is Competitive with the Company;

(c)provide or sell any products or services competitive with those offered by the Company and/or its Subsidiaries to any Company Customer;

(d)provide or sell any products or services competitive with those offered by the Company and/or its Subsidiaries to any Prospective Customer;

(e)interfere with, disrupt or attempt to interfere with or disrupt the relationship, contractual or otherwise, that the Company and/or its Subsidiaries have with any sponsor, supplier,

D-3

US-DOCS\119733922.3

 

vendor, distributor, lessor, lessee, licensor or business partner that transacts business with the Company and/or its Subsidiaries;

(f)solicit, induce, encourage, entice or attempt to solicit, induce, encourage or entice any Company Person to terminate or alter his or her employment or engagement with the Company or any of its Subsidiaries; or

(g)employ or hire as an officer, director, employee, agent, consultant or independent contractor any Company Person.

3.Non-Competition.

(a)The Participant agrees that, during the Participant’s employment with the Company or any of its Subsidiaries, and during the Non-Compete Restricted Period, the Participant will not, within the Restricted Area, for the Participant’s own behalf or for any other person or entity, own, manage, operate or participate in the ownership, management, operation or control of, or be employed by or provide services to, any person, business or entity which competes with the Company Business if Participant would:

(i)have responsibilities or perform services that are entirely or substantially similar to the responsibilities or services that the Participant had or provided at the time of, or at any time within the twelve (12) months preceding the Termination Date;

(ii)be involved in creating, developing, modifying, accessing, utilizing or relying upon confidential information that is similar or relevant to that Confidential Information to which Participant created, developed, modified, accessed, utilized or relied upon during the Participant’s employment with the Company or any of its Subsidiaries; or

(iii)use, disclose, or engage in activity in which the Participant would be reasonably expected to use or disclose any Confidential Information.

(b)Notwithstanding the foregoing, the Participant’s ownership, directly or indirectly, of not more than one percent (1%) of the issued and outstanding stock of a corporation the shares of which are regularly traded on a national securities exchange or in the over-the-counter market shall not violate this Section.

4.Business Opportunities. The Participant, while he or she is employed by the Company and its Subsidiaries, agrees to offer or otherwise make known or available to the Company or any Subsidiary, as directed by the Company and without additional compensation or consideration, any business prospects, contracts or other business opportunities that he or she may discover, find, develop or otherwise have available to him or her in any field in which the Company or any of its Subsidiaries is engaged, and further agrees that any such prospects, contracts or other business opportunities shall be the property of the Company.

5.Confidentiality.

(a)The Participant acknowledges that during his or her employment with the Company, he or she has and will necessarily become informed of, and have access to, the

D-4

US-DOCS\119733922.3

 

Confidential Information of the Company, and that the Confidential Information, even though it may be contributed, developed or acquired in whole or in part by the Participant is the Company’s exclusive property to be held by the Participant in trust and solely for the Company’s benefit. Accordingly, except as required by law, the Participant shall not, at any time, either during or subsequent to his or her employment, as applicable, use, reveal, report, publish, copy, transcribe, transfer or otherwise disclose to any person, corporation or other entity, any of the Confidential Information without the prior written consent of the Company, except to responsible officers and employees of the Company and its Subsidiaries and other responsible persons who are in a contractual or fiduciary relationship with the Company or one of its Subsidiaries and except for information that legally and legitimately is or becomes of general public knowledge from authorized sources other than the Participant.

(b)This RCA shall not prevent Participant from (i) reporting, without prior approval from the Company, possible violations of federal securities laws or regulations to any governmental agency or entity, including but not limited to, the Department of Justice, the Securities and Exchange Commission, the Congress, and any Inspector General, or making other disclosures that are protected under the whistleblower provisions of federal law or regulation; (ii) filing a charge of discrimination with the Equal Employment Opportunity Commission; (iii) cooperating with the Equal Employment Opportunity Commission in an investigation of alleged discrimination; (iv) revealing evidence of criminal wrongdoing to law enforcement; (v) testifying in any cause of action when required to do so by law, or (vi) divulging Confidential Information pursuant to an order of court or agency of competent jurisdiction. However, with respect to (v) and (vi) only, Participant must promptly inform the Company of any such situations and shall take such reasonable steps to prevent disclosure of the Company’s Confidential Information until the Company has been informed of such requested disclosure and the Company has had an opportunity to respond to the court or agency.

Further, 18 U.S.C. § 1833(b) states: “An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that—(A) is made—(i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.” Accordingly, the parties to this RCA have the right to disclose in confidence trade secrets to federal, state, and local government officials, or to an attorney, for the sole purpose of reporting or investigating a suspected violation of law. The parties also have the right to disclose trade secrets in a document filed in a lawsuit or other proceeding, but only if the filing is made under seal and protected from public disclosure. Nothing in this RCA is intended to conflict with 18 U.S.C. § 1833(b) or create liability for disclosures of trade secrets that are expressly allowed by 18 U.S.C.§ 1833(b).

6.Prior Restrictive Covenants. The restrictive covenants contained in this RCA are in addition to, and not in lieu of, any other restrictive covenants between the Participant and the Company or any of its Subsidiaries. For the avoidance of doubt, any and all of the Participant’s restrictive covenants agreed to prior to entering into this RCA (“Prior Restrictive Covenants”) will survive and supersede the restrictive covenants set forth in this RCA to the extent that any Prior Restrictive Covenant is for a longer period of time or is more restrictive in scope or location than

D-5

US-DOCS\119733922.3

 

the restrictive covenants set forth in this RCA. A breach of any such Prior Restrictive Covenant will also constitute a breach of this RCA.

7.Injunctive Relief and Tolling. Participant acknowledges and agrees that if Participant breaches any of the provisions of Sections 2 through 6 hereof, it will cause irreparable damage to the Company and/or its Subsidiaries for which monetary damages alone will not constitute an adequate remedy. In the event of such breach or threatened breach, the Company shall be entitled as a matter of right (without being required to prove damages or furnish any bond or other security) to obtain a restraining order or an injunction to preserve or restore the status quo, and will additionally be entitled to an award of attorneys’ fees incurred in connection with securing any relief hereunder. Such right to equitable or extraordinary relief shall not be exclusive but shall be in addition to all other rights and remedies to which the Company may be entitled at law or in equity, including, without limitation, the right to recover monetary damages for the breach by Participant of any of the provisions of this RCA. Further, Participant understands that if Participant breaches any of the provisions in Sections 2 through 6 of this RCA, the applicable restricted period will be extended for a period of time equal to the period of time Participant spent in breach of this RCA. If the Company is required to seek injunctive relief from such breach, then the applicable restricted period shall be extended for a period of time equal to the pendency of such proceedings, including all appeals.

8.Termination. Participant may terminate the employment relationship for any reason at any time upon giving the Company thirty (30) days prior written notice, as applicable law permits. In the case of a termination by the Company other than a termination for Cause (as defined in the Plan), the Company will provide thirty (30) days prior written notice of termination, as applicable law permits. In each case, the Company may, in its discretion, relieve the Participant of some or all of his/her duties during all or a part of such notice period. Subject to the forgoing notice obligation, the Participant’s employment with the Company shall remain at will, as applicable law permits.

9.Return of Company Property. By no later than the Termination Date, the Participant shall promptly deliver to the Company all property and possessions of the Company and its Subsidiaries, including all drawings, manuals, letters, notes, notebooks, reports, copies, deliverables containing Confidential Information and all other materials relating to the Company and any of its Subsidiaries’ business that are in the Participant’s possession or control.

10.Governing Law, Forum. This RCA and all disputes, claims or controversies arising out of or related to this RCA, shall be governed by the laws of the country in which Participant is employed without regard for reference to any choice or conflict of law principles of any jurisdiction, and the parties agree that any action or proceeding with respect to this RCA or the Participant’s employment with the Company shall be brought exclusively in the courts in the country in which the Participant is employed.

11.Amendment, Modification or Waiver. This RCA may not be changed orally, and no provision of this RCA may be amended or modified unless such amendment or modification is in writing, signed by the Participant and by a duly authorized officer of the Company. No act or failure to act by the Company will waive any right, condition or provision contained herein. Any

D-6

US-DOCS\119733922.3

 

waiver by the Company must be in writing and signed by a duly authorized officer of the Company to be effective.

12.Severability. In case any one or more of the provisions contained in this RCA shall, for any reason, be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provisions of this RCA, but this RCA shall be construed as if such invalid, illegal, or other unenforceable provision had never been contained herein. If, moreover, any one or more of the provisions contained in this RCA shall for any reason be held to be excessively broad as to duration, geographical scope or subject, it shall be construed by limiting it and reducing it so as to be enforceable to the extent compatible with applicable law as it shall then appear.

13.Miscellaneous.

(a)The Participant’s and the Company’s obligations hereunder shall continue in full force and effect in the event that the Participant’s job title, responsibilities, work location or other conditions of his/her employment with the Company change subsequent to the execution of the RCA, without the need to execute a new RCA.

(b)Participant agrees to provide a copy of Sections 1 through 6 of this RCA to any subsequent employers or prospective employers during the applicable period of restriction (including but not limited to the Non-Solicit Restricted Period and the Non-Compete Restricted Period). The Participant specifically authorizes the Company to notify any subsequent employers or prospective employers of the Participant of the restrictions on the Participant contained in this RCA and of any concerns the Company may have about actual or possible conduct by the Participant that may be in breach of this RCA. The Participant agrees to promptly notify the Company of any offers to perform services, any engagements to provide services, and/or actual work of any kind, whether as an individual, proprietor, partner, stockholder, officer, employee, director, consultant, joint venturer, investor, lender, or in any other capacity whatsoever during the period of his/her employment by the Company or any of its Subsidiaries and during the Non-Solicit Restricted Period and the Non-Compete Restricted Period. Such notice must be provided prior to the commencement of any such services or work.

(c)The rights and remedies of the parties under this RCA are cumulative (not alternative) and in addition to all other rights and remedies available to such parties at law, in equity, by contract or otherwise.

(d)The obligations in this RCA shall survive Participant’s termination of employment with the Company or a Subsidiary and the assignment of this RCA by the Company to any successor in interest or other assignee.

 

[remainder of page intentionally blank]

 

D-7

US-DOCS\119733922.3

 EX-10.11.9 6 synh-ex10119_429.htm EX-10.11.9 2022 FORM OF RSU AWARD AGREEMENT US synh-ex10119_429.htm

Exhibit 10.11.9

SYNEOS HEALTH, INC.
2018 Equity Incentive Plan

Global Restricted Stock Unit Award Agreement

This Global Restricted Stock Unit Award Agreement (the “Restricted Stock Unit Agreement”), including any special terms and conditions for the Participant’s country set forth in the Appendix C attached hereto (the Global Restricted Stock Unit Agreement, the Appendix C and all other appendices attached hereto, collectively, the “Agreement”), is made by and between Syneos Health, Inc., a Delaware corporation (the “Company”), and [NAME OF EMPLOYEE] (the “Participant”), effective as of [Grant Date] (the “Date of Grant”).

Attention:  Attached to this Agreement as Appendix A is a Restrictive Covenants Agreement, which imposes certain restrictions upon you both during and after your employment with the Company.  Attached to this Agreement as Appendix B is a Mutual Arbitration Agreement, which requires you and the Company to arbitrate on an individual basis most disputes arising from or relating to your employment with the Company, as set forth in more detail in the Mutual Arbitration Agreement.  Your acceptance of the Restricted Stock Unit Award requires that you agree to the terms and conditions of this Agreement, the Restrictive Covenants Agreement, and the Mutual Arbitration Agreement.  It is important that you review the terms of each of these Agreements.

RECITALS

WHEREAS, the Company has adopted the Syneos Health, Inc. 2018 Equity Incentive Plan (as the same may be amended and/or amended and restated from time to time, the “Plan”), which Plan is incorporated herein by reference and made a part of this Agreement, and capitalized terms not otherwise defined in this Agreement will have the meanings ascribed to those terms in the Plan; and

WHEREAS, the Committee has authorized and approved the grant of an Award to the Participant of Restricted Stock Units payable in shares of Common Stock (the “Shares”), subject to the terms and conditions set forth in the Plan and this Agreement.

NOW THEREFORE, in consideration of the premises and mutual covenants set forth in this Agreement, the parties agree as follows:

1.

Grant of Restricted Stock Units. The Company has granted to the Participant, effective as of the Date of Grant, [Quantity Granted] Restricted Stock Units, on the terms and conditions set forth in the Plan and this Agreement, subject to adjustment as set forth in Section 4.5 of the Plan (the “RSUs”).

 

 

2.

Vesting of RSUs. Subject to the terms and conditions set forth in the Plan and this Agreement, the RSUs will vest as follows:

 

(a)

General. Except as otherwise provided in Sections 2(b) through 2(d) and Section 4, the RSUs will vest in equal annual installments of 33 and 1/3% of the Shares (each annual installment, a “Tranche”) over a three-year period on each anniversary of the Date of Grant (each annual vesting period within such three-year period, a “Vesting Period”), subject to the Participant’s continued Service through the last day of the applicable Vesting Period. Any fractional installments which result from the vesting of a Tranche shall be carried forward and vest when such combined fractional installments result in a full Share.

 

(b)

Effect of Death and Termination Due to Disability. The RSUs will become fully vested immediately upon the Participant’s death or termination of Service due to Disability.

 

(c)

Effect of Retirement. Upon the Participant’s Retirement after the first anniversary of the Date of Grant, the Participant shall be eligible to vest in a Pro-Rated Award. The number of RSUs that shall vest under a “Pro-Rated Award” shall be calculated by multiplying (i) the number of RSUs subject to the unvested Tranche of RSUs corresponding to the Vesting Period during which the Participant’s Retirement occurs, by (ii) a fraction, the numerator of which shall be the number of days that have elapsed between the first day of the applicable Vesting Period and the date of the Participant’s Retirement, and the denominator of which shall be 365. No fractional Shares shall be issued, and any fractional Shares that would have been deemed vested based on the foregoing calculation shall be rounded down to the next whole Share. For the avoidance of any doubt, the remaining unvested Tranches corresponding to Vesting Periods commencing following the date of the Participant’s Retirement shall be forfeited upon the Participant’s Retirement and all of the RSUs shall be forfeited in the event of the Participant’s Retirement on or prior to the first anniversary of the Date of Grant. For purposes of this Agreement, “Retirement” means a voluntary termination of Service on or after the Participant (i) has attained age 55; and (ii) completed 10 years of continuous Service. For purposes of this Section 2(c), a Participant’s Retirement shall not include: (i) a termination by the Company for Cause (as defined in the Plan), as determined in the sole discretion of the Company, (ii) a resignation by the Participant after being notified that the Company has elected to terminate the Participant for Cause, (iii) a termination or resignation by the Participant during the pendency of an investigation with respect to the Participant or while the Participant is on a performance improvement plan, or (iv) any other circumstance upon which the Company determines in good faith the Participant is not in good standing at the time of such termination at the sole discretion of the Company.

Notwithstanding the foregoing, if the Company receives a legal opinion that there has been a legal judgment and/or legal development in the Participant’s jurisdiction that likely would result in the favorable treatment that applies to the RSUs if the Participant attains the conditions set forth in this Section 2(c) being deemed

 

2

US-DOCS\112623669.1

 

unlawful and/or discriminatory, the provisions above regarding the treatment of the RSUs shall not be applicable to the Participant.

 

(d)

Effect of Involuntary Termination in Connection with Change in Control. The RSUs will become fully vested immediately upon the Participant’s termination of Service in the event that (A) the Participant’s Service is terminated by the Company for any reason other than Cause (as defined in the Plan), or (B) the Participant resigns for Good Reason, in each case, at the time of, or within twenty-four (24) months following, the consummation of a Change in Control occurring after the Date of Grant (either of such events of termination within such twenty-four-month period, a “CIC Termination”).

As used in this Agreement, “Good Reason” shall mean the occurrence, without the Participant’s express written consent, of any of the following events: (i) a material reduction in the Participant’s annual base salary; (ii) a material adverse change to the Participant’s title compared to the Participant’s title immediately prior to the Change in Control; (iii) a requirement that the Participant relocate to a principal place of employment more than fifty (50) miles from the Participant’s assigned principal office location as of immediately prior to the occurrence of the Change in Control; or (iv) if the Participant has an effective employment agreement, service agreement, or other similar agreement with the Company or any Subsidiary, a material breach of such agreement, provided, that, any event described in clauses (i), (ii), (iii) and (iv) above shall constitute Good Reason only if the Participant provides the Company with written notice of the basis for the Participant’s Good Reason within forty-five (45) days of the initial actions or inactions of the Company or any Subsidiary giving rise to such Good Reason and the Company or applicable Subsidiary has not cured the identified actions or inactions within sixty (60) days of such notice, and provided further that the Participant terminates his or her Service within thirty (30) days following the Company’s or applicable Subsidiary’s failure to cure within the 60-day cure period.

Any vesting acceleration contemplated under this Section 2(d) shall be subject to the limitations provided in Section 5.5 of the Plan.

3.

Settlement of RSUs Upon Vesting.

 

(a)

Settlement in Stock. RSUs vested as described in Section 2 above will be settled by delivering to the Participant a number of Shares equal to the number of vested RSUs within sixty (60) days of the date on which the RSUs vest, subject to any special timing requirements applicable under Section 17(l), the terms of this Agreement and payment of any Tax-Related Items. In any case, the Company may provide a reasonable delay in the delivery of the Shares to address Tax-Related Items, withholding, and other administrative matters, provided that any such delay does not result in a violation of Section 409A of the Code (to the extent the Participant is a U.S. taxpayer). Neither the Company nor the Committee will be liable to the Participant or any other Person for damages relating to any delays in issuing the Shares or any mistakes or errors in the issuance of the Shares.

 

3

US-DOCS\112623669.1

 

 

(b)

Book-Entry Registration of the Shares. The Company will deliver the Shares payable pursuant to this Agreement within the settlement period set forth in Section 3(a) by registering such Shares with the Company’s transfer agent (or another custodian selected by the Company) in book-entry form in the Participant’s name.

 

(c)

Shareholder Rights. The Participant will not have any rights of a stockholder with respect to the Shares subject to the RSUs, including voting and dividend rights, unless and until the Shares are delivered as described in Section 3(b) above.

 

(d)

Responsibility for Taxes. The Participant acknowledges that, regardless of any action taken by the Company or, if different, the Subsidiary employing or retaining the Participant (the “Employer”), the ultimate liability for all Tax-Related Items is and remains the Participant’s responsibility and may exceed the amount, if any, actually withheld by the Company or the Employer. The Participant further acknowledges that the Company and/or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSUs, including, but not limited to, the grant or vesting of the RSUs, the delivery of Shares following the vesting date of the RSUs, the subsequent sale of Shares acquired pursuant to such vesting/delivery and the receipt of any dividends and/or dividend equivalents; and (2) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate the Participant’s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant is subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Company and/or the Employer (or former Employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

 

(e)

Withholding Requirements. Prior to any relevant taxable or tax withholding event, as applicable, the Participant agrees to make adequate arrangements satisfactory to the Company and/or the Employer to satisfy all Tax-Related Items. In this regard, the Participant authorizes the Company and/or the Employer, or their respective agents, at the Company’s and/or the Employer’s discretion, to satisfy their obligations, if any, with regard to all Tax-Related Items by one or a combination of the following: (1) cash payment by the Participant to the Company prior to the day of vesting of an amount that the Company will apply to the required withholding; (2) withholding from the Participant’s wages or other cash compensation payable to the Participant by the Company and/or the Employer; (3) withholding from proceeds of the sale of Shares acquired upon vesting/settlement of the RSUs either through a voluntary sale or through a mandatory sale arranged by the Company (on the Participant’s behalf pursuant to this authorization); (4) withholding in Shares to be issued upon settlement of the RSUs, subject to approval by the Committee if the Participant is subject to the short-swing profit rules of Section 16(b) of the Exchange Act; or (5) any other method of withholding determined by the Company to be permitted under the Plan and, to the extent required by applicable law or under the Plan, approved by the Committee.  For the purposes of alternative (4) above, any Shares withheld shall be credited for purposes of the withholding requirements at the fair market value of the Shares on the date that the tax withholding is

 

4

US-DOCS\112623669.1

 

 

determined. Until such time as the Company provides notice to the contrary, it will satisfy any withholding requirements for Tax-Related Items pursuant to alternative (3) above; provided, however, that if such method (A) cannot be processed by the broker or (B) the Participant is subject to the Company’s Insider Trading Compliance Policy (the “Insider Trading Policy”), the sale of Shares pursuant to alternative (3) is prohibited under the Insider Trading Policy and the Participant has not entered into an arrangement that is intended to comply with the requirements of Rule 10b5-1(c)(1) of the Exchange Act and that provides for the sale of all of the Shares subject to this Agreement, the Company will instead collect withholding for Tax-Related Items pursuant to alternative (4).

The Company may withhold or account for Tax-Related Items by considering statutory withholding amounts or other applicable withholding rates, including the maximum applicable rates in the Participant’s jurisdiction(s). In the event of over-withholding, the Participant may receive a refund of any over-withheld amount in cash (with no entitlement to the equivalent amount in Common Stock) from the Company or the Employer.  In the event of under-withholding, the Participant may be required to pay any additional Tax-Related Items directly to the applicable tax authority or to the Company and/or the Employer.  If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant is deemed to have been issued the full number of Shares subject to the vested RSUs, notwithstanding that a number of the Shares is held back solely for the purpose of paying the Tax-Related Items.

Finally, the Participant agrees to pay to the Company or the Employer, including through withholding from the Participant’s wages or other cash compensation payable to the Participant by the Company and/or the Employer, any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of the Participant’s participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse to issue or deliver the Shares or the proceeds of the sale of Shares, if the Participant fails to comply with the Participant’s obligations in connection with the Tax-Related Items.

In addition, to the extent that any U.S. Federal Insurance Contributions Act tax withholding obligations arise in connection with the RSUs prior to the applicable vesting or settlement date, the vesting of the Award shall be accelerated with respect to a number of RSUs sufficient to satisfy (but not in excess of) such tax withholding obligations and any other tax withholding obligations associated with any such acceleration, and the withholding obligations shall be satisfied pursuant to the tax withholding method noted in alternative (4) above.

4.

Forfeiture. Except as provided in Sections 2(b) through 2(d) above, any unvested RSUs will be forfeited immediately, automatically and without consideration upon a termination of the Participant’s Service (regardless of the reason for such termination and whether or not later to be found invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant’s employment agreement, if any).

 

5

US-DOCS\112623669.1

 

Without limiting the generality of the foregoing, the RSUs and the Shares (and any resulting proceeds) will continue to be subject to Section 13 of the Plan.

5.

Adjustment to RSUs. In the event of any change with respect to the outstanding Shares contemplated by Section 4.5 of the Plan, the RSUs may be adjusted in accordance with Section 4.5 of the Plan.

6.

Nature of Grant. In accepting the RSUs, the Participant acknowledges, understands and agrees that:

 

(a)

the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan; provided, however, that the Mutual Arbitration Agreement set forth at Appendix B is a binding contract that may only be modified, amended, suspended or terminated by further agreement of the parties;

 

(b)

the grant of the RSUs is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of RSUs, or benefits in lieu of RSUs, even if RSUs have been granted in the past;

 

(c)

all decisions with respect to future RSUs or other grants, if any, will be at the sole discretion of the Company;

 

(d)

the RSUs and the Participant’s participation in the Plan shall not create a right to employment or be interpreted as forming an employment or services contract, nor be interpreted as amending the terms of an existing employment or services contract, with the Company or any Subsidiary, including the Employer if applicable; provided, however, that the Mutual Arbitration Agreement set forth at Appendix B is a binding contract between the parties;

 

(e)

the Participant is voluntarily participating in the Plan;

 

(f)

the RSUs and the Shares subject to the RSUs, and the income from and value of same, are not intended to replace any pension rights or compensation;

 

(g)

the RSUs and the Shares subject to the RSUs, and the income from and value of same, are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, holiday pay, long-service awards, pension or retirement or welfare benefits or similar payments;

 

(h)

unless otherwise agreed with the Company, the RSUs and the Shares subject to the RSUs, and the income from and value of same, are not granted as consideration for, or in connection with, the service the Participant may provide as a director of a Subsidiary;

 

(i)

the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty;

 

6

US-DOCS\112623669.1

 

 

(j)

no claim or entitlement to compensation or damages shall arise from forfeiture of the RSUs resulting from the termination of the Participant’s Service (for any reason whatsoever whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant’s employment agreement, if any);

 

(k)

the following provision shall not apply to Participants in the state of California: In consideration of the grant of the RSUs to which the Participant is otherwise not entitled, the Participant irrevocably agrees to release and never to institute any claims which have arisen, occurred or existed at any time prior to the date of this Restricted Stock Unit Agreement (“Claim”) against the Company or any of its Subsidiaries, and waives his or her ability, if any, to bring any such Claim; if, notwithstanding the foregoing, any such Claim is allowed by an arbitrator or other tribunal of competent jurisdiction, then, by participating in the Plan, the Participant shall be deemed irrevocably to have agreed not to pursue such Claim and agrees to execute any and all documents necessary to request dismissal or withdrawal of such Claim; and

 

(l)

The following provision applies if the Participant is providing services outside the United States: neither the Company nor any Subsidiary shall be liable for any foreign exchange rate fluctuation between the Participant’s local currency and the United States Dollar that may affect the value of the RSUs or of any amounts due to the Participant pursuant to the settlement of the RSUs or the subsequent sale of any Shares acquired upon settlement.

7.

No Advice Regarding Grant. The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Participant’s participation in the Plan, or the Participant’s acquisition or sale of the underlying Shares. The Participant should consult with the Participant’s own personal tax, legal and financial advisors regarding the Participant’s participation in the Plan before taking any action related to the Plan.

8.

Restrictive Covenants. The Participant acknowledges and recognizes that during the course of Participant’s employment with the Company or its Subsidiaries, the Participant will be given access to and become informed of Confidential Information and the Participant will be the beneficiary of the goodwill of the Company and its Subsidiaries, and, accordingly, agrees to the provisions of the Restrictive Covenants Agreement (“RCA”) annexed as Appendix A to this Agreement (the “Restrictive Covenants”). For the avoidance of doubt, the Restrictive Covenants contained in this Agreement are in addition to, and not in lieu of, any other restrictive covenants or similar covenants between the Participant and the Company or any of its Subsidiaries, including the Employer. If Participant breaches any non-competition, confidentiality or other restrictive covenant owed to the Company or any of its Subsidiaries pursuant to the RCA annexed hereto or any other agreement, as determined by the Committee in its sole discretion: (i) any unvested portion of the RSUs held by the Participant shall be immediately rescinded; and (ii) the Participant shall automatically forfeit any rights that the Participant may have with respect to the RSUs as of the date of such determination. The foregoing remedies set forth in this Section 8 shall

 

7

US-DOCS\112623669.1

 

not be the Company’s exclusive remedies. The Company reserves all other rights and remedies available to it at law or in equity.

9.

Data Privacy Provisions Applicable to Participants Outside the European Union/European Economic Area/United Kingdom (“EEA+”).

The Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant’s personal data as described in this Agreement and any other RSU grant materials by and among, as applicable, the Employer, the Company and its Subsidiaries for the purpose of implementing, administering and managing the Participant’s participation in the Plan.

The Participant understands that the Company and the Employer may hold certain personal information about the Participant, including, but not limited to, the Participant’s name, home address, email address and telephone number, date of birth, passport, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all RSUs, Performance RSUs or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in the Participant’s favor (“Data”), for the exclusive purpose of implementing, administering and managing the Plan.

The Participant understands that Data will be transferred to Fidelity Stock Plan Services, LLC or any other broker selected by the Company, or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan. The Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipients’ country (e.g., the United States) may have different data privacy laws and protections than the Participant’s country. The Participant understands that the Participant may request a list with the names and addresses of any potential recipients of the Data by contacting the Syneos Health, Inc. Human Resources Department (HRSupportServicesAmerica@SyneosHealth.com). The Participant authorizes the Company, Fidelity Stock Plan Services, LLC or any other broker selected by the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purpose of implementing, administering and managing the Participant’s participation in the Plan. The Participant understands that Data will be held only as long as is necessary to implement, administer and manage the Participant’s participation in the Plan. The Participant understands that the Participant may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Syneos Health, Inc. Human Resources Department (HRSupportServicesAmerica@SyneosHealth.com). Further, the Participant understands that the Participant is providing the consents herein on a purely voluntary basis. If the Participant does not consent, or if the Participant later seeks to revoke the Participant’s consent, the Participant’s Service with the Employer will not be affected; the only consequence of refusing or withdrawing the Participant’s consent is

 

8

US-DOCS\112623669.1

 

that the Company would not be able to grant RSUs or other equity awards to the Participant or administer or maintain such awards. Therefore, the Participant understands that refusing or withdrawing the Participant’s consent may affect the Participant’s ability to participate in the Plan. For more information on the consequences of the Participant’s refusal to consent or withdrawal of consent, the Participant understands that the Participant may contact the Syneos Health Privacy Office (data.privacy@syneoshealth.com).

Finally, upon request by the Company or the Employer, the Participant agrees to provide an executed data privacy consent form (or any other agreements or consents) that the Company and/or the Employer may deem necessary to obtain from the Participant for the purpose of administering the Participant’s participation in the Plan in compliance with the data privacy laws in the Participant’s country, either now or in the future. The Participant understands and agrees that the Participant will not be able to participate in the Plan if the Participant fails to provide any such consent or agreement requested by the Company and/or the Employer.

10.

Data Privacy Provisions Applicable to Participants in the EEA+.

The Company and the Employer hereby notify the Participant of the following in relation to the Participant’s Data (as defined below) and the collection, processing and transfer in electronic or other form of such Data in relation to the grant of RSUs and the Participant’s participation in the Plan. The collection, processing and transfer of the Participant’s Data is necessary for the legitimate purpose of the Company’s administration of the Plan and the Participant’s participation in the Plan, and the Participant’s denial and/or objection to the collection, processing and transfer of Data may affect the Participant’s participation in the Plan. As such, by participating in the Plan, the Participant acknowledges the collection, use, processing and transfer of Data and with respect to the limited transfer to the third party administrator Fidelity Stock Plan Services, LLC, consents to the transfer of Data as described herein.

The Participant understands that the Company and the Employer will hold certain personal information about the Participant to administer the Plan. This personal information may include, the Participant’s name, home address, email address and telephone number, date of birth, passport, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all RSUs, Performance RSUs or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in the Participant’s favor (“Data”), for the exclusive purpose of implementing, administering and managing the Plan.

The Company and the Employer will transfer Data amongst themselves as necessary for the purpose of implementation, administration and management of the Plan, and the Company and the Employer may each further transfer Data to third parties assisting the Company or the Employer in the implementation, administration and management of the Plan. The Participant understands that Data will be transferred to Fidelity Stock Plan Services, LLC or any other broker selected by the Company, or such other stock

 

9

US-DOCS\112623669.1

 

plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan. The Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipients’ country (e.g., the United States) may have different data privacy laws and protections than the Participant’s country. The Participant understands that the Participant may request a list with the names and addresses of any potential recipients of the Data by contacting the Syneos Health, Inc. Human Resources Department (HRSupportServicesAmerica@SyneosHealth.com). For any intragroup transfers of Data outside the EEA or the UK, the transfer will be under the European Commission’s model contracts for the transfer of personal data to third countries  (i.e., the standard contractual clauses) (the “Model Clauses”), or any equivalent contracts issued by the relevant competent authority of the UK (as applicable), unless the data transfer is to a country that has been determined by the European Commission or the relevant UK authorities (as applicable) to provide an adequate level of protection for individuals’ rights and freedoms for their personal data. Please contact the Syneos Health Privacy Office (data.privacy@syneoshealth.com) should you wish to receive a copy of the relevant Model Clauses.  

11.

Data Privacy Provisions Applicable to Participants in all Countries.

Where provided by applicable law, the Participant may have the right to exercise certain rights with respect to their Data, which may be subject to certain limitations and exclusions. For example, these rights may include the right to know what Data is processed, access to Data, rectification of Data, erasure of Data, restriction of processing of Data (including, where applicable, the restriction on the sale of Data), and portability of Data. The Participant may also have the right to object to the processing of Data, as well as to opt-out of the Plan, in any case without cost, by contacting in writing the Syneos Health, Inc. Human Resources Department. The Participant understands, however, that the Participant's participation in the Plan may be limited and the Company and the Employer may not be able to grant the Participant RSUs or other equity awards or administer or maintain such awards if the Participant refuses to provide Data. The Participant agrees to provide full cooperation in executing data privacy consent forms, agreements or any related documentation that the Company and/or the Employer deem necessary for the purpose of administering the Plan in compliance with the data privacy laws in the Participant’s country, either now or in the future.

When the Company and the Employer no longer need to use Data for the purposes above or do not need to retain it for compliance with any legal or regulatory purpose, each will take reasonable steps to remove Data from their systems and/or records containing the Data and/or take steps to properly anonymize it so that the Participant can no longer be identified from it. Further information concerning the Company’s data retention practices can be found in the Company’s Records Management Policy.

12.

Language. The Participant acknowledges that he or she is sufficiently proficient in English, or has consulted with an advisor who is sufficiently proficient in English, so as to allow the Participant to understand the terms and conditions of this Agreement. Furthermore, if the Participant has received this Agreement or any other document related to the Plan

 

10

US-DOCS\112623669.1

 

translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

13.

Electronic Delivery and Acceptance. The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.

14.

Imposition of Other Requirements. The Company reserves the right to impose any other requirements on the Participant’s participation in the Plan, on the RSUs and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require the Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

15.

Appendix C. Notwithstanding any provisions in this Agreement, the RSUs shall be subject to any additional terms and conditions set forth in Appendix C for the Participant’s country. Appendix C constitutes part of this Restricted Stock Unit Agreement.

16.

Insider Trading Restrictions/Market Abuse Laws. The Participant acknowledges that, depending on the Participant’s or the Participant’s broker’s country of residence or where the Shares are listed, the Participant may be subject to insider trading restrictions and/or market abuse laws, which may affect the Participant’s ability to accept, acquire, sell or otherwise dispose of Shares or rights to Shares or rights linked to the value of Shares (e.g., phantom awards, futures) during such times as the Participant is considered to have “inside information” regarding the Company (as defined by the laws or regulations in the applicable jurisdiction). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders the Participant places before possessing inside information. Furthermore, the Participant could be prohibited from (i) disclosing the inside information to any third party (other than on a “need to know” basis) and (ii) “tipping” third parties or causing them otherwise to buy or sell securities. Keep in mind third parties include fellow employees.

Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. The Participant is responsible for complying with any applicable restrictions and should speak with a personal legal advisor on this matter.

17.

Foreign Asset/Account Reporting; Exchange Controls. The Participant’s country may have certain foreign asset and/or account reporting requirements and/or exchange controls which may affect the Participant’s ability to acquire or hold Shares under the Plan or cash received from participating in the Plan (including from any dividends received or sale proceeds arising from the sale of Shares) in a brokerage or bank account outside the Participant’s country. The Participant may be required to report such accounts, assets or transactions to the tax or other authorities in his or her country. The Participant also may be required to repatriate sale proceeds or other funds received as a result of the Participant’s participation in the Plan to his or her country through a designated bank or broker and/or within a certain

 

11

US-DOCS\112623669.1

 

time after receipt. The Participant acknowledges that it is his or her responsibility to be compliant with such regulations, and the Participant should consult his or her personal legal advisor for any details.

18.

Miscellaneous Provisions.

 

(a)

Securities or Exchange Control Laws Requirements. No Shares will be issued or transferred pursuant to this Agreement unless and until all then applicable requirements imposed by U.S. or non-U.S. federal and state securities or exchange control laws, rules and regulations and by any regulatory agencies having jurisdiction, and by any exchanges upon which the Shares may be listed, have been fully met. As a condition precedent to the issuance of Shares pursuant to this Agreement, the Company may require the Participant to take any reasonable action to meet those requirements. The Committee may impose such conditions on any Shares issuable pursuant to this Agreement as it may deem advisable, including, without limitation, restrictions under the U.S. Securities Act of 1933, as amended, under the requirements of any exchange upon which shares of the same class are then listed and under any blue sky or other securities laws applicable to those Shares.

 

(b)

Non-Transferability. The RSUs and the rights and privileges conferred thereby shall be non-transferrable except as provided by Section 15.3 of the Plan. Any Shares delivered hereunder will be subject to such stop transfer orders and other restrictions as the Committee may deem advisable under the Plan or the rules, regulations and other requirements of the U.S. Securities and Exchange Commission, any stock exchange upon which such shares are listed, any applicable U.S. or non-U.S. federal, state or local laws and any agreement with, or policy of, the Company or the Committee to which the Participant is a party or subject, and the Committee may cause orders or designations to be placed upon any certificate(s) or other document(s) delivered to the Participant, or on the books and records of the Company’s transfer agent, to make appropriate reference to such restrictions.

 

(c)

No Right to Continued Service. Nothing in this Agreement or the Plan confers any right or obligation upon the Participant or the Company or any Subsidiary, including the Employer, to continue the Participant’s employment with the Employer.

 

(d)

Notification. Any notification required by the terms of this Agreement will be given by the Participant (i) in a writing addressed to the Company at its principal executive office and will be deemed effective upon actual receipt when delivered by personal delivery or by registered or certified mail, with postage and fees prepaid, or (ii) by electronic transmission to the Company’s e-mail address of the Company’s General Counsel and will be deemed effective upon actual receipt. Any notification required by the terms of this Agreement will be given by the Company: (x) in a writing addressed to the address that the Participant most recently provided to the Company and will be deemed effective upon personal delivery or within three

 

12

US-DOCS\112623669.1

 

 

(3) days of deposit with the United States Postal Service or non-U.S. equivalent, by registered or certified mail, with postage and fees prepaid; or (y) by facsimile or electronic transmission to the Participant’s primary work fax number or e-mail address (as applicable) and will be deemed effective upon confirmation of receipt by the sender of such transmission.

 

(e)

Entire Agreement. This Agreement and the Plan constitute the entire agreement between the parties hereto with regard to the subject matter of this Agreement. This Agreement and the Plan supersede any other agreements, representations or understandings (whether oral or written and whether express or implied) that relate to the subject matter of this Agreement.

 

(f)

Waiver. No waiver by the Company of any breach or condition of this Agreement by the Participant or any other Participant will be deemed to be a waiver by the Company of any other or subsequent breach or condition whether of like or different nature.

 

(g)

Successors and Assigns. The provisions of this Agreement will inure to the benefit of, and be binding upon, the Company and its successors and assigns and upon the Participant, the Participant’s executor, personal representative(s), distributees, administrator, permitted transferees, permitted assignees, beneficiaries, and legatee(s), as applicable, whether or not any such person will have become a party to this Agreement and have agreed in writing to be joined herein and be bound by the terms hereof.

 

(h)

Severability. Except as provided in the Mutual Arbitration Agreement, the provisions of this Agreement are severable, and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, then the remaining provisions will nevertheless be binding and enforceable.

 

(i)

Amendment. Except as otherwise provided in the Plan or the Mutual Arbitration Agreement, this Agreement will not be amended unless the amendment is agreed to in writing by both the Participant and the Company.

 

(j)

Choice of Law; Jurisdiction. Except as provided in the Mutual Arbitration Agreement, this Agreement and all claims, causes of action or proceedings (whether in contract, in tort, at law or otherwise) that may be based upon, arise out of or relate to this Agreement will be governed by the internal laws of the State of Delaware, excluding any conflicts or choice-of-law rule or principle that might otherwise refer construction or interpretation of this Agreement to the substantive law of another jurisdiction.

 

(k)

Signature in Counterparts. This Agreement may be signed in counterparts, manually or electronically, each of which will be an original, with the same effect as if the signatures to each were upon the same instrument.

 

13

US-DOCS\112623669.1

 

 

(l)

IRC Section 409A. This Section 18(l) applies only to Participants who are U.S. taxpayers.

Anything in this Agreement to the contrary notwithstanding, RSUs that are non‑qualified deferred compensation subject to Section 409A of the Code and that vest as a result of the Participant’s termination of employment under Section 2(b), 2(c), or 2(d) hereof shall be settled within 60 days of the date the Participant experiences a “separation from service,” within the meaning of Section 409A of the Code (“Separation from Service”). If the Participant is a “specified employee” within the meaning of Section 409A of the Code as of the date of the Separation from Service (as determined in accordance with the methodology established by the Company as in effect on the Date of Termination), any RSUs that are non-qualified deferred compensation that are payable upon a Separation from Service shall instead be settled on the first business day that is after the earlier of (i) the date that is six months following the date of the Participant’s Separation from Service or (ii) the date of the Participant’s death, to the extent such delayed payment is otherwise required in order to avoid a prohibited distribution under Section 409A(a)(2) of the Code, or any successor provision thereto.

 

(m)

Acceptance. The Participant hereby acknowledges receipt of a copy of the Plan and this Agreement, together with any appendices hereto. The Participant has read and understands the terms and provisions of the Plan and this Agreement, as well as the attached Restrictive Covenants Agreement and Mutual Arbitration Agreement and accepts the RSUs subject to all of the terms and conditions of the Plan and these Agreements. In the event of a conflict between any term or provision contained in this Agreement and a term or provision of the Plan, the applicable term and provision of the Plan will govern and prevail. The Participant must accept this Agreement electronically pursuant to the online acceptance procedure established by the Company within 30 days after the Agreement is presented to the Participant for review. If the Participant fails to accept the Agreement within such 30-day period, the Company may, in its sole discretion, rescind the Award in its entirety. By electronically accepting the Agreement, the Participant is also accepting the Restrictive Covenants Agreement and Mutual Arbitration Agreement, and this Award is granted under and governed by the terms and conditions of the Plan and these Agreements.

[Signature page follows]

 

 

14

US-DOCS\112623669.1

 

 

IN WITNESS WHEREOF, the Company and the Participant have executed this Global Restricted Stock Unit Award Agreement and any appendices thereto as of the date first written above.

 

 

 

 

SYNEOS HEALTH, INC.

 

 

 

 

 

 

 

 

 

 

 

 

By:

 

/s/ Alistair Macdonald

 

 

Name:

 

Alistair Macdonald

 

 

Title:

 

Chief Executive Officer

 

 

 

 

 

 

 

 

 

 

PARTICIPANT

 

 

 

 

 

 

 

 

 

[Electronic Signature]

 

 

 

 

 

 

 

 

 

Participant Signature

 

 

 

 

Name: [Participant Name]

 

 

 

 

Acceptance Date: [Acceptance Date]

 

 

 

 

 

 

 

 

[Signature Page – Global Restricted Stock Unit Award Agreement]

US-DOCS\112623669.1

 

 

APPENDIX A

RESTRICTIVE COVENANTS AGREEMENT

The Participant acknowledges and agrees that in light of the Participant’s access to Confidential Information and Participant’s position of trust and confidence with the Company or its Subsidiaries, Participant shall be subject to the restrictive covenants set forth herein. The Participant knows that the promises in this Restrictive Covenants Agreement (“RCA”) are an important way for the Company and its Subsidiaries to protect their proprietary interests and understands that the terms of this RCA are affected by the location in which the Participant is employed, as stated in Attachment A and Attachment B to this RCA. As a condition of the grant of the RSUs, the Participant agrees as follows:

1.Definitions. Capitalized terms not otherwise defined in this RCA shall have the same meanings as set forth in the Syneos Health, Inc. 2018 Equity Incentive Plan, and the Global Restricted Stock Unit Award Agreement (including the Appendix C and any other appendix attached thereto). The following terms shall have the following meanings for the purposes of this RCA:

(a)“Termination Date” means the last day of the Participant’s employment by the Company or any of its Subsidiaries.

(b)“Non-Solicit Restricted Period” means the period commencing on the Termination Date and ending twelve (12) months after the Termination Date.

(c)“Non-Compete Restricted Period” means the period commencing on the Termination Date and ending twelve (12) months after the Termination Date.

(d)“Company Customer” means a person or entity for whom the Company or any of its Subsidiaries was providing services either at the time of, or at any time within the twelve (12) months preceding the Termination Date, and for whom the Participant had direct contact with and/or carried out or oversaw a material business responsibility during said twelve (12) month period or about whom the Participant had exposure to or received Confidential Information as a result of the Participant’s employment with the Company or any of its Subsidiaries.

(e)“Prospective Customer” means a person or entity (i) that the Participant contacted for the purpose of soliciting business on behalf of the Company or any of its Subsidiaries during the twelve (12) months preceding the Termination Date; or (ii) to which the Company or any of its Subsidiaries had submitted a bid or proposal for services during the twelve (12) months preceding the Termination Date, and in which bid or proposal the Participant was involved in any material respect.

(f)“Company Person” means any person who is an employee of or consultant to the Company or any of its Subsidiaries as of the Termination Date.

(g)“Company Business” means (i) developing, marketing, selling and/or providing services to pharmaceutical, biotechnology, life sciences, medical device and medical diagnostic companies regarding: (A) the commercialization of pharmaceuticals, biologics, medical devices

 

A-1

US-DOCS\112623669.1

 

or diagnostic products, including, but not limited to, outsourced sales and related operations, marketing, naming/branding, advertising, public relations, medical communications and medication adherence services for the Company’s clients, (B) the provision of clinical trials and related support services including, but not limited to, bioanalysis, biostatistics, data management, feasibility studies, global safety and pharmacovigilance, laboratory operations, medical writing, project management, protocol and case report form design, quality assurance, regulatory affairs and consulting, medical oversight, risk management, site and patient recruitment, site management, strategic planning, study monitoring and late stage services for the Company’s clients, (C) the staffing of clinical trial and/or clinical research and development personnel for the Company’s clients, and (D) the provision of consulting services including, but not limited to, brand management, business development, clinical development, commercial strategy and organizational design, product launch planning, medical affairs, pricing and market access and risk evaluation and mitigation strategy for the Company’s clients; and (ii) any other business that the Company and its Subsidiaries engage in, or that the Company and its Subsidiaries have developed definitive plans to engage in, as of the Termination Date.

(h)“Restricted Area” means the following geographical areas: (i) any city, metropolitan area, county (or similar political subdivision in foreign countries) in which the Participant personally provided material services on behalf of the Company during the twelve (12) months prior to the Termination Date; (ii) within a 60-mile radius of the location(s) where the Participant had an office during the twelve (12) months prior to the Termination Date; (iii) within a 60 mile radius of Raleigh, North Carolina; and (iv) any city, metropolitan area, county (or similar political subdivision in foreign countries) in which the Company or any of its Subsidiaries is located or does or did business, during the twelve (12) months prior to the Termination Date.

(i)“Confidential Information” means without limitation, any confidential or proprietary information or materials of the Company or its Subsidiaries, whether of a technical, business, or other nature, including information and materials which relate to operations, processes, products, promotional material, developments, patent applications, formulas, sponsor or client lists, manufacturing processes, trade secrets, basic scientific data, data systems, employment policies, formulation information, budgets, bids, proposals, study protocols, coding devices, and any other confidential data or proprietary information in connection with the Company, its Subsidiaries or their business affairs, including but not limited to any information relating to the operation of the Company’s and/or its Subsidiaries’ business which the Company or its Subsidiaries may from time to time designate as confidential or proprietary or that Participant reasonably knows should be, or has been, treated by the Company and/or its Subsidiaries as confidential or proprietary. Confidential Information encompasses all formats in which information is preserved, whether electronic, print or in any other form, including all originals, copies, notes or other reproductions or replicas thereof. Any trade secrets of the Company or its Subsidiaries will be entitled to all of the protections and benefits under any applicable trade secrets law, whether statutory or common law, including but not limited to the Delaware Uniform Trade Secrets Act, Del. Code Ann. tit. 6, §§ 2001–2009, the North Carolina Trade Secrets Protection Act, N.C. Gen. Stat. §§ 66-152 et seq., the Massachusetts Uniform Trade Secrets Act, M.G.L. ch. 93, §§ 42 to 42G, and the California Uniform Trade Secrets Act, Cal. Civ. Code §§ 3426 et seq. If any information that the Company deems to be a trade secret is found by a court of competent jurisdiction not to be a trade secret, such information will, nevertheless, be considered Confidential Information for purposes of this RCA.

 

A-2

US-DOCS\112623669.1

 

Notwithstanding the foregoing, the term “Confidential Information” shall not include information which (i) is already known to the Participant prior to its disclosure to the Participant by the Company; (ii) is or becomes generally available to the public through no wrongful act of any person; (iii) is at the time of disclosure part of the public knowledge or literature through no wrongful action by the Participant; or (iv) is received by the Participant from a third party without restriction and without any wrongful conduct on the part of such third party relating to such disclosure. The Participant acknowledges and agrees that the Confidential Information he/she obtains or becomes aware of as a result of his/her employment with the Company or any of its Subsidiaries is not generally known or available to the general public, but has been developed, compiled or acquired by the Company at its great effort and expense and that the Participant is required to protect and not disclose such information.

(j)“Subsidiary” or “Subsidiaries” means any corporation, partnership, limited liability company, joint venture, association, public or private limited company or other business entity at least 50% of the outstanding voting stock or voting interests of which is at the time owned or controlled, directly or indirectly, by the Company.

2.Non-Solicitation of Customers and Employees. The Participant agrees that during the Participant’s employment with the Company or any of its Subsidiaries and during the Non‑Solicit Restricted Period, the Participant will not, on the Participant’s own behalf, nor as an officer, director, stockholder, partner, associate, employee, owner, executive, consultant or otherwise on behalf of any person, firm, partnership, corporation, or other entity:

(a)solicit, induce, influence or attempt to solicit, induce or influence any Company Customer to (i) cease doing business in whole or in part with the Company and/or its Subsidiaries, or to otherwise limit or reduce its business with the Company and/or its Subsidiaries, (ii) purchase or accept products or services competitive with those offered by the Company and/or its Subsidiaries from any person or entity (other than the Company and/or its Subsidiaries), or (iii) do business with any other person or business that is Competitive with the Company;

(b)solicit, induce, influence or attempt to solicit, induce or influence any Prospective Customer to (i) cease doing business in whole or in part with the Company and/or its Subsidiaries, or to otherwise limit or reduce its business with the Company and/or its Subsidiaries, (ii) purchase or accept products or services competitive with those offered by the Company and/or its Subsidiaries from any person or entity (other than the Company and/or its Subsidiaries), or (iii) do business with any other person or business that is Competitive with the Company;

(c)provide or sell any products or services competitive with those offered by the Company and/or its Subsidiaries to any Company Customer;

(d)provide or sell any products or services competitive with those offered by the Company and/or its Subsidiaries to any Prospective Customer;

(e)interfere with, disrupt or attempt to interfere with or disrupt the relationship, contractual or otherwise, that the Company and/or its Subsidiaries have with any sponsor, supplier, vendor, distributor, lessor, lessee, licensor or business partner that transacts business with the Company and/or its Subsidiaries;

 

A-3

US-DOCS\112623669.1

 

(f)solicit, induce, encourage, entice or attempt to solicit, induce, encourage or entice any Company Person to terminate or alter his or her employment or engagement with the Company or any of its Subsidiaries; or

(g)employ or hire as an officer, director, employee, agent, consultant or independent contractor any Company Person.

3.Non-Competition.

(a)The Participant agrees that, during the Participant’s employment with the Company or any of its Subsidiaries, and during the Non-Compete Restricted Period, the Participant will not, within the Restricted Area, for the Participant’s own behalf or for any other person or entity, own, manage, operate or participate in the ownership, management, operation or control of, or be employed by or provide services to, any person, business or entity which competes with the Company Business if Participant would:

(i)have responsibilities or perform services that are entirely or substantially similar to the responsibilities or services that the Participant had or provided at the time of, or at any time within the twelve (12) months preceding the Termination Date;

(ii)be involved in creating, developing, modifying, accessing, utilizing or relying upon confidential information that is similar or relevant to that Confidential Information to which Participant created, developed, modified, accessed, utilized or relied upon during the Participant’s employment with the Company or any of its Subsidiaries; or

(iii)use, disclose, or engage in activity in which the Participant would be reasonably expected to use or disclose any Confidential Information.

(b)Notwithstanding the foregoing, the Participant’s ownership, directly or indirectly, of not more than one percent (1%) of the issued and outstanding stock of a corporation the shares of which are regularly traded on a national securities exchange or in the over-the-counter market shall not violate this Section.

4.Business Opportunities. The Participant, while he or she is employed by the Company and its Subsidiaries, agrees to offer or otherwise make known or available to the Company or any Subsidiary, as directed by the Company and without additional compensation or consideration, any business prospects, contracts or other business opportunities that he or she may discover, find, develop or otherwise have available to him or her in any field in which the Company or any of its Subsidiaries is engaged, and further agrees that any such prospects, contracts or other business opportunities shall be the property of the Company.

5.Confidentiality.

(a)The Participant acknowledges that during his or her employment with the Company, he or she has and will necessarily become informed of, and have access to, the Confidential Information of the Company, and that the Confidential Information, even though it may be contributed, developed or acquired in whole or in part by the Participant is the Company’s exclusive property to be held by the Participant in trust and solely for the Company’s benefit.

 

A-4

US-DOCS\112623669.1

 

Accordingly, except as required by law, the Participant shall not, at any time, either during or subsequent to his or her employment, as applicable, use, reveal, report, publish, copy, transcribe, transfer or otherwise disclose to any person, corporation or other entity, any of the Confidential Information without the prior written consent of the Company, except to responsible officers and employees of the Company and its Subsidiaries and other responsible persons who are in a contractual or fiduciary relationship with the Company or one of its Subsidiaries and except for information that legally and legitimately is or becomes of general public knowledge from authorized sources other than the Participant.

(b)This RCA shall not prevent Participant from (i) reporting, without prior approval from the Company, possible violations of federal securities laws or regulations to any governmental agency or entity, including but not limited to, the Department of Justice, the Securities and Exchange Commission, the Congress, and any Inspector General, or making other disclosures that are protected under the whistleblower provisions of federal law or regulation; (ii) filing a charge of discrimination with the Equal Employment Opportunity Commission; (iii) cooperating with the Equal Employment Opportunity Commission in an investigation of alleged discrimination; (iv) revealing evidence of criminal wrongdoing to law enforcement; (v) testifying in any cause of action when required to do so by law, or (vi) divulging Confidential Information pursuant to an order of court or agency of competent jurisdiction. However, with respect to (v) and (vi) only, Participant must promptly inform the Company of any such situations and shall take such reasonable steps to prevent disclosure of the Company’s Confidential Information until the Company has been informed of such requested disclosure and the Company has had an opportunity to respond to the court or agency.

Further, 18 U.S.C. § 1833(b) states: “An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that—(A) is made—(i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.” Accordingly, the parties to this RCA have the right to disclose in confidence trade secrets to federal, state, and local government officials, or to an attorney, for the sole purpose of reporting or investigating a suspected violation of law. The parties also have the right to disclose trade secrets in a document filed in a lawsuit or other proceeding, but only if the filing is made under seal and protected from public disclosure. Nothing in this RCA is intended to conflict with 18 U.S.C. § 1833(b) or create liability for disclosures of trade secrets that are expressly allowed by 18 U.S.C. § 1833(b).

6.Prior Restrictive Covenants. The restrictive covenants contained in this RCA are in addition to, and not in lieu of, any other restrictive covenants between the Participant and the Company or any of its Subsidiaries. For the avoidance of doubt, any and all of the Participant’s restrictive covenants agreed to prior to entering into this RCA (“Prior Restrictive Covenants”) will survive and supersede the restrictive covenants set forth in this RCA to the extent that any Prior Restrictive Covenant is for a longer period of time or is more restrictive in scope or location than the restrictive covenants set forth in this RCA. A breach of any such Prior Restrictive Covenant will also constitute a breach of this RCA.

 

A-5

US-DOCS\112623669.1

 

7.Injunctive Relief and Tolling. Participant acknowledges and agrees that if Participant breaches any of the provisions of Sections 2 through 6 hereof, it will cause irreparable damage to the Company and/or its Subsidiaries for which monetary damages alone will not constitute an adequate remedy. In the event of such breach or threatened breach, the Company shall be entitled as a matter of right (without being required to prove damages or furnish any bond or other security) to obtain a restraining order or an injunction to preserve or restore the status quo pending arbitration under the Mutual Arbitration Agreement, and will additionally be entitled to an award of attorneys’ fees incurred in connection with securing any relief hereunder. Such right to equitable or extraordinary relief shall not be exclusive but shall be in addition to all other rights and remedies to which the Company may be entitled at law or in equity, including, without limitation, the right to recover monetary damages for the breach by Participant of any of the provisions of this RCA. Further, Participant understands that if Participant breaches any of the provisions in Sections 2 through 6 of this RCA, the applicable restricted period will be extended for a period of time equal to the period of time Participant spent in breach of this RCA. If the Company is required to seek injunctive relief from such breach, then the applicable restricted period shall be extended for a period of time equal to the pendency of such proceedings, including all appeals.

8.Termination. Participant may terminate the employment relationship for any reason at any time upon giving the Company thirty (30) days prior written notice, as applicable law permits. In the case of a termination by the Company other than a termination for Cause (as defined in the Plan), the Company will provide thirty (30) days prior written notice of termination, as applicable law permits. In each case, the Company may, in its discretion, relieve the Participant of some or all of his/her duties during all or a part of such notice period. Subject to the forgoing notice obligation, the Participant’s employment with the Company shall remain at will, as applicable law permits.

9.Return of Company Property. By no later than the Termination Date, the Participant shall promptly deliver to the Company all property and possessions of the Company and its Subsidiaries, including all drawings, manuals, letters, notes, notebooks, reports, copies, deliverables containing Confidential Information and all other materials relating to the Company and any of its Subsidiaries’ business that are in the Participant’s possession or control.

10.Governing Law, Forum. Except as provided in any Mutual Arbitration Agreement, this RCA and all disputes, claims or controversies arising out of or related to this RCA, shall be governed (i) for U.S. Participants, by the laws of the State of Delaware without regard for reference to any choice or conflict of law principles of any jurisdiction. The parties agree that any proceeding seeking temporary or preliminary injunctive relief to preserve or restore the status quo pending arbitration of any disputes, claims or controversies arising out of or related to this RCA shall be brought exclusively in the state or federal courts in the State of Delaware, and the Participant voluntarily submits to the exclusive jurisdiction over the Participant’s person by a court of competent jurisdiction located within the State of Delaware. The parties hereby irrevocably waive any objection they may now or hereafter have to the laying of venue of any such proceeding in the State of Delaware, and further irrevocably waive any claim they may now or hereafter have that any such proceeding brought in said court(s) has been brought in an inconvenient forum. (ii) for Participants employed outside of the U.S, by the laws of the country in which Participant is employed without regard for reference to any choice or conflict of law principles of any

 

A-6

US-DOCS\112623669.1

 

jurisdiction, and the parties agree that any action or proceeding with respect to this RCA or the Participant’s employment with the Company shall be brought exclusively in the courts in the country in which the Participant is employed.

11.Amendment, Modification or Waiver. This RCA may not be changed orally, and no provision of this RCA may be amended or modified unless such amendment or modification is in writing, signed by the Participant and by a duly authorized officer of the Company. No act or failure to act by the Company will waive any right, condition or provision contained herein. Any waiver by the Company must be in writing and signed by a duly authorized officer of the Company to be effective.

12.Severability. In case any one or more of the provisions contained in this RCA shall, for any reason, be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provisions of this RCA, but this RCA shall be construed as if such invalid, illegal, or other unenforceable provision had never been contained herein. If, moreover, any one or more of the provisions contained in this RCA shall for any reason be held to be excessively broad as to duration, geographical scope or subject, it shall be construed by limiting it and reducing it so as to be enforceable to the extent compatible with applicable law as it shall then appear.

13.Miscellaneous.

(a)The Participant’s and the Company’s obligations hereunder shall continue in full force and effect in the event that the Participant’s job title, responsibilities, work location or other conditions of his/her employment with the Company change subsequent to the execution of the RCA, without the need to execute a new RCA.

(b)Participant agrees to provide a copy of Sections 1 through 6 of this RCA to any subsequent employers or prospective employers during the applicable period of restriction (including but not limited to the Non-Solicit Restricted Period and the Non-Compete Restricted Period). The Participant specifically authorizes the Company to notify any subsequent employers or prospective employers of the Participant of the restrictions on the Participant contained in this RCA and of any concerns the Company may have about actual or possible conduct by the Participant that may be in breach of this RCA. The Participant agrees to promptly notify the Company of any offers to perform services, any engagements to provide services, and/or actual work of any kind, whether as an individual, proprietor, partner, stockholder, officer, employee, director, consultant, joint venturer, investor, lender, or in any other capacity whatsoever during the period of his/her employment by the Company or any of its Subsidiaries and during the Non‑Solicit Restricted Period and the Non-Compete Restricted Period. Such notice must be provided prior to the commencement of any such services or work.

(c)The rights and remedies of the parties under this RCA are cumulative (not alternative) and in addition to all other rights and remedies available to such parties at law, in equity, by contract or otherwise.

 

A-7

US-DOCS\112623669.1

 

(d)The obligations in this RCA shall survive Participant’s termination of employment with the Company or a Subsidiary and the assignment of this RCA by the Company to any successor in interest or other assignee.

[remainder of page intentionally blank]

 

 

 

A-8

US-DOCS\112623669.1

 

 

Attachment A to RCA

California Law Modifications

This Attachment A modifies certain terms of the RCA while Participant is providing services to the Company, if Participant is based in California. If, at any time, Participant is relocated by the Company, to another state outside of California, the unmodified terms of the RCA will apply and this Attachment A will no longer apply. Similarly if Participant is originally based in a state outside of California, but the Company relocates Participant to California, the modified terms of this Attachment A will apply, as set forth below. For purposes of this RCA, Participant may only be employed in one state at any given time and any travel required by Participant’s role will not affect the Company’s determination of where Participant is based.

Section 2 shall be deleted and replaced as follows:

2. Non-Solicitation of Employees.  The Participant agrees that during the Participant’s employment with the Company or any of its Subsidiaries and during the Non-Solicit Restricted Period, the Participant will not, on the Participant’s own behalf, nor as an officer, director, stockholder, partner, associate, employee, owner, executive, consultant or otherwise on behalf of any person, firm, partnership, corporation, or other entity, solicit, induce, encourage, entice or attempt to solicit, induce, encourage or entice any Company Person to terminate or alter his or her employment or engagement with the Company or any Subsidiaries or to accept employment or engagement with any other person or entity.

Section 3(a) shall be deleted and replaced as follows:

(a) During Participant’s employment with the Company or any of its Subsidiaries, Participant shall not, directly or indirectly, either alone or in conjunction with any person, firm, association, company, corporation or other entity own, manage, operate or participate in the ownership, management, operation or control of, or be employed by or provide services to, any person, business or entity which is competitive with the Company Business if Participant would: (i) have responsibilities that are entirely or substantially similar to the responsibilities Participant has, or had held, at any time during Participant’s employment with the Company or any of its Subsidiaries; or (ii) be involved in creating, developing, modifying, accessing, utilizing or relying upon confidential information that is similar or relevant to that Confidential Information to which Participant created, developed, modified, accessed, utilized or relied upon during Participant’s employment with the Company or any of its Subsidiaries.

Section 10 shall be deleted and replaced as follows:

10.Governing Law

This RCA and all disputes, claims or controversies arising out of or related to this RCA, shall be governed by and construed in accordance with the laws of the state of California, without giving effect to any choice of law or conflict of law provision or rule (whether of California or any other jurisdiction) that would cause the application of the law of any jurisdiction other than the State of California. Participant agrees that venue for any proceeding seeking temporary or preliminary injunctive relief to preserve or restore the status quo pending arbitration of any

 

A-9

US-DOCS\112623669.1

 

disputes, claims or controversies arising out of or related to this RCA is proper in the federal or state courts of Orange County, California and that these courts shall have exclusive jurisdiction over any such proceeding and Participant specifically consents to personal jurisdiction in such court(s), even if Participant does not reside in Orange County at the time of the dispute. Participant hereby irrevocably waives any objection Participant may now or hereafter have to the laying of venue of any such proceeding in the State of California, and further irrevocably waives any claim Participant may now or hereafter have that any such proceeding brought in said court(s) has been brought in an inconvenient forum.

 

 

 

A-10

US-DOCS\112623669.1

 

 

Attachment B to RCA

This Attachment B modifies certain terms of the RCA while Participant is providing services to the Company, if Participant is based in Massachusetts. If, at any time, Participant is relocated by the Company, to another state outside of Massachusetts, the unmodified terms of the RCA will apply and this Attachment B will no longer apply. Similarly if Participant is originally based in a state outside of Massachusetts, but the Company relocates Participant to Massachusetts, the modified terms of this Attachment B will apply, as set forth below. For purposes of this RCA, Participant may only be employed in one state at any given time and any travel required by Participant’s role will not affect the Company’s determination of where Participant is based.

Section 1(c) of the RCA shall be deleted and replaced as follows:

(c) “Non-Compete Restricted Period” means the period commencing on the Termination Date and ending twelve (12) months after the Termination Date, provided that the Participant’s employment with the Company was due to the Participant’s voluntary separation from employment with the Company or the involuntary termination of the Participant’s employment by the Company for cause; provided, however, that in the event that the Company files an action to enforce rights arising out of this RCA, the Non-Compete Restricted Period shall be extended for all periods in which the Participant is determined by the Court to have been in violation of the Participant’s obligations under this RCA or any other fiduciary obligation owed to the Company.

Section 3 of the RCA shall be amended to include the following:

(c) If, prior to October 1, 2018, the Participant entered into an agreement with the Company containing non-competition and/or non-solicitation covenants, the Participant hereby reaffirms that the Participant is subject to, and bound by, the pre- and post-termination non‑competition and non-solicitation covenants set forth in those agreements.

Section 10 shall be deleted and replaced as follows:

10.Governing Law

This RCA and all disputes, claims or controversies arising out of or related to this RCA, shall be governed by and construed in accordance with the laws of the Commonwealth of Massachusetts, without giving effect to any choice of law or conflict of law provision or rule (whether of Massachusetts or any other jurisdiction) that would cause the application of the law of any jurisdiction other than the Commonwealth of Massachusetts. Participant agrees that venue for any proceeding seeking temporary or preliminary injunctive relief to preserve or restore the status quo pending arbitration of any disputes, claims or controversies arising out of or related to this RCA is proper in the federal or state courts in the county within Massachusetts where the Participant resides or the Suffolk County Business Litigation Session, and that these courts shall have exclusive jurisdiction over any such proceeding and Participant specifically consents to personal jurisdiction in such court(s), even if Participant does not reside in Suffolk County at the time of the dispute.  Participant hereby irrevocably waives any objection Participant may now or hereafter have to the laying of venue of any such proceeding in the Commonwealth of

 

A-11

US-DOCS\112623669.1

 

Massachusetts, and further irrevocably waives any claim Participant may now or hereafter have that any such proceeding brought in said court(s) has been brought in an inconvenient forum.

Section 13 of the RCA shall be amended to include the following:

(e)Participant has the right to consult with legal counsel prior to entering into this RCA.

 

 

 

A-12

US-DOCS\112623669.1

 

 

APPENDIX B

 

MUTUAL ARBITRATION AGREEMENT

This Mutual Arbitration Agreement (“Agreement”) sets forth the terms of the agreement between Syneos Health, Inc. and the Participant (the “Parties”) regarding an alternative approach for resolving employment-related disputes.

1.Mutual Arbitration Agreement

 

a.

Except as described in Section 3, titled “Claims Not Covered by this Agreement,” all disputes, claims, complaints, or controversies (“Claims”) that Participant has now, or at any time in the future may have, against the Company and/or any of its parents, subsidiaries, affiliates, predecessors, successors, assigns, current, former, or future officers, directors, employees, and/or those acting as an agent of the Company (which make up the definition of the “Company” for purposes of this Agreement), or that the Company has now or at any time in the future may have against Participant (“Covered Claims”), arising out of and/or related to Participant’s application for employment with the Company, employment with the Company, and/or the termination of Participant’s employment with the Company will be resolved by arbitration and NOT by a court or jury.  

Claims that the Parties agree to arbitrate include, but are not limited to, the following:

 

•

claims for breach of contract, tort claims, and claims for wrongful discharge;

 

 

•

discrimination and/or harassment claims, retaliation claims, and claims for failure to accommodate;

 

 

•

claims for overtime, wages, leaves, paid time off, sick days, compensation, penalties or restitution, or any other form of remuneration or pay;

 

 

•

all claims for violation of a federal, state, or local statute or ordinance creating employment rights including but not limited to claims under the Fair Labor Standards Act (“FLSA”), Title VII of the Civil Rights Act of 1964 (“Title VII”), the Age Discrimination in Employment Act (“ADEA”), the Worker Adjustment and Retraining Notification Act (“WARN”), the Equal Pay Act (“EPA”), the Americans With Disabilities Act (“ADA”), and the Family and Medical Leave Act (“FMLA”); and

 

•

any other claim under any federal, state, or local statute, constitution, regulation, rule, ordinance, or common law, arising out of and/or related to your application for employment with the Company, your employment with the Company, and/or the termination of your employment with the Company.

THE PARTIES HEREBY FOREVER WAIVE AND GIVE UP THE RIGHT TO HAVE A JUDGE OR A JURY DECIDE ANY COVERED CLAIMS. Either party to

 

B-1

 

this Agreement may make application to a court for temporary or preliminary injunctive relief in aid of arbitration or for the maintenance of the status quo pending arbitration.

2.Class, Collective, and Representative Action Waiver:

 

a.

Waiver of Class, Collective, and Representative Actions: To the maximum extent permitted by applicable law, the parties agree that no Covered Claims may be initiated or maintained on a class action, collective action, or representative action basis either in court or arbitration. In California, however, this waiver does not extend to representative claims brought pursuant to California’s Private Attorney General Act (“PAGA”). This means that neither party may serve or participate as a class, collective, or representative action member or representative, or receive any recovery from a class, collective, or representative action involving Covered Claims either in court or in arbitration. In addition, neither Participant nor the Company may participate as a plaintiff or claimant in a class, collective, or representative action to the extent that the action asserts Covered Claims against Participant or the Company. Nothing in this Agreement will preclude Participant or the Company from testifying or providing information in a class action, collective action or representative action.  Claims brought pursuant to the PAGA will be litigated in Court, not arbitration.

 

b.

Court to Decide Enforceability of the Waiver: A court of competent jurisdiction, not an arbitrator, must resolve issues concerning the enforceability or validity of the class action, collective action, or representative action waiver set forth above.

 

c.

No Prohibition On Filings Or Communications With Government Agencies: Nothing in this Agreement shall prohibit Participant from filing a charge, complaint or claim, or communicating or cooperating with, providing information to, or participating in an investigation by the U.S. Equal Employment Opportunity Commission, the National Labor Relations Board, the U.S. Department of Labor, the Occupational Safety and Health Administration, or any other federal, state or local administrative agency. To the extend a Covered Claim is not fully and finally resolved before the agency, it is subject to arbitration under this Agreement rather than any proceeding in court.

3.Claims Not Covered by this Agreement. The following claims shall not be covered by this Agreement:

 

a.

Claims for workers’ compensation benefits (provided that claims for workers’ compensation retaliation remain Covered Claims);

 

b.

Claims for unemployment compensation benefits;

 

c.

Claims for any relief asserted under or governed by the Employee Retirement Income Security Act of 1974 (“ERISA”); resolution of such claims will be governed by the terms of the applicable plan and applicable law;

 

B-2

 

 

d.

Claims that are subject to the exclusive jurisdiction of the National Labor Relations Board;

 

e.

Claims brought with the California Division of Labor Standards Enforcement while pending with the agency;

 

f.

Claims brought pursuant to California’s Private Attorney General Act (“PAGA”); and

 

g.

Any claim that is expressly precluded from inclusion in this Arbitration Agreement by a governing federal statute.

4.Arbitration Procedures

 

a.

The parties will use the Judicial Arbitration and Mediation Services (“JAMS”), subject to the JAMS Employment Arbitration Rules and Procedures and the JAMS Policy on Employment Arbitration Minimum Standards of Procedural Fairness (“JAMS Arbitration Rules”), or any successor rules, available at www.jamsadr.com or a copy will be provided upon request from Human Resources, unless those rules and/or procedures conflict with any express term of this Agreement, in which case this Agreement is controlling.  To the extent JAMS is unavailable to process the arbitration, any successor arbitration forum will be used or, if there is no successor forum, the parties will select an alternative arbitrator or forum or one will be appointed by a court, and the arbitration will proceed under the rules most applicable to employment claims, except to the extent that such rules conflict with this Agreement, in which case this Agreement is controlling.

 

To initiate an arbitration with JAMS, complete a Demand for Arbitration Form, available at: www.jamsadr.com/files/Uploads/Documents/JAMS_Arbitration_Demand.pdf.  Please follow the instructions contained in the Demand for Arbitration Form and submit your completed Demand for Arbitration Form, along with a form showing that you served the Demand for Arbitration (“Proof of Service”), the entire contract containing the arbitration clause, and the requisite filing fee, to your local JAMS Resolution Center.  JAMS Resolution Centers can be found on the JAMS website at:  www.jamsadr.com/locations/

 

b.

No arbitration under this Agreement shall be subject to the JAMS Class Action Procedures.  

 

c.

The arbitration will be heard by a single arbitrator at a location within 50 miles of where Participant worked for the Company in the U.S. at the time the claim arose, unless both parties agree otherwise.  In the event Participant is a field-based employee, or works primarily from their residence, the residence at the time the claim arose shall be considered the work location for purposes of determining the location of the arbitration.  In the event Participant is working for the Company outside of the U.S. on temporary assignment or is otherwise located outside the

 

B-3

 

 

U.S. when the claim arises, Participant agrees that the arbitration will take place in North Carolina.

 

d.

Any Party shall have the right to file a motion to dismiss and/or a motion for summary judgment, which the arbitrator shall have the authority and obligation to decide by application of the Federal Rules of Civil Procedure governing such motions.

 

e.

The arbitrator is authorized to award any party the full remedies that would be available to such party if the Covered Claim had been filed in court, including attorneys’ fees and costs. Thus, for example, Participant shall be entitled to recover attorney’s fees and costs in any arbitration in which Participant asserts and prevails on any statutory claims to the same extent as Participant could in court.

 

f.

The arbitrator shall issue a final and binding written award, subject to review on the grounds set forth in the Federal Arbitration Act (“FAA”). No award or decision by the arbitrator shall have any preclusive effect on issues or claims in any other arbitration or court proceeding, unless all of the parties in the other proceeding were also named parties in the arbitration in which the award or decision was issued.

5.Arbitration Fees and Costs

 

a.

In the event Participant files a claim under this Agreement, Participant will pay the arbitration provider’s employee-designated filing fee, or the normal filing fee in the state or federal court in which the dispute arose, whichever is lowest, and the Company will pay any amount of the JAMS fee in excess of that amount.

 

b.

The Company will pay any other JAMS administrative fees, the arbitrator’s fees, and any additional fees charged by the arbitral forum.

6.Other Provisions:

 

a.

Time Limitation for Commencing Arbitration: The same statute of limitations (the maximum time that parties have to initiate legal proceedings from the date a claim arises) that would have applied if the Covered Claim was filed in court will apply to any Covered Claim. Arbitration is to be commenced consistent with the JAMS arbitration rules and procedures, as applicable

 

b.

Agreement Survives Termination of Employment: This Agreement will survive the termination of Participant’s employment with the Company. This Agreement supersedes any prior agreement between the parties regarding the subject matter of dispute resolution of Covered Claims.

c. Construction and Severability:

 

i.

Except as expressly provided elsewhere in this Agreement, any issue concerning the validity or enforceability of this Agreement, and any issue concerning the arbitrability of a particular issue or claim pursuant to this

 

B-4

 

 

Agreement, must be resolved by the arbitrator, not the court.  A court, not an arbitrator, must resolve issues concerning the enforceability or validity of the class action, collective action, or representative action waivers set forth above.  

 

ii.

Except at stated below, if any part or provision of this Agreement is found to be void, voidable, or otherwise unenforceable, that part or provision shall be severed and such a finding will not affect the validity of the remainder of the Agreement, and all other parts and provisions remain in full force and effect.  To the extent any claims (or portions of claims) are found to be required to proceed in court, all other Covered Claims (or portions of such claims), shall still be required to be arbitrated.  

 

iii.

If any portion of the class action, collective action, or representative action waiver above is found to be void, voidable, or otherwise unenforceable, then the portion of the waiver found void or unenforceable shall be severed from this Agreement, and all other parts and provisions shall remain in full force and effect. In such a case, the claims (or portions of claims) found to be able to proceed on a class action, collective action, or representative action basis shall proceed in court and not in arbitration.

 

d.

Governing Law: This Agreement is governed by the FAA and, to the extent not inconsistent with or preempted by the FAA, by the laws of the state in which Participant last worked for the Company without regard to choice or conflicts of law rules. The Company’s business, Participant’s employment with the Company, and this Agreement affect interstate commerce.  The arbitrator is obligated to follow and apply the law applicable to any Covered Claims, and does not have the authority to enlarge upon or add to, subtract from or disregard, or otherwise alter the Parties’ rights under such laws.

7.Acknowledgements: By accepting the terms of this Agreement, Participant acknowledges and represent that:

 

 

a.

Participant has carefully read this Agreement, understand the terms of this Agreement, and is entering into this Agreement voluntarily;

 

b.

Participant is not relying on any promises or representations by the Company except those contained in this Agreement;

 

c.

Participant is giving up the right to have Covered Claims decided by a court, judge or jury;

 

d.

Participant remains employed “at will,” and for no definite period of time;

 

e.

These obligations are binding both upon Participant and Participant’s assigns, executors, administrators and legal representatives;

 

B-5

 

 

f.

Participant has been given a reasonable period of time in which to consider this Agreement; and

 

g.

Participant has been given the opportunity to discuss this Agreement with Participant’s own attorney or advisor if Participant wished to do so.

 

 

 

B-6

 

 

APPENDIX C

SYNEOS HEALTH, INC.

2018 Equity Incentive Plan
Global Restricted Stock Unit Award Agreement

Country-Specific Terms and Conditions

Capitalized terms used but not otherwise defined herein shall have the meaning given to such terms in the Syneos Health, Inc. 2018 Equity Incentive Plan, and the Global Restricted Stock Unit Award Agreement.

Terms and Conditions

This Appendix C includes additional terms and conditions that govern the RSUs granted to the Participant if the Participant resides and/or works in a country listed below. If the Participant moves to another country after receiving the grant of the RSUs, the Company will, in its discretion, determine the extent to which the terms and conditions herein will be applicable to the Participant.

Notifications

This Appendix C also includes information regarding exchange controls and certain other issues of which the Participant should be aware with respect to the Participant’s participation in the Plan. The information is based on the securities, exchange control and other laws in effect in the respective countries as of January 2021. Such laws are often complex and change frequently. As a result, the Company strongly recommends that the Participant not rely on the information in this Appendix C as the only source of information relating to the consequences of the Participant’s participation in the Plan because the information may be out of date at the time that the RSUs vest or the Participant sells Shares acquired under the Plan.

In addition, the information contained herein is general in nature and may not apply to the Participant’s particular situation and the Company is not in a position to assure the Participant of a particular result. Accordingly, the Participant should seek appropriate professional advice as to how the relevant laws in the Participant’s country may apply to the Participant’s situation.

Finally, if the Participant is a citizen or resident of a country other than the one in which he or she is currently residing and/or working (or if the Participant is considered as such for local law purposes), the information contained herein may not be applicable to the Participant in the same manner.

ARGENTINA

Terms and Conditions

Nature of Grant. This provision supplements Section 6 of the Global Restricted Stock Unit Award Agreement:

 

 

C-1

 

 

The RSUs are an extraordinary benefit, which for labor law purposes (e.g., thirteenth month salary, Christmas bonuses, or similar payments) are valued at the fair market value of the Shares on the date of vesting, when the Shares are delivered to the Participant. Such value is inclusive of thirteenth month salary for the month in which the vesting occurs.

Notifications

Securities Law Information. Shares of the Company are not publicly offered or listed on any stock exchange in Argentina.

Exchange Control Information. Argentine currency exchange restrictions and reporting requirements may apply to the RSUs and any Shares acquired under the Plan; the relevant laws and regulations are subject to frequent change. The Participant should consult with the Participant’s personal legal advisor regarding any exchange control obligations the Participant may have in connection with participation in the Plan.

Foreign Asset/Account Reporting Information. The Participant must report holdings of any equity interest in a foreign company (e.g., Shares acquired under the Plan) on his or her annual tax return each year.

AUSTRALIA

Terms and Conditions

Tax Information. The Plan is a plan to which Subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) applies (subject to the conditions in that Act).

Australia Offer Document. The grant of RSUs under the Plan is intended to comply with the provisions of the Corporations Act 2001, ASIC Regulatory Guide 49 and ASIC Class Order CO 14/1000. Additional details are set forth in the Participant’s Australia Offer Document.

BELGIUM

Notifications

Foreign Asset/Account Reporting Information. Belgian residents are required to report any security (e.g., Shares acquired under the Plan) or bank account held outside of Belgium on their annual tax return.  In a separate report, they will be required to provide the National Bank of Belgium with certain details regarding such foreign accounts (including the account number, bank name and country in which such account was opened).  The forms to complete the report are available on the National Bank of Belgium website.

Stock Exchange Tax Information.  A stock exchange tax applies to transactions executed by a Belgian resident through a non-Belgian financial intermediary, such as a U.S. broker.  The stock exchange tax may apply when Shares acquired under the Plan are sold.  Belgian residents should consult with a personal tax or financial advisor for additional details on their obligations with respect to the stock exchange tax.

 

C-2

 

 

CANADA

Terms and Conditions

RSUs Settled in Shares Only. Notwithstanding any discretion contained in the Plan, or any provision in this Agreement to the contrary, RSUs granted to employees in Canada shall be settled in Shares only and do not provide any right for the Participant to receive a cash payment.

The following terms and conditions apply to residents of Quebec:

Language Consent. The parties acknowledge that it is their express wish that this Global Restricted Stock Unit Award Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be provided to them in English.

Consentement Relatif à la Langue Utilisée. Les parties reconnaissent avoir expressément souhaité que la présente convention («Agreement»), ainsi que tous les documents exécutés, avis donnés et procédures judiciaires intentées, en vertu de, ou liés directement ou indirectement à la présente convention, soient rédigés en langue anglaise.

Data Privacy. This provision supplements Section 9 of the Global Restricted Stock Unit Award Agreement:

The Participant hereby authorizes the Company and the Company’s representatives to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Plan. The Participant further authorizes the Company, its Subsidiaries and any stock plan service provider that may be selected by the Company to assist with the Plan to disclose and discuss the Plan with their respective advisors. The Participant further authorizes the Company and its Subsidiaries to record such information and to keep such information in the Participant’s employee file.

Notifications

Securities Law Information. The Participant is permitted to sell Shares acquired under the Plan through a broker acceptable to the Company, provided the resale of Shares acquired under the Plan takes place outside of Canada through the facilities of a stock exchange on which the Shares are listed. The Shares are currently listed on the Nasdaq Global Select Market.

Foreign Asset/Account Reporting Information. Canadian residents are required to report foreign specified property, including Shares and rights to receive Shares (e.g., RSUs granted or Shares acquired under the Plan) in a non-Canadian company, on Form T1135 (Foreign Income Verification Statement), on an annual basis, if the total cost of the individual’s foreign specified property exceeds C$100,000 at any time during the year. Thus, if the C$100,000 cost threshold is exceeded by other foreign property held by the individual, RSUs must be reported.  Such RSUs may be reported at a nil cost.

 

C-3

 

For purposes of the reporting, Shares acquired under the Plan may be reported at their adjusted cost bases. The adjusted cost basis of a Share is generally equal to the fair market value of such Share at the time of acquisition; however, if the individual owns other Shares (e.g., acquired under other circumstances or at another time), the adjusted cost basis may be different.

The Participant should consult his or her personal tax advisor to determine the Participant’s exact reporting requirements in this regard.

FRANCE

Terms and Conditions

 

Consent to Receive Information in English.  By accepting the Agreement providing for the terms and conditions of the Participant’s grant, the Participant confirms having read and understood the documents relating to this grant (the Plan and this Agreement) which were provided in English language.  The Participant accepts the terms of those documents accordingly.

 

En acceptant le Contrat  décrivant les termes et conditions de l’attribution, le participant confirme ainsi avoir lu et compris les documents relatifs à cette attribution (le Plan U.S. et ce Contrat) qui ont été communiqués en langue anglaise.  Le participant accepte les termes en connaissance de cause.

 

Notifications

 

RSUs Not Tax-Qualified.  The Participant understands that the RSUs are not intended to be French tax-qualified.

 

Foreign Asset/Account Reporting Information.  French residents holding Shares outside France or maintaining a foreign bank account are required to report such to the French tax authorities when filing their annual tax returns, including any accounts that were closed during the year.  Failure to comply could trigger significant penalties.

 

GERMANY

 

Notifications

Exchange Control Information.  Cross-border payments in excess of €12,500 must be reported monthly to the German Federal Bank (Bundesbank).  In case of payments in connection with securities (including proceeds realized from the sale of Shares or the receipt of dividends), the report must be made by the 5th day of the month following the month in which the payment was received.  The report must be filed electronically and the form of report (“Allgemeine Meldeportal Statistik”) can be accessed via the Bundesbank’s website (www.bundesbank.de), in both German and English.  The Participant is responsible for making this report.

 

 

C-4

 

 

IRELAND

Notifications

Director Notification Requirement. Directors, shadow directors or secretaries of an Irish Subsidiary whose interest in the Company represents more than 1% of the Company’s voting share capital must notify the Irish Subsidiary in writing when acquiring or disposing of their interest in the Company (e.g., RSUs granted under the Plan, Shares, etc.), when becoming aware of the event giving rise to the notification requirement or when becoming a director or secretary if such an interest exists at the time.  This notification requirement also applies with respect to the interests of the spouse or children under the age of 18 of the director, shadow director or secretary (whose interests will be attributed to the director, shadow director or secretary).

ITALY

Terms and Conditions

Plan Document Acknowledgment. By accepting the grant of these RSUs, the Participant acknowledges that the Participant has received a copy of the Plan and the Agreement and has reviewed the Plan and the Agreement, in their entirety and fully understands and accepts all provisions of the Plan and the Agreement.  The Participant further acknowledges that the Participant has read and expressly approves the following sections of the Global Restricted Stock Unit Award Agreement: “Responsibility for Taxes”; “Withholding Requirements,” “Nature of Grant”; “Data Privacy Provisions Applicable to Participants in the EEA+;” and “Choice of Law; Jurisdiction.”

Notifications

Foreign Asset/Account Reporting Information.  Italian residents who, at any time during the fiscal year, hold foreign financial assets (such as cash, Shares or RSUs) which may generate income taxable in Italy are required to report such assets on their annual tax returns or on a special form if no tax return is due.  The same reporting duties apply to Italian residents who are beneficial owners of the foreign financial assets pursuant to Italian money laundering provisions, even if they do not directly hold the foreign asset abroad.  The Participant should consult a personal legal advisor to ensure compliance with applicable reporting requirements.

Foreign Asset Tax Information.  The value of the financial assets held outside of Italy (including Shares) by Italian residents is subject to a foreign asset tax. The taxable amount will be the fair market value of the financial assets (e.g., Shares acquired under the Plan) assessed at the end of the calendar year.

JAPAN

Notifications

Foreign Asset/Account Reporting Information.  Japanese residents are required to report details of any assets held outside of Japan as of December 31, including Shares acquired under the Plan, to the extent such assets have a total net fair market value exceeding ¥50 million.  Such report will

 

C-5

 

be due by March 15 each year.  The Participant is responsible for complying with this reporting obligation if applicable to the Participant and the Participant should consult his or her personal tax advisor in this regard.

POLAND

Terms and Conditions

Consent to Receive Information in English. By accepting the RSUs, the Participant confirms having read and understood the Plan and the Agreement, which were provided in the English language. The Participant accepts the terms of these documents accordingly.

Notifications

Exchange Control Information. If the Participant holds foreign securities (including Shares) and maintains such securities in an account abroad, he or she may be required to file certain reports with the National Bank of Poland. Specifically, if the value of the Participant’s securities and cash held in an account abroad (when combined with all other assets held abroad) exceeds PLN 7 million, he or she must file reports with the National Bank of Poland regarding any transactions and the balances of the foreign accounts on a quarterly basis. Such reports are filed on special forms available on the website of the National Bank of Poland.  Additionally, any funds transfer by a Polish resident into or out of Poland in excess of a specified threshold (currently €15,000, unless the transfer of funds is considered to be connected with the business activity of an entrepreneur, in which case a lower threshold may apply) must be effected through a bank in Poland. Polish residents are required to store all documents related to any foreign exchange transactions for a period of five years.

SERBIA

Notifications

Securities Law Information. The grant of RSUs and the issuance of any Shares are not subject to the regulations concerning public offers and private placements under the Law on Capital Markets.

Exchange Control Information. Pursuant to the Law on Foreign Exchange Transactions, the Participant is permitted to acquire Shares under the Plan. However, the National Bank of Serbia may require that Serbian residents obtain permission to hold any proceeds from the sale of Shares in an offshore account. The Participant should consult with a personal legal advisor to determine his or her reporting obligations upon the acquisition of Shares under the Plan as such obligations are subject to change without notice based on the interpretation of applicable regulations by the National Bank of Serbia.

SINGAPORE

Terms and Conditions

Restriction on Sale of Shares. The RSUs are subject to section 257 of the Securities and Futures Act (Chapter 289, 2006 Ed.) (“SFA”). The Participant will not be able to make any subsequent

 

C-6

 

sale of the Shares in Singapore, or any offer of such subsequent sale of the Shares in Singapore, unless such sale or offer is made (i) after 6 months from the Date of Grant or (ii) pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA or (iii) pursuant to, and in accordance with, the conditions of any applicable provision of the SFA.

Notifications

Securities Law Information. The grant of the RSUs is being made pursuant to the “Qualifying Person” exemption under section 273(1)(f) of the SFA, under which it is exempt from the prospectus and registration requirements and is not made with a view to the underlying Shares being subsequently offered for sale to any other party. The Plan has not been lodged or registered as a prospectus with the Monetary Authority of Singapore.

Director Notification Requirement. If the Participant is a director, associate director or shadow director of a Singapore Subsidiary, the Participant is subject to certain notification requirements under the Singapore Companies Act, regardless of whether the Participant is a Singapore resident or employed in Singapore. Among these requirements is the obligation to notify the Singapore Subsidiary in writing when the Participant receives or disposes of an interest (e.g., RSUs, Shares) in the Company or a Subsidiary. These notifications must be made within two (2) business days of (i) acquiring or disposing of an interest in the Company or any Subsidiary, (ii) any change in a previously disclosed interest (e.g., sale of Shares acquired under the Plan) or (iii) becoming a director, associate director or shadow director if such an interest exists at that time. Futhermore, if the Participant is the Chief Executive Officer (“CEO”) of a Singapore Subsidiary and the above notification requirements are determined to apply to the CEO of a Singapore Subsidiary, the above notification requirements also may apply to the Participant.

 

SPAIN

 

Terms and Conditions

 

Nature of Grant.  The following provisions supplement Section 6 of the Global Restricted Stock Unit Award Agreement:

By accepting the grant of the RSUs, the Participant consents to participation in the Plan and acknowledge that the Participant has received a copy of the Plan.

The Participant understands that the Company has unilaterally, gratuitously, and in its sole discretion decided to grant the RSUs under the Plan to individuals who may be employees of the Company or its Subsidiaries throughout the world.  The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not bind the Company or any Subsidiary, other than to the extent set forth in the Agreement.  Consequently, the Participant understands that the grant of the RSUs is made on the assumption and condition that the RSUs and any Shares acquired under the Plan are not part of any service agreement (either with the Company or any Subsidiary), and shall not be considered a mandatory benefit, compensation for any purpose, or any other right whatsoever.  In addition, the Participant understands that the RSUs would not be granted but for the assumptions and conditions referred to above; thus, the Participant acknowledges and freely accept that, should any or all of the

 

C-7

 

assumptions be mistaken or should any of the conditions not be met for any reason, then any grant of or right to the RSUs shall be null and void.

Further, the Participant understands that unless otherwise set forth in this Agreement, the Participant will not be entitled to continue vesting in the RSUs after termination of the Participant’s Service.  This will be the case, for example, even in the event of a termination of the Participant’s Service by reason of, but not limited to, resignation, retirement, disciplinary dismissal adjudged to be with cause, disciplinary dismissal adjudged or recognized to be without cause, individual or collective dismissal on objective grounds, whether adjudged or recognized to be without cause, material modification of the terms of employment agreement under Article 41 of the Workers’ Statute, relocation under Article 40 of the Workers’ Statute, Article 50 of the Workers’ Statute, unilateral withdrawal by the Company or Subsidiary and under Article 10.3 of the Royal Decree 1382/1985. The Participant acknowledges that the Participant has read and specifically accepts the conditions referred to in Section 6 of the Global Restricted Stock Unit Award Agreement.

Notifications

Securities Law Information.  No “offer to the public,” as defined under Spanish law, has taken place or will take place in the Spanish territory in connection with the grant of the RSUs.  The Plan, the Agreement and any other documents evidencing the grant of the RSUs have not been, nor will they be, registered with the Comisión Nacional del Mercado de Valores, and none of those documents constitutes a public offering prospectus.

Exchange Control Information.  The Participant must declare the acquisition of Shares to the Spanish Dirección General de Comercio Internacional e Inversiones (the “DGCI”), the Bureau for Commerce and Investments, which is a department of the Ministry of Economy and Competitiveness.  The Participant must also declare ownership of any Shares by filing a Form D-6 with the Directorate of Foreign Transactions each January while the Shares are owned.  In addition, the sale of Shares must be declared on Form D-6 filed with the DGCI in January, unless the sale proceeds exceed the applicable threshold (currently EUR 1,502,530), in which case, the filing is due within one month after the sale.  

Foreign Asset/Account Reporting Information.  The Participant is required to declare electronically to the Bank of Spain any securities accounts (including brokerage accounts held abroad), any foreign instruments (e.g., Shares) and any transactions with non-Spanish residents (including any payments of cash or Shares made to the Participant by the Company or any U.S. brokerage account) if the balances in such accounts together with the value of such instruments as of December 31, or the volume of transactions with non-Spanish residents during the prior or current year, exceed EUR 1 million.

Further, to the extent the Participant holds Shares and/or has a bank account outside Spain with a value in excess of EUR 50,000 (for each type of asset) as of December 31, the Participant will be required to report information on such assets on the Participant’s tax return (tax form 720) no later than March 31 for such year.  After such Shares and/or accounts are initially reported, the reporting obligation will apply for subsequent years only if the value of any previously-reported rights or assets increases by more than EUR 20,000 of if the Participant transfers or disposes of previously-reported rights or assets.

 

C-8

 

SWITZERLAND

Terms and Conditions

Securities Law Information.  Neither this document nor any materials relating to the Shares (i) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (“FinSA”), (ii) may be publicly distributed or otherwise made publicly available in Switzerland to any person other than an employee of the Company or one of its Subsidiaries, and (iii) has been or will be filed with, approved or supervised by any Swiss reviewing body according to Article 51 of FinSA or any Swiss regulatory authority (in particular, the Swiss Financial Supervisory Authority (FINMA)).

UNITED KINGDOM

Terms and Conditions

Responsibility for Taxes. The following provisions supplement Section 3 of the Global Restricted Stock Unit Award Agreement:

Without limitation to Section 3 of the Global Restricted Stock Unit Award Agreement, the Participant agrees that the Participant is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items, as and when requested by the Company or the Employer or by Her Majesty’s Revenue and Customs (“HMRC”) (or any other tax authority or any other relevant authority). The Participant also agrees to indemnify and keep indemnified the Company and the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on the Participant’s behalf.

Notwithstanding the foregoing, if the Participant is a director or executive officer of the Company (within the meaning of Section 13(k) of the Exchange Act), the immediately foregoing provision will not apply; instead, the amount of any uncollected income tax may constitute a benefit to the Participant on which additional income tax and national insurance contributions may be payable. The Participant is responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for paying the Company or the Employer (as applicable) for the value of any employee national insurance contributions due on this additional benefit.

 

C-9

 EX-10.11.10 7 synh-ex101110_428.htm EX-10.11.10 2022 FORM OF RSU AWARD AGREEMENT NON-US synh-ex101110_428.htm

Exhibit 10.11.10

 

SYNEOS HEALTH, INC.
2018 Equity Incentive Plan

Global Restricted Stock Unit Award Agreement

This Global Restricted Stock Unit Award Agreement (the “Restricted Stock Unit Agreement”), including any special terms and conditions for the Participant’s country set forth in the Appendix B attached hereto (the Global Restricted Stock Unit Agreement, the Appendix B and all other appendices attached hereto, collectively, the “Agreement”), is made by and between Syneos Health, Inc., a Delaware corporation (the “Company”), and [NAME OF EMPLOYEE] (the “Participant”), effective as of [Grant Date] (the “Date of Grant”).

Attention:  Attached to this Agreement as Appendix A is a Restrictive Covenants Agreement, which imposes certain restrictions upon you both during and after your employment with the Company.  Your acceptance of the Restricted Stock Unit Award requires that you agree to the terms and conditions of this Agreement and the Restrictive Covenants Agreement.  It is important that you review the terms of each of these Agreements.

RECITALS

WHEREAS, the Company has adopted the Syneos Health, Inc. 2018 Equity Incentive Plan (as the same may be amended and/or amended and restated from time to time, the “Plan”), which Plan is incorporated herein by reference and made a part of this Agreement, and capitalized terms not otherwise defined in this Agreement will have the meanings ascribed to those terms in the Plan; and

WHEREAS, the Committee has authorized and approved the grant of an Award to the Participant of Restricted Stock Units payable in shares of Common Stock (the “Shares”), subject to the terms and conditions set forth in the Plan and this Agreement.

NOW THEREFORE, in consideration of the premises and mutual covenants set forth in this Agreement, the parties agree as follows:

1.

Grant of Restricted Stock Units. The Company has granted to the Participant, effective as of the Date of Grant, [Quantity Granted] Restricted Stock Units, on the terms and conditions set forth in the Plan and this Agreement, subject to adjustment as set forth in Section 4.5 of the Plan (the “RSUs”).

2.

Vesting of RSUs. Subject to the terms and conditions set forth in the Plan and this Agreement, the RSUs will vest as follows:

 

(a)

General. Except as otherwise provided in Sections 2(b) through 2(d) and Section 4, the RSUs will vest in equal annual installments of 33 and 1/3% of the Shares (each annual installment, a “Tranche”) over a three-year period on each anniversary of the Date of Grant (each annual vesting period within such three-year period, a “Vesting Period”), subject to the Participant’s continued Service through the last day of the applicable Vesting Period. Any fractional installments which result from

 

 

 

the vesting of a Tranche shall be carried forward and vest when such combined fractional installments result in a full Share.

 

(b)

Effect of Death and Termination Due to Disability. The RSUs will become fully vested immediately upon the Participant’s death or termination of Service due to Disability.

 

(c)

Effect of Retirement. Upon the Participant’s Retirement after the first anniversary of the Date of Grant, the Participant shall be eligible to vest in a Pro-Rated Award. The number of RSUs that shall vest under a “Pro-Rated Award” shall be calculated by multiplying (i) the number of RSUs subject to the unvested Tranche of RSUs corresponding to the Vesting Period during which the Participant’s Retirement occurs, by (ii) a fraction, the numerator of which shall be the number of days that have elapsed between the first day of the applicable Vesting Period and the date of the Participant’s Retirement, and the denominator of which shall be 365. No fractional Shares shall be issued, and any fractional Shares that would have been deemed vested based on the foregoing calculation shall be rounded down to the next whole Share. For the avoidance of any doubt, the remaining unvested Tranches corresponding to Vesting Periods commencing following the date of the Participant’s Retirement shall be forfeited upon the Participant’s Retirement and all of the RSUs shall be forfeited in the event of the Participant’s Retirement on or prior to the first anniversary of the Date of Grant. For purposes of this Agreement, “Retirement” means a voluntary termination of Service on or after the Participant (i) has attained age 55; and (ii) completed 10 years of continuous Service. For purposes of this Section 2(c), a Participant’s Retirement shall not include: (i) a termination by the Company for Cause (as defined in the Plan), as determined in the sole discretion of the Company, (ii) a resignation by the Participant after being notified that the Company has elected to terminate the Participant for Cause, (iii) a termination or resignation by the Participant during the pendency of an investigation with respect to the Participant or while the Participant is on a performance improvement plan, or (iv) any other circumstance upon which the Company determines in good faith the Participant is not in good standing at the time of such termination at the sole discretion of the Company.

Notwithstanding the foregoing, if the Company receives a legal opinion that there has been a legal judgment and/or legal development in the Participant’s jurisdiction that likely would result in the favorable treatment that applies to the RSUs if the Participant attains the conditions set forth in this Section 2(c) being deemed unlawful and/or discriminatory, the provisions above regarding the treatment of the RSUs shall not be applicable to the Participant.

 

(d)

Effect of Involuntary Termination in Connection with Change in Control. The RSUs will become fully vested immediately upon the Participant’s termination of Service in the event that (A) the Participant’s Service is terminated by the Company for any reason other than Cause (as defined in the Plan), or (B) the Participant resigns for Good Reason, in each case, at the time of, or within twenty-four (24) months following, the consummation of a Change in Control occurring after the

2

US-DOCS\112623669.1

 

 

Date of Grant (either of such events of termination within such twenty-four-month period, a “CIC Termination”).

As used in this Agreement, “Good Reason” shall mean the occurrence, without the Participant’s express written consent, of any of the following events: (i) a material reduction in the Participant’s annual base salary; (ii) a material adverse change to the Participant’s title compared to the Participant’s title immediately prior to the Change in Control; (iii) a requirement that the Participant relocate to a principal place of employment more than fifty (50) miles from the Participant’s assigned principal office location as of immediately prior to the occurrence of the Change in Control; or (iv) if the Participant has an effective employment agreement, service agreement, or other similar agreement with the Company or any Subsidiary, a material breach of such agreement, provided, that, any event described in clauses (i), (ii), (iii) and (iv) above shall constitute Good Reason only if the Participant provides the Company with written notice of the basis for the Participant’s Good Reason within forty-five (45) days of the initial actions or inactions of the Company or any Subsidiary giving rise to such Good Reason and the Company or applicable Subsidiary has not cured the identified actions or inactions within sixty (60) days of such notice, and provided further that the Participant terminates his or her Service within thirty (30) days following the Company’s or applicable Subsidiary’s failure to cure within the 60-day cure period.

Any vesting acceleration contemplated under this Section 2(d) shall be subject to the limitations provided in Section 5.5 of the Plan.

3.

Settlement of RSUs Upon Vesting.

 

(a)

Settlement in Stock. RSUs vested as described in Section 2 above will be settled by delivering to the Participant a number of Shares equal to the number of vested RSUs within sixty (60) days of the date on which the RSUs vest, subject to any special timing requirements applicable under Section 17(l), the terms of this Agreement and payment of any Tax-Related Items. In any case, the Company may provide a reasonable delay in the delivery of the Shares to address Tax-Related Items, withholding, and other administrative matters, provided that any such delay does not result in a violation of Section 409A of the Code (to the extent the Participant is a U.S. taxpayer). Neither the Company nor the Committee will be liable to the Participant or any other Person for damages relating to any delays in issuing the Shares or any mistakes or errors in the issuance of the Shares.

 

(b)

Book-Entry Registration of the Shares. The Company will deliver the Shares payable pursuant to this Agreement within the settlement period set forth in Section 3(a) by registering such Shares with the Company’s transfer agent (or another custodian selected by the Company) in book-entry form in the Participant’s name.

 

(c)

Shareholder Rights. The Participant will not have any rights of a stockholder with respect to the Shares subject to the RSUs, including voting and dividend rights, unless and until the Shares are delivered as described in Section 3(b) above.

3

US-DOCS\112623669.1

 

 

(d)

Responsibility for Taxes. The Participant acknowledges that, regardless of any action taken by the Company or, if different, the Subsidiary employing or retaining the Participant (the “Employer”), the ultimate liability for all Tax-Related Items is and remains the Participant’s responsibility and may exceed the amount, if any, actually withheld by the Company or the Employer. The Participant further acknowledges that the Company and/or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSUs, including, but not limited to, the grant or vesting of the RSUs, the delivery of Shares following the vesting date of the RSUs, the subsequent sale of Shares acquired pursuant to such vesting/delivery and the receipt of any dividends and/or dividend equivalents; and (2) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate the Participant’s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant is subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Company and/or the Employer (or former Employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

 

(e)

Withholding Requirements. Prior to any relevant taxable or tax withholding event, as applicable, the Participant agrees to make adequate arrangements satisfactory to the Company and/or the Employer to satisfy all Tax-Related Items. In this regard, the Participant authorizes the Company and/or the Employer, or their respective agents, at the Company’s and/or the Employer’s discretion, to satisfy their obligations, if any, with regard to all Tax-Related Items by one or a combination of the following: (1) cash payment by the Participant to the Company prior to the day of vesting of an amount that the Company will apply to the required withholding; (2) withholding from the Participant’s wages or other cash compensation payable to the Participant by the Company and/or the Employer; (3) withholding from proceeds of the sale of Shares acquired upon vesting/settlement of the RSUs either through a voluntary sale or through a mandatory sale arranged by the Company (on the Participant’s behalf pursuant to this authorization); (4) withholding in Shares to be issued upon settlement of the RSUs, subject to approval by the Committee if the Participant is subject to the short-swing profit rules of Section 16(b) of the Exchange Act; or (5) any other method of withholding determined by the Company to be permitted under the Plan and, to the extent required by applicable law or under the Plan, approved by the Committee.  For the purposes of alternative (4) above, any Shares withheld shall be credited for purposes of the withholding requirements at the fair market value of the Shares on the date that the tax withholding is determined. Until such time as the Company provides notice to the contrary, it will satisfy any withholding requirements for Tax-Related Items pursuant to alternative (3) above; provided, however, that if such method (A) cannot be processed by the broker or (B) the Participant is subject to the Company’s Insider Trading Compliance Policy (the “Insider Trading Policy”), the sale of Shares pursuant to alternative (3) is prohibited under the Insider Trading Policy and the Participant has not entered into an arrangement that is intended to comply with the requirements of Rule 10b5-1(c)(1) of the Exchange Act and that provides for the sale of all of the

4

US-DOCS\112623669.1

 

 

Shares subject to this Agreement, the Company will instead collect withholding for Tax-Related Items pursuant to alternative (4).

The Company may withhold or account for Tax-Related Items by considering statutory withholding amounts or other applicable withholding rates, including the maximum applicable rates in the Participant’s jurisdiction(s). In the event of over-withholding, the Participant may receive a refund of any over-withheld amount in cash (with no entitlement to the equivalent amount in Common Stock) from the Company or the Employer.  In the event of under-withholding, the Participant may be required to pay any additional Tax-Related Items directly to the applicable tax authority or to the Company and/or the Employer.  If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant is deemed to have been issued the full number of Shares subject to the vested RSUs, notwithstanding that a number of the Shares is held back solely for the purpose of paying the Tax-Related Items.

Finally, the Participant agrees to pay to the Company or the Employer, including through withholding from the Participant’s wages or other cash compensation payable to the Participant by the Company and/or the Employer, any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of the Participant’s participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse to issue or deliver the Shares or the proceeds of the sale of Shares, if the Participant fails to comply with the Participant’s obligations in connection with the Tax-Related Items.

In addition, to the extent that any U.S. Federal Insurance Contributions Act tax withholding obligations arise in connection with the RSUs prior to the applicable vesting or settlement date, the vesting of the Award shall be accelerated with respect to a number of RSUs sufficient to satisfy (but not in excess of) such tax withholding obligations and any other tax withholding obligations associated with any such acceleration, and the withholding obligations shall be satisfied pursuant to the tax withholding method noted in alternative (4) above.

4.

Forfeiture. Except as provided in Sections 2(b) through 2(d) above, any unvested RSUs will be forfeited immediately, automatically and without consideration upon a termination of the Participant’s Service (regardless of the reason for such termination and whether or not later to be found invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant’s employment agreement, if any). Without limiting the generality of the foregoing, the RSUs and the Shares (and any resulting proceeds) will continue to be subject to Section 13 of the Plan.

5.

Adjustment to RSUs. In the event of any change with respect to the outstanding Shares contemplated by Section 4.5 of the Plan, the RSUs may be adjusted in accordance with Section 4.5 of the Plan.

6.

Nature of Grant. In accepting the RSUs, the Participant acknowledges, understands and agrees that:

5

US-DOCS\112623669.1

 

 

(a)

the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan;

 

(b)

the grant of the RSUs is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of RSUs, or benefits in lieu of RSUs, even if RSUs have been granted in the past;

 

(c)

all decisions with respect to future RSUs or other grants, if any, will be at the sole discretion of the Company;

 

(d)

the RSUs and the Participant’s participation in the Plan shall not create a right to employment or be interpreted as forming an employment or services contract, nor be interpreted as amending the terms of an existing employment or services contract, with the Company or any Subsidiary, including the Employer if applicable;

 

(e)

the Participant is voluntarily participating in the Plan;

 

(f)

the RSUs and the Shares subject to the RSUs, and the income from and value of same, are not intended to replace any pension rights or compensation;

 

(g)

the RSUs and the Shares subject to the RSUs, and the income from and value of same, are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, holiday pay, long-service awards, pension or retirement or welfare benefits or similar payments;

 

(h)

unless otherwise agreed with the Company, the RSUs and the Shares subject to the RSUs, and the income from and value of same, are not granted as consideration for, or in connection with, the service the Participant may provide as a director of a Subsidiary;

 

(i)

the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty;

 

(j)

no claim or entitlement to compensation or damages shall arise from forfeiture of the RSUs resulting from the termination of the Participant’s Service (for any reason whatsoever whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant’s employment agreement, if any);

 

(k)

the following provision shall not apply to Participants in the state of California: In consideration of the grant of the RSUs to which the Participant is otherwise not entitled, the Participant irrevocably agrees to release and never to institute any claims which have arisen, occurred or existed at any time prior to the date of this Restricted Stock Unit Agreement (“Claim”) against the Company or any of its Subsidiaries, and waives his or her ability, if any, to bring any such Claim; if,

6

US-DOCS\112623669.1

 

 

notwithstanding the foregoing, any such Claim is allowed by an arbitrator or other tribunal of competent jurisdiction, then, by participating in the Plan, the Participant shall be deemed irrevocably to have agreed not to pursue such Claim and agrees to execute any and all documents necessary to request dismissal or withdrawal of such Claim; and

 

(l)

The following provision applies if the Participant is providing services outside the United States: neither the Company nor any Subsidiary shall be liable for any foreign exchange rate fluctuation between the Participant’s local currency and the United States Dollar that may affect the value of the RSUs or of any amounts due to the Participant pursuant to the settlement of the RSUs or the subsequent sale of any Shares acquired upon settlement.

7.

No Advice Regarding Grant. The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Participant’s participation in the Plan, or the Participant’s acquisition or sale of the underlying Shares. The Participant should consult with the Participant’s own personal tax, legal and financial advisors regarding the Participant’s participation in the Plan before taking any action related to the Plan.

8.

Restrictive Covenants. The Participant acknowledges and recognizes that during the course of Participant’s employment with the Company or its Subsidiaries, the Participant will be given access to and become informed of Confidential Information and the Participant will be the beneficiary of the goodwill of the Company and its Subsidiaries, and, accordingly, agrees to the provisions of the Restrictive Covenants Agreement (“RCA”) annexed as Appendix A to this Agreement (the “Restrictive Covenants”). For the avoidance of doubt, the Restrictive Covenants contained in this Agreement are in addition to, and not in lieu of, any other restrictive covenants or similar covenants between the Participant and the Company or any of its Subsidiaries, including the Employer. If Participant breaches any non-competition, confidentiality or other restrictive covenant owed to the Company or any of its Subsidiaries pursuant to the RCA annexed hereto or any other agreement, as determined by the Committee in its sole discretion: (i) any unvested portion of the RSUs held by the Participant shall be immediately rescinded; and (ii) the Participant shall automatically forfeit any rights that the Participant may have with respect to the RSUs as of the date of such determination. The foregoing remedies set forth in this Section 8 shall not be the Company’s exclusive remedies. The Company reserves all other rights and remedies available to it at law or in equity.

9.

Data Privacy Provisions Applicable to Participants Outside the European Union/European Economic Area/United Kingdom (“EEA+”).

The Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant’s personal data as described in this Agreement and any other RSU grant materials by and among, as applicable, the Employer, the Company and its Subsidiaries for the purpose of implementing, administering and managing the Participant’s participation in the Plan.

7

US-DOCS\112623669.1

 

The Participant understands that the Company and the Employer may hold certain personal information about the Participant, including, but not limited to, the Participant’s name, home address, email address and telephone number, date of birth, passport, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all RSUs, Performance RSUs or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in the Participant’s favor (“Data”), for the exclusive purpose of implementing, administering and managing the Plan.

The Participant understands that Data will be transferred to Fidelity Stock Plan Services, LLC or any other broker selected by the Company, or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan. The Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipients’ country (e.g., the United States) may have different data privacy laws and protections than the Participant’s country. The Participant understands that the Participant may request a list with the names and addresses of any potential recipients of the Data by contacting the Syneos Health, Inc. Human Resources Department (HRSupportServicesAmerica@SyneosHealth.com). The Participant authorizes the Company, Fidelity Stock Plan Services, LLC or any other broker selected by the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purpose of implementing, administering and managing the Participant’s participation in the Plan. The Participant understands that Data will be held only as long as is necessary to implement, administer and manage the Participant’s participation in the Plan. The Participant understands that the Participant may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Syneos Health, Inc. Human Resources Department (HRSupportServicesAmerica@SyneosHealth.com). Further, the Participant understands that the Participant is providing the consents herein on a purely voluntary basis. If the Participant does not consent, or if the Participant later seeks to revoke the Participant’s consent, the Participant’s Service with the Employer will not be affected; the only consequence of refusing or withdrawing the Participant’s consent is that the Company would not be able to grant RSUs or other equity awards to the Participant or administer or maintain such awards. Therefore, the Participant understands that refusing or withdrawing the Participant’s consent may affect the Participant’s ability to participate in the Plan. For more information on the consequences of the Participant’s refusal to consent or withdrawal of consent, the Participant understands that the Participant may contact the Syneos Health, Inc. Privacy Office (data.privacy@syneoshealth.com).

Finally, upon request by the Company or the Employer, the Participant agrees to provide an executed data privacy consent form (or any other agreements or consents) that the Company and/or the Employer may deem necessary to obtain from the Participant for the purpose of administering the Participant’s participation in the Plan in compliance

8

US-DOCS\112623669.1

 

with the data privacy laws in the Participant’s country, either now or in the future. The Participant understands and agrees that the Participant will not be able to participate in the Plan if the Participant fails to provide any such consent or agreement requested by the Company and/or the Employer.

10.

Data Privacy Provisions Applicable to Participants in the EEA+.

The Company and the Employer hereby notify the Participant of the following in relation to the Participant’s Data (as defined below) and the collection, processing and transfer in electronic or other form of such Data in relation to the grant of RSUs and the Participant’s participation in the Plan. The collection, processing and transfer of the Participant’s Data is necessary for the legitimate purpose of the Company’s administration of the Plan and the Participant’s participation in the Plan, and the Participant’s denial and/or objection to the collection, processing and transfer of Data may affect the Participant’s participation in the Plan. As such, by participating in the Plan, the Participant acknowledges the collection, use, processing and transfer of Data and with respect to the limited transfer to the third party administrator Fidelity Stock Plan Services, LLC, consents to the transfer of Data as described herein.

The Participant understands that the Company and the Employer will hold certain personal information about the Participant to administer the Plan. This personal information may include, the Participant’s name, home address, email address and telephone number, date of birth, passport, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all RSUs, Performance RSUs or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in the Participant’s favor (“Data”), for the exclusive purpose of implementing, administering and managing the Plan.

The Company and the Employer will transfer Data amongst themselves as necessary for the purpose of implementation, administration and management of the Plan, and the Company and the Employer may each further transfer Data to third parties assisting the Company or the Employer in the implementation, administration and management of the Plan. The Participant understands that Data will be transferred to Fidelity Stock Plan Services, LLC or any other broker selected by the Company, or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan. The Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipients’ country (e.g., the United States) may have different data privacy laws and protections than the Participant’s country. The Participant understands that the Participant may request a list with the names and addresses of any potential recipients of the Data by contacting the Syneos Health, Inc. Human Resources Department (HRSupportServicesAmerica@SyneosHealth.com). For any intragroup transfers of Data outside the EEA or the UK, the transfer will be under the European Commission’s model contracts for the transfer of personal data to third countries  (i.e., the standard contractual clauses) (the “Model Clauses”), or any equivalent contracts issued by the relevant competent authority of the UK (as applicable),

9

US-DOCS\112623669.1

 

unless the data transfer is to a country that has been determined by the European Commission or the relevant UK authorities (as applicable) to provide an adequate level of protection for individuals’ rights and freedoms for their personal data. Please contact the Syneos Health Privacy Office (data.privacy@syneoshealth.com) should you wish to receive a copy of the relevant Model Clauses.  

11.

Data Privacy Provisions Applicable to Participants in all Countries.

Where provided by applicable law, the Participant may have the right to exercise certain rights with respect to their Data, which may be subject to certain limitations and exclusions. For example, these rights may include the right to know what Data is processed, access to Data, rectification of Data, erasure of Data, restriction of processing of Data (including, where applicable, the restriction on the sale of Data), and portability of Data. The Participant may also have the right to object to the processing of Data, as well as to opt-out of the Plan, in any case without cost, by contacting in writing the Syneos Health, Inc. Human Resources Department. The Participant understands, however, that the Participant's participation in the Plan may be limited and the Company and the Employer may not be able to grant the Participant RSUs or other equity awards or administer or maintain such awards if the Participant refuses to provide Data. The Participant agrees to provide full cooperation in executing data privacy consent forms, agreements or any related documentation that the Company and/or the Employer deem necessary for the purpose of administering the Plan in compliance with the data privacy laws in the Participant’s country, either now or in the future.

When the Company and the Employer no longer need to use Data for the purposes above or do not need to retain it for compliance with any legal or regulatory purpose, each will take reasonable steps to remove Data from their systems and/or records containing the Data and/or take steps to properly anonymize it so that the Participant can no longer be identified from it. Further information concerning the Company’s data retention practices can be found in the Company’s Records Management Policy.

12.

Language. The Participant acknowledges that he or she is sufficiently proficient in English, or has consulted with an advisor who is sufficiently proficient in English, so as to allow the Participant to understand the terms and conditions of this Agreement. Furthermore, if the Participant has received this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

13.

Electronic Delivery and Acceptance. The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.

14.

Imposition of Other Requirements. The Company reserves the right to impose any other requirements on the Participant’s participation in the Plan, on the RSUs and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable

10

US-DOCS\112623669.1

 

for legal or administrative reasons, and to require the Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

15.

Appendix B. Notwithstanding any provisions in this Agreement, the RSUs shall be subject to any additional terms and conditions set forth in Appendix B for the Participant’s country. Appendix B constitutes part of this Restricted Stock Unit Agreement.

16.

Insider Trading Restrictions/Market Abuse Laws. The Participant acknowledges that, depending on the Participant’s or the Participant’s broker’s country of residence or where the Shares are listed, the Participant may be subject to insider trading restrictions and/or market abuse laws, which may affect the Participant’s ability to accept, acquire, sell or otherwise dispose of Shares or rights to Shares or rights linked to the value of Shares (e.g., phantom awards, futures) during such times as the Participant is considered to have “inside information” regarding the Company (as defined by the laws or regulations in the applicable jurisdiction). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders the Participant places before possessing inside information. Furthermore, the Participant could be prohibited from (i) disclosing the inside information to any third party (other than on a “need to know” basis) and (ii) “tipping” third parties or causing them otherwise to buy or sell securities. Keep in mind third parties include fellow employees.

Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. The Participant is responsible for complying with any applicable restrictions and should speak with a personal legal advisor on this matter.

17.

Foreign Asset/Account Reporting; Exchange Controls. The Participant’s country may have certain foreign asset and/or account reporting requirements and/or exchange controls which may affect the Participant’s ability to acquire or hold Shares under the Plan or cash received from participating in the Plan (including from any dividends received or sale proceeds arising from the sale of Shares) in a brokerage or bank account outside the Participant’s country. The Participant may be required to report such accounts, assets or transactions to the tax or other authorities in his or her country. The Participant also may be required to repatriate sale proceeds or other funds received as a result of the Participant’s participation in the Plan to his or her country through a designated bank or broker and/or within a certain time after receipt. The Participant acknowledges that it is his or her responsibility to be compliant with such regulations, and the Participant should consult his or her personal legal advisor for any details.

18.

Miscellaneous Provisions.

 

(a)

Securities or Exchange Control Laws Requirements. No Shares will be issued or transferred pursuant to this Agreement unless and until all then applicable requirements imposed by U.S. or non-U.S. federal and state securities or exchange control laws, rules and regulations and by any regulatory agencies having jurisdiction, and by any exchanges upon which the Shares may be listed, have been fully met. As a condition precedent to the issuance of Shares pursuant to this

11

US-DOCS\112623669.1

 

 

Agreement, the Company may require the Participant to take any reasonable action to meet those requirements. The Committee may impose such conditions on any Shares issuable pursuant to this Agreement as it may deem advisable, including, without limitation, restrictions under the U.S. Securities Act of 1933, as amended, under the requirements of any exchange upon which shares of the same class are then listed and under any blue sky or other securities laws applicable to those Shares.

 

(b)

Non-Transferability. The RSUs and the rights and privileges conferred thereby shall be non-transferrable except as provided by Section 15.3 of the Plan. Any Shares delivered hereunder will be subject to such stop transfer orders and other restrictions as the Committee may deem advisable under the Plan or the rules, regulations and other requirements of the U.S. Securities and Exchange Commission, any stock exchange upon which such shares are listed, any applicable U.S. or non-U.S. federal, state or local laws and any agreement with, or policy of, the Company or the Committee to which the Participant is a party or subject, and the Committee may cause orders or designations to be placed upon any certificate(s) or other document(s) delivered to the Participant, or on the books and records of the Company’s transfer agent, to make appropriate reference to such restrictions.

 

(c)

No Right to Continued Service. Nothing in this Agreement or the Plan confers any right or obligation upon the Participant or the Company or any Subsidiary, including the Employer, to continue the Participant’s employment with the Employer.

 

(d)

Notification. Any notification required by the terms of this Agreement will be given by the Participant (i) in a writing addressed to the Company at its principal executive office and will be deemed effective upon actual receipt when delivered by personal delivery or by registered or certified mail, with postage and fees prepaid, or (ii) by electronic transmission to the Company’s e-mail address of the Company’s General Counsel and will be deemed effective upon actual receipt. Any notification required by the terms of this Agreement will be given by the Company: (x) in a writing addressed to the address that the Participant most recently provided to the Company and will be deemed effective upon personal delivery or within three (3) days of deposit with the United States Postal Service or non-U.S. equivalent, by registered or certified mail, with postage and fees prepaid; or (y) by facsimile or electronic transmission to the Participant’s primary work fax number or e-mail address (as applicable) and will be deemed effective upon confirmation of receipt by the sender of such transmission.

 

(e)

Entire Agreement. This Agreement and the Plan constitute the entire agreement between the parties hereto with regard to the subject matter of this Agreement. This Agreement and the Plan supersede any other agreements, representations or understandings (whether oral or written and whether express or implied) that relate to the subject matter of this Agreement.

12

US-DOCS\112623669.1

 

 

(f)

Waiver. No waiver by the Company of any breach or condition of this Agreement by the Participant or any other Participant will be deemed to be a waiver by the Company of any other or subsequent breach or condition whether of like or different nature.

 

(g)

Successors and Assigns. The provisions of this Agreement will inure to the benefit of, and be binding upon, the Company and its successors and assigns and upon the Participant, the Participant’s executor, personal representative(s), distributees, administrator, permitted transferees, permitted assignees, beneficiaries, and legatee(s), as applicable, whether or not any such person will have become a party to this Agreement and have agreed in writing to be joined herein and be bound by the terms hereof.

 

(h)

Severability. The provisions of this Agreement are severable, and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, then the remaining provisions will nevertheless be binding and enforceable.

 

(i)

Amendment. Except as otherwise provided in the Plan, this Agreement will not be amended unless the amendment is agreed to in writing by both the Participant and the Company.

 

(j)

Choice of Law; Jurisdiction. This Agreement and all claims, causes of action or proceedings (whether in contract, in tort, at law or otherwise) that may be based upon, arise out of or relate to this Agreement will be governed by the internal laws of the State of Delaware, excluding any conflicts or choice-of-law rule or principle that might otherwise refer construction or interpretation of this Agreement to the substantive law of another jurisdiction.

 

(k)

Signature in Counterparts. This Agreement may be signed in counterparts, manually or electronically, each of which will be an original, with the same effect as if the signatures to each were upon the same instrument.

 

(l)

IRC Section 409A. This Section 18(l) applies only to Participants who are U.S. taxpayers.

Anything in this Agreement to the contrary notwithstanding, RSUs that are non‑qualified deferred compensation subject to Section 409A of the Code and that vest as a result of the Participant’s termination of employment under Section 2(b), 2(c), or 2(d) hereof shall be settled within 60 days of the date the Participant experiences a “separation from service,” within the meaning of Section 409A of the Code (“Separation from Service”). If the Participant is a “specified employee” within the meaning of Section 409A of the Code as of the date of the Separation from Service (as determined in accordance with the methodology established by the Company as in effect on the Date of Termination), any RSUs that are non-qualified deferred compensation that are payable upon a Separation from Service shall instead be settled on the first business day that is after the earlier of (i) the date

13

US-DOCS\112623669.1

 

that is six months following the date of the Participant’s Separation from Service or (ii) the date of the Participant’s death, to the extent such delayed payment is otherwise required in order to avoid a prohibited distribution under Section 409A(a)(2) of the Code, or any successor provision thereto.

 

(m)

Acceptance. The Participant hereby acknowledges receipt of a copy of the Plan and this Agreement, together with any appendices hereto. The Participant has read and understands the terms and provisions of the Plan and this Agreement, as well as the attached Restrictive Covenants Agreement and accepts the RSUs subject to all of the terms and conditions of the Plan and these Agreements. In the event of a conflict between any term or provision contained in this Agreement and a term or provision of the Plan, the applicable term and provision of the Plan will govern and prevail. The Participant must accept this Agreement electronically pursuant to the online acceptance procedure established by the Company within 30 days after the Agreement is presented to the Participant for review. If the Participant fails to accept the Agreement within such 30-day period, the Company may, in its sole discretion, rescind the Award in its entirety. By electronically accepting the Agreement, the Participant is also accepting the Restrictive Covenants Agreement, and this Award is granted under and governed by the terms and conditions of the Plan and these Agreements.

[Signature page follows]

 

14

US-DOCS\112623669.1

 

 

IN WITNESS WHEREOF, the Company and the Participant have executed this Global Restricted Stock Unit Award Agreement and any appendices thereto as of the date first written above.

SYNEOS HEALTH, INC.

 

By:

 

/s/ Alistair Macdonald

Name:

 

Alistair Macdonald

Title:

 

Chief Executive Officer

 

 

PARTICIPANT

 

[Electronic Signature]

 

Participant Signature

Name:

 

[Participant Name]

Acceptance Date: [Acceptance Date]

 

 

[Signature Page – Global Restricted Stock Unit Award Agreement]

US-DOCS\112623669.1

 

 

Appendix A

RESTRICTIVE COVENANTS AGREEMENT

The Participant acknowledges and agrees that in light of the Participant’s access to Confidential Information and Participant’s position of trust and confidence with the Company or its Subsidiaries, Participant shall be subject to the restrictive covenants set forth herein. The Participant knows that the promises in this Restrictive Covenants Agreement (“RCA”) are an important way for the Company and its Subsidiaries to protect their proprietary interests and understands that the terms of this RCA are affected by the location in which the Participant is employed, as stated in Attachment A and Attachment B to this RCA. As a condition of the grant of the RSUs, the Participant agrees as follows:

1.Definitions. Capitalized terms not otherwise defined in this RCA shall have the same meanings as set forth in the Syneos Health, Inc. 2018 Equity Incentive Plan, and the Global Restricted Stock Unit Award Agreement (including the Appendix B and any other appendix attached thereto). The following terms shall have the following meanings for the purposes of this RCA:

(a)“Termination Date” means the last day of the Participant’s employment by the Company or any of its Subsidiaries.

(b)“Non-Solicit Restricted Period” means the period commencing on the Termination Date and ending twelve (12) months after the Termination Date.

(c)“Non-Compete Restricted Period” means the period commencing on the Termination Date and ending twelve (12) months after the Termination Date.

(d)“Company Customer” means a person or entity for whom the Company or any of its Subsidiaries was providing services either at the time of, or at any time within the twelve (12) months preceding the Termination Date, and for whom the Participant had direct contact with and/or carried out or oversaw a material business responsibility during said twelve (12) month period or about whom the Participant had exposure to or received Confidential Information as a result of the Participant’s employment with the Company or any of its Subsidiaries.

(e)“Prospective Customer” means a person or entity (i) that the Participant contacted for the purpose of soliciting business on behalf of the Company or any of its Subsidiaries during the twelve (12) months preceding the Termination Date; or (ii) to which the Company or any of its Subsidiaries had submitted a bid or proposal for services during the twelve (12) months preceding the Termination Date, and in which bid or proposal the Participant was involved in any material respect.

(f)“Company Person” means any person who is an employee of or consultant to the Company or any of its Subsidiaries as of the Termination Date.

(g)“Company Business” means (i) developing, marketing, selling and/or providing services to pharmaceutical, biotechnology, life sciences, medical device and medical diagnostic companies regarding: (A) the commercialization of pharmaceuticals, biologics, medical devices

A-1

US-DOCS\112623669.1

 

or diagnostic products, including, but not limited to, outsourced sales and related operations, marketing, naming/branding, advertising, public relations, medical communications and medication adherence services for the Company’s clients, (B) the provision of clinical trials and related support services including, but not limited to, bioanalysis, biostatistics, data management, feasibility studies, global safety and pharmacovigilance, laboratory operations, medical writing, project management, protocol and case report form design, quality assurance, regulatory affairs and consulting, medical oversight, risk management, site and patient recruitment, site management, strategic planning, study monitoring and late stage services for the Company’s clients, (C) the staffing of clinical trial and/or clinical research and development personnel for the Company’s clients, and (D) the provision of consulting services including, but not limited to, brand management, business development, clinical development, commercial strategy and organizational design, product launch planning, medical affairs, pricing and market access and risk evaluation and mitigation strategy for the Company’s clients; and (ii) any other business that the Company and its Subsidiaries engage in, or that the Company and its Subsidiaries have developed definitive plans to engage in, as of the Termination Date.

(h)“Restricted Area” means the following geographical areas: (i) any city, metropolitan area, county (or similar political subdivision in foreign countries) in which the Participant personally provided material services on behalf of the Company during the twelve (12) months prior to the Termination Date; (ii) within a 60-mile radius of the location(s) where the Participant had an office during the twelve (12) months prior to the Termination Date; (iii) within a 60 mile radius of Raleigh, North Carolina; and (iv) any city, metropolitan area, county (or similar political subdivision in foreign countries) in which the Company or any of its Subsidiaries is located or does or did business, during the twelve (12) months prior to the Termination Date.

(i)“Confidential Information” means without limitation, any confidential or proprietary information or materials of the Company or its Subsidiaries, whether of a technical, business, or other nature, including information and materials which relate to operations, processes, products, promotional material, developments, patent applications, formulas, sponsor or client lists, manufacturing processes, trade secrets, basic scientific data, data systems, employment policies, formulation information, budgets, bids, proposals, study protocols, coding devices, and any other confidential data or proprietary information in connection with the Company, its Subsidiaries or their business affairs, including but not limited to any information relating to the operation of the Company’s and/or its Subsidiaries’ business which the Company or its Subsidiaries may from time to time designate as confidential or proprietary or that Participant reasonably knows should be, or has been, treated by the Company and/or its Subsidiaries as confidential or proprietary. Confidential Information encompasses all formats in which information is preserved, whether electronic, print or in any other form, including all originals, copies, notes or other reproductions or replicas thereof. Any trade secrets of the Company or its Subsidiaries will be entitled to all of the protections and benefits under any applicable trade secrets law, whether statutory or common law, including but not limited to the Delaware Uniform Trade Secrets Act, Del. Code Ann. tit. 6, §§ 2001–2009, the North Carolina Trade Secrets Protection Act, N.C. Gen. Stat. §§ 66-152 et seq., the Massachusetts Uniform Trade Secrets Act, M.G.L. ch. 93, §§ 42 to 42G, and the California Uniform Trade Secrets Act, Cal. Civ. Code §§ 3426 et seq. If any information that the Company deems to be a trade secret is found by a court of competent jurisdiction not to be a trade secret, such information will, nevertheless, be considered Confidential Information for purposes of this RCA.

A-2

US-DOCS\112623669.1

 

Notwithstanding the foregoing, the term “Confidential Information” shall not include information which (i) is already known to the Participant prior to its disclosure to the Participant by the Company; (ii) is or becomes generally available to the public through no wrongful act of any person; (iii) is at the time of disclosure part of the public knowledge or literature through no wrongful action by the Participant; or (iv) is received by the Participant from a third party without restriction and without any wrongful conduct on the part of such third party relating to such disclosure. The Participant acknowledges and agrees that the Confidential Information he/she obtains or becomes aware of as a result of his/her employment with the Company or any of its Subsidiaries is not generally known or available to the general public, but has been developed, compiled or acquired by the Company at its great effort and expense and that the Participant is required to protect and not disclose such information.

(j)“Subsidiary” or “Subsidiaries” means any corporation, partnership, limited liability company, joint venture, association, public or private limited company or other business entity at least 50% of the outstanding voting stock or voting interests of which is at the time owned or controlled, directly or indirectly, by the Company.

2.Non-Solicitation of Customers and Employees. The Participant agrees that during the Participant’s employment with the Company or any of its Subsidiaries and during the Non‑Solicit Restricted Period, the Participant will not, on the Participant’s own behalf, nor as an officer, director, stockholder, partner, associate, employee, owner, executive, consultant or otherwise on behalf of any person, firm, partnership, corporation, or other entity:

(a)solicit, induce, influence or attempt to solicit, induce or influence any Company Customer to (i) cease doing business in whole or in part with the Company and/or its Subsidiaries, or to otherwise limit or reduce its business with the Company and/or its Subsidiaries, (ii) purchase or accept products or services competitive with those offered by the Company and/or its Subsidiaries from any person or entity (other than the Company and/or its Subsidiaries), or (iii) do business with any other person or business that is Competitive with the Company;

(b)solicit, induce, influence or attempt to solicit, induce or influence any Prospective Customer to (i) cease doing business in whole or in part with the Company and/or its Subsidiaries, or to otherwise limit or reduce its business with the Company and/or its Subsidiaries, (ii) purchase or accept products or services competitive with those offered by the Company and/or its Subsidiaries from any person or entity (other than the Company and/or its Subsidiaries), or (iii) do business with any other person or business that is Competitive with the Company;

(c)provide or sell any products or services competitive with those offered by the Company and/or its Subsidiaries to any Company Customer;

(d)provide or sell any products or services competitive with those offered by the Company and/or its Subsidiaries to any Prospective Customer;

(e)interfere with, disrupt or attempt to interfere with or disrupt the relationship, contractual or otherwise, that the Company and/or its Subsidiaries have with any sponsor, supplier, vendor, distributor, lessor, lessee, licensor or business partner that transacts business with the Company and/or its Subsidiaries;

A-3

US-DOCS\112623669.1

 

(f)solicit, induce, encourage, entice or attempt to solicit, induce, encourage or entice any Company Person to terminate or alter his or her employment or engagement with the Company or any of its Subsidiaries; or

(g)employ or hire as an officer, director, employee, agent, consultant or independent contractor any Company Person.

3.Non-Competition.

(a)The Participant agrees that, during the Participant’s employment with the Company or any of its Subsidiaries, and during the Non-Compete Restricted Period, the Participant will not, within the Restricted Area, for the Participant’s own behalf or for any other person or entity, own, manage, operate or participate in the ownership, management, operation or control of, or be employed by or provide services to, any person, business or entity which competes with the Company Business if Participant would:

(i)have responsibilities or perform services that are entirely or substantially similar to the responsibilities or services that the Participant had or provided at the time of, or at any time within the twelve (12) months preceding the Termination Date;

(ii)be involved in creating, developing, modifying, accessing, utilizing or relying upon confidential information that is similar or relevant to that Confidential Information to which Participant created, developed, modified, accessed, utilized or relied upon during the Participant’s employment with the Company or any of its Subsidiaries; or

(iii)use, disclose, or engage in activity in which the Participant would be reasonably expected to use or disclose any Confidential Information.

(b)Notwithstanding the foregoing, the Participant’s ownership, directly or indirectly, of not more than one percent (1%) of the issued and outstanding stock of a corporation the shares of which are regularly traded on a national securities exchange or in the over-the-counter market shall not violate this Section.

4.Business Opportunities. The Participant, while he or she is employed by the Company and its Subsidiaries, agrees to offer or otherwise make known or available to the Company or any Subsidiary, as directed by the Company and without additional compensation or consideration, any business prospects, contracts or other business opportunities that he or she may discover, find, develop or otherwise have available to him or her in any field in which the Company or any of its Subsidiaries is engaged, and further agrees that any such prospects, contracts or other business opportunities shall be the property of the Company.

5.Confidentiality.

(a)The Participant acknowledges that during his or her employment with the Company, he or she has and will necessarily become informed of, and have access to, the Confidential Information of the Company, and that the Confidential Information, even though it may be contributed, developed or acquired in whole or in part by the Participant is the Company’s exclusive property to be held by the Participant in trust and solely for the Company’s benefit.

A-4

US-DOCS\112623669.1

 

Accordingly, except as required by law, the Participant shall not, at any time, either during or subsequent to his or her employment, as applicable, use, reveal, report, publish, copy, transcribe, transfer or otherwise disclose to any person, corporation or other entity, any of the Confidential Information without the prior written consent of the Company, except to responsible officers and employees of the Company and its Subsidiaries and other responsible persons who are in a contractual or fiduciary relationship with the Company or one of its Subsidiaries and except for information that legally and legitimately is or becomes of general public knowledge from authorized sources other than the Participant.

(b)This RCA shall not prevent Participant from (i) reporting, without prior approval from the Company, possible violations of federal securities laws or regulations to any governmental agency or entity, including but not limited to, the Department of Justice, the Securities and Exchange Commission, the Congress, and any Inspector General, or making other disclosures that are protected under the whistleblower provisions of federal law or regulation; (ii) filing a charge of discrimination with the Equal Employment Opportunity Commission; (iii) cooperating with the Equal Employment Opportunity Commission in an investigation of alleged discrimination; (iv) revealing evidence of criminal wrongdoing to law enforcement; (v) testifying in any cause of action when required to do so by law, or (vi) divulging Confidential Information pursuant to an order of court or agency of competent jurisdiction. However, with respect to (v) and (vi) only, Participant must promptly inform the Company of any such situations and shall take such reasonable steps to prevent disclosure of the Company’s Confidential Information until the Company has been informed of such requested disclosure and the Company has had an opportunity to respond to the court or agency.

Further, 18 U.S.C. § 1833(b) states: “An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that—(A) is made—(i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.” Accordingly, the parties to this RCA have the right to disclose in confidence trade secrets to federal, state, and local government officials, or to an attorney, for the sole purpose of reporting or investigating a suspected violation of law. The parties also have the right to disclose trade secrets in a document filed in a lawsuit or other proceeding, but only if the filing is made under seal and protected from public disclosure. Nothing in this RCA is intended to conflict with 18 U.S.C. § 1833(b) or create liability for disclosures of trade secrets that are expressly allowed by 18 U.S.C. § 1833(b).

6.Prior Restrictive Covenants. The restrictive covenants contained in this RCA are in addition to, and not in lieu of, any other restrictive covenants between the Participant and the Company or any of its Subsidiaries. For the avoidance of doubt, any and all of the Participant’s restrictive covenants agreed to prior to entering into this RCA (“Prior Restrictive Covenants”) will survive and supersede the restrictive covenants set forth in this RCA to the extent that any Prior Restrictive Covenant is for a longer period of time or is more restrictive in scope or location than the restrictive covenants set forth in this RCA. A breach of any such Prior Restrictive Covenant will also constitute a breach of this RCA.

A-5

US-DOCS\112623669.1

 

7.Injunctive Relief and Tolling. Participant acknowledges and agrees that if Participant breaches any of the provisions of Sections 2 through 6 hereof, it will cause irreparable damage to the Company and/or its Subsidiaries for which monetary damages alone will not constitute an adequate remedy. In the event of such breach or threatened breach, the Company shall be entitled as a matter of right (without being required to prove damages or furnish any bond or other security) to obtain a restraining order or an injunction to preserve or restore the status quo and will additionally be entitled to an award of attorneys’ fees incurred in connection with securing any relief hereunder. Such right to equitable or extraordinary relief shall not be exclusive but shall be in addition to all other rights and remedies to which the Company may be entitled at law or in equity, including, without limitation, the right to recover monetary damages for the breach by Participant of any of the provisions of this RCA. Further, Participant understands that if Participant breaches any of the provisions in Sections 2 through 6 of this RCA, the applicable restricted period will be extended for a period of time equal to the period of time Participant spent in breach of this RCA. If the Company is required to seek injunctive relief from such breach, then the applicable restricted period shall be extended for a period of time equal to the pendency of such proceedings, including all appeals.

8.Termination. Participant may terminate the employment relationship for any reason at any time upon giving the Company thirty (30) days prior written notice, as applicable law permits. In the case of a termination by the Company other than a termination for Cause (as defined in the Plan), the Company will provide thirty (30) days prior written notice of termination, as applicable law permits. In each case, the Company may, in its discretion, relieve the Participant of some or all of his/her duties during all or a part of such notice period. Subject to the forgoing notice obligation, the Participant’s employment with the Company shall remain at will, as applicable law permits.

9.Return of Company Property. By no later than the Termination Date, the Participant shall promptly deliver to the Company all property and possessions of the Company and its Subsidiaries, including all drawings, manuals, letters, notes, notebooks, reports, copies, deliverables containing Confidential Information and all other materials relating to the Company and any of its Subsidiaries’ business that are in the Participant’s possession or control.

10.Governing Law, Forum. All disputes, claims or controversies arising out of or related to this RCA, shall be governed by the laws of the country in which Participant is employed without regard for reference to any choice or conflict of law principles of any jurisdiction, and the parties agree that any action or proceeding with respect to this RCA or the Participant’s employment with the Company shall be brought exclusively in the courts in the country in which the Participant is employed.

11.Amendment, Modification or Waiver. This RCA may not be changed orally, and no provision of this RCA may be amended or modified unless such amendment or modification is in writing, signed by the Participant and by a duly authorized officer of the Company. No act or failure to act by the Company will waive any right, condition or provision contained herein. Any waiver by the Company must be in writing and signed by a duly authorized officer of the Company to be effective.

A-6

US-DOCS\112623669.1

 

12.Severability. In case any one or more of the provisions contained in this RCA shall, for any reason, be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provisions of this RCA, but this RCA shall be construed as if such invalid, illegal, or other unenforceable provision had never been contained herein. If, moreover, any one or more of the provisions contained in this RCA shall for any reason be held to be excessively broad as to duration, geographical scope or subject, it shall be construed by limiting it and reducing it so as to be enforceable to the extent compatible with applicable law as it shall then appear.

13.Miscellaneous.

(a)The Participant’s and the Company’s obligations hereunder shall continue in full force and effect in the event that the Participant’s job title, responsibilities, work location or other conditions of his/her employment with the Company change subsequent to the execution of the RCA, without the need to execute a new RCA.

(b)Participant agrees to provide a copy of Sections 1 through 6 of this RCA to any subsequent employers or prospective employers during the applicable period of restriction (including but not limited to the Non-Solicit Restricted Period and the Non-Compete Restricted Period). The Participant specifically authorizes the Company to notify any subsequent employers or prospective employers of the Participant of the restrictions on the Participant contained in this RCA and of any concerns the Company may have about actual or possible conduct by the Participant that may be in breach of this RCA. The Participant agrees to promptly notify the Company of any offers to perform services, any engagements to provide services, and/or actual work of any kind, whether as an individual, proprietor, partner, stockholder, officer, employee, director, consultant, joint venturer, investor, lender, or in any other capacity whatsoever during the period of his/her employment by the Company or any of its Subsidiaries and during the Non‑Solicit Restricted Period and the Non-Compete Restricted Period. Such notice must be provided prior to the commencement of any such services or work.

(c)The rights and remedies of the parties under this RCA are cumulative (not alternative) and in addition to all other rights and remedies available to such parties at law, in equity, by contract or otherwise.

(d)The obligations in this RCA shall survive Participant’s termination of employment with the Company or a Subsidiary and the assignment of this RCA by the Company to any successor in interest or other assignee.

[remainder of page intentionally blank]

 

 

A-7

US-DOCS\112623669.1

 

 

APPENDIX B

SYNEOS HEALTH, INC.

2018 Equity Incentive Plan
Global Restricted Stock Unit Award Agreement

Country-Specific Terms and Conditions

Capitalized terms used but not otherwise defined herein shall have the meaning given to such terms in the Syneos Health, Inc. 2018 Equity Incentive Plan, and the Global Restricted Stock Unit Award Agreement.

Terms and Conditions

This Appendix B includes additional terms and conditions that govern the RSUs granted to the Participant if the Participant resides and/or works in a country listed below. If the Participant moves to another country after receiving the grant of the RSUs, the Company will, in its discretion, determine the extent to which the terms and conditions herein will be applicable to the Participant.

Notifications

This Appendix B also includes information regarding exchange controls and certain other issues of which the Participant should be aware with respect to the Participant’s participation in the Plan. The information is based on the securities, exchange control and other laws in effect in the respective countries as of March 2021. Such laws are often complex and change frequently. As a result, the Company strongly recommends that the Participant not rely on the information in this Appendix B as the only source of information relating to the consequences of the Participant’s participation in the Plan because the information may be out of date at the time that the RSUs vest or the Participant sells Shares acquired under the Plan.

In addition, the information contained herein is general in nature and may not apply to the Participant’s particular situation and the Company is not in a position to assure the Participant of a particular result. Accordingly, the Participant should seek appropriate professional advice as to how the relevant laws in the Participant’s country may apply to the Participant’s situation.

Finally, if the Participant is a citizen or resident of a country other than the one in which he or she is currently residing and/or working (or if the Participant is considered as such for local law purposes), the information contained herein may not be applicable to the Participant in the same manner.

ARGENTINA

Terms and Conditions

Nature of Grant. This provision supplements Section 6 of the Global Restricted Stock Unit Award Agreement:

B-1

US-DOCS\112623669.1

 

The RSUs are an extraordinary benefit, which for labor law purposes (e.g., thirteenth month salary, Christmas bonuses, or similar payments) are valued at the fair market value of the Shares on the date of vesting, when the Shares are delivered to the Participant. Such value is inclusive of thirteenth month salary for the month in which the vesting occurs.

Notifications

Securities Law Information. Shares of the Company are not publicly offered or listed on any stock exchange in Argentina.

Exchange Control Information. Argentine currency exchange restrictions and reporting requirements may apply to the RSUs and any Shares acquired under the Plan; the relevant laws and regulations are subject to frequent change. The Participant should consult with the Participant’s personal legal advisor regarding any exchange control obligations the Participant may have in connection with participation in the Plan.

Foreign Asset/Account Reporting Information. The Participant must report holdings of any equity interest in a foreign company (e.g., Shares acquired under the Plan) on his or her annual tax return each year.

AUSTRALIA

Terms and Conditions

Tax Information. The Plan is a plan to which Subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) applies (subject to the conditions in that Act).

Australia Offer Document. The grant of RSUs under the Plan is intended to comply with the provisions of the Corporations Act 2001, ASIC Regulatory Guide 49 and ASIC Class Order CO 14/1000. Additional details are set forth in the Participant’s Australia Offer Document.

BELGIUM

Notifications

Foreign Asset/Account Reporting Information.  Belgian residents are required to report any security (e.g., Shares acquired under the Plan) or bank account held outside of Belgium on their annual tax return.  In a separate report, they will be required to provide the National Bank of Belgium with certain details regarding such foreign accounts (including the account number, bank name and country in which such account was opened).  The forms to complete the report are available on the National Bank of Belgium website.

Stock Exchange Tax Information.  A stock exchange tax applies to transactions executed by a Belgian resident through a non-Belgian financial intermediary, such as a U.S. broker.  The stock exchange tax may apply when Shares acquired under the Plan are sold.  Belgian residents should consult with a personal tax or financial advisor for additional details on their obligations with respect to the stock exchange tax.

B-2

US-DOCS\112623669.1

 

CANADA

Terms and Conditions

RSUs Settled in Shares Only. Notwithstanding any discretion contained in the Plan, or any provision in this Agreement to the contrary, RSUs granted to employees in Canada shall be settled in Shares only and do not provide any right for the Participant to receive a cash payment.

The following terms and conditions apply to residents of Quebec:

Language Consent. The parties acknowledge that it is their express wish that this Global Restricted Stock Unit Award Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be provided to them in English.

Consentement Relatif à la Langue Utilisée. Les parties reconnaissent avoir expressément souhaité que la présente convention («Agreement»), ainsi que tous les documents exécutés, avis donnés et procédures judiciaires intentées, en vertu de, ou liés directement ou indirectement à la présente convention, soient rédigés en langue anglaise.

Data Privacy. This provision supplements Section 9 of the Global Restricted Stock Unit Award Agreement:

The Participant hereby authorizes the Company and the Company’s representatives to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Plan. The Participant further authorizes the Company, its Subsidiaries and any stock plan service provider that may be selected by the Company to assist with the Plan to disclose and discuss the Plan with their respective advisors. The Participant further authorizes the Company and its Subsidiaries to record such information and to keep such information in the Participant’s employee file.

Notifications

Securities Law Information. The Participant is permitted to sell Shares acquired under the Plan through a broker acceptable to the Company, provided the resale of Shares acquired under the Plan takes place outside of Canada through the facilities of a stock exchange on which the Shares are listed. The Shares are currently listed on the Nasdaq Global Select Market.

Foreign Asset/Account Reporting Information. Canadian residents are required to report foreign specified property, including Shares and rights to receive Shares (e.g., RSUs granted or Shares acquired under the Plan) in a non-Canadian company, on Form T1135 (Foreign Income Verification Statement), on an annual basis, if the total cost of the individual’s foreign specified property exceeds C$100,000 at any time during the year. Thus, if the C$100,000 cost threshold is exceeded by other foreign property held by the individual, RSUs must be reported.  Such RSUs may be reported at a nil cost.

For purposes of the reporting, Shares acquired under the Plan may be reported at their adjusted cost bases. The adjusted cost basis of a Share is generally equal to the fair market value of such

B-3

US-DOCS\112623669.1

 

Share at the time of acquisition; however, if the individual owns other Shares (e.g., acquired under other circumstances or at another time), the adjusted cost basis may be different.

The Participant should consult his or her personal tax advisor to determine the Participant’s exact reporting requirements in this regard.

FRANCE

Terms and Conditions

Consent to Receive Information in English.  By accepting the Agreement providing for the terms and conditions of the Participant’s grant, the Participant confirms having read and understood the documents relating to this grant (the Plan and this Agreement) which were provided in English language.  The Participant accepts the terms of those documents accordingly.

En acceptant le Contrat  décrivant les termes et conditions de l’attribution, le participant confirme ainsi avoir lu et compris les documents relatifs à cette attribution (le Plan U.S. et ce Contrat) qui ont été communiqués en langue anglaise.  Le participant accepte les termes en connaissance de cause.

Notifications

RSUs Not Tax-Qualified.  The Participant understands that the RSUs are not intended to be French tax-qualified.

Foreign Asset/Account Reporting Information.  French residents holding Shares outside France or maintaining a foreign bank account are required to report such to the French tax authorities when filing their annual tax returns, including any accounts that were closed during the year.  Failure to comply could trigger significant penalties.

GERMANY

Notifications

Exchange Control Information.  Cross-border payments in excess of €12,500 must be reported monthly to the German Federal Bank (Bundesbank).  In case of payments in connection with securities (including proceeds realized from the sale of Shares or the receipt of dividends), the report must be made by the 5th day of the month following the month in which the payment was received.  The report must be filed electronically and the form of report (“Allgemeine Meldeportal Statistik”) can be accessed via the Bundesbank’s website (www.bundesbank.de), in both German and English.  The Participant is responsible for making this report.

IRELAND

Notifications

Director Notification Requirement.  Directors, shadow directors or secretaries of an Irish Subsidiary whose interest in the Company represents more than 1% of the Company’s voting share

B-4

US-DOCS\112623669.1

 

capital must notify the Irish Subsidiary in writing when acquiring or disposing of their interest in the Company (e.g., RSUs granted under the Plan, Shares, etc.), when becoming aware of the event giving rise to the notification requirement or when becoming a director or secretary if such an interest exists at the time.  This notification requirement also applies with respect to the interests of the spouse or children under the age of 18 of the director, shadow director or secretary (whose interests will be attributed to the director, shadow director or secretary).

ITALY

Terms and Conditions

Plan Document Acknowledgment.  By accepting the grant of these RSUs, the Participant acknowledges that the Participant has received a copy of the Plan and the Agreement and has reviewed the Plan and the Agreement, in their entirety and fully understands and accepts all provisions of the Plan and the Agreement.  The Participant further acknowledges that the Participant has read and expressly approves the following sections of the Global Restricted Stock Unit Award Agreement: “Responsibility for Taxes”; “Withholding Requirements,” “Nature of Grant”; “Data Privacy Provisions Applicable to Participants in the EEA+;” and “Choice of Law; Jurisdiction.”

Notifications

Foreign Asset/Account Reporting Information.  Italian residents who, at any time during the fiscal year, hold foreign financial assets (such as cash, Shares or RSUs) which may generate income taxable in Italy are required to report such assets on their annual tax returns or on a special form if no tax return is due.  The same reporting duties apply to Italian residents who are beneficial owners of the foreign financial assets pursuant to Italian money laundering provisions, even if they do not directly hold the foreign asset abroad.  The Participant should consult a personal legal advisor to ensure compliance with applicable reporting requirements.

Foreign Asset Tax Information.  The value of the financial assets held outside of Italy (including Shares) by Italian residents is subject to a foreign asset tax. The taxable amount will be the fair market value of the financial assets (e.g., Shares acquired under the Plan) assessed at the end of the calendar year.

JAPAN

Notifications

Foreign Asset/Account Reporting Information.  Japanese residents are required to report details of any assets held outside of Japan as of December 31, including Shares acquired under the Plan, to the extent such assets have a total net fair market value exceeding ¥50 million.  Such report will be due by March 15 each year.  The Participant is responsible for complying with this reporting obligation if applicable to the Participant and the Participant should consult his or her personal tax advisor in this regard.

B-5

US-DOCS\112623669.1

 

POLAND

Terms and Conditions

Consent to Receive Information in English. By accepting the RSUs, the Participant confirms having read and understood the Plan and the Agreement, which were provided in the English language. The Participant accepts the terms of these documents accordingly.

Notifications

Exchange Control Information. If the Participant holds foreign securities (including Shares) and maintains such securities in an account abroad, he or she may be required to file certain reports with the National Bank of Poland. Specifically, if the value of the Participant’s securities and cash held in an account abroad (when combined with all other assets held abroad) exceeds PLN 7 million, he or she must file reports with the National Bank of Poland regarding any transactions and the balances of the foreign accounts on a quarterly basis. Such reports are filed on special forms available on the website of the National Bank of Poland.  Additionally, any funds transfer by a Polish resident into or out of Poland in excess of a specified threshold (currently €15,000, unless the transfer of funds is considered to be connected with the business activity of an entrepreneur, in which case a lower threshold may apply) must be effected through a bank in Poland. Polish residents are required to store all documents related to any foreign exchange transactions for a period of five years.

SERBIA

Notifications

Securities Law Information. The grant of RSUs and the issuance of any Shares are not subject to the regulations concerning public offers and private placements under the Law on Capital Markets.

Exchange Control Information. Pursuant to the Law on Foreign Exchange Transactions, the Participant is permitted to acquire Shares under the Plan. However, the National Bank of Serbia may require that Serbian residents obtain permission to hold any proceeds from the sale of Shares in an offshore account. The Participant should consult with a personal legal advisor to determine his or her reporting obligations upon the acquisition of Shares under the Plan as such obligations are subject to change without notice based on the interpretation of applicable regulations by the National Bank of Serbia.

SINGAPORE

Terms and Conditions

Restriction on Sale of Shares. The RSUs are subject to section 257 of the Securities and Futures Act (Chapter 289, 2006 Ed.) (“SFA”). The Participant will not be able to make any subsequent sale of the Shares in Singapore, or any offer of such subsequent sale of the Shares in Singapore, unless such sale or offer is made (i) after 6 months from the Date of Grant or (ii) pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA or (iii) pursuant to, and in accordance with, the conditions of any applicable provision of the SFA.

B-6

US-DOCS\112623669.1

 

Notifications

Securities Law Information. The grant of the RSUs is being made pursuant to the “Qualifying Person” exemption under section 273(1)(f) of the SFA, under which it is exempt from the prospectus and registration requirements and is not made with a view to the underlying Shares being subsequently offered for sale to any other party. The Plan has not been lodged or registered as a prospectus with the Monetary Authority of Singapore.

Director Notification Requirement. If the Participant is a director, associate director or shadow director of a Singapore Subsidiary, the Participant is subject to certain notification requirements under the Singapore Companies Act, regardless of whether the Participant is a Singapore resident or employed in Singapore. Among these requirements is the obligation to notify the Singapore Subsidiary in writing when the Participant receives or disposes of an interest (e.g., RSUs, Shares) in the Company or a Subsidiary. These notifications must be made within two (2) business days of (i) acquiring or disposing of an interest in the Company or any Subsidiary, (ii) any change in a previously disclosed interest (e.g., sale of Shares acquired under the Plan) or (iii) becoming a director, associate director or shadow director if such an interest exists at that time. Futhermore, if the Participant is the Chief Executive Officer (“CEO”) of a Singapore Subsidiary and the above notification requirements are determined to apply to the CEO of a Singapore Subsidiary, the above notification requirements also may apply to the Participant.

SPAIN

Terms and Conditions

Nature of Grant.  The following provisions supplement Section 6 of the Global Restricted Stock Unit Award Agreement:

By accepting the grant of the RSUs, the Participant consents to participation in the Plan and acknowledge that the Participant has received a copy of the Plan.

The Participant understands that the Company has unilaterally, gratuitously, and in its sole discretion decided to grant the RSUs under the Plan to individuals who may be employees of the Company or its Subsidiaries throughout the world.  The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not bind the Company or any Subsidiary, other than to the extent set forth in the Agreement.  Consequently, the Participant understands that the grant of the RSUs is made on the assumption and condition that the RSUs and any Shares acquired under the Plan are not part of any service agreement (either with the Company or any Subsidiary), and shall not be considered a mandatory benefit, compensation for any purpose, or any other right whatsoever.  In addition, the Participant understands that the RSUs would not be granted but for the assumptions and conditions referred to above; thus, the Participant acknowledges and freely accept that, should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, then any grant of or right to the RSUs shall be null and void.

Further, the Participant understands that unless otherwise set forth in this Agreement, the Participant will not be entitled to continue vesting in the RSUs after termination of the Participant’s Service.  This will be the case, for example, even in the event of a termination of the Participant’s

B-7

US-DOCS\112623669.1

 

Service by reason of, but not limited to, resignation, retirement, disciplinary dismissal adjudged to be with cause, disciplinary dismissal adjudged or recognized to be without cause, individual or collective dismissal on objective grounds, whether adjudged or recognized to be without cause, material modification of the terms of employment agreement under Article 41 of the Workers’ Statute, relocation under Article 40 of the Workers’ Statute, Article 50 of the Workers’ Statute, unilateral withdrawal by the Company or Subsidiary and under Article 10.3 of the Royal Decree 1382/1985.  The Participant acknowledges that the Participant has read and specifically accepts the conditions referred to in Section 6 of the Global Restricted Stock Unit Award Agreement.

Notifications

Securities Law Information.  No “offer to the public,” as defined under Spanish law, has taken place or will take place in the Spanish territory in connection with the grant of the RSUs.  The Plan, the Agreement and any other documents evidencing the grant of the RSUs have not been, nor will they be, registered with the Comisión Nacional del Mercado de Valores, and none of those documents constitutes a public offering prospectus.

Exchange Control Information.  The Participant must declare the acquisition of Shares to the Spanish Dirección General de Comercio Internacional e Inversiones (the “DGCI”), the Bureau for Commerce and Investments, which is a department of the Ministry of Economy and Competitiveness.  The Participant must also declare ownership of any Shares by filing a Form D-6 with the Directorate of Foreign Transactions each January while the Shares are owned.  In addition, the sale of Shares must be declared on Form D-6 filed with the DGCI in January, unless the sale proceeds exceed the applicable threshold (currently EUR 1,502,530), in which case, the filing is due within one month after the sale.  

Foreign Asset/Account Reporting Information.  The Participant is required to declare electronically to the Bank of Spain any securities accounts (including brokerage accounts held abroad), any foreign instruments (e.g., Shares) and any transactions with non-Spanish residents (including any payments of cash or Shares made to the Participant by the Company or any U.S. brokerage account) if the balances in such accounts together with the value of such instruments as of December 31, or the volume of transactions with non-Spanish residents during the prior or current year, exceed EUR 1 million.

Further, to the extent the Participant holds Shares and/or has a bank account outside Spain with a value in excess of EUR 50,000 (for each type of asset) as of December 31, the Participant will be required to report information on such assets on the Participant’s tax return (tax form 720) no later than March 31 for such year.  After such Shares and/or accounts are initially reported, the reporting obligation will apply for subsequent years only if the value of any previously-reported rights or assets increases by more than EUR 20,000 of if the Participant transfers or disposes of previously-reported rights or assets.

B-8

US-DOCS\112623669.1

 

SWITZERLAND

Terms and Conditions

Securities Law Information.  Neither this document nor any materials relating to the Shares (i) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (“FinSA”), (ii) may be publicly distributed or otherwise made publicly available in Switzerland to any person other than an employee of the Company or one of its Subsidiaries, and (iii) has been or will be filed with, approved or supervised by any Swiss reviewing body according to Article 51 of FinSA or any Swiss regulatory authority (in particular, the Swiss Financial Supervisory Authority (FINMA)).

UNITED KINGDOM

Terms and Conditions

Responsibility for Taxes. The following provisions supplement Section 3 of the Global Restricted Stock Unit Award Agreement:

Without limitation to Section 3 of the Global Restricted Stock Unit Award Agreement, the Participant agrees that the Participant is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items, as and when requested by the Company or the Employer or by Her Majesty’s Revenue and Customs (“HMRC”) (or any other tax authority or any other relevant authority). The Participant also agrees to indemnify and keep indemnified the Company and the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on the Participant’s behalf.

Notwithstanding the foregoing, if the Participant is a director or executive officer of the Company (within the meaning of Section 13(k) of the Exchange Act), the immediately foregoing provision will not apply; instead, the amount of any uncollected income tax may constitute a benefit to the Participant on which additional income tax and national insurance contributions may be payable. The Participant is responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for paying the Company or the Employer (as applicable) for the value of any employee national insurance contributions due on this additional benefit.

B-9

US-DOCS\112623669.1

 EX-10.12.7 8 synh-ex10127_427.htm EX-10.12.7 AMEND NO. 6 TO EXISITING CREDIT AGREEMENT synh-ex10127_427.htm

Exhibit 10.12.7

 

EXECUTION VERSION

 

AMENDMENT NO. 6

AMENDMENT NO. 6, dated as of December 17, 2021 (this “Amendment No. 6” or this “Agreement”), among SYNEOS HEALTH, INC. (f/k/a INC Research Holdings, Inc.), a Delaware corporation (the “Administrative Borrower”), JPMORGAN CHASE BANK, N.A., as administrative agent and collateral agent for the Lenders (in such capacities, the “Agent”), and the other parties hereto, relating to the Credit Agreement, dated as of August 1, 2017 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time prior to the date hereof, the “Credit Agreement” and the Credit Agreement as amended by this Amendment No. 6, the “Amended Credit Agreement”), among the Administrative Borrower and the other borrowers party thereto, the Lenders from time to time party thereto, the Issuing Banks from time to time party thereto and the Agent.

RECITALS:

WHEREAS, the Administrative Borrower wishes to effectuate certain amendments to the Credit Agreement as set forth herein.

WHEREAS, pursuant to Section 9.02 of the Credit Agreement, the Administrative Borrower, the Administrative Agent, the Revolving Lenders, the 2020 Extending Term A Lenders and the 2021 Incremental Term A Lenders, agree to amend the Credit Agreement on the terms and subject to the conditions set forth herein.

NOW THEREFORE, the parties hereto hereby agree as follows:

Section 1  Defined Terms. Unless otherwise specifically defined herein, each term used herein that is defined in the Credit Agreement has the meaning assigned to such term in the Credit Agreement. Each reference in the Credit Agreement to “this Agreement”, “hereof”, “hereunder”, “herein” and “hereby” and each other similar reference, and each reference in any other Loan Document to “the Credit Agreement”, “thereof”, “thereunder”, “therein” or “thereby” or any other similar reference to the Credit Agreement shall, on and from the Amendment No. 6 Closing Date, refer to the Credit Agreement as amended hereby.

Section 2  Amendments to Credit Agreement.  On the Amendment No. 6 Closing Date, the Administrative Borrower, the Agent and the Lenders party hereto agree that the Credit Agreement is, effective as of the Amendment No. 6 Closing Date, hereby amended as follows:

 

a)

Section 1.01 thereof shall be amended by:

 

i.

Adding a new paragraph at the end of the definition of “Eurocurrency Rate” thereof to read as follows:

“Notwithstanding anything herein to the contrary, with respect to any Adjusted Eurocurrency Rate Loan denominated in Dollars with an Interest Period of one week, the Eurocurrency Rate shall be the rate per annum determined by the Administrative Agent (which determination shall be conclusive and binding absent manifest error) to be equal to the rate that results from interpolating on a linear basis between (x) the Overnight LIBOR Rate on the date that is two Business Days prior to the first day of such Interest Period and (y) the Eurocurrency Rate for a one-month Interest Period determined in accordance with clause (a) above for such Interest Period.  For the purpose of this paragraph, the “Overnight LIBOR Rate” means, for any day, a rate per annum equal to the London interbank offered rate as administered by the ICE Benchmark Administration (or any other Person that takes over the administration of such rate) for overnight

#95278732v6

 

deposits in Dollars as displayed on the applicable Reuters screen page at approximately 11:00 a.m., London time, on such day; provided that if such rate shall be less than zero, such rate shall be deemed to be zero for all purposes of this Agreement.”

 

ii.

Adding the following definition in the appropriate alphabetical order:

“Overnight LIBOR Rate” has the meaning assigned to such term in the definition of “Eurocurrency Rate”.

Section 3  Conditions to the Amendment No. 6 Closing Date.  This Amendment No. 6 shall become a binding agreement of the parties hereto and the agreements set forth herein, and the amendments set forth in Section 2 shall each become effective on the date (the “Amendment No. 6 Closing Date”) on which each of the following conditions is satisfied or waived:

(a)The Agent shall have received from the Administrative Borrower, each Revolving Lender, each 2020 Extending Term A Lender and each 2021 Incremental Term A Lender an executed counterpart hereof or other written confirmation (in form satisfactory to the Agent) that such party has signed a counterpart hereof.

Section 4  Governing Law.  This Agreement shall be governed by and construed and interpreted in accordance with the laws of the State of New York.

Section 5  Credit Agreement Governs.  Except as expressly set forth herein, this Agreement shall not by implication or otherwise limit, impair, constitute a waiver of or otherwise affect the rights and remedies of any Lender or the Agent under the Credit Agreement or any other Loan Document, and shall not alter, modify, amend, novate or in any way affect any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or any other Loan Document, all of which are ratified and affirmed in all respects and shall continue in full force and effect.  Nothing herein shall be deemed to entitle any Loan Party to a future consent to, or a waiver, amendment, modification or other change of, any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or any other Loan Document in similar or different circumstances.

Section 6  Waiver. Neither the Agent nor any of its Affiliates shall be liable to the Borrowers, any other Loan Party or any Lender or any of their respective Affiliates, equity holders or debt holders for any losses, costs, damages or liabilities incurred, directly or indirectly, as a result of the Agent, or any of its Affiliates, taking any action in accordance with this Agreement.

Section 7  Counterparts.  This Agreement may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. Delivery of an executed counterpart of a signature page to this Agreement by facsimile or electronic (i.e., “pdf” or “tif”) transmission shall be effective as delivery of a manually executed counterpart of this Agreement.  The words “execution,” “signed,” “signature,” and words of like import in this Agreement shall be deemed to include electronic signatures or electronic records, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act.

 

2

#95278732v6

 

Section 8  Miscellaneous.  This Agreement shall constitute a “Loan Document” for all purposes of the Credit Agreement and the other Loan Documents.  The provisions of this Agreement are deemed incorporated into the Credit Agreement as if fully set forth therein.  

[Remainder of page intentionally left blank]

 

 

 

3

#95278732v6

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first above written.

 

SYNEOS HEALTH, INC.,

 

as the Administrative Borrower

 

 

 

 

By:

/s/ Jason Meggs

 

Name: Jason Meggs

 

Title: Chief Financial Officer

 

 

[Signature Page – Amendment No. 6 to Credit Agreement]

 

 

 

 

JPMORGAN CHASE BANK, N.A.

 

as Agent, Revolving Lender, 2020 Extending Term A Lender and 2021 Incremental Term A Lender

 

 

 

 

By:

/s/ Li Ling

 

Name: Li Ling

 

Title: Executive Director

 

 

[Signature Page – Amendment No. 6 to Credit Agreement]

#95278732v5

 

 

 

Bank of America, N.A.,

 

as Revolving Lender, 2020 Extending Term A Lender and 2021 Incremental Term A Lender

 

 

 

 

By:

/s/ Alexandra Korchmar

 

Name: Alexandra Korchmar

 

Title: Vice President

 

 

 

[Signature Page – Amendment No. 6 to Credit Agreement]

#95285306v1

 

 

 

PNC BANK, NATIONAL ASSOCIATION

 

as Revolving Lender, 2020 Extending Term A Lender and 2021 Incremental Term A Lender

 

 

 

 

By:

/s/ Richard C. Brown

 

Name: Richard C. Brown

 

Title: Senior Vice President

 

 

 

[Signature Page – Amendment No. 6 to Credit Agreement]

#95285306v1

 

 

 

Wells Fargo Bank, N.A.

 

as Revolving Lender, 2020 Extending Term A Lender and 2021 Incremental Term A Lender

 

 

 

 

By:

/s/ Lindsey Stuckey

 

Name: Lindsey Stuckey

 

Title: Director

 

 

 

[Signature Page – Amendment No. 6 to Credit Agreement]

#95285306v1

 

 

 

Truist Bank

 

as Revolving Lender, 2020 Extending Term A Lender and 2021 Incremental Term A Lender

 

 

 

 

By:

/s/ Jonathan Hart

 

Name: Jonathan Hart

 

Title: Director

 

 

 

[Signature Page – Amendment No. 6 to Credit Agreement]

#95285306v1

 

 

 

 

ING CAPITAL LLC

 

as Revolving Lender and 2020 Extending Term A Lender

 

 

 

 

By:

/s/ Michael Kim

 

Name: Michael Kim

 

Title: Director

 

 

 

 

By:

/s/ Stephen Farrelly

 

Name: Stephen Farrelly

 

Title: Director

 

 

 

[Signature Page – Amendment No. 6 to Credit Agreement]

#95285306v1

 

 

 

 

GOLDMAN SACHS BANK USA,

 

as Revolving Lender and 2020 Extending Term A Lender

 

 

 

 

By:

/s/ Mahesh Mahon

 

Name: Mahesh Mahon

 

Title: Authorized Signatory

 

 

 

[Signature Page – Amendment No. 6 to Credit Agreement]

#95285306v1

 

 

 

 

MUFG Bank, Ltd.

 

as Revolving Lender, 2020 Extending Term A Lender

 

 

 

 

By:

/s/ Kevin Wood

 

Name: Kevin Wood

 

Title: Director

 

 

 

[Signature Page – Amendment No. 6 to Credit Agreement]

#95285306v1

 

 

 

 

Regions Bank

 

as Revolving Lender and 2020 Extending Term A Lender

 

 

 

 

By:

/s/ Ned Spitzer

 

Name: Ned Spitzer

 

Title: Managing Director

 

 

 

[Signature Page – Amendment No. 6 to Credit Agreement]

#95285306v1

 

 

 

 

FIFTH THIRD BANK, NATIONAL SOCIATION

 

as Revolving Lender, 2020 Extending Term A Lender

 

 

 

 

By:

/s/ Shailesh Patel

 

Name: Shailesh Patel

 

Title: Managing Director

 

 

 

[Signature Page – Amendment No. 6 to Credit Agreement]

#95285306v1

 

 

 

 

KeyBank National Association,

 

as Revolving Lender & 2020 Extending Term A Lender

 

 

 

 

By:

/s/ Alyssa Suckow

 

Name: Alyssa Suckow

 

Title: Vice President

 

 

 

[Signature Page – Amendment No. 6 to Credit Agreement]

#95285306v1

 

 

 

 

TD Bank N.A.

 

as 2020 Extending Term A Lender

 

 

 

 

By:

/s/ Bernadette Collins

 

Name: Bernadette Collins

 

Title: Senior Vice President

 

 

 

[Signature Page – Amendment No. 6 to Credit Agreement]

#95285306v1

 

 

 

 

The Huntington National Bank

 

as Revolving Lender and 2020 Extending Term A Lender

 

 

 

 

By:

/s/ Joseph D. Hricovsky

 

Name: Joseph D. Hricovsky

 

Title: Senior Vice President

 

 

 

[Signature Page – Amendment No. 6 to Credit Agreement]

#95285306v1

 

 

 

 

First National Bank of Pennsylvania

 

as Revolving Lender and 2020 Extending Term A Lender

 

 

 

 

By:

/s/ Robert B. Weaver

 

Name: Robert B. Weaver

 

Title: Senior Vice President

 

 

 

 

 

 

 

 

[Signature Page – Amendment No. 6 to Credit Agreement]

#95285306v1

 

 

 

 

HSBC Bank USA, National Association

 

as Revolving Lender and 2020 Extending Term A Lender

 

 

 

 

By:

/s/ Randy Chung

 

Name: Randy Chung

 

Title: Vice President

 

 

 

[Signature Page – Amendment No. 6 to Credit Agreement]

#95285306v1

 

 

 

 

CREDIT SUISSE AG, CAYMAN ISLANDS

BRANCH,

 

as Revolving Lender

 

 

 

 

By:

/s/ Vipul Dhadda

 

Name: Vipul Dhadda

 

Title: Authorized Signatory

 

By:

/s/ Daniel Kogan

 

Name: Daniel Kogan

 

Title: Authorized Signatory

 

 

 

[Signature Page – Amendment No. 6 to Credit Agreement]

#95285306v1

 

 

 

 

Citibank N.A.

 

as Revolving Lender

 

 

 

 

By:

/s/ Stanislav Andreev

 

Name: Stanislav Andreev

 

Title: Vice President

 

 

 

[Signature Page – Amendment No. 6 to Credit Agreement]

#95285306v1

 

 

 

 

12/16/2021

 

Morgan Stanley Bank N.A. as Revolving Lender.

 

 

 

 

By:

/s/ Gilroy D Souza

 

Name: Gilroy D Souza

 

Title: Authorized Signatory

 

 

 

[Signature Page – Amendment No. 6 to Credit Agreement]

#95285306v1

 

 

 

 

THE TORONTO-DOMINION BANK, NEW YORK

BRANCH

 

as Revolving Lender

 

 

 

 

By:

/s/ Michael Borowiecki

 

Name: Michael Borowiecki

 

Title: Authorized Signatory

 

 

 

[Signature Page – Amendment No. 6 to Credit Agreement]

#95285306v1

 

 

 

 

Western Alliance Bank,

 

as 2020 Extending Term A Lender

 

 

 

 

By:

/s/ Adam Dolkart

 

Name: Adam Dolkart

 

Title: Vice President

 

 

 

[Signature Page – Amendment No. 6 to Credit Agreement]

#95285306v1

 

 

 

 

Atlantic Union Bank

 

as 2020 Extending Term A Lender

 

 

 

 

By:

/s/ William P. Massie

 

Name: William P. Massie

 

Title: Vice President

 

 

 

[Signature Page – Amendment No. 6 to Credit Agreement]

#95285306v1

 

 

 

 

Mizuho Bank Ltd.,

 

as 2020 Extending Term A Lender

 

 

 

 

By:

/s/ Douglas Glickman

 

Name: Douglas Glickman

 

Title: Managing Director

 

 

[Signature Page – Amendment No. 6 to Credit Agreement]

#95285306v1

 EX-21.1 9 synh-ex211_9.htm EX-21.1 SUBSIDIARIES OF THE REGISTRANT synh-ex211_9.htm

 

Exhibit 21.1

List of Subsidiaries of Syneos Health, Inc.

Entity Name

 

Jurisdiction

Addison Whitney LLC

 

North Carolina

Allidura Communications LLC

 

Delaware

AmberCRO Armenia Limited

 

Armenia

BioSector 2 LLC

 

New York

Cadent Medical Communications, LLC

 

Ohio

Caerus Marketing Group, LLC

 

California

Chamberlain Communications Group LLC

 

Delaware

Chandler Chicco Agency, L.L.C.

 

New York

Gerbig Snell/Weisheimer Advertising, LLC

 

Ohio

Groupe Synteract Canada, S.E.C. / Synteract Group Canada, L.P.

 

Québec

Haas & Health Partner Public Relations GmbH

 

Germany

Harrison Clinical Research AR S.A.

 

Argentina

Harrison Clinical Research Limited

 

United Kingdom

Harrison Clinical Research Peru S.A.C.

 

Peru

HCR Acquisition GmbH

 

Germany

Illingworth Research Group (Australia) Pty Ltd.

 

Australia

Illingworth Research Group (France) SARL

 

France

Illingworth Research Group (Italy) S.R.L.

 

Italy

Illingworth Research Group (Spain) Sociedad Limitada

 

Spain

Illingworth Research Group (USA) Inc.

 

Delaware

Illingworth Research Group Limited

 

England & Wales

Illingworth Research Limited

 

England & Wales

Improved Outcome Kabushiki Kaisha

 

Japan

INC Research BR Servicos de Pesquisas Clinicas Ltda.

 

Brazil

Inc Research Branches Limited - Jordan Branch

 

Jordan

INC Research Clinical Services Mexico Limited, S.A. de C.V.

 

Mexico

INC Research CRO Argentina S.R.L.

 

Argentina

INC Research CRO Malaysia Sdn. Bhd.

 

Malaysia

INC Research do Brasil - Pesquisas Clínicas Ltda.

 

Brazil

INC Research South Korea

 

Korea (the Republic of)

INC Research UK Limited - Portugal Rep Office

 

Portugal

INC Research, S.A. de C.V.

 

Mexico

INCResearch Australia Holdings Pty Limited

 

Australia

INCResearch Australia Pty Limited

 

Australia

inVentiv European Holdings Limited

 

United Kingdom

inVentiv Health (Hong Kong) Limited

 

Hong Kong

inVentiv Health (Malaysia) SDN. BHD.

 

Malaysia

inVentiv Health Clinical Mexico, S.A. de C.V.

 

Mexico

inVentiv Health Clinical Peru S.A.

 

Peru

inVentiv Health Clinical Uruguay SRL

 

Uruguay

inVentiv Health Clinical, LLC

 

Delaware

inVentiv Health Korea LLC

 

Korea (the Republic of)

inVentiv Health Philippines, Inc.

 

Philippines

inVentiv Health Singapore Pte Ltd Taipei Branch

 

Taiwan (Province of China)

inVentiv Health Singapore Pte. Ltd.

 

Singapore

inVentiv Health Ukraine LLC

 

Ukraine

inVentiv International Pharma Services Private Ltd.

 

India

JourneyBegins LLC

 

Delaware

Kendle Americas Investment Inc.

 

Ohio

Kendle Americas Management Inc.

 

Ohio

Kendle India Private Limited

 

India

Kendle NC LLC

 

North Carolina

Kendle Servicios, S.A. de C.V.

 

Mexico

Kinapse India Scientific Services Private Limited

 

India

Kinapse Limited

 

United Kingdom

Kinapse, Inc.

 

Delaware

 

 

Limited Liability Company Syneos Health RUS

 

Russian Federation

Litmus Medical Marketing Services LLC

 

New York

Navicor Group, LLC

 

Ohio

Palio + Ignite, LLC

 

Ohio

Pharmaceutical Institute, LLC

 

North Carolina

PNET US, LLC

 

Delaware

PT Syneos Health Indonesia

 

Indonesia

Research Nurses Limited

 

England & Wales

RxDataScience, Inc.

 

Delaware

Servicios Clinicos INC Research Chile Limitada

 

Chile

Sharpview Ophthalmology Limited

 

United Kingdom

SHCR Holdings Corporation

 

Delaware

SIA Syneos Health Latvia

 

Latvia

StudyKIK Corporation

 

Delaware

StudyKIK, LLC

 

California

Syneos Health (Barbados) SRL

 

Barbados

Syneos Health (Barbados) SRL, LLC

 

Texas

Syneos Health (Beijing) Inc. Ltd. 赛纽仕医药信息咨询（北京）有限公司

 

China

Syneos Health (Shanghai ) Inc. Ltd. Dalian Branch 赛纽仕医药咨询（上海）有限公司大连分公司

 

China

Syneos Health (Shanghai) Inc. Ltd. Jingan Branch 赛纽仕医药咨询（上海）有限公司静安分公司

 

China

Syneos Health (Shanghai) Inc. Ltd. 赛纽仕医药咨询（上海）有限公司

 

China

Syneos Health (Thailand) Limited

 

Thailand

Syneos Health Argentina S.A.

 

Argentina

Syneos Health Australia Pty Ltd

 

Australia

Syneos Health Austria GmbH

 

Austria

Syneos Health BA Limited

 

United Kingdom

Syneos Health Belgium BV

 

Belgium

Syneos Health Branches Limited

 

United Kingdom

Syneos Health Brasil Ltda

 

Brazil

Syneos Health Brasil Ltda.

 

Brazil

Syneos Health Bulgaria EOOD

 

Bulgaria

Syneos Health Canada Inc.

 

Ontario

Syneos Health Canada LP

 

Ontario

Syneos Health Canada ULC

 

Nova Scotia

Syneos Health Chile S.A.

 

Chile

Syneos Health Clinical K.K.

 

Japan

Syneos Health Clinical Lab, Inc.

 

New Jersey

Syneos Health Clinical Ltd

 

Israel

Syneos Health Clinical Research Services, LLC

 

Delaware

Syneos Health Clinical Spain, S.L.U.

 

Spain

Syneos Health Clinical SRE, LLC

 

Delaware

Syneos Health Clinical, Inc.

 

Delaware

Syneos Health Clinical, LLC

 

Delaware

Syneos Health Clinique Inc.

 

Canada

Syneos Health Colombia Ltda

 

Colombia

Syneos Health Commercial Europe Limited

 

United Kingdom

Syneos Health Commercial Europe Limited - the Netherlands branch

 

Netherlands

Syneos Health Commercial France Sarl

 

France

Syneos Health Commercial Germany GmbH

 

Germany

Syneos Health Commercial Italy S.R.L.

 

Italy

Syneos Health Commercial K.K.

 

Japan

Syneos Health Commercial Services, LLC

 

New Jersey

Syneos Health Commercial Spain S.L.

 

Spain

Syneos Health Communications Europe Limited

 

United Kingdom

Syneos Health Communications France S.a.r.l.

 

France

Syneos Health Communications Germany GmbH

 

Germany

Syneos Health Communications Holding Corp.

 

Delaware

 

 

Syneos Health Communications UK Limited

 

United Kingdom

Syneos Health Communications, Inc.

 

Ohio

Syneos Health Consulting, Inc.

 

North Carolina

Syneos Health Costa Rica S.A.

 

Costa Rica

Syneos Health Croatia d.o.o.

 

Croatia

Syneos Health CZ s.r.o.

 

Czech Republic

Syneos Health d.o.o. Beograd

 

Serbia

Syneos Health Denmark ApS

 

Denmark

Syneos Health Egypt, Limited Liability Company

 

Egypt

Syneos Health Finland Oy

 

Finland

Syneos Health France SARL

 

France

Syneos Health G.K.

 

Japan

Syneos Health Georgia LLC

 

Georgia

Syneos Health Germany GmbH

 

Germany

Syneos Health Germany GmbH Sede Secondaria

 

Italy

Syneos Health Guatemala S.A.

 

Guatemala

Syneos Health Hellas Single Member S.A.

 

Greece

Syneos Health Holdings (Hong Kong) Limited

 

Hong Kong

Syneos Health Holdings Germany GmbH

 

Germany

Syneos Health Holdings UK Limited

 

United Kingdom

Syneos Health Holdings, Inc.

 

Delaware

Syneos Health Hong Kong Limited

 

Hong Kong

Syneos Health Hungary Korlátolt Felelősségű Társaság

 

Hungary

Syneos Health II L.P.

 

United Kingdom

Syneos Health International Holdings Limited

 

United Kingdom

Syneos Health Investment, LLC

 

Delaware

Syneos Health Ireland Limited

 

Ireland

Syneos Health Italy S.R.L.

 

Italy

Syneos Health IVH UK Limited

 

United Kingdom

Syneos Health Klinik Arastirma Limited Sirketi

 

Turkey

Syneos Health Lebanon SARL

 

Lebanon

Syneos Health Medical Communications, LLC

 

Ohio

Syneos Health Netherlands B.V.

 

Netherlands

Syneos Health New Zealand Limited

 

New Zealand

Syneos Health Norway AS

 

Norway

Syneos Health Peru S.R.L.

 

Peru

Syneos Health Philippines, Inc.

 

Philippines

Syneos Health Poland sp. z o.o.

 

Poland

Syneos Health Portugal, Unipessoal LDA

 

Portugal

Syneos Health Public Relations Holding, LLC

 

Delaware

Syneos Health Receivables LLC

 

Delaware

Syneos Health Research & Insights, LLC

 

Delaware

Syneos Health Romania S.R.L.

 

Romania

Syneos Health Singapore Pte. Ltd

 

Singapore

Syneos Health Slovakia s.r.o.

 

Slovakia

Syneos Health South Africa (Pty) Limited

 

South Africa

Syneos Health Sweden AB

 

Sweden

Syneos Health Switzerland GmbH

 

Switzerland

Syneos Health UK Limited

 

United Kingdom

Syneos Health UK Limited - Jordan Branch

 

Jordan

Syneos Health Ukraine Limited Liability Company

 

Ukraine

Syneos Health US, Inc.

 

Delaware

Syneos Health, Inc.

 

Delaware

Syneos Health, LLC

 

Delaware

Syneos Pharma Partners, Co., Ltd.

 

Japan

Synteract (Pty) Ltd

 

South Africa

Synteract GmbH

 

Germany

Synteract HCR Limited

 

United Kingdom

Synteract Lanka (Pvt) Ltd

 

Sri Lanka

Synteract, Inc.

 

California

SynteractHCR Benelux NV

 

Belgium

 

 

SynteractHCR Corporation

 

Delaware

SynteractHCR Denmark ApS

 

Denmark

SynteractHCR Eastern Europe Forschungsgesellschaft mbH

 

Austria

SynteractHCR France SAS

 

France

SynteractHCR Group GmbH

 

Germany

SynteractHCR Holdings Corporation

 

Delaware

SynteractHCR Iberica, S.L.

 

Spain

SynteractHCR Italia S.R.L.

 

Italy

SynteractHCR Latin America Holding GmbH

 

Germany

SynteractHCR Mexico S.A. de C.V.

 

Mexico

SynteractHCR Poland sp.zo.o

 

Poland

SynteractHCR RUS OOO

 

Russian Federation

SynteractHCR Sweden AB

 

Sweden

SynteractHCR Ukraine LLC

 

Ukraine

SynteractHCR, s.r.o.

 

Czech Republic

Taiwan Syneos Health Company Limited 台灣賽紐仕醫藥股份有限公司

 

Taiwan (Province of China)

Taylor Strategy Partners, LLC

 

Ohio

The Selva Group, LLC

 

Ohio

 

 

 EX-23.1 10 synh-ex231_7.htm EX-23.1 CONSENT OF DELOITTE & TOUCHE LLP synh-ex231_7.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in Registration Statement Nos. 333-225459, 333-219607, 333-212154, and 333-199960 on Forms S-8 of our reports dated February 16, 2022, relating to the financial statements of Syneos Health, Inc. and the effectiveness of Syneos Health, Inc.’s internal control over financial reporting appearing in this Annual Report on Form 10-K for the year ended December 31, 2021.

 

/s/ Deloitte & Touche LLP

Raleigh, North Carolina

February 16, 2021

 

 

 EX-31.1 11 synh-ex311_10.htm EX-31.1 SECTION 302 CEO CERTIFICATION synh-ex311_10.htm

Exhibit 31.1

CERTIFICATIONS

I, Alistair Macdonald, certify that:

1. I have reviewed this Annual Report on Form 10-K of Syneos Health, Inc. (the “registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 16, 2022

 

/s/ Alistair Macdonald

Alistair Macdonald

Chief Executive Officer

(Principal Executive Officer)

 

 

 EX-31.2 12 synh-ex312_6.htm EX-31.2 SECTION 302 CFO CERTIFICATION synh-ex312_6.htm

Exhibit 31.2

CERTIFICATIONS

I, Jason Meggs, certify that:

1. I have reviewed this Annual Report on Form 10-K of Syneos Health, Inc. (the “registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 16, 2022

 

/s/ Jason Meggs

Jason Meggs

Chief Financial Officer

(Principal Financial Officer)

 

 EX-32.1 13 synh-ex321_11.htm EX-32.1 SECTION 906 CEO CERTIFICATION synh-ex321_11.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Alistair Macdonald, Chief Executive Officer of Syneos Health, Inc. (the “registrant”), do hereby certify, that to the best of my knowledge:

1. The registrant's Annual Report on Form 10-K for the period ended December 31, 2021, (the “Report”), to which this Certification is attached as Exhibit 32.1, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 16, 2022

 

 

 

 

/s/ Alistair Macdonald

Alistair Macdonald

Chief Executive Officer

(Principal Executive Officer)

 

This certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed “filed” by the registrant for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing of the registrant under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of the Report, irrespective of any general incorporation language contained in such filing.

 

 EX-32.2 14 synh-ex322_8.htm EX-32.2 SECTION 906 CFO CERTIFICATION synh-ex322_8.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Jason Meggs, Chief Financial Officer of Syneos Health, Inc. (the “registrant”), do hereby certify, that to the best of my knowledge:

1. The registrant's Annual Report on Form 10-K for the period ended December 31, 2021 (the “Report”), to which this Certification is attached as Exhibit 32.2, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 16, 2022

 

 

 

 

/s/ Jason Meggs

Jason Meggs

Chief Financial Officer

(Principal Financial Officer)

 

This certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed “filed” by the registrant for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing of the registrant under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of the Report, irrespective of any general incorporation language contained in such filing.

 GRAPHIC 15 g1v4ad3roqet000001.jpg GRAPHIC begin 644 g1v4ad3roqet000001.jpg M_]C_X 02D9)1@ ! @$ 2 !( #_[@ .061O8F4 9 !_^$ 2D5X:68 M $U- "H ( ,!&@ % 0 #(!&P % 0 #H!* # 0 " M $@ ! 2 $ /_B#%A)0T-?4%)/1DE,10 ! 0 #$A, M:6YO A &UN=')21T(@6%E:( ?. ( "0 & #$ &%C &, : !M '( =P!\ ($ A@"+ ) E0": )\ I "I *X L@"W +P MP0#& ,L T #5 -L X #E .L \ #V /L! 0$' 0T!$P$9 1\!)0$K 3(!. $^ M 44!3 %2 5D!8 %G 6X!=0%\ 8,!BP&2 9H!H0&I ;$!N0'! $! MZ0'R ?H" P(, A0"'0(F B\". )! DL"5 )= F<"<0)Z H0"C@*8 J("K *V M L$"RP+5 N "ZP+U P #"P,6 R$#+0,X T,#3P-: V8#<@-^ XH#E@.B ZX# MN@/' ],#X /L _D$!@03!" $+00[!$@$501C!'$$?@2,!)H$J 2V!,0$TP3A M!/ $_@4-!1P%*P4Z!4D%6 5G!7<%A@66!:8%M07%!=4%Y07V!@8&%@8G!C<& M2 99!FH&>P:,!IT&KP; !M$&XP;U!P<'&09!ZP'OP?2 M!^4'^ @+"!\(,@A&"%H(;@B"")8(J@B^"-((YPC["1 ))0DZ"4\)9 EY"8\) MI FZ"<\)Y0G["A$*)PH]"E0*:@J!"I@*K@K%"MP*\PL+"R(+.0M1"VD+@ N8 M"[ +R OA"_D,$@PJ#$,,7 QU#(X,IPS #-D,\PT-#28-0 U:#70-C@VI#<,- MW@WX#A,.+@Y)#F0.?PZ;#K8.T@[N#PD/)0]!#UX/>@^6#[,/SP_L$ D0)A!# M$&$0?A";$+D0UQ#U$1,1,1%/$6T1C!&J$)%ZX7TA?W&!L80!AE&(H8KQC5&/H9 M(!E%&6L9D1FW&=T:!!HJ&E$:=QJ>&L4:[!L4&SL;8QN*&[(;VAP"'"H<4AQ[ M'*,0!YJ'I0>OA[I'Q,?/A]I'Y0?OQ_J(!4@ M02!L()@@Q"#P(1PA2"%U(:$ASB'[(B--@U$S5--8Y",$)R0K5"]T,Z0WU#P$0#1$=$BD3.11)%546:1=Y&(D9G1JM&\$25^!8+UA]6,M9&EEI6;A:!UI66J9:]5M% M6Y5;Y5PU7(9O5\/7V%?LV %8%=@JF#\84]AHF'U8DEB MG&+P8T-CEV/K9$!DE&3I93UEDF7G9CUFDF;H9SUGDV?I:#]HEFCL:4-IFFGQ M:DAJGVKW:T]KIVO_;%=LKVT(;6!MN6X2;FMNQ&\>;WAOT7 K<(9PX'$Z<95Q M\')+%V/G:;=OAW5G>S>!%X;GC,>2IYB7GG M>D9ZI7L$>V-[PGPA?(%\X7U!?:%^ 7YB?L)_(W^$?^6 1X"H@0J!:X'-@C"" MDH+T@U>#NH0=A("$XX5'A:N&#H9RAM>'.X>?B 2(:8C.B3.)F8G^BF2*RHLP MBY:+_(QCC,J-,8V8C?^.9H[.CS:/GI &D&Z0UI$_D:B2$9)ZDN.339.VE""4 MBI3TE5^5R98TEI^7"I=UE^"83)BXF229D)G\FFB:U9M"FZ^<')R)G/>=9)W2 MGD">KI\=GXN?^J!IH-BA1Z&VHB:BEJ,&HW:CYJ16I,>E.*6IIAJFBZ;]IVZG MX*A2J,2I-ZFIJARJCZL"JW6KZ:QK_UP'# [,%GP>/"7\+;PUC#U,11Q,[%2\7(QD;&P\=! MQ[_(/%$XIZ#+HO.E&Z=#J M6^KEZW#K^^R&[1'MG.XH[K3O0._,\%CPY?%R\?_RC/,9\Z?T-/3"]5#UWO9M M]OOWBO@9^*CY./G'^E?ZY_MW_ ?\F/TI_;K^2_[<_VW____; $, 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0(" @(" @(" M @(" P,# P,# P,# __; $,! 0$! 0$! @$! @(" 0(" P,# P,# P,# P,# M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# __ !$( P$% M10,!$0 "$0$#$0'_Q ? $ @(" P$! " D'"@4& P0+ @'_ MQ !T$ !@(! 0,#"PX*! D' 1D 0(#! 4&!P@1$A,)(109,2(5U=875Y?7 M&%A!U%465I:FISB8J.AI&E$R(Y6EMK=X.0K3)'=984+2,U0EAF?G<5)B4S1U M=H(N*'!UC*TJX@"O8J:+[P6US=/Z*UC?))2M&M M+C3LT )HNBV&W]35'7V5VAKNLZ.JCG[(9MC4+H^CM=MD_.;-KHZGL'U3ZI=# M&$N-6Z5M/^U9/'Q;:=O<0MV]C:\;?06R6F@]7D74W^3G&R*\Y'D\A-'QY#2C0ZP_MC F7FEEZJ7&G+]*T*+^ R(QBG\ M2>'43S')G\*UXY0;ZU!'U095G(N#G%V:,2PZ5U(^)PJ"W&7I!^H1!0KK[G,/ MBNVXMM7(/4AJ;6I"C;SBB=;,TF:3-#K4M;3B#,O(I)FDR\I&9#P.XN<,&N+3 MG\54&FRYB(_4(=0_5&Q95O /C6]H>-*YVA%=MG,#M[(+00?0(!'.OQ\\;BK] M(+4_WZ4WUR/YY7>%_C_%>Z(_37Z\@/&SZ+9SW)+ZU(5JC,RZD:$6-M%6XGI]5)&1#[P\5.&T;AM$["V; MA4IOO2[)FWVV+MQ/>%VB\G7KY2&0AX@:#N&[]OF\0]M:5;>6[A7L;)#M6*N. M%/%&T?T=UIK/Q/I6C\?=M-.S0PC9L.U=YKLXPJW4:*G,,6M%DXVT:*[(*F:H MG7C,FFS3&ENF3CIET27JJ^H,W;YK#79W;6[M975 [25CMIY!L<=IYNRM;N]- MZAL&[U]87L+:$UD@E8*#E/;-&PJ#(EDW01I,BZ>-LU%VNQ'5V>I=>G4AI^YKXK?$O%E/-TEIF^PGF^J4_:EB$F'&6[TZ=#DYI*Q+JTE?D4XA M+A&1&:"673K$>9ZTG"K&$MLI;W(/'VB M%?JW#H-G9(![(KLK/>GNI'QRS0: M_(PXW%1G:>^;IKG ?\VT;<[2.1I+>P[=VTBEE_C0))3K&!:)4I/D-BSR_-"0 MH_)ZXG:.FHED7E]0RL3_ /((NRW7$%2S!8/9S/GN/\L<<7_\U3=@?\/.UM*_K32S#]F#]51IR?Q;^4UV:TTD/6>&M&1):538K.L922(UGVG'L MFO+R,XZ?:(C,F$)Z)+HDO*9QQD^M;Q.O:BR9C;-O-T<#GN_5,TD@)_\ 5 V# M9RUE_#=1;@KC@#D9,QD'\_2W+(VGDV 6\,+@/JO)VG;R4C]D//WF%DYJ.QWI ME,0E$9=G'H>.XF22,VSZ)^U>EIU$9=T7EZ]KU?+ZY770\AQWXMY*O?&;NFU^ MU-B@['VF./L?5Y>R:REBNJ_P$PX'>FFK)]/M[I[GL^$RR]D[.3DV;!3"=WO; M=^2]HLBW'M2^)9D:DW.P0QIE[KC6F2 MK\89?*3@_;+J=_9'UTAYB1]0T4B8[AIPYP]/BG 82U(^U6-M&>4'E9$.< _5 M /*L8RIQ%S8UO8)Q9.+)'F$RE?C.SM;FM*]+%')6@H*[[3R#8/067Z+E9R8Q MM2/8??FW&&VU$I$63GV2V4%*NWWAF5?9V,R#Z]9]5?R?KOJ]2&VV/%'B1CB. M],[EFM'(TW4SV\M?4O>YOU=FWG6AY/@EP>RX/?\ IC!.>10N;96\;^2GJXV, M?L')VVSFHLY8YXEO,G'20VK:C601F^STC9'A^'6!J[*4I]?/9HHELYVDI+KU MD'Y>I^J9F>[8[K'<7\?1IR@N(QS36]N_]=PC;(?W?[-5&^6ZH' #*UN+>CW[W-.SL)IR5.PPWG_\ #\UE;!SM,Y_&WE!4"YAFM"?0]C-V M*]BI )I6@-1+'"O$AX?9H;+*=IHQ6<\HD^8YK07V/DUU5V2-ZWKM)H9Z_4B#Q.>Y;>92\Q3/<%SN*<[!\TQ/,H1))1S,4R.GR&*23[/11R*B M9,:))]HO+U^J0EC%YW"9R+IL+>6MY#]E!+'*W]>-S@H(S>F-2Z:F[VU'CK[' MW%:;MS!+ ZO_ #96-/-V%VP958- 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 M1 1 1 1 1 1 1=!SW:FM=6P$V>Q\]Q+"(3B'%QW,FOZVH0O+7QLQ I,7!868[5 MLFR64=VJJE8OCCCJ"+JB1;Y.F';M(-1]"6S624GT,R/IT,X!U)UJ^'6)#H\& MR[RER.0L9T,)/8,DV[(/JMA>/U*5M5H_J,\7<\63:EDQ^$LS3>$DG?$X!YVQ M6^]$3V0^XC(J!RUI7SL?Q>>0F3><1M?8WA&L8+BE''EIANYGD<=)]HD)587I M-8\]V2,O*=0751=?(7D$":BZV6OLEO1X"VLL;">1VZ;B8?\ K2TB/<.7]96F MTEU$.%>'W9M4W>1S-R -YN\+2!W9[2&LXK]]'9Z.U01V!R7Y ;3.0G/=OY]D M$222B>J7,AG0,?42_P".2<0/F-/1D*P< M-)4D("("("("("("("("("("("("("("("("("("("+W:^RL:B8S854^;63X MRNW'G5\I^%,85T,NTS)C.-O-*Z'ZJ5$8^UO<7%I*+BUD?%.WDT=C<>V@V TV*#M5]63@=J_>?D-/V=M=._TEGO6;@3RNW;=T M<3W'GZ2-X)VD$[5//6_C+9=$\VB[:U#0WC?D1(NL"MYN/2D(3ZCWL#>^S\:: M^LB+M)3.B([1F:2271 G/3O6_P K%NQ:JQ,$[>0R6LCHG#T>BEZ4./9 D8*[ M10;%675O^'[@I]^?0V>N;9_*V*]B9.TGL=-#T#F-',3#*:4!J>V5A>K_ !)> M)FS/-X[F?N:[MI"DI*JV; /&4-&KR=I[(6G['#V6R/ZJ[%)]/*9$0GW376*X M5ZDW8W7YQ]T[ZR\;T-/JR@OMP/JRA56UEU1>.6C]^5N+&6L6#^$Q[^^"?J0% ML=T3]2 _54X*JWJ;ZOC6U':5US536^]AV=5-C6-?+:,^A.1ID-UZ,^V9EZJ5 M&0FJUN[6^@;=64LTLF\KYI&QMK2M 7$5)YFBI/,"LW@--:AU5D&XG3-C=W^2=R1 MV\3Y7TJ!4A@)#03M<:-'*2 JS]Q>+=H;"52JW5])D&WKEDU-HG,I7B&'$ZE2 MFUE[,7$-Z[EFTM/:(V*Q3#R?*A_H9&*X:NZUFAL*76VFH;C+7@V;P]@MZ\A] MDD:9'4_:PEKAR/YU<'0/47XFZB#+O6=Q:X''NH2PTNKJAH1[%$\0MJ-AW[@/ M:?51U%%5EMOQ-.4^SU2HE5ED75E"^9I15ZYBJJK F^SV$&YEP$_6C92Z M>A>IYP5T:&3WUB_-9-O+)?NZ1E>4TMFAEN6]@21R. V;QJ:P*MKBWOI\BUO; M2QNK26LW)5E;3I-C/DN'Y37(F3'7I#RS,_54HS$&75W=WT[KJ]EDFN7FKGO< M7N)[)<+5=4:'T=K:T[RU=C+'(V]"!T\+)',K MSQO<-^,]AS'-<.8JRG4/B[[PQ(XT#:^-8YM>K1V$.VD=+>%9;V>UV5.JEU4. M1CDONF_*3?L:RIQ1>N=+KVBL9I/K8:UQ6[!JFVM\I:CE>*6\_P!7>8TPNH.; MH6DGE>*U50]=]1'AQG=^ZT1>7>$O34B-U;NU] ;LKVSMJ>5W?#PT,OB&5/3X\NGH-IJZ M97V@./;,AK8>>0"R)EKMM83CW9O\RD*-*'&FUTT)P_8H MGVUDIMVP@6.;G[Z/XP J+:+V6X/.!T;3VE0=CI3&P_9* M8.&_ ?BCQ4D8_2N,E^*7&AO)_8+1NT@D2O'LFZ11S8&RO'.Q4V[P\7G:.4'+ MJ-'XM7:TJ%*4AG)[]$/)\R>;[)D3K,)]IS%Z92C4?:;4S8J(TD:7B\I"H6M> MMEJ;)[]IHJUCQMH>2:4-FN".R&D&&/T06RG8"'A7_P"''40T9A0R^XCWLN8O M@*FW@+[>T![!>TBXEI38X.@&T@L.PJJW.-AYWLNZ=R/8.89'F=X[VB.RR2WF MVTEIM1D91XJICSJ8<1!$1(9:)#2$D1)21$1"L&:U!G-27AR&?N[B\O3]?-(Z M0@=AN\3NM',UM&@; %=?3FE-,Z/QS<3I:PM,?CF_P"CMXF1-)^R=N ;[CSO M=5Q)))))731AUL" B B B B B B B B BD7QJP#1NP\NR.KWUM69J;&J_#+B MWI;B%#;E.661Q51DPZXS>ASD+2VPXZ_YLEM+\[NNX9<;<6DQ(7#G Z)S^5N+ M;7.4?BL='9R21R-:'%\S:;K-K7#8"7;@ =)N[C'-<05$W%_5'$G2N"M+SAEA M(\YEY53,(1WO;4]:,0W(+:4=POJ:G"(NPK^ QE8<'F[BS. M1M[.ZDQ[>65L4CHQ2O*\-+1R'GYCV%@[C4VF[3(-Q-WD+&+*N(#87SQ-E)-* M 1EX>:U%*#G'9"8-A&4;)RZ@P3"JSV:RK)[!NKHZKSVNKO/ISJ5K;8\^MI<" MMC=I*#]<\\V@NGE,,)ATAYV ,6X]X?,'QM-N'-8XM;,&/<*%K"T@KW]:\ M*.4NW*-C)<$T[D-A03&428%M<3 M7HH^A]/OIS@UQ.U79-R6#Q%Q)8/ +7R.BMVO:>1T9N)(M]IYG,W@>RO-J_K$ M<%M"Y)V'U+G[2+*1N+7Q1,GNGQN'*V46D4_1/'.V3=<.<;0L.[,U/L?3F1JQ M+9^'76&7Y1T3&H5O'2E$R$XM;:)U;.CK?K[6"IUM:.^C.NM=XA2.UVDJ(M1U M)I746D,@<5J6TFL[_=W@V0;'-.S>8X$L>VH(WF.\:W"7V^I]3/K.W6!Q> M*Q>&T@RPMH+>ZDPH?-T<;8W/<66]'2;K07.J'[75-:]E5@ZJ.:SF:U#K^3*7 MEU=V4.HW1V_2S/E9&T2W1+(M]S@QNZ8]C*-IN]@*L$5I5RE8/R'T1K+7/$#B MOLNBQIZLV/M%F5,RRYCUC@96L;(^A9)LD<^I<2#NM:! B1 M4VL2'$L)5;81H$]/;@SI$.0S#FH);K9JB27&TLR4]XPM/5"C+JA1?4,07):W M443+B6.1L$GJ7%I#7PK.Q7UE/.^U@FB?=1&CV->TN8: ]LT M&K=A!V@;".R%QX\Z]2 B B[YG6K]AZR0'81VE-*4 MI+4V-WA>4NTGHM!]'6^I=M*>TGKG]EL>]IJIMXWG<7F/(N\1DFX?5_O,:MT3 M*EEV0DS)3[+;4DO52XE1$9;[I#B=KK0KQ\V\C/#:@U,+CTD!KRUADWF GG-9D1+?L<7DN2+^K81T,S.*_9K49]" M:21=3MKHGK;8R[++/7ED;64T!N+8.DB]$OA),K!_S'3$\S0J%\2>H5FK$29# MA=D6WT J1:7A;%/3F;'<-#8)''DI(RW I4O*MPUYM+76V:)&2:US3'LTI5=V M3DRALF)JH;KJ36B-9Q$J*;53>RDS-B2VT\GIY4D+6Z?U-I_55B,CIR\M[RSV M5=$\.W2?K7M]4QW[5X:XHD9 M^WC]G*J,=_^)SR#W$=A38A-1IW"91.,)JL0ENKRB7$5U];;9LM MJ-9DZI)F2BKFZYM2#[*TK\IG277G63U[J[I+/$O&(PKJC<@<>F%W4YX6:!$60ST9S^HF4/2730+9KO^BM 71TYQT[IW [6N;L MKGD2'Y3[TJ4\[)DR77)$B1(<6\_(?>6;CSSSSAJ<===<4:E*49FHSZGY17N2 M1\KW2RN+I'$DDFI).TDD[22=I)Y5;***."-L,+6LA8T-:UH #0!0 ; -@ MV +PC\+Z("("("("("+.O&[23G(C;V-:DCY778;,R9JV@P'3;2IUI*E(Z=HC,AN_#O1CN(&K+;2D=U'9RW(D+9'M+Q6- MCI"T-!;5Q:UU 7 $BE5&O%SB*SA3H.\UU+8RY""S=$'11O;&:2R-B:XO<'4: M'O:'$-<0#6AH5T'/L#N, V)F.MI[3TJ[P_+;W$9"68RR8'4%WIV<%U[:7C2&5=AUB0TMEYI9>4TN-.)2M"NA^H9$8Q$D^ANH;=3+JZ(F77R;4PX3B4S'(;BVU(6E)H6E9S?IS@'JO+XR'-Y MVZQV#Q-P 8G7TPBDE::'>9%0FE#4"0QD@@@%I!5:=7]:?0N S-QIO3%EE]39 MVT);.S&6YGBA>"06R35 K4$$Q-E:'!S20YI:.N;)XF2>.&X]:8OR#MC?U-G< MN,^G8NLY[#S,O'W'8\:RG5KL;C-?2[VE;YX/?=FX$.B) >YAE80'1;S'/:YAJP@L+MX%9;2/'&'BWH#, M9KA9!NZXQC'--AD&.!;. YT;)&PR ED^Y(R-S9&D2 AX;NN"XSEOQ@D\>]VL M8!C$F?DF'9G$J+O5UY+?B3)5[3W;J8;,61-KH\6NE6,*U2ME2FFVTN-&T\2$ MI=20\W%;AI)H'6;<#C7/N,1>,CDLI'%KG2QR'=#2Y@:PO:^K26@ C=?0!X7M MX%\98>*?#IVJ,RR*TS^/?+#D86AS&PRPC?+FL>YTC8WQT> YSBUV_'O$L)5D MC6N]#ZZ\1O2&B*36N#R,9K-42Z?*&[:C@7*+C.['$VGJTN4XI!))?46);I_0VGNL-A=#V6.LG8V/%.CF#XVR=)!> M6LB#:C87N(H'5517ZKXF:LZI>H^)>1R^2;F)LXV6W,4SXC%91W5O Z&,Q[A$ M8?).7T-'"-H<26T47.-?'?$,U\0W.]8YO6Q)^*:\S;:EZO'I)(3 O6<4R23$ MH*]Z.3*6Y58Z],C27(YI0V]&:4A9=A2D'&?#GA_BR]$ M?4RB"8MB:12CF$N8\MH YC2TBA(4T<7N*V>T]U5,9K+3DSXLWE<=C81.VN_" M;FW:Z=X=6K9 &R1M?4N9(X.:=X!P]G-/%#Y*U&V;-[$9>.8WK?&K^14U&JE8 MCCJZD\?I93U?%KK*V76GD[$QV&RGO50YL9IIU)$TVALNP?TS'68XC6FJI7XE M]O;Z=MIRR.RZ"(LZ*-Q8UCW[G3!Q:!O='(QH([5H;L7QT]U,N$%]H:&/.QW= MWJZ\M6RRY+OJ<2]/,T/=)'$).]W,#R=T2PR.(UN][G7&36F,U[+4)NOOK6_IZYZ0B!&:B'!;N8U_&3*1W2$N2&Y#A]36 MM*=VUK@\'A.-VCM582(6EOG)K29\+ &ADKY8V$[H#=T2"5@>-T O$CCM<0(U MX<:EU-J3JU<0M#ZEG-_=Z9M[^WCN'DO+X8X99 TO<7;YB=#(8SO$M8Z)@V-: M3'+Q-=O[+L>3&PM7R,FMZS W MG9 \XZZ\VMQ#:TM=HR0:E1[UD=6ZDN.)&0TS) MQM&ODD=*XES@2 0VII4RSU.]!Z/M.#^*UG%9P3:HOW7#Y;N6-KIQT%U-;1Q1 MR.#GQQ1,@8UK6.#207T!=092S'5%#IS']:X1RJYQ;0P_+H.$5,S']5Z_HLLO M*_ ,=<[V/70'K"OEKKU2(RH:X_4V&'>C))1VV&VUJV?+Z6L=(6&.PO%#6N3M M,LRRC=%96L<\C;6(U#&ES';E1NEGJ6N[4!N\QK7'3-/ZWR>O\IF-1\$^&^%O M\%+D96SY*^FMH7WLXHZ1X8]H?NNW@_U;V]N2[=D<]HY3Q*YM!D7'[AKE%+DE MOGC$BERB!79_DU8[5Y1E-4Q4X@TBTN8\EIF6F38NQ"?7WA&I:U&YU,UJ4KT] M8V:QR&@M(9.SN);YCH9FLNIF%DTS R !\@(#JO+=XUVDDNJ=XD^+J@V^4Q7% M+B!AS1<:O# M[PY'FZ'8VGW;*R9:[U9IEIPS53!2&GE]"-F7,D3%&73KU(O(DNA':KC[2QX< MZ"Q#=T.;B"]X%3VW>]D*@GF%3'O;8?L+8]KK^)?XG&V'"F6N.X>F7C5!9Y);R MZ)J572GKQ:LJ:AQ?Y1A3*52>RYT2I#D@:LUI9\,.$^C6?%UID-0RV#98!=M< M^*WWH8GS2.B#F.,GL[8V;6EH,E';"'15H/ASD.-7';B)+\;W^*TE!E'07+K% M[(Y[K=N)X[>)LQ;(T0CO9TLG:O#R(:LVAS';=U;3I;!:@X M=9O"\-L%F^QSXG-V%QQ=K'C MWQXU_P 0\+Y*;>U;L;>SV=W5Q%MH^!Y!/J:?6=' M+VH:LK%=/.K7B=;>I>C MSLM2XJ9;Z6%&WV4F]K.FM \/\#PFL^(VK,9D,X^^FD:\6TKF1V<;7RQA[S&Y MAJ#'VSI"6![@P[M 7[GK'BIQ6U3QXR'"'0F:Q.F8\9;Q.B=>P,EER$SXX93' M&)62"A$W:MB D,3#(-^I$<4MI8)QYR[:.J\=XM9#GMA6;0F4E598WG%4S[+X M/D>09*W00:)N='6VW5XTVN,BO,- M'-)'/9RGHKR""W,[YBQP)B&PMJ0QSB'U@C#6F3MW.*DVO0[OJM,9UMFUWMG&&*.DRY2W$)4M9I28RW& MJRU38ZTBT=F\K+G+RPMH887="(W 2M:]D0C87E\CFN82XN?(\D N=0+ ]7#( MZ(R?#F?B%IK!PZ:Q^5O+BXN&=\.F8XPN='),99&QM9$US9 UC61Q1AKB&MJ5 MQ-KX?G+^FQ)6:3=*WBJIJ(].D0H5KC-EDL:(TVAPG7<2K[N3DJG7$J5_(-Q5 MR$=A7;;1ZWM>6ZX"\6K/%?'$V&G[U#"XM:^%\P: #4P-D,U3M[4,+Q0[S1LK M[K'K2X;AOCN(MW=1-AR-PZ*.V+7"789:/K MM:6%L1=4[M Y@V[P44X'C-C=0\8);+A%T6DR\@R^%SV:TY?-R6!NI[.^;R/B M>YAI6M#0C>::;6NJT\X*P&H]+:;U?C'8;5-C:Y#%OY8YXVR-!H1O-W@2QX!. MZ]I#V\K2"K?>/GB]9-4+AX_R+QA&4UW5MG[?L+B1*W(HZ?(DW[K%I+C)#5L&RN]I[RNW.D@=^UBN*.FBV; V43ASCMDC:KKM4;LU M5O"A+)-69O1YA6I2TP7=OLW@PT>PGD$D;J21GT'M:3RBH7.[6_#K6W#C)_%&M M<;O.*> MC.'5MTNHKH=^N;5EO%1]P_ZD=1NM/VEW3ON'/'$V22FW.Z/9#'<%=O1$1V%&VXM]/KCHGQ#ZR>M=8])C\&3B,$Z MHW8G5GD;_P!)/1KF@\[8@P4):XO&T]/N$G4YX;\/>BRNI6C/ZH80[?G8!:Q. MY1T5J2YKBT\CYS*:@/8V([!6RI2EJ4M:E+6M1J6M1FI2E*/JI2E'U-2E&?4S M/U170DN)<0TTA;KKJTMMMMI M4MQQQ:B2A"$)(U+6M1D1$1=3,?IK7/<&,!+B: #:23S!?E[VQM+WD!@%23L M Y23S *8&O> W+39=3[.4&G[JOJEL=_&DY?.IL)=GDI1DT4&ORFPJK20B0E) MJ0Z3'FYHZ*[PB4CM2U@.!7%74=KW[88B:.U+:@SNCMR[L;K)WL>:\H=N[M-N M]M%8%U5UGN!NC[[XMRF>MY;T.W7-M62W89V=]]LR2-I;R%N_O@U&[4.I&K.\ M"S#6.67.#9[03\8RO'Y)1;:FL4MD_&<6VA]EQ#K#CT67$E1W4.LOLN.,/M+2 MMM:D*(SCG.8++Z:RLV$SL#[;*0.W7QOI4&@((():YK@0YKFDM?;.R \4QB=-0[YNXQ6O-P;.RGI;E?R*GFHRHY/]6N M\[Q*TID#17!O6.N,:[.6?>EE@&NW1=7DO00N<#0AA#7O=1W:[P86[W:[V\"! M%/$?K#\/>&F8;IK(=_9+53F;YLL?!WS<,81O!T@+XXV5;VX:Z0/W*/W=TM)[ M;8Z7VYP6W?I38F<-TMAC;&7X_D5-F^%V;][A^1U$&PB.W];$LU0H$QMZ51/N M)-MZ.RXXP]VVB6DC,LM<:.U7P1UIAM09H0R8YMW%+'P MALP:0YKW-:]NZ_=- ;*N:&]*7A1LZ?D6F,!Q"TVWOU2,^R7.\MKW+:-18]!K MJW%XU+BR8$JND$F]L:F582E')-OO7U&I#I+9\WL9QBUO9\&M2OR&C["TEU7G M?YU-(.4OX= M"Z7!LK>RM7B)TT[Y)+ETUR7MD;[#'+'!&!'O;K&@.86R=+@/EM=[7AB!W=PDLI4U=N[[H'QM>28Q,YF\ZN\Z3 MN!F/O^!G6&R? IU]<76C)B-[I T25#0&L#^C9J=#Z#V[RPL=Q;QR#9^+.IU?K_'LH]B\0PW":-%5,C4TJZERCLX*6 MX-W&6341;;:77W&TQS[I4@]?N-.Z,TMH;!:LXIR9?-W^3M3WE:Q3;D%O;QAC MA&Z1SM]M&R,.[&0*NE#G%K&O,HWQ$LYJ[Q.J>*ZN&(MI+B7!PZJ5'[<6X+?4W5 M^PNI+'&RXJTL;MK8;>21\SF6KND@8>DD#7N;)NP/:7CU) !P[&,QM#B1L3#L^Q&UG?RTK)-3UEY7NV>//O.H,TP(S45F%(( MNO93'KS,R(W%%].#MSB^+FG,9IO4$C6ZFTID+>Z@>[:Z:Q9(POB)/UH#6QN[ M 9;[1VQ'QZPEGG. >K\UK#2L3W:,UUBKJRNHV;&V^3DA>(YV@'U;BY\S.R7W M0 -&@P\MMWU[WB3JW!;6[,7&X7(>#6R;V7)2B)#PBEN(V"(M9$@D&E%?$Q*" MEU1=#[+*>SU/U1$=UK6!_6+^=MU*&XYFH&L,KG=JVVCD%MOD\S6P-#CV&BE> M=3Y8\.+J/JB#05C Y^7DTH^1L+6U&-K:[7NN7EH[+S6G,OSMKD3#U M1SUS+?VCKZIS.B5D<.ZBR&''RI,IJ\CQ.J1E]'(-2$OMMJFS)<!5H7] MT-PHGUOU9,?POXCVL^/R?>CXG-(;TUM)!07VKZM5&G#+S(GW%S)KSSB+=LRK[">DU/DU M+AH<[TS\V+JI!;7D-5=6S-Y9^L,CC24G><2>D':O=M=NO MC!WB>CVD+1L3H;KC:;P4?#[$9C3W8PT9O12EN MZ!TQH'&->Y^8^3[!UK;!W:LCMY1*UK MG;M"Y[@=]P90;&ANZT!2]P^X X;0O"7)\-&W3[B]S5M=,OKQS>VDENX# ][6 M;U0R-A 8PR$DASBX.>XK$_)'=;O(C<>5[?DXVQB[HV5AM%&H:O8]MDLZD\,BE:;COA\Y86IUSI>PS.H[. 1,NY)G1E[6UW>F MB$3^DVDNYSFM9O4$%V_5>U!IG*7PX9:VRNGM(9"Y=-)816[)@QSZ;W M>\SIV=": ,8\1&01M8U[Y-VIQ?R9YJY#R;U[KK![_ L=Q-[7]C.G,SL9E.L5 M,EF5#*!'JZ['50D-TM95PVVVHZ"DR%):;(E*4?50UGB1QDO^). Q^%O[&WM7 MV$CG!T+B&$.;NAC(MVD;&- :P;[B "2=JW/@]U>,5P=U5EM1XO)W=\S*1,8 M67#0Z5I:_?=(^??)FDD<7.>>C8"YQ( &Q=3Y42&US$4F1&2N<.H=X[]6UWJ;NP**0BU3;2 M;*)9-V,DF:IAZSC+CU\!<1IYJJ;3W"N\)LDEV5>50EOBCQ+AXAP8>WM[5]I% MBK'O>A>UX>:,!>*-;N@A@&Z:TIL.TJ!>"7!FXX2W.H+JZOF7T^O0ZI)^1)$79ZGEN-.O\!K?XCM].F8V6-QC8'=(P1D M2=J#1H+A3=8W:"1S0TUW MI'["T'G-:[.YXWM?7>/^&EGNHHN74R=D9WM^#>6F(FZI-NFEBW&&/-V2FG&G MB=8)&&,&?G4C3VNWF,=JG3]AU<;[2<5W#\XK[+-D?!7V3HVR6Y#Z$& MH_F[?4D&G-2M=?R^B-5Y3K?XS7Y/ZH7C^1\-MRZWWYI7)44D_+,1MKZ-65\:TF0(2,F9O\ &;=' MLCBLGOVE)0]$<;M>Y0A$F,KL&VN3.'VDN)>EC;Y#A!F,=G=&W(C=/!)*&,#W M-:)A+#)V\!J" Z,B;=#1)&=W=,,\6->\&M;MNL3U@-/Y?3'$.S,S+:ZBA=(] MT;'O-N8;B(]'+G0RC>#F_V?K;3U[XKVO:C4$>G;H:)EG/,]C8 MTW"^U^IS_&*G)+]]NO:A&J"TEV7$I_.4M$GNI\AXNB5I/HGTYI&^ZTN/M-)- MA%C !B9=0LFE(8&]J*N;!OAM*2O>* @K^6NKM>XWJ0Y6_UX^-U7UH[ M_*7KF/$=S>NMJ[0]UNTP1%NVE6PM=(T[:;@(H0",WQ7L,QH7J1XO"8UCXS+9 MXYMYN[#&RZ>+F<.V5HZX>V%X%-[I"TDM)!A5E._N4SO)>WO6,RSV#M9O8\NI MKL6C6ELB)#L4W;E;!PR-CCKS,%=,7:3#*&XR33S1GWA&:U&<-Y/7G$YW$>:^ M9>7S-4#(N8R$/D#6OZ0L;;B$D-Z/DCZ,MHYOJ@:DJP^%X7\%6<'X,;)C\9)H MDXALLERZ.(N?'T(D?=NG +Q+RR]*U^\QP[4@- $U/%FO)>2[;T/HS'(D-N32 M8L4]FBI^Z9K&LDV+?,TL2N:0AJ*GM-MXTT;7;;1V&I1*(D]XLA,G6HO9XN#(S/,X1RAC:1=JTM,CRY[@3MK&/5_U) MQNOKK5/$KAUIFWRV0S>4?)-\.(9XJ3A7F".-^TN0FQK&VU?&P611HQC',DQ*8VYGS%U'K%Q)-7-DSZ M]QF#/E9#!:BRVF)4=U1O%UZM*[/YLN#>6'#O)Z^U#)+C([%T8ABF@<#="0,W M2QQ"]C8)G21.?&]HZ,TH]M83B&58E 1 1 1 1 1 1=IPS.,PUUD,'+,%R6 MYQ/)*U?;A7-%/?KYK1&:3<94XPM)/Q7R21.LN$IIU/K5I4D^@RF'S66T_D&9 M7"7,UKD8SVLD;BUP[(J.5IYVFK7#800L)J#3F!U9BI<'J6SM[[$3"CXIF->P M]@@$;'#E:]M'-.UI!VJZ'C9XN$O9L'?D#0'#T9H&@ CE)? M#0BE!"XFJY[\7>HG!+TN:X/W CDVN..NGDM/*:6]TXDM/(&QW%02277#0*&[ M3!=@83LW'866Z_RBER['+!/6-;42V\TKR+ M2D_(+FX3/8;4F/9E<#.DY'QN#A7G!IM:X<[7 .:=A *YU:ETMJ+1V6DP M6J;*XL,M$>VBF86.IS.;78]A^M>PN8X;6N(VKN RZP* B B B B B B B B MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B MB B B B B B B B B B B B B B B B B B B B BZGF^=X;K;&[#,,]R6GQ M/&:MOMS;B[FM0HC:E$KNH[1N'WDJ;)4GLLQVDK?>7T2VA2C(ABLUG,1IW'29 M;.W,-KC8A5TDC@UH[ %=KG'D:UH+G'8T$[%G-.:9U!J_+Q8'3%G<7V8F-&10 ML+W'LN--C6-Y7O<0Q@[9S@ 2J*.4/BRWU_[)8;QJA/XS3+[Z'(V=>PVCR6P: M/^3<=Q:CD$]&Q^.\DE=W)EI=FFVLE):B/)(RI#Q,ZU%]?=)B.'+'6UF:M-Y* MT=,X>]V'E N9 MFT=.X;-Z.(MAW@07SQFAIGNKNYR.UGWN06ME>75I(7+LK>WFR;&SL)3G3O)$ MV=,<>DR7E]/*I:C/R"G]Y>WF1NGWU_+)/>2NWGR2.+WN<>4N9>U 1 1 1 1 16C^$WG MF-XYR(L<,R"MI%R]AXO*BXG?S:VM?N*7*<>3(M&(U/:3F'7JQJXI')Z74-*( MI3[,9*DK[*2*S758SF.Q_$"3#W\<)ER%LYL$KF,,DW MX=RVDC(MCYE@V,X5FUC#;S>=?>][@Z:RCN7T-W>/830O0W MV@?+0ERCQNO.IOH'A_#%BL3C\EF,CCHW&S9#W]>=) M-$TF&>[F#Q ]CW;LC1*Q\;@XQ0U:&KIWBH:HV7DFP5611":1IW'U?*YC'L8Z19ZY,X'Q_O]"< M6<[VGM7.\5T11ZMQ2MQ'7>K,5HD='NV;R3WKB1@]!W^A=,9S4^4OK70\.,@9!:64!>99G1-N^%&/![4W%'%\3M:Z:T7A,9>\2[G-7,EU?9*Y$38+9LSFL:(6[EQ M-%TAZ0][O+=TQ>Q[O1N$5]K;)B[!X;7>#Z(XXY73\<=:Y;3VCFU=EYNW97M5 MD]CWER'RLF?(=L3"=WMMXQR-A>]K3-M8USP737HC2$^EN/\ ;ZCXEZML M;CBUE[&6,8W'VACADMXXALFD:W?[7<;+$ZX9&]XMS1[VQEK.+Y?9SA&X>(_# MS/6#BT-)FJ*@A M>W@-IO4>@N.NOM,26-XS1M])EGI[AUG]!9.VEN8(?!G(:MXNZ6XI8:]@L[C!ES+D/8]S[B#I YL4>Z6AM62W M3'.D:0UXW@N6U+S_ -VZEUS5ZM9I=9; Q3'7W9&)M[+Q&3D7..Z:2X%<*=#WEAD]-X>W@S&-@ M=%!<5>Z<-?TO2%SW..^^3II0YS@3NO,;:1AK6QR2M:2625*23B20X25&1+02 MTN$E9$?1226A*NA^3J1']01X"0" =AY?1Y_\H4LEK202 2#4>@:4V?J$CZA7 MY'\7Z0$0$0$0$0$0$0$0$0$0$0$7E:?>84I3#SK*EM.L+4TXMM2V7VU-/LJ- M!D:FGFEFE:3\BDF9'Y#'[8]\9)82"01L--A%"/J$;".<+YOCCE $K6N <"*@ M&A::@BO." 0>4$5"[]K':^PM-9.C,]99/,Q/)D09-:5K"8@27#@3%LN28JV+ M*)-B.,O+CH-1*;/KV2&=TUJG/Z/R8S&F[E]KD@PLWVAI.ZZA+2'MVQQN +02TN+J[Q-0.C N\QH*Y>+6^$#&OCM+0,H)96%P<6AP8&4W0T@GI62")L MEQNG?GTY!MC'K?>>EM#ZWI\1E(L\_P!]/8SAY9]9X]2(\XG4\#(8N6W<1#.0 M1(R8S\F-!C,1H1+7WK2TI)5N](^6Z_U5;W>ML-@\=9VCM^ZR9A@[Z?%'M=&V M5L\C0)6@,<]D;&LCJ=YA !H%K[S:\7H>[L>&VH=39?(7[#'9847%UWE'/,=U MDKX'6T+B8'.,C(Y)I'R2EK=Q[2XMA)C^RM<[Z\4)G9>1YKC=-K7&\L1.QBZR M6XKJ:HL$ZYH6JW#45,RV=8B=[>9= 8GQT*4EQPG5&C^4-)"&+#4>GM<]9@:C MR-[;0ZADFD9'&_O2(,M]QTA#:R3M;*T5!.\=WMJ!6+RFD-6<,NIF[2& M)QUY<:ON[$LN(;>*265G?\QDNS*R(%U(;5[X7D M;N@.[6I4(.4FQ)&Z^2.U MLUA*=L&<@SB=5XTEHU/N2:*F=:QG%D,(21]5R:>MCF2$]2[:S(NOJG"W$W4$ MFLN(F4S,-9&3WKF0TVDQ1D0PT^K&QFP*GF&VG()P>)2^UK/ N*?%Z(\VM_6NLHV0Y/V%I=[^XG M1HV.1'S4VGNFU*FTML]V24?:3)2?0D]DU33UC)&Z;P6EN&<1!?CL:)9MM:R. M B:=FP=M'.[EVAX/)0FN/5#B?K#4^M^,T[2(\OF'06]13=B8YT[F[=I[2:V; M4@4,9%2:@2&Y&V5FMU@WL]M2FVU EYM!DU"FV%,8]8LV M4YF>Y#9N["3$B*[Q)LL5"&R2E!=V6_\ $+B%G.$NA=,:/D;;Y',S672WL=\U MUPTQT%(GA[@XM$CGL8:C=; &@!O:J*N$W";3/'GB=K3B!"^[Q&G;?)=#C9<8 M]EH]LM36>,QL+ \PLCEE&Z=]]TYQ)=VRBWK?0_'_ "_2FP>9>_:W-J;#KW9U MC38_K70%?31*W"ZZ5:,L)D<0R1SGEP'1QQ/+?BB:QVZ=;B&X6Z_5&PGR:C-6CTE2->9%,5ZPO,K6:Z MM[&93Z_4C6#BF?42B4XM1(*^7#+K,::U88\3JT1XO/NH \G^:RN_:O<:PN/, MR4EO(!*YQHN7/&CJ9:QT()L]H(RYO2K:N,8;6^@8-O;QL %PT#ED@:'\I= Q MH+E:0R%G00X!S34%4K9?H?U?Q 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 M1 1 1 15^\K_ !"M3<;T6&+4RV-C[9:2XP6(5$U":W&Y1H/L.YI;K5-& M?:. R3D]?0B6AA"TO% W%/C[I7AV),99EN1U4*CH(W=I"[F-Q(*AE.7HFUE. MRH8UP>K1\$.JMKCBXZ+-9 .Q&AW$.[ZE8>DN&UVBTB-#)7DZ9V["-I:Z1S3& M=<3>?(S;G(O)3R3:.4R+;N'7E4V/0^W Q7&V7NRE4:AHT.+CQ"-M"4K>6;LM M\D$;SKBB[0YXZVXA:KX@Y'XQU-=.EW2>CB;VL,(/-%NP %QWGNH-][CM7 M6OAMPFT+PGQ'Q1HRR9!O =+.ZC[FX(^NFF(#G;22&#=B94B-C!L6#AI2DA 1 M 1 1 1 1 1 1=NP#-+K7&<8CGV.O&Q>8;D51DE8KMK0AV=Q',SL%T;@X TY6NINN'.TD'8 M5@=4:>Q^K=.7VE\LW>QN0M);>04!(;*PL+FUY'-KO,/*UP!%" KUN:FD.0W+ MF[T_EV@[^]O--;+UM67T^ALR23=@Q:6]6O\ BO>XC+:%GGGTADL.(_"K@3CL]@N)]K;6W$##Y>2%DT=H9;RXC-6.CBDW"6MBD MB>XETD41CDBY7&KL+;%GZWX9<-MC\7[+:%+MKX09'AG<9.'*ZORDQ<^ M*W=O16I)C#BXG:RC8@:.#9'O 7=MN%Y9O$N#0YQ)L-Q*ZMG#CB;GV:L MOSD,9JMH:'7F/G;;S2!K=QO2;\6^Y.0\6KI M,SLJ:EPJB=)^DU[A%2G&\*K)"">0U(:K$ORY^+N1IH2TR;K6M#B YXC8S?=0NKNMW8RB-E,2 B MB B B B B B B B B B B B B B B B B_2%K;6EQM2D+0I*T+0HTK0M)D:5 M)41D:5),NI&7E(Q_02TAS31P7Y22[I/D[OIZTOX"&P7>K=57]C\5WV3R$V- M'^ADN)GQ0XTM3$AE M*B)25),R\I&7D'HM;J>RNH[VU=N7,,C7L=L.ZYA#FFAJ-A .T$=E>6^LK7)6 M4V.O6"2RN(GQR-)(#F/:6O;4$$5:2*@@]@K(N=;HV'L_8D3:6Q+M.69A&5CW M:G3J^NBQY+.,M16:Z,_75D2#7DRIN(7?$AI/?+6M:NJEJ,]@S>L=0:EU S4^ MH)N^LNWHNV)).TDK4]-E+8V. >)Z M,8^1SFFX+C(X22.>^M7'=JX[H#6B@: IU\N]^\3N5=91[0[>W,(WC'K<3Q2; M0.Q*FVPR)01[]4F_E$:>T];/5D&TFN03:E5AR5]COFD*,^DW\6-=\+.*-M!J M:N6LM:MC@@=$6L?;MB$M97=EY8U\ACW7P[YIOL:2JU<".&''#@E>7.C*8+(\ M-WS7-RR<.EBNW3N@W86]B(2/CA;-O1W'1C>Z-[@!64W'G3VZM*9[4R..%AC_ M "9X6[ELZZ-D\.;=XZZW55%NU&K[R1D]-:+A*K,FH(+JRE-LQG43([28\MAM M[L-LR=H#2.LM&9V*3AY);ZDX.9B1@F:Z2(AD<@#)#-&_=W)HFD[X:QPD8T1R ML:^C60KQ5U[P\XB:8GBXMQ76C^L+I^&1UN]D,X,LL1<^%MO+&']);SO Z-SY M&F)[C+!*^/>?)6-S/QI M2C4;D>IM9;K2$&I2HR2[A:C6THQ6SC/@-/Z8XDY/"Z9(&*BD80P'>$3WQL?) M$'YS0*DL]027-*N/U=-5:KUIP..:2.&=S1R.E MC:UQ- )#[*T!KP%%(1:IN0$0$0$0$0$0$0$0$5@G%/Q#=N<>KR92?4H+Y.P5D1I0EA:S>*>^%W'_5?#UT>- MO2[(Z6%!T$CCOQ-[-O(:EE/M;MZ,\@#"2\5:XV]530O%EDN9QK68C6[JN[ZB M8.CG=38+N$4#Z\G3,W9AL+C(UHC.QWHSD3J;D7BZ%4%IE.77E9CF.4L5.PUA+D\M/%;X^%I<^21P:QH'.2=GH ][CS!K03Z)/( "20 2M?_E_XI.1YNNTU]QQD M6&(X<9OPK/9+B'(.7Y(U_P TLL::5V7\2J'?7&F0KI9O)-!EYF9+;70[BUUF M\AFC+@.'CI+3$;6ONR"V>8HO ;J78G3C8=4\6F1 M7V?V/CL 0^UMSRCO@BK;F4;*L'\W:=X'IP6N;3FZZZ^ZX^^XX\\\XMUYYU:G M'777%&MQQQQ9FM;BUF9F9F9F9]3%1'.<]Q>\DO)J2=I)/*2>K M+G7)PUC)JR[D:^2YDC$KP]C&,#HQ)O-A=NL;5T+6.<=YSB7.<3A4::I$0$0$ M0$0$0$0$0$61\5T[MO.DM+PK5VP\N;>)M3;V-87D=XPI#J5+;<[^MK9+1-J; M0:NT9]GLD9]>A&8V+%Z1U7FP'8;&9"[::4,-O+(-NT&K&$4IMKR4VK4LUK[0 MNFR6ZAS6*L7MK47%W!"00:$4DD::U(%*5J0.52&QOP]N8N4$TN#I&^KVG#3V MGULTR;2^1FE+2G#(E$E)FE1%O^.X!<7-AY MYI(8*#9M(EE8[97D#2>6@)!459?K4< L+O-N=1VLKQS6\5STF[S*7(-GJ@UGWGVMT&0)/LJ+LGV#7 MZX_)U+RC<[+JJ<4[H S_ !;;5^V7#C39S]#%+]397;Z&U1UD>O-P/L21;?'% MY3DZ&U:VNVFSOB:#ZNVFST=BRE5^#3N1ULCNMM:R@.]A@S15QW^>97&QNH/4-GD%>?:YD?)S;-O. M M+O?\0'0#'4Q^"S$K*G;(ZVB-/K=C9)MIYQ7M>8N7?(7@LVSBEE8\B:Z*@D MD;:H6KI,]2U=?*2T/Y]6DVDB^J2E&9_4&14^5U['<^9: MLCU_=].WWG>]_L&R[WM=4]GIV.ST/KUZ^3WP]3BV;7OC4+W=C=L@VG9K6Z?7 MF[%/1YL7FDXF_%[7 M^ZP??S.L;X^G]RM]O7F_2%9CZ+VWNY_P9<(KP54FI1HY**2@U'V$JTZ2U)3U M]:2EEM-!*41>J9)+K_ 0\1ZFPKVNH]GWA_71_D62'^(<:#>T@"ZFW_6M/V/B MX_Y2NJ3?!@S9#:#KMZXM*=-?1:)N&6T!M+?0_7(<8O+)2U]KH79-*2Z>7K]0 M\7-U.\RUH[WSEJYU=N];R-%/JB1_ZU!]59NW_P 0C3KG$76FKUC*;"R[B>:^ MB##'0>C4_46/+?P=>1,5*G*?/M/6R4$X?=2+;,*N2YT41-)90>&S8IK6DS-7 M;>023+IU/U1K]WU1>($0WK2_Q$H%=A?<,)[%/YNX;?1<*=DK:K#K]<*)B&W^ M+S\!--K8K61H[-3WVQU!S4:2>P%B6^\+3F)3]YYAA6,Y239GT50YWC#/>))? M9[3:CR?K%27B.L'P2SA#;'4^'#G<@FG;;$D[ +CHB23R"E3L[( M4?[S&LCQB24+):"[QZ89N$42\JIU3),VC2ETB8GL1W3-LU$2O)Y#,NHT.]QV M0QLO0Y&":WFV]K(QS';.78X [.=2EC3MF.<- MM-FW:N$'B610$0$0$0$0$0$79<>S3,<2*66*99DN,E8-]U/+'KVTI2FM=E2> MZEE6RHWG+?949=E?:+H9C)6&8R^*WQB[JYMA(*.Z*5\>\.P[<<*CZJP^5T]@ M,[T9S=C9WAB-6=/#'+N'EJWI&NW3Z(HNN+6MQ:G'%*6M:E+6M:C4M:U&9J4I M1F9J4HSZF9^4S&.)+B7.-7%99K6M:&M #0* #D 7Y'\7Z0$0$0$0$0$0$0$0 M$0$7=]=[(SK4^5UV;ZZR>TQ/)ZM1^;6E4_W:ULK4A3T*;'6ER)95LKNTD]&D M-NQWDET6A1#-:?U%F]*Y2/-:?N9;7)1"UPV$%:YJO M2.FM<8273FK+.&^PTP[:.05 (K1['"CHY&U.Y(QS7L.UK@5L5\/?$MPC=JZO M7^WO8O7FU)!M0JZQ[WS7"6XXF. MCH-PDZQV%UF8L#JSHL?J=U&L?7=M[AW( QSB>BE<=@C>2'&@C>7.$8Y/\>^J M!J/ATV;5.@^FRNBFU?)'3>N[1HJ29&M Z:%HVF:,!S&U,L;6-,KK3!9Q4L0$ M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$ M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$ M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$ M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$6 >0O)35W&C#7TGKYI40%N([+#:E%W\IXVXL'& M(.5U!-21P(B@90S3N'UL;:C8/KGNHQGUQJ0#*'"KA#K/B_GVX/2EO6%A!GN9 M*MM[9A/JI7@':=NY&T.D>0=UM XC6"Y2QG751*> M.CJDI)2&9MDZI+3F07ZFC/O)CZ2))J43#;#:N['-/B;Q=U1Q.O\ ?R3^@PD; MJPVD9/1LY@YYV&66G+(X;*D,:QIW5V4X+\ M$\%L4(L/'WUJ25@%Q?RM'32< MY9&-H@AKZF)A-0 9'R/&\HF"*E.2 B B B B B B B B B B B B B B B]V MNK;&WFQZVI@3;2QF.=U$KZZ*_-FRG>AJ[N/%C-NOON=E)GT2DSZ$/M;V]Q=S M-MK6-\MP\T:UC2YSCV T DGZ@7FN[NTL+=]Y?2QPVD8JY\C@QC1V7.<0T#T2 M5,G6WAY\M=E]P_#U598C5OD1G;;#D1\-;:2HR)*UU%HI.3N(47KB-J X79+K M]4NLOZ=X \5=1[KX<7):6SOK[LBW _\ V;_9C_ZL1_R* -7=:K@9H_>BN,W# M?WK?]%8M==D_4EC_ )N".2CIFFOU#2>&OO!DMG$LR=J;IKH:B['G%/K['I-F ME?4R-?ODZ=#G' ]3VZ%OQ M%PXV';/%CN-F1^5)GY1,N$ MZLG"?$;KKFUN;^5O/A7:J\:DZZ'';/[S+.]L\5 [E;9 MVT8-.P)+GOB5O9JU[75Y"!L4NL,T-I/7:62P?4VN\7=8_B3*?$**)9J5T4GO M'[5$'V2DO=E1I[;CJU]GR=>GD$KX?0VC-/AOQ+BL?;.;R.C@B:_ZI?N[Y/HE MQ--B@G4'$SB)JMSCJ3.9:]8[E9+=3.C^H(R_HVCGHUH%=M*K+ VI:.@(@(@( M@(@(@(@(@(@(@(@(O2L*VNMHCL"U@0K."^DT/P["*Q-B/)4DTJ2['DMN,N)- M*C(R,C+H8^-Q;V]U$8+J-DD#N5KVAS3]4$$%>BUN[NQG;ET%,G#I[I*]5QRPP]RBG+?(O(3IN M=X1$1$KH1"/,QP>X89VIR&#Q^^X4+HH^]W'T2^W,3J^C6OHJ6M/]8+C7IC=& M)U+E>C::AL\O?3!Z 9="9@;^UW=T\XVJ'N<^$)QTOT//87DNP\ FJ)?<-(LX M&44;1J\J3<@W,%-P\2/J$5DCJ7J^7RB),WU3.'U^"_#W.0L)CR#?;-&/JMD; MTAI_UP4]Z;Z^'%C%N:S4-GBLI;BF\3&^WF/U'Q/Z(5_Z@J$6PO!ZWC0(?DZ\ MSS!=AQF26;<.P3881?2NG4VTL0Y?LW1)6LB\O>V;9),_5,NIE"^?ZI&M; .D MT_?6.0C%:-=O6TKNQ1KNDB_=3"G9/*K&:5Z^_#?*.;#JO&9+%3.I5["R\A;V M=YS>AFH.;=MW$CF!V* VRN+G(;4)27=A:AS6A@1.UYS=M52KO&FNRDU*[648 M^NUQWR((S\DH^I$9^H1B"=1\,M?Z3WG9_$WL$#.60,Z2$?\ [:+?B_\ ;5G] M(<:.%6O-QFE<]CKJYD]3"9.AN#79_P!GG$<_+L_@^6G96!!HJDY 1 1 1 1 M1 1 1 1 1 1 1 1 1 1 1 16Y\,O$UR;5ZJG6^_)=GF.N4=Q7T^9J)RPR["6 M.J&F6K!1FJ3E&-1$_P#$5VY\5KJ32GD(:C%:_@]UD(W.?,=A[&R]& MDLJ4A9$I)I47\9"TFE1$HC(N@&-R6/S%A%D\5-'<8^=@=')&X.8YIYP1L] \ MX((-""N4^8P^5T_E)\+G+>:TRUM(62Q2M+)&.',YIVCF(/(0002""N='M6-0 M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0 M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0 M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0 M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$4".97.[!.+U4_CE043,MQV,(G M:?$6GS57T#<@C*/=9I)CK2Y"A)3Z]F&V93)G1)%W32CD(@OB_P <,'PSM78^ MTW+S5\C*QP ]K$#R27!!JUO.V,>R2;*;C#T@L[U?^K1J;C->MRU]TF/T!%)2 M6Z([>LJ8+1(B555$[9DU'80AM/4SZ&I2E'S7U-JC.ZPR\N=U%B=,(A&QK15SW&F])* M\U=)(Z@WGO)<: 5H !CP:^MK0$0$0$0$0$0$0$0$0$0$0$0$0$7M0H,VSF1J M^MARK"?->;C0X,*.[+F2Y#RB0U'C1F$.//O.K,B2A*34HSZ$0^L,$US,VWMV M.DG>X!K6@N\,[E)M5,:PL\7B:KQZ0E+GLILB0]462V^J36AC$XD>=D[7I.VDNK?Q-U0&SW-JS%V#MN_=DQOIZ$#0Z8'L=(R-I^R58->]<+ M@OHDOM;.]?F\JTTZ.P:)8P>8FY<.89BAN$:5GW==225Y"KLF79ZKM30M/JMD9^2S>ENJAH7%-;-J6 M>ZREV.5M3;P5]!D9Z7T-LU"/K0J7:XZ]G$_.N?;Z-MK+!V))W7[HN[FG)MDF M:(/1H+:H/UQ5CFOM1ZNU1!.NUMK_ !'"(RV4,2%8Y15]9+G(;['959V$=A,^ MT>]8DSF=+0=[Z=L+2RC(H>AB8QSJ?9O WGGT7EQ/95 M2]4Z[UGK>Y[[U=E+_(S!Q+>GF?(UA-?X-CCN1C:>UC:UHJ:!9$&P+5$!$!$! M$!%CS)-NZGPU2T9?L_7F*K:-1.IR3-<;HU-FE24*):;2SBF@TK41'U]0S(AK M^1U9I;#DC+9/'VI'+TUQ#'3ZN^]JVO$:$UQJ !V!PV5O0[D[WM+B:O/LZ.-U M=FU80O>=7$7'>T5AOK!9'9/H?L%)GY1U\CJO6GC,"W)9=&3\I=2ZFDO54GKI M=]QNX3X_^'SMBZGVHNF[/VELG8_R=D5D;&=6OCMEJ=ZZ8R3*_;FLMNQX0^*G M*.7T>P:8IM?%$X:UQ+\TV%>WO9)LTE58!FK)N=L^BB1[.4E,1&T7E5VNR1E_ M%ZC5[KK,\(+>O19">>E/46MP*]TCCY.>M/0JMVLNICU@+JG3XJVMJU_A+VT- M*=GH9I>7FI7T:+HL_P 7+BI$.04>#M>T)E)FV<#$*ALI9]DE=F/[)Y57&E1F M?9_E2;+J7J]/*,'/UKN%\1<(V926G)NP1C>^IOSL^IVU/UELMMU%.-DX;TLF M$AWCMW[J4[O_ #NCMI/J]KO?K[%P'IBN,OW#;V^]G7_RG#P^=UPW\!SG<;7X M8LIY@O&+QEIKW1>_DY/3%<9?N&WM][.O_E.#SNN&_@.<[C:_#$\P7C%XRTU[ MHO?RXF-LB0^:2_\ 10H_^ ?I MG6XX:O>&NL\TT'G,-M0?5I=D_K K\2]0CC''&7MR&FWN ]2VXO*GT!O6#6_K MD!=I@^+-Q,E]OSA[9%7V5()/GV&-N=X2NO52/8RXL>B6^GE[79/R^0C\HR<' M6IX5RUZ0Y&*GV5N#7]Q(_D]&GH56%N>HYQQ@IT3<1-4'U%V13T#TD4?+S4KZ M-%D6I\2WAA:GW9[=75O&M:4M6V#[!B$I*&TK[WSI&+/P4(5U-*26ZE9J29=G MREUV&UZQW!VZ.Z$):.QM<#46+MI-*;IN0\GG-&D 'EY:9>Q_F%Q9R93:*K?VJR=>-*6F;7+ZG'I#JUJ:0 MAIJ/D$BL><><6^DDH))K4?7H1]E73;+#BWPQR1 M<]B]X\@?.R(GDV 2EA)- M104J=NS85HF4X"<:<."Z]TOF]QO*8K66=H J22Z!L@ !J2:#94[17.%#EN* MY4SYQC&38_D M)FUZ[L/O7E,J7&K4NI29I1-\V>Z%Y4$*PZOX3<0-#[TF?QL[;% MO^GC'2P4[)DCW@RO,)-QWH*ZF@./'"GB7N0Z6S%L_)O'_99CT%S7G AEW724 MYS%TC.PXJ-0CE2^@(@(@(@(@(@(@(@(@(@(@(@(@(@(IE<2N:6R>*^0):KW7 MLHUG:34/91KZ?*<3$<-9H0_;XV^OO$T60I921&XE)LR4I2A]"^RVIN8.%7&/ M4?#"_#+CEIS@;KZ /::-+:_<<^KUI'C5BC)=-;9: MPAC(M[YC1O"E2V*<"G305/J20^,DNBZUO6K:JE);: ML(+G88NL=M#:2Y(I,@K>VMROLHIJZ&7533R>CC*W&E(<5TQT;K73VO,+'G=. M3B6U=0/:=DD3Z5,W]5KAVS'.:0X\9>(G#?5O"[4=OB*5>F$6VIM+S(-YME;2X=]DJ28L*+79/MNMO,MD3JF;/-(_5)IC MK2N-"49'():TJCG5CC?U@K;1PETKHY[)]5$;LLVQT5I4$$#;1]P-E&$%D9VR M;S@8U>'JT]5"\XA.@USQ"CDMM# A\-OM9-?4(()V5CM';07@B28"D6ZTB5:X MMSYQJYSG&I))VDDU*ZTX_'V.)L8<9C(8K M?'6\;8XHHVAD<;&BC6,8T!K6M 7&CS+V("("("("("("("("("("("( M"+)&L]0;.W)>EC>K\(O\TMB[LY#5/#-<2O;=4:&Y%O:/J8JJ:(M9=">EOLM= M?)VNHV+3>DM2ZOOOB[3-E/>7>RHC;5K >0R/-&1M_;/ZG,K?\ 1G@]3Y/F=UR$SLJYKJV\ MO!]>K:DS5$1J5W%KEUC&J1/)N7FOK[HV M[#WM:D%WU'SO!:.P1'&^H)W9 =JH9Q)Z^]M#TF.X5XSI7[0+R^!:S_G1VL;@ M]W.6NEE90@;T+@2%;YJ+CII314%$/5NN\>QA_N/-Y%VW%.?D]@V?0UIL;"7;ENP\W1V\8;"P@;-X,WCSN)VK-8 MW)1V@(@(NAYSM+6VL816&Q,]Q#"(BFENLN91D-72KE)1U)10F)\IE^9CY;K)3C MF@A+65]%\YB%/18'^A565TKU)N-NH=V7*PV.'M30UNKAKGT]".V$Y#OVLAC/ M9HH29YXS.;RS?9UGIO%Z)!&I#%AFU[:9.\X@^G9>55TC>*-17>G7UGG3Z2/H M9FHO(<,9SK@YJ4N9IO#VT#>9]S*^8GT=R,0!I]#?)-S"S$WVRVB6*P7S(RK\-QS': M0F>A]?Y"V.MEY&@C^J1S3(Q$N8ZQ7%O+ES?C/O6!WUEO#%'3ZC]QTW\8IZT_ MU1. F #7_$O?URWZ^[GGFK]6+I&P'N(46LKW#MK.S>^W79^PM[!))!)(B(NA=!&.4U=JK.5^.13FI2E-G(IIPF@=#::W?F[AL58EE*&"U@B((Y#O,C::UVU)K7;6JQP-= M6VH"("("("("("("("("+S,2'XKS7U M2,C'[8]\3Q)&2UXY"#0CZA"^@'T4K<)\5CE MIBRV$WMSANPXS1I2XUEF(083[C)>M-)2\,; M-!D,:A[CL)]0E63G:/ZJ1+^#ZX5@^C-2X::/LOMIFR5^I%*(J=V-?05?]3?X M?64CWI=&ZBMY2?4QWL#XJ=BL\#IJU]"W;3L%3EUSXB/$?9!L1XNU:_$+-XDF MJKV)#EX:;':Z$E+MU9MEBJUFH^G9;L'#+IU,B(R,YLT]U@.%.HBV.+*1VER? MK+MKK>GU9'CH/U!*56W5G52XZZ1#I9L)+?V;?])8O;=UIV(8SWR!Z+H&CL;: MTF356]3>P6+.DM*ZXK9*>W&L*J;&L(,A/_G,2XCKT=U/E]5*C$OVMW:WT#;F MRECFMG,-',D8YCVGT6N :R%CE'5/3VE(75.VKXP##(2?5%T9>=M'@FJL5PZZT_&+AT8[:W MR+LGA&4'>U_O7# T; V.4N%Q$ -C6LE$8V5C< J%/OC6OGEQK)^'N;% MV34X3%.P5/F\5CKU_E\7ER7V;0V^T22]CY4E]TR-7<(3Y"J)KCJNZYTYOWFF MW,S&,&VD8Z.Y:/1A<2'TY/8GO<[EZ-H5_.&G7:X9ZOZ.PUBV33^9=LK*>ELW M._:W#6@QUVGV>.-C=@Z5QY:R+2KLZ2PF5%U73ZBUKGW(MA66D.1 L(,IH^R[ M&F0I;;4F,^VKR*0M*5$?JD*V7-K1S'M):YIYB"05Z ^"]2 B B B B B MB B B B B B BSAH+D+LKC?G,;.-<6_FSQ]TQ>X_.-]_',JK&U*4=7?US3[' MG+*>\4;+J%(D1EJ-;3B%=3/==":_U'P[S;PFK' J..)_"O2'%S3;]-ZM@WX]KH9V4$]M(:>R02$.W3L&\T@LD W7M<% MM1\8.56MN4N%(R+#Y/L7DE:4DI?9;-)V5#*<,_-)[:$M MOI]:M+3Z7&6^GW#3BAIWB=AAD,0[HLC& )[9Y'2PN_4]7$X_P.%P]G';R#H-ULVO\XXXZXMUU:W'7%J<<<<4:W''%F:EK6M1FI2U M*/J9GY3,4-HI(9F@R)V4^RA2O6D9J,B/9=+Z/U-K/(#%Z9LYKN[/+N"C& _722.(CC;^V M>YH)V#;0+3=;<0=&<.L217<7F3=F'>7'K5=%MPD5Z6W$ M^1]Y!^6YV@.J=C;/@Z4SES3MCC<%<)A^%8CK^AA8M@^,T M>)8[7I,HE-C];$JJ]I2B23CWF\-II#DE\TD;KJ^TZZKURU*49F+;XG#8G V+ M,9A+:"TQ\?J8XF-8P=DT:!4GG<:EQVDDJA.>U#G=4Y.3-:DO+F^RTI[:6>1T MCSV!O.)(:.1K11K1L: -B[.,DL,@(L6;-W?J/35>=GM#8>+X8P;*WV(UO9LI MMI[;9*-?L511^_N[=PB2?K(L=Y9_P#6-2:TTIH^W[YU-D+6S90D"1XZ1P'V$ M0K)(?08QQ]!;KH[ASKKB!=]YZ,Q5[D)-X!SHHST3">3I)G;L,0]&1[1Z*J_V M]XPVMJ(Y-=IC +S/)J>VVWD65O?:EC:5DK^3E1*QMN=D-JPI)>5M]%6LNOJ^ M3H=:-6=;C3MCO6^CK":^F%0)9ST$/H%K '2O'H.$)]%7+T)U!]79+AMV5F;4\1OEAM/SF,O82L II':+V%UG$/ M%$-I7U(TIODOS,O4DT>0TJL309?4\HK=J?K"\4]3[T9R'>%F[_1V;>@I_P#M M:NG_ %Y:>@KAZ*ZIG _1>Y,W%#*9!E/9<@[ODFG9AHRUY=M1 #Z*A-9VEG=3 MI%G3NN;R1\MR\ MU<][BYSCV2YQ))^J58FSLK/'6S+/'Q106<8HUD;6L8T=AK6@- ] !>@/@O4@ M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(N\X-L[8NLK'V5UWG66838&I*G M9&,7]G2G)))I/NIC<"2RU.85V")3;R5MK(NBB,O(,WA-2:ATW<=]:?OKJRGY MS#*^.OH.#2 X=D.!!YPM;U)H[2>L;7O+5>-LM MNHWPEU&77&F)+W!7IY!$\W%O7LF&=QDY=M&7$;1M :!2EGVH?%/XS;&.+ RV M9=ZBOGB2A;.81"EXZN09)-2(N4TWG<9$=/4R[V>Q7EU(_(7DZV5TGUGN&^H= MV#*OFQ-\=A%PW>BK^UFCW@!^VE;%]3DK3;7?4JXPZ2W[K!1VV=QC=H-J[=G# M>RZVEW7%W[6%\YV\O+2Q*BR"ARBKBWF,W=1D5).0;D&XHK*%;U](B2$$HC+JA9EU%@;&_L3PM MZ_&YBVGM,C$:/BFC?%(P]AS'AKFGZH"Y<>M>! 18&W=QFTIR&J_,-HX/6W,U MIA3%;D\1)U>74R?7*1[&Y%"[JP0PVZKM^;.J=AN*(N\:67D&C:TX;Z,U_;=! MJ:RCFF#:,F;VD\?8W)6T=0';N.+HR?5,*DWASQAXB<*KWOK1F2FM[=SMZ2W= M[):R]GI('U87$;.D:&RM'J)&\JHZY#>$SM/ _/LAT=:^^OC#7>/_ &MS?-*K M85?'3U5V&FNK%)E/=-),U+C*B2G5&26X:C\HI3K_ *J^I\'OW^BI?C7&"IZ% MVZRZ8.P!LCFH.=A8]QV-A*Z/\*NO'HK4W1XKB1!\1YEU!WPS>DL7N[).V:VJ M>02"6-HJ7SA5/VM3:45E-I[NML*:WK9#D2QJK6'(K[*!+95V7HLV#+;9E19# M2BZ*0XE*DGZI"K5U:W5CTEKFGF()!7'CSKU("("("("("("("("(" M("("+(VJ=KYWI3.*?8>N;U^AR6F<5W;S9$[#GPGC24RIMX2S[BRJ9Z$DEYEP MC(^A*2:7$H6G8=+:ISFC,U#G]/3N@R,)V$;6N:?51R-.Q['#8YI] BC@"-2U MOHC3/$33=QI75ELVZQ%P-H.QS'CU$L3QMCE835KV[>5IJUSFG:GX?\P,)Y68 M3Y["\VH-CT$9A.]=V%N]0 M.$O%K#<4<-TT.[!J*!H[YMJ[6GDZ2.NUT+CR':6$[C]NZYW%'CUP%U%P2U%W MO<;]UI*Z>[O.\W=CQR]#-38RX8/5-V-D:.DCV;S63!$MJ!$!$!$!$!$!$!$! M$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$! M$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$! M$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$! M$!$!$!$!$!%1OXAOB%G7G>Z"T-=FFP21] MIJ?/;/\ D/7,,GWO;6U2GC_Q^[WZ?0FAIOYQMCN[MA]1S.@@JIU5A="VXG\3;;^:]K+86,C?5_7,NKEA^LY'00N';[))!N;K7T,B MC*Z:H"("("("("("("("("("("+EZ&@ODR'>RDSZ)29DDC/U",>NQL+W*7<>/QL,MQ?2NW61QM+WO/8: MUH))^H%X,GE,;A;"7*YBXAM<9 S>DEE>V.-C>R][R&M%:"I/*0.570\8_"4M MK9-=E_)>S>HH"^Q)9U?C6XCR&" [190N'2$R1N! Y[\8^O/8V M)EP/!^%MS="K3D;AA$+3M!-M;N =*1LW9)]UF\#[#*PAQO#P+7>#:NQN'B&O M,5I,/QN 7\A54<%J&PITTI2Y+E+01OS["1V"-V2^MQ]Y7KEK4KRBZN"T_A-, MXYF)T_:PVF.9R,C:&BO.YW.YQ^N>XESCM<25S@U/JO4FL\O)G=57MQ?Y>7U4 MDSR]U-I#6@[&,;7M8V!KUH&Q=S&86OH"*"V^/$0XW:,5,JG,G/8N8Q3<9 M5BFOEQ+I<64VHFU,7%_YPWC]2METS)YHY#DMKLG_ "!F70X1UQU@.'>B2^U= M<_&&7;4=!:[LFZX;*22U$3*'U3=XR-H>T)V*RG#/JI\7.)(COFV?Q3@'T/?- M\'1!S3MWHH=TSR@C:UP8V)U1[(!M5-N[?%0Y%;-5,K,$'QKJ@"'MYR#]E M7TLD]W(:N?(YSWN/9S>L,\R7"IZG&G)'L)9/,0; V3ZMMVU2X;M5<,), M_P#FI3#S?_HC8].:NU/I&Z[]TU?7-G/4$]&\AKZ<@>PU9(/0>UP]!:AJ_0.B M]?6/Q=K+&6>1M0"&]-&"]E>4Q2BDL3C]E&]CO15LNC?&$R>J\UI^0&#LY1"2 M2&UYG@3<:IR!*4D1*?L,7FOL4-H^ZH^JE19%8A!%Y&E&+4:)ZV^2M=VTUY9- MN8=@[XM0&2_5?"XB)Y/.6/A YFE4=X5QVFN2.D]_5_GNK,_I,BE-,]_.Q]3RJW*JMLE$A3EEC-DF+ ML<47E%O-(<1=&:[M^FTQ?PW$H;5T5=R=@Y*OA?NR 5V; MV[N$^I<50/B!PCXB<+[KO?6N+N+2$NW63TZ2VD/*!'<1[T3G4VEF\)&CU36K M.(W51N@(HV[_ .)VD>25:LL=Q69O0FS4YG5((C[M#%PF.\4Z(T:C M-,6:W*BD9FHFR5Y1'6O.%>B^(MMT>HK4=_!M&7,5&7#.P!)0[S1S,D#V<^[7 M:I(W"*[Z725\[XL<[>DLYJRVDAYR8BX;CCSR1.CD( &_38M?/D_P"' M#NC0!3\FQIE[:FM(_?2%Y%CL!TKZ@AI49D>4XRVN3+CM,L]37,BG)AI2DUNJ M8ZD@4(XE]7C6.@Q)DL<#E--MJ3+$T]+$W_IH15P '+(S?C %7%E0%U-X-=;; MA[Q0,6'R[FX36#Z-$$[QT,[J?^[7!#6N).P12".4DAK!)0N5=XK^K6H"("(" M("("("("("("("("+NFO=AYGJK+Z7.\!OYV-Y102D2J^R@N=D_(9=[$EL*)4 M>?73&R-N1&>2ME]I1H6E23,AFQP#FD$56 MU?PTY@8IRKP,I7^H4.SL<89:SK#&GU&;*S-+3>1T2'U'(DXU:.GZWJ;BX;Q] MPZI1]VZ]U#X/\6L7Q1P?2]I!J6W:!?RL)3:Z%T;>M_;@\W(KMBYQ52#-S$&UEW3^+8],9 M/L(RAY"E)FRFU&JL3_)-F4LU*BT[ZP?'@X82Z%T5./C<@LN[EAVP#D,,3A_I MCM$CP:PCM6^RDF+H1U3^J\-1.@XF\2+8_$+2V2PLY6[+H\HN9V':;<&ABC<* M7![=U8 !-KY&9J,U*,S49F9F9]3,S\IF9GY3,S%""234\JZF@ "@Y%_!_%_4 M!$!$!$!$!$!$!$!$!$!%-?BSP5W!R=EQK:!$5A6LD/J1/V)?PWO,Y),K[M^- MBM::X\C)IZ%DI)FVMN&TI*DNOH61(5,W#'@CJWB5*VZ@9WGIL.HZ[E:=TT-" M(&;#,[E&PB-I!#I&F@-=N-/64T%P;@?8W3QD=8EM66,+QOMJ*M=2_D,E@F;K/+XF+',+KJ9&MMVR)AENM MKC,BZ0X;<>-ZTE*0MSM.*Z'\/^%6C^&]GT. M][(.;22YEH^XD[(+Z ,9_T< M8:S8"075<>27%?CEQ!XPY#OC5-V6XICJPV4.]':P]@B.I,DG+665SY-I#7-9 M1HDN)'4/H"*OCD3XD>@=%JL*&FL%;7S^&IZ.O&L.EL*J*V:T:D*8R'+C1(JH M"FG4*0ZU%3.ELN)[+C*/5$!\0.L3H/1!DL;.3XTSK*CH;=PZ-CAS2S[6-H:A MS6"21IV.8%:?A1U1N*'$H19/(1#!Z7D <+BZ:X2R,.W>@M:MD?4$%KI##$]I MJV1W(J)^0O/'D%R'.;57>2GA^"R3<;+ L*7)J:>1%49D35]-)Y=ODAK1V>\1 M*>5%-9=IMAOU!2'7_'+7O$ OM;VY[TPCJCO6W)CC+>Q*ZO23;*5#W%E=K6-7 M2OA7U9N%G"D1WN.L^_\ 4K*'OV[#996N[,+*"*WH:[IC8)*'==*_E4,!#JL( M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(N1 MJ;>VH;&)<4=G8TMO7O%(@6E3-DUUC"?(C23\2=#=9DQGB2HR)2%)/H?JCT6M MW=6-PR[LI9(;N,U:]CBQ[3V6N:00?1!7DOK"QR=I)89*&*XL96[KXY6-DC>W ML.8X%KAZ!!"M0X\^*]MW7?F./[G@>^[BC/=L>S?>L5NPJZ.GHGM^R7836Y-W M2"Z]B:AN4\K^/,(6>T!UI=6:?W+#6$?QMBQ0=)4,NF#L[_J)J#FD >X\LRI5 MQ5ZD.A-5])E.'TOQ#FW5/0T,EC([L='7I+>IYXBZ-H]3 5>;HOD_I3D75'/U MAF4.RL([*7K3%+$BJLOI25V24=C0R5^=1SD0UKZDAY1D8NUHCB7H MWB%:]/IJ\9)<-;5\#^TGC_Y\1VTYM]F]&3L#RN;7$K@UQ$X3WO>NLL?)#:O= M2.YC]DM9?^KF:-W>(V]&_4S%]7#/(:2$DO8V;)=Z]NP@H)PU+4X\S*7TZ5OXH=7'3&MNDR MVG>CQ>I75)+6_P WF=R^RQM]0XGEEB%:DN>R4T5PN"77 UKPVZ+!:NZ7-Z-; M1H:]];NV:-GL$S_X1C1R03'=H&MCDA;6NNWN+1^S]"Y6]AVT<5GXW:EWKE?) M=24BGOH+3A-^R>/V[';@VT!1F7532S6TH^PZEMPE(+G[J[16I="Y0XC4UJ^W MNMI83MCE:#3?BD':O;Z(-6GM7!KJ@=7- \1]&\3L&W/Z+O8KNRV![1VLL+R* M]'/$:/B?R['"C@-YAVCFN%0ML;B5RMPOE5KY.1TI-TV8T:8L+/,,<>[R30 MVCS2C1+A+5T\<^".H>">J3BX(YVE:WHI[7\G,[:2-*/X,]=;JH]6QW$K(,UYK2$C05I+[% M$X?]OF8=K*>#1N_A74I*X&%M:2EFM1(D/RWWI4IYZ3)DO.2)$B0XMY^0^\M3 MCSSSSBE..O.N*-2E*,S49F9GU'.621\KW2RN+I'$DDFI).TDD[22=I)Y5U\B MBB@B;#"UK(6-#6M: &M:!0 ; -@ V +PC\+Z("("("("("("("("("+D:F MHM;^S@4E'6S[BXM9;$"LJJN(_/L;&=*<2U&APH45MV1*DONJ)*$(2I2C/H1# MT6EI=7US'964;YKR5X:QC&ESWN<:!K6M!+B3L J5Y+Z^LL99RY')316^/@8 M7R2R.:R.-C15SGO<0UK6C:22 !RJ][B!X5T*M*JV)R2IQ@KP\)>K!#;]%J#B4T27&QS+$& MK&\X-RYI[V8V.WC:&M:T!K6M H&M:* #8 !0#D7 M.FYN;B\N'W=Y(^6ZE>7/>]Q<][G&KG.1G,/2?& M:N<^WK(4V&7/1N_JM?8ZIBQRVP[Q"E1GI,3O4,T=:\:3Z2IJV&EDE1-=ZLNP M<8\0N+FC.&]N?CNXZ3+%M66L5'SOKR$MJ!&P_9R%K30[N\1NJ:>$W /B+QAN MQ\VK0Q8)K]V6^GK';,H>V#74)FD'VN$/<"1O[C3O#7LY+^(;O+D,<^@B3UZU MUO))Z.>&8I.D(D6T-SR&UE>1)3&GWA.(\BV$)C05%ZK!F7:.@O$?C]K;7YDL M8I#C=.NJ.]X'$%[3S3R['25'*T!D9YV$[5U1X/\ 55X;\*A%E)XAF-7,H[ON MY8TMB>.>V@[9D-#M#R9)@>24#8H%""U9Q 1 16':GX3:YS'C[BO(+9_)FJTQ M097DUQB<2';ZY?R",BWK9ETS'BHMH^;U*WWY\*AD2"2<5!(2A2>TKH1G/^EN M#.GLOH*UU[J74D6'L;JYD@:V2T,HZ1CI &AXN8ZES8G/IN"@!%3RFJFN.L3J MW <4KWA;HW1\^HFZX!QY7&S9#AMG\?J*6V;O26\;>@N-T<[(C)+O&OJ0XLW^1A9=0IMUIUM1H<:=;625MN-K29*29$9&70Q7E['1N+'@M>T MT(.P@CE!',0K:1R,E8)8B'1N ((-00=H((V$$;01RKQC\K]H"("("("("("( M"+//(+%M$8GE-!!X_P"QV^24JJ:3"RJ03YV=?&:7 JU^;):2 MT[W1LK.*IPV3D2%(4L;SKW&:'Q63@@T'D+C(XQUI&Z62:/HRV M#AT@:)!%$'!JP,-&4FH"+^D1J,DI(U*49$1$1F9F9]"(B+RF9F/Z 2:#E7\) M %3R*PCD!X?>7Z%T1CNYIN9Q\CL%2,7A['P>/COL=*UI,RBJ9F1X]A;_ &P6 M"K%42RF1H3O:APU&Y):6DC0KJ)\U[P$RVA=#V^L)KQMQ<%T+;NV$6XZS=,P. M ?)TK]_=>YD9K'&:O:0""JL<+NM+@>)O$R[X?6^/=:6H;0L MP@)6H0$0$0$0$0$0$0$4R>.7'C"MOZ4Y7[ M(R6TRB#>:*PG'\DQ&+1S:F-56,ZV@YU)D-9&Q/I+.9+B(Y[;DD2AT;W.;6%M QT9VNJ3 M44K_ ,6>*NH=!\1-$:2Q$-E)C=2Y&>WNG3,E=+&R)]FUI@+)HVM<1.7'C"MOZ4Y7[(R6TRB#>:*PG'\DQ&+1S:F-56,ZV@YU) MD-9&Q/I+.9+B(Y[;DD2AT;W.;6%M QT9VNJ344K_ ,6>*NH=!\1-$:2Q$-E)C=2Y&>WN MG3,E=+&R)]FUI@+)HVM<1G)>V&I1* M5#K)5Z_2I8K#BQZJ%BE3G[\278N9 UB8E<-, MHQ<*\U+I!^J6NVLC=*8Z,W0QL$=T6N>91()C:2QW36B!T1@<*SB8&$0E/QQT MY!K]FAWLHV29L(F+I-YTC[F6R:YL8@,1MQ?0RV+GNN63BY8:6SKSH+VJD(EUES33Y59:5TI'4D2(4^$ZS*BO)(S(E(4D^AC MU65]>XV[CO\ '32P7T3MYDD;G,>QPYVN:0YI]$%>')8W'9BQEQ>6@ANL;.PM MDBE8V2.1IY6O8\%KAZ!!"N*XR>+/E6-*KL2Y'U[^8T*2;BL[%H8L=G+:YM*4 M-,KOZ=KS6OR..T1$;C[/F\WLDI:DRG#Z';KAMUJ0V\E*5.0YL=9-S* MVQ8)9=[&DMM2&C,B6A)B[V U'@]4XUF7T]=0W>.?R/C-0#SM<-CF/%=K'AKF M\X"YIZJTAJ;1&8DT_JVRN+#+QGM9XE^%U);1W-@_: X=LQU" ^-XHZ-XJ:.:0:5!J"0=OT1 MKS5G#K.QZCT=>RV649L)::LD94$QS1FK)8W$"K'@BH!%' $:W_,'PZ-@\>56 M6;8&=CL33[:EON6;<A>R<9"6#Z&;S4;J@E\\. M+?5\S^@#)F<'TF0TD-I>!6>W'_3M: "P?;F -^S;'LKUMX"];'2W%5L.G=3= M%B=>D!HC+J6UT[LVKWDEKSX/(2_DZ-\W;%M;8KJK=("("("("("("("("("( M"++>D-UYWQ_V+2;*U]8E#N:E:V9<&1WKE1D%/)[*;"AO8C;C7GE7/;274NI+ M:=2AYI2'FVW$[7HO66 DW+R(TFN*.D[G2&J8NDQ\X!:]M!+!*WU$T+B#N2,//0AS2Z-X=&][3MP<> M.0&#VI,+&O2*K7 M=LY8SR@;>C8>0;.D?V@V![F6 M.ZN/ 7(\:M55O1+!H>Q[MC&U^J1D&07>5 MWEODV26DV[R"^L)=M1SY)'FKGO<:NDQ^N-?8=N,AM#;6S6UK!=?*9*==41-LH==4EM6UZ.T5J/7F99A-- MVYFNG;7..R.)E=LDKZ$,8/U7./:L:YQ#3HO$+B/I#A?IZ34NL;IMO8MJ&,'; M33R4J(H(Z@R2.[&QK1VTCF,#G#9WXC\'-9\6ZIJU;0SF.U9T,F;O/K"(A+D, MGFNS*JL2B.=ZJBJ%=HTK62CE2R\KR^QV&F^E/"G@IIOAE:BZ:&W>J'LI)=.: M*MJ.V9 TUZ*/F)KOO^O-*-;QOXZ=9#6'&B]=9/+K#1,PZCLLFRN[J\&1Q1,=)(]QYFM:"3V3LV"I.P*BCEAXKM ME:*L<&XQ$]4UI]Y$G[7M())MIR%$I#R<-I)[*BJ6%I\B9TQLY?KC-IB.M*'C MI#Q3ZTEQW=S'O>-P[0=B20;_ -BR,@/72O@?U(;2R$6I M.,>[/=[',QL;_8F'E'?7TLDUY* MXN>][B][W':7.E/^.'4W_P!GQ?O\4HU<'KG+J7EAHM>&.S$3[+/Z.FMV8BW"*5B-G*1' MS%J6VA1)?AL8T)Y+^..0-KVT#W4N M X#E:(=]QKL&Z'6\CB%9]L"-C^\*OGQQ1HO-9-OJ_-['?NH8C)LFXW<1TM3]E4%6PHF6H MZ493.G1$DDB2AV]&'&_);[+',XZ/"Y1QK0Q.JS'SR':75MF0RFI) M+;-E!4FD2ZB0?'CPZ+>Q22X.?H9I<#06LAVL0Q(<)9,LLO M)Z&3BDJD?6.NF:$X5:)OK*QL[K4VWFN8^E;;1B.V,[F1D@=*\F$->:[K M6O%"'$&(.'W#&3BAQSXDXS(Y3(66D(,U&^ZM[27H'WDIEO1;-EE#2[H(VBX+ MV-IOO?&:@L!&.MS9]$Y:^'[;[^SW$,7J]MZJVW7X/]M..U:*YV[@R&L6*0AW M^5=?:A2H.8,&Y'4XXTF5")QM+:5=DM?UAG8N*O :77>=M+6+5>+RS+;IHF;A MD:1#6NTD- MTW.[38&E[7VK]UX:UQCE+7EQ%3D77$WEEJ76^LZ>'L'@YQ4B/8?2R8^-[-N: M'$\^SRN)!J+)\O8[8V#3LW%32FG<;9PW^BM+ MQ&TC(AO)(H+JY9]NG!CDJZ3Z^A8X&H< _>6IZNM^!VN=79B_N,5Q(UM.V_E: MZ?'Q37-E925_[/:N$T.ZR*E(PYLC"VA871[JZMS(P7%Z7D5P=V+3U^"Q,CVG M)UU:YO8:R<2_@&27E;D^$O?;)B\I#;";.HLDW:BBS#;0Y+A-L+7U5U&+XO83 M&6?$'16H;2.Q9D4F;8_IO7^NZ[)8Z\-M=CYQDE [>Y+F-I*P7'/8ZK:L%38CM-C=?B*H, M8F(QH6J03SI+2IQ?:R7&#C+?\/N)M[8:0L,?'D6FW?=W,T1EFN'NMHMQ@?O- M,<+8.C9NLH=[?<""YUKOBN*_!?'977^4RTN(>+N.PL[><0V]K&V\GZ2 M0LW'"6X?=":3?D! 88V%K@QN[[G*[>.)Z*K-'&^2KGFWA;;&2*#D$EP\AP:W=.#.;-I M2;PXH\:N5T_$<>Q?9V;Y#E.(9A(QN$<*->)J9^45RY4GMNO27TIL,16_&)]Q M]YA$U;9NJ(B,])XS75EK7A;ISBE/:6]MJ2]N)H+@PMW1)N.F9O':2>W@+F;Q MZ.QMI;75JVX?ONAZ5EO(&MH T=I=!DF MXUC7F)K]QI-%F_E'J:FWCX@'$S6&1FZ>/Y#H3#I5ZRR^N,[,I\9L-N9795R) M+1&ZP=G#HUQ^V@TK3WO5*DJZ*+=.)NE;/6O'C2NFLA7O"XP5NZ4 T+HX77T[ MV5&T;[8RRHH1780=JCC@QKG(<-^J[KG66)W?C6UU/=-A) <&RW#,7;1R%IV. MZ-\P?0U!W:$$5!P_MCQ%L[UGM3,M6:QUMJ:GT?@>56V$LZXFX1&*!D5;C4]V MCL'[CS>0PEA^T<@&MLFFVTLMI:2XAU2%FYJ.JNL'G--ZGO-,::QV*AT58W3[ M<6CK8;LK(7&-QDH10O+:C= #1NAP<0XNWW0_5/TUK#16/UKK++YRXXCY.RBN MS?LO';\$EPP3,;%O-=O",/ <7.<7N+RUS YH;5QG62P\QS+)LJK\9HL,@W]U M/M(F*8Q'7$Q_'X\M];K-74QEJ4;,.(A1)2DNRCR>M2A/1)5FS>1BR^7N1+CFN.:5]_$9?+LF1&);ZONB1K+B);.NF;^(QH[[FV5#NC( MZ*,CGWY2VK:'>8UXH150)UK^)+N'?".\98R='G\P>\+:AHYO3-/3R@_6]' ' M@/J-R1\9J#165Z9Q/D3MK<'*K%]]ZGSG%]1R)Y#KN.=W M27H(W07-?<5.Z22V"6;MN4F"'":OU_IOD3M;"MVS,+PS9>/XWEN'ZTR;95>F M?@^,;/AS_8]BSL$3G84(FG6DF[&?>=C(?BDXAM]M;[?;@[@Q;X'2'$#*8;6; M[.SU';VT]O9S7C=ZVAO&NW ]P<6MH1VS'.+ YF\UKVN>VME^L5=:HU_PIPFH MN',>0R&C[J\MKK(6^/?N7EQCGLWS&PL#WU![61C6R%DFZY\;FQ/W>_"SLEJ["DWMKNBJ)\II3+%BU$I2NH<>NDTM7;E)0KO%5['?J9 M2RB0LE.-JSW&MW%YNF8V:YAQ.0PC[ECH\E:11N<*!X;'TC0PQLDJ#4Q-WBT, M$AJYIUCJW,X /UG++PSN<]BM2QV 5SIZXTG':,Z3%O9$VYWVCM MQ.'T+G$D;SGR0.+B#V^]OFO3<7HO#YJ^@ZU-IJVTUY+?R=%FHY)G6G1N/L9M M71[S6M: XL:R*Y:&@M]CW!$(^\4-)9I;47)WD:UH?%,IY%T^S[;"->:CN*[' M<8P[ I3XW\1=/6 M.2T;PE?J:^LN$]QAHKR^RD4D]Q=7MM[+% PS0LEE<9WVSA(1&6!TH<]FY&(U MF1W5?*7>VJ=VXQS8U#B%;)SS8-7@1YE6' M=4.+VTS/-JN6.4KJCD1V9EG#J(SL>)VSZ-/22V,.:RO(Y^]MH0=^O-!77$?KA:QTY)D;W' MZ<.,L9+WO23HIKF)EEC1';"7=<61NE08;)<,,SPSX]X_@[PVS^5Q^C]78Y[YP9B^:W9&9YKGO=] ULSHK5S(;@ MM,K!,]KB_87=-UWNN9S7XOC16_8XVB6I:I3"E)>0\1MJ2OW<,^+62X MDZGAX=Z[L<==:8R+98XXX[=D7>KFQOD:8=W:&CL?-'"\7&_L M(^;^D^*6 WM_O&$6^]]ET)R,=>;EW:\@7NXMY_YV:\X(:I+!&.1M7'W:+<1)2K.;)0XA6)V$ MHDJ5($^G^(5N#-G[!_Q7>AO;/<:^P. M=SDN):ZG*7W6P4VK/<(C!P.+NUC8T@]\L;]: UH M.P1V6TU-%P//NRC:PQ7CYP^HWT%%TQ@<')<_1'4WW4O9F:L*L;!3Z65=RI<1 MN7)ELJ(C,FK@R-:S\I>'CM X263AT6'L6S75*4=>7 WW5IL[4.?(T_ M8SFI=RK)=6"SFUEF]4\>\DT]-J')OM[(NK5N/M#T;-VNVCBV.)X-.VM00UHV M*%#>\=I-8$O6;>4J3B#D.16JBE3X_P"S/L5+>KWY=,G+3J3RYNCE'51D.0DS MBBN,QVVE-FTDD%#3=:ZG;@CIMMU3$EA9N]'%TFXXM+H^GW.G$;MQ@,8DW"UK M6ENZ %8EW#?1;]3C6#K('/"1LF]TL_1=*T/#93:]+WJ9F])(6S&'I&O>YX<' MN+EB<:JMX0$0$66].;SVEH3*6LNU;EEAC=B9LHL8C:BDTM]#:<)SV.OZ>02X M-I#5Y2(G$=XT9]II;;A$LMKTAK;4^AT<3R12'>V@,?( M:TY2<<>J'K'AGTVH-)=+FM%-JXN:VMW;,&W^<1,%'L:.6>%N[0%TD<(I6S 6 M/5/E^'&VW6UM.H0ZTZA3;C;B4K;<;6DTK0M"B-*T+29D9&70R'\PD/!J"-A!'(0>8A4MEX2M1MQZ.W4?:-5>LTPI'7^1..M/=OTXXQ]6FWR0EU-PZC;#D=K MI;(4;'+SEUOR".3EK$:1O^L,9&Z_H7U>>N5=X8P:,XNRON,3L9!DC5TT(Y V M[ JZ:+D G%98Z>R"5IWHZ!K*ML:>PG5-O FU5K62Y$"RK+**_!L*^=$=6Q+A M3H4IMJ3$EQ7VU(<;<2E:%I,C(C(41N+>XM+A]K=QOBNHWEKV/:6O8YIHYKFD M MTEKFN!!:YI(((( M-%Z0^*]" B B B B B B B B BE#Q.Y09=Q:V;$R^F.19XK:G'K<^Q!+R6X^ M24*735VF2=)3,:\JE.*>@R/(I"S4VH^Y>>2J3.%G$O+<,=2,RUGO28N6C+J" MM!-%7FKL$C*ET;^4&K2=Q[P89XX<&L%QIT=)@DLKJE76\U.>FUT, MM V:/:"*/ Z2.-S=MO7V?XGM+#,>S_![=B\Q;**]NRJ;".?3MMK-3;T:2T?\ MI%GP9+:V)#"R)QA]M;:R)23(=6PLK9\9E]20.MLU92F.5CN8C:'-/(YCVD/C>.U>QS7-)! M"[D,NM?0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0 M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0 M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0 M$0$0$0$0$0$0$0$6&=^[RPSCOK&_V;FKYG"JFBCU-0PZVW8Y+?R4.>Q>/U9. M$HCE3G6S-:^RI+#"''EEV&U#3]=ZVP_#_34^I,R[V&(49&" ^:4UW(F5^N<1 MM-"&M#GG8TJ0>&'#?4'%;6-KH[3K?YQ.=Z64@F.W@:1TD\E/K6 [!4%[RV-O M;."U"MS[AS7?&QLBV;GMAYY>7\GJW&9-Q-;1U3!J164%+&<6X<2IJHQDVVDS M4MQ7:==4MYQQQ?)K6.KLSKC4-QJ3.R;][.[8!7$NHN*&4Z"P!@PD+AWQ=.%61 M@[=U@J.DE(&QC3LJ'/+6FJ@WC=QYTEP3P??.5<+K4MPP]ZV+'4DE((&^]U'= M#"TGMI'#MJ%L;7O! VEM&Z%UKQXPB+@NM*-%;7H-N1;6LDVY%_DMHELFW+?( M;-+32ITYPBZ)(DH881_)LMMMD2"Z<:)T-ISA_A6X33D C@%"]YH99GTH9)7T M&\X\VP-:.U8UK0 N+?$CB;J_BMJ-^I=87)FNC5L4;:MAMXZU$4$=3N,'.22] MY[:1SW$N.91MZC]1:Y-\N]3<6\>*;FEB=KEUC%<>QG7U,\RYD=XHC6VU)?2K MMMTE%W[9I=3W1QCQ)XL:5X96'39B3I]F =<33O)=;5&0GO>AD:B21G9+37$?A7+PMLN'FO;3,SFTO9+FMH( W M?U[H6N&TQQLDE:3S"A97Z\O;5A^%_P ".-/%2XM[+CKJ:Q=HV"5L MC\?B8WQLN7,-6B6:2*!X'.26R;M/8VL?248LX,O[N9Y1ZNV?B^*9AES.2Y]9 MT>79"4&Q--^^!(N,@7&)M'B=<[274LJ/HI2#/6>";]:,XF MXS4N,M;N[9V0#OHR2T+*QLD$SMXU#@P\I"W7K)1\.9.#&:T;F M;ZPL9+/%QS6L&_&)8WPD]XMB@#A)NRR0FV86MH6F1O('+D?$?V53Y;R!>UWA MS,.!K[0]% U;B]76D2*Z+,JTD]DRF6O+W;T:V<]CE^4^TBN0KU3,S]'6'U': M977IT_B R/ 8.!ME"QFQC7,VS4',0\]$>R(FGEJO)U2=(7^#X6MU7GW22ZIU M-1O(?"MOZ4XH:WQJKRB#>:*PG(, M;RZ5>0JF-56,ZV@X+&CNXX_ N[.9+B((>O\-JW M1NEM.XZ*Y9>X.REAG=(U@8]SVVP!B+9'N.<)P^&-K7$7#*"-\HJ'5<*#>8KR'PJCX1 M;+XURZO*',ZS+;L#/JNVCPJE>)L4\6-@#+D:?.=NV;AJS-6*R.B&X#K71;?5 MPNJNPQ>O\-9<%\EPYEBN3F[S+-NF/#6= (VBU!#G&02!_L#]@BI-D;^T_N.1NBNQNHI+YC ,DHJ[ LSDT[?=MRK"5-LH]U1L2>TLR1# MB&XRVHFS6Z:"<]Q,X1:]?#J+7>(R[M8QVT<=0.49Z6X,2S0NO;>:2]M&RFI:QK(W13%NS M;++NO<"[=9O%BX'D/S%U7MW+^(V1XC@^4894:&1C_P!L^+JBTJX,%BKM,,G* MI,%D,7BU6U96QL>>CQ79K=8MU!-&MMOM*)'@X@<7=+ZLRVD\AB;*YL[3!"+I MH=V,M:&/MW=';$2'?8P1.8PR"$D;I+6U.[D^%/ +6NA,#KO$YW)660OM3&?O M>YWI0]YDCNV=->-,($4DCIVR2-A=^>D?;N>^$]->7%PW<=)'$\T9*T.WHVT<' 5 #CW;D_R'PK M=>N>+6(8K5Y17V6D=15N Y6_D$*IBP;"XAT6(U;LG'G:Z[M9$NL5(H'C2N2U M$=-"D&;9&:B3F>)>O\-K+3VF,3BXKF.YPN)9:SF5K&M?(V*!A,19(\N96)U" M\,=0CM>4#7>#7"K4/#O5FM,]FIK*6SU'GI+VV$#Y7/9$^:ZD#9Q)#&ULF[,P M$1NE;4.[<@ EG_(?"LJX8Z)XZUU7E#.;:PS;+,DO[2;"J6\6EP;V[SNRB-4\ MUB[D6TB6VQE$:5[FL$+ MFRR7+VB-PD,AI>*]W-9.T[F<=;6\$;'RFY: M^&&SC<96&%L36EUN\M+)GD@MJT$D-[WR-YF5^;\AM+[YTM#R*BL-3:[P[&D, MYK75<=RWZU9YSB%Q@@S6O\ M-KG1S+B"XQ6/MX:7#&#>DBEG>\;LFAB+9XI(#(WM'L!##5W;-'=LMW_P"' M]M#)I>W-@:"W1"V;=S$7>4XCBN44):UR/(%N,NV$V9:OVU??QTV;I+6^<:#' M[U9FI23<<6L9G*Z\X#:FR3]5Y[!9AFI)GB2:"":+O.66H+W.>9&2C?-2[59ID^28SB,# J"[N9MC4X;63I=E QR')=-QJLBSII( M?D-,$?J]AI!&?1#;:"2A, YV_LLIF+G(XVT98V$TSGLMV.<]L32:AC7.VD#Z M@'V+6MHT6JTQB\EA-/6>(S%_+D\I;V[(Y;N1C8WSO:*&1S&5:TN[%7'G<][J MN,N-60_;*5D M3+3I=3AQR0=G)[+O\FV:Y6TQQ-QVB^&%]IW3??T&N\E=L=+=LW8V101GM60R MLEZ;?H'?Z-M.FDH[M6U@O6O!?+\1N-6,U=K'XLNN&&&L9&P6#]^9\UU*.WDN M()(.]^CJ6G9*^O>\-6=L_=P]5\L^3E59UUHWR!W/-76SX<]$.TVAG-C62UPY M#*G$JUN8[EN>S#W1O:[=?>W+V M.W2#1[#+1S32CFG8X5!V%;]>\#N#E]9RV3M+:>C;-$YA?'CK..1H>TMWHWMA M#F/;6K7M-6N (VA2TVAR;X9[9W)D.Q8F9#A#E7D$J%?0KJF3$C/)G+@K-4/O%)5WZT(E74W$G@_JK5]QJ#,X3(3VN M1LH&W%'QPRV]U$2'2VQ9*YLK9(]QCND,9K'O$'?($&:,X.]8'0W#^TTGI[4N M)MK[$9&Y?:UCEN(+JRG +(+P20-?"^*7I)&&$3 "7=#AT;7.ZQLCE+HBEX_W M'&SCM@>SF\%S+,J?+LTN-NW]2YST'-PZX?6.2&$O+R.>XDOY6&0B-\;^CB9$7M8'.B95[ M7-( -6N+JMS.D>"W$O(<48.+O%?)X8ZEQ^/EM;2+%P2B(&5DT?3323MC?(6, MGDI&YKFDEM',#*.[5B._O#^Q;,<>W)2Z,WQA>RL8MH6356&8IF5-)ULW?P'6 MI323N;"YC9(BI=D$HG(Z(91EL_R2F#:6IL93$Z[X#8S+V^K[/"9RSU';2MF9 M;P7$9M!*TAP]D?()@PFM6B/<+>U+-TEJPF=X7]:/-8"ZT!D=2Z9R.D+R!]O) M=W-I*V_,#P6D]$R)UN90VA:\RF0/[<2![0]=;Q7GFQ:9COR-NO6L;-M+\BKE M-SE. 5%FJ!9XK85[$.%16F-W"FXWG=G"K:J$V^XOS5;\B(S);6PI"FW,=B^. M3+G+YV/66-;>Z.U!-TDUK&_=? YH:V)\,E!O/:QD8<3N%SXV2-+""UV7S75E MDL\!IB;AWF'X[B%I.WZ*VO98]^.Y8\O?-'<1 NW8WR2RN8T=(&1RR0N;*'![ M<<[.SGA!$PC(Z+2&F]M6.89$F.S!S/;N55\+[26VI3,IY^AI,0M;&';2'DQ^ MY(IBBZ(=49J41=A>O:ES?!:+"W%CHO$963+7 ;<7\[&][@.#B8HX'O;(33= M]D/(XDDTW3MFC=-]8Z?4=IDN(^H,%%@;0N+[3%VSW]]DM+0V::ZBC=$T;V_[ M$.5H )WF^MG_(?"LJX8Z)XZUU7E#.;:PS;+,DO[2;"J6\6EP;V[SNRB-4\U MB[D6TB6VQE$:5[FL$+F MRR7+VB-PD,A4/9ML_-L3R2@M( M4*IUK#"UL4EL]PD<9!('$0NH&QN%2VI%20U1PJU#F^L'IKBO:36 M3=.X;'7-O/&]\HN7/FAO(VF)@A=$YH=<,+B^9A #J-) #G&#D/A6E-<\I<0R MJKRBPLMW:BLL!Q1_'X53*@U]Q,HLNJVI.0NV-W52(E8F1?LFI<9J6Z2$K,FS M,DDIPTU_AM&Z>U/BXJ8/AQAM06>6LY;VXRD$#(HPUA@=T;;ELC+ M@ND8YK)!,&U8R0TWB6[ '8'K!<#]2\8-1:4R."R$&.M<)!XG<'M!R2:CT M-@\F=8NB>R+ON9C[:V,@()C8N+Y[%RN[S+DCCE;#IK>G@T\BM9OT-Y^NVGY,]-N:J3#CRYN6M+2<2/+49) M#8ON*WO,KJ)U?15MUA4Z!F&'VU:W8QF& MK)5K4$JQ;4RI27&ZYA9]I'8ZRUU:F9?"G,PZIL9F:(%E#?R23QN;&R2WP/ #]^.LH+201$QQJ**!.N3+@=1#3MQHC)VTO$DY*XQ44-M*Q\TD5VQ]K=1 M2&-Q,?1RT@<'@%KIY6BCMY53[;V-;;IF?E%7=5ZAN]6:DOM27NRXO;E\I'+NAQ[1@]"- MFZQOH-"NWH72=CH31V-T?C=MICK.. .I0O<:+'8U];6@ M(@(@(@(@(K6>'_B:YOIY57@6ZW+78>L6R9@P+Q3GGF;X5&0E#4=,:1)<2>2T M,5*>R<20X4EAOIW#W8;3&7:/A+UD\SCMZ5C>C> M[^%CWGNF;L38)GV&;.Q:JS7 ,CK,JQ:Z9)^NN*I_OF'2+R.L/MK2W)A3HR_6 M/QGT-R&'"-#B$K(R+H'@\[A]2XR+,X&XBNL9,VK)&&H/9!&PM<.1S' .::AP M!%%RBU+I?4&CLU/IW5%I-99JW=1\4HHX=AP(JU['#:R1AA&EYI!,B!.,7 S#<2;9^5QVY9ZQ8SM9J=I/NBC8[@#:10!K90"^,4V M/: Q6FZO?6;U%P=O(\'E^ER'#V1_;V]:R6V\ZKIK0NV U)<^ D1RFM#&]QD6 ML5L'7F9ZKRZYP7/\?GXSE-#)5&L:N>V1*+H9]U*BOMJCD8=GHM',U[COFR< SNR=]YG.;)HK!V0XM;."Y'()N,QE<='178K M)24-LVB$]/Y%*'RZJ8[#EB^K_P 87\/\U\0YR0_,^^D&\2=EM*: 3CL,=L;, M!]: \5+-UU0^M9U?8^*VG#JC3,(\H.-A.X&@ WD#:N=;.//(VKGVY/UY=$:" M3>9M!M.M/M-OL.-O,O-H=9>:6EQIUIQ)+;<;<09H6VM!D9&1F1D?4ATO:YKV MA[""PBH(V@@\A!YP5QG>Q\3S'("V1I(((H01L((.T$'E"\@_2_* B B B B MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B MB B B B B B B B B B B B B B B B B B B B B B B B B B B BX^VM: MVBJ[&[N9\6KJ*B#*L[2RG/(C0H%?!87)F3)WCVQ6D3'/>]Q :UC02YSB=@ ))/(%ZK&QO,G>Q8['Q/FOYY&QQQL M!<][WD-:QK1M+G.( Y25J<\X^65IRCVF])K7I4/5N&NS*K7M*[VVO.&%.DB M=EEDP9^2WR)3*%$DR+S:*AIGRK2XMSEAQKXJ7/$W4YDMBYFF;,N9:QG945[: M=X^V2T!I]8P-9RASG=P^K?P.LN#&BVPWC62:TR 9)?2BAW74JRVC=]J@J17_ M $DA?)ZDL:R$XAE6)0$0$0$0$0$0$0$0$0$4]>%7!S+N4M\F_MU2\7TY0V+; M.191W9HG7TADTN2,:Q GFELR+-39D4B4HE1X"%DI1..&AER<^#?!3+<3K_OZ M[W[;2$$@$LU*.E(VF&"HH7T]4\U;$#4[SMUCJQ]8?K(8+@MC#B[ ,O=?W,1, M%O6K(6FH;<75""V.OJ(Q1\Q! +6!TC=HG L P[5^)4V"X#00,9Q6@C>:U=17 MH43+*36IUYYYUU;DF9-EOK4Z_(>6X^^ZI2W%*4HS/IE@L#B-,XJ'"8*!EMBX M&[K(V<@YR234NDE>14FE M UC&@!K&,#6,: UK0T +N RZP"JJYJ^)%C6DE6FM=..UN8[8:[Z%;W"NQ M-Q; )!$IMUJ4:%=U>9/'5Y"AH,X\99'YRHUH..JK_&3K$X[19ETYI QW>JA5 MLDGJH;4\A#N:28?:QVK#_"&H,9NQU>.J/E^(PAU?K\36&AS1\46UES>MY06U MVPV[A_I2-^0?P(W7"5NN5E^891GV26V89I?6>39/>RE3+:[N)3DR=,?-*6T= MMUPS[#+#*$MLM()+3+2$MMI2A*4ESTRV7R>=R,N6S,\MSDIW;SY)'%SG'DY3 MR -:*-:T!K0 %UGP6!PNF,1!@=/6L-GAK9FY%#$T-8PYADC).T]&]NW;RJ*-5\#>$^N=1,U7JS"VU[GF-:WI'NE M >U@HT2QLD;%,&C8.E8_9LY-BCV^^])>>DR7G9$B0ZX_(D/N+=>?>=6;CKSS MKAJ6ZZZM1J4I1F:C/J8T%[WR/,DA+I'$DDFI).TDD[22>4J4XXXX8VPPM:R) MC0&M % !L V #8 O$/POH@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@( M@(@(@(@(@(I'9CRZY(Y_@+&K\NVSD5O@S$2+ 71FU40?/X4(V518ES9UM;#N M+V,RJ.@R1-D/I[2",RZD0D/+\6.(F>P3=,Y;*W$N$:QK>CI&W>:VFZV1[&-D ME H-DCW#8%$F X$\(]+ZH=K/!8.T@U(Z1SQ-65^X]]=YT4(K$QAH M2.=1Q$>*6T!$!$!$!$!$!$!%)+C;RHVKQ@RLK[ K4Y-#/>9^VK!K1UYW&,HB MMFE)^>QV9+!^M,ULJ<9V>28 M9FCLCZV0#U$K:/;R=LPN8Z(N+O!71/&7!_%FIX-S)Q-/>UY& +BW<&_K6V"RS!K1UI.18Q*>ZI2IYI' M938U$E:3\VG,D;+Q$:5=V\EQI'3#AQQ0TSQ,Q7?V$DW+^,#I[9Y'2PN/9'U\ M9/J)&]J[D.Z\.8WC+Q@X)ZSX,9WXLU)%TF+F)[VO(P>@N&CL$_PU#"8KZ(U!&UDC#7=EB=0;T;J;#L M((+7!KVN:.UW#_B!ICB;IBWU9I.X$^,G%"#020R #?AF94[DK*C>;4@@M>QS MHW-<[%8U=;J@(@(@(@(@(@(@(@(@(MI/PL\OS#+N*-5]MMI(MF\9S'(,3Q1^ M6RM,B-B-5"I':ZM5+<6M=BQ6SILIEASR$S'0W'2798(=-^K%ELOEN%L7QM*Z M5MM>2P0%P-1 QL98S>).^&.<]K3]:P-C&Q@7%SKIX' 8+C=/\10L@?>6$%S< MAI&ZZZE?,))-T ",R,9&][?KWETI-9"K&Q855,0$0$0$0$0$0$0$0$0$0$0$ M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$ M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$ M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$5$'BJV9I M98.),VY;P7O^?>-+[AI@ M)*,;NNOI&GE.QS+8$'D&Q\WH[D=121IZ8=2?@.UD;>,NJH:R.WF8R)XY!M;) M>D$DEH=Z%XHP%)5TF0$0$0$0$0$0$0$0$0$5B'!/@W<\G;\LQS MI=+I3&K(H]Q/96J/8YE:1B:?=Q>@<+HXPPEMU'GTTO\ F&UDVT9O*-35@>"' M!.\XE7_QOE]^'1MM)21PV/N'BA,,1Y0*$=+)]:#NM[AA^O(WGTC%'[/V*8IC>#8Y38CB%+7X[C M./P6JZFIJMA,:% AL]>RVTVGRJ6M:C6XXHU..N*4M:E+4I1]+,7B\=A,=#B< M3#';XVW8&1QL%&M:.8#T>4DU+B2XDDDKC5F\WE]29:XSN>N);O,74ADEED=O M/>X\Y/8 H&M%&M: UH#0 .;>>9C,NR)#K4>/':<>??><0TRRRT@UNNNNK-*& MVFT),U*,R(B+J8]KWLC89)"&QM!))- -I))V <_B7OVIW.H.-UR]$K$JD5F6;9K9"V9EBI"W(\NIP*2U MV5Q*[UO1=NA?>R.T?FO8;)+[U&.-O6/?=&;27#N8LMMK)[YAHY^TAS+4CU+. MS.#5U?8MUH#W]-^K;U/H[(6^O.+ENU]X0V2VQDC06QU MS[SB8HZ03,U&:E&9J,S,S,^IF9^4S,S\IF9BEI))J>5=&P !086Y;1\;QS_ %KV.';,D8>V9(PA M[' %I!6SUPMYVX9RAJF<8O2@XCN>L@J=ML5)QQ-=DD>&RTEMR>5O*71$ MF2,5/;,&^N-O6%ZM&H.#-\[,XSI+_A]-)2*YH#);N<3NP70;2CN0-F#6Q2D@ M ,>>C$_1.ZJ\HP\I^+& \IL!;<;1RUUAH_.Z&SLVGM0PF*^B-01M9(PUW98G4&]&ZFP["""UP M:]KFCM[P_P"(&F.)NF+?5FD[@3XR<4(-!)#( -^&9E3N2LJ-YM2""U['.C;WM( ME;J7")+2S;ID]"1ZPT$E7\92AU!ZM%IWMP?QTM #/-=2<_-4E<3NN9?=^=8'+05)%K;V47(*;;.&:@IRBLIVG;6HY %/M,V&N8]7(EQE6$ M>-&FR(*7VE3&(#7%P:XCE <6N -*$MTD .%?9'T7Q0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0 M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$6KWMSQ@N6 M.$;7V=A=-7:C53XAL+-,7JE36LMO23BQ$=XI*$$I? M4R27J"U6'X,Z0O\ $6M].Z\Z::VB>ZDC0-Y[&N-!T9H*G9M5#-1]9+B'BM0W M^+M68[O:VO9XF;T+R[=CE]U9[6L+YT/$K[7C.X2>W)Z:KF']C--?>5>^[(/(?HO[*][JSVM/.AXE?: M\9W"3VY/35UIYT/$K[7C.X2>W+\K\:GF(I" MTIK].-J4E22<1A-T:T&9&1+03F7K;-23\I=I)EU]4C(!P/T6#7>O3_\ M6^U MH>M#Q*(H&8P'_J'^W+K_ *8_FM]G=>?>!7_70]/D6T/]KN>['TEX_.7XH_;; M+W.WTT],?S6^SNO/O K_ *Z#R+:'^UW/=CZ2>? M>!7_ %T'D6T/]KN>['TD\Y?BC]MLO<[?33TQ_-;[.Z\^\"O^N@\BVA_M=SW8 M^DGG+\4?MME[G;Z:>F/YK?9W7GW@5_UT'D6T/]KN>['TD\Y?BC]MLO<[?33T MQ_-;[.Z\^\"O^N@\BVA_M=SW8^DGG+\4?MME[G;Z:>F/YK?9W7GW@5_UT'D6 MT/\ :[GNQ])/.7XH_;;+W.WTT],?S6^SNO/O K_KH/(MH?[7<]V/I)YR_%'[ M;9>YV^FGIC^:WV=UY]X%?]=!Y%M#_:[GNQ])/.7XH_;;+W.WTT],?S6^SNO/ MO K_ *Z#R+:'^UW/=CZ2>?>!7_ %T'D6T/]KN> M['TD\Y?BC]MLO<[?33TQ_-;[.Z\^\"O^N@\BVA_M=SW8^DGG+\4?MME[G;Z: M>F/YK?9W7GW@5_UT'D6T/]KN>['TD\Y?BC]MLO<[?33TQ_-;[.Z\^\"O^N@\ MBVA_M=SW8^DGG+\4?MME[G;Z:>F/YK?9W7GW@5_UT'D6T/\ :[GNQ])/.7XH M_;;+W.WTT],?S6^SNO/O K_KH/(MH?[7<]V/I)YR_%'[;9>YV^FGIC^:WV=U MY]X%?]=!Y%M#_:[GNQ])/.7XH_;;+W.WTT],?S6^SNO/O K_ *Z#R+:'^UW/ M=CZ2>?>!7_ %T'D6T/]KN>['TD\Y?BC]MLO<[? M33TQ_-;[.Z\^\"O^N@\BVA_M=SW8^DGG+\4?MME[G;Z:>F/YK?9W7GW@5_UT M'D6T/]KN>['TD\Y?BC]MLO<[?33TQ_-;[.Z\^\"O^N@\BVA_M=SW8^DGG+\4 M?MME[G;Z:>F/YK?9W7GW@5_UT'D6T/\ :[GNQ])/.7XH_;;+W.WTT],?S6^S MNO/O K_KH/(MH?[7<]V/I)YR_%'[;9>YV^FGIC^:WV=UY]X%?]=!Y%M#_:[G MNQ])/.7XH_;;+W.WTT],?S6^SNO/O K_ *Z#R+:'^UW/=CZ2>?>!7_ %T'D6T/]KN>['TD\Y?BC]MLO<[?33TQ_-;[.Z\^\"O^ MN@\BVA_M=SW8^DGG+\4?MME[G;Z:>F/YK?9W7GW@5_UT'D6T/]KN>['TD\Y? MBC]MLO<[?33TQ_-;[.Z\^\"O^N@\BVA_M=SW8^DGG+\4?MME[G;Z:>F/YK?9 MW7GW@5_UT'D6T/\ :[GNQ])/.7XH_;;+W.WTT],?S6^SNO/O K_KH/(MH?[7 M<]V/I)YR_%'[;9>YV^FGIC^:WV=UY]X%?]=!Y%M#_:[GNQ])/.7XH_;;+W.W MTT],?S6^SNO/O K_ *Z#R+:'^UW/=CZ2>?>!7_ M %T'D6T/]KN>['TD\Y?BC]MLO<[?33TQ_-;[.Z\^\"O^N@\BVA_M=SW8^DGG M+\4?MME[G;Z:>F/YK?9W7GW@5_UT'D6T/]KN>['TD\Y?BC]MLO<[?33TQ_-; M[.Z\^\"O^N@\BVA_M=SW8^DGG+\4?MME[G;Z:>F/YK?9W7GW@5_UT'D6T/\ M:[GNQ])/.7XH_;;+W.WTUU7,/&JYJTU-(-K(M?,SIC;L6 MO *LW6GEMF1RT M)=?=;/S0E=LNTE237V2,C(QB\OPBT-9V;BUER)W@M;28U!(]5M!':\NT$5H# MRK-8#K#<4VY-A!I4@[%4M9\B-GW5E87%O;1 MK.VMITNSL[*=#*5-L+&>^Y*FSIDEYU;LB5+DNJ<<6HS4M:C,S,S%5;GJ-]U](7.>XESG.);4N<222=I)JKSV?^)[UIL?:16%A<8"&Q M@C;''&S&1-8QC&AK&-:' -:UH#6@"@ "]'W]L__ .DU?\V-?\L?#S$> '@V M4]V/]:O1^E)ZV'AF#_LZ/UZ>_MG_ /TFK_FQK_EAYB/ #P;*>['^M3]*3UL/ M#,'_ &='Z]/?VS__ *35_P V-?\ +#S$> '@V4]V/]:GZ4GK8>&8/^SH_7I[ M^V?_ /2:O^;&O^6'F(\ /!LI[L?ZU/TI/6P\,P?]G1^O3W]L_P#^DU?\V-?\ ML/,1X >#93W8_P!:GZ4GK8>&8/\ LZ/UZ>_MG_\ TFK_ )L:_P"6'F(\ /!L MI[L?ZU/TI/6P\,P?]G1^O3W]L_\ ^DU?\V-?\L/,1X >#93W8_UJ?I2>MAX9 M@_[.C]>GO[9__P!)J_YL:_Y8>8CP \&RGNQ_K4_2D];#PS!_V='Z]/?VS_\ MZ35_S8U_RP\Q'@!X-E/=C_6I^E)ZV'AF#_LZ/UZ[?B.T-B7LU#SSM9[%Q74G M+6JM2DI!IZ+\S;4AU"^TZ70EFDR-"#Z]2/L]^VRG>K3VW\ M]DV_M1VO/STY!Z-%@<]_BP]:W&6YCCO<'WZ]O:CXNB[7FWC5Q&SF!!J=E*55 MJ&)^+'RQP7&Z7#\/7JW'L9QZ S6TU-6ZZKF(<&&P1]EMM/G1K6XM9FMQQ9J= M==4I:U*6I2CL]BN '#;!XZ'$8BUFM\;;L#(XV2D-:T4DU+B2YQ))*I M3G.MGQHU+E[C/9Z]M[O,7><[: 4#6@!K6@-: T #GW/&3YI- M(6Z[D&NFVVTJ6XXO JY*$(21J4I2E2B)*4D74S/U![W<%]"M:7.9*;W!C)+,O)H +=M2>P-JBAOOQ>>8&ZL8L-=V&98_7X;9?R-XUCN*0 M:23D<=*DJ.#-F-*7.*G4I/KV$+;3(3U)TE(/L"+==<"^'FLL;)I^X.1CP\FR M017+HS,/L7.#=[H^RT$!XV/J-BG#AAUI.+_#S,Q:KM1AY=00[83/9MF; [[- MC"\,Z7;L>0XQG:PM=VR@A[^V?_\ 2:O^;&O^6(.\Q'@!X-E/=C_6JS'Z4GK8 M>&8/^SH_7I[^V?\ _2:O^;&O^6'F(\ /!LI[L?ZU/TI/6P\,P?\ 9T?KT]_; M/_\ I-7_ #8U_P L/,1X >#93W8_UJ?I2>MAX9@_[.C]>GO[9_\ ])J_YL:_ MY8>8CP \&RGNQ_K4_2D];#PS!_V='Z]/?VS_ /Z35_S8U_RP\Q'@!X-E/=C_ M %J?I2>MAX9@_P"SH_7KUU[OV&I1J*SAMD?J(150#2G_ ("-QE:__LF8R$/4 M>ZN\488_%WDCA]_T=KCM/8V+\^_=L3[+1?YJK?K8?3S(>KKXHNO=UY[9#U=?%%U[NO/;D_29];_Q_8_V7CO@Z>_=L3[+1?YJ MK?K8/,AZNOBBZ]W7GMR?I,^M_P"/['^R\=\'3W[MB?9:+_-5;];!YD/5U\47 M7NZ\]N3])GUO_']C_9>.^#I[]VQ/LM%_FJM^M@\R'JZ^*+KW=>>W)^DSZW_C M^Q_LO'?!T]^[8GV6B_S56_6P>9#U=?%%U[NO/;D_29];_P ?V/\ 9>.^#I[] MVQ/LM%_FJM^M@\R'JZ^*+KW=>>W)^DSZW_C^Q_LO'?!T]^[8GV6B_P U5OUL M'F0]77Q1=>[KSVY/TF?6_P#']C_9>.^#I[]VQ/LM%_FJM^M@\R'JZ^*+KW=> M>W)^DSZW_C^Q_LO'?!T]^[8GV6B_S56_6P>9#U=?%%U[NO/;D_29];_Q_8_V M7CO@Z>_=L3[+1?YJK?K8/,AZNOBBZ]W7GMR?I,^M_P"/['^R\=\'3W[MB?9: M+_-5;];!YD/5U\477NZ\]N3])GUO_']C_9>.^#I[]VQ/LM%_FJM^M@\R'JZ^ M*+KW=>>W)^DSZW_C^Q_LO'?!T]^[8GV6B_S56_6P>9#U=?%%U[NO/;D_29]; M_P ?V/\ 9>.^#I[]VQ/LM%_FJM^M@\R'JZ^*+KW=>>W)^DSZW_C^Q_LO'?!T M]^[8GV6B_P U5OUL'F0]77Q1=>[KSVY/TF?6_P#']C_9>.^#I[]VQ/LM%_FJ MM^M@\R'JZ^*+KW=>>W)^DSZW_C^Q_LO'?!T]^[8GV6B_S56_6P>9#U=?%%U[ MNO/;D_29];_Q_8_V7CO@Z>_=L3[+1?YJK?K8/,AZNOBBZ]W7GMR?I,^M_P"/ M['^R\=\'3W[MB?9:+_-5;];!YD/5U\477NZ\]N3])GUO_']C_9>.^#I[]VQ/ MLM%_FJM^M@\R'JZ^*+KW=>>W)^DSZW_C^Q_LO'?!T]^[8GV6B_S56_6P>9#U M=?%%U[NO/;D_29];_P ?V/\ 9>.^#I[]VQ/LM%_FJM^M@\R'JZ^*+KW=>>W) M^DSZW_C^Q_LO'?!T]^[8GV6B_P U5OUL'F0]77Q1=>[KSVY/TF?6_P#']C_9 M>.^#I[]VQ/LM%_FJM^M@\R'JZ^*+KW=>>W)^DSZW_C^Q_LO'?!T]^[8GV6B_ MS56_6P>9#U=?%%U[NO/;D_29];_Q_8_V7CO@Z>_=L3[+1?YJK?K8/,AZNOBB MZ]W7GMR?I,^M_P"/['^R\=\'3W[MB?9:+_-5;];!YD/5U\477NZ\]N3])GUO M_']C_9>.^#I[]VQ/LM%_FJM^M@\R'JZ^*+KW=>>W)^DSZW_C^Q_LO'?!T]^[ M8GV6B_S56_6P>9#U=?%%U[NO/;D_29];_P ?V/\ 9>.^#I[]VQ/LM%_FJM^M M@\R'JZ^*+KW=>>W)^DSZW_C^Q_LO'?!T]^[8GV6B_P U5OUL'F0]77Q1=>[K MSVY/TF?6_P#']C_9>.^#I[]VQ/LM%_FJM^M@\R'JZ^*+KW=>>W)^DSZW_C^Q M_LO'?!T]^[8GV6B_S56_6P>9#U=?%%U[NO/;D_29];_Q_8_V7CO@Z>_=L3[+ M1?YJK?K8/,AZNOBBZ]W7GMR?I,^M_P"/['^R\=\'3W[MB?9:+_-5;];!YD/5 MU\477NZ\]N3])GUO_']C_9>.^#I[]VQ/LM%_FJM^M@\R'JZ^*+KW=>>W)^DS MZW_C^Q_LO'?!T]^[8GV6B_S56_6P>9#U=?%%U[NO/;D_29];_P ?V/\ 9>.^ M#I[]VQ/LM%_FJM^M@\R'JZ^*+KW=>>W)^DSZW_C^Q_LO'?!T]^[8GV6B_P U M5OUL'F0]77Q1=>[KSVY/TF?6_P#']C_9>.^#I[]VQ/LM%_FJM^M@\R'JZ^*+ MKW=>>W)^DSZW_C^Q_LO'?!T]^[8GV6B_S56_6P>9#U=?%%U[NO/;D_29];_Q M_8_V7CO@ZY.EY$;;QRWK+^@RERFNZ:=&LJFVK8<.'85UA#=2_%F0Y3#*'H\B M.\@E)4DR,C(>FSZEO #'7<=_88V]AO87A['LR%ZUS'--6N:X35!!V@A>+(_X MD76PR]A-B\IF<;<8ZXC='+%)B<:]DC'@MG/LB.P*=:AXX<6;*1UY:7D/>3C6@MH#T=>;:PG= MY@221R$UVG(/I=>='PF8]\6^!^T(S_D=T%X+)W:7UZU;SC>+'AT/N:W]K6 M M^H??2E,EEBRK*J),573TH23\92U M,N&A"S3WC;:DZ)KKJK\%^(EC'::EQCYGP.+HI!<3LDC)Y0'LD:[<=0;S"2TT M!IO-:1)_##KV=9+A)DI;_1N;C@BN6AL\1M+62*4#U),.V>@?YOL(YPO3]^[ M8GV6B_S56_6P^/F0]77Q1=>[KSVY>G])GUO_ !_8_P!EX[X.GOW;$^RT7^:J MWZV#S(>KKXHNO=UY[9#U=?%%U M[NO/;D_29];_ ,?V/]EX[X.GOW;$^RT7^:JWZV#S(>KKXHNO=UY[.^#I[]VQ M/LM%_FJM^M@\R'JZ^*+KW=>>W)^DSZW_ (_L?[+QWP=/?NV)]EHO\U5OUL'F M0]77Q1=>[KSVY/TF?6_\?V/]EX[X.GOW;$^RT7^:JWZV#S(>KKXHNO=UY[32E3^QK\MB=) M[UI]3??H-)))9(-23PV4X(<-K36<6IFVMR+YMD+=P%U.&.A,CY*&/I-PN#CO M-<1O"E 0"0=BP?6>XSW_ ZGT8Z^LCC'Y)UVPFQM3(RX$,<6\V7HND#7,;NN M8';A!)+2X B0#'B^S//L_A3EVUV+CO2M\^OA MZ_%=ICY.A]/))P]\7_Q]S[E;Y]?#U^*[3'R=!Y).'OB M_P#C[GVY/.#XO^-_>ME\&3TK?/KX>OQ7:8^3H/))P]\7_P ?<^W)YP?%_P ; M^];+X,GI6^?7P]?BNTQ\G0>23A[XO_C[GVY/.#XO^-_>ME\&3TK?/KX>OQ7: M8^3H/))P]\7_ ,?<^W)YP?%_QO[ULO@R>E;Y]?#U^*[3'R=!Y).'OB_^/N?; MD\X/B_XW]ZV7P9/2M\^OAZ_%=ICY.@\DG#WQ?_'W/MR><'Q?\;^];+X,GI6^ M?7P]?BNTQ\G0>23A[XO_ (^Y]N3S@^+_ (W]ZV7P9/2M\^OAZ_%=ICY.@\DG M#WQ?_'W/MR><'Q?\;^];+X,GI6^?7P]?BNTQ\G0>23A[XO\ X^Y]N3S@^+_C M?WK9?!D]*WSZ^'K\5VF/DZ#R2<'Q?\ &_O6R^#)Z5OGU\/7 MXKM,?)T'DDX>^+_X^Y]N3S@^+_C?WK9?!D]*WSZ^'K\5VF/DZ#R2<'Q?\;^];+X,GI6^?7P]?BNTQ\G0>23A[XO_C[GVY/.#XO^-_>ME\&3 MTK?/KX>OQ7:8^3H/))P]\7_Q]S[^+_P"/N?;D\X/B_P"-_>ME\&3TK?/KX>OQ7:8^3H/))P]\7_Q]S[^+_ ./N?;D\X/B_XW]ZV7P9/2M\^OAZ M_%=ICY.@\DG#WQ?_ !]S[E;Y]?#U^*[3'R=!Y).'OB_ M^/N?;D\X/B_XW]ZV7P9/2M\^OAZ_%=ICY.@\DG#WQ?\ Q]S[^+_X^Y]N3S@^+_C?WK9?!D]*WSZ^'K\5VF/DZ M#R2E;Y]?#U^*[3'R=!Y).'OB_\ C[GVY/.# MXO\ C?WK9?!E-C@MXLVT9FWHV#\L\E>U+NACC M!B>3NO18:&;6 MLH"("("("("("("("("("("("("("("("("("("("("("("("("("("("("( M"("("("("("("("("("("("+\..-LMN.NK2VTTA3CBU'T2AM"34M:C/R$E*2 MZF/RYS6-+W&C0*D]@!?IC'2/#& E[B .F>4_K!91 1 1 1 1 1 1 1 1<_CM!)R"=9QPW+BMFTUUBXE-DTGHTX?1)3FTEY5$70DE(01>N(OX MQ>N(O5Z;MB,L+MO>]P0+D6K+JF58TSD$3JV2&[*.DSB/GY"67E4<9XR]5IQ7J'Y>PKRE]4CQ64Q MK+^*K:"X:.U/^8^@?V#^K7-X3,28J>CJFT>>V;V/VP]$?LC9V"(^/L.QGG8[ M[:FGF5J;=;6712%H/HI*B_A(R&@O8^-YC>"'@T(*E6.2.:,2Q$.C<*@CD(*\ M8_*_: B B B B B BD_2M]S35+73H;=;!0?DZ'U3&:)1F7U#,_5_X1)EFW?_:(_P R[+KO(.AJH92_(?;>KE*/ MU#\JWXI?\"O*XG_A[7\)$,CI^_H>\93LVEG^4M_SC]58?5F*J!DX1MV"3_(' M?_I/ZGHK+8VQ:(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@( M@(@(MG;PF.>/OET-?QCVQ;DK8.*5?=ZPOY[YF_FN)U492G,:EO/&9OY+BD%C MM,J[1KF5J#,T]Y%=<>JQQ?X?_%=P[5.(9_JZ9_L[ -D4CCZL4Y&2$[>9KSV' M@-O=U=^+?Q[:,T)J&3_7-O'_ #61QVSPL'\$2>66)HV<[XAR5C<77B""%:M M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1:%7(S\H3>_P#MEVA_7>\'0/37 MYN8_[R@^Y-7(S6OYY9?\9W7W>18:&;6LH"("("("("("("("("("("("("(" M("("("("("("("("("("("("("("("("("("("("("("("("("("("+%^Q+[ MN644<9?1V027IRDGY4QR/JTQU+RD;RB[2B\GK2(O44-9U!?;C!91GMG;7?4Y MA^KS^A]5;II/&=)(<+#HU!;^@(@(@(@(@(@(@(@( MO>K:Z5:S6(,1';>?5T(SZ]AM!>5;KAD1]EMM/E,__P!8^]O;RW4S8(A5[C^M MZ)] +S7EW#8V[KF8#T2I'4M/%HX#4&,77L^O?>,B)<_\N0;%$>1R$V2NG7,W/L YFMY@/\_9 M.U M2:M)_P 5)EZL5"B_\BS\OJ$773,SEN^";6V/L .T_9'TA^S^LI&T[@1:-%]> M#^=$=JT_6#LG]L?V!LY:K'0UY;:@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(IL< M!^&60G9KGF6G *R>I\8K9]96*9K(*Y$-B;>6UI;QX\9 MM;J20E;CZDK0PM)Z[JC4,6F\8;Y[.DF<\,8VM*N()VG;0 D[.P.4A;GH71] MQK7.#%QR=%;LC,DLE*[K 0-@J 7.+@ *]EVT-(4Z4<3_ < M0+9HNKK%PR6IV[L;CT@'+0^R/-:=AAH>4KH[G:]7A.2_:+7/.S8 M42J*]O\ V/=J<;FVQ6L)3429(;?)4QE'0U+3VM][^M6S1VD\D;+Z1N\(B]N^ M=A)W6UJX"AJ0*;#V%$_Q7?/MILA:PS2XJ%^ZZ=L;^B&T!N\ZFZPNWFT:X@]L M!SA<=@FM-C;2M9E#K' ,VV->5U3*O["FP3%;W+[6!107XL:;=3*['X%A,BU, M.3/8;=DK0EEM;R$J41K21_NZO+2R8);R6.&,N#07N:P%QJ0 7$ D@&@Y=A7S ML<=D,G*8,;!-<3-87%L3'2.#00"XAH)#02 2=@)'97GJM5[/O,,F;&I-<9Y< M:]KL@C8G89Y58AD-AAD'*9IUB8>-3,HB5SU)%R"6=U#)J&M],EPY;/90?>H[ M7\?>V45P+22:)MV6;P87M#RT5JX-)J6BAVTIL/8*_L6,R4]F!NAQWFT:34[PV;0O=S73.X-;5U9;[%U3LG :FZ_P#F/:9K@N48 MM76WE>3_ -63;RK@QI_ECN%_)*7Y4*_@/I^+?(6%X]T=I/#*]O*&/:XCZH:3 M3]5?2\P^6QT;9P.^H7- /(>3L+I%/37&16D&CQ^ILKVZLY" M(E;44\&59VEA*F22.)ADE<&QM%220 !Z) M.P+Q0PS7$K88&.?,XT#6@EQ/8 %23]1=ZV#I7Y.EB?'7ZF^T5_474\6Q+*\XNXF-85C&0YAD=@:DP*#%J6R MR"[FJ07528E54QI6VM+J]F M%M9QR37#N1K&ESC]1K02?UEVC86F]O:C?AQMK:JV1K&38DI5?'V%@V3X6_.2 M@B4M4-K)*NM(ER!OM. M2=DU;5Y@NB]8TK-SMRQIUH9?*5:NSJG((M))-B0WWC;M<<6(M:6WY27^L=,? MS:MRF2OI+#2=JVX$+MU\TAI$#V!0M)'U'5/*&TVJ7K;A]@L)BX[5>U9>'1QSY&:XS/8'AS<@+F\M+)@DO)8XHW M.#07N:T%QJ0 7$ D@$@U8Q9=3Q^WTK"??,3I';JM<%&5-]\!.MLR/"?,T-& M\J7]M94OL%YLEDC6;GG'9))=>O0>#XUQG?/>??,'?E:;G2,WZ]C=KO5_466^ M(U+GEME$>3EE_1-R4L8G! M@Y5;'45K$_"JZ+,F5N#WV/9)#L.XZ6.SGKB%):?CDW@-2YF M[QDD4<)$<3OKB6BIH\D O:YI#-T;S!223I&B-S2#7;=$Z;QV;AGEN099V5[0 M![MT Q@$B-S'@R=([TL> 6$4(/(0L\X?E:+M@HL1E&WK.BEH+EH_=#LCT>R/U>3DC#/X- MV-EZ> $V3S^X/V)]#L']0[>7NXS2UQ8\SC%O9)E5K :ZV$='5]I!>NF1T%]1 M)?QI#*2];]52?6^4R20U_-8SOEG?4 _G#1M'V0],<'E"DGC]P MU>5<>I(NI^L5U)2?_147U1(UA=MO;9LP]5R.'8<. M7TQZ!"B#*X]^-O76SO48^B"N;'M6.0$0$0$0$0$0$0$0$0$0$0 M$0$0$0$0$0$0$0$0$0$0$0$0$0$7,X[D5YB-_393C-K-H\BQZSA7-)<5SRH\ MZLM*Z0W*A38KR?*V]'D-)4D_4ZEY>I#X7-M!>6[[2Z8V2VD86N:X5#FN%"". MP0O397MWCKR*_L)'17L,C7L>TTR"*KS<98Z,MJFN-J1#RVDCFI2OM=R7S=Q:$=35#DH=CJ-24-NO4GXA:(N-&9 M4'W)JY&:U_/++_ (SNON\BPT,VM90$ M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$ M0$0$0$0$0$0$0$0$0$7H6=@Q50)4^0?\G&:-?9Z]#<6?1+32?_2=<422_P"$ MQ\+FX9:P.GD]2T?K]@?JG8O396LE[=,M8O5O=3Z@YS^H*E1FG3'["9(FR5=I M^2ZIUP_J$:O42DOJ(0DB21?4(A&T\S[B5TTFU[C4_P#+T.0*8[:WCM+=EM"* M1L;0>G]4\I]%>J/DON@(@(@(@(@(@(@(OZE*EJ2E*34I1DE*4D9J4HSZ$E)% MU,S,S\A#^@$F@VDH2&@N<: *0.'XVFBA=Z^DCLIB$JDJ\AFPW_&1%0?U"1ZJ MS+^,O^$B(;[B,<+&'?>/YR\;?0'V/I]D_4"BO/YAV3N=R(_S.,]KZ)YW'ZO- MV!Z)*[@,NL L3YUE?9[RCK7?+Y46,AM1ET_AAMJ(_5,O^=/_ .U_\XAJNJ.Q4[* C;M&ZER^DLH[-8N/I6,CW9FD$L,;G-V.&7XIN:6^$XKJO8'$'E!E%=>93!=Q6/R2CH-^3)9158TX^TT9MR#<,T#1KR?6.BK=MS//%?X5A#3O#=D:#L&WU M0Y@#O24)VBFU2GCK7AOQ.O'V=K:SXG4LK7/&X0Z)Q WG4'J33:2-R$D#8ZNQ M8/\ #06WB'('E%X;VZ;",QC&_J/9>DK7NG._A5>X];.Y#65EQ4OND333YQXE MF4975LY,UJ"GJ:DMI/):PK/BK+5V.!,UJZ.8=DQ2;I(/Z[:]@%WHK"\."+3/ M9/AYF' 6U^R:V=V&W$.\T.:>S0/IR5<&<] O>T]BV0\"N G,O:68P_M>W;NS M8EIPVUZVMUQJ?#K<7E6]9MBYJD/-,R&X2UM6K*)/=DZU.IXQEW/;2I?YOYXM M3ZHQ]E;G?QUM$+N3L$N ,0/-7U)IR$//+S?O$6MQH;0F8R=V.CS-[<.Q\79 M87-GC3>X>9/"7Q*-=4F0 MUV-[!R6*DYL&OBJF1H>0XE7RHO>=7(AMN-H5W:TH;^>>PUAI_4>'N\.SH'37 M0C>&DT+2YC3L)-*M^<@BXSA>H M\=]CL'GVUV=Y,I\@BU5CDAYRY'A&[$6U*L8D5ISM-DMM?[UO=B;45CA[N*YG MQ?1F5\4+2Y\KJO % 6DANY4[:AI<1MVKY<+\<;?1N4U%CI[*USIF%O'<7+PR M.!E(RYV\6N#2_I"&U;1SVM!J*@YKP21?SM&\H-39UJ/);#74> MEY+8YG>QL-W'3,.SL3M,81D>.XL\J.MY:G4-(F/*;F1(S3$?NY$DSQUR(FY* MROM-XG)6=W%.T25MW,C?$=C@[=<[ZE:#822:@+-6+IWX7)8K6FH,+D,EECN&BK',WV,V!6;PWIO]_6&8 M[08K8MADN!X9!CY&J'!KY4EB2S7LDYB;9,]X@THDWIO%_+)CJ;S.1MHL_KP8 MG*$G&VUKTC(ZD->\[M2>2OJMOH,IR5KK6&O9](\*#J#!!K'9OS:W.'".6'%SE9D<[<.LF= 95L^DS3/DHN;[7&9 MT%A5UE1.KLED->>-O).\78Q>_=<5'75*)KHTM]"_/JS%V.F[FQS6#8+>\[Z; M&6,V-D8X$D%O)];NF@V[VW: O9P_SN4UK9973.J)'7>-%@^9LDO;.BD:6M:0 M\[:]L7MJ33<--A<#CW@+R2TU\T'(N*SG*"[X,;NG;==S^OW;5T!OTF>U#U3' M@P\;R;)X;D"121HCK9I?[^=6);;C1E-27D.2HBO7JC$9#X^9FQ9-R6-$&X82 M[:PUJ7-::UKS4:[E-0"&N6/T+J+$?-.32YR3\)FG7?2BX#:ME;N@!CWBA:!S MUL.9%$7+D/IDK>CO1>Q+DLI:469T;-* 5<-]N\34D M%M'.: 5 G44_&ZK:^L+3,D-NXA6[#PJ?E3;I$IIS&X>25LB\0ZD_(IM=8VZ2 MB^J0VB_;,^QF9;_]H,3PW_G%IW?V:+1L3);Q92VENZ=Z-N(R_P#Y@>"[]BJM M&\<>@SZ'SFO,KR7SF7@N::_U]-U#;),Y%._B57C4"ONZ^LG-I.(MR-G)6DMU ME"U+0B>TZHB0^V:M+X;2VKM--@AH+F.5XE'/O%Q()'+ZC= /[4CF*DSC5!?, MUL^ZN*FRFMXC [E:6!@#@#R;)-]Q'[8'D<%UKP5<9V+<\]M;WN%,SF\>Q"CS M>TV=:-(<]B8.&3L0NJEN+<.DA3'2TR.9!;BMK\IR20XGIW2E)^O$2:TCTQ-% M6A MH[-#S5$Q/"EOL-G^)KSGRC$XL2RU[-UAR:OL:A,*:.#/PV1R UU84T5E9)=9 M.)*I%MH29$I/85ZAD,!K>*X;H[&PSDB[$UNUQYP_H) 3]4%;=POGLW\2,WPOYFOQ=TY[# &- M$;&B-Y8(P&U:&4 Y3O-V.J=HPOQ"XY:KS;QB,]U%?4-=)UGK/>7(NPIL+F,, M/U5C$UEDV6LX?0RHKJ>XE5U=)B17W6%(4V^S$4TM)MK4,AGLO>VV@(K^)Q%Y M-;0 O'*#(UN^X'F)J0#S$UY5A])Z>QE[Q;GQ,[&G&VU[=EL9 +2(7OZ-I'(0 M"&DBE"&T(H584K87+ZLY5N;4O?%#\/*)KN!L-QNXT&[REAPL7AZZC7*H<_!5 MXG*U^B%%R&+CJ%QO/75>?HGI[U;YK(S&J]Z8%^$[QBPN5-V8MD_>Q+C)2H?O M!]2TNVT':[NRBWXW^K(M4?&<^IL ,>VX[:U[] 8(@ZABW#%0/#-F\>V#MI=5 M4/>(32:AH.9>]X>AKS#,BU1-R:KR/%;/7EO37F$__/=BF/Y7>UN.6&/2IE(= M=1Y)TU!7SFABN(G0S .B<*$'L?\OUE( M;&,C8R"$2_6MSF"2F9'(_45ZA/-D?E-EWIU+U>R?4C]3J<@8S(,OX=[8)V^J M'^<>@?V.111F<3)BKG=VFV=M8[_,?1'[/*NS#)+#K"F>8SYB\=Q";Z0Y+G^M MMH+HF-(6?D<(B_BLR%'_ .1*_)]4B&F9S&] _ON$>Q./;#L$\_U#_E^JI%TQ MF>^8_B^Y/\X8.U)^N:.;ZK?V1]0K' UU;<@(@(@(@(O:@-]].A,_^MEQV_5Z M?QWD)]7ZGJCZP-WYV,[+P/UROA=/Z.VDD^QC.=]A"-+UV_>2N[,CO\I4S8UG1XZ!G8A9^]"XL>5>U= MUP>]]B;5,9]?2%8FAAWJ?K6G^IE'?\ID22)2NRH__-5U^H,SA+WO6ZZ-Y]AD MV'T#S'_,?0/H+7=28SOZR,T8_G,-2/1;].'(+.N,>V<;VS@4@CGT M[IQKBED/.M5>58W+6W[+XU;DV2C.'8--D:%]E2H\A#;Z"[QI(P&IM.V&JI>WT1V/K@2T["5MFB=8Y;0FHH-18@^S1&CV$D-EB--^)] M.9P&P[2UP:\;6A;M&BMVX)R'U=BVV-=6/GN/9+"2XY%?-I-I06[))1:XW>QF MG'4P[FFE]6GD$I3:R)+K2G&7&W%T9S^"R&F\K+B,DW=N8G38ST&@[3^J?V!Z*QD-:6Y("("("("("("("("+ M*6O\;[U97LUO^3;4I-/W([/U M>Q^OS+9-.X;XQF[XG'\SC.W]L[['ZGV7ZW.L"F9J,U*,S,S,S,SZF9GY3,S/ MRF9F-&))-3RJ3P !0;";21V2:=. M.YWG1]EY)$DL!G].66H86,N721SQ$F-['4+":5-.0\@Y14NE.4M!5:_PI4%M+Y]ZB,N<]"4M#9/,O-H[M6KG05U=N;% MF;RNG\79G&921L<,ENX M!@!),8&Z0T $5VT:#RD&G(::=I? :OSV1;F\#"^:YAO(W&4D -E+ND#G$D$@ M$;SR*T!%:;S:S=\=#D/%V-R,QK1F-3JUS&-"44TLCCT1MIJG=O9]*;OL[=ZQ MC)J5(KXK4!ATW2-]BP.:E9DXMTCUOAKB76F)?DI@[IKIPW=[EZ)@W6?4J=XB MFPMW:;*+<^-F?;D-0QX2V3E(&Z#7:';]=I*@KB7,/[5 MN"6T.%'O=>?>^3N2OVU[Y?VW>:^POF,77<;[7_M-^UB1[(][]H/:\[]E6.SY MWT[D^ZZN;-/@.GU-#J+I:=#;F+H]VM:F3MM_>V>KY-T\G+MV:1:ZM[VT1X:_P7JM\>JY-FUQ5YA_-EUGRPUW[W7V[?.@TW::E M]F/MN^UO[1_9*@S*C^V#V/\ M8O_ +9NY^VWO?-._K^UYOV>^+O.TAF\!\5P):;N]OT;N^II6CN7DV)I?5OS;QV4Q_>_3?&=FZ#>Z3OQ%YL9WQ/)IYEYE?9>9<4W'6S_ '/:=MLX(I2^2#(0.K'+ M'L458\;:$?8N%:5H01R@T: M1DG='-30F5ZUR_7&AN!NEM"_;ZB)'R7-;/(+3;^<0X42='LB9PF[OZ/'BPMU MV9#9[2X[;B2;)24H2M27$>/':=RD%Y'=Y/)W%UT5=U@:(F$D4[<-<[?V$\O_ M *%D>8<9L M3S?4&2Z^PW?/'?9XY;,L35X_=/(K8I..JC2VE>: MLN);0^TV\C[YW3%OF)X[^&62URT(HR:/EIM[5PV;PVG94;2NN;O3E MI-B;FWAOM/W)K);R^IWMG;,<*[CMC:FCAVH- X C+.RO$IK&=-YIHGB3QEP/ MB)@^T(ZX.T+3'2W]S":QAS0QC#R[VX"ZI! -:C: 2#04RN1XBQC$3832 MN-@Q-E-Y.O(+?66R8SE_-183HMMFU159%,N*]$I!$TSW3"4-$EL^I)(>O*: M>R-U?.O\9D;BTE>T!S=T21]J* AA+0#3E-3MVK'X+6&'L,6S$YS#6F0@B].FU MF*TTM%6B>[*M; VW;6UG-4D-IQ]+$5!LQ&B-LW"<<<]. T_%@FS2=*^>^N7[ M\LCZ N(K2@'(!4FE3M)VTH!X=6ZON-5/MHA!%:XNSBZ."&.I:QIW:UYFL,@_:\Q[ M6//9M(- X"H,?N M"G,/YE6S,_V)[W7OE_;SIO*M2^P_VW?:;[%_;-?XA>?;![(?:QE7GOF7VJ]U MYIW#/>=_VN^1V.RO*ZEP'SBLXK3I>AZ*X;+7=WZ[K7-W:;S:5WJUJ>3DVK : M)U;\SLC/D.]^^>GLWP;O2='N[[HW;U=Q]:;E-V@K6M13;C#B=OSYKW(;66^O MM4^WCWNK6RL_M4]G?M9]F/9''KBA[CV=]AL@]C^Y]EN][7F;_:[OL]"[7:+V M9S%_'6*FQF_T?3- WMW>I1P=ZFK:\E.4+&Z6SOS:S]MG.BZ?O=Y=N;VYO5:Y MM-[==3U5?4GDHO?G74W& M9LQV!6LY#5JK+YZMEFN+'1.BK<)339.&@ORW"VK\&S WGLMLVW9$XTW=[<:T M!P%3NFK0X;3NFFTT7T?J:^CU5+JO&_S>]?>2SM%=[=Z1[G%A-!OMHXL=VHWF MD[!6BG7>^)GH#*;U[:N2^&UQ^NN0D/KZFX\I:NV6LQ:.RD$0L8,&[0FNTU>2>$I_NXT='K664I277IU&]0Q M""%D(+G!C0*N-7&@I5Q/*3SGG*BRYG-UB/V>3D4CZJSBW$%F?$5U;=+UR#,NVRZ73O&7"+U%H,_ M_KET,O(9"1+6YBNX!/$>U/[!YP?1"B.^LIK"Y=;3CMV\_,1S$>@?_0O;D1V9 M;#L:0VEUA]M33K:BZI6A9=#+^$C_ (#+RD?E(?62-DK#'(*L<*$+X12R02MF MB);(TU!',0NC.ZXH'.O=NV+!]/)V)#*D]>GDZD['<,RZ_P#"0PCM.V#O4F1O MU"/\X*V1FKLHWU38G#T6G_,X+C7=81#Z]Q;2&_5Z=[&;>_@Z=>PZQUZ#S/TU M$?42N'U0#_G"]C-9SC^$@8?J.(_RARXUW6,TNO<6L5S^#O8[K/7R_5["W^GD M_P#+Y?\ [(\[M-3#U$K3]4$?YRO8S6=N?X6!X^HX'_*&KC7=0QN^H3_G 7K9J[%.]4)6_5:/\SBN-=PC)VO*=8:R M_A:DQ'/J=?XJ7^W_ /H'G=AQ&2) MX8)&DFAIL(.T\B_&1RV.EQLXAGB,AB< -X5)((V#EJI!#?E%:BD^YWS[SO\ MZUUQSU.G\=9J]0O(7JB+7NWWE_9)/ZZG")G1QM9]BT#]8+Q#\+]H"*0V&W7L MS3M&ZOM3(?2+*ZGZY9I3_(OG]7^6;+RG]59*$@8B\[\M 7GV9G:N_P Q_5'[ M-5%&H,=\7Y!P8*6\G;-]"O*/U#^P0NV#*K!H"("("("("("("("("("("("( M"("("("("("("("("("("("("*Q/PZ^;=CQ'VB4#)I,R9I3/Y<2%G]4TEZ4N MAE%_J\#.JB(WVEG.IR629C325+F0"4@DK>;C]B-N).A8]8XKI+4-;G+<$PNY M-\P[ZTG8U]#4 NK-'!;BG-PYS_0WSG.TM>.#;A@J>C/(V=@^R9]> *O MCJ*%S64W&*JTK+RLK;NEL(5M3W$"':5-K6R69M=9UEA';EP+"!,CK^/FOL@(@(@(@(@(@(@(@(@( M@(@(@(@(@(@(M"KD9^4)O?\ VR[0_KO>#H'IK\W,?]Y0?A]PT9MH,^G>OJ]8RU_#Z M]Q1$?3U"ZG]0>:\N6VEL^X=]:-@[)YA^J5[,?9OO[QEJSZX[3V -I/Z@_9V* M,K[[LE]Z0^LW'GW5O.K/U5N.*-:U'_Y5&(V>]TCS(\U>XDD^B5,D4;(8VQ1B MD;0 !V -@7B'X7[0$0$0$0$0$0$0$7/8Y2.WUFU$3VDQT?RTQXO_ +E'29=H MB/U.\=,^RG_A/KZA&/?CK)U]P/3/(%C,ODF8RS=.=LIV,'9PRU&9:CL-I:99;0TTV@NB4-H224I+_ ("(A(;&-C8(V"C * =@ M!1%)(^:1TLI+I'$DD\Y/*N,O+B/1U[TY_P!O13\A1'W;9?P%Y.JC^ MHDC/_@'FO;N.RMS._EYAV3S#T_07LQN/ER5TVVBV#E7LH0DB2DO4))$0CN::2XE=-*:R.-3_R[ YE+UM; MQ6D#;> 4B8*#TSZ)Y2>%SG.<7.)+B:DGE)7B']7Y0$0$0$0$0$0$0$0$0$0$0 M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$7;<1R-=#/[+RC M.NEJ2B6CRGW2O41*01=?7-]?7=/XR?\ A(NF6Q.0-C/1Y_F[_5>AV'?J<_9' MZBP6>Q#;L']52#2I*TI6A1*0M)*2I)D:5)475*DF7 MD,C(_(-^!#@'#:"HJ5^F,RSDB#AZ#F_P"<@KDVLHQY[IV+B"77I_SKZ6/5+KY>_P"[ MZ#T-R>/?R3,_5-/\M%XWX7+1^JMY?U!O?Y*KD6K&O?Z=Q/AO=?4[J4PYU\G7 MR=A9_4\H]+;BW?ZA[#]1P/\ G7D?:747\)%(WZK2/\H7NCZKSKT+24U!KILI MY:4(9C/+[2CZ$:NP9(07E(S4M9DDB+RF9]"'QN96PV[Y7FC6M/\ D7ILH'W- MW'!&"7.>!L^KM/Z@VE1<$8J:D!$!%VK#KGV'N6%.*Z1)G2)*ZGZU*7%%W3Q_ M4+N7>AF?J]GM%]493$7G>EXTN/L3^U=^KR']0_L56$U!C_C#'N#![/'VS?U. M4?JC]FBD0)!43H"("("("("("("("("("("("("("("("("("("("("("("( M"("("*_'PCN>!8S/J^*6VKDD8]<3%-::R.Q?)**6[G/./.Z_G27UDA-;>RG3 M75&9D;4Y:HQ=HI#*6:]\8M =]1OU=AV?SEC?YRQH]4T"G3 #ZY@V2=EHWMFZ MZMO.KGQ;%C-'P^U%+2SE=2RD_^V7:']=[P= ]-?FYC_O*#[DU M18:&;6LH"("("("+9MT)X1/%796B]+[&R*QVRC(,_P!3 M:YS6]16Y?2QJY%QE6'T][9I@1G<2DNQX29L]9-(4XXI".A&I1EU.K>H.,>K< M7GK[&VS;,V]O>31-WHW%V['(YC:D2"IH!4T&WF5Z](=7+A]G-)XO-7K\B+R\ MQUM/)NS,#=^6%DCMT&$D-WG&@)-!SE98]"IP\^RFYOOUH?<8,1Y<=9_86/X:_;,GW>/VE/0J7'6?V%CW)_MJ>:]PU^V9/N\?M*>A4X>?93Y/]M3 MS7N&OVS)]WC]I3T*G#S[*;F^_6A]Q@>7'6?V%CW)_MJ>:]PU^V9/N\?M*>A4 MX>?93Y/]M3S7N&OVS)]WC]I3T*G#S[*;F^_6A]Q@>7' M6?V%CW)_MJ>:]PU^V9/N\?M*>A4X>?93Y/]M3S7N&OV MS)]WC]I3T*G#S[*;F^_6A]Q@>7'6?V%CW)_MJ>:]PU^V9/N\?M*>A4X>?93< MWWZT/N,#RXZS^PL>Y/\ ;4\U[AK]LR?=X_:4]"IP\^RFYOOUH?<8'EQUG]A8 M]R?[:GFO<-?MF3[O'[2GH5.'GV4W-]^M#[C \N.L_L+'N3_;4\U[AK]LR?=X M_:4]"IP\^RFYOOUH?<8'EQUG]A8]R?[:GFO<-?MF3[O'[2GH5.'GV4W-]^M# M[C \N.L_L+'N3_;4\U[AK]LR?=X_:4]"IP\^RFYOOUH?<8'EQUG]A8]R?[:G MFO<-?MF3[O'[2GH5.'GV4W-]^M#[C \N.L_L+'N3_;4\U[AK]LR?=X_:4]"I MP\^RFYOOUH?<8'EQUG]A8]R?[:GFO<-?MF3[O'[2GH5.'GV4W-]^M#[C \N. ML_L+'N3_ &U/->X:_;,GW>/VE/0JX:_;,GW>/VE/0JX:_;,GW>/VE/0JX:_;,GW>/VE/0J7'6?V%CW)_MJ>:]PU^V9/N\?M*>A M4X>?93Y/]M3S7N&OVS)]WC]I3T*G#S[*;F^_6A]Q@>7 M'6?V%CW)_MJ>:]PU^V9/N\?M*>A4X>?93Y/]M3S7N&O MVS)]WC]I3T*G#S[*;F^_6A]Q@>7'6?V%CW)_MJ>:]PU^V9/N\?M*>A4X>?93 MY/]M3S7N&OVS)]WC]I3T*G#S[*;F^_6A]Q@>7'6?V%C MW)_MJ>:]PU^V9/N\?M*I:\0KB5QMU!M.MU%JN;G\QW':>-:YS+O.W#H(!1EU](M$ATU]LU^?((NSV#[5../O7EXE:3U1'I/2\>(>ZWA#[ METL$CZ2R .CC ;<-H61T>:UKT@&S=V]#.JM_AA<%]>:*FUWK6;4$;+NX='9M MANH8ZPPDMEE<76C]X/F!C;2E.A<=N\*5^^\#@W_KK[^<(WU@(&\__CI]IP/N M2;X4K2?HG^J_X1JKW?;_ %/>!P;_P!=??SA&^L \_\ XZ?:<#[DF^%)^B?Z MK_A&JO=]O\!3W@<&_P#77W\X1OK //\ ^.GVG ^Y)OA2?HG^J_X1JKW?;_ 4 M]X'!O_77W\X1OK //_XZ?:<#[DF^%)^B?ZK_ (1JKW?;_ 4]X'!O_77W\X1O MK //_P".GVG ^Y)OA2?HG^J_X1JKW?;_ %/>!P;_P!=??SA&^L \_\ XZ?: M<#[DF^%)^B?ZK_A&JO=]O\!3W@<&_P#77W\X1OK //\ ^.GVG ^Y)OA2?HG^ MJ_X1JKW?;_ 4]X'!O_77W\X1OK //_XZ?:<#[DF^%)^B?ZK_ (1JKW?;_ 5Y MH_'K#9;[,6*6229,EYN/'CQY;+S\A]Y:6V6666ZY3CKSKBB2E*2,U&9$1=1^ MH^OWQWE>(HK?!.D<0 !:3$DG8 +JI).P :C5^,/[4M-H%LBXKF+;+8U)E-)!KJF;- M3W[- PT[BTUQ:Z2,XEAYSO5I=DI=6@R0I)%T-T)QDXH6FF;9^J&8SYQ31A\X MC@>UC'.VB( S./L8(:X[Q!>'$=J0!R5XH=6_@??ZSO(M%/S7S1MY716SIKF- M\DK&=J9W$6[ !,X%[&[H+8RQKJN!)S/Z%3AY]E-S??K0^XP;CY<=9_86/X:_;,GW>/VE<#<>!CPKO5LKL+7=ZBCI4EIMK/*-MI)K/JM?8+"S(UK MZ$1G_ 1#P7G=\09V6AW1L 8\#[IRK*8_JZZ QC7-M7Y %QVDRQD[.05Z' MD'^5+4?VNT_5+4?VNT_5+4?VNT_I]3/S2<2M4/>7-?"QIYA&*#]T7'T=I M/ZR]D7!+0L<88^.YD1;0?VB?NS_ $T]!1P*^Q&UOC'D>U0>4C5/VV+N;?23R+:# M^T3]V?Z:>@HX%?8C:WQCR/:H/*1JG[;%W-OI)Y%M!_:)^[/]-/04<"OL1M;X MQY'M4'E(U3]MB[FWTD\BV@_M$_=G^FGH*.!7V(VM\8\CVJ#RD:I^VQ=S;Z2> M1;0?VB?NS_33T%' K[$;6^,>1[5!Y2-4_;8NYM])/(MH/[1/W9_IIZ"C@5]B M-K?&/(]J@\I&J?ML7U0>4C5/VV+N; M?23R+:#^T3]V?Z:>@HX%?8C:WQCR/:H/*1JG[;%W-OI)Y%M!_:)^[/\ 33T% M' K[$;6^,>1[5!Y2-4_;8NYM])/(MH/[1/W9_IIZ"C@5]B-K?&/(]J@\I&J? MML7U0>4C5/VV+N;?23R+:#^T3]V?Z M:>@HX%?8C:WQCR/:H/*1JG[;%W-OI)Y%M!_:)^[/]-/04<"OL1M;XQY'M4'E M(U3]MB[FWTD\BV@_M$_=G^FGH*.!7V(VM\8\CVJ#RD:I^VQ=S;Z2>1;0?VB? MNS_33T%' K[$;6^,>1[5!Y2-4_;8NYM])/(MH/[1/W9_IIZ"C@5]B-K?&/(] MJ@\I&J?ML71;0?VB?NS_33T%' K[$;6 M^,>1[5!Y2-4_;8NYM])/(MH/[1/W9_IIZ"C@5]B-K?&/(]J@\I&J?ML7U0>4C5/VV+N;?23R+:#^T3]V?Z:>@HX%? M8C:WQCR/:H/*1JG[;%W-OI)Y%M!_:)^[/]-/04<"OL1M;XQY'M4'E(U3]MB[ MFWTD\BV@_M$_=G^FGH*.!7V(VM\8\CVJ#RD:I^VQ=S;Z2>1;0?VB?NS_ $T] M!1P*^Q&UOC'D>U0>4C5/VV+N;?23R+:#^T3]V?Z:>@HX%?8C:WQCR/:H/*1J MG[;%W-OI)Y%M!_:)^[/]-/04<"OL1M;XQY'M4'E(U3]MB[FWTD\BV@_M$_=G M^FGH*.!7V(VM\8\CVJ#RD:I^VQ=S;Z2>1;0?VB?NS_33T%' K[$;6^,>1[5! MY2-4_;8NYM])/(MH/[1/W9_IIZ"C@5]B-K?&/(]J@\I&J?ML7U0>4C5/VV+N;?23R+:#^T3]V?Z:>@HX%?8C:WQCR M/:H/*1JG[;%W-OI)Y%M!_:)^[/\ 33T%' K[$;6^,>1[5!Y2-4_;8NYM])/( MMH/[1/W9_IIZ"C@5]B-K?&/(]J@\I&J?ML7U0>4C5/VV+N;?23R+:#^T3]V?Z:>@HX%?8C:WQCR/:H/*1JG[;%W-O MI)Y%M!_:)^[/]-/04<"OL1M;XQY'M4'E(U3]MB[FWTD\BV@_M$_=G^FGH*.! M7V(VM\8\CVJ#RD:I^VQ=S;Z2>1;0?VB?NS_33T%' K[$;6^,>1[5!Y2-4_;8 MNYM])/(MH/[1/W9_IIZ"C@5]B-K?&/(]J@\I&J?ML71;0?VB?NS_33T%' K[$;6^,>1[5!Y2-4_;8NYM])/(MH/[1/W M9_IIZ"C@5]B-K?&/(]J@\I&J?ML7U M0>4C5/VV+N;?23R+:#^T3]V?Z:>@HX%?8C:WQCR/:H/*1JG[;%W-OI)Y%M!_ M:)^[/]-/04<"OL1M;XQY'M4'E(U3]MB[FWTD\BV@_M$_=G^FNX5O@O\ "6KA M,06*C9;K,B2Z>0NA#+6_&+6UM"V!DL!8WD MK$TG_EV%@+SJY<,KVX=]#?PJ^PFQ/O\ YWUH M/OY:=;S:.%WVJ]]T.])55>(WX4VI=$P<=VSJFORMW!;!]-!FT* MPO7[-^AOWE*537)2O-D*35WC7:C.=LB2S+:;(E*.2245?ZPO6#XY:'@M]5:6 MFL#A)'=%<-?:->8I3_!R;U?42#M#78U[6[29 !=GJE]4;JP\2[F[T-K:VRK= M2Q-,]H]E^^-LT(_A8MW=/LD)I(VE2^)S]@$)+JE?>)P#_H]I_.3G_(%5//OX M_P#A&+]QL]JAX)G/[1D]8GO$X!_T>T_G)S_D!Y]_'_P (Q?N-GKD_ M1:]5#P3.?VC)ZQ/>)P#_ */:?SDY_P @//OX_P#A&+]QL]"9S^T9 M/6+S-:1PACRLE=,G_"U;OM_P?^8DOX!^V]?/K!L]1=8P?4LVC_\ 4OF__"PZ MI>4MOW@_KB->G[Q. ?]'M M/YR<_P"0/CY]_'_PC%^XV>N7H_1:]5#P3.?VC)ZQ/>)P#_H]I_.3G_(#S[^/ M_A&+]QL]"9S^T9/6+RM:-U\WU[4">]UZ="=M)1=GI_!W*FC\O_#U M'FN>O/UA)P!%?X^&G+N64!K]7I&R-K7W#9^TKW_ *,SJ@>( M+[^U,A\(6P'P-X,\'^2>B*R_R' +E_86)SY.*9XB/L'-H:7I\;I)J+EJ(U>D MAMBZHWV5J4A*&O.T2$((B;Z%?/@;UIN(/$70\5_?WD#L_:R&"YI!"VKAMCD# M0W8)(RTD@ =() !1JY;]9KJ+<(N$7$R;%XK&W+=*WT3;FR+KNY=1CNUEB+C) M4NBF#P 27=$8G.)+E-/T17!CX-,B^,C._;T3'Y8]>^%1=QB]8J\^;EPG\!F] MTS^V)Z(K@Q\&F1?&1G?MZ'ECU[X5%W&+UB>;EPG\!F]TS^V)Z(K@Q\&F1?&1 MG?MZ'ECU[X5%W&+UB>;EPG\!F]TS^V)Z(K@Q\&F1?&1G?MZ'ECU[X5%W&+UB M>;EPG\!F]TS^V)Z(K@Q\&F1?&1G?MZ'ECU[X5%W&+UB>;EPG\!F]TS^V)Z(K M@Q\&F1?&1G?MZ'ECU[X5%W&+UB>;EPG\!F]TS^V)Z(K@Q\&F1?&1G?MZ'ECU M[X5%W&+UB>;EPG\!F]TS^V)Z(K@Q\&F1?&1G?MZ'ECU[X5%W&+UB>;EPG\!F M]TS^V)Z(K@Q\&F1?&1G?MZ'ECU[X5%W&+UB>;EPG\!F]TS^V)Z(K@Q\&F1?& M1G?MZ'ECU[X5%W&+UB>;EPG\!F]TS^V)Z(K@Q\&F1?&1G?MZ'ECU[X5%W&+U MB>;EPG\!F]TS^V)Z(K@Q\&F1?&1G?MZ'ECU[X5%W&+UB>;EPG\!F]TS^V)Z( MK@Q\&F1?&1G?MZ'ECU[X5%W&+UB>;EPG\!F]TS^V)Z(K@Q\&F1?&1G?MZ'EC MU[X5%W&+UB>;EPG\!F]TS^V)Z(K@Q\&F1?&1G?MZ'ECU[X5%W&+UB>;EPG\! MF]TS^V)Z(K@Q\&F1?&1G?MZ'ECU[X5%W&+UB>;EPG\!F]TS^V)Z(K@Q\&F1? M&1G?MZ'ECU[X5%W&+UB>;EPG\!F]TS^V)Z(K@Q\&F1?&1G?MZ'ECU[X5%W&+ MUB>;EPG\!F]TS^V)Z(K@Q\&F1?&1G?MZ'ECU[X5%W&+UB>;EPG\!F]TS^V*( MO-'PB-8UVGK',.*^-WE;G^%^ M<0D,&7GG1R/W:W7&#;W'1'&/*R9IMEJR6-V.GHT2!C6=$^O:N=N@ L=ZEQ/J M=CJ@!U8YXG]7'!0Z:?DN'\$L>8M:R.A,CY>GC [9K ]SB)6TWF!OJ^V90N

$1JPB B B B B MB B B B B B B B B BT*N1GY0F]_P#;+M#^N]X.@>FOS-*_V;8T*"ZR_._*_C*Y^[/7 M6;AQ_=Y@?Q+9?T:)5)>)9X^.HO#4Y$PN.V<:!V/LRZFZXQG8ZYBBC$KF;KFN M)JT--:C_ )R\FI=>VFFLB,=/;R2O,;7U:YH%'$BFWZBKZ_>]N.7T/]V??U@G M^@&S>1+*>'6_[AZU_P KV.\#G_=-3][VXY?0_P!V??U@G^@#R)93PZW_ '#T M\KV.\#G_ '34_>]N.7T/]V??U@G^@#R)93PZW_]N.7T/\ =GW]8)_H \B64\.M_P!P]/*]CO Y_P!TU/WO M;CE]#_=GW]8)_H \B64\.M_W#T\KV.\#G_=-3][VXY?0_P!V??U@G^@#R)93 MPZW_ '#T\KV.\#G_ '34_>]N.7T/]V??U@G^@#R)93PZW_]N.7T/\ =GW]8)_H \B64\.M_P!P]/*]CO Y M_P!TU/WO;CE]#_=GW]8)_H \B64\.M_W#T\KV.\#G_=-3][VXY?0_P!V??U@ MG^@#R)93PZW_ '#T\KV.\#G_ '34_>]N.7T/]V??U@G^@#R)93PZW_]N.7T/\ =GW]8)_H \B64\.M_P!P M]/*]CO Y_P!TU/WO;CE]#_=GW]8)_H \B64\.M_W#T\KV.\#G_=-3][VXY?0 M_P!V??U@G^@#R)93PZW_ '#T\KV.\#G_ '34_>]N.7T/]V??U@G^@#R)93PZ MW_]N.7T/\ =GW]8)_H \B6 M4\.M_P!P]/*]CO Y_P!TU/WO;CE]#_=GW]8)_H \B64\.M_W#T\KV.\#G_=- M3][VXY?0_P!V??U@G^@#R)93PZW_ '#T\KV.\#G_ '34_>]N.7T/]V??U@G^ M@#R)93PZW_]N.7T/\ =GW] M8)_H \B64\.M_P!P]/*]CO Y_P!TU/WO;CE]#_=GW]8)_H \B64\.M_W#T\K MV.\#G_=-3][VXY?0_P!V??U@G^@#R)93PZW_ '#T\KV.\#G_ '35^'/\WOQU M)M9MA^H/R[@EE@T[M[ M;EU-E6O KZ)VT^K0_47Z;Q=Q9< ^TN RNTAS"0.>@J*GT*BO9"HLM,8?2&:9B["UC@B'?-M7<>4N))VE=3]*YK[X)\R_GND_Y MQ7Z-'7'TFQ/N>X]-9S]+%P\^B69]TVWI)Z5S7WP3YE_/=)_R _1HZX^DV)]S MW'II^EBX>?1+,^Z;;TD]*YK[X)\R_GND_P"0'Z-'7'TFQ/N>X]-/TL7#SZ)9 MGW3;>DGI7-??!/F7\]TG_(#]&CKCZ38GW/<>FGZ6+AY]$LS[IMO23TKFOO@G MS+^>Z3_D!^C1UQ])L3[GN/33]+%P\^B69]TVWI)Z5S7WP3YE_/=)_P @/T:. MN/I-B?<]QZ:?I8N'GT2S/NFV])/2N:^^"?,OY[I/^0'Z-'7'TFQ/N>X]-/TL M7#SZ)9GW3;>DGI7-??!/F7\]TG_(#]&CKCZ38GW/<>FGZ6+AY]$LS[IMO24@ MN,/C2\>=/;@QS9FR>/6RGLG&I75*E- M(01FJ6TR:C["5)5OW#7_ \\OI'5MOJ34>)U[H*[T?I# Y+&W=^!%-/+/"XBV/\ "QQA@]5,*1N) M-!$Z0#MB"VY#][VXY?0_W9]_6"?Z 6\\B64\.M_W#U0'RO8[P.?]TU/WO;CE M]#_=GW]8)_H \B64\.M_W#T\KV.\#G_=-3][VXY?0_W9]_6"?Z /(EE/#K?] MP]/*]CO Y_W34_>]N.7T/]V??U@G^@#R)93PZW_]N.7T/]V??U@G^@#R)93PZW_]N.7T/]V??U@G^@#R)93PZW_]N.7T/]V??U@G^@#R)93PZW_+]M798OI_UH]8O'^^"ZY^@KFWQ\T7R6AY$+KQC'W$^V+^>5^W\ ?W4> ML3]\%US]!7-OCYHODM#R(77C&/N)]L3ROV_@#^ZCUB?O@NN?H*YM\?-%\EH> M1"Z\8Q]Q/MB>5^W\ ?W4>L3]\%US]!7-OCYHODM#R(77C&/N)]L3ROV_@#^Z MCUB?O@NN?H*YM\?-%\EH>1"Z\8Q]Q/MB>5^W\ ?W4>L3]\%US]!7-OCYHODM M#R(77C&/N)]L3ROV_@#^ZCUB?O@NN?H*YM\?-%\EH>1"Z\8Q]Q/MB>5^W\ ? MW4>L3]\%US]!7-OCYHODM#R(77C&/N)]L3ROV_@#^ZCUB?O@NN?H*YM\?-%\ MEH>1"Z\8Q]Q/MB>5^W\ ?W4>L3]\%US]!7-OCYHODM#R(77C&/N)]L3ROV_@ M#^ZCUB?O@NN?H*YM\?-%\EH>1"Z\8Q]Q/MB>5^W\ ?W4>L3]\%US]!7-OCYH MODM#R(77C&/N)]L3ROV_@#^ZCUB?O@NN?H*YM\?-%\EH>1"Z\8Q]Q/MB>5^W M\ ?W4>L3]\%US]!7-OCYHODM#R(77C&/N)]L3ROV_@#^ZCUB?O@NN?H*YM\? M-%\EH>1"Z\8Q]Q/MB>5^W\ ?W4>L3]\%US]!7-OCYHODM#R(77C&/N)]L3RO MV_@#^ZCUB?O@NN?H*YM\?-%\EH>1"Z\8Q]Q/MB>5^W\ ?W4>L3]\%US]!7-O MCYHODM#R(77C&/N)]L3ROV_@#^ZCUB?O@NN?H*YM\?-%\EH>1"Z\8Q]Q/MB> M5^W\ ?W4>L3]\%US]!7-OCYHODM#R(77C&/N)]L3ROV_@#^ZCUB?O@NN?H*Y MM\?-%\EH>1"Z\8Q]Q/MB>5^W\ ?W4>L3]\%US]!7-OCYHODM#R(77C&/N)]L M3ROV_@#^ZCUB?O@NN?H*YM\?-%\EH>1"Z\8Q]Q/MB>5^W\ ?W4>L3]\%US]! M7-OCYHODM#R(77C&/N)]L3ROV_@#^ZCUB?O@NN?H*YM\?-%\EH>1"Z\8Q]Q/ MMB>5^W\ ?W4>L3]\%US]!7-OCYHODM#R(77C&/N)]L3ROV_@#^ZCUB?O@NN? MH*YM\?-%\EH>1"Z\8Q]Q/MB>5^W\ ?W4>L3]\%US]!7-OCYHODM#R(77C&/N M)]L3ROV_@#^ZCUB?O@NN?H*YM\?-%\EH>1"Z\8Q]Q/MB>5^W\ ?W4>L3]\%U MS]!7-OCYHODM#R(77C&/N)]L3ROV_@#^ZCUB?O@NN?H*YM\?-%\EH>1"Z\8Q M]Q/MB>5^W\ ?W4>L3]\%US]!7-OCYHODM#R(77C&/N)]L3ROV_@#^ZCUB?O@ MNN?H*YM\?-%\EH>1"Z\8Q]Q/MB>5^W\ ?W4>L3]\%US]!7-OCYHODM#R(77C M&/N)]L3ROV_@#^ZCUB?O@NN?H*YM\?-%\EH>1"Z\8Q]Q/MB>5^W\ ?W4>L3] M\%US]!7-OCYHODM#R(77C&/N)]L3ROV_@#^ZCUB?O@NN?H*YM\?-%\EH>1"Z M\8Q]Q/MB>5^W\ ?W4>L3]\%US]!7-OCYHODM#R(77C&/N)]L3ROV_@#^ZCUB M?O@NN?H*YM\?-%\EH>1"Z\8Q]Q/MB>5^W\ ?W4>L3]\%US]!7-OCYHODM#R( M77C&/N)]L3ROV_@#^ZCUB?O@NN?H*YM\?-%\EH>1"Z\8Q]Q/MB>5^W\ ?W4> ML3]\%US]!7-OCYHODM#R(77C&/N)]L3ROV_@#^ZCUB?O@NN?H*YM\?-%\EH> M1"Z\8Q]Q/MB>5^W\ ?W4>L3]\%US]!7-OCYHODM#R(77C&/N)]L3ROV_@#^Z MCUB?O@NN?H*YM\?-%\EH>1"Z\8Q]Q/MB>5^W\ ?W4>L3]\%US]!7-OCYHODM M#R(77C&/N)]L3ROV_@#^ZCUB?O@NN?H*YM\?-%\EH>1"Z\8Q]Q/MB>5^W\ ? MW4>L3]\%US]!7-OCYHODM#R(77C&/N)]L3ROV_@#^ZCUB?O@NN?H*YM\?-%\ MEH>1"Z\8Q]Q/MB>5^W\ ?W4>L3]\%US]!7-OCYHODM#R(77C&/N)]L3ROV_@ M#^ZCUBZ;L3_-D:3VC@^4Z\S'@-F=EC67TTREMHJM\T!+)F4WT;E17#U6HX]A M7R$HD1GD^O9D-(<29*21C#Z@ZN<&IL)=8#+WL4F-NX71O;T)K1PV.:>DV.:: M.8X;6N <-H"V#2G6&O\ 1FI++56 M9(C_.UT<9_BTX'<'2:(O ^@K3)QD5YZ5LAL[&P+\> MEBQ_X%+G[^(7N9'\_1EYSZ7VG]GR?"U^OTM.GOH1>_VG%\"3TL6/_ I<_?Q" M]S(?HR\Y]+[3^SY/A:?I:=/?0B]_M.+X$GI8L?\ @4N?OXA>YD/T9><^E]I_ M9\GPM/TM.GOH1>_VG%\"3TL6/_ I<_?Q"]S(?HR\Y]+[3^SY/A:?I:=/?0B] M_M.+X$GI8L?^!2Y^_B%[F0_1EYSZ7VG]GR?"T_2TZ>^A%[_:<7P)/2Q8_P# MI<_?Q"]S(?HR\Y]+[3^SY/A:?I:=/?0B]_M.+X$N/E>+/$0YTA:'DR&>R1FN M5LMJ(YV^I]I/=-8'.2:2+IT/M]3_ ("^K[K?_#'NG1UN]:1LEKR,Q)>*=FKL MC&:^AN_JK'77^+=:,EI9:"DDAIROS+8W5YQNMQ,> MRZA:J;K%%[V0[\*>]OZPJH>6'\'>^/Y%/WQ3]G5^ES^K$'D._"GO;^L)Y8?P=[X_D M4_?%/V=7Z7/ZL0>0[\*>]OZPGEA_!WOC^13]\4_9U?I<_JQ!Y#OPI[V_K">6 M'\'>^/Y%/WQ3]G5^ES^K$'D._"GO;^L)Y8?P=[X_D4_?%/V=7Z7/ZL0>0[\* M>]OZPGEA_!WOC^13]\4_9U?I<_JQ!Y#OPI[V_K">6'\'>^/Y%/WQ3]G5^ES^ MK$'D._"GO;^L)Y8?P=[X_D4_?%/V=7Z7/ZL0>0[\*>]OZPGEA_!WOC^13]\4 M_9U?I<_JQ!Y#OPI[V_K">6'\'>^/Y%/WQ3]G5^ES^K$'D._"GO;^L)Y8?P=[ MX_D4_?%/V=7Z7/ZL0>0[\*>]OZPGEA_!WOC^13]\4_9U?I<_JQ!Y#OPI[V_K M">6'\'>^/Y%/WQ3]G5^ES^K$'D._"GO;^L)Y8?P=[X_D4_?%/V=7Z7/ZL0>0 M[\*>]OZPGEA_!WOC^13]\4_9U?I<_JQ!Y#OPI[V_K">6'\'>^/Y%/WQ3]G5^ MES^K$'D._"GO;^L)Y8?P=[X_D4_?%/V=7Z7/ZL0>0[\*>]OZPGEA_!WOC^17 MMP?\XC"@KS5/3FGU:'ZA7];QA;O#>QQ#:[:3U-/ MJ="*_KCZJV_-!;WU=R[C?R;BH[YK9EUMI#49O MU5_1V+#T*QA/$E^%.CNL.I2XVHBA')8Z\Q-]+C;]A9=PN+7#_(0><$4+2-A! M!&PJ7K"_MM9[(S'4&>8OLK +A^AR M[$+1FVIK%@SZ)=;)3;\26SU2F76V,1QR/*CKZMR([JVUD:5&0Q^4QEEF9S30M(V@@$;0LM@LYD]-Y>#.8>4PY&VD#V.'9Y"".=K@2 MU[3L'M;*<:FM_ M0$0$0$0$0$0$0$0$0$0$0$0$0$6A5R,_*$WO_MEVA_7>\'0/37YN8_[R@^Y- M7(S6OYY9?\9W7W>18:&;6LH"("("("+>SXA_DG<8/[O&E?[-L:%!=9?G?E?Q ME<_=GKK-PX_N\P/XELOZ-$M!'_-6_P")S0_W7-4_UOVB+ <'/S2=]^2?O8U$ MO%3\YV_>L?[YZUJ1*RC5 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1;%?@!^+V M_P "-P^\%O+(G4\1MUY!'.TGV#ZU0])['GE$K8>RXW4E]QBMNQ'9AY&TGLDB M.VQ.2?:AN-28OXDZ)&H['XRQ[?\ 7=NW8!RRL&TQ_P#.&TL/9JWZX$2+H#5Y MP-YWA?._U1.[:3_HWG9O_P#-.P/]"CN8@_2&MJF@S'';&DN85;D6+Y13RJRS MKY2&;"HNZ.YAKC2XK[9]Y'F5]C!D*2HO*AQM?U2,5;@FGL[AEQ;N='4$$5] JQ-U:VN0M)+.\8R6RFCM[]XG7SA-)<[V9A=Q+4:^U=X\EU*4N+/K,B& MV^7KS>0W=7AUKB'66(K,6MS4 #9F#97L2M'V+^<#U+JMY-TGF=QCX7W/#C4) M;;![]-794'W)JY&:U_/++_C.Z^[R+#0S:UE 1 1 1 1;V?$/\D[C!_=XT MK_9MC0H+K+\[\K^,KG[L]=9N'']WF!_$ME_1HEH(_P":M_Q.:'^ZYJG^M^T1 M8#@Y^:3OOR3][&HEXJ?G.W[UC_?/6M2)64:H"("("("("("("("("("("("( M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("("( M"("("("("("("("("("("*9LGP]N8T3B+&YWR=)7#/%&7-;@L;77DF#DTM;N M8.8"U+5AA90>PVZ=[,&S@(GJJ2A*>-/1TTJ2H\$-38)V;.G1<-^.0*]'NO\ ML=^F]N[E=W;3>K3F6:.GLP,0,\8#\5$TZ2K?LMSU.]OTWME=VGHJ&0SJPJ B MF_SSX#;A\/#9VOM4;JR36N3Y%LG3&)[SHYNKKC*+JEB8EF.09AC=976TC+,. MPF-VCQ0D@UKL[.NB=))"V4%A<1NN+@ =YK36K3781R;5" M; L&IK<5N!6[^86MN4VT]46.MX&,\1-7L;7V>WG>:L8I:6=%*:R&5'K,+BO0 M9;%M7E138Y2HF/9@]KK+W2U["6CE 761MW1VY--X.8X GF=N.=NGT' M4*@<-B6!6:=!\<]Y\I-AP=4\>M79?MK8$^)*L6\E,M-QV$+=<-+:%J3K^/U M]I#)SBVM+Z(SN- 'A\=2>0 R-8"3R [3L&TK.7VBM4XZ$W%U9R"$"I+2R2@ MYR1&YQ '.2-@VE5MTN&Y?DM;?W&.XIDE_48I$1/RBUI:*TM:W&X+K4MYN;?S MH,5^+3Q'&:]]:7)"FT&EAPR/HA73:I)X(GM9*]C7O-&@D N.S8 >4[1R=D+6 MV0S2-<^-CG,8*N(!( [)(Y.0\O876Q]5\D!$!%S./8YD.6W$3'L4H;G)K^P\ MX\PH\>JYUU<3?-(KTZ5YI6UK$F;)\VA1G'G.PA78:;4L^B4F9?.66*%AEF(XFN=(>0 $D\_(-O(O1GP)U5.FU=I"EUMG6RY, M"QKI\9Z'.@3H;RX\N%-B2$-R(LN+(;4AQM:4K0M)I41&1D/VUS7M#V$%A%01 MM!!Y"#V%^7-4'L%>H/ZOR@(@(IK<&^!6[_$$V%GNM=%V.MJJ] MUSJC*=PY%,V=FK&$TOVLXK(K(+\6)/7!LEJLK"QN(T=IQYMFMC*<)R;+B,$; MQ8#4.H\?IJVCN\B)3'+,V)HC9OG>=4[14; 3LJX\C6N.Q9O!X&^U!<26UB8 MQ)'$Z0[[MT;K:#EH=I) Y@.5Q VJ%(SZPB B BGYQ5\+?GWS9QJ1FG&;C5F. MQ<*CS9E:6:R[?#, PV98UQI180*G*]EY-AV/W M!Z) %=G*O-E,%E\*X-REO)#O&@)%6D]@.%6D^@#Z*B8,TL0@(@(@(IF\%^"N MZ?$(W%=:1T58Z\JLMQ_6N7;4LINS,L5A^/(QO#G:F)-CL6#-9<2I5Q/LKV)' MCLMQU(1WJGY#D>(Q(DLX+4.HK#3-BW(9$2NA=*V,"-N\[>=6FRHV DFOH % MQ .:P6"O=0WCK&Q,8F;$YY+W;HHVE=M#M)( V>B: $B'D_RUGC 'FE/CWAS M\D

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end GRAPHIC 16 g1v4ad3roqet000002.jpg GRAPHIC begin 644 g1v4ad3roqet000002.jpg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ⅅ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�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end EX-101.SCH 17 synh-20211231.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Cover Page link:calculationLink link:presentationLink link:definitionLink 100010 - Statement - CONSOLIDATED STATEMENTS OF INCOME link:calculationLink link:presentationLink link:definitionLink 100020 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:calculationLink link:presentationLink link:definitionLink 100030 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100040 - Statement - CONSOLIDATED BALANCE SHEETS link:calculationLink link:presentationLink link:definitionLink 100050 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100060 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:calculationLink link:presentationLink link:definitionLink 100070 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY link:calculationLink link:presentationLink link:definitionLink 100080 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 100090 - Disclosure - Financial Statement Details link:calculationLink link:presentationLink link:definitionLink 100100 - Disclosure - Acquisitions, Divestitures, and Investments link:calculationLink link:presentationLink link:definitionLink 100110 - Disclosure - Long-Term Debt Obligations link:calculationLink link:presentationLink link:definitionLink 100120 - Disclosure - Leases link:calculationLink link:presentationLink link:definitionLink 100130 - Disclosure - Derivatives link:calculationLink link:presentationLink link:definitionLink 100140 - Disclosure - Fair Value Measurements link:calculationLink link:presentationLink link:definitionLink 100150 - Disclosure - Restructuring and Other Costs link:calculationLink link:presentationLink link:definitionLink 100160 - Disclosure - Shareholders' Equity link:calculationLink link:presentationLink link:definitionLink 100170 - Disclosure - Earnings Per Share link:calculationLink link:presentationLink link:definitionLink 100180 - Disclosure - Income Taxes link:calculationLink link:presentationLink link:definitionLink 100190 - Disclosure - Revenue from Contracts with Customers link:calculationLink link:presentationLink link:definitionLink 100200 - Disclosure - Segment Information link:calculationLink link:presentationLink link:definitionLink 100210 - Disclosure - Operations by Geographic Location link:calculationLink link:presentationLink link:definitionLink 100220 - Disclosure - Concentration of Credit Risk link:calculationLink link:presentationLink link:definitionLink 100230 - Disclosure - Related-Party Transactions link:calculationLink link:presentationLink link:definitionLink 100240 - Disclosure - Commitments and Contingencies link:calculationLink link:presentationLink link:definitionLink 100250 - Disclosure - Share-Based Compensation link:calculationLink link:presentationLink link:definitionLink 100260 - Disclosure - Employee Benefit Plans link:calculationLink link:presentationLink link:definitionLink 100270 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 100280 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) link:calculationLink link:presentationLink link:definitionLink 100290 - Disclosure - Financial Statement Details (Tables) link:calculationLink link:presentationLink link:definitionLink 100300 - Disclosure - Acquisitions, Divestitures, and Investments (Tables) link:calculationLink link:presentationLink link:definitionLink 100310 - Disclosure - Long-Term Debt Obligations (Tables) link:calculationLink link:presentationLink link:definitionLink 100320 - Disclosure - Leases (Tables) link:calculationLink link:presentationLink link:definitionLink 100330 - Disclosure - Derivatives (Tables) link:calculationLink link:presentationLink link:definitionLink 100340 - Disclosure - Fair Value Measurements (Tables) link:calculationLink link:presentationLink link:definitionLink 100350 - Disclosure - Restructuring and Other Costs (Tables) link:calculationLink link:presentationLink link:definitionLink 100360 - Disclosure - Shareholders' Equity (Tables) link:calculationLink link:presentationLink link:definitionLink 100370 - Disclosure - Earnings Per Share (Tables) link:calculationLink link:presentationLink link:definitionLink 100380 - Disclosure - Income Taxes (Tables) link:calculationLink link:presentationLink link:definitionLink 100390 - Disclosure - Segment Information (Tables) link:calculationLink link:presentationLink link:definitionLink 100400 - Disclosure - Operations by Geographic Location (Tables) link:calculationLink link:presentationLink link:definitionLink 100410 - Disclosure - Share-Based Compensation (Tables) link:calculationLink link:presentationLink link:definitionLink 100420 - Disclosure - Employee Benefit Plans (Tables) link:calculationLink link:presentationLink link:definitionLink 100430 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details) link:calculationLink link:presentationLink link:definitionLink 100440 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Net Cash Pool Position (Details) link:calculationLink link:presentationLink link:definitionLink 100450 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Estimated Useful Lives of Property and Equipment (Details) link:calculationLink link:presentationLink link:definitionLink 100460 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Estimated Useful Lives of Intangible Assets (Details) link:calculationLink link:presentationLink link:definitionLink 100470 - Disclosure - Financial Statement Details - Accounts Receivable and Unbilled Services, net (Details) link:calculationLink link:presentationLink link:definitionLink 100480 - Disclosure - Financial Statement Details - Narrative (Details) link:calculationLink link:presentationLink link:definitionLink 100490 - Disclosure - Financial Statement Details - Schedule of Property and Equipment, Net (Details) link:calculationLink link:presentationLink link:definitionLink 100500 - Disclosure - Financial Statement Details - Schedule of Goodwill (Details) link:calculationLink link:presentationLink link:definitionLink 100510 - Disclosure - Financial Statement Details - Schedule of Intangible Assets (Details) link:calculationLink link:presentationLink link:definitionLink 100520 - Disclosure - Financial Statement Details - Schedule of Future Amortization Expense (Details) link:calculationLink link:presentationLink link:definitionLink 100530 - Disclosure - Financial Statement Details - Schedule of Accrued Expenses (Details) link:calculationLink link:presentationLink link:definitionLink 100540 - Disclosure - Financial Statement Details - Accumulated Other Comprehensive Loss, Net of Taxes (Details) link:calculationLink link:presentationLink link:definitionLink 100550 - Disclosure - Financial Statement Details - Tax Effects Allocated to Each Component of Other Comprehensive (Loss) Income (Details) link:calculationLink link:presentationLink link:definitionLink 100560 - Disclosure - Financial Statement Details - Schedule of Other (Income) Expense, Net (Details) link:calculationLink link:presentationLink link:definitionLink 100570 - Disclosure - Financial Statement Details - Supplemental Cash Flow Information (Details) link:calculationLink link:presentationLink link:definitionLink 100580 - Disclosure - Acquisitions, Divestitures, and Investments - Narrative (Details) link:calculationLink link:presentationLink link:definitionLink 100590 - Disclosure - Acquisitions, Divestitures, and Investments - Preliminary Estimates of Fair Values of Intangible Assets and Estimated Useful Lives (Details) link:calculationLink link:presentationLink link:definitionLink 100600 - Disclosure - Acquisitions, Divestitures, and Investments - Allocation of Consideration Transferred (Details) link:calculationLink link:presentationLink link:definitionLink 100610 - Disclosure - Acquisitions, Divestitures, and Investments - Preliminary Estimates of Fair Value of Intangible Assets and Estimated Useful Lives (Details) link:calculationLink link:presentationLink link:definitionLink 100620 - Disclosure - Long-Term Debt Obligations - Schedule of Debt Obligations (Details) link:calculationLink link:presentationLink link:definitionLink 100630 - Disclosure - Long-Term Debt Obligations - Narrative (Details) link:calculationLink link:presentationLink link:definitionLink 100640 - Disclosure - Long-Term Debt Obligations - Schedule of Variable Rate Margins (Details) link:calculationLink link:presentationLink link:definitionLink 100650 - Disclosure - Long-Term Debt Obligations - Accounts Receivable Financing Agreement (Details) link:calculationLink link:presentationLink link:definitionLink 100660 - Disclosure - Long-Term Debt Obligations - Contractual Maturities of Debt Obligations (Details) link:calculationLink link:presentationLink link:definitionLink 100670 - Disclosure - Leases - Narrative (Details) link:calculationLink link:presentationLink link:definitionLink 100680 - Disclosure - Leases - Components of Lease Cost (Details) link:calculationLink link:presentationLink link:definitionLink 100690 - Disclosure - Leases - Supplemental Balance Sheet Information Related to Leases (Details) link:calculationLink link:presentationLink link:definitionLink 100700 - Disclosure - Leases - Supplemental Cash Flow Information Related to Leases (Details) link:calculationLink link:presentationLink link:definitionLink 100710 - Disclosure - Leases - Supplemental Cash Flow Information, Weighted Average (Details) link:calculationLink link:presentationLink link:definitionLink 100720 - Disclosure - Leases - Maturities of Lease Liabilities (Details) link:calculationLink link:presentationLink link:definitionLink 100730 - Disclosure - Leases - Maturities of Lease Liabilities (Details)2 link:calculationLink link:presentationLink link:definitionLink 100740 - Disclosure - Derivatives - Narrative (Details) link:calculationLink link:presentationLink link:definitionLink 100750 - Disclosure - Derivatives - Interest Rate Swaps Designated as Hedging Instruments on Consolidated Balance Sheets (Details) link:calculationLink link:presentationLink link:definitionLink 100760 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) link:calculationLink link:presentationLink link:definitionLink 100770 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Parenthetical) (Details) link:calculationLink link:presentationLink link:definitionLink 100780 - Disclosure - Fair Value Measurements - Reconciliation of Changes in the Carrying Amount of Contingent Consideration (Details) link:calculationLink link:presentationLink link:definitionLink 100790 - Disclosure - Fair Value Measurements - Narrative (Details) link:calculationLink link:presentationLink link:definitionLink 100800 - Disclosure - Fair Value Measurements - Schedule of Estimated Fair Value (Details) link:calculationLink link:presentationLink link:definitionLink 100810 - Disclosure - Restructuring and Other Costs - Schedule of Restructuring and other costs (Details) link:calculationLink link:presentationLink link:definitionLink 100820 - Disclosure - Restructuring and Other Costs - Liabilities Associated with Restructuring and Other Costs (Details) link:calculationLink link:presentationLink link:definitionLink 100830 - Disclosure - Shareholders' Equity - Shares of Common Stock Outstanding (Details) link:calculationLink link:presentationLink link:definitionLink 100840 - Disclosure - Shareholders' Equity - Narrative (Details) link:calculationLink link:presentationLink link:definitionLink 100850 - Disclosure - Shareholders' Equity - Repurchase Activity (Details) link:calculationLink link:presentationLink link:definitionLink 100860 - Disclosure - Shareholders' Equity - Schedule of Stock by Class (Details) link:calculationLink link:presentationLink link:definitionLink 100870 - Disclosure - Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) link:calculationLink link:presentationLink link:definitionLink 100880 - Disclosure - Earnings Per Share - Narrative (Details) link:calculationLink link:presentationLink link:definitionLink 100890 - Disclosure - Income Taxes - Components of Income before Provision for Income Taxes (Details) link:calculationLink link:presentationLink link:definitionLink 100900 - Disclosure - Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details) link:calculationLink link:presentationLink link:definitionLink 100910 - Disclosure - Income Taxes - Narrative (Details) link:calculationLink link:presentationLink link:definitionLink 100920 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) link:calculationLink link:presentationLink link:definitionLink 100930 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Parenthetical) (Details) link:calculationLink link:presentationLink link:definitionLink 100940 - Disclosure - Income Taxes - Summary of Valuation Allowance (Details) link:calculationLink link:presentationLink link:definitionLink 100950 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) link:calculationLink link:presentationLink link:definitionLink 100960 - Disclosure - Income Taxes - Schedule of Unrecognized Tax Benefits (Details) link:calculationLink link:presentationLink link:definitionLink 100970 - Disclosure - Revenue from Contracts with Customers - Narrative (Details) link:calculationLink link:presentationLink link:definitionLink 100980 - Disclosure - Segment Information (Details) link:calculationLink link:presentationLink link:definitionLink 100990 - Disclosure - Operations by Geographic Location - Total Revenue by Geographic Area (Details) link:calculationLink link:presentationLink link:definitionLink 101000 - Disclosure - Operations by Geographic Location - Long-Lived Assets by Geographic Area (Details) link:calculationLink link:presentationLink link:definitionLink 101010 - Disclosure - Concentration of Credit Risk - Narrative (Details) link:calculationLink link:presentationLink link:definitionLink 101020 - Disclosure - Related-Party Transactions - Narrative (Details) link:calculationLink link:presentationLink link:definitionLink 101030 - Disclosure - Commitments and Contingencies - Narrative (Details) link:calculationLink link:presentationLink link:definitionLink 101040 - Disclosure - Share-Based Compensation - Narrative (Details) link:calculationLink link:presentationLink link:definitionLink 101050 - Disclosure - Share-Based Compensation - Stock Option Valuation Assumptions (Details) link:calculationLink link:presentationLink link:definitionLink 101060 - Disclosure - Share-Based Compensation - Summary of Option Activity (Details) link:calculationLink link:presentationLink link:definitionLink 101070 - Disclosure - Share-Based Compensation - Summary of Restricted Stock Unit Activity (Details) link:calculationLink link:presentationLink link:definitionLink 101080 - Disclosure - Share-Based Compensation - Summary of Share-Based Compensation Expense (Details) link:calculationLink link:presentationLink link:definitionLink 101090 - Disclosure - Employee Benefit Plans - Schedule of Contributions to Defined Contribution Plan (Details) link:calculationLink link:presentationLink link:definitionLink 101100 - Disclosure - Employee Benefit Plans - Narrative (Details) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 18 synh-20211231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 19 synh-20211231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 20 synh-20211231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Lessee Operating Lease Liability Management Fee Finance Lease, Liability, Management Fee Foreign income inclusion under Internal Revenue Code Section 956 and Subpart F Change in income tax expense resulting from foreign earnings not indefinitely reinvested. Income tax reconciliation nondeductible expense capital loss carryforward Loss (gain) on sale of business, income tax. Tax Cuts And Jobs Act Of 2017, Base Erosion And Anti-Abuse Tax Effective Income Tax Rate Reconciliation, Executive Compensation Limitation, Amount Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Annual Report Document Annual Report Document Transition Report Document Transition Report Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Current Fiscal Year End Date Current Fiscal Year End Date Entity File Number Entity File Number Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation State Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Title of 12(b) Security Security12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Well-known Seasoned Issuer Entity Well Known Seasoned Issuer Entity Voluntary Filers Entity Voluntary Filers Entity Current Reporting Status Entity Current Reporting Status Entity Interactive Data Current Entity Interactive Data Current Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company ICFR Auditor Attestation Flag Icfr Auditor Attestation Flag Entity Shell Company Entity Shell Company Entity Public Float Entity Public Float Entity Common Stock, Shares Outstanding Entity Common Stock Shares Outstanding Documents Incorporated by Reference Documents Incorporated By Reference [Text Block] Entity Central Index Key Auditor Name Auditor Name Auditor Location Auditor Location Auditor Firm ID Auditor Firm Id Restructuring Charge, Including Other Costs Income Statement [Abstract] Revenue Revenue From Contract With Customer Excluding Assessed Tax Costs and operating expenses: Operating Costs And Expenses [Abstract] Direct costs (exclusive of depreciation and amortization) Cost Of Goods And Services Sold Selling, general, and administrative expenses Selling General And Administrative Expense Restructuring and other costs Restructuring Charge Including Other Costs Depreciation Depreciation Amortization Amortization Of Intangible Assets Total operating expenses Costs And Expenses Income from operations Operating Income Loss Total other expense, net: Other Income And Expenses [Abstract] Interest income Interest And Other Income Interest expense Interest Expense Loss (gain) on extinguishment of debt Gains Losses On Extinguishment Of Debt Other (income) expense, net Other Nonoperating Income Expense Total other expense, net Nonoperating Income Expense Income before provision for income taxes Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest Income tax expense (benefit) Income Tax Expense Benefit Net income Net Income Loss Earnings per share: Earnings Per Share Basic And Diluted [Abstract] Basic (USD per share) Earnings Per Share Basic Diluted (USD per share) Earnings Per Share Diluted Weighted average common shares outstanding: Weighted Average Number Of Shares Outstanding Diluted Disclosure Items [Abstract] Basic (in shares) Weighted Average Number Of Shares Outstanding Basic Diluted (in shares) Weighted Average Number Of Diluted Shares Outstanding Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss), attributable to parent entity. Statement Of Income And Comprehensive Income [Abstract] Net income Unrealized gain (loss) on derivative instruments, net of income tax expense (benefit) of $5,599, $(1,394), and $(2,122), respectively Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent1 Foreign currency translation adjustments, net of income tax (benefit) expense of $(1,472), $1,354, and $0, respectively Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent Comprehensive income Comprehensive Income Net Of Tax Income tax expense (benefit) related to unrealized gain (loss) on derivative instruments recorded in other comprehensive loss Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Other comprehensive expense (benefit), foreign currency translation adjustment, tax Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax Receivables, Net, Current And Contract With Customer, Asset, Net, Current Statement Of Financial Position [Abstract] ASSETS Assets [Abstract] Current assets: Assets Current [Abstract] Cash, cash equivalents, and restricted cash Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Accounts receivable and unbilled services, net Receivables Net Current And Contract With Customer Asset Net Current Prepaid expenses and other current assets Prepaid Expense And Other Assets Current Total current assets Assets Current Property and equipment, net Property Plant And Equipment Net Operating lease right-of-use assets Operating Lease Right Of Use Asset Goodwill Goodwill Intangible assets, net Intangible Assets Net Excluding Goodwill Deferred income tax assets Deferred Income Tax Assets Net Other long-term assets Other Assets Noncurrent Total assets Assets LIABILITIES AND SHAREHOLDERS’ EQUITY Liabilities And Stockholders Equity [Abstract] Current liabilities: Liabilities Current [Abstract] Accounts payable Accounts Payable Current Accrued expenses Accrued Liabilities Current Deferred revenue Contract With Customer Liability Current Current portion of operating lease obligations Operating Lease Liability Current Current portion of finance lease obligations Finance Lease Liability Current Total current liabilities Liabilities Current Long-term debt Long Term Debt Noncurrent Operating lease long-term obligations Operating Lease Liability Noncurrent Finance lease long-term obligations Finance Lease Liability Noncurrent Deferred income tax liabilities Deferred Income Tax Liabilities Net Other long-term liabilities Other Liabilities Noncurrent Total liabilities Liabilities Commitments and contingencies (Note 17) Commitments And Contingencies Shareholders’ equity: Stockholders Equity [Abstract] Preferred stock, $0.01 par value; 30,000 shares authorized, 0 shares issued and outstanding as of December 31, 2021 and 2020 Preferred Stock Value Common stock, $0.01 par value; 600,000 shares authorized, 103,764 and 103,935 shares issued and outstanding as of December 31, 2021 and 2020, respectively Common Stock Value Additional paid-in capital Additional Paid In Capital Accumulated other comprehensive loss, net of taxes Accumulated Other Comprehensive Income Loss Net Of Tax Accumulated deficit Retained Earnings Accumulated Deficit Total shareholders’ equity Stockholders Equity Total liabilities and shareholders’ equity Liabilities And Stockholders Equity Preferred stock par value (USD per share) Preferred Stock Par Or Stated Value Per Share Preferred stock shares authorized (in shares) Preferred Stock Shares Authorized Preferred stock shares issued (in shares) Preferred Stock Shares Issued Preferred stock shares outstanding (in shares) Preferred Stock Shares Outstanding Common stock par value (USD per share) Common Stock Par Or Stated Value Per Share Common stock shares authorized (in shares) Common Stock Shares Authorized Common stock shares issued (in shares) Common Stock Shares Issued Common stock shares outstanding (in shares) Common Stock Shares Outstanding Increase (Decrease) In Accounts Receivable, Contract With Customer Asset, Net Current And Contract With Customer Liability, Current Payment of loans to unconsolidated affiliates. The cash outflow for the extinguishment of long-term borrowing, including associated breakage fees. Statement Of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided By Used In Operating Activities [Abstract] Adjustments to reconcile net income to net cash provided by operating activities: Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Depreciation and amortization Depreciation Depletion And Amortization Share-based compensation Share Based Compensation Provision for doubtful accounts Provision For Doubtful Accounts Provision for (benefit from) deferred income taxes Deferred Income Tax Expense Benefit Foreign currency transaction adjustments Foreign Currency Transaction Gain Loss Before Tax Fair value adjustment of contingent obligations Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 Gain on sale of business Gain Loss On Sale Of Business Other non-cash items Other Noncash Income Expense Changes in operating assets and liabilities, net of effect of acquisitions: Increase Decrease In Other Operating Assets And Liabilities Net [Abstract] Accounts receivable, unbilled services, and deferred revenue Increase Decrease In Accounts Receivable Contract With Customer Asset Net Current And Contract With Customer Liability Current Accounts payable and accrued expenses Increase Decrease In Accounts Payable And Accrued Liabilities Other assets and liabilities Increase Decrease In Other Operating Capital Net Net cash provided by operating activities Net Cash Provided By Used In Operating Activities Cash flows from investing activities: Net Cash Provided By Used In Investing Activities [Abstract] Payments related to acquisitions of businesses, net of cash acquired Payments To Acquire Businesses Net Of Cash Acquired Proceeds from notes receivable from divestiture Proceeds From Collection Of Notes Receivable Proceeds from sale of business Proceeds From Sales Of Business Affiliate And Productive Assets Purchases of property and equipment Payments To Acquire Property Plant And Equipment Investments in unconsolidated affiliates Payments To Acquire Interest In Subsidiaries And Affiliates Loan to unconsolidated affiliate Payment Of Loans To Unconsolidated Affiliates Net cash used in investing activities Net Cash Provided By Used In Investing Activities Cash flows from financing activities: Net Cash Provided By Used In Financing Activities [Abstract] Proceeds from issuance of long-term debt, net of discount Proceeds From Issuance Of Long Term Debt Payments of debt financing costs Payments Of Debt Issuance Costs Repayments of long-term debt Repayments Of Long Term Debt Proceeds from accounts receivable financing agreement Proceeds From Accounts Receivable Securitization Repayments of accounts receivable financing agreement Repayments Of Accounts Receivable Securitization Proceeds from revolving line of credit Proceeds From Lines Of Credit Repayments of revolving line of credit Repayments Of Lines Of Credit Redemption of Senior Notes and associated breakage fees Repaymentsof Long Term Debtand Breakage Fees Payments of contingent consideration related to acquisitions Payment For Contingent Consideration Liability Financing Activities Payments of finance leases Finance Lease Principal Payments Payments for repurchases of common stock Payments For Repurchase Of Common Stock Proceeds from exercises of stock options Proceeds From Stock Options Exercised Payments related to tax withholdings for share-based compensation Payments Related To Tax Withholding For Share Based Compensation Net cash (used in) provided by financing activities Net Cash Provided By Used In Financing Activities Effect of exchange rate changes on cash, cash equivalents, and restricted cash Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Net change in cash, cash equivalents, and restricted cash Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Cash, cash equivalents, and restricted cash - beginning of period Cash, cash equivalents, and restricted cash - end of period Stockholders' Equity Attributable To Parent, Adjusted Balance Statement Of Stockholders Equity [Abstract] Statement [Table] Statement [Table] Cumulative Effect, Period of Adoption Cumulative Effect Period Of Adoption [Axis] Cumulative Effect, Period of Adoption Cumulative Effect Period Of Adoption [Domain] Cumulative Effect, Period of Adoption, Adjustment Cumulative Effect Period Of Adoption Adjustment [Member] Accounting Standards Update Adjustments For New Accounting Pronouncements [Axis] Accounting Standards Update Type Of Adoption [Member] Accounting Standards Update 2016-13 Accounting Standards Update201613 [Member] Equity Components Statement Equity Components [Axis] Equity Component Equity Component [Domain] Common Stock Common Stock [Member] Additional Paid-in Capital Additional Paid In Capital [Member] Accumulated Other Comprehensive Loss Accumulated Other Comprehensive Income [Member] Accumulated Deficit Retained Earnings [Member] Statement [Line Items] Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase Decrease In Stockholders Equity Roll Forward Balance at beginning of period Adjusted beginning balance Stockholders Equity Attributable To Parent Adjusted Balance Business combinations Stock Issued During Period Value Acquisitions Repurchases of common stock Stock Repurchased During Period Value Issuances of common stock Stock Issued During Period Value New Issues Share-based compensation Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Unrealized gain (loss) on derivative instruments, net of taxes Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Foreign currency translation adjustment, net of taxes Balance at end of period Unrealized gain (loss) on derivative instruments, net of taxes Accounting Policies [Abstract] Basis of Presentation and Summary of Significant Accounting Policies Basis Of Presentation And Significant Accounting Policies [Text Block] Text Block [Abstract] Financial Statement Details Additional Financial Information Disclosure [Text Block] Business Combinations [Abstract] Acquisitions, Divestitures, and Investments Business Combination Disclosure [Text Block] Debt Disclosure [Abstract] Long-Term Debt Obligations Debt Disclosure [Text Block] Leases [Abstract] Leases Lessee Finance Leases [Text Block] Derivative Instruments And Hedging Activities Disclosure [Abstract] Derivatives Derivative Instruments And Hedging Activities Disclosure [Text Block] Fair Value Disclosures [Abstract] Fair Value Measurements Fair Value Disclosures [Text Block] Restructuring And Related Activities [Abstract] Restructuring and Other Costs Restructuring And Related Activities Disclosure [Text Block] Equity [Abstract] Shareholders' Equity Stockholders Equity Note Disclosure [Text Block] Earnings Per Share [Abstract] Earnings Per Share Earnings Per Share [Text Block] Income Tax Disclosure [Abstract] Income Taxes Income Tax Disclosure [Text Block] Revenue From Contract With Customer [Abstract] Revenue from Contract with Customers Revenue From Contract With Customer [Text Block] Segment Reporting [Abstract] Segment Information Segment Reporting Disclosure [Text Block] Disclosure for geographic information. Segments Geographical Areas [Abstract] Operations by Geographic Location Geographic Information [Text Block] Risks And Uncertainties [Abstract] Concentration of Credit Risk Concentration Risk Disclosure [Text Block] Related Party Transactions [Abstract] Related-Party Transactions Related Party Transactions Disclosure [Text Block] Commitments And Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments And Contingencies Disclosure [Text Block] Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] Share-Based Compensation Disclosure Of Compensation Related Costs Share Based Payments [Text Block] Compensation And Retirement Disclosure [Abstract] Employee Benefit Plans Pension And Other Postretirement Benefits Disclosure [Text Block] Principles of Consolidation Consolidation Policy [Text Block] Reclassification Prior Period Reclassification Adjustment Description Use of Estimates Use Of Estimates Acquisitions Business Combinations Policy Foreign Currency Translation and Transactions Foreign Currency Transactions And Translations Policy [Text Block] Comprehensive Income Comprehensive Income Policy Policy [Text Block] Cash and Cash Equivalents Cash And Cash Equivalents Unrestricted Cash And Cash Equivalents Policy Restricted Cash Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy Fair Value Fair Value Measurement Policy Policy [Text Block] Derivative Financial Instruments Derivatives Policy [Text Block] Allowance for Doubtful Accounts Receivables Trade And Other Accounts Receivable Allowance For Doubtful Accounts Policy Property and Equipment Property Plant And Equipment Policy [Text Block] Leases Lessee Leases Policy [Text Block] Goodwill and intangible assets Goodwill And Intangible Assets Goodwill Policy Contingencies Commitments And Contingencies Policy [Text Block] Revenue Recognition Revenue From Contract With Customer Policy [Text Block] Disclosure of accounting policy for recognition and treatment of costs and out-of-pocket expenses incurred on behalf of the Company's customers in connection with management of clinical trials. Reimbursable Out-of-pocket Expenses Reimbursable Expenses Policy Policy [Text Block] Share-Based Compensation Share Based Compensation Option And Incentive Plans Policy Income Taxes Income Tax Policy [Text Block] Restructuring and Other Costs Costs Associated With Exit Or Disposal Activities Or Restructurings Policy [Text Block] Earnings Per Share Earnings Per Share Policy [Text Block] Subsequent Events Subsequent Events Policy Policy [Text Block] Recently Adopted Accounting Standards New Accounting Pronouncements Policy Policy [Text Block] Schedule Of Cash Pool Position [Table Text Block] Schedule Of Cash Pool Position Schedule Of Cash Pool Position Table [Text Block] Estimated Useful Lives of Property and Equipment Property Plant And Equipment [Text Block] Schedule of Finite and Indefinite Lived Intangible Assets, Estimated Useful Life [Table Text Block] Estimated Useful Lives of Intangible Assets Schedule Of Finite And Indefinite Lived Intangible Assets Estimated Useful Life Table [Text Block] Organization Consolidation And Presentation Of Financial Statements [Abstract] Schedule of Billed Accounts Receivable, Net Schedule Of Accounts Notes Loans And Financing Receivable [Text Block] Schedule of Changes in the Allowance for Doubtful Accounts Schedule Of Credit Losses For Financing Receivables Current Table [Text Block] Schedule of Goodwill Schedule Of Goodwill [Text Block] Schedule of Finite Lived Intangible Assets Schedule Of Finite Lived Intangible Assets Table [Text Block] Schedule of Indefinite Lived Intangible Assets Schedule Of Indefinite Lived Intangible Assets Table [Text Block] Schedule of Future Amortization Expense Scheduleof Finite Lived Intangible Assets Future Amortization Expense Table [Text Block] Schedule of Accrued Expenses Schedule Of Accrued Liabilities Table [Text Block] Schedule of Accumulated Other Comprehensive Loss, Net of Tax Schedule Of Accumulated Other Comprehensive Income Loss Table [Text Block] Reclassification out of Accumulated Other Comprehensive (Loss) Income Reclassification Out Of Accumulated Other Comprehensive Income Table [Text Block] Schedule of Other (Income) Expense, Net (Details) Schedule Of Other Nonoperating Income Expense Table [Text Block] Supplemental Disclosure of Cash Flow Information Schedule Of Cash Flow Supplemental Disclosures Table [Text Block] Schedule Of Business Acquisitions By Acquisition [Table] Schedule Of Business Acquisitions By Acquisition [Table] Business Acquisition Business Acquisition [Axis] Business Acquisition, Acquiree Business Acquisition Acquiree [Domain] StudyKik acquisition. StudyKIK Acquisition [Member] Study Kik Acquisition [Member] Synteract acquisition. Synteract Acquisition [Member] Synteract Acquisition [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Preliminary Estimates of Fair Values of Intangible Assets and Estimated Useful Lives Schedule Of Finite Lived Intangible Assets Acquired As Part Of Business Combination [Text Block] Allocation of Consideration Transferred Schedule Of Recognized Identified Assets Acquired And Liabilities Assumed Table [Text Block] Schedule of Debt Obligations Schedule Of Debt Instruments [Text Block] Contractual Maturities of Debt Obligations Schedule Of Maturities Of Long Term Debt Table [Text Block] Schedule of Lease, Cost Lease Cost Table [Text Block] Assets And Liabilities, Lessee [Table Text Block] Schedule of Assets And Liabilities Assets And Liabilities Lessee Table [Text Block] Lessee, Supplemental Cash Flow Information Supplemental Cash Flow Information Lessee Supplemental Cash Flow Information Table [Text Block] Tabular disclosure for Lessee's supplemental cash flow information, weighted average. Supplemental Cash Flow Information, Weighted Average Lessee Supplemental Cash Flow Information Weighted Average Table [Text Block] Schedule of Lessee, Operating Lease, Liability, Maturity Lessee Operating Lease Liability Maturity Table [Text Block] Schedule of Finance Lease, Liability, Maturity Finance Lease Liability Maturity Table [Text Block] Interest Rate Swaps Designated as Hedging Instruments on Consolidated Balance Sheets Schedule Of Derivative Instruments In Statement Of Financial Position Fair Value [Text Block] Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block] Reconciliation of Changes in the Carrying Amount of Contingent Consideration Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Text Block] Schedule of Estimated Fair Value Fair Value By Balance Sheet Grouping [Text Block] Schedule of Restructuring and Related Costs Schedule Of Restructuring And Related Costs [Text Block] Shares of Common Stock Outstanding Schedule Of Stockholders Equity Table [Text Block] Schedule of Repurchase Activity Schedule Of Repurchase Agreements Schedule of Stock by Class Schedule Of Stock By Class [Text Block] Schedule of Earnings Per Share, Basic and Diluted Schedule Of Earnings Per Share Basic And Diluted Table [Text Block] Components of Income before Provision for Income Taxes Schedule Of Income Before Income Tax Domestic And Foreign Table [Text Block] Schedule of Components of Income Tax Expense (Benefit) Schedule Of Components Of Income Tax Expense Benefit Table [Text Block] Schedule of Effective Income Tax Rate Reconciliation Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block] Summary of Valuation Allowance Summary Of Valuation Allowance [Text Block] Schedule of Deferred Tax Assets and Liabilities Schedule Of Deferred Tax Assets And Liabilities Table [Text Block] Schedule Of Unrecognized Tax Benefits Schedule Of Unrecognized Tax Benefits Roll Forward Table [Text Block] Schedule of Segment Information Schedule Of Segment Reporting Information By Segment [Text Block] Total Revenue by Geographic Area Revenue From External Customers By Geographic Areas Table [Text Block] Long-Lived Assets by Geographic Area Long Lived Assets By Geographic Areas Table [Text Block] Stock Option Valuation Assumptions Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block] Summary of Stock Option Activity Schedule Of Share Based Compensation Stock Options Activity Table [Text Block] Summary of Restricted Stock Unit Activity Schedule Of Nonvested Restricted Stock Units Activity Table [Text Block] Summary of Share-Based Compensation Expense Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block] Schedule of Contributions to Defined Contribution Plan Defined Contribution Plan Disclosures Table [Text Block] New Accounting Pronouncements Or Change In Accounting Principle [Table] New Accounting Pronouncements Or Change In Accounting Principle [Table] Long-Lived Tangible Asset Property Plant And Equipment By Type [Axis] Long-Lived Tangible Asset Property Plant And Equipment Type [Domain] Computer Equipment and Software Computer equipment and software Computer Equipmentand Software [Member] Inventiv [Member] Inventiv Inventiv [Member] Statistical Measurement Range [Axis] Statistical Measurement Range [Member] Minimum Minimum [Member] Maximum Maximum [Member] New Accounting Pronouncements Or Change In Accounting Principle [Line Items] New Accounting Pronouncements Or Change In Accounting Principle [Line Items] Number of reportable segments Number Of Reportable Segments Cash and Cash Equivalents, Cash Pooling Agreement, Gross Cash Position Cash and Cash Equivalents, Cash Pooling Agreement, Cash Pool Borrowings Cash and Cash Equivalents, Cash Pooling Agreement, Net Cash Position Gross cash position Cashand Cash Equivalents Cash Pooling Agreement Gross Cash Position Less: cash borrowings Cashand Cash Equivalents Cash Pooling Agreement Cash Pool Borrowings Net cash position Cashand Cash Equivalents Cash Pooling Agreement Net Cash Position Restricted cash Restricted Cash Current Schedule Of Property Plant And Equipment [Table] Schedule Of Property Plant And Equipment [Table] Buildings Building [Member] Furniture and fixtures Furniture And Fixtures [Member] Equipment Equipment [Member] Automobiles Automobiles [Member] Leasehold Improvements Leasehold Improvements [Member] Property Plant And Equipment [Line Items] Property Plant And Equipment [Line Items] Property and equipment, estimated useful life Property Plant And Equipment Useful Life Number of reporting units with goodwill assigned Number Of Reporting Units Impairment of goodwill Goodwill Impairment Loss Schedule Of Finite Lived Intangible Assets [Table] Schedule Of Finite Lived Intangible Assets [Table] Finite-Lived Intangible Assets by Major Class Finite Lived Intangible Assets By Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name Finite Lived Intangible Assets Major Class Name [Domain] Customer relationships Customer Relationships [Member] Acquired backlog Order Or Production Backlog [Member] Trade names and trademarks Trademarks And Trade Names [Member] Intellectual property (medical patent) Intellectual Property [Member] Patient communities member. Patient Communities Patient Communities [Member] Acquired technology member. Acquired Technology Acquired Technology [Member] Weighted Average Weighted Average [Member] Finite Lived Intangible Assets [Line Items] Finite Lived Intangible Assets [Line Items] Estimated Useful Life Finite Lived Intangible Asset Useful Life Impairment charge Impairment Of Intangible Assets Indefinitelived Excluding Goodwill Contract termination notice period. Contract Termination Notice Period Contract Termination Notice Period Accounting Standards Update [Extensible Enumeration] Accounting Standards Update Extensible List Impact from adoption of ASU Accounts Receivable Change In Method Credit Loss Expense Reversal Change in accounting principle, accounting standards update, adopted [true/false] Change In Accounting Principle Accounting Standards Update Adopted Change in accounting principle, accounting standards update, adoption date Change In Accounting Principle Accounting Standards Update Adoption Date Receivables [Abstract] Accounts receivable billed Accounts Receivable Gross Current Accounts receivable unbilled Unbilled Receivables Current Contract assets Contract With Customer Asset Net Current Less: Allowance for doubtful accounts Allowance For Doubtful Accounts Receivable Current Accounts receivable and unbilled services, net Allowance for Doubtful Accounts Receivable [Roll Forward] Allowance For Doubtful Accounts Receivable Rollforward Balance at the beginning of the period Valuation Allowances And Reserves Balance Current year provision Valuation Allowances And Reserves Charged To Cost And Expense Write-offs, net of recoveries and the effects of foreign currency exchange Valuation Allowances And Reserves Adjustments Balance at the end of the period Amount of trade receivables sold. Vehicles Vehicles [Member] Trade receivables sold Trade Receivables Sold Proceeds from sale of trade receivables Proceeds From Sale And Collection Of Receivables Software Software And Software Development Costs [Member] Computer equipment Computer Equipment [Member] Buildings and land Building And Building Improvements [Member] Assets Not Yet Placed In Service Assets not yet placed in service Assets Not Yet Placed In Service [Member] Property and equipment, gross Property Plant And Equipment Gross Less: Accumulated depreciation Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Property and equipment, net Property and equipment, gross Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization Accumulated depreciation Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization Amortization charges, net of rebates Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization Schedule Of Goodwill [Table] Schedule Of Goodwill [Table] Segments Statement Business Segments [Axis] Segments Segment [Domain] Clinical Solutions Segment [Member] Clinical Solutions Clinical Solutions Segment [Member] Commercial Solutions Segment [Member] Commercial Solutions Commercial Solutions Segment [Member] Goodwill [Line Items] Goodwill [Line Items] Goodwill [Roll Forward] Goodwill Roll Forward Balance as of December 31, 2019 Acquisitions Goodwill Purchase Accounting Adjustments Impact of foreign currency translation and other Goodwill Foreign Currency Translation Gain Loss Balance as of December 31, 2020 Accumulated impairment loss Goodwill Impaired Accumulated Impairment Loss Transfer of goodwill Goodwill Transfers Backlog Patient communities Patents [Member] Finite-lived intangible assets, gross Finite Lived Intangible Assets Gross Accumulated amortization Finite Lived Intangible Assets Accumulated Amortization Finite-lived intangible assets, net Finite Lived Intangible Assets Net 2022 Finite Lived Intangible Assets Amortization Expense Next Twelve Months 2023 Finite Lived Intangible Assets Amortization Expense Year Two 2024 Finite Lived Intangible Assets Amortization Expense Year Three 2025 Finite Lived Intangible Assets Amortization Expense Year Four 2026 Finite Lived Intangible Assets Amortization Expense Year Five 2027 and thereafter Finite Lived Intangible Assets Amortization Expense After Year Five Accrual for rebates provided to customers (current). Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Tax Sharing Obligation Professional fees, investigator fees, and pass-through costs Accrued Professional Fees Current Compensation, including bonuses, fringe benefits, and payroll taxes Employee Related Liabilities Current Income and other taxes Taxes Payable Current Rebates to customers Accrued Rebates To Customers Current Restructuring and other costs, current portion Restructuring Reserve Current Contingent obligations, current Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Current Tax Sharing Obligation Interest rate swaps - current Interest Payable Current Other liabilities Other Accrued Liabilities Current Total accrued expenses Accumulated Other Comprehensive Income Loss [Table] Accumulated Other Comprehensive Income Loss [Table] Foreign Currency Translation Accumulated Translation Adjustment [Member] Derivative Instruments Accumulated Gain Loss Net Cash Flow Hedge Parent [Member] Accumulated Other Comprehensive Income Loss [Line Items] Accumulated Other Comprehensive Income Loss [Line Items] AOCI Attributable to Parent, Net of Tax [Roll Forward] A O C I Attributable To Parent Net Of Tax Roll Forward Other comprehensive gain (loss) before reclassifications Oci Before Reclassifications Net Of Tax Attributable To Parent Reclassification adjustments Reclassification From Aoci Current Period Net Of Tax Attributable To Parent Unrealized gain (loss) during period, before taxes Oci Before Reclassifications Before Tax Attributable To Parent Income tax expense (benefit) Other Comprehensive Income Loss Before Reclassifications Tax Reclassification adjustment, before taxes Reclassification From Aoci Current Period Before Tax Attributable To Parent Income tax expense Reclassification From Aoci Current Period Tax Reclassification adjustment, net of taxes Total unrealized gain (loss) on derivative instruments, net of taxes Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent Income tax (benefit) expense Other comprehensive income before reclassifications Other nonoperating income or expense not including foreign currency gain or loss. Net realized foreign currency loss Foreign Currency Transaction Gain Loss Realized Net unrealized foreign currency (gain) loss Foreign Currency Transaction Gain Loss Unrealized Equity investment (income) expense Debt And Equity Securities Unrealized Gain Loss Other, net Other Sundry Nonoperating Income Expense Total other (income) expense, net Cash paid for income taxes, net of refunds Income Taxes Paid Cash paid for interest (excluding finance leases) Interest Paid Net Supplemental disclosure of noncash investing and financing activities Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract] Non-cash investment to acquire certain intellectual property rights from a customer in lieu of cash payment for services rendered Fair Value Of Assets Acquired Fair value of contingent consideration related to acquisitions Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 Change in property and equipment included in liabilities Capital Expenditures Incurred But Not Yet Paid Vehicles acquired through finance lease agreements Capital Lease Obligations Incurred Rx data science acquisition member. Rx Data Science Acquisitions Rx Data Science Acquisitions [Member] Illingworth Research. Illingworth Research Group Acquisition Illingworth Research [Member] Related Party Related Party Transactions By Related Party [Axis] Related Party Related Party [Domain] Related party. Related Party Related Party [Member] Name of acquired entity Business Acquisition Name Of Acquired Entity Date of Acquisition Business Acquisition Date Of Acquisition Agreement1 Aggregate purchase price for the acquisition Business Combination Consideration Transferred1 Cash acquired Cash Acquired From Acquisition Intangible assets Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill Acquired backlog. Acquired backlog Acquired Backlog [Member] Trade name Trade Names [Member] Estimated Fair Value Finitelived Intangible Assets Acquired1 Percentage of Outstanding Shares Purchase. Percentage of Outstanding Shares Purchase Percentage Of Outstanding Shares Purchase Business acquisition payment of cash Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Current Assets Accounts Receivable And Unbilled Services. Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Right-Of-Use Assets. Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Accounts Payable And Accrued Expenses. Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Contract With Customer, Liability Schedule Of Restructuring And Related Costs [Table] Schedule Of Restructuring And Related Costs [Table] Restructuring Cost And Reserve [Line Items] Restructuring Cost And Reserve [Line Items] Assets acquired: Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets [Abstract] Cash and cash equivalents Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents Accounts receivable and unbilled services Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Accounts Receivable And Unbilled Services Prepaid expenses and other current assets Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets Property and equipment Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment Operating lease right-of-use assets Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Operating Lease Right Of Use Assets Other identifiable intangible assets Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles Other assets Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets Total assets acquired Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets Liabilities assumed: Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities [Abstract] Accounts payable and accrued expenses Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Accounts Payable And Accrued Expenses Deferred revenue Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Contract With Customer Liability Operating lease obligations Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Capital Lease Obligation Deferred income taxes, net Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities Other liabilities Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Other Total liabilities assumed Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities Net assets acquired Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net Minimum Cash consideration Proceeds From Divestiture Of Businesses Contingent consideration Business Combination Contingent Consideration Asset Divestiture, consideration received Disposal Group Including Discontinued Operation Consideration Convertible notes Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 Proceeds from notes receivable Proceeds From Sale Of Notes Receivable Gain (loss) on divestiture Assets exchanged in cash. Assets Exchanged In Cash Assets Exchanged In Cash Income (Loss) from Equity Method Investments Income Loss From Equity Method Investments Other long-term investments Other Long Term Investments Maximum loss on investment for a VIE Variable Interest Entity Entity Maximum Loss Exposure Amount Debt Instrument [Table] Debt Instrument [Table] Long-term Debt, Type Longterm Debt Type [Axis] Long-term Debt, Type Longterm Debt Type [Domain] Secured Debt Secured Debt [Member] Unsecured Debt Unsecured Debt [Member] Debt Instrument Debt Instrument [Axis] Debt Instrument, Name Debt Instrument Name [Domain] Term Loan A tranche one due march 2024. Term Loan A - tranche one due March 2024 Term Loan A Tranche One Due March2024 [Member] Term Loan A tranche two due August 2024. Term Loan A - tranche two due August 2024 Term Loan A Tranche Two Due August2024 [Member] 2017 Credit agreement term loan B due August 2024. 2017 Credit Agreement - Amendment No 2 - Term Loan B Due August 2024 A2017 Credit Agreement Term Loan B Due August2024 [Member] Accounts receivable financing agreement due october 2022. Accounts receivable financing agreement due October 2022 Accounts Receivable Financing Agreement Due October2022 [Member] Senior Unsecured Notes due January 2029 [Member] Senior Unsecured Notes due January 2029 Senior Unsecured Notes Due January2029 [Member] Credit Facility Credit Facility [Axis] Credit Facility Credit Facility [Domain] Accounts Receivable Securitization [Member] Accounts Receivable Securitization Accounts Receivable Securitization [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Total debt obligations Debt Instrument Carrying Amount Less: Term loans original issuance discount Debt Instrument Unamortized Discount Premium Net Less: Unamortized deferred issuance costs Deferred Finance Costs Net 2017 Credit agreement - Amendment No 2 - Term loan A due March 2024. 2017 Credit Agreement - Amendment No 2 - Term Loan B Due March 2024 A2017 Credit Agreement Amendment No2 Term Loan A Due March2024 [Member] Amendment No 2 - Revolving Credit Facility due August 2024. 2017 Credit Agreement - Amendment No 2 - Term Loan B Due August 2024 A2017 Credit Agreement Amendment No2 Revolving Credit Facility Due August2024 [Member] Term Loan [Member] Term Loan Term Loan [Member] Revolving credit facility due August 2024 Revolving Credit Facility [Member] Credit Agreement Amendment No 5 Term Loan A. Credit Agreement Amendment No5 Term Loan A Credit Agreement Amendment No5 Term Loan A [Member] Incremental term loan. Incremental Term Loan Incremental Term Loan [Member] 2017 Credit Agreement - Amendment No 2 - Term Loan A Due March 2024, Funded Amount [Member] 2017 Credit Agreement A2017 Credit Agreement Amendment No2 Term Loan A Due March2024 Funded Amount [Member] 2017 Credit Agreement, Term B Loan [Member] 2017 Credit Agreement A2017 Credit Agreement Term B Loan [Member] Variable Rate Variable Rate [Axis] Variable Rate Variable Rate [Domain] Federal Funds Effective Rate Federal Funds Effective Swap Rate [Member] Eurodollar Rate Eurodollar [Member] Base Rate Base Rate [Member] 2017 Credit Agreement - Revolving Credit Facility Due August 2022 [Member] 2017 Credit Agreement - Revolving Credit Facility A2017 Credit Agreement Revolving Credit Facility Due August2022 [Member] 2017 Credit agreement - Amendment No 2 - Term loan B due August 2024. 2017 Credit Agreement - Amendment No 2 - Term Loan B Due August 2024 A2017 Credit Agreement Amendment No2 Term Loan B Due August2024 [Member] Letter of credit Letter Of Credit [Member] 3.625% senior unsecured notes due 2029. Senior Unsecured Notes Due2029 Senior Unsecured Notes Due2029 [Member] 3.625 percentage senior notes member 3.625% Senior Notes Three Point Six Hundred Twenty Five Percentage Senior Notes [Member] Term loan facility Debt Instrument Face Amount Maximum borrowing capacity under accounts receivable financing agreement Line Of Credit Facility Maximum Borrowing Capacity Additional discount on Term loan Debt Instrument Unamortized Discount Repayments of Long-term debt Loss on extinguishment of debt Guarantor obligations percent of foreign subsidiary capital stock securing debt. Percentage of capital stock of certain controlled foreign subsidiaries securing debt obligation Guarantor Obligations Percent Of Foreign Subsidiary Capital Stock Securing Debt Applicable margin on variable rate (percent) Debt Instrument Basis Spread On Variable Rate1 2017 Credit Agreement - Amendment No. 1 - Term Loan A Due August 2022 [Member] Term Loan A A2017 Credit Agreement Amendment No1 Term Loan A Due August2022 [Member] Amendment No. 1, Term B Loan [Member] Term Loan B Amendment No1 Term B Loan [Member] Eurocurrency Rate [Member] Eurocurrency Rate Eurocurrency Rate [Member] Debt Instrument, Covenant, First Lien Leverage Ratio, Maximum Quarterly commitment fee on average daily unused balance Line Of Credit Facility Unused Capacity Commitment Fee Percentage Interest rate Line Of Credit Facility Interest Rate At Period End Maximum first lien leverage ratio Debt Instrument Covenant First Lien Leverage Ratio Maximum Derivative, Basis Spread on Variable Rate Derivative Basis Spread On Variable Rate Outstanding borrowings Line Of Credit Available borrowings Line Of Credit Facility Remaining Borrowing Capacity Line of credit facility, capacity available for trade purchases Line Of Credit Facility Capacity Available For Trade Purchases Receivables Financing Agreement, Prepayment of Loan Facility, Notice Term Receivables Financing Agreement, Termination Or Reduction To Facility Limit Notice Term Consolidated Entities Consolidated Entities [Axis] Consolidated Entities Consolidated Entities [Domain] Subsidiaries Subsidiaries [Member] Accounts receivable financing agreement due September 2021. Accounts receivable financing agreement due September 2021 Accounts Receivable Financing Agreement Due September2021 [Member] Federal Funds Rate [Member] Federal Funds Rate Federal Funds Rate [Member] Line of credit facility, decrease, forgiveness Line Of Credit Facility Decrease Forgiveness1 Prepay notice, term Receivables Financing Agreement Prepayment Of Loan Facility Notice Term Termination or reduction to limit notice, term Receivables Financing Agreement Termination Or Reduction To Facility Limit Notice Term Long-term debt Long Term Debt Weighted average imputed interest rate Debt Instrument Interest Rate Effective Percentage Voluntary prepayments on term loans Early Repayment Of Senior Debt Debt instrument, interest rate Debt Instrument Interest Rate During Period Percentage redeemed Debt Instrument Redemption Price Percentage Of Principal Amount Redeemed Debt redemption price percentage Debt Instrument Redemption Price Percentage 2022 Long Term Debt Maturities Repayments Of Principal In Next Twelve Months 2023 Long Term Debt Maturities Repayments Of Principal In Year Two 2024 Long Term Debt Maturities Repayments Of Principal In Year Three 2025 Long Term Debt Maturities Repayments Of Principal In Year Four 2026 Long Term Debt Maturities Repayments Of Principal In Year Five 2027 and thereafter Long Term Debt Maturities Repayments Of Principal After Year Five Total Lease, Remaining Lease Term Lessee Lease Description [Table] Lessee Lease Description [Table] Lessee Lease Description [Line Items] Lessee Lease Description [Line Items] Lease, remaining lease term Lease Remaining Lease Term Fixed Lease, Costs Operating Lease, Variable Lease, Cost Finance Lease, Variable Lease, Cost Finance Lease, Costs Fixed lease costs Fixed Lease Costs Short-term lease costs Short Term Lease Cost Variable lease costs Operating Lease Variable Lease Cost Total operating lease costs Operating Lease Cost Amortization of right-of-use assets Finance Lease Right Of Use Asset Amortization Interest on lease liabilities Finance Lease Interest Expense Variable lease costs Finance Lease Variable Lease Cost Total finance lease costs Finance Lease Costs Finance Lease, Right-Of-Use Asset, Accumulated Depreciation Accumulated depreciation Finance Lease Right Of Use Asset Accumulated Depreciation Property and equipment, net Total finance lease liabilities Finance Lease Liability Operating Lease Liability Closed Out In Exchange For Right-Of-Use Asset Operating cash flows for operating leases Operating Lease Payments Operating cash flows for finance leases Finance Lease Interest Payment On Liability Right-of-use asset obtained in exchange for lease liability, Operating leases Right Of Use Asset Obtained In Exchange For Operating Lease Liability Right-of-use asset obtained in exchange for lease liability, Finance leases Right Of Use Asset Obtained In Exchange For Finance Lease Liability Lease obligations closed out in exchange for right-of-use asset, Operating leases Operating Lease Liability Closed Out In Exchange For Right Of Use Asset Weighted average remaining lease term, Operating lease Operating Lease Weighted Average Remaining Lease Term1 Weighted average remaining lease term, Finance lease Finance Lease Weighted Average Remaining Lease Term1 Weighted average discount rate, Operating leases Operating Lease Weighted Average Discount Rate Percent Weighted average discount rate, Finance leases Finance Lease Weighted Average Discount Rate Percent Operating And Finance Lease, Liability, Payments, Due Operating And Finance Lease, Liability, Payments, Next Twelve Months Operating And Finance Lease, Liability, Payments, Due Year Two Operating And Finance Lease, Liability, Payments, Due Year Three Operating And Finance Lease, Liability, Payments, Due Year Four Operating And Finance Lease, Liability, Payments, Due Year Five Operating And Finance Lease, Liability, Payments, Due After Year Five Operating Leases Operating Lease Liabilities Payments Due [Abstract] 2022 Lessee Operating Lease Liability Payments Due Next Twelve Months 2023 Lessee Operating Lease Liability Payments Due Year Two 2024 Lessee Operating Lease Liability Payments Due Year Three 2025 Lessee Operating Lease Liability Payments Due Year Four 2026 Lessee Operating Lease Liability Payments Due Year Five 2027 and thereafter Lessee Operating Lease Liability Payments Due After Year Five Total lease payments Lessee Operating Lease Liability Payments Due Less: Management fee Lessee Operating Lease Liability Management Fee Less: Imputed interest Lessee Operating Lease Liability Undiscounted Excess Amount Total lease liabilities Operating Lease Liability Finance Leases Finance Lease Liabilities Payments Due [Abstract] 2022 Finance Lease Liability Payments Due Next Twelve Months 2023 Finance Lease Liability Payments Due Year Two 2024 Finance Lease Liability Payments Due Year Three 2025 Finance Lease Liability Payments Due Year Four 2026 Finance Lease Liability Payments Due Year Five 2027 and thereafter Finance Lease Liability Payments Due After Year Five Total lease payments Finance Lease Liability Payments Due Less: Management fee Finance Lease Liability Management Fee Less: Imputed interest Finance Lease Liability Undiscounted Excess Amount Total lease liabilities 2022 Operating And Finance Lease Liability Payments Next Twelve Months 2023 Operating And Finance Lease Liability Payments Due Year Two 2024 Operating And Finance Lease Liability Payments Due Year Three 2025 Operating And Finance Lease Liability Payments Due Year Four 2026 Operating And Finance Lease Liability Payments Due Year Five 2027 and thereafter Operating And Finance Lease Liability Payments Due After Year Five Total lease payments Operating And Finance Lease Liability Payments Due Derivative [Table] Derivative [Table] Derivative Instrument Derivative Instrument Risk [Axis] Derivative Contract Derivative Contract Type [Domain] Interest rate swap expiring June 30, 2021. Interest Rate Swap, expiring June 30, 2021 Interest Rate Swap Expiring June302021 [Member] Interest rate swap expiring March 31, 2023. Interest Rate Swap, expiring March 31, 2023 Interest Rate Swap Expiring March312023 [Member] Foreign Exchange Forward Foreign Exchange Forward [Member] Derivative [Line Items] Derivative [Line Items] Notional amount Derivative Notional Amount Foreign currency forward gain loss realized Fair Values Derivatives Balance Sheet Location By Derivative Contract Type By Hedging Designation [Table] Fair Values Derivatives Balance Sheet Location By Derivative Contract Type By Hedging Designation [Table] Hedging Relationship Derivative Instruments Gain Loss By Hedging Relationship [Axis] Hedging Relationship Hedging Relationship [Domain] Cash Flow Hedging Cash Flow Hedging [Member] Intrest rate swaps Interest Rate Swap [Member] Balance Sheet Location Balance Sheet Location [Axis] Balance Sheet Location Balance Sheet Location [Domain] Other Noncurrent Assets Other Noncurrent Assets [Member] Accrued expenses Accrued Liabilities [Member] Other Noncurrent Liabilities Other Noncurrent Liabilities [Member] Derivatives, Fair Value [Line Items] Derivatives Fair Value [Line Items] Derivative assets - non-current Derivative Liabilities Noncurrent Derivative assets Derivative Assets Derivative liability - current Derivative Assets Current Derivative liability Derivative Liabilities Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Measurement Frequency Fair Value By Measurement Frequency [Axis] Measurement Frequency Fair Value Measurement Frequency [Domain] Recurring Fair Value Measurements Recurring [Member] Fair Value Hierarchy and NAV Fair Value By Fair Value Hierarchy Level [Axis] Fair Value Hierarchy and NAV Fair Value Measurements Fair Value Hierarchy [Domain] Level 1 Fair Value Inputs Level1 [Member] Level 2 Fair Value Inputs Level2 [Member] Level 3 Fair Value Inputs Level3 [Member] Investments Measured at Net Asset Value Fair Value Measured At Net Asset Value Per Share [Member] Investment Type Investment Type [Axis] Investments Investment Type Categorization [Member] Partnership Interest Partnership Interest [Member] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Assets: Assets Fair Value Disclosure [Abstract] Trading securities Trading Securities Partnership interest Alternative Investment Total assets Assets Fair Value Disclosure Liabilities: Liabilities Fair Value Disclosure [Abstract] Derivative instruments Contingent obligations related to acquisitions Business Combination Contingent Consideration Liability Total liabilities Liabilities Fair Value Disclosure Contractual obligation not yet satisfied. Number of private equity funds. Ownership Ownership [Axis] Ownership Ownership [Domain] Healthcare and life sciences industry. Healthcare and Life Sciences Industry Healthcare And Life Sciences Industry [Member] Commitment to invest a limited partner in private equity funds Contractual Obligation Remaining unfunded commitment Contractual Obligation Not Yet Satisfied Minority interest ownership percentage Minority Interest Ownership Percentage By Parent Number of private equity funds Number Of Private Equity Funds Balance at Beginning of period Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value Additions Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases Changes in fair value recognized in earnings Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings Payments Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements Balance at End of period Nonrecurring Fair Value Measurements Nonrecurring [Member] Fair value assets transferred from level 1 to level 2 Fair Value Assets Level1 To Level2 Transfers Amount Fair value assets transferred from level 2 to level 1 Fair Value Assets Level2 To Level1 Transfers Amount Fair value liabilities transferred from level 1 to level 2 Fair Value Liabilities Level1 To Level2 Transfers Amount Fair value liabilities transferred from level 2 to level 1 Fair Value Liabilities Level2 To Level1 Transfers Amount Fair value assets transferred into level 3 Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 Fair value assets transferred out of level 3 Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 Fair value liabilities transferred into level 3 Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 Fair value liabilities transferred out of level 3 Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 Goodwill and identifiable intangible assets Intangible Assets Net Including Goodwill 2017 Credit agreement - Amendment No 2 - Term loan A tranche one due March 2024. Term Loan A - Tranche One Due March 2024 A2017 Credit Agreement Amendment No2 Term Loan A Tranche One Due March2024 [Member] 2017 Credit agreement - Amendment No 2 - Term loan A tranche two due August 2024. Term Loan A - Tranche Two Due August 2024 A2017 Credit Agreement Amendment No2 Term Loan A Tranche Two Due August2024 [Member] Measurement Basis Fair Value By Measurement Basis [Axis] Fair Value Disclosure Item Amounts [Default] Portion At Fair Value Fair Value Disclosure [Member] Fair Value Measurement Fair Value Disclosure Item Amounts [Domain] Reported Value Measurement Carrying Reported Amount Fair Value Disclosure [Member] Estimate of Fair Value Measurement Estimate Of Fair Value Fair Value Disclosure [Member] Senior Note Due 2029. Senior Notes Due January 2029 Senior Note Due2029 [Member] Long-term debt, carrying value Debt Longterm And Shortterm Combined Amount Long-term debt, fair value Long Term Debt Fair Value Restructuring Type Restructuring Cost And Reserve [Axis] Type of Restructuring Type Of Restructuring [Domain] Employee severance and benefit costs Employee Severance [Member] Facility and lease termination costs Facility Closing [Member] Other costs Other Restructuring [Member] Total non-Merger related restructuring and other costs: Restructuring And Related Cost Incurred Cost Restructuring Charge Including Other Costs. SEC Schedule, 12-09, Valuation Allowances and Reserves Type Valuation Allowances And Reserves Type [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves Valuation Allowances And Reserves [Domain] Business Restructuring Reserves Business Restructuring Reserves [Member] Employee Severance Costs, Including Executive Transition Costs [Member] Employee Severance Costs Employee Severance Costs Including Executive Transition Costs [Member] Other Costs Balance at the beginning of the period Expenses incurred (a) Restructuring Charge Including Other Costs1 Cash payments made Valuation Allowances And Reserves Deductions Balance at the end of the period Business Exit Costs And (Gain) Loss On Termination Of Lease Other restructuring expenses, non-cash Other Cost And Expense Operating Business exit costs and (gain) loss on termination of lease Business Exit Costs And Gain Loss On Termination Of Lease Schedule Of Stock By Class [Table] Schedule Of Stock By Class [Table] Class of Stock [Line Items] Class Of Stock [Line Items] Common stock shares, beginning balance Shares Outstanding Repurchases of common stock Stock Repurchased During Period Shares Issuances of common stock Stock Issued During Period Shares Other Common stock shares, ending balance Class of Stock Statement Class Of Stock [Axis] Class of Stock Class Of Stock [Domain] Common Class A [Member] Common Class A [Member] Common Stock Common Class B [Member] Common Class B [Member] Stock repurchase program, authorized amount Stock Repurchase Program Remaining Authorized Repurchase Amount1 Stock Repurchase Program 2021, Authorized Amount Stock Repurchase Program Authorized Amount1 Stock repurchased during period, shares Stock repurchased during period, value Stock Repurchase Program, Shares Purchased, Value Stock repurchased (in shares) Stock repurchased, average price paid per share (USD per share) Treasury Stock Acquired Average Cost Per Share Stock repurchase program, shares purchased, value Stock Repurchase Program Shares Purchased Value Shares Authorized [Abstract] Common and Preferred Stock, Shares Authorized Shares Issued [Abstract] Shares Outstanding [Abstract] Shares Authorized: Shares Authorized [Abstract] Common and Preferred stock, shares authorized (in shares) Commonand Preferred Stock Shares Authorized Shares Issued: Shares Issued [Abstract] Shares Outstanding: Shares Outstanding [Abstract] Common Stock, Votes Class B Common Stock, Conversion Ratio Number of votes Common Stock Votes Class B common stock, conversion ratio Class B Common Stock Conversion Ratio Class C common stock dividends Dividends Common Stock Cash Numerator: Income Loss From Discontinued Operations And Disposal Of Discontinued Operations Net Of Tax Per Basic Share [Abstract] Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Basic weighted average common shares outstanding (in shares) Effect of dilutive securities: Weighted Average Number Diluted Shares Outstanding Adjustment [Abstract] Stock options and other awards under deferred share-based compensation programs (in shares) Incremental Common Shares Attributable To Share Based Payment Arrangements Diluted weighted average common shares outstanding (in shares) Earnings per share: Earnings Per Share Basic [Abstract] Anti-dillutive shares outstanding excluded from the computation of diluted earnings per share Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Domestic Income Loss From Continuing Operations Before Income Taxes Domestic Foreign Income Loss From Continuing Operations Before Income Taxes Foreign Federal income taxes: Federal Income Tax Expense Benefit Continuing Operations [Abstract] Current Current Federal Tax Expense Benefit Deferred Deferred Federal Income Tax Expense Benefit Foreign income taxes: Foreign Income Tax Expense Benefit Continuing Operations [Abstract] Current Current Foreign Tax Expense Benefit Deferred Deferred Foreign Income Tax Expense Benefit State income taxes: State And Local Income Tax Expense Benefit Continuing Operations [Abstract] Current Current State And Local Tax Expense Benefit Deferred Deferred State And Local Income Tax Expense Benefit Income tax expense (benefit) Amount of foreign earnings previously taxed in the U.S., total. Foreign Earnings Previously Taxed in the US, Intended To Be Permanently Reinvested Foreign Earnings Previously Taxed in the US, Intended To Be Repatriated Condensed Balance Sheet Statement [Table] Condensed Balance Sheet Statement [Table] Income Tax Authority Income Tax Authority [Axis] Income Tax Authority Income Tax Authority [Domain] Domestic Tax Authority Domestic Country [Member] State and Local Jurisdiction State And Local Jurisdiction [Member] Foreign Tax Authority Foreign Country [Member] Foreign Jurisdictions Tax Credit Carryforward Tax Credit Carryforward [Axis] Tax Credit Carryforward, Name Tax Credit Carryforward Name [Domain] Research and Development Credit Carry Forwards Research [Member] Income Tax Authority, Name Income Tax Authority Name [Axis] Income Tax Authority, Name Income Tax Authority Name [Domain] Canada Revenue Agency Canada Revenue Agency [Member] Condensed Balance Sheet Statements Captions [Line Items] Condensed Balance Sheet Statements Captions [Line Items] Accumulated foreign earnings Foreign Earnings Previously Taxedinthe U S Total Foreign earnings previously taxed in the US, intended to be permanently reinvested Foreign Earnings Previously Taxedinthe U S Intended To Be Permanently Reinvested Foreign earnings previously taxed in the US, intended to be repatriated Foreign Earnings Previously Taxedinthe U S Intended To Be Repatriated Undistributed foreign earnings Deferred Tax Liabilities Undistributed Foreign Earnings Federal tax rate Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Expected income tax expense at statutory rate Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate Change in income tax expense resulting from: Income Tax Expense Benefit Continuing Operations Income Tax Reconciliation [Abstract] Foreign income inclusion Effective Income Tax Rate Reconciliation Foreign Income Inclusion Foreign earnings not indefinitely reinvested Effective Income Tax Rate Reconciliation Foreign Earnings Not Indefinitely Reinvested Foreign tax credits Income Tax Reconciliation Tax Credits Foreign Changes in income tax valuation allowance (all jurisdictions) Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance Change in fair value of contingent obligations Income Tax Reconciliation Tax Exempt Income Share-based compensation Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount Research and general business tax credits Income Tax Reconciliation Tax Credits State and local taxes, net of federal benefit Income Tax Reconciliation State And Local Income Taxes Capital loss carryforward Income Tax Reconciliation Nondeductible Expense Capital Loss Carryforward Foreign rate differential Income Tax Reconciliation Foreign Income Tax Rate Differential Changes in reserve for uncertain tax positions including interest Income Tax Reconciliation Tax Contingencies Provision to tax return and other deferred tax adjustments Income Tax Reconciliation Prior Year Income Taxes Gain on sale of business Loss Gain On Sale Of Business Income Tax Base erosion and anti-abuse tax Tax Cuts And Jobs Act Of2017 Base Erosion And Anti Abuse Tax Nondeductible executive compensation Effective Income Tax Rate Reconciliation Executive Compensation Limitation Amount Other, net Income Tax Reconciliation Other Adjustments Tax Credit Carryforward [Table] Tax Credit Carryforward [Table] Research and general business tax credits. Research and general business tax credits Research And General Business Tax Credits [Member] Capital loss carryforward Capital Loss Carryforward [Member] Tax Credit Carryforward [Line Items] Tax Credit Carryforward [Line Items] Valuation allowances and reserves deferred tax assets assumed through business combinations Valuation allowances and reserves deferred tax assets released through business dispositions Valuation Allowance And Reserves, Charged To Equity Valuation Allowances and Reserves, Foreign Currency Exchange Amount of change in valuation allowance from other adjustments. Valuation Allowance [Table] Valuation Allowance [Table] SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset Valuation Allowance Of Deferred Tax Assets [Member] Valuation Allowance [Line Items] Valuation Allowance [Line Items] Deferred tax assets assumed through acquisitions Valuation Allowances And Reserves Deferred Tax Assets Assumed Through Business Combinations Deferred tax assets released through divestitures Valuation Allowances And Reserves Deferred Tax Assets Released Through Business Dispositions (Credited) charged to income tax expense Valuation Allowances And Reserves Charged To Other Accounts Charged to equity Valuation Allowance And Reserves Charged To Equity Foreign currency exchange Valuation Allowancesand Reserves Foreign Currency Exchange Other adjustments Valuation Allowances And Reserves Other Adjustments Valuation allowance increase (decrease) Valuation Allowance Deferred Tax Asset Change In Amount Deferred Tax Assets, Tax Deferred Expense, Lease Obligations Deferred Tax Assets, Tax Deferred Expense, Prepaid Royalty Deferred Tax Asset, Interest Limitation Carryforward Deferred Tax Liabilities, Right of Use Assets Deferred tax assets: Deferred Tax Assets Gross [Abstract] Net operating losses Deferred Tax Assets Operating Loss Carryforwards Tax credits Deferred Tax Assets Tax Credit Carryforwards Deferred revenue Deferred Tax Assets Deferred Income Employee compensation and other benefits Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits Allowance for doubtful accounts Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts Lease obligations Deferred Tax Assets Tax Deferred Expense Lease Obligations Accrued expenses Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities Prepaid royalty Deferred Tax Assets Tax Deferred Expense Prepaid Royalty Capital loss carryforward Deferred Tax Assets Capital Loss Carryforwards Interest limitation carryforwards Deferred Tax Asset Interest Limitation Carryforward Other Deferred Tax Assets Other Total deferred tax assets Deferred Tax Assets Gross Less: valuation allowance Deferred Tax Assets Valuation Allowance Net deferred tax assets Deferred Tax Assets Net Deferred tax liabilities: Deferred Tax Liabilities [Abstract] Undistributed foreign earnings Right of use asset Deferred Tax Liabilities Right Of Use Assets Depreciation and amortization Deferred Tax Liabilities Property Plant And Equipment Deferred revenue Deferred Tax Liabilities Tax Deferred Income Other Deferred Tax Liabilities Other Total deferred tax liabilities Deferred Income Tax Liabilities Net deferred tax assets (liabilities) Deferred Tax Liabilities Net deferred tax assets (liabilities) Deferred Tax Assets Liabilities Net Operating loss carryforwards expiration year. Operating loss carryforwards Operating Loss Carryforwards Operating loss carryforwards, expiration year Operating Loss Carryforwards Expiration Year Canadian research and development credit carry forwards Tax Credit Carryforward Amount Valuation allowance, Canadian research and development credit carry forwards Tax Credit Carryforward Valuation Allowance Gross unrecognized tax benefits Unrecognized Tax Benefits Decrease in unrecognized tax benefit in foreign jurisdictions Unrecognized Tax Benefits Period Increase Decrease Accrued income tax interest and penalties Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Decrease in unrecognized tax benefits Decrease In Unrecognized Tax Benefits Is Reasonably Possible Unrecognized tax benefits Increases for tax positions in the current year Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions Increases for tax positions of prior years Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions Decreases for tax positions in prior year Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions Settlements with tax authorities Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities Impact of foreign currency translation Unrecognized Tax Benefits Decreases Resulting From Foreign Currency Translation Impact of foreign currency translation Unrecognized Tax Benefits Increases Resulting From Foreign Currency Translation Lapse of statute limitations Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations Unrecognized tax benefits balance Revenue, Performance Obligation, Contract Term Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Table] Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Table] Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] Unsatisfied performance obligations under contracts with a contract term greater than one year Revenue Remaining Performance Obligation Contract term Revenue Performance Obligation Contract Term Revenue from change in estimate. Revenue recognized, included in contract liabilities balance at beginning of period Contract With Customer Liability Revenue Recognized Increase (decrease) in revenue recognized, allocated to performance obligation partially satisfied in previous periods Contract With Customer Performance Obligation Satisfied In Previous Period Revenue from change in estimate Revenue From Change In Estimate Schedule Of Segment Reporting Information By Segment [Table] Schedule Of Segment Reporting Information By Segment [Table] Consolidation Items Consolidation Items [Axis] Consolidation Items Consolidation Items [Domain] Operating Segments Operating Segments [Member] Corporate Corporate Non Segment [Member] Income Statement Location Income Statement Location [Axis] Income Statement Location Income Statement Location [Domain] Cost of Services [Member] Direct costs Costof Services [Member] Selling, general, and administrative expenses Selling General And Administrative Expenses [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Operating income (loss) Share-based compensation expense Allocated Share Based Compensation Expense Depreciation and amortization Depreciation Amortization And Accretion Net Schedule Of Revenues From External Customers And Long Lived Assets [Table] Schedule Of Revenues From External Customers And Long Lived Assets [Table] Geographical Statement Geographical [Axis] Geographical Segment Geographical [Domain] North America North America [Member] Europe, Middle East, and Africa E M E A [Member] Asia-Pacific Asia Pacific [Member] Latin America Latin America [Member] United States UNITED STATES Concentration Risk Type Concentration Risk By Type [Axis] Concentration Risk Type Concentration Risk Type [Domain] Geographic Concentration Risk Geographic Concentration Risk [Member] Concentration Risk Benchmark Concentration Risk By Benchmark [Axis] Concentration Risk Benchmark Concentration Risk Benchmark [Domain] Net Service Revenue Sales Revenue Net [Member] Revenues by Geographic Location Revenues From External Customers And Long Lived Assets [Line Items] Concentration risk percentage Concentration Risk Percentage1 Long-Lived Assets by Geographic Location Total property and equipment, net Concentration Risk [Table] Concentration Risk [Table] Customer Concentration Risk Customer Concentration Risk [Member] Customer Major Customers [Axis] Customer Name Of Major Customer [Domain] Major Customer Other Customer [Member] Accounts Receivable Accounts Receivable [Member] Concentration Risk Concentration Risk [Line Items] Related Party Transaction, Number Of Counterparties Schedule Of Related Party Transactions By Related Party [Table] Schedule Of Related Party Transactions By Related Party [Table] Title of Individual Title Of Individual [Axis] Title of Individual Title Of Individual With Relationship To Entity [Domain] Board of Directors Director [Member] Affiliated Entity Affiliated Entity [Member] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Revenue from related parties Revenue From Related Parties Receivables from related party Related Party Transaction Purchases From Related Party Number of counterparties Related Party Transaction Number Of Counterparties Professional services expenses from transaction with related party Related Party Transaction Expenses From Transactions With Related Party Potential future cash consideration, in exchange of sale of company's contingent staffing business to related party Loss Contingency, Number Of Actions Taken By Plaintiff Loss Contingencies [Table] Loss Contingencies [Table] Litigation Status Litigation Status [Axis] Litigation Status Litigation Status [Domain] Pending Litigation Pending Litigation [Member] Litigation Case Litigation Case [Axis] Litigation Case Litigation Case Type [Domain] Bermudez And Vaitkuviene Action [Member] Bermudez and Vaitkuviene Actions Bermudez And Vaitkuviene Action [Member] Represents the aggregation and reporting of information related to the Company's merger with InVentiv Health, Inc. InVentiv Merger In Ventiv Merger [Member] RxDataScience. RxDataScience [Member] Rx Data Science [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Number of actions taken by plaintiff Loss Contingency Number Of Actions Taken By Plaintiff Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Plan Name Plan Name [Axis] Plan Name Plan Name [Domain] Two Thousand Fourteen Equity Incentive Plan 2014 Equity Incentive Plan Two Thousand Fourteen Equity Incentive Plan [Member] Award Type Award Type [Axis] Award Type Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain] Stock options Employee Stock Option [Member] Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan (ESPP) Employee Stock Purchase Plan [Member] Time based restricted stock units awards Restricted Stock Units (RSUs) Time Based Restricted Stock Units Awards [Member] Performance based restricted stock units Performance Based Restricted Stock Units Performance Based Restricted Stock Units [Member] Performance Based Restricted Stock Units Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Number of plans Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans Vesting period Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 Expiration term Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period Number of shares authorized Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Number of shares available for future grants Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Payroll deductions as a percentage of employee base salary, maximum Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate Discount from market price of common stock, offering date Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Offering Date Shares issued (in shares) Stock Issued During Period Shares Employee Stock Purchase Plans Shares available for future grants (in shares) Common Stock Capital Shares Reserved For Future Issuance ESPP Employee Stock [Member] Expected volatility - minimum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum Expected volatility - maximum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum Risk-free interest rate - minimum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum Risk-free interest rate - maximum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum Expected term (in years) Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 Number of Options Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Roll Forward Outstanding as of December 31, 2020 (in shares) Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Exercised (in shares) Stock Issued During Period Shares Stock Options Exercised Forfeited (in shares) Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Outstanding as of December 31, 2021 (in shares) Vested and expected to vest as of December 31, 2021 (in shares) Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number Exercisable as of December 31, 2021 (in shares) Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Rollforward Outstanding as of December 31, 2020 (in usd per share) Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Exercised (in usd per share) Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price Forfeited (in usd per share) Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price Outstanding at December 31, 2020 (in usd per share) Vested and expected to vest as of December 31, 2021 (in usd per share) Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price Exercisable as of December 31, 2021 (in usd per share) Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Share-based Compensation Arrangement By Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Life [Abstract] Weighted Average Remaining Contractual Life (in years) Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Life [Abstract] Outstanding as of December 31, 2021 (in years) Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 Vested and expected to vest as of December 31, 2021 (in years) Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 Exercisable as of December 31, 2021 (in years) Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 Aggregate Intrinsic Value (in thousands)(a) Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value [Abstract] Outstanding as of December 31, 2021 (in usd) Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Vested and expected to vest as of December 31, 2021 (in usd) Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value Exercisable as of December 31, 2021 (in usd) Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 Share price (in USD per share) Share Price Unrecognized compensation expense related to non-vested stock options Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options Stock options granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Total intrinsic value of options exercised Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value Time-based Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) Restricted Stock Units R S U [Member] Number of Shares Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Roll Forward Non-vested at December 31, 2020 (in shares) Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Granted (in shares) Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Vested (in shares) Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Forfeited (in shares) Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Non-vested at December 31, 2021 (in shares) Unrecognized compensation expense (in millions) Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Weighted average period unrecognized compensation is expected to be recognized Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 Weighted Average Grant Date Fair Value Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Roll Forward Non-vested at December 31, 2020 (in usd per share) Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Granted (in usd per share) Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value Vested (in usd per share) Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value Forfeited (in usd per share) Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value Non-vested at December 31, 2021 (in usd per share) Weighted-average grant-date fair value of the RSUs granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value Total fair value of shares vested Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value Fair value of shares vested Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Income tax benefit recognized for stock-based compensation arrangements Employee Service Share Based Compensation Tax Benefit From Compensation Expense Total defined contribution retirement plan contributions Defined Contribution Plan Cost Recognized Schedule Of Deferred Compensation Arrangement With Individual Excluding Share Based Payments And Postretirement Benefits By Title Of Individual And By Type Of Deferred Compensation [Table] Schedule Of Deferred Compensation Arrangement With Individual Excluding Share Based Payments And Postretirement Benefits By Title Of Individual And By Type Of Deferred Compensation [Table] Retirement Plan Sponsor Location Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location Retirement Plan Sponsor Location [Domain] Foreign Plan Foreign Plan [Member] Deferred Compensation Arrangement [Line Items] Deferred Compensation Arrangement With Individual Excluding Share Based Payments And Postretirement Benefits [Line Items] Employer contribution amount Defined Contribution Plan Employer Discretionary Contribution Amount Deferred Compensation Arrangement with Individual, Cash Awards Granted, Commissions, Percentage Allowable deferred amount, salary, percent Deferred Compensation Arrangement With Individual Cash Awards Granted Percentage Allowable deferred amount, commissions, percent Deferred Compensation Arrangement With Individual Cash Awards Granted Commissions Percentage Deferred compensation liabilities Deferred Compensation Liability Classified Noncurrent EX-101.PRE 21 synh-20211231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 22 R1.htm IDEA: XBRL DOCUMENT v3.22.0.1
Cover Page - USD ($)
 12 Months Ended
Dec. 31, 2021
Feb. 10, 2022
Jun. 30, 2021
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2021    
Document Fiscal Year Focus 2021    
Document Fiscal Period Focus FY    
Current Fiscal Year End Date --12-31    
Entity File Number 001-36730    
Entity Registrant Name SYNEOS HEALTH, INC.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 27-3403111    
Entity Address, Address Line One 1030 Sync Street    
Entity Address, City or Town Morrisville    
Entity Address, State or Province NC    
Entity Address, Postal Zip Code 27560-5468    
City Area Code 919    
Local Phone Number 876-9300    
Title of 12(b) Security Class A Common Stock, par value $0.01 per share    
Trading Symbol SYNH    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Entity Shell Company false    
Entity Public Float     $ 9,235,907,535
Entity Common Stock, Shares Outstanding   104,221,138  
Documents Incorporated by Reference Portions of the registrant’s Proxy Statement for its 2022 Annual Meeting of Stockholders are incorporated by reference into Part III hereof    
Entity Central Index Key 0001610950    
Auditor Name Deloitte & Touche LLP    
Auditor Location Raleigh, North Carolina    
Auditor Firm ID 34    

XML 23 R2.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]      
Revenue $ 5,212,970 $ 4,415,777 $ 4,675,815
Costs and operating expenses:      
Direct costs (exclusive of depreciation and amortization) 3,994,484 3,398,142 3,645,905
Selling, general, and administrative expenses 570,765 472,726 507,556
Restructuring and other costs 22,816 29,414 42,135
Depreciation 73,832 70,185 76,532
Amortization 161,793 152,167 165,933
Total operating expenses 4,823,690 4,122,634 4,438,061
Income from operations 389,280 293,143 237,754
Total other expense, net:      
Interest income (111) (265) (7,542)
Interest expense 79,252 91,145 129,820
Loss (gain) on extinguishment of debt 3,612 1,581 (10,395)
Other (income) expense, net (8,633) (2,976) 24,162
Total other expense, net 74,120 89,485 136,045
Income before provision for income taxes 315,160 203,658 101,709
Income tax expense (benefit) 80,329 10,871 (29,549)
Net income $ 234,831 $ 192,787 $ 131,258
Earnings per share:      
Basic (USD per share) $ 2.26 $ 1.85 $ 1.27
Diluted (USD per share) $ 2.24 $ 1.83 $ 1.25
Weighted average common shares outstanding:      
Basic (in shares) 103,872 104,168 103,618
Diluted (in shares) 105,065 105,465 105,005
XML 24 R3.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Statement Of Income And Comprehensive Income [Abstract]      
Net income $ 234,831 $ 192,787 $ 131,258
Unrealized gain (loss) on derivative instruments, net of income tax expense (benefit) of $5,599, $(1,394), and $(2,122), respectively 16,140 (3,925) (7,596)
Foreign currency translation adjustments, net of income tax (benefit) expense of $(1,472), $1,354, and $0, respectively (24,957) 34,717 24,198
Comprehensive income $ 226,014 $ 223,579 $ 147,860
XML 25 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Statement Of Income And Comprehensive Income [Abstract]      
Income tax expense (benefit) related to unrealized gain (loss) on derivative instruments recorded in other comprehensive loss $ 5,599 $ (1,394) $ (2,122)
Other comprehensive expense (benefit), foreign currency translation adjustment, tax $ (1,472) $ 1,354 $ 0
XML 26 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Current assets:    
Cash, cash equivalents, and restricted cash $ 106,475 $ 272,173
Accounts receivable and unbilled services, net 1,524,890 1,344,781
Prepaid expenses and other current assets 135,091 121,058
Total current assets 1,766,456 1,738,012
Property and equipment, net 222,657 216,200
Operating lease right-of-use assets 209,408 223,285
Goodwill 4,956,015 4,776,178
Intangible assets, net 854,067 933,525
Deferred income tax assets 35,387 35,059
Other long-term assets 193,103 141,047
Total assets 8,237,093 8,063,306
Current liabilities:    
Accounts payable 107,535 113,684
Accrued expenses 614,441 611,042
Deferred revenue 868,455 793,068
Current portion of operating lease obligations 43,058 42,082
Current portion of finance lease obligations 20,627 17,455
Total current liabilities 1,654,116 1,577,331
Long-term debt 2,775,721 2,902,054
Operating lease long-term obligations 205,798 221,760
Finance lease long-term obligations 34,181 31,522
Deferred income tax liabilities 78,062 20,216
Other long-term liabilities 76,660 68,311
Total liabilities 4,824,538 4,821,194
Commitments and contingencies (Note 17)
Shareholders’ equity:    
Preferred stock, $0.01 par value; 30,000 shares authorized, 0 shares issued and outstanding as of December 31, 2021 and 2020
Common stock, $0.01 par value; 600,000 shares authorized, 103,764 and 103,935 shares issued and outstanding as of December 31, 2021 and 2020, respectively 1,038 1,039
Additional paid-in capital 3,474,088 3,461,747
Accumulated other comprehensive loss, net of taxes (49,618) (40,801)
Accumulated deficit (12,953) (179,873)
Total shareholders’ equity 3,412,555 3,242,112
Total liabilities and shareholders’ equity $ 8,237,093 $ 8,063,306
XML 27 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Dec. 31, 2021
Dec. 31, 2020
Statement Of Financial Position [Abstract]    
Preferred stock par value (USD per share) $ 0.01 $ 0.01
Preferred stock shares authorized (in shares) 30,000,000 30,000,000
Preferred stock shares issued (in shares) 0 0
Preferred stock shares outstanding (in shares) 0 0
Common stock par value (USD per share) $ 0.01 $ 0.01
Common stock shares authorized (in shares) 600,000,000 600,000,000
Common stock shares issued (in shares) 103,764,000 103,935,000
Common stock shares outstanding (in shares) 103,763,635 103,934,738
XML 28 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Net income $ 234,831 $ 192,787 $ 131,258
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 235,625 222,352 242,465
Share-based compensation 65,204 58,491 55,193
Provision for doubtful accounts 367 695 1,897
Provision for (benefit from) deferred income taxes 46,522 (3,839) (40,069)
Foreign currency transaction adjustments (5,928) 4,148 11,166
Fair value adjustment of contingent obligations (597) (3,664) 17,260
Gain on sale of business   (7,133)  
Loss (gain) on extinguishment of debt 3,612 1,581 (10,395)
Other non-cash items 7,789 1,765 2,766
Changes in operating assets and liabilities, net of effect of acquisitions:      
Accounts receivable, unbilled services, and deferred revenue (109,364) 16,316 (120,389)
Accounts payable and accrued expenses 24,620 (2,561) 28,316
Other assets and liabilities (52,403) (55,445) (987)
Net cash provided by operating activities 450,278 425,493 318,481
Cash flows from investing activities:      
Payments related to acquisitions of businesses, net of cash acquired (278,920) (456,455) (712)
Proceeds from notes receivable from divestiture 5,000    
Proceeds from sale of business   17,970  
Purchases of property and equipment (56,841) (50,010) (63,973)
Investments in unconsolidated affiliates (5,741) (15,589) (16,976)
Loan to unconsolidated affiliate (3,844)    
Net cash used in investing activities (340,346) (504,084) (81,661)
Cash flows from financing activities:      
Proceeds from issuance of long-term debt, net of discount 494,505 600,000 582,000
Payments of debt financing costs (1,008) (9,570) (2,636)
Repayments of long-term debt (727,277) (327,294) (437,936)
Proceeds from accounts receivable financing agreement 100,000 31,600 127,815
Repayments of accounts receivable financing agreement   (6,600) (22,400)
Proceeds from revolving line of credit 80,000 300,000  
Repayments of revolving line of credit (80,000) (300,000)  
Redemption of Senior Notes and associated breakage fees     (418,112)
Payments of contingent consideration related to acquisitions 7,197 26,634 178
Payments of finance leases (15,774) (16,434) (14,493)
Payments for repurchases of common stock (117,521) (70,151) (56,716)
Proceeds from exercises of stock options 28,148 24,568 40,322
Payments related to tax withholdings for share-based compensation (31,453) (21,220) (13,135)
Net cash (used in) provided by financing activities (277,577) 178,265 (215,469)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 1,947 8,810 (13,594)
Net change in cash, cash equivalents, and restricted cash (165,698) 108,484 7,757
Cash, cash equivalents, and restricted cash - beginning of period 272,173 163,689 155,932
Cash, cash equivalents, and restricted cash - end of period $ 106,475 $ 272,173 $ 163,689
XML 29 R8.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Balance at beginning of period at Dec. 31, 2018 $ 2,856,144 $ 1,034 $ 3,402,638 $ (88,195) $ (459,333)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Repurchases of common stock   (13) (43,515)   (13,188)    
Issuances of common stock   18 27,155        
Share-based compensation     55,193        
Unrealized gain (loss) on derivative instruments, net of taxes (7,596)            
Foreign currency translation adjustment, net of taxes 24,198     24,198      
Net income 131,258            
Balance at end of period at Dec. 31, 2019 3,029,654 1,039 3,441,471 (71,593) (341,263)    
Balance at end of period (Accounting Standards Update 2016-13) at Dec. 31, 2019           $ (2,771) $ (2,771)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Unrealized gain (loss) on derivative instruments, net of taxes (7,596)            
Adjusted beginning balance 2,856,144       (459,333)    
Repurchases of common stock   (13) (41,512)   (28,626)    
Issuances of common stock   13 3,297        
Share-based compensation     58,491        
Unrealized gain (loss) on derivative instruments, net of taxes (3,925)            
Foreign currency translation adjustment, net of taxes 34,717     34,717      
Net income 192,787            
Balance at end of period at Dec. 31, 2020 3,242,112 1,039 3,461,747 (40,801) (179,873)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Unrealized gain (loss) on derivative instruments, net of taxes (3,925)            
Adjusted beginning balance 3,026,883       (344,034)    
Repurchases of common stock   (15) (49,595)   (67,911)    
Issuances of common stock   14 (3,268)        
Share-based compensation     65,204        
Unrealized gain (loss) on derivative instruments, net of taxes 16,140            
Foreign currency translation adjustment, net of taxes (24,957)     (24,957)      
Net income 234,831            
Balance at end of period at Dec. 31, 2021 3,412,555 $ 1,038 $ 3,474,088 $ (49,618) (12,953)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Unrealized gain (loss) on derivative instruments, net of taxes 16,140            
Adjusted beginning balance $ 3,242,112       $ (179,873)    
XML 30 R9.htm IDEA: XBRL DOCUMENT v3.22.0.1
Basis of Presentation and Summary of Significant Accounting Policies
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Basis of Presentation and Summary of Significant Accounting Policies

1. Basis of Presentation and Summary of Significant Accounting Policies

Principal Business

Syneos Health, Inc. (the “Company”) is a global provider of end-to-end biopharmaceutical outsourcing solutions. The Company operates under two reportable segments, Clinical Solutions and Commercial Solutions, and derives its revenue through a suite of services designed to enhance its customers’ ability to successfully develop, launch, and market their products. The Company offers its solutions on both a standalone and integrated basis with biopharmaceutical development and commercialization services ranging from Phase I to IV clinical trial services to services associated with the commercialization of biopharmaceutical products. The Company’s customers include small, mid-sized, and large companies in the pharmaceutical, biotechnology, and medical device industries.

Principles of Consolidation

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), and include the accounts and results of operations of the Company and its controlled subsidiaries. All intercompany balances and transactions have been eliminated.

Reclassification

Certain previously reported amounts have been reclassified to conform to the current year presentation.

COVID-19 Pandemic

The ongoing COVID-19 pandemic and associated economic repercussions have significantly impacted, and are expected to continue to impact, the Company’s business and operations. The continued availability and effectiveness of vaccines may partially mitigate the risks around the continued spread of COVID-19, however, with the spread of COVID-19 variants, the ongoing impacts of the COVID-19 pandemic could adversely impact its business and results of operations. See Part I, Item 1A “Risk Factors” in this Annual Report on Form 10-K for further discussion of the potential impact of the pandemic on its business.

Use of Estimates

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of revenue and expenses for the periods presented in the financial statements. Examples of estimates and assumptions include, but are not limited to, determining the fair value of goodwill and intangible assets and their potential impairment, useful lives of tangible and intangible assets, useful lives of assets subject to leases, valuation of the Company’s right of use assets, allowances for doubtful accounts, potential future outcomes of events for which income tax consequences have been recognized in the Company’s consolidated financial statements or tax returns, valuation allowances for deferred tax assets, fair value of share-based compensation and its recognition period, loss contingencies, fair value of derivative instruments and related hedge effectiveness, fair value of contingent tax sharing obligations, and judgments related to revenue recognition, among others. In addition, estimates and assumptions are used in the accounting for acquisitions, including the fair value and useful lives of acquired tangible and intangible assets and the fair value of assumed liabilities.

The Company evaluates its estimates and assumptions on an ongoing basis and bases its estimates on historical experience, current and expected future conditions, third-party evaluations, and various other assumptions that management believes are reasonable under the circumstances based on the information available to management at the time these estimates and assumptions are made. Actual results and outcomes may differ significantly from these estimates and assumptions.

Acquisitions

The Company accounts for acquisitions in accordance with ASC Topic 805, Business Combinations, using the acquisition method of accounting. The purchase price, or total consideration transferred, is determined as the fair value of assets exchanged, equity instruments issued, and liabilities assumed at the acquisition date. The acquisition method of accounting requires that the identifiable assets acquired, the liabilities assumed, and any non-controlling interest in the acquiree are measured and recorded at their fair values on the date of an acquisition. Goodwill represents the excess of the purchase price over the estimated fair value of the net assets acquired, including the amount assigned to identifiable intangible assets. Acquisition-related costs are expensed as incurred. The consolidated financial statements reflect the results of operations of the acquiree from the date of the acquisition. For additional information, see “Note 3 – Acquisitions, Divestitures, and Investments.”

Foreign Currency Translation and Transactions

For subsidiaries outside of the U.S. that operate in a local currency environment, revenue and expenses are translated to U.S. dollars at the monthly average rates of exchange prevailing during the period, assets and liabilities are translated at period-end exchange rates, and equity accounts are translated at historical exchange rates. The net effect of foreign currency translation adjustments is included in shareholders’ equity as a component of accumulated other comprehensive loss in the accompanying consolidated balance sheets.

Foreign currency transaction gains and losses are the result of exchange rate changes during the period of time between the consummation and cash settlement of transactions denominated in currencies other than the functional currency. Foreign currency transaction gains and losses are recognized in earnings as incurred and are included in other (income) expense, net in the accompanying consolidated statements of income.

Comprehensive Income

Comprehensive income refers to revenue, expenses, gains, and losses that, under U.S. GAAP, are recorded as an element of shareholders’ equity but are excluded from net income. The Company’s comprehensive income consists of foreign currency translation adjustments, net of applicable taxes, resulting from the translation of foreign subsidiaries with functional currencies other than the U.S. dollar and the effective portions of the unrealized gains or losses associated with derivative instruments designated and accounted for as hedging instruments.

Cash and Cash Equivalents

Cash and cash equivalents consist of demand deposits with banks and other financial institutions and highly liquid investments with an original maturity of three months or less at the date of purchase. Cash and cash equivalents are carried at cost, which approximates their fair value.

Certain of the Company’s subsidiaries participate in a notional cash pooling arrangement to manage global liquidity requirements. As part of a master netting arrangement, the participants combine their cash balances in pooling accounts at the same financial institution with the ability to offset bank overdrafts of one participant against positive cash account balances held by another participant. Under the terms of the master netting arrangement, the financial institution has the right, ability, and intent to offset a positive balance in one account against an overdrawn amount in another account. Amounts in each of the accounts are unencumbered and unrestricted with respect to use. As such, the net cash balance related to this pooling arrangement is included in cash, cash equivalents, and restricted cash in the accompanying consolidated balance sheets.

The Company’s net cash pool position consisted of the following as of December 31 (in thousands):

 

 

 

2021

 

 

2020

 

Gross cash position

 

$

179,160

 

 

$

220,261

 

Less: cash borrowings

 

 

(167,507

)

 

 

(204,647

)

Net cash position

 

$

11,653

 

 

$

15,614

 

 

Restricted Cash

Restricted cash represents cash and deposits held as security over bank deposits, lease guarantees, and insurance obligations that are restricted as to withdrawal or use. Restricted cash is classified as a current or long-term asset based on the timing and nature of when and how the cash is expected to be used or when the restrictions are expected to lapse. As of December 31, 2021 and 2020, restricted cash balances were $0.1 million and $0.3 million, respectively.

Fair Value

The Company records certain assets and liabilities at fair value in accordance with ASC Topic 820, Fair Value Measurement (see “Note 7 - Fair Value Measurements”). Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. This guidance also specifies a fair value hierarchy that distinguishes between valuation assumptions developed based on market data obtained from independent external sources and the reporting entity’s own assumptions. Fair value measurements are classified according to the lowest level input or value-driver that is significant to the valuation. In accordance with this guidance, fair value measurements are classified under the following hierarchy:

Level 1 – Unadjusted quoted prices in active markets for identical instruments;

Level 2 – Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs or significant value-drivers are observable in active markets; and

Level 3 – Model-derived valuations in which one or more significant inputs or significant value-drivers are unobservable, including internally developed models.

Derivative Financial Instruments

Interest Rate Swaps

The Company uses interest rate swaps to manage exposure to variable interest rates on its debt obligations. The Company designates its interest rate swaps as cash flow hedges because they are executed to hedge the Company’s exposure to the variability in expected future cash flows that are attributable to changes in interest rates.

Derivative financial instruments are measured at fair value and recognized in the accompanying consolidated balance sheets in prepaid expenses and other current assets, other long-term assets, accrued expenses, and other long-term liabilities, as disclosed in “Note 6 – Derivatives.” The fair value of interest rate swaps is determined using the market standard methodology of discounted future variable cash receipts. The variable cash receipts are determined by discounting the future expected cash receipts that would occur if variable interest rates rise above the fixed rate of the swaps. The variable interest rates used in the calculation of projected receipts on the swap are based on an expectation of future interest rates derived from observable market interest rate curves and volatilities. Changes in the fair value of derivative instruments designated as hedging instruments are recorded each period according to the determination of the derivative’s effectiveness. The effective portion of changes in the fair value of derivatives designated as cash flow hedges is recorded in accumulated other comprehensive loss and subsequently reclassified into earnings in the period during which the hedged transaction is recognized in earnings. The ineffective portion of the change in fair value of the derivatives is recognized as non-operating income or expense immediately when incurred and included in interest expense in the accompanying consolidated statements of income.

Foreign Exchange Forward

The Company utilizes a foreign exchange forward in order to minimize monthly foreign currency remeasurement gains or losses on non-functional currency monetary balances. The Company did not designate the derivative as a hedge. All changes in the fair value of the foreign exchange forward are recorded in earnings every month to other (income) expense, net in the accompanying consolidated statements of income, as disclosed in “Note 6 – Derivatives.”

Allowance for Doubtful Accounts

The Company maintains a credit approval process and makes judgments in connection with assessing its customers’ ability to pay for contracted services. Generally, the Company has the ability to limit credit exposure by discontinuing services in the event of non-payment. The Company monitors its customers’ credit worthiness and applies judgment in establishing a provision for estimated credit losses based on historical experience, the aging of receivables, and customer-specific circumstances that would affect the customers’ ability to pay for services rendered.

Property and Equipment

Property and equipment primarily consists of furniture, vehicles, software, office equipment, computer equipment, and lab equipment. Purchased and constructed property and equipment is initially recorded at historical cost plus the estimated value of any associated legally or contractually required retirement obligations. Property and equipment acquired in an acquisition are recorded based on the estimated fair value as of the acquisition date. The Company leases vehicles for certain sales representatives in the Commercial Solutions segment. These leases are classified and accounted for as leases in accordance with ASC Topic 842, Leases (“ASC 842”). For further information about lease arrangements, see “Note 5 - Leases.”

Property and equipment assets are depreciated using the straight-line method over the respective estimated useful lives as follows:

 

 

 

Useful Life

Buildings

 

39 years

Furniture and fixtures

 

7 years

Equipment

 

5 to 10 years

Computer equipment and software

 

2 to 3 years

Vehicles

 

Lesser of lease term or the estimated economic life of the leased asset

Leasehold improvements

 

Lesser of remaining life of lease or the useful life of the asset

 

Expenditures for repairs and maintenance are expensed as incurred and expenditures for major improvements that increase the functionality or extend the useful life of the asset are capitalized and depreciated over the estimated useful life of the asset.

The Company capitalizes costs of computer software obtained for internal use and amortizes these costs on a straight-line basis over the estimated useful life of the product, not to exceed five years. Software cloud computing arrangements containing a software license are accounted for consistently with the acquisition of other software licenses. In the event such an arrangement does not contain a software license, the Company accounts for the arrangement as a service contract.

The Company reviews property and equipment for impairment whenever facts and circumstances indicate that the carrying amounts of these assets might not be recoverable. For assessment purposes, property and equipment are grouped with other assets and liabilities at the lowest level that identifiable cash flows are largely independent of the cash flows of other assets and liabilities. Recoverability of the carrying amount of an asset group is assessed by comparing its carrying amount to the estimated undiscounted future cash flows expected to be generated by the asset group. If the carrying value of the asset group exceeds its fair value, an impairment charge is recognized for the excess.

Leases

At inception, a contract contains a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. In evaluating whether it has the right to control the use of an identified asset, the Company assesses whether they have the right to direct the use of the identified asset and to obtain substantially all of the economic benefit from the use of the identified asset.

Right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset during the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Assets and liabilities are recognized based on the present value of lease payments over the lease term. Most leases include one or more options to renew. The exercise of the renewal option is at the Company’s sole discretion and the Company includes these options in determining the lease term used to establish its right-of-use assets and lease liabilities when it is reasonably certain the Company will exercise its option.

Because most of the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The Company uses the implicit rate when readily determinable. Operating lease expense is generally recognized on a straight-line basis over the lease term.

The Company has agreements with lease and non-lease components, which are accounted for as a single lease component. Leases with a lease term of 12 months or less are not recorded on the balance sheet. The Company recognizes lease expense for these leases on a straight-line basis over the lease term. Variable lease payment amounts that cannot be determined at the commencement of the lease, such as increases in lease payments based on changes in index rates, are not included in the right-of-use assets or liabilities. These variable lease payments are expensed as incurred.

Goodwill and Intangible Assets

Goodwill represents the excess of the purchase price over the estimated fair value of net assets acquired, including the amount assigned to identifiable intangible assets, in acquisitions. In accordance with ASC Topic 350, Intangibles – Goodwill and Other, goodwill is not subject to amortization but must be tested for impairment annually or more frequently if events or changes in circumstances indicate that goodwill might be impaired. Goodwill is tested for impairment at the reporting unit level, which is one level below the operating segment level. This test requires the Company to determine if the implied fair value of the reporting unit’s goodwill is less than its carrying amount.

The Company has assigned goodwill to four reporting units. The Company completed an annual impairment test as of October 1, 2021 for all of its reporting units, and concluded that there were no impairments.

Intangible assets consist of customer relationships, acquired backlog, trade names, trademarks, patient communities, and acquired technologies. The Company amortizes intangible assets related to customer relationships, trade names, trademarks, patient communities, and acquired technologies on a straight-line basis over the estimated useful life of the asset. Intangible assets related to acquired backlog are amortized based on the Company’s expectations of the timing of when revenue associated with the backlog is expected to be recognized.

The Company reviews intangible assets at the end of each reporting period to determine if facts and circumstances indicate that the useful life is shorter than originally estimated or that the carrying amount of the assets might not be recoverable. If such facts and circumstances exist, the Company assesses the recoverability of identified assets by comparing the projected undiscounted cash flows associated with the related asset or group of assets to their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amount over the fair value of those assets and occur in the period in which the impairment determination is made.

The weighted average estimated useful lives of the Company’s intangible assets were as follows as of December 31:

 

 

 

2021

 

2020

Customer relationships

 

9.8 years

 

9.9 years

Acquired backlog

 

2.6 years

 

2.6 years

Trade names and trademarks

 

5.5 years

 

5.5 years

Intellectual property (medical patent)

 

n/a

 

9.0 years

Patient communities

 

6.0 years

 

n/a

Acquired technologies

 

6.0 years

 

n/a

No intangible asset impairment charges were recorded for the years ended December 31, 2021 or 2020. For additional information regarding the carrying values of intangible assets, see “Note 2 – Financial Statement Details.”

Contingencies

In the normal course of business, the Company periodically becomes involved in various proceedings and claims, including investigations, disputes, litigations, and regulatory matters that are incidental to its business. The Company evaluates the likelihood of an unfavorable outcome of all legal and regulatory matters and records accruals for probable loss contingencies for which the amount of the loss can be reasonably estimated. Gain contingencies are not recognized until realized. Legal fees are expensed as incurred.

Because these matters are inherently unpredictable, and unfavorable developments or resolutions can occur, assessing contingencies is highly subjective and requires judgments about future events. These judgments and estimates are based, among other factors, on the status of the proceedings, the merits of the Company’s defenses, and the consultation with in-house and external counsel. The Company regularly reviews contingencies to determine whether its accruals and related disclosures are adequate. Although the Company believes that it has substantial defenses in these matters, the amount of losses incurred as a result of actual outcomes may differ significantly from the Company’s estimates.

Revenue Recognition

In accordance with ASC Topic 606, Revenue from Contracts with Customers and all related amendments (“ASC 606”), revenue is recognized when, or as, a customer obtains control of promised services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these services.

A performance obligation is a promise (or a combination of promises) in a contract to transfer distinct goods or services to a customer and is the unit of accounting under ASC 606 for the purposes of revenue recognition. A contract’s transaction price is allocated to each performance obligation and is recognized as revenue, when, or as, each performance obligation is satisfied. The majority of the Company’s Clinical Solutions segment contracts have a single performance obligation because the promise to transfer individual services is not separately identifiable from other promises in the contracts, and therefore, is not distinct. For contracts with multiple performance obligations, the contract’s transaction price is allocated to each performance obligation using the best estimate of the standalone selling price of each distinct good or service in the contract.

The majority of the Company’s revenue arrangements are service contracts that range in duration from a few months to several years. Substantially all of the Company’s performance obligations, and associated revenue, are transferred to the customer over time. The Company generally receives compensation based on measuring progress toward completion using anticipated project budgets for direct labor and prices for each service offering. The Company is also reimbursed for certain third-party pass-through and out-of-pocket costs. In addition, in certain instances a customer contract may include forms of variable consideration such as incentive fees, volume rebates or other provisions that can increase or decrease the transaction price. This variable consideration is generally awarded upon achievement of certain performance metrics, program milestones or cost targets. For the purposes of revenue recognition, variable consideration is assessed on a contract-by-contract basis and the amount included in the transaction price is estimated based on the Company’s anticipated performance and consideration of all information that is reasonably available. Variable consideration is recognized as revenue if and when it is deemed probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved in the future.

Most of the Company’s contracts can be terminated by the customer without cause with a notice period that generally ranges from 30 to 90 days. In the event of termination, the Company’s contracts generally provide that the customer pay the Company for: (i) fees earned through the termination date; (ii) fees and expenses for winding down the project, which include both fees incurred and actual expenses; (iii) non-cancellable expenditures; and (iv) in some cases, a fee to cover a portion of the remaining professional fees on the project. The Company’s long-term clinical trial contracts contain implied substantive termination penalties because of the significant wind-down cost of terminating a clinical trial. These provisions for termination penalties result in these types of contracts being treated as long-term for revenue recognition purposes.

Changes in the scope of work are common, especially under long-term contracts, and generally result in a change in the total contract transaction price. If the customer does not agree to a contract modification, the Company could bear the risk of cost overruns. Most of the Company’s contract modifications are for services that are not distinct from the services under the existing contract due to the significant integration service provided in the context of the contract and therefore result in a cumulative catch-up adjustment to revenue at the date of contract modification.

Capitalized Costs

The Company capitalizes certain costs associated with commissions and bonuses paid to its employees in the Clinical Solutions segment because these costs are incurred in obtaining contracts that have a term greater than one year. Capitalized costs are included in prepaid expenses and other current assets and other long-term assets in the accompanying consolidated balance sheets. The Company amortizes these costs in a manner that is consistent with the pattern of revenue recognition described below. The Company expenses costs to obtain contracts that have a term of one year or less.

Clinical Solutions

The Company’s Clinical Solutions segment provides solutions to address the clinical development needs of customers. The Company provides total biopharmaceutical program development through its full-service platform, while also providing discrete services for any part of a clinical trial, primarily through functional service provider, Early Stage, and Real World and Late Phase (“RWLP”) services. The services provided via the full-service platform and RWLP platforms generally span several years and a significant benefit to the customer is provided by integrating the services provided by the Company’s employees as well as those performed by third parties. Because the Company’s full-service platform provides a significant integration service to the customer, these contracts contain a single performance obligation. Revenue is recognized over time using an input measure of progress. The input measure reflects costs (including investigator payments and pass-through costs) incurred to date relative to total estimated costs to complete (“cost-to-cost measure of progress”). Under the cost-to-cost measure of progress methodology, revenue is recorded proportionally to costs incurred. Contract costs principally include direct labor, investigator payments, and pass-through costs. The estimate of total estimated costs at completion requires significant judgment. Contract estimates are based on various assumptions to project future outcomes of events that often span several years. These estimates are reviewed periodically and any adjustments are recognized on a cumulative catch-up basis in the period they become known.

The remaining service offerings within the Clinical Solutions segment are generally short-term, month-to-month contracts, time and materials basis contracts, or provide a series of distinct services that are substantially the same and have the same pattern of transfer to the customer (“series”). As such, revenue for these service offerings is generally recognized as services are performed for the amount the Company estimates it is entitled to for the period.

Commercial Solutions

The Company’s Commercial Solutions segment provides a broad suite of complementary commercialization services including Deployment Solutions, communications (advertising and public relations), and consulting services. Deployment Solutions contracts offer outsourced services to promote commercial products on behalf of a customer.

The remaining Commercial Solutions contracts are generally short-term, month-to-month contracts or time and materials contracts. As such, Commercial Solutions revenue is generally recognized as services are performed for the amount of consideration the Company estimates it is entitled to for the period. For contracts billed on a fixed price basis, revenue is recognized over time based on the proportion of labor costs expended to total labor costs expected to complete the contract.

Accounts Receivable, Unbilled Services, and Deferred Revenue

Accounts receivable are recorded at net realizable value. Unbilled accounts receivable arise when services have been rendered for which revenue has been recognized but the customers have not been billed. Contractual provisions and payment schedules may or may not correspond to the timing of the performance of services under the contract.

Unbilled services include contract assets, under which the right to bill the customer is subject to factors other than the passage of time. These amounts may not exceed their net realizable value. Contract assets are generally classified as current.

Deferred revenue is a contract liability that consists of customer payments received in advance of performance and billings in excess of revenue recognized, net of revenue recognized from the balance at the beginning of the period.

Timing of Billing and Performance

Differences in the timing of revenue recognition and associated billings and cash collections result in recording of billed accounts receivable, unbilled accounts receivable (including contract assets), and deferred revenue on the consolidated balance sheet. Amounts are billed as work progresses in accordance with agreed-upon contractual terms either at periodic intervals or upon achievement of contractual milestones. Billings generally occur subsequent to revenue recognition, resulting in recording unbilled accounts receivable in instances where the right to bill is contingent solely on the passage of time (e.g., in the following month), and contract assets in instances where the right to bill is associated with achievement of a milestone.

Reimbursable Out-of-Pocket Expenses

The Company incurs and is reimbursed by its customers for certain costs, including fees paid to principal investigators and for other out-of-pocket costs (such as travel expenses for the Company’s clinical monitors and sales representatives). The Company includes these costs in total operating expenses, and the related reimbursements in revenue, as the Company is the principal in the applicable arrangements and is responsible for fulfilling the promise to provide the specified services.

Share-Based Compensation

The Company measures and recognizes compensation expense related to all share-based awards based on the estimated fair value of the awards. The fair value of restricted stock and stock unit awards is measured on the grant date based on the fair market value of the Company’s common stock.

Share-based compensation expense is recognized on a straight-line basis over the shorter of the requisite service period or the vesting term. For awards with performance conditions, stock-based compensation expense is recognized when the achievement of each individual performance target becomes probable, and the number of shares expected to vest is adjusted for the weighted probability of attainment of the relevant performance targets. Forfeitures are accounted for as they occur.

All excess tax benefits and tax deficiencies (including tax benefits of dividends on share-based payment awards, if applicable) are recognized as income tax expense or benefit in the consolidated statements of income. The tax effects of exercised or vested awards are treated as discrete items in the reporting period in which they occur. The Company also recognizes excess tax benefits regardless of whether the benefit reduces taxes payable in the current period.

Income Taxes

The majority of the Company’s U.S. subsidiaries file a consolidated U.S. federal income tax return, while certain U.S. subsidiaries, including recently acquired entities, may file separate U.S. federal tax returns. The Company’s subsidiaries in international jurisdictions file tax returns in their respective jurisdictions.

The Company estimates its tax liability based on current tax laws in the statutory jurisdictions in which it operates. Accordingly, the impact of changes in income tax laws on deferred tax assets and deferred tax liabilities is recognized in earnings in the period during which such changes are enacted. The Company records deferred tax assets and liabilities based on temporary differences between the financial reporting basis and tax basis of the Company’s assets and liabilities at enacted tax rates expected to be in effect when the differences are realized or settled.

Deferred income tax assets represent amounts available to reduce income taxes payable on taxable income in future years. Such assets arise because of temporary differences between the financial reporting and tax bases of assets and liabilities, as well as from net operating loss and tax credit carryforwards. The Company evaluates recoverability of these future tax deductions. The Company establishes a valuation allowance for deferred income tax assets when the Company believes it is more likely than not the assets will not be realized. The Company evaluates the recoverability of these future tax deductions by assessing future expected taxable income. In estimating future taxable income, the Company considers both positive and negative evidence, such as historical and forecasted results of operations, and implementation of prudent and feasible tax planning strategies. If the objectively verifiable negative evidence outweighs any available positive evidence (or the only available positive is subjective and cannot be verified), then a valuation allowance will likely be deemed necessary. If a valuation allowance is deemed to be unnecessary, such allowance is released and any related benefit is recognized in the period of the change.

The Company recognizes a tax benefit from any uncertain tax positions only if they are more likely than not to be sustained upon examination based on the technical merits of the position. The Company evaluates uncertain tax positions pursuant to the more likely than not standard, and benefits related to such uncertain tax positions are recognized as the largest amount of benefit, determined on a cumulative probability basis, to be realized upon ultimate settlement of the position. Components of the reserve for uncertain tax positions are classified as either a current or a long-term liability in the accompanying consolidated balance sheets based on management’s expectation of future cash settlements.

Judgment is required in determining what constitutes an uncertain tax position, as well as assessing the outcome of each tax position. The Company considers many factors when evaluating and estimating tax positions and tax benefits. In addition, the calculation of tax liabilities involves dealing with uncertainties in the application of complex tax regulations in domestic and foreign jurisdictions. If the calculation of the liability related to uncertain tax positions proves to be more or less than the ultimate settlement, a tax expense or tax benefit, respectively, would result. Unrecognized tax benefits are presented as either a reduction to a deferred tax asset or as a separate liability.

Restructuring and Other Costs

Restructuring and other costs primarily consist of one-time employee termination benefits, contract termination costs, and other costs associated with an exit or disposal activity. The Company accounts for restructuring costs in accordance with ASC Topic 420, Exit or Disposal Cost Obligations. This guidance requires that a liability for a cost associated with an exit or disposal activity be recognized in the period in which the liability is incurred, as opposed to the period in which management commits to a plan of action for termination. The guidance also requires that the liabilities associated with an exit or disposal activity be measured at the fair value in the period in which the liability is incurred, except for: (i) liabilities related to one-time employee termination benefits, which shall be measured and recognized at the date the entity notifies employees of termination, unless employees are required to render services beyond a minimum retention period, in which case the liability is recognized ratably over the future service period; and (ii) liabilities related to an operating lease, which shall be measured and recognized when the contract does not have any future economic benefit to the entity (i.e., the entity ceases to utilize the rights conveyed by the contract). Restructuring liabilities are included in accrued expenses and other long-term liabilities in the accompanying consolidated balance sheets.

Earnings Per Share

The Company determines earnings per share in accordance with ASC Topic 260, Earnings Per Share. The Company has one class of common stock for purposes of the earnings per share calculation and therefore computes basic earnings per share by dividing net income (loss) by the weighted average number of common shares outstanding for the applicable period. Diluted earnings per share are computed in the same manner as basic earnings per share, except that the number of shares is increased to assume exercise of potentially dilutive equity awards using the treasury stock method, unless the effect of such increase would be anti-dilutive. Under the treasury stock method, the amount the employee must pay for exercising equity awards and the amount of compensation cost for future service that the Company has not yet recognized are assumed to be used to repurchase shares.

Subsequent Events

The Company considers events or transactions that occur after the balance sheet date but before the financial statements are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. The Company evaluated all events and transactions through the date that these financial statements were issued.

Recently Adopted Accounting Standards

In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13 (“ASU 2016-13”), Financial Instruments - Credit Losses (Topic 326) to modify the impairment model to utilize an expected loss methodology in place of the previous incurred loss methodology and require consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The Company adopted ASU 2016-13 on January 1, 2020, and recorded the impact of the adoption through a cumulative-effect adjustment to accumulated deficit. Results for reporting periods beginning on January 1, 2020 are presented under ASU No. 2016-13, while prior period amounts continue to be reported and disclosed in accordance with the Company’s historical accounting treatment. Adoption of the new standard resulted in the recording of additional allowance for doubtful accounts of approximately $2.8 million as of January 1, 2020.
XML 31 R10.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Statement Details
 12 Months Ended
Dec. 31, 2021
Text Block [Abstract]  
Financial Statement Details

2. Financial Statement Details

Accounts Receivable and Unbilled Services, net

Accounts receivable and unbilled services (including contract assets), net of allowance for doubtful accounts, consisted of the following as of December 31 (in thousands):

 

 

 

2021

 

 

2020

 

Accounts receivable billed

 

$

873,265

 

 

$

774,605

 

Accounts receivable unbilled

 

 

241,799

 

 

 

211,285

 

Contract assets

 

 

417,411

 

 

 

366,506

 

Less: Allowance for doubtful accounts

 

 

(7,585

)

 

 

(7,615

)

Accounts receivable and unbilled services, net

 

$

1,524,890

 

 

$

1,344,781

 

The following table summarizes the changes in the allowance for doubtful accounts (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Balance at the beginning of the period

 

$

(7,615

)

 

$

(5,381

)

 

$

(4,587

)

Impact from adoption of ASU 2016-13

 

 

—

 

 

 

(2,771

)

 

 

—

 

Current year provision

 

 

(367

)

 

 

(695

)

 

 

(1,897

)

Write-offs, net of recoveries and the effects of foreign currency exchange

 

 

397

 

 

 

1,232

 

 

 

1,103

 

Balance at the end of the period

 

$

(7,585

)

 

$

(7,615

)

 

$

(5,381

)

 

Accounts Receivable Factoring Arrangement

The Company has an accounts receivable factoring agreement to sell certain eligible unsecured trade accounts receivable, at its option, without recourse, to an unrelated third-party financial institution for cash. For the years ended December 31, 2021 and 2020, the Company factored $129.1 million and $152.4 million, respectively, of trade accounts receivable on a non-recourse basis and received $128.9 million and $151.9 million, respectively, in cash proceeds from the sale. The fees associated with these transactions were insignificant.

Property and Equipment, net

Property and equipment, net of accumulated depreciation, consisted of the following as of December 31 (in thousands):

 

 

 

2021

 

 

2020

 

Software

 

$

159,736

 

 

$

129,731

 

Leasehold improvements

 

 

96,188

 

 

 

94,596

 

Computer equipment

 

 

91,937

 

 

 

108,230

 

Vehicles

 

 

77,674

 

 

 

63,985

 

Office furniture, fixtures, and equipment

 

 

65,018

 

 

 

37,287

 

Buildings and land

 

 

5,692

 

 

 

5,211

 

Assets not yet placed in service

 

 

28,706

 

 

 

28,129

 

Property and equipment, gross

 

 

524,951

 

 

 

467,169

 

Less: Accumulated depreciation

 

 

(302,294

)

 

 

(250,969

)

Property and equipment, net

 

$

222,657

 

 

$

216,200

 

 

As of December 31, 2021 and 2020, the gross book value of vehicles under finance leases was $77.7 million and $64.0 million, respectively, and accumulated depreciation was $30.0 million and $20.5 million, respectively. For the years ended December 31, 2021 and 2020, amortization charges related to these assets, net of rebates, were $17.5 million and $15.8 million, respectively, and were included in depreciation on the accompanying consolidated statements of income.

Goodwill and Intangible Assets

The changes in carrying amount of goodwill by segment were as follows (in thousands):

 

 

 

Clinical

Solutions (a)

 

 

Commercial

Solutions (b)

 

 

Total

 

Balance as of December 31, 2019

 

$

2,784,952

 

 

$

1,565,428

 

 

$

4,350,380

 

Acquisitions and divestitures (c)

 

 

418,619

 

 

 

(14,453

)

 

 

404,166

 

Impact of foreign currency translation

 

 

12,764

 

 

 

8,868

 

 

 

21,632

 

Balance as of December 31, 2020

 

 

3,216,335

 

 

 

1,559,843

 

 

 

4,776,178

 

Acquisitions (d)

 

 

192,286

 

 

 

—

 

 

 

192,286

 

Impact of foreign currency translation and other (e)

 

 

40,078

 

 

 

(52,527

)

 

 

(12,449

)

Balance as of December 31, 2021

 

$

3,448,699

 

 

$

1,507,316

 

 

$

4,956,015

 

 

(a) Accumulated impairment losses of $8.1 million associated with the Clinical Solutions segment were recorded prior to 2016 and related to the former Phase I Services segment, now a component of the Clinical Solutions segment. No impairment of goodwill was recorded for the years ended December 31, 2021, 2020, or 2019.

(b) Accumulated impairment losses of $8.0 million associated with the Commercial Solutions segment were recorded prior to 2015 and related to the former Global Consulting segment, now a component of the Commercial Solutions segment. No impairment of goodwill was recorded for the years ended December 31, 2021, 2020, or 2019.

(c) Amounts represent goodwill recognized in connection with the 2020 acquisitions of SHCR Holdings Corporation (“Synteract”) and Illingworth Research Group™ (“Illingworth Research”) within the Clinical Solutions segment and goodwill disposed upon the sale of the medication adherence business within the Commercial Solutions segment.

(d) Amount represents goodwill recognized in connection with the acquisitions of StudyKIK Corporation (“StudyKIK”) and RxDataScience, Inc. (“RxDataScience”), other insignificant acquisitions in 2021, and insignificant measurement period adjustments recognized in connection with the 2020 acquisitions of Synteract and Illingworth Research within the Clinical Solutions segment.

(e) Includes $44.2 million reallocation of goodwill from the Commercial Solutions segment to the Clinical Solutions segment to reflect the transfer of the Kinapse Regulatory and Operations Consulting service lines to align with management reporting in 2021.

Intangible assets, net consisted of the following (in thousands):

 

 

 

December 31, 2021

 

 

December 31, 2020

 

 

 

Gross

 

 

Accumulated

Amortization

 

 

Net

 

 

Gross

 

 

Accumulated

Amortization

 

 

Net

 

Customer relationships

 

$

1,547,925

 

 

$

(811,542

)

 

$

736,383

 

 

$

1,518,081

 

 

$

(685,021

)

 

$

833,060

 

Acquired backlog

 

 

175,826

 

 

 

(154,475

)

 

 

21,351

 

 

 

174,180

 

 

 

(132,733

)

 

 

41,447

 

Trade names and trademarks

 

 

55,728

 

 

 

(28,806

)

 

 

26,922

 

 

 

52,475

 

 

 

(21,817

)

 

 

30,658

 

Intellectual property (medical patent)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

30,028

 

 

 

(1,668

)

 

 

28,360

 

Patient communities

 

 

45,100

 

 

 

(2,192

)

 

 

42,908

 

 

 

—

 

 

 

—

 

 

 

—

 

Acquired technologies

 

 

27,800

 

 

 

(1,297

)

 

 

26,503

 

 

 

—

 

 

 

—

 

 

 

—

 

Intangible assets, net

 

$

1,852,379

 

 

$

(998,312

)

 

$

854,067

 

 

$

1,774,764

 

 

$

(841,239

)

 

$

933,525

 

 

 

The future estimated amortization expense for intangible assets as of December 31, 2021 is expected to be as follows (in thousands):

 

Year Ended December 31,

 

 

 

 

2022

 

$

162,193

 

2023

 

 

153,334

 

2024

 

 

146,487

 

2025

 

 

132,512

 

2026

 

 

110,597

 

2027 and thereafter

 

 

148,944

 

Total

 

$

854,067

 

 

Accrued Expenses

Accrued expenses consisted of the following as of December 31 (in thousands):

 

 

 

2021

 

 

2020

 

Professional fees, investigator fees, and pass-through costs

 

$

283,432

 

 

$

231,638

 

Compensation, including bonuses, fringe benefits, and payroll taxes

 

 

215,386

 

 

 

255,042

 

Income and other taxes

 

 

25,723

 

 

 

28,890

 

Rebates to customers

 

 

22,367

 

 

 

22,528

 

Restructuring and other costs, current portion

 

 

6,657

 

 

 

5,830

 

Contingent obligations, current

 

 

3,397

 

 

 

4,327

 

Interest rate swaps - current

 

 

1,827

 

 

 

17,045

 

Other liabilities

 

 

55,652

 

 

 

45,742

 

Total accrued expenses

 

$

614,441

 

 

$

611,042

 

Accumulated Other Comprehensive Loss, Net of Taxes

Accumulated other comprehensive loss, net of taxes, consisted of the following (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Beginning balance

 

$

(40,801

)

 

$

(71,593

)

 

 

 

 

 

 

 

 

 

Derivative Instruments:

 

 

 

 

 

 

 

 

Beginning balance

 

 

(18,761

)

 

 

(14,836

)

Other comprehensive gain (loss) before reclassifications

 

 

2,963

 

 

 

(20,446

)

Reclassification adjustments

 

 

13,177

 

 

 

16,521

 

Ending balance

 

 

(2,621

)

 

 

(18,761

)

 

 

 

 

 

 

 

 

 

Foreign Currency Translation:

 

 

 

 

 

 

 

 

Beginning balance

 

 

(22,040

)

 

 

(56,757

)

Other comprehensive (loss) income before reclassifications

 

 

(24,957

)

 

 

34,717

 

Ending balance

 

 

(46,997

)

 

 

(22,040

)

 

 

 

 

 

 

 

 

 

Accumulated other comprehensive loss, net of taxes

 

$

(49,618

)

 

$

(40,801

)

 

Changes in accumulated other comprehensive loss consisted of the following (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Unrealized loss on derivative instruments:

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized gain (loss) during period, before taxes

 

$

4,084

 

 

$

(27,647

)

 

$

(14,306

)

Income tax expense (benefit)

 

 

1,121

 

 

 

(7,201

)

 

 

(2,777

)

Unrealized gain (loss) during period, net of taxes

 

 

2,963

 

 

 

(20,446

)

 

 

(11,529

)

Reclassification adjustment, before taxes

 

 

17,655

 

 

 

22,328

 

 

 

4,588

 

Income tax expense

 

 

4,478

 

 

 

5,807

 

 

 

655

 

Reclassification adjustment, net of taxes

 

 

13,177

 

 

 

16,521

 

 

 

3,933

 

Total unrealized gain (loss) on derivative instruments, net of taxes

 

 

16,140

 

 

 

(3,925

)

 

 

(7,596

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments, before taxes

 

 

(26,429

)

 

 

36,071

 

 

 

24,198

 

Income tax (benefit) expense

 

 

(1,472

)

 

 

1,354

 

 

 

—

 

Foreign currency translation adjustments, net of taxes

 

 

(24,957

)

 

 

34,717

 

 

 

24,198

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total other comprehensive (loss) income, net of taxes

 

$

(8,817

)

 

$

30,792

 

 

$

16,602

 

Other (Income) Expense, Net

Other (income) expense, net consisted of the following (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Net realized foreign currency loss

 

$

2,190

 

 

$

3,175

 

 

$

11,853

 

Net unrealized foreign currency (gain) loss

 

 

(5,928

)

 

 

4,147

 

 

 

11,166

 

Gain on sale of business

 

 

—

 

 

 

(7,133

)

 

 

—

 

Equity investment (income) expense

 

 

(1,950

)

 

 

(3,745

)

 

 

261

 

Other, net

 

 

(2,945

)

 

 

580

 

 

 

882

 

Total other (income) expense, net

 

$

(8,633

)

 

$

(2,976

)

 

$

24,162

 

 

Supplemental disclosure of cash flow information

The following table provides details of supplemental cash flow information (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Cash paid for income taxes, net of refunds

 

$

35,100

 

 

$

23,400

 

 

$

12,200

 

Cash paid for interest (excluding finance leases)

 

 

63,952

 

 

 

83,690

 

 

 

129,756

 

Supplemental disclosure of noncash investing and financing activities

 

 

 

 

 

 

 

 

 

 

 

 

Non-cash investment to acquire certain intellectual property rights from a customer in lieu of cash payment for services rendered

 

 

—

 

 

 

27,300

 

 

 

—

 

Fair value of contingent consideration related to acquisitions

 

 

19,158

 

 

 

—

 

 

 

—

 

Change in property and equipment included in liabilities

 

 

1,753

 

 

 

11,684

 

 

 

5,977

 

Vehicles acquired through finance lease agreements

 

 

28,994

 

 

 

20,203

 

 

 

37,701

 
XML 32 R11.htm IDEA: XBRL DOCUMENT v3.22.0.1
Acquisitions, Divestitures, and Investments
 12 Months Ended
Dec. 31, 2021
Business Combinations [Abstract]  
Acquisitions, Divestitures, and Investments

3. Acquisitions, Divestitures, and Investments

StudyKIK Acquisition

On September 13, 2021, the Company completed the acquisition of StudyKIK, a leading clinical trial recruitment and retention company, expanding the Company’s portfolio of patient-direct, technology-enabled solutions. The total purchase consideration was $203.6 million (net of cash acquired of $1.0 million). The Company recognized $115.3 million of goodwill and $91.8 million of intangible assets. The remainder of consideration was attributed to other net assets, primarily related to net working capital.

The purchase price has been allocated to the tangible assets and identifiable intangible assets acquired and liabilities assumed based upon their fair values. The excess of the purchase price over the tangible and intangible assets acquired and liabilities assumed has been recorded as goodwill. Goodwill is attributable to the acquired workforce as well as future synergies and is not deductible for income tax purposes. The operating results from the acquisition have been included in the Company’s Clinical Solutions segment from the date of acquisition.

The following table summarizes the fair values of identified intangible assets and their respective useful lives (dollars in thousands):

 

 

 

Estimated Fair Value

 

 

Estimated Useful Life

Customer relationships

 

$

22,300

 

 

6 years

Acquired backlog

 

 

1,800

 

 

1.25 years

Trade name

 

 

2,700

 

 

6 years

Patient communities

 

 

45,100

 

 

6 years

Acquired technologies

 

 

19,900

 

 

6 years

Total intangible assets

 

$

91,800

 

 

 

 

RxDataScience Acquisition

On October 6, 2021, the Company completed the acquisition of RxDataScience, a specialist organization that helps biopharmaceutical customers solve challenging problems through advanced analytics, data management, and artificial intelligence. The total purchase consideration was $67.5 million (net of cash acquired of $2.4 million). The Company recognized $52.9 million of goodwill and $18.0 million of intangible assets. The remainder of consideration was attributed to other net assets, primarily related to net working capital. Refer to “Note 16 – Related-Party Transactions” for further information.

The purchase price has been allocated to the tangible assets and identifiable intangible assets acquired and liabilities assumed based upon their fair values. The excess of the purchase price over the tangible and intangible assets acquired and liabilities assumed has been recorded as goodwill. Goodwill is attributable to the acquired workforce as well as future synergies and is not deductible for income tax purposes. The operating results from the acquisition have been included in the Company’s Clinical Solutions segment from the date of acquisition.

The Company’s assessments of fair value and the purchase price allocations related to these 2021 acquisitions are preliminary and further adjustments may be necessary as additional information related to the fair values of assets acquired and liabilities assumed is assessed during the measurement period (up to one year from the respective acquisition dates).

Synteract Acquisition

On December 9, 2020, the Company completed the acquisition of Synteract, effected through the purchase of 100% of the outstanding shares of Synteract for approximately $385.5 million in cash (net of approximately $28.0 million of cash acquired), which included payment of $1.0 million during the first quarter of 2021. Synteract is a contract research organization focused on the emerging biopharmaceutical industry, strengthening the Company’s position in the small to mid-sized (“SMID”) category. The Company recognized $363.7 million of goodwill and $56.4 million of intangible assets, including acquired backlog and trade name, as a result of the acquisition.

Allocation of Consideration Transferred

The following table summarizes the estimated fair value of the net assets acquired at the date of the acquisition:

 

Assets acquired:

 

 

 

 

Cash and cash equivalents

 

$

28,028

 

Accounts receivable and unbilled services

 

 

39,723

 

Prepaid expenses and other current assets

 

 

2,160

 

Property and equipment

 

 

3,978

 

Operating lease right-of-use assets

 

 

10,839

 

Other identifiable intangible assets

 

 

56,400

 

Goodwill

 

 

363,733

 

Other assets

 

 

4,121

 

Total assets acquired

 

 

508,982

 

Liabilities assumed:

 

 

 

 

Accounts payable and accrued expenses

 

 

25,623

 

Deferred revenue

 

 

45,272

 

Operating lease obligations

 

 

15,693

 

Deferred income taxes, net

 

 

7,754

 

Other liabilities

 

 

1,126

 

Total liabilities assumed

 

 

95,468

 

Net assets acquired

 

$

413,514

 

 

The purchase price has been allocated to the tangible assets and identifiable intangible assets acquired and liabilities assumed based upon their fair values. The excess of the purchase price over the tangible and intangible assets acquired and liabilities assumed has been recorded as goodwill. Goodwill is attributable to the acquired workforce as well as future synergies and is not deductible for income tax purposes. The operating results from the acquisition of Synteract have been included in the Company’s Clinical Solutions segment from the date of acquisition.

The following table summarizes the fair value of identified intangible assets and their respective useful lives at the date of the acquisition (dollars in thousands):

 

 

 

Estimated Fair Value

 

 

Estimated Useful Life

Acquired backlog

 

$

37,200

 

 

4 years

Trade name

 

 

19,200

 

 

8 years

Total intangible assets

 

$

56,400

 

 

 

 

Illingworth Research Group Acquisition

On December 17, 2020, the Company completed the acquisition of Illingworth Research, a leading provider of clinical research home health services, adding new scale and capabilities to the Company’s clinical trial solutions. The total purchase consideration was $80.9 million (net of cash acquired of $1.1 million), which included payments of $9.0 million during the first quarter of 2021. The Company recognized $64.6 million of goodwill and $21.5 million of intangible assets, principally customer relationships, as a result of the acquisition.

The purchase price has been allocated to the tangible assets and identifiable intangible assets acquired and liabilities assumed based upon their fair values. The excess of the purchase price over the tangible and intangible assets acquired and liabilities assumed has been recorded as goodwill. Goodwill is attributable to the acquired workforce as well as future synergies and is not deductible for income tax purposes. The operating results from the acquisition of Illingworth Research have been included in the Company’s Clinical Solutions segment from the date of acquisition.

Pro forma information for these acquisitions is not presented as the operations of the acquired businesses, individually and in the aggregate, are not significant to the overall operations of the Company.

Divestitures

During the second quarter of 2020, the Company sold its contingent staffing business to a related party in exchange for potential future cash consideration not to exceed $4.0 million. Based on the financial results of the business one year after the divestiture date, the Company recognized $1.8 million of contingent consideration in other (income) expense, net in the accompanying statement of income during the second quarter of 2021. Refer to “Note 16 – Related-Party Transactions” for further information.

During the fourth quarter of 2020, the Company sold its medication adherence business for consideration of $23.0 million, including cash consideration of $18.0 million, net of cash transferred, and convertible notes of $5.0 million, resulting in a gain on sale of $7.1 million. The Company received $5.0 million of cash proceeds from the notes receivable during the second quarter of 2021. Based on the performance of the business through 2021, the Company recognized $3.0 million and $3.6 million of contingent consideration for the years ended December 31, 2021 and 2020, respectively. The gain on sale and contingent consideration were recognized in other (income) expense, net in the accompanying consolidated statements of income.

Investments

During the second quarter of 2020, the Company made a non-cash investment of $27.3 million to acquire certain intellectual property rights from a customer in lieu of cash payment for services rendered. The Company subsequently exchanged the intellectual property for an equity method investment in an unconsolidated variable interest entity. The Company provided the entity $3.8 million in cash, in the form of a loan, during the third quarter of 2021. Based on the hypothetical liquidation book value of its investment as of December 31, 2021, the Company recorded a $5.3 million loss to other (income) expense, net in the accompanying statement of income for the year ended December 31, 2021. As of December 31, 2021, the book value of the Company’s investment was $16.2 million and was included in other long-term assets in the accompanying consolidated balance sheet, with a maximum exposure to loss of approximately $20.3 million, which includes the outstanding loan balance and accrued interest.
XML 33 R12.htm IDEA: XBRL DOCUMENT v3.22.0.1
Long-Term Debt Obligations
 12 Months Ended
Dec. 31, 2021
Debt Disclosure [Abstract]  
Long-Term Debt Obligations

4. Long-Term Debt Obligations

The Company’s debt obligations consisted of the following as of December 31 (in thousands):

 

 

 

2021

 

 

2020

 

Secured Debt

 

 

 

 

 

 

 

 

Term Loan A - tranche one due March 2024

 

$

149,195

 

 

$

183,715

 

Term Loan A - tranche two due August 2024

 

 

1,636,797

 

 

 

1,273,991

 

Term Loan B due August 2024

 

 

—

 

 

 

560,564

 

Accounts receivable financing agreement due October 2024

 

 

400,000

 

 

 

300,000

 

Total secured debt

 

 

2,185,992

 

 

 

2,318,270

 

Unsecured Debt

 

 

 

 

 

 

 

 

Senior notes due January 2029 (the “Notes”)

 

 

600,000

 

 

 

600,000

 

Total debt obligations

 

 

2,785,992

 

 

 

2,918,270

 

Less: Term loans original issuance discount

 

 

(2,228

)

 

 

(3,500

)

Less: Unamortized deferred issuance costs

 

 

(8,043

)

 

 

(12,716

)

Total long-term debt

 

$

2,775,721

 

 

$

2,902,054

 

 

Credit Agreement

 

The Company is party to a credit agreement (as amended, the “Credit Agreement”) that included a $1.55 billion Term Loan A facility (“Term Loan A”) that has two tranches, tranche one that matures on March 26, 2024 and tranche two that matures on August 1, 2024, a $1.60 billion Term Loan B facility (“Term Loan B”) that was paid in full during the second quarter of 2021, and a $600.0 million revolving credit facility (the “Revolver”) that matures on August 1, 2024.

On June 30, 2021 (the “Closing Date”), the Company entered into Amendment No. 5 (the “Fifth Amendment”) to the Credit Agreement. The Fifth Amendment modified the Credit Agreement to increase Term Loan A in an aggregate principal amount of $495.0 million (“Incremental Term Loan A”). Incremental Term Loan A was funded on the Closing Date, and the proceeds were used, along with cash on hand, to repay the outstanding Term Loan B in full under the Credit Agreement and to pay fees and expenses in connection with the Fifth Amendment and the incurrence of Incremental Term Loan A. Incremental Term Loan A has the same terms as Term Loan A under the Credit Agreement, and is subject to the same covenants. The Company recorded an additional discount of $0.5 million against the Term Loan A borrowings in connection with the Fifth Amendment, which is being amortized as a component of interest expense using the effective interest method over the term of Term Loan A.

During the year ended December 31, 2021, the Company made $166.8 million and $560.5 million of voluntary prepayments against Term Loan A and Term Loan B, respectively, that were applied to future mandatory principal payments due. As a result of these and previous voluntary prepayments, the Company is not required to make a mandatory payment against the principal balance of Term Loan A until October 2023 and Term Loan B has been paid in full. In connection with these prepayments, the Company recorded a $3.6 million loss on extinguishment of debt during the year ended December 31, 2021.

All obligations under the Credit Agreement are guaranteed by the Company and certain of the Company’s direct and indirect wholly-owned domestic subsidiaries. The obligations under the Credit Agreement are secured by substantially all of the assets of the Company and the guarantors, including 65% of the capital stock of certain controlled foreign subsidiaries.

The term loans and the Revolver bear interest at a rate per annum equal to the Adjusted Eurocurrency Rate (“Eurocurrency Rate”) plus an applicable margin or an Alternate Base Rate plus an applicable margin. The Company may select among the Adjusted Eurocurrency Rate or the Alternate Base Rate, whichever is lower, except in circumstances where the Company requests a loan with less than a three-day notice. In such cases, the Company must use the Alternate Base Rate. The Adjusted Eurocurrency Rate is equal to the London Inter-bank Offered Rate (“LIBOR”), subject to adjustment for reserve requirements. The Alternate Base Rate is equal to the highest of: (i) the federal funds rate plus 0.50%; (ii) the Adjusted Eurocurrency Rate for an interest period of one month plus 1.00%; (iii) the rate of interest per annum quoted by The Wall Street Journal as the prime rate; and (iv) 0.00%. 

The applicable margins with respect to Alternate Base Rate and Adjusted Eurocurrency Rate borrowings are determined depending on the “First Lien Leverage Ratio” or the “Secured Net Leverage Ratio” (as defined in the Credit Agreement) and range as follows:

 

 

 

Alternate Base Rate

 

Adjusted

Eurocurrency Rate

Term Loan A

 

0.25% - 0.50%

 

1.25% - 1.50%

Term Loan B

 

0.75% - 1.00%

 

1.75% - 2.00%

Revolver

 

0.25% - 0.50%

 

1.25% - 1.50%

In February 2021, as a result of the Company’s First Lien Leverage Ratio (as defined in the Credit Agreement) being less than or equal to 2.5x, the Adjusted Eurocurrency Rate Spread (as defined in the Credit Agreement) on Term Loan A and the Revolver decreased from 1.50% to 1.25%. As of December 31, 2021, the interest rate on the Term Loan A and the Revolver was 1.35%. 

The Company also pays a quarterly commitment fee between 0.25% and 0.375% on the average daily unused balance of the Revolver depending on the “First Lien Leverage Ratio” at the adjustment date.

Revolver and Letters of Credit

The Revolver includes letters of credit (“LOCs”) with a sublimit of $150.0 million. Fees are charged on all outstanding LOCs at an annual rate equal to the margin in effect on Eurocurrency Rate revolving loans plus participation and fronting fees. The fee is payable quarterly in arrears on the last day of each quarter ending April, July, October and January until the underlying LOC expires. As of December 31, 2021, there were no outstanding Revolver borrowings and $14.2 million of LOCs outstanding, leaving $585.8 million of available borrowings under the Revolver, including $135.8 million available for LOCs.

Accounts Receivable Financing Agreement

Under the Company’s accounts receivable financing agreement, certain of the Company’s consolidated subsidiaries sell accounts receivable and unbilled services (including contract assets) balances to a wholly-owned, bankruptcy-remote special purpose entity (“SPE”), which is the borrower under the facility. The facility is without recourse to the Company or any subsidiaries of the Company other than the SPE, other than with respect to limited indemnity obligations of the selling entities and the servicer of the receivables in respect of the character of the receivables sold by them and the performance of the servicing duties.

On January 28, 2021, the Company amended its accounts receivable financing agreement to increase the amount it can borrow from $300.0 million to $365.0 million and drew down the additional $65.0 million to partially fund the Term Loan A and Term Loan B voluntary prepayments. Accordingly, there was no incremental impact on the Company’s total debt.

On October 13, 2021, the Company further amended its accounts receivable financing agreement to increase the amount it can borrow from $365.0 million to $400.0 million, extended the maturity to October 2024, and drew down the additional $35.0 million. At the same time, the Company paid down $35.0 million on facilities under its Credit Agreement, resulting in no net impact on leverage.

As of December 31, 2021, the Company had $400.0 million of outstanding borrowings under this agreement, which are recorded in long-term debt on the accompanying consolidated balance sheet. There was no remaining borrowing capacity available under this agreement as of December 31, 2021.

This agreement is secured by a lien on certain receivables and other assets, and the Company has guaranteed the performance of the obligations of existing and future subsidiaries that sell and service the accounts receivable under this agreement. The available borrowing capacity varies monthly according to the levels of its eligible accounts receivable and unbilled receivables. Loans under this agreement will accrue interest at a reserve-adjusted LIBOR rate or a base rate equal to the higher of (i) the applicable lender’s prime rate and (ii) the federal funds rate plus 0.50%. As of December 31, 2021, the interest rate on the accounts receivable financing agreement was 1.05%.

The Notes

On November 24, 2020, the Company completed the issuance and sale of the Notes, with an aggregate principal amount of $600.0 million, which bears interest at a rate of 3.625% per annum, payable semi-annually in arrears beginning on July 15, 2021, and matures on January 15, 2029. The Notes were issued pursuant to an indenture (the “Indenture”), which provides, among other things, that the Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, on a senior unsecured basis, by certain of the Company’s subsidiaries.

The Company may redeem some or all of the Notes at any time prior to January 15, 2024 at a redemption price equal to 100% of the aggregate principal amount of the Notes to be redeemed plus a “make-whole” premium and accrued and unpaid interest. In addition, prior to July 15, 2023, the Company may redeem up to 40% of the original principal amount of the Notes with proceeds of certain equity offerings at a redemption price equal to 103.625% of the aggregate principal amount of such Notes plus accrued and unpaid interest. On or after January 15, 2024, the Company may redeem some or all of the Notes at the redemption prices set forth in the Indenture plus accrued and unpaid interest.

The Indenture contains covenants that limit the ability of the Company and its restricted subsidiaries to, among other things, (1) incur additional liens, (2) engage in certain sale and leaseback transactions, and (3) conduct mergers, consolidations, or asset sales. These covenants are subject to exceptions and qualifications set forth in the Indenture.

If the Company sells certain of its assets or experience specific kinds of changes of control, the Company is required to offer to repurchase the Notes at a repurchase price equal to (1) par plus any accrued and unpaid interest in the case of an asset sale or (2) 101% of the aggregate principal amount thereof plus any accrued and unpaid interest in the case of a change of control.

Maturities of Debt Obligations

As of December 31, 2021, the contractual maturities of the Company’s debt obligations (excluding finance leases that are presented in “Note 5 – Leases”) were as follows (in thousands):

 

2022

 

$

—

 

2023

 

 

21,732

 

2024

 

 

2,164,260

 

2025

 

 

—

 

2026

 

 

—

 

2027 and thereafter

 

 

600,000

 

Less: Term loan original issuance discount

 

 

(2,228

)

Less: Unamortized deferred issuance costs

 

 

(8,043

)

Total

 

$

2,775,721

 
XML 34 R13.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases
 12 Months Ended
Dec. 31, 2021
Leases [Abstract]  
Leases

5. Leases

The Company’s operating leases are primarily related to its office facilities. The Company’s finance leases are related to vehicles that the Company leases for certain sales representatives in its Commercial Solutions segment. The Company’s leases have remaining lease terms of less than one year to 11 years, some of which include options to extend the term or terminate the lease.

ROU assets and lease liabilities are recognized based on the present value of the fixed lease payments over the lease term at the commencement date. The ROU assets also include any initial direct costs incurred and lease payments made at or before the commencement date, and are reduced by lease incentives. The Company uses its incremental borrowing rate as the discount rate to determine the present value of the lease payments for leases that do not have a readily determinable implicit discount rate. The Company’s incremental borrowing rate is the rate of interest that it would have to borrow on a collateralized basis over a similar term and amount in a similar economic environment. The Company determines the incremental borrowing rates for its leases by adjusting the local risk free interest rate with a credit risk premium corresponding to the Company’s credit rating.

The Company records rent expense for its operating leases on a straight-line basis from the lease commencement date until the end of the lease term. The Company records finance lease cost as a combination of the amortization expense for the ROU assets and interest expense for the outstanding lease liabilities using the discount rate discussed above. Variable lease payments for operating leases are related to office facilities and include but are not limited to common area maintenance, parking, electricity, and management fees. The variable lease payments for finance leases are related to maintenance programs for leased vehicles. Variable lease payments are based on occurrence or based on usage; therefore, they are not included as part of the initial calculations of the ROU assets and liabilities.

The components of lease cost were as follows for the year ended December 31 and the line items on the accompanying consolidated statements of income to which they were recorded were as follows (in thousands):

 

 

 

Statement of Income Classification

 

2021

 

 

2020

 

Operating leases:

 

 

 

 

 

 

 

 

 

 

Fixed lease costs

 

Direct costs, selling, general, and administrative expenses and restructuring and other costs

 

$

55,168

 

 

$

53,531

 

Short-term lease costs

 

Direct costs and selling, general, and administrative expenses

 

 

1,994

 

 

 

2,930

 

Variable lease costs

 

Direct costs, selling, general, and administrative expenses and restructuring and other costs

 

 

36,760

 

 

 

29,572

 

Total operating lease costs

 

 

 

$

93,922

 

 

$

86,033

 

Finance leases:

 

 

 

 

 

 

 

 

 

 

Amortization of right-of-use assets

 

Depreciation

 

$

17,453

 

 

$

15,843

 

Interest on lease liabilities

 

Interest expense

 

 

605

 

 

 

944

 

Variable lease costs

 

Direct costs

 

 

6,231

 

 

 

6,321

 

Total finance lease costs

 

 

 

$

24,289

 

 

$

23,108

 

 

Supplemental balance sheet information related to finance leases was as follows as of December 31 (in thousands):

 

 

2021

 

 

2020

 

Property and equipment, gross

 

$

77,674

 

 

$

63,985

 

Accumulated depreciation

 

 

(30,021

)

 

 

(20,479

)

Property and equipment, net

 

$

47,653

 

 

$

43,506

 

 

 

 

 

 

 

 

 

 

Current portion of finance lease obligations

 

$

20,627

 

 

$

17,455

 

Finance lease long-term obligations

 

 

34,181

 

 

 

31,522

 

Total finance lease liabilities

 

$

54,808

 

 

$

48,977

 

Supplemental cash flow information related to leases was as follows for the year ended December 31 (in thousands):

 

 

2021

 

 

2020

 

Cash paid for amounts included in the measurement of lease liabilities:

 

 

 

 

 

 

 

 

Operating cash flows for operating leases

 

$

(59,863

)

 

$

(60,361

)

Operating cash flows for finance leases

 

 

(605

)

 

 

(944

)

Financing cash flows for finance leases

 

 

(15,774

)

 

 

(16,434

)

 

 

 

 

 

 

 

 

 

Right-of-use assets obtained in exchange for lease obligations:

 

 

 

 

 

 

 

 

Operating leases

 

$

43,385

 

 

$

47,415

 

Finance leases

 

 

28,994

 

 

 

20,203

 

 

 

 

 

 

 

 

 

 

Lease obligations closed out in exchange for right-of-use assets:

 

 

 

 

 

 

 

 

Operating leases

 

$

(10,122

)

 

$

(2,834

)

 

Weighted average remaining lease term as of December 31:

 

2021

 

2020

Operating leases

 

6 years

 

7 years

Finance leases

 

3 years

 

3 years

 

 

Weighted average discount rate as of December 31:

 

2021

 

 

2020

 

Operating leases

 

 

4.7

%

 

 

4.8

%

Finance leases

 

 

1.1

%

 

 

1.3

%

As of December 31, 2021, maturities of lease liabilities were as follows (in thousands):

 

 

 

Operating Leases

 

 

Finance Leases

 

 

Total

 

2022

 

$

53,612

 

 

$

21,443

 

 

$

75,055

 

2023

 

 

53,033

 

 

 

17,768

 

 

 

70,801

 

2024

 

 

44,428

 

 

 

11,624

 

 

 

56,052

 

2025

 

 

38,036

 

 

 

5,688

 

 

 

43,724

 

2026

 

 

29,128

 

 

 

130

 

 

 

29,258

 

2027 and thereafter

 

 

73,262

 

 

 

—

 

 

 

73,262

 

Total lease payments

 

 

291,499

 

 

 

56,653

 

 

$

348,152

 

Less: Management fee

 

 

—

 

 

 

(762

)

 

 

 

 

Less: Imputed interest

 

 

(42,643

)

 

 

(1,083

)

 

 

 

 

Total lease liabilities

 

$

248,856

 

 

$

54,808

 

 

 

 

 

 
XML 35 R14.htm IDEA: XBRL DOCUMENT v3.22.0.1
Derivatives
 12 Months Ended
Dec. 31, 2021
Derivative Instruments And Hedging Activities Disclosure [Abstract]  
Derivatives

6. Derivatives

Interest Rate Swaps

The Company has entered into various interest rate swaps to mitigate its exposure to changes in interest rates on its term loan. In June 2018, the Company entered into an interest rate swap with multiple counterparties that had an initial aggregate notional value of $1.01 billion, an effective date of December 31, 2018, and expired on June 30, 2021.

In March 2020, the Company entered into interest rate swaps with multiple counterparties. The interest rate swaps had an initial aggregate notional value of $549.2 million that increased to $1.42 billion on June 30, 2021, an effective date of March 31, 2020, and will expire on March 31, 2023. As of December 31, 2021, the notional value of this interest rate swap was $1.16 billion.

The significant terms of these derivatives are substantially the same as those contained within the Credit Agreement, including monthly settlements with the swap counterparties. Interest rate swaps are designated as hedging instruments. The amounts of hedge ineffectiveness recorded in net income during the years ended December 31, 2021, 2020, and 2019 were insignificant.

Foreign Exchange Forward

On October 30, 2020, the Company entered into a foreign exchange forward in order to minimize monthly foreign currency remeasurement gains or losses on non-functional currency monetary balances. The foreign exchange forward notional value may be adjusted each month as the exposure balance changes. The Company did not designate the derivative as a hedge. All changes in the fair value of the foreign exchange forward are recorded in earnings every month to other (income) expense, net in the accompanying consolidated statements of income. The Company recognized $0.7 million of realized losses and $1.5 million of realized gains during the years ended December 31, 2021 and 2020, respectively, related to this foreign exchange forward. As of December 31, 2021, the notional value of this foreign exchange forward was $70.0 million.

Fair Values

The fair values of the Company’s derivative financial instruments as of December 31 and the line items on the accompanying consolidated balance sheets to which they were recorded were as follows (in thousands):

 

 

Balance Sheet Classification

 

2021

 

 

2020

 

Interest rate swaps - non-current

 

Other long-term assets

 

$

948

 

 

$

—

 

Fair value of derivative assets

 

 

 

$

948

 

 

$

—

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps - current

 

Accrued expenses

 

$

1,827

 

 

$

17,045

 

Interest rate swaps - non-current

 

Other long-term liabilities

 

 

—

 

 

 

5,572

 

Fair value of derivative liabilities

 

 

 

$

1,827

 

 

$

22,617

 
XML 36 R15.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value Measurements
 12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
Fair Value Measurements

7. Fair Value Measurements

Assets and Liabilities Carried at Fair Value

As of December 31, 2021 and 2020, the Company’s financial assets and liabilities carried at fair value included cash and cash equivalents, restricted cash, trading securities, accounts receivable, unbilled services (including contract assets), accounts payable, accrued expenses, deferred revenue, contingent obligations, liabilities under the accounts receivable financing agreement, and derivative instruments.

The fair values of cash and cash equivalents, restricted cash, accounts receivable, unbilled services (including contract assets), accounts payable, accrued expenses, deferred revenue, and the liabilities under the accounts receivable financing agreement approximate their respective carrying amounts because of the liquidity and short-term nature of these financial instruments.

Financial Instruments Subject to Recurring Fair Value Measurements

As of December 31, 2021, the fair values of the major classes of the Company’s assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Investments

Measured

at Net Asset

Value

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trading securities (a)

 

$

24,775

 

 

$

—

 

 

$

—

 

 

$

—

 

 

$

24,775

 

Partnership interest (b)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

11,176

 

 

 

11,176

 

Derivative instruments (c)

 

 

—

 

 

 

948

 

 

 

—

 

 

 

—

 

 

 

948

 

Total assets

 

$

24,775

 

 

$

948

 

 

$

—

 

 

$

11,176

 

 

$

36,899

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative instruments (c)

 

$

—

 

 

$

1,827

 

 

$

—

 

 

$

—

 

 

$

1,827

 

Contingent obligations related to acquisitions (d)

 

 

—

 

 

 

—

 

 

 

17,997

 

 

 

—

 

 

 

17,997

 

Total liabilities

 

$

—

 

 

$

1,827

 

 

$

17,997

 

 

$

—

 

 

$

19,824

 

 

 

As of December 31, 2020, the fair value of the major classes of the Company’s assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Investments

Measured

at Net Asset

Value

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trading securities (a)

 

$

22,950

 

 

$

—

 

 

$

—

 

 

$

—

 

 

$

22,950

 

Partnership interest (b)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

8,665

 

 

 

8,665

 

Total assets

 

$

22,950

 

 

$

—

 

 

$

—

 

 

$

8,665

 

 

$

31,615

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative instruments (c)

 

$

—

 

 

$

22,617

 

 

$

—

 

 

$

—

 

 

$

22,617

 

Contingent obligations related to acquisitions (d)

 

 

—

 

 

 

—

 

 

 

6,793

 

 

 

—

 

 

 

6,793

 

Total liabilities

 

$

—

 

 

$

22,617

 

 

$

6,793

 

 

$

—

 

 

$

29,410

 

 

(a) Represents the fair value of investments in mutual funds based on quoted market prices that are used to fund the liability associated with the Company’s deferred compensation plan.

(b) The Company has committed to invest $21.5 million as a limited partner in two private equity funds. The private equity funds invest in opportunities in the healthcare and life sciences industry. As of December 31, 2021, the Company’s remaining unfunded commitment in the private equity funds was $12.8 million. The Company holds minor ownership interests (less than 3%) in each of the private equity funds and has determined that it does not exercise significant influence over the private equity funds’ operating or finance activities. As the private equity funds do not have readily determinable fair values, the Company has estimated the fair values using each fund’s Net Asset Value, the amount by which the value of all assets exceeds all debt and liabilities, in accordance with ASC Topic 946, Financial Services – Investment Companies.

(c) Represents the fair value of interest rate swap arrangements (see “Note 6 – Derivatives” for further information).

(d) Represents the fair value of contingent consideration obligations related to acquisitions. The fair values of these liabilities are determined based on the Company’s best estimate of the probable timing and amount of settlement.

The following table presents a reconciliation of changes in the carrying amount of contingent obligations classified as Level 3 for the years ended December 31, 2021 and 2020 (in thousands):

 

Balance as of December 31, 2019

 

$

37,324

 

Additions

 

 

—

 

Changes in fair value recognized in earnings (a)

 

 

(3,897

)

Payments

 

 

(26,634

)

Balance as of December 31, 2020

 

 

6,793

 

Additions (b)

 

 

19,158

 

Changes in fair value recognized in earnings

 

 

(757

)

Payments (c)

 

 

(7,197

)

Balance as of December 31, 2021

 

$

17,997

 

 

(a) The change in fair value recognized in earnings for the year ended December 31, 2020 is primarily due to a decrease in the estimate of the contingent consideration associated with the acquisition of Kinapse (see “Note 17 – Commitments and Contingencies” for further information).

(b) Represents obligations in connection with the acquisition of RxDataScience and insignificant acquisitions completed during 2021.

(c) The Company made payments to fully settle the contingent tax-sharing obligation arising from inVentiv Health, Inc.’s 2016 merger with Double Eagle Parent, Inc. (see “Note 17 – Commitments and Contingencies” for further information) during the first quarter of 2021 and obligations in connection with the insignificant acquisition completed during the second quarter of 2021.

During the years ended December 31, 2021 and 2020, there were no transfers of assets or liabilities between Level 1, Level 2, or Level 3 fair value measurements.

Financial Instruments Subject to Non-Recurring Fair Value Measurements

Certain assets, including goodwill and identifiable intangible assets, are carried on the accompanying consolidated balance sheets at cost and, subsequent to initial recognition, are measured at fair value on a non-recurring basis when certain identified events or changes in circumstances that may have a significant adverse effect on the carrying values of these assets occur. These assets are classified as Level 3 fair value measurements within the fair value hierarchy. Goodwill is tested for impairment annually or more frequently if events or changes in circumstances indicate a triggering event has occurred. Intangible assets are tested for impairment upon the occurrence of certain triggering events. As of December 31, 2021 and 2020, assets carried on the consolidated balance sheets and not remeasured to fair value on a recurring basis totaled $5.83 billion and $5.71 billion, respectively.

Fair Value Disclosures for Financial Instruments Not Carried at Fair Value

The estimated fair values of the term loans and the Notes are determined based on the price that the Company would have had to pay to settle the liabilities. As these liabilities are not actively traded, they are classified as Level 2 fair value measurements. The estimated fair values of the Company’s term loans and the Notes were as follows (in thousands):

 

 

 

December 31, 2021

 

 

December 31, 2020

 

 

 

Carrying

Value (a)

 

 

Estimated

Fair Value

 

 

Carrying

Value (a)

 

 

Estimated

Fair Value

 

Term Loan A - tranche one due March 2024

 

$

149,008

 

 

$

148,945

 

 

$

183,320

 

 

$

183,026

 

Term Loan A - tranche two due August 2024

 

 

1,634,756

 

 

 

1,635,138

 

 

 

1,271,255

 

 

 

1,269,213

 

Term Loan B due August 2024

 

 

—

 

 

 

—

 

 

 

560,194

 

 

 

560,144

 

Senior notes due January 2029

 

 

600,000

 

 

 

595,500

 

 

 

600,000

 

 

 

602,412

 

 

(a) The carrying value of the term loan debt is shown net of original issue discounts.

XML 37 R16.htm IDEA: XBRL DOCUMENT v3.22.0.1
Restructuring and Other Costs
 12 Months Ended
Dec. 31, 2021
Restructuring And Related Activities [Abstract]  
Restructuring and Other Costs

8. Restructuring and Other Costs

During the year ended December 31, 2021, the Company incurred employee severance and benefit costs, facility and lease termination costs, and other costs related to its restructuring activities. These costs were primarily related to the Company’s ForwardBound margin enhancement initiative. The costs incurred during the year ended December 31, 2020 were primarily related to the Company’s cost management strategies in response to the COVID-19 pandemic as well as the Company’s ForwardBound initiative.

Restructuring and other costs consisted of the following (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Employee severance and benefit costs

 

$

14,526

 

 

$

26,321

 

 

$

25,243

 

Facility and lease termination costs

 

 

8,226

 

 

 

2,313

 

 

 

16,202

 

Other costs

 

 

64

 

 

 

780

 

 

 

690

 

Total restructuring and other costs

 

$

22,816

 

 

$

29,414

 

 

$

42,135

 

 

The Company expects to continue to incur costs related to restructuring of its operations in order to achieve cost savings and the targeted synergies related to its acquisitions. However, the timing and the amount of these costs depends on various factors, including, but not limited to, identifying and realizing synergy opportunities and executing the integration of its combined operations. The Company may also continue to incur additional restructuring and other costs during and beyond 2022 related to its ForwardBound margin enhancement initiative.

Accrued Restructuring Liabilities

The following table summarizes activity related to the liabilities associated with restructuring and other costs (in thousands):

 

 

 

Employee

Severance Costs

 

 

Other Costs

 

 

Total

 

Balance as of December 31, 2019

 

$

5,728

 

 

$

22

 

 

$

5,750

 

Expenses incurred (a)

 

 

26,321

 

 

 

791

 

 

 

27,112

 

Payments

 

 

(26,219

)

 

 

(813

)

 

 

(27,032

)

Balance as of December 31, 2020

 

 

5,830

 

 

 

—

 

 

 

5,830

 

Expenses incurred (a)

 

 

14,574

 

 

 

17

 

 

 

14,591

 

Payments

 

 

(13,747

)

 

 

(17

)

 

 

(13,764

)

Balance as of December 31, 2021

 

$

6,657

 

 

$

—

 

 

$

6,657

 

 

(a) There were no non-cash restructuring and other expenses incurred for the years ended December 31, 2021 and 2020. The amount of expenses incurred for the years ended December 31, 2021 and 2020 excludes $8.2 million and $2.3 million, respectively, of facility lease closure and lease termination costs that are reflected as a reduction of operating lease right-of-use assets on the accompanying consolidated balance sheets under ASC 842.

The Company expects the employee severance costs accrued as of December 31, 2021 will be paid within the next twelve months. Liabilities associated with restructuring and other costs are included in accrued expenses and other long-term liabilities on the accompanying consolidated balance sheets.
XML 38 R17.htm IDEA: XBRL DOCUMENT v3.22.0.1
Shareholders' Equity
 12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Shareholders' Equity

9. Shareholders’ Equity

Shares Outstanding

Shares of common stock outstanding were as follows (in thousands):

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Common stock shares, beginning balance

 

 

103,935

 

 

 

103,866

 

 

 

103,372

 

Repurchases of common stock

 

 

(1,500

)

 

 

(1,256

)

 

 

(1,323

)

Issuances of common stock

 

 

1,329

 

 

 

1,325

 

 

 

1,817

 

Common stock shares, ending balance

 

 

103,764

 

 

 

103,935

 

 

 

103,866

 

Stock Repurchase Programs

On February 26, 2018, the Company’s Board of Directors (the “Board”) authorized the repurchase of up to an aggregate of $250.0 million of the Company’s common stock to be executed from time to time in open market transactions effected through a broker at prevailing market prices, in block trades or through privately negotiated transactions through December 31, 2019 (the “2018 Stock Repurchase Program”). On December 5, 2019, the Board increased the dollar amount authorized under the 2018 Stock Repurchase Program to up to an aggregate of $300.0 million and extended the term of the 2018 Stock Repurchase Program to December 31, 2020. The 2018 Stock Repurchase Program expired on December 31, 2020.

On November 17, 2020, the Company’s Board authorized the repurchase of up to an aggregate of $300.0 million of the Company’s Class A common stock, par value $0.01 per share, to be executed from time to time in open market transactions effected through a broker at prevailing market prices, in block trades, or through privately negotiated transactions through December 31, 2022 (the “2021 Stock Repurchase Program”). The 2021 Stock Repurchase Program took effect on January 1, 2021.

The 2021 Stock Repurchase Program does not obligate the Company to repurchase any particular amount of the Company’s common stock, and may be modified, extended, suspended, or discontinued at any time. The timing and amount of repurchases are determined by the Company’s management based on a variety of factors such as the market price of the Company’s common stock, the Company’s corporate cash requirements, and overall market conditions. The 2021 Stock Repurchase Program is subject to applicable legal requirements, including federal and state securities laws and applicable Nasdaq rules. The Company may also repurchase shares of its common stock pursuant to a trading plan meeting the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, which would permit shares of the Company’s common stock to be repurchased when the Company might otherwise be precluded from doing so by law.

During the year ended December 31, 2021, the Company repurchased 1,500,000 shares of its common stock in private transactions under the 2021 Stock Repurchase Program, for a total purchase price of approximately $117.5 million.

The following table sets forth repurchase activity under the Company’s stock repurchase programs from inception through December 31, 2021:

 

 

Total number of

shares purchased

 

 

Average price

paid per share

 

 

Approximate dollar

value of shares

purchased

(in thousands)

 

March 2018

 

 

948,100

 

 

$

39.55

 

 

$

37,493

 

April 2018

 

 

1,024,400

 

 

 

36.60

 

 

 

37,492

 

January 2019

 

 

552,100

 

 

 

39.16

 

 

 

21,623

 

February 2019

 

 

120,600

 

 

 

41.40

 

 

 

4,993

 

June 2019

 

 

509,100

 

 

 

45.29

 

 

 

23,055

 

August 2019

 

 

141,100

 

 

 

49.93

 

 

 

7,045

 

March 2020

 

 

600,000

 

 

 

53.38

 

 

 

32,029

 

September 2020

 

 

506,244

 

 

 

59.26

 

 

 

30,000

 

October 2020

 

 

150,000

 

 

 

54.14

 

 

 

8,122

 

March 2021

 

 

600,000

 

 

 

74.18

 

 

 

44,505

 

May 2021

 

 

400,000

 

 

 

81.04

 

 

 

32,416

 

June 2021

 

 

500,000

 

 

 

81.20

 

 

 

40,600

 

Total

 

 

6,051,644

 

 

 

 

 

 

$

319,373

 

 

The Company immediately retired all of the repurchased common stock and charged the par value of the shares to common stock. The excess of the repurchase price over the par value was applied on a pro rata basis against additional paid-in capital, with the remainder applied to accumulated deficit.

 

As of December 31, 2021, the Company had remaining authorization to repurchase up to approximately $182.5 million of shares of its common stock under the 2021 Stock Repurchase Program.

The following is a summary of the Company’s authorized, issued, and outstanding shares as of December 31:

 

 

2021

 

 

2020

 

Shares Authorized:

 

 

 

 

 

 

 

 

Class A common stock

 

 

300,000,000

 

 

 

300,000,000

 

Class B common stock

 

 

300,000,000

 

 

 

300,000,000

 

Preferred stock

 

 

30,000,000

 

 

 

30,000,000

 

Total shares authorized

 

 

630,000,000

 

 

 

630,000,000

 

Shares Issued and Outstanding:

 

 

 

 

 

 

 

 

Class A common stock

 

 

103,763,635

 

 

 

103,934,738

 

Class B common stock

 

 

—

 

 

 

—

 

Preferred stock

 

 

—

 

 

 

—

 

Total shares issued and outstanding

 

 

103,763,635

 

 

 

103,934,738

 

Voting Rights and Conversion Rights of Common Stock

Each share of Class A common stock is entitled to one vote on all matters to be voted on by the shareholders of the Company, including the election of directors. Each share of Class B common stock is entitled to one vote on all matters to be voted on by the shareholders of the Company, except for the right to vote in the election of directors. Additionally, each share of Class B common stock is convertible (on a one-for-one basis) into Class A common stock at any time at the election of the holder.

Dividend Rights and Preferences of Common Stock

The holders of Class A and Class B common stock are entitled to dividends on a pro rata basis at such time and in such amounts as declared by the Board. There were no dividends paid during the years ended December 31, 2021, 2020, or 2019.

Liquidation Rights and Preferences of Common Stock

The holders of Class A and Class B common stock are entitled to participate on a pro rata basis in all distributions made in connection with a voluntary or involuntary liquidation, dissolution, or winding up of the affairs of the Company.
XML 39 R18.htm IDEA: XBRL DOCUMENT v3.22.0.1
Earnings Per Share
 12 Months Ended
Dec. 31, 2021
Earnings Per Share [Abstract]  
Earnings Per Share

10. Earnings Per Share

The following table provides a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations (in thousands, except per share data):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

234,831

 

 

$

192,787

 

 

$

131,258

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Basic weighted average common shares outstanding

 

 

103,872

 

 

 

104,168

 

 

 

103,618

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

Stock options and other awards under deferred share-based compensation programs

 

 

1,193

 

 

 

1,297

 

 

 

1,387

 

Diluted weighted average common shares outstanding

 

 

105,065

 

 

 

105,465

 

 

 

105,005

 

Earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

2.26

 

 

$

1.85

 

 

$

1.27

 

Diluted

 

$

2.24

 

 

$

1.83

 

 

$

1.25

 

 

 

Potential common shares outstanding that are considered anti-dilutive are excluded from the computation of diluted earnings per share. Potential common shares related to stock options and other awards under share-based compensation programs may be determined to be anti-dilutive based on the application of the treasury stock method. Potential common shares are also anti-dilutive in periods when the Company incurs a net loss.

The number of potential shares outstanding that were anti-dilutive and therefore excluded from the computation of diluted earnings per share, weighted for the portion of the period they were outstanding, were 145,342, 582,760, and 277,128 for the years ended December 31, 2021, 2020, and 2019, respectively.
XML 40 R19.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes
 12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Income Taxes

11. Income Taxes

The components of income before provision for income taxes were as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Domestic

 

$

186,445

 

 

$

122,659

 

 

$

(17,066

)

Foreign

 

 

128,715

 

 

 

80,999

 

 

 

118,775

 

Income before provision for income taxes

 

$

315,160

 

 

$

203,658

 

 

$

101,709

 

The components of income tax expense (benefit) were as follows (in thousands):

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Federal income taxes:

 

 

 

 

 

 

 

 

 

 

 

 

Current

 

$

926

 

 

$

(15,537

)

 

$

(13,952

)

Deferred

 

 

45,819

 

 

 

10,188

 

 

 

(11,693

)

Foreign income taxes:

 

 

 

 

 

 

 

 

 

 

 

 

Current

 

 

27,718

 

 

 

16,019

 

 

 

21,452

 

Deferred

 

 

(4,309

)

 

 

(3,106

)

 

 

(2,206

)

State income taxes:

 

 

 

 

 

 

 

 

 

 

 

 

Current

 

 

5,163

 

 

 

14,229

 

 

 

2,850

 

Deferred

 

 

5,012

 

 

 

(10,922

)

 

 

(26,000

)

Income tax expense (benefit)

 

$

80,329

 

 

$

10,871

 

 

$

(29,549

)

 

Foreign Earnings

The Company has approximately $689.7 million of undistributed foreign earnings, of which approximately $278.4 million will remain indefinitely reinvested in the foreign jurisdictions. These earnings are expected to be used to support the growth and working capital needs of the Company’s foreign subsidiaries. It is impracticable to determine the total amount of unrecognized deferred taxes with respect to these indefinitely reinvested earnings. The remaining $411.3 million of undistributed foreign earnings are not considered indefinitely reinvested, and the Company has provided a $7.8 million deferred tax liability, primarily related to the estimated withholding tax and state taxes that would be due upon repatriation.

BEAT

The Company’s base eroding payments do not exceed the three percent threshold of its deductible payments in 2021; therefore, the Company has not recorded any base erosion and anti-abuse minimum tax (“BEAT”) liability for the years ended December 31, 2021 and December 31, 2020.

Actual income tax expense differed from the amount computed by applying the U.S. federal tax rate of 21% to pre-tax income as a result of the following (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Expected income tax expense at statutory rate

 

$

66,184

 

 

$

42,768

 

 

$

21,359

 

Change in income tax expense resulting from:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign income inclusion

 

 

11,019

 

 

 

6,013

 

 

 

39,557

 

Foreign earnings not indefinitely reinvested

 

 

278

 

 

 

5,071

 

 

 

—

 

Foreign tax credits

 

 

(4,390

)

 

 

—

 

 

 

—

 

Changes in income tax valuation allowance (all jurisdictions)

 

 

(1,462

)

 

 

14,503

 

 

 

(68,537

)

Change in fair value of contingent obligations

 

 

(122

)

 

 

(769

)

 

 

3,625

 

Share-based compensation

 

 

(5,662

)

 

 

(2,800

)

 

 

1,094

 

Research and general business tax credits (a)

 

 

(8,902

)

 

 

(12,872

)

 

 

(1,871

)

State and local taxes, net of federal benefit

 

 

11,978

 

 

 

6,924

 

 

 

(9,085

)

Capital loss carryforward (b)

 

 

(214

)

 

 

(16,506

)

 

 

—

 

Foreign rate differential

 

 

2,865

 

 

 

(1,777

)

 

 

(3,595

)

Changes in reserve for uncertain tax positions including interest

 

 

4,721

 

 

 

(18,839

)

 

 

5,393

 

Provision to tax return and other deferred tax adjustments

 

 

(771

)

 

 

(12,325

)

 

 

(6,950

)

Gain on sale of business

 

 

—

 

 

 

(2,350

)

 

 

—

 

Base erosion and anti-abuse tax

 

 

—

 

 

 

—

 

 

 

(15,054

)

Nondeductible executive compensation

 

 

1,649

 

 

 

367

 

 

 

1,802

 

Other, net

 

 

3,158

 

 

 

3,463

 

 

 

2,713

 

Income tax expense (benefit)

 

$

80,329

 

 

$

10,871

 

 

$

(29,549

)

 

(a) Year ended December 31, 2021 included a $0.8 million valuation allowance release and year ended December 31, 2020 was offset by a $9.4 million valuation allowance.

(b) Years ended December 31, 2021 and 2020 are offset by $0.2 million and $16.5 million, respectively, in valuation allowances.

The changes in the valuation allowance for deferred tax assets were as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Balance at the beginning of the period

 

$

100,310

 

 

$

84,159

 

 

$

150,316

 

Deferred tax assets assumed through acquisitions

 

 

—

 

 

 

479

 

 

 

—

 

Deferred tax assets released through divestitures

 

 

—

 

 

 

(271

)

 

 

—

 

(Credited) charged to income tax expense

 

 

(1,462

)

 

 

14,503

 

 

 

(68,537

)

Charged to equity

 

 

—

 

 

 

—

 

 

 

42

 

Foreign currency exchange

 

 

(407

)

 

 

1,440

 

 

 

2,338

 

Other adjustments

 

 

(479

)

 

 

—

 

 

 

—

 

Balance at the end of the period

 

$

97,962

 

 

$

100,310

 

 

$

84,159

 

 

As of December 31, 2021, the valuation allowance decreased by $2.3 million, resulting primarily from a net decrease of $1.5 million primarily due to releasing a domestic valuation allowance related to state deferred tax assets.

 

As of December 31, 2020, the valuation allowance increased by $16.2 million, resulting from a net increase of $14.5 million primarily due to recording a federal U.S. valuation allowance related to capital loss carryforwards as well as recording a valuation allowance related to foreign research and development credits, partially offset by the release of a valuation allowance on U.S. state deferred tax assets and an increase of $1.4 million for changes related to foreign currency exchange.

The income tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities are as follows as of December 31 (in thousands):

 

 

 

2021

 

 

2020

 

Deferred tax assets:

 

 

 

 

 

 

 

 

Net operating losses

 

$

134,143

 

 

$

122,018

 

Tax credits

 

 

58,901

 

 

 

58,603

 

Deferred revenue

 

 

—

 

 

 

77,138

 

Employee compensation and other benefits

 

 

28,538

 

 

 

29,048

 

Allowance for doubtful accounts

 

 

1,787

 

 

 

1,739

 

Lease obligations

 

 

57,749

 

 

 

57,142

 

Accrued expenses

 

 

13,158

 

 

 

6,526

 

Prepaid royalty

 

 

—

 

 

 

3,451

 

Capital loss carryforward

 

 

20,021

 

 

 

20,157

 

Interest limitation carryforwards

 

 

30,847

 

 

 

20,219

 

Other

 

 

1,151

 

 

 

7,913

 

Total deferred tax assets

 

 

346,295

 

 

 

403,954

 

Less: valuation allowance

 

 

(97,962

)

 

 

(100,310

)

Net deferred tax assets

 

 

248,333

 

 

 

303,644

 

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Undistributed foreign earnings

 

 

(7,778

)

 

 

(10,912

)

Right of use asset

 

 

(47,532

)

 

 

(49,316

)

Depreciation and amortization

 

 

(214,636

)

 

 

(226,170

)

Deferred revenue

 

 

(17,247

)

 

 

—

 

Other

 

 

(3,814

)

 

 

(2,404

)

Total deferred tax liabilities

 

 

(291,007

)

 

 

(288,802

)

Net deferred tax assets

 

$

(42,674

)

 

$

14,842

 

 

As of December 31, 2021 and 2020, the Company had U.S. federal net operating loss (“NOL”) carryforwards of approximately $317.4 million and $260.6 million, respectively. These carryforwards begin to expire in 2029, but the Company anticipates utilizing such carryforwards prior to their expirations.

As of December 31, 2021 and 2020, the Company had state NOL carryforwards of approximately $840.4 million and $821.0 million, respectively, a portion of which expire annually. The Company also had foreign NOL carryforwards of $98.9 million and $80.1 million as of December 31, 2021 and 2020, respectively. The majority of these carryforwards have indefinite carryforward periods, but valuation allowances have been established for jurisdictions where the future benefits of the NOL carryforwards are not more likely than not to be realized.

As of December 31, 2021 and 2020, the Company had Canadian research and development credit carryforwards of $56.1 million and $56.7 million, respectively. These credit carryforwards have an indefinite life, but for the years ended December 31, 2021 and 2020, valuation allowances of $56.1 million and $56.7 million, respectively, have been established against these tax credits where the future benefits of the credits are not more likely than not to be realized.

The Company’s gross unrecognized tax benefits, exclusive of associated interest and penalties, were $12.1 million and $9.0 million as of December 31, 2021 and 2020, respectively. The increase of $3.1 million was primarily due to increase in positions relating to prior years in foreign jurisdictions partially offset with the settlement of unrecognized tax benefits in the U.S. The Company recognizes accrued interest and penalties related to uncertain tax positions in income tax expense in the accompanying consolidated statements of income. As of December 31, 2021 and 2020, the Company had accrued interest and penalties related to uncertain tax positions of $2.4 million and $2.8 million, respectively.

The Company believes it is reasonably possible that its unrecognized tax benefits may decrease by approximately $1.6 million within the next 12 months as a result of lapses in statutes of limitations. A reconciliation of the beginning and ending balances of unrecognized tax benefits, excluding accrued interest and penalties, is as follows (in thousands):

 

Unrecognized tax benefits balance as of December 31, 2018

 

$

19,245

 

Increases for tax positions in the current year

 

 

2,222

 

Increases for tax positions of prior years

 

 

2,255

 

Decreases for tax positions in prior year

 

 

(440

)

Impact of foreign currency translation

 

 

(44

)

Unrecognized tax benefits balance as of December 31, 2019

 

 

23,238

 

Increases for tax positions in the current year

 

 

254

 

Increases for tax positions of prior years

 

 

3,237

 

Decreases for tax positions in prior year

 

 

(2,540

)

Impact of foreign currency translation

 

 

132

 

Lapse of statute limitations

 

 

(15,288

)

Unrecognized tax benefits balance as of December 31, 2020

 

 

9,033

 

Increases for tax positions in the current year

 

 

386

 

Increases for tax positions of prior years

 

 

4,233

 

Settlements with tax authorities

 

 

(1,131

)

Impact of foreign currency translation

 

 

(169

)

Lapse of statute limitations

 

 

(234

)

Unrecognized tax benefits balance as of December 31, 2021

 

$

12,118

 

 

Due to the geographic breadth of the Company’s operations, numerous tax audits may be ongoing throughout the world at any point in time. Income tax liabilities are recorded based on estimates of additional income taxes which will be due upon the conclusion of these audits. Estimates of these income tax liabilities are made based upon prior experience and are updated in light of changes in facts and circumstances. However, due to the uncertain and complex application of tax regulations, it is possible that the ultimate resolution of audits may result in liabilities which could be materially different from these estimates. In such an event, the Company will record additional income tax expense or benefit in the period in which such resolution occurs.

The Company is not currently under any U.S. federal income tax audits, however, income tax returns are under examination by tax authorities in several state and foreign jurisdictions. The Company’s federal and state tax filings are open to investigations in numerous years due to NOL carryforwards. Additionally, the Company currently has an ongoing examination for tax years 2017 to 2019 in the United Kingdom. The United Kingdom is the jurisdiction with the Company’s largest foreign operations. The Company believes that its reserve for uncertain tax positions is adequate to cover existing risks or exposures related to all open tax years and jurisdictions.
XML 41 R20.htm IDEA: XBRL DOCUMENT v3.22.0.1
Revenue from Contracts with Customers
 12 Months Ended
Dec. 31, 2021
Revenue From Contract With Customer [Abstract]  
Revenue from Contract with Customers

12. Revenue from Contracts with Customers

Unsatisfied Performance Obligations

As of December 31, 2021, the total aggregate transaction price allocated to the unsatisfied performance obligations under contracts with contract terms greater than one year and that are not accounted for as a series pursuant to ASC 606 was $6.70 billion. This amount includes revenue associated with reimbursable out-of-pocket expenses. The Company expects to recognize revenue over the remaining contract term of the individual projects, with contract terms generally ranging from one to five years. The amount of unsatisfied performance obligations is presented net of any constraints and, as a result, is lower than the potential contractual revenue. The contracts excluded due to constraints include contracts that do not commence within a certain period of time or that require the Company to undertake numerous activities to fulfill these performance obligations, including various activities that are outside of the Company’s control.

Timing of Billing and Performance

During the year ended December 31, 2021, the Company recognized approximately $611.9 million of revenue that was included in the deferred revenue balance at the beginning of the year. During the year ended December 31, 2021, approximately $120.9 million of the Company’s revenue recognized was allocated to performance obligations partially satisfied in previous periods, substantially all of which was associated with changes in scope or price for full-service clinical studies. The Company reviews its portfolio level risk and inflation factors during the third quarter of each year. Based on this review, the Company modified the application of its portfolio level inflation factor, which was considered a change in estimate, and recognized additional revenue of $23.5 million related to this change during the third quarter of 2021. As a result of changing service delivery trends in connection with the COVID-19 pandemic and adoption of decentralized trial methodologies, the Company implemented a comprehensive approach during the fourth quarter of 2021 related to anticipated reductions in reimbursable out-of-pocket expenses, which was considered a change in estimate, and recognized additional net revenue of $44.0 million during the period. This amount related to anticipated changes in reimbursable out-of-pocket expenses, inclusive of both the revised approach as well as updates to project estimates made in the normal course of business. The additional revenue related to these changes in estimates was partially offset by insignificant changes in estimates related to projects recognized in the normal course of the Company’s revenue recognition processes.
XML 42 R21.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Information
 12 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
Segment Information

13. Segment Information

The Company is managed through two reportable segments: Clinical Solutions and Commercial Solutions. Each reportable segment consists of multiple service offerings that, when combined, create a fully integrated biopharmaceutical services organization. Clinical Solutions offers comprehensive global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. The segment is organized around clinical pharmacology and bioanalytical services, workforce deployment, full-service clinical studies, real world evidence, and consulting. This segment offers individual services including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs; all across a comprehensive range of therapeutic areas. Commercial Solutions provides the pharmaceutical, biotechnology, and healthcare industries with commercialization services, including deployment solutions, communications solutions (public relations, advertising, and medical communications), and consulting services.

The Company’s Chief Operating Decision Maker (the “CODM”) reviews segment performance and allocates resources based upon segment revenue and income from operations. Inter-segment revenue is eliminated from the segment reporting provided to the CODM and is not included in the segment revenue presented in the table below. Certain costs are not allocated to the Company’s reportable segments and are reported as general corporate expenses. These costs primarily consist of share-based compensation, general operating expenses associated with the Board and the Company’s senior leadership, finance, investor relations, and internal audit functions, and transaction and integration-related expenses. The Company does not allocate depreciation, amortization, asset impairment charges, or restructuring and other costs to its segments. Prior period segment results have been recast to reflect the transfer of the Kinapse Regulatory and Operations Consulting service lines from Commercial Solutions to Clinical Solutions to align with management reporting in 2021. Additionally, the CODM reviews the Company’s assets on a consolidated basis and does not allocate assets to its reportable segments for purposes of assessing segment performance or allocating resources.

Information about reportable segment operating results was as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Revenue:

 

 

 

 

 

 

 

 

 

 

 

 

Clinical Solutions

 

$

4,009,057

 

 

$

3,339,451

 

 

$

3,450,223

 

Commercial Solutions

 

 

1,203,913

 

 

 

1,076,326

 

 

 

1,225,592

 

Total revenue

 

 

5,212,970

 

 

 

4,415,777

 

 

 

4,675,815

 

Segment direct costs:

 

 

 

 

 

 

 

 

 

 

 

 

Clinical Solutions

 

 

3,005,938

 

 

 

2,513,240

 

 

 

2,637,016

 

Commercial Solutions

 

 

955,326

 

 

 

853,555

 

 

 

979,878

 

Total segment direct costs

 

 

3,961,264

 

 

 

3,366,795

 

 

 

3,616,894

 

Segment selling, general, and administrative expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Clinical Solutions

 

 

353,990

 

 

 

283,633

 

 

 

280,674

 

Commercial Solutions

 

 

82,516

 

 

 

82,709

 

 

 

87,258

 

Total segment selling, general, and administrative expenses

 

 

436,506

 

 

 

366,342

 

 

 

367,932

 

Segment operating income:

 

 

 

 

 

 

 

 

 

 

 

 

Clinical Solutions

 

 

649,129

 

 

 

542,578

 

 

 

532,533

 

Commercial Solutions

 

 

166,071

 

 

 

140,062

 

 

 

158,456

 

Total segment operating income

 

 

815,200

 

 

 

682,640

 

 

 

690,989

 

Direct costs and operating expenses not allocated to segments:

 

 

 

 

 

 

 

 

 

 

 

 

Share-based compensation included in direct costs

 

 

33,220

 

 

 

31,347

 

 

 

29,011

 

Share-based compensation included in selling, general, and administrative expenses

 

 

31,984

 

 

 

27,144

 

 

 

26,182

 

Corporate selling, general, and administrative expenses

 

 

102,275

 

 

 

79,240

 

 

 

113,442

 

Restructuring and other costs

 

 

22,816

 

 

 

29,414

 

 

 

42,135

 

Depreciation and amortization

 

 

235,625

 

 

 

222,352

 

 

 

242,465

 

Total income from operations

 

$

389,280

 

 

$

293,143

 

 

$

237,754

 

 
XML 43 R22.htm IDEA: XBRL DOCUMENT v3.22.0.1
Operations by Geographic Location
 12 Months Ended
Dec. 31, 2021
Segments Geographical Areas [Abstract]  
Operations by Geographic Location

14. Operations by Geographic Location

The following table summarizes total revenue by geographic area (in thousands, all intercompany transactions have been eliminated):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Revenue:

 

 

 

 

 

 

 

 

 

 

 

 

North America (a)

 

$

3,144,475

 

 

$

2,791,590

 

 

$

3,079,608

 

Europe, Middle East and Africa

 

 

1,333,540

 

 

 

1,059,968

 

 

 

1,055,007

 

Asia-Pacific

 

 

594,163

 

 

 

465,116

 

 

 

444,819

 

Latin America

 

 

140,792

 

 

 

99,103

 

 

 

96,381

 

Total revenue

 

$

5,212,970

 

 

$

4,415,777

 

 

$

4,675,815

 

 

(a) Revenue for the North America region includes revenue attributable to the U.S. of $2.95 billion, $2.64 billion, and $2.93 billion, or 56.6%, 59.9%, and 62.7% of total revenue, for the years ended December 31, 2021, 2020 and 2019, respectively. No other country represented more than 10% of total revenue for any year.

The following table summarizes long-lived assets by geographic area as of December 31 (in thousands, all intercompany transactions have been eliminated):

 

 

 

2021

 

 

2020

 

Property and equipment, net:

 

 

 

 

 

 

 

 

North America (a)

 

$

165,446

 

 

$

161,531

 

Europe, Middle East and Africa

 

 

37,004

 

 

 

38,745

 

Asia-Pacific

 

 

13,615

 

 

 

11,167

 

Latin America

 

 

6,592

 

 

 

4,757

 

Total property and equipment, net

 

$

222,657

 

 

$

216,200

 

 

(a) Long-lived assets for the North America region include property and equipment, net attributable to the U.S. of $160.0 million and $156.0 million as of December 31, 2021 and 2020, respectively.
XML 44 R23.htm IDEA: XBRL DOCUMENT v3.22.0.1
Concentration of Credit Risk
 12 Months Ended
Dec. 31, 2021
Risks And Uncertainties [Abstract]  
Concentration of Credit Risk

15. Concentration of Credit Risk

Financial assets that subject the Company to credit risk primarily consist of cash and cash equivalents, accounts receivable and unbilled services (including contract assets). The Company’s cash and cash equivalents consist principally of cash and are maintained at several financial institutions with reputable credit ratings. The Company maintains cash depository accounts with several financial institutions worldwide and is exposed to credit risk related to the potential inability to access liquidity in financial institutions where its cash and cash equivalents are concentrated. The Company has not historically incurred any losses with respect to these balances and believes that they bear minimal credit risk.

As of December 31, 2021 and 2020, substantially all of the Company’s cash and cash equivalents were held within the U.S.

Substantially all of the Company’s revenue is earned by performing services under contracts with pharmaceutical and biotechnology companies. The concentration of credit risk is equal to the outstanding accounts receivable and unbilled services (including contract assets) balances less deferred revenue.

No single customer accounted for greater than 10% of the Company’s revenue for the years ended December 31, 2021, 2020 or 2019.

No single customer accounted for greater than 10% of the Company’s accounts receivable and unbilled services (including contract assets) balances for the year ended December 31, 2021 or 2020.

XML 45 R24.htm IDEA: XBRL DOCUMENT v3.22.0.1
Related-Party Transactions
 12 Months Ended
Dec. 31, 2021
Related Party Transactions [Abstract]  
Related-Party Transactions

16. Related-Party Transactions

For the year ended December 31, 2021, the Company had combined revenue of $3.7 million from three customers whose board of directors each included a member who was also a member of the Company’s Board. The combined revenue reflects the periods in which the member served on both the customer’s board of directors and the Company’s Board. As of December 31, 2021, the Company had combined receivables of $0.6 million from two customers whose board of directors each included a member who was also a member of the Company’s Board. For the year ended December 31, 2021, the Company incurred expenses of $0.6 million for professional services obtained from the party noted below that purchased its contingent staffing business, for the period in which such party was a related party.

On October 6, 2021, the Company completed the acquisition of RxDataScience through an arm’s-length transaction. A member of the Company’s management was the co-founder and minority shareholder of RxDataScience and continued to be an executive advisor at RxDataScience up until the acquisition date. For additional information, refer to “Note 3 – Acquisitions, Divestitures, and Investments” and “Note 7 – Fair Value Measurements.”

For the year ended December 31, 2020, the Company had revenue of $1.8 million and, as of December 31, 2020, receivables of $1.3 million from a customer whose board of directors included a member who was also a member of the Company’s Board. This customer became a related party during the third quarter of 2020. During the second quarter of 2020, the Company sold its contingent staffing business to a related party in exchange for potential future cash consideration not to exceed $4.0 million. The acquiring company had a significant shareholder who was also a significant shareholder of the Company. The significant shareholder sold their interest in the acquiring company during March 2021. Based on the financial results of the business one year after the divestiture date, the Company recognized $1.8 million of contingent consideration in other (income) expense, net in the second quarter of 2021. The future cash consideration is contingent on the financial performance of the sold business through May 31, 2023. The Company will recognize the contingent consideration in the consolidated statements of income in the period the contingency is resolved.

For the year ended December 31, 2019, the Company had revenue of $0.4 million from a customer whose board of directors included a member who was also a member of the Company’s Board. This customer became a related party of the Company during the fourth quarter of 2019. For the year ended December 31, 2018, the Company had revenue of $0.4 million from two customers each of whose respective boards of directors included a member who was also a member of the Company’s Board.

For the year ended December 31, 2019, the Company incurred reimbursable out-of-pocket expenses of $1.1 million for professional services obtained from a provider whose board of directors included a member who was also a member of the Company’s Board. These expenses are included within direct costs in the consolidated statements of income. This provider ceased to be a related party as of December 31, 2019.
XML 46 R25.htm IDEA: XBRL DOCUMENT v3.22.0.1
Commitments and Contingencies
 12 Months Ended
Dec. 31, 2021
Commitments And Contingencies Disclosure [Abstract]  
Commitments and Contingencies

17. Commitments and Contingencies

Legal Contingencies

The Company is involved in various claims and legal actions arising in the ordinary course of business. The Company accrues a liability when a loss is considered probable and the amount can be reasonably estimated. When a material loss contingency is reasonably possible but not probable, the Company does not record a liability, but instead discloses the nature and the amount of the claim, and an estimate of the loss or range of loss, if such an estimate can be made. Legal fees are expensed as incurred. In the opinion of management, the outcome of any existing claims and legal or regulatory proceedings, other than the specific matters described below, if decided adversely, is not expected to have a material adverse effect on the Company's business, financial condition, results of operations, or cash flows.

On December 1, 2017, the first of two virtually identical actions alleging federal securities law claims was filed against the Company and certain of its officers on behalf of a putative class of its shareholders. The first action, captioned Bermudez v. INC Research, Inc., et al, No. 17-09457 (S.D.N.Y.), was filed in the Southern District of New York (the “Bermudez action”), and the second action, Vaitkuvienë v. Syneos Health, Inc., et al, No. 18-0029 (E.D.N.C.), was filed on January 25, 2018 in the Eastern District of North Carolina (the “Vaitkuvienë action”). On March 30, 2018, the Bermudez action was dismissed voluntarily. After the San Antonio Fire & Police Pension Fund and El Paso Firemen & Policemen’s Pension Fund were appointed as Lead Plaintiffs in the Vaitkuvienë action, Lead Plaintiffs filed an amended complaint on July 30, 2018, which named as defendants the Company, Alistair Macdonald, Gregory S. Rush, Michael A. Bell, and each member of the Company’s Board at the time of the stockholder vote on the 2017 merger (the “Merger”) of INC Research with an affiliate of inVentiv Health, Inc. (“inVentiv”). The amended complaint alleged claims under Sections 10(b), 14(a) and 20(a) of the Securities Exchange Act of 1934 on behalf of a putative class of purchasers of the Company’s common stock between May 10, 2017 and November 8, 2017, contending that the Company published inaccurate or incomplete information regarding, among other things, the financial performance and business outlook for inVentiv’s business prior to and following the Merger. Lead Plaintiffs seek, among other things, orders (i) declaring that the lawsuit is a proper class

action and (ii) awarding compensatory damages in an amount to be proven at trial, including interest thereon, and reasonable costs and expenses incurred in this action, including attorneys’ fees and expert fees, to Lead Plaintiffs and other class members. On September 20, 2018, Defendants moved to dismiss the action. On August 30, 2021, the District Court entered an order granting the motion to dismiss in its entirety, and on October 21, 2021, the Court entered judgment for Defendants. On November 19, 2021, Lead Plaintiffs appealed from this judgment to the U.S. Court of Appeals for the Fourth Circuit, which appeal remains pending.

The Company is presently unable to predict the duration, scope, or result of the foregoing putative class actions, or any other related lawsuit. As such, the Company is presently unable to develop a reasonable estimate of a possible loss or range of losses, if any, related to these matters. While the Company intends to defend any further proceedings in the putative class action litigation vigorously, the outcome of such litigation or any other litigation is necessarily uncertain. The Company could be forced to expend significant resources in the defense of these lawsuits or future ones, and it may not prevail. As such, these matters could have a material adverse effect on the Company's business, annual, or interim results of operations, cash flows, or its financial condition.

Assumed Contingent Tax-Sharing Obligation

As a result of the Merger, the Company assumed contingent tax-sharing obligations arising from inVentiv Health, Inc.’s 2016 merger with Double Eagle Parent, Inc. During the first quarter of 2021, the Company made payments of $6.2 million to fully settle this outstanding obligation. As of December 31, 2020, the estimated fair value of the assumed contingent tax-sharing obligations was $6.8 million.

Contingent Earn-out Liabilities

In connection with the RxDataScience acquisition, the Company recorded a contingent earn-out liability to be paid based on achievement of revenue targets in 2022 and the renewal of a specific customer contract. The estimated fair value of the contingent earn-out liability as of December 31, 2021 was $14.6 million and was included in other long-term liabilities in the accompanying consolidated balance sheet. For additional information, refer to “Note 3 - Acquisitions, Divestitures, and Investments.”

In connection with an insignificant acquisition in 2021, the Company recorded a contingent earn-out liability to be paid based on achievement of employee retention benchmarks. The estimated fair value of the contingent obligation was $3.4 million as of December 31, 2021 and was included in accrued expenses in the accompanying consolidated balance sheet.
XML 47 R26.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation
 12 Months Ended
Dec. 31, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Share-Based Compensation

18. Share-Based Compensation

Overview of Employee Share-Based Compensation Plans

The Company has two share-based compensation plans, the Syneos Health, Inc. 2018 Equity Incentive Plan (“2018 Plan”) and the Syneos Health, Inc. 2016 Employee Stock Purchase Plan, as amended and restated (“ESPP”). In addition, the Company had the INC Research Holdings, Inc. 2014 Equity Incentive Plan (“2014 Plan”) and the INC Research Holdings, Inc. 2010 Equity Incentive Plan (“2010 Plan”) that were terminated effective May 24, 2018 and October 30, 2014, respectively, except as to outstanding awards. No further awards can be issued under the 2014 Plan or 2010 Plan. The 2018 Plan was effective on May 24, 2018, and permits granting of stock options, stock appreciation rights, restricted stock awards, restricted stock units (“RSUs”), or stock awards to employees, as well as non-employee directors, consultants, or other personal service providers. The terms of share-based instruments granted are determined at the time of grant and are typically subject to such conditions as continued employment, passage of time, and/or satisfaction of performance criteria. The Company has granted stock options and RSUs, which typically vest ratably over a three-year period from the grant date. In addition, the Company has granted performance-vesting RSUs. The Board and the Compensation and Management Development Committee have the discretion to determine different vesting schedules. Stock options have a maximum term of ten years. The exercise price per share of stock options may not be less than the fair market value of a share of the Company’s common stock on the date of grant.

As of December 31, 2021, the maximum number of shares reserved for issuance under the Company’s share-based compensation plans was 15,167,325, of which 3,446,778 shares were available for future grants as of December 31, 2021. In addition, under the 2018 Plan, any shares of the Company’s common stock that are retained by or returned to the Company under any outstanding awards that are canceled, expired, forfeited, surrendered, settled in cash, or otherwise terminated without delivery of the shares, in each case, will prior to vesting or exercise become available for future grants.

Employee Stock Purchase Plan

In March 2016, the Board approved the ESPP, which was also approved by the Company’s shareholders in May 2016. The ESPP was subsequently amended and restated and approved by the Board in March 2018, and also approved by the Company’s shareholders in May 2018. The ESPP allows eligible employees to authorize payroll deductions of up to 10% of their annual base salary or wages to be applied toward the purchase of full shares of the Company’s common stock on the last trading day of the offering period. Participating employees can purchase shares of the Company’s common stock at a 15% discount to the lesser of the closing price of the Company’s common stock as quoted on the Nasdaq Stock Exchange on (i) the first trading day of the offering period or (ii) the last trading day of the offering period. Offering periods under the ESPP are six months in duration, and the first offering period began on September 1, 2016. Under the ESPP, the Company recognized share-based compensation expense of $6.2 million, $5.8 million, and $6.5 million for the years ended December 31, 2021, 2020, and 2019, respectively. As of December 31, 2021, there were 1,594,312 shares issued and 1,905,688 shares reserved for future issuance under the ESPP.

The fair values of ESPP offerings were determined using the Black-Scholes valuation model and the following assumptions:

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Expected volatility

 

25.3% - 38.3%

 

 

27.7% - 55.1%

 

 

39.1% - 51.9%

 

Risk-free interest rate

 

0.06% - 0.07%

 

 

0.13% - 0.95%

 

 

1.88% - 2.52%

 

Expected term (in years)

 

 

0.5

 

 

 

0.5

 

 

 

0.5

 

 

 

Stock Option Awards

The following table sets forth the summary of stock option activity for the year ended December 31, 2021:

 

 

 

Number

of

Options

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Contractual

Life (in years)

 

 

Aggregate

Intrinsic Value

(in thousands)(a)

 

Outstanding as of December 31, 2020

 

 

663,559

 

 

$

30.12

 

 

 

 

 

 

 

 

 

Exercised

 

 

(279,072

)

 

 

33.31

 

 

 

 

 

 

 

 

 

Forfeited

 

 

—

 

 

 

—

 

 

 

 

 

 

 

 

 

Outstanding as of December 31, 2021

 

 

384,487

 

 

 

27.81

 

 

 

3.26

 

 

$

28,787

 

Vested and expected to vest as of December 31, 2021

 

 

384,487

 

 

 

27.81

 

 

 

3.26

 

 

$

28,787

 

Exercisable as of December 31, 2021

 

 

384,487

 

 

 

27.81

 

 

 

3.26

 

 

$

28,787

 

 

(a) Represents the total pre-tax intrinsic value (i.e., the aggregate difference between the closing price of the Company’s common stock on December 31, 2021 of $102.68 and the exercise price for in-the-money options) that would have been received by the holders if all instruments had been exercised on December 31, 2021.

As of December 31, 2021, there was no unrecognized compensation expense related to non-vested stock options.

There have been no stock options granted since 2017. The total intrinsic value of options exercised was $14.7 million, $12.7 million, and $20.3 million for the years ended December 31, 2021, 2020, and 2019, respectively.

Restricted Stock Units Awards

The following table sets forth a summary of RSUs outstanding under the 2014 and 2018 Plans as of December 31, 2021 and changes during the year then ended:

 

 

 

Time-based

 

 

Performance-based

 

 

 

 

 

 

 

Number of Shares

 

 

Weighted Average

Grant Date Fair Value

 

 

Number of Shares

 

 

Weighted Average

Grant Date Fair Value

 

 

Total Number of Shares

 

Non-vested as of December 31, 2020

 

 

1,909,882

 

 

$

51.98

 

 

 

461,499

 

 

$

48.99

 

 

 

2,371,381

 

Granted

 

 

939,031

 

 

 

76.96

 

 

 

59,055

 

 

 

75.43

 

 

 

998,086

 

Vested

 

 

(997,632

)

 

 

48.45

 

 

 

(136,665

)

 

 

46.47

 

 

 

(1,134,297

)

Forfeited

 

 

(226,094

)

 

 

64.07

 

 

 

(27,890

)

 

 

58.71

 

 

 

(253,984

)

Non-vested as of December 31, 2021

 

 

1,625,187

 

 

$

66.90

 

 

 

355,999

 

 

$

60.75

 

 

 

1,981,186

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrecognized compensation expense (in millions)

 

$

62.6

 

 

 

 

 

 

$

10.7

 

 

 

 

 

 

 

 

 

Weighted average period unrecognized compensation is expected to be recognized

 

1.9 years

 

 

 

 

 

 

1.9 years

 

 

 

 

 

 

 

 

 

 

Time-based Awards

The weighted-average grant-date fair value of the RSUs granted during the years ended December 31, 2020 and 2019 was $62.12 and $45.45, respectively. The total fair value of shares vested during the years ended December 31, 2021, 2020, and 2019, was $48.3 million, $43.0 million, and $30.3 million, respectively.

Performance-Based Awards

During the years ended December 31, 2021, 2020, and 2019, the Board and Compensation and Management Development Committee granted certain executive officers performance-based RSUs (“PRSUs”). The PRSUs are subject to the Company’s achieving certain performance targets including revenue growth, adjusted diluted EPS growth, and return on invested capital. Compensation expense related to PRSUs is recorded based on the estimated quantity of awards that are expected to vest. At each reporting period, management re-assesses the probability that the performance conditions will be achieved and adjusts compensation expense to reflect any changes in the estimated probability of vesting until the actual level of achievement of the performance targets is known.

The weighted-average grant-date fair value of the PRSUs granted during the years ended December 31, 2020 and 2019 was $62.50 and $45.00, respectively. The total fair value of shares vested during the year ended December 31, 2021, was $6.4 million. No PRSUs were vested or distributed in the years ended December 31, 2020 and 2019.

Share-Based Compensation Expense

Total share-based compensation expense recognized was as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Direct costs

 

$

33,220

 

 

$

31,347

 

 

$

29,011

 

Selling, general, and administrative expenses

 

 

31,984

 

 

 

27,144

 

 

 

26,182

 

Total share-based compensation expense

 

$

65,204

 

 

$

58,491

 

 

$

55,193

 

The total income tax benefit recognized in the consolidated statements of income for share-based compensation arrangements was approximately $13.8 million, $11.8 million, and $10.8 million for the years ended December 31, 2021, 2020, and 2019, respectively.
XML 48 R27.htm IDEA: XBRL DOCUMENT v3.22.0.1
Employee Benefit Plans
 12 Months Ended
Dec. 31, 2021
Compensation And Retirement Disclosure [Abstract]  
Employee Benefit Plans

19. Employee Benefit Plans

Defined Contribution Retirement Plans

In the U.S., the Company offers defined contribution retirement benefit plans that comply with Section 401(a) of the Internal Revenue Code under which it matches employee deferrals at varying percentages and at specified limits of the employee’s salary. In 2020, the Company implemented cost management strategies, including suspending the Company match on U.S. employee 401(k) contributions for six months. The match was resumed in the fourth quarter of 2020.

The Company’s contributions related to these defined contribution retirement plans were as follows (in thousands):

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Defined contribution retirement plan contributions

 

$

30,932

 

 

$

15,049

 

 

$

29,834

 

 

The Company also has defined contribution retirement plans outside of the U.S. The Company’s contributions related to these plans were approximately $23.2 million, $18.4 million, and $10.0 million for the years ended December 31, 2021, 2020, and 2019, respectively. The Company’s contributions associated with all of its defined contribution retirement plans are recorded in direct costs and selling, general, and administrative expenses on the accompanying consolidated statements of income.

Deferred Compensation Plan

The Company offers a Nonqualified Deferred Compensation Plan for certain employees pursuant to Section 409A of the Internal Revenue Code (“NQDC Plan”). Under this plan, participants can defer, on a pre-tax basis, from 1.0% up to a maximum of 80.0% of salary and from 1.0% up to a maximum of 100.0% of commissions and annual bonuses. The Company does not make matching contributions into the NQDC Plan. Distributions will be made to participants upon termination of employment or death in a lump sum, unless installments are selected.

As of December 31, 2021 and 2020, the NQDC Plan deferred compensation liabilities were $23.4 million and $22.3 million, respectively, and are included in other long-term liabilities on the accompanying consolidated balance sheets. The assets associated with the NQDC Plan are subject to the claims of the creditors and primarily consist of investments in mutual funds maintained in a “rabbi trust”. These investments are classified as trading securities and are included in other long-term assets on the accompanying consolidated balance sheets.
XML 49 R28.htm IDEA: XBRL DOCUMENT v3.22.0.1
Basis of Presentation and Summary of Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Principles of Consolidation

Principles of Consolidation

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), and include the accounts and results of operations of the Company and its controlled subsidiaries. All intercompany balances and transactions have been eliminated.
Reclassification

Reclassification

Certain previously reported amounts have been reclassified to conform to the current year presentation.
Use of Estimates

Use of Estimates

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of revenue and expenses for the periods presented in the financial statements. Examples of estimates and assumptions include, but are not limited to, determining the fair value of goodwill and intangible assets and their potential impairment, useful lives of tangible and intangible assets, useful lives of assets subject to leases, valuation of the Company’s right of use assets, allowances for doubtful accounts, potential future outcomes of events for which income tax consequences have been recognized in the Company’s consolidated financial statements or tax returns, valuation allowances for deferred tax assets, fair value of share-based compensation and its recognition period, loss contingencies, fair value of derivative instruments and related hedge effectiveness, fair value of contingent tax sharing obligations, and judgments related to revenue recognition, among others. In addition, estimates and assumptions are used in the accounting for acquisitions, including the fair value and useful lives of acquired tangible and intangible assets and the fair value of assumed liabilities.

The Company evaluates its estimates and assumptions on an ongoing basis and bases its estimates on historical experience, current and expected future conditions, third-party evaluations, and various other assumptions that management believes are reasonable under the circumstances based on the information available to management at the time these estimates and assumptions are made. Actual results and outcomes may differ significantly from these estimates and assumptions.
Acquisitions

Acquisitions

The Company accounts for acquisitions in accordance with ASC Topic 805, Business Combinations, using the acquisition method of accounting. The purchase price, or total consideration transferred, is determined as the fair value of assets exchanged, equity instruments issued, and liabilities assumed at the acquisition date. The acquisition method of accounting requires that the identifiable assets acquired, the liabilities assumed, and any non-controlling interest in the acquiree are measured and recorded at their fair values on the date of an acquisition. Goodwill represents the excess of the purchase price over the estimated fair value of the net assets acquired, including the amount assigned to identifiable intangible assets. Acquisition-related costs are expensed as incurred. The consolidated financial statements reflect the results of operations of the acquiree from the date of the acquisition. For additional information, see “Note 3 – Acquisitions, Divestitures, and Investments.”
Foreign Currency Translation and Transactions

Foreign Currency Translation and Transactions

For subsidiaries outside of the U.S. that operate in a local currency environment, revenue and expenses are translated to U.S. dollars at the monthly average rates of exchange prevailing during the period, assets and liabilities are translated at period-end exchange rates, and equity accounts are translated at historical exchange rates. The net effect of foreign currency translation adjustments is included in shareholders’ equity as a component of accumulated other comprehensive loss in the accompanying consolidated balance sheets.

Foreign currency transaction gains and losses are the result of exchange rate changes during the period of time between the consummation and cash settlement of transactions denominated in currencies other than the functional currency. Foreign currency transaction gains and losses are recognized in earnings as incurred and are included in other (income) expense, net in the accompanying consolidated statements of income.
Comprehensive Income

Comprehensive Income

Comprehensive income refers to revenue, expenses, gains, and losses that, under U.S. GAAP, are recorded as an element of shareholders’ equity but are excluded from net income. The Company’s comprehensive income consists of foreign currency translation adjustments, net of applicable taxes, resulting from the translation of foreign subsidiaries with functional currencies other than the U.S. dollar and the effective portions of the unrealized gains or losses associated with derivative instruments designated and accounted for as hedging instruments.
Cash and Cash Equivalents

Cash and Cash Equivalents

Cash and cash equivalents consist of demand deposits with banks and other financial institutions and highly liquid investments with an original maturity of three months or less at the date of purchase. Cash and cash equivalents are carried at cost, which approximates their fair value.

Certain of the Company’s subsidiaries participate in a notional cash pooling arrangement to manage global liquidity requirements. As part of a master netting arrangement, the participants combine their cash balances in pooling accounts at the same financial institution with the ability to offset bank overdrafts of one participant against positive cash account balances held by another participant. Under the terms of the master netting arrangement, the financial institution has the right, ability, and intent to offset a positive balance in one account against an overdrawn amount in another account. Amounts in each of the accounts are unencumbered and unrestricted with respect to use. As such, the net cash balance related to this pooling arrangement is included in cash, cash equivalents, and restricted cash in the accompanying consolidated balance sheets.

The Company’s net cash pool position consisted of the following as of December 31 (in thousands):

 

 

 

2021

 

 

2020

 

Gross cash position

 

$

179,160

 

 

$

220,261

 

Less: cash borrowings

 

 

(167,507

)

 

 

(204,647

)

Net cash position

 

$

11,653

 

 

$

15,614

 
Restricted Cash

Restricted Cash

Restricted cash represents cash and deposits held as security over bank deposits, lease guarantees, and insurance obligations that are restricted as to withdrawal or use. Restricted cash is classified as a current or long-term asset based on the timing and nature of when and how the cash is expected to be used or when the restrictions are expected to lapse. As of December 31, 2021 and 2020, restricted cash balances were $0.1 million and $0.3 million, respectively.
Fair Value

Fair Value

The Company records certain assets and liabilities at fair value in accordance with ASC Topic 820, Fair Value Measurement (see “Note 7 - Fair Value Measurements”). Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. This guidance also specifies a fair value hierarchy that distinguishes between valuation assumptions developed based on market data obtained from independent external sources and the reporting entity’s own assumptions. Fair value measurements are classified according to the lowest level input or value-driver that is significant to the valuation. In accordance with this guidance, fair value measurements are classified under the following hierarchy:

Level 1 – Unadjusted quoted prices in active markets for identical instruments;

Level 2 – Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs or significant value-drivers are observable in active markets; and

Level 3 – Model-derived valuations in which one or more significant inputs or significant value-drivers are unobservable, including internally developed models.
Derivative Financial Instruments

Derivative Financial Instruments

Interest Rate Swaps

The Company uses interest rate swaps to manage exposure to variable interest rates on its debt obligations. The Company designates its interest rate swaps as cash flow hedges because they are executed to hedge the Company’s exposure to the variability in expected future cash flows that are attributable to changes in interest rates.

Derivative financial instruments are measured at fair value and recognized in the accompanying consolidated balance sheets in prepaid expenses and other current assets, other long-term assets, accrued expenses, and other long-term liabilities, as disclosed in “Note 6 – Derivatives.” The fair value of interest rate swaps is determined using the market standard methodology of discounted future variable cash receipts. The variable cash receipts are determined by discounting the future expected cash receipts that would occur if variable interest rates rise above the fixed rate of the swaps. The variable interest rates used in the calculation of projected receipts on the swap are based on an expectation of future interest rates derived from observable market interest rate curves and volatilities. Changes in the fair value of derivative instruments designated as hedging instruments are recorded each period according to the determination of the derivative’s effectiveness. The effective portion of changes in the fair value of derivatives designated as cash flow hedges is recorded in accumulated other comprehensive loss and subsequently reclassified into earnings in the period during which the hedged transaction is recognized in earnings. The ineffective portion of the change in fair value of the derivatives is recognized as non-operating income or expense immediately when incurred and included in interest expense in the accompanying consolidated statements of income.

Foreign Exchange Forward

The Company utilizes a foreign exchange forward in order to minimize monthly foreign currency remeasurement gains or losses on non-functional currency monetary balances. The Company did not designate the derivative as a hedge. All changes in the fair value of the foreign exchange forward are recorded in earnings every month to other (income) expense, net in the accompanying consolidated statements of income, as disclosed in “Note 6 – Derivatives.”

Allowance for Doubtful Accounts

Allowance for Doubtful Accounts

The Company maintains a credit approval process and makes judgments in connection with assessing its customers’ ability to pay for contracted services. Generally, the Company has the ability to limit credit exposure by discontinuing services in the event of non-payment. The Company monitors its customers’ credit worthiness and applies judgment in establishing a provision for estimated credit losses based on historical experience, the aging of receivables, and customer-specific circumstances that would affect the customers’ ability to pay for services rendered.
Property and Equipment

Property and Equipment

Property and equipment primarily consists of furniture, vehicles, software, office equipment, computer equipment, and lab equipment. Purchased and constructed property and equipment is initially recorded at historical cost plus the estimated value of any associated legally or contractually required retirement obligations. Property and equipment acquired in an acquisition are recorded based on the estimated fair value as of the acquisition date. The Company leases vehicles for certain sales representatives in the Commercial Solutions segment. These leases are classified and accounted for as leases in accordance with ASC Topic 842, Leases (“ASC 842”). For further information about lease arrangements, see “Note 5 - Leases.”

Property and equipment assets are depreciated using the straight-line method over the respective estimated useful lives as follows:

 

 

 

Useful Life

Buildings

 

39 years

Furniture and fixtures

 

7 years

Equipment

 

5 to 10 years

Computer equipment and software

 

2 to 3 years

Vehicles

 

Lesser of lease term or the estimated economic life of the leased asset

Leasehold improvements

 

Lesser of remaining life of lease or the useful life of the asset

 

Expenditures for repairs and maintenance are expensed as incurred and expenditures for major improvements that increase the functionality or extend the useful life of the asset are capitalized and depreciated over the estimated useful life of the asset.

The Company capitalizes costs of computer software obtained for internal use and amortizes these costs on a straight-line basis over the estimated useful life of the product, not to exceed five years. Software cloud computing arrangements containing a software license are accounted for consistently with the acquisition of other software licenses. In the event such an arrangement does not contain a software license, the Company accounts for the arrangement as a service contract.

The Company reviews property and equipment for impairment whenever facts and circumstances indicate that the carrying amounts of these assets might not be recoverable. For assessment purposes, property and equipment are grouped with other assets and liabilities at the lowest level that identifiable cash flows are largely independent of the cash flows of other assets and liabilities. Recoverability of the carrying amount of an asset group is assessed by comparing its carrying amount to the estimated undiscounted future cash flows expected to be generated by the asset group. If the carrying value of the asset group exceeds its fair value, an impairment charge is recognized for the excess.
Leases

Leases

At inception, a contract contains a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. In evaluating whether it has the right to control the use of an identified asset, the Company assesses whether they have the right to direct the use of the identified asset and to obtain substantially all of the economic benefit from the use of the identified asset.

Right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset during the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Assets and liabilities are recognized based on the present value of lease payments over the lease term. Most leases include one or more options to renew. The exercise of the renewal option is at the Company’s sole discretion and the Company includes these options in determining the lease term used to establish its right-of-use assets and lease liabilities when it is reasonably certain the Company will exercise its option.

Because most of the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The Company uses the implicit rate when readily determinable. Operating lease expense is generally recognized on a straight-line basis over the lease term.

The Company has agreements with lease and non-lease components, which are accounted for as a single lease component. Leases with a lease term of 12 months or less are not recorded on the balance sheet. The Company recognizes lease expense for these leases on a straight-line basis over the lease term. Variable lease payment amounts that cannot be determined at the commencement of the lease, such as increases in lease payments based on changes in index rates, are not included in the right-of-use assets or liabilities. These variable lease payments are expensed as incurred.
Goodwill and intangible assets

Goodwill and Intangible Assets

Goodwill represents the excess of the purchase price over the estimated fair value of net assets acquired, including the amount assigned to identifiable intangible assets, in acquisitions. In accordance with ASC Topic 350, Intangibles – Goodwill and Other, goodwill is not subject to amortization but must be tested for impairment annually or more frequently if events or changes in circumstances indicate that goodwill might be impaired. Goodwill is tested for impairment at the reporting unit level, which is one level below the operating segment level. This test requires the Company to determine if the implied fair value of the reporting unit’s goodwill is less than its carrying amount.

The Company has assigned goodwill to four reporting units. The Company completed an annual impairment test as of October 1, 2021 for all of its reporting units, and concluded that there were no impairments.

Intangible assets consist of customer relationships, acquired backlog, trade names, trademarks, patient communities, and acquired technologies. The Company amortizes intangible assets related to customer relationships, trade names, trademarks, patient communities, and acquired technologies on a straight-line basis over the estimated useful life of the asset. Intangible assets related to acquired backlog are amortized based on the Company’s expectations of the timing of when revenue associated with the backlog is expected to be recognized.

The Company reviews intangible assets at the end of each reporting period to determine if facts and circumstances indicate that the useful life is shorter than originally estimated or that the carrying amount of the assets might not be recoverable. If such facts and circumstances exist, the Company assesses the recoverability of identified assets by comparing the projected undiscounted cash flows associated with the related asset or group of assets to their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amount over the fair value of those assets and occur in the period in which the impairment determination is made.

The weighted average estimated useful lives of the Company’s intangible assets were as follows as of December 31:

 

 

 

2021

 

2020

Customer relationships

 

9.8 years

 

9.9 years

Acquired backlog

 

2.6 years

 

2.6 years

Trade names and trademarks

 

5.5 years

 

5.5 years

Intellectual property (medical patent)

 

n/a

 

9.0 years

Patient communities

 

6.0 years

 

n/a

Acquired technologies

 

6.0 years

 

n/a

No intangible asset impairment charges were recorded for the years ended December 31, 2021 or 2020. For additional information regarding the carrying values of intangible assets, see “Note 2 – Financial Statement Details.”
Contingencies

Contingencies

In the normal course of business, the Company periodically becomes involved in various proceedings and claims, including investigations, disputes, litigations, and regulatory matters that are incidental to its business. The Company evaluates the likelihood of an unfavorable outcome of all legal and regulatory matters and records accruals for probable loss contingencies for which the amount of the loss can be reasonably estimated. Gain contingencies are not recognized until realized. Legal fees are expensed as incurred.

Because these matters are inherently unpredictable, and unfavorable developments or resolutions can occur, assessing contingencies is highly subjective and requires judgments about future events. These judgments and estimates are based, among other factors, on the status of the proceedings, the merits of the Company’s defenses, and the consultation with in-house and external counsel. The Company regularly reviews contingencies to determine whether its accruals and related disclosures are adequate. Although the Company believes that it has substantial defenses in these matters, the amount of losses incurred as a result of actual outcomes may differ significantly from the Company’s estimates.
Revenue Recognition

Revenue Recognition

In accordance with ASC Topic 606, Revenue from Contracts with Customers and all related amendments (“ASC 606”), revenue is recognized when, or as, a customer obtains control of promised services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these services.

A performance obligation is a promise (or a combination of promises) in a contract to transfer distinct goods or services to a customer and is the unit of accounting under ASC 606 for the purposes of revenue recognition. A contract’s transaction price is allocated to each performance obligation and is recognized as revenue, when, or as, each performance obligation is satisfied. The majority of the Company’s Clinical Solutions segment contracts have a single performance obligation because the promise to transfer individual services is not separately identifiable from other promises in the contracts, and therefore, is not distinct. For contracts with multiple performance obligations, the contract’s transaction price is allocated to each performance obligation using the best estimate of the standalone selling price of each distinct good or service in the contract.

The majority of the Company’s revenue arrangements are service contracts that range in duration from a few months to several years. Substantially all of the Company’s performance obligations, and associated revenue, are transferred to the customer over time. The Company generally receives compensation based on measuring progress toward completion using anticipated project budgets for direct labor and prices for each service offering. The Company is also reimbursed for certain third-party pass-through and out-of-pocket costs. In addition, in certain instances a customer contract may include forms of variable consideration such as incentive fees, volume rebates or other provisions that can increase or decrease the transaction price. This variable consideration is generally awarded upon achievement of certain performance metrics, program milestones or cost targets. For the purposes of revenue recognition, variable consideration is assessed on a contract-by-contract basis and the amount included in the transaction price is estimated based on the Company’s anticipated performance and consideration of all information that is reasonably available. Variable consideration is recognized as revenue if and when it is deemed probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved in the future.

Most of the Company’s contracts can be terminated by the customer without cause with a notice period that generally ranges from 30 to 90 days. In the event of termination, the Company’s contracts generally provide that the customer pay the Company for: (i) fees earned through the termination date; (ii) fees and expenses for winding down the project, which include both fees incurred and actual expenses; (iii) non-cancellable expenditures; and (iv) in some cases, a fee to cover a portion of the remaining professional fees on the project. The Company’s long-term clinical trial contracts contain implied substantive termination penalties because of the significant wind-down cost of terminating a clinical trial. These provisions for termination penalties result in these types of contracts being treated as long-term for revenue recognition purposes.

Changes in the scope of work are common, especially under long-term contracts, and generally result in a change in the total contract transaction price. If the customer does not agree to a contract modification, the Company could bear the risk of cost overruns. Most of the Company’s contract modifications are for services that are not distinct from the services under the existing contract due to the significant integration service provided in the context of the contract and therefore result in a cumulative catch-up adjustment to revenue at the date of contract modification.

Capitalized Costs

The Company capitalizes certain costs associated with commissions and bonuses paid to its employees in the Clinical Solutions segment because these costs are incurred in obtaining contracts that have a term greater than one year. Capitalized costs are included in prepaid expenses and other current assets and other long-term assets in the accompanying consolidated balance sheets. The Company amortizes these costs in a manner that is consistent with the pattern of revenue recognition described below. The Company expenses costs to obtain contracts that have a term of one year or less.

Clinical Solutions

The Company’s Clinical Solutions segment provides solutions to address the clinical development needs of customers. The Company provides total biopharmaceutical program development through its full-service platform, while also providing discrete services for any part of a clinical trial, primarily through functional service provider, Early Stage, and Real World and Late Phase (“RWLP”) services. The services provided via the full-service platform and RWLP platforms generally span several years and a significant benefit to the customer is provided by integrating the services provided by the Company’s employees as well as those performed by third parties. Because the Company’s full-service platform provides a significant integration service to the customer, these contracts contain a single performance obligation. Revenue is recognized over time using an input measure of progress. The input measure reflects costs (including investigator payments and pass-through costs) incurred to date relative to total estimated costs to complete (“cost-to-cost measure of progress”). Under the cost-to-cost measure of progress methodology, revenue is recorded proportionally to costs incurred. Contract costs principally include direct labor, investigator payments, and pass-through costs. The estimate of total estimated costs at completion requires significant judgment. Contract estimates are based on various assumptions to project future outcomes of events that often span several years. These estimates are reviewed periodically and any adjustments are recognized on a cumulative catch-up basis in the period they become known.

The remaining service offerings within the Clinical Solutions segment are generally short-term, month-to-month contracts, time and materials basis contracts, or provide a series of distinct services that are substantially the same and have the same pattern of transfer to the customer (“series”). As such, revenue for these service offerings is generally recognized as services are performed for the amount the Company estimates it is entitled to for the period.

Commercial Solutions

The Company’s Commercial Solutions segment provides a broad suite of complementary commercialization services including Deployment Solutions, communications (advertising and public relations), and consulting services. Deployment Solutions contracts offer outsourced services to promote commercial products on behalf of a customer.

The remaining Commercial Solutions contracts are generally short-term, month-to-month contracts or time and materials contracts. As such, Commercial Solutions revenue is generally recognized as services are performed for the amount of consideration the Company estimates it is entitled to for the period. For contracts billed on a fixed price basis, revenue is recognized over time based on the proportion of labor costs expended to total labor costs expected to complete the contract.

Accounts Receivable, Unbilled Services, and Deferred Revenue

Accounts receivable are recorded at net realizable value. Unbilled accounts receivable arise when services have been rendered for which revenue has been recognized but the customers have not been billed. Contractual provisions and payment schedules may or may not correspond to the timing of the performance of services under the contract.

Unbilled services include contract assets, under which the right to bill the customer is subject to factors other than the passage of time. These amounts may not exceed their net realizable value. Contract assets are generally classified as current.

Deferred revenue is a contract liability that consists of customer payments received in advance of performance and billings in excess of revenue recognized, net of revenue recognized from the balance at the beginning of the period.

Timing of Billing and Performance

Differences in the timing of revenue recognition and associated billings and cash collections result in recording of billed accounts receivable, unbilled accounts receivable (including contract assets), and deferred revenue on the consolidated balance sheet. Amounts are billed as work progresses in accordance with agreed-upon contractual terms either at periodic intervals or upon achievement of contractual milestones. Billings generally occur subsequent to revenue recognition, resulting in recording unbilled accounts receivable in instances where the right to bill is contingent solely on the passage of time (e.g., in the following month), and contract assets in instances where the right to bill is associated with achievement of a milestone.

The Company expects to recognize revenue over the remaining contract term of the individual projects, with contract terms generally ranging from one to five years. The amount of unsatisfied performance obligations is presented net of any constraints and, as a result, is lower than the potential contractual revenue. The contracts excluded due to constraints include contracts that do not commence within a certain period of time or that require the Company to undertake numerous activities to fulfill these performance obligations, including various activities that are outside of the Company’s control.
Reimbursable Out-of-pocket Expenses

Reimbursable Out-of-Pocket Expenses

The Company incurs and is reimbursed by its customers for certain costs, including fees paid to principal investigators and for other out-of-pocket costs (such as travel expenses for the Company’s clinical monitors and sales representatives). The Company includes these costs in total operating expenses, and the related reimbursements in revenue, as the Company is the principal in the applicable arrangements and is responsible for fulfilling the promise to provide the specified services.

Share-Based Compensation

Share-Based Compensation

The Company measures and recognizes compensation expense related to all share-based awards based on the estimated fair value of the awards. The fair value of restricted stock and stock unit awards is measured on the grant date based on the fair market value of the Company’s common stock.

Share-based compensation expense is recognized on a straight-line basis over the shorter of the requisite service period or the vesting term. For awards with performance conditions, stock-based compensation expense is recognized when the achievement of each individual performance target becomes probable, and the number of shares expected to vest is adjusted for the weighted probability of attainment of the relevant performance targets. Forfeitures are accounted for as they occur.

All excess tax benefits and tax deficiencies (including tax benefits of dividends on share-based payment awards, if applicable) are recognized as income tax expense or benefit in the consolidated statements of income. The tax effects of exercised or vested awards are treated as discrete items in the reporting period in which they occur. The Company also recognizes excess tax benefits regardless of whether the benefit reduces taxes payable in the current period.
Income Taxes

Income Taxes

The majority of the Company’s U.S. subsidiaries file a consolidated U.S. federal income tax return, while certain U.S. subsidiaries, including recently acquired entities, may file separate U.S. federal tax returns. The Company’s subsidiaries in international jurisdictions file tax returns in their respective jurisdictions.

The Company estimates its tax liability based on current tax laws in the statutory jurisdictions in which it operates. Accordingly, the impact of changes in income tax laws on deferred tax assets and deferred tax liabilities is recognized in earnings in the period during which such changes are enacted. The Company records deferred tax assets and liabilities based on temporary differences between the financial reporting basis and tax basis of the Company’s assets and liabilities at enacted tax rates expected to be in effect when the differences are realized or settled.

Deferred income tax assets represent amounts available to reduce income taxes payable on taxable income in future years. Such assets arise because of temporary differences between the financial reporting and tax bases of assets and liabilities, as well as from net operating loss and tax credit carryforwards. The Company evaluates recoverability of these future tax deductions. The Company establishes a valuation allowance for deferred income tax assets when the Company believes it is more likely than not the assets will not be realized. The Company evaluates the recoverability of these future tax deductions by assessing future expected taxable income. In estimating future taxable income, the Company considers both positive and negative evidence, such as historical and forecasted results of operations, and implementation of prudent and feasible tax planning strategies. If the objectively verifiable negative evidence outweighs any available positive evidence (or the only available positive is subjective and cannot be verified), then a valuation allowance will likely be deemed necessary. If a valuation allowance is deemed to be unnecessary, such allowance is released and any related benefit is recognized in the period of the change.

The Company recognizes a tax benefit from any uncertain tax positions only if they are more likely than not to be sustained upon examination based on the technical merits of the position. The Company evaluates uncertain tax positions pursuant to the more likely than not standard, and benefits related to such uncertain tax positions are recognized as the largest amount of benefit, determined on a cumulative probability basis, to be realized upon ultimate settlement of the position. Components of the reserve for uncertain tax positions are classified as either a current or a long-term liability in the accompanying consolidated balance sheets based on management’s expectation of future cash settlements.

Judgment is required in determining what constitutes an uncertain tax position, as well as assessing the outcome of each tax position. The Company considers many factors when evaluating and estimating tax positions and tax benefits. In addition, the calculation of tax liabilities involves dealing with uncertainties in the application of complex tax regulations in domestic and foreign jurisdictions. If the calculation of the liability related to uncertain tax positions proves to be more or less than the ultimate settlement, a tax expense or tax benefit, respectively, would result. Unrecognized tax benefits are presented as either a reduction to a deferred tax asset or as a separate liability.
Restructuring and Other Costs

Restructuring and Other Costs

Restructuring and other costs primarily consist of one-time employee termination benefits, contract termination costs, and other costs associated with an exit or disposal activity. The Company accounts for restructuring costs in accordance with ASC Topic 420, Exit or Disposal Cost Obligations. This guidance requires that a liability for a cost associated with an exit or disposal activity be recognized in the period in which the liability is incurred, as opposed to the period in which management commits to a plan of action for termination. The guidance also requires that the liabilities associated with an exit or disposal activity be measured at the fair value in the period in which the liability is incurred, except for: (i) liabilities related to one-time employee termination benefits, which shall be measured and recognized at the date the entity notifies employees of termination, unless employees are required to render services beyond a minimum retention period, in which case the liability is recognized ratably over the future service period; and (ii) liabilities related to an operating lease, which shall be measured and recognized when the contract does not have any future economic benefit to the entity (i.e., the entity ceases to utilize the rights conveyed by the contract). Restructuring liabilities are included in accrued expenses and other long-term liabilities in the accompanying consolidated balance sheets.
Earnings Per Share

Earnings Per Share

The Company determines earnings per share in accordance with ASC Topic 260, Earnings Per Share. The Company has one class of common stock for purposes of the earnings per share calculation and therefore computes basic earnings per share by dividing net income (loss) by the weighted average number of common shares outstanding for the applicable period. Diluted earnings per share are computed in the same manner as basic earnings per share, except that the number of shares is increased to assume exercise of potentially dilutive equity awards using the treasury stock method, unless the effect of such increase would be anti-dilutive. Under the treasury stock method, the amount the employee must pay for exercising equity awards and the amount of compensation cost for future service that the Company has not yet recognized are assumed to be used to repurchase shares.
Subsequent Events

Subsequent Events

The Company considers events or transactions that occur after the balance sheet date but before the financial statements are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. The Company evaluated all events and transactions through the date that these financial statements were issued.
Recently Adopted Accounting Standards

Recently Adopted Accounting Standards

In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13 (“ASU 2016-13”), Financial Instruments - Credit Losses (Topic 326) to modify the impairment model to utilize an expected loss methodology in place of the previous incurred loss methodology and require consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The Company adopted ASU 2016-13 on January 1, 2020, and recorded the impact of the adoption through a cumulative-effect adjustment to accumulated deficit. Results for reporting periods beginning on January 1, 2020 are presented under ASU No. 2016-13, while prior period amounts continue to be reported and disclosed in accordance with the Company’s historical accounting treatment. Adoption of the new standard resulted in the recording of additional allowance for doubtful accounts of approximately $2.8 million as of January 1, 2020.
XML 50 R29.htm IDEA: XBRL DOCUMENT v3.22.0.1
Basis of Presentation and Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Schedule Of Cash Pool Position

The Company’s net cash pool position consisted of the following as of December 31 (in thousands):

 

 

 

2021

 

 

2020

 

Gross cash position

 

$

179,160

 

 

$

220,261

 

Less: cash borrowings

 

 

(167,507

)

 

 

(204,647

)

Net cash position

 

$

11,653

 

 

$

15,614

 
Estimated Useful Lives of Property and Equipment

Property and equipment assets are depreciated using the straight-line method over the respective estimated useful lives as follows:

 

 

 

Useful Life

Buildings

 

39 years

Furniture and fixtures

 

7 years

Equipment

 

5 to 10 years

Computer equipment and software

 

2 to 3 years

Vehicles

 

Lesser of lease term or the estimated economic life of the leased asset

Leasehold improvements

 

Lesser of remaining life of lease or the useful life of the asset

Property and equipment, net of accumulated depreciation, consisted of the following as of December 31 (in thousands):

 

 

 

2021

 

 

2020

 

Software

 

$

159,736

 

 

$

129,731

 

Leasehold improvements

 

 

96,188

 

 

 

94,596

 

Computer equipment

 

 

91,937

 

 

 

108,230

 

Vehicles

 

 

77,674

 

 

 

63,985

 

Office furniture, fixtures, and equipment

 

 

65,018

 

 

 

37,287

 

Buildings and land

 

 

5,692

 

 

 

5,211

 

Assets not yet placed in service

 

 

28,706

 

 

 

28,129

 

Property and equipment, gross

 

 

524,951

 

 

 

467,169

 

Less: Accumulated depreciation

 

 

(302,294

)

 

 

(250,969

)

Property and equipment, net

 

$

222,657

 

 

$

216,200

 
Estimated Useful Lives of Intangible Assets

The weighted average estimated useful lives of the Company’s intangible assets were as follows as of December 31:

 

 

 

2021

 

2020

Customer relationships

 

9.8 years

 

9.9 years

Acquired backlog

 

2.6 years

 

2.6 years

Trade names and trademarks

 

5.5 years

 

5.5 years

Intellectual property (medical patent)

 

n/a

 

9.0 years

Patient communities

 

6.0 years

 

n/a

Acquired technologies

 

6.0 years

 

n/a
XML 51 R30.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Statement Details (Tables)
 12 Months Ended
Dec. 31, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Schedule of Billed Accounts Receivable, Net

Accounts receivable and unbilled services (including contract assets), net of allowance for doubtful accounts, consisted of the following as of December 31 (in thousands):

 

 

 

2021

 

 

2020

 

Accounts receivable billed

 

$

873,265

 

 

$

774,605

 

Accounts receivable unbilled

 

 

241,799

 

 

 

211,285

 

Contract assets

 

 

417,411

 

 

 

366,506

 

Less: Allowance for doubtful accounts

 

 

(7,585

)

 

 

(7,615

)

Accounts receivable and unbilled services, net

 

$

1,524,890

 

 

$

1,344,781

 
Schedule of Changes in the Allowance for Doubtful Accounts

The following table summarizes the changes in the allowance for doubtful accounts (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Balance at the beginning of the period

 

$

(7,615

)

 

$

(5,381

)

 

$

(4,587

)

Impact from adoption of ASU 2016-13

 

 

—

 

 

 

(2,771

)

 

 

—

 

Current year provision

 

 

(367

)

 

 

(695

)

 

 

(1,897

)

Write-offs, net of recoveries and the effects of foreign currency exchange

 

 

397

 

 

 

1,232

 

 

 

1,103

 

Balance at the end of the period

 

$

(7,585

)

 

$

(7,615

)

 

$

(5,381

)

 
Estimated Useful Lives of Property and Equipment

Property and equipment assets are depreciated using the straight-line method over the respective estimated useful lives as follows:

 

 

 

Useful Life

Buildings

 

39 years

Furniture and fixtures

 

7 years

Equipment

 

5 to 10 years

Computer equipment and software

 

2 to 3 years

Vehicles

 

Lesser of lease term or the estimated economic life of the leased asset

Leasehold improvements

 

Lesser of remaining life of lease or the useful life of the asset

Property and equipment, net of accumulated depreciation, consisted of the following as of December 31 (in thousands):

 

 

 

2021

 

 

2020

 

Software

 

$

159,736

 

 

$

129,731

 

Leasehold improvements

 

 

96,188

 

 

 

94,596

 

Computer equipment

 

 

91,937

 

 

 

108,230

 

Vehicles

 

 

77,674

 

 

 

63,985

 

Office furniture, fixtures, and equipment

 

 

65,018

 

 

 

37,287

 

Buildings and land

 

 

5,692

 

 

 

5,211

 

Assets not yet placed in service

 

 

28,706

 

 

 

28,129

 

Property and equipment, gross

 

 

524,951

 

 

 

467,169

 

Less: Accumulated depreciation

 

 

(302,294

)

 

 

(250,969

)

Property and equipment, net

 

$

222,657

 

 

$

216,200

 
Schedule of Goodwill

The changes in carrying amount of goodwill by segment were as follows (in thousands):

 

 

 

Clinical

Solutions (a)

 

 

Commercial

Solutions (b)

 

 

Total

 

Balance as of December 31, 2019

 

$

2,784,952

 

 

$

1,565,428

 

 

$

4,350,380

 

Acquisitions and divestitures (c)

 

 

418,619

 

 

 

(14,453

)

 

 

404,166

 

Impact of foreign currency translation

 

 

12,764

 

 

 

8,868

 

 

 

21,632

 

Balance as of December 31, 2020

 

 

3,216,335

 

 

 

1,559,843

 

 

 

4,776,178

 

Acquisitions (d)

 

 

192,286

 

 

 

—

 

 

 

192,286

 

Impact of foreign currency translation and other (e)

 

 

40,078

 

 

 

(52,527

)

 

 

(12,449

)

Balance as of December 31, 2021

 

$

3,448,699

 

 

$

1,507,316

 

 

$

4,956,015

 

 

(a) Accumulated impairment losses of $8.1 million associated with the Clinical Solutions segment were recorded prior to 2016 and related to the former Phase I Services segment, now a component of the Clinical Solutions segment. No impairment of goodwill was recorded for the years ended December 31, 2021, 2020, or 2019.

(b) Accumulated impairment losses of $8.0 million associated with the Commercial Solutions segment were recorded prior to 2015 and related to the former Global Consulting segment, now a component of the Commercial Solutions segment. No impairment of goodwill was recorded for the years ended December 31, 2021, 2020, or 2019.

(c) Amounts represent goodwill recognized in connection with the 2020 acquisitions of SHCR Holdings Corporation (“Synteract”) and Illingworth Research Group™ (“Illingworth Research”) within the Clinical Solutions segment and goodwill disposed upon the sale of the medication adherence business within the Commercial Solutions segment.

(d) Amount represents goodwill recognized in connection with the acquisitions of StudyKIK Corporation (“StudyKIK”) and RxDataScience, Inc. (“RxDataScience”), other insignificant acquisitions in 2021, and insignificant measurement period adjustments recognized in connection with the 2020 acquisitions of Synteract and Illingworth Research within the Clinical Solutions segment.

(e) Includes $44.2 million reallocation of goodwill from the Commercial Solutions segment to the Clinical Solutions segment to reflect the transfer of the Kinapse Regulatory and Operations Consulting service lines to align with management reporting in 2021.
Schedule of Finite Lived Intangible Assets

Intangible assets, net consisted of the following (in thousands):

 

 

 

December 31, 2021

 

 

December 31, 2020

 

 

 

Gross

 

 

Accumulated

Amortization

 

 

Net

 

 

Gross

 

 

Accumulated

Amortization

 

 

Net

 

Customer relationships

 

$

1,547,925

 

 

$

(811,542

)

 

$

736,383

 

 

$

1,518,081

 

 

$

(685,021

)

 

$

833,060

 

Acquired backlog

 

 

175,826

 

 

 

(154,475

)

 

 

21,351

 

 

 

174,180

 

 

 

(132,733

)

 

 

41,447

 

Trade names and trademarks

 

 

55,728

 

 

 

(28,806

)

 

 

26,922

 

 

 

52,475

 

 

 

(21,817

)

 

 

30,658

 

Intellectual property (medical patent)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

30,028

 

 

 

(1,668

)

 

 

28,360

 

Patient communities

 

 

45,100

 

 

 

(2,192

)

 

 

42,908

 

 

 

—

 

 

 

—

 

 

 

—

 

Acquired technologies

 

 

27,800

 

 

 

(1,297

)

 

 

26,503

 

 

 

—

 

 

 

—

 

 

 

—

 

Intangible assets, net

 

$

1,852,379

 

 

$

(998,312

)

 

$

854,067

 

 

$

1,774,764

 

 

$

(841,239

)

 

$

933,525

 

 

 
Schedule of Indefinite Lived Intangible Assets

Intangible assets, net consisted of the following (in thousands):

 

 

 

December 31, 2021

 

 

December 31, 2020

 

 

 

Gross

 

 

Accumulated

Amortization

 

 

Net

 

 

Gross

 

 

Accumulated

Amortization

 

 

Net

 

Customer relationships

 

$

1,547,925

 

 

$

(811,542

)

 

$

736,383

 

 

$

1,518,081

 

 

$

(685,021

)

 

$

833,060

 

Acquired backlog

 

 

175,826

 

 

 

(154,475

)

 

 

21,351

 

 

 

174,180

 

 

 

(132,733

)

 

 

41,447

 

Trade names and trademarks

 

 

55,728

 

 

 

(28,806

)

 

 

26,922

 

 

 

52,475

 

 

 

(21,817

)

 

 

30,658

 

Intellectual property (medical patent)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

30,028

 

 

 

(1,668

)

 

 

28,360

 

Patient communities

 

 

45,100

 

 

 

(2,192

)

 

 

42,908

 

 

 

—

 

 

 

—

 

 

 

—

 

Acquired technologies

 

 

27,800

 

 

 

(1,297

)

 

 

26,503

 

 

 

—

 

 

 

—

 

 

 

—

 

Intangible assets, net

 

$

1,852,379

 

 

$

(998,312

)

 

$

854,067

 

 

$

1,774,764

 

 

$

(841,239

)

 

$

933,525

 

 

 
Schedule of Future Amortization Expense The future estimated amortization expense for intangible assets as of December 31, 2021 is expected to be as follows (in thousands):

 

Year Ended December 31,

 

 

 

 

2022

 

$

162,193

 

2023

 

 

153,334

 

2024

 

 

146,487

 

2025

 

 

132,512

 

2026

 

 

110,597

 

2027 and thereafter

 

 

148,944

 

Total

 

$

854,067

 

 
Schedule of Accrued Expenses

Accrued expenses consisted of the following as of December 31 (in thousands):

 

 

 

2021

 

 

2020

 

Professional fees, investigator fees, and pass-through costs

 

$

283,432

 

 

$

231,638

 

Compensation, including bonuses, fringe benefits, and payroll taxes

 

 

215,386

 

 

 

255,042

 

Income and other taxes

 

 

25,723

 

 

 

28,890

 

Rebates to customers

 

 

22,367

 

 

 

22,528

 

Restructuring and other costs, current portion

 

 

6,657

 

 

 

5,830

 

Contingent obligations, current

 

 

3,397

 

 

 

4,327

 

Interest rate swaps - current

 

 

1,827

 

 

 

17,045

 

Other liabilities

 

 

55,652

 

 

 

45,742

 

Total accrued expenses

 

$

614,441

 

 

$

611,042

 
Schedule of Accumulated Other Comprehensive Loss, Net of Tax

Accumulated other comprehensive loss, net of taxes, consisted of the following (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Beginning balance

 

$

(40,801

)

 

$

(71,593

)

 

 

 

 

 

 

 

 

 

Derivative Instruments:

 

 

 

 

 

 

 

 

Beginning balance

 

 

(18,761

)

 

 

(14,836

)

Other comprehensive gain (loss) before reclassifications

 

 

2,963

 

 

 

(20,446

)

Reclassification adjustments

 

 

13,177

 

 

 

16,521

 

Ending balance

 

 

(2,621

)

 

 

(18,761

)

 

 

 

 

 

 

 

 

 

Foreign Currency Translation:

 

 

 

 

 

 

 

 

Beginning balance

 

 

(22,040

)

 

 

(56,757

)

Other comprehensive (loss) income before reclassifications

 

 

(24,957

)

 

 

34,717

 

Ending balance

 

 

(46,997

)

 

 

(22,040

)

 

 

 

 

 

 

 

 

 

Accumulated other comprehensive loss, net of taxes

 

$

(49,618

)

 

$

(40,801

)
Reclassification out of Accumulated Other Comprehensive (Loss) Income

Changes in accumulated other comprehensive loss consisted of the following (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Unrealized loss on derivative instruments:

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized gain (loss) during period, before taxes

 

$

4,084

 

 

$

(27,647

)

 

$

(14,306

)

Income tax expense (benefit)

 

 

1,121

 

 

 

(7,201

)

 

 

(2,777

)

Unrealized gain (loss) during period, net of taxes

 

 

2,963

 

 

 

(20,446

)

 

 

(11,529

)

Reclassification adjustment, before taxes

 

 

17,655

 

 

 

22,328

 

 

 

4,588

 

Income tax expense

 

 

4,478

 

 

 

5,807

 

 

 

655

 

Reclassification adjustment, net of taxes

 

 

13,177

 

 

 

16,521

 

 

 

3,933

 

Total unrealized gain (loss) on derivative instruments, net of taxes

 

 

16,140

 

 

 

(3,925

)

 

 

(7,596

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments, before taxes

 

 

(26,429

)

 

 

36,071

 

 

 

24,198

 

Income tax (benefit) expense

 

 

(1,472

)

 

 

1,354

 

 

 

—

 

Foreign currency translation adjustments, net of taxes

 

 

(24,957

)

 

 

34,717

 

 

 

24,198

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total other comprehensive (loss) income, net of taxes

 

$

(8,817

)

 

$

30,792

 

 

$

16,602

 
Schedule of Other (Income) Expense, Net (Details)

Other (income) expense, net consisted of the following (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Net realized foreign currency loss

 

$

2,190

 

 

$

3,175

 

 

$

11,853

 

Net unrealized foreign currency (gain) loss

 

 

(5,928

)

 

 

4,147

 

 

 

11,166

 

Gain on sale of business

 

 

—

 

 

 

(7,133

)

 

 

—

 

Equity investment (income) expense

 

 

(1,950

)

 

 

(3,745

)

 

 

261

 

Other, net

 

 

(2,945

)

 

 

580

 

 

 

882

 

Total other (income) expense, net

 

$

(8,633

)

 

$

(2,976

)

 

$

24,162

 

 
Supplemental Disclosure of Cash Flow Information

The following table provides details of supplemental cash flow information (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Cash paid for income taxes, net of refunds

 

$

35,100

 

 

$

23,400

 

 

$

12,200

 

Cash paid for interest (excluding finance leases)

 

 

63,952

 

 

 

83,690

 

 

 

129,756

 

Supplemental disclosure of noncash investing and financing activities

 

 

 

 

 

 

 

 

 

 

 

 

Non-cash investment to acquire certain intellectual property rights from a customer in lieu of cash payment for services rendered

 

 

—

 

 

 

27,300

 

 

 

—

 

Fair value of contingent consideration related to acquisitions

 

 

19,158

 

 

 

—

 

 

 

—

 

Change in property and equipment included in liabilities

 

 

1,753

 

 

 

11,684

 

 

 

5,977

 

Vehicles acquired through finance lease agreements

 

 

28,994

 

 

 

20,203

 

 

 

37,701

 
XML 52 R31.htm IDEA: XBRL DOCUMENT v3.22.0.1
Acquisitions, Divestitures, and Investments (Tables)
 12 Months Ended
Dec. 31, 2021
Business Acquisition [Line Items]  
Allocation of Consideration Transferred

The following table summarizes the estimated fair value of the net assets acquired at the date of the acquisition:

 

Assets acquired:

 

 

 

 

Cash and cash equivalents

 

$

28,028

 

Accounts receivable and unbilled services

 

 

39,723

 

Prepaid expenses and other current assets

 

 

2,160

 

Property and equipment

 

 

3,978

 

Operating lease right-of-use assets

 

 

10,839

 

Other identifiable intangible assets

 

 

56,400

 

Goodwill

 

 

363,733

 

Other assets

 

 

4,121

 

Total assets acquired

 

 

508,982

 

Liabilities assumed:

 

 

 

 

Accounts payable and accrued expenses

 

 

25,623

 

Deferred revenue

 

 

45,272

 

Operating lease obligations

 

 

15,693

 

Deferred income taxes, net

 

 

7,754

 

Other liabilities

 

 

1,126

 

Total liabilities assumed

 

 

95,468

 

Net assets acquired

 

$

413,514

 

 
StudyKIK Acquisition [Member]  
Business Acquisition [Line Items]  
Preliminary Estimates of Fair Values of Intangible Assets and Estimated Useful Lives

The following table summarizes the fair values of identified intangible assets and their respective useful lives (dollars in thousands):

 

 

 

Estimated Fair Value

 

 

Estimated Useful Life

Customer relationships

 

$

22,300

 

 

6 years

Acquired backlog

 

 

1,800

 

 

1.25 years

Trade name

 

 

2,700

 

 

6 years

Patient communities

 

 

45,100

 

 

6 years

Acquired technologies

 

 

19,900

 

 

6 years

Total intangible assets

 

$

91,800

 

 

 

 
Synteract Acquisition [Member]  
Business Acquisition [Line Items]  
Preliminary Estimates of Fair Values of Intangible Assets and Estimated Useful Lives

The following table summarizes the fair value of identified intangible assets and their respective useful lives at the date of the acquisition (dollars in thousands):

 

 

 

Estimated Fair Value

 

 

Estimated Useful Life

Acquired backlog

 

$

37,200

 

 

4 years

Trade name

 

 

19,200

 

 

8 years

Total intangible assets

 

$

56,400

 

 

 
XML 53 R32.htm IDEA: XBRL DOCUMENT v3.22.0.1
Long-Term Debt Obligations (Tables)
 12 Months Ended
Dec. 31, 2021
Debt Disclosure [Abstract]  
Schedule of Debt Obligations

The Company’s debt obligations consisted of the following as of December 31 (in thousands):

 

 

 

2021

 

 

2020

 

Secured Debt

 

 

 

 

 

 

 

 

Term Loan A - tranche one due March 2024

 

$

149,195

 

 

$

183,715

 

Term Loan A - tranche two due August 2024

 

 

1,636,797

 

 

 

1,273,991

 

Term Loan B due August 2024

 

 

—

 

 

 

560,564

 

Accounts receivable financing agreement due October 2024

 

 

400,000

 

 

 

300,000

 

Total secured debt

 

 

2,185,992

 

 

 

2,318,270

 

Unsecured Debt

 

 

 

 

 

 

 

 

Senior notes due January 2029 (the “Notes”)

 

 

600,000

 

 

 

600,000

 

Total debt obligations

 

 

2,785,992

 

 

 

2,918,270

 

Less: Term loans original issuance discount

 

 

(2,228

)

 

 

(3,500

)

Less: Unamortized deferred issuance costs

 

 

(8,043

)

 

 

(12,716

)

Total long-term debt

 

$

2,775,721

 

 

$

2,902,054

 

The applicable margins with respect to Alternate Base Rate and Adjusted Eurocurrency Rate borrowings are determined depending on the “First Lien Leverage Ratio” or the “Secured Net Leverage Ratio” (as defined in the Credit Agreement) and range as follows:

 

 

 

Alternate Base Rate

 

Adjusted

Eurocurrency Rate

Term Loan A

 

0.25% - 0.50%

 

1.25% - 1.50%

Term Loan B

 

0.75% - 1.00%

 

1.75% - 2.00%

Revolver

 

0.25% - 0.50%

 

1.25% - 1.50%
Contractual Maturities of Debt Obligations

As of December 31, 2021, the contractual maturities of the Company’s debt obligations (excluding finance leases that are presented in “Note 5 – Leases”) were as follows (in thousands):

 

2022

 

$

—

 

2023

 

 

21,732

 

2024

 

 

2,164,260

 

2025

 

 

—

 

2026

 

 

—

 

2027 and thereafter

 

 

600,000

 

Less: Term loan original issuance discount

 

 

(2,228

)

Less: Unamortized deferred issuance costs

 

 

(8,043

)

Total

 

$

2,775,721

 
XML 54 R33.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases (Tables)
 12 Months Ended
Dec. 31, 2021
Leases [Abstract]  
Schedule of Lease, Cost

The components of lease cost were as follows for the year ended December 31 and the line items on the accompanying consolidated statements of income to which they were recorded were as follows (in thousands):

 

 

 

Statement of Income Classification

 

2021

 

 

2020

 

Operating leases:

 

 

 

 

 

 

 

 

 

 

Fixed lease costs

 

Direct costs, selling, general, and administrative expenses and restructuring and other costs

 

$

55,168

 

 

$

53,531

 

Short-term lease costs

 

Direct costs and selling, general, and administrative expenses

 

 

1,994

 

 

 

2,930

 

Variable lease costs

 

Direct costs, selling, general, and administrative expenses and restructuring and other costs

 

 

36,760

 

 

 

29,572

 

Total operating lease costs

 

 

 

$

93,922

 

 

$

86,033

 

Finance leases:

 

 

 

 

 

 

 

 

 

 

Amortization of right-of-use assets

 

Depreciation

 

$

17,453

 

 

$

15,843

 

Interest on lease liabilities

 

Interest expense

 

 

605

 

 

 

944

 

Variable lease costs

 

Direct costs

 

 

6,231

 

 

 

6,321

 

Total finance lease costs

 

 

 

$

24,289

 

 

$

23,108

 
Schedule of Assets And Liabilities

Supplemental balance sheet information related to finance leases was as follows as of December 31 (in thousands):

 

 

2021

 

 

2020

 

Property and equipment, gross

 

$

77,674

 

 

$

63,985

 

Accumulated depreciation

 

 

(30,021

)

 

 

(20,479

)

Property and equipment, net

 

$

47,653

 

 

$

43,506

 

 

 

 

 

 

 

 

 

 

Current portion of finance lease obligations

 

$

20,627

 

 

$

17,455

 

Finance lease long-term obligations

 

 

34,181

 

 

 

31,522

 

Total finance lease liabilities

 

$

54,808

 

 

$

48,977

 
Supplemental Cash Flow Information

Supplemental cash flow information related to leases was as follows for the year ended December 31 (in thousands):

 

 

2021

 

 

2020

 

Cash paid for amounts included in the measurement of lease liabilities:

 

 

 

 

 

 

 

 

Operating cash flows for operating leases

 

$

(59,863

)

 

$

(60,361

)

Operating cash flows for finance leases

 

 

(605

)

 

 

(944

)

Financing cash flows for finance leases

 

 

(15,774

)

 

 

(16,434

)

 

 

 

 

 

 

 

 

 

Right-of-use assets obtained in exchange for lease obligations:

 

 

 

 

 

 

 

 

Operating leases

 

$

43,385

 

 

$

47,415

 

Finance leases

 

 

28,994

 

 

 

20,203

 

 

 

 

 

 

 

 

 

 

Lease obligations closed out in exchange for right-of-use assets:

 

 

 

 

 

 

 

 

Operating leases

 

$

(10,122

)

 

$

(2,834

)
Supplemental Cash Flow Information, Weighted Average

Weighted average remaining lease term as of December 31:

 

2021

 

2020

Operating leases

 

6 years

 

7 years

Finance leases

 

3 years

 

3 years

 

 

Weighted average discount rate as of December 31:

 

2021

 

 

2020

 

Operating leases

 

 

4.7

%

 

 

4.8

%

Finance leases

 

 

1.1

%

 

 

1.3

%
Schedule of Lessee, Operating Lease, Liability, Maturity

As of December 31, 2021, maturities of lease liabilities were as follows (in thousands):

 

 

 

Operating Leases

 

 

Finance Leases

 

 

Total

 

2022

 

$

53,612

 

 

$

21,443

 

 

$

75,055

 

2023

 

 

53,033

 

 

 

17,768

 

 

 

70,801

 

2024

 

 

44,428

 

 

 

11,624

 

 

 

56,052

 

2025

 

 

38,036

 

 

 

5,688

 

 

 

43,724

 

2026

 

 

29,128

 

 

 

130

 

 

 

29,258

 

2027 and thereafter

 

 

73,262

 

 

 

—

 

 

 

73,262

 

Total lease payments

 

 

291,499

 

 

 

56,653

 

 

$

348,152

 

Less: Management fee

 

 

—

 

 

 

(762

)

 

 

 

 

Less: Imputed interest

 

 

(42,643

)

 

 

(1,083

)

 

 

 

 

Total lease liabilities

 

$

248,856

 

 

$

54,808

 

 

 

 

 
Schedule of Finance Lease, Liability, Maturity

As of December 31, 2021, maturities of lease liabilities were as follows (in thousands):

 

 

 

Operating Leases

 

 

Finance Leases

 

 

Total

 

2022

 

$

53,612

 

 

$

21,443

 

 

$

75,055

 

2023

 

 

53,033

 

 

 

17,768

 

 

 

70,801

 

2024

 

 

44,428

 

 

 

11,624

 

 

 

56,052

 

2025

 

 

38,036

 

 

 

5,688

 

 

 

43,724

 

2026

 

 

29,128

 

 

 

130

 

 

 

29,258

 

2027 and thereafter

 

 

73,262

 

 

 

—

 

 

 

73,262

 

Total lease payments

 

 

291,499

 

 

 

56,653

 

 

$

348,152

 

Less: Management fee

 

 

—

 

 

 

(762

)

 

 

 

 

Less: Imputed interest

 

 

(42,643

)

 

 

(1,083

)

 

 

 

 

Total lease liabilities

 

$

248,856

 

 

$

54,808

 

 

 

 

 
XML 55 R34.htm IDEA: XBRL DOCUMENT v3.22.0.1
Derivatives (Tables)
 12 Months Ended
Dec. 31, 2021
Derivative Instruments And Hedging Activities Disclosure [Abstract]  
Interest Rate Swaps Designated as Hedging Instruments on Consolidated Balance Sheets

Fair Values

The fair values of the Company’s derivative financial instruments as of December 31 and the line items on the accompanying consolidated balance sheets to which they were recorded were as follows (in thousands):

 

 

Balance Sheet Classification

 

2021

 

 

2020

 

Interest rate swaps - non-current

 

Other long-term assets

 

$

948

 

 

$

—

 

Fair value of derivative assets

 

 

 

$

948

 

 

$

—

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps - current

 

Accrued expenses

 

$

1,827

 

 

$

17,045

 

Interest rate swaps - non-current

 

Other long-term liabilities

 

 

—

 

 

 

5,572

 

Fair value of derivative liabilities

 

 

 

$

1,827

 

 

$

22,617

 
XML 56 R35.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value Measurements (Tables)
 12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis

As of December 31, 2021, the fair values of the major classes of the Company’s assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Investments

Measured

at Net Asset

Value

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trading securities (a)

 

$

24,775

 

 

$

—

 

 

$

—

 

 

$

—

 

 

$

24,775

 

Partnership interest (b)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

11,176

 

 

 

11,176

 

Derivative instruments (c)

 

 

—

 

 

 

948

 

 

 

—

 

 

 

—

 

 

 

948

 

Total assets

 

$

24,775

 

 

$

948

 

 

$

—

 

 

$

11,176

 

 

$

36,899

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative instruments (c)

 

$

—

 

 

$

1,827

 

 

$

—

 

 

$

—

 

 

$

1,827

 

Contingent obligations related to acquisitions (d)

 

 

—

 

 

 

—

 

 

 

17,997

 

 

 

—

 

 

 

17,997

 

Total liabilities

 

$

—

 

 

$

1,827

 

 

$

17,997

 

 

$

—

 

 

$

19,824

 

As of December 31, 2020, the fair value of the major classes of the Company’s assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Investments

Measured

at Net Asset

Value

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trading securities (a)

 

$

22,950

 

 

$

—

 

 

$

—

 

 

$

—

 

 

$

22,950

 

Partnership interest (b)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

8,665

 

 

 

8,665

 

Total assets

 

$

22,950

 

 

$

—

 

 

$

—

 

 

$

8,665

 

 

$

31,615

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative instruments (c)

 

$

—

 

 

$

22,617

 

 

$

—

 

 

$

—

 

 

$

22,617

 

Contingent obligations related to acquisitions (d)

 

 

—

 

 

 

—

 

 

 

6,793

 

 

 

—

 

 

 

6,793

 

Total liabilities

 

$

—

 

 

$

22,617

 

 

$

6,793

 

 

$

—

 

 

$

29,410

 

 

(a) Represents the fair value of investments in mutual funds based on quoted market prices that are used to fund the liability associated with the Company’s deferred compensation plan.

(b) The Company has committed to invest $21.5 million as a limited partner in two private equity funds. The private equity funds invest in opportunities in the healthcare and life sciences industry. As of December 31, 2021, the Company’s remaining unfunded commitment in the private equity funds was $12.8 million. The Company holds minor ownership interests (less than 3%) in each of the private equity funds and has determined that it does not exercise significant influence over the private equity funds’ operating or finance activities. As the private equity funds do not have readily determinable fair values, the Company has estimated the fair values using each fund’s Net Asset Value, the amount by which the value of all assets exceeds all debt and liabilities, in accordance with ASC Topic 946, Financial Services – Investment Companies.

(c) Represents the fair value of interest rate swap arrangements (see “Note 6 – Derivatives” for further information).

(d) Represents the fair value of contingent consideration obligations related to acquisitions. The fair values of these liabilities are determined based on the Company’s best estimate of the probable timing and amount of settlement.
Reconciliation of Changes in the Carrying Amount of Contingent Consideration

The following table presents a reconciliation of changes in the carrying amount of contingent obligations classified as Level 3 for the years ended December 31, 2021 and 2020 (in thousands):

 

Balance as of December 31, 2019

 

$

37,324

 

Additions

 

 

—

 

Changes in fair value recognized in earnings (a)

 

 

(3,897

)

Payments

 

 

(26,634

)

Balance as of December 31, 2020

 

 

6,793

 

Additions (b)

 

 

19,158

 

Changes in fair value recognized in earnings

 

 

(757

)

Payments (c)

 

 

(7,197

)

Balance as of December 31, 2021

 

$

17,997

 

 

(a) The change in fair value recognized in earnings for the year ended December 31, 2020 is primarily due to a decrease in the estimate of the contingent consideration associated with the acquisition of Kinapse (see “Note 17 – Commitments and Contingencies” for further information).

(b) Represents obligations in connection with the acquisition of RxDataScience and insignificant acquisitions completed during 2021.

(c) The Company made payments to fully settle the contingent tax-sharing obligation arising from inVentiv Health, Inc.’s 2016 merger with Double Eagle Parent, Inc. (see “Note 17 – Commitments and Contingencies” for further information) during the first quarter of 2021 and obligations in connection with the insignificant acquisition completed during the second quarter of 2021.
Schedule of Estimated Fair Value The estimated fair values of the Company’s term loans and the Notes were as follows (in thousands):

 

 

December 31, 2021

 

 

December 31, 2020

 

 

 

Carrying

Value (a)

 

 

Estimated

Fair Value

 

 

Carrying

Value (a)

 

 

Estimated

Fair Value

 

Term Loan A - tranche one due March 2024

 

$

149,008

 

 

$

148,945

 

 

$

183,320

 

 

$

183,026

 

Term Loan A - tranche two due August 2024

 

 

1,634,756

 

 

 

1,635,138

 

 

 

1,271,255

 

 

 

1,269,213

 

Term Loan B due August 2024

 

 

—

 

 

 

—

 

 

 

560,194

 

 

 

560,144

 

Senior notes due January 2029

 

 

600,000

 

 

 

595,500

 

 

 

600,000

 

 

 

602,412

 

 

(a) The carrying value of the term loan debt is shown net of original issue discounts.
XML 57 R36.htm IDEA: XBRL DOCUMENT v3.22.0.1
Restructuring and Other Costs (Tables)
 12 Months Ended
Dec. 31, 2021
Restructuring And Related Activities [Abstract]  
Schedule of Restructuring and Related Costs

Restructuring and other costs consisted of the following (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Employee severance and benefit costs

 

$

14,526

 

 

$

26,321

 

 

$

25,243

 

Facility and lease termination costs

 

 

8,226

 

 

 

2,313

 

 

 

16,202

 

Other costs

 

 

64

 

 

 

780

 

 

 

690

 

Total restructuring and other costs

 

$

22,816

 

 

$

29,414

 

 

$

42,135

 

The following table summarizes activity related to the liabilities associated with restructuring and other costs (in thousands):

 

 

 

Employee

Severance Costs

 

 

Other Costs

 

 

Total

 

Balance as of December 31, 2019

 

$

5,728

 

 

$

22

 

 

$

5,750

 

Expenses incurred (a)

 

 

26,321

 

 

 

791

 

 

 

27,112

 

Payments

 

 

(26,219

)

 

 

(813

)

 

 

(27,032

)

Balance as of December 31, 2020

 

 

5,830

 

 

 

—

 

 

 

5,830

 

Expenses incurred (a)

 

 

14,574

 

 

 

17

 

 

 

14,591

 

Payments

 

 

(13,747

)

 

 

(17

)

 

 

(13,764

)

Balance as of December 31, 2021

 

$

6,657

 

 

$

—

 

 

$

6,657

 

 

(a) There were no non-cash restructuring and other expenses incurred for the years ended December 31, 2021 and 2020. The amount of expenses incurred for the years ended December 31, 2021 and 2020 excludes $8.2 million and $2.3 million, respectively, of facility lease closure and lease termination costs that are reflected as a reduction of operating lease right-of-use assets on the accompanying consolidated balance sheets under ASC 842.
XML 58 R37.htm IDEA: XBRL DOCUMENT v3.22.0.1
Shareholders' Equity (Tables)
 12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Shares of Common Stock Outstanding

Shares of common stock outstanding were as follows (in thousands):

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Common stock shares, beginning balance

 

 

103,935

 

 

 

103,866

 

 

 

103,372

 

Repurchases of common stock

 

 

(1,500

)

 

 

(1,256

)

 

 

(1,323

)

Issuances of common stock

 

 

1,329

 

 

 

1,325

 

 

 

1,817

 

Common stock shares, ending balance

 

 

103,764

 

 

 

103,935

 

 

 

103,866

 
Schedule of Repurchase Activity

The following table sets forth repurchase activity under the Company’s stock repurchase programs from inception through December 31, 2021:

 

 

Total number of

shares purchased

 

 

Average price

paid per share

 

 

Approximate dollar

value of shares

purchased

(in thousands)

 

March 2018

 

 

948,100

 

 

$

39.55

 

 

$

37,493

 

April 2018

 

 

1,024,400

 

 

 

36.60

 

 

 

37,492

 

January 2019

 

 

552,100

 

 

 

39.16

 

 

 

21,623

 

February 2019

 

 

120,600

 

 

 

41.40

 

 

 

4,993

 

June 2019

 

 

509,100

 

 

 

45.29

 

 

 

23,055

 

August 2019

 

 

141,100

 

 

 

49.93

 

 

 

7,045

 

March 2020

 

 

600,000

 

 

 

53.38

 

 

 

32,029

 

September 2020

 

 

506,244

 

 

 

59.26

 

 

 

30,000

 

October 2020

 

 

150,000

 

 

 

54.14

 

 

 

8,122

 

March 2021

 

 

600,000

 

 

 

74.18

 

 

 

44,505

 

May 2021

 

 

400,000

 

 

 

81.04

 

 

 

32,416

 

June 2021

 

 

500,000

 

 

 

81.20

 

 

 

40,600

 

Total

 

 

6,051,644

 

 

 

 

 

 

$

319,373

 
Schedule of Stock by Class

The following is a summary of the Company’s authorized, issued, and outstanding shares as of December 31:

 

 

2021

 

 

2020

 

Shares Authorized:

 

 

 

 

 

 

 

 

Class A common stock

 

 

300,000,000

 

 

 

300,000,000

 

Class B common stock

 

 

300,000,000

 

 

 

300,000,000

 

Preferred stock

 

 

30,000,000

 

 

 

30,000,000

 

Total shares authorized

 

 

630,000,000

 

 

 

630,000,000

 

Shares Issued and Outstanding:

 

 

 

 

 

 

 

 

Class A common stock

 

 

103,763,635

 

 

 

103,934,738

 

Class B common stock

 

 

—

 

 

 

—

 

Preferred stock

 

 

—

 

 

 

—

 

Total shares issued and outstanding

 

 

103,763,635

 

 

 

103,934,738

 
XML 59 R38.htm IDEA: XBRL DOCUMENT v3.22.0.1
Earnings Per Share (Tables)
 12 Months Ended
Dec. 31, 2021
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted

The following table provides a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations (in thousands, except per share data):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

234,831

 

 

$

192,787

 

 

$

131,258

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Basic weighted average common shares outstanding

 

 

103,872

 

 

 

104,168

 

 

 

103,618

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

Stock options and other awards under deferred share-based compensation programs

 

 

1,193

 

 

 

1,297

 

 

 

1,387

 

Diluted weighted average common shares outstanding

 

 

105,065

 

 

 

105,465

 

 

 

105,005

 

Earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

2.26

 

 

$

1.85

 

 

$

1.27

 

Diluted

 

$

2.24

 

 

$

1.83

 

 

$

1.25

 
XML 60 R39.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Components of Income before Provision for Income Taxes

The components of income before provision for income taxes were as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Domestic

 

$

186,445

 

 

$

122,659

 

 

$

(17,066

)

Foreign

 

 

128,715

 

 

 

80,999

 

 

 

118,775

 

Income before provision for income taxes

 

$

315,160

 

 

$

203,658

 

 

$

101,709

 
Schedule of Components of Income Tax Expense (Benefit)

The components of income tax expense (benefit) were as follows (in thousands):

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Federal income taxes:

 

 

 

 

 

 

 

 

 

 

 

 

Current

 

$

926

 

 

$

(15,537

)

 

$

(13,952

)

Deferred

 

 

45,819

 

 

 

10,188

 

 

 

(11,693

)

Foreign income taxes:

 

 

 

 

 

 

 

 

 

 

 

 

Current

 

 

27,718

 

 

 

16,019

 

 

 

21,452

 

Deferred

 

 

(4,309

)

 

 

(3,106

)

 

 

(2,206

)

State income taxes:

 

 

 

 

 

 

 

 

 

 

 

 

Current

 

 

5,163

 

 

 

14,229

 

 

 

2,850

 

Deferred

 

 

5,012

 

 

 

(10,922

)

 

 

(26,000

)

Income tax expense (benefit)

 

$

80,329

 

 

$

10,871

 

 

$

(29,549

)
Schedule of Effective Income Tax Rate Reconciliation

Actual income tax expense differed from the amount computed by applying the U.S. federal tax rate of 21% to pre-tax income as a result of the following (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Expected income tax expense at statutory rate

 

$

66,184

 

 

$

42,768

 

 

$

21,359

 

Change in income tax expense resulting from:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign income inclusion

 

 

11,019

 

 

 

6,013

 

 

 

39,557

 

Foreign earnings not indefinitely reinvested

 

 

278

 

 

 

5,071

 

 

 

—

 

Foreign tax credits

 

 

(4,390

)

 

 

—

 

 

 

—

 

Changes in income tax valuation allowance (all jurisdictions)

 

 

(1,462

)

 

 

14,503

 

 

 

(68,537

)

Change in fair value of contingent obligations

 

 

(122

)

 

 

(769

)

 

 

3,625

 

Share-based compensation

 

 

(5,662

)

 

 

(2,800

)

 

 

1,094

 

Research and general business tax credits (a)

 

 

(8,902

)

 

 

(12,872

)

 

 

(1,871

)

State and local taxes, net of federal benefit

 

 

11,978

 

 

 

6,924

 

 

 

(9,085

)

Capital loss carryforward (b)

 

 

(214

)

 

 

(16,506

)

 

 

—

 

Foreign rate differential

 

 

2,865

 

 

 

(1,777

)

 

 

(3,595

)

Changes in reserve for uncertain tax positions including interest

 

 

4,721

 

 

 

(18,839

)

 

 

5,393

 

Provision to tax return and other deferred tax adjustments

 

 

(771

)

 

 

(12,325

)

 

 

(6,950

)

Gain on sale of business

 

 

—

 

 

 

(2,350

)

 

 

—

 

Base erosion and anti-abuse tax

 

 

—

 

 

 

—

 

 

 

(15,054

)

Nondeductible executive compensation

 

 

1,649

 

 

 

367

 

 

 

1,802

 

Other, net

 

 

3,158

 

 

 

3,463

 

 

 

2,713

 

Income tax expense (benefit)

 

$

80,329

 

 

$

10,871

 

 

$

(29,549

)

 

(a) Year ended December 31, 2021 included a $0.8 million valuation allowance release and year ended December 31, 2020 was offset by a $9.4 million valuation allowance.

(b) Years ended December 31, 2021 and 2020 are offset by $0.2 million and $16.5 million, respectively, in valuation allowances.
Summary of Valuation Allowance

The changes in the valuation allowance for deferred tax assets were as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Balance at the beginning of the period

 

$

100,310

 

 

$

84,159

 

 

$

150,316

 

Deferred tax assets assumed through acquisitions

 

 

—

 

 

 

479

 

 

 

—

 

Deferred tax assets released through divestitures

 

 

—

 

 

 

(271

)

 

 

—

 

(Credited) charged to income tax expense

 

 

(1,462

)

 

 

14,503

 

 

 

(68,537

)

Charged to equity

 

 

—

 

 

 

—

 

 

 

42

 

Foreign currency exchange

 

 

(407

)

 

 

1,440

 

 

 

2,338

 

Other adjustments

 

 

(479

)

 

 

—

 

 

 

—

 

Balance at the end of the period

 

$

97,962

 

 

$

100,310

 

 

$

84,159

 
Schedule of Deferred Tax Assets and Liabilities

The income tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities are as follows as of December 31 (in thousands):

 

 

 

2021

 

 

2020

 

Deferred tax assets:

 

 

 

 

 

 

 

 

Net operating losses

 

$

134,143

 

 

$

122,018

 

Tax credits

 

 

58,901

 

 

 

58,603

 

Deferred revenue

 

 

—

 

 

 

77,138

 

Employee compensation and other benefits

 

 

28,538

 

 

 

29,048

 

Allowance for doubtful accounts

 

 

1,787

 

 

 

1,739

 

Lease obligations

 

 

57,749

 

 

 

57,142

 

Accrued expenses

 

 

13,158

 

 

 

6,526

 

Prepaid royalty

 

 

—

 

 

 

3,451

 

Capital loss carryforward

 

 

20,021

 

 

 

20,157

 

Interest limitation carryforwards

 

 

30,847

 

 

 

20,219

 

Other

 

 

1,151

 

 

 

7,913

 

Total deferred tax assets

 

 

346,295

 

 

 

403,954

 

Less: valuation allowance

 

 

(97,962

)

 

 

(100,310

)

Net deferred tax assets

 

 

248,333

 

 

 

303,644

 

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Undistributed foreign earnings

 

 

(7,778

)

 

 

(10,912

)

Right of use asset

 

 

(47,532

)

 

 

(49,316

)

Depreciation and amortization

 

 

(214,636

)

 

 

(226,170

)

Deferred revenue

 

 

(17,247

)

 

 

—

 

Other

 

 

(3,814

)

 

 

(2,404

)

Total deferred tax liabilities

 

 

(291,007

)

 

 

(288,802

)

Net deferred tax assets

 

$

(42,674

)

 

$

14,842

 
Schedule Of Unrecognized Tax Benefits A reconciliation of the beginning and ending balances of unrecognized tax benefits, excluding accrued interest and penalties, is as follows (in thousands):

 

Unrecognized tax benefits balance as of December 31, 2018

 

$

19,245

 

Increases for tax positions in the current year

 

 

2,222

 

Increases for tax positions of prior years

 

 

2,255

 

Decreases for tax positions in prior year

 

 

(440

)

Impact of foreign currency translation

 

 

(44

)

Unrecognized tax benefits balance as of December 31, 2019

 

 

23,238

 

Increases for tax positions in the current year

 

 

254

 

Increases for tax positions of prior years

 

 

3,237

 

Decreases for tax positions in prior year

 

 

(2,540

)

Impact of foreign currency translation

 

 

132

 

Lapse of statute limitations

 

 

(15,288

)

Unrecognized tax benefits balance as of December 31, 2020

 

 

9,033

 

Increases for tax positions in the current year

 

 

386

 

Increases for tax positions of prior years

 

 

4,233

 

Settlements with tax authorities

 

 

(1,131

)

Impact of foreign currency translation

 

 

(169

)

Lapse of statute limitations

 

 

(234

)

Unrecognized tax benefits balance as of December 31, 2021

 

$

12,118

 

 
XML 61 R40.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Information (Tables)
 12 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
Schedule of Segment Information

Information about reportable segment operating results was as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Revenue:

 

 

 

 

 

 

 

 

 

 

 

 

Clinical Solutions

 

$

4,009,057

 

 

$

3,339,451

 

 

$

3,450,223

 

Commercial Solutions

 

 

1,203,913

 

 

 

1,076,326

 

 

 

1,225,592

 

Total revenue

 

 

5,212,970

 

 

 

4,415,777

 

 

 

4,675,815

 

Segment direct costs:

 

 

 

 

 

 

 

 

 

 

 

 

Clinical Solutions

 

 

3,005,938

 

 

 

2,513,240

 

 

 

2,637,016

 

Commercial Solutions

 

 

955,326

 

 

 

853,555

 

 

 

979,878

 

Total segment direct costs

 

 

3,961,264

 

 

 

3,366,795

 

 

 

3,616,894

 

Segment selling, general, and administrative expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Clinical Solutions

 

 

353,990

 

 

 

283,633

 

 

 

280,674

 

Commercial Solutions

 

 

82,516

 

 

 

82,709

 

 

 

87,258

 

Total segment selling, general, and administrative expenses

 

 

436,506

 

 

 

366,342

 

 

 

367,932

 

Segment operating income:

 

 

 

 

 

 

 

 

 

 

 

 

Clinical Solutions

 

 

649,129

 

 

 

542,578

 

 

 

532,533

 

Commercial Solutions

 

 

166,071

 

 

 

140,062

 

 

 

158,456

 

Total segment operating income

 

 

815,200

 

 

 

682,640

 

 

 

690,989

 

Direct costs and operating expenses not allocated to segments:

 

 

 

 

 

 

 

 

 

 

 

 

Share-based compensation included in direct costs

 

 

33,220

 

 

 

31,347

 

 

 

29,011

 

Share-based compensation included in selling, general, and administrative expenses

 

 

31,984

 

 

 

27,144

 

 

 

26,182

 

Corporate selling, general, and administrative expenses

 

 

102,275

 

 

 

79,240

 

 

 

113,442

 

Restructuring and other costs

 

 

22,816

 

 

 

29,414

 

 

 

42,135

 

Depreciation and amortization

 

 

235,625

 

 

 

222,352

 

 

 

242,465

 

Total income from operations

 

$

389,280

 

 

$

293,143

 

 

$

237,754

 
XML 62 R41.htm IDEA: XBRL DOCUMENT v3.22.0.1
Operations by Geographic Location (Tables)
 12 Months Ended
Dec. 31, 2021
Segments Geographical Areas [Abstract]  
Total Revenue by Geographic Area

The following table summarizes total revenue by geographic area (in thousands, all intercompany transactions have been eliminated):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Revenue:

 

 

 

 

 

 

 

 

 

 

 

 

North America (a)

 

$

3,144,475

 

 

$

2,791,590

 

 

$

3,079,608

 

Europe, Middle East and Africa

 

 

1,333,540

 

 

 

1,059,968

 

 

 

1,055,007

 

Asia-Pacific

 

 

594,163

 

 

 

465,116

 

 

 

444,819

 

Latin America

 

 

140,792

 

 

 

99,103

 

 

 

96,381

 

Total revenue

 

$

5,212,970

 

 

$

4,415,777

 

 

$

4,675,815

 

 

(a) Revenue for the North America region includes revenue attributable to the U.S. of $2.95 billion, $2.64 billion, and $2.93 billion, or 56.6%, 59.9%, and 62.7% of total revenue, for the years ended December 31, 2021, 2020 and 2019, respectively. No other country represented more than 10% of total revenue for any year.
Long-Lived Assets by Geographic Area

The following table summarizes long-lived assets by geographic area as of December 31 (in thousands, all intercompany transactions have been eliminated):

 

 

 

2021

 

 

2020

 

Property and equipment, net:

 

 

 

 

 

 

 

 

North America (a)

 

$

165,446

 

 

$

161,531

 

Europe, Middle East and Africa

 

 

37,004

 

 

 

38,745

 

Asia-Pacific

 

 

13,615

 

 

 

11,167

 

Latin America

 

 

6,592

 

 

 

4,757

 

Total property and equipment, net

 

$

222,657

 

 

$

216,200

 

 

a) Long-lived assets for the North America region include property and equipment, net attributable to the U.S. of $160.0 million and $156.0 million as of December 31, 2021 and 2020, respectively.
XML 63 R42.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock Option Valuation Assumptions

The fair values of ESPP offerings were determined using the Black-Scholes valuation model and the following assumptions:

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Expected volatility

 

25.3% - 38.3%

 

 

27.7% - 55.1%

 

 

39.1% - 51.9%

 

Risk-free interest rate

 

0.06% - 0.07%

 

 

0.13% - 0.95%

 

 

1.88% - 2.52%

 

Expected term (in years)

 

 

0.5

 

 

 

0.5

 

 

 

0.5

 
Summary of Stock Option Activity

The following table sets forth the summary of stock option activity for the year ended December 31, 2021:

 

 

 

Number

of

Options

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Contractual

Life (in years)

 

 

Aggregate

Intrinsic Value

(in thousands)(a)

 

Outstanding as of December 31, 2020

 

 

663,559

 

 

$

30.12

 

 

 

 

 

 

 

 

 

Exercised

 

 

(279,072

)

 

 

33.31

 

 

 

 

 

 

 

 

 

Forfeited

 

 

—

 

 

 

—

 

 

 

 

 

 

 

 

 

Outstanding as of December 31, 2021

 

 

384,487

 

 

 

27.81

 

 

 

3.26

 

 

$

28,787

 

Vested and expected to vest as of December 31, 2021

 

 

384,487

 

 

 

27.81

 

 

 

3.26

 

 

$

28,787

 

Exercisable as of December 31, 2021

 

 

384,487

 

 

 

27.81

 

 

 

3.26

 

 

$

28,787

 

 

(a) Represents the total pre-tax intrinsic value (i.e., the aggregate difference between the closing price of the Company’s common stock on December 31, 2021 of $102.68 and the exercise price for in-the-money options) that would have been received by the holders if all instruments had been exercised on December 31, 2021.
Summary of Restricted Stock Unit Activity

The following table sets forth a summary of RSUs outstanding under the 2014 and 2018 Plans as of December 31, 2021 and changes during the year then ended:

 

 

 

Time-based

 

 

Performance-based

 

 

 

 

 

 

 

Number of Shares

 

 

Weighted Average

Grant Date Fair Value

 

 

Number of Shares

 

 

Weighted Average

Grant Date Fair Value

 

 

Total Number of Shares

 

Non-vested as of December 31, 2020

 

 

1,909,882

 

 

$

51.98

 

 

 

461,499

 

 

$

48.99

 

 

 

2,371,381

 

Granted

 

 

939,031

 

 

 

76.96

 

 

 

59,055

 

 

 

75.43

 

 

 

998,086

 

Vested

 

 

(997,632

)

 

 

48.45

 

 

 

(136,665

)

 

 

46.47

 

 

 

(1,134,297

)

Forfeited

 

 

(226,094

)

 

 

64.07

 

 

 

(27,890

)

 

 

58.71

 

 

 

(253,984

)

Non-vested as of December 31, 2021

 

 

1,625,187

 

 

$

66.90

 

 

 

355,999

 

 

$

60.75

 

 

 

1,981,186

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrecognized compensation expense (in millions)

 

$

62.6

 

 

 

 

 

 

$

10.7

 

 

 

 

 

 

 

 

 

Weighted average period unrecognized compensation is expected to be recognized

 

1.9 years

 

 

 

 

 

 

1.9 years

 

 

 

 

 

 

 

 

 
Summary of Share-Based Compensation Expense

Total share-based compensation expense recognized was as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Direct costs

 

$

33,220

 

 

$

31,347

 

 

$

29,011

 

Selling, general, and administrative expenses

 

 

31,984

 

 

 

27,144

 

 

 

26,182

 

Total share-based compensation expense

 

$

65,204

 

 

$

58,491

 

 

$

55,193

 
XML 64 R43.htm IDEA: XBRL DOCUMENT v3.22.0.1
Employee Benefit Plans (Tables)
 12 Months Ended
Dec. 31, 2021
Compensation And Retirement Disclosure [Abstract]  
Schedule of Contributions to Defined Contribution Plan

The Company’s contributions related to these defined contribution retirement plans were as follows (in thousands):

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Defined contribution retirement plan contributions

 

$

30,932

 

 

$

15,049

 

 

$

29,834

 
XML 65 R44.htm IDEA: XBRL DOCUMENT v3.22.0.1
Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)
 12 Months Ended 39 Months Ended
Jan. 01, 2020
USD ($)
Dec. 31, 2021
USD ($)
Segment
reportingunit
Dec. 31, 2020
USD ($)
Dec. 31, 2021
USD ($)
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]        
Number of reportable segments | Segment   2    
Restricted cash   $ 100,000 $ 300,000 $ 100,000
Number of reporting units with goodwill assigned | reportingunit   4    
Impairment of goodwill       $ 0
Impact from adoption of ASU     (2,771,000)  
Cumulative Effect, Period of Adoption, Adjustment        
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]        
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-13      
Impact from adoption of ASU $ 2,800,000      
Change in accounting principle, accounting standards update, adopted [true/false]   true   true
Change in accounting principle, accounting standards update, adoption date   Jan. 01, 2020   Jan. 01, 2020
Minimum        
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]        
Contract Termination Notice Period   30 days    
Maximum        
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]        
Contract Termination Notice Period   90 days    
Inventiv        
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]        
Impairment charge   $ 0 $ 0  
Computer equipment and software        
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]        
Property and equipment, estimated useful life   5 years    
Computer equipment and software | Minimum        
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]        
Property and equipment, estimated useful life   2 years    
Computer equipment and software | Maximum        
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]        
Property and equipment, estimated useful life   3 years    
XML 66 R45.htm IDEA: XBRL DOCUMENT v3.22.0.1
Basis of Presentation and Summary of Significant Accounting Policies - Net Cash Pool Position (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Accounting Policies [Abstract]    
Gross cash position $ 179,160 $ 220,261
Less: cash borrowings (167,507) (204,647)
Net cash position $ 11,653 $ 15,614
XML 67 R46.htm IDEA: XBRL DOCUMENT v3.22.0.1
Basis of Presentation and Summary of Significant Accounting Policies - Estimated Useful Lives of Property and Equipment (Details)
 12 Months Ended
Dec. 31, 2021
Buildings  
Property Plant And Equipment [Line Items]  
Property and equipment, estimated useful life 39 years
Furniture and fixtures  
Property Plant And Equipment [Line Items]  
Property and equipment, estimated useful life 7 years
Equipment | Minimum  
Property Plant And Equipment [Line Items]  
Property and equipment, estimated useful life 5 years
Equipment | Maximum  
Property Plant And Equipment [Line Items]  
Property and equipment, estimated useful life 10 years
Computer equipment and software  
Property Plant And Equipment [Line Items]  
Property and equipment, estimated useful life 5 years
Computer equipment and software | Minimum  
Property Plant And Equipment [Line Items]  
Property and equipment, estimated useful life 2 years
Computer equipment and software | Maximum  
Property Plant And Equipment [Line Items]  
Property and equipment, estimated useful life 3 years
XML 68 R47.htm IDEA: XBRL DOCUMENT v3.22.0.1
Basis of Presentation and Summary of Significant Accounting Policies - Estimated Useful Lives of Intangible Assets (Details) - Weighted Average
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Customer relationships    
Finite Lived Intangible Assets [Line Items]    
Estimated Useful Life 9 years 9 months 18 days 9 years 10 months 24 days
Acquired backlog    
Finite Lived Intangible Assets [Line Items]    
Estimated Useful Life 2 years 7 months 6 days 2 years 7 months 6 days
Trade names and trademarks    
Finite Lived Intangible Assets [Line Items]    
Estimated Useful Life 5 years 6 months 5 years 6 months
Intellectual property (medical patent)    
Finite Lived Intangible Assets [Line Items]    
Estimated Useful Life   9 years
Patient Communities    
Finite Lived Intangible Assets [Line Items]    
Estimated Useful Life 6 years  
Acquired Technology    
Finite Lived Intangible Assets [Line Items]    
Estimated Useful Life 6 years  
XML 69 R48.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Statement Details - Accounts Receivable and Unbilled Services, net (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Receivables [Abstract]      
Accounts receivable billed $ 873,265 $ 774,605  
Accounts receivable unbilled 241,799 211,285  
Contract assets 417,411 366,506  
Less: Allowance for doubtful accounts (7,585) (7,615)  
Accounts receivable and unbilled services, net 1,524,890 1,344,781  
Allowance for Doubtful Accounts Receivable [Roll Forward]      
Balance at the beginning of the period (7,615) (5,381) $ (4,587)
Impact from adoption of ASU   (2,771)  
Current year provision (367) (695) (1,897)
Write-offs, net of recoveries and the effects of foreign currency exchange 397 1,232 1,103
Balance at the end of the period $ (7,585) $ (7,615) $ (5,381)
XML 70 R49.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Statement Details - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Property Plant And Equipment [Line Items]    
Trade receivables sold $ 129,100 $ 152,400
Proceeds from sale of trade receivables 128,900 151,900
Property and equipment, gross 77,674 63,985
Amortization charges, net of rebates 47,653 43,506
Vehicles    
Property Plant And Equipment [Line Items]    
Property and equipment, gross 77,700 64,000
Accumulated depreciation 30,000 20,500
Amortization charges, net of rebates $ 17,500 $ 15,800
XML 71 R50.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Statement Details - Schedule of Property and Equipment, Net (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Property Plant And Equipment [Line Items]    
Property and equipment, gross $ 524,951 $ 467,169
Less: Accumulated depreciation (302,294) (250,969)
Property and equipment, net 222,657 216,200
Software    
Property Plant And Equipment [Line Items]    
Property and equipment, gross 159,736 129,731
Leasehold Improvements    
Property Plant And Equipment [Line Items]    
Property and equipment, gross 96,188 94,596
Computer equipment    
Property Plant And Equipment [Line Items]    
Property and equipment, gross 91,937 108,230
Vehicles    
Property Plant And Equipment [Line Items]    
Property and equipment, gross 77,674 63,985
Furniture and fixtures    
Property Plant And Equipment [Line Items]    
Property and equipment, gross 65,018 37,287
Buildings and land    
Property Plant And Equipment [Line Items]    
Property and equipment, gross 5,692 5,211
Assets not yet placed in service    
Property Plant And Equipment [Line Items]    
Property and equipment, gross $ 28,706 $ 28,129
XML 72 R51.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Statement Details - Schedule of Goodwill (Details) - USD ($)
 12 Months Ended 39 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2021
Goodwill [Roll Forward]        
Balance as of December 31, 2019 $ 4,776,178,000 $ 4,350,380,000    
Acquisitions 192,286,000 404,166,000    
Impact of foreign currency translation and other (12,449,000) 21,632,000    
Balance as of December 31, 2020 4,956,015,000 4,776,178,000 $ 4,350,380,000 $ 4,956,015,000
Impairment of goodwill       0
Clinical Solutions        
Goodwill [Roll Forward]        
Balance as of December 31, 2019 3,216,335,000 2,784,952,000    
Acquisitions 192,286,000 418,619,000    
Impact of foreign currency translation and other 40,078,000 12,764,000    
Balance as of December 31, 2020 3,448,699,000 3,216,335,000 2,784,952,000 3,448,699,000
Accumulated impairment loss 8,100,000 8,100,000 8,100,000 8,100,000
Impairment of goodwill 0 0 0  
Transfer of goodwill 44,200,000      
Commercial Solutions        
Goodwill [Roll Forward]        
Balance as of December 31, 2019 1,559,843,000 1,565,428,000    
Acquisitions   (14,453,000)    
Impact of foreign currency translation and other (52,527,000) 8,868,000    
Balance as of December 31, 2020 1,507,316,000 1,559,843,000 1,565,428,000 1,507,316,000
Accumulated impairment loss 8,000,000.0 8,000,000.0 8,000,000.0 $ 8,000,000.0
Impairment of goodwill $ 0 $ 0 $ 0  
XML 73 R52.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Statement Details - Schedule of Intangible Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Finite Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross $ 1,852,379 $ 1,774,764
Accumulated amortization (998,312) (841,239)
Finite-lived intangible assets, net 854,067 933,525
Customer relationships    
Finite Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross 1,547,925 1,518,081
Accumulated amortization (811,542) (685,021)
Finite-lived intangible assets, net 736,383 833,060
Backlog    
Finite Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross 175,826 174,180
Accumulated amortization (154,475) (132,733)
Finite-lived intangible assets, net 21,351 41,447
Trade names and trademarks    
Finite Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross 55,728 52,475
Accumulated amortization (28,806) (21,817)
Finite-lived intangible assets, net 26,922 30,658
Intellectual property (medical patent)    
Finite Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross   30,028
Accumulated amortization   (1,668)
Finite-lived intangible assets, net   $ 28,360
Patient communities    
Finite Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross 45,100  
Accumulated amortization (2,192)  
Finite-lived intangible assets, net 42,908  
Acquired Technology    
Finite Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross 27,800  
Accumulated amortization (1,297)  
Finite-lived intangible assets, net $ 26,503  
XML 74 R53.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Statement Details - Schedule of Future Amortization Expense (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract]    
2022 $ 162,193  
2023 153,334  
2024 146,487  
2025 132,512  
2026 110,597  
2027 and thereafter 148,944  
Finite-lived intangible assets, net $ 854,067 $ 933,525
XML 75 R54.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Statement Details - Schedule of Accrued Expenses (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract]    
Professional fees, investigator fees, and pass-through costs $ 283,432 $ 231,638
Compensation, including bonuses, fringe benefits, and payroll taxes 215,386 255,042
Income and other taxes 25,723 28,890
Rebates to customers 22,367 22,528
Restructuring and other costs, current portion 6,657 5,830
Contingent obligations, current 3,397 4,327
Interest rate swaps - current 1,827 17,045
Other liabilities 55,652 45,742
Total accrued expenses $ 614,441 $ 611,042
XML 76 R55.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Statement Details - Accumulated Other Comprehensive Loss, Net of Taxes (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Balance at beginning of period $ 3,242,112 $ 3,029,654 $ 2,856,144
Other comprehensive gain (loss) before reclassifications 2,963 (20,446)  
Balance at end of period 3,412,555 3,242,112 3,029,654
Accumulated Other Comprehensive Loss      
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Balance at beginning of period (40,801) (71,593) (88,195)
Balance at end of period (49,618) (40,801) (71,593)
Foreign Currency Translation      
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Balance at beginning of period (22,040) (56,757)  
Other comprehensive gain (loss) before reclassifications (24,957) 34,717 24,198
Balance at end of period (46,997) (22,040) (56,757)
Derivative Instruments      
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Balance at beginning of period (18,761) (14,836)  
Other comprehensive gain (loss) before reclassifications 2,963 (20,446) (11,529)
Reclassification adjustments 13,177 16,521 3,933
Balance at end of period $ (2,621) $ (18,761) $ (14,836)
XML 77 R56.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Statement Details - Tax Effects Allocated to Each Component of Other Comprehensive (Loss) Income (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Accumulated Other Comprehensive Income Loss [Line Items]      
Unrealized gain (loss) during period, before taxes $ 4,084 $ (27,647) $ (14,306)
Other comprehensive gain (loss) before reclassifications 2,963 (20,446)  
Income tax (benefit) expense 1,472 (1,354) 0
Other comprehensive income before reclassifications 2,963 (20,446)  
Foreign Currency Translation      
Accumulated Other Comprehensive Income Loss [Line Items]      
Income tax expense (benefit) (26,429) 36,071 24,198
Other comprehensive gain (loss) before reclassifications (24,957) 34,717 24,198
Total unrealized gain (loss) on derivative instruments, net of taxes (8,817) 30,792 16,602
Income tax (benefit) expense (1,472) 1,354  
Other comprehensive income before reclassifications (24,957) 34,717 24,198
Derivative Instruments      
Accumulated Other Comprehensive Income Loss [Line Items]      
Income tax expense (benefit) 1,121 (7,201) (2,777)
Other comprehensive gain (loss) before reclassifications 2,963 (20,446) (11,529)
Reclassification adjustment, before taxes 17,655 22,328 4,588
Income tax expense 4,478 5,807 655
Reclassification adjustment, net of taxes 13,177 16,521 3,933
Total unrealized gain (loss) on derivative instruments, net of taxes 16,140 (3,925) (7,596)
Other comprehensive income before reclassifications $ 2,963 $ (20,446) $ (11,529)
XML 78 R57.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Statement Details - Schedule of Other (Income) Expense, Net (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Organization Consolidation And Presentation Of Financial Statements [Abstract]      
Net realized foreign currency loss $ 2,190 $ 3,175 $ 11,853
Net unrealized foreign currency (gain) loss (5,928) 4,147 11,166
Gain on sale of business   (7,133)  
Equity investment (income) expense (1,950) (3,745) 261
Other, net (2,945) 580 882
Total other (income) expense, net $ (8,633) $ (2,976) $ 24,162
XML 79 R58.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Statement Details - Supplemental Cash Flow Information (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Jun. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Organization Consolidation And Presentation Of Financial Statements [Abstract]        
Cash paid for income taxes, net of refunds   $ 35,100 $ 23,400 $ 12,200
Cash paid for interest (excluding finance leases)   63,952 83,690 129,756
Supplemental disclosure of noncash investing and financing activities        
Non-cash investment to acquire certain intellectual property rights from a customer in lieu of cash payment for services rendered $ 27,300   27,300  
Fair value of contingent consideration related to acquisitions   19,158    
Change in property and equipment included in liabilities   1,753 11,684 5,977
Vehicles acquired through finance lease agreements   $ 28,994 $ 20,203 $ 37,701
XML 80 R59.htm IDEA: XBRL DOCUMENT v3.22.0.1
Acquisitions, Divestitures, and Investments - Narrative (Details) - USD ($)
 3 Months Ended 12 Months Ended
Oct. 06, 2021
Sep. 13, 2021
Dec. 17, 2020
Dec. 09, 2020
Sep. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Jun. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Business Acquisition [Line Items]                      
Goodwill             $ 4,776,178,000   $ 4,956,015,000 $ 4,776,178,000 $ 4,350,380,000
Business acquisition payment of cash                 278,920,000 456,455,000 712,000
Contingent consideration             1,800,000     1,800,000  
Gain (loss) on divestiture                   7,133,000  
Non-cash investment to acquire certain intellectual property rights from a customer in lieu of cash payment for services rendered               $ 27,300,000   27,300,000  
Assets Exchanged In Cash         $ 3,800,000            
Income (Loss) from Equity Method Investments                 5,300,000    
Other long-term investments                 16,200    
Maximum loss on investment for a VIE                 20,300    
Clinical Solutions                      
Business Acquisition [Line Items]                      
Goodwill             3,216,335,000   3,448,699,000 3,216,335,000 $ 2,784,952,000
Cash consideration             18,000,000.0        
Contingent consideration             3,600,000   $ 3,000,000.0 3,600,000  
Divestiture, consideration received             23,000,000.0     $ 23,000,000.0  
Convertible notes             5,000,000.0        
Proceeds from notes receivable             5,000,000.0        
Gain (loss) on divestiture             $ 7,100,000        
Related Party                      
Business Acquisition [Line Items]                      
Contingent consideration               1,800      
Related Party | Maximum                      
Business Acquisition [Line Items]                      
Cash consideration               $ 4,000,000.0      
StudyKIK Acquisition [Member]                      
Business Acquisition [Line Items]                      
Name of acquired entity   StudyKIK                  
Date of Acquisition   Sep. 13, 2021                  
Aggregate purchase price for the acquisition   $ 203,600                  
Cash acquired   1,000.0                  
Goodwill   115,300                  
Intangible assets   $ 91,800                  
Rx Data Science Acquisitions                      
Business Acquisition [Line Items]                      
Name of acquired entity RxDataScience                    
Date of Acquisition Oct. 06, 2021                    
Aggregate purchase price for the acquisition $ 67,500,000                    
Cash acquired 2,400,000                    
Goodwill 52,900,000                    
Intangible assets $ 18,000,000.0                    
Synteract Acquisition [Member]                      
Business Acquisition [Line Items]                      
Name of acquired entity       Synteract              
Date of Acquisition       Dec. 09, 2020              
Aggregate purchase price for the acquisition       $ 385,500,000              
Cash acquired       28,000,000.0              
Goodwill       363,733,000              
Intangible assets       $ 56,400,000              
Percentage of Outstanding Shares Purchase       100.00%              
Business acquisition payment of cash           $ 1,000,000.0          
Illingworth Research Group Acquisition                      
Business Acquisition [Line Items]                      
Date of Acquisition     Dec. 17, 2020                
Aggregate purchase price for the acquisition     $ 80,900,000                
Cash acquired     1,100,000                
Goodwill     64,600,000                
Intangible assets     $ 21,500,000                
Business acquisition payment of cash           $ 9,000,000.0          
XML 81 R60.htm IDEA: XBRL DOCUMENT v3.22.0.1
Acquisitions, Divestitures, and Investments - Preliminary Estimates of Fair Values of Intangible Assets and Estimated Useful Lives (Details) - StudyKIK Acquisition [Member]
$ in Thousands
Sep. 13, 2021
USD ($)
Finite Lived Intangible Assets [Line Items]  
Estimated Fair Value $ 91,800
Customer relationships  
Finite Lived Intangible Assets [Line Items]  
Estimated Fair Value $ 22,300
Estimated Useful Life 6 years
Acquired backlog  
Finite Lived Intangible Assets [Line Items]  
Estimated Fair Value $ 1,800
Estimated Useful Life 1 year 3 months
Trade name  
Finite Lived Intangible Assets [Line Items]  
Estimated Fair Value $ 2,700
Estimated Useful Life 6 years
Patient Communities  
Finite Lived Intangible Assets [Line Items]  
Estimated Fair Value $ 45,100
Estimated Useful Life 6 years
Acquired Technology  
Finite Lived Intangible Assets [Line Items]  
Estimated Fair Value $ 19,900
Estimated Useful Life 6 years
XML 82 R61.htm IDEA: XBRL DOCUMENT v3.22.0.1
Acquisitions, Divestitures, and Investments - Allocation of Consideration Transferred (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Dec. 09, 2020
Dec. 31, 2019
Assets acquired:        
Goodwill $ 4,956,015 $ 4,776,178   $ 4,350,380
Synteract Acquisition [Member]        
Assets acquired:        
Cash and cash equivalents     $ 28,028  
Accounts receivable and unbilled services     39,723  
Prepaid expenses and other current assets     2,160  
Property and equipment     3,978  
Operating lease right-of-use assets     10,839  
Other identifiable intangible assets     56,400  
Goodwill     363,733  
Other assets     4,121  
Total assets acquired     508,982  
Liabilities assumed:        
Accounts payable and accrued expenses     25,623  
Deferred revenue     45,272  
Operating lease obligations     15,693  
Deferred income taxes, net     7,754  
Other liabilities     1,126  
Total liabilities assumed     95,468  
Net assets acquired     $ 413,514  
XML 83 R62.htm IDEA: XBRL DOCUMENT v3.22.0.1
Acquisitions, Divestitures, and Investments - Preliminary Estimates of Fair Value of Intangible Assets and Estimated Useful Lives (Details) - Synteract Acquisition [Member]
$ in Thousands
Dec. 09, 2020
USD ($)
Finite Lived Intangible Assets [Line Items]  
Estimated Fair Value $ 56,400
Acquired backlog  
Finite Lived Intangible Assets [Line Items]  
Estimated Fair Value $ 37,200
Acquired backlog | Maximum  
Finite Lived Intangible Assets [Line Items]  
Estimated Useful Life 4 years
Trade name  
Finite Lived Intangible Assets [Line Items]  
Estimated Fair Value $ 19,200
Trade name | Maximum  
Finite Lived Intangible Assets [Line Items]  
Estimated Useful Life 8 years
XML 84 R63.htm IDEA: XBRL DOCUMENT v3.22.0.1
Long-Term Debt Obligations - Schedule of Debt Obligations (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Debt Instrument [Line Items]    
Less: Term loans original issuance discount $ (2,228) $ (3,500)
Less: Unamortized deferred issuance costs (8,043) (12,716)
Long-term debt 2,775,721 2,902,054
Secured Debt    
Debt Instrument [Line Items]    
Total debt obligations 2,185,992 2,318,270
Secured Debt | Term Loan A - tranche one due March 2024    
Debt Instrument [Line Items]    
Total debt obligations 149,195 183,715
Secured Debt | Term Loan A - tranche two due August 2024    
Debt Instrument [Line Items]    
Total debt obligations 1,636,797 1,273,991
Secured Debt | 2017 Credit Agreement - Amendment No 2 - Term Loan B Due August 2024    
Debt Instrument [Line Items]    
Total debt obligations   560,564
Secured Debt | Accounts receivable financing agreement due October 2022 | Accounts Receivable Securitization    
Debt Instrument [Line Items]    
Total debt obligations 400,000 300,000
Unsecured Debt    
Debt Instrument [Line Items]    
Total debt obligations 2,785,992 2,918,270
Unsecured Debt | Senior Unsecured Notes due January 2029    
Debt Instrument [Line Items]    
Total debt obligations $ 600,000 $ 600,000
XML 85 R64.htm IDEA: XBRL DOCUMENT v3.22.0.1
Long-Term Debt Obligations - Narrative (Details)
 12 Months Ended
Feb. 28, 2021
Aug. 01, 2017
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Nov. 24, 2020
USD ($)
Debt Instrument [Line Items]            
Repayments of Long-term debt     $ 727,277,000 $ 327,294,000 $ 437,936,000  
Loss on extinguishment of debt     (3,612,000) (1,581,000) 10,395,000  
Proceeds from issuance of long-term debt, net of discount     $ 494,505,000 600,000,000 $ 582,000,000  
Senior Unsecured Notes Due2029            
Debt Instrument [Line Items]            
Percentage redeemed     40.00%      
Debt redemption price percentage     103.625%      
Secured Debt            
Debt Instrument [Line Items]            
Loss on extinguishment of debt     $ 3,600,000      
Secured Debt | Letter of credit            
Debt Instrument [Line Items]            
Line of credit facility, capacity available for trade purchases     135,800,000      
Secured Debt | 2017 Credit Agreement - Amendment No 2 - Term Loan B Due March 2024            
Debt Instrument [Line Items]            
Repayments of Long-term debt     166,800,000      
Secured Debt | 2017 Credit Agreement - Amendment No 2 - Term Loan B Due March 2024 | Term Loan            
Debt Instrument [Line Items]            
Term loan facility     1,550,000,000      
Secured Debt | 2017 Credit Agreement - Amendment No 2 - Term Loan B Due August 2024            
Debt Instrument [Line Items]            
Repayments of Long-term debt     560,500,000      
Secured Debt | 2017 Credit Agreement - Amendment No 2 - Term Loan B Due August 2024 | Term Loan            
Debt Instrument [Line Items]            
Term loan facility     1,600,000,000      
Secured Debt | 2017 Credit Agreement - Amendment No 2 - Term Loan B Due August 2024 | Revolving credit facility due August 2024            
Debt Instrument [Line Items]            
Maximum borrowing capacity under accounts receivable financing agreement     600,000,000.0      
Secured Debt | Credit Agreement Amendment No5 Term Loan A | Term Loan            
Debt Instrument [Line Items]            
Additional discount on Term loan     500,000      
Secured Debt | Credit Agreement Amendment No5 Term Loan A | Incremental Term Loan            
Debt Instrument [Line Items]            
Term loan facility     $ 495,000,000.0      
Secured Debt | 2017 Credit Agreement            
Debt Instrument [Line Items]            
Percentage of capital stock of certain controlled foreign subsidiaries securing debt obligation     65.00%      
Secured Debt | 2017 Credit Agreement | Federal Funds Effective Rate            
Debt Instrument [Line Items]            
Applicable margin on variable rate (percent)   0.50%        
Secured Debt | 2017 Credit Agreement | Eurodollar Rate            
Debt Instrument [Line Items]            
Applicable margin on variable rate (percent)   1.00%        
Secured Debt | 2017 Credit Agreement | Base Rate            
Debt Instrument [Line Items]            
Applicable margin on variable rate (percent)   0.00%        
Secured Debt | 2017 Credit Agreement - Revolving Credit Facility | Revolving credit facility due August 2024            
Debt Instrument [Line Items]            
Interest rate     1.35%      
Outstanding borrowings     $ 0      
Available borrowings     $ 585,800,000      
Secured Debt | 2017 Credit Agreement - Revolving Credit Facility | Revolving credit facility due August 2024 | Minimum            
Debt Instrument [Line Items]            
Quarterly commitment fee on average daily unused balance   0.25%        
Secured Debt | 2017 Credit Agreement - Revolving Credit Facility | Revolving credit facility due August 2024 | Maximum            
Debt Instrument [Line Items]            
Quarterly commitment fee on average daily unused balance   0.375%        
Secured Debt | 2017 Credit Agreement - Revolving Credit Facility | Revolving credit facility due August 2024 | Base Rate | Minimum            
Debt Instrument [Line Items]            
Applicable margin on variable rate (percent)     0.25%      
Secured Debt | 2017 Credit Agreement - Revolving Credit Facility | Revolving credit facility due August 2024 | Base Rate | Maximum            
Debt Instrument [Line Items]            
Applicable margin on variable rate (percent)     0.50%      
Secured Debt | 2017 Credit Agreement - Revolving Credit Facility | Letter of credit            
Debt Instrument [Line Items]            
Maximum borrowing capacity under accounts receivable financing agreement       150,000,000.0    
Outstanding borrowings       $ 14,200,000    
Secured Debt | 2017 Credit Agreement - Amendment No 2 - Term Loan B Due August 2024 | Term Loan            
Debt Instrument [Line Items]            
Maximum first lien leverage ratio 0.025          
Secured Debt | 2017 Credit Agreement - Amendment No 2 - Term Loan B Due August 2024 | Term Loan | Minimum            
Debt Instrument [Line Items]            
Derivative, Basis Spread on Variable Rate 1.25%          
Secured Debt | 2017 Credit Agreement - Amendment No 2 - Term Loan B Due August 2024 | Term Loan | Maximum            
Debt Instrument [Line Items]            
Derivative, Basis Spread on Variable Rate 1.50%          
3.625% Senior Notes | Senior Unsecured Notes Due2029            
Debt Instrument [Line Items]            
Term loan facility           $ 600,000,000.0
Debt instrument, interest rate     3.625%      
XML 86 R65.htm IDEA: XBRL DOCUMENT v3.22.0.1
Long-Term Debt Obligations - Schedule of Variable Rate Margins (Details) - Secured Debt
 12 Months Ended
Dec. 31, 2021
Minimum | Term Loan A | Base Rate | Term Loan  
Debt Instrument [Line Items]  
Applicable margin on variable rate (percent) 0.25%
Minimum | Term Loan A | Eurocurrency Rate | Term Loan  
Debt Instrument [Line Items]  
Applicable margin on variable rate (percent) 1.25%
Minimum | Term Loan B | Base Rate | Term Loan  
Debt Instrument [Line Items]  
Applicable margin on variable rate (percent) 0.75%
Minimum | Term Loan B | Eurocurrency Rate | Term Loan  
Debt Instrument [Line Items]  
Applicable margin on variable rate (percent) 1.75%
Minimum | 2017 Credit Agreement - Revolving Credit Facility | Base Rate | Revolving credit facility due August 2024  
Debt Instrument [Line Items]  
Applicable margin on variable rate (percent) 0.25%
Minimum | 2017 Credit Agreement - Revolving Credit Facility | Eurocurrency Rate | Revolving credit facility due August 2024  
Debt Instrument [Line Items]  
Applicable margin on variable rate (percent) 1.25%
Maximum | Term Loan A | Base Rate | Term Loan  
Debt Instrument [Line Items]  
Applicable margin on variable rate (percent) 0.50%
Maximum | Term Loan A | Eurocurrency Rate | Term Loan  
Debt Instrument [Line Items]  
Applicable margin on variable rate (percent) 1.50%
Maximum | Term Loan B | Base Rate | Term Loan  
Debt Instrument [Line Items]  
Applicable margin on variable rate (percent) 1.00%
Maximum | Term Loan B | Eurocurrency Rate | Term Loan  
Debt Instrument [Line Items]  
Applicable margin on variable rate (percent) 2.00%
Maximum | 2017 Credit Agreement - Revolving Credit Facility | Base Rate | Revolving credit facility due August 2024  
Debt Instrument [Line Items]  
Applicable margin on variable rate (percent) 0.50%
Maximum | 2017 Credit Agreement - Revolving Credit Facility | Eurocurrency Rate | Revolving credit facility due August 2024  
Debt Instrument [Line Items]  
Applicable margin on variable rate (percent) 1.50%
XML 87 R66.htm IDEA: XBRL DOCUMENT v3.22.0.1
Long-Term Debt Obligations - Accounts Receivable Financing Agreement (Details) - USD ($)
$ in Thousands
 12 Months Ended
Oct. 13, 2021
Jan. 28, 2021
Dec. 31, 2021
Jan. 27, 2021
Sep. 25, 2020
Sep. 24, 2020
Debt Instrument [Line Items]            
Line of credit facility, decrease, forgiveness $ 35,000 $ 65,000        
Long-term debt     $ 2,775,721      
Voluntary prepayments on term loans     $ 35,000      
Accounts Receivable Securitization | Secured Debt | Accounts receivable financing agreement due September 2021            
Debt Instrument [Line Items]            
Weighted average imputed interest rate     1.05%      
Subsidiaries | Accounts Receivable Securitization | Secured Debt | Accounts receivable financing agreement due October 2022            
Debt Instrument [Line Items]            
Maximum borrowing capacity under accounts receivable financing agreement   $ 365,000 $ 400,000 $ 300,000 $ 400,000 $ 365,000
Subsidiaries | Accounts Receivable Securitization | Secured Debt | Accounts receivable financing agreement due October 2022 | Federal Funds Rate            
Debt Instrument [Line Items]            
Applicable margin on variable rate (percent)     0.50%      
XML 88 R67.htm IDEA: XBRL DOCUMENT v3.22.0.1
Long-Term Debt Obligations - Contractual Maturities of Debt Obligations (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Debt Instrument [Line Items]    
2023 $ 21,732  
2024 2,164,260  
2027 and thereafter 600,000  
Less: Term loans original issuance discount (2,228) $ (3,500)
Less: Unamortized deferred issuance costs (8,043) $ (12,716)
Total 2,775,721  
Senior Unsecured Notes Due2029    
Debt Instrument [Line Items]    
Less: Term loans original issuance discount $ (2,228)  
XML 89 R68.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases - Narrative (Details)
 12 Months Ended
Dec. 31, 2021
Minimum  
Lessee Lease Description [Line Items]  
Lease, remaining lease term 1 year
Maximum  
Lessee Lease Description [Line Items]  
Lease, remaining lease term 11 years
XML 90 R69.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases - Components of Lease Cost (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Leases [Abstract]    
Fixed lease costs $ 55,168 $ 53,531
Short-term lease costs 1,994 2,930
Variable lease costs 36,760 29,572
Total operating lease costs 93,922 86,033
Amortization of right-of-use assets 17,453 15,843
Interest on lease liabilities 605 944
Variable lease costs 6,231 6,321
Total finance lease costs $ 24,289 $ 23,108
XML 91 R70.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases - Supplemental Balance Sheet Information Related to Leases (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Leases [Abstract]    
Property and equipment, gross $ 77,674 $ 63,985
Accumulated depreciation (30,021) (20,479)
Property and equipment, net 47,653 43,506
Current portion of finance lease obligations 20,627 17,455
Finance lease long-term obligations 34,181 31,522
Total finance lease liabilities $ 54,808 $ 48,977
XML 92 R71.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases - Supplemental Cash Flow Information Related to Leases (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Leases [Abstract]      
Operating cash flows for operating leases $ (59,863) $ (60,361)  
Operating cash flows for finance leases (605) (944)  
Payments of finance leases (15,774) (16,434) $ (14,493)
Right-of-use asset obtained in exchange for lease liability, Operating leases 43,385 47,415  
Right-of-use asset obtained in exchange for lease liability, Finance leases 28,994 20,203  
Lease obligations closed out in exchange for right-of-use asset, Operating leases $ (10,122) $ (2,834)  
XML 93 R72.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases - Supplemental Cash Flow Information, Weighted Average (Details)
Dec. 31, 2021
Dec. 31, 2020
Leases [Abstract]    
Weighted average remaining lease term, Operating lease 6 years 7 years
Weighted average remaining lease term, Finance lease 3 years 3 years
Weighted average discount rate, Operating leases 4.70% 4.80%
Weighted average discount rate, Finance leases 1.10% 1.30%
XML 94 R73.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases - Maturities of Lease Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Operating Leases    
2022 $ 53,612  
2023 53,033  
2024 44,428  
2025 38,036  
2026 29,128  
2027 and thereafter 73,262  
Total lease payments 291,499  
Less: Imputed interest (42,643)  
Total lease liabilities 248,856  
Finance Leases    
2022 21,443  
2023 17,768  
2024 11,624  
2025 5,688  
2026 130  
Total lease payments 56,653  
Less: Management fee (762)  
Less: Imputed interest (1,083)  
Total lease liabilities 54,808 $ 48,977
2022 75,055  
2023 70,801  
2024 56,052  
2025 43,724  
2026 29,258  
2027 and thereafter 73,262  
Total lease payments $ 348,152  
XML 95 R74.htm IDEA: XBRL DOCUMENT v3.22.0.1
Derivatives - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Jun. 30, 2021
Mar. 31, 2020
Dec. 31, 2018
Derivative [Line Items]            
Foreign currency forward gain loss realized $ (2,190) $ (3,175) $ (11,853)      
Interest Rate Swap, expiring June 30, 2021            
Derivative [Line Items]            
Notional amount           $ 1,010,000
Interest Rate Swap, expiring March 31, 2023            
Derivative [Line Items]            
Notional amount 1,160,000     $ 1,420,000 $ 549,200  
Foreign Exchange Forward            
Derivative [Line Items]            
Notional amount 70,000          
Foreign currency forward gain loss realized $ 700 $ 1,500        
XML 96 R75.htm IDEA: XBRL DOCUMENT v3.22.0.1
Derivatives - Interest Rate Swaps Designated as Hedging Instruments on Consolidated Balance Sheets (Details) - Cash Flow Hedging - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Derivatives, Fair Value [Line Items]    
Derivative assets $ 948  
Derivative liability 1,827 $ 22,617
Intrest rate swaps | Other Noncurrent Assets    
Derivatives, Fair Value [Line Items]    
Derivative assets - non-current 948  
Intrest rate swaps | Accrued expenses    
Derivatives, Fair Value [Line Items]    
Derivative liability - current $ 1,827 17,045
Intrest rate swaps | Other Noncurrent Liabilities    
Derivatives, Fair Value [Line Items]    
Derivative assets - non-current   $ 5,572
XML 97 R76.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Liabilities:    
Contingent obligations related to acquisitions $ 3,400  
Recurring    
Assets:    
Trading securities 24,775 $ 22,950
Total assets 36,899 31,615
Derivative liability - current 948  
Liabilities:    
Derivative instruments 1,827 22,617
Contingent obligations related to acquisitions 17,997 6,793
Total liabilities 19,824 29,410
Recurring | Partnership Interest    
Assets:    
Partnership interest 11,176 8,665
Recurring | Level 1    
Assets:    
Trading securities 24,775 22,950
Total assets 24,775 22,950
Recurring | Level 2    
Assets:    
Total assets 948  
Derivative liability - current 948  
Liabilities:    
Derivative instruments 1,827 22,617
Total liabilities 1,827 22,617
Recurring | Level 3    
Liabilities:    
Contingent obligations related to acquisitions 17,997 6,793
Total liabilities 17,997 6,793
Recurring | Investments Measured at Net Asset Value    
Assets:    
Total assets 11,176 8,665
Recurring | Investments Measured at Net Asset Value | Partnership Interest    
Assets:    
Partnership interest $ 11,176 $ 8,665
XML 98 R77.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Parenthetical) (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2021
USD ($)
EquityFund
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Commitment to invest a limited partner in private equity funds $ 21.5
Remaining unfunded commitment $ 12.8
Number of private equity funds | EquityFund 2
Healthcare and Life Sciences Industry  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Minority interest ownership percentage 3.00%
XML 99 R78.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value Measurements - Reconciliation of Changes in the Carrying Amount of Contingent Consideration (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Fair Value Disclosures [Abstract]    
Balance at Beginning of period $ 6,793 $ 37,324
Additions 19,158  
Changes in fair value recognized in earnings (757) (3,897)
Payments (7,197) (26,634)
Balance at End of period $ 17,997 $ 6,793
XML 100 R79.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value Measurements - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Fair value assets transferred from level 1 to level 2 $ 0 $ 0
Fair value assets transferred from level 2 to level 1 0 0
Fair value liabilities transferred from level 1 to level 2 0 0
Fair value liabilities transferred from level 2 to level 1 0 0
Fair value assets transferred into level 3 0 0
Fair value assets transferred out of level 3 0 0
Fair value liabilities transferred into level 3 0 0
Fair value liabilities transferred out of level 3 0 0
Nonrecurring    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Goodwill and identifiable intangible assets $ 5,830,000 $ 5,710,000
XML 101 R80.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value Measurements - Schedule of Estimated Fair Value (Details) - Level 2 - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Secured Debt | Term Loan A - Tranche One Due March 2024 | Reported Value Measurement    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Long-term debt, carrying value $ 149,008 $ 183,320
Secured Debt | Term Loan A - Tranche One Due March 2024 | Estimate of Fair Value Measurement    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Long-term debt, fair value 148,945 183,026
Secured Debt | Term Loan A - Tranche Two Due August 2024 | Reported Value Measurement    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Long-term debt, carrying value 1,634,756 1,271,255
Secured Debt | Term Loan A - Tranche Two Due August 2024 | Estimate of Fair Value Measurement    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Long-term debt, fair value 1,635,138 1,269,213
Secured Debt | 2017 Credit Agreement - Amendment No 2 - Term Loan B Due August 2024 | Reported Value Measurement    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Long-term debt, carrying value   560,194
Secured Debt | 2017 Credit Agreement - Amendment No 2 - Term Loan B Due August 2024 | Estimate of Fair Value Measurement    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Long-term debt, fair value   560,144
Unsecured Debt | Senior Notes Due January 2029 | Reported Value Measurement    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Long-term debt, carrying value 600,000 600,000
Unsecured Debt | Senior Notes Due January 2029 | Estimate of Fair Value Measurement    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Long-term debt, fair value $ 595,500 $ 602,412
XML 102 R81.htm IDEA: XBRL DOCUMENT v3.22.0.1
Restructuring and Other Costs - Schedule of Restructuring and other costs (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Restructuring Cost And Reserve [Line Items]      
Total non-Merger related restructuring and other costs: $ 22,816 $ 29,414 $ 42,135
Employee severance and benefit costs      
Restructuring Cost And Reserve [Line Items]      
Total non-Merger related restructuring and other costs: 14,526 26,321 25,243
Facility and lease termination costs      
Restructuring Cost And Reserve [Line Items]      
Total non-Merger related restructuring and other costs: 8,226 2,313 16,202
Other costs      
Restructuring Cost And Reserve [Line Items]      
Total non-Merger related restructuring and other costs: $ 64 $ 780 $ 690
XML 103 R82.htm IDEA: XBRL DOCUMENT v3.22.0.1
Restructuring and Other Costs - Liabilities Associated with Restructuring and Other Costs (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Restructuring Cost And Reserve [Line Items]    
Balance at the beginning of the period $ 7,615 $ 5,381
Balance at the end of the period 7,585 7,615
Business exit costs and (gain) loss on termination of lease 8,200 2,300
Other Costs    
Restructuring Cost And Reserve [Line Items]    
Other restructuring expenses, non-cash 0 0
Business Restructuring Reserves    
Restructuring Cost And Reserve [Line Items]    
Balance at the beginning of the period 5,830 5,750
Expenses incurred (a) [1] 14,591 27,112
Cash payments made (13,764) (27,032)
Balance at the end of the period 6,657 5,830
Business Restructuring Reserves | Employee Severance Costs    
Restructuring Cost And Reserve [Line Items]    
Balance at the beginning of the period 5,830 5,728
Expenses incurred (a) [1] 14,574 26,321
Cash payments made (13,747) (26,219)
Balance at the end of the period 6,657 5,830
Business Restructuring Reserves | Other Costs    
Restructuring Cost And Reserve [Line Items]    
Balance at the beginning of the period   22
Expenses incurred (a) [1] 17 791
Cash payments made $ (17) $ (813)
[1] There were no non-cash restructuring and other expenses incurred for the years ended December 31, 2021 and 2020. The amount of expenses incurred for the years ended December 31, 2021 and 2020 excludes $8.2 million and $2.3 million, respectively, of facility lease closure and lease termination costs that are reflected as a reduction of operating lease right-of-use assets on the accompanying consolidated balance sheets under ASC 842.
XML 104 R83.htm IDEA: XBRL DOCUMENT v3.22.0.1
Shareholders' Equity - Shares of Common Stock Outstanding (Details) - Common Stock - shares
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Common stock shares, beginning balance 103,935 103,866 103,372
Repurchases of common stock (1,500) (1,256) (1,323)
Issuances of common stock 1,329 1,325 1,817
Common stock shares, ending balance 103,764 103,935 103,866
XML 105 R84.htm IDEA: XBRL DOCUMENT v3.22.0.1
Shareholders' Equity - Narrative (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Jun. 30, 2021
shares
May 31, 2021
shares
Mar. 31, 2021
shares
Oct. 31, 2020
shares
Sep. 30, 2020
shares
Mar. 31, 2020
shares
Aug. 31, 2019
shares
Jun. 30, 2019
shares
Feb. 28, 2019
shares
Jan. 31, 2019
shares
Apr. 30, 2018
shares
Mar. 31, 2018
shares
Dec. 31, 2021
USD ($)
NumberOfVote
$ / shares
shares
Dec. 31, 2020
USD ($)
$ / shares
Dec. 31, 2019
USD ($)
Dec. 05, 2019
USD ($)
Feb. 26, 2018
USD ($)
Class of Stock [Line Items]                                  
Stock repurchase program, authorized amount                               $ 300,000 $ 250,000
Common stock par value (USD per share) | $ / shares                         $ 0.01 $ 0.01      
Class C common stock dividends                         $ 0 $ 0 $ 0    
Common Class A [Member]                                  
Class of Stock [Line Items]                                  
Stock Repurchase Program 2021, Authorized Amount                         $ 300,000        
Common stock par value (USD per share) | $ / shares                         $ 0.01        
Stock repurchased during period, shares | shares                         1,500,000        
Stock repurchased during period, value                         $ 117,500        
Number of votes | NumberOfVote                         1        
Class B common stock, conversion ratio                         1        
Common Stock                                  
Class of Stock [Line Items]                                  
Stock repurchase program, authorized amount                         $ 182,500        
Stock repurchased during period, shares | shares 500,000 400,000 600,000 150,000 506,244 600,000 141,100 509,100 120,600 552,100 1,024,400 948,100 6,051,644        
Common Class B [Member]                                  
Class of Stock [Line Items]                                  
Number of votes | NumberOfVote                         1        
XML 106 R85.htm IDEA: XBRL DOCUMENT v3.22.0.1
Shareholders' Equity - Repurchase Activity (Details) - Common Stock - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Jun. 30, 2021
May 31, 2021
Mar. 31, 2021
Oct. 31, 2020
Sep. 30, 2020
Mar. 31, 2020
Aug. 31, 2019
Jun. 30, 2019
Feb. 28, 2019
Jan. 31, 2019
Apr. 30, 2018
Mar. 31, 2018
Dec. 31, 2021
Class of Stock [Line Items]                          
Stock repurchased (in shares) 500,000 400,000 600,000 150,000 506,244 600,000 141,100 509,100 120,600 552,100 1,024,400 948,100 6,051,644
Stock repurchased, average price paid per share (USD per share) $ 81.20 $ 81.04 $ 74.18 $ 54.14 $ 59.26 $ 53.38 $ 49.93 $ 45.29 $ 41.40 $ 39.16 $ 36.60 $ 39.55  
Stock repurchase program, shares purchased, value $ 40,600 $ 32,416 $ 44,505 $ 8,122 $ 30,000 $ 32,029 $ 7,045 $ 23,055 $ 4,993 $ 21,623 $ 37,492 $ 37,493 $ 319,373
XML 107 R86.htm IDEA: XBRL DOCUMENT v3.22.0.1
Shareholders' Equity - Schedule of Stock by Class (Details) - shares
Dec. 31, 2021
Dec. 31, 2020
Shares Authorized:    
Common stock shares authorized (in shares) 600,000,000 600,000,000
Preferred stock shares authorized (in shares) 30,000,000 30,000,000
Common and Preferred stock, shares authorized (in shares) 630,000,000 630,000,000
Shares Issued:    
Common stock shares issued (in shares) 103,764,000 103,935,000
Preferred stock shares issued (in shares) 0 0
Shares Outstanding:    
Common stock shares outstanding (in shares) 103,763,635 103,934,738
Preferred stock shares outstanding (in shares) 0 0
Common Class A [Member]    
Shares Authorized:    
Common stock shares authorized (in shares) 300,000,000 300,000,000
Shares Issued:    
Common stock shares issued (in shares) 103,763,635 103,934,738
Common Class B [Member]    
Shares Authorized:    
Common stock shares authorized (in shares) 300,000,000 300,000,000
XML 108 R87.htm IDEA: XBRL DOCUMENT v3.22.0.1
Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Numerator:      
Net income $ 234,831 $ 192,787 $ 131,258
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]      
Basic weighted average common shares outstanding (in shares) 103,872 104,168 103,618
Effect of dilutive securities:      
Stock options and other awards under deferred share-based compensation programs (in shares) 1,193 1,297 1,387
Diluted weighted average common shares outstanding (in shares) 105,065 105,465 105,005
Earnings per share:      
Basic (USD per share) $ 2.26 $ 1.85 $ 1.27
Diluted (USD per share) $ 2.24 $ 1.83 $ 1.25
XML 109 R88.htm IDEA: XBRL DOCUMENT v3.22.0.1
Earnings Per Share - Narrative (Details) - shares
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Earnings Per Share [Abstract]      
Anti-dillutive shares outstanding excluded from the computation of diluted earnings per share 145,342 582,760 277,128
XML 110 R89.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes - Components of Income before Provision for Income Taxes (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Tax Disclosure [Abstract]      
Domestic $ 186,445 $ 122,659 $ (17,066)
Foreign 128,715 80,999 118,775
Income before provision for income taxes $ 315,160 $ 203,658 $ 101,709
XML 111 R90.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Federal income taxes:      
Current $ 926 $ (15,537) $ (13,952)
Deferred 45,819 10,188 (11,693)
Foreign income taxes:      
Current 27,718 16,019 21,452
Deferred (4,309) (3,106) (2,206)
State income taxes:      
Current 5,163 14,229 2,850
Deferred 5,012 (10,922) (26,000)
Income tax expense (benefit) $ 80,329 $ 10,871 $ (29,549)
XML 112 R91.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Condensed Balance Sheet Statements Captions [Line Items]        
Accumulated foreign earnings $ 689,700      
Foreign earnings previously taxed in the US, intended to be permanently reinvested 278,400      
Foreign earnings previously taxed in the US, intended to be repatriated 411,300      
Undistributed foreign earnings $ 7,778 $ 10,912    
Federal tax rate 21.00%      
Valuation allowance increase (decrease) $ 2,300 16,200    
(Credited) charged to income tax expense 1,500 14,500    
Foreign currency exchange   1,400    
Gross unrecognized tax benefits 12,118 9,033 $ 23,238 $ 19,245
Accrued income tax interest and penalties 2,400 2,800    
Decrease in unrecognized tax benefits 1,600      
Research and Development Credit Carry Forwards | Canada Revenue Agency        
Condensed Balance Sheet Statements Captions [Line Items]        
Canadian research and development credit carry forwards 56,100 56,700    
Valuation allowance, Canadian research and development credit carry forwards 56,100 56,700    
Domestic Tax Authority        
Condensed Balance Sheet Statements Captions [Line Items]        
Operating loss carryforwards $ 317,400 $ 260,600    
Operating loss carryforwards, expiration year 2029 2029    
State and Local Jurisdiction        
Condensed Balance Sheet Statements Captions [Line Items]        
Operating loss carryforwards $ 840,400 $ 821,000    
Foreign Jurisdictions        
Condensed Balance Sheet Statements Captions [Line Items]        
Operating loss carryforwards 98,900 $ 80,100    
Decrease in unrecognized tax benefit in foreign jurisdictions $ 3,100      
XML 113 R92.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Tax Disclosure [Abstract]      
Expected income tax expense at statutory rate $ 66,184 $ 42,768 $ 21,359
Change in income tax expense resulting from:      
Foreign income inclusion 11,019 6,013 39,557
Foreign earnings not indefinitely reinvested 278 5,071  
Foreign tax credits (4,390)    
Changes in income tax valuation allowance (all jurisdictions) (1,462) 14,503 (68,537)
Change in fair value of contingent obligations (122) (769) 3,625
Share-based compensation (5,662) (2,800) 1,094
Research and general business tax credits [1] (8,902) (12,872) (1,871)
State and local taxes, net of federal benefit 11,978 6,924 (9,085)
Capital loss carryforward [2] (214) (16,506)  
Foreign rate differential 2,865 (1,777) (3,595)
Changes in reserve for uncertain tax positions including interest 4,721 (18,839) 5,393
Provision to tax return and other deferred tax adjustments (771) (12,325) (6,950)
Gain on sale of business   (2,350)  
Base erosion and anti-abuse tax     (15,054)
Nondeductible executive compensation 1,649 367 1,802
Other, net 3,158 3,463 2,713
Income tax expense (benefit) $ 80,329 $ 10,871 $ (29,549)
[1]

(a) Year ended December 31, 2021 included a $0.8 million valuation allowance release and year ended December 31, 2020 was offset by a $9.4 million valuation allowance.

[2] (b) Years ended December 31, 2021 and 2020 are offset by $0.2 million and $16.5 million, respectively, in valuation allowances.
XML 114 R93.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Parenthetical) (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Tax Credit Carryforward [Line Items]      
Changes in income tax valuation allowance (all jurisdictions) $ (1,462,000) $ 14,503,000 $ (68,537,000)
Research and general business tax credits      
Tax Credit Carryforward [Line Items]      
Changes in income tax valuation allowance (all jurisdictions) 800 9,400  
Capital loss carryforward      
Tax Credit Carryforward [Line Items]      
Changes in income tax valuation allowance (all jurisdictions) $ 200 $ 16,500  
XML 115 R94.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes - Summary of Valuation Allowance (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Valuation Allowance [Line Items]      
Balance at the beginning of the period $ 7,615 $ 5,381 $ 4,587
(Credited) charged to income tax expense 1,500 14,500  
Foreign currency exchange   1,400  
Balance at the end of the period 7,585 7,615 5,381
SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset      
Valuation Allowance [Line Items]      
Balance at the beginning of the period 100,310 84,159 150,316
Deferred tax assets assumed through acquisitions   479  
Deferred tax assets released through divestitures   (271)  
(Credited) charged to income tax expense (1,462) 14,503 (68,537)
Charged to equity     42
Foreign currency exchange (407) 1,440 2,338
Other adjustments (479)    
Balance at the end of the period $ 97,962 $ 100,310 $ 84,159
XML 116 R95.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Deferred tax assets:    
Net operating losses $ 134,143 $ 122,018
Tax credits 58,901 58,603
Deferred revenue   77,138
Employee compensation and other benefits 28,538 29,048
Allowance for doubtful accounts 1,787 1,739
Lease obligations 57,749 57,142
Accrued expenses 13,158 6,526
Prepaid royalty   3,451
Capital loss carryforward 20,021 20,157
Interest limitation carryforwards 30,847 20,219
Other 1,151 7,913
Total deferred tax assets 346,295 403,954
Less: valuation allowance (97,962) (100,310)
Net deferred tax assets 248,333 303,644
Deferred tax liabilities:    
Undistributed foreign earnings (7,778) (10,912)
Right of use asset (47,532) (49,316)
Depreciation and amortization (214,636) (226,170)
Deferred revenue (17,247)  
Other (3,814) (2,404)
Total deferred tax liabilities (291,007) (288,802)
Net deferred tax assets (liabilities) $ (42,674)  
Net deferred tax assets (liabilities)   $ 14,842
XML 117 R96.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes - Schedule of Unrecognized Tax Benefits (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Tax Disclosure [Abstract]      
Unrecognized tax benefits $ 9,033 $ 23,238 $ 19,245
Increases for tax positions in the current year 386 254 2,222
Increases for tax positions of prior years 4,233 3,237 2,255
Decreases for tax positions in prior year   (2,540) (440)
Settlements with tax authorities (1,131)    
Impact of foreign currency translation (169)   (44)
Impact of foreign currency translation   132  
Lapse of statute limitations (234) (15,288)  
Unrecognized tax benefits balance $ 12,118 $ 9,033 $ 23,238
XML 118 R97.htm IDEA: XBRL DOCUMENT v3.22.0.1
Revenue from Contracts with Customers - Narrative (Details)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 31, 2021
USD ($)
Dec. 31, 2021
USD ($)
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]    
Unsatisfied performance obligations under contracts with a contract term greater than one year $ 6,700.0 $ 6,700.0
Revenue recognized, included in contract liabilities balance at beginning of period   611.9
Increase (decrease) in revenue recognized, allocated to performance obligation partially satisfied in previous periods   120.9
Revenue from change in estimate $ 44.0 $ 23.5
Minimum    
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]    
Contract term   1 year
Maximum    
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]    
Contract term   5 years
XML 119 R98.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Information (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
USD ($)
Segment
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Segment Reporting Information [Line Items]      
Number of reportable segments | Segment 2    
Revenue $ 5,212,970 $ 4,415,777 $ 4,675,815
Direct costs (exclusive of depreciation and amortization) 3,994,484 3,398,142 3,645,905
Selling, general, and administrative expenses 570,765 472,726 507,556
Operating income (loss) 389,280 293,143 237,754
Share-based compensation expense 65,204 58,491 55,193
Restructuring and other costs 22,816 29,414 42,135
Direct costs      
Segment Reporting Information [Line Items]      
Share-based compensation expense 33,220 31,347 29,011
Selling, general, and administrative expenses      
Segment Reporting Information [Line Items]      
Share-based compensation expense 31,984 27,144 26,182
Operating Segments      
Segment Reporting Information [Line Items]      
Direct costs (exclusive of depreciation and amortization) 3,961,264 3,366,795 3,616,894
Selling, general, and administrative expenses 436,506 366,342 367,932
Operating income (loss) 815,200 682,640 690,989
Corporate      
Segment Reporting Information [Line Items]      
Selling, general, and administrative expenses 102,275 79,240 113,442
Restructuring and other costs 22,816 29,414 42,135
Depreciation and amortization 235,625 222,352 242,465
Corporate | Direct costs      
Segment Reporting Information [Line Items]      
Share-based compensation expense 33,220 31,347 29,011
Corporate | Selling, general, and administrative expenses      
Segment Reporting Information [Line Items]      
Share-based compensation expense 31,984 27,144 26,182
Clinical Solutions | Operating Segments      
Segment Reporting Information [Line Items]      
Revenue 4,009,057 3,339,451 3,450,223
Direct costs (exclusive of depreciation and amortization) 3,005,938 2,513,240 2,637,016
Selling, general, and administrative expenses 353,990 283,633 280,674
Operating income (loss) 649,129 542,578 532,533
Commercial Solutions | Operating Segments      
Segment Reporting Information [Line Items]      
Revenue 1,203,913 1,076,326 1,225,592
Direct costs (exclusive of depreciation and amortization) 955,326 853,555 979,878
Selling, general, and administrative expenses 82,516 82,709 87,258
Operating income (loss) $ 166,071 $ 140,062 $ 158,456
XML 120 R99.htm IDEA: XBRL DOCUMENT v3.22.0.1
Operations by Geographic Location - Total Revenue by Geographic Area (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Revenues by Geographic Location      
Revenue $ 5,212,970 $ 4,415,777 $ 4,675,815
North America      
Revenues by Geographic Location      
Revenue 3,144,475 2,791,590 3,079,608
Europe, Middle East, and Africa      
Revenues by Geographic Location      
Revenue 1,333,540 1,059,968 1,055,007
Asia-Pacific      
Revenues by Geographic Location      
Revenue 594,163 465,116 444,819
Latin America      
Revenues by Geographic Location      
Revenue 140,792 99,103 96,381
United States      
Revenues by Geographic Location      
Revenue $ 2,950,000 $ 2,640,000 $ 2,930,000
United States | Geographic Concentration Risk | Net Service Revenue      
Revenues by Geographic Location      
Concentration risk percentage 56.60% 59.90% 62.70%
XML 121 R100.htm IDEA: XBRL DOCUMENT v3.22.0.1
Operations by Geographic Location - Long-Lived Assets by Geographic Area (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Long-Lived Assets by Geographic Location    
Total property and equipment, net $ 222,657 $ 216,200
North America    
Long-Lived Assets by Geographic Location    
Total property and equipment, net 165,446 161,531
Europe, Middle East, and Africa    
Long-Lived Assets by Geographic Location    
Total property and equipment, net 37,004 38,745
Asia-Pacific    
Long-Lived Assets by Geographic Location    
Total property and equipment, net 13,615 11,167
Latin America    
Long-Lived Assets by Geographic Location    
Total property and equipment, net 6,592 4,757
United States    
Long-Lived Assets by Geographic Location    
Total property and equipment, net $ 160,000 $ 156,000
XML 122 R101.htm IDEA: XBRL DOCUMENT v3.22.0.1
Concentration of Credit Risk - Narrative (Details) - Customer Concentration Risk - Major Customer
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Net Service Revenue      
Concentration Risk      
Concentration risk percentage 10.00% 10.00% 10.00%
Accounts Receivable      
Concentration Risk      
Concentration risk percentage 10.00% 10.00%  
XML 123 R102.htm IDEA: XBRL DOCUMENT v3.22.0.1
Related-Party Transactions - Narrative (Details)
$ in Thousands
 12 Months Ended
Oct. 06, 2021
Dec. 31, 2021
USD ($)
Customer
Dec. 31, 2020
USD ($)
Customer
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Customer
Related Party Transaction [Line Items]          
Revenue from related parties   $ 3,700 $ 1,800 $ 400 $ 400
Number of counterparties | Customer   2 1   2
Professional services expenses from transaction with related party   $ 600      
Potential future cash consideration, in exchange of sale of company's contingent staffing business to related party   597 $ 3,664 (17,260)  
Contingent consideration     1,800    
Affiliated Entity          
Related Party Transaction [Line Items]          
Professional services expenses from transaction with related party       $ 1,100  
Maximum          
Related Party Transaction [Line Items]          
Potential future cash consideration, in exchange of sale of company's contingent staffing business to related party     4,000    
Rx Data Science Acquisitions          
Related Party Transaction [Line Items]          
Name of acquired entity RxDataScience        
Date of Acquisition Oct. 06, 2021        
Board of Directors          
Related Party Transaction [Line Items]          
Receivables from related party   $ 600 $ 1,300    
XML 124 R103.htm IDEA: XBRL DOCUMENT v3.22.0.1
Commitments and Contingencies - Narrative (Details)
$ in Thousands
Dec. 01, 2017
numberOfAction
Dec. 31, 2021
USD ($)
Mar. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Loss Contingencies [Line Items]        
Contingent obligations related to acquisitions   $ 3,400    
Recurring        
Loss Contingencies [Line Items]        
Contingent obligations related to acquisitions   17,997   $ 6,793
InVentiv Merger | Recurring        
Loss Contingencies [Line Items]        
Contingent obligations related to acquisitions     $ 6,200 $ 6,800
RxDataScience [Member]        
Loss Contingencies [Line Items]        
Contingent obligations related to acquisitions   $ 14,600    
Pending Litigation | Bermudez and Vaitkuviene Actions        
Loss Contingencies [Line Items]        
Number of actions taken by plaintiff | numberOfAction 2      
XML 125 R104.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation - Narrative (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Mar. 31, 2016
Dec. 31, 2021
USD ($)
Plan
shares
Dec. 31, 2020
USD ($)
$ / shares
shares
Dec. 31, 2019
USD ($)
$ / shares
shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Number of plans | Plan   2    
Number of shares authorized | shares   15,167,325    
Number of shares available for future grants | shares   3,446,778    
Share-based compensation expense | $   $ 65,204 $ 58,491 $ 55,193
Stock options granted | shares   0    
Total intrinsic value of options exercised | $   $ 14,700 12,700 20,300
Income tax benefit recognized for stock-based compensation arrangements | $   13,800 $ 11,800 $ 10,800
Stock options        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Unrecognized compensation expense related to non-vested stock options | $   0    
Restricted Stock Units (RSUs)        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Weighted-average grant-date fair value of the RSUs granted | $ / shares     $ 62.12 $ 45.45
Total fair value of shares vested | $   $ 48,300 $ 43,000 $ 30,300
Granted (in shares) | shares   939,031    
Performance Based Restricted Stock Units        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Weighted-average grant-date fair value of the RSUs granted | $ / shares     $ 62.50 $ 45.00
Fair value of shares vested | $   $ 6,400    
Granted (in shares) | shares   59,055 0 0
2014 Equity Incentive Plan        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Vesting period   3 years    
Employee Stock Purchase Plan (ESPP)        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Vesting period   6 months    
Payroll deductions as a percentage of employee base salary, maximum 10.00%      
Discount from market price of common stock, offering date 15.00%      
Share-based compensation expense | $   $ 6,200 $ 5,800 $ 6,500
Shares issued (in shares) | shares   1,594,312    
Shares available for future grants (in shares) | shares   1,905,688    
Maximum | 2014 Equity Incentive Plan | Stock options        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Expiration term   10 years    
XML 126 R105.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation - Stock Option Valuation Assumptions (Details) - ESPP
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Expected volatility - minimum 25.30% 27.70% 39.10%
Expected volatility - maximum 38.30% 55.10% 51.90%
Risk-free interest rate - minimum 0.06% 0.13% 1.88%
Risk-free interest rate - maximum 0.07% 0.95% 2.52%
Expected term (in years) 6 months 6 months 6 months
XML 127 R106.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation - Summary of Option Activity (Details)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2021
USD ($)
$ / shares
shares
Common Stock  
Aggregate Intrinsic Value (in thousands)(a)  
Share price (in USD per share) $ 102.68
Stock options  
Number of Options  
Outstanding as of December 31, 2020 (in shares) | shares 663,559
Exercised (in shares) | shares (279,072)
Outstanding as of December 31, 2021 (in shares) | shares 384,487
Vested and expected to vest as of December 31, 2021 (in shares) | shares 384,487
Exercisable as of December 31, 2021 (in shares) | shares 384,487
Weighted Average Exercise Price  
Outstanding as of December 31, 2020 (in usd per share) $ 30.12
Exercised (in usd per share) 33.31
Outstanding at December 31, 2020 (in usd per share) 27.81
Vested and expected to vest as of December 31, 2021 (in usd per share) 27.81
Exercisable as of December 31, 2021 (in usd per share) $ 27.81
Weighted Average Remaining Contractual Life (in years)  
Outstanding as of December 31, 2021 (in years) 3 years 3 months 3 days
Vested and expected to vest as of December 31, 2021 (in years) 3 years 3 months 3 days
Exercisable as of December 31, 2021 (in years) 3 years 3 months 3 days
Aggregate Intrinsic Value (in thousands)(a)  
Outstanding as of December 31, 2021 (in usd) | $ $ 28,787
Vested and expected to vest as of December 31, 2021 (in usd) | $ 28,787
Exercisable as of December 31, 2021 (in usd) | $ $ 28,787
XML 128 R107.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation - Summary of Restricted Stock Unit Activity (Details) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Restricted Stock Units (RSUs)      
Number of Shares      
Non-vested at December 31, 2020 (in shares) 1,909,882    
Granted (in shares) 939,031    
Vested (in shares) (997,632)    
Forfeited (in shares) (226,094)    
Non-vested at December 31, 2021 (in shares) 1,625,187 1,909,882  
Unrecognized compensation expense (in millions) $ 62.6    
Weighted average period unrecognized compensation is expected to be recognized 1 year 10 months 24 days    
Weighted Average Grant Date Fair Value      
Non-vested at December 31, 2020 (in usd per share) $ 51.98    
Granted (in usd per share) 76.96    
Vested (in usd per share) 48.45    
Forfeited (in usd per share) 64.07    
Non-vested at December 31, 2021 (in usd per share) $ 66.90 $ 51.98  
Performance Based Restricted Stock Units      
Number of Shares      
Non-vested at December 31, 2020 (in shares) 461,499    
Granted (in shares) 59,055 0 0
Vested (in shares) (136,665)    
Forfeited (in shares) (27,890)    
Non-vested at December 31, 2021 (in shares) 355,999 461,499  
Unrecognized compensation expense (in millions) $ 10.7    
Weighted average period unrecognized compensation is expected to be recognized 1 year 10 months 24 days    
Weighted Average Grant Date Fair Value      
Non-vested at December 31, 2020 (in usd per share) $ 48.99    
Granted (in usd per share) 75.43    
Vested (in usd per share) 46.47    
Forfeited (in usd per share) 58.71    
Non-vested at December 31, 2021 (in usd per share) $ 60.75 $ 48.99  
Restricted Stock Units (RSUs)      
Number of Shares      
Non-vested at December 31, 2020 (in shares) 2,371,381    
Granted (in shares) 998,086    
Vested (in shares) (1,134,297)    
Forfeited (in shares) (253,984)    
Non-vested at December 31, 2021 (in shares) 1,981,186 2,371,381  
XML 129 R108.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation - Summary of Share-Based Compensation Expense (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]      
Share-based compensation expense $ 65,204 $ 58,491 $ 55,193
Direct costs      
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]      
Share-based compensation expense 33,220 31,347 29,011
Selling, general, and administrative expenses      
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]      
Share-based compensation expense $ 31,984 $ 27,144 $ 26,182
XML 130 R109.htm IDEA: XBRL DOCUMENT v3.22.0.1
Employee Benefit Plans - Schedule of Contributions to Defined Contribution Plan (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Compensation And Retirement Disclosure [Abstract]      
Total defined contribution retirement plan contributions $ 30,932 $ 15,049 $ 29,834
XML 131 R110.htm IDEA: XBRL DOCUMENT v3.22.0.1
Employee Benefit Plans - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Deferred Compensation Arrangement [Line Items]      
Deferred compensation liabilities $ 23.4 $ 22.3  
Minimum      
Deferred Compensation Arrangement [Line Items]      
Allowable deferred amount, salary, percent 1.00%    
Allowable deferred amount, commissions, percent 1.00%    
Maximum      
Deferred Compensation Arrangement [Line Items]      
Allowable deferred amount, salary, percent 80.00%    
Allowable deferred amount, commissions, percent 100.00%    
Foreign Plan      
Deferred Compensation Arrangement [Line Items]      
Employer contribution amount $ 23.2 $ 18.4 $ 10.0
XML 132 synh-10k_20211231_htm.xml IDEA: XBRL DOCUMENT 0001610950 2021-01-01 2021-12-31 0001610950 2021-06-30 0001610950 2022-02-10 0001610950 2020-01-01 2020-12-31 0001610950 2019-01-01 2019-12-31 0001610950 2021-12-31 0001610950 2020-12-31 0001610950 2019-12-31 0001610950 2018-12-31 0001610950 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201613Member 2019-12-31 0001610950 us-gaap:CommonStockMember 2020-12-31 0001610950 us-gaap:CommonStockMember 2019-12-31 0001610950 us-gaap:CommonStockMember 2018-12-31 0001610950 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001610950 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001610950 us-gaap:CommonStockMember 2019-01-01 2019-12-31 0001610950 us-gaap:CommonStockMember 2021-12-31 0001610950 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001610950 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001610950 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001610950 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001610950 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001610950 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0001610950 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001610950 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001610950 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001610950 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001610950 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001610950 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001610950 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0001610950 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001610950 us-gaap:RetainedEarningsMember 2020-12-31 0001610950 us-gaap:RetainedEarningsMember 2019-12-31 0001610950 us-gaap:RetainedEarningsMember 2018-12-31 0001610950 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201613Member us-gaap:RetainedEarningsMember 2019-12-31 0001610950 us-gaap:RetainedEarningsMember 2021-12-31 0001610950 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001610950 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001610950 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0001610950 synh:StudyKikAcquisitionMember 2021-01-01 2021-12-31 0001610950 synh:SynteractAcquisitionMember 2021-01-01 2021-12-31 0001610950 us-gaap:BuildingMember 2021-01-01 2021-12-31 0001610950 us-gaap:FurnitureAndFixturesMember 2021-01-01 2021-12-31 0001610950 srt:MinimumMember us-gaap:EquipmentMember 2021-01-01 2021-12-31 0001610950 srt:MaximumMember us-gaap:EquipmentMember 2021-01-01 2021-12-31 0001610950 srt:MinimumMember synh:ComputerEquipmentandSoftwareMember 2021-01-01 2021-12-31 0001610950 srt:MaximumMember synh:ComputerEquipmentandSoftwareMember 2021-01-01 2021-12-31 0001610950 synh:ComputerEquipmentandSoftwareMember 2021-01-01 2021-12-31 0001610950 2018-10-01 2021-12-31 0001610950 srt:WeightedAverageMember us-gaap:CustomerRelationshipsMember 2021-01-01 2021-12-31 0001610950 srt:WeightedAverageMember us-gaap:CustomerRelationshipsMember 2020-01-01 2020-12-31 0001610950 srt:WeightedAverageMember us-gaap:OrderOrProductionBacklogMember 2021-01-01 2021-12-31 0001610950 srt:WeightedAverageMember us-gaap:OrderOrProductionBacklogMember 2020-01-01 2020-12-31 0001610950 srt:WeightedAverageMember us-gaap:TrademarksAndTradeNamesMember 2021-01-01 2021-12-31 0001610950 srt:WeightedAverageMember us-gaap:TrademarksAndTradeNamesMember 2020-01-01 2020-12-31 0001610950 srt:WeightedAverageMember us-gaap:IntellectualPropertyMember 2020-01-01 2020-12-31 0001610950 srt:WeightedAverageMember synh:PatientCommunitiesMember 2021-01-01 2021-12-31 0001610950 srt:WeightedAverageMember synh:AcquiredTechnologyMember 2021-01-01 2021-12-31 0001610950 synh:InventivMember 2021-01-01 2021-12-31 0001610950 synh:InventivMember 2020-01-01 2020-12-31 0001610950 srt:MinimumMember 2021-01-01 2021-12-31 0001610950 srt:MaximumMember 2021-01-01 2021-12-31 0001610950 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-01-01 2020-01-01 0001610950 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2021-12-31 0001610950 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2021-12-31 0001610950 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2020-12-31 0001610950 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001610950 us-gaap:LeaseholdImprovementsMember 2020-12-31 0001610950 us-gaap:ComputerEquipmentMember 2021-12-31 0001610950 us-gaap:ComputerEquipmentMember 2020-12-31 0001610950 us-gaap:VehiclesMember 2021-12-31 0001610950 us-gaap:VehiclesMember 2020-12-31 0001610950 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001610950 us-gaap:FurnitureAndFixturesMember 2020-12-31 0001610950 us-gaap:BuildingAndBuildingImprovementsMember 2021-12-31 0001610950 us-gaap:BuildingAndBuildingImprovementsMember 2020-12-31 0001610950 synh:AssetsNotYetPlacedInServiceMember 2021-12-31 0001610950 synh:AssetsNotYetPlacedInServiceMember 2020-12-31 0001610950 synh:ClinicalSolutionsSegmentMember 2019-12-31 0001610950 synh:CommercialSolutionsSegmentMember 2019-12-31 0001610950 synh:ClinicalSolutionsSegmentMember 2020-01-01 2020-12-31 0001610950 synh:CommercialSolutionsSegmentMember 2020-01-01 2020-12-31 0001610950 synh:ClinicalSolutionsSegmentMember 2020-12-31 0001610950 synh:CommercialSolutionsSegmentMember 2020-12-31 0001610950 synh:ClinicalSolutionsSegmentMember 2021-01-01 2021-12-31 0001610950 synh:CommercialSolutionsSegmentMember 2021-01-01 2021-12-31 0001610950 synh:ClinicalSolutionsSegmentMember 2021-12-31 0001610950 synh:CommercialSolutionsSegmentMember 2021-12-31 0001610950 synh:ClinicalSolutionsSegmentMember 2019-01-01 2019-12-31 0001610950 synh:CommercialSolutionsSegmentMember 2019-01-01 2019-12-31 0001610950 us-gaap:CustomerRelationshipsMember 2021-12-31 0001610950 us-gaap:OrderOrProductionBacklogMember 2021-12-31 0001610950 us-gaap:TrademarksAndTradeNamesMember 2021-12-31 0001610950 us-gaap:PatentsMember 2021-12-31 0001610950 synh:AcquiredTechnologyMember 2021-12-31 0001610950 us-gaap:CustomerRelationshipsMember 2020-12-31 0001610950 us-gaap:OrderOrProductionBacklogMember 2020-12-31 0001610950 us-gaap:TrademarksAndTradeNamesMember 2020-12-31 0001610950 us-gaap:IntellectualPropertyMember 2020-12-31 0001610950 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-12-31 0001610950 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-31 0001610950 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-01 2021-12-31 0001610950 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-12-31 0001610950 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-12-31 0001610950 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0001610950 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0001610950 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-12-31 0001610950 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-12-31 0001610950 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0001610950 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-01-01 2019-12-31 0001610950 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-12-31 0001610950 synh:StudyKikAcquisitionMember 2021-09-12 2021-09-13 0001610950 synh:StudyKikAcquisitionMember 2021-09-13 0001610950 synh:StudyKikAcquisitionMember us-gaap:CustomerRelationshipsMember 2021-09-12 2021-09-13 0001610950 synh:StudyKikAcquisitionMember synh:AcquiredBacklogMember 2021-09-12 2021-09-13 0001610950 synh:StudyKikAcquisitionMember us-gaap:TradeNamesMember 2021-09-12 2021-09-13 0001610950 synh:StudyKikAcquisitionMember synh:PatientCommunitiesMember 2021-09-12 2021-09-13 0001610950 synh:StudyKikAcquisitionMember synh:AcquiredTechnologyMember 2021-09-12 2021-09-13 0001610950 synh:RxDataScienceAcquisitionsMember 2021-10-05 2021-10-06 0001610950 synh:RxDataScienceAcquisitionsMember 2021-10-06 0001610950 synh:SynteractAcquisitionMember 2020-12-08 2020-12-09 0001610950 synh:SynteractAcquisitionMember 2020-12-09 0001610950 synh:SynteractAcquisitionMember 2021-01-01 2021-03-31 0001610950 synh:SynteractAcquisitionMember us-gaap:OrderOrProductionBacklogMember 2020-12-08 2020-12-09 0001610950 synh:SynteractAcquisitionMember us-gaap:TradeNamesMember 2020-12-08 2020-12-09 0001610950 srt:MaximumMember synh:SynteractAcquisitionMember us-gaap:OrderOrProductionBacklogMember 2020-12-08 2020-12-09 0001610950 srt:MaximumMember synh:SynteractAcquisitionMember us-gaap:TradeNamesMember 2020-12-08 2020-12-09 0001610950 synh:IllingworthResearchMember 2020-12-17 2020-12-17 0001610950 synh:IllingworthResearchMember 2021-01-01 2021-03-31 0001610950 synh:IllingworthResearchMember 2020-12-17 0001610950 srt:MaximumMember synh:RelatedPartyMember 2020-04-01 2020-06-30 0001610950 synh:RelatedPartyMember 2020-06-30 0001610950 synh:ClinicalSolutionsSegmentMember 2020-10-01 2020-12-31 0001610950 2020-04-01 2020-06-30 0001610950 2021-07-01 2021-09-30 0001610950 synh:TermLoanATrancheOneDueMarch2024Member us-gaap:SecuredDebtMember 2021-12-31 0001610950 synh:TermLoanATrancheOneDueMarch2024Member us-gaap:SecuredDebtMember 2020-12-31 0001610950 synh:TermLoanATrancheTwoDueAugust2024Member us-gaap:SecuredDebtMember 2021-12-31 0001610950 synh:TermLoanATrancheTwoDueAugust2024Member us-gaap:SecuredDebtMember 2020-12-31 0001610950 synh:A2017CreditAgreementTermLoanBDueAugust2024Member us-gaap:SecuredDebtMember 2020-12-31 0001610950 synh:AccountsReceivableSecuritizationMember synh:AccountsReceivableFinancingAgreementDueOctober2022Member us-gaap:SecuredDebtMember 2021-12-31 0001610950 synh:AccountsReceivableSecuritizationMember synh:AccountsReceivableFinancingAgreementDueOctober2022Member us-gaap:SecuredDebtMember 2020-12-31 0001610950 us-gaap:SecuredDebtMember 2021-12-31 0001610950 us-gaap:SecuredDebtMember 2020-12-31 0001610950 synh:SeniorUnsecuredNotesDueJanuary2029Member us-gaap:UnsecuredDebtMember 2021-12-31 0001610950 synh:SeniorUnsecuredNotesDueJanuary2029Member us-gaap:UnsecuredDebtMember 2020-12-31 0001610950 us-gaap:UnsecuredDebtMember 2021-12-31 0001610950 us-gaap:UnsecuredDebtMember 2020-12-31 0001610950 synh:TermLoanMember synh:A2017CreditAgreementAmendmentNo2TermLoanADueMarch2024Member us-gaap:SecuredDebtMember 2021-12-31 0001610950 synh:TermLoanMember synh:A2017CreditAgreementTermLoanBDueAugust2024Member us-gaap:SecuredDebtMember 2021-12-31 0001610950 us-gaap:RevolvingCreditFacilityMember synh:A2017CreditAgreementAmendmentNo2RevolvingCreditFacilityDueAugust2024Member us-gaap:SecuredDebtMember 2021-12-31 0001610950 synh:IncrementalTermLoanMember synh:CreditAgreementAmendmentNo5TermLoanAMember us-gaap:SecuredDebtMember 2021-12-31 0001610950 synh:TermLoanMember synh:CreditAgreementAmendmentNo5TermLoanAMember us-gaap:SecuredDebtMember 2021-12-31 0001610950 synh:A2017CreditAgreementAmendmentNo2TermLoanADueMarch2024Member us-gaap:SecuredDebtMember 2021-01-01 2021-12-31 0001610950 synh:A2017CreditAgreementTermLoanBDueAugust2024Member us-gaap:SecuredDebtMember 2021-01-01 2021-12-31 0001610950 us-gaap:SecuredDebtMember 2021-01-01 2021-12-31 0001610950 synh:A2017CreditAgreementAmendmentNo2TermLoanADueMarch2024FundedAmountMember us-gaap:SecuredDebtMember 2021-01-01 2021-12-31 0001610950 synh:A2017CreditAgreementTermBLoanMember us-gaap:SecuredDebtMember us-gaap:FederalFundsEffectiveSwapRateMember 2017-08-01 2017-08-01 0001610950 synh:A2017CreditAgreementTermBLoanMember us-gaap:SecuredDebtMember us-gaap:EurodollarMember 2017-08-01 2017-08-01 0001610950 synh:A2017CreditAgreementTermBLoanMember us-gaap:SecuredDebtMember us-gaap:BaseRateMember 2017-08-01 2017-08-01 0001610950 srt:MinimumMember synh:TermLoanMember synh:A2017CreditAgreementAmendmentNo1TermLoanADueAugust2022Member us-gaap:SecuredDebtMember us-gaap:BaseRateMember 2021-01-01 2021-12-31 0001610950 srt:MaximumMember synh:TermLoanMember synh:A2017CreditAgreementAmendmentNo1TermLoanADueAugust2022Member us-gaap:SecuredDebtMember us-gaap:BaseRateMember 2021-01-01 2021-12-31 0001610950 srt:MinimumMember synh:TermLoanMember synh:A2017CreditAgreementAmendmentNo1TermLoanADueAugust2022Member us-gaap:SecuredDebtMember synh:EurocurrencyRateMember 2021-01-01 2021-12-31 0001610950 srt:MaximumMember synh:TermLoanMember synh:A2017CreditAgreementAmendmentNo1TermLoanADueAugust2022Member us-gaap:SecuredDebtMember synh:EurocurrencyRateMember 2021-01-01 2021-12-31 0001610950 srt:MinimumMember synh:TermLoanMember synh:AmendmentNo1TermBLoanMember us-gaap:SecuredDebtMember us-gaap:BaseRateMember 2021-01-01 2021-12-31 0001610950 srt:MaximumMember synh:TermLoanMember synh:AmendmentNo1TermBLoanMember us-gaap:SecuredDebtMember us-gaap:BaseRateMember 2021-01-01 2021-12-31 0001610950 srt:MinimumMember synh:TermLoanMember synh:AmendmentNo1TermBLoanMember us-gaap:SecuredDebtMember synh:EurocurrencyRateMember 2021-01-01 2021-12-31 0001610950 srt:MaximumMember synh:TermLoanMember synh:AmendmentNo1TermBLoanMember us-gaap:SecuredDebtMember synh:EurocurrencyRateMember 2021-01-01 2021-12-31 0001610950 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember synh:A2017CreditAgreementRevolvingCreditFacilityDueAugust2022Member us-gaap:SecuredDebtMember us-gaap:BaseRateMember 2021-01-01 2021-12-31 0001610950 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember synh:A2017CreditAgreementRevolvingCreditFacilityDueAugust2022Member us-gaap:SecuredDebtMember us-gaap:BaseRateMember 2021-01-01 2021-12-31 0001610950 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember synh:A2017CreditAgreementRevolvingCreditFacilityDueAugust2022Member us-gaap:SecuredDebtMember synh:EurocurrencyRateMember 2021-01-01 2021-12-31 0001610950 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember synh:A2017CreditAgreementRevolvingCreditFacilityDueAugust2022Member us-gaap:SecuredDebtMember synh:EurocurrencyRateMember 2021-01-01 2021-12-31 0001610950 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember synh:A2017CreditAgreementRevolvingCreditFacilityDueAugust2022Member us-gaap:SecuredDebtMember 2017-08-01 2017-08-01 0001610950 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember synh:A2017CreditAgreementRevolvingCreditFacilityDueAugust2022Member us-gaap:SecuredDebtMember 2017-08-01 2017-08-01 0001610950 us-gaap:RevolvingCreditFacilityMember synh:A2017CreditAgreementRevolvingCreditFacilityDueAugust2022Member us-gaap:SecuredDebtMember 2021-12-31 0001610950 synh:TermLoanMember synh:A2017CreditAgreementAmendmentNo2TermLoanBDueAugust2024Member us-gaap:SecuredDebtMember 2021-02-26 2021-02-28 0001610950 srt:MaximumMember synh:TermLoanMember synh:A2017CreditAgreementAmendmentNo2TermLoanBDueAugust2024Member us-gaap:SecuredDebtMember 2021-02-28 0001610950 srt:MinimumMember synh:TermLoanMember synh:A2017CreditAgreementAmendmentNo2TermLoanBDueAugust2024Member us-gaap:SecuredDebtMember 2021-02-28 0001610950 us-gaap:LetterOfCreditMember synh:A2017CreditAgreementRevolvingCreditFacilityDueAugust2022Member us-gaap:SecuredDebtMember 2020-12-31 0001610950 us-gaap:LetterOfCreditMember us-gaap:SecuredDebtMember 2021-12-31 0001610950 srt:SubsidiariesMember synh:AccountsReceivableSecuritizationMember synh:AccountsReceivableFinancingAgreementDueOctober2022Member us-gaap:SecuredDebtMember 2020-09-24 0001610950 srt:SubsidiariesMember synh:AccountsReceivableSecuritizationMember synh:AccountsReceivableFinancingAgreementDueOctober2022Member us-gaap:SecuredDebtMember 2021-01-27 0001610950 srt:SubsidiariesMember synh:AccountsReceivableSecuritizationMember synh:AccountsReceivableFinancingAgreementDueOctober2022Member us-gaap:SecuredDebtMember 2021-12-31 0001610950 srt:SubsidiariesMember synh:AccountsReceivableSecuritizationMember synh:AccountsReceivableFinancingAgreementDueOctober2022Member us-gaap:SecuredDebtMember 2020-09-25 0001610950 srt:SubsidiariesMember synh:AccountsReceivableSecuritizationMember synh:AccountsReceivableFinancingAgreementDueOctober2022Member us-gaap:SecuredDebtMember 2021-01-28 0001610950 2021-10-11 2021-10-13 0001610950 2021-01-27 2021-01-28 0001610950 srt:SubsidiariesMember synh:AccountsReceivableSecuritizationMember synh:AccountsReceivableFinancingAgreementDueOctober2022Member us-gaap:SecuredDebtMember synh:FederalFundsRateMember 2021-01-01 2021-12-31 0001610950 synh:AccountsReceivableSecuritizationMember synh:AccountsReceivableFinancingAgreementDueSeptember2021Member us-gaap:SecuredDebtMember 2021-12-31 0001610950 synh:SeniorUnsecuredNotesDue2029Member synh:ThreePointSixHundredTwentyFivePercentageSeniorNotesMember 2020-11-24 0001610950 synh:SeniorUnsecuredNotesDue2029Member synh:ThreePointSixHundredTwentyFivePercentageSeniorNotesMember 2021-01-01 2021-12-31 0001610950 synh:SeniorUnsecuredNotesDue2029Member 2021-01-01 2021-12-31 0001610950 synh:SeniorUnsecuredNotesDue2029Member 2021-12-31 0001610950 synh:InterestRateSwapExpiringJune302021Member 2018-12-31 0001610950 synh:InterestRateSwapExpiringMarch312023Member 2020-03-31 0001610950 synh:InterestRateSwapExpiringMarch312023Member 2021-06-30 0001610950 synh:InterestRateSwapExpiringMarch312023Member 2021-12-31 0001610950 us-gaap:ForeignExchangeForwardMember 2021-12-31 0001610950 us-gaap:ForeignExchangeForwardMember 2021-01-01 2021-12-31 0001610950 us-gaap:ForeignExchangeForwardMember 2020-01-01 2020-12-31 0001610950 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2021-12-31 0001610950 us-gaap:CashFlowHedgingMember 2021-12-31 0001610950 us-gaap:AccruedLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2021-12-31 0001610950 us-gaap:AccruedLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2020-12-31 0001610950 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2020-12-31 0001610950 us-gaap:CashFlowHedgingMember 2020-12-31 0001610950 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001610950 us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001610950 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:FairValueMeasurementsRecurringMember srt:PartnershipInterestMember 2021-12-31 0001610950 us-gaap:FairValueMeasurementsRecurringMember srt:PartnershipInterestMember 2021-12-31 0001610950 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001610950 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001610950 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001610950 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001610950 us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001610950 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:FairValueMeasurementsRecurringMember srt:PartnershipInterestMember 2020-12-31 0001610950 us-gaap:FairValueMeasurementsRecurringMember srt:PartnershipInterestMember 2020-12-31 0001610950 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001610950 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001610950 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001610950 synh:HealthcareAndLifeSciencesIndustryMember 2021-12-31 0001610950 us-gaap:FairValueMeasurementsNonrecurringMember 2021-12-31 0001610950 us-gaap:FairValueMeasurementsNonrecurringMember 2020-12-31 0001610950 synh:A2017CreditAgreementAmendmentNo2TermLoanATrancheOneDueMarch2024Member us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2021-12-31 0001610950 synh:A2017CreditAgreementAmendmentNo2TermLoanATrancheTwoDueAugust2024Member us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2021-12-31 0001610950 synh:A2017CreditAgreementAmendmentNo2TermLoanATrancheOneDueMarch2024Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2021-12-31 0001610950 synh:A2017CreditAgreementAmendmentNo2TermLoanATrancheTwoDueAugust2024Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2021-12-31 0001610950 synh:A2017CreditAgreementAmendmentNo2TermLoanATrancheOneDueMarch2024Member us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2020-12-31 0001610950 synh:A2017CreditAgreementAmendmentNo2TermLoanATrancheTwoDueAugust2024Member us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2020-12-31 0001610950 synh:A2017CreditAgreementAmendmentNo2TermLoanBDueAugust2024Member us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2020-12-31 0001610950 synh:A2017CreditAgreementAmendmentNo2TermLoanATrancheOneDueMarch2024Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2020-12-31 0001610950 synh:A2017CreditAgreementAmendmentNo2TermLoanATrancheTwoDueAugust2024Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2020-12-31 0001610950 synh:A2017CreditAgreementAmendmentNo2TermLoanBDueAugust2024Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2020-12-31 0001610950 synh:SeniorNoteDue2029Member us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2021-12-31 0001610950 synh:SeniorNoteDue2029Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2021-12-31 0001610950 synh:SeniorNoteDue2029Member us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2020-12-31 0001610950 synh:SeniorNoteDue2029Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2020-12-31 0001610950 us-gaap:EmployeeSeveranceMember 2021-01-01 2021-12-31 0001610950 us-gaap:EmployeeSeveranceMember 2020-01-01 2020-12-31 0001610950 us-gaap:EmployeeSeveranceMember 2019-01-01 2019-12-31 0001610950 us-gaap:FacilityClosingMember 2021-01-01 2021-12-31 0001610950 us-gaap:FacilityClosingMember 2020-01-01 2020-12-31 0001610950 us-gaap:FacilityClosingMember 2019-01-01 2019-12-31 0001610950 us-gaap:OtherRestructuringMember 2021-01-01 2021-12-31 0001610950 us-gaap:OtherRestructuringMember 2020-01-01 2020-12-31 0001610950 us-gaap:OtherRestructuringMember 2019-01-01 2019-12-31 0001610950 synh:EmployeeSeveranceCostsIncludingExecutiveTransitionCostsMember us-gaap:BusinessRestructuringReservesMember 2019-12-31 0001610950 us-gaap:OtherRestructuringMember us-gaap:BusinessRestructuringReservesMember 2019-12-31 0001610950 us-gaap:BusinessRestructuringReservesMember 2019-12-31 0001610950 synh:EmployeeSeveranceCostsIncludingExecutiveTransitionCostsMember us-gaap:BusinessRestructuringReservesMember 2020-01-01 2020-12-31 0001610950 us-gaap:OtherRestructuringMember us-gaap:BusinessRestructuringReservesMember 2020-01-01 2020-12-31 0001610950 us-gaap:BusinessRestructuringReservesMember 2020-01-01 2020-12-31 0001610950 synh:EmployeeSeveranceCostsIncludingExecutiveTransitionCostsMember us-gaap:BusinessRestructuringReservesMember 2020-12-31 0001610950 us-gaap:BusinessRestructuringReservesMember 2020-12-31 0001610950 synh:EmployeeSeveranceCostsIncludingExecutiveTransitionCostsMember us-gaap:BusinessRestructuringReservesMember 2021-01-01 2021-12-31 0001610950 us-gaap:OtherRestructuringMember us-gaap:BusinessRestructuringReservesMember 2021-01-01 2021-12-31 0001610950 us-gaap:BusinessRestructuringReservesMember 2021-01-01 2021-12-31 0001610950 synh:EmployeeSeveranceCostsIncludingExecutiveTransitionCostsMember us-gaap:BusinessRestructuringReservesMember 2021-12-31 0001610950 us-gaap:BusinessRestructuringReservesMember 2021-12-31 0001610950 2018-02-26 0001610950 2019-12-05 0001610950 us-gaap:CommonClassAMember 2021-12-31 0001610950 us-gaap:CommonClassAMember 2021-01-01 2021-12-31 0001610950 us-gaap:CommonStockMember 2018-03-01 2018-03-31 0001610950 us-gaap:CommonStockMember 2018-04-01 2018-04-30 0001610950 us-gaap:CommonStockMember 2019-01-01 2019-01-31 0001610950 us-gaap:CommonStockMember 2019-02-01 2019-02-28 0001610950 us-gaap:CommonStockMember 2019-06-01 2019-06-30 0001610950 us-gaap:CommonStockMember 2019-08-01 2019-08-31 0001610950 us-gaap:CommonStockMember 2020-03-01 2020-03-31 0001610950 us-gaap:CommonStockMember 2020-09-01 2020-09-30 0001610950 us-gaap:CommonStockMember 2020-10-01 2020-10-31 0001610950 us-gaap:CommonStockMember 2021-03-01 2021-03-31 0001610950 us-gaap:CommonStockMember 2021-05-01 2021-05-31 0001610950 us-gaap:CommonStockMember 2021-06-01 2021-06-30 0001610950 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001610950 us-gaap:CommonStockMember 2021-12-31 0001610950 us-gaap:CommonClassAMember 2020-12-31 0001610950 us-gaap:CommonClassBMember 2021-12-31 0001610950 us-gaap:CommonClassBMember 2020-12-31 0001610950 us-gaap:CommonClassBMember 2021-01-01 2021-12-31 0001610950 synh:ResearchAndGeneralBusinessTaxCreditsMember 2021-01-01 2021-12-31 0001610950 synh:ResearchAndGeneralBusinessTaxCreditsMember 2020-01-01 2020-12-31 0001610950 us-gaap:CapitalLossCarryforwardMember 2021-01-01 2021-12-31 0001610950 us-gaap:CapitalLossCarryforwardMember 2020-01-01 2020-12-31 0001610950 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2020-12-31 0001610950 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-12-31 0001610950 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-12-31 0001610950 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2020-01-01 2020-12-31 0001610950 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2021-01-01 2021-12-31 0001610950 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-01-01 2019-12-31 0001610950 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2021-12-31 0001610950 us-gaap:DomesticCountryMember 2021-12-31 0001610950 us-gaap:DomesticCountryMember 2020-12-31 0001610950 us-gaap:StateAndLocalJurisdictionMember 2021-12-31 0001610950 us-gaap:StateAndLocalJurisdictionMember 2020-12-31 0001610950 us-gaap:ForeignCountryMember 2021-12-31 0001610950 us-gaap:ForeignCountryMember 2020-12-31 0001610950 us-gaap:DomesticCountryMember 2021-01-01 2021-12-31 0001610950 us-gaap:DomesticCountryMember 2020-01-01 2020-12-31 0001610950 us-gaap:CanadaRevenueAgencyMember us-gaap:ResearchMember 2021-12-31 0001610950 us-gaap:CanadaRevenueAgencyMember us-gaap:ResearchMember 2020-12-31 0001610950 us-gaap:ForeignCountryMember 2021-01-01 2021-12-31 0001610950 2021-10-01 2021-12-31 0001610950 us-gaap:OperatingSegmentsMember synh:ClinicalSolutionsSegmentMember 2021-01-01 2021-12-31 0001610950 us-gaap:OperatingSegmentsMember synh:ClinicalSolutionsSegmentMember 2020-01-01 2020-12-31 0001610950 us-gaap:OperatingSegmentsMember synh:ClinicalSolutionsSegmentMember 2019-01-01 2019-12-31 0001610950 us-gaap:OperatingSegmentsMember synh:CommercialSolutionsSegmentMember 2021-01-01 2021-12-31 0001610950 us-gaap:OperatingSegmentsMember synh:CommercialSolutionsSegmentMember 2020-01-01 2020-12-31 0001610950 us-gaap:OperatingSegmentsMember synh:CommercialSolutionsSegmentMember 2019-01-01 2019-12-31 0001610950 us-gaap:OperatingSegmentsMember 2021-01-01 2021-12-31 0001610950 us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0001610950 us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0001610950 us-gaap:CorporateNonSegmentMember synh:CostofServicesMember 2021-01-01 2021-12-31 0001610950 us-gaap:CorporateNonSegmentMember synh:CostofServicesMember 2020-01-01 2020-12-31 0001610950 us-gaap:CorporateNonSegmentMember synh:CostofServicesMember 2019-01-01 2019-12-31 0001610950 us-gaap:CorporateNonSegmentMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0001610950 us-gaap:CorporateNonSegmentMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0001610950 us-gaap:CorporateNonSegmentMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-12-31 0001610950 us-gaap:CorporateNonSegmentMember 2021-01-01 2021-12-31 0001610950 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-12-31 0001610950 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-12-31 0001610950 srt:NorthAmericaMember 2021-01-01 2021-12-31 0001610950 srt:NorthAmericaMember 2020-01-01 2020-12-31 0001610950 srt:NorthAmericaMember 2019-01-01 2019-12-31 0001610950 us-gaap:EMEAMember 2021-01-01 2021-12-31 0001610950 us-gaap:EMEAMember 2020-01-01 2020-12-31 0001610950 us-gaap:EMEAMember 2019-01-01 2019-12-31 0001610950 srt:AsiaPacificMember 2021-01-01 2021-12-31 0001610950 srt:AsiaPacificMember 2020-01-01 2020-12-31 0001610950 srt:AsiaPacificMember 2019-01-01 2019-12-31 0001610950 srt:LatinAmericaMember 2021-01-01 2021-12-31 0001610950 srt:LatinAmericaMember 2020-01-01 2020-12-31 0001610950 srt:LatinAmericaMember 2019-01-01 2019-12-31 0001610950 country:US 2021-01-01 2021-12-31 0001610950 country:US 2020-01-01 2020-12-31 0001610950 country:US 2019-01-01 2019-12-31 0001610950 country:US us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-12-31 0001610950 country:US us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-12-31 0001610950 country:US us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2019-01-01 2019-12-31 0001610950 srt:NorthAmericaMember 2021-12-31 0001610950 srt:NorthAmericaMember 2020-12-31 0001610950 us-gaap:EMEAMember 2021-12-31 0001610950 us-gaap:EMEAMember 2020-12-31 0001610950 srt:AsiaPacificMember 2021-12-31 0001610950 srt:AsiaPacificMember 2020-12-31 0001610950 srt:LatinAmericaMember 2021-12-31 0001610950 srt:LatinAmericaMember 2020-12-31 0001610950 country:US 2021-12-31 0001610950 country:US 2020-12-31 0001610950 us-gaap:OtherCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001610950 us-gaap:OtherCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001610950 us-gaap:OtherCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-12-31 0001610950 us-gaap:OtherCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001610950 us-gaap:OtherCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001610950 srt:DirectorMember 2021-01-01 2021-12-31 0001610950 srt:DirectorMember 2020-01-01 2020-12-31 0001610950 srt:MaximumMember 2020-01-01 2020-12-31 0001610950 2018-01-01 2018-12-31 0001610950 srt:AffiliatedEntityMember 2019-01-01 2019-12-31 0001610950 synh:BermudezAndVaitkuvieneActionMember us-gaap:PendingLitigationMember 2017-12-01 2017-12-01 0001610950 synh:InVentivMergerMember us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001610950 synh:InVentivMergerMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001610950 synh:RxDataScienceMember 2021-12-31 0001610950 synh:TwoThousandFourteenEquityIncentivePlanMember 2021-01-01 2021-12-31 0001610950 srt:MaximumMember us-gaap:EmployeeStockOptionMember synh:TwoThousandFourteenEquityIncentivePlanMember 2021-01-01 2021-12-31 0001610950 synh:EmployeeStockPurchasePlanMember 2021-01-01 2021-12-31 0001610950 synh:EmployeeStockPurchasePlanMember 2016-03-31 0001610950 synh:EmployeeStockPurchasePlanMember 2016-03-01 2016-03-31 0001610950 synh:EmployeeStockPurchasePlanMember 2020-01-01 2020-12-31 0001610950 synh:EmployeeStockPurchasePlanMember 2019-01-01 2019-12-31 0001610950 synh:EmployeeStockPurchasePlanMember 2021-12-31 0001610950 us-gaap:EmployeeStockMember 2021-01-01 2021-12-31 0001610950 us-gaap:EmployeeStockMember 2020-01-01 2020-12-31 0001610950 us-gaap:EmployeeStockMember 2019-01-01 2019-12-31 0001610950 us-gaap:EmployeeStockOptionMember 2020-12-31 0001610950 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001610950 us-gaap:EmployeeStockOptionMember 2021-12-31 0001610950 synh:TimeBasedRestrictedStockUnitsAwardsMember 2020-12-31 0001610950 synh:TimeBasedRestrictedStockUnitsAwardsMember 2021-01-01 2021-12-31 0001610950 synh:TimeBasedRestrictedStockUnitsAwardsMember 2021-12-31 0001610950 synh:PerformanceBasedRestrictedStockUnitsMember 2020-12-31 0001610950 synh:PerformanceBasedRestrictedStockUnitsMember 2021-01-01 2021-12-31 0001610950 synh:PerformanceBasedRestrictedStockUnitsMember 2021-12-31 0001610950 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001610950 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001610950 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001610950 synh:TimeBasedRestrictedStockUnitsAwardsMember 2020-01-01 2020-12-31 0001610950 synh:TimeBasedRestrictedStockUnitsAwardsMember 2019-01-01 2019-12-31 0001610950 synh:PerformanceBasedRestrictedStockUnitsMember 2020-01-01 2020-12-31 0001610950 synh:PerformanceBasedRestrictedStockUnitsMember 2019-01-01 2019-12-31 0001610950 synh:CostofServicesMember 2021-01-01 2021-12-31 0001610950 synh:CostofServicesMember 2020-01-01 2020-12-31 0001610950 synh:CostofServicesMember 2019-01-01 2019-12-31 0001610950 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0001610950 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0001610950 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-12-31 0001610950 us-gaap:ForeignPlanMember 2021-01-01 2021-12-31 0001610950 us-gaap:ForeignPlanMember 2020-01-01 2020-12-31 0001610950 us-gaap:ForeignPlanMember 2019-01-01 2019-12-31 iso4217:USD shares iso4217:USD shares synh:Segment synh:reportingunit pure synh:EquityFund synh:NumberOfVote synh:Customer synh:numberOfAction synh:Plan false FY --12-31 0001610950 P30D P90D http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member true P1Y P3Y P5Y P2Y P10Y P3Y P4Y P8Y 0.0025 0.0125 0.0075 0.0175 0.0025 0.0125 0.0050 0.0150 0.0100 0.0200 0.0050 0.0150 0.253 0.277 0.391 0.0006 0.0013 0.0188 P6M P6M P6M 0.383 0.551 0.519 0.0007 0.0095 0.0252 P3Y3M3D P3Y3M3D P3Y3M3D 10-K true 2021-12-31 2021 false 001-36730 SYNEOS HEALTH, INC. DE 27-3403111 1030 Sync Street Morrisville NC 27560-5468 919 876-9300 Class A Common Stock, par value $0.01 per share SYNH NASDAQ Yes No Yes Yes Large Accelerated Filer false false true false 9235907535 104221138 Portions of the registrant’s Proxy Statement for its 2022 Annual Meeting of Stockholders are incorporated by reference into Part III hereof 34 Deloitte & Touche LLP Raleigh, North Carolina 5212970000 4415777000 4675815000 3994484000 3398142000 3645905000 570765000 472726000 507556000 22816000 29414000 42135000 73832000 70185000 76532000 161793000 152167000 165933000 4823690000 4122634000 4438061000 389280000 293143000 237754000 111000 265000 7542000 79252000 91145000 129820000 -3612000 -1581000 10395000 8633000 2976000 -24162000 -74120000 -89485000 -136045000 315160000 203658000 101709000 80329000 10871000 -29549000 234831000 192787000 131258000 2.26 1.85 1.27 2.24 1.83 1.25 103872000 104168000 103618000 105065000 105465000 105005000 234831000 192787000 131258000 -5599000 1394000 2122000 16140000 -3925000 -7596000 1472000 -1354000 0 -24957000 34717000 24198000 226014000 223579000 147860000 106475000 272173000 1524890000 1344781000 135091000 121058000 1766456000 1738012000 222657000 216200000 209408000 223285000 4956015000 4776178000 854067000 933525000 35387000 35059000 193103000 141047000 8237093000 8063306000 107535000 113684000 614441000 611042000 868455000 793068000 43058000 42082000 20627000 17455000 1654116000 1577331000 2775721000 2902054000 205798000 221760000 34181000 31522000 78062000 20216000 76660000 68311000 4824538000 4821194000 0.01 0.01 30000000 30000000 0 0 0 0 0.01 0.01 600000000 600000000 103764000 103764000 103935000 103935000 1038000 1039000 3474088000 3461747000 -49618000 -40801000 -12953000 -179873000 3412555000 3242112000 8237093000 8063306000 234831000 192787000 131258000 235625000 222352000 242465000 65204000 58491000 55193000 367000 695000 1897000 46522000 -3839000 -40069000 5928000 -4148000 -11166000 597000 3664000 -17260000 7133000 -3612000 -1581000 10395000 -7789000 -1765000 -2766000 109364000 -16316000 120389000 24620000 -2561000 28316000 52403000 55445000 987000 450278000 425493000 318481000 278920000 456455000 712000 5000000 17970000 56841000 50010000 63973000 5741000 15589000 16976000 3844000 -340346000 -504084000 -81661000 494505000 600000000 582000000 1008000 9570000 2636000 727277000 327294000 437936000 100000000 31600000 127815000 6600000 22400000 80000000 300000000 80000000 300000000 418112000 7197000 26634000 178000 15774000 16434000 14493000 117521000 70151000 56716000 28148000 24568000 40322000 31453000 21220000 13135000 -277577000 178265000 -215469000 1947000 8810000 -13594000 -165698000 108484000 7757000 272173000 163689000 155932000 106475000 272173000 163689000 3242112000 3029654000 2856144000 -2771000 3242112000 3026883000 2856144000 1039000 1039000 1034000 15000 13000 13000 14000 13000 18000 1038000 1039000 1039000 3461747000 3441471000 3402638000 49595000 41512000 43515000 -3268000 3297000 27155000 65204000 58491000 55193000 3474088000 3461747000 3441471000 -40801000 -71593000 -88195000 16140000 -3925000 -7596000 -24957000 34717000 24198000 -49618000 -40801000 -71593000 -179873000 -341263000 -459333000 -2771000 -179873000 -344034000 -459333000 67911000 28626000 13188000 234831000 192787000 131258000 -12953000 -179873000 -341263000 3412555000 3242112000 3029654000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">1. Basis of Presentation and Summary of Significant Accounting Policies</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Principal Business</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Syneos Health, Inc. (the “Company”) is a global provider of end-to-end biopharmaceutical outsourcing solutions. The Company operates under two reportable segments, Clinical Solutions and Commercial Solutions, and derives its revenue through a suite of services designed to enhance its customers’ ability to successfully develop, launch, and market their products. The Company offers its solutions on both a standalone and integrated basis with biopharmaceutical development and commercialization services ranging from Phase I to IV clinical trial services to services associated with the commercialization of biopharmaceutical products. The Company’s customers include small, mid-sized, and large companies in the pharmaceutical, biotechnology, and medical device industries.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Principles of Consolidation</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (<span style="Background-color:#FFFFFF;color:#000000;">“</span>U.S. GAAP<span style="Background-color:#FFFFFF;color:#000000;">”</span>), and include the accounts and results of operations of the Company and its controlled subsidiaries. All intercompany balances and transactions have been eliminated.</p> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Reclassification</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain previously reported amounts have been reclassified to conform to the current year presentation.</p> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">COVID-19 Pandemic</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The ongoing COVID-19 pandemic and associated economic repercussions have significantly impacted, and are expected to continue to impact, the Company’s business and operations. The continued availability and effectiveness of vaccines may partially mitigate the risks around the continued spread of COVID-19, however, with the spread of COVID-19 variants, the ongoing impacts of the COVID-19 pandemic could adversely impact its business and results of operations. See Part I, Item 1A “Risk Factors” in this Annual Report on Form 10-K for further discussion of the potential impact of the pandemic on its business. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of revenue and expenses for the periods presented in the financial statements. Examples of estimates and assumptions include, but are not limited to, determining the fair value of goodwill and intangible assets and their potential impairment, useful lives of tangible and intangible assets, useful lives of assets subject to leases, valuation of the Company’s right of use assets, allowances for doubtful accounts, potential future outcomes of events for which income tax consequences have been recognized in the Company’s consolidated financial statements or tax returns, valuation allowances for deferred tax assets, fair value of share-based compensation and its recognition period, loss contingencies, fair value of derivative instruments and related hedge effectiveness, fair value of contingent tax sharing obligations, and judgments related to revenue recognition, among others. In addition, estimates and assumptions are used in the accounting for acquisitions, including the fair value and useful lives of acquired tangible and intangible assets and the fair value of assumed liabilities.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company evaluates its estimates and assumptions on an ongoing basis and bases its estimates on historical experience, current and expected future conditions, third-party evaluations, and various other assumptions that management believes are reasonable under the circumstances based on the information available to management at the time these estimates and assumptions are made. Actual results and outcomes may differ significantly from these estimates and assumptions.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Acquisitions</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for acquisitions in accordance with ASC Topic 805, <span style="font-style:italic;">Business Combinations</span>, using the acquisition method of accounting. The purchase price, or total consideration transferred, is determined as the fair value of assets exchanged, equity instruments issued, and liabilities assumed at the acquisition date. The acquisition method of accounting requires that the identifiable assets acquired, the liabilities assumed, and any non-controlling interest in the acquiree are measured and recorded at their fair values on the date of an acquisition. Goodwill represents the excess of the purchase price over the estimated fair value of the net assets acquired, including the amount assigned to identifiable intangible assets. Acquisition-related costs are expensed as incurred. The consolidated financial statements reflect the results of operations of the acquiree from the date of the acquisition. For additional information, see <span style="Background-color:#FFFFFF;color:#000000;">“</span>Note 3 – Acquisitions, Divestitures, and Investments.<span style="Background-color:#FFFFFF;color:#000000;">”</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Foreign Currency Translation and Transactions</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For subsidiaries outside of the U.S. that operate in a local currency environment, revenue and expenses are translated to U.S. dollars at the monthly average rates of exchange prevailing during the period, assets and liabilities are translated at period-end exchange rates, and equity accounts are translated at historical exchange rates. The net effect of foreign currency translation adjustments is included in shareholders’ equity as a component of accumulated other comprehensive loss in the accompanying consolidated balance sheets.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign currency transaction gains and losses are the result of exchange rate changes during the period of time between the consummation and cash settlement of transactions denominated in currencies other than the functional currency. Foreign currency transaction gains and losses are recognized in earnings as incurred and are included in other (income) expense, net in the accompanying consolidated statements of income.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Comprehensive Income</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Comprehensive income<span style="color:#FF0000;"> </span>refers to revenue, expenses, gains, and losses that, under U.S. GAAP, are recorded as an element of shareholders’ equity but are excluded from net income. The Company’s comprehensive income consists of foreign currency translation adjustments, net of applicable taxes, resulting from the translation of foreign subsidiaries with functional currencies other than the U.S. dollar and the effective portions of the unrealized gains or losses associated with derivative instruments designated and accounted for as hedging instruments.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Cash and Cash Equivalents</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents consist of demand deposits with banks and other financial institutions and highly liquid investments with an original maturity of three months or less at the date of purchase. Cash and cash equivalents are carried at cost, which approximates their fair value.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain of the Company’s subsidiaries participate in a notional cash pooling arrangement to manage global liquidity requirements. As part of a master netting arrangement, the participants combine their cash balances in pooling accounts at the same financial institution with the ability to offset bank overdrafts of one participant against positive cash account balances held by another participant. Under the terms of the master netting arrangement, the financial institution has the right, ability, and intent to offset a positive balance in one account against an overdrawn amount in another account. Amounts in each of the accounts are unencumbered and unrestricted with respect to use. As such, the net cash balance related to this pooling arrangement is included in cash, cash equivalents, and restricted cash in the accompanying consolidated balance sheets.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s net cash pool position consisted of the following as of December 31 (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross cash position</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">179,160</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">220,261</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: cash borrowings</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(167,507</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(204,647</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash position</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,653</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,614</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Restricted Cash</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash represents cash and deposits held as security over bank deposits, lease guarantees, and insurance obligations that are restricted as to withdrawal or use. Restricted cash is classified as a current or long-term asset based on the timing and nature of when and how the cash is expected to be used or when the restrictions are expected to lapse. As of December 31, 2021 and 2020, restricted cash balances were $0.1 million and $0.3 million, respectively.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Fair Value</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company records certain assets and liabilities at fair value in accordance with ASC Topic 820, <span style="font-style:italic;">Fair Value Measurement</span> (see <span style="Background-color:#FFFFFF;color:#000000;">“</span>Note 7 - Fair Value Measurements<span style="Background-color:#FFFFFF;color:#000000;">”</span>). Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. This guidance also specifies a fair value hierarchy that distinguishes between valuation assumptions developed based on market data obtained from independent external sources and the reporting entity’s own assumptions. Fair value measurements are classified according to the lowest level input or value-driver that is significant to the valuation. In accordance with this guidance, fair value measurements are classified under the following hierarchy:</p> <p style="margin-bottom:0pt;margin-top:12pt;margin-left:6.77%;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1 – Unadjusted quoted prices in active markets for identical instruments;</p> <p style="margin-bottom:0pt;margin-top:12pt;margin-left:6.77%;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2 – Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs or significant value-drivers are observable in active markets; and</p> <p style="margin-bottom:0pt;margin-top:12pt;margin-left:6.77%;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 3 – Model-derived valuations in which one or more significant inputs or significant value-drivers are unobservable, including internally developed models.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Derivative Financial Instruments</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Interest Rate Swaps</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company uses interest rate swaps to manage exposure to variable interest rates on its debt obligations. The Company designates its interest rate swaps as cash flow hedges because they are executed to hedge the Company’s exposure to the variability in expected future cash flows that are attributable to changes in interest rates.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Derivative financial instruments are measured at fair value and recognized in the accompanying consolidated balance sheets in prepaid expenses and other current assets, other long-term assets, accrued expenses, and other long-term liabilities, as disclosed in <span style="Background-color:#FFFFFF;color:#000000;">“</span>Note 6 – Derivatives.<span style="Background-color:#FFFFFF;color:#000000;">”</span> The fair value of interest rate swaps is determined using the market standard methodology of discounted future variable cash receipts. The variable cash receipts are determined by discounting the future expected cash receipts that would occur if variable interest rates rise above the fixed rate of the swaps. The variable interest rates used in the calculation of<span style="font-size:12pt;"> </span>projected receipts on the swap are based on an expectation of future interest rates derived from observable market interest rate curves and volatilities. Changes in the fair value of derivative instruments designated as hedging instruments are recorded each period according to the determination of the derivative’s effectiveness. The effective portion of changes in the fair value of derivatives designated as cash flow hedges is recorded in accumulated other comprehensive loss and subsequently reclassified into earnings in the period during which the hedged transaction is recognized in earnings. The ineffective portion of the change in fair value of the derivatives is recognized as non-operating income or expense immediately when incurred and included in interest expense in the accompanying consolidated statements of income.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Foreign Exchange Forward</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company utilizes a foreign exchange forward in order to minimize monthly foreign currency remeasurement gains or losses on non-functional currency monetary balances. The Company did not designate the derivative as a hedge. All changes in the fair value of the foreign exchange forward are recorded in earnings every month to other (income) expense, net <span style="Background-color:#FFFFFF;">in the </span><span style="Background-color:#FFFFFF;color:#000000;">accompanying consolidated statements of income</span>, as disclosed in <span style="Background-color:#FFFFFF;color:#000000;">“</span>Note 6 – Derivatives.<span style="Background-color:#FFFFFF;color:#000000;">”</span> </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Allowance for Doubtful Accounts</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company maintains a credit approval process and makes judgments in connection with assessing its customers’ ability to pay for contracted services. Generally, the Company has the ability to limit credit exposure by discontinuing services in the event of non-payment. The Company monitors its customers’ credit worthiness and applies judgment in establishing a provision for estimated credit losses based on historical experience, the aging of receivables, and customer-specific circumstances that would affect the customers’ ability to pay for services rendered.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Property and Equipment</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment primarily consists of furniture, vehicles, software, office equipment, computer equipment, and lab equipment. Purchased and constructed property and equipment is initially recorded at historical cost plus the estimated value of any associated legally or contractually required retirement obligations. Property and equipment acquired in an acquisition are recorded based on the estimated fair value as of the acquisition date. The Company leases vehicles for certain sales representatives in the Commercial Solutions segment. These leases are classified and accounted for as leases in accordance with ASC Topic 842, <span style="font-style:italic;">Leases</span> (<span style="Background-color:#FFFFFF;color:#000000;">“</span>ASC 842<span style="Background-color:#FFFFFF;color:#000000;">”</span>). For further information about lease arrangements, see <span style="Background-color:#FFFFFF;color:#000000;">“</span>Note 5 - Leases.<span style="Background-color:#FFFFFF;color:#000000;">”</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment assets are depreciated using the straight-line method over the respective estimated useful lives as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.78%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.36%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Useful Life</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Buildings</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.36%; border-top:solid 0.75pt #000000;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39 years</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and fixtures</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7 years</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Equipment</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000466">5 to 10 years</span></p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment and software</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000468">2 to 3 years</span></p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vehicles</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lesser of lease term or the estimated economic life of the leased asset</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lesser of remaining life of lease or the useful life of the asset</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expenditures for repairs and maintenance are expensed as incurred and expenditures for major improvements that increase the functionality or extend the useful life of the asset are capitalized and depreciated over the estimated useful life of the asset.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company capitalizes costs of computer software obtained for internal use and amortizes these costs on a straight-line basis over the estimated useful life of the product, not to exceed five years. Software cloud computing arrangements containing a software license are accounted for consistently with the acquisition of other software licenses. In the event such an arrangement does not contain a software license, the Company accounts for the arrangement as a service contract.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company reviews property and equipment for impairment whenever facts and circumstances indicate that the carrying amounts of these assets might not be recoverable. For assessment purposes, property and equipment are grouped with other assets and liabilities at the lowest level that identifiable cash flows are largely independent of the cash flows of other assets and liabilities. Recoverability of the carrying amount of an asset group is assessed by comparing its carrying amount to the estimated undiscounted future cash flows expected to be generated by the asset group. If the carrying value of the asset group exceeds its fair value, an impairment charge is recognized for the excess.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Leases</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#212529;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At inception, a contract contains a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. In evaluating whether it has the right to control the use of an identified asset, the Company assesses whether they have the right to direct the use of the identified asset and to obtain substantially all of the economic benefit from the use of the identified asset.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#212529;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right-of-use (<span style="Background-color:#FFFFFF;color:#000000;">“</span>ROU<span style="Background-color:#FFFFFF;color:#000000;">”</span>) assets represent the Company<span style="color:#000000;">’</span>s right to use an underlying asset during the lease term and lease liabilities represent the Company<span style="color:#000000;">’</span>s obligation to make lease payments arising from the lease. Assets and liabilities are recognized based on the present value of lease payments over the lease term. Most leases include one or more options to renew. The exercise of the renewal option is at the Company<span style="color:#000000;">’</span>s sole discretion and the Company includes these options in determining the lease term used to establish its right-of-use assets and lease liabilities when it is reasonably certain the Company will exercise its option.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#212529;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because most of the Company<span style="color:#000000;">’</span>s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The Company uses the implicit rate when readily determinable. Operating lease expense is generally recognized on a straight-line basis over the lease term.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#212529;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#212529;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has agreements with lease and non-lease components, which are accounted for as a single lease component. Leases with a lease term of 12 months or less are not recorded on the balance sheet. The Company recognizes lease expense for these leases on a straight-line basis over the lease term. Variable lease payment amounts that cannot be determined at the commencement of the lease, such as increases in lease payments based on changes in index rates, are not included in the right-of-use assets or liabilities. These variable lease payments are expensed as incurred.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Goodwill and Intangible Assets</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill represents the excess of the purchase price over the estimated fair value of net assets acquired, including the amount assigned to identifiable intangible assets, in acquisitions. In accordance with ASC Topic 350, <span style="font-style:italic;">Intangibles </span>–<span style="font-style:italic;"> Goodwill and Other</span>, goodwill is not subject to amortization but must be tested for impairment annually or more frequently if events or changes in circumstances indicate that goodwill might be impaired. Goodwill is tested for impairment at the reporting unit level, which is one level below the operating segment level. This test requires the Company to determine if the implied fair value of the reporting unit’s goodwill is less than its carrying amount.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has assigned goodwill to four reporting units. The Company completed an annual impairment test as of October 1, 2021 for all of its reporting units, and concluded that there were no impairments.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets consist of customer relationships, acquired backlog, trade names, trademarks, patient communities, and acquired technologies. The Company amortizes intangible assets related to customer relationships, trade names, trademarks, patient communities, and acquired technologies on a straight-line basis over the estimated useful life of the asset. Intangible assets related to acquired backlog are amortized based on the Company’s expectations of the timing of when revenue associated with the backlog is expected to be recognized.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company reviews intangible assets at the end of each reporting period to determine if facts and circumstances indicate that the useful life is shorter than originally estimated or that the carrying amount of the assets might not be recoverable. If such facts and circumstances exist, the Company assesses the recoverability of identified assets by comparing the projected undiscounted cash flows associated with the related asset or group of assets to their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amount over the fair value of those assets and occur in the period in which the impairment determination is made.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The weighted average estimated useful lives of the Company’s intangible assets were as follows as of December 31:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer relationships</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.8 years</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.9 years</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired backlog</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.6 years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.6 years</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trade names and trademarks</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.5 years</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.5 years</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intellectual property (medical patent)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">n/a</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.0 years</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Patient communities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.0 years</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">n/a</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired technologies</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.0 years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">n/a</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No intangible asset impairment charges were recorded for the years ended December 31, 2021 or 2020. For additional information regarding the carrying values of intangible assets, see <span style="Background-color:#FFFFFF;color:#000000;">“</span>Note 2 – Financial Statement Details.<span style="Background-color:#FFFFFF;color:#000000;">”</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Contingencies</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the normal course of business, the Company periodically becomes involved in various proceedings and claims, including investigations, disputes, litigations, and regulatory matters that are incidental to its business. The Company evaluates the likelihood of an unfavorable outcome of all legal and regulatory matters and records accruals for probable loss contingencies for which the amount of the loss can be reasonably estimated. Gain contingencies are not recognized until realized. Legal fees are expensed as incurred.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because these matters are inherently unpredictable, and unfavorable developments or resolutions can occur, assessing contingencies is highly subjective and requires judgments about future events. These judgments and estimates are based, among other factors, on the status of the proceedings, the merits of the Company’s defenses, and the consultation with in-house and external counsel. The Company regularly reviews contingencies to determine whether its accruals and related disclosures are adequate. Although the Company believes that it has substantial defenses in these matters, the amount of losses incurred as a result of actual outcomes may differ significantly from the Company’s estimates.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Revenue Recognition</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accordance with ASC Topic 606, <span style="font-style:italic;">Revenue from Contracts with Customers</span> and all related amendments (“ASC 606”), revenue is recognized when, or as, a customer obtains control of promised services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these services.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A performance obligation is a promise (or a combination of promises) in a contract to transfer distinct goods or services to a customer and is the unit of accounting under ASC 606 for the purposes of revenue recognition. A contract’s transaction price is allocated to each performance obligation and is recognized as revenue, when, or as, each performance obligation is satisfied. The majority of the Company’s Clinical Solutions segment contracts have a single performance obligation because the promise to transfer individual services is not separately identifiable from other promises in the contracts, and therefore, is not distinct. For contracts with multiple performance obligations, the contract’s transaction price is allocated to each performance obligation using the best estimate of the standalone selling price of each distinct good or service in the contract.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The majority of the Company’s revenue arrangements are service contracts that range in duration from a few months to several years. Substantially all of the Company’s performance obligations, and associated revenue, are transferred to the customer over time. The Company generally receives compensation based on measuring progress toward completion using anticipated project budgets for direct labor and prices for each service offering. The Company is also reimbursed for certain third-party pass-through and out-of-pocket costs. In addition, in certain instances a customer contract may include forms of variable consideration such as incentive fees, volume rebates or other provisions that can increase or decrease the transaction price. This variable consideration is generally awarded upon achievement of certain performance metrics, program milestones or cost targets. For the purposes of revenue recognition, variable consideration is assessed on a contract-by-contract basis and the amount included in the transaction price is estimated based on the Company’s anticipated performance and consideration of all information that is reasonably available. Variable consideration is recognized as revenue if and when it is deemed probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved in the future.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Most of the Company’</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s contracts can be terminated by the customer without cause with a </span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">notice period that generally ranges from 30</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> to </span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90 </span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">day</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. In the event of </span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">termination, the Company’</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s contracts generally provide that the customer pay the Company for: (i) fees earned through the termination date; (ii) fees and expenses for winding down the project, which include both fees incurred and actual expenses; (iii) non-cancellable expenditures; and (iv) in some cases, a fee to cover a portion of the remaining professional fees on the project</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> long-term clinical trial contracts contain implied substantive termination penalties because of the significant wind-down cost of terminating a clinical trial. These provisions for termination penalties result in these types of contracts being treated as long-term for revenue recognition purposes. </span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in the scope of work are common, especially under long-term contracts, and generally result in a change in the total contract transaction price. If the customer does not agree to a contract modification, the Company could bear the risk of cost overruns. Most of the Company’s contract modifications are for services that are not distinct from the services under the existing contract due to the significant integration service provided in the context of the contract and therefore result in a cumulative catch-up adjustment to revenue at the date of contract modification.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">Capitalized Costs</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company capitalizes certain costs associated with commissions and bonuses paid to its employees in the Clinical Solutions segment because these costs are incurred in obtaining contracts that have a term greater than one year. Capitalized costs are included in prepaid expenses and other current assets and other long-term assets in the accompanying consolidated balance sheets. The Company amortizes these costs in a manner that is consistent with the pattern of revenue recognition described below. The Company expenses costs to obtain contracts that have a term of one year or less.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">Clinical Solutions</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s Clinical Solutions segment provides solutions to address the clinical development needs of customers. The Company provides total biopharmaceutical program development through its full-service platform, while also providing discrete services for any part of a clinical trial, primarily through functional service provider, Early Stage, and Real World and Late Phase (“RWLP”) services. The services provided via the full-service platform and RWLP platforms generally span several years and a significant benefit to the customer is provided by integrating the services provided by the Company’s employees as well as those performed by third parties. Because the Company’s full-service platform provides a significant integration service to the customer, these contracts contain a single performance obligation. Revenue is recognized over time using an input measure of progress. The input measure reflects costs (including investigator payments and pass-through costs) incurred to date relative to total estimated costs to complete (“cost-to-cost measure of progress”). Under the cost-to-cost measure of progress methodology, revenue is recorded proportionally to costs incurred. Contract costs principally include direct labor, investigator payments, and pass-through costs. The estimate of total estimated costs at completion requires significant judgment. Contract estimates are based on various assumptions to project future outcomes of events that often span several years. These estimates are reviewed periodically and any adjustments are recognized on a cumulative catch-up basis in the period they become known.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The remaining service offerings within the Clinical Solutions segment are generally short-term, month-to-month contracts, time and materials basis contracts, or provide a series of distinct services that are substantially the same and have the same pattern of transfer to the customer (“series”). As such, revenue for these service offerings is generally recognized as services are performed for the amount the Company estimates it is entitled to for the period.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-size:10pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">Commercial Solutions</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s Commercial Solutions segment provides a broad suite of complementary commercialization services including Deployment Solutions, communications (advertising and public relations), and consulting services. Deployment Solutions contracts offer outsourced services to promote commercial products on behalf of a customer.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The remaining Commercial Solutions contracts are generally short-term, month-to-month contracts or time and materials contracts. As such, Commercial Solutions revenue is generally recognized as services are performed for the amount of consideration the Company estimates it is entitled to for the period. For contracts billed on a fixed price basis, revenue is recognized over time based on the proportion of labor costs expended to total labor costs expected to complete the contract.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Accounts Receivable, Unbilled Services, and Deferred Revenue</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable are recorded at net realizable value. Unbilled accounts receivable arise when services have been rendered for which revenue has been recognized but the customers have not been billed. Contractual provisions and payment schedules may or may not correspond to the timing of the performance of services under the contract.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unbilled services include contract assets, under which the right to bill the customer is subject to factors other than the passage of time. These amounts may not exceed their net realizable value. Contract assets are generally classified as current.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue is a contract liability that consists of customer payments received in advance of performance and billings in excess of revenue recognized, net of revenue recognized from the balance at the beginning of the period.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">Timing of Billing and Performance</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Differences in the timing of revenue recognition and associated billings and cash collections result in recording of billed accounts receivable, unbilled accounts receivable (including contract assets), and deferred revenue on the consolidated balance sheet. Amounts are billed as work progresses in accordance with agreed-upon contractual terms either at periodic intervals or upon achievement of contractual milestones. Billings generally occur subsequent to revenue recognition, resulting in recording unbilled accounts receivable in instances where the right to bill is contingent solely on the passage of time (e.g., in the following month), and contract assets in instances where the right to bill is associated with achievement of a milestone.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Reimbursable Out-of-Pocket Expenses</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company incurs and is reimbursed by its customers for certain costs, including fees paid to principal investigators and for other out-of-pocket costs (such as travel expenses for the Company’s clinical monitors and sales representatives). The Company includes these costs in total operating expenses, and the related reimbursements in revenue, as the Company is the principal in the applicable arrangements and is responsible for fulfilling the promise to provide the specified services. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Share-Based Compensation</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company measures and recognizes compensation expense related to all share-based awards based on the estimated fair value of the awards. The fair value of restricted stock and stock unit awards is measured on the grant date based on the fair market value of the Company’s common stock. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based compensation expense is recognized on a straight-line basis over the shorter of the requisite service period or the vesting term. For awards with performance conditions, stock-based compensation expense is recognized when the achievement of each individual performance target becomes probable, and the number of shares expected to vest is adjusted for the weighted probability of attainment of the relevant performance targets. Forfeitures are accounted for as they occur.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All excess tax benefits and tax deficiencies (including tax benefits of dividends on share-based payment awards, if applicable) are recognized as income tax expense or benefit in the consolidated statements of income. The tax effects of exercised or vested awards are treated as discrete items in the reporting period in which they occur. The Company also recognizes excess tax benefits regardless of whether the benefit reduces taxes payable in the current period.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Income Taxes</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The majority of the Company’s U.S. subsidiaries file a consolidated U.S. federal income tax return, while certain U.S. subsidiaries, including recently acquired entities, may file separate U.S. federal tax returns. The Company’s subsidiaries in international jurisdictions file tax returns in their respective jurisdictions.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimates its tax liability based on current tax laws in the statutory jurisdictions in which it operates. Accordingly, the impact of changes in income tax laws on deferred tax assets and deferred tax liabilities is recognized in earnings in the period during which such changes are enacted. The Company records deferred tax assets and liabilities based on temporary differences between the financial reporting basis and tax basis of the Company’s assets and liabilities at enacted tax rates expected to be in effect when the differences are realized or settled.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred income tax assets represent amounts available to reduce income taxes payable on taxable income in future years. Such assets arise because of temporary differences between the financial reporting and tax bases of assets and liabilities, as well as from net operating loss and tax credit carryforwards. The Company evaluates recoverability of these future tax deductions. The Company establishes a valuation allowance for deferred income tax assets when the Company believes it is more likely than not the assets will not be realized. The Company evaluates the recoverability of these future tax deductions by assessing future expected taxable income. In estimating future taxable income, the Company considers both positive and negative evidence, such as historical and forecasted results of operations, and implementation of prudent and feasible tax planning strategies. If the objectively verifiable negative evidence outweighs any available positive evidence (or the only available positive is subjective and cannot be verified), then a valuation allowance will likely be deemed necessary. If a valuation allowance is deemed to be unnecessary, such allowance is released and any related benefit is recognized in the period of the change.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes a tax benefit from any uncertain tax positions only if they are more likely than not to be sustained upon examination based on the technical merits of the position. The Company evaluates uncertain tax positions pursuant to the more likely than not standard, and benefits related to such uncertain tax positions are recognized as the largest amount of benefit, determined on a cumulative probability basis, to be realized upon ultimate settlement of the position. Components of the reserve for uncertain tax positions are classified as either a current or a long-term liability in the accompanying consolidated balance sheets based on management’s expectation of future cash settlements.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Judgment is required in determining what constitutes an uncertain tax position, as well as assessing the outcome of each tax position. The Company considers many factors when evaluating and estimating tax positions and tax benefits. In addition, the calculation of tax liabilities involves dealing with uncertainties in the application of complex tax regulations in domestic and foreign jurisdictions. If the calculation of the liability related to uncertain tax positions proves to be more or less than the ultimate settlement, a tax expense or tax benefit, respectively, would result. Unrecognized tax benefits are presented as either a reduction to a deferred tax asset or as a separate liability.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Restructuring and Other Costs</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restructuring and other costs primarily consist of one-time employee termination benefits, contract termination costs, and other costs associated with an exit or disposal activity. The Company accounts for restructuring costs in accordance with ASC Topic 420, <span style="font-style:italic;">Exit or Disposal Cost Obligations</span>. This guidance requires that a liability for a cost associated with an exit or disposal activity be recognized in the period in which the liability is incurred, as opposed to the period in which management commits to a plan of action for termination. The guidance also requires that the liabilities associated with an exit or disposal activity be measured at the fair value in the period in which the liability is incurred, except for: (i) liabilities related to one-time employee termination benefits, which shall be measured and recognized at the date the entity notifies employees of termination, unless employees are required to render services beyond a minimum retention period, in which case the liability is recognized ratably over the future service period; and (ii) liabilities related to an operating lease, which shall be measured and recognized when the contract does not have any future economic benefit to the entity (i.e., the entity ceases to utilize the rights conveyed by the contract). Restructuring liabilities are included in accrued expenses and other long-term liabilities in the accompanying consolidated balance sheets.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Earnings Per Share</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company determines earnings per share in accordance with ASC Topic 260, <span style="font-style:italic;">Earnings Per Share</span>. The Company has one class of common stock for purposes of the earnings per share calculation and therefore computes basic earnings per share by dividing net income (loss) by the weighted average number of common shares outstanding for the applicable period. Diluted earnings per share are computed in the same manner as basic earnings per share, except that the number of shares is increased to assume exercise of potentially dilutive equity awards using the treasury stock method, unless the effect of such increase would be anti-dilutive. Under the treasury stock method, the amount the employee must pay for exercising equity awards and the amount of compensation cost for future service that the Company has not yet recognized are assumed to be used to repurchase shares.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Subsequent Events</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company considers events or transactions that occur after the balance sheet date but before the financial statements are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. The Company evaluated all events and transactions through the date that these financial statements were issued.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Recently Adopted Accounting Standards</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13 (“ASU 2016-13”), </span><span style="font-style:italic;Background-color:#FFFFFF;">Financial Instruments - Credit Losses (Topic 326) </span><span style="Background-color:#FFFFFF;">to modify the impairment model to utilize an expected loss methodology in place of the previous incurred loss methodology and require consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The Company adopted ASU 2016-13 on January 1, 2020, and recorded the impact of the adoption through a cumulative-effect adjustment to accumulated deficit. </span>Results<span style="Background-color:#FFFFFF;"> for reporting periods beginning on January 1, 2020 are presented under ASU No. 2016-13, while prior period amounts continue to be reported and disclosed in accordance with the Company’s historical accounting treatment. Adoption of the new standard resulted in the recording of additional allowance for doubtful accounts of approximately $2.8 million as of January 1, 2020.</span></p> 2 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Principles of Consolidation</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (<span style="Background-color:#FFFFFF;color:#000000;">“</span>U.S. GAAP<span style="Background-color:#FFFFFF;color:#000000;">”</span>), and include the accounts and results of operations of the Company and its controlled subsidiaries. All intercompany balances and transactions have been eliminated.</p> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Reclassification</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain previously reported amounts have been reclassified to conform to the current year presentation.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of revenue and expenses for the periods presented in the financial statements. Examples of estimates and assumptions include, but are not limited to, determining the fair value of goodwill and intangible assets and their potential impairment, useful lives of tangible and intangible assets, useful lives of assets subject to leases, valuation of the Company’s right of use assets, allowances for doubtful accounts, potential future outcomes of events for which income tax consequences have been recognized in the Company’s consolidated financial statements or tax returns, valuation allowances for deferred tax assets, fair value of share-based compensation and its recognition period, loss contingencies, fair value of derivative instruments and related hedge effectiveness, fair value of contingent tax sharing obligations, and judgments related to revenue recognition, among others. In addition, estimates and assumptions are used in the accounting for acquisitions, including the fair value and useful lives of acquired tangible and intangible assets and the fair value of assumed liabilities.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company evaluates its estimates and assumptions on an ongoing basis and bases its estimates on historical experience, current and expected future conditions, third-party evaluations, and various other assumptions that management believes are reasonable under the circumstances based on the information available to management at the time these estimates and assumptions are made. Actual results and outcomes may differ significantly from these estimates and assumptions.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Acquisitions</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for acquisitions in accordance with ASC Topic 805, <span style="font-style:italic;">Business Combinations</span>, using the acquisition method of accounting. The purchase price, or total consideration transferred, is determined as the fair value of assets exchanged, equity instruments issued, and liabilities assumed at the acquisition date. The acquisition method of accounting requires that the identifiable assets acquired, the liabilities assumed, and any non-controlling interest in the acquiree are measured and recorded at their fair values on the date of an acquisition. Goodwill represents the excess of the purchase price over the estimated fair value of the net assets acquired, including the amount assigned to identifiable intangible assets. Acquisition-related costs are expensed as incurred. The consolidated financial statements reflect the results of operations of the acquiree from the date of the acquisition. For additional information, see <span style="Background-color:#FFFFFF;color:#000000;">“</span>Note 3 – Acquisitions, Divestitures, and Investments.<span style="Background-color:#FFFFFF;color:#000000;">”</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Foreign Currency Translation and Transactions</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For subsidiaries outside of the U.S. that operate in a local currency environment, revenue and expenses are translated to U.S. dollars at the monthly average rates of exchange prevailing during the period, assets and liabilities are translated at period-end exchange rates, and equity accounts are translated at historical exchange rates. The net effect of foreign currency translation adjustments is included in shareholders’ equity as a component of accumulated other comprehensive loss in the accompanying consolidated balance sheets.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign currency transaction gains and losses are the result of exchange rate changes during the period of time between the consummation and cash settlement of transactions denominated in currencies other than the functional currency. Foreign currency transaction gains and losses are recognized in earnings as incurred and are included in other (income) expense, net in the accompanying consolidated statements of income.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Comprehensive Income</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Comprehensive income<span style="color:#FF0000;"> </span>refers to revenue, expenses, gains, and losses that, under U.S. GAAP, are recorded as an element of shareholders’ equity but are excluded from net income. The Company’s comprehensive income consists of foreign currency translation adjustments, net of applicable taxes, resulting from the translation of foreign subsidiaries with functional currencies other than the U.S. dollar and the effective portions of the unrealized gains or losses associated with derivative instruments designated and accounted for as hedging instruments.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Cash and Cash Equivalents</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents consist of demand deposits with banks and other financial institutions and highly liquid investments with an original maturity of three months or less at the date of purchase. Cash and cash equivalents are carried at cost, which approximates their fair value.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain of the Company’s subsidiaries participate in a notional cash pooling arrangement to manage global liquidity requirements. As part of a master netting arrangement, the participants combine their cash balances in pooling accounts at the same financial institution with the ability to offset bank overdrafts of one participant against positive cash account balances held by another participant. Under the terms of the master netting arrangement, the financial institution has the right, ability, and intent to offset a positive balance in one account against an overdrawn amount in another account. Amounts in each of the accounts are unencumbered and unrestricted with respect to use. As such, the net cash balance related to this pooling arrangement is included in cash, cash equivalents, and restricted cash in the accompanying consolidated balance sheets.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s net cash pool position consisted of the following as of December 31 (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross cash position</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">179,160</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">220,261</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: cash borrowings</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(167,507</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(204,647</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash position</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,653</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,614</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s net cash pool position consisted of the following as of December 31 (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross cash position</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">179,160</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">220,261</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: cash borrowings</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(167,507</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(204,647</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash position</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,653</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,614</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 179160000 220261000 167507000 204647000 11653000 15614000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Restricted Cash</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash represents cash and deposits held as security over bank deposits, lease guarantees, and insurance obligations that are restricted as to withdrawal or use. Restricted cash is classified as a current or long-term asset based on the timing and nature of when and how the cash is expected to be used or when the restrictions are expected to lapse. As of December 31, 2021 and 2020, restricted cash balances were $0.1 million and $0.3 million, respectively.</p> 100000 300000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Fair Value</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company records certain assets and liabilities at fair value in accordance with ASC Topic 820, <span style="font-style:italic;">Fair Value Measurement</span> (see <span style="Background-color:#FFFFFF;color:#000000;">“</span>Note 7 - Fair Value Measurements<span style="Background-color:#FFFFFF;color:#000000;">”</span>). Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. This guidance also specifies a fair value hierarchy that distinguishes between valuation assumptions developed based on market data obtained from independent external sources and the reporting entity’s own assumptions. Fair value measurements are classified according to the lowest level input or value-driver that is significant to the valuation. In accordance with this guidance, fair value measurements are classified under the following hierarchy:</p> <p style="margin-bottom:0pt;margin-top:12pt;margin-left:6.77%;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1 – Unadjusted quoted prices in active markets for identical instruments;</p> <p style="margin-bottom:0pt;margin-top:12pt;margin-left:6.77%;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2 – Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs or significant value-drivers are observable in active markets; and</p> <p style="margin-bottom:0pt;margin-top:12pt;margin-left:6.77%;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 3 – Model-derived valuations in which one or more significant inputs or significant value-drivers are unobservable, including internally developed models.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Derivative Financial Instruments</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Interest Rate Swaps</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company uses interest rate swaps to manage exposure to variable interest rates on its debt obligations. The Company designates its interest rate swaps as cash flow hedges because they are executed to hedge the Company’s exposure to the variability in expected future cash flows that are attributable to changes in interest rates.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Derivative financial instruments are measured at fair value and recognized in the accompanying consolidated balance sheets in prepaid expenses and other current assets, other long-term assets, accrued expenses, and other long-term liabilities, as disclosed in <span style="Background-color:#FFFFFF;color:#000000;">“</span>Note 6 – Derivatives.<span style="Background-color:#FFFFFF;color:#000000;">”</span> The fair value of interest rate swaps is determined using the market standard methodology of discounted future variable cash receipts. The variable cash receipts are determined by discounting the future expected cash receipts that would occur if variable interest rates rise above the fixed rate of the swaps. The variable interest rates used in the calculation of<span style="font-size:12pt;"> </span>projected receipts on the swap are based on an expectation of future interest rates derived from observable market interest rate curves and volatilities. Changes in the fair value of derivative instruments designated as hedging instruments are recorded each period according to the determination of the derivative’s effectiveness. The effective portion of changes in the fair value of derivatives designated as cash flow hedges is recorded in accumulated other comprehensive loss and subsequently reclassified into earnings in the period during which the hedged transaction is recognized in earnings. The ineffective portion of the change in fair value of the derivatives is recognized as non-operating income or expense immediately when incurred and included in interest expense in the accompanying consolidated statements of income.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Foreign Exchange Forward</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company utilizes a foreign exchange forward in order to minimize monthly foreign currency remeasurement gains or losses on non-functional currency monetary balances. The Company did not designate the derivative as a hedge. All changes in the fair value of the foreign exchange forward are recorded in earnings every month to other (income) expense, net <span style="Background-color:#FFFFFF;">in the </span><span style="Background-color:#FFFFFF;color:#000000;">accompanying consolidated statements of income</span>, as disclosed in <span style="Background-color:#FFFFFF;color:#000000;">“</span>Note 6 – Derivatives.<span style="Background-color:#FFFFFF;color:#000000;">”</span> </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Allowance for Doubtful Accounts</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company maintains a credit approval process and makes judgments in connection with assessing its customers’ ability to pay for contracted services. Generally, the Company has the ability to limit credit exposure by discontinuing services in the event of non-payment. The Company monitors its customers’ credit worthiness and applies judgment in establishing a provision for estimated credit losses based on historical experience, the aging of receivables, and customer-specific circumstances that would affect the customers’ ability to pay for services rendered.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Property and Equipment</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment primarily consists of furniture, vehicles, software, office equipment, computer equipment, and lab equipment. Purchased and constructed property and equipment is initially recorded at historical cost plus the estimated value of any associated legally or contractually required retirement obligations. Property and equipment acquired in an acquisition are recorded based on the estimated fair value as of the acquisition date. The Company leases vehicles for certain sales representatives in the Commercial Solutions segment. These leases are classified and accounted for as leases in accordance with ASC Topic 842, <span style="font-style:italic;">Leases</span> (<span style="Background-color:#FFFFFF;color:#000000;">“</span>ASC 842<span style="Background-color:#FFFFFF;color:#000000;">”</span>). For further information about lease arrangements, see <span style="Background-color:#FFFFFF;color:#000000;">“</span>Note 5 - Leases.<span style="Background-color:#FFFFFF;color:#000000;">”</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment assets are depreciated using the straight-line method over the respective estimated useful lives as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.78%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.36%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Useful Life</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Buildings</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.36%; border-top:solid 0.75pt #000000;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39 years</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and fixtures</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7 years</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Equipment</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000466">5 to 10 years</span></p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment and software</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000468">2 to 3 years</span></p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vehicles</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lesser of lease term or the estimated economic life of the leased asset</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lesser of remaining life of lease or the useful life of the asset</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expenditures for repairs and maintenance are expensed as incurred and expenditures for major improvements that increase the functionality or extend the useful life of the asset are capitalized and depreciated over the estimated useful life of the asset.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company capitalizes costs of computer software obtained for internal use and amortizes these costs on a straight-line basis over the estimated useful life of the product, not to exceed five years. Software cloud computing arrangements containing a software license are accounted for consistently with the acquisition of other software licenses. In the event such an arrangement does not contain a software license, the Company accounts for the arrangement as a service contract.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company reviews property and equipment for impairment whenever facts and circumstances indicate that the carrying amounts of these assets might not be recoverable. For assessment purposes, property and equipment are grouped with other assets and liabilities at the lowest level that identifiable cash flows are largely independent of the cash flows of other assets and liabilities. Recoverability of the carrying amount of an asset group is assessed by comparing its carrying amount to the estimated undiscounted future cash flows expected to be generated by the asset group. If the carrying value of the asset group exceeds its fair value, an impairment charge is recognized for the excess.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment assets are depreciated using the straight-line method over the respective estimated useful lives as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.78%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.36%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Useful Life</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Buildings</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.36%; border-top:solid 0.75pt #000000;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39 years</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and fixtures</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7 years</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Equipment</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000466">5 to 10 years</span></p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment and software</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000468">2 to 3 years</span></p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vehicles</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lesser of lease term or the estimated economic life of the leased asset</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lesser of remaining life of lease or the useful life of the asset</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net of accumulated depreciation, consisted of the following as of December 31 (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Software</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">159,736</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">129,731</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">96,188</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94,596</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91,937</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108,230</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vehicles</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77,674</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63,985</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Office furniture, fixtures, and equipment</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65,018</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,287</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Buildings and land</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,692</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,211</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets not yet placed in service</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,706</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,129</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, gross</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">524,951</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">467,169</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Accumulated depreciation</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(302,294</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(250,969</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">222,657</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">216,200</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> P39Y P7Y P5Y <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Leases</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#212529;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At inception, a contract contains a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. In evaluating whether it has the right to control the use of an identified asset, the Company assesses whether they have the right to direct the use of the identified asset and to obtain substantially all of the economic benefit from the use of the identified asset.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#212529;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right-of-use (<span style="Background-color:#FFFFFF;color:#000000;">“</span>ROU<span style="Background-color:#FFFFFF;color:#000000;">”</span>) assets represent the Company<span style="color:#000000;">’</span>s right to use an underlying asset during the lease term and lease liabilities represent the Company<span style="color:#000000;">’</span>s obligation to make lease payments arising from the lease. Assets and liabilities are recognized based on the present value of lease payments over the lease term. Most leases include one or more options to renew. The exercise of the renewal option is at the Company<span style="color:#000000;">’</span>s sole discretion and the Company includes these options in determining the lease term used to establish its right-of-use assets and lease liabilities when it is reasonably certain the Company will exercise its option.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#212529;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because most of the Company<span style="color:#000000;">’</span>s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The Company uses the implicit rate when readily determinable. Operating lease expense is generally recognized on a straight-line basis over the lease term.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#212529;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#212529;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has agreements with lease and non-lease components, which are accounted for as a single lease component. Leases with a lease term of 12 months or less are not recorded on the balance sheet. The Company recognizes lease expense for these leases on a straight-line basis over the lease term. Variable lease payment amounts that cannot be determined at the commencement of the lease, such as increases in lease payments based on changes in index rates, are not included in the right-of-use assets or liabilities. These variable lease payments are expensed as incurred.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Goodwill and Intangible Assets</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill represents the excess of the purchase price over the estimated fair value of net assets acquired, including the amount assigned to identifiable intangible assets, in acquisitions. In accordance with ASC Topic 350, <span style="font-style:italic;">Intangibles </span>–<span style="font-style:italic;"> Goodwill and Other</span>, goodwill is not subject to amortization but must be tested for impairment annually or more frequently if events or changes in circumstances indicate that goodwill might be impaired. Goodwill is tested for impairment at the reporting unit level, which is one level below the operating segment level. This test requires the Company to determine if the implied fair value of the reporting unit’s goodwill is less than its carrying amount.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has assigned goodwill to four reporting units. The Company completed an annual impairment test as of October 1, 2021 for all of its reporting units, and concluded that there were no impairments.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets consist of customer relationships, acquired backlog, trade names, trademarks, patient communities, and acquired technologies. The Company amortizes intangible assets related to customer relationships, trade names, trademarks, patient communities, and acquired technologies on a straight-line basis over the estimated useful life of the asset. Intangible assets related to acquired backlog are amortized based on the Company’s expectations of the timing of when revenue associated with the backlog is expected to be recognized.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company reviews intangible assets at the end of each reporting period to determine if facts and circumstances indicate that the useful life is shorter than originally estimated or that the carrying amount of the assets might not be recoverable. If such facts and circumstances exist, the Company assesses the recoverability of identified assets by comparing the projected undiscounted cash flows associated with the related asset or group of assets to their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amount over the fair value of those assets and occur in the period in which the impairment determination is made.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The weighted average estimated useful lives of the Company’s intangible assets were as follows as of December 31:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer relationships</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.8 years</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.9 years</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired backlog</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.6 years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.6 years</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trade names and trademarks</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.5 years</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.5 years</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intellectual property (medical patent)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">n/a</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.0 years</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Patient communities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.0 years</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">n/a</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired technologies</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.0 years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">n/a</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No intangible asset impairment charges were recorded for the years ended December 31, 2021 or 2020. For additional information regarding the carrying values of intangible assets, see <span style="Background-color:#FFFFFF;color:#000000;">“</span>Note 2 – Financial Statement Details.<span style="Background-color:#FFFFFF;color:#000000;">”</span></p> 4 0 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The weighted average estimated useful lives of the Company’s intangible assets were as follows as of December 31:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer relationships</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.8 years</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.9 years</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired backlog</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.6 years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.6 years</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trade names and trademarks</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.5 years</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.5 years</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intellectual property (medical patent)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">n/a</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.0 years</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Patient communities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.0 years</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">n/a</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired technologies</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.0 years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">n/a</p></td> </tr> </table></div> P9Y9M18D P9Y10M24D P2Y7M6D P2Y7M6D P5Y6M P5Y6M P9Y P6Y P6Y 0 0 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Contingencies</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the normal course of business, the Company periodically becomes involved in various proceedings and claims, including investigations, disputes, litigations, and regulatory matters that are incidental to its business. The Company evaluates the likelihood of an unfavorable outcome of all legal and regulatory matters and records accruals for probable loss contingencies for which the amount of the loss can be reasonably estimated. Gain contingencies are not recognized until realized. Legal fees are expensed as incurred.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because these matters are inherently unpredictable, and unfavorable developments or resolutions can occur, assessing contingencies is highly subjective and requires judgments about future events. These judgments and estimates are based, among other factors, on the status of the proceedings, the merits of the Company’s defenses, and the consultation with in-house and external counsel. The Company regularly reviews contingencies to determine whether its accruals and related disclosures are adequate. Although the Company believes that it has substantial defenses in these matters, the amount of losses incurred as a result of actual outcomes may differ significantly from the Company’s estimates.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Revenue Recognition</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accordance with ASC Topic 606, <span style="font-style:italic;">Revenue from Contracts with Customers</span> and all related amendments (“ASC 606”), revenue is recognized when, or as, a customer obtains control of promised services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these services.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A performance obligation is a promise (or a combination of promises) in a contract to transfer distinct goods or services to a customer and is the unit of accounting under ASC 606 for the purposes of revenue recognition. A contract’s transaction price is allocated to each performance obligation and is recognized as revenue, when, or as, each performance obligation is satisfied. The majority of the Company’s Clinical Solutions segment contracts have a single performance obligation because the promise to transfer individual services is not separately identifiable from other promises in the contracts, and therefore, is not distinct. For contracts with multiple performance obligations, the contract’s transaction price is allocated to each performance obligation using the best estimate of the standalone selling price of each distinct good or service in the contract.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The majority of the Company’s revenue arrangements are service contracts that range in duration from a few months to several years. Substantially all of the Company’s performance obligations, and associated revenue, are transferred to the customer over time. The Company generally receives compensation based on measuring progress toward completion using anticipated project budgets for direct labor and prices for each service offering. The Company is also reimbursed for certain third-party pass-through and out-of-pocket costs. In addition, in certain instances a customer contract may include forms of variable consideration such as incentive fees, volume rebates or other provisions that can increase or decrease the transaction price. This variable consideration is generally awarded upon achievement of certain performance metrics, program milestones or cost targets. For the purposes of revenue recognition, variable consideration is assessed on a contract-by-contract basis and the amount included in the transaction price is estimated based on the Company’s anticipated performance and consideration of all information that is reasonably available. Variable consideration is recognized as revenue if and when it is deemed probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved in the future.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Most of the Company’</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s contracts can be terminated by the customer without cause with a </span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">notice period that generally ranges from 30</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> to </span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90 </span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">day</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. In the event of </span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">termination, the Company’</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s contracts generally provide that the customer pay the Company for: (i) fees earned through the termination date; (ii) fees and expenses for winding down the project, which include both fees incurred and actual expenses; (iii) non-cancellable expenditures; and (iv) in some cases, a fee to cover a portion of the remaining professional fees on the project</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> long-term clinical trial contracts contain implied substantive termination penalties because of the significant wind-down cost of terminating a clinical trial. These provisions for termination penalties result in these types of contracts being treated as long-term for revenue recognition purposes. </span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in the scope of work are common, especially under long-term contracts, and generally result in a change in the total contract transaction price. If the customer does not agree to a contract modification, the Company could bear the risk of cost overruns. Most of the Company’s contract modifications are for services that are not distinct from the services under the existing contract due to the significant integration service provided in the context of the contract and therefore result in a cumulative catch-up adjustment to revenue at the date of contract modification.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">Capitalized Costs</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company capitalizes certain costs associated with commissions and bonuses paid to its employees in the Clinical Solutions segment because these costs are incurred in obtaining contracts that have a term greater than one year. Capitalized costs are included in prepaid expenses and other current assets and other long-term assets in the accompanying consolidated balance sheets. The Company amortizes these costs in a manner that is consistent with the pattern of revenue recognition described below. The Company expenses costs to obtain contracts that have a term of one year or less.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">Clinical Solutions</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s Clinical Solutions segment provides solutions to address the clinical development needs of customers. The Company provides total biopharmaceutical program development through its full-service platform, while also providing discrete services for any part of a clinical trial, primarily through functional service provider, Early Stage, and Real World and Late Phase (“RWLP”) services. The services provided via the full-service platform and RWLP platforms generally span several years and a significant benefit to the customer is provided by integrating the services provided by the Company’s employees as well as those performed by third parties. Because the Company’s full-service platform provides a significant integration service to the customer, these contracts contain a single performance obligation. Revenue is recognized over time using an input measure of progress. The input measure reflects costs (including investigator payments and pass-through costs) incurred to date relative to total estimated costs to complete (“cost-to-cost measure of progress”). Under the cost-to-cost measure of progress methodology, revenue is recorded proportionally to costs incurred. Contract costs principally include direct labor, investigator payments, and pass-through costs. The estimate of total estimated costs at completion requires significant judgment. Contract estimates are based on various assumptions to project future outcomes of events that often span several years. These estimates are reviewed periodically and any adjustments are recognized on a cumulative catch-up basis in the period they become known.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The remaining service offerings within the Clinical Solutions segment are generally short-term, month-to-month contracts, time and materials basis contracts, or provide a series of distinct services that are substantially the same and have the same pattern of transfer to the customer (“series”). As such, revenue for these service offerings is generally recognized as services are performed for the amount the Company estimates it is entitled to for the period.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-size:10pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">Commercial Solutions</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s Commercial Solutions segment provides a broad suite of complementary commercialization services including Deployment Solutions, communications (advertising and public relations), and consulting services. Deployment Solutions contracts offer outsourced services to promote commercial products on behalf of a customer.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The remaining Commercial Solutions contracts are generally short-term, month-to-month contracts or time and materials contracts. As such, Commercial Solutions revenue is generally recognized as services are performed for the amount of consideration the Company estimates it is entitled to for the period. For contracts billed on a fixed price basis, revenue is recognized over time based on the proportion of labor costs expended to total labor costs expected to complete the contract.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Accounts Receivable, Unbilled Services, and Deferred Revenue</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable are recorded at net realizable value. Unbilled accounts receivable arise when services have been rendered for which revenue has been recognized but the customers have not been billed. Contractual provisions and payment schedules may or may not correspond to the timing of the performance of services under the contract.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unbilled services include contract assets, under which the right to bill the customer is subject to factors other than the passage of time. These amounts may not exceed their net realizable value. Contract assets are generally classified as current.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue is a contract liability that consists of customer payments received in advance of performance and billings in excess of revenue recognized, net of revenue recognized from the balance at the beginning of the period.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">Timing of Billing and Performance</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Differences in the timing of revenue recognition and associated billings and cash collections result in recording of billed accounts receivable, unbilled accounts receivable (including contract assets), and deferred revenue on the consolidated balance sheet. Amounts are billed as work progresses in accordance with agreed-upon contractual terms either at periodic intervals or upon achievement of contractual milestones. Billings generally occur subsequent to revenue recognition, resulting in recording unbilled accounts receivable in instances where the right to bill is contingent solely on the passage of time (e.g., in the following month), and contract assets in instances where the right to bill is associated with achievement of a milestone.</p>The Company expects to recognize revenue over the remaining contract term of the individual projects, with contract terms generally ranging from one to five years. The amount of unsatisfied performance obligations is presented net of any constraints and, as a result, is lower than the potential contractual revenue. The contracts excluded due to constraints include contracts that do not commence within a certain period of time or that require the Company to undertake numerous activities to fulfill these performance obligations, including various activities that are outside of the Company’s control. <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Reimbursable Out-of-Pocket Expenses</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company incurs and is reimbursed by its customers for certain costs, including fees paid to principal investigators and for other out-of-pocket costs (such as travel expenses for the Company’s clinical monitors and sales representatives). The Company includes these costs in total operating expenses, and the related reimbursements in revenue, as the Company is the principal in the applicable arrangements and is responsible for fulfilling the promise to provide the specified services. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Share-Based Compensation</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company measures and recognizes compensation expense related to all share-based awards based on the estimated fair value of the awards. The fair value of restricted stock and stock unit awards is measured on the grant date based on the fair market value of the Company’s common stock. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based compensation expense is recognized on a straight-line basis over the shorter of the requisite service period or the vesting term. For awards with performance conditions, stock-based compensation expense is recognized when the achievement of each individual performance target becomes probable, and the number of shares expected to vest is adjusted for the weighted probability of attainment of the relevant performance targets. Forfeitures are accounted for as they occur.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All excess tax benefits and tax deficiencies (including tax benefits of dividends on share-based payment awards, if applicable) are recognized as income tax expense or benefit in the consolidated statements of income. The tax effects of exercised or vested awards are treated as discrete items in the reporting period in which they occur. The Company also recognizes excess tax benefits regardless of whether the benefit reduces taxes payable in the current period.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Income Taxes</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The majority of the Company’s U.S. subsidiaries file a consolidated U.S. federal income tax return, while certain U.S. subsidiaries, including recently acquired entities, may file separate U.S. federal tax returns. The Company’s subsidiaries in international jurisdictions file tax returns in their respective jurisdictions.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimates its tax liability based on current tax laws in the statutory jurisdictions in which it operates. Accordingly, the impact of changes in income tax laws on deferred tax assets and deferred tax liabilities is recognized in earnings in the period during which such changes are enacted. The Company records deferred tax assets and liabilities based on temporary differences between the financial reporting basis and tax basis of the Company’s assets and liabilities at enacted tax rates expected to be in effect when the differences are realized or settled.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred income tax assets represent amounts available to reduce income taxes payable on taxable income in future years. Such assets arise because of temporary differences between the financial reporting and tax bases of assets and liabilities, as well as from net operating loss and tax credit carryforwards. The Company evaluates recoverability of these future tax deductions. The Company establishes a valuation allowance for deferred income tax assets when the Company believes it is more likely than not the assets will not be realized. The Company evaluates the recoverability of these future tax deductions by assessing future expected taxable income. In estimating future taxable income, the Company considers both positive and negative evidence, such as historical and forecasted results of operations, and implementation of prudent and feasible tax planning strategies. If the objectively verifiable negative evidence outweighs any available positive evidence (or the only available positive is subjective and cannot be verified), then a valuation allowance will likely be deemed necessary. If a valuation allowance is deemed to be unnecessary, such allowance is released and any related benefit is recognized in the period of the change.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes a tax benefit from any uncertain tax positions only if they are more likely than not to be sustained upon examination based on the technical merits of the position. The Company evaluates uncertain tax positions pursuant to the more likely than not standard, and benefits related to such uncertain tax positions are recognized as the largest amount of benefit, determined on a cumulative probability basis, to be realized upon ultimate settlement of the position. Components of the reserve for uncertain tax positions are classified as either a current or a long-term liability in the accompanying consolidated balance sheets based on management’s expectation of future cash settlements.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Judgment is required in determining what constitutes an uncertain tax position, as well as assessing the outcome of each tax position. The Company considers many factors when evaluating and estimating tax positions and tax benefits. In addition, the calculation of tax liabilities involves dealing with uncertainties in the application of complex tax regulations in domestic and foreign jurisdictions. If the calculation of the liability related to uncertain tax positions proves to be more or less than the ultimate settlement, a tax expense or tax benefit, respectively, would result. Unrecognized tax benefits are presented as either a reduction to a deferred tax asset or as a separate liability.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Restructuring and Other Costs</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restructuring and other costs primarily consist of one-time employee termination benefits, contract termination costs, and other costs associated with an exit or disposal activity. The Company accounts for restructuring costs in accordance with ASC Topic 420, <span style="font-style:italic;">Exit or Disposal Cost Obligations</span>. This guidance requires that a liability for a cost associated with an exit or disposal activity be recognized in the period in which the liability is incurred, as opposed to the period in which management commits to a plan of action for termination. The guidance also requires that the liabilities associated with an exit or disposal activity be measured at the fair value in the period in which the liability is incurred, except for: (i) liabilities related to one-time employee termination benefits, which shall be measured and recognized at the date the entity notifies employees of termination, unless employees are required to render services beyond a minimum retention period, in which case the liability is recognized ratably over the future service period; and (ii) liabilities related to an operating lease, which shall be measured and recognized when the contract does not have any future economic benefit to the entity (i.e., the entity ceases to utilize the rights conveyed by the contract). Restructuring liabilities are included in accrued expenses and other long-term liabilities in the accompanying consolidated balance sheets.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Earnings Per Share</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company determines earnings per share in accordance with ASC Topic 260, <span style="font-style:italic;">Earnings Per Share</span>. The Company has one class of common stock for purposes of the earnings per share calculation and therefore computes basic earnings per share by dividing net income (loss) by the weighted average number of common shares outstanding for the applicable period. Diluted earnings per share are computed in the same manner as basic earnings per share, except that the number of shares is increased to assume exercise of potentially dilutive equity awards using the treasury stock method, unless the effect of such increase would be anti-dilutive. Under the treasury stock method, the amount the employee must pay for exercising equity awards and the amount of compensation cost for future service that the Company has not yet recognized are assumed to be used to repurchase shares.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Subsequent Events</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company considers events or transactions that occur after the balance sheet date but before the financial statements are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. The Company evaluated all events and transactions through the date that these financial statements were issued.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Recently Adopted Accounting Standards</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13 (“ASU 2016-13”), </span><span style="font-style:italic;Background-color:#FFFFFF;">Financial Instruments - Credit Losses (Topic 326) </span><span style="Background-color:#FFFFFF;">to modify the impairment model to utilize an expected loss methodology in place of the previous incurred loss methodology and require consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The Company adopted ASU 2016-13 on January 1, 2020, and recorded the impact of the adoption through a cumulative-effect adjustment to accumulated deficit. </span>Results<span style="Background-color:#FFFFFF;"> for reporting periods beginning on January 1, 2020 are presented under ASU No. 2016-13, while prior period amounts continue to be reported and disclosed in accordance with the Company’s historical accounting treatment. Adoption of the new standard resulted in the recording of additional allowance for doubtful accounts of approximately $2.8 million as of January 1, 2020.</span></p> 2020-01-01 2800000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2. Financial Statement Details</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Accounts Receivable and Unbilled Services, net</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable and unbilled services (including contract assets), net of allowance for doubtful accounts, consisted of the following as of December 31 (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable billed</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">873,265</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">774,605</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable unbilled</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">241,799</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">211,285</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contract assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">417,411</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">366,506</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Allowance for doubtful accounts</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,585</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,615</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable and unbilled services, net</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,524,890</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,344,781</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the changes in the allowance for doubtful accounts (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.12%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at the beginning of the period</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,615</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,381</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,587</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Impact from adoption of ASU 2016-13</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,771</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current year provision</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(367</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(695</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,897</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Write-offs, net of recoveries and the effects of foreign currency exchange</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">397</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,232</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,103</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at the end of the period</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,585</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,615</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,381</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Accounts Receivable Factoring Arrangement</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has an accounts receivable factoring agreement to sell certain eligible unsecured trade accounts receivable, at its option, without recourse, to an unrelated third-party financial institution for cash. For the years ended December 31, 2021 and 2020, the Company factored $129.1 million and $152.4 million, respectively, of trade accounts receivable on a non-recourse basis and received $128.9 million and $151.9 million, respectively, in cash proceeds from the sale. The fees associated with these transactions were insignificant.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Property and Equipment, net</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net of accumulated depreciation, consisted of the following as of December 31 (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Software</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">159,736</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">129,731</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">96,188</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94,596</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91,937</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108,230</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vehicles</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77,674</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63,985</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Office furniture, fixtures, and equipment</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65,018</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,287</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Buildings and land</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,692</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,211</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets not yet placed in service</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,706</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,129</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, gross</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">524,951</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">467,169</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Accumulated depreciation</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(302,294</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(250,969</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">222,657</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">216,200</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021 and 2020, the gross book value of vehicles under finance leases was $77.7 million and $64.0 million, respectively, and accumulated depreciation was $30.0 million and $20.5 million, respectively. For the years ended December 31, 2021 and 2020, amortization charges related to these assets, net of rebates, were $17.5 million and $15.8 million, respectively, and were included in depreciation on the accompanying consolidated statements of income.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Goodwill and Intangible Assets</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The changes in carrying amount of goodwill by segment were as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.92%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Clinical</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Solutions (a)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.92%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Commercial</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Solutions (b)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.92%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,784,952</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,565,428</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,350,380</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquisitions and divestitures (c)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">418,619</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(14,453</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">404,166</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Impact of foreign currency translation</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,764</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,868</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,632</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,216,335</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,559,843</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,776,178</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquisitions (d)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">192,286</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">192,286</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Impact of foreign currency translation and other (e)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,078</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(52,527</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12,449</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2021</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,448,699</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,507,316</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,956,015</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) Accumulated impairment losses of $8.1 million associated with the Clinical Solutions segment were recorded prior to 2016 and related to the former Phase I Services segment, now a component of the Clinical Solutions segment. No impairment of goodwill was recorded for the years ended December 31, 2021, 2020, or 2019.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b) Accumulated impairment losses of $8.0 million associated with the Commercial Solutions segment were recorded prior to 2015 and related to the former Global Consulting segment, now a component of the Commercial Solutions segment. No impairment of goodwill was recorded for the years ended December 31, 2021, 2020, or 2019.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c) Amounts represent goodwill recognized in connection with the 2020 acquisitions of <span style="Background-color:#FFFFFF;color:#000000;">SHCR Holdings Corporation (“Synteract”)</span> and <span style="Background-color:#FFFFFF;color:#000000;">Illingworth Research Group™ (“Illingworth Research”)</span><span style="color:#000000;"> </span>within the Clinical Solutions segment and goodwill disposed upon the sale of the medication adherence business within the Commercial Solutions segment.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d) <span style="color:#000000;">Amount represents goodwill recognized in connection with the acquisitions of StudyKIK Corporation (“StudyKIK”) and RxDataScience, Inc. (“RxDataScience”), other insignificant acquisitions in 2021, and insignificant measurement period adjustments recognized in connection with the 2020 acquisitions of </span><span style="Background-color:#FFFFFF;color:#000000;">Synteract and Illingworth Research</span><span style="color:#000000;"> within the Clinical Solutions segment.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e) <span style="Background-color:#FFFFFF;">Includes $44.2 million reallocation of goodwill from the Commercial Solutions segment to the Clinical Solutions segment to reflect the transfer of the Kinapse Regulatory and Operations Consulting service lines to align with management reporting in 2021.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets, net consisted of the following (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.52%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.52%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Gross</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Gross</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.52%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer relationships</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,547,925</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(811,542</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">736,383</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,518,081</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(685,021</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">833,060</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.52%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired backlog</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">175,826</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(154,475</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,351</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">174,180</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(132,733</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,447</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.52%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trade names and trademarks</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55,728</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(28,806</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,922</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52,475</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21,817</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,658</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.52%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intellectual property (medical patent)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,028</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,668</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,360</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.52%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Patient communities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45,100</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,192</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,908</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.52%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired technologies</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,800</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,297</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,503</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.52%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets, net</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,852,379</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(998,312</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">854,067</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,774,764</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(841,239</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">933,525</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The future estimated amortization expense for intangible assets as of December 31, 2021 is expected to be as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%; border-bottom:solid 0.75pt #000000;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:15.8%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%; border-top:solid 0.75pt #000000;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">162,193</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">153,334</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">146,487</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">132,512</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">110,597</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2027 and thereafter</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">148,944</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">854,067</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Accrued Expenses</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses consisted of the following as of December 31 (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Professional fees, investigator fees, and pass-through costs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">283,432</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">231,638</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Compensation, including bonuses, fringe benefits, and payroll taxes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">215,386</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">255,042</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income and other taxes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,723</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,890</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Rebates to customers</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,367</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,528</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restructuring and other costs, current portion</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,657</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,830</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contingent obligations, current</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,397</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,327</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest rate swaps - current</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,827</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,045</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55,652</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45,742</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accrued expenses</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">614,441</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">611,042</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Accumulated Other Comprehensive Loss, Net of Taxes</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated other comprehensive loss, net of taxes, consisted of the following (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.32%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning balance</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(40,801</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(71,593</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Derivative Instruments:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning balance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18,761</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(14,836</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive gain (loss) before reclassifications</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,963</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,446</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reclassification adjustments</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,177</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,521</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ending balance</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,621</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18,761</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign Currency Translation:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning balance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(22,040</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(56,757</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive (loss) income before reclassifications</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(24,957</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,717</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ending balance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(46,997</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(22,040</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated other comprehensive loss, net of taxes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(49,618</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(40,801</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in accumulated other comprehensive loss consisted of the following (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrealized loss on derivative instruments:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrealized gain (loss) during period, before taxes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,084</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(27,647</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(14,306</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax expense (benefit)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,121</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,201</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,777</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrealized gain (loss) during period, net of taxes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,963</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,446</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11,529</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reclassification adjustment, before taxes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,655</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,328</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,588</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax expense</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,478</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,807</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">655</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reclassification adjustment, net of taxes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,177</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,521</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,933</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total unrealized gain (loss) on derivative instruments, net of taxes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,140</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,925</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,596</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign currency translation adjustments:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign currency translation adjustments, before taxes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26,429</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,071</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,198</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax (benefit) expense</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,472</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,354</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign currency translation adjustments, net of taxes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(24,957</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,717</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,198</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total other comprehensive (loss) income, net of taxes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,817</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,792</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,602</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Other (Income) Expense, Net</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other (income) expense, net consisted of the following (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.88%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.88%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net realized foreign currency loss</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,190</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,175</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,853</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net unrealized foreign currency (gain) loss</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,928</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,147</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,166</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain on sale of business</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,133</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Equity investment (income) expense</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,950</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,745</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">261</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.88%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other, net</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,945</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">580</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">882</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.88%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total other (income) expense, net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,633</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,976</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,162</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Supplemental disclosure of cash flow information</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table provides details of supplemental cash flow information (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.4%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.26%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.4%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.4%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for income taxes, net of refunds</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,100</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,400</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,200</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.4%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for interest (excluding finance leases)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63,952</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83,690</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">129,756</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.4%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Supplemental disclosure of noncash investing and financing activities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.4%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-cash investment to acquire certain intellectual property rights from a customer in lieu of cash payment for services rendered</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,300</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.4%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value of contingent consideration related to acquisitions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,158</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.4%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in property and equipment included in liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,753</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,684</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,977</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.4%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vehicles acquired through finance lease agreements</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,994</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,203</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,701</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable and unbilled services (including contract assets), net of allowance for doubtful accounts, consisted of the following as of December 31 (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable billed</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">873,265</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">774,605</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable unbilled</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">241,799</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">211,285</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contract assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">417,411</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">366,506</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Allowance for doubtful accounts</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,585</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,615</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable and unbilled services, net</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,524,890</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,344,781</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 873265000 774605000 241799000 211285000 417411000 366506000 7585000 7615000 1524890000 1344781000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the changes in the allowance for doubtful accounts (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.12%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at the beginning of the period</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,615</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,381</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,587</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Impact from adoption of ASU 2016-13</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,771</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current year provision</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(367</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(695</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,897</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Write-offs, net of recoveries and the effects of foreign currency exchange</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">397</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,232</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,103</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at the end of the period</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,585</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,615</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,381</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> 7615000 5381000 4587000 -2771000 -367000 -695000 -1897000 397000 1232000 1103000 7585000 7615000 5381000 129100000 152400000 128900000 151900000 159736000 129731000 96188000 94596000 91937000 108230000 77674000 63985000 65018000 37287000 5692000 5211000 28706000 28129000 524951000 467169000 302294000 250969000 222657000 216200000 77700000 64000000.0 30000000.0 20500000 17500000 15800000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The changes in carrying amount of goodwill by segment were as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.92%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Clinical</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Solutions (a)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.92%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Commercial</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Solutions (b)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.92%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,784,952</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,565,428</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,350,380</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquisitions and divestitures (c)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">418,619</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(14,453</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">404,166</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Impact of foreign currency translation</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,764</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,868</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,632</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,216,335</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,559,843</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,776,178</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquisitions (d)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">192,286</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">192,286</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Impact of foreign currency translation and other (e)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,078</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(52,527</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12,449</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2021</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,448,699</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,507,316</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,956,015</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) Accumulated impairment losses of $8.1 million associated with the Clinical Solutions segment were recorded prior to 2016 and related to the former Phase I Services segment, now a component of the Clinical Solutions segment. No impairment of goodwill was recorded for the years ended December 31, 2021, 2020, or 2019.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b) Accumulated impairment losses of $8.0 million associated with the Commercial Solutions segment were recorded prior to 2015 and related to the former Global Consulting segment, now a component of the Commercial Solutions segment. No impairment of goodwill was recorded for the years ended December 31, 2021, 2020, or 2019.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c) Amounts represent goodwill recognized in connection with the 2020 acquisitions of <span style="Background-color:#FFFFFF;color:#000000;">SHCR Holdings Corporation (“Synteract”)</span> and <span style="Background-color:#FFFFFF;color:#000000;">Illingworth Research Group™ (“Illingworth Research”)</span><span style="color:#000000;"> </span>within the Clinical Solutions segment and goodwill disposed upon the sale of the medication adherence business within the Commercial Solutions segment.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d) <span style="color:#000000;">Amount represents goodwill recognized in connection with the acquisitions of StudyKIK Corporation (“StudyKIK”) and RxDataScience, Inc. (“RxDataScience”), other insignificant acquisitions in 2021, and insignificant measurement period adjustments recognized in connection with the 2020 acquisitions of </span><span style="Background-color:#FFFFFF;color:#000000;">Synteract and Illingworth Research</span><span style="color:#000000;"> within the Clinical Solutions segment.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e) <span style="Background-color:#FFFFFF;">Includes $44.2 million reallocation of goodwill from the Commercial Solutions segment to the Clinical Solutions segment to reflect the transfer of the Kinapse Regulatory and Operations Consulting service lines to align with management reporting in 2021.</span></p> 2784952000 1565428000 4350380000 418619000 -14453000 404166000 -12764000 -8868000 -21632000 3216335000 1559843000 4776178000 192286000 192286000 -40078000 52527000 12449000 3448699000 1507316000 4956015000 8100000 8100000 8100000 0 0 0 0 0 0 8000000.0 8000000.0 8000000.0 44200000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets, net consisted of the following (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.52%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.52%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Gross</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Gross</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.52%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer relationships</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,547,925</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(811,542</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">736,383</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,518,081</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(685,021</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">833,060</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.52%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired backlog</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">175,826</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(154,475</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,351</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">174,180</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(132,733</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,447</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.52%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trade names and trademarks</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55,728</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(28,806</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,922</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52,475</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21,817</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,658</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.52%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intellectual property (medical patent)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,028</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,668</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,360</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.52%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Patient communities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45,100</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,192</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,908</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.52%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired technologies</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,800</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,297</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,503</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.52%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets, net</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,852,379</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(998,312</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">854,067</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,774,764</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(841,239</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">933,525</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets, net consisted of the following (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.52%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.52%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Gross</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Gross</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.52%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer relationships</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,547,925</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(811,542</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">736,383</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,518,081</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(685,021</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">833,060</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.52%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired backlog</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">175,826</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(154,475</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,351</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">174,180</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(132,733</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,447</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.52%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trade names and trademarks</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55,728</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(28,806</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,922</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52,475</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21,817</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,658</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.52%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intellectual property (medical patent)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,028</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,668</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,360</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.52%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Patient communities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45,100</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,192</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,908</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.52%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired technologies</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,800</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,297</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,503</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.52%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets, net</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,852,379</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(998,312</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">854,067</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,774,764</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(841,239</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">933,525</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> 1547925000 811542000 736383000 1518081000 685021000 833060000 175826000 154475000 21351000 174180000 132733000 41447000 55728000 28806000 26922000 52475000 21817000 30658000 30028000 1668000 28360000 45100000 2192000 42908000 27800000 1297000 26503000 1852379000 998312000 854067000 1774764000 841239000 933525000 The future estimated amortization expense for intangible assets as of December 31, 2021 is expected to be as follows (in thousands): <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%; border-bottom:solid 0.75pt #000000;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:15.8%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%; border-top:solid 0.75pt #000000;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">162,193</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">153,334</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">146,487</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">132,512</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">110,597</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2027 and thereafter</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">148,944</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">854,067</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> 162193000 153334000 146487000 132512000 110597000 148944000 854067000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses consisted of the following as of December 31 (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Professional fees, investigator fees, and pass-through costs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">283,432</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">231,638</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Compensation, including bonuses, fringe benefits, and payroll taxes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">215,386</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">255,042</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income and other taxes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,723</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,890</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Rebates to customers</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,367</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,528</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restructuring and other costs, current portion</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,657</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,830</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contingent obligations, current</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,397</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,327</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest rate swaps - current</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,827</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,045</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55,652</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45,742</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accrued expenses</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">614,441</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">611,042</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 283432000 231638000 215386000 255042000 25723000 28890000 22367000 22528000 6657000 5830000 3397000 4327000 1827000 17045000 55652000 45742000 614441000 611042000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated other comprehensive loss, net of taxes, consisted of the following (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.32%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning balance</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(40,801</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(71,593</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Derivative Instruments:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning balance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18,761</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(14,836</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive gain (loss) before reclassifications</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,963</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,446</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reclassification adjustments</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,177</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,521</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ending balance</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,621</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18,761</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign Currency Translation:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning balance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(22,040</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(56,757</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive (loss) income before reclassifications</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(24,957</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,717</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ending balance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(46,997</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(22,040</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated other comprehensive loss, net of taxes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(49,618</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(40,801</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> -40801000 -71593000 -18761000 -14836000 2963000 -20446000 -13177000 -16521000 -2621000 -18761000 -22040000 -56757000 -24957000 34717000 -46997000 -22040000 -49618000 -40801000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in accumulated other comprehensive loss consisted of the following (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrealized loss on derivative instruments:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrealized gain (loss) during period, before taxes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,084</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(27,647</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(14,306</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax expense (benefit)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,121</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,201</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,777</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrealized gain (loss) during period, net of taxes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,963</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,446</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11,529</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reclassification adjustment, before taxes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,655</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,328</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,588</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax expense</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,478</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,807</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">655</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reclassification adjustment, net of taxes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,177</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,521</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,933</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total unrealized gain (loss) on derivative instruments, net of taxes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,140</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,925</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,596</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign currency translation adjustments:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign currency translation adjustments, before taxes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26,429</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,071</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,198</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax (benefit) expense</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,472</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,354</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign currency translation adjustments, net of taxes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(24,957</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,717</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,198</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total other comprehensive (loss) income, net of taxes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,817</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,792</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,602</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 4084000 -27647000 -14306000 1121000 -7201000 -2777000 2963000 -20446000 -11529000 -17655000 -22328000 -4588000 4478000 5807000 655000 -13177000 -16521000 -3933000 16140000 -3925000 -7596000 -26429000 36071000 24198000 -1472000 1354000 -24957000 34717000 24198000 -8817000 30792000 16602000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other (income) expense, net consisted of the following (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.88%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.88%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net realized foreign currency loss</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,190</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,175</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,853</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net unrealized foreign currency (gain) loss</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,928</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,147</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,166</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain on sale of business</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,133</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Equity investment (income) expense</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,950</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,745</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">261</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.88%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other, net</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,945</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">580</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">882</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.88%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total other (income) expense, net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,633</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,976</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,162</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:12pt;"> </p> -2190000 -3175000 -11853000 5928000 -4147000 -11166000 7133000 1950000 3745000 -261000 2945000 -580000 -882000 8633000 2976000 -24162000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table provides details of supplemental cash flow information (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.4%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.26%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.4%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.4%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for income taxes, net of refunds</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,100</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,400</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,200</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.4%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for interest (excluding finance leases)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63,952</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83,690</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">129,756</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.4%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Supplemental disclosure of noncash investing and financing activities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.4%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-cash investment to acquire certain intellectual property rights from a customer in lieu of cash payment for services rendered</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,300</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.4%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value of contingent consideration related to acquisitions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,158</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.4%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in property and equipment included in liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,753</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,684</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,977</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.4%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vehicles acquired through finance lease agreements</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,994</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,203</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,701</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 35100000 23400000 12200000 63952000 83690000 129756000 27300000 19158000 1753000 11684000 5977000 28994000 20203000 37701000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">3. Acquisitions, Divestitures, and Investments</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">StudyKIK Acquisition</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">On September 13, 2021, the Company completed the acquisition of StudyKIK, a leading clinical trial recruitment and retention company, expanding the Company’s portfolio of patient-direct, technology-enabled solutions. The total purchase consideration was $203.6 million (net of cash acquired of $1.0 million). The Company recognized $115.3 million of goodwill and $91.8 million of intangible assets. The remainder of consideration was attributed to other net assets, primarily related to net working capital. </span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The purchase price has been allocated to the tangible assets and identifiable intangible assets acquired and liabilities assumed based upon their fair values. The excess of the purchase price over the tangible and intangible assets acquired and liabilities assumed has been recorded as goodwill. Goodwill is attributable to the acquired workforce as well as future synergies and is not deductible for income tax purposes. The operating results from the acquisition have been included in the Company’s Clinical Solutions segment from the date of acquisition.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The following table summarizes the fair values of identified intangible assets and their respective useful lives (dollars in thousands):</span></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Estimated Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Estimated Useful Life</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.18%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer relationships</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,300</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.82%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6 years</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.18%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired backlog</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,800</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.25 years</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.18%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trade name</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,700</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6 years</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.18%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Patient communities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45,100</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6 years</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.18%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired technologies</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,900</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:22.82%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6 years</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.18%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total intangible assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91,800</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:22.82%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">RxDataScience Acquisition</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On October 6, 2021, the Company completed the acquisition of RxDataScience, a specialist organization that helps biopharmaceutical customers solve challenging problems through advanced analytics, data management, and artificial intelligence. <span style="Background-color:#FFFFFF;">The total purchase consideration was $67.5 million (net of cash acquired of $2.4 million). The Company recognized $52.9 million of goodwill and $18.0 million of intangible assets. The remainder of consideration was attributed to other net assets, primarily related to net working capital. Refer to “Note 16 – Related-Party Transactions” for further information.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The purchase price has been allocated to the tangible assets and identifiable intangible assets acquired and liabilities assumed based upon their fair values. The excess of the purchase price over the tangible and intangible assets acquired and liabilities assumed has been recorded as goodwill. Goodwill is attributable to the acquired workforce as well as future synergies and is not deductible for income tax purposes. The operating results from the acquisition have been included in the Company’s Clinical Solutions segment from the date of acquisition.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s assessments of fair value and the purchase price allocations related to these 2021 acquisitions are preliminary and further adjustments may be necessary as additional information related to the fair values of assets acquired and liabilities assumed is assessed during the measurement period (up to one year from the respective acquisition dates).</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Synteract Acquisition</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">On December 9, 2020, the Company completed the acquisition of Synteract, effected through the purchase of 100% of the outstanding shares of Synteract for approximately $385.5 million in cash (net of approximately $28.0 million of cash acquired), which included payment of $1.0 million during the first quarter of 2021. Synteract is a contract research organization focused on the emerging biopharmaceutical industry, strengthening the Company’s position in the </span><span style="Background-color:#FFFFFF;color:#000000;">small to mid-</span><span style="color:#000000;">sized (“SMID”)</span> c<span style="Background-color:#FFFFFF;">ategory. </span>The Company recognized $363.7 million of goodwill and $56.4 million of intangible assets, including acquired backlog and trade name, as a result of the acquisition.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Allocation of Consideration Transferred</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the estimated fair value of the net assets acquired at the date of the acquisition:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Assets acquired:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,028</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable and unbilled services</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,723</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,160</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,978</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,839</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other identifiable intangible assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,400</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">363,733</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,121</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets acquired</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">508,982</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Liabilities assumed:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable and accrued expenses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,623</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45,272</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease obligations</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,693</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred income taxes, net</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,754</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,126</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities assumed</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">95,468</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net assets acquired</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">413,514</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The purchase price has been allocated to the tangible assets and identifiable intangible assets acquired and liabilities assumed based upon their fair values. The excess of the purchase price over the tangible and intangible assets acquired and liabilities assumed has been recorded as goodwill. Goodwill is attributable to the acquired workforce as well as future synergies and is not deductible for income tax purposes. The operating results from the acquisition of Synteract have been included in the Company’s Clinical Solutions segment from the date of acquisition.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the fair value of identified intangible assets and their respective useful lives at the date of the acquisition (dollars in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Estimated Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Estimated Useful Life</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.18%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired backlog</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,200</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.82%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4 years</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.18%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trade name</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,200</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:22.82%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8 years</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.18%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total intangible assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,400</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:22.82%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Illingworth Research Group Acquisition</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December 17, 2020, the Company completed the acquisition of Illingworth Research, a leading provider of clinical research home health services, adding new scale and capabilities to the Company’s clinical trial solutions. The total purchase consideration was $80.9 million (net of cash acquired of $1.1 million), which included payments of $9.0 million during the first quarter of 2021. The Company recognized $64.6 million of goodwill and $21.5 million of intangible assets, principally customer relationships, as a result of the acquisition. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The purchase price has been allocated to the tangible assets and identifiable intangible assets acquired and liabilities assumed based upon their fair values. The excess of the purchase price over the tangible and intangible assets acquired and liabilities assumed has been recorded as goodwill. Goodwill is attributable to the acquired workforce as well as future synergies and is not deductible for income tax purposes. The operating results from the acquisition of Illingworth Research have been included in the Company’s Clinical Solutions segment from the date of acquisition.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Pro forma information for these acquisitions is not presented as the operations of the acquired businesses, individually and in the aggregate, are not significant to the overall operations of the Company.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Divestitures </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">During the second quarter of 2020, the Company sold its contingent staffing business to a related party in exchange for potential future cash consideration not to exceed $4.0 million. Based on the financial results of the business one year after the divestiture date, the Company recognized $1.8 million of contingent considerati</span><span style="Background-color:#FFFFFF;">on in other (income) expense, net in the accompanying statement of income</span><span style="Background-color:#FFFFFF;"> during the second quarter of 2021. Refer to “Note 16 – Related-Party Transactions” for further information.</span><span style="Background-color:#FFFFFF;"> </span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the fourth quarter of 2020, the Company sold its medication adherence business for consideration of $23.0 million, including cash consideration of $18.0 million, net of cash transferred, and convertible notes of $5.0 million, resulting in a gain on sale of <span style="Background-color:#FFFFFF;">$7.1 million</span>. The Company received $5.0 million of cash proceeds from the notes receivable during the second quarter of 2021. Based on the performance of the business through 2021, the Company recognized $3.0 million and <span style="Background-color:#FFFFFF;">$3.6 million</span> of contingent consideration for the years ended December 31, 2021 and 2020, respectively. <span style="Background-color:#FFFFFF;">The gain on sale and contingent consideration were recognized in other (income) expense, net in the accompanying consolidated statements of income.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Investments</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">During the second quarter of 2020, the Company made a non-cash investment of $27.3 million to acquire certain intellectual property rights from a customer in lieu of cash payment for services rendered. The Company subsequently exchanged the intellectual property for an equity method investment in an unconsolidated variable interest entity. The Company provided the entity $3.8 million in cash, in the form of a loan, during the third quarter of 2021. </span><span style="Background-color:#FFFFFF;">Based on the hypothetical liquidation book value of its investment as of December 31, 2021, the Company recorded a $5.3 million loss to other (income) expense, net in the accompanying statement of income for the year ended December 31, 2021. As of December 31, 2021, the book value of the Company’s investment was $16.2 million and was included in other long-term assets in the accompanying consolidated balance sheet, with a maximum</span><span style="Background-color:#FFFFFF;"> exposure to loss of approximately </span><span style="Background-color:#FFFFFF;">$20.3 million</span><span style="Background-color:#FFFFFF;">, which includes the outstanding loan balance and accrued interest</span>.</p> 2021-09-13 StudyKIK 203600 1000.0 115300 91800 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The following table summarizes the fair values of identified intangible assets and their respective useful lives (dollars in thousands):</span></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Estimated Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Estimated Useful Life</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.18%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer relationships</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,300</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.82%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6 years</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.18%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired backlog</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,800</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.25 years</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.18%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trade name</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,700</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6 years</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.18%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Patient communities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45,100</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6 years</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.18%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired technologies</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,900</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:22.82%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6 years</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.18%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total intangible assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91,800</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:22.82%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> 22300000 P6Y 1800000 P1Y3M 2700000 P6Y 45100000 P6Y 19900000 P6Y 91800000 2021-10-06 RxDataScience 67500000 2400000 52900000 18000000.0 2020-12-09 Synteract 1 385500000 28000000.0 1000000.0 363700000 56400000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the estimated fair value of the net assets acquired at the date of the acquisition:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Assets acquired:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,028</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable and unbilled services</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,723</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,160</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,978</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,839</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other identifiable intangible assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,400</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">363,733</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,121</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets acquired</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">508,982</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Liabilities assumed:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable and accrued expenses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,623</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45,272</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease obligations</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,693</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred income taxes, net</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,754</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,126</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities assumed</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">95,468</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net assets acquired</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">413,514</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> 28028000 39723000 2160000 3978000 10839000 56400000 363733000 4121000 508982000 25623000 45272000 15693000 7754000 1126000 95468000 413514000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the fair value of identified intangible assets and their respective useful lives at the date of the acquisition (dollars in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Estimated Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Estimated Useful Life</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.18%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired backlog</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,200</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.82%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4 years</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.18%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trade name</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,200</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:22.82%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8 years</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.18%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total intangible assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,400</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:22.82%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 37200000 19200000 56400000 2020-12-17 80900000 1100000 9000000.0 64600000 21500000 4000000.0 1800 23000000.0 18000000.0 5000000.0 7100000 5000000.0 3000000.0 3600000 27300000 3800000 5300000 16200 20300 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">4. Long-Term Debt Obligations</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s debt obligations consisted of the following as of December 31 (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Secured Debt</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term Loan A - tranche one due March 2024</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">149,195</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">183,715</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term Loan A - tranche two due August 2024</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,636,797</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,273,991</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term Loan B due August 2024</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">560,564</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable financing agreement due October 2024</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">400,000</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">300,000</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total secured debt</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,185,992</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,318,270</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Unsecured Debt</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior notes due January 2029 (the “Notes”)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">600,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">600,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total debt obligations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,785,992</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,918,270</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Term loans original issuance discount</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,228</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,500</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Unamortized deferred issuance costs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,043</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12,716</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total long-term debt</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,775,721</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,902,054</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Credit Agreement</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is party to a credit agreement (as amended, the <span style="Background-color:#FFFFFF;color:#000000;">“</span>Credit Agreement<span style="Background-color:#FFFFFF;color:#000000;">”</span>) that included a $1.55 billion Term Loan A facility (“Term Loan A”) that has two tranches, tranche one that matures on March 26, 2024 and tranche two that matures on August 1, 2024, a $1.60 billion Term Loan B facility (“Term Loan B”) that was paid in full during the second quarter of 2021, and a $600.0 million revolving credit facility (the “Revolver”) that matures on August 1, 2024.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June 30, 2021 (the “Closing Date”), the Company entered into Amendment No. 5 (the “Fifth Amendment”) to the Credit Agreement. The Fifth Amendment modified the Credit Agreement to increase Term Loan A in an aggregate principal amount of $495.0 million (“Incremental Term Loan A”). Incremental Term Loan A was funded on the Closing Date, and the proceeds were used, along with cash on hand, to repay the outstanding Term Loan B in full under the Credit Agreement and to pay fees and expenses in connection with the Fifth Amendment and the incurrence of Incremental Term Loan A. Incremental Term Loan A has the same terms as Term Loan A under the Credit Agreement, and is subject to the same covenants. The Company recorded an additional discount of $0.5 million against the Term Loan A borrowings in connection with the Fifth Amendment, which is being amortized as a component of interest expense using the effective interest method over the term of Term Loan A.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2021, the Company made $166.8 million and $560.5 million of voluntary prepayments against Term Loan A and Term Loan B, respectively, that were applied to future mandatory principal payments due. As a result of these and previous voluntary prepayments, the Company is not required to make a mandatory payment against the principal balance of Term Loan A until October 2023 and Term Loan B has been paid in full. In connection with these prepayments, the Company recorded a $3.6 million loss on extinguishment of debt during the year ended December 31, 2021.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All obligations under the Credit Agreement are guaranteed by the Company and certain of the Company’s direct and indirect wholly-owned domestic subsidiaries. The obligations under the Credit Agreement are secured by substantially all of the assets of the Company and the guarantors, including 65% of the capital stock of certain controlled foreign subsidiaries.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The term loans and the Revolver bear interest at a rate per annum equal to the Adjusted Eurocurrency Rate (“Eurocurrency Rate”) plus an applicable margin or an Alternate Base Rate plus an applicable margin. The Company may select among the Adjusted Eurocurrency Rate or the Alternate Base Rate, whichever is lower, except in circumstances where the Company requests a loan with less than a three-day notice. In such cases, the Company must use the Alternate Base Rate. The Adjusted Eurocurrency Rate is equal to the London Inter-bank Offered Rate (“LIBOR”), subject to adjustment for reserve requirements. The Alternate Base Rate is equal to the highest of: (i) the federal funds rate plus 0.50%; (ii) the Adjusted Eurocurrency Rate for an interest period of one month plus 1.00%; (iii) the rate of interest per annum quoted by The Wall Street Journal as the prime rate; and (iv) 0.00%. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The applicable margins with respect to Alternate Base Rate and Adjusted Eurocurrency Rate borrowings are determined depending on the “First Lien Leverage Ratio” or the <span style="Background-color:#FFFFFF;color:#000000;">“</span>Secured Net Leverage Ratio<span style="Background-color:#FFFFFF;color:#000000;">”</span> (as defined in the Credit Agreement) and range as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.92%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Alternate Base Rate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.92%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Adjusted</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Eurocurrency Rate</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.18%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term Loan A</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.92%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000817">0.25% - 0.50%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.92%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000819">1.25% - 1.50%</span></p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.18%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term Loan B</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.92%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000821">0.75% - 1.00%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.92%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000823">1.75% - 2.00%</span></p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.18%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revolver</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.92%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000825">0.25% - 0.50%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.92%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000827">1.25% - 1.50%</span></p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In February 2021, as a result of the Company’s First Lien Leverage Ratio (as defined in the Credit Agreement) being less than or equal to </span>2.5<span style="Background-color:#FFFFFF;">x, the Adjusted Eurocurrency Rate Spread (as defined in the Credit Agreement) on Term Loan A and the Revolver decreased from </span>1.50<span style="Background-color:#FFFFFF;">% to </span>1.25<span style="Background-color:#FFFFFF;">%.</span><span style="color:#000000;"> As of December 31, 2021, the interest rate on the Term Loan A and the Revolver was 1.35%.</span><span style="font-family:Calibri;font-size:11pt;color:#000000;"> </span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company also pays a quarterly commitment fee between 0.25% and 0.375% on the average daily unused balance of the Revolver depending on the “First Lien Leverage Ratio” at the adjustment date.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Revolver and Letters of Credit</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Revolver includes letters of credit (<span style="Background-color:#FFFFFF;color:#000000;">“</span>LOCs<span style="Background-color:#FFFFFF;color:#000000;">”</span>) with a sublimit of $150.0 million. Fees are charged on all outstanding LOCs at an annual rate equal to the margin in effect on Eurocurrency Rate revolving loans plus participation and fronting fees. The fee is payable quarterly in arrears on the last day of each quarter ending April, July, October and January until the underlying LOC expires. As of December 31, 2021, there were no outstanding Revolver borrowings and $14.2 million of LOCs outstanding, leaving $585.8 million of available borrowings under the Revolver, including $135.8 million available for LOCs.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Accounts Receivable Financing Agreement</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the Company’s accounts receivable financing agreement, certain of the Company’s consolidated subsidiaries sell accounts receivable and unbilled services (including contract assets) balances to a wholly-owned, bankruptcy-remote special purpose entity (“SPE”), which is the borrower under the facility. The facility is without recourse to the Company or any subsidiaries of the Company other than the SPE, other than with respect to limited indemnity obligations of the selling entities and the servicer of the receivables in respect of the character of the receivables sold by them and the performance of the servicing duties.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January 28, 2021, the Company amended its accounts receivable financing agreement to increase the amount it can borrow from $300.0 million to $365.0 million and drew down the additional $65.0 million to partially fund the Term Loan A and Term Loan B voluntary prepayments. Accordingly, there was no incremental impact on the Company’s total debt.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On October 13, 2021, the Company further amended its accounts receivable financing agreement to increase the amount it can borrow from $</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">365.0</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million to $</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">400.0</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million, extended the maturity to October 2024, and drew down the additional $</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35.0</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million. At the same time, the Company paid down $</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35.0</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million on facilities under its Credit Agreement, resulting in no net impact on leverage.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, the Company had $400.0 million of outstanding borrowings under this agreement, which are recorded in long-term debt on the accompanying consolidated balance sheet. There was no remaining borrowing capacity available under this agreement as of December 31, 2021.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This agreement is secured by a lien on certain receivables and other assets, and the Company has guaranteed the performance of the obligations of existing and future subsidiaries that sell and service the accounts receivable under this agreement. The available borrowing capacity varies monthly according to the levels of its eligible accounts receivable and unbilled receivables. Loans under this agreement will accrue interest at a reserve-adjusted LIBOR rate or a base rate equal to the higher of (i) the applicable lender’s prime rate and (ii) the federal funds rate plus 0.50%. As of December 31, 2021, the interest rate on the accounts receivable financing agreement was 1.05%.</p> <p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">The Notes</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On November 24, 2020, the Company completed the issuance and sale of the Notes, with an aggregate principal amount of $600.0 million, which bears interest at a rate of 3.625% per annum, payable semi-annually in arrears beginning on July 15, 2021, and matures on January 15, 2029.<span style="Background-color:#FFFFFF;color:#000000;"> </span>The Notes were issued pursuant to an indenture (the “Indenture”), which provides, among other things, that the Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, on a senior unsecured basis, by certain of the Company’s subsidiaries. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company may redeem some or all of the Notes at any time prior to January 15, 2024 at a redemption price equal to 100% of the aggregate principal amount of the Notes to be redeemed plus a “make-whole” premium and accrued and unpaid interest. In addition, prior to July 15, 2023, the Company may redeem up to 40% of the original principal amount of the Notes with proceeds of certain equity offerings at a redemption price equal to 103.625% of the aggregate principal amount of such Notes plus accrued and unpaid interest. On or after January 15, 2024, the Company may redeem some or all of the Notes at the redemption prices set forth in the Indenture plus accrued and unpaid interest. <br/><br/>The Indenture contains covenants that limit the ability of the Company and its restricted subsidiaries to, among other things, (1) incur additional liens, (2) engage in certain sale and leaseback transactions, and (3) conduct mergers, consolidations, or asset sales. These covenants are subject to exceptions and qualifications set forth in the Indenture. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Company sells certain of its assets or experience specific kinds of changes of control, the Company is required to offer to repurchase the Notes at a repurchase price equal to (1) par plus any accrued and unpaid interest in the case of an asset sale or (2) 101% of the aggregate principal amount thereof plus any accrued and unpaid interest in the case of a change of control. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Maturities of Debt Obligations</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, the contractual maturities of the Company’s debt obligations (excluding finance leases that are presented in <span style="Background-color:#FFFFFF;color:#000000;">“</span>Note 5 – Leases<span style="Background-color:#FFFFFF;color:#000000;">”</span>) were as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,732</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,164,260</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2027 and thereafter</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">600,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Term loan original issuance discount</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,228</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Unamortized deferred issuance costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,043</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,775,721</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s debt obligations consisted of the following as of December 31 (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Secured Debt</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term Loan A - tranche one due March 2024</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">149,195</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">183,715</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term Loan A - tranche two due August 2024</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,636,797</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,273,991</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term Loan B due August 2024</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">560,564</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable financing agreement due October 2024</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">400,000</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">300,000</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total secured debt</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,185,992</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,318,270</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Unsecured Debt</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior notes due January 2029 (the “Notes”)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">600,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">600,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total debt obligations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,785,992</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,918,270</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Term loans original issuance discount</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,228</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,500</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Unamortized deferred issuance costs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,043</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12,716</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total long-term debt</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,775,721</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,902,054</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The applicable margins with respect to Alternate Base Rate and Adjusted Eurocurrency Rate borrowings are determined depending on the “First Lien Leverage Ratio” or the <span style="Background-color:#FFFFFF;color:#000000;">“</span>Secured Net Leverage Ratio<span style="Background-color:#FFFFFF;color:#000000;">”</span> (as defined in the Credit Agreement) and range as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.92%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Alternate Base Rate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.92%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Adjusted</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Eurocurrency Rate</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.18%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term Loan A</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.92%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000817">0.25% - 0.50%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.92%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000819">1.25% - 1.50%</span></p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.18%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term Loan B</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.92%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000821">0.75% - 1.00%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.92%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000823">1.75% - 2.00%</span></p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.18%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revolver</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.92%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000825">0.25% - 0.50%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.92%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000827">1.25% - 1.50%</span></p></td> </tr> </table></div> 149195000 183715000 1636797000 1273991000 560564000 400000000 300000000 2185992000 2318270000 600000000 600000000 2785992000 2918270000 2228000 3500000 8043000 12716000 2775721000 2902054000 1550000000 1600000000 600000000.0 495000000.0 500000 166800000 560500000 3600000 0.65 0.0050 0.0100 0.0000 0.025 0.0150 0.0125 0.0135 0.0025 0.00375 150000000.0 0 14200000 585800000 135800000 300000000.0 365000000.0 65000000.0 365000000.0 400000000.0 35000000.0 35000000.0 400000000.0 0.0050 0.0105 600000000.0 0.03625 0.40 1.03625 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, the contractual maturities of the Company’s debt obligations (excluding finance leases that are presented in <span style="Background-color:#FFFFFF;color:#000000;">“</span>Note 5 – Leases<span style="Background-color:#FFFFFF;color:#000000;">”</span>) were as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,732</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,164,260</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2027 and thereafter</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">600,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Term loan original issuance discount</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,228</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Unamortized deferred issuance costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,043</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,775,721</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 21732000 2164260000 600000000 2228000 8043000 2775721000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">5. Leases</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s operating leases are primarily related to its office facilities. The Company’s finance leases are related to vehicles that the Company leases for certain sales representatives in its Commercial Solutions segment. The Company’s leases have remaining lease terms of less than one year to 11 years, some of which include options to extend the term or terminate the lease. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ROU assets and lease liabilities are recognized based on the present value of the fixed lease payments over the lease term at the commencement date. The ROU assets also include any initial direct costs incurred and lease payments made at or before the commencement date, and are reduced by lease incentives. The Company uses its incremental borrowing rate as the discount rate to determine the present value of the lease payments for leases that do not have a readily determinable implicit discount rate. The Company’s incremental borrowing rate is the rate of interest that it would have to borrow on a collateralized basis over a similar term and amount in a similar economic environment. The Company determines the incremental borrowing rates for its leases by adjusting the local risk free interest rate with a credit risk premium corresponding to the Company’s credit rating.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company records rent expense for its operating leases on a straight-line basis from the lease commencement date until the end of the lease term. The Company records finance lease cost as a combination of the amortization expense for the ROU assets and interest expense for the outstanding lease liabilities using the discount rate discussed above. Variable lease payments for operating leases are related to office facilities and include but are not limited to common area maintenance, parking, electricity, and management fees. The variable lease payments for finance leases are related to maintenance programs for leased vehicles. Variable lease payments are based on occurrence or based on usage; therefore, they are not included as part of the initial calculations of the ROU assets and liabilities.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of lease cost were as follows for the year ended December 31 and the line items on the accompanying consolidated statements of income to which they were recorded were as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:20.92%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.44%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Statement of Income Classification</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.92%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Operating leases:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.44%; border-top:solid 0.75pt #000000;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.92%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fixed lease costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Direct costs, selling, general, and administrative expenses and restructuring and other costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55,168</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53,531</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.92%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term lease costs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Direct costs and selling, general, and administrative expenses</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,994</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,930</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:20.92%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Variable lease costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.44%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Direct costs, selling, general, and administrative expenses and restructuring and other costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,760</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,572</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:20.92%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating lease costs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.44%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93,922</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86,033</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.92%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Finance leases:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.92%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of right-of-use assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,453</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,843</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.92%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest on lease liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">605</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">944</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:20.92%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Variable lease costs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.44%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Direct costs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,231</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,321</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:20.92%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total finance lease costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.44%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,289</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,108</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental balance sheet information related to finance leases was as follows as of December 31 (in thousands):</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, gross</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77,674</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63,985</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated depreciation</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(30,021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,479</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,653</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,506</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current portion of finance lease obligations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,627</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,455</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance lease long-term obligations</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,181</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,522</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total finance lease liabilities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,808</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48,977</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental cash flow information related to leases was as follows for the year ended December 31 (in thousands):</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for amounts included in the measurement of lease liabilities:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating cash flows for operating leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(59,863</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(60,361</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating cash flows for finance leases</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(605</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(944</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing cash flows for finance leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,774</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,434</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right-of-use assets obtained in exchange for lease obligations:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating leases</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,385</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,415</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,994</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,203</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease obligations closed out in exchange for right-of-use assets:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating leases</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10,122</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,834</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average remaining lease term as of December 31:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating leases</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.88%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6 years</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.88%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7 years</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.88%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.88%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 years</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average discount rate as of December 31:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating leases</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.7</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.8</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.3</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, maturities of lease liabilities were as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Operating Leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Finance Leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53,612</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,443</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,055</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53,033</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,768</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70,801</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44,428</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,624</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,052</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,036</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,688</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,724</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,128</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">130</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,258</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2027 and thereafter</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73,262</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73,262</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease payments</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">291,499</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,653</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">348,152</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Management fee</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(762</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Imputed interest</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(42,643</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,083</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">248,856</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,808</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> P1Y P11Y <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of lease cost were as follows for the year ended December 31 and the line items on the accompanying consolidated statements of income to which they were recorded were as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:20.92%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.44%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Statement of Income Classification</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.92%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Operating leases:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.44%; border-top:solid 0.75pt #000000;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.92%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fixed lease costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Direct costs, selling, general, and administrative expenses and restructuring and other costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55,168</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53,531</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.92%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term lease costs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Direct costs and selling, general, and administrative expenses</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,994</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,930</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:20.92%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Variable lease costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.44%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Direct costs, selling, general, and administrative expenses and restructuring and other costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,760</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,572</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:20.92%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating lease costs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.44%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93,922</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86,033</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.92%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Finance leases:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.92%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of right-of-use assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,453</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,843</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.92%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest on lease liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">605</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">944</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:20.92%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Variable lease costs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.44%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Direct costs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,231</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,321</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:20.92%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total finance lease costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.44%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,289</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,108</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 55168000 53531000 1994000 2930000 36760000 29572000 93922000 86033000 17453000 15843000 605000 944000 6231000 6321000 24289000 23108000 <p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental balance sheet information related to finance leases was as follows as of December 31 (in thousands):</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, gross</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77,674</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63,985</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated depreciation</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(30,021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,479</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,653</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,506</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current portion of finance lease obligations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,627</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,455</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance lease long-term obligations</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,181</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,522</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total finance lease liabilities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,808</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48,977</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 77674000 63985000 30021000 20479000 47653000 43506000 20627000 17455000 34181000 31522000 54808000 48977000 <p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental cash flow information related to leases was as follows for the year ended December 31 (in thousands):</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for amounts included in the measurement of lease liabilities:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating cash flows for operating leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(59,863</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(60,361</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating cash flows for finance leases</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(605</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(944</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing cash flows for finance leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,774</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,434</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right-of-use assets obtained in exchange for lease obligations:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating leases</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,385</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,415</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,994</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,203</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease obligations closed out in exchange for right-of-use assets:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating leases</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10,122</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,834</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> 59863000 60361000 605000 944000 15774000 16434000 43385000 47415000 28994000 20203000 -10122000 -2834000 <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average remaining lease term as of December 31:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating leases</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.88%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6 years</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.88%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7 years</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.88%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.88%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 years</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average discount rate as of December 31:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating leases</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.7</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.8</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.3</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> </table></div> P6Y P7Y P3Y P3Y 0.047 0.048 0.011 0.013 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, maturities of lease liabilities were as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Operating Leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Finance Leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53,612</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,443</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,055</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53,033</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,768</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70,801</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44,428</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,624</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,052</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,036</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,688</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,724</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,128</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">130</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,258</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2027 and thereafter</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73,262</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73,262</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease payments</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">291,499</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,653</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">348,152</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Management fee</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(762</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Imputed interest</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(42,643</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,083</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">248,856</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,808</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, maturities of lease liabilities were as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Operating Leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Finance Leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53,612</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,443</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,055</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53,033</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,768</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70,801</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44,428</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,624</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,052</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,036</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,688</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,724</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,128</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">130</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,258</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2027 and thereafter</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73,262</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73,262</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease payments</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">291,499</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,653</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">348,152</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Management fee</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(762</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Imputed interest</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(42,643</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,083</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">248,856</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,808</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 53612000 21443000 75055000 53033000 17768000 70801000 44428000 11624000 56052000 38036000 5688000 43724000 29128000 130000 29258000 73262000 73262000 291499000 56653000 348152000 762000 42643000 1083000 248856000 54808000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">6. Derivatives </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Interest Rate Swaps</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has entered into various interest rate swaps to mitigate its exposure to changes in interest rates on its term loan. In June 2018, the Company entered into an interest rate swap with multiple counterparties that had an initial aggregate notional value of $1.01 billion, an effective date of December 31, 2018, and expired on June 30, 2021.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In March 2020, the Company entered into interest rate swaps with multiple counterparties. The interest rate swaps had an initial aggregate notional value of $549.2 million that increased to $1.42 billion on June 30, 2021, an effective date of March 31, 2020, and will expire on March 31, 2023. As of December 31, 2021, the notional value of this interest rate swap was $1.16 billion.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The significant terms of these derivatives are substantially the same as those contained within the Credit Agreement, including monthly settlements with the swap counterparties. Interest rate swaps are designated as hedging instruments. The amounts of hedge ineffectiveness recorded in net income during the years ended December 31, 2021, 2020, and 2019 were insignificant.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Foreign Exchange Forward</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On October 30, 2020, the Company entered into a foreign exchange forward in order to minimize monthly foreign currency remeasurement gains or losses on non-functional currency monetary balances. The foreign exchange forward notional value may be adjusted each month as the exposure balance changes. The Company did not designate the derivative as a hedge. All changes in the fair value of the foreign exchange forward are recorded in earnings every month to other (income) expense, net <span style="Background-color:#FFFFFF;">in the accompanying consolidated statements of income.</span> <span style="Background-color:#FFFFFF;">The Company recognized $0.7 million of realized losses and $1.5 million of realized gains during the years ended December 31, 2021 and 2020, respectively, related to this foreign exchange forward. As of December 31, 2021, the notional value of this foreign exchange forward was $70.0 million. </span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Fair Values</p> <p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair values of the Company’s derivative financial instruments as of December 31 and the line items on the accompanying consolidated balance sheets to which they were recorded were as follows (in thousands):</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:33.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Balance Sheet Classification</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:33.2%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest rate swaps - non-current</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other long-term assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">948</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:33.2%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value of derivative assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.82%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">948</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.82%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest rate swaps - current</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,827</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,045</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:33.2%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest rate swaps - non-current</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.82%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other long-term liabilities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,572</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:33.2%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value of derivative liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.82%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,827</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,617</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 1010000000.00 549200000 1420000000 1160000000 700000 1500000 70000000.0 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Fair Values</p> <p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair values of the Company’s derivative financial instruments as of December 31 and the line items on the accompanying consolidated balance sheets to which they were recorded were as follows (in thousands):</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:33.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Balance Sheet Classification</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:33.2%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest rate swaps - non-current</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other long-term assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">948</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:33.2%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value of derivative assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.82%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">948</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.82%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest rate swaps - current</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,827</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,045</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:33.2%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest rate swaps - non-current</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.82%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other long-term liabilities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,572</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:33.2%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value of derivative liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.82%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,827</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,617</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 948000 948000 1827000 17045000 5572000 1827000 22617000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">7. Fair Value Measurements</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Assets and Liabilities Carried at Fair Value</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021 and 2020, the Company’s financial assets and liabilities carried at fair value included cash and cash equivalents, restricted cash, trading securities, accounts receivable, unbilled services (including contract assets), accounts payable, accrued expenses, deferred revenue, contingent obligations, liabilities under the accounts receivable financing agreement, and derivative instruments.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair values of cash and cash equivalents, restricted cash, accounts receivable, unbilled services (including contract assets), accounts payable, accrued expenses, deferred revenue, and the liabilities under the accounts receivable financing agreement approximate their respective carrying amounts because of the liquidity and short-term nature of these financial instruments.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Financial Instruments Subject to Recurring Fair Value Measurements</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, the fair values of the major classes of the Company’s assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.9%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Investments</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Measured</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">at Net Asset</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trading securities (a)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,775</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,775</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Partnership interest (b)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,176</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,176</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.9%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Derivative instruments (c)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">948</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">948</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.9%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,775</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">948</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,176</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,899</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Liabilities:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Derivative instruments (c)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,827</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,827</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.9%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contingent obligations related to acquisitions (d)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,997</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,997</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.9%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,827</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,997</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,824</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, the fair value of the major classes of the Company’s assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.9%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Investments</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Measured</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">at Net Asset</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trading securities (a)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,950</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,950</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Partnership interest (b)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,665</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,665</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.9%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,950</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,665</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,615</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Liabilities:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Derivative instruments (c)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,617</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,617</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.9%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contingent obligations related to acquisitions (d)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,793</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,793</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.9%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,617</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,793</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,410</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) Represents the fair value of investments in mutual funds based on quoted market prices that are used to fund the liability associated with the Company’s deferred compensation plan.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b) The Company has committed to invest $21.5 million as a limited partner in two private equity funds. The private equity funds invest in opportunities in the healthcare and life sciences industry. As of December 31, 2021, the Company’s remaining unfunded commitment in the private equity funds was $12.8 million. The Company holds minor ownership interests (less than 3%) in each of the private equity funds and has determined that it does not exercise significant influence over the private equity funds’ operating or finance activities. As the private equity funds do not have readily determinable fair values, the Company has estimated the fair values using each fund’s Net Asset Value, the amount by which the value of all assets exceeds all debt and liabilities, in accordance with ASC Topic 946<span style="font-style:italic;">, Financial Services – Investment Companies.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c) Represents the fair value of interest rate swap arrangements (see <span style="Background-color:#FFFFFF;color:#000000;">“</span>Note 6 <span style="font-size:10pt;">–</span> Derivatives<span style="Background-color:#FFFFFF;color:#000000;">”</span> for further information).</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d) Represents the fair value of contingent consideration obligations related to acquisitions. The fair values of these liabilities are determined based on the Company’s best estimate of the probable timing and amount of settlement.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents a reconciliation of changes in the carrying amount of contingent obligations classified as Level 3 for the years ended December 31, 2021 and 2020 (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,324</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additions</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in fair value recognized in earnings (a)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,897</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payments</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26,634</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,793</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additions (b)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,158</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in fair value recognized in earnings</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(757</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payments (c)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,197</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2021</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,997</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) The change in fair value recognized in earnings for the year ended December 31, 2020 is primarily due to a decrease in the estimate of the contingent consideration associated with the acquisition of Kinapse (see <span style="Background-color:#FFFFFF;color:#000000;">“</span>Note 17 – Commitments and Contingencies<span style="Background-color:#FFFFFF;color:#000000;">”</span> for further information).</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b) Represents obligations in connection with the acquisition of RxDataScience and insignificant acquisitions completed during 2021.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(</span><span style="font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">c</span><span style="font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) The Company made payments to fully settle </span><span style="font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the contingent tax-sharing obligation arising from inVentiv Health, Inc.’s 2016 merger with Double Eagle Parent, Inc. (see “Note 1</span><span style="font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</span><span style="font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> – Commitments and Contingencies” for further information) during the first quarter of 2021</span><span style="color:#FF0000;"> </span><span style="font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and </span><span style="font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">obligations in connection with the insignificant acquisition completed during the second quarter of 2021</span><span style="font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the years ended December 31, 2021 and 2020, there were no transfers of assets or liabilities between Level 1, Level 2, or Level 3 fair value measurements.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Financial Instruments Subject to Non-Recurring Fair Value Measurements</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain assets, including goodwill and identifiable intangible assets, are carried on the accompanying consolidated balance sheets at cost and, subsequent to initial recognition, are measured at fair value on a non-recurring basis when certain identified events or changes in circumstances that may have a significant adverse effect on the carrying values of these assets occur. These assets are classified as Level 3 fair value measurements within the fair value hierarchy. Goodwill is tested for impairment annually or more frequently if events or changes in circumstances indicate a triggering event has occurred. Intangible assets are tested for impairment upon the occurrence of certain triggering events. As of December 31, 2021 and 2020, assets carried on the consolidated balance sheets and not remeasured to fair value on a recurring basis totaled $5.83 billion and $5.71 billion, respectively.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Fair Value Disclosures for Financial Instruments Not Carried at Fair Value</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The estimated fair values of the term loans and the Notes are determined based on the price that the Company would have had to pay to settle the liabilities. As these liabilities are not actively traded, they are classified as Level 2 fair value measurements. The estimated fair values of the Company’s term loans and the Notes were as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.46%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.56%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.56%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.46%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Carrying</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Value (a)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Carrying</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Value (a)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term Loan A - tranche one due March 2024</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">149,008</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">148,945</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">183,320</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">183,026</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term Loan A - tranche two due August 2024</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,634,756</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,635,138</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,271,255</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,269,213</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term Loan B due August 2024</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">560,194</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">560,144</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior notes due January 2029</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">600,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">595,500</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">600,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">602,412</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) The carrying value of the term loan debt is shown net of original issue discounts. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, the fair values of the major classes of the Company’s assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.9%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Investments</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Measured</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">at Net Asset</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trading securities (a)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,775</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,775</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Partnership interest (b)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,176</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,176</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.9%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Derivative instruments (c)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">948</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">948</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.9%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,775</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">948</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,176</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,899</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Liabilities:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Derivative instruments (c)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,827</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,827</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.9%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contingent obligations related to acquisitions (d)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,997</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,997</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.9%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,827</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,997</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,824</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, the fair value of the major classes of the Company’s assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.9%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Investments</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Measured</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">at Net Asset</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trading securities (a)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,950</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,950</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Partnership interest (b)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,665</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,665</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.9%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,950</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,665</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,615</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Liabilities:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Derivative instruments (c)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,617</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,617</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.9%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contingent obligations related to acquisitions (d)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,793</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,793</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.9%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,617</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,793</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,410</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) Represents the fair value of investments in mutual funds based on quoted market prices that are used to fund the liability associated with the Company’s deferred compensation plan.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b) The Company has committed to invest $21.5 million as a limited partner in two private equity funds. The private equity funds invest in opportunities in the healthcare and life sciences industry. As of December 31, 2021, the Company’s remaining unfunded commitment in the private equity funds was $12.8 million. The Company holds minor ownership interests (less than 3%) in each of the private equity funds and has determined that it does not exercise significant influence over the private equity funds’ operating or finance activities. As the private equity funds do not have readily determinable fair values, the Company has estimated the fair values using each fund’s Net Asset Value, the amount by which the value of all assets exceeds all debt and liabilities, in accordance with ASC Topic 946<span style="font-style:italic;">, Financial Services – Investment Companies.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c) Represents the fair value of interest rate swap arrangements (see <span style="Background-color:#FFFFFF;color:#000000;">“</span>Note 6 <span style="font-size:10pt;">–</span> Derivatives<span style="Background-color:#FFFFFF;color:#000000;">”</span> for further information).</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d) Represents the fair value of contingent consideration obligations related to acquisitions. The fair values of these liabilities are determined based on the Company’s best estimate of the probable timing and amount of settlement.</p> 24775000 24775000 11176000 11176000 948000 948000 24775000 948000 11176000 36899000 1827000 1827000 17997000 17997000 1827000 17997000 19824000 22950000 22950000 8665000 8665000 22950000 8665000 31615000 22617000 22617000 6793000 6793000 22617000 6793000 29410000 21500000 2 12800000 0.03 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents a reconciliation of changes in the carrying amount of contingent obligations classified as Level 3 for the years ended December 31, 2021 and 2020 (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,324</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additions</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in fair value recognized in earnings (a)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,897</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payments</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26,634</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,793</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additions (b)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,158</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in fair value recognized in earnings</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(757</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payments (c)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,197</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2021</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,997</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) The change in fair value recognized in earnings for the year ended December 31, 2020 is primarily due to a decrease in the estimate of the contingent consideration associated with the acquisition of Kinapse (see <span style="Background-color:#FFFFFF;color:#000000;">“</span>Note 17 – Commitments and Contingencies<span style="Background-color:#FFFFFF;color:#000000;">”</span> for further information).</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b) Represents obligations in connection with the acquisition of RxDataScience and insignificant acquisitions completed during 2021.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(</span><span style="font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">c</span><span style="font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) The Company made payments to fully settle </span><span style="font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the contingent tax-sharing obligation arising from inVentiv Health, Inc.’s 2016 merger with Double Eagle Parent, Inc. (see “Note 1</span><span style="font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</span><span style="font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> – Commitments and Contingencies” for further information) during the first quarter of 2021</span><span style="color:#FF0000;"> </span><span style="font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and </span><span style="font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">obligations in connection with the insignificant acquisition completed during the second quarter of 2021</span><span style="font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p> 37324000 -3897000 -26634000 6793000 19158000 -757000 -7197000 17997000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5830000000 5710000000 The estimated fair values of the Company’s term loans and the Notes were as follows (in thousands): <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.46%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.56%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.56%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.46%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Carrying</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Value (a)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Carrying</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Value (a)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term Loan A - tranche one due March 2024</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">149,008</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">148,945</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">183,320</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">183,026</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term Loan A - tranche two due August 2024</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,634,756</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,635,138</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,271,255</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,269,213</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term Loan B due August 2024</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">560,194</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">560,144</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior notes due January 2029</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">600,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">595,500</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">600,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">602,412</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p>(a) The carrying value of the term loan debt is shown net of original issue discounts. 149008000 148945000 183320000 183026000 1634756000 1635138000 1271255000 1269213000 560194000 560144000 600000000 595500000 600000000 602412000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">8. Restructuring and Other Costs</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2021, the Company incurred employee severance and benefit costs, facility and lease termination costs, and other costs related to its restructuring activities. <span style="Background-color:#FFFFFF;color:#000000;">These costs were primarily related to the Company’s </span><span style="font-style:italic;color:#000000;">ForwardBound</span><span style="Background-color:#FFFFFF;color:#000000;"> margin enhancement initiative. The costs incurred during the year ended December 31, 2020 were primarily related to the Company’s cost management strategies in response to the COVID-19 pandemic as well as the Company’s </span><span style="font-style:italic;color:#000000;">ForwardBound</span><span style="Background-color:#FFFFFF;color:#000000;"> initiative.</span> </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restructuring and other costs consisted of the following (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee severance and benefit costs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,526</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,321</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,243</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Facility and lease termination costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,226</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,313</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,202</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other costs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">780</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">690</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total restructuring and other costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,816</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,414</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,135</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company expects to continue to incur costs related to restructuring of its operations in order to achieve cost savings and the targeted synergies related to its acquisitions. However, the timing and the amount of these costs depends on various factors, including, but not limited to, identifying and realizing synergy opportunities and executing the integration of its combined operations. The Company may also continue to incur additional restructuring and other costs during and beyond 2022 related to its <span style="font-style:italic;">ForwardBound</span> margin enhancement initiative.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Accrued Restructuring Liabilities</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes activity related to the liabilities associated with restructuring and other costs (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.44%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Employee</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Severance Costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Other Costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,728</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,750</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expenses incurred (a)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,321</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">791</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,112</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.44%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payments</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26,219</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(813</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(27,032</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,830</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,830</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expenses incurred (a)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,574</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,591</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.44%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payments</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13,747</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13,764</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.44%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2021</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,657</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,657</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) There were no non-cash restructuring and other expenses incurred for the years ended December 31, 2021 and 2020. The amount of expenses incurred for the years ended December 31, 2021 and 2020 excludes $8.2 million and $2.3 million, respectively, of facility lease closure and lease termination costs that are reflected as a reduction of operating lease right-of-use assets on the accompanying consolidated balance sheets under ASC 842.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company expects the employee severance costs accrued as of December 31, 2021 will be paid within the next twelve months. Liabilities associated with restructuring and other costs are included in accrued expenses and other long-term liabilities on the accompanying consolidated balance sheets.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restructuring and other costs consisted of the following (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee severance and benefit costs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,526</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,321</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,243</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Facility and lease termination costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,226</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,313</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,202</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other costs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">780</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">690</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total restructuring and other costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,816</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,414</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,135</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes activity related to the liabilities associated with restructuring and other costs (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.44%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Employee</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Severance Costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Other Costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,728</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,750</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expenses incurred (a)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,321</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">791</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,112</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.44%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payments</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26,219</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(813</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(27,032</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,830</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,830</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expenses incurred (a)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,574</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,591</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.44%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payments</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13,747</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13,764</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.44%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2021</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,657</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,657</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) There were no non-cash restructuring and other expenses incurred for the years ended December 31, 2021 and 2020. The amount of expenses incurred for the years ended December 31, 2021 and 2020 excludes $8.2 million and $2.3 million, respectively, of facility lease closure and lease termination costs that are reflected as a reduction of operating lease right-of-use assets on the accompanying consolidated balance sheets under ASC 842.</p> 14526000 26321000 25243000 8226000 2313000 16202000 64000 780000 690000 22816000 29414000 42135000 5728000 22000 5750000 26321000 791000 27112000 26219000 813000 27032000 5830000 5830000 14574000 17000 14591000 13747000 17000 13764000 6657000 6657000 0 0 8200000 2300000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">9. Shareholders’ Equity</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Shares Outstanding</p> <p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares of common stock outstanding were as follows (in thousands):</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53.56%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53.56%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.56%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock shares, beginning balance</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,935</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,866</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,372</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.56%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Repurchases of common stock</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,500</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,256</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,323</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53.56%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuances of common stock</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,329</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,325</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,817</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53.56%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock shares, ending balance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,764</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,935</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,866</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Stock Repurchase Programs</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February 26, 2018, the Company’s Board of Directors (the <span style="Background-color:#FFFFFF;color:#000000;">“</span>Board<span style="Background-color:#FFFFFF;color:#000000;">”</span>) authorized the repurchase of up to an aggregate of $250.0 million of the Company’s common stock to be executed from time to time in open market transactions effected through a broker at prevailing market prices, in block trades or through privately negotiated transactions through December 31, 2019 (the <span style="Background-color:#FFFFFF;color:#000000;">“2018 St</span>ock Repurchase Program<span style="Background-color:#FFFFFF;color:#000000;">”</span>). On December 5, 2019, the Board increased the dollar amount authorized under the 2018 Stock Repurchase Program to up to an aggregate of $300.0 million and extended the term of the 2018 Stock Repurchase Program to December 31, 2020. The 2018 Stock Repurchase Program expired on December 31, 2020. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On November 17, 2020, the Company’s Board authorized the repurchase of up to an aggregate of $300.0 million of the Company’s Class A common stock, par value $0.01 per share, to be executed from time to time in open market transactions effected through a broker at prevailing market prices, in block trades, or through privately negotiated transactions through December 31, 2022 (the “2021 Stock Repurchase Program”). The 2021 Stock Repurchase Program took effect on January 1, 2021.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2021 Stock Repurchase Program does not obligate the Company to repurchase any particular amount of the Company’s common stock, and may be modified, extended, suspended, or discontinued at any time. The timing and amount of repurchases are determined by the Company’s management based on a variety of factors such as the market price of the Company’s common stock, the Company’s corporate cash requirements, and overall market conditions. The 2021 Stock Repurchase Program is subject to applicable legal requirements, including federal and state securities laws and applicable Nasdaq rules. The Company may also repurchase shares of its common stock pursuant to a trading plan meeting the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, which would permit shares of the Company’s common stock to be repurchased when the Company might otherwise be precluded from doing so by law.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">During the year ended December 31, 2021, the Company repurchased </span><span style="Background-color:#FFFFFF;">1,500,000 </span>shares<span style="Background-color:#FFFFFF;"> of its common stock in </span><span style="Background-color:#FFFFFF;">private transactions under the 2021 Stock Repurchase Program, for a total purchase price of approximately $117.5 million. </span></p> <p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth repurchase activity under the Company’s stock repurchase programs from inception through December 31, 2021:</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:23.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.36%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Total number of</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">shares purchased</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.36%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Average price</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">paid per share</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.36%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Approximate dollar</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">value of shares</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">purchased</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 2018</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">948,100</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39.55</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,493</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">April 2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,024,400</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36.60</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,492</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">January 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">552,100</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39.16</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,623</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120,600</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41.40</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,993</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">509,100</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45.29</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,055</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">August 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">141,100</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49.93</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,045</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">600,000</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53.38</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,029</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">September 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">506,244</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59.26</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">October 2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150,000</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54.14</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,122</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">600,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74.18</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44,505</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">May 2021</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">400,000</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81.04</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,416</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:23.36%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June 2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">500,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:21.36%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81.20</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,600</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:23.36%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,051,644</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:21.36%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">319,373</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company immediately retired all of the repurchased common stock and charged the par value of the shares to common stock. The excess of the repurchase price over the par value was applied on a pro rata basis against additional paid-in capital, with the remainder applied to accumulated deficit.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">As of December 31, 2021, the Company had remaining authorization to repurchase up to approximately </span><span style="Background-color:#FFFFFF;">$182.5 million </span><span style="Background-color:#FFFFFF;">of shares of its common stock under the 2021 Stock Repurchase Program.</span></p> <p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following is a summary of the Company’s authorized, issued, and outstanding shares as of December 31:</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Shares Authorized:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Class A common stock</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">300,000,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">300,000,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Class B common stock</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">300,000,000</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">300,000,000</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preferred stock</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,000,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,000,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total shares authorized</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">630,000,000</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">630,000,000</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Shares Issued and Outstanding:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Class A common stock</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,763,635</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,934,738</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Class B common stock</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preferred stock</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total shares issued and outstanding</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,763,635</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,934,738</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Voting Rights and Conversion Rights of Common Stock</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each share of Class A common stock is entitled to one vote on all matters to be voted on by the shareholders of the Company, including the election of directors. Each share of Class B common stock is entitled to one vote on all matters to be voted on by the shareholders of the Company, except for the right to vote in the election of directors. Additionally, each share of Class B common stock is convertible (on a one-for-one basis) into Class A common stock at any time at the election of the holder.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Dividend Rights and Preferences of Common Stock</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The holders of Class A and Class B common stock are entitled to dividends on a pro rata basis at such time and in such amounts as declared by the Board. There were no dividends paid during the years ended December 31, 2021, 2020, or 2019.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Liquidation Rights and Preferences of Common Stock</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The holders of Class A and Class B common stock are entitled to participate on a pro rata basis in all distributions made in connection with a voluntary or involuntary liquidation, dissolution, or winding up of the affairs of the Company.</p> <p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares of common stock outstanding were as follows (in thousands):</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53.56%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53.56%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.56%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock shares, beginning balance</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,935</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,866</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,372</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.56%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Repurchases of common stock</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,500</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,256</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,323</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53.56%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuances of common stock</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,329</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,325</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,817</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53.56%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock shares, ending balance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,764</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,935</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,866</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 103935 103866 103372 1500 1256 1323 1329 1325 1817 103764 103935 103866 250000000.0 300000000.0 300000000.0 0.01 1500000 117500000 <p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth repurchase activity under the Company’s stock repurchase programs from inception through December 31, 2021:</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:23.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.36%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Total number of</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">shares purchased</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.36%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Average price</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">paid per share</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.36%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Approximate dollar</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">value of shares</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">purchased</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 2018</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">948,100</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39.55</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,493</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">April 2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,024,400</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36.60</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,492</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">January 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">552,100</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39.16</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,623</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120,600</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41.40</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,993</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">509,100</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45.29</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,055</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">August 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">141,100</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49.93</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,045</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">600,000</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53.38</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,029</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">September 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">506,244</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59.26</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">October 2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150,000</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54.14</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,122</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">600,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74.18</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44,505</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.36%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">May 2021</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">400,000</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81.04</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,416</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:23.36%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June 2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">500,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:21.36%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81.20</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,600</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:23.36%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,051,644</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:21.36%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">319,373</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 948100 39.55 37493000 1024400 36.60 37492000 552100 39.16 21623000 120600 41.40 4993000 509100 45.29 23055000 141100 49.93 7045000 600000 53.38 32029000 506244 59.26 30000000 150000 54.14 8122000 600000 74.18 44505000 400000 81.04 32416000 500000 81.20 40600000 6051644 319373000 182500000 <p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following is a summary of the Company’s authorized, issued, and outstanding shares as of December 31:</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Shares Authorized:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Class A common stock</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">300,000,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">300,000,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Class B common stock</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">300,000,000</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">300,000,000</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preferred stock</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,000,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,000,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total shares authorized</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">630,000,000</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">630,000,000</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Shares Issued and Outstanding:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Class A common stock</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,763,635</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,934,738</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Class B common stock</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preferred stock</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total shares issued and outstanding</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,763,635</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,934,738</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 300000000 300000000 300000000 300000000 30000000 30000000 630000000 630000000 103763635 103934738 103763635 103934738 1 1 1 0 0 0 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">10. Earnings Per Share</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table provides a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations (in thousands, except per share data):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Numerator:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net income</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">234,831</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">192,787</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">131,258</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Denominator:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic weighted average common shares outstanding</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,872</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104,168</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,618</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effect of dilutive securities:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options and other awards under deferred share-based compensation programs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,193</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,297</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,387</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diluted weighted average common shares outstanding</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">105,065</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">105,465</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">105,005</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Earnings per share:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.26</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.85</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.27</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diluted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.24</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.83</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.25</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Potential common shares outstanding that are considered anti-dilutive are excluded from the computation of diluted earnings per share. Potential common shares related to stock options and other awards under share-based compensation programs may be determined to be anti-dilutive based on the application of the treasury stock method. Potential common shares are also anti-dilutive in periods when the Company incurs a net loss.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The number of potential shares outstanding that were anti-dilutive and therefore excluded from the computation of diluted earnings per share, weighted for the portion of the period they were outstanding, were 145,342, 582,760, and 277,128 for the years ended December 31, 2021, 2020, and 2019, respectively.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table provides a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations (in thousands, except per share data):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Numerator:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net income</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">234,831</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">192,787</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">131,258</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Denominator:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic weighted average common shares outstanding</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,872</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104,168</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,618</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effect of dilutive securities:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options and other awards under deferred share-based compensation programs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,193</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,297</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,387</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diluted weighted average common shares outstanding</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">105,065</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">105,465</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">105,005</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Earnings per share:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.26</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.85</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.27</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diluted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.24</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.83</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.25</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 234831000 192787000 131258000 103872000 104168000 103618000 1193000 1297000 1387000 105065000 105465000 105005000 2.26 1.85 1.27 2.24 1.83 1.25 145342 582760 277128 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">11. Income Taxes</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of income before provision for income taxes were as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Domestic</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">186,445</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">122,659</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,066</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">128,715</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80,999</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,775</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income before provision for income taxes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">315,160</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">203,658</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101,709</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of income tax expense (benefit) were as follows (in thousands):</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal income taxes:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">926</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,537</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13,952</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45,819</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,188</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11,693</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign income taxes:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,718</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,452</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,309</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,106</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,206</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State income taxes:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,163</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,229</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,850</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,012</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10,922</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26,000</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax expense (benefit)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80,329</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,871</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(29,549</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Foreign Earnings</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The Company ha</span><span style="Background-color:#FFFFFF;">s approximately $</span><span style="color:#000000;">689.7</span><span style="Background-color:#FFFFFF;"> million of undistributed foreign earnings, of which approximately $</span><span style="color:#000000;">278.4</span><span style="Background-color:#FFFFFF;"> million will remain indefinitely reinvested in the foreign jurisdictions. These earnings are expected to be used to support the growth and working capital needs of the Company’s foreign subsidiaries. It is impracticable to determine the total amount of unrecognized deferred taxes with respect to these indefinitely reinvested earnings. The remaining $</span><span style="color:#000000;">411.3</span><span style="Background-color:#FFFFFF;"> million of undistributed foreign earnings are not considered indefinitely reinvested, and the Company has provided a $</span><span style="color:#000000;">7.8</span><span style="Background-color:#FFFFFF;"> million deferred t</span><span style="Background-color:#FFFFFF;">ax liability, primarily related to the estimated withholding tax and state taxes that would be due upon repatriation.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">BEAT<span style="font-weight:normal;font-style:normal;"> </span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company<span style="color:#000000;">’</span>s base erodin<span style="color:#000000;">g payments do not exceed the </span>three percent threshold of its deductible payments in 2021; therefore, the Company has not recorded any <span style="Background-color:#FFFFFF;">base erosion and anti-abuse minimum tax (“BEAT”) </span>liability for the years ended December 31, 2021 and December 31, 2020. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Actual income tax expense differed from the amount computed by applying the U.S. federal tax rate of 21% to pre-tax income as a result of the following (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected income tax expense at statutory rate</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66,184</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,768</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,359</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">Change in income tax expense resulting from:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign income inclusion</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,013</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,557</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign earnings not indefinitely reinvested</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">278</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,071</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign tax credits</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,390</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in income tax valuation allowance (all jurisdictions)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,462</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,503</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(68,537</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in fair value of contingent obligations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(122</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(769</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,625</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based compensation</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,662</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,800</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,094</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and general business tax credits (a)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,902</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12,872</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,871</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State and local taxes, net of federal benefit</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,978</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,924</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,085</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Capital loss carryforward (b)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(214</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,506</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign rate differential</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,865</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,777</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,595</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in reserve for uncertain tax positions including interest</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,721</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18,839</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,393</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provision to tax return and other deferred tax adjustments</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(771</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12,325</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6,950</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain on sale of business</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,350</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Base erosion and anti-abuse tax</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,054</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nondeductible executive compensation</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,649</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">367</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,802</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.88%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other, net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,158</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,463</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,713</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.88%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax expense (benefit)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80,329</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,871</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(29,549</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) Year ended December 31, 2021 included a $0.8 million valuation allowance release and year ended December 31, 2020 was offset by a $9.4 million valuation allowance.<span style="color:#FF0000;"> </span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b) Years ended December 31, 2021 and 2020 are offset by $0.2 million and $16.5 million, respectively, in valuation allowances.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The changes in the valuation allowance for deferred tax assets were as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at the beginning of the period</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,310</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84,159</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150,316</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets assumed through acquisitions</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">479</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets released through divestitures</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(271</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Credited) charged to income tax expense</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,462</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,503</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(68,537</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Charged to equity</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign currency exchange</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(407</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,440</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,338</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.88%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other adjustments</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(479</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.88%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at the end of the period</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97,962</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,310</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84,159</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, the valuation allowance decreased by $2.3 million, resulting primarily from a net decrease of $1.5 million primarily due to releasing a domestic valuation allowance related to state deferred tax assets.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, the valuation allowance increased by $16.2 million, resulting from a net increase of $14.5 million primarily due to recording a federal U.S. valuation allowance related to capital loss carryforwards as well as recording a valuation allowance related to foreign research and development credits, partially offset by the release of a valuation allowance on U.S. state deferred tax assets and an increase of $1.4 million for changes related to foreign currency exchange.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The income tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities are as follows as of December 31 (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">Deferred tax assets:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net operating losses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">134,143</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">122,018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax credits</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58,901</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58,603</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77,138</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee compensation and other benefits</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,538</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,048</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for doubtful accounts</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,787</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,739</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease obligations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57,749</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57,142</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,158</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,526</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid royalty</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,451</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Capital loss carryforward</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,157</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest limitation carryforwards</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,847</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,219</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,151</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,913</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">346,295</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">403,954</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: valuation allowance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(97,962</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(100,310</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">248,333</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">303,644</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">Deferred tax liabilities:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Undistributed foreign earnings</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,778</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10,912</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right of use asset</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47,532</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(49,316</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation and amortization</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(214,636</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(226,170</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,247</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,814</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,404</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(291,007</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(288,802</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.32%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:54.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(42,674</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,842</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021 and 2020, the Company had U.S. federal net operating loss (“NOL”) carryforwards of approximately $317.4 million and $260.6 million, respectively. These carryforwards begin to expire in 2029, but the Company anticipates utilizing such carryforwards prior to their expirations. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021 and 2020, the Company had state NOL carryforwards of approximately $840.4 million and $821.0 million, respectively, a portion of which expire annually. The Company also had foreign NOL carryforwards of $98.9 million and $80.1 million as of December 31, 2021 and 2020, respectively. The majority of these carryforwards have indefinite carryforward periods, but valuation allowances have been established for jurisdictions where the future benefits of the NOL carryforwards are not more likely than not to be realized.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021 and 2020, the Company had Canadian research and development credit carryforwards of $56.1 million and $56.7 million, respectively. These credit carryforwards have an indefinite life, but for the years ended December 31, 2021 and 2020, valuation allowances of $56.1 million and $56.7 million, respectively, have been established against these tax credits where the future benefits of the credits are not more likely than not to be realized.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s gross unrecognized tax benefits, exclusive of associated interest and penalties, were $12.1 million and $9.0 million as of December 31, 2021 and 2020, respectively. The increase of $3.1 million was primarily due to increase in positions relating to prior years in foreign jurisdictions partially offset with the settlement of unrecognized tax benefits in the U.S. The Company recognizes accrued interest and penalties related to uncertain tax positions in income tax expense in the accompanying consolidated statements of income. As of December 31, 2021 and 2020, the Company had accrued interest and penalties related to uncertain tax positions of $2.4 million and $2.8 million, respectively.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company believes it is reasonably possible that its unrecognized tax benefits may decrease by approximately $1.6 million within the next 12 months as a result of lapses in statutes of limitations. A reconciliation of the beginning and ending balances of unrecognized tax benefits, excluding accrued interest and penalties, is as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized tax benefits balance as of December 31, 2018</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,245</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases for tax positions in the current year</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,222</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases for tax positions of prior years</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,255</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases for tax positions in prior year</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(440</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Impact of foreign currency translation</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(44</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized tax benefits balance as of December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,238</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases for tax positions in the current year</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">254</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases for tax positions of prior years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,237</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases for tax positions in prior year</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,540</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Impact of foreign currency translation</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">132</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lapse of statute limitations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,288</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized tax benefits balance as of December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,033</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases for tax positions in the current year</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">386</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases for tax positions of prior years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,233</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Settlements with tax authorities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,131</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Impact of foreign currency translation</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(169</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lapse of statute limitations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(234</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized tax benefits balance as of December 31, 2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,118</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Due to the geographic breadth of the Company’s operations, numerous tax audits may be ongoing throughout the world at any point in time. Income tax liabilities are recorded based on estimates of additional income taxes which will be due upon the conclusion of these audits. Estimates of these income tax liabilities are made based upon prior experience and are updated in light of changes in facts and circumstances. However, due to the uncertain and complex application of tax regulations, it is possible that the ultimate resolution of audits may result in liabilities which could be materially different from these estimates. In such an event, the Company will record additional income tax expense or benefit in the period in which such resolution occurs.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is not currently under any U.S. federal income tax audits, however, income tax returns are under examination by tax authorities in several state and foreign jurisdictions. The Company’s federal and state tax filings are open to investigations in numerous years due to NOL carryforwards. Additionally, the Company currently has an ongoing examination for tax years 2017 to 2019 in the United Kingdom. The United Kingdom is the jurisdiction with the Company’s largest foreign operations. The Company believes that its reserve for uncertain tax positions is adequate to cover existing risks or exposures related to all open tax years and jurisdictions.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of income before provision for income taxes were as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Domestic</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">186,445</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">122,659</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,066</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">128,715</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80,999</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,775</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income before provision for income taxes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">315,160</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">203,658</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101,709</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 186445000 122659000 -17066000 128715000 80999000 118775000 315160000 203658000 101709000 <p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of income tax expense (benefit) were as follows (in thousands):</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal income taxes:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">926</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,537</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13,952</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45,819</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,188</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11,693</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign income taxes:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,718</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,452</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,309</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,106</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,206</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State income taxes:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,163</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,229</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,850</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,012</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10,922</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26,000</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax expense (benefit)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80,329</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,871</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(29,549</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> 926000 -15537000 -13952000 45819000 10188000 -11693000 27718000 16019000 21452000 -4309000 -3106000 -2206000 5163000 14229000 2850000 5012000 -10922000 -26000000 80329000 10871000 -29549000 689700000 278400000 411300000 7800000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Actual income tax expense differed from the amount computed by applying the U.S. federal tax rate of 21% to pre-tax income as a result of the following (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected income tax expense at statutory rate</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66,184</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,768</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,359</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">Change in income tax expense resulting from:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign income inclusion</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,013</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,557</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign earnings not indefinitely reinvested</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">278</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,071</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign tax credits</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,390</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in income tax valuation allowance (all jurisdictions)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,462</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,503</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(68,537</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in fair value of contingent obligations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(122</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(769</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,625</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based compensation</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,662</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,800</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,094</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and general business tax credits (a)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,902</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12,872</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,871</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State and local taxes, net of federal benefit</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,978</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,924</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,085</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Capital loss carryforward (b)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(214</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,506</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign rate differential</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,865</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,777</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,595</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in reserve for uncertain tax positions including interest</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,721</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18,839</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,393</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provision to tax return and other deferred tax adjustments</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(771</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12,325</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6,950</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain on sale of business</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,350</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Base erosion and anti-abuse tax</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,054</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nondeductible executive compensation</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,649</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">367</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,802</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.88%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other, net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,158</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,463</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,713</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.88%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax expense (benefit)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80,329</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,871</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(29,549</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) Year ended December 31, 2021 included a $0.8 million valuation allowance release and year ended December 31, 2020 was offset by a $9.4 million valuation allowance.<span style="color:#FF0000;"> </span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b) Years ended December 31, 2021 and 2020 are offset by $0.2 million and $16.5 million, respectively, in valuation allowances.</p> 0.21 66184000 42768000 21359000 -11019000 -6013000 -39557000 -278000 -5071000 4390000 -1462000 14503000 -68537000 122000 769000 -3625000 -5662000 -2800000 1094000 8902000 12872000 1871000 11978000 6924000 -9085000 -214000 -16506000 2865000 -1777000 -3595000 4721000 -18839000 5393000 -771000 -12325000 -6950000 2350000 -15054000 1649000 367000 1802000 3158000 3463000 2713000 80329000 10871000 -29549000 800 9400 200 16500 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The changes in the valuation allowance for deferred tax assets were as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at the beginning of the period</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,310</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84,159</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150,316</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets assumed through acquisitions</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">479</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets released through divestitures</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(271</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Credited) charged to income tax expense</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,462</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,503</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(68,537</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Charged to equity</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign currency exchange</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(407</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,440</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,338</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.88%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other adjustments</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(479</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.88%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at the end of the period</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97,962</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,310</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84,159</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 100310000 84159000 150316000 479000 -271000 -1462000 14503000 -68537000 42000 -407000 1440000 2338000 -479000 97962000 100310000 84159000 2300000 1500000 16200000 14500000 1400000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The income tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities are as follows as of December 31 (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">Deferred tax assets:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net operating losses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">134,143</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">122,018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax credits</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58,901</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58,603</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77,138</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee compensation and other benefits</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,538</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,048</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for doubtful accounts</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,787</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,739</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease obligations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57,749</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57,142</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,158</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,526</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid royalty</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,451</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Capital loss carryforward</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,157</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest limitation carryforwards</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,847</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,219</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,151</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,913</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">346,295</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">403,954</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: valuation allowance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(97,962</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(100,310</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">248,333</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">303,644</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">Deferred tax liabilities:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Undistributed foreign earnings</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,778</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10,912</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right of use asset</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47,532</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(49,316</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation and amortization</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(214,636</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(226,170</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,247</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,814</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,404</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(291,007</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(288,802</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.32%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:54.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(42,674</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,842</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 134143000 122018000 58901000 58603000 77138000 28538000 29048000 1787000 1739000 57749000 57142000 13158000 6526000 3451000 20021000 20157000 30847000 20219000 1151000 7913000 346295000 403954000 97962000 100310000 248333000 303644000 7778000 10912000 47532000 49316000 214636000 226170000 17247000 3814000 2404000 291007000 288802000 42674000 14842000 317400000 260600000 2029 2029 840400000 821000000.0 98900000 80100000 56100000 56700000 56100000 56700000 12100000 9000000.0 3100000 2400000 2800000 1600000 A reconciliation of the beginning and ending balances of unrecognized tax benefits, excluding accrued interest and penalties, is as follows (in thousands): <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized tax benefits balance as of December 31, 2018</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,245</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases for tax positions in the current year</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,222</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases for tax positions of prior years</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,255</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases for tax positions in prior year</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(440</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Impact of foreign currency translation</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(44</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized tax benefits balance as of December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,238</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases for tax positions in the current year</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">254</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases for tax positions of prior years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,237</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases for tax positions in prior year</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,540</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Impact of foreign currency translation</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">132</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lapse of statute limitations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,288</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized tax benefits balance as of December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,033</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases for tax positions in the current year</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">386</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases for tax positions of prior years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,233</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Settlements with tax authorities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,131</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Impact of foreign currency translation</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(169</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lapse of statute limitations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(234</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized tax benefits balance as of December 31, 2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,118</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> 19245000 2222000 2255000 440000 44000 23238000 254000 3237000 2540000 132000 15288000 9033000 386000 4233000 1131000 169000 234000 12118000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">12. Revenue from Contracts with Customers</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Unsatisfied Performance Obligations</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, the total aggregate transaction price allocated to the unsatisfied performance obligations under contracts with contract terms greater than one year and that are not accounted for as a series pursuant to ASC 606 was $6.70 billion. This amount includes revenue associated with reimbursable out-of-pocket expenses. The Company expects to recognize revenue over the remaining contract term of the individual projects, with contract terms generally ranging from one to five years. The amount of unsatisfied performance obligations is presented net of any constraints and, as a result, is lower than the potential contractual revenue. The contracts excluded due to constraints include contracts that do not commence within a certain period of time or that require the Company to undertake numerous activities to fulfill these performance obligations, including various activities that are outside of the Company’s control.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Timing of Billing and Performance</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2021, the Company recognized approximately $611.9 million of revenue that was included in the deferred revenue balance at the beginning of the year. During the year ended December 31, 2021, approximately $120.9 million of the Company’s revenue recognized was allocated to performance obligations partially satisfied in previous periods, substantially all of which was associated with changes in scope or price for full-service clinical studies. <span style="color:#000000;">The Company reviews its portfolio level risk and inflation factors during the third quarter of each year. Based on this review, the Company modified the application of its portfolio level inflation factor, which was considered a change in estimate, and recognized additional revenue of $23.5 million related to this change during the third quarter of 2021. As a result of changing service delivery trends in connection with the COVID-19 pandemic and adoption of decentralized trial methodologies, the Company implemented a comprehensive approach during the fourth quarter of 2021 related to anticipated reductions in reimbursable out-of-pocket expenses, which was considered a change in estimate, and recognized additional net revenue of $44.0 million during the period. This amount related to anticipated changes in reimbursable out-of-pocket expenses, inclusive of both the revised approach as well as updates to project estimates made in the normal course of business. The additional revenue related to these changes in estimates was partially offset by insignificant changes in estimates related to projects recognized in the normal course of the Company’s revenue recognition processes</span>.</p> 6700000000 P5Y 611900000 120900000 23500000 44000000.0 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">13. Segment Information</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is managed through two reportable segments: Clinical Solutions and Commercial Solutions. <span style="color:#231F20;">Each reportable segment consists of multiple service offerings that, when combined, create a fully integrated</span> biopharmaceutical services organization<span style="color:#231F20;">.</span> Clinical Solutions offers comprehensive global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. <span style="Background-color:#FFFFFF;color:#000000;">The segment is organized around clinical pharmacology and bioanalytical services, workforce deployment, full-service clinical studies, real world evidence, and consulting. This segment offers individual services including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs; all across a comprehensive range of therapeutic areas. </span><span style="color:#231F20;">Commercial Solutions provides the pharmaceutical, biotechnology, and healthcare industries with commercialization services, including deployment solutions, communications solutions (public relations, advertising, and medical communications), and consulting services.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s Chief Operating Decision Maker (the <span style="Background-color:#FFFFFF;color:#000000;">“</span>CODM<span style="Background-color:#FFFFFF;color:#000000;">”</span>) reviews segment performance and allocates resources based upon segment revenue and income from operations. Inter-segment revenue is eliminated from the segment reporting provided to the CODM and is not included in the segment revenue presented in the table below. Certain costs are not allocated to the Company’s reportable segments and are reported as general corporate expenses. These costs primarily consist of share-based compensation, general operating expenses associated with the Board and the Company’s senior leadership, finance, investor relations, and internal audit functions, and transaction and integration-related expenses. The Company does not allocate depreciation, amortization, asset impairment charges, or restructuring and other costs to its segments. <span style="Background-color:#FFFFFF;color:#000000;">Prior period segment results have been recast to reflect the transfer of the Kinapse Regulatory and Operations Consulting service lines from Commercial Solutions to Clinical Solutions to align with management reporting in 2021. </span>Additionally, the CODM reviews the Company’s assets on a consolidated basis and does not allocate assets to its reportable segments for purposes of assessing segment performance or allocating resources.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Information about reportable segment operating results was as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Revenue:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clinical Solutions</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,009,057</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,339,451</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,450,223</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial Solutions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,203,913</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,076,326</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,225,592</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,212,970</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,415,777</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,675,815</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Segment direct costs:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clinical Solutions</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,005,938</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,513,240</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,637,016</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial Solutions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">955,326</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">853,555</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">979,878</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total segment direct costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,961,264</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,366,795</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,616,894</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Segment selling, general, and administrative expenses:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clinical Solutions</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">353,990</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">283,633</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">280,674</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial Solutions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82,516</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82,709</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87,258</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total segment selling, general, and administrative expenses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">436,506</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">366,342</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">367,932</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Segment operating income:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clinical Solutions</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">649,129</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">542,578</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">532,533</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial Solutions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">166,071</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">140,062</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">158,456</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total segment operating income</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">815,200</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">682,640</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">690,989</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">Direct costs and operating expenses not allocated to segments:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based compensation included in direct costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,220</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,347</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,011</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based compensation included in selling, general, and administrative expenses</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,984</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,144</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,182</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate selling, general, and administrative expenses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">102,275</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79,240</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113,442</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restructuring and other costs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,816</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,414</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,135</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation and amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">235,625</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">222,352</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">242,465</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total income from operations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">389,280</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">293,143</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">237,754</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> 2 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Information about reportable segment operating results was as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Revenue:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clinical Solutions</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,009,057</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,339,451</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,450,223</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial Solutions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,203,913</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,076,326</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,225,592</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,212,970</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,415,777</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,675,815</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Segment direct costs:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clinical Solutions</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,005,938</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,513,240</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,637,016</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial Solutions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">955,326</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">853,555</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">979,878</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total segment direct costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,961,264</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,366,795</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,616,894</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Segment selling, general, and administrative expenses:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clinical Solutions</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">353,990</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">283,633</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">280,674</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial Solutions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82,516</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82,709</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87,258</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total segment selling, general, and administrative expenses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">436,506</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">366,342</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">367,932</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Segment operating income:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clinical Solutions</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">649,129</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">542,578</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">532,533</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial Solutions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">166,071</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">140,062</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">158,456</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total segment operating income</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">815,200</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">682,640</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">690,989</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">Direct costs and operating expenses not allocated to segments:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based compensation included in direct costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,220</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,347</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,011</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based compensation included in selling, general, and administrative expenses</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,984</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,144</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,182</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate selling, general, and administrative expenses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">102,275</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79,240</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113,442</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restructuring and other costs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,816</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,414</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,135</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation and amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">235,625</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">222,352</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">242,465</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total income from operations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">389,280</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">293,143</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">237,754</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 4009057000 3339451000 3450223000 1203913000 1076326000 1225592000 5212970000 4415777000 4675815000 3005938000 2513240000 2637016000 955326000 853555000 979878000 3961264000 3366795000 3616894000 353990000 283633000 280674000 82516000 82709000 87258000 436506000 366342000 367932000 649129000 542578000 532533000 166071000 140062000 158456000 815200000 682640000 690989000 33220000 31347000 29011000 31984000 27144000 26182000 102275000 79240000 113442000 22816000 29414000 42135000 235625000 222352000 242465000 389280000 293143000 237754000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">14. Operations by Geographic Location</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes total revenue by geographic area (in thousands, all intercompany transactions have been eliminated):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.12%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">North America (a)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,144,475</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,791,590</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,079,608</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Europe, Middle East and Africa</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,333,540</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,059,968</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,055,007</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Asia-Pacific</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">594,163</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">465,116</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">444,819</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Latin America</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">140,792</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99,103</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">96,381</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,212,970</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,415,777</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,675,815</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) Revenue for the North America region includes revenue attributable to the U.S. of $2.95 billion, $2.64 billion, and $2.93 billion, or 56.6%, 59.9%, and 62.7% of total revenue, for the years ended December 31, 2021, 2020 and 2019, respectively. No other country represented more than 10% of total revenue for any year.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes long-lived assets by geographic area as of December 31 (in thousands, all intercompany transactions have been eliminated):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">North America (a)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">165,446</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">161,531</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Europe, Middle East and Africa</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,004</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,745</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Asia-Pacific</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,615</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,167</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Latin America</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,592</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,757</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total property and equipment, net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">222,657</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">216,200</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) Long-lived assets for the North America region include property and equipment, net attributable to the U.S. of $160.0 million and $156.0 million as of December 31, 2021 and 2020, respectively.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes total revenue by geographic area (in thousands, all intercompany transactions have been eliminated):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.12%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">North America (a)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,144,475</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,791,590</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,079,608</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Europe, Middle East and Africa</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,333,540</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,059,968</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,055,007</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.44%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Asia-Pacific</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">594,163</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">465,116</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">444,819</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Latin America</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">140,792</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99,103</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">96,381</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,212,970</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,415,777</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,675,815</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) Revenue for the North America region includes revenue attributable to the U.S. of $2.95 billion, $2.64 billion, and $2.93 billion, or 56.6%, 59.9%, and 62.7% of total revenue, for the years ended December 31, 2021, 2020 and 2019, respectively. No other country represented more than 10% of total revenue for any year.</p> 3144475000 2791590000 3079608000 1333540000 1059968000 1055007000 594163000 465116000 444819000 140792000 99103000 96381000 5212970000 4415777000 4675815000 2950000000 2640000000 2930000000 0.566 0.599 0.627 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes long-lived assets by geographic area as of December 31 (in thousands, all intercompany transactions have been eliminated):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">North America (a)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">165,446</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">161,531</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Europe, Middle East and Africa</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,004</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,745</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Asia-Pacific</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,615</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,167</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Latin America</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,592</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,757</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total property and equipment, net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">222,657</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">216,200</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p>a) Long-lived assets for the North America region include property and equipment, net attributable to the U.S. of $160.0 million and $156.0 million as of December 31, 2021 and 2020, respectively. 165446000 161531000 37004000 38745000 13615000 11167000 6592000 4757000 222657000 216200000 160000000.0 156000000.0 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">15. Concentration of Credit Risk</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial assets that subject the Company to credit risk primarily consist of cash and cash equivalents, accounts receivable and unbilled services (including contract assets). The Company’s cash and cash equivalents consist principally of cash and are maintained at several financial institutions with reputable credit ratings. The Company maintains cash depository accounts with several financial institutions worldwide and is exposed to credit risk related to the potential inability to access liquidity in financial institutions where its cash and cash equivalents are concentrated. The Company has not historically incurred any losses with respect to these balances and believes that they bear minimal credit risk.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021 and 2020, substantially all of the Company’s cash and cash equivalents were held within the U.S. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Substantially all of the Company’s revenue is earned by performing services under contracts with pharmaceutical and biotechnology companies. The concentration of credit risk is equal to the outstanding accounts receivable and unbilled services (including contract assets) balances less deferred revenue.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No single customer accounted for greater than 10% of the Company’s revenue for the years ended December 31, 2021, 2020 or 2019.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No single customer accounted for greater than 10% of the Company’s accounts receivable and unbilled services (including contract assets) balances for the year ended December 31, 2021 or 2020. </p> 0.10 0.10 0.10 0.10 0.10 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">16. Related-Party Transactions</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">For the year ended December 31, 2021, the Company had combined revenue of $3.7 million from three customers whose board of directors each included a member who was also a member of the Company’s Board. The combined revenue reflects the periods in which the member served on both the customer’s board of directors and the Company’s Board. As of December 31, 2021, the Company had combined receivables of $0.6 million from </span>two customers whose board of directors each included a member who was also a member of the Company’s Board. For the year ended December 31, 2021, the Company incurred expenses of $0.6 million for professional services obtained from the party noted below that purchased its contingent staffing business, for the period in which such party was a related party.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">On October 6, 2021, the Company completed the acquisition of RxDataScience </span><span style="Background-color:#FFFFFF;">through an arm’s-length transaction. A member of the Company’s management was the co-founder and minority shareholder of RxDataScience and continued </span><span style="Background-color:#FFFFFF;">to be an executive advisor at RxDataScience up until the acquisition date. For additional information, refer to “Note 3 </span><span style="color:#000000;">–</span><span style="Background-color:#FFFFFF;"> Acquisitions, Divestitures, and Investments” and “Note 7 </span><span style="color:#000000;">–</span><span style="Background-color:#FFFFFF;"> Fair Value Measurements.”</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">For the year ended December 31, 2020, the Company had revenue of $1.8 million and, as of December 31, 2020, receivables of $1.3 million from a customer whose board of directors included a member who was also a member of the Company’s Board. This customer became a related party during the third quarter of 2020. During the second quarter of 2020, the Company sold its contingent staffing business to a related party in exchange for potential future cash consideration not to exceed $4.0 million. </span><span style="color:#000000;">The acquiring company had a significant </span><span style="Background-color:#FFFFFF;color:#000000;">shareholder </span><span style="color:#000000;">who was also a significant </span><span style="Background-color:#FFFFFF;color:#000000;">shareholder</span><span style="color:#000000;"> of the Company. The significant shareholder sold their interest in the acquiring company during March 2021. </span><span style="Background-color:#FFFFFF;color:#000000;">Based on the financial results of the business one year after the divestiture date, the Company recognized $1.8 million of contingent consideration </span><span style="Background-color:#FFFFFF;">in other (income) expense, net i</span><span style="Background-color:#FFFFFF;color:#000000;">n the second quarter of 2021. The future cash consideration is contingent on the financial performance of the sold business through May 31, 2023. The Company will recognize the contingent consideration in the consolidated statements of income in the period the contingency is resolved.</span> </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">For the year ended December 31, 2019, the Company had revenue of $0.4 million from a customer whose board of directors included a member who was also a member of the Company’s Board. This customer became a related party of the Company during the fourth quarter of 2019. For the year ended December 31, 2018, the Company had revenue of $0.4 million from two customers each of whose respective boards of directors included a member who was also a member of the Company’s Board</span>.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">For the year ended December 31, 2019, the Company incurred reimbursable out-of-pocket expenses of $1.1 million for professional services obtained from a provider whose board of directors included a member who was also a member of the Company’s Board. These expenses are included within direct costs in the consolidated statements of income. This provider ceased to be a related party as of December 31, 2019.</span></p> 3700000 600000 2 600000 2021-10-06 RxDataScience 1800000 1300000 4000000.0 1 1800000 400000 400000 2 1100000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">17. Commitments and Contingencies</p> <p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Legal Contingencies</p> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is involved in various claims and legal actions arising in the ordinary course of business. The Company accrues a liability when a loss is considered probable and the amount can be reasonably estimated. When a material loss contingency is reasonably possible but not probable, the Company does not record a liability, but instead discloses the nature and the amount of the claim, and an estimate of the loss or range of loss, if such an estimate can be made. Legal fees are expensed as incurred. In the opinion of management, the outcome of any existing claims and legal or regulatory proceedings, other than the specific matters described below, if decided adversely, is not expected to have a material adverse effect on the Company's business, financial condition, results of operations, or cash flows.</p> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December 1, 2017, the first of two virtually identical actions alleging federal securities law claims was filed against the Company and certain of its officers on behalf of a putative class of its shareholders. The first action, captioned Bermudez v. INC Research, Inc., et al, No. 17-09457 (S.D.N.Y.), was filed in the Southern District of New York (the “Bermudez action”), and the second action, Vaitkuvienë v. Syneos Health, Inc., et al, No. 18-0029 (E.D.N.C.), was filed on January 25, 2018 in the Eastern District of North Carolina (the “Vaitkuvienë action”). On March 30, 2018, the Bermudez action was dismissed voluntarily. After the San Antonio Fire &amp; Police Pension Fund and El Paso Firemen &amp; Policemen’s Pension Fund were appointed as Lead Plaintiffs in the Vaitkuvienë action, Lead Plaintiffs filed an amended complaint on July 30, 2018, which named as defendants the Company, Alistair Macdonald, Gregory S. Rush, Michael A. Bell, and each member of the Company’s Board at the time of the stockholder vote on the 2017 merger (the “Merger”) of INC Research with an affiliate of inVentiv Health, Inc. (“inVentiv”). The amended complaint alleged claims under Sections 10(b), 14(a) and 20(a) of the Securities Exchange Act of 1934 on behalf of a putative class of purchasers of the Company’s common stock between May 10, 2017 and November 8, 2017, contending that the Company published inaccurate or incomplete information regarding, among other things, the financial performance and business outlook for inVentiv’s business prior to and following the Merger. Lead Plaintiffs seek, among other things, orders (i) declaring that the lawsuit is a proper class </p> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">action and (ii) awarding compensatory damages in an amount to be proven at trial, including interest thereon, and reasonable costs and expenses incurred in this action, including attorneys’ fees and expert fees, to Lead Plaintiffs and other class members. </span><span style="color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 20, 2018, Defendants moved to dismiss the action. On August 30, 2021, the District Court entered an order granting the motion to dismiss in its entirety,</span><span style="color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and on October 21, 2021, the Court entered judgment for Defendants. </span><span style="color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On November 19, 2021, Lead Plaintiffs appealed from this judgment to the U.S. Court of Appeals for the Fourth Circuit, which appeal remains pending.</span></p> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is presently unable to predict the duration, scope, or result of the foregoing putative class actions, or any other related lawsuit. As such, the Company is presently unable to develop a reasonable estimate of a possible loss or range of losses, if any, related to these matters. While the Company intends to defend any further proceedings in the putative class action litigation vigorously, the outcome of such litigation or any other litigation is necessarily uncertain. The Company could be forced to expend significant resources in the defense of these lawsuits or future ones, and it may not prevail. As such, these matters could have a material adverse effect on the Company's business, annual, or interim results of operations, cash flows, or its financial condition.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Assumed Contingent Tax-Sharing Obligation</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a result of the Merger, the Company assumed contingent tax-sharing obligations arising from inVentiv Health, Inc.’s 2016 merger with Double Eagle Parent, Inc. During the first quarter of 2021, the Company made payments of $6.2 million to fully settle this outstanding obligation. As of December 31, 2020, the estimated fair value of the assumed contingent tax-sharing obligations was $6.8 million.</p> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Contingent Earn-out Liabilities </p> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the RxDataScience acquisition, the Company recorded a contingent earn-out liability to be paid based on achievement of revenue targets in 2022 and the renewal of a specific customer contract. The estimated fair value of the contingent earn-out liability as of December 31, 2021 was $14.6 million and was included in other long-term liabilities in the accompanying consolidated balance sheet. For additional information, refer to “Note 3 - Acquisitions, Divestitures, and Investments.”</p> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with an insignificant acquisition in 2021, the Company recorded a contingent earn-out liability to be paid based on achievement of employee retention benchmarks. The estimated fair value of the contingent obligation was $3.4 million as of December 31, 2021 and was included in accrued expenses in the accompanying consolidated balance sheet.</p> 2 6200000 6800000 14600000 3400000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">18. Share-Based Compensation</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Overview of Employee Share-Based Compensation Plans</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has two share-based compensation plans, the Syneos Health, Inc. 2018 Equity Incentive Plan (“2018 Plan”) and the Syneos Health, Inc. 2016 Employee Stock Purchase Plan, as amended and restated (<span style="Background-color:#FFFFFF;color:#000000;">“</span>ESPP<span style="Background-color:#FFFFFF;color:#000000;">”</span>). In addition, the Company had the INC Research Holdings, Inc. 2014 Equity Incentive Plan (<span style="Background-color:#FFFFFF;color:#000000;">“</span>2014 Plan<span style="Background-color:#FFFFFF;color:#000000;">”</span>) and the INC Research Holdings, Inc. 2010 Equity Incentive Plan (<span style="Background-color:#FFFFFF;color:#000000;">“</span>2010 Plan<span style="Background-color:#FFFFFF;color:#000000;">”</span>) that were terminated effective May 24, 2018 and October 30, 2014, respectively, except as to outstanding awards. No further awards can be issued under the 2014 Plan or 2010 Plan. The 2018 Plan was effective on May 24, 2018, and permits granting of stock options, stock appreciation rights, restricted stock awards, restricted stock units (<span style="Background-color:#FFFFFF;color:#000000;">“</span>RSUs<span style="Background-color:#FFFFFF;color:#000000;">”</span>), or stock awards to employees, as well as non-employee directors, consultants, or other personal service providers. The terms of share-based instruments granted are determined at the time of grant and are typically subject to such conditions as continued employment, passage of time, and/or satisfaction of performance criteria. The Company has granted stock options and RSUs, which typically vest ratably over a <span style="-sec-ix-hidden:F_001457">three-year</span> period from the grant date. In addition, the Company has granted performance-vesting RSUs. The Board and the Compensation and Management Development Committee have the discretion to determine different vesting schedules. Stock options have a maximum term of ten years. The exercise price per share of stock options may not be less than the fair market value of a share of the Company’s common stock on the date of grant.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, the maximum number of shares reserved for issuance under the Company’s share-based compensation plans was 15,167,325, of which 3,446,778 shares were available for future grants as of December 31, 2021. In addition, under the 2018 Plan, any shares of the Company’s common stock that are retained by or returned to the Company under any outstanding awards that are canceled, expired, forfeited, surrendered, settled in cash, or otherwise terminated without delivery of the shares, in each case, will prior to vesting or exercise become available for future grants.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Employee Stock Purchase Plan</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2016, the Board approved the ESPP, which was also approved by the Company’s shareholders in May 2016. The ESPP was subsequently amended and restated and approved by the Board in March 2018, and also approved by the Company’s shareholders in May 2018. The ESPP allows eligible employees to authorize payroll deductions of up to 10% of their annual base salary or wages to be applied toward the purchase of full shares of the Company’s common stock on the last trading day of the offering period. Participating employees can purchase shares of the Company’s common stock at a 15% discount to the lesser of the closing price of the Company’s common stock as quoted on the Nasdaq Stock Exchange on (i) the first trading day of the offering period or (ii) the last trading day of the offering period. Offering periods under the ESPP are six months in duration, and the first offering period began on September 1, 2016. Under the ESPP, the Company recognized share-based compensation expense of $6.2 million, $5.8 million, and $6.5 million for the years ended December 31, 2021, 2020, and 2019, respectively. As of December 31, 2021, there were 1,594,312 shares issued and 1,905,688 shares reserved for future issuance under the ESPP.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair values of ESPP offerings were determined using the Black-Scholes valuation model and the following assumptions:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.9%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.28%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.28%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.8%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001469">25.3% - 38.3%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.68%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001470">27.7% - 55.1%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.8%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001471">39.1% - 51.9%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.8%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001475">0.06% - 0.07%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.68%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001476">0.13% - 0.95%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.8%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001477">1.88% - 2.52%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (in years)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001481">0.5</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.68%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001482">0.5</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001483">0.5</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Stock Option Awards</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth the summary of stock option activity for the year ended December 31, 2021:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Number</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">of</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Average</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Price</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Average</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Contractual</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Life (in years)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic Value</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)(a)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">663,559</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30.12</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(279,072</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33.31</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">384,487</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27.81</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001494">3.26</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,787</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested and expected to vest as of December 31, 2021</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">384,487</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27.81</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001495">3.26</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,787</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercisable as of December 31, 2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">384,487</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27.81</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001496">3.26</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,787</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) Represents the total pre-tax intrinsic value (i.e., the aggregate difference between the closing price of the Company’s common stock on December 31, 2021 of $102.68 and the exercise price for in-the-money options) that would have been received by the holders if all instruments had been exercised on December 31, 2021.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, there was no unrecognized compensation expense related to non-vested stock options.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There have been no stock options granted since 2017. The total intrinsic value of options exercised was $14.7 million, $12.7 million, and $20.3 million for the years ended December 31, 2021, 2020, and 2019, respectively. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Restricted Stock Units Awards</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth a summary of RSUs outstanding under the 2014 and 2018 Plans as of December 31, 2021 and changes during the year then ended:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:31.62%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.98%; border-bottom:solid 0.75pt #000000;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Time-based</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.06%; border-bottom:solid 0.75pt #000000;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Performance-based</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.32%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:31.62%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Number of Shares</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Grant Date Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Number of Shares</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Grant Date Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.32%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Total Number of Shares</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.62%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-vested as of December 31, 2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,909,882</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51.98</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">461,499</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48.99</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,371,381</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.62%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">939,031</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76.96</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59,055</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75.43</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">998,086</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.62%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(997,632</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48.45</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(136,665</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46.47</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,134,297</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:31.62%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(226,094</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.32%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64.07</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(27,890</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.32%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58.71</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(253,984</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:31.62%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-vested as of December 31, 2021</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,625,187</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.32%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66.90</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">355,999</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.32%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60.75</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,981,186</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.62%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.62%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized compensation expense (in millions)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62.6</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.7</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.62%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average period unrecognized compensation is expected to be recognized</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.32%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.9 years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.32%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.9 years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Time-based Awards</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The weighted-average grant-date fair value of the RSUs granted during the years ended December 31, 2020 and 2019 was $62.12<span style="color:#FF0000;"> </span>and $45.45, respectively. The total fair value of shares vested during the years ended December 31, 2021, 2020, and 2019, was $48.3 million, $43.0 million, and $30.3 million, respectively.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Performance-Based Awards</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the years ended December 31, 2021, 2020, and 2019, the Board and Compensation and Management Development Committee granted certain executive officers performance-based RSUs (“PRSUs”). The PRSUs are subject to the Company’s achieving certain performance targets including revenue growth, adjusted diluted EPS growth, and return on invested capital. Compensation expense related to PRSUs is recorded based on the estimated quantity of awards that are expected to vest. At each reporting period, management re-assesses the probability that the performance conditions will be achieved and adjusts compensation expense to reflect any changes in the estimated probability of vesting until the actual level of achievement of the performance targets is known.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The weighted-average grant-date fair value of the PRSUs granted during the years ended December 31, 2020 and 2019 was $62.50 and $45.00, respectively. The total fair value of shares vested during the year ended December 31, 2021, was $6.4 million. No PRSUs were vested or distributed in the years ended December 31, 2020 and 2019.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Share-Based Compensation Expense</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total share-based compensation expense recognized was as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Direct costs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,220</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,347</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,011</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, general, and administrative expenses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,984</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,144</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,182</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total share-based compensation expense</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65,204</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58,491</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55,193</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The total income tax benefit recognized in the consolidated statements of income for share-based compensation arrangements was approximately $13.8 million, $11.8 million, and $10.8 million for the years ended December 31, 2021, 2020, and 2019, respectively.</p> 2 P10Y 15167325 3446778 0.10 0.15 P6M 6200000 5800000 6500000 1594312 1905688 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair values of ESPP offerings were determined using the Black-Scholes valuation model and the following assumptions:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.9%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.28%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.28%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.8%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001469">25.3% - 38.3%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.68%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001470">27.7% - 55.1%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.8%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001471">39.1% - 51.9%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.8%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001475">0.06% - 0.07%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.68%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001476">0.13% - 0.95%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.8%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001477">1.88% - 2.52%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (in years)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001481">0.5</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.68%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001482">0.5</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001483">0.5</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth the summary of stock option activity for the year ended December 31, 2021:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Number</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">of</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Average</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Price</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Average</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Contractual</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Life (in years)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic Value</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)(a)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">663,559</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30.12</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(279,072</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33.31</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">384,487</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27.81</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001494">3.26</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,787</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested and expected to vest as of December 31, 2021</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">384,487</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27.81</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001495">3.26</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,787</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercisable as of December 31, 2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">384,487</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27.81</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001496">3.26</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,787</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) Represents the total pre-tax intrinsic value (i.e., the aggregate difference between the closing price of the Company’s common stock on December 31, 2021 of $102.68 and the exercise price for in-the-money options) that would have been received by the holders if all instruments had been exercised on December 31, 2021.</p> 663559 30.12 279072 33.31 384487 27.81 28787000 384487 27.81 28787000 384487 27.81 28787000 102.68 0 0 14700000 12700000 20300000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth a summary of RSUs outstanding under the 2014 and 2018 Plans as of December 31, 2021 and changes during the year then ended:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:31.62%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.98%; border-bottom:solid 0.75pt #000000;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Time-based</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.06%; border-bottom:solid 0.75pt #000000;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Performance-based</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.32%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:31.62%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Number of Shares</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Grant Date Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Number of Shares</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Grant Date Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.32%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Total Number of Shares</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.62%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-vested as of December 31, 2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,909,882</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51.98</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">461,499</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48.99</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,371,381</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.62%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">939,031</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76.96</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59,055</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75.43</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">998,086</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.62%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(997,632</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48.45</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(136,665</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46.47</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,134,297</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:31.62%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(226,094</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.32%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64.07</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(27,890</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.32%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58.71</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(253,984</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:31.62%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-vested as of December 31, 2021</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,625,187</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.32%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66.90</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">355,999</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.32%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60.75</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,981,186</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.62%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.62%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized compensation expense (in millions)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62.6</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.7</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.62%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average period unrecognized compensation is expected to be recognized</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.32%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.9 years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.32%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.9 years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.32%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 1909882 51.98 461499 48.99 2371381 939031 76.96 59055 75.43 998086 997632 48.45 136665 46.47 1134297 226094 64.07 27890 58.71 253984 1625187 66.90 355999 60.75 1981186 62600000 10700000 P1Y10M24D P1Y10M24D 62.12 45.45 48300000 43000000.0 30300000 62.50 45.00 6400000 0 0 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total share-based compensation expense recognized was as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Direct costs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,220</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,347</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,011</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, general, and administrative expenses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,984</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,144</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,182</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total share-based compensation expense</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65,204</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58,491</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55,193</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 33220000 31347000 29011000 31984000 27144000 26182000 65204000 58491000 55193000 13800000 11800000 10800000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">19. Employee Benefit Plans</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Defined Contribution Retirement Plans</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the U.S., the Company offers defined contribution retirement benefit plans that comply with Section 401(a) of the Internal Revenue Code under which it matches employee deferrals at varying percentages and at specified limits of the employee’s salary. In 2020, the Company implemented cost management strategies, including suspending the Company match on U.S. employee 401(k) contributions for six months. The match was resumed in the fourth quarter of 2020. </p> <p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s contributions related to these defined contribution retirement plans were as follows (in thousands):</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Defined contribution retirement plan contributions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,932</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,049</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,834</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company also has defined contribution retirement plans outside of the U.S. The Company’s contributions related to these plans were approximately $23.2 million, $18.4 million, and $10.0 million for the years ended December 31, 2021, 2020, and 2019, respectively. The Company’s contributions associated with all of its defined contribution retirement plans are recorded in direct costs and selling, general, and administrative expenses on the accompanying consolidated statements of income.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Deferred Compensation Plan</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company offers a Nonqualified Deferred Compensation Plan for certain employees pursuant to Section 409A of the Internal Revenue Code (“NQDC Plan”). Under this plan, participants can defer, on a pre-tax basis, from 1.0% up to a maximum of 80.0% of salary and from 1.0% up to a maximum of 100.0% of commissions and annual bonuses. The Company does not make matching contributions into the NQDC Plan. Distributions will be made to participants upon termination of employment or death in a lump sum, unless installments are selected.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021 and 2020, the NQDC Plan deferred compensation liabilities were $23.4 million<span style="color:#FF0000;"> </span>and $22.3 million, respectively, and are included in other long-term liabilities on the accompanying consolidated balance sheets. The assets associated with the NQDC Plan are subject to the claims of the creditors and primarily consist of investments in mutual funds maintained in a “rabbi trust”. These investments are classified as trading securities and are included in other long-term assets on the accompanying consolidated balance sheets.</p> <p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s contributions related to these defined contribution retirement plans were as follows (in thousands):</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Defined contribution retirement plan contributions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,932</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,049</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,834</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 30932000 15049000 29834000 23200000 18400000 10000000.0 0.010 0.800 0.010 1.000 23400000 22300000 (b) Years ended December 31, 2021 and 2020 are offset by $0.2 million and $16.5 million, respectively, in valuation allowances. There were no non-cash restructuring and other expenses incurred for the years ended December 31, 2021 and 2020. The amount of expenses incurred for the years ended December 31, 2021 and 2020 excludes $8.2 million and $2.3 million, respectively, of facility lease closure and lease termination costs that are reflected as a reduction of operating lease right-of-use assets on the accompanying consolidated balance sheets under ASC 842. (a) Year ended December 31, 2021 included a $0.8 million valuation allowance release and year ended December 31, 2020 was offset by a $9.4 million valuation allowance. EXCEL 133 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 134 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 135 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 136 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.0.1 html 400 666 1 true 133 0 false 11 false false R1.htm 100000 - Document - Cover Page Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage Cover Page Cover 1 false false R2.htm 100010 - Statement - CONSOLIDATED STATEMENTS OF INCOME Sheet http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME CONSOLIDATED STATEMENTS OF INCOME Statements 2 false false R3.htm 100020 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Statements 3 false false R4.htm 100030 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) Statements 4 false false R5.htm 100040 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS CONSOLIDATED BALANCE SHEETS Statements 5 false false R6.htm 100050 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETSParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 6 false false R7.htm 100060 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 100070 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Sheet http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Statements 8 false false R9.htm 100080 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies Basis of Presentation and Summary of Significant Accounting Policies Notes 9 false false R10.htm 100090 - Disclosure - Financial Statement Details Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetails Financial Statement Details Notes 10 false false R11.htm 100100 - Disclosure - Acquisitions, Divestitures, and Investments Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestments Acquisitions, Divestitures, and Investments Notes 11 false false R12.htm 100110 - Disclosure - Long-Term Debt Obligations Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligations Long-Term Debt Obligations Notes 12 false false R13.htm 100120 - Disclosure - Leases Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeases Leases Notes 13 false false R14.htm 100130 - Disclosure - Derivatives Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivatives Derivatives Notes 14 false false R15.htm 100140 - Disclosure - Fair Value Measurements Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 15 false false R16.htm 100150 - Disclosure - Restructuring and Other Costs Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCosts Restructuring and Other Costs Notes 16 false false R17.htm 100160 - Disclosure - Shareholders' Equity Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquity Shareholders' Equity Notes 17 false false R18.htm 100170 - Disclosure - Earnings Per Share Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShare Earnings Per Share Notes 18 false false R19.htm 100180 - Disclosure - Income Taxes Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxes Income Taxes Notes 19 false false R20.htm 100190 - Disclosure - Revenue from Contracts with Customers Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRevenueFromContractsWithCustomers Revenue from Contracts with Customers Notes 20 false false R21.htm 100200 - Disclosure - Segment Information Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformation Segment Information Notes 21 false false R22.htm 100210 - Disclosure - Operations by Geographic Location Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocation Operations by Geographic Location Notes 22 false false R23.htm 100220 - Disclosure - Concentration of Credit Risk Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureConcentrationOfCreditRisk Concentration of Credit Risk Notes 23 false false R24.htm 100230 - Disclosure - Related-Party Transactions Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactions Related-Party Transactions Notes 24 false false R25.htm 100240 - Disclosure - Commitments and Contingencies Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 25 false false R26.htm 100250 - Disclosure - Share-Based Compensation Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensation Share-Based Compensation Notes 26 false false R27.htm 100260 - Disclosure - Employee Benefit Plans Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlans Employee Benefit Plans Notes 27 false false R28.htm 100270 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies Basis of Presentation and Summary of Significant Accounting Policies (Policies) Policies http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies 28 false false R29.htm 100280 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables Basis of Presentation and Summary of Significant Accounting Policies (Tables) Tables http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies 29 false false R30.htm 100290 - Disclosure - Financial Statement Details (Tables) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTables Financial Statement Details (Tables) Tables http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetails 30 false false R31.htm 100300 - Disclosure - Acquisitions, Divestitures, and Investments (Tables) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsTables Acquisitions, Divestitures, and Investments (Tables) Tables http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestments 31 false false R32.htm 100310 - Disclosure - Long-Term Debt Obligations (Tables) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsTables Long-Term Debt Obligations (Tables) Tables http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligations 32 false false R33.htm 100320 - Disclosure - Leases (Tables) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesTables Leases (Tables) Tables http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeases 33 false false R34.htm 100330 - Disclosure - Derivatives (Tables) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesTables Derivatives (Tables) Tables http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivatives 34 false false R35.htm 100340 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurements 35 false false R36.htm 100350 - Disclosure - Restructuring and Other Costs (Tables) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsTables Restructuring and Other Costs (Tables) Tables http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCosts 36 false false R37.htm 100360 - Disclosure - Shareholders' Equity (Tables) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityTables Shareholders' Equity (Tables) Tables http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquity 37 false false R38.htm 100370 - Disclosure - Earnings Per Share (Tables) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShareTables Earnings Per Share (Tables) Tables http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShare 38 false false R39.htm 100380 - Disclosure - Income Taxes (Tables) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables Income Taxes (Tables) Tables http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxes 39 false false R40.htm 100390 - Disclosure - Segment Information (Tables) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationTables Segment Information (Tables) Tables http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformation 40 false false R41.htm 100400 - Disclosure - Operations by Geographic Location (Tables) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationTables Operations by Geographic Location (Tables) Tables http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocation 41 false false R42.htm 100410 - Disclosure - Share-Based Compensation (Tables) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationTables Share-Based Compensation (Tables) Tables http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensation 42 false false R43.htm 100420 - Disclosure - Employee Benefit Plans (Tables) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlansTables Employee Benefit Plans (Tables) Tables http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlans 43 false false R44.htm 100430 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details) Details http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 44 false false R45.htm 100440 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Net Cash Pool Position (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNetCashPoolPositionDetails Basis of Presentation and Summary of Significant Accounting Policies - Net Cash Pool Position (Details) Details 45 false false R46.htm 100450 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Estimated Useful Lives of Property and Equipment (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfPropertyAndEquipmentDetails Basis of Presentation and Summary of Significant Accounting Policies - Estimated Useful Lives of Property and Equipment (Details) Details 46 false false R47.htm 100460 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Estimated Useful Lives of Intangible Assets (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfIntangibleAssetsDetails Basis of Presentation and Summary of Significant Accounting Policies - Estimated Useful Lives of Intangible Assets (Details) Details 47 false false R48.htm 100470 - Disclosure - Financial Statement Details - Accounts Receivable and Unbilled Services, net (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccountsReceivableAndUnbilledServicesNetDetails Financial Statement Details - Accounts Receivable and Unbilled Services, net (Details) Details 48 false false R49.htm 100480 - Disclosure - Financial Statement Details - Narrative (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsNarrativeDetails Financial Statement Details - Narrative (Details) Details 49 false false R50.htm 100490 - Disclosure - Financial Statement Details - Schedule of Property and Equipment, Net (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfPropertyAndEquipmentNetDetails Financial Statement Details - Schedule of Property and Equipment, Net (Details) Details 50 false false R51.htm 100500 - Disclosure - Financial Statement Details - Schedule of Goodwill (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfGoodwillDetails Financial Statement Details - Schedule of Goodwill (Details) Details 51 false false R52.htm 100510 - Disclosure - Financial Statement Details - Schedule of Intangible Assets (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfIntangibleAssetsDetails Financial Statement Details - Schedule of Intangible Assets (Details) Details 52 false false R53.htm 100520 - Disclosure - Financial Statement Details - Schedule of Future Amortization Expense (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfFutureAmortizationExpenseDetails Financial Statement Details - Schedule of Future Amortization Expense (Details) Details 53 false false R54.htm 100530 - Disclosure - Financial Statement Details - Schedule of Accrued Expenses (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfAccruedExpensesDetails Financial Statement Details - Schedule of Accrued Expenses (Details) Details 54 false false R55.htm 100540 - Disclosure - Financial Statement Details - Accumulated Other Comprehensive Loss, Net of Taxes (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccumulatedOtherComprehensiveLossNetOfTaxesDetails Financial Statement Details - Accumulated Other Comprehensive Loss, Net of Taxes (Details) Details 55 false false R56.htm 100550 - Disclosure - Financial Statement Details - Tax Effects Allocated to Each Component of Other Comprehensive (Loss) Income (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTaxEffectsAllocatedToEachComponentOfOtherComprehensiveLossIncomeDetails Financial Statement Details - Tax Effects Allocated to Each Component of Other Comprehensive (Loss) Income (Details) Details 56 false false R57.htm 100560 - Disclosure - Financial Statement Details - Schedule of Other (Income) Expense, Net (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfOtherIncomeExpenseNetDetails Financial Statement Details - Schedule of Other (Income) Expense, Net (Details) Details 57 false false R58.htm 100570 - Disclosure - Financial Statement Details - Supplemental Cash Flow Information (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsSupplementalCashFlowInformationDetails Financial Statement Details - Supplemental Cash Flow Information (Details) Details 58 false false R59.htm 100580 - Disclosure - Acquisitions, Divestitures, and Investments - Narrative (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails Acquisitions, Divestitures, and Investments - Narrative (Details) Details 59 false false R60.htm 100590 - Disclosure - Acquisitions, Divestitures, and Investments - Preliminary Estimates of Fair Values of Intangible Assets and Estimated Useful Lives (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValuesOfIntangibleAssetsAndEstimatedUsefulLivesDetails Acquisitions, Divestitures, and Investments - Preliminary Estimates of Fair Values of Intangible Assets and Estimated Useful Lives (Details) Details 60 false false R61.htm 100600 - Disclosure - Acquisitions, Divestitures, and Investments - Allocation of Consideration Transferred (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails Acquisitions, Divestitures, and Investments - Allocation of Consideration Transferred (Details) Details 61 false false R62.htm 100610 - Disclosure - Acquisitions, Divestitures, and Investments - Preliminary Estimates of Fair Value of Intangible Assets and Estimated Useful Lives (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValueOfIntangibleAssetsAndEstimatedUsefulLivesDetails Acquisitions, Divestitures, and Investments - Preliminary Estimates of Fair Value of Intangible Assets and Estimated Useful Lives (Details) Details 62 false false R63.htm 100620 - Disclosure - Long-Term Debt Obligations - Schedule of Debt Obligations (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfDebtObligationsDetails Long-Term Debt Obligations - Schedule of Debt Obligations (Details) Details 63 false false R64.htm 100630 - Disclosure - Long-Term Debt Obligations - Narrative (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails Long-Term Debt Obligations - Narrative (Details) Details 64 false false R65.htm 100640 - Disclosure - Long-Term Debt Obligations - Schedule of Variable Rate Margins (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails Long-Term Debt Obligations - Schedule of Variable Rate Margins (Details) Details 65 false false R66.htm 100650 - Disclosure - Long-Term Debt Obligations - Accounts Receivable Financing Agreement (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails Long-Term Debt Obligations - Accounts Receivable Financing Agreement (Details) Details 66 false false R67.htm 100660 - Disclosure - Long-Term Debt Obligations - Contractual Maturities of Debt Obligations (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails Long-Term Debt Obligations - Contractual Maturities of Debt Obligations (Details) Details 67 false false R68.htm 100670 - Disclosure - Leases - Narrative (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesNarrativeDetails Leases - Narrative (Details) Details 68 false false R69.htm 100680 - Disclosure - Leases - Components of Lease Cost (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesComponentsOfLeaseCostDetails Leases - Components of Lease Cost (Details) Details 69 false false R70.htm 100690 - Disclosure - Leases - Supplemental Balance Sheet Information Related to Leases (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalBalanceSheetInformationRelatedToLeasesDetails Leases - Supplemental Balance Sheet Information Related to Leases (Details) Details 70 false false R71.htm 100700 - Disclosure - Leases - Supplemental Cash Flow Information Related to Leases (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalCashFlowInformationRelatedToLeasesDetails Leases - Supplemental Cash Flow Information Related to Leases (Details) Details 71 false false R72.htm 100710 - Disclosure - Leases - Supplemental Cash Flow Information, Weighted Average (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalCashFlowInformationWeightedAverageDetails Leases - Supplemental Cash Flow Information, Weighted Average (Details) Details 72 false false R73.htm 100720 - Disclosure - Leases - Maturities of Lease Liabilities (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails Leases - Maturities of Lease Liabilities (Details) Details 73 false false R74.htm 100740 - Disclosure - Derivatives - Narrative (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesNarrativeDetails Derivatives - Narrative (Details) Details 74 false false R75.htm 100750 - Disclosure - Derivatives - Interest Rate Swaps Designated as Hedging Instruments on Consolidated Balance Sheets (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesInterestRateSwapsDesignatedAsHedgingInstrumentsOnConsolidatedBalanceSheetsDetails Derivatives - Interest Rate Swaps Designated as Hedging Instruments on Consolidated Balance Sheets (Details) Details 75 false false R76.htm 100760 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Details 76 false false R77.htm 100770 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Parenthetical) (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisParentheticalDetails Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Parenthetical) (Details) Details 77 false false R78.htm 100780 - Disclosure - Fair Value Measurements - Reconciliation of Changes in the Carrying Amount of Contingent Consideration (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfChangesInCarryingAmountOfContingentConsiderationDetails Fair Value Measurements - Reconciliation of Changes in the Carrying Amount of Contingent Consideration (Details) Details 78 false false R79.htm 100790 - Disclosure - Fair Value Measurements - Narrative (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsNarrativeDetails Fair Value Measurements - Narrative (Details) Details 79 false false R80.htm 100800 - Disclosure - Fair Value Measurements - Schedule of Estimated Fair Value (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueDetails Fair Value Measurements - Schedule of Estimated Fair Value (Details) Details 80 false false R81.htm 100810 - Disclosure - Restructuring and Other Costs - Schedule of Restructuring and other costs (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsScheduleOfRestructuringAndOtherCostsDetails Restructuring and Other Costs - Schedule of Restructuring and other costs (Details) Details 81 false false R82.htm 100820 - Disclosure - Restructuring and Other Costs - Liabilities Associated with Restructuring and Other Costs (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsLiabilitiesAssociatedWithRestructuringAndOtherCostsDetails Restructuring and Other Costs - Liabilities Associated with Restructuring and Other Costs (Details) Details 82 false false R83.htm 100830 - Disclosure - Shareholders' Equity - Shares of Common Stock Outstanding (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquitySharesOfCommonStockOutstandingDetails Shareholders' Equity - Shares of Common Stock Outstanding (Details) Details 83 false false R84.htm 100840 - Disclosure - Shareholders' Equity - Narrative (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityNarrativeDetails Shareholders' Equity - Narrative (Details) Details 84 false false R85.htm 100850 - Disclosure - Shareholders' Equity - Repurchase Activity (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityRepurchaseActivityDetails Shareholders' Equity - Repurchase Activity (Details) Details 85 false false R86.htm 100860 - Disclosure - Shareholders' Equity - Schedule of Stock by Class (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityScheduleOfStockByClassDetails Shareholders' Equity - Schedule of Stock by Class (Details) Details 86 false false R87.htm 100870 - Disclosure - Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) Details 87 false false R88.htm 100880 - Disclosure - Earnings Per Share - Narrative (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShareNarrativeDetails Earnings Per Share - Narrative (Details) Details 88 false false R89.htm 100890 - Disclosure - Income Taxes - Components of Income before Provision for Income Taxes (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeBeforeProvisionForIncomeTaxesDetails Income Taxes - Components of Income before Provision for Income Taxes (Details) Details 89 false false R90.htm 100900 - Disclosure - Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details) Details 90 false false R91.htm 100910 - Disclosure - Income Taxes - Narrative (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 91 false false R92.htm 100920 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) Details 92 false false R93.htm 100930 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Parenthetical) (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationParentheticalDetails Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Parenthetical) (Details) Details 93 false false R94.htm 100940 - Disclosure - Income Taxes - Summary of Valuation Allowance (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfValuationAllowanceDetails Income Taxes - Summary of Valuation Allowance (Details) Details 94 false false R95.htm 100950 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) Details 95 false false R96.htm 100960 - Disclosure - Income Taxes - Schedule of Unrecognized Tax Benefits (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnrecognizedTaxBenefitsDetails Income Taxes - Schedule of Unrecognized Tax Benefits (Details) Details 96 false false R97.htm 100970 - Disclosure - Revenue from Contracts with Customers - Narrative (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRevenueFromContractsWithCustomersNarrativeDetails Revenue from Contracts with Customers - Narrative (Details) Details 97 false false R98.htm 100980 - Disclosure - Segment Information (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationDetails Segment Information (Details) Details http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationTables 98 false false R99.htm 100990 - Disclosure - Operations by Geographic Location - Total Revenue by Geographic Area (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationTotalRevenueByGeographicAreaDetails Operations by Geographic Location - Total Revenue by Geographic Area (Details) Details 99 false false R100.htm 101000 - Disclosure - Operations by Geographic Location - Long-Lived Assets by Geographic Area (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationLongLivedAssetsByGeographicAreaDetails Operations by Geographic Location - Long-Lived Assets by Geographic Area (Details) Details 100 false false R101.htm 101010 - Disclosure - Concentration of Credit Risk - Narrative (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureConcentrationOfCreditRiskNarrativeDetails Concentration of Credit Risk - Narrative (Details) Details 101 false false R102.htm 101020 - Disclosure - Related-Party Transactions - Narrative (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails Related-Party Transactions - Narrative (Details) Details 102 false false R103.htm 101030 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 103 false false R104.htm 101040 - Disclosure - Share-Based Compensation - Narrative (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails Share-Based Compensation - Narrative (Details) Details 104 false false R105.htm 101050 - Disclosure - Share-Based Compensation - Stock Option Valuation Assumptions (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationStockOptionValuationAssumptionsDetails Share-Based Compensation - Stock Option Valuation Assumptions (Details) Details 105 false false R106.htm 101060 - Disclosure - Share-Based Compensation - Summary of Option Activity (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails Share-Based Compensation - Summary of Option Activity (Details) Details 106 false false R107.htm 101070 - Disclosure - Share-Based Compensation - Summary of Restricted Stock Unit Activity (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfRestrictedStockUnitActivityDetails Share-Based Compensation - Summary of Restricted Stock Unit Activity (Details) Details 107 false false R108.htm 101080 - Disclosure - Share-Based Compensation - Summary of Share-Based Compensation Expense (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfShareBasedCompensationExpenseDetails Share-Based Compensation - Summary of Share-Based Compensation Expense (Details) Details 108 false false R109.htm 101090 - Disclosure - Employee Benefit Plans - Schedule of Contributions to Defined Contribution Plan (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlansScheduleOfContributionsToDefinedContributionPlanDetails Employee Benefit Plans - Schedule of Contributions to Defined Contribution Plan (Details) Details 109 false false R110.htm 101100 - Disclosure - Employee Benefit Plans - Narrative (Details) Sheet http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlansNarrativeDetails Employee Benefit Plans - Narrative (Details) Details 110 false false All Reports Book All Reports synh-10k_20211231.htm synh-20211231.xsd synh-20211231_cal.xml synh-20211231_def.xml synh-20211231_lab.xml synh-20211231_pre.xml synh-ex101110_428.htm synh-ex10117_431.htm synh-ex10118_430.htm synh-ex10119_429.htm synh-ex10127_427.htm synh-ex107_432.htm synh-ex211_9.htm synh-ex231_7.htm synh-ex311_10.htm synh-ex312_6.htm synh-ex321_11.htm synh-ex322_8.htm synh-ex46_433.htm g1v4ad3roqet000001.jpg g1v4ad3roqet000002.jpg http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true JSON 139 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "synh-10k_20211231.htm": { "axisCustom": 0, "axisStandard": 40, "contextCount": 400, "dts": { "calculationLink": { "local": [ "synh-20211231_cal.xml" ] }, "definitionLink": { "local": [ "synh-20211231_def.xml" ] }, "inline": { "local": [ "synh-10k_20211231.htm" ] }, "labelLink": { "local": [ "synh-20211231_lab.xml" ] }, "presentationLink": { "local": [ "synh-20211231_pre.xml" ] }, "schema": { "local": [ "synh-20211231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 927, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 43, "http://www.syneoshealth.com/20211231": 3, "http://xbrl.sec.gov/dei/2021q4": 4, "total": 50 }, "keyCustom": 78, "keyStandard": 588, "memberCustom": 51, "memberStandard": 81, "nsprefix": "synh", "nsuri": "http://www.syneoshealth.com/20211231", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Cover Page", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100090 - Disclosure - Financial Statement Details", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetails", "shortName": "Financial Statement Details", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentNet", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101000 - Disclosure - Operations by Geographic Location - Long-Lived Assets by Geographic Area (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationLongLivedAssetsByGeographicAreaDetails", "shortName": "Operations by Geographic Location - Long-Lived Assets by Geographic Area (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_srtStatementGeographicalAxis_srtNorthAmericaMember_20211231", "decimals": "-3", "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentNet", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R101": { "firstAnchor": { "ancestors": [ "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_srtMajorCustomersAxis_us-gaapOtherCustomerMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20210101_20211231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101010 - Disclosure - Concentration of Credit Risk - Narrative (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureConcentrationOfCreditRiskNarrativeDetails", "shortName": "Concentration of Credit Risk - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_srtMajorCustomersAxis_us-gaapOtherCustomerMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20210101_20211231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R102": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RevenueFromRelatedParties", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101020 - Disclosure - Related-Party Transactions - Narrative (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails", "shortName": "Related-Party Transactions - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RevenueFromRelatedParties", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R103": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationContingentConsiderationLiability", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101030 - Disclosure - Commitments and Contingencies - Narrative (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "shortName": "Commitments and Contingencies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapBusinessAcquisitionAxis_synhInVentivMergerMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20210331", "decimals": "-5", "lang": null, "name": "us-gaap:BusinessCombinationContingentConsiderationLiability", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R104": { "firstAnchor": { "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "INF", "first": true, "lang": null, "name": "synh:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans", "reportCount": 1, "unique": true, "unitRef": "U_synhPlan", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101040 - Disclosure - Share-Based Compensation - Narrative (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails", "shortName": "Share-Based Compensation - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "INF", "first": true, "lang": null, "name": "synh:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans", "reportCount": 1, "unique": true, "unitRef": "U_synhPlan", "xsiNil": "false" } }, "R105": { "firstAnchor": null, "groupType": "disclosure", "isDefault": "false", "longName": "101050 - Disclosure - Share-Based Compensation - Stock Option Valuation Assumptions (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationStockOptionValuationAssumptionsDetails", "shortName": "Share-Based Compensation - Stock Option Valuation Assumptions (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R106": { "firstAnchor": { "ancestors": [ "p", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapStatementClassOfStockAxis_us-gaapCommonStockMember_20211231", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101060 - Disclosure - Share-Based Compensation - Summary of Option Activity (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails", "shortName": "Share-Based Compensation - Summary of Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapStatementClassOfStockAxis_us-gaapCommonStockMember_20211231", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" } }, "R107": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapAwardTypeAxis_synhTimeBasedRestrictedStockUnitsAwardsMember_20201231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101070 - Disclosure - Share-Based Compensation - Summary of Restricted Stock Unit Activity (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfRestrictedStockUnitActivityDetails", "shortName": "Share-Based Compensation - Summary of Restricted Stock Unit Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapAwardTypeAxis_synhTimeBasedRestrictedStockUnitsAwardsMember_20210101_20211231", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R108": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101080 - Disclosure - Share-Based Compensation - Summary of Share-Based Compensation Expense (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfShareBasedCompensationExpenseDetails", "shortName": "Share-Based Compensation - Summary of Share-Based Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R109": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DefinedContributionPlanCostRecognized", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101090 - Disclosure - Employee Benefit Plans - Schedule of Contributions to Defined Contribution Plan (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlansScheduleOfContributionsToDefinedContributionPlanDetails", "shortName": "Employee Benefit Plans - Schedule of Contributions to Defined Contribution Plan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DefinedContributionPlanCostRecognized", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100100 - Disclosure - Acquisitions, Divestitures, and Investments", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestments", "shortName": "Acquisitions, Divestitures, and Investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R110": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101100 - Disclosure - Employee Benefit Plans - Narrative (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlansNarrativeDetails", "shortName": "Employee Benefit Plans - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100110 - Disclosure - Long-Term Debt Obligations", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligations", "shortName": "Long-Term Debt Obligations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeFinanceLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100120 - Disclosure - Leases", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeFinanceLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100130 - Disclosure - Derivatives", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivatives", "shortName": "Derivatives", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100140 - Disclosure - Fair Value Measurements", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100150 - Disclosure - Restructuring and Other Costs", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCosts", "shortName": "Restructuring and Other Costs", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100160 - Disclosure - Shareholders' Equity", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquity", "shortName": "Shareholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100170 - Disclosure - Earnings Per Share", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShare", "shortName": "Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100180 - Disclosure - Income Taxes", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100010 - Statement - CONSOLIDATED STATEMENTS OF INCOME", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME", "shortName": "CONSOLIDATED STATEMENTS OF INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100190 - Disclosure - Revenue from Contracts with Customers", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRevenueFromContractsWithCustomers", "shortName": "Revenue from Contracts with Customers", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100200 - Disclosure - Segment Information", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformation", "shortName": "Segment Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "synh:GeographicInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100210 - Disclosure - Operations by Geographic Location", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocation", "shortName": "Operations by Geographic Location", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "synh:GeographicInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100220 - Disclosure - Concentration of Credit Risk", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureConcentrationOfCreditRisk", "shortName": "Concentration of Credit Risk", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100230 - Disclosure - Related-Party Transactions", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactions", "shortName": "Related-Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100240 - Disclosure - Commitments and Contingencies", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100250 - Disclosure - Share-Based Compensation", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensation", "shortName": "Share-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100260 - Disclosure - Employee Benefit Plans", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlans", "shortName": "Employee Benefit Plans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100270 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "synh:ScheduleOfCashPoolPositionTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100280 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "synh:ScheduleOfCashPoolPositionTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100020 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "lang": null, "name": "synh:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent1", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100290 - Disclosure - Financial Statement Details (Tables)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTables", "shortName": "Financial Statement Details (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100300 - Disclosure - Acquisitions, Divestitures, and Investments (Tables)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsTables", "shortName": "Acquisitions, Divestitures, and Investments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100310 - Disclosure - Long-Term Debt Obligations (Tables)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsTables", "shortName": "Long-Term Debt Obligations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100320 - Disclosure - Leases (Tables)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100330 - Disclosure - Derivatives (Tables)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesTables", "shortName": "Derivatives (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100340 - Disclosure - Fair Value Measurements (Tables)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100350 - Disclosure - Restructuring and Other Costs (Tables)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsTables", "shortName": "Restructuring and Other Costs (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100360 - Disclosure - Shareholders' Equity (Tables)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityTables", "shortName": "Shareholders' Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100370 - Disclosure - Earnings Per Share (Tables)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100380 - Disclosure - Income Taxes (Tables)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100030 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100390 - Disclosure - Segment Information (Tables)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationTables", "shortName": "Segment Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "synh:GeographicInformationTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100400 - Disclosure - Operations by Geographic Location (Tables)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationTables", "shortName": "Operations by Geographic Location (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "synh:GeographicInformationTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100410 - Disclosure - Share-Based Compensation (Tables)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationTables", "shortName": "Share-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100420 - Disclosure - Employee Benefit Plans (Tables)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlansTables", "shortName": "Employee Benefit Plans (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "p", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unitRef": "U_synhSegment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100430 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20201231", "decimals": "-5", "lang": null, "name": "us-gaap:RestrictedCashCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "synh:ScheduleOfCashPoolPositionTableTextBlock", "us-gaap:CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "synh:CashandCashEquivalentsCashPoolingAgreementGrossCashPosition", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100440 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Net Cash Pool Position (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNetCashPoolPositionDetails", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Net Cash Pool Position (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "synh:ScheduleOfCashPoolPositionTableTextBlock", "us-gaap:CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "synh:CashandCashEquivalentsCashPoolingAgreementGrossCashPosition", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100450 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Estimated Useful Lives of Property and Equipment (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Estimated Useful Lives of Property and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "synh:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsEstimatedUsefulLifeTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_srtRangeAxis_srtWeightedAverageMember_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapCustomerRelationshipsMember_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100460 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Estimated Useful Lives of Intangible Assets (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfIntangibleAssetsDetails", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Estimated Useful Lives of Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "synh:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsEstimatedUsefulLifeTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_srtRangeAxis_srtWeightedAverageMember_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapCustomerRelationshipsMember_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGrossCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100470 - Disclosure - Financial Statement Details - Accounts Receivable and Unbilled Services, net (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccountsReceivableAndUnbilledServicesNetDetails", "shortName": "Financial Statement Details - Accounts Receivable and Unbilled Services, net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGrossCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "p", "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-5", "first": true, "lang": null, "name": "synh:TradeReceivablesSold", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100480 - Disclosure - Financial Statement Details - Narrative (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsNarrativeDetails", "shortName": "Financial Statement Details - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-5", "first": true, "lang": null, "name": "synh:TradeReceivablesSold", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100040 - Statement - CONSOLIDATED BALANCE SHEETS", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "lang": null, "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100490 - Disclosure - Financial Statement Details - Schedule of Property and Equipment, Net (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfPropertyAndEquipmentNetDetails", "shortName": "Financial Statement Details - Schedule of Property and Equipment, Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100500 - Disclosure - Financial Statement Details - Schedule of Goodwill (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfGoodwillDetails", "shortName": "Financial Statement Details - Schedule of Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "lang": null, "name": "us-gaap:GoodwillPurchaseAccountingAdjustments", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100510 - Disclosure - Financial Statement Details - Schedule of Intangible Assets (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfIntangibleAssetsDetails", "shortName": "Financial Statement Details - Schedule of Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100520 - Disclosure - Financial Statement Details - Schedule of Future Amortization Expense (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfFutureAmortizationExpenseDetails", "shortName": "Financial Statement Details - Schedule of Future Amortization Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccruedProfessionalFeesCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100530 - Disclosure - Financial Statement Details - Schedule of Accrued Expenses (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfAccruedExpensesDetails", "shortName": "Financial Statement Details - Schedule of Accrued Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccruedProfessionalFeesCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100540 - Disclosure - Financial Statement Details - Accumulated Other Comprehensive Loss, Net of Taxes (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccumulatedOtherComprehensiveLossNetOfTaxesDetails", "shortName": "Financial Statement Details - Accumulated Other Comprehensive Loss, Net of Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedTranslationAdjustmentMember_20211231", "decimals": "-3", "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100550 - Disclosure - Financial Statement Details - Tax Effects Allocated to Each Component of Other Comprehensive (Loss) Income (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTaxEffectsAllocatedToEachComponentOfOtherComprehensiveLossIncomeDetails", "shortName": "Financial Statement Details - Tax Effects Allocated to Each Component of Other Comprehensive (Loss) Income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ForeignCurrencyTransactionGainLossRealized", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100560 - Disclosure - Financial Statement Details - Schedule of Other (Income) Expense, Net (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfOtherIncomeExpenseNetDetails", "shortName": "Financial Statement Details - Schedule of Other (Income) Expense, Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "lang": null, "name": "us-gaap:ForeignCurrencyTransactionGainLossUnrealized", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeTaxesPaid", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100570 - Disclosure - Financial Statement Details - Supplemental Cash Flow Information (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsSupplementalCashFlowInformationDetails", "shortName": "Financial Statement Details - Supplemental Cash Flow Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeTaxesPaid", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100580 - Disclosure - Acquisitions, Divestitures, and Investments - Narrative (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails", "shortName": "Acquisitions, Divestitures, and Investments - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210701_20210930", "decimals": "-5", "lang": null, "name": "synh:AssetsExchangedInCash", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100050 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETSParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapBusinessAcquisitionAxis_synhStudyKikAcquisitionMember_20210912_20210913", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100590 - Disclosure - Acquisitions, Divestitures, and Investments - Preliminary Estimates of Fair Values of Intangible Assets and Estimated Useful Lives (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValuesOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "shortName": "Acquisitions, Divestitures, and Investments - Preliminary Estimates of Fair Values of Intangible Assets and Estimated Useful Lives (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapBusinessAcquisitionAxis_synhStudyKikAcquisitionMember_20210912_20210913", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100600 - Disclosure - Acquisitions, Divestitures, and Investments - Allocation of Consideration Transferred (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails", "shortName": "Acquisitions, Divestitures, and Investments - Allocation of Consideration Transferred (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapBusinessAcquisitionAxis_synhSynteractAcquisitionMember_20201209", "decimals": "-3", "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapBusinessAcquisitionAxis_synhSynteractAcquisitionMember_20201208_20201209", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100610 - Disclosure - Acquisitions, Divestitures, and Investments - Preliminary Estimates of Fair Value of Intangible Assets and Estimated Useful Lives (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValueOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "shortName": "Acquisitions, Divestitures, and Investments - Preliminary Estimates of Fair Value of Intangible Assets and Estimated Useful Lives (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapBusinessAcquisitionAxis_synhSynteractAcquisitionMember_20201208_20201209", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100620 - Disclosure - Long-Term Debt Obligations - Schedule of Debt Obligations (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfDebtObligationsDetails", "shortName": "Long-Term Debt Obligations - Schedule of Debt Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapLongtermDebtTypeAxis_us-gaapSecuredDebtMember_20211231", "decimals": "-3", "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RepaymentsOfLongTermDebt", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100630 - Disclosure - Long-Term Debt Obligations - Narrative (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "shortName": "Long-Term Debt Obligations - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapDebtInstrumentAxis_synhSeniorUnsecuredNotesDue2029Member_20210101_20211231", "decimals": "INF", "lang": null, "name": "us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R65": { "firstAnchor": null, "groupType": "disclosure", "isDefault": "false", "longName": "100640 - Disclosure - Long-Term Debt Obligations - Schedule of Variable Rate Margins (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails", "shortName": "Long-Term Debt Obligations - Schedule of Variable Rate Margins (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R66": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211011_20211013", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityDecreaseForgiveness1", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100650 - Disclosure - Long-Term Debt Obligations - Accounts Receivable Financing Agreement (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails", "shortName": "Long-Term Debt Obligations - Accounts Receivable Financing Agreement (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211011_20211013", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityDecreaseForgiveness1", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100660 - Disclosure - Long-Term Debt Obligations - Contractual Maturities of Debt Obligations (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails", "shortName": "Long-Term Debt Obligations - Contractual Maturities of Debt Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "p", "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_srtRangeAxis_srtMinimumMember_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "synh:LeaseRemainingLeaseTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100670 - Disclosure - Leases - Narrative (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesNarrativeDetails", "shortName": "Leases - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_srtRangeAxis_srtMinimumMember_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "synh:LeaseRemainingLeaseTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "synh:FixedLeaseCosts", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100680 - Disclosure - Leases - Components of Lease Cost (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesComponentsOfLeaseCostDetails", "shortName": "Leases - Components of Lease Cost (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "synh:FixedLeaseCosts", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100060 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "synh:AssetsAndLiabilitiesLesseeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100690 - Disclosure - Leases - Supplemental Balance Sheet Information Related to Leases (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalBalanceSheetInformationRelatedToLeasesDetails", "shortName": "Leases - Supplemental Balance Sheet Information Related to Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "synh:AssetsAndLiabilitiesLesseeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "lang": null, "name": "synh:FinanceLeaseRightOfUseAssetAccumulatedDepreciation", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "synh:LesseeSupplementalCashFlowInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100700 - Disclosure - Leases - Supplemental Cash Flow Information Related to Leases (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalCashFlowInformationRelatedToLeasesDetails", "shortName": "Leases - Supplemental Cash Flow Information Related to Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "synh:LesseeSupplementalCashFlowInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "synh:LesseeSupplementalCashFlowInformationWeightedAverageTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100710 - Disclosure - Leases - Supplemental Cash Flow Information, Weighted Average (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalCashFlowInformationWeightedAverageDetails", "shortName": "Leases - Supplemental Cash Flow Information, Weighted Average (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "synh:LesseeSupplementalCashFlowInformationWeightedAverageTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100720 - Disclosure - Leases - Maturities of Lease Liabilities (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails", "shortName": "Leases - Maturities of Lease Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ForeignCurrencyTransactionGainLossRealized", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100740 - Disclosure - Derivatives - Narrative (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesNarrativeDetails", "shortName": "Derivatives - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapDerivativeInstrumentRiskAxis_synhInterestRateSwapExpiringJune302021Member_20181231", "decimals": "-7", "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaapCashFlowHedgingMember_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100750 - Disclosure - Derivatives - Interest Rate Swaps Designated as Hedging Instruments on Consolidated Balance Sheets (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesInterestRateSwapsDesignatedAsHedgingInstrumentsOnConsolidatedBalanceSheetsDetails", "shortName": "Derivatives - Interest Rate Swaps Designated as Hedging Instruments on Consolidated Balance Sheets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaapCashFlowHedgingMember_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationContingentConsiderationLiability", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100760 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails", "shortName": "Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231", "decimals": "-3", "lang": null, "name": "us-gaap:TradingSecurities", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ContractualObligation", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100770 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Parenthetical) (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisParentheticalDetails", "shortName": "Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Parenthetical) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ContractualObligation", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100780 - Disclosure - Fair Value Measurements - Reconciliation of Changes in the Carrying Amount of Contingent Consideration (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfChangesInCarryingAmountOfContingentConsiderationDetails", "shortName": "Fair Value Measurements - Reconciliation of Changes in the Carrying Amount of Contingent Consideration (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20191231", "decimals": "-3", "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3", "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3", "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3", "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3", "us-gaap:FairValueLiabilitiesLevel2ToLevel1TransfersAmount", "us-gaap:FairValueLiabilitiesLevel1ToLevel2TransfersAmount", "us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount", "us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount", "p", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100790 - Disclosure - Fair Value Measurements - Narrative (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsNarrativeDetails", "shortName": "Fair Value Measurements - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3", "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3", "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3", "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3", "us-gaap:FairValueLiabilitiesLevel2ToLevel1TransfersAmount", "us-gaap:FairValueLiabilitiesLevel1ToLevel2TransfersAmount", "us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount", "us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount", "p", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20181231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100070 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY", "shortName": "CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231", "decimals": "-3", "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapDebtInstrumentAxis_synhA2017CreditAgreementAmendmentNo2TermLoanATrancheOneDueMarch2024Member_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_us-gaapLongtermDebtTypeAxis_us-gaapSecuredDebtMember_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtLongtermAndShorttermCombinedAmount", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100800 - Disclosure - Fair Value Measurements - Schedule of Estimated Fair Value (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueDetails", "shortName": "Fair Value Measurements - Schedule of Estimated Fair Value (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapDebtInstrumentAxis_synhA2017CreditAgreementAmendmentNo2TermLoanATrancheOneDueMarch2024Member_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_us-gaapLongtermDebtTypeAxis_us-gaapSecuredDebtMember_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtLongtermAndShorttermCombinedAmount", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RestructuringAndRelatedCostIncurredCost", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100810 - Disclosure - Restructuring and Other Costs - Schedule of Restructuring and other costs (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsScheduleOfRestructuringAndOtherCostsDetails", "shortName": "Restructuring and Other Costs - Schedule of Restructuring and other costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RestructuringAndRelatedCostIncurredCost", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock", "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100820 - Disclosure - Restructuring and Other Costs - Liabilities Associated with Restructuring and Other Costs (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsLiabilitiesAssociatedWithRestructuringAndOtherCostsDetails", "shortName": "Restructuring and Other Costs - Liabilities Associated with Restructuring and Other Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "link:footnote", "p", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-5", "lang": null, "name": "synh:BusinessExitCostsAndGainLossOnTerminationOfLease", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharesOutstanding", "reportCount": 1, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100830 - Disclosure - Shareholders' Equity - Shares of Common Stock Outstanding (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquitySharesOfCommonStockOutstandingDetails", "shortName": "Shareholders' Equity - Shares of Common Stock Outstanding (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231", "decimals": "INF", "lang": null, "name": "us-gaap:SharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20191205", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100840 - Disclosure - Shareholders' Equity - Narrative (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityNarrativeDetails", "shortName": "Shareholders' Equity - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20191205", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfRepurchaseAgreements", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapStatementClassOfStockAxis_us-gaapCommonStockMember_20210601_20210630", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockRepurchasedDuringPeriodShares", "reportCount": 1, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100850 - Disclosure - Shareholders' Equity - Repurchase Activity (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityRepurchaseActivityDetails", "shortName": "Shareholders' Equity - Repurchase Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfRepurchaseAgreements", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapStatementClassOfStockAxis_us-gaapCommonStockMember_20210601_20210630", "decimals": "2", "lang": null, "name": "us-gaap:TreasuryStockAcquiredAverageCostPerShare", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100860 - Disclosure - Shareholders' Equity - Schedule of Stock by Class (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityScheduleOfStockByClassDetails", "shortName": "Shareholders' Equity - Schedule of Stock by Class (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfStockByClassTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "INF", "lang": null, "name": "synh:CommonandPreferredStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100870 - Disclosure - Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails", "shortName": "Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "lang": null, "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100880 - Disclosure - Earnings Per Share - Narrative (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShareNarrativeDetails", "shortName": "Earnings Per Share - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100890 - Disclosure - Income Taxes - Components of Income before Provision for Income Taxes (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeBeforeProvisionForIncomeTaxesDetails", "shortName": "Income Taxes - Components of Income before Provision for Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100080 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100900 - Disclosure - Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails", "shortName": "Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-5", "first": true, "lang": null, "name": "synh:ForeignEarningsPreviouslyTaxedintheUSTotal", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100910 - Disclosure - Income Taxes - Narrative (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails", "shortName": "Income Taxes - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-5", "first": true, "lang": null, "name": "synh:ForeignEarningsPreviouslyTaxedintheUSTotal", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100920 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails", "shortName": "Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100930 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Parenthetical) (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationParentheticalDetails", "shortName": "Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Parenthetical) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "link:footnote", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapTaxCreditCarryforwardAxis_synhResearchAndGeneralBusinessTaxCreditsMember_20210101_20211231", "decimals": "-2", "lang": null, "name": "us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock", "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100940 - Disclosure - Income Taxes - Summary of Valuation Allowance (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfValuationAllowanceDetails", "shortName": "Income Taxes - Summary of Valuation Allowance (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:SummaryOfValuationAllowanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapValuationAllowanceOfDeferredTaxAssetsMember_20181231", "decimals": "-3", "lang": null, "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100950 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails", "shortName": "Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100960 - Disclosure - Income Taxes - Schedule of Unrecognized Tax Benefits (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnrecognizedTaxBenefitsDetails", "shortName": "Income Taxes - Schedule of Unrecognized Tax Benefits (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "lang": null, "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20211231", "decimals": "-7", "first": true, "lang": null, "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100970 - Disclosure - Revenue from Contracts with Customers - Narrative (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRevenueFromContractsWithCustomersNarrativeDetails", "shortName": "Revenue from Contracts with Customers - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-5", "lang": null, "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "p", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unitRef": "U_synhSegment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100980 - Disclosure - Segment Information (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationDetails", "shortName": "Segment Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_srtConsolidationItemsAxis_us-gaapOperatingSegmentsMember_20210101_20211231", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100990 - Disclosure - Operations by Geographic Location - Total Revenue by Geographic Area (Details)", "role": "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationTotalRevenueByGeographicAreaDetails", "shortName": "Operations by Geographic Location - Total Revenue by Geographic Area (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "synh:GeographicInformationTextBlock", "body", "html" ], "baseRef": "synh-10k_20211231.htm", "contextRef": "C_0001610950_srtStatementGeographicalAxis_srtNorthAmericaMember_20210101_20211231", "decimals": "-3", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } } }, "segmentCount": 133, "tag": { "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationLongLivedAssetsByGeographicAreaDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationTotalRevenueByGeographicAreaDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r903", "r904", "r905" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm Id", "terseLabel": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r903", "r904", "r905" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r903", "r904", "r905" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r903", "r904", "r905" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r906" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r901" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated By Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r900" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r900" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r900" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r908" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r900" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r900" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r900" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r900" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r909" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well Known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r903", "r904", "r905" ], "lang": { "en-us": { "role": { "label": "Icfr Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r899" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r902" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DocumentCoverPage" ], "xbrltype": "tradingSymbolItemType" }, "srt_AffiliatedEntityMember": { "auth_ref": [ "r489", "r766", "r767", "r770", "r896" ], "lang": { "en-us": { "role": { "label": "Affiliated Entity [Member]", "terseLabel": "Affiliated Entity" } } }, "localname": "AffiliatedEntityMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asia Pacific [Member]", "terseLabel": "Asia-Pacific" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationLongLivedAssetsByGeographicAreaDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationTotalRevenueByGeographicAreaDetails" ], "xbrltype": "domainItemType" }, "srt_CondensedBalanceSheetStatementTable": { "auth_ref": [ "r132", "r641" ], "lang": { "en-us": { "role": { "label": "Condensed Balance Sheet Statement [Table]", "terseLabel": "Condensed Balance Sheet Statement [Table]" } } }, "localname": "CondensedBalanceSheetStatementTable", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_CondensedBalanceSheetStatementsCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Balance Sheet Statements Captions [Line Items]", "terseLabel": "Condensed Balance Sheet Statements Captions [Line Items]" } } }, "localname": "CondensedBalanceSheetStatementsCaptionsLineItems", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r132", "r327", "r332", "r340", "r644", "r645", "r650", "r651", "r773", "r896" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]", "terseLabel": "Consolidated Entities" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r132", "r327", "r332", "r340", "r644", "r645", "r650", "r651", "r773", "r896" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]", "terseLabel": "Consolidated Entities" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r132", "r202", "r215", "r216", "r217", "r218", "r220", "r222", "r226", "r327", "r328", "r329", "r330", "r331", "r332", "r334", "r335", "r337", "r339", "r340" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r132", "r202", "r215", "r216", "r217", "r218", "r220", "r222", "r226", "r327", "r328", "r329", "r330", "r331", "r332", "r334", "r335", "r337", "r339", "r340" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [ "r2", "r145", "r154", "r160", "r255", "r560", "r561", "r562", "r605", "r606", "r680", "r683", "r685", "r686", "r912" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect Period Of Adoption Adjustment [Member]", "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r2", "r145", "r154", "r160", "r255", "r560", "r561", "r562", "r605", "r606", "r680", "r683", "r685", "r686", "r912" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect Period Of Adoption [Axis]", "terseLabel": "Cumulative Effect, Period of Adoption" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r2", "r145", "r154", "r160", "r255", "r560", "r561", "r562", "r605", "r606", "r680", "r683", "r685", "r686", "r912" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect Period Of Adoption [Domain]", "terseLabel": "Cumulative Effect, Period of Adoption" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "srt_DirectorMember": { "auth_ref": [ "r237" ], "lang": { "en-us": { "role": { "label": "Director [Member]", "terseLabel": "Board of Directors" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_LatinAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Latin America [Member]", "terseLabel": "Latin America" } } }, "localname": "LatinAmericaMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationLongLivedAssetsByGeographicAreaDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationTotalRevenueByGeographicAreaDetails" ], "xbrltype": "domainItemType" }, "srt_LitigationCaseAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Litigation Case [Axis]", "terseLabel": "Litigation Case" } } }, "localname": "LitigationCaseAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_LitigationCaseTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Litigation Case Type [Domain]", "terseLabel": "Litigation Case" } } }, "localname": "LitigationCaseTypeDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r235", "r432", "r437", "r848" ], "lang": { "en-us": { "role": { "label": "Major Customers [Axis]", "terseLabel": "Customer" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureConcentrationOfCreditRiskNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r345", "r386", "r515", "r518", "r780", "r781", "r782", "r783", "r784", "r785", "r786", "r844", "r849", "r897", "r898" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValueOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfIntangibleAssetsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlansNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRevenueFromContractsWithCustomersNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r345", "r386", "r515", "r518", "r780", "r781", "r782", "r783", "r784", "r785", "r786", "r844", "r849", "r897", "r898" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum", "verboseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValueOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfIntangibleAssetsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlansNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRevenueFromContractsWithCustomersNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r235", "r432", "r437", "r848" ], "lang": { "en-us": { "role": { "label": "Name Of Major Customer [Domain]", "terseLabel": "Customer" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureConcentrationOfCreditRiskNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "North America [Member]", "terseLabel": "North America" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationLongLivedAssetsByGeographicAreaDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationTotalRevenueByGeographicAreaDetails" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Axis]", "terseLabel": "Ownership" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisParentheticalDetails" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Domain]", "terseLabel": "Ownership" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisParentheticalDetails" ], "xbrltype": "domainItemType" }, "srt_PartnershipInterestMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Partnership Interest [Member]", "terseLabel": "Partnership Interest" } } }, "localname": "PartnershipInterestMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r345", "r386", "r462", "r515", "r518", "r780", "r781", "r782", "r783", "r784", "r785", "r786", "r844", "r849", "r897", "r898" ], "lang": { "en-us": { "role": { "label": "Range [Axis]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValueOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfIntangibleAssetsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlansNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRevenueFromContractsWithCustomersNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r345", "r386", "r462", "r515", "r518", "r780", "r781", "r782", "r783", "r784", "r785", "r786", "r844", "r849", "r897", "r898" ], "lang": { "en-us": { "role": { "label": "Range [Member]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValueOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfIntangibleAssetsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlansNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRevenueFromContractsWithCustomersNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r230", "r231", "r432", "r436", "r847", "r887", "r888", "r889", "r890", "r891", "r892", "r893", "r894", "r895" ], "lang": { "en-us": { "role": { "label": "Segment Geographical [Domain]", "terseLabel": "Geographical" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationLongLivedAssetsByGeographicAreaDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationTotalRevenueByGeographicAreaDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r230", "r231", "r432", "r436", "r847", "r881", "r887", "r888", "r889", "r890", "r891", "r892", "r893", "r894", "r895" ], "lang": { "en-us": { "role": { "label": "Statement Geographical [Axis]", "terseLabel": "Geographical" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationLongLivedAssetsByGeographicAreaDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationTotalRevenueByGeographicAreaDetails" ], "xbrltype": "stringItemType" }, "srt_SubsidiariesMember": { "auth_ref": [ "r489", "r766", "r767", "r770" ], "lang": { "en-us": { "role": { "label": "Subsidiaries [Member]", "terseLabel": "Subsidiaries" } } }, "localname": "SubsidiariesMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r237", "r769" ], "lang": { "en-us": { "role": { "label": "Title Of Individual [Axis]", "terseLabel": "Title of Individual" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title Of Individual With Relationship To Entity [Domain]", "terseLabel": "Title of Individual" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_WeightedAverageMember": { "auth_ref": [ "r780", "r782", "r785", "r897", "r898" ], "lang": { "en-us": { "role": { "label": "Weighted Average [Member]", "terseLabel": "Weighted Average" } } }, "localname": "WeightedAverageMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "synh_A2017CreditAgreementAmendmentNo1TermLoanADueAugust2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2017 Credit Agreement - Amendment No. 1 - Term Loan A Due August 2022 [Member]", "label": "A2017 Credit Agreement Amendment No1 Term Loan A Due August2022 [Member]", "terseLabel": "Term Loan A" } } }, "localname": "A2017CreditAgreementAmendmentNo1TermLoanADueAugust2022Member", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails" ], "xbrltype": "domainItemType" }, "synh_A2017CreditAgreementAmendmentNo2RevolvingCreditFacilityDueAugust2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amendment No 2 - Revolving Credit Facility due August 2024.", "label": "A2017 Credit Agreement Amendment No2 Revolving Credit Facility Due August2024 [Member]", "terseLabel": "2017 Credit Agreement - Amendment No 2 - Term Loan B Due August 2024" } } }, "localname": "A2017CreditAgreementAmendmentNo2RevolvingCreditFacilityDueAugust2024Member", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "synh_A2017CreditAgreementAmendmentNo2TermLoanADueMarch2024FundedAmountMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2017 Credit Agreement - Amendment No 2 - Term Loan A Due March 2024, Funded Amount [Member]", "label": "A2017 Credit Agreement Amendment No2 Term Loan A Due March2024 Funded Amount [Member]", "terseLabel": "2017 Credit Agreement" } } }, "localname": "A2017CreditAgreementAmendmentNo2TermLoanADueMarch2024FundedAmountMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "synh_A2017CreditAgreementAmendmentNo2TermLoanADueMarch2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2017 Credit agreement - Amendment No 2 - Term loan A due March 2024.", "label": "A2017 Credit Agreement Amendment No2 Term Loan A Due March2024 [Member]", "terseLabel": "2017 Credit Agreement - Amendment No 2 - Term Loan B Due March 2024" } } }, "localname": "A2017CreditAgreementAmendmentNo2TermLoanADueMarch2024Member", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "synh_A2017CreditAgreementAmendmentNo2TermLoanATrancheOneDueMarch2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2017 Credit agreement - Amendment No 2 - Term loan A tranche one due March 2024.", "label": "A2017 Credit Agreement Amendment No2 Term Loan A Tranche One Due March2024 [Member]", "terseLabel": "Term Loan A - Tranche One Due March 2024" } } }, "localname": "A2017CreditAgreementAmendmentNo2TermLoanATrancheOneDueMarch2024Member", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueDetails" ], "xbrltype": "domainItemType" }, "synh_A2017CreditAgreementAmendmentNo2TermLoanATrancheTwoDueAugust2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2017 Credit agreement - Amendment No 2 - Term loan A tranche two due August 2024.", "label": "A2017 Credit Agreement Amendment No2 Term Loan A Tranche Two Due August2024 [Member]", "terseLabel": "Term Loan A - Tranche Two Due August 2024" } } }, "localname": "A2017CreditAgreementAmendmentNo2TermLoanATrancheTwoDueAugust2024Member", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueDetails" ], "xbrltype": "domainItemType" }, "synh_A2017CreditAgreementAmendmentNo2TermLoanBDueAugust2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2017 Credit agreement - Amendment No 2 - Term loan B due August 2024.", "label": "A2017 Credit Agreement Amendment No2 Term Loan B Due August2024 [Member]", "terseLabel": "2017 Credit Agreement - Amendment No 2 - Term Loan B Due August 2024" } } }, "localname": "A2017CreditAgreementAmendmentNo2TermLoanBDueAugust2024Member", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "synh_A2017CreditAgreementRevolvingCreditFacilityDueAugust2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2017 Credit Agreement - Revolving Credit Facility Due August 2022 [Member]", "label": "A2017 Credit Agreement Revolving Credit Facility Due August2022 [Member]", "terseLabel": "2017 Credit Agreement - Revolving Credit Facility" } } }, "localname": "A2017CreditAgreementRevolvingCreditFacilityDueAugust2022Member", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails" ], "xbrltype": "domainItemType" }, "synh_A2017CreditAgreementTermBLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2017 Credit Agreement, Term B Loan [Member]", "label": "A2017 Credit Agreement Term B Loan [Member]", "terseLabel": "2017 Credit Agreement" } } }, "localname": "A2017CreditAgreementTermBLoanMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "synh_A2017CreditAgreementTermLoanBDueAugust2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2017 Credit agreement term loan B due August 2024.", "label": "A2017 Credit Agreement Term Loan B Due August2024 [Member]", "terseLabel": "2017 Credit Agreement - Amendment No 2 - Term Loan B Due August 2024" } } }, "localname": "A2017CreditAgreementTermLoanBDueAugust2024Member", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfDebtObligationsDetails" ], "xbrltype": "domainItemType" }, "synh_AccountsReceivableFinancingAgreementDueOctober2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounts receivable financing agreement due october 2022.", "label": "Accounts Receivable Financing Agreement Due October2022 [Member]", "terseLabel": "Accounts receivable financing agreement due October 2022" } } }, "localname": "AccountsReceivableFinancingAgreementDueOctober2022Member", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfDebtObligationsDetails" ], "xbrltype": "domainItemType" }, "synh_AccountsReceivableFinancingAgreementDueSeptember2021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounts receivable financing agreement due September 2021.", "label": "Accounts Receivable Financing Agreement Due September2021 [Member]", "terseLabel": "Accounts receivable financing agreement due September 2021" } } }, "localname": "AccountsReceivableFinancingAgreementDueSeptember2021Member", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails" ], "xbrltype": "domainItemType" }, "synh_AccountsReceivableSecuritizationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounts Receivable Securitization [Member]", "label": "Accounts Receivable Securitization [Member]", "terseLabel": "Accounts Receivable Securitization" } } }, "localname": "AccountsReceivableSecuritizationMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfDebtObligationsDetails" ], "xbrltype": "domainItemType" }, "synh_AccruedRebatesToCustomersCurrent": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfAccruedExpensesDetails": { "order": 10040.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrual for rebates provided to customers (current).", "label": "Accrued Rebates To Customers Current", "terseLabel": "Rebates to customers" } } }, "localname": "AccruedRebatesToCustomersCurrent", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "synh_AcquiredBacklogMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acquired backlog.", "label": "Acquired Backlog [Member]", "terseLabel": "Acquired backlog" } } }, "localname": "AcquiredBacklogMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValuesOfIntangibleAssetsAndEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "synh_AcquiredTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acquired technology member.", "label": "Acquired Technology [Member]", "terseLabel": "Acquired Technology" } } }, "localname": "AcquiredTechnologyMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValuesOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfIntangibleAssetsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "synh_AmendmentNo1TermBLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amendment No. 1, Term B Loan [Member]", "label": "Amendment No1 Term B Loan [Member]", "terseLabel": "Term Loan B" } } }, "localname": "AmendmentNo1TermBLoanMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails" ], "xbrltype": "domainItemType" }, "synh_AssetsAndLiabilitiesLesseeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets And Liabilities, Lessee [Table Text Block]", "label": "Assets And Liabilities Lessee Table [Text Block]", "terseLabel": "Schedule of Assets And Liabilities" } } }, "localname": "AssetsAndLiabilitiesLesseeTableTextBlock", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "synh_AssetsExchangedInCash": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Assets exchanged in cash.", "label": "Assets Exchanged In Cash", "terseLabel": "Assets Exchanged In Cash" } } }, "localname": "AssetsExchangedInCash", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "synh_AssetsNotYetPlacedInServiceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets Not Yet Placed In Service", "label": "Assets Not Yet Placed In Service [Member]", "terseLabel": "Assets not yet placed in service" } } }, "localname": "AssetsNotYetPlacedInServiceMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "synh_BermudezAndVaitkuvieneActionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bermudez And Vaitkuviene Action [Member]", "label": "Bermudez And Vaitkuviene Action [Member]", "terseLabel": "Bermudez and Vaitkuviene Actions" } } }, "localname": "BermudezAndVaitkuvieneActionMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "synh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails": { "order": 10030.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Accounts Payable And Accrued Expenses.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Accounts Payable And Accrued Expenses", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails" ], "xbrltype": "monetaryItemType" }, "synh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiability": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails": { "order": 10040.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Contract With Customer, Liability", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Contract With Customer Liability", "terseLabel": "Deferred revenue" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiability", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails" ], "xbrltype": "monetaryItemType" }, "synh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAccountsReceivableAndUnbilledServices": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails": { "order": 10090.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Current Assets Accounts Receivable And Unbilled Services.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Accounts Receivable And Unbilled Services", "terseLabel": "Accounts receivable and unbilled services" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAccountsReceivableAndUnbilledServices", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails" ], "xbrltype": "monetaryItemType" }, "synh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails": { "order": 10120.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Right-Of-Use Assets.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Operating Lease Right Of Use Assets", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails" ], "xbrltype": "monetaryItemType" }, "synh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentTaxSharingObligation": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfAccruedExpensesDetails": { "order": 10060.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Tax Sharing Obligation", "label": "Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Current Tax Sharing Obligation", "terseLabel": "Contingent obligations, current" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentTaxSharingObligation", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "synh_BusinessExitCostsAndGainLossOnTerminationOfLease": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Exit Costs And (Gain) Loss On Termination Of Lease", "label": "Business Exit Costs And Gain Loss On Termination Of Lease", "terseLabel": "Business exit costs and (gain) loss on termination of lease" } } }, "localname": "BusinessExitCostsAndGainLossOnTerminationOfLease", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsLiabilitiesAssociatedWithRestructuringAndOtherCostsDetails" ], "xbrltype": "monetaryItemType" }, "synh_CashandCashEquivalentsCashPoolingAgreementCashPoolBorrowings": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNetCashPoolPositionDetails": { "order": 10020.0, "parentTag": "synh_CashandCashEquivalentsCashPoolingAgreementNetCashPosition", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash and Cash Equivalents, Cash Pooling Agreement, Cash Pool Borrowings", "label": "Cashand Cash Equivalents Cash Pooling Agreement Cash Pool Borrowings", "negatedLabel": "Less: cash borrowings" } } }, "localname": "CashandCashEquivalentsCashPoolingAgreementCashPoolBorrowings", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNetCashPoolPositionDetails" ], "xbrltype": "monetaryItemType" }, "synh_CashandCashEquivalentsCashPoolingAgreementGrossCashPosition": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNetCashPoolPositionDetails": { "order": 10010.0, "parentTag": "synh_CashandCashEquivalentsCashPoolingAgreementNetCashPosition", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash and Cash Equivalents, Cash Pooling Agreement, Gross Cash Position", "label": "Cashand Cash Equivalents Cash Pooling Agreement Gross Cash Position", "terseLabel": "Gross cash position" } } }, "localname": "CashandCashEquivalentsCashPoolingAgreementGrossCashPosition", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNetCashPoolPositionDetails" ], "xbrltype": "monetaryItemType" }, "synh_CashandCashEquivalentsCashPoolingAgreementNetCashPosition": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNetCashPoolPositionDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash and Cash Equivalents, Cash Pooling Agreement, Net Cash Position", "label": "Cashand Cash Equivalents Cash Pooling Agreement Net Cash Position", "totalLabel": "Net cash position" } } }, "localname": "CashandCashEquivalentsCashPoolingAgreementNetCashPosition", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNetCashPoolPositionDetails" ], "xbrltype": "monetaryItemType" }, "synh_ClassBCommonStockConversionRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class B Common Stock, Conversion Ratio", "label": "Class B Common Stock Conversion Ratio", "terseLabel": "Class B common stock, conversion ratio" } } }, "localname": "ClassBCommonStockConversionRatio", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityNarrativeDetails" ], "xbrltype": "pureItemType" }, "synh_ClinicalSolutionsSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Clinical Solutions Segment [Member]", "label": "Clinical Solutions Segment [Member]", "terseLabel": "Clinical Solutions" } } }, "localname": "ClinicalSolutionsSegmentMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfGoodwillDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "synh_CommercialSolutionsSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commercial Solutions Segment [Member]", "label": "Commercial Solutions Segment [Member]", "terseLabel": "Commercial Solutions" } } }, "localname": "CommercialSolutionsSegmentMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfGoodwillDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "synh_CommonStockVotes": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock, Votes", "label": "Common Stock Votes", "terseLabel": "Number of votes" } } }, "localname": "CommonStockVotes", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityNarrativeDetails" ], "xbrltype": "integerItemType" }, "synh_CommonandPreferredStockSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common and Preferred Stock, Shares Authorized", "label": "Commonand Preferred Stock Shares Authorized", "terseLabel": "Common and Preferred stock, shares authorized (in shares)" } } }, "localname": "CommonandPreferredStockSharesAuthorized", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityScheduleOfStockByClassDetails" ], "xbrltype": "sharesItemType" }, "synh_ComputerEquipmentandSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Computer Equipment and Software", "label": "Computer Equipmentand Software [Member]", "terseLabel": "Computer equipment and software" } } }, "localname": "ComputerEquipmentandSoftwareMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "synh_ContractTerminationNoticePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contract termination notice period.", "label": "Contract Termination Notice Period", "terseLabel": "Contract Termination Notice Period" } } }, "localname": "ContractTerminationNoticePeriod", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "synh_ContractualObligationNotYetSatisfied": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contractual obligation not yet satisfied.", "label": "Contractual Obligation Not Yet Satisfied", "terseLabel": "Remaining unfunded commitment" } } }, "localname": "ContractualObligationNotYetSatisfied", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "synh_CostofServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cost of Services [Member]", "label": "Costof Services [Member]", "terseLabel": "Direct costs" } } }, "localname": "CostofServicesMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfShareBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "synh_CreditAgreementAmendmentNo5TermLoanAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Credit Agreement Amendment No 5 Term Loan A.", "label": "Credit Agreement Amendment No5 Term Loan A [Member]", "terseLabel": "Credit Agreement Amendment No5 Term Loan A" } } }, "localname": "CreditAgreementAmendmentNo5TermLoanAMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "synh_DebtInstrumentCovenantFirstLienLeverageRatioMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Covenant, First Lien Leverage Ratio, Maximum", "label": "Debt Instrument Covenant First Lien Leverage Ratio Maximum", "terseLabel": "Maximum first lien leverage ratio" } } }, "localname": "DebtInstrumentCovenantFirstLienLeverageRatioMaximum", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "pureItemType" }, "synh_DeferredCompensationArrangementWithIndividualCashAwardsGrantedCommissionsPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred Compensation Arrangement with Individual, Cash Awards Granted, Commissions, Percentage", "label": "Deferred Compensation Arrangement With Individual Cash Awards Granted Commissions Percentage", "terseLabel": "Allowable deferred amount, commissions, percent" } } }, "localname": "DeferredCompensationArrangementWithIndividualCashAwardsGrantedCommissionsPercentage", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "synh_DeferredTaxAssetInterestLimitationCarryforward": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10190.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Asset, Interest Limitation Carryforward", "label": "Deferred Tax Asset Interest Limitation Carryforward", "terseLabel": "Interest limitation carryforwards" } } }, "localname": "DeferredTaxAssetInterestLimitationCarryforward", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "synh_DeferredTaxAssetsTaxDeferredExpenseLeaseObligations": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10150.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Tax Deferred Expense, Lease Obligations", "label": "Deferred Tax Assets Tax Deferred Expense Lease Obligations", "terseLabel": "Lease obligations" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseLeaseObligations", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "synh_DeferredTaxAssetsTaxDeferredExpensePrepaidRoyalty": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10170.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Tax Deferred Expense, Prepaid Royalty", "label": "Deferred Tax Assets Tax Deferred Expense Prepaid Royalty", "terseLabel": "Prepaid royalty" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpensePrepaidRoyalty", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "synh_DeferredTaxLiabilitiesRightOfUseAssets": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10040.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Liabilities, Right of Use Assets", "label": "Deferred Tax Liabilities Right Of Use Assets", "negatedLabel": "Right of use asset" } } }, "localname": "DeferredTaxLiabilitiesRightOfUseAssets", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "synh_EffectiveIncomeTaxRateReconciliationExecutiveCompensationLimitationAmount": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "order": 10160.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Executive Compensation Limitation, Amount", "label": "Effective Income Tax Rate Reconciliation Executive Compensation Limitation Amount", "terseLabel": "Nondeductible executive compensation" } } }, "localname": "EffectiveIncomeTaxRateReconciliationExecutiveCompensationLimitationAmount", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "synh_EffectiveIncomeTaxRateReconciliationForeignEarningsNotIndefinitelyReinvested": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "order": 10030.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Change in income tax expense resulting from foreign earnings not indefinitely reinvested.", "label": "Effective Income Tax Rate Reconciliation Foreign Earnings Not Indefinitely Reinvested", "negatedLabel": "Foreign earnings not indefinitely reinvested" } } }, "localname": "EffectiveIncomeTaxRateReconciliationForeignEarningsNotIndefinitelyReinvested", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "synh_EffectiveIncomeTaxRateReconciliationForeignIncomeInclusion": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "order": 10020.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Foreign income inclusion under Internal Revenue Code Section 956 and Subpart F", "label": "Effective Income Tax Rate Reconciliation Foreign Income Inclusion", "negatedLabel": "Foreign income inclusion" } } }, "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeInclusion", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "synh_EmployeeSeveranceCostsIncludingExecutiveTransitionCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee Severance Costs, Including Executive Transition Costs [Member]", "label": "Employee Severance Costs Including Executive Transition Costs [Member]", "terseLabel": "Employee Severance Costs" } } }, "localname": "EmployeeSeveranceCostsIncludingExecutiveTransitionCostsMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsLiabilitiesAssociatedWithRestructuringAndOtherCostsDetails" ], "xbrltype": "domainItemType" }, "synh_EmployeeStockPurchasePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee Stock Purchase Plan [Member]", "label": "Employee Stock Purchase Plan [Member]", "terseLabel": "Employee Stock Purchase Plan (ESPP)" } } }, "localname": "EmployeeStockPurchasePlanMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "synh_EurocurrencyRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Eurocurrency Rate [Member]", "label": "Eurocurrency Rate [Member]", "terseLabel": "Eurocurrency Rate" } } }, "localname": "EurocurrencyRateMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails" ], "xbrltype": "domainItemType" }, "synh_FederalFundsRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Federal Funds Rate [Member]", "label": "Federal Funds Rate [Member]", "terseLabel": "Federal Funds Rate" } } }, "localname": "FederalFundsRateMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails" ], "xbrltype": "domainItemType" }, "synh_FinanceLeaseCosts": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesComponentsOfLeaseCostDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Finance Lease, Costs", "label": "Finance Lease Costs", "totalLabel": "Total finance lease costs" } } }, "localname": "FinanceLeaseCosts", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesComponentsOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "synh_FinanceLeaseLiabilityManagementFee": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails2": { "order": 10010.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Finance Lease, Liability, Management Fee", "label": "Finance Lease Liability Management Fee", "negatedLabel": "Less: Management fee" } } }, "localname": "FinanceLeaseLiabilityManagementFee", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "synh_FinanceLeaseRightOfUseAssetAccumulatedDepreciation": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalBalanceSheetInformationRelatedToLeasesDetails": { "order": 10040.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Finance Lease, Right-Of-Use Asset, Accumulated Depreciation", "label": "Finance Lease Right Of Use Asset Accumulated Depreciation", "negatedLabel": "Accumulated depreciation" } } }, "localname": "FinanceLeaseRightOfUseAssetAccumulatedDepreciation", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalBalanceSheetInformationRelatedToLeasesDetails" ], "xbrltype": "monetaryItemType" }, "synh_FinanceLeaseVariableLeaseCost": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesComponentsOfLeaseCostDetails": { "order": 10030.0, "parentTag": "synh_FinanceLeaseCosts", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Finance Lease, Variable Lease, Cost", "label": "Finance Lease Variable Lease Cost", "terseLabel": "Variable lease costs" } } }, "localname": "FinanceLeaseVariableLeaseCost", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesComponentsOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "synh_FixedLeaseCosts": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesComponentsOfLeaseCostDetails": { "order": 10040.0, "parentTag": "us-gaap_OperatingLeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fixed Lease, Costs", "label": "Fixed Lease Costs", "terseLabel": "Fixed lease costs" } } }, "localname": "FixedLeaseCosts", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesComponentsOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "synh_ForeignEarningsPreviouslyTaxedintheUSIntendedToBePermanentlyReinvested": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Foreign Earnings Previously Taxed in the US, Intended To Be Permanently Reinvested", "label": "Foreign Earnings Previously Taxedinthe U S Intended To Be Permanently Reinvested", "terseLabel": "Foreign earnings previously taxed in the US, intended to be permanently reinvested" } } }, "localname": "ForeignEarningsPreviouslyTaxedintheUSIntendedToBePermanentlyReinvested", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "synh_ForeignEarningsPreviouslyTaxedintheUSIntendedToBeRepatriated": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Foreign Earnings Previously Taxed in the US, Intended To Be Repatriated", "label": "Foreign Earnings Previously Taxedinthe U S Intended To Be Repatriated", "terseLabel": "Foreign earnings previously taxed in the US, intended to be repatriated" } } }, "localname": "ForeignEarningsPreviouslyTaxedintheUSIntendedToBeRepatriated", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "synh_ForeignEarningsPreviouslyTaxedintheUSTotal": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign earnings previously taxed in the U.S., total.", "label": "Foreign Earnings Previously Taxedinthe U S Total", "terseLabel": "Accumulated foreign earnings" } } }, "localname": "ForeignEarningsPreviouslyTaxedintheUSTotal", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "synh_GeographicInformationTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure for geographic information.", "label": "Geographic Information [Text Block]", "terseLabel": "Operations by Geographic Location" } } }, "localname": "GeographicInformationTextBlock", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocation" ], "xbrltype": "textBlockItemType" }, "synh_GuarantorObligationsPercentOfForeignSubsidiaryCapitalStockSecuringDebt": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Guarantor obligations percent of foreign subsidiary capital stock securing debt.", "label": "Guarantor Obligations Percent Of Foreign Subsidiary Capital Stock Securing Debt", "terseLabel": "Percentage of capital stock of certain controlled foreign subsidiaries securing debt obligation" } } }, "localname": "GuarantorObligationsPercentOfForeignSubsidiaryCapitalStockSecuringDebt", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "percentItemType" }, "synh_HealthcareAndLifeSciencesIndustryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Healthcare and life sciences industry.", "label": "Healthcare And Life Sciences Industry [Member]", "terseLabel": "Healthcare and Life Sciences Industry" } } }, "localname": "HealthcareAndLifeSciencesIndustryMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisParentheticalDetails" ], "xbrltype": "domainItemType" }, "synh_IllingworthResearchMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Illingworth Research.", "label": "Illingworth Research [Member]", "terseLabel": "Illingworth Research Group Acquisition" } } }, "localname": "IllingworthResearchMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "synh_InVentivMergerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the aggregation and reporting of information related to the Company's merger with InVentiv Health, Inc.", "label": "In Ventiv Merger [Member]", "terseLabel": "InVentiv Merger" } } }, "localname": "InVentivMergerMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "synh_IncomeTaxReconciliationNondeductibleExpenseCapitalLossCarryforward": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "order": 10100.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Income tax reconciliation nondeductible expense capital loss carryforward", "label": "Income Tax Reconciliation Nondeductible Expense Capital Loss Carryforward", "terseLabel": "Capital loss carryforward" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpenseCapitalLossCarryforward", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "synh_IncreaseDecreaseInAccountsReceivableContractWithCustomerAssetNetCurrentAndContractWithCustomerLiabilityCurrent": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10340.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) In Accounts Receivable, Contract With Customer Asset, Net Current And Contract With Customer Liability, Current", "label": "Increase Decrease In Accounts Receivable Contract With Customer Asset Net Current And Contract With Customer Liability Current", "negatedLabel": "Accounts receivable, unbilled services, and deferred revenue" } } }, "localname": "IncreaseDecreaseInAccountsReceivableContractWithCustomerAssetNetCurrentAndContractWithCustomerLiabilityCurrent", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "synh_IncrementalTermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Incremental term loan.", "label": "Incremental Term Loan [Member]", "terseLabel": "Incremental Term Loan" } } }, "localname": "IncrementalTermLoanMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "synh_InterestRateSwapExpiringJune302021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate swap expiring June 30, 2021.", "label": "Interest Rate Swap Expiring June302021 [Member]", "terseLabel": "Interest Rate Swap, expiring June 30, 2021" } } }, "localname": "InterestRateSwapExpiringJune302021Member", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesNarrativeDetails" ], "xbrltype": "domainItemType" }, "synh_InterestRateSwapExpiringMarch312023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate swap expiring March 31, 2023.", "label": "Interest Rate Swap Expiring March312023 [Member]", "terseLabel": "Interest Rate Swap, expiring March 31, 2023" } } }, "localname": "InterestRateSwapExpiringMarch312023Member", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesNarrativeDetails" ], "xbrltype": "domainItemType" }, "synh_InventivMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Inventiv [Member]", "label": "Inventiv [Member]", "terseLabel": "Inventiv" } } }, "localname": "InventivMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "synh_LeaseRemainingLeaseTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease, Remaining Lease Term", "label": "Lease Remaining Lease Term", "terseLabel": "Lease, remaining lease term" } } }, "localname": "LeaseRemainingLeaseTerm", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "synh_LesseeOperatingLeaseLiabilityManagementFee": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails2": { "order": 10040.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Lessee Operating Lease Liability Management Fee", "label": "Lessee Operating Lease Liability Management Fee", "negatedLabel": "Less: Management fee" } } }, "localname": "LesseeOperatingLeaseLiabilityManagementFee", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "synh_LesseeSupplementalCashFlowInformationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee, Supplemental Cash Flow Information", "label": "Lessee Supplemental Cash Flow Information Table [Text Block]", "terseLabel": "Supplemental Cash Flow Information" } } }, "localname": "LesseeSupplementalCashFlowInformationTableTextBlock", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "synh_LesseeSupplementalCashFlowInformationWeightedAverageTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for Lessee's supplemental cash flow information, weighted average.", "label": "Lessee Supplemental Cash Flow Information Weighted Average Table [Text Block]", "terseLabel": "Supplemental Cash Flow Information, Weighted Average" } } }, "localname": "LesseeSupplementalCashFlowInformationWeightedAverageTableTextBlock", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "synh_LossContingencyNumberOfActionsTakenByPlaintiff": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss Contingency, Number Of Actions Taken By Plaintiff", "label": "Loss Contingency Number Of Actions Taken By Plaintiff", "terseLabel": "Number of actions taken by plaintiff" } } }, "localname": "LossContingencyNumberOfActionsTakenByPlaintiff", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "synh_LossGainOnSaleOfBusinessIncomeTax": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "order": 10140.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Loss (gain) on sale of business, income tax.", "label": "Loss Gain On Sale Of Business Income Tax", "negatedLabel": "Gain on sale of business" } } }, "localname": "LossGainOnSaleOfBusinessIncomeTax", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "synh_NumberOfPrivateEquityFunds": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of private equity funds.", "label": "Number Of Private Equity Funds", "terseLabel": "Number of private equity funds" } } }, "localname": "NumberOfPrivateEquityFunds", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisParentheticalDetails" ], "xbrltype": "integerItemType" }, "synh_OperatingAndFinanceLeaseLiabilityPaymentsDue": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating And Finance Lease, Liability, Payments, Due", "label": "Operating And Finance Lease Liability Payments Due", "totalLabel": "Total lease payments" } } }, "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDue", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "synh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 10060.0, "parentTag": "synh_OperatingAndFinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating And Finance Lease, Liability, Payments, Due After Year Five", "label": "Operating And Finance Lease Liability Payments Due After Year Five", "terseLabel": "2027 and thereafter" } } }, "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "synh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 10050.0, "parentTag": "synh_OperatingAndFinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating And Finance Lease, Liability, Payments, Due Year Five", "label": "Operating And Finance Lease Liability Payments Due Year Five", "terseLabel": "2026" } } }, "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "synh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 10040.0, "parentTag": "synh_OperatingAndFinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating And Finance Lease, Liability, Payments, Due Year Four", "label": "Operating And Finance Lease Liability Payments Due Year Four", "terseLabel": "2025" } } }, "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "synh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 10030.0, "parentTag": "synh_OperatingAndFinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating And Finance Lease, Liability, Payments, Due Year Three", "label": "Operating And Finance Lease Liability Payments Due Year Three", "terseLabel": "2024" } } }, "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "synh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 10020.0, "parentTag": "synh_OperatingAndFinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating And Finance Lease, Liability, Payments, Due Year Two", "label": "Operating And Finance Lease Liability Payments Due Year Two", "terseLabel": "2023" } } }, "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "synh_OperatingAndFinanceLeaseLiabilityPaymentsNextTwelveMonths": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 10010.0, "parentTag": "synh_OperatingAndFinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating And Finance Lease, Liability, Payments, Next Twelve Months", "label": "Operating And Finance Lease Liability Payments Next Twelve Months", "terseLabel": "2022" } } }, "localname": "OperatingAndFinanceLeaseLiabilityPaymentsNextTwelveMonths", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "synh_OperatingLeaseLiabilityClosedOutInExchangeForRightOfUseAsset": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating Lease Liability Closed Out In Exchange For Right-Of-Use Asset", "label": "Operating Lease Liability Closed Out In Exchange For Right Of Use Asset", "terseLabel": "Lease obligations closed out in exchange for right-of-use asset, Operating leases" } } }, "localname": "OperatingLeaseLiabilityClosedOutInExchangeForRightOfUseAsset", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalCashFlowInformationRelatedToLeasesDetails" ], "xbrltype": "monetaryItemType" }, "synh_OperatingLeaseVariableLeaseCost": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesComponentsOfLeaseCostDetails": { "order": 10060.0, "parentTag": "us-gaap_OperatingLeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Lease, Variable Lease, Cost", "label": "Operating Lease Variable Lease Cost", "terseLabel": "Variable lease costs" } } }, "localname": "OperatingLeaseVariableLeaseCost", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesComponentsOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "synh_OperatingLossCarryforwardsExpirationYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating loss carryforwards expiration year.", "label": "Operating Loss Carryforwards Expiration Year", "terseLabel": "Operating loss carryforwards, expiration year" } } }, "localname": "OperatingLossCarryforwardsExpirationYear", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails" ], "xbrltype": "gYearItemType" }, "synh_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent1": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 10020.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss), attributable to parent entity.", "label": "Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent1", "terseLabel": "Unrealized gain (loss) on derivative instruments, net of income tax expense (benefit) of $5,599, $(1,394), and $(2,122), respectively" } } }, "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent1", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "synh_OtherSundryNonoperatingIncomeExpense": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfOtherIncomeExpenseNetDetails": { "order": 10050.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other nonoperating income or expense not including foreign currency gain or loss.", "label": "Other Sundry Nonoperating Income Expense", "negatedLabel": "Other, net" } } }, "localname": "OtherSundryNonoperatingIncomeExpense", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfOtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "synh_PatientCommunitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Patient communities member.", "label": "Patient Communities [Member]", "terseLabel": "Patient Communities" } } }, "localname": "PatientCommunitiesMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValuesOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "synh_PaymentOfLoansToUnconsolidatedAffiliates": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10230.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment of loans to unconsolidated affiliates.", "label": "Payment Of Loans To Unconsolidated Affiliates", "negatedLabel": "Loan to unconsolidated affiliate" } } }, "localname": "PaymentOfLoansToUnconsolidatedAffiliates", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "synh_PercentageOfOutstandingSharesPurchase": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Outstanding Shares Purchase.", "label": "Percentage Of Outstanding Shares Purchase", "terseLabel": "Percentage of Outstanding Shares Purchase" } } }, "localname": "PercentageOfOutstandingSharesPurchase", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails" ], "xbrltype": "percentItemType" }, "synh_PerformanceBasedRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance based restricted stock units", "label": "Performance Based Restricted Stock Units [Member]", "terseLabel": "Performance Based Restricted Stock Units", "verboseLabel": "Performance Based Restricted Stock Units" } } }, "localname": "PerformanceBasedRestrictedStockUnitsMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "domainItemType" }, "synh_ReceivablesFinancingAgreementPrepaymentOfLoanFacilityNoticeTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Receivables Financing Agreement, Prepayment of Loan Facility, Notice Term", "label": "Receivables Financing Agreement Prepayment Of Loan Facility Notice Term", "terseLabel": "Prepay notice, term" } } }, "localname": "ReceivablesFinancingAgreementPrepaymentOfLoanFacilityNoticeTerm", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails" ], "xbrltype": "durationItemType" }, "synh_ReceivablesFinancingAgreementTerminationOrReductionToFacilityLimitNoticeTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Receivables Financing Agreement, Termination Or Reduction To Facility Limit Notice Term", "label": "Receivables Financing Agreement Termination Or Reduction To Facility Limit Notice Term", "terseLabel": "Termination or reduction to limit notice, term" } } }, "localname": "ReceivablesFinancingAgreementTerminationOrReductionToFacilityLimitNoticeTerm", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails" ], "xbrltype": "durationItemType" }, "synh_ReceivablesNetCurrentAndContractWithCustomerAssetNetCurrent": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccountsReceivableAndUnbilledServicesNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10280.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Receivables, Net, Current And Contract With Customer, Asset, Net, Current", "label": "Receivables Net Current And Contract With Customer Asset Net Current", "terseLabel": "Accounts receivable and unbilled services, net", "totalLabel": "Accounts receivable and unbilled services, net" } } }, "localname": "ReceivablesNetCurrentAndContractWithCustomerAssetNetCurrent", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccountsReceivableAndUnbilledServicesNetDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "synh_ReimbursableExpensesPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognition and treatment of costs and out-of-pocket expenses incurred on behalf of the Company's customers in connection with management of clinical trials.", "label": "Reimbursable Expenses Policy Policy [Text Block]", "terseLabel": "Reimbursable Out-of-pocket Expenses" } } }, "localname": "ReimbursableExpensesPolicyPolicyTextBlock", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "synh_RelatedPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related party.", "label": "Related Party [Member]", "terseLabel": "Related Party" } } }, "localname": "RelatedPartyMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "synh_RelatedPartyTransactionNumberOfCounterparties": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Number Of Counterparties", "label": "Related Party Transaction Number Of Counterparties", "terseLabel": "Number of counterparties" } } }, "localname": "RelatedPartyTransactionNumberOfCounterparties", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "integerItemType" }, "synh_RepaymentsofLongTermDebtandBreakageFees": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10120.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the extinguishment of long-term borrowing, including associated breakage fees.", "label": "Repaymentsof Long Term Debtand Breakage Fees", "negatedLabel": "Redemption of Senior Notes and associated breakage fees" } } }, "localname": "RepaymentsofLongTermDebtandBreakageFees", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "synh_ResearchAndGeneralBusinessTaxCreditsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Research and general business tax credits.", "label": "Research And General Business Tax Credits [Member]", "terseLabel": "Research and general business tax credits" } } }, "localname": "ResearchAndGeneralBusinessTaxCreditsMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationParentheticalDetails" ], "xbrltype": "domainItemType" }, "synh_RestructuringChargeIncludingOtherCosts": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 10130.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Restructuring Charge, Including Other Costs", "label": "Restructuring Charge Including Other Costs", "terseLabel": "Restructuring and other costs" } } }, "localname": "RestructuringChargeIncludingOtherCosts", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "synh_RestructuringChargeIncludingOtherCosts1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Restructuring Charge Including Other Costs.", "label": "Restructuring Charge Including Other Costs1", "terseLabel": "Expenses incurred (a)" } } }, "localname": "RestructuringChargeIncludingOtherCosts1", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsLiabilitiesAssociatedWithRestructuringAndOtherCostsDetails" ], "xbrltype": "monetaryItemType" }, "synh_RevenueFromChangeInEstimate": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Revenue from change in estimate.", "label": "Revenue From Change In Estimate", "terseLabel": "Revenue from change in estimate" } } }, "localname": "RevenueFromChangeInEstimate", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRevenueFromContractsWithCustomersNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "synh_RevenuePerformanceObligationContractTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue, Performance Obligation, Contract Term", "label": "Revenue Performance Obligation Contract Term", "terseLabel": "Contract term" } } }, "localname": "RevenuePerformanceObligationContractTerm", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRevenueFromContractsWithCustomersNarrativeDetails" ], "xbrltype": "durationItemType" }, "synh_RxDataScienceAcquisitionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rx data science acquisition member.", "label": "Rx Data Science Acquisitions [Member]", "terseLabel": "Rx Data Science Acquisitions" } } }, "localname": "RxDataScienceAcquisitionsMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "synh_RxDataScienceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RxDataScience.", "label": "Rx Data Science [Member]", "terseLabel": "RxDataScience [Member]" } } }, "localname": "RxDataScienceMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "synh_ScheduleOfCashPoolPositionTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Cash Pool Position [Table Text Block]", "label": "Schedule Of Cash Pool Position Table [Text Block]", "terseLabel": "Schedule Of Cash Pool Position" } } }, "localname": "ScheduleOfCashPoolPositionTableTextBlock", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "synh_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsEstimatedUsefulLifeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Finite and Indefinite Lived Intangible Assets, Estimated Useful Life [Table Text Block]", "label": "Schedule Of Finite And Indefinite Lived Intangible Assets Estimated Useful Life Table [Text Block]", "terseLabel": "Estimated Useful Lives of Intangible Assets" } } }, "localname": "ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsEstimatedUsefulLifeTableTextBlock", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "synh_SeniorNoteDue2029Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Note Due 2029.", "label": "Senior Note Due2029 [Member]", "terseLabel": "Senior Notes Due January 2029" } } }, "localname": "SeniorNoteDue2029Member", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueDetails" ], "xbrltype": "domainItemType" }, "synh_SeniorUnsecuredNotesDue2029Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "3.625% senior unsecured notes due 2029.", "label": "Senior Unsecured Notes Due2029 [Member]", "terseLabel": "Senior Unsecured Notes Due2029" } } }, "localname": "SeniorUnsecuredNotesDue2029Member", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "synh_SeniorUnsecuredNotesDueJanuary2029Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Unsecured Notes due January 2029 [Member]", "label": "Senior Unsecured Notes Due January2029 [Member]", "terseLabel": "Senior Unsecured Notes due January 2029" } } }, "localname": "SeniorUnsecuredNotesDueJanuary2029Member", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfDebtObligationsDetails" ], "xbrltype": "domainItemType" }, "synh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans", "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans", "terseLabel": "Number of plans" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails" ], "xbrltype": "integerItemType" }, "synh_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLifeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Life [Abstract]", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Life [Abstract]", "terseLabel": "Weighted Average Remaining Contractual Life (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLifeAbstract", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "stringItemType" }, "synh_SharesAuthorizedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares Authorized [Abstract]", "label": "Shares Authorized [Abstract]", "terseLabel": "Shares Authorized:" } } }, "localname": "SharesAuthorizedAbstract", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityScheduleOfStockByClassDetails" ], "xbrltype": "stringItemType" }, "synh_SharesIssuedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares Issued [Abstract]", "label": "Shares Issued [Abstract]", "terseLabel": "Shares Issued:" } } }, "localname": "SharesIssuedAbstract", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityScheduleOfStockByClassDetails" ], "xbrltype": "stringItemType" }, "synh_SharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares Outstanding [Abstract]", "label": "Shares Outstanding [Abstract]", "terseLabel": "Shares Outstanding:" } } }, "localname": "SharesOutstandingAbstract", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityScheduleOfStockByClassDetails" ], "xbrltype": "stringItemType" }, "synh_StockRepurchaseProgramSharesPurchasedValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock Repurchase Program, Shares Purchased, Value", "label": "Stock Repurchase Program Shares Purchased Value", "terseLabel": "Stock repurchase program, shares purchased, value" } } }, "localname": "StockRepurchaseProgramSharesPurchasedValue", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityRepurchaseActivityDetails" ], "xbrltype": "monetaryItemType" }, "synh_StockholdersEquityAttributableToParentAdjustedBalance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stockholders' Equity Attributable To Parent, Adjusted Balance", "label": "Stockholders Equity Attributable To Parent Adjusted Balance", "terseLabel": "Adjusted beginning balance" } } }, "localname": "StockholdersEquityAttributableToParentAdjustedBalance", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "synh_StudyKikAcquisitionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "StudyKik acquisition.", "label": "Study Kik Acquisition [Member]", "terseLabel": "StudyKIK Acquisition [Member]" } } }, "localname": "StudyKikAcquisitionMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValuesOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsTables" ], "xbrltype": "domainItemType" }, "synh_SynteractAcquisitionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Synteract acquisition.", "label": "Synteract Acquisition [Member]", "terseLabel": "Synteract Acquisition [Member]" } } }, "localname": "SynteractAcquisitionMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValueOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsTables" ], "xbrltype": "domainItemType" }, "synh_TaxCutsAndJobsActOf2017BaseErosionAndAntiAbuseTax": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "order": 10150.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Tax Cuts And Jobs Act Of 2017, Base Erosion And Anti-Abuse Tax", "label": "Tax Cuts And Jobs Act Of2017 Base Erosion And Anti Abuse Tax", "terseLabel": "Base erosion and anti-abuse tax" } } }, "localname": "TaxCutsAndJobsActOf2017BaseErosionAndAntiAbuseTax", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "synh_TermLoanATrancheOneDueMarch2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term Loan A tranche one due march 2024.", "label": "Term Loan A Tranche One Due March2024 [Member]", "terseLabel": "Term Loan A - tranche one due March 2024" } } }, "localname": "TermLoanATrancheOneDueMarch2024Member", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfDebtObligationsDetails" ], "xbrltype": "domainItemType" }, "synh_TermLoanATrancheTwoDueAugust2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term Loan A tranche two due August 2024.", "label": "Term Loan A Tranche Two Due August2024 [Member]", "terseLabel": "Term Loan A - tranche two due August 2024" } } }, "localname": "TermLoanATrancheTwoDueAugust2024Member", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfDebtObligationsDetails" ], "xbrltype": "domainItemType" }, "synh_TermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term Loan [Member]", "label": "Term Loan [Member]", "terseLabel": "Term Loan" } } }, "localname": "TermLoanMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails" ], "xbrltype": "domainItemType" }, "synh_ThreePointSixHundredTwentyFivePercentageSeniorNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "3.625 percentage senior notes member", "label": "Three Point Six Hundred Twenty Five Percentage Senior Notes [Member]", "terseLabel": "3.625% Senior Notes" } } }, "localname": "ThreePointSixHundredTwentyFivePercentageSeniorNotesMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "synh_TimeBasedRestrictedStockUnitsAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Time based restricted stock units awards", "label": "Time Based Restricted Stock Units Awards [Member]", "terseLabel": "Restricted Stock Units (RSUs)", "verboseLabel": "Time-based Restricted Stock Units (RSUs)" } } }, "localname": "TimeBasedRestrictedStockUnitsAwardsMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "domainItemType" }, "synh_TradeReceivablesSold": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of trade receivables sold.", "label": "Trade Receivables Sold", "terseLabel": "Trade receivables sold" } } }, "localname": "TradeReceivablesSold", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "synh_TwoThousandFourteenEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Thousand Fourteen Equity Incentive Plan", "label": "Two Thousand Fourteen Equity Incentive Plan [Member]", "terseLabel": "2014 Equity Incentive Plan" } } }, "localname": "TwoThousandFourteenEquityIncentivePlanMember", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "synh_ValuationAllowanceAndReservesChargedToEquity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Valuation Allowance And Reserves, Charged To Equity", "label": "Valuation Allowance And Reserves Charged To Equity", "terseLabel": "Charged to equity" } } }, "localname": "ValuationAllowanceAndReservesChargedToEquity", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfValuationAllowanceDetails" ], "xbrltype": "monetaryItemType" }, "synh_ValuationAllowancesAndReservesDeferredTaxAssetsAssumedThroughBusinessCombinations": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Valuation allowances and reserves deferred tax assets assumed through business combinations", "label": "Valuation Allowances And Reserves Deferred Tax Assets Assumed Through Business Combinations", "terseLabel": "Deferred tax assets assumed through acquisitions" } } }, "localname": "ValuationAllowancesAndReservesDeferredTaxAssetsAssumedThroughBusinessCombinations", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfValuationAllowanceDetails" ], "xbrltype": "monetaryItemType" }, "synh_ValuationAllowancesAndReservesDeferredTaxAssetsReleasedThroughBusinessDispositions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Valuation allowances and reserves deferred tax assets released through business dispositions", "label": "Valuation Allowances And Reserves Deferred Tax Assets Released Through Business Dispositions", "terseLabel": "Deferred tax assets released through divestitures" } } }, "localname": "ValuationAllowancesAndReservesDeferredTaxAssetsReleasedThroughBusinessDispositions", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfValuationAllowanceDetails" ], "xbrltype": "monetaryItemType" }, "synh_ValuationAllowancesAndReservesOtherAdjustments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of change in valuation allowance from other adjustments.", "label": "Valuation Allowances And Reserves Other Adjustments", "terseLabel": "Other adjustments" } } }, "localname": "ValuationAllowancesAndReservesOtherAdjustments", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfValuationAllowanceDetails" ], "xbrltype": "monetaryItemType" }, "synh_ValuationAllowancesandReservesForeignCurrencyExchange": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Valuation Allowances and Reserves, Foreign Currency Exchange", "label": "Valuation Allowancesand Reserves Foreign Currency Exchange", "terseLabel": "Foreign currency exchange" } } }, "localname": "ValuationAllowancesandReservesForeignCurrencyExchange", "nsuri": "http://www.syneoshealth.com/20211231", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfValuationAllowanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "A O C I Attributable To Parent Net Of Tax Roll Forward", "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]" } } }, "localname": "AOCIAttributableToParentNetOfTaxRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccumulatedOtherComprehensiveLossNetOfTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201613Member": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.", "label": "Accounting Standards Update201613 [Member]", "terseLabel": "Accounting Standards Update 2016-13" } } }, "localname": "AccountingStandardsUpdate201613Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdateExtensibleList": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r147", "r148", "r149", "r150", "r244", "r245", "r252", "r253", "r254", "r255", "r256", "r257", "r326", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r605", "r606", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r712", "r713", "r715", "r716", "r717", "r718", "r719", "r720", "r763", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r910", "r911", "r912", "r913", "r914" ], "lang": { "en-us": { "role": { "documentation": "Indicates amendment to accounting standards.", "label": "Accounting Standards Update Extensible List", "terseLabel": "Accounting Standards Update [Extensible Enumeration]" } } }, "localname": "AccountingStandardsUpdateExtensibleList", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r40", "r776" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10150.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal": { "auth_ref": [ "r259" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable from change in methodology.", "label": "Accounts Receivable Change In Method Credit Loss Expense Reversal", "terseLabel": "Impact from adoption of ASU" } } }, "localname": "AccountsReceivableChangeInMethodCreditLossExpenseReversal", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccountsReceivableAndUnbilledServicesNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableGrossCurrent": { "auth_ref": [ "r238", "r239" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccountsReceivableAndUnbilledServicesNetDetails": { "order": 10010.0, "parentTag": "synh_ReceivablesNetCurrentAndContractWithCustomerAssetNetCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable Gross Current", "terseLabel": "Accounts receivable billed" } } }, "localname": "AccountsReceivableGrossCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccountsReceivableAndUnbilledServicesNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r882" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]", "terseLabel": "Accounts Receivable" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureConcentrationOfCreditRiskNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r44" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfAccruedExpensesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10160.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities Current", "terseLabel": "Accrued expenses", "totalLabel": "Total accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfAccruedExpensesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesMember": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.", "label": "Accrued Liabilities [Member]", "terseLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesInterestRateSwapsDesignatedAsHedgingInstrumentsOnConsolidatedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r11", "r12", "r44" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfAccruedExpensesDetails": { "order": 10010.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Professional Fees Current", "terseLabel": "Professional fees, investigator fees, and pass-through costs" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r38", "r289" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfPropertyAndEquipmentNetDetails": { "order": 10020.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation Depletion And Amortization Property Plant And Equipment", "negatedLabel": "Less: Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "auth_ref": [ "r66", "r75", "r76", "r77", "r78", "r647" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Accumulated Gain Loss Net Cash Flow Hedge Parent [Member]", "terseLabel": "Derivative Instruments" } } }, "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccumulatedOtherComprehensiveLossNetOfTaxesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTaxEffectsAllocatedToEachComponentOfOtherComprehensiveLossIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income Loss [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income Loss [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccumulatedOtherComprehensiveLossNetOfTaxesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTaxEffectsAllocatedToEachComponentOfOtherComprehensiveLossIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r27", "r63", "r65", "r66", "r829", "r858", "r862" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10070.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income Loss Net Of Tax", "terseLabel": "Accumulated other comprehensive loss, net of taxes" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r75", "r76", "r727", "r728", "r729", "r730", "r731", "r734" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income Loss [Table]", "terseLabel": "Accumulated Other Comprehensive Income Loss [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccumulatedOtherComprehensiveLossNetOfTaxesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTaxEffectsAllocatedToEachComponentOfOtherComprehensiveLossIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r62", "r66", "r75", "r76", "r77", "r142", "r143", "r144", "r648", "r853", "r854", "r914" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "Accumulated Other Comprehensive Income [Member]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccumulatedOtherComprehensiveLossNetOfTaxesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r60", "r66", "r75", "r76", "r77", "r648", "r728", "r729", "r730", "r731", "r734" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Translation Adjustment [Member]", "terseLabel": "Foreign Currency Translation" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccumulatedOtherComprehensiveLossNetOfTaxesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTaxEffectsAllocatedToEachComponentOfOtherComprehensiveLossIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.", "label": "Additional Financial Information Disclosure [Text Block]", "terseLabel": "Financial Statement Details" } } }, "localname": "AdditionalFinancialInformationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetails" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r25", "r563", "r776" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10060.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid In Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r142", "r143", "r144", "r560", "r561", "r562", "r685" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid In Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r147", "r148", "r149", "r150", "r160", "r244", "r245", "r252", "r253", "r254", "r255", "r256", "r257", "r326", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r603", "r604", "r605", "r606", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r712", "r713", "r715", "r716", "r717", "r718", "r719", "r720", "r763", "r789", "r790", "r791", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r910", "r911", "r912", "r913", "r914" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Adjustments For New Accounting Pronouncements [Axis]", "terseLabel": "Accounting Standards Update" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r520", "r522", "r566", "r567" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value", "terseLabel": "Share-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r522", "r552", "r565" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Allocated Share Based Compensation Expense", "terseLabel": "Share-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfShareBasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r31", "r241", "r258" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccountsReceivableAndUnbilledServicesNetDetails": { "order": 10040.0, "parentTag": "synh_ReceivablesNetCurrentAndContractWithCustomerAssetNetCurrent", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Allowance For Doubtful Accounts Receivable Current", "negatedLabel": "Less: Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccountsReceivableAndUnbilledServicesNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Allowance For Doubtful Accounts Receivable Rollforward", "terseLabel": "Allowance for Doubtful Accounts Receivable [Roll Forward]" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableRollforward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccountsReceivableAndUnbilledServicesNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AlternativeInvestment": { "auth_ref": [ "r689", "r702" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails": { "order": 10040.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment other than investment in equity security, investment in debt security and equity method investment. Includes, but is not limited to, investment in certain entities that calculate net asset value per share. Example includes, but is not limited to, investment in hedge fund, venture capital fund, private equity fund, and real estate partnership or fund.", "label": "Alternative Investment", "terseLabel": "Partnership interest" } } }, "localname": "AlternativeInvestment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r111", "r274", "r281" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 10150.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization Of Intangible Assets", "terseLabel": "Amortization" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount", "terseLabel": "Anti-dillutive shares outstanding excluded from the computation of diluted earnings per share" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShareNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_Assets": { "auth_ref": [ "r126", "r210", "r217", "r224", "r247", "r327", "r328", "r329", "r331", "r332", "r333", "r334", "r336", "r338", "r340", "r341", "r644", "r650", "r711", "r774", "r776", "r808", "r827" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r9", "r10", "r54", "r126", "r247", "r327", "r328", "r329", "r331", "r332", "r333", "r334", "r336", "r338", "r340", "r341", "r644", "r650", "r711", "r774", "r776" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10200.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r690" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets Fair Value Disclosure", "totalLabel": "Total assets" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets Fair Value Disclosure [Abstract]", "terseLabel": "Assets:" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AutomobilesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vehicles that are used primarily for transporting people.", "label": "Automobiles [Member]", "terseLabel": "Automobiles" } } }, "localname": "AutomobilesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r523", "r554" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationStockOptionValuationAssumptionsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesInterestRateSwapsDesignatedAsHedgingInstrumentsOnConsolidatedBalanceSheetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r661", "r664" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesInterestRateSwapsDesignatedAsHedgingInstrumentsOnConsolidatedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BaseRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum rate investor will accept.", "label": "Base Rate [Member]", "terseLabel": "Base Rate" } } }, "localname": "BaseRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r141" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis Of Presentation And Significant Accounting Policies [Text Block]", "terseLabel": "Basis of Presentation and Summary of Significant Accounting Policies" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BuildingAndBuildingImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.", "label": "Building And Building Improvements [Member]", "terseLabel": "Buildings and land" } } }, "localname": "BuildingAndBuildingImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r288" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "Buildings" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r513", "r516" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValueOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValuesOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsTables", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r513", "r516", "r622", "r623" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValueOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValuesOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsTables", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date when the business acquisition agreement was executed, in YYYY-MM-DD format.", "label": "Business Acquisition Date Of Acquisition Agreement1", "terseLabel": "Date of Acquisition" } } }, "localname": "BusinessAcquisitionDateOfAcquisitionAgreement1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "dateItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionNameOfAcquiredEntity": { "auth_ref": [ "r621" ], "lang": { "en-us": { "role": { "documentation": "Name of the acquired entity.", "label": "Business Acquisition Name Of Acquired Entity", "terseLabel": "Name of acquired entity" } } }, "localname": "BusinessAcquisitionNameOfAcquiredEntity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r634", "r635", "r637" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination Consideration Transferred1", "terseLabel": "Aggregate purchase price for the acquisition" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1": { "auth_ref": [ "r110", "r639" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10300.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the value of right to a contingent consideration asset.", "label": "Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1", "negatedLabel": "Fair value adjustment of contingent obligations", "terseLabel": "Potential future cash consideration, in exchange of sale of company's contingent staffing business to related party" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationAsset": { "auth_ref": [ "r633", "r636", "r638" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset recognized arising from contingent consideration in a business combination.", "label": "Business Combination Contingent Consideration Asset", "terseLabel": "Contingent consideration" } } }, "localname": "BusinessCombinationContingentConsiderationAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [ "r632", "r636", "r638" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails": { "order": 10020.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.", "label": "Business Combination Contingent Consideration Liability", "terseLabel": "Contingent obligations related to acquisitions" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r640" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Acquisitions, Divestitures, and Investments" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestments" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r625" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails": { "order": 10010.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets", "totalLabel": "Total assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets [Abstract]", "terseLabel": "Assets acquired:" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation": { "auth_ref": [ "r625" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails": { "order": 10050.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lease obligation assumed in business combination.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Capital Lease Obligation", "terseLabel": "Operating lease obligations" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r625" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails": { "order": 10080.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents", "terseLabel": "Cash and cash equivalents" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "auth_ref": [ "r625" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails": { "order": 10100.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [ "r625" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails": { "order": 10060.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities", "terseLabel": "Deferred income taxes, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r625" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill", "terseLabel": "Intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "auth_ref": [ "r624", "r625" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails": { "order": 10130.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles", "terseLabel": "Other identifiable intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r625" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails": { "order": 10020.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities", "totalLabel": "Total liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities [Abstract]", "terseLabel": "Liabilities assumed:" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r624", "r625" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net", "totalLabel": "Net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": { "auth_ref": [ "r625" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails": { "order": 10070.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Other", "terseLabel": "Other liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": { "auth_ref": [ "r625" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails": { "order": 10150.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets", "terseLabel": "Other assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r624", "r625" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails": { "order": 10110.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment", "terseLabel": "Property and equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [ "r619" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.", "label": "Business Combinations Policy", "terseLabel": "Acquisitions" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessRestructuringReservesMember": { "auth_ref": [ "r133", "r134", "r135", "r138", "r139" ], "lang": { "en-us": { "role": { "documentation": "Reserve for expected cost from exit or disposal obligation excluding cost pertaining to entity newly acquired in business combination and asset retirement obligation. Includes, but is not limited to, cost for one-time termination benefit, termination of contract, and consolidating or closing facility.", "label": "Business Restructuring Reserves [Member]", "terseLabel": "Business Restructuring Reserves" } } }, "localname": "BusinessRestructuringReservesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsLiabilitiesAssociatedWithRestructuringAndOtherCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CanadaRevenueAgencyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government of Canada.", "label": "Canada Revenue Agency [Member]", "terseLabel": "Canada Revenue Agency" } } }, "localname": "CanadaRevenueAgencyMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r116", "r117", "r118" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Capital Expenditures Incurred But Not Yet Paid", "terseLabel": "Change in property and equipment included in liabilities" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeaseObligationsIncurred": { "auth_ref": [ "r116", "r117" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in lease obligation from new lease.", "label": "Capital Lease Obligations Incurred", "terseLabel": "Vehicles acquired through finance lease agreements" } } }, "localname": "CapitalLeaseObligationsIncurred", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLossCarryforwardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deductions derived from capital losses that cannot be utilized on the tax return during a period that have been carried forward to reduce taxable income or taxes payable in a future year.", "label": "Capital Loss Carryforward [Member]", "terseLabel": "Capital loss carryforward" } } }, "localname": "CapitalLossCarryforwardMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "auth_ref": [ "r706", "r707" ], "lang": { "en-us": { "role": { "documentation": "Measured as reported on the statement of financial position (balance sheet).", "label": "Carrying Reported Amount Fair Value Disclosure [Member]", "terseLabel": "Reported Value Measurement" } } }, "localname": "CarryingReportedAmountFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAcquiredFromAcquisition": { "auth_ref": [ "r95" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).", "label": "Cash Acquired From Acquisition", "terseLabel": "Cash acquired" } } }, "localname": "CashAcquiredFromAcquisition", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r14", "r114", "r806" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy", "terseLabel": "Restricted Cash" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r114" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents with respect to unrestricted balances.", "label": "Cash And Cash Equivalents Unrestricted Cash And Cash Equivalents Policy", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r106", "r113", "r119" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10270.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents, and restricted cash - end of period", "periodStartLabel": "Cash, cash equivalents, and restricted cash - beginning of period", "terseLabel": "Cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r106", "r726" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect", "totalLabel": "Net change in cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r658" ], "lang": { "en-us": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash Flow Hedging" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesInterestRateSwapsDesignatedAsHedgingInstrumentsOnConsolidatedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract]", "terseLabel": "Supplemental disclosure of noncash investing and financing activities" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsSupplementalCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted": { "auth_ref": [ "r0", "r1", "r142", "r143", "r146", "r244", "r245", "r249", "r250", "r251", "r252", "r253", "r326", "r556", "r557", "r558", "r603", "r674", "r677", "r678", "r712", "r714", "r715", "r716", "r719", "r720", "r743", "r763", "r789", "r790", "r851", "r852", "r910" ], "lang": { "en-us": { "role": { "documentation": "Indicates (true false) whether accounting standards update was adopted.", "label": "Change In Accounting Principle Accounting Standards Update Adopted", "terseLabel": "Change in accounting principle, accounting standards update, adopted [true/false]" } } }, "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "booleanItemType" }, "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate": { "auth_ref": [ "r0", "r1", "r142", "r143", "r154", "r244", "r245", "r249", "r250", "r251", "r252", "r253", "r326", "r556", "r557", "r558", "r603", "r674", "r677", "r678", "r679", "r682", "r712", "r714", "r715", "r716", "r719", "r720", "r743", "r763", "r789", "r790", "r851", "r852", "r910" ], "lang": { "en-us": { "role": { "documentation": "Date accounting standards update was adopted, in YYYY-MM-DD format.", "label": "Change In Accounting Principle Accounting Standards Update Adoption Date", "terseLabel": "Change in accounting principle, accounting standards update, adoption date" } } }, "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "dateItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r123", "r126", "r163", "r167", "r168", "r170", "r172", "r180", "r181", "r182", "r247", "r327", "r332", "r333", "r334", "r340", "r341", "r384", "r385", "r389", "r393", "r711", "r907" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class Of Stock [Domain]", "terseLabel": "Class of Stock" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityRepurchaseActivityDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityScheduleOfStockByClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class Of Stock [Line Items]", "terseLabel": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityRepurchaseActivityDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityScheduleOfStockByClassDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquitySharesOfCommonStockOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r49", "r313", "r813", "r833" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10020.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments And Contingencies", "terseLabel": "Commitments and contingencies (Note 17)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments And Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r310", "r311", "r312", "r320", "r883" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments And Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "auth_ref": [ "r323", "r884" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.", "label": "Commitments And Contingencies Policy [Text Block]", "terseLabel": "Contingencies" } } }, "localname": "CommitmentsAndContingenciesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]", "verboseLabel": "Common Class A [Member]" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityScheduleOfStockByClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]", "terseLabel": "Common Class B [Member]" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityScheduleOfStockByClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock Capital Shares Reserved For Future Issuance", "terseLabel": "Shares available for future grants (in shares)" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r142", "r143", "r685" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock", "verboseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityRepurchaseActivityDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquitySharesOfCommonStockOutstandingDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock Par Or Stated Value Per Share", "terseLabel": "Common stock par value (USD per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock Shares Authorized", "terseLabel": "Common stock shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityScheduleOfStockByClassDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock Shares Issued", "terseLabel": "Common stock shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityScheduleOfStockByClassDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r24", "r400" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock Shares Outstanding", "terseLabel": "Common stock shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityScheduleOfStockByClassDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r24", "r776" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10050.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock Value", "terseLabel": "Common stock, $0.01 par value; 600,000 shares authorized, 103,764 and 103,935 shares issued and outstanding as of December 31, 2021 and 2020, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Compensation And Retirement Disclosure [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r70", "r72", "r73", "r84", "r818", "r837" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income Net Of Tax", "totalLabel": "Comprehensive income" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive Income Policy Policy [Text Block]", "terseLabel": "Comprehensive Income" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]", "terseLabel": "Computer equipment" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r190", "r191", "r235", "r708", "r709", "r882" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureConcentrationOfCreditRiskNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationTotalRevenueByGeographicAreaDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r190", "r191", "r235", "r708", "r709", "r864", "r882" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk By Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureConcentrationOfCreditRiskNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationTotalRevenueByGeographicAreaDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r190", "r191", "r235", "r708", "r709", "r864", "r882" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk By Type [Axis]", "terseLabel": "Concentration Risk Type" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureConcentrationOfCreditRiskNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationTotalRevenueByGeographicAreaDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r196" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentration Risk Disclosure [Text Block]", "terseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureConcentrationOfCreditRisk" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]", "terseLabel": "Concentration Risk" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureConcentrationOfCreditRiskNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r190", "r191", "r235", "r708", "r709" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk Percentage1", "terseLabel": "Concentration risk percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureConcentrationOfCreditRiskNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationTotalRevenueByGeographicAreaDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r187", "r190", "r191", "r192", "r708", "r710", "r882" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]", "terseLabel": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureConcentrationOfCreditRiskNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r190", "r191", "r235", "r708", "r709", "r882" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureConcentrationOfCreditRiskNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationTotalRevenueByGeographicAreaDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r120", "r646" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation Policy [Text Block]", "terseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetNetCurrent": { "auth_ref": [ "r410", "r412", "r433" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccountsReceivableAndUnbilledServicesNetDetails": { "order": 10030.0, "parentTag": "synh_ReceivablesNetCurrentAndContractWithCustomerAssetNetCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.", "label": "Contract With Customer Asset Net Current", "terseLabel": "Contract assets" } } }, "localname": "ContractWithCustomerAssetNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccountsReceivableAndUnbilledServicesNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r410", "r411", "r433" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10170.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract With Customer Liability Current", "terseLabel": "Deferred revenue" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r434" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract With Customer Liability Revenue Recognized", "terseLabel": "Revenue recognized, included in contract liabilities balance at beginning of period" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRevenueFromContractsWithCustomersNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod": { "auth_ref": [ "r419" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.", "label": "Contract With Customer Performance Obligation Satisfied In Previous Period", "terseLabel": "Increase (decrease) in revenue recognized, allocated to performance obligation partially satisfied in previous periods" } } }, "localname": "ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRevenueFromContractsWithCustomersNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.", "label": "Contractual Obligation", "terseLabel": "Commitment to invest a limited partner in private equity funds" } } }, "localname": "ContractualObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r215", "r216", "r217", "r218", "r220", "r226", "r228" ], "lang": { "en-us": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate Non Segment [Member]", "terseLabel": "Corporate" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r89", "r787" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 10110.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost Of Goods And Services Sold", "terseLabel": "Direct costs (exclusive of depreciation and amortization)" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r87" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 10100.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs And Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock": { "auth_ref": [ "r301", "r302", "r308" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.", "label": "Costs Associated With Exit Or Disposal Activities Or Restructurings Policy [Text Block]", "terseLabel": "Restructuring and Other Costs" } } }, "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfDebtObligationsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfDebtObligationsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r127", "r599", "r609" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "order": 10010.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Federal Tax Expense Benefit", "terseLabel": "Current" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r127", "r599" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "order": 10030.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense Benefit", "terseLabel": "Current" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r127", "r599", "r609" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "order": 10050.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current State And Local Tax Expense Benefit", "terseLabel": "Current" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r188", "r235" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureConcentrationOfCreditRiskNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r629" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValuesOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfIntangibleAssetsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfOtherIncomeExpenseNetDetails": { "order": 10040.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment in debt and equity securities.", "label": "Debt And Equity Securities Unrealized Gain Loss", "negatedLabel": "Equity investment (income) expense" } } }, "localname": "DebtAndEquitySecuritiesUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfOtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r122", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r359", "r366", "r367", "r369", "r379" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Long-Term Debt Obligations" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligations" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r17", "r18", "r19", "r125", "r132", "r342", "r343", "r344", "r345", "r346", "r347", "r349", "r355", "r356", "r357", "r358", "r360", "r361", "r362", "r363", "r364", "r365", "r373", "r374", "r375", "r376", "r741", "r809", "r811", "r826" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfDebtObligationsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument Basis Spread On Variable Rate1", "terseLabel": "Applicable margin on variable rate (percent)" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r19", "r370", "r811", "r826" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Debt Instrument Carrying Amount", "terseLabel": "Total debt obligations" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfDebtObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r342", "r373", "r374", "r738", "r741", "r742" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument Face Amount", "terseLabel": "Term loan facility" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r46", "r362", "r738" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Debt Instrument Interest Rate During Period", "terseLabel": "Debt instrument, interest rate" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r46", "r372", "r738", "r741" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument Interest Rate Effective Percentage", "terseLabel": "Weighted average imputed interest rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfDebtObligationsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r47", "r125", "r132", "r342", "r343", "r344", "r345", "r346", "r347", "r349", "r355", "r356", "r357", "r358", "r360", "r361", "r362", "r363", "r364", "r365", "r373", "r374", "r375", "r376", "r741" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument Name [Domain]", "terseLabel": "Debt Instrument, Name" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfDebtObligationsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r823" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument Redemption Price Percentage", "terseLabel": "Debt redemption price percentage" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of principal amount of debt redeemed.", "label": "Debt Instrument Redemption Price Percentage Of Principal Amount Redeemed", "terseLabel": "Percentage redeemed" } } }, "localname": "DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r47", "r125", "r132", "r342", "r343", "r344", "r345", "r346", "r347", "r349", "r355", "r356", "r357", "r358", "r360", "r361", "r362", "r363", "r364", "r365", "r368", "r373", "r374", "r375", "r376", "r401", "r404", "r405", "r406", "r737", "r738", "r741", "r742", "r824" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Debt Instrument [Table]", "terseLabel": "Debt Instrument [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfDebtObligationsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r355", "r737", "r742" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument Unamortized Discount", "terseLabel": "Additional discount on Term loan" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": { "auth_ref": [ "r355", "r737", "r738", "r739", "r740", "r742" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails": { "order": 10070.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount (premium).", "label": "Debt Instrument Unamortized Discount Premium Net", "negatedLabel": "Less: Term loans original issuance discount" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfDebtObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtLongtermAndShorttermCombinedAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.", "label": "Debt Longterm And Shortterm Combined Amount", "terseLabel": "Long-term debt, carrying value" } } }, "localname": "DebtLongtermAndShorttermCombinedAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": { "auth_ref": [ "r579" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.", "label": "Decrease In Unrecognized Tax Benefits Is Reasonably Possible", "terseLabel": "Decrease in unrecognized tax benefits" } } }, "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitment made to pay deferred cash remuneration expressed as a percentage of the individual's base salary.", "label": "Deferred Compensation Arrangement With Individual Cash Awards Granted Percentage", "terseLabel": "Allowable deferred amount, salary, percent" } } }, "localname": "DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Deferred Compensation Arrangement With Individual Excluding Share Based Payments And Postretirement Benefits [Line Items]", "terseLabel": "Deferred Compensation Arrangement [Line Items]" } } }, "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).", "label": "Deferred Compensation Liability Classified Noncurrent", "terseLabel": "Deferred compensation liabilities" } } }, "localname": "DeferredCompensationLiabilityClassifiedNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r127", "r600", "r609" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "order": 10020.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Federal Income Tax Expense Benefit", "terseLabel": "Deferred" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r39", "r355", "r739" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails": { "order": 10080.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Deferred Finance Costs Net", "negatedLabel": "Less: Unamortized deferred issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfDebtObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r127", "r600", "r609" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "order": 10040.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense Benefit", "terseLabel": "Deferred" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r573", "r574" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10250.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets Net", "terseLabel": "Deferred income tax assets" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r111", "r127", "r600", "r609", "r610", "r611" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10280.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense Benefit", "terseLabel": "Provision for (benefit from) deferred income taxes" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r20", "r21", "r589", "r810", "r825" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10020.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Income Tax Liabilities", "negatedTotalLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r573", "r574" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10130.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities Net", "terseLabel": "Deferred income tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r127", "r600", "r609" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "order": 10060.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred State And Local Income Tax Expense Benefit", "terseLabel": "Deferred" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsCapitalLossCarryforwards": { "auth_ref": [ "r597", "r598" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10180.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.", "label": "Deferred Tax Assets Capital Loss Carryforwards", "terseLabel": "Capital loss carryforward" } } }, "localname": "DeferredTaxAssetsCapitalLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsDeferredIncome": { "auth_ref": [ "r597", "r598" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10120.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.", "label": "Deferred Tax Assets Deferred Income", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredTaxAssetsDeferredIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r590" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10080.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets Gross", "totalLabel": "Total deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGrossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets Gross [Abstract]", "terseLabel": "Deferred tax assets:" } } }, "localname": "DeferredTaxAssetsGrossAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r592" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets Liabilities Net", "totalLabel": "Net deferred tax assets (liabilities)" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r592" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10010.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets Net", "totalLabel": "Net deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r597", "r598" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10100.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets Operating Loss Carryforwards", "terseLabel": "Net operating losses" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r597", "r598" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10200.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred Tax Assets Other", "terseLabel": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "auth_ref": [ "r595", "r597", "r598" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10110.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.", "label": "Deferred Tax Assets Tax Credit Carryforwards", "terseLabel": "Tax credits" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits": { "auth_ref": [ "r597", "r598" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10130.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from employee benefits, classified as other.", "label": "Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits", "terseLabel": "Employee compensation and other benefits" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": { "auth_ref": [ "r597", "r598" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10160.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.", "label": "Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": { "auth_ref": [ "r597", "r598" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10140.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.", "label": "Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r591" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10090.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets Valuation Allowance", "negatedLabel": "Less: valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r574", "r592" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities", "negatedTotalLabel": "Net deferred tax assets (liabilities)" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities [Abstract]", "terseLabel": "Deferred tax liabilities:" } } }, "localname": "DeferredTaxLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxLiabilitiesOther": { "auth_ref": [ "r597", "r598" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10070.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.", "label": "Deferred Tax Liabilities Other", "negatedLabel": "Other" } } }, "localname": "DeferredTaxLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "auth_ref": [ "r597", "r598" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10050.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.", "label": "Deferred Tax Liabilities Property Plant And Equipment", "negatedLabel": "Depreciation and amortization" } } }, "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome": { "auth_ref": [ "r597", "r598" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10060.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from tax deferred revenue or income classified as other.", "label": "Deferred Tax Liabilities Tax Deferred Income", "negatedLabel": "Deferred revenue" } } }, "localname": "DeferredTaxLiabilitiesTaxDeferredIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": { "auth_ref": [ "r597" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10030.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.", "label": "Deferred Tax Liabilities Undistributed Foreign Earnings", "negatedLabel": "Undistributed foreign earnings", "terseLabel": "Undistributed foreign earnings" } } }, "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanCostRecognized": { "auth_ref": [ "r511" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for defined contribution plan.", "label": "Defined Contribution Plan Cost Recognized", "terseLabel": "Total defined contribution retirement plan contributions" } } }, "localname": "DefinedContributionPlanCostRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlansScheduleOfContributionsToDefinedContributionPlanDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanDisclosuresTableTextBlock": { "auth_ref": [ "r511" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans.", "label": "Defined Contribution Plan Disclosures Table [Text Block]", "terseLabel": "Schedule of Contributions to Defined Contribution Plan" } } }, "localname": "DefinedContributionPlanDisclosuresTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.", "label": "Defined Contribution Plan Employer Discretionary Contribution Amount", "terseLabel": "Employer contribution amount" } } }, "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r111", "r287" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 10140.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAmortizationAndAccretionNet": { "auth_ref": [ "r111" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Depreciation Amortization And Accretion Net", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAmortizationAndAccretionNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r111", "r205" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10250.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation Depletion And Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r56", "r57", "r58", "r705" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesInterestRateSwapsDesignatedAsHedgingInstrumentsOnConsolidatedBalanceSheetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Assets", "totalLabel": "Derivative assets" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesInterestRateSwapsDesignatedAsHedgingInstrumentsOnConsolidatedBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetsCurrent": { "auth_ref": [ "r56" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails": { "order": 10050.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Assets Current", "terseLabel": "Derivative liability - current" } } }, "localname": "DerivativeAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesInterestRateSwapsDesignatedAsHedgingInstrumentsOnConsolidatedBalanceSheetsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeBasisSpreadOnVariableRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.", "label": "Derivative Basis Spread On Variable Rate", "terseLabel": "Derivative, Basis Spread on Variable Rate" } } }, "localname": "DerivativeBasisSpreadOnVariableRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract Type [Domain]", "terseLabel": "Derivative Contract" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesInterestRateSwapsDesignatedAsHedgingInstrumentsOnConsolidatedBalanceSheetsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r58", "r662", "r663", "r666", "r668" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument Risk [Axis]", "terseLabel": "Derivative Instrument" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesInterestRateSwapsDesignatedAsHedgingInstrumentsOnConsolidatedBalanceSheetsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments And Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r676", "r688" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments And Hedging Activities Disclosure [Text Block]", "terseLabel": "Derivatives" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivatives" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r659", "r662", "r666" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Derivative Instruments Gain Loss By Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesInterestRateSwapsDesignatedAsHedgingInstrumentsOnConsolidatedBalanceSheetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r56", "r57", "r58", "r705" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesInterestRateSwapsDesignatedAsHedgingInstrumentsOnConsolidatedBalanceSheetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails": { "order": 10010.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liabilities", "terseLabel": "Derivative instruments", "totalLabel": "Derivative liability" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesInterestRateSwapsDesignatedAsHedgingInstrumentsOnConsolidatedBalanceSheetsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesNoncurrent": { "auth_ref": [ "r56" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesInterestRateSwapsDesignatedAsHedgingInstrumentsOnConsolidatedBalanceSheetsDetails": { "order": 10020.0, "parentTag": "us-gaap_DerivativeAssets", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liabilities Noncurrent", "terseLabel": "Derivative assets - non-current" } } }, "localname": "DerivativeLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesInterestRateSwapsDesignatedAsHedgingInstrumentsOnConsolidatedBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r655", "r657" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative Notional Amount", "terseLabel": "Notional amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r654", "r656", "r657", "r659", "r660", "r665", "r666", "r669", "r671", "r675", "r676" ], "lang": { "en-us": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesFairValueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivatives Fair Value [Line Items]", "terseLabel": "Derivatives, Fair Value [Line Items]" } } }, "localname": "DerivativesFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesInterestRateSwapsDesignatedAsHedgingInstrumentsOnConsolidatedBalanceSheetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r131", "r654", "r656", "r659", "r660", "r670" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives Policy [Text Block]", "terseLabel": "Derivative Financial Instruments" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r569" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Disclosure Of Compensation Related Costs Share Based Payments [Text Block]", "terseLabel": "Share-Based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.", "label": "Disposal Group Including Discontinued Operation Consideration", "terseLabel": "Divestiture, consideration received" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsCommonStockCash": { "auth_ref": [ "r407" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.", "label": "Dividends Common Stock Cash", "terseLabel": "Class C common stock dividends" } } }, "localname": "DividendsCommonStockCash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Country [Member]", "terseLabel": "Domestic Tax Authority" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EMEAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Regions of Europe, Middle East and Africa.", "label": "E M E A [Member]", "terseLabel": "Europe, Middle East, and Africa" } } }, "localname": "EMEAMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationLongLivedAssetsByGeographicAreaDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationTotalRevenueByGeographicAreaDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarlyRepaymentOfSeniorDebt": { "auth_ref": [ "r102" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the extinguishment of long-term borrowing, with the highest claim on the assets of the entity in case of bankruptcy or liquidation, before its maturity.", "label": "Early Repayment Of Senior Debt", "terseLabel": "Voluntary prepayments on term loans" } } }, "localname": "EarlyRepaymentOfSeniorDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r85", "r152", "r153", "r154", "r155", "r156", "r161", "r163", "r170", "r171", "r172", "r176", "r177", "r686", "r687", "r819", "r838" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share Basic", "terseLabel": "Basic (USD per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share Basic [Abstract]", "terseLabel": "Earnings per share:" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share Basic And Diluted [Abstract]", "terseLabel": "Earnings per share:" } } }, "localname": "EarningsPerShareBasicAndDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r85", "r152", "r153", "r154", "r155", "r156", "r163", "r170", "r171", "r172", "r176", "r177", "r686", "r687", "r819", "r838" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share Diluted", "terseLabel": "Diluted (USD per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r173", "r174" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share Policy [Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r173", "r174", "r175", "r178" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r726" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10040.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents", "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r129", "r576", "r613" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate", "terseLabel": "Federal tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": { "auth_ref": [ "r568", "r576" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "order": 10070.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.", "label": "Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount", "terseLabel": "Share-based compensation" } } }, "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r44" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfAccruedExpensesDetails": { "order": 10020.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee Related Liabilities Current", "terseLabel": "Compensation, including bonuses, fringe benefits, and payroll taxes" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]", "terseLabel": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfShareBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r553" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized", "terseLabel": "Unrecognized compensation expense (in millions)" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r553" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1", "terseLabel": "Weighted average period unrecognized compensation is expected to be recognized" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r553" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options", "terseLabel": "Unrecognized compensation expense related to non-vested stock options" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": { "auth_ref": [ "r552" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.", "label": "Employee Service Share Based Compensation Tax Benefit From Compensation Expense", "terseLabel": "Income tax benefit recognized for stock-based compensation arrangements" } } }, "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeSeveranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Employee Severance [Member]", "terseLabel": "Employee severance and benefit costs" } } }, "localname": "EmployeeSeveranceMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsScheduleOfRestructuringAndOtherCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock [Member]", "verboseLabel": "ESPP" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationStockOptionValuationAssumptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r550" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Employee Stock Option [Member]", "terseLabel": "Stock options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services.", "label": "Equipment [Member]", "terseLabel": "Equipment" } } }, "localname": "EquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r2", "r75", "r76", "r77", "r142", "r143", "r144", "r148", "r157", "r159", "r179", "r255", "r400", "r407", "r560", "r561", "r562", "r605", "r606", "r685", "r727", "r728", "r729", "r730", "r731", "r734", "r853", "r854", "r855", "r914" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccumulatedOtherComprehensiveLossNetOfTaxesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTaxEffectsAllocatedToEachComponentOfOtherComprehensiveLossIncomeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquitySharesOfCommonStockOutstandingDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "auth_ref": [ "r357", "r373", "r374", "r705" ], "lang": { "en-us": { "role": { "documentation": "Measured as an estimate of fair value.", "label": "Estimate Of Fair Value Fair Value Disclosure [Member]", "terseLabel": "Estimate of Fair Value Measurement" } } }, "localname": "EstimateOfFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EurodollarMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate based on U.S. dollar denominated deposits at foreign banks or foreign branches of U.S. banks.", "label": "Eurodollar [Member]", "terseLabel": "Eurodollar Rate" } } }, "localname": "EurodollarMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FacilityClosingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Facility Closing [Member]", "terseLabel": "Facility and lease termination costs" } } }, "localname": "FacilityClosingMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsScheduleOfRestructuringAndOtherCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisParentheticalDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r690", "r691", "r692", "r701" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]", "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisParentheticalDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount": { "auth_ref": [ "r692" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.", "label": "Fair Value Assets Level1 To Level2 Transfers Amount", "terseLabel": "Fair value assets transferred from level 1 to level 2" } } }, "localname": "FairValueAssetsLevel1ToLevel2TransfersAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount": { "auth_ref": [ "r692" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of assets measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1.", "label": "Fair Value Assets Level2 To Level1 Transfers Amount", "terseLabel": "Fair value assets transferred from level 2 to level 1" } } }, "localname": "FairValueAssetsLevel2ToLevel1TransfersAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "auth_ref": [ "r690", "r706" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value By Balance Sheet Grouping [Text Block]", "terseLabel": "Schedule of Estimated Fair Value" } } }, "localname": "FairValueByBalanceSheetGroupingTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r357", "r373", "r374", "r463", "r465", "r466", "r467", "r468", "r469", "r470", "r508", "r691", "r777", "r778", "r779" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value By Fair Value Hierarchy Level [Axis]", "terseLabel": "Fair Value Hierarchy and NAV" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r357", "r373", "r374", "r690", "r702" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement basis.", "label": "Fair Value By Measurement Basis [Axis]", "terseLabel": "Measurement Basis" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r690", "r691", "r693", "r694", "r703" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Fair Value By Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "auth_ref": [ "r357", "r373", "r374" ], "lang": { "en-us": { "role": { "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.", "label": "Fair Value Disclosure Item Amounts [Domain]", "terseLabel": "Fair Value Measurement" } } }, "localname": "FairValueDisclosureItemAmountsDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r357", "r463", "r465", "r470", "r508", "r691", "r777" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value Inputs Level1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r357", "r373", "r374", "r463", "r465", "r470", "r508", "r691", "r778" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value Inputs Level2 [Member]", "terseLabel": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r357", "r373", "r374", "r463", "r465", "r466", "r467", "r468", "r469", "r470", "r508", "r691", "r779" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Inputs Level3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesLevel1ToLevel2TransfersAmount": { "auth_ref": [ "r692" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of liabilities measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.", "label": "Fair Value Liabilities Level1 To Level2 Transfers Amount", "terseLabel": "Fair value liabilities transferred from level 1 to level 2" } } }, "localname": "FairValueLiabilitiesLevel1ToLevel2TransfersAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueLiabilitiesLevel2ToLevel1TransfersAmount": { "auth_ref": [ "r692" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of liabilities measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1.", "label": "Fair Value Liabilities Level2 To Level1 Transfers Amount", "terseLabel": "Fair value liabilities transferred from level 2 to level 1" } } }, "localname": "FairValueLiabilitiesLevel2ToLevel1TransfersAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r695", "r701" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Text Block]", "terseLabel": "Reconciliation of Changes in the Carrying Amount of Contingent Consideration" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": { "auth_ref": [ "r465", "r689", "r703" ], "lang": { "en-us": { "role": { "documentation": "Fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Measured At Net Asset Value Per Share [Member]", "terseLabel": "Investments Measured at Net Asset Value" } } }, "localname": "FairValueMeasuredAtNetAssetValuePerShareMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Fair Value Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement Policy Policy [Text Block]", "terseLabel": "Fair Value" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3": { "auth_ref": [ "r698" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of financial instrument classified as a liability into level 3 of the fair value hierarchy.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3", "terseLabel": "Fair value liabilities transferred into level 3" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3": { "auth_ref": [ "r698" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of financial instrument classified as a liability out of level 3 of the fair value hierarchy.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3", "terseLabel": "Fair value liabilities transferred out of level 3" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3": { "auth_ref": [ "r698" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3", "terseLabel": "Fair value assets transferred into level 3" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": { "auth_ref": [ "r698" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3", "terseLabel": "Fair value assets transferred out of level 3" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r696" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings", "terseLabel": "Changes in fair value recognized in earnings" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfChangesInCarryingAmountOfContingentConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": { "auth_ref": [ "r697" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases", "terseLabel": "Additions" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfChangesInCarryingAmountOfContingentConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "auth_ref": [ "r697" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements", "terseLabel": "Payments" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfChangesInCarryingAmountOfContingentConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r695" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value", "periodEndLabel": "Balance at End of period", "periodStartLabel": "Balance at Beginning of period" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfChangesInCarryingAmountOfContingentConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r357", "r373", "r374", "r463", "r465", "r466", "r467", "r468", "r469", "r470", "r508", "r777", "r778", "r779" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Measurements Fair Value Hierarchy [Domain]", "terseLabel": "Fair Value Hierarchy and NAV" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsNonrecurringMember": { "auth_ref": [ "r690", "r691", "r693", "r694", "r699", "r703" ], "lang": { "en-us": { "role": { "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.", "label": "Fair Value Measurements Nonrecurring [Member]", "terseLabel": "Nonrecurring" } } }, "localname": "FairValueMeasurementsNonrecurringMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r700", "r703" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value Measurements Recurring [Member]", "terseLabel": "Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfAssetsAcquired": { "auth_ref": [ "r116", "r117", "r118" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The fair value of assets acquired in noncash investing or financing activities.", "label": "Fair Value Of Assets Acquired", "terseLabel": "Non-cash investment to acquire certain intellectual property rights from a customer in lieu of cash payment for services rendered" } } }, "localname": "FairValueOfAssetsAcquired", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r661", "r665", "r672" ], "lang": { "en-us": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives Balance Sheet Location By Derivative Contract Type By Hedging Designation [Table]", "terseLabel": "Fair Values Derivatives Balance Sheet Location By Derivative Contract Type By Hedging Designation [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesInterestRateSwapsDesignatedAsHedgingInstrumentsOnConsolidatedBalanceSheetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FederalFundsEffectiveSwapRateMember": { "auth_ref": [ "r673" ], "lang": { "en-us": { "role": { "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.", "label": "Federal Funds Effective Swap Rate [Member]", "terseLabel": "Federal Funds Effective Rate" } } }, "localname": "FederalFundsEffectiveSwapRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Federal Income Tax Expense Benefit Continuing Operations [Abstract]", "terseLabel": "Federal income taxes:" } } }, "localname": "FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinanceLeaseInterestExpense": { "auth_ref": [ "r746", "r752", "r761" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesComponentsOfLeaseCostDetails": { "order": 10020.0, "parentTag": "synh_FinanceLeaseCosts", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense on finance lease liability.", "label": "Finance Lease Interest Expense", "terseLabel": "Interest on lease liabilities" } } }, "localname": "FinanceLeaseInterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesComponentsOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseInterestPaymentOnLiability": { "auth_ref": [ "r748", "r755" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest paid on finance lease liability.", "label": "Finance Lease Interest Payment On Liability", "negatedLabel": "Operating cash flows for finance leases" } } }, "localname": "FinanceLeaseInterestPaymentOnLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalCashFlowInformationRelatedToLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finance Lease Liabilities Payments Due [Abstract]", "terseLabel": "Finance Leases" } } }, "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r745", "r760" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails2": { "order": 10030.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 }, "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalBalanceSheetInformationRelatedToLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Finance Lease Liability", "terseLabel": "Total lease liabilities", "totalLabel": "Total finance lease liabilities" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalBalanceSheetInformationRelatedToLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [ "r745" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalBalanceSheetInformationRelatedToLeasesDetails": { "order": 10010.0, "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0 }, "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10190.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.", "label": "Finance Lease Liability Current", "terseLabel": "Current portion of finance lease obligations" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalBalanceSheetInformationRelatedToLeasesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r760" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.", "label": "Finance Lease Liability Maturity Table [Text Block]", "terseLabel": "Schedule of Finance Lease, Liability, Maturity" } } }, "localname": "FinanceLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [ "r745" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalBalanceSheetInformationRelatedToLeasesDetails": { "order": 10020.0, "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0 }, "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10120.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.", "label": "Finance Lease Liability Noncurrent", "terseLabel": "Finance lease long-term obligations" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalBalanceSheetInformationRelatedToLeasesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "auth_ref": [ "r760" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.", "label": "Finance Lease Liability Payments Due", "totalLabel": "Total lease payments" } } }, "localname": "FinanceLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r760" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 10120.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease Liability Payments Due After Year Five", "terseLabel": "2027 and thereafter" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r760" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 10070.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease Liability Payments Due Next Twelve Months", "terseLabel": "2022" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r760" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 10110.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease Liability Payments Due Year Five", "terseLabel": "2026" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r760" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 10100.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease Liability Payments Due Year Four", "terseLabel": "2025" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r760" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 10090.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease Liability Payments Due Year Three", "terseLabel": "2024" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r760" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 10080.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease Liability Payments Due Year Two", "terseLabel": "2023" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r760" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails2": { "order": 10020.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.", "label": "Finance Lease Liability Undiscounted Excess Amount", "negatedLabel": "Less: Imputed interest" } } }, "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeasePrincipalPayments": { "auth_ref": [ "r747", "r755" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10140.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for principal payment on finance lease.", "label": "Finance Lease Principal Payments", "negatedLabel": "Payments of finance leases" } } }, "localname": "FinanceLeasePrincipalPayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalCashFlowInformationRelatedToLeasesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "auth_ref": [ "r746", "r752", "r761" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesComponentsOfLeaseCostDetails": { "order": 10010.0, "parentTag": "synh_FinanceLeaseCosts", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.", "label": "Finance Lease Right Of Use Asset Amortization", "terseLabel": "Amortization of right-of-use assets" } } }, "localname": "FinanceLeaseRightOfUseAssetAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesComponentsOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r758", "r761" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for finance lease calculated at point in time.", "label": "Finance Lease Weighted Average Discount Rate Percent", "terseLabel": "Weighted average discount rate, Finance leases" } } }, "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalCashFlowInformationWeightedAverageDetails" ], "xbrltype": "percentItemType" }, "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r757", "r761" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Finance Lease Weighted Average Remaining Lease Term1", "terseLabel": "Weighted average remaining lease term, Finance lease" } } }, "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalCashFlowInformationWeightedAverageDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite Lived Intangible Asset Useful Life", "terseLabel": "Estimated Useful Life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValueOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValuesOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r280" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfIntangibleAssetsDetails": { "order": 10020.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite Lived Intangible Assets Accumulated Amortization", "negatedLabel": "Accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfFutureAmortizationExpenseDetails": { "order": 10060.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense After Year Five", "terseLabel": "2027 and thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r282" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfFutureAmortizationExpenseDetails": { "order": 10010.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Next Twelve Months", "terseLabel": "2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r282" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfFutureAmortizationExpenseDetails": { "order": 10050.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Year Five", "terseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r282" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfFutureAmortizationExpenseDetails": { "order": 10040.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Year Four", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r282" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfFutureAmortizationExpenseDetails": { "order": 10030.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Year Three", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r282" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfFutureAmortizationExpenseDetails": { "order": 10020.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Year Two", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r275", "r277", "r280", "r284", "r788", "r792" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite Lived Intangible Assets By Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValueOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValuesOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfIntangibleAssetsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r280", "r792" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfIntangibleAssetsDetails": { "order": 10010.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite Lived Intangible Assets Gross", "terseLabel": "Finite-lived intangible assets, gross" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite Lived Intangible Assets [Line Items]", "terseLabel": "Finite Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValueOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValuesOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfIntangibleAssetsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r275", "r279" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite Lived Intangible Assets Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValueOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValuesOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfIntangibleAssetsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r280", "r788" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfFutureAmortizationExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite Lived Intangible Assets Net", "totalLabel": "Finite-lived intangible assets, net" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfFutureAmortizationExpenseDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinitelivedIntangibleAssetsAcquired1": { "auth_ref": [ "r276" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.", "label": "Finitelived Intangible Assets Acquired1", "terseLabel": "Estimated Fair Value" } } }, "localname": "FinitelivedIntangibleAssetsAcquired1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValueOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValuesOfIntangibleAssetsAndEstimatedUsefulLivesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Country [Member]", "terseLabel": "Foreign Tax Authority", "verboseLabel": "Foreign Jurisdictions" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r721", "r722", "r723", "r725" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10290.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain Loss Before Tax", "negatedLabel": "Foreign currency transaction adjustments" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossRealized": { "auth_ref": [ "r723", "r725" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfOtherIncomeExpenseNetDetails": { "order": 10010.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain Loss Realized", "negatedLabel": "Net realized foreign currency loss", "terseLabel": "Foreign currency forward gain loss realized" } } }, "localname": "ForeignCurrencyTransactionGainLossRealized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfOtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": { "auth_ref": [ "r112", "r723", "r725" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfOtherIncomeExpenseNetDetails": { "order": 10020.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain Loss Unrealized", "negatedLabel": "Net unrealized foreign currency (gain) loss" } } }, "localname": "ForeignCurrencyTransactionGainLossUnrealized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfOtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r735" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions And Translations Policy [Text Block]", "terseLabel": "Foreign Currency Translation and Transactions" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignExchangeForwardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.", "label": "Foreign Exchange Forward [Member]", "terseLabel": "Foreign Exchange Forward" } } }, "localname": "ForeignExchangeForwardMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Foreign Income Tax Expense Benefit Continuing Operations [Abstract]", "terseLabel": "Foreign income taxes:" } } }, "localname": "ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ForeignPlanMember": { "auth_ref": [ "r512", "r514", "r517" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Foreign Plan [Member]", "terseLabel": "Foreign Plan" } } }, "localname": "ForeignPlanMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture And Fixtures [Member]", "terseLabel": "Furniture and fixtures" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnSaleOfBusiness": { "auth_ref": [ "r111", "r649" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfOtherIncomeExpenseNetDetails": { "order": 10030.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0 }, "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10310.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.", "label": "Gain Loss On Sale Of Business", "negatedLabel": "Gain on sale of business", "terseLabel": "Gain (loss) on divestiture" } } }, "localname": "GainLossOnSaleOfBusiness", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfOtherIncomeExpenseNetDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r111", "r377", "r378" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10320.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 10070.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gains Losses On Extinguishment Of Debt", "negatedLabel": "Loss (gain) on extinguishment of debt", "terseLabel": "Loss on extinguishment of debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeographicConcentrationRiskMember": { "auth_ref": [ "r189", "r882" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).", "label": "Geographic Concentration Risk [Member]", "terseLabel": "Geographic Concentration Risk" } } }, "localname": "GeographicConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationTotalRevenueByGeographicAreaDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r262", "r264", "r776", "r807" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails": { "order": 10140.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 }, "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10230.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Balance as of December 31, 2020", "periodStartLabel": "Balance as of December 31, 2019", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfGoodwillDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "auth_ref": [ "r270" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.", "label": "Goodwill And Intangible Assets Goodwill Policy", "terseLabel": "Goodwill and intangible assets" } } }, "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r267" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill Foreign Currency Translation Gain Loss", "negatedLabel": "Impact of foreign currency translation and other" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": { "auth_ref": [ "r265", "r269" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill Impaired Accumulated Impairment Loss", "terseLabel": "Accumulated impairment loss" } } }, "localname": "GoodwillImpairedAccumulatedImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r111", "r263", "r266", "r271" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill Impairment Loss", "terseLabel": "Impairment of goodwill" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillPurchaseAccountingAdjustments": { "auth_ref": [ "r268", "r620" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill Purchase Accounting Adjustments", "terseLabel": "Acquisitions" } } }, "localname": "GoodwillPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill Roll Forward", "terseLabel": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillTransfers": { "auth_ref": [ "r268" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill Transfers", "terseLabel": "Transfer of goodwill" } } }, "localname": "GoodwillTransfers", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r659" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesInterestRateSwapsDesignatedAsHedgingInstrumentsOnConsolidatedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": { "auth_ref": [ "r111", "r285" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.", "label": "Impairment Of Intangible Assets Indefinitelived Excluding Goodwill", "terseLabel": "Impairment charge" } } }, "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r128", "r612" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeBeforeProvisionForIncomeTaxesDetails": { "order": 10010.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Income Loss From Continuing Operations Before Income Taxes Domestic", "terseLabel": "Domestic" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeBeforeProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r81", "r210", "r216", "r220", "r223", "r226", "r805", "r816", "r821", "r839" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeBeforeProvisionForIncomeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 10010.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest", "totalLabel": "Income before provision for income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeBeforeProvisionForIncomeTaxesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r128", "r612" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeBeforeProvisionForIncomeTaxesDetails": { "order": 10020.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Income Loss From Continuing Operations Before Income Taxes Foreign", "terseLabel": "Foreign" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeBeforeProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Loss From Discontinued Operations And Disposal Of Discontinued Operations Net Of Tax Per Basic Share [Abstract]", "terseLabel": "Numerator:" } } }, "localname": "IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r82", "r111", "r207", "r246", "r815", "r835" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income Loss From Equity Method Investments", "terseLabel": "Income (Loss) from Equity Method Investments" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r291", "r296" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfShareBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r296" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfShareBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r580" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityNameAxis": { "auth_ref": [ "r580" ], "lang": { "en-us": { "role": { "documentation": "Information by name of taxing authority.", "label": "Income Tax Authority Name [Axis]", "terseLabel": "Income Tax Authority, Name" } } }, "localname": "IncomeTaxAuthorityNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority Name [Domain]", "terseLabel": "Income Tax Authority, Name" } } }, "localname": "IncomeTaxAuthorityNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r129", "r577", "r587", "r594", "r607", "r614", "r616", "r617", "r618" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r130", "r158", "r159", "r208", "r575", "r608", "r615", "r840" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 10020.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense Benefit", "terseLabel": "Income tax expense (benefit)", "totalLabel": "Income tax expense (benefit)" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Expense Benefit Continuing Operations Income Tax Reconciliation [Abstract]", "terseLabel": "Change in income tax expense resulting from:" } } }, "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r74", "r571", "r572", "r587", "r588", "r593", "r601" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax Policy [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r576" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "order": 10050.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance", "terseLabel": "Changes in income tax valuation allowance (all jurisdictions)" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r576" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "order": 10110.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).", "label": "Income Tax Reconciliation Foreign Income Tax Rate Differential", "terseLabel": "Foreign rate differential" } } }, "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r576" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "order": 10010.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate", "terseLabel": "Expected income tax expense at statutory rate" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "auth_ref": [ "r576" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "order": 10170.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Income Tax Reconciliation Other Adjustments", "terseLabel": "Other, net" } } }, "localname": "IncomeTaxReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": { "auth_ref": [ "r576" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "order": 10130.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).", "label": "Income Tax Reconciliation Prior Year Income Taxes", "terseLabel": "Provision to tax return and other deferred tax adjustments" } } }, "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r576" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "order": 10090.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).", "label": "Income Tax Reconciliation State And Local Income Taxes", "terseLabel": "State and local taxes, net of federal benefit" } } }, "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationTaxContingencies": { "auth_ref": [ "r576" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "order": 10120.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.", "label": "Income Tax Reconciliation Tax Contingencies", "terseLabel": "Changes in reserve for uncertain tax positions including interest" } } }, "localname": "IncomeTaxReconciliationTaxContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationTaxCredits": { "auth_ref": [ "r576" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "order": 10080.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.", "label": "Income Tax Reconciliation Tax Credits", "negatedLabel": "Research and general business tax credits" } } }, "localname": "IncomeTaxReconciliationTaxCredits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationTaxCreditsForeign": { "auth_ref": [ "r576" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "order": 10040.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.", "label": "Income Tax Reconciliation Tax Credits Foreign", "negatedLabel": "Foreign tax credits" } } }, "localname": "IncomeTaxReconciliationTaxCreditsForeign", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationTaxExemptIncome": { "auth_ref": [ "r576" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "order": 10060.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes.", "label": "Income Tax Reconciliation Tax Exempt Income", "negatedLabel": "Change in fair value of contingent obligations" } } }, "localname": "IncomeTaxReconciliationTaxExemptIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r108", "r115" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Cash paid for income taxes, net of refunds" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r110" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10350.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase Decrease In Accounts Payable And Accrued Liabilities", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase Decrease In Other Operating Assets And Liabilities Net [Abstract]", "terseLabel": "Changes in operating assets and liabilities, net of effect of acquisitions:" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "auth_ref": [ "r110" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10360.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.", "label": "Increase Decrease In Other Operating Capital Net", "negatedLabel": "Other assets and liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase Decrease In Stockholders Equity Roll Forward", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquitySharesOfCommonStockOutstandingDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r164", "r165", "r166", "r172" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails": { "order": 10020.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable To Share Based Payment Arrangements", "terseLabel": "Stock options and other awards under deferred share-based compensation programs (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r273", "r278" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10240.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets Net Excluding Goodwill", "terseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetIncludingGoodwill": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.", "label": "Intangible Assets Net Including Goodwill", "terseLabel": "Goodwill and identifiable intangible assets" } } }, "localname": "IntangibleAssetsNetIncludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntellectualPropertyMember": { "auth_ref": [ "r631" ], "lang": { "en-us": { "role": { "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights.", "label": "Intellectual Property [Member]", "terseLabel": "Intellectual property (medical patent)" } } }, "localname": "IntellectualPropertyMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfIntangibleAssetsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestAndOtherIncome": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 10050.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).", "label": "Interest And Other Income", "negatedLabel": "Interest income" } } }, "localname": "InterestAndOtherIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r79", "r204", "r736", "r739", "r820" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 10060.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "terseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r105", "r107", "r115" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid Net", "terseLabel": "Cash paid for interest (excluding finance leases)" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r12", "r13", "r44" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfAccruedExpensesDetails": { "order": 10070.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable Current", "terseLabel": "Interest rate swaps - current" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r667" ], "lang": { "en-us": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]", "terseLabel": "Intrest rate swaps" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesInterestRateSwapsDesignatedAsHedgingInstrumentsOnConsolidatedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875", "r876", "r877", "r878", "r879", "r880" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]", "terseLabel": "Investment Type" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875", "r876", "r877", "r878", "r879", "r880" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investment Type Categorization [Member]", "terseLabel": "Investments" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r759" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease Cost Table [Text Block]", "terseLabel": "Schedule of Lease, Cost" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r288" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold Improvements" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_LesseeFinanceLeasesTextBlock": { "auth_ref": [ "r762" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.", "label": "Lessee Finance Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeFinanceLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee Lease Description [Line Items]", "terseLabel": "Lessee Lease Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r751" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee Lease Description [Table]", "terseLabel": "Lessee Lease Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r750" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee Leases Policy [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r760" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee Operating Lease Liability Maturity Table [Text Block]", "terseLabel": "Schedule of Lessee, Operating Lease, Liability, Maturity" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r760" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee Operating Lease Liability Payments Due", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r760" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 10180.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due After Year Five", "terseLabel": "2027 and thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r760" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 10130.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Next Twelve Months", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r760" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 10170.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Five", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r760" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 10160.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Four", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r760" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 10150.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Three", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r760" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 10140.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Two", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r760" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails2": { "order": 10050.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee Operating Lease Liability Undiscounted Excess Amount", "negatedLabel": "Less: Imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LetterOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).", "label": "Letter Of Credit [Member]", "terseLabel": "Letter of credit" } } }, "localname": "LetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r43", "r126", "r218", "r247", "r327", "r328", "r329", "r332", "r333", "r334", "r336", "r338", "r340", "r341", "r645", "r650", "r651", "r711", "r774", "r775" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10010.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r30", "r126", "r247", "r711", "r776", "r812", "r831" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities And Stockholders Equity", "totalLabel": "Total liabilities and shareholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities And Stockholders Equity [Abstract]", "terseLabel": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r45", "r126", "r247", "r327", "r328", "r329", "r332", "r333", "r334", "r336", "r338", "r340", "r341", "r645", "r650", "r651", "r711", "r774", "r775", "r776" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10090.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r690" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Liabilities Fair Value Disclosure", "totalLabel": "Total liabilities" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r19", "r811", "r826" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Line Of Credit", "terseLabel": "Outstanding borrowings" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityCapacityAvailableForTradePurchases": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The maximum amount of borrowing capacity under a line of credit that is available as of the balance sheet date for financing purchases of goods acquired for inventory or imminent delivery to a customer.", "label": "Line Of Credit Facility Capacity Available For Trade Purchases", "terseLabel": "Line of credit facility, capacity available for trade purchases" } } }, "localname": "LineOfCreditFacilityCapacityAvailableForTradePurchases", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityDecreaseForgiveness1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in line of credit facility from forgiveness by the holder of the line of credit.", "label": "Line Of Credit Facility Decrease Forgiveness1", "terseLabel": "Line of credit facility, decrease, forgiveness" } } }, "localname": "LineOfCreditFacilityDecreaseForgiveness1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": { "auth_ref": [ "r41" ], "lang": { "en-us": { "role": { "documentation": "The effective interest rate at the end of the reporting period.", "label": "Line Of Credit Facility Interest Rate At Period End", "terseLabel": "Interest rate" } } }, "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r41" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line Of Credit Facility Maximum Borrowing Capacity", "terseLabel": "Maximum borrowing capacity under accounts receivable financing agreement" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r41" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line Of Credit Facility Remaining Borrowing Capacity", "terseLabel": "Available borrowings" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.", "label": "Line Of Credit Facility Unused Capacity Commitment Fee Percentage", "terseLabel": "Quarterly commitment fee on average daily unused balance" } } }, "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LitigationStatusAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by status of pending, threatened, or settled litigation.", "label": "Litigation Status [Axis]", "terseLabel": "Litigation Status" } } }, "localname": "LitigationStatusAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LitigationStatusDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Status of pending, threatened, or settled litigation.", "label": "Litigation Status [Domain]", "terseLabel": "Litigation Status" } } }, "localname": "LitigationStatusDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.", "label": "Long Lived Assets By Geographic Areas Table [Text Block]", "terseLabel": "Long-Lived Assets by Geographic Area" } } }, "localname": "LongLivedAssetsByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r19", "r356", "r371", "r373", "r374", "r811", "r828" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long Term Debt", "terseLabel": "Long-term debt", "totalLabel": "Total" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long Term Debt Fair Value", "terseLabel": "Long-term debt, fair value" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": { "auth_ref": [ "r132", "r324", "r361" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails": { "order": 10060.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal After Year Five", "terseLabel": "2027 and thereafter" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r132", "r324", "r361" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails": { "order": 10010.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Next Twelve Months", "terseLabel": "2022" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "auth_ref": [ "r132", "r324", "r361" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails": { "order": 10050.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Five", "terseLabel": "2026" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r132", "r324", "r361" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails": { "order": 10040.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Four", "terseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r132", "r324", "r361" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails": { "order": 10030.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Three", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r132", "r324", "r361" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails": { "order": 10020.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Two", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsContractualMaturitiesOfDebtObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r47" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10100.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long Term Debt Noncurrent", "terseLabel": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfDebtObligationsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r47" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Longterm Debt Type [Axis]", "terseLabel": "Long-term Debt, Type" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfDebtObligationsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r47", "r325" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Longterm Debt Type [Domain]", "terseLabel": "Long-term Debt, Type" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfDebtObligationsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r321", "r322" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "Minority Interest Ownership Percentage By Parent", "terseLabel": "Minority interest ownership percentage" } } }, "localname": "MinorityInterestOwnershipPercentageByParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisParentheticalDetails" ], "xbrltype": "percentItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r106" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10030.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided By Used In Financing Activities", "totalLabel": "Net cash (used in) provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r106" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10020.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided By Used In Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r106", "r109", "r112" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10010.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided By Used In Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r7", "r68", "r71", "r77", "r83", "r112", "r126", "r147", "r152", "r153", "r154", "r155", "r158", "r159", "r169", "r210", "r216", "r220", "r223", "r226", "r247", "r327", "r328", "r329", "r332", "r333", "r334", "r336", "r338", "r340", "r341", "r687", "r711", "r817", "r836" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10240.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 10010.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income Loss", "terseLabel": "Net income", "totalLabel": "Net income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "New Accounting Pronouncements Or Change In Accounting Principle [Line Items]", "terseLabel": "New Accounting Pronouncements Or Change In Accounting Principle [Line Items]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r145", "r147", "r148", "r149", "r150", "r151", "r154", "r160", "r176", "r244", "r245", "r252", "r253", "r254", "r255", "r256", "r257", "r326", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r603", "r604", "r605", "r606", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r712", "r713", "r715", "r716", "r717", "r718", "r719", "r720", "r763", "r789", "r790", "r791", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r910", "r911", "r912", "r913", "r914" ], "lang": { "en-us": { "role": { "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.", "label": "New Accounting Pronouncements Or Change In Accounting Principle [Table]", "terseLabel": "New Accounting Pronouncements Or Change In Accounting Principle [Table]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements Policy Policy [Text Block]", "terseLabel": "Recently Adopted Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1": { "auth_ref": [ "r116", "r117", "r118" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities, classified as other, assumed in acquiring a business or in consideration for an asset received in a noncash or part noncash acquisition.", "label": "Noncash Or Part Noncash Acquisition Other Liabilities Assumed1", "terseLabel": "Fair value of contingent consideration related to acquisitions" } } }, "localname": "NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1": { "auth_ref": [ "r116", "r117", "r118" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash consideration received for selling an asset or business through a noncash (or part noncash) transaction.", "label": "Noncash Or Part Noncash Divestiture Amount Of Consideration Received1", "terseLabel": "Convertible notes" } } }, "localname": "NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r92" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 10040.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income Expense", "negatedTotalLabel": "Total other expense, net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r198" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number Of Reportable Segments", "terseLabel": "Number of reportable segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportingUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.", "label": "Number Of Reporting Units", "terseLabel": "Number of reporting units with goodwill assigned" } } }, "localname": "NumberOfReportingUnits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent": { "auth_ref": [ "r66" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.", "label": "Oci Before Reclassifications Before Tax Attributable To Parent", "terseLabel": "Unrealized gain (loss) during period, before taxes" } } }, "localname": "OciBeforeReclassificationsBeforeTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTaxEffectsAllocatedToEachComponentOfOtherComprehensiveLossIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": { "auth_ref": [ "r66", "r78" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.", "label": "Oci Before Reclassifications Net Of Tax Attributable To Parent", "terseLabel": "Other comprehensive gain (loss) before reclassifications", "verboseLabel": "Other comprehensive income before reclassifications" } } }, "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccumulatedOtherComprehensiveLossNetOfTaxesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTaxEffectsAllocatedToEachComponentOfOtherComprehensiveLossIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingCostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Costs And Expenses [Abstract]", "terseLabel": "Costs and operating expenses:" } } }, "localname": "OperatingCostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r210", "r216", "r220", "r223", "r226" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 10030.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income Loss", "terseLabel": "Operating income (loss)", "totalLabel": "Income from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r753", "r761" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesComponentsOfLeaseCostDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease Cost", "totalLabel": "Total operating lease costs" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesComponentsOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Lease Liabilities Payments Due [Abstract]", "terseLabel": "Operating Leases" } } }, "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r745" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails2": { "order": 10060.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease Liability", "terseLabel": "Total lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r745" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10180.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease Liability Current", "terseLabel": "Current portion of operating lease obligations" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r745" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10110.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease Liability Noncurrent", "terseLabel": "Operating lease long-term obligations" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r749", "r755" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease Payments", "negatedLabel": "Operating cash flows for operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalCashFlowInformationRelatedToLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r744" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10220.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease Right Of Use Asset", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r758", "r761" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease Weighted Average Discount Rate Percent", "terseLabel": "Weighted average discount rate, Operating leases" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalCashFlowInformationWeightedAverageDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r757", "r761" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease Weighted Average Remaining Lease Term1", "terseLabel": "Weighted average remaining lease term, Operating lease" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalCashFlowInformationWeightedAverageDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r595" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "Operating loss carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r215", "r216", "r217", "r218", "r220", "r226" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrderOrProductionBacklogMember": { "auth_ref": [ "r628" ], "lang": { "en-us": { "role": { "documentation": "Orders, production or production backlog arising from contracts such as purchase or sales orders acquired in a business combination.", "label": "Order Or Production Backlog [Member]", "terseLabel": "Acquired backlog", "verboseLabel": "Backlog" } } }, "localname": "OrderOrProductionBacklogMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValueOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfIntangibleAssetsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization Consolidation And Presentation Of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r11", "r12", "r13", "r44" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfAccruedExpensesDetails": { "order": 10080.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities Current", "terseLabel": "Other liabilities" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r39" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10260.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets Noncurrent", "terseLabel": "Other long-term assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r642", "r643", "r647" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 10030.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent", "terseLabel": "Foreign currency translation adjustments, net of income tax (benefit) expense of $(1,472), $1,354, and $0, respectively", "verboseLabel": "Foreign currency translation adjustment, net of taxes" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": { "auth_ref": [ "r64", "r75" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).", "label": "Other Comprehensive Income Loss Before Reclassifications Tax", "terseLabel": "Income tax expense (benefit)" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTaxEffectsAllocatedToEachComponentOfOtherComprehensiveLossIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "auth_ref": [ "r61", "r63" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax", "terseLabel": "Unrealized gain (loss) on derivative instruments, net of taxes", "verboseLabel": "Unrealized gain (loss) on derivative instruments, net of taxes" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": { "auth_ref": [ "r64" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax", "negatedLabel": "Income tax expense (benefit) related to unrealized gain (loss) on derivative instruments recorded in other comprehensive loss" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": { "auth_ref": [ "r59", "r64", "r724", "r733" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax", "negatedLabel": "Other comprehensive expense (benefit), foreign currency translation adjustment, tax", "terseLabel": "Income tax (benefit) expense" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTaxEffectsAllocatedToEachComponentOfOtherComprehensiveLossIncomeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r69", "r72", "r642", "r643", "r647" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent", "terseLabel": "Total unrealized gain (loss) on derivative instruments, net of taxes" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTaxEffectsAllocatedToEachComponentOfOtherComprehensiveLossIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCostAndExpenseOperating": { "auth_ref": [ "r90" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.", "label": "Other Cost And Expense Operating", "terseLabel": "Other restructuring expenses, non-cash" } } }, "localname": "OtherCostAndExpenseOperating", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsLiabilitiesAssociatedWithRestructuringAndOtherCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCustomerMember": { "auth_ref": [ "r841", "r843", "r845", "r846", "r850", "r863" ], "lang": { "en-us": { "role": { "documentation": "Customer classified as other.", "label": "Other Customer [Member]", "terseLabel": "Major Customer" } } }, "localname": "OtherCustomerMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureConcentrationOfCreditRiskNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherIncomeAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income And Expenses [Abstract]", "terseLabel": "Total other expense, net:" } } }, "localname": "OtherIncomeAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r48" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10140.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities Noncurrent", "terseLabel": "Other long-term liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLongTermInvestments": { "auth_ref": [ "r35", "r834" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term investments classified as other.", "label": "Other Long Term Investments", "terseLabel": "Other long-term investments" } } }, "localname": "OtherLongTermInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r112" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10330.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income Expense", "negatedLabel": "Other non-cash items" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent assets.", "label": "Other Noncurrent Assets [Member]", "terseLabel": "Other Noncurrent Assets" } } }, "localname": "OtherNoncurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesInterestRateSwapsDesignatedAsHedgingInstrumentsOnConsolidatedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Member]", "terseLabel": "Other Noncurrent Liabilities" } } }, "localname": "OtherNoncurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesInterestRateSwapsDesignatedAsHedgingInstrumentsOnConsolidatedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r93" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfOtherIncomeExpenseNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 10080.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income Expense", "negatedLabel": "Other (income) expense, net", "negatedTotalLabel": "Total other (income) expense, net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfOtherIncomeExpenseNetDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherRestructuringMember": { "auth_ref": [ "r294", "r295", "r304", "r305" ], "lang": { "en-us": { "role": { "documentation": "Restructuring and related activities classified as other.", "label": "Other Restructuring [Member]", "terseLabel": "Other costs", "verboseLabel": "Other Costs" } } }, "localname": "OtherRestructuringMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsLiabilitiesAssociatedWithRestructuringAndOtherCostsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsScheduleOfRestructuringAndOtherCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PatentsMember": { "auth_ref": [ "r630" ], "lang": { "en-us": { "role": { "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.", "label": "Patents [Member]", "terseLabel": "Patient communities" } } }, "localname": "PatentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": { "auth_ref": [ "r104" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10130.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.", "label": "Payment For Contingent Consideration Liability Financing Activities", "terseLabel": "Payments of contingent consideration related to acquisitions" } } }, "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r101" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10150.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments For Repurchase Of Common Stock", "negatedLabel": "Payments for repurchases of common stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r103" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10060.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments Of Debt Issuance Costs", "negatedLabel": "Payments of debt financing costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r101" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10170.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payments Related To Tax Withholding For Share Based Compensation", "negatedLabel": "Payments related to tax withholdings for share-based compensation" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r97" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10180.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments To Acquire Businesses Net Of Cash Acquired", "negatedLabel": "Payments related to acquisitions of businesses, net of cash acquired", "terseLabel": "Business acquisition payment of cash" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates": { "auth_ref": [ "r97" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10220.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).", "label": "Payments To Acquire Interest In Subsidiaries And Affiliates", "negatedLabel": "Investments in unconsolidated affiliates" } } }, "localname": "PaymentsToAcquireInterestInSubsidiariesAndAffiliates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r98" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10210.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments To Acquire Property Plant And Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PendingLitigationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.", "label": "Pending Litigation [Member]", "terseLabel": "Pending Litigation" } } }, "localname": "PendingLitigationMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r462", "r464", "r470", "r488", "r490", "r491", "r492", "r493", "r494", "r508", "r509", "r510", "r511", "r519" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for retirement benefits.", "label": "Pension And Other Postretirement Benefits Disclosure [Text Block]", "terseLabel": "Employee Benefit Plans" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r523", "r554" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r704" ], "lang": { "en-us": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion At Fair Value Fair Value Disclosure [Member]", "terseLabel": "Fair Value Disclosure Item Amounts [Default]" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r23", "r384" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock Par Or Stated Value Per Share", "terseLabel": "Preferred stock par value (USD per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock Shares Authorized", "terseLabel": "Preferred stock shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityScheduleOfStockByClassDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r23", "r384" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock Shares Issued", "terseLabel": "Preferred stock shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityScheduleOfStockByClassDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock Shares Outstanding", "terseLabel": "Preferred stock shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityScheduleOfStockByClassDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r23", "r776" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10040.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock Value", "terseLabel": "Preferred stock, $0.01 par value; 30,000 shares authorized, 0 shares issued and outstanding as of December 31, 2021 and 2020" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r9", "r33", "r34" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10290.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense And Other Assets Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Prior Period Reclassification Adjustment Description", "terseLabel": "Reclassification" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromAccountsReceivableSecuritization": { "auth_ref": [ "r100" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10080.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions.", "label": "Proceeds From Accounts Receivable Securitization", "terseLabel": "Proceeds from accounts receivable financing agreement" } } }, "localname": "ProceedsFromAccountsReceivableSecuritization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromCollectionOfNotesReceivable": { "auth_ref": [ "r94" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10190.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds From Collection Of Notes Receivable", "terseLabel": "Proceeds from notes receivable from divestiture" } } }, "localname": "ProceedsFromCollectionOfNotesReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinesses": { "auth_ref": [ "r95" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.", "label": "Proceeds From Divestiture Of Businesses", "terseLabel": "Cash consideration" } } }, "localname": "ProceedsFromDivestitureOfBusinesses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r100" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10050.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds From Issuance Of Long Term Debt", "terseLabel": "Proceeds from issuance of long-term debt, net of discount" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLinesOfCredit": { "auth_ref": [ "r100", "r125" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10100.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Proceeds From Lines Of Credit", "terseLabel": "Proceeds from revolving line of credit" } } }, "localname": "ProceedsFromLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndCollectionOfReceivables": { "auth_ref": [ "r96" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the proceeds from sale and collection of receivables during the period.", "label": "Proceeds From Sale And Collection Of Receivables", "terseLabel": "Proceeds from sale of trade receivables" } } }, "localname": "ProceedsFromSaleAndCollectionOfReceivables", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfNotesReceivable": { "auth_ref": [ "r94" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the sale of a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds From Sale Of Notes Receivable", "terseLabel": "Proceeds from notes receivable" } } }, "localname": "ProceedsFromSaleOfNotesReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets": { "auth_ref": [ "r96" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10200.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.", "label": "Proceeds From Sales Of Business Affiliate And Productive Assets", "terseLabel": "Proceeds from sale of business" } } }, "localname": "ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r99", "r555" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10160.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds From Stock Options Exercised", "terseLabel": "Proceeds from exercises of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": { "auth_ref": [ "r289", "r746", "r752" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.", "label": "Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization", "terseLabel": "Accumulated depreciation" } } }, "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": { "auth_ref": [ "r55", "r290", "r752" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalBalanceSheetInformationRelatedToLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.", "label": "Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization", "terseLabel": "Amortization charges, net of rebates", "totalLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalBalanceSheetInformationRelatedToLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": { "auth_ref": [ "r15", "r288", "r744" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalBalanceSheetInformationRelatedToLeasesDetails": { "order": 10030.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.", "label": "Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization", "terseLabel": "Property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalBalanceSheetInformationRelatedToLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r38", "r290" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property Plant And Equipment By Type [Axis]", "terseLabel": "Long-Lived Tangible Asset" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r37", "r288" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfPropertyAndEquipmentNetDetails": { "order": 10010.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property Plant And Equipment Gross", "terseLabel": "Property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property Plant And Equipment [Line Items]", "terseLabel": "Property Plant And Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r15", "r16", "r290", "r776", "r822", "r832" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfPropertyAndEquipmentNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10210.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property Plant And Equipment Net", "terseLabel": "Property and equipment, net", "totalLabel": "Property and equipment, net", "verboseLabel": "Total property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfPropertyAndEquipmentNetDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationLongLivedAssetsByGeographicAreaDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r36", "r290", "r885", "r886" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property Plant And Equipment Policy [Text Block]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r15", "r290" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property Plant And Equipment [Text Block]", "terseLabel": "Estimated Useful Lives of Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r15", "r288" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property Plant And Equipment Type [Domain]", "terseLabel": "Long-Lived Tangible Asset" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property Plant And Equipment Useful Life", "terseLabel": "Property and equipment, estimated useful life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r86", "r260" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10270.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Provision For Doubtful Accounts", "terseLabel": "Provision for doubtful accounts" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": { "auth_ref": [ "r32", "r242" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.", "label": "Receivables Trade And Other Accounts Receivable Allowance For Doubtful Accounts Policy", "terseLabel": "Allowance for Doubtful Accounts" } } }, "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent": { "auth_ref": [ "r66" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.", "label": "Reclassification From Aoci Current Period Before Tax Attributable To Parent", "negatedLabel": "Reclassification adjustment, before taxes" } } }, "localname": "ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTaxEffectsAllocatedToEachComponentOfOtherComprehensiveLossIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": { "auth_ref": [ "r66", "r78" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.", "label": "Reclassification From Aoci Current Period Net Of Tax Attributable To Parent", "negatedLabel": "Reclassification adjustments", "negatedTerseLabel": "Reclassification adjustment, net of taxes" } } }, "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccumulatedOtherComprehensiveLossNetOfTaxesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTaxEffectsAllocatedToEachComponentOfOtherComprehensiveLossIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodTax": { "auth_ref": [ "r64", "r67", "r75" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).", "label": "Reclassification From Aoci Current Period Tax", "terseLabel": "Income tax expense" } } }, "localname": "ReclassificationFromAociCurrentPeriodTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTaxEffectsAllocatedToEachComponentOfOtherComprehensiveLossIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification Out Of Accumulated Other Comprehensive Income Table [Text Block]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive (Loss) Income" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r489", "r766", "r767" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": { "auth_ref": [ "r766" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction Expenses From Transactions With Related Party", "terseLabel": "Professional services expenses from transaction with related party" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction Purchases From Related Party", "terseLabel": "Receivables from related party" } } }, "localname": "RelatedPartyTransactionPurchasesFromRelatedParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r489", "r766", "r770", "r793", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party Transactions By Related Party [Axis]", "terseLabel": "Related Party" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r764", "r765", "r767", "r771", "r772" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related-Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfAccountsReceivableSecuritization": { "auth_ref": [ "r102" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10090.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Repayments of securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions.", "label": "Repayments Of Accounts Receivable Securitization", "negatedLabel": "Repayments of accounts receivable financing agreement" } } }, "localname": "RepaymentsOfAccountsReceivableSecuritization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLinesOfCredit": { "auth_ref": [ "r102", "r125" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10110.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Repayments Of Lines Of Credit", "negatedLabel": "Repayments of revolving line of credit" } } }, "localname": "RepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r102" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10070.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments Of Long Term Debt", "negatedLabel": "Repayments of long-term debt", "terseLabel": "Repayments of Long-term debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchMember": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.", "label": "Research [Member]", "terseLabel": "Research and Development Credit Carry Forwards" } } }, "localname": "ResearchMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashCurrent": { "auth_ref": [ "r8", "r14", "r119" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash Current", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCashCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units R S U [Member]", "terseLabel": "Restricted Stock Units (RSUs)" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring And Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [ "r293", "r295", "r298", "r307", "r309" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.", "label": "Restructuring And Related Activities Disclosure [Text Block]", "terseLabel": "Restructuring and Other Costs" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCosts" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringAndRelatedCostIncurredCost": { "auth_ref": [ "r294", "r297", "r304", "r306" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.", "label": "Restructuring And Related Cost Incurred Cost", "terseLabel": "Total non-Merger related restructuring and other costs:" } } }, "localname": "RestructuringAndRelatedCostIncurredCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsScheduleOfRestructuringAndOtherCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [ "r294", "r295", "r304", "r305" ], "lang": { "en-us": { "role": { "documentation": "Information by type of restructuring cost.", "label": "Restructuring Cost And Reserve [Axis]", "terseLabel": "Restructuring Type" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsLiabilitiesAssociatedWithRestructuringAndOtherCostsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsScheduleOfRestructuringAndOtherCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost And Reserve [Line Items]", "terseLabel": "Restructuring Cost And Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsLiabilitiesAssociatedWithRestructuringAndOtherCostsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsScheduleOfRestructuringAndOtherCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringReserveCurrent": { "auth_ref": [ "r18", "r295", "r305" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfAccruedExpensesDetails": { "order": 10050.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "Restructuring Reserve Current", "terseLabel": "Restructuring and other costs, current portion" } } }, "localname": "RestructuringReserveCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r26", "r407", "r563", "r776", "r830", "r857", "r862" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10080.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings Accumulated Deficit", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r2", "r142", "r143", "r144", "r148", "r157", "r159", "r255", "r560", "r561", "r562", "r605", "r606", "r685", "r853", "r855" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanSponsorLocationAxis": { "auth_ref": [ "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r489", "r492", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r512", "r514", "r517" ], "lang": { "en-us": { "role": { "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Axis]", "terseLabel": "Retirement Plan Sponsor Location" } } }, "localname": "RetirementPlanSponsorLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanSponsorLocationDomain": { "auth_ref": [ "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r489", "r492", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r512", "r514", "r517" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Domain]", "terseLabel": "Retirement Plan Sponsor Location" } } }, "localname": "RetirementPlanSponsorLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue From Contract With Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r201", "r202", "r215", "r221", "r222", "r229", "r230", "r235", "r431", "r432", "r787" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 10090.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue From Contract With Customer Excluding Assessed Tax", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationTotalRevenueByGeographicAreaDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r121", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r438" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue From Contract With Customer Policy [Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r413", "r414", "r415", "r416", "r417", "r418", "r421", "r422", "r435", "r438" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue From Contract With Customer [Text Block]", "terseLabel": "Revenue from Contract with Customers" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRevenueFromContractsWithCustomers" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": { "auth_ref": [ "r232" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.", "label": "Revenue From External Customers By Geographic Areas Table [Text Block]", "terseLabel": "Total Revenue by Geographic Area" } } }, "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromRelatedParties": { "auth_ref": [ "r88", "r330", "r332", "r333", "r339", "r340", "r341", "r865" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.", "label": "Revenue From Related Parties", "terseLabel": "Revenue from related parties" } } }, "localname": "RevenueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r420" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue Remaining Performance Obligation", "terseLabel": "Unsatisfied performance obligations under contracts with a contract term greater than one year" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRevenueFromContractsWithCustomersNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]", "terseLabel": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRevenueFromContractsWithCustomersNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.", "label": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Table]", "terseLabel": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Table]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRevenueFromContractsWithCustomersNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenues From External Customers And Long Lived Assets [Line Items]", "terseLabel": "Revenues by Geographic Location", "verboseLabel": "Long-Lived Assets by Geographic Location" } } }, "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationLongLivedAssetsByGeographicAreaDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationTotalRevenueByGeographicAreaDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving credit facility due August 2024" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": { "auth_ref": [ "r756", "r761" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.", "label": "Right Of Use Asset Obtained In Exchange For Finance Lease Liability", "terseLabel": "Right-of-use asset obtained in exchange for lease liability, Finance leases" } } }, "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalCashFlowInformationRelatedToLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r756", "r761" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right Of Use Asset Obtained In Exchange For Operating Lease Liability", "terseLabel": "Right-of-use asset obtained in exchange for lease liability, Operating leases" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesSupplementalCashFlowInformationRelatedToLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks And Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r190", "r235" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Sales Revenue Net [Member]", "terseLabel": "Net Service Revenue" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureConcentrationOfCreditRiskNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationTotalRevenueByGeographicAreaDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r53" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule Of Accounts Notes Loans And Financing Receivable [Text Block]", "terseLabel": "Schedule of Billed Accounts Receivable, Net" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule Of Accrued Liabilities Table [Text Block]", "terseLabel": "Schedule of Accrued Expenses" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r66", "r732", "r734" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule Of Accumulated Other Comprehensive Income Loss Table [Text Block]", "terseLabel": "Schedule of Accumulated Other Comprehensive Loss, Net of Tax" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r622", "r623" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule Of Business Acquisitions By Acquisition [Table]", "terseLabel": "Schedule Of Business Acquisitions By Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.", "label": "Schedule Of Cash Flow Supplemental Disclosures Table [Text Block]", "terseLabel": "Supplemental Disclosure of Cash Flow Information" } } }, "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r601" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule Of Components Of Income Tax Expense Benefit Table [Text Block]", "terseLabel": "Schedule of Components of Income Tax Expense (Benefit)" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock": { "auth_ref": [ "r240", "r261" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allowance for credit loss of financing receivable, classified as current.", "label": "Schedule Of Credit Losses For Financing Receivables Current Table [Text Block]", "terseLabel": "Schedule of Changes in the Allowance for Doubtful Accounts" } } }, "localname": "ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r47", "r132", "r373", "r375", "r401", "r404", "r405", "r406", "r737", "r738", "r742", "r824" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule Of Debt Instruments [Text Block]", "terseLabel": "Schedule of Debt Obligations" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": { "auth_ref": [ "r439", "r440" ], "lang": { "en-us": { "role": { "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.", "label": "Schedule Of Deferred Compensation Arrangement With Individual Excluding Share Based Payments And Postretirement Benefits By Title Of Individual And By Type Of Deferred Compensation [Table]", "terseLabel": "Schedule Of Deferred Compensation Arrangement With Individual Excluding Share Based Payments And Postretirement Benefits By Title Of Individual And By Type Of Deferred Compensation [Table]" } } }, "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r592" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule Of Deferred Tax Assets And Liabilities Table [Text Block]", "terseLabel": "Schedule of Deferred Tax Assets and Liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "auth_ref": [ "r665" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Schedule Of Derivative Instruments In Statement Of Financial Position Fair Value [Text Block]", "terseLabel": "Interest Rate Swaps Designated as Hedging Instruments on Consolidated Balance Sheets" } } }, "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureDerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r172" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]", "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r576" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]", "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r522", "r551", "r565" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]", "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfShareBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r522", "r551", "r565" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]", "terseLabel": "Summary of Share-Based Compensation Expense" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r690", "r691" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block]", "terseLabel": "Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": { "auth_ref": [ "r275" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.", "label": "Schedule Of Finite Lived Intangible Assets Acquired As Part Of Business Combination [Text Block]", "terseLabel": "Preliminary Estimates of Fair Values of Intangible Assets and Estimated Useful Lives" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r275", "r279", "r788" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule Of Finite Lived Intangible Assets [Table]", "terseLabel": "Schedule Of Finite Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValueOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValuesOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfIntangibleAssetsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r275", "r279" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule Of Finite Lived Intangible Assets Table [Text Block]", "terseLabel": "Schedule of Finite Lived Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r270", "r272" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule Of Goodwill [Table]", "terseLabel": "Schedule Of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r270", "r272" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule Of Goodwill [Text Block]", "terseLabel": "Schedule of Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r127" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule Of Income Before Income Tax Domestic And Foreign Table [Text Block]", "terseLabel": "Components of Income before Provision for Income Taxes" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r283", "r286" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.", "label": "Schedule Of Indefinite Lived Intangible Assets Table [Text Block]", "terseLabel": "Schedule of Indefinite Lived Intangible Assets" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule Of Maturities Of Long Term Debt Table [Text Block]", "terseLabel": "Contractual Maturities of Debt Obligations" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [ "r537" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.", "label": "Schedule Of Nonvested Restricted Stock Units Activity Table [Text Block]", "terseLabel": "Summary of Restricted Stock Unit Activity" } } }, "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.", "label": "Schedule Of Other Nonoperating Income Expense Table [Text Block]", "terseLabel": "Schedule of Other (Income) Expense, Net (Details)" } } }, "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r38", "r290" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Schedule Of Property Plant And Equipment [Table]", "terseLabel": "Schedule Of Property Plant And Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r626" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule Of Recognized Identified Assets Acquired And Liabilities Assumed Table [Text Block]", "terseLabel": "Allocation of Consideration Transferred" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r768", "r770" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule Of Related Party Transactions By Related Party [Table]", "terseLabel": "Schedule Of Related Party Transactions By Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRepurchaseAgreements": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for repurchase agreements.", "label": "Schedule Of Repurchase Agreements", "terseLabel": "Schedule of Repurchase Activity" } } }, "localname": "ScheduleOfRepurchaseAgreements", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r294", "r295", "r296", "r297", "r304", "r305", "r306" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule Of Restructuring And Related Costs [Table]", "terseLabel": "Schedule Of Restructuring And Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsAllocationOfConsiderationTransferredDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsLiabilitiesAssociatedWithRestructuringAndOtherCostsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsScheduleOfRestructuringAndOtherCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "auth_ref": [ "r299", "r300", "r303" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.", "label": "Schedule Of Restructuring And Related Costs [Text Block]", "terseLabel": "Schedule of Restructuring and Related Costs" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "auth_ref": [ "r80", "r234" ], "lang": { "en-us": { "role": { "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule Of Revenues From External Customers And Long Lived Assets [Table]", "terseLabel": "Schedule Of Revenues From External Customers And Long Lived Assets [Table]" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationLongLivedAssetsByGeographicAreaDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureOperationsByGeographicLocationTotalRevenueByGeographicAreaDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r210", "r213", "r219", "r270" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule Of Segment Reporting Information By Segment [Table]", "terseLabel": "Schedule Of Segment Reporting Information By Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r210", "r213", "r219", "r270" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule Of Segment Reporting Information By Segment [Text Block]", "terseLabel": "Schedule of Segment Information" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r523", "r554" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]", "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationStockOptionValuationAssumptionsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r530", "r542", "r545" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]", "terseLabel": "Summary of Stock Option Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r548" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]", "terseLabel": "Stock Option Valuation Assumptions" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r50", "r123", "r180", "r181", "r380", "r382", "r383", "r384", "r385", "r386", "r387", "r389", "r393", "r398", "r401", "r402", "r403", "r404", "r405", "r406", "r407" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule Of Stock By Class [Table]", "terseLabel": "Schedule Of Stock By Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityRepurchaseActivityDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityScheduleOfStockByClassDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquitySharesOfCommonStockOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTextBlock": { "auth_ref": [ "r22", "r23", "r24", "r381", "r382", "r383", "r401", "r402", "r403", "r404", "r405", "r406", "r407" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.", "label": "Schedule Of Stock By Class [Text Block]", "terseLabel": "Schedule of Stock by Class" } } }, "localname": "ScheduleOfStockByClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.", "label": "Schedule Of Stockholders Equity Table [Text Block]", "terseLabel": "Shares of Common Stock Outstanding" } } }, "localname": "ScheduleOfStockholdersEquityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "auth_ref": [ "r586", "r602" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in unrecognized tax benefits.", "label": "Schedule Of Unrecognized Tax Benefits Roll Forward Table [Text Block]", "terseLabel": "Schedule Of Unrecognized Tax Benefits" } } }, "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r279" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Scheduleof Finite Lived Intangible Assets Future Amortization Expense Table [Text Block]", "terseLabel": "Schedule of Future Amortization Expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.", "label": "Secured Debt [Member]", "terseLabel": "Secured Debt" } } }, "localname": "SecuredDebtMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfDebtObligationsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r197", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r215", "r216", "r217", "r218", "r220", "r221", "r222", "r223", "r224", "r226", "r235", "r297", "r306", "r842" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segment [Domain]", "terseLabel": "Segments" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfGoodwillDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r197", "r199", "r200", "r210", "r214", "r220", "r224", "r225", "r226", "r227", "r229", "r234", "r235", "r236" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentsGeographicalAreasAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segments Geographical Areas [Abstract]" } } }, "localname": "SegmentsGeographicalAreasAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r91" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 10120.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling General And Administrative Expense", "terseLabel": "Selling, general, and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling General And Administrative Expenses [Member]", "terseLabel": "Selling, general, and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfShareBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r110" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10260.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share Based Compensation", "terseLabel": "Share-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1", "terseLabel": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate": { "auth_ref": [ "r554" ], "lang": { "en-us": { "role": { "documentation": "Discount rate from fair value on offering date that participants pay for shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Offering Date", "terseLabel": "Discount from market price of common stock, offering date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r536" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period", "negatedLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r541" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited (in usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r539" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r539" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value", "terseLabel": "Granted (in usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r538" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number", "periodEndLabel": "Non-vested at December 31, 2021 (in shares)", "periodStartLabel": "Non-vested at December 31, 2020 (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Roll Forward", "terseLabel": "Number of Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r538" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value", "periodEndLabel": "Non-vested at December 31, 2021 (in usd per share)", "periodStartLabel": "Non-vested at December 31, 2020 (in usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Roll Forward", "terseLabel": "Weighted Average Grant Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period", "negatedLabel": "Vested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "auth_ref": [ "r544" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value", "terseLabel": "Total fair value of shares vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value", "terseLabel": "Vested (in usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum", "terseLabel": "Expected volatility - maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationStockOptionValuationAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum", "terseLabel": "Expected volatility - minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationStockOptionValuationAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum", "terseLabel": "Risk-free interest rate - maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationStockOptionValuationAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum", "terseLabel": "Risk-free interest rate - minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationStockOptionValuationAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]", "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationStockOptionValuationAssumptionsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": { "auth_ref": [ "r554" ], "lang": { "en-us": { "role": { "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate", "terseLabel": "Payroll deductions as a percentage of employee base salary, maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized", "terseLabel": "Number of shares authorized" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r554" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant", "terseLabel": "Number of shares available for future grants" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number", "terseLabel": "Exercisable as of December 31, 2021 (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price", "terseLabel": "Exercisable as of December 31, 2021 (in usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r544" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value", "terseLabel": "Total intrinsic value of options exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r536" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period", "negatedLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r534" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period", "terseLabel": "Stock options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r543" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value", "terseLabel": "Weighted-average grant-date fair value of the RSUs granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r554" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value", "terseLabel": "Outstanding as of December 31, 2021 (in usd)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r532", "r554" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number", "periodEndLabel": "Outstanding as of December 31, 2021 (in shares)", "periodStartLabel": "Outstanding as of December 31, 2020 (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Roll Forward", "terseLabel": "Number of Options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r531" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price", "periodEndLabel": "Outstanding at December 31, 2020 (in usd per share)", "periodStartLabel": "Outstanding as of December 31, 2020 (in usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Rollforward", "terseLabel": "Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": { "auth_ref": [ "r547" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value", "terseLabel": "Vested and expected to vest as of December 31, 2021 (in usd)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": { "auth_ref": [ "r547" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number", "terseLabel": "Vested and expected to vest as of December 31, 2021 (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r546" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price", "terseLabel": "Vested and expected to vest as of December 31, 2021 (in usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r521", "r527" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]", "terseLabel": "Award Type" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationStockOptionValuationAssumptionsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price", "terseLabel": "Exercised (in usd per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price", "terseLabel": "Forfeited (in usd per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r523", "r528" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share Based Compensation Option And Incentive Plans Policy", "terseLabel": "Share-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price (in USD per share)" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value [Abstract]", "terseLabel": "Aggregate Intrinsic Value (in thousands)(a)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period", "terseLabel": "Expiration term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r549", "r564" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1", "terseLabel": "Expected term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationStockOptionValuationAssumptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r554" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1", "terseLabel": "Exercisable as of December 31, 2021 (in usd)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r554" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1", "terseLabel": "Exercisable as of December 31, 2021 (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r546" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2", "terseLabel": "Outstanding as of December 31, 2021 (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r547" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1", "terseLabel": "Vested and expected to vest as of December 31, 2021 (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "auth_ref": [ "r529" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1", "terseLabel": "Fair value of shares vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares Outstanding", "periodEndLabel": "Common stock shares, ending balance", "periodStartLabel": "Common stock shares, beginning balance" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquitySharesOfCommonStockOutstandingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r754", "r761" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesComponentsOfLeaseCostDetails": { "order": 10050.0, "parentTag": "us-gaap_OperatingLeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short Term Lease Cost", "terseLabel": "Short-term lease costs" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLeasesComponentsOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.", "label": "Software And Software Development Costs [Member]", "terseLabel": "Software" } } }, "localname": "SoftwareAndSoftwareDevelopmentCostsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "State And Local Income Tax Expense Benefit Continuing Operations [Abstract]", "terseLabel": "State income taxes:" } } }, "localname": "StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.", "label": "State And Local Jurisdiction [Member]", "terseLabel": "State and Local Jurisdiction" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r6", "r197", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r215", "r216", "r217", "r218", "r220", "r221", "r222", "r223", "r224", "r226", "r235", "r270", "r292", "r297", "r306", "r842" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Statement Business Segments [Axis]", "terseLabel": "Segments" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfGoodwillDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r22", "r23", "r24", "r123", "r126", "r163", "r167", "r168", "r170", "r172", "r180", "r181", "r182", "r247", "r327", "r332", "r333", "r334", "r340", "r341", "r384", "r385", "r389", "r393", "r400", "r711", "r907" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Statement Class Of Stock [Axis]", "terseLabel": "Class of Stock" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityRepurchaseActivityDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityScheduleOfStockByClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r2", "r52", "r75", "r76", "r77", "r142", "r143", "r144", "r148", "r157", "r159", "r179", "r255", "r400", "r407", "r560", "r561", "r562", "r605", "r606", "r685", "r727", "r728", "r729", "r730", "r731", "r734", "r853", "r854", "r855", "r914" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Statement Equity Components [Axis]", "terseLabel": "Equity Components" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccumulatedOtherComprehensiveLossNetOfTaxesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsTaxEffectsAllocatedToEachComponentOfOtherComprehensiveLossIncomeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquitySharesOfCommonStockOutstandingDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Income And Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Stockholders Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r142", "r143", "r144", "r179", "r787" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r23", "r24", "r400", "r407" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Stock Issued During Period Shares Employee Stock Purchase Plans", "terseLabel": "Shares issued (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period Shares Other", "terseLabel": "Issuances of common stock" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquitySharesOfCommonStockOutstandingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r23", "r24", "r400", "r407", "r535" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Stock Issued During Period Shares Stock Options Exercised", "negatedLabel": "Exercised (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r52", "r400", "r407" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period Value Acquisitions", "terseLabel": "Business combinations" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r23", "r24", "r400", "r407" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period Value New Issues", "terseLabel": "Issuances of common stock" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program Authorized Amount1", "terseLabel": "Stock Repurchase Program 2021, Authorized Amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount remaining of a stock repurchase plan authorized.", "label": "Stock Repurchase Program Remaining Authorized Repurchase Amount1", "terseLabel": "Stock repurchase program, authorized amount" } } }, "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r23", "r24", "r400", "r407" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period Shares", "negatedLabel": "Repurchases of common stock", "terseLabel": "Stock repurchased during period, shares", "verboseLabel": "Stock repurchased (in shares)" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityRepurchaseActivityDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquitySharesOfCommonStockOutstandingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r23", "r24", "r400", "r407" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period Value", "negatedLabel": "Repurchases of common stock", "terseLabel": "Stock repurchased during period, value" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r24", "r28", "r29", "r126", "r243", "r247", "r711", "r776" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS": { "order": 10030.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders Equity", "periodEndLabel": "Balance at end of period", "periodStartLabel": "Balance at beginning of period", "totalLabel": "Total shareholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccumulatedOtherComprehensiveLossNetOfTaxesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders Equity [Abstract]", "terseLabel": "Shareholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r124", "r385", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r399", "r407", "r409" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders Equity Note Disclosure [Text Block]", "terseLabel": "Shareholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reporting subsequent events.", "label": "Subsequent Events Policy Policy [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SummaryOfValuationAllowanceTextBlock": { "auth_ref": [ "r591" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.", "label": "Summary Of Valuation Allowance [Text Block]", "terseLabel": "Summary of Valuation Allowance" } } }, "localname": "SummaryOfValuationAllowanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_TaxCreditCarryforwardAmount": { "auth_ref": [ "r595" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Tax Credit Carryforward Amount", "terseLabel": "Canadian research and development credit carry forwards" } } }, "localname": "TaxCreditCarryforwardAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxCreditCarryforwardAxis": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "Information by specific tax credit related to an unused tax credit.", "label": "Tax Credit Carryforward [Axis]", "terseLabel": "Tax Credit Carryforward" } } }, "localname": "TaxCreditCarryforwardAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Tax Credit Carryforward [Line Items]", "terseLabel": "Tax Credit Carryforward [Line Items]" } } }, "localname": "TaxCreditCarryforwardLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardNameDomain": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "The name of the tax credit carryforward.", "label": "Tax Credit Carryforward Name [Domain]", "terseLabel": "Tax Credit Carryforward, Name" } } }, "localname": "TaxCreditCarryforwardNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxCreditCarryforwardTable": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "A listing of tax credit carryforwards available to reduce future taxable income including descriptions, amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.", "label": "Tax Credit Carryforward [Table]", "terseLabel": "Tax Credit Carryforward [Table]" } } }, "localname": "TaxCreditCarryforwardTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardValuationAllowance": { "auth_ref": [ "r591" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from tax credit carryforwards for which it is more likely than not that a tax benefit will not be realized.", "label": "Tax Credit Carryforward Valuation Allowance", "terseLabel": "Valuation allowance, Canadian research and development credit carry forwards" } } }, "localname": "TaxCreditCarryforwardValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r42" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfAccruedExpensesDetails": { "order": 10030.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Taxes Payable Current", "terseLabel": "Income and other taxes" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Text Block [Abstract]" } } }, "localname": "TextBlockAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r627" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]", "terseLabel": "Trade name" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValueOfIntangibleAssetsAndEstimatedUsefulLivesDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsPreliminaryEstimatesOfFairValuesOfIntangibleAssetsAndEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TrademarksAndTradeNamesMember": { "auth_ref": [ "r627" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trademarks And Trade Names [Member]", "terseLabel": "Trade names and trademarks" } } }, "localname": "TrademarksAndTradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfIntangibleAssetsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradingSecurities": { "auth_ref": [ "r814" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails": { "order": 10030.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Trading Securities", "terseLabel": "Trading securities" } } }, "localname": "TradingSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockAcquiredAverageCostPerShare": { "auth_ref": [ "r408" ], "lang": { "en-us": { "role": { "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.", "label": "Treasury Stock Acquired Average Cost Per Share", "terseLabel": "Stock repurchased, average price paid per share (USD per share)" } } }, "localname": "TreasuryStockAcquiredAverageCostPerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureShareholdersEquityRepurchaseActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r147", "r148", "r149", "r150", "r160", "r244", "r245", "r252", "r253", "r254", "r255", "r256", "r257", "r326", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r603", "r604", "r605", "r606", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r712", "r713", "r715", "r716", "r717", "r718", "r719", "r720", "r763", "r789", "r790", "r791", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r910", "r911", "r912", "r913", "r914" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Type Of Adoption [Member]", "terseLabel": "Accounting Standards Update" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [ "r294", "r295", "r304", "r305" ], "lang": { "en-us": { "role": { "documentation": "Identification of the types of restructuring costs.", "label": "Type Of Restructuring [Domain]", "terseLabel": "Type of Restructuring" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsLiabilitiesAssociatedWithRestructuringAndOtherCostsDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsScheduleOfRestructuringAndOtherCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnbilledReceivablesCurrent": { "auth_ref": [], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccountsReceivableAndUnbilledServicesNetDetails": { "order": 10020.0, "parentTag": "synh_ReceivablesNetCurrentAndContractWithCustomerAssetNetCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer.", "label": "Unbilled Receivables Current", "terseLabel": "Accounts receivable unbilled" } } }, "localname": "UnbilledReceivablesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccountsReceivableAndUnbilledServicesNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r570", "r581" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Unrecognized tax benefits balance", "periodStartLabel": "Unrecognized tax benefits", "terseLabel": "Gross unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation": { "auth_ref": [ "r581" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from foreign currency translation.", "label": "Unrecognized Tax Benefits Decreases Resulting From Foreign Currency Translation", "negatedLabel": "Impact of foreign currency translation" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r582" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions", "negatedLabel": "Decreases for tax positions in prior year" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": { "auth_ref": [ "r584" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.", "label": "Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities", "negatedLabel": "Settlements with tax authorities" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r578" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued", "terseLabel": "Accrued income tax interest and penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [ "r583" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.", "label": "Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions", "terseLabel": "Increases for tax positions in the current year" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation": { "auth_ref": [ "r581" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from foreign currency translation.", "label": "Unrecognized Tax Benefits Increases Resulting From Foreign Currency Translation", "terseLabel": "Impact of foreign currency translation" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r582" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions", "terseLabel": "Increases for tax positions of prior years" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": { "auth_ref": [ "r581" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.", "label": "Unrecognized Tax Benefits Period Increase Decrease", "terseLabel": "Decrease in unrecognized tax benefit in foreign jurisdictions" } } }, "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": { "auth_ref": [ "r585" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.", "label": "Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations", "negatedLabel": "Lapse of statute limitations" } } }, "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnsecuredDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.", "label": "Unsecured Debt [Member]", "terseLabel": "Unsecured Debt" } } }, "localname": "UnsecuredDebtMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfDebtObligationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r183", "r184", "r185", "r186", "r193", "r194", "r195" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use Of Estimates", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r592" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance Deferred Tax Asset Change In Amount", "terseLabel": "Valuation allowance increase (decrease)" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowanceLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Valuation Allowance [Line Items]", "terseLabel": "Valuation Allowance [Line Items]" } } }, "localname": "ValuationAllowanceLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfValuationAllowanceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": { "auth_ref": [ "r133", "r134", "r135", "r138", "r139" ], "lang": { "en-us": { "role": { "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.", "label": "Valuation Allowance Of Deferred Tax Assets [Member]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset" } } }, "localname": "ValuationAllowanceOfDeferredTaxAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfValuationAllowanceDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowanceTable": { "auth_ref": [ "r591" ], "lang": { "en-us": { "role": { "documentation": "A listing of an entity's valuation allowances to reduce deferred tax assets to amounts which it is more likely than not will not be realized, including a description of the deferred tax assets for which the valuation allowance has been recorded and the amount of the valuation allowance.", "label": "Valuation Allowance [Table]", "terseLabel": "Valuation Allowance [Table]" } } }, "localname": "ValuationAllowanceTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfValuationAllowanceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationAllowancesAndReservesAdjustments": { "auth_ref": [ "r140" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in valuation and qualifying accounts and reserves from adjustment.", "label": "Valuation Allowances And Reserves Adjustments", "terseLabel": "Write-offs, net of recoveries and the effects of foreign currency exchange" } } }, "localname": "ValuationAllowancesAndReservesAdjustments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccountsReceivableAndUnbilledServicesNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesBalance": { "auth_ref": [ "r133", "r139" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation and qualifying accounts and reserves.", "label": "Valuation Allowances And Reserves Balance", "negatedPeriodEndLabel": "Balance at the end of the period", "negatedPeriodStartLabel": "Balance at the beginning of the period", "periodEndLabel": "Balance at the end of the period", "periodStartLabel": "Balance at the beginning of the period" } } }, "localname": "ValuationAllowancesAndReservesBalance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccountsReceivableAndUnbilledServicesNetDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfValuationAllowanceDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsLiabilitiesAssociatedWithRestructuringAndOtherCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": { "auth_ref": [ "r136" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.", "label": "Valuation Allowances And Reserves Charged To Cost And Expense", "terseLabel": "Current year provision" } } }, "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsAccountsReceivableAndUnbilledServicesNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": { "auth_ref": [ "r137" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.", "label": "Valuation Allowances And Reserves Charged To Other Accounts", "terseLabel": "(Credited) charged to income tax expense" } } }, "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfValuationAllowanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDeductions": { "auth_ref": [ "r138" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.", "label": "Valuation Allowances And Reserves Deductions", "negatedLabel": "Cash payments made" } } }, "localname": "ValuationAllowancesAndReservesDeductions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsLiabilitiesAssociatedWithRestructuringAndOtherCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDomain": { "auth_ref": [ "r133", "r134", "r135", "r138", "r139" ], "lang": { "en-us": { "role": { "documentation": "Valuation and qualifying accounts and reserves.", "label": "Valuation Allowances And Reserves [Domain]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves" } } }, "localname": "ValuationAllowancesAndReservesDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfValuationAllowanceDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsLiabilitiesAssociatedWithRestructuringAndOtherCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowancesAndReservesTypeAxis": { "auth_ref": [ "r133", "r134", "r135", "r138", "r139" ], "lang": { "en-us": { "role": { "documentation": "Information by valuation and qualifying accounts and reserves.", "label": "Valuation Allowances And Reserves Type [Axis]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type" } } }, "localname": "ValuationAllowancesAndReservesTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfValuationAllowanceDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureRestructuringAndOtherCostsLiabilitiesAssociatedWithRestructuringAndOtherCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": { "auth_ref": [ "r652", "r653" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).", "label": "Variable Interest Entity Entity Maximum Loss Exposure Amount", "terseLabel": "Maximum loss on investment for a VIE" } } }, "localname": "VariableInterestEntityEntityMaximumLossExposureAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureAcquisitionsDivestituresAndInvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsAccountsReceivableFinancingAgreementDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureLongTermDebtObligationsScheduleOfVariableRateMarginsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VehiclesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment used primarily for road transportation.", "label": "Vehicles [Member]", "terseLabel": "Vehicles" } } }, "localname": "VehiclesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsNarrativeDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureFinancialStatementDetailsScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number Diluted Shares Outstanding Adjustment [Abstract]", "terseLabel": "Effect of dilutive securities:" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r162", "r172" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number Of Diluted Shares Outstanding", "terseLabel": "Diluted (in shares)", "totalLabel": "Diluted weighted average common shares outstanding (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r161", "r172" ], "calculation": { "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails": { "order": 10010.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number Of Shares Outstanding Basic", "terseLabel": "Basic (in shares)", "verboseLabel": "Basic weighted average common shares outstanding (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number Of Shares Outstanding Diluted Disclosure Items [Abstract]", "terseLabel": "Weighted average common shares outstanding:", "verboseLabel": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.syneoshealth.com/20211231/taxonomy/role/DisclosureEarningsPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://www.syneoshealth.com/20211231/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "stringItemType" } }, "unitCount": 11 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column B))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column D))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column E))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r141": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r178": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r196": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "a", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "b", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r236": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL82887624-210437" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL120254519-210437" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b),(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(e))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r309": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "420", "URI": "http://asc.fasb.org/topic&trid=2175745" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r312": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S65", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629" }, "r379": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r409": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL108322424-203045" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r438": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(l)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(o)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(p)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r519": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "740", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120384911&loc=d3e23163-113944" }, "r569": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r618": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "44", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5558-128473" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6411-128476" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580" }, "r640": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=d3e5283-111683" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "b", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121483254&loc=SL120254523-199619" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r688": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "54B", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=122636397&loc=SL7495116-110257" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r735": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "http://asc.fasb.org/topic&trid=2175825" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123341672&loc=SL120154346-209984" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r762": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r772": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.4)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r822": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r829": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r830": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r831": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r832": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r833": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r834": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(f))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r835": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r836": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r837": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r838": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r839": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r840": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124505477&loc=SL117422543-158416" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r843": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439" }, "r844": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r845": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r846": { "Name": "Accounting Standards Codification", "Paragraph": "7B", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782768-158439" }, "r847": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r848": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r849": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r850": { "Name": "Accounting Standards Codification", "Paragraph": "9C", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=122147696&loc=SL65671395-207642" }, "r851": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r852": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r853": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r854": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r855": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r856": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r857": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r858": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r859": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r860": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r861": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r862": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r863": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=SL117422267-158473" }, "r864": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r865": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.1(c))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272" }, "r866": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r867": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r868": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r869": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r870": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r871": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r872": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r873": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r874": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r875": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r876": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r877": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r878": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r879": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1(e))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r880": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r881": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r882": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594" }, "r883": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r884": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "450", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624" }, "r885": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r886": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r887": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r888": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r889": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r890": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r891": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r892": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r893": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r894": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r895": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r896": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r897": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r898": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r899": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r900": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r901": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r902": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r903": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r904": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r905": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r906": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r907": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r908": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r909": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r910": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848" }, "r911": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "848" }, "r912": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848" }, "r913": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848" }, "r914": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" } }, "version": "2.1" } ZIP 140 0001564590-22-005428-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-22-005428-xbrl.zip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�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�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�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end

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�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